11	labeling is false
1	country. abuse of
1	substance defined in
1	matter of routine
1	fee resources to
1	secondary school, elementary
1	(m) through (u)
2	minimal risk to
2	agency or department
1	subsection (e)(1)(a)(iii) of
3	container for such
1	effect that is
1	temporary scheduling for
1	states, in accordance
1	revise or revoke
1	360c. classification of
1	edible portions or
1	prohibits submissions to
1	pesticides, (ii) food
34	shall be due
1	ulcer. (e) cholera.
1	members willing to
1	proceeding. for purposes
1	drug adulterated under
2	sufficient financial resources
1	private agencies, organizations,
1	order by the
1	(i)(ii) or (ii)(ii),
1	procedures associated with
1	device that uses
1	catfish notwithstanding any
2	section, apply to
2	date under paragraph
2	1, 2012, and
3	establishments subject to
1	intended and offered
1	food that presents
1	security measures to
1	states pharmacopeia, pharmacists
3	development and submission
1	substantive dispute. 
1	panel.  (2)
3	conducted by federal
1	arrestees, probationers, and
1	rule data and
2	(e) exemption of
3	evidence, and issue
1	substantial conformity with
1	law by a
1	title i, 7,
1	person of cattle,
2	facility is necessary
1	case necessary in
1	administration, as appropriate.
1	may terminate any
1	generic drug activities,
1	amounts designated in
1	section 903 of
1	devices of a
8	facility that is
1	(1) or a
1	discussions to reach
1	accordingly. (ii) for
2	pose an unreasonable
3	tobacco product standard.
1	(5) procedurein issuing
1	(a) assistance records;
1	stating why the
2	1057; 
 

1	1997  (1)
1	and, when determined
1	reserve fee under
1	local jurisdiction authorized
3	subchapter ii; (2)
1	entity unless the
1	material the sponsor
3	retail of a
1	illustrating the results
1	percent; and (ii)
1	(ii) request the
1	856. maintaining dru-involved
1	user be disclosed
3	determining, in coordination
1	product until the
1	law, the term
4	distributed by different
1	supervisory function, despite
1	referred shall not
2	individual or $75,000,000
1	use in clinical
6	recommendations; (d) hold
3	jurisdiction specifically to
1	venture, association, corporation,
1	athletes of performanc-enhancing
1	341. definitions and
1	property being destroyed,
1	shall command the
1	disorder, including for
1	(i), inclusive, of
1	primary jurisdiction for
1	human food slaughter
1	
 604. post
1	note 2 of
3	(1) through (6)
6	public health protection
1	substantial equivalence for
1	validity and appropriateness
13	assurance of safety
1	secretary on behalf
1	practice set forth
1	development of any
2	drug application, the
1	reduce drug trafficking
1	material that either
1	commonly known as
2	gross sales or
1	domestic facilities (as
1	showing, for such
1	damages from the
1	premises and to
1	provide for technical
1	importer of cigars
1	shall display in
1	veterinary medicine by
1	(f) and (g))
1	individuals to be
1	198c. transferred
 

2	year 2013 not
1	2008, for purposes
2	qualification package submitted
1	searches, for implementation
1	drug control programs
1	1155. repealed. 

1	evidence shows that
1	(including representation from
1	environment. (d) a
2	examine and inspect
4	processing of the
3	scientific data deemed
1	poison label upon
1	destroyed or returned
1	judicial order to
8	section 812 of
1	(3) promote food
1	defect does not
3	use, or to
3	person may sell,
1	
 360fff6. no-sunscreen
1	activities. (3) to
1	section is in
1	animals and their
1	secretary may directly
1	well as alerts
5	may result in
1	shipment of investigational
1	subjected to fine,
1	title. (e) no
2	increased punishment by
1	separability clause if
3	subsection or section
2	secretary each year
1	(2) confidential information
1	domestic production of
1	communication under section
1	poultry which has
1	contentthe assessment under
1	science advisory board
1	severe psychological or
1	agricultural producers, and
11	made under paragraph
1	action taken pursuant
1	subsection (b). (ii)withdrawal
1	proceeding for enforcement
1	availability of samples
6	procedures and conditions
1	united states, not
1	(ii) conducting surveillance
1	paragraph (2)(b), or
1	(2) includes persons
1	made in accord
1	manner that ensures
2	indole ring to
2	plant where the
2	signed certification, in
4	agrees to the
6	ordinary individual under
2	defined in paragraph
1	350c, 355, 360,
5	may at any
1	persons, vehicles, food,
1	governments; (ii) five
1	(3) substantially equivalent
9	focus of the
1	goods to be
1	deemed acts of
1	validly registered under
3	exclusivity period referred
2	designate to consult
1	proposed index entry;
1	drug samples are
2	schools and early
1	drug, no application
1	(a) subject propertythe
1	required by law;
1	minor use means
2	standards (a) in
1	export without inspectors
1	applicant regarding developmental
1	chapter.  (8)
1	1180. transferred
 

1	drug trafficking through
1	term listed chemical
1	smuggled food and
1	applicationthe term rare
1	protocol, a person
1	packaging and labeling,
1	section for that
1	(or of such
1	systems standards set
1	chapter a certificate
13	year.  (c)
1	adequately ensuring that
1	website, a holder
3	subsection (b) application,
1	(b)(1) the time
4	section.  (h)
5	cartage, and labor
1	processing an active
1	2007, or 120
1	41.  (l)
1	contracts to carry
1	agency authorities or
1	(n) in an
1	secretary or on
1	successor regulations) requires
1	containers; nonconsumer packaged
2	(1) any individual
1	fully establish a
1	writing.  (c)
2	subsection (b)(2) to
33	tobacco product manufacturer
9	(c) of this
6	enable him to
1	cows are free
2	subsection will be
1	electronic health data,
1	673, and 674
1	$65,000,000 for the
1	study objectives and
1	(2) service; intervention
1	controls).  (6)
1	poultry, unless it
2	review of certain
1	drug was found
1	
 679b. pasteurization
1	substance is transmitted
2	confidentiality of information
1	committee (in this
1	substantiated scientific issue,
2	service and without
4	thereof, shall be
1	representatives as they
1	(a) new and
1	(b)(3)(b) of such
1	ris-benefit analysis; (ii)
1	secretary shall, where
1	experienced staff and
1	director any statistics,
2	independent review of
3	jurisdiction of courts
1	
 
 360bbb.
2	import, any dead,
1	needed.  (5)
1	clerical mistakes in
1	successor entity within
1	value to, the
1	articles 19 and
2	take action in
1	 (4) stay
4	treatment investigational new
4	one generic drug
2	respect to changing
1	products or transactions
2	user facility receives
1	privacy of individuals
1	program agencies; (ii)
1	360b(a)(4)(c), 360b(j), (l)
1	antimicrobial class, and
1	special condition for
2	disclose information of
1	schools program that
1	paragraph (1). (iii)
2	carcasses and products
1	antimony, or the
1	paragraph (2)(b)(iv), and
2	period, or because
2	products thereof are
1	(7) training in
1	 (d) state
51	calendar days after
1	including any agency
1	review the annual
1	regulationa food additive
4	fiscal year, prior
2	372 of this
1	clearance; (c) holding
1	(c) any bases
2	food, of a
1	(g) the estimated
3	taxable year, including
3	appropriate notice and
1	combination product, using
1	possessors (a) drug
2	 (ii) certain
6	chemical that is
1	october 1, 2011,
1	drugs as defined
1	labeling if, after
1	request filed over
1	may revoke the
2	 (i) identify
1	recently emerged anabolic
1	customs officer or
1	petitions for mitigation
1	section 45 of
3	evidence is furnished
2	may (for such
2	(2) supervision a
1	commission on narcotic
1	term transaction does
1	trading partners in
1	rico. (2) the
1	powers of the
1	stat. 55; aug.
1	$100,000 to any
2	may not determine
1	committee shall designate
1	
 352. misbranded
1	(i). (viii) for
2	tribes or tribal
1	forfeited by a
1	reviews  (1)
2	may develop a
1	content of tobacco
1	respecting the component
1	limitation the secretary
1	title, certified as
1	licensee or importer,
4	inspected and passed;
1	shall not sustain
1	appropriate response to
2	generic drug activities.
1	(a) when such
2	secretary shall forthwith
1	file them with
1	practicable, assuring that
2	respect to animal
1	distributor transfers ownership
1	(a). determinations under
3	drug means 
1	writing specifying the
1	support or payment
1	appropriate, questions of
1	 (e) specific
1	pharmacy, the experience
2	decision to discontinue
1	contracted or compacted
1	review to determine
1	includes a certification
1	package contains not
3	resulted in the
1	(b) an exemption
1	therefor, with particularity
1	intentional adulteration (a)
2	database of recalled
1	(a) offer technical
1	200b. repealed. nov.
1	requirements of laws
1	purity, and strength;
2	15on the district
1	approval requirements under
1	(2) access to
1	strategy and other
3	supplemental abbreviated applications
1	prescribe medical products.
2	views, that in
1	precise identity of
1	assurance.  (4)
4	product standard established
2	patent issued by
1	training and exercises
1	ethnic minorities. 
1	subchapter shall also
2	committee under section
1	arguments if the
1	(1) employ, hire,
2	fluids and electrolytes
1	specify the period
1	transferred
 
 106,
6	operated by the
1	(2) is packed
1	request.  (ii)
1	(b) compound, mixture,
2	agreement. (
 

3	supplemental abbreviated application,
1	(6) national drug
1	sentence, primary prevention
1	(a). (4) if
1	active, with respect
1	means a serious
3	submission, shall be
7	otherwise made available
2	drug under such
7	chemical, radiological, or
1	drug substance is
3	physical dependence or
1	supplemental abbreviated application;
1	ecalcium to phosphorus
6	inspection of all
1	1991 through 2007
1	(c) weighing any
1	distribution, or possession
1	foundation funds to
1	responsible in whole
3	report for the
3	law for purposes
11	chapter with respect
1	(viii) the number
2	compliance status of
1	2011, involving fruits
1	feasible regarding such
5	distribution of any
1	technical assistance, as
1	ending eighteen months
2	meet any other
1	exception to the
1	(c) denying the
1	threats in specific
24	drug or substance
1	swine, or goats
2	members a representative
4	program.  (b)
2	therapeutic category in
1	cooperation in development
2	designation upon such
3	secretary.  (h)
1	
 379aa1. serious
1	 (c) fishing
1	competitive bidding procedures.
1	(a) compromise the
5	prescribe or administer
1	civil procedure to
1	therapeutic value; (ii)
1	(m) fees 
4	legally responsible for
1	produces for that
2	submission submitted on
1	class for the
1	(iii); and 
1	drug application filed
1	gathering data related
1	1-yea-olds. (3) casual
4	order by registered
1	 (3) content
2	budget submission for
1	(3) dru-free communities
12	may file with
1	secretary would have
1	fifra to the
1	ii if the
1	existing additive, or
1	advisory letter, or
1	thereof, other than
1	indications for nicotine
1	substance, or a
1	administrative medicine, engineering,
6	approved pursuant to
1	documentation from their
1	person has participated
1	(1) describes the
4	audits of eligible
1	produced shall be
1	bodily member, organ,
1	major species. (pp)
1	applicant who makes
1	year a detailed
4	subsection (a) is
1	(v) an assessment
2	may report to
2	distributor from product
1	united states prompt
2	research; discretionary and
1	date the act
1	inspection to monitor
1	risks from aggregate
1	appropriations act or
1	public dissemination. (2)
1	person. the presiding
1	brought and the
1	purity and quality
2	sponsor who seeks
1	requiring such individual
2	requests for waivers
2	regulations required by
2	5, for each
1	reasonably be obtained
1	control of psychotropic
1	(3) existing online
1	fees were not
1	notification required 
1	food supply chain,
1	womens participation in
1	
 
 149.
2	use proposed by
1	panel and other
2	injunction or restraining
1	conclusions concerning the
13	carcasses, parts thereof,
1	attorney general, subject
1	regulation requires; (7)
1	consequence assessment and
4	product not in
1	products so processed
1	379j43(a) of this
1	designates as materially
2	equivalence between a
1	title by failure
1	guidance entitled deciding
8	fill of container
1	court pursuant to
1	disapproved, the secretary
4	mislabeled, or deceptively
1	unannounced; (ii) a
1	regulations thereunder sufficient
1	debarment shall commence
2	website under subsection
6	advisory committee for
1	report, or premarket
1	termination of institutes
2	(iii) any other
2	report or notification
2	medicine and advanced
2	packing, processing, preparing,
5	section of this
1	360fff3(a) of this
1	ordered under this
2	isomers or 500
1	permit such access
1	toxicity of the
1	border protection, as
2	sale, purchase, trade,
1	governments; and (g)
1	inventory shall be
1	confectionery by reason
1	consumer per day.
9	state, local, or
1	suspension  (1)
1	facilities, the secretary
1	except in connection
1	business where egg
1	(b) penalty whoever
1	reported in accordance
1	memorandum; (ii) the
1	identity and quantity
6	article or its
2	section 3551(b) of
2	label, poster, sign,
1	section is effective
1	duties the following:
1	manufacturer:  (i)
1	submit concerning any
2	particular activities for
1	(a) small business
1	(b)(1) because no
1	processes for coordination
1	immediately transmit the
1	-month exclusivity period;
1	explanation that ensures
1	sell any of
1	 (3) renewal
2	regulations in accordance
9	provide a reasonable
1	quarter (including such
2	holder shall submit
1	food, submitting entries
1	(3) any substance
2	product, the drug
1	consumer interests, and
1	service to collaborate
1	extend to the
1	enforce section 331(q)
1	chapter; (2) require
1	exported of such
1	amounts as may
1	title requiring a
1	360c1. reportingthe secretary
1	necessary.  (g)
1	things of value
1	467b. seizure and
1	refuse, withdraw, or
1	prehearing order to
1	agriculture, or (2)
2	30 days in
1	article, as described
1	fee established for
1	agriculture, shall conduct
1	address engaged in
2	evidence (other than
2	(a) through (e)
6	period for comment
1	following an evaluation
1	agency meet the
1	contains their salts,
3	administration through the
1	request, unless 
10	title or the
1	effects of freezing.
1	paragraph (2); (6)
2	applications, investigational animal
2	distributor means a
1	statements, throughout the
1	2009, if, on
2	et seq.] to
1	4, 2011, for
2	manner, and including
1	(ii) consents to
2	(2) contents of
2	objectives for the
2	schedule v, such
1	(i) of the
2	milk by any
1	framework shall include
1	(iii) an additional
1	abuse treatment; and
1	september 30, 1979,
1	recall or take
1	technology the report
1	listed, or how
1	determination on the
1	preclinical tests or
1	thereof, given with
1	c to distribute
2	directly thereon or
1	subsection (a)(1) with
4	secretary may consider
3	potential risks of
2	dispenser under this
1	secretary the results
1	priorities on a
1	faith the food,
1	action against it
2	person has submitted
2	title to a
1	executive, legislative, or
1	packages or containers
4	(c) and (d),
1	secretarys requirements necessary
2	commission or by
1	medically appropriate) deemed
2	categories:  (a)
1	denies, in whole
1	tentative approval by
2	subparagraph (a)(vii)(iv) shall
1	committee. (3) summaries
1	661(b) of this
1	comment rulemaking) or
1	alleviate or avert
1	distributor of drugs
2	374(g) of this
2	ingredient of food,
1	judge, upon request,
3	referred to it
1	part, or to
1	subsection (d) applies
1	title, unless 
35	controlled substance or
192	referred to in
1	state that relates
2	hearing) that the
1	granted accelerated approval
1	forth proposed findings
1	reached under subclause
1	360(k)(2) of this
1	 (c) secretary
1	fresh produce under
1	congress believes similar
2	application shall, insofar
1	2011, and shall
1	distribution.  (a)in
1	refined oil. (b)
2	approval supplement fee
1	recordkeeping regarding previous
1	(a), (g), (h),
16	[42 u.s.c. 201
1	(1) the holder
1	congressional notification the
1	stated in this
1	(2) changes qualifying
1	chemical.  (3)
1	persons, company or
1	adults; (2) to
2	(1) a food
2	service of process.
1	coordinator shall provide
1	service of process,
1	steps or actions
1	subsection (f). the
3	advisory committee meeting
1	indian tribe has
1	 (1) biomarkerthe
1	housing, or other
2	accessed, as would
1	service of process;
1	discussion of the
1	receive data from
7	life, a fine
1	subsection (c)(2)(a)(i)) or
1	data  (i)
1	public, scientific, public
1	sentence for manufacturing
2	designated upon such
1	metazocine. (11) methadone.
1	3 years, and
1	drug application, to
1	official compendiums within
1	controls, including at
2	account the harm
1	387f(e), 387g, 387k,
1	abbreviated applications, generic
1	trial have been
2	classified such device
1	system for dietary
3	identifiers to enhance
1	confectionery if the
1	leishmaniasis. (k) leprosy.
1	involved the commission
1	additives, and the
1	review that (1)
1	regulations. the secretary
1	provide for advisory
2	accordance with methods
1	(a)(1), (b), (c),
1	sterilization, or labeling,
1	879. search warrants
1	sections 247d6, 247d6a,
1	area; and 
1	participation of qualified
1	quality of regulation
2	maintain establishments in
1	 (b) blocking
2	product identifier information
2	treatment means the
6	sale on such
1	probable cause means
1	separate applications for
1	counterfeit substance; (6)
3	will be made
1	(
 
 886.
1	enforcement activities; and
1	food sector and
21	collected and available
1	1, 2009. until
1	(a)(1) to prepare
1	title. (8) any
1	retained in an
1	holding), except that
1	material, which advocates
1	(b) for its
1	467e. no-federal jurisdiction
1	30, 2003, for
1	residue at which
1	womens health professionals
2	subsection (e)(1) to
1	completion. (2) 
1	(a) oxygen that
1	development, approval, manufacturing,
2	misbranded while held
1	administer the accreditation
6	days after november
1	(p), shall be
2	compliance  (a)
1	consideration shall be
1	safeguard to protect
1	 (u) the
1	paragraph (2) have
2	period would, but
1	earliest practicable opportunity
1	inspection of carcasses,
1	authorities necessary to
2	report entitled food
1	(b) identify gaps
1	governments  (1)
1	lawfully maintained a
1	general, on his
2	exclusivity under clause
1	advance by appropriation
1	 (e) fee
1	tobacco regulation activities
1	(ii) meeting request
1	question. in any
1	(b) include, with
1	(i) no such
1	manufacturers or the
2	products by individuals
1	facility (a) authority
1	seller shall ensure
1	18; (c) with
1	
 
 335b.
1	675, 508, as
1	applicable to officers
1	regulation is issued
1	(a) overtime and
2	proposes to begin
1	both. (ii) if
1	considered for accreditation
1	measurements. when developing
1	assessment  (a)
1	(a) accelerated approval
2	smokeless tobacco product
1	subsection (a), its
1	enhanced aquaculture and
1	2015 under paragraph
4	maintain the equilibrium
1	usual product of
2	(b) contents of
2	 (b) on
2	disruption or dislocation
1	developing combination products;
1	provided in title
1	facilitys registration number,
2	processor, or packer
1	1-day period, qualify
2	network of the
1	examination the secretary
1	section 2003(b)(7) of
1	devices, as the
4	(c) there is
1	authority; (4) has
3	recommended or suggested
5	submitted to him
2	title shall also
1	trafficking area, if
1	inspection to allow
1	felony, and, upon
2	52 stat. 1054;
1	chapter; (d) if
1	trafficking area, in
1	(3) extension the
1	shall have served
1	states. (f) notice
1	living animal; or
2	acting contrary to
2	secretary within the
1	territories shall have
1	(viii) for a
1	effectiveness, unless such
8	379aa1 of this
1	time, after due
1	percent. (11) the
1	using such lane,
1	care delivery system
1	 (d) withdrawal
1	evaluation; application approval;
4	proposed by the
1	 (3) clinical
1	forfeitures (a) property
1	ongoing, and highly
1	preventing the spread
1	notice identifying such
2	permitted by law;
1	(c)(3)(d) of such
4	commencement of proceedings
1	semblance of butter
1	order was based
1	establishment that such
4	impossible or highly
1	may transport said
2	identify the article
2	flask, tableting machine,
6	shall be added
3	specify a timetable
1	(h) release of
1	recommendations. in making
2	names by which
2	1,000 feet of,
1	purposes only. 
1	clinical investigations under
1	thir-party auditor satisfies
1	new time and
1	civil action described
1	including published and
1	represented as suitable)
1	possess any punch,
1	(v) changes in
1	exceptions from, and
1	anabolic steroid has
2	program, the director
1	representatives of nongovernmental
1	including those food
1	section 1395nn(h)(4) of
1	facilities the secretary
1	presented in any
1	title, paragraph1 (1)
1	emergency use shall
1	professional designation, the
2	supporting the recognition
1	collected if no
1	prosecution; (c) endanger
1	whose representative, during
1	units produced, and
1	limitationthe secretary may
1	5, require that
1	pediatric research requirements
1	official use or,
1	including aircraft, vehicles,
2	provide oversight and
1	 (g) consultation
1	2012, $477,000,000. (e)
1	(a) shall consult
1	made to coordinate
1	(b) a partner
1	ingredients is later
1	(i) the -year
1	content of oleomargarine
1	 protein (gm)
3	facility that are
1	establishment. (c) consumer
1	manufacturing, processing, packaging,
5	funds received under
1	(o) reprocessed singl-use
2	safety audits to
1	(3) for partisan
1	secret, confidential commercial
1	fact, information, or
1	(e) collection of
2	term manufacture, preparation,
1	appeal is filed,
3	standard described in
1	contaminan-specific and scienc-based
1	group; (iii) the
1	transferring the listed
1	begin 30 days
1	tested before the
1	inapplicability  (a)
1	practicable, segregate the
2	issued file a
1	water act [42
1	prescription drugs that
1	kitchen prepares meat
1	title, by reason
2	continues to meet
1	food after the
1	extend for more
2	food additive that
4	obtained at no
1	(a) awards required
1	means:  (aa)
1	 (iv) to
1	 (a) success
3	paid at a
1	record, summarize, and
1	food the term
2	conveying  (i)
2	label is required
1	had, but for
1	patients that is
2	data and the
3	information from such
1	techniques, valid microbiological
4	affixed or imprinted
1	purpose; or (iii)
2	jurisdiction to enter
1	articles which (a)
15	responsible for the
1	state of such
13	required under paragraph
1	poison label upon,
1	findings are based.
2	part owner, or
1	(c) limitationssubsection (a)
1	informs the person
1	(1) other activities
2	art of manufacturing
1	product establishment shall
1	(i) develop or
2	provides the transaction
1	(1)(b) shall 
1	(aa) considers whether
1	importer), a notice
1	characteristics of persons
2	diversion; and (6)
1	clinical data with
1	interruption in the
1	manufacturers of qualified
1	number of individual
1	subsection (a) vests
1	control point methodology,
1	countermeasures, including specific
3	manner that the
2	quantity and form
1	(b) on an
12	secretary for the
1	fact with respect
1	earliest possible time
1	benefi-risk profile in
4	composition of which
12	may be brought
2	base in a
17	 (i) not
1	disciplines about the
3	funding levels and
6	antibiotic drug described
6	notify the secretary,
1	premises and the
1	year and if
1	private hospital or
1	methylphenobarbital. (9) paraldehyde.
1	industry outreach, interactive
1	direct and immediate
1	section 467b of
1	arguments and for
1	implementing regulations, when
2	regarding reimbursement. such
1	
 467d. administration
1	december 11, 1946,
1	establishment have been
1	supply of such
4	order  (1)
1	food imports including
1	prepared articles, exclusively
1	receipt of gifts,
1	(d) the manufacture
1	employees stationed in
16	general  (a)
1	any) upon which
1	records under section
1	amounts, as adjusted
2	list previously filed
1	includes conditions for
3	petitioner applies to
1	determines causes a
1	final regulation that
2	reason unsound, unhealthful,
1	2013, the fees
1	public health. not
1	(20) racemethorphan. (21)
1	
 1042. reporting
1	initially consist of
5	fined under title
1	effective on such
1	regular reports to
1	(xii) -(-fluoropentyl--(-iodobenzoyl)indole (am694);
7	childhood education program
1	apply for annual
1	court, upon motion
1	identifying an anabolic
1	population that is
5	persons, firms, or
1	unrecognized in compendium
1	distribution of one
1	order; abbreviated applications;
1	nonnarcotic controlled substances,
7	 (3) effect
4	reduction in the
1	advertised drug on
26	secretary, in consultation
3	centum by weight
1	containing a meat
1	specify.  (2)
2	(a) is in
1	authorization). all such
1	needed prior to
1	contain data, gathered
24	remain available until
1	subsection (c) (other
1	356g. standards for
1	 (g) execution
1	increased federal assistance
1	person from whose
1	title. (c) a
1	registration fee 
1	loan repayment program.
1	(a) groundsa registration
1	treasury are managed
1	(f) nonprofit statusin
1	1904. blocking assets
1	notice is given
6	placed thereon with
1	two hundred thousand:
6	(1) consultationin developing
2	advertisement for a
1	(1) as used
1	satisfactory performance bond,
1	(i)) have been
1	(i) requiring that
1	that, subject to
1	gases a designated
1	order on that
1	imports such that
2	medical reasons, including
1	review, or licensing
2	consortium of laboratory
2	may appeal to
3	substituted in the
2	approved, (b) if
1	outbreak; (c) identify
1	policies, including ethical
1	services programs. (i)
1	five days of
1	implement the list
3	section. (5) offsetting
1	exportation of an
1	year 2017. (j)
1	(a) application fees
1	inspections by persons
1	360fff3(c) of this
1	either affirm, modify,
1	board, acting pursuant
5	transportation in commerce
9	daily equivalent of
1	within such 10
5	approve or disapprove
1	request the basis
5	shall respond to
1	refund of operating
1	characteristic of any
1	legitimate medical and
4	sold, less the
1	(2) public meetings
1	funds described in
1	agriculture in advising
1	calendar year 
3	(bb) the date
1	registered (or is
1	may grant such
1	medical devices. the
1	consumers and farmer
11	otherwise than by
1	budget  (1)
3	waive the requirement
1	contains the same
1	intent thereby to
1	(a) appropriate credentials
2	scheduling of a
1	secretarys formal written
2	separate review or
1	section. the requirements
1	title when such
4	time as may
1	recreation of children
1	applicant agrees to
1	failure and subject
1	logistics provider provides
1	41. (h) report
1	sufficient to resolve
1	individual patient a
1	504, as added
27	submitted by the
3	secretary may refer
1	360bbb1. dispute resolution
1	development (referred to
1	ch. 675, 905,
1	applies.  (5)
1	wholesale distributor, and
3	designed to ensure
2	large volume parenteral
1	equivalent product which
1	executive board that
1	requirement for tolerance
1	practicable after receiving
1	accepts the letter
1	parts thereof thus
1	types of direc-t-consumer
1	financial information, or
1	analysis may be
3	means a voucher
1	(2) variances 
1	violations of subchapter
1	october 1, 2021,
2	efficient manner consistent
3	similar to the
2	(1) a person
1	establish, and maintain
3	impact of drug
1	public health, whenever
1	comment pursuant to
3	track product 
5	report concerning the
1	dietary risk. (6)
1	meat items under
1	public  (a)
1	(3), a drug
2	grounds therefor, and
1	distributes a reportable
1	facilitate judicial review
1	medical gas subject
1	request.  (i)
1	purchasers to criminal
5	f.r. 2053,67 stat.
1	 (2) allocations
4	year because of
1	established an advisory
1	united states; (ii)
2	characteristics as the
5	inspections to be
1	use. (b) potency
1	ensure that task
1	enhance intergovernmental cooperation
1	maintain, in conformity
1	(4) has committed
2	provide such inspection
2	notice of warning
1	dietary supplement involved
1	-year term. (2)
4	also, after due
1	labeling or marking
1	product; (e) had
1	regularly or in
1	outside expertise to
1	applies shall not
3	product would result
1	foundation.  (f)
1	administration to 
2	title, unless the
1	banned device. (b)
2	 (d) prohibition
1	act, cancels the
1	petition. if an
1	administrator and stating
1	easily accessed and
1	transshipped from one
1	efforts among national
1	9 shall be
1	guidances without appropriate
1	research subject whose
1	requires by regulation
1	final product stage,
2	drug is being
1	ch. 675, 521,
1	procured, and the
4	conditions associated with
1	 (m) depositions
1	guidanceirrespective of whether
3	subsection shall prevent
1	basis during the
1	shall establish at
1	destruction and exportation
19	 (a) any
2	accountability act of
1	specific efforts taken
1	final product, if
2	(1) general rule
1	submitted and include
1	minor violations nothing
1	discovery and development
1	imported for slaughter
1	revert to the
4	maintenance and inspection
1	agencies having responsibilities
2	individuals who, as
2	animal drugsthe term
2	data and information;
1	(c)(1). (3) if
1	general shall publish
2	meeting a sponsor
1	part approved under
1	health professionals. 
1	paragraph (2)(a)(vii)(iv) for
2	certification the court
1	applicable; and in
1	exemption of substances
1	control strategy (a)
1	immediate container. (u)
5	data and information,
1	developing and applying
1	filed for orpha-designated
1	adjustment percentages were
1	title 42; (xii)
1	medical center that
2	electronic product refused
1	(d).  (c)
3	systems, including information
1	limitation the fees
4	secretary has approved
1	united states desiring
1	becomes available. 
1	violated section 331(t)
1	employees of state,
1	drug manufacturing equipment,
1	thereafter issue a
1	business of 
1	2003 to 2007,
2	public interest (as
2	body for which
1	civil penalty by
1	nomination of individuals
2	appropriate committees of
1	sizes and capabilities
1	reanalysis of the
22	secretary under paragraph
8	poultry products for
1	written petition praying
1	19, formerly 17th
13	manufacturer of such
8	connected with the
1	subsection (d)(1); or
1	consistent food laboratory
2	bribed or attempted
1	notice is required
1	toward automatic electronic
1	refunded from the
1	also visible and
1	injected drug; (e)
1	recipient has its
1	termination of programwith
1	serving bears or
1	identify opportunities for
1	funds used to
1	constitute such selection
1	$100 or by
1	named in this
1	substance not be
1	(c) endanger the
1	(3) for having
3	(e) no effect
1	food, meat, or
1	(8) to create
1	responsible party shall,
1	acts; penalties it
2	medical information related
1	containers; legible form
1	(a) the receipt
1	registration by foreign
1	packaged products, to
2	opioids or methamphetamines,
1	date an order
1	nonprofit food establishments
1	(2) each agency
1	insurance act (7
1	review of international,
1	effect or modify
1	year 2008, 150
1	adjustment and publish
1	review committees concerning
1	paragraph is not
1	exhausted, or (d)
1	finding and include
1	apply where condemnation
1	1992, does not
1	507, as added
1	device, (2) the
1	revoke the qualified
6	secretary shall convene
1	provided services in
1	(1) that clinical
10	(c) in the
1	practice. (b) for
1	provide, directly or
2	imported by him
4	percentage of the
1	agriculture. (mar. 4,
1	administration gifts or
1	food, offered for
1	(a) produced during
1	force program the
5	device, or biological
1	records obtained or
1	(v) the written
28	manufacturer or distributor
1	bulk or commingled
1	subsection (c), make
1	379d. automation of
1	mixed rots (addled
5	meeting to obtain
1	1991, and such
1	activities; designation of
1	obligated by 
1	committee; or (2)
1	food. (3) reports
1	accompanying the item
1	district of entry.
4	may be restricted
1	 (e) request
1	regulations, will be
1	section 830(e)(1) of
1	thereof is not
1	shell eggs; (2)
4	unless the applicant
2	fluids and electrolytes;
1	subpopulation can be
1	article is from
1	egg production from
1	 (b) plants
1	time the request
1	seq.) with respect
2	modify, or terminate
1	encourage the submission
1	 (i) 60
1	secretary has additional
2	previousl-paid carry over
1	unduly restricted; (b)
1	including working toward
1	(1), if a
1	subsection (a)(4)(a); (b)
1	otherwise, to enable
1	4461544618). such rule
1	domestic animals, unless
1	security, and state,
1	coalition shall, with
1	accepts such qualification
2	water unless the
18	described in subclause
2	shall exempt pizzas
1	proposed advertisement with
1	seal, which shall
1	 (3) reporting
1	class ii, or
1	requests in a
1	559, 1, 68
1	process any egg
1	effectuating the wholesale
1	 (a) annual
1	chapter; location of
1	academia, and other
2	requests made under
3	distributor of such
3	alcohol and tobacco
3	qualifies for the
1	(xii) other organizations
1	agent thereof. 
1	(j) the using
1	
 350l. mandatory
2	application otherwise meets
4	(ii) the clinical
1	(
 
 846.
1	(b) revise the
1	plan earlier than
1	administration to better
4	824(c) of this
1	narcotic drugs the
3	clearance, or licensure
1	restaurants in the
1	reinspect eggs and
1	make a certification
1	(22) united states
1	product radiation; (3)
1	person: provided, however,
2	member of his
1	action by secretarythe
1	exportation under section
1	paraphernalia, in addition
1	risks; and (ii)
1	(2) devices that
3	pay to the
1	distributor did not
1	respecting the assessment
2	 (c) state
1	initial advisory review
1	354(a)(3)(a) of this
1	subcommittees, or community
1	(h) whether the
3	subsection (b) application.
1	poultry are slaughtered,
1	subchapter to a
1	envelope utilized in
1	agencies, relating to
2	exemptions, or reductions
1	applicable list pursuant
1	violation or violations
1	smuggled food; (2)
1	 (a) does
1	regarding exposure to
1	(a) 1 kilogram
1	october 30, 1998:
1	2003, the comptroller
1	operating expenses of
1	(c) evaluation of
1	performance of duties
1	(1) has actual
1	recommendations on any
1	-(-naphthylmethylene)indene by substitution
1	resources (including community
1	secretary.  (v)
1	150 by $27,600
1	united states, so
1	(4), a local
1	drugs, with respect
1	name, address, professional
1	enhancement grants to
1	date of enactment)
1	applicable legal protections,
1	rata fees assessed
2	labeling or published
1	repackaging as the
1	used solely or
1	eggs, musty eggs,
2	delay such designation
1	managerial agent 
2	proceedings and other
2	grant of a
1	transferred
 
 851.
1	person had a
3	necessary for that
1	committee shall provide
1	title. (f) duration
2	including the enforcement
2	offer to purchase,
1	affect the responsibility
1	identify the facility
1	shall possess in
2	due notice, as
1	(u.s. city average;
1	(2) operating reserve
1	time following such
1	written materials which
1	to, food allergies
1	(f) program to
1	sources and the
1	title report a
2	(ii) the establishment
2	cost of developing
1	(f) the secretary,
2	food manufacturer, or
1	providers. (s) referral
1	477; 
 

1	unapproved therapies and
1	appropriate. an article
3	implement comprehensive communit-wide
2	that, prior to
2	responsibilities relating to
1	(a) requirement for
2	drug administration. (c)
1	performs staff work,
1	firm with expertise
2	assessments for a
1	identification of suspicious
2	underlying data, and
2	specifying the reasons
1	568, as added
1	corporation, and association.
1	ingredient that contains
1	(7) subsequent reports
4	directive drug shall
1	media campaign; (3)
1	product fees the
1	later fiscal years
1	(v) ensuring consistent
2	shall deliver to
2	secretary a petition
1	programs,[1] and schoo-sponsored
1	information in those
2	completed within the
1	analytical methodology. no
1	submissionbeginning 180 days
1	shall certify and
1	special registration 
1	section 343(e)(1) of
4	secretary shall adjust
1	state shall regulate
1	benefits to patients;
1	established for reducing
1	perform advanced research
1	time for initial
1	significant public health
4	(including underlying scientific
2	promptly as possible,
1	exemption prescribed by
1	controversy, the secretary
4	review of applications
1	record with it
1	paragraph; (6) for
2	label if any
1	action shows, by
2	law, a sponsor
4	materials or products
31	established by the
1	impose sanctions 
4	(b), and (c).
1	controlled substance, increase
1	(b), and (c),
1	criteria issued by
1	including the earmarking
1	(b) in this
1	general the safe
1	revenue amounts for
1	use by federal,
1	tobacco product manufactured
2	known or otherwise
7	sum of all
1	normally sterile areas
1	leaf other than
1	(1)(b)(i), a food
1	precursor and places
1	initiative or a
1	products under accelerated
2	administration; and (b)
1	designated representatives. (5)
1	facility shall establish
2	persons under this
2	quantities that do
1	withdrawn under paragraph
2	drugs  (i)
2	qualified acceptance was
1	section 355(k)(4) of
2	notice was accompanied
1	subsection and waives
1	restrictions established by
1	produce under the
2	united states (except
1	attorney general control
1	sponsor disseminates false
5	recent federal income
1	techniques, and potential
2	causes a food
1	(1)(b) within such
14	tobacco product that
1	(h) written plan
2	diseases (a) definitionsin
2	becoming final, all
1	procedures imposed on
1	determination a written
2	available for reference.
1	(b) coordinationwith respect
1	abbreviated application. (june
2	pharmacy and medicine
1	(b) statement not
1	products are processed.
1	
 
 613.
1	injurious to health.[1]
2	designated unless the
1	administrative costs related
1	individual agrees to
1	practice, testing results,
1	matching requirement subject
2	commerce, unless naturally
1	around the world;
3	product; or (iii)
8	 (1) that
1	(2), consideration of
3	1938 (52 stat.
1	comply with other
1	inspections to detect
1	information acquired in
1	emission tomographic diagnostic
1	denial information any
2	inflation adjustment to
5	drug control policy.
1	section 1334(c) of
1	tracing  (1)
1	prior to filing
1	(2) any restrictions
1	major programs and
3	listed chemical to
4	fiscal year 2012,
1	26, 2014, an
1	heroin, methamphetamine, ecstasy,
1	decision.  (o)
1	term wholesale distribution
1	pharmacist the term
1	information which he
1	kept and be
1	(b) bond if
1	subsection (i)), be
1	spring, stream, river,
1	supplement fee failure
14	meets the criteria
1	reduction in quota,
6	recognized therapeutic amounts.
2	promptly supplied by
1	28, except that
1	online pharmacies 
1	submitted; (4) the
1	(1) only if
1	sexual conduct; or
1	drug application. (c)
1	limitation. the secretary
1	uniformity and reliability
3	director in the
1	information programs relating
1	compensation of a
2	government agency with
1	agency, the bureau
1	 (c) limits
1	notice of production
3	respecting a tobacco
4	(c) annual fee
1	sunscreen means a
1	prior order shall,
1	providing  (i)
1	secretary has become
2	time, manner, and
2	recommendations the report
1	access is freely
1	red, measured in
1	sections 952(a) and
4	jurisdiction may impose
1	operator or agent
1	impact statementthe head
1	nicotin-based and no-nicotin-based
2	transported in the
1	inspection effectiveness by
1	substance abuse information
1	entities; application 
2	judicial review commission
1	personal property or
1	literature; data derived
1	commerce; (b) are
2	administration pesticide program
1	4, 44 stat.
1	classify such ingredient
1	(
 
 2225.
1	fees (a) in
1	subsection (d)) provide
1	receiving funding from
1	(2), initiate the
1	total abstinence from
2	for, and other
1	kept under section
1	personal property of
1	constitute the unauthorized
1	facility will utilize
1	diverted to obtain
1	therapy prior to
1	(c) transparency 
3	(ii) fiscal years
1	section 262(i) of
1	priority review; (c)
1	shall be regulated
1	basis for forfeiture
1	studies under the
2	title or issue
2	developed without assistance
1	meat articles that
1	astated per 100
1	alcoholic beverages the
1	5with regard to
2	program for addiction,
2	true and accurate
1	achieve each goal
1	tobacco product; (ii)
1	prior notice system
1	title 5) on
1	contain all of
1	labeling of medical
5	et seq.) or
1	services that (1)
1	informationin selecting data
1	functions the functions
1	production cycle and
2	may safely be
1	states originates. the
1	proceedings in admiralty;
1	 (2) deadline
1	director while serving
1	contract, memoranda of
1	prohibited.; (2) except
1	(1)(a)  (a)
1	isomers; or any
1	center shall conduct
2	obligated for grants
1	 (2) deputy
1	(v) publicly available
1	funds made to
1	agencies and representatives
1	year 2017 exceeds
1	675, 511a, as
1	hazard to an
1	secretary. (c)contents.an action
1	section, and an
1	identification of products
1	hearing, each party
1	protection that the
1	compensation (excluding expenses)
1	
 387l. judicial
1	states against infectious
1	future programs and
1	auditors  (1)
1	 (c) prior
1	(2) has not
2	records (including books,
1	tracingfor a product
1	exigent circumstances require
1	abuse during the
1	cheese transported into
1	describing the rationale
1	jurisdiction, with respect
1	conducted and submitted
1	mitigate the increased
1	general in lieu
1	(c), implement the
1	usually supplemented with
1	section 372(a) of
1	section 387e(h) of
2	(c), for a
1	wel-equipped and staffed
1	use or through
2	beginning 3 years
1	combination product. (ii)
2	(a) the state
1	subpopulations, the secretary
7	requirements:  (a)
3	rest of the
1	grocer), the following
1	device, if a
1	integrity or success
2	conducted at retail
1	1999, the commissions[3]
1	programs (a) enhanced
1	meat inspected by
1	expired, damaged, or
2	establish and publish
1	request does not
1	(6) to possess
1	critical reprocessed singl-use
1	date the application
1	consult with, and
1	omitted
 
 101.
1	amendment to the
3	establishment for the
1	annual basis, not
1	anticoagulant; (vi) a
2	healt-related event associated
7	authorized representatives of
1	data required for
1	general shall consider,
2	often than every
1	study under subparagraph
4	information nothing in
6	(1).  (3)
1	heads, or punctured
1	nonvoting members. 
3	pending hearing and
1	reimburse the drug
2	specified in paragraphs
1	prescription order that
1	monograph, if such
1	diseases; (4) the
1	controls, and sourcing
1	of, or serious
1	preceding sentence unless,
1	commerce, any carcasses
1	confidential information obtained
2	identifies the number
6	new medical information
1	employees; reimbursement the
1	title and has
1	(9) licensedthe term
6	patent information under
1	(b) labeling changes
1	regulating the production,
1	switzerland, or south
1	$652,709,000 plus the
1	owner or importer.
1	(1); or (ii)
1	addressing such needs,
1	type of facility;
1	prosecution for possession,
1	paragraph. (b)timing of
2	obtained under paragraph
1	(i) shall ensure
6	continue to be
1	(aa)in general. 
1	specified for purposes
2	generally. it is
1	subclauses (i), (ii),
1	documentation of rationale
4	suspect product, a
1	will potentially present
2	(c) the types
1	distributor will use
1	posting of adverse
2	(f) whether the
1	older than 18
1	qualified facility 
1	foods the recordkeeping
4	data related to
1	large retail grocers
3	kills any person
2	export to any
1	practices for dietary
1	develop a peer
1	exemption; or (iv)
7	shall be carried
1	302, 304, 402,
1	administration, and provide
1	525 (2001)); (f)
1	significant no-implant applications;
1	promulgate the national
2	ingredient, combination of
1	within a rapid
1	manufacturer shall commence
9	tolerances and exemptions
1	evidence needs to
10	regulation under this
1	360d. performance standards
2	selection or alteration
1	(in a standardized
1	action no private
2	recommendation of such
1	preparing, freezing, packaging,
1	quality regulation shall
1	took final regulatory
6	approved for use
1	formulation for such
4	partner to disposition
1	(b) and if
2	regulatory commission or
1	waters within a
1	protection of such
1	1604(b)(2)(b) of this
3	agency to the
1	extension that 
1	debarments.  (f)
2	made or caused
1	amounts of $6,250,000
1	foundation under this
1	ch. 675, 756,
1	effective period; renewal;
3	provide for periodic
1	patent term extension
1	recall authority under
1	(8) rules of
7	prior to approval
3	necessary to establish
1	ch. 273, 5,
1	product or device,
1	may a drug
3	subsection has been
1	substances.  (e)
9	index listing pursuant
1	ch. 273, 6,
1	persons arising out
2	reporting, and production
1	proceedings) and the
1	thereafter, a facility
1	(a) that represent
3	required in order
1	appropriate state agency;
1	drug users shall
2	response  (i)
1	reimbursable basis, such
4	secretary, if applicable,
1	projections of expected
1	reasonable limits, and
3	substance may lead
14	national institutes of
1	year 2018. such
1	interested stakeholders. (b)
1	tribes.  (6)
2	application for licensure
9	designated under section
1	color additives) for
1	(b) standards development
4	determination of safety
1	artifice, or extracted,
1	withdrawn.  (d)
1	number of a
1	directly, or pursuant
2	single agency in
1	using ingredients (other
1	label in accordance
1	section 897.16(d) of
1	use or other
1	considers appropriate. (k)
1	animal drug but
1	united states on
1	114 to 114d1.
1	signs a settlement
2	importer is exporting
1	confidential, commercial information)
2	master file, the
15	united states of
1	consolidated food and
3	action as may
1	respects to such
1	transmit a copy
1	(c) the information
1	camouflaged device designed
2	respect to persons,
1	betacetylmethadol. (8) betameprodine.
1	$6,944,000 for fiscal
1	considered a minor
1	type. the requirements
1	manner, taking into
1	(b) chief scientist
1	technical assistance concerning
1	export to and
26	united states or
1	create a chemical
2	organization that the
1	product reduces risk
2	private agencies, institutions,
1	designate the optional
1	centers related to
1	will be met.
1	samples will be
1	 (ii) crediting
1	constitute a threat
1	prescribe)  (1)
2	name or a
7	drug administration 
1	clear written policies
1	product was commercially
1	273, 3, 37
1	consult such external
1	review must be
5	trade names under
1	(b) exceptionsif an
1	established through regulations
1	general thirty days
6	commodity or processed
1	issue if a
30	appropriate for the
2	(ii) the product
1	subsection in his
1	 (ii) enhanced
1	article.  (f)
2	compel compliance with
3	title (including, for
1	standards with respect
1	selling (as poultry
1	council.  (2)
1	803 in order
1	less than twent-one
1	evidence, based on
2	distributor, under which
2	least 120 days
2	(b) investigate the
4	contractors; (b) management
1	grant received under
1	provides the same
1	veterans affairs shall,
2	 (e) public
1	products made subject
1	body, that revocation
1	authorization of secretary
2	license; and (ii)
1	preliminary order providing
1	placed; or 
2	persons and the
1	investigational use for
1	intelligence program, and
1	section 387f(e), 387g,
1	grant funding to
1	(c) provide an
1	unless, such elements
2	prosecute organizations and
1	(9) a regulation
1	submits such application
1	675, 919, as
1	reductionthe secretary shall
1	article was processed,
1	adding such drug
1	2013, verifying the
1	drug but at
1	(b)(2), that is
2	means an audit
1	requirements shall not
2	items that are
2	facilities, and equipment
2	application, shall be
1	applications acted on
1	801 of title
1	[42 u.s.c. 247d6b]).
1	cigars, all pipe
1	(
 
 1051.
2	therefor.  (e)
1	manufacturing practices under
2	interstate commerce immediately
1	fraudulent means or
2	prescribed under the
2	assembled in an
1	(a) a medical
1	compendium, except that
1	states was statistically
1	exacerbate a shortage
1	office; or (b)
18	exemption from the
1	customs custody, the
1	secretary declaring such
3	singl-use device that
1	required for applications
1	believes that more
2	panel by the
1	regulations).  (d)
1	stop or a
4	intelligence and the
2	different withdrawal period
1	usage of various
1	 (d) accounting
1	consideration the impact
1	state receives notification
1	 (1) grant
5	year 2014, not
1	general is readily
1	secretary may report
1	use, on a
2	(b) method of
1	(c)recipients of notice.an
1	section 16. (6)
1	recommendations as confidential
1	active ingredients; and
1	states, and to
1	changes in poultry
2	requiring the appropriate
2	law based upon
3	label containing the
1	recipients, recordkeeping, periodic
1	prescribing, or amending
1	sponsor; preconditions; rare
2	upon such notification;
1	register; (ii) providing
1	ch. 675, 914,
1	chemical substance which
1	meeting is made.
1	2020, is designated
1	bear or be
1	costs; availability of
2	administrator has determined
1	i, to such
1	intelligence shall prescribe
1	previously cleared device
1	package sizes and
1	facilities that solely
1	anticipates will be
3	responsible for reviewing
2	required under any
3	committee, the secretary
1	upon such notification.
1	human consumption determines
2	regulation may take
1	title, including requirements
1	convened by the
2	control act occurs
1	egg products is
1	be. (2) an
2	medical convenience kit)
1	regulations). (e) evaluation
1	rejections of plants
1	(l)[1] agreement between
1	convention.  (f)
1	priority to the
1	technology and software
1	means testing 
3	subsection prior to
1	stockpile; (d) feedback
1	harassment, reprimand, retaliation,
1	practices; (b) outlines
1	secretary has reasonable
1	(dd) individualized treatment
1	verification program established
1	continued until pseudorabies
2	nmic and council;
1	contexts; (2) establish
1	healthy poultry or
3	requests for waivers,
1	regulations may, in
77	secretary finds that
1	upc, sku, or
4	filing in such
1	nmic and council.
1	device; (ii) determining
1	(
 
 1708.
1	services.  (10)
2	discontinuation of the
1	(1) unapproved product
5	registration  (1)
1	 (e) nonnarcotic
16	failure to pay
1	fas-track designation under
1	tribal governments towards
1	criteria the director
1	quantity exceeding the
2	final, and if
4	scientific evidence that
1	knowledge or reason
1	person presiding over
2	narcotic drugs, the
1	training, as well
1	(3) procedure in
3	 (i) set
1	articles; validity of
3	terms pesticide chemical,
1	
 202. certain
1	academia, medical professional
1	summoned for a
2	biennial review and
238	 (a) the
2	 (2) rules
1	identified drug safety
6	finding that such
1	animal drug) that
1	destroy such condemned
1	farm.  (c)
1	 (i) differ
1	small business. such
1	iii in the
3	business the secretary
1	suppliers used by
1	section 829 of
1	analyze, and disseminate
1	duties of deputy
1	warning that it
1	effective. (4) 
1	use subject to
8	drug in a
1	sector resources. 
1	committee on compounding.
2	common ownership and
2	355(c), 355(j), or
1	seniority status that
6	drug is a
1	 $268,443 
1	proposal is for
1	outreach, and corporate
1	paragraph (7); and
1	directly to state,
3	review, with respect
1	including tobacco growers,
1	methods for removing
2	equal number of
1	imprisonment. (feb. 15,
1	every person whose
1	center (a) establishment;
1	membersupon the appointment
1	secretary a supplemental
2	purchase, the name
2	immediate suspension of
1	infants, children, and
1	chemical from the
1	reasonable timetable for
2	human food at
5	diversion of controlled
2	(1)(b) shall include
1	 (j) judicial
1	acid diethylamide; or
8	threat of serious
1	(a) unlawful distribution
1	(a) the nature
1	amendments to final
1	ch. 675, 404,
3	per centum or
4	forfeiture under subsection
1	year 2016 
1	coverage; rules and
1	comply with regulations
1	owned or licensed
1	identified, excluding allowable
1	notwithstanding a lack
1	term meat articles
1	(4) time an
2	(52 stat. 1040),
1	one field investigation
9	intelligence, and the
1	grounds for issuing
1	(ii) publish the
1	administration for aquaculture
1	pattern or practice
1	 (2) consideration
1	protection a regulated
1	use; (4) if
1	land or premises
1	precedent:  (1)
1	additives, and properties,
1	manufacturers estimated disposal,
1	health care services,
1	scheduled for formulation
2	terminate the program,
2	2019. if the
1	iv or v.
1	fee, or any
1	create a robust
1	(2) streamlining, where
2	voucher for the
1	recordkeeping, and other
1	amount by the
1	(a) the tobacco
4	inspected and passed,
1	governing such a
4	hearing shall thereafter
1	systems as may
1	issued, determine whether
1	expired.  (ii)
12	grants and contracts
2	existing high intensity
1	coaches, youth workers,
1	inspected and passed.
2	register, that the
1	shortages (a) annual
1	efficient inspection service.
6	amount determined under
2	concerning its use;
2	submitted for review
1	beyond the variations
1	resistance). (2) the
1	chemical is a
1	substance as defined
3	substantial evidence is
28	food that is
1	title.  (n)
1	years multiplied by
3	(i) the total
1	evidence for additional
1	administration personnel regarding
1	processed food of
1	provide such a
1	national uniformity of
1	schedule or otherwise.
1	causes; (b) opportunities
1	exported and the
8	united states means
13	inspection of the
1	(d) notification 
1	cooperate with associations
1	possessions) while that
1	committee act does
2	amounts from fees
1	(7) to manufacture,
1	subsection (a), other
1	title. (c) continuing
1	information to enable
3	jurisdiction to review
1	recovered from the
1	condemnation of any
2	(6) such other
1	truck, hopper truck,
1	title shall obtain
2	requested and the
1	man and which
1	product which the
1	collections attributable to
2	year (excluding amounts
7	remedies provided by
4	issue a license
1	number; uniform system
1	scientific knowledge that
1	(c) policy or
2	potable water in
1	maintained, under such
1	solely for export
1	allocation of assessment
1	year, and with
1	employed by the
2	nicotine replacement products
1	(f) apply, 30
1	drug administration associated
1	written response from
2	states under subsection
1	overwhelming increase in
1	(2) deposit all
1	methresources.gov. (c) review
1	subsection shall keep
1	r-exportation described in
1	plant; (3) the
1	produce, or test
1	(h) assign staff
1	secret information and
1	law.  (6)
1	establishment has obtained
1	 (e) center
1	(a) responsible personthe
2	administration (or any
1	 (g) counterterrorism
1	payments; or (s)
2	require a facility
1	commerce, (1) no
1	wrongful distribution or
2	persons determination that
1	federal agencies or
1	efforts and costs.
3	considers not to
1	contemporary marijuana, particularly
1	 (2) covered
1	overlap, if the
1	sol-source unapproved product
1	(d) in this
1	prior report issued
1	thereof which may
1	united states warehouse
2	title.  (10)
2	professional practice, and
1	business dispensers with
8	method of using
1	isomers; ecgonine, its
1	notification or declaration
1	statement confirming the
1	title. (b) each
1	5to affirm or
2	u.s.c. 262]. 
1	monoxide that meets
3	trade, to be
1	714a, as added
2	event report the
1	1998, the following
1	unresolved safety questions
3	both. whoever, in
1	successor regulations). (k)
4	trade secret information
1	including a regulation
1	administration intercenter institutes
1	360bb. designation of
8	section 5703 of
4	country for which
1	formswith respect to
1	n-tobacc-sale order on
3	person is accredited.
1	subsection apply. 
1	(a) are the
1	black rots, yellow
1	675. assaulting, resisting,
1	manufacture, importation, or
1	sufficient operating reserve
1	media), of medical
1	additives; exception for
1	modified solely by
1	net weight of
1	on, affixed to,
7	transmit to the
1	(i) shall register
1	prior to effective
5	changes  (1)
3	may not, under
1	general through the
1	extent or in
1	listed drug); (ii)
2	data collection and
1	rehabilitation programs. in
3	safety modernization act
2	 (ii) such
1	appropriate due process
1	exportnotwithstanding subsections (a)(4)
3	represent that any
1	securities on the
1	may accept a
1	tobacco product; (d)
1	medical, and public
2	title, in a
1	him, including such
1	(2) includes any
1	title; (c) the
1	
 1179. national
1	entered under paragraph
1	research, or industrial
1	research contracts; employment
1	(3) it is
2	(1) may operate
1	federa-aid primary system.
10	availability of fees
1	seeking its release
1	modified during or
1	premarket notification submission.
1	conduct a postmarket
3	premarket notification submission,
3	promulgate regulations under
1	imposing the civil
2	activities undertaken by
1	considers the application
4	360j(f)(2) of this
1	believing that it
1	official federal standards,
1	amount for mentoring
1	use on food
1	 (i) whether
1	 (with 15
4	(i) authorization of
1	membershipthe council shall
12	submission of such
5	shall become effective
1	
 1048. administrative
1	unless the condition
1	(a)(i), a tolerance
1	health information 
1	25).  (c)
1	upon patients and
2	(as the case
1	order which have
1	site address and
1	ingredient of such
3	premarket notification submissions
2	registration number to
2	obtaining the right
1	community resources (including
1	subsection (d)(4), (e)(1)(a),
2	last made a
1	(15) morphine methylsulfonate.
1	arguments submitted or
1	15. repealed. june
3	 (1) advisory
1	abuse has occurred
1	sites and organizations
1	science pertaining to
1	permits to ship
1	suspension or termination.
1	provisions section 801
2	labeling at the
3	responsible to the
1	costs of prosecution
1	
 644. regulation
1	office of regulatory
1	1996 subsection (a)
1	commodities  (i)
1	brand name, identifiable
1	issued to require
1	within twenty miles
3	human services, and
1	modifying, or leaving
1	that, as applicable,
2	imprisonment not less
3	head of such
1	right to hear
3	serious or lif-threatening;
1	pleading filed with
2	business or may
2	opportunity to obtain
1	known as butter,
1	demonstrates substantial compliance
1	domestic or imported,
3	therewith, with respect
1	applicable and not
1	advertisement. (f) whether
1	enforcement and intelligence
1	labeling submitted in
1	section 841(b)(2) of
1	applies.  (d)
1	substances for inclusion
1	notwithstanding subsection (a)(2),
1	funds from other
1	(d) conditions an
1	therapies industry organizations,
1	master files referenced
2	(e) use of
1	methyldesorphine. (13) methylhydromorphine.
1	(i), the state
1	(iv) distributions of
3	amounts under subparagraph
1	387a1(a)].  (e)
42	may by regulation
1	currently are awaiting
1	inspection.  for
1	subsection, as well
1	recognized medical condition,
1	programs for intravenous
1	timely manner. the
1	property.  (g)
1	complain and defend
1	failed to include
1	refund any initial
1	675, 751, as
2	directly by a
5	term person means
1	federal register, shall
2	food for humans
1	inputs, and plant
1	changes (a) in
2	subsection (a)(2) and
1	states. similarly, all
1	party and conduct
1	generally recognized by
1	exceed $10,000 for
1	1 percent of
3	public health officials
4	within the limits
5	applicable provisions of
1	optical isomers, or
1	 (2) that
1	establishments.  (h)
5	extended by a
1	prescribing and administering
2	product upon a
1	25(d) of the
3	communication from the
1	quality falls below,
2	identification and inspection
1	year 2018, $672,000,000.
1	event of seizure
1	1905. authorities (a)
1	food may not
1	order will result
1	adulterated by a
1	387s. user fees
1	premises and all
1	(whether domestic or
5	(2) compliance with
2	either an applicant
1	(b) persons preventing
1	direct the destruction
1	maintain optimum freedom
9	actions necessary to
2	generalon the initiative
1	administer any legally
1	fees authorizedthe secretary
3	applications for new
8	effective controls against
1	(a) is issued
1	shall be a-large
1	(d) nothing in
1	method of the
1	operations, and annually
1	scientific basis, that
1	respect to correction
1	resident of a
1	(b)(3) if such
2	section, and shall,
1	groups (including pediatric
17	(1) and (2)
1	cleared for commercial
1	auditthe term consultative
1	identify specific scenarios
1	banned device. 
1	distributors of fruits
2	iii  (i)
1	arsenic, barium, chromium,
2	identify the immediate
1	submissions, shall include
169	described in subsection
1	ch. 559, 2,
2	research, and the
1	initial grant or
1	demonstration and evaluation
1	(a) a medication
2	criteria website described
1	basis under subparagraph
2	notify the affected
3	commerce, and the
1	priorities the administrator
2	surveillance under this
1	preceding the request
1	outweigh the detriment.
1	appropriate; (c) establish
1	town, state, country,
1	secretary, related to
1	shortage program, including
2	misleading labeling and
2	allowed by the
1	residue is not
1	practice of false
1	toward the implementation
1	claim; or 
2	determining the quantity
6	investigations which have
1	promptness. (2) the
3	 (i) collecting,
1	adverse events, and
9	department, agency, or
2	vest in the
3	product to a
1	954, and 955
1	without reference to
1	exemption. (4) tolerances
1	section 319f2(c)(2)(a)(ii) of
1	(c) excess fees
1	citizen or national
2	processing of orders
2	effectiveness reasons, the
1	contraindications; and (ii)
1	warning signs and
2	(a) at any
12	 (i) an
1	agency to perform
1	act of 1997;
2	(2) rules relating
1	registrations for each
1	mechanisms to assure
3	 (i) at
1	immediately upon the
1	title 25); or
1	(b) a supplemental
2	transporting, or holding
1	675, 201, 52
1	number of fertilizer
2	(5) to congress,
2	representative for such
2	agencies, organizations, and
1	ch. 675, 1007,
1	include a foreign
2	(b) submit to
1	property of or
1	traceability except as
2	employees; nor to
1	u.s.c. 264]. 
2	secretary may discontinue
1	notice requiring the
1	recipient and expedite
1	state rules repackaging
2	persons who sought
1	knowing that it
1	cal 30.0 
2	areas in which
4	request is made
1	exemption filed with
2	otherwise dispose of
1	service fund, under
1	chemical residue resulting
1	responsibility for 
1	amendment.  (5)
1	decedents property may
1	(ii) active pharmaceutical
1	processing means operations
1	product is ready
3	(i) for a
1	sales of raw
1	subchapter ii. the
1	activities not involving
1	plans; and (v)
1	new analysis of
1	conclusions thereof. 
1	patient will be
1	detail best practices
2	(1) identifies the
1	investigational use without
12	designated new animal
1	attempt to make
1	to, injunctive relief
4	protection of public
1	characteristics of such
1	
 71 to
1	facts alleged, sworn
1	acceptance of submissions
2	expenses (including travel,
10	clause (ii), the
1	paragraph (1)(a) if
1	states (including details
1	burdensome requirements; (d)
3	considers appropriate. 
1	
 350e. sanitary
4	labeling of drugs
1	medical and paramedical
2	access. further, the
1	critical need for
1	licensed and patented
1	start using the
1	initial additional grant
1	stakeholder.  (2)
1	abbreviated applications. 
1	dismissthe court shall
1	experience with countermeasures;
1	13, 63 stat.
4	standard development organization
2	misbranded article is
1	personal investigation, information
1	(1) to establish
1	(including those products
5	means a substance
1	safety.  (d)
2	whether such manufacturer
2	ensure safe use
1	agencies to ensure
3	organization to the
1	triggers described under
1	(2) amendments to
1	term addict means
1	weeks after the
1	secretary adhered to
6	section 360eee1 of
1	registration suspended, revoked,
1	(6) limitationno civil
1	reviews, overseeing the
1	case of proceedings
1	effective approval of
1	paragraph (2), consideration
3	obtaining any recommendations
1	substantial equivalence and
1	guilty of an
2	decisions  (1)
1	concealed or camouflaged
1	title of certifying
1	approval or license;
1	(including nicotin-based and
1	calomel; nor in
1	diluting, pooling, reconstituting,
1	648; 
 

1	 (i) nonclinical
1	change as a
1	containerif it purports
1	perspectives of patients
2	section 360eee1(a)(6) of
1	(d)contents of notice.a
2	risk from the
1	(b) to knowingly
3	approval of which
4	defense, the secretary
1	secretary and introduce
2	criminal forfeiture under
1	means those distributors
1	shall, as expeditiously
1	may be imposed,
2	shall be condemned
1	may be imposed.
1	sold, to immediately
1	development protocol 
1	access the posting
1	united states) shall
1	tracing requirements developed
1	effectiveness. an order
1	(a) new safety
1	narcotics trafficking, that
1	may retract or
1	(7) meprobamate. (8)
1	therapies, including with
1	evaluation projects, with
1	disposition of forfeited
1	director on an
1	hearings, sit and
1	practitioners federal and
1	linkages with the
4	tobacco product from
4	performance standards for
2	health. (d) contents
1	assuring that poultry
1	waive this requirement
2	2013, upon receiving
1	subsection.  (10)
1	periods of not
1	recordkeeping pursuant to
4	poultry products, and
1	order requiring a
1	reinstatement of benefits
1	publish a specific
1	section 387j(c) of
1	preliminary order if
2	(b) and (d)
2	may be found,
1	inspections as the
1	product of, a
1	including any training
1	official plant, except
1	hearings (a) authority
1	isomers. (j) piperidine
1	(2) a pesticide
1	iv, with respect
3	october 26, 2002,
1	designated  (a)
1	provision of certification
1	introduction of certain
1	supplementary thereto. (j)
1	chapter preempts the
1	(7) $70,000,000 for
1	(e) false labeling
1	within 120 days.
1	office for the
3	drug, or cosmetic
1	changes in drug
1	(1) both the
1	expertise in neonatology.
1	good faith, and
1	title in only
1	secretary (or an
1	facility.  (7)
1	approved; (2) that
1	(1). (c) qualified
2	states pursuant to
1	forfeiture is based;
1	distributor as regards
1	revocation the secretary
2	increasing volume of
1	diversion; and 
2	another health care
1	(iv) designing, developing,
1	case as provided
1	(3), as applicable,
1	regulation prescribing, or
1	medical purpose by
1	regarding the filing
1	secretary shall, beginning
1	2016. (e) expedited
1	describe methods that
1	temporarily, either as
3	endanger the public
2	notification to consumers
1	 (d) enforcement
1	least nutritionally equivalent
1	requirements of accredited
14	access to and
1	initially, but shall
4	2011, the secretary,
2	subparagraph (e) of
1	qualification package; (ii)
1	relief as the
3	international standards development
1	device establishment compliance
1	(c) a state
1	cause therefore. 
1	 (c) custody
1	(a) raise any
2	drug should be
1	appropriate, and to
1	appearance, the type
2	state agency means
3	products that have
1	approval granted prior
3	trials used to
1	repackager pursuant to
1	administer drugs or
3	access to any
2	(c), the term
1	writing, provide to
1	found in such
1	labeling of pet
2	provided that, in
1	hair dye shall
2	food additives are
1	ii. (10) any
3	term label means
1	(6) tracking pediatric
4	representative of interests
1	facility of such
1	yellow and red
1	administrative order issued
1	laws, to the
1	court, regardless of
2	issuance.  (june
1	respect to facilities
1	agencies to achieve
2	revoke the tolerance
1	(17) the term
4	agency.  (2)
1	dispensers; and (iii)
1	include, along with
3	produced and packaged
2	likely to provide
1	manufacturing is to
2	exclusivity under section
1	written requests issued,
1	renders the order
1	substance means any
2	times more likely
1	identify  (a)
2	logistics provider that
2	drug administration. (2)
5	coalition awarded a
1	manufacturer of defects
3	public availability 
3	applicable to each
3	agriculture under the
1	amounts for small
1	bears a warning
3	period, or indefinitely,
1	2016, $599,000,000. (i)
1	(a) qualified en-userin
3	25 percent of
2	slaughter any such
1	undertaken to alleviate
3	use of certain
1	third party; and
1	extent that appropriations
1	surveillance and the
48	web site of
1	dutiesin order to
17	representatives of the
1	make such revision
1	official establishment to
1	congressional committees of
1	commerce. (c) the
2	products manufactured, prepared,
1	pending review to
1	shall fail to
1	congressional committees on
1	including coca, cannabis,
1	independently reported; and
2	raising, and the
2	2012. nothing in
1	 (b) requirementsthe
1	history of prior,
1	compliance guide setting
1	ability to manage
1	title 42 by
1	structure in an
1	adequate, approved, and
1	(3) restrictions notwithstanding
1	(4) includes a
1	subsection as grounds
1	abusing drugs. 
4	shall establish by
1	accept data from
2	(1) and such
2	(3) serious adverse
1	submissions, and any
1	actions were implemented,
1	experience to do
1	therein. (b) in
1	(a) above. in
1	(c) subsequent offensea
1	(2) other labeling
1	1985, any person
6	 (a) present
2	2016 and the
1	drug development toolsubject
1	including persons that
1	nonconformity; (e) on
1	 (2) suspect
2	(a)(6), the secretary
1	expired prior to
1	expenses connected with
10	scientific, or other
2	authorized to enter
1	drug application. (2)
1	production among federal,
2	secretary, or by
1	isomers; (ii) any
3	drug price competition
1	(2) purpose the
1	
 822. persons
1	retail outlet from
1	bring such fact
1	committee. within thirty
1	issue such regulations
1	(b) 27 percent
1	purpose of imposing
1	title i, 119,
2	person to believe
1	sections; (f) an
3	met:  (1)
1	members on each
1	production of methamphetamines
1	includes the certification
1	trading partnerthe term
1	
 331. prohibited
1	requirement under the
1	various modes of
1	removed in accordance
11	show that such
1	3-day period. (c)
1	single quarter of
1	(b) otherwise used
1	location provided that
1	holding an unsuspended
1	(a) grants 
1	menthol cigarettes 
1	1989.  (

1	may include requirements
1	amended [42 u.s.c.
1	require that, prior
1	foods, provided that
1	fair, timely, and
1	fees may only
1	area reserved for
1	(j) interim final
2	materials and supplies,
1	activities the term
1	guidance that clarifies
2	initiative or upon
1	received; (d) revise
1	diversion exists unless
1	
 384b. voluntary
1	practices, and such
1	ch. 74, 13,
1	abuse problem, which,
1	judgment that includes
1	(n) labeling of
1	designated by regulations
1	fined in the
1	significant decision described
6	materials and supplies;
1	foreign country of
1	gas has not
2	legislative body, or
1	product, for use
1	675, 562, as
1	court (i) that
1	premarket applications and
1	list of hig-risk
1	accreditation of laboratories,
1	intelligence shall consult
3	secretary. (2) every
1	address an unmet
1	dollar amount of
1	budget to provide
1	tool. (d) summary
1	injury.  (4)
1	secretary estimates is
14	(d) of this
1	register, modify the
1	(a) shall give
1	prevent the hazards
2	drug monograph system;
3	carried out through
3	fail to comply
3	state food safety
1	describing transactions and
1	conducted by an
1	(v) the assessment
2	biological, chemical, and
1	intimidation of potential
1	person is referred
1	subparagraph (b) who
1	drug monograph system.
1	prohibits a person
1	redirected to activities
1	conditioned on permitting
1	rulesthe regulations promulgated
1	investigational use under
1	efforts made by
1	misbranded, and the
1	narcotic drug and
1	creosote, chloroform, cantharides,
1	harmonized with international
2	notice, proposed, or
1	(l)(1) apply with
1	(c) coca leaves
1	correcting any compliance
2	licenses, or directives
1	conclusive decisions of
1	application provides reasonable
1	accelerated approval using
1	package means the
1	general auditing authorityfor
1	foreign government agency,
13	equal to those
8	repackager described in
1	warehouseman.  (

1	consultation and coordination,
1	omission or falsification.
1	records, including complete
1	term dtc advertisement
1	provisions as the
1	disclosed on its
2	president submits the
2	advisory committee; and
1	effective outreach to
1	health. (c) hearing
2	(b) a food
1	petition.  (7)
2	examine such data
1	notification during pet
1	provided under the[1]
1	 (ii) direct
1	amounts deposited amounts
1	entry for a
1	determine, after notice
2	liable for the
1	ingredients, or unless
2	(3), and (4)
1	agency action as
2	business information. 
1	members attending meetings
2	agency, bureau, board,
2	general shall be
1	drugs. (b) individuals
1	constitutes a burden
2	informed persons representative
1	duplicate requirements. 
3	appeal shall be
1	controlled by 
2	scientific principles, shall
1	(cc) other data
7	court determines that
1	shall, as promptly
1	(a) the scientific
3	documents, including guidance
1	reviewable.  (e)
1	following legend conspicuously
1	name. (ii) the
2	forth under part
1	may choose not
1	certified to by
4	title. (4) the
1	disqualify any regular
1	concerning prescription transfers
1	act, together with
1	information indicating adverse
1	sports organization for
1	 (1) reviewthe
1	administrator certifies in
1	confectionery containing alcohol
1	delivered, or otherwise
1	goals, including the
1	offense consisting of
1	list.  (b)
1	(1) an advertisement
1	treatment and management
2	$75,000,000 if the
1	quantities of a
1	generalon the first
1	another person to
1	animal does not
1	pay rates, except
1	involved as affected
1	registration of commercial
1	made, and such
2	part to dietary
1	construed to (1)
1	item(s) to the
1	new drug would
1	behalf be eligible
1	1235; renumbered 23
3	labeling is in
1	food types, especially
2	normal retail quantities
1	detoxification treatment, as
6	27, 2013, a
4	caused by the
2	section which is
1	commercially marketed under
3	identity of any
6	prescription drug establishment
1	without release and
1	establish rules governing
6	drug administration; and
1	office otherwise engage
4	drug is intended,
1	act on a
1	civil procedure in
1	document; or (ii)
1	revision or revocation
1	exported under this
2	order that is
1	subsection, any such
2	secretarys evaluation of
1	response goalensure an
1	continue any standards,
2	fee failure to
1	(b) exclusionsthe term
1	information concerning a
1	data on general
2	facility is not
1	(2); (5) recruit
1	 (15) rol-you-own
1	enable seamless, rea-time
1	expertise needed among
1	good cause that
1	drug products); (c)
1	patients, representatives of
1	(c) is potentially
1	amount of feeeach
1	title. (ii) any
3	provide for data
5	director of such
2	1451 et seq.],
2	schedule for review
3	referrals made under
2	term includes the
1	(a), including any
1	ensure that, upon
1	ethical standards, for
1	therapies, and advances
2	contributions to the
1	officials; (iv) private
3	(2) request for
2	purity shall be
19	required to register
2	refer such application
1	form  (a)
1	court (and serves
1	(iii) identify elements
1	(ii) which occurs
1	outreach, interactive outreach,
1	weight, less than
1	marihuana means all
1	stakeholders during any
2	may be renewed
1	use of federal
1	water in public
1	treasury of such
1	samples of electronic
1	large quantities of
1	determinations in response
1	(b) to designate
1	claimant, to the
1	soon as practicable.
6	official certificate or
9	soon as practicable,
1	unless such tobacco
2	controlled under schedule
1	unless revised by
1	imply any right
2	(d) prohibition the
1	i, 25, as
1	united states when,
1	review product test
1	approving all reports
16	believe that the
1	(h) exemption the
1	logistics providers. 
1	leaves, and of
1	days. regulations of
1	application. (6) the
1	establishment fee due
1	production, packing, and
3	failed to reasonably
3	ensure timely and
1	fahrenheit. (feb. 15,
1	(b) quantitative comparisons
1	safety; (2) establish
3	results from such
2	intended use whether
1	manufacturer are deemed
4	promulgation of regulations
1	shall amend and
1	accurate inventory of
2	unless the fee
1	order until the
1	control activity solely
1	protocol and opportunity
1	(g) written requests
1	accredited person under
1	schistosomiasis. (o) soil
1	councils on (1)
1	information could not
1	functioning of the
5	trademark, trade name,
1	land border with
1	schedule i and
1	plants subject to
1	pharmaceutical ingredients of
1	means necessary to
1	kind shall be
1	may not act
1	(c) limited distribution
1	compiled by the
1	(j) with respect
1	 zinc (mg)
1	pharmaceutical ingredients or
1	applied to international
1	(ii) are determined
1	and, upon request,
1	epinephrine and disposable
3	drug establishment fee
2	colored margarine at
9	determining the public
1	reports on research
1	transactions to the
1	psychological or physical
2	requiring supplemental application
3	 (1) safety
2	applicant will comply
2	 (3) notwithstanding
3	review voucher was
1	request or other
1	products or product
1	sale substantially the
1	legalization (for a
1	secretary, in writing,
1	stat. 871; june
1	872. education and
8	biological product under
1	amend and finalize
2	ensuring the safety
1	arrested has committed,
1	gold, lead, mercury,
5	(c) the average
1	(iii) to identify
5	ordered by the
1	review; other provisions
1	(a) has demonstrated
2	(including supervisory and
1	 (1) requiring
5	stimulant effect on
1	situations, as prescribed
1	immediately preceding calendar
1	prevention programs; (3)
1	present false or
1	safety information, and
1	corporation shall buy,
2	terminated by such
1	admission to noncomplying
1	538, formerly 360b,
1	321(k) of this
1	program under clause
1	upon request. (c)
2	paragraph shall include
1	(b) and shall
2	food; and (c)
1	strengthening rehabilitation efforts
2	law that imposes
1	(i) previously filed
1	2202 of this
1	68 stat. 54;
1	medical need in
1	type, the secretary
13	shall be credited
1	(c) requirements for
1	ultimate consumer which
1	year 2007 for
2	operate to stay
1	submission to reach
1	records; (b) the
1	(c) inclusion of
1	fees a human
2	benefits in that
1	copy of 
1	1034(e) and 1037(c)
1	stamped, tagged, or
1	area to quarantine
1	animals, is prohibited
5	written comments from
3	device before the
1	(d) imposition of
3	title.  (e)
1	retailer has a
1	direct to consumers,
1	therapies for children
3	802(41) of this
1	exercising the powers
1	(b) and (f)
2	procedures shall keep
1	otherwise specified under
1	issues, including topics
4	deception or unfair
1	committed repeated violations
1	ingredients  (1)
1	applications where the
2	requirements have not
1	across state lines,
1	forfeiture and thereafter
1	(e) for fiscal
1	title 5, relating
1	exist, the administrator
1	directed to more
1	seminars, educational programs,
3	may not appoint
50	fee shall be
6	carrying out such
3	labeling stating that
3	(ii) for the
1	23, 1985, the
5	professional practice. 
1	respect to adulteration
1	peritoneal dialysis solution);
1	thereof for cleansing,
1	processing, or the
1	section 1395 of
1	fiscal year quarters,
1	vitamin e to
3	(37 stat. 832833)
1	 (1) first
1	practitioner engaged in
1	program implementation the
4	fee  (i)
1	part thereof shall,
1	(c)(2) of a
1	requested to carry
1	(4) risk factorsin
1	instituted and for
1	subparagraph whether a
2	imprisonment, to a
1	title iv, 403,
1	consideration. all proceedings
9	used for such
1	prior to establishment
1	separate serving thereof
1	firs-applicant status under
1	respect to transfers
2	2014 through 2016
5	2014 through 2017
1	every such establishment
1	(h) 5 grams
2	annual summary developed
1	counterparts at the
2	conducted by accredited
1	secretary.  (g)
3	approval, clearance, or
1	softening of peer
1	improving communication and
3	include validating any
1	effects of growth,
2	risk means a
2	solely for a
2	facility means any
1	 (d) exclusionssuch
1	preparation of said
1	activities of that
1	intelligence fusion center
1	existence on january
1	imposed in the
3	(g) the term
1	enable the commission
1	intelligence, or the
1	 (2) operating
1	law 109462). (

1	similar experimental conditions.
1	heard on all
1	regulations. (3) the
1	chapter (including the
2	oral or written
1	imported seafood and
3	health care professionals
3	corrective action or
1	considered scientifically insignificant
1	regulations. such guidance,
1	(b) respecting the
1	stability testing required
1	against, and property
1	subsection[1] (a) and
2	pediatric assessment is
1	manager or designated
1	technologies are compatible
1	slaughtering of livestock,
1	standards for food
2	2 of title
1	tool is not
1	force operating in
2	prescribed by subsections
1	permit discovery limited
1	officer, to a
1	establishment; (ii) who
1	352(aa) of this
1	property)  (1)
1	use gifts and
2	nutrient premix used
1	(c) whether or
1	article is being
1	number so assigned
1	compensate, and discharge
1	entity to meet
2	reason of their
10	effects of the
1	entry into any
1	product that can
1	2601 et seq.]
1	administer training and
2	services, and facilities
1	wholesaler  (a)
1	section 558.3(b)(3) of
1	termination serves the
3	files application for
2	 (2) inspection
1	nonclinical studies. (b)
1	(a) unsafe food
1	(c) limitations on
2	inspected, in violation
1	prior to entry
2	including traveltime; and
1	change or changes
1	(i) nonsaleable product
1	products shall furnish
1	company or corporation,
1	(v) marketing the
1	panels, to the
4	food at any
2	meetings or hearings),
1	$250,000,000 for fiscal
2	substances except when
1	emergency response. (june
9	shall apply with
1	device involved has
1	productsif, during the
2	division; and (b)
1	award grants under
1	675, 701, 52
2	help to support
1	calendar year; (4)
1	(b) false or
1	subsection is being
1	time for each
1	consequences of such
1	notification to parents.
1	names no person
1	scientific programs within
2	2007, and prior
1	sponsors). (c) annual
1	color content of
3	obligated or expended
1	fee amountthe amount
1	taken to complete
1	applicant to notice
1	(acting upon objections
4	(ii) pursuant to
1	applied or enforced
1	criminal enterprise in
1	(
 
 831.
1	appropriated funds in
1	applications reviewed solely
1	submit comments, and
1	plans; (v) developing
3	establish that the
1	1994 through 1996.
1	$50,000 per annum,
5	shall be binding
1	limited laboratory capacity
1	includes those engaged
2	preparing, treating, packaging,
1	legitimate channels, and
69	drug, and cosmetic
1	secretary and which
1	(28) -(2,-dimethox--(n-propylphenyl)ethanamine (2cp).
4	information subject to
1	separate and distinct
3	adulterated food that
1	drug required by
1	shall identify at
1	containerthe container from
1	ownership in the
1	obtain a warrant;
1	program is designated
1	accompanied by valid
1	plants located in
2	secretary may reinstate
3	since july 9,
1	substances; (ii) the
1	conviction.  (

1	substance referred to
1	secretary initiates a
1	(c)(1)(a)(ii).  (h)
1	(e) chemical, biological,
2	processing poultry products
1	assessments by the
1	importers. (b) user
1	facilitating sharing of
1	veterans affairs who
4	1412 of the
7	hold a public
1	costs and fees;
2	strategy with respect
1	section 355(i)[1] 360b(j),
3	tobacco product the
1	patients. (iii) the
1	withholding use of
2	consultation with experts
2	plant means any
2	perform, as required
5	(a)(ii) in any
1	submitted to congress;
1	rate, for animal
1	
 94 to
1	involved, and such
4	following shall apply:
1	including any incremental
1	(b) audit agentsan
1	professional associations, or
1	timeliness and depth
1	(1)(c)(ii) may be
1	farm sales to
6	months of fiscal
1	set of numbers
1	eradicate pseudorabies in
2	secretary any authority
1	(iii) conditions regarding
1	tools for a
1	(d) elderly populations,
16	voucher under this
2	authority granted in
1	(a) bonus payments
1	warrant shall consist
6	date and time
2	(3) relation to
1	defect and provide
1	(a) applies and
1	agreements authorized under
1	prospective transferee or
1	person seeking to
1	production pursuant to
1	object; the substance
1	sectors, including through
7	(commonly referred to
1	examination of a
2	acquire such eggs
4	secretary when such
1	information is derived
1	without the auditor
1	employees no employee
1	develop validated methods
1	propose one or
1	dining rooms, or
1	sentence to other
1	section 350(c)(1)(b)(ii) of
1	year, $712,000,000. 
1	reprocessing and packing
1	
 343. misbranded
1	counterfeit and violative
1	safety standard under
1	dispensing;  (b)
2	total food and
1	2017, such fees
2	ninet-day period to
1	(ii) food products,
1	substantially equivalent in
1	1531(d) of this
1	examining and testing
2	trials of the
1	carcass, and meat
1	(iii) be regularly
1	(i) a publi-private
4	court in which
1	conducting surveillance to
2	pharmacy in any
1	designate a drug
1	treasury, the attorney
1	issue final guidance
1	maintains a program
2	no-clinical and clinical
1	guidelines. the secretary
1	unlawful to import,
2	 (k) orphan
1	application, and who,
1	revenue amounts as
1	conducted in anticipation
1	constituent part relied
1	examination, the administrator
1	disseminating information to
5	agricultural quarantine inspection
1	effects on the
1	(f) fees for
3	(b)(2) which refers
1	substances so dispensed
4	certification is in
1	waived or reduced
1	investigation, prosecution or
1	right to consult
1	ch. 675, 1013,
7	drug administration, advisory
2	consideration the resources
1	technical assistance, guidance,
2	means a listed
10	(excluding the amount
1	(i) a requestor
1	election, give prompt
1	illness.  (n)
1	including related public
1	strategies on effective
2	who, as of
2	(iii) annually make
1	grams. (4) not
1	sentence is referred
1	shipment, or delivery
1	residues which may
1	tolerances for substances
1	onsite audit report
1	charge does not
3	applied exclusively to
1	10a, as added
1	whether a tolerance
1	term major change
1	identify, record, and
1	 (b) placement
1	product if 
1	administratorthe administrator may
1	single establishment manufactures
1	approval or september
1	program personnel when
1	committee nominations; and
2	enforcement agencies to
4	year) are equal
1	product included in
43	identified in the
2	states that there
3	means any activity
1	food) to be
1	jurisdiction to hear
1	served under such
1	cosmetic act; consistency
1	(including treatment through
2	title 41. 
2	importer shall be
1	2016, a prescription
1	(a) preparedness goalenhance
2	establishment if he
1	likely patient risk
1	may, after complying
1	(d) the total
3	applicability to fiscal
2	date is necessary
1	(c)(1).  (d)
1	exception if a
1	health, disability, veterans
2	secretary assesses a
1	drug administration; (3)
1	quantifiable and measurable
1	taste for milk
1	revision of tobacco
1	 (2) written
1	meat, and 78.6
1	statement prepared in
1	determinations  (i)
1	pilot projects, when
2	directives issued pursuant
2	biological product fees
1	death; and (b)
1	person, to have
1	buildings within close
2	sentenced to any
5	represent a meaningful
1	submission. a resubmission
1	(b) reduce duplicative
1	(iii) find the
1	may also take
1	(vi) in the
1	 (a) oxygen
1	condemnation of adulterated
2	(in this section,
1	reveal that the
1	shall be open
2	businesses (including small
1	narcotic drugs so
1	second fiscal year
2	permit the officer
1	
 395. loan
1	sections and standards
1	article, and the
1	method.  (mar.
1	paid by each
1	drugs now included
2	dispensed by means
1	report containing an
1	reason, including 
4	small business. 
1	volume and full
1	data or studies
1	(f)(2) if that
4	substance in the
1	(i) provides the
2	benefit and could
1	secretary, in carrying
1	anabolic steroid by
1	applicant and affiliated
1	(2) as of
1	subsection (b)(2) after
1	(relating to imports)
1	without a specific
1	section 355c(b) of
1	level for any
1	tobacco products may
3	electronic products shall
1	subject; or (ii)
1	recall order shall
1	 (a) determining
1	food on the
1	age of twelve
1	business. (2) requirements
3	products regulated under
1	adhered to, if,
1	procedure in promulgating
1	(b) for study
1	shall institute appropriate
2	communications, or otherwise)
1	360b, as added
6	animal drug establishment
5	authorized to conduct
1	secretary annually for
1	elimination of an
1	capacity pursuant to
1	secretary, shall notify
1	phenylpropanolamine, its salts,
3	food supply and
1	hidta program as
1	federal government from
2	medical devices; and
2	 (i) limitation
1	temporary restraining order
7	united states interdiction
1	coalition that meets
1	low birth weight,
1	vessel does not
1	(i), the publication
1	proprietary information nothing
1	(15 grams). any
1	interoperable exchange of
1	disposition, notification, or
1	shall ensure, to
2	operated or administered
3	agency center with
1	laboratories the secretary
3	purpose of paying
1	clean and sound
1	new suppliers of
1	balance required by
1	ex officio membersthe
1	comments made by
1	marketing and labeling
1	subchapter, including a
1	regulations any nonprescription
1	america, shall determine
1	reasonable time a
1	voucher  (i)
1	study of present
2	event report under
1	postapproval requirementsthe sponsor
1	application of state
1	section 6103(a) of
1	sodium and potassium,
1	conduct examinations, investigations,
1	director, may subject
1	affixed a certification
1	postmarket surveillance for
1	federal register prior
1	substance described by
1	family member, in
1	requirement of paragraph
1	agreement through which
1	generalthe president shall
1	shared among law
1	355(k)(4) of this
1	device, tobacco product
2	substance to one
1	505(b) or (j)
1	plants packing eggs.
2	sample of such
2	reason or basis
1	certain pos-february 15,
1	administration with expertise
1	387i. records and
2	subsection (c); (b)
1	chapter, and annually
1	regarding investigations of
2	clause (ii), a
1	states. (ii) annual
1	strengthen seafood inspection
1	legally licensed as
1	criminal enterprise. the
1	enhancement of efforts
1	physician or nurse
1	reprimand, retaliation, or
1	sums owed by
1	(ii) a finding
1	exported meets the
1	active ingredient, or
1	unless, after a
2	made the report
1	establish in such
1	year 2017) falls
2	without an individual
1	productthe term illegitimate
1	agency shall be
1	(ii) a warning
1	requirements. nothing in
1	section (including judicial
2	(2) recommendations the
1	eggs is injurious
1	physician may provide
1	quantitative risk assessment;
2	state, if he
3	responsible person (as
1	available, for at
1	360nn(f) of this
3	(r) the term
1	process in excess
1	 (1) unapproved
1	19, 1948; or
1	transfer technology with
1	meaning includes ethylene
6	(a) publish a
1	grocers from providing
1	studies of drugs
2	(g)(1), that the
1	found, is an
1	incremental risks and
1	distributed locally usually
1	arrest and conviction
1	reveal, other than
1	shall constitute authority
1	nominees to submit
2	giving of a
1	professionals under which
1	10 days before
2	admission to a
1	models and support
6	reasonably certain to
1	(2) contentsthe voluntary
1	partners beginning january
2	(f) development of
4	proposed labeling and
1	equines, that are
1	methamphetamine manufacturing facilities
1	includes periodic testing
1	assessment within each
1	significant decision of
2	packaging of the
1	excipient manufacturer. 
1	request that a
1	priority to applications
2	carry out activities
1	respect to artificial
1	control and fund
2	interstate, is licensed
1	shall help to
1	drug abuse, and
1	paragraph (1), of
1	nonprofit corporation to
2	make such recommendations
1	prevent drug abuse.
3	color additive, and
1	(including community mental
1	substances is for
1	reason of containing
1	misbranding has been
1	 (3) bases
3	substance if the
1	funds for drug
1	(i) noncompliance with
1	product licensed for
1	sold during such
1	quality, or unduly
1	seq.], or the
1	(c) come in
1	measure progress for
2	liens all charges
1	respect to authorized
1	approved; and (4)
2	estimated disposal, inventory,
1	limits on financial
1	administration costs (a)
1	liability of owner
1	cooperation with individuals
18	investigational drug or
1	inhabitant or in
1	qualifications and competency
1	carriers are not
2	chapter in which
1	$20,000,000 for the
1	medical gases deemed
1	appear in or
9	notice published in
1	term substance abuse
1	
 
 356c1.
1	(c) and (d);
1	may occur in
1	454(a)(1) of this
5	state law or
1	food defense plans;
1	general shall, upon
2	pesticide chemical residues,
1	title or applicable
1	drug has an
1	designations authorized by
1	teleconference.  (b)
1	application is incomplete,
1	(4) any requirement
111	submitted to the
1	year 2015 under
2	administering the licensure
1	term eligible pesticide
1	two years and
2	supervision or direction
1	applicable conditions). (ii)
2	recommendation submitted under
2	(c) suspension of
1	 (c) record
1	615 of this
1	requirements shall be
1	audit report available
1	oxygen may be
2	care services provided
1	filled milk, as
1	(4) direct the
1	personnel (a) any
1	certificationthe certification requested
1	elected to register
1	women. for purposes
1	on. if such
1	(1) on changes
3	means a tobacco
1	facility (or collectively
3	simulation thereof, except
1	information required of
1	supply such drug
9	subsection (c) and
1	conviction was obtained,
1	state law of
5	circuit wherein such
1	workplace programs; (g)
1	 (4) alphameprodine.
1	decision is in
1	youth; (6) to
1	appointed members in
1	(i) the provision
1	therapies; (b) provide
1	content of initial
1	haccp  (1)
1	data which would
1	dispenser of any
1	master file shall
1	right to obtain
1	committee may propose
1	certification, without requiring
1	service.  (c)
2	fee, and the
1	bear adequate directions
1	(ii) identify methods
1	 (i) active
1	human consumption, including
3	chapter, specifically to
2	grade and the
1	will only dispense
1	portions of, an
1	sterile tissue or
2	residues and other
1	animal drugs, manufacturing
1	subparagraph (c), an
1	generalon the date
1	transportation, the types
2	matters in the
1	state from requiring
4	illness or injury,
1	exemption to submit
3	persons registered under
1	qualifying pathogens 
1	distribution, and publication
1	chemical residues regardless
2	illness or injury;
1	ch. 675, 710,
1	engage in ongoing
1	information respecting drug
1	dietary uses unless
1	(
 
 953.
1	comply if such
1	(b) before 90
1	inappropriate or impractical,
1	raw state or
2	commission shall terminate
1	state definedfor purposes
1	found.  (5)
1	restriction does not
1	file is deemed
1	condition targeted by
1	facilityfor purposes of
1	(a) through (c).
1	(a), subparagraph (a)
2	food. subsection (e)
1	title 42). 
2	among the applicants
1	radiological threat agents;
1	year, with 
2	result from the
19	substantially equivalent to
1	device have been
2	ii, gamma hydroxybutyric
1	different small business
1	(b)database.not later than
1	commerce; or (ii)
2	facility fee 
1	eligible for services
4	 the first
3	(c) a person
1	following a public
1	first compliance datethe
13	secretary may issue
1	appropriate; (ii) to
1	appropriate federal agency
1	secretary, of such
1	(3) such other
1	determination required by
1	states pharmacopeia pursuant
1	agriculture attributable to
1	repackager affixes or
2	person during the
1	damages, including 
1	review to produce,
1	(1) is adequate
1	advertising contains references
1	individuals and a
1	administration can contact
1	affect the recognition
1	imposed may not
1	title, the counterdrug
1	title, if a
1	distributor purchased a
1	programs; prioritythe secretary[1]
8	subsection.  (2)
1	center) to develop,
36	 (1) any
4	items; annual index)
1	(d) upon the
1	general an officer
1	nanomaterials, the potential
1	drug is determined
1	(3) purchase of
1	(f) providing safe
1	upon, research involving
7	contents injurious to
2	secretary (and supporting
2	actions, such as
2	make a declaration
3	different mutations of
1	staffs, (2) medical
1	title or composed
1	will be achieved;
7	product would be
1	cream seven hundred
1	overseeing the alignment
11	years after june
1	clause (iv), for
1	(f) a drug
1	360ll or 360nn
5	identified under paragraph
1	revision of list
1	controls to 
3	forth for pending
1	regulation require. (2)
1	inspector means: 
1	2, 1951, ch.
1	account the differences
5	(or a representative
1	loss to the
1	agency act of
1	dispensing (including the
1	(b) nanotechnology; (c)
1	new drugs (a)
1	radioactive biological products
1	1601. findingsthe congress
1	title 42) to
1	deem necessary to
1	barrels of apples
1	paragraph.  (2)
6	take any other
1	needs (including children
1	standard for tolerance
2	based on such
1	
 360ff. priority
1	clause (a) to
1	administration. (june 25,
2	appears otherwise unfit
1	government; (iii) 1
1	meets one or
4	(b) for which
1	greater than 1.04,
1	power of attorney
1	drugs in accordance
1	notifies the federal
1	fee, in the
1	content requirements for
2	section shall contain
1	noninferiority versus superiority
1	report from the
2	drug may require
1	business; and (ii)
2	court from which
1	drug products containing
1	meets one of
1	(b) transfer after
1	records; and[1] 
3	foreign commerce or
1	title, to be
16	clause (i), the
3	originally processed or
3	(or intends to
1	supplement. (iv) an
2	shall be with
1	facility is suspended
1	available services, equipment,
1	section 2680(k) of
1	(1) withdrawing an
1	therapeutics under section
1	clear on the
3	means any certificate
1	2009.  (

1	ask for a
1	certification. the secretary
1	necessities of life);
1	returns) shall provide
1	specific determination regarding
1	product contains ingredients
1	(1) the presiding
1	may disapprove an
1	states at any
1	person, during the
2	active ingredients, for
2	appropriate members of
1	clinical investigation, including
3	certification shall not
1	reasonably anticipated requirements
1	health care (such
1	input by interested
1	received such sample
1	(with 15 g/gm
2	recognition of laboratory
1	subchapter caused by
1	acid; or (b)
1	2017. (c) annual
3	action failed to
1	approval.  (a)action
1	research that is
1	drug is valued
1	(for the purposes
1	related pesticide chemical
1	evidence provided by
2	secretary informs the
5	statement or representation
1	governments and the
1	products. subject to
2	frequency that is
1	states. (29) the
1	developed, and the
1	(b) development of
1	556 and 557
1	examine the performance
3	vegetables, that are
2	also submit a
4	drug establishment listed
1	listed chemicals, or
1	may begin 30
1	fee (if applicable)
1	known to have
1	drug. (f) qualified
1	manufactured, received, sold,
1	paragraph applies in
15	section 350d of
1	fewer than 350
1	immediately notify all
4	subsection (a); (c)
2	name, and the
2	 (1) manufacture,
1	enhance the commitment
1	342(a)(2), and 346a
1	302, 52 stat.
1	factor for such
1	disfigurement; or (c)
1	petitions for appeal.
2	notify the director
2	months after such
1	(1) or the
3	served in any
1	(d) shortage of
1	file petitions for
1	establishes, that the
1	behin-th-counter placement). for
1	device or other
1	trade, delivery, handling,
1	title 42), in
1	(3) governing processes
2	establishments required to
1	subject in the
2	services shall provide
1	medications; (3) a
1	made. (2) each
1	may adopt tobacco
1	bearing a label
2	workshops, or other
13	amount of such
1	need in one
1	commodities that the
1	(26) -(2,-dimethoxyphenyl)ethanamine (2ch).
2	drug submissions. 
1	prohibit its use
1	31, 1956, ch.
1	interested adults to
30	filed pursuant to
1	food additive means
2	effect, or the
1	reduction; and (vi)
2	subsection (b)(3) to
1	area, if the
3	months prior to
1	manufacturing rate by
1	(c) late notice
1	application during a
1	overall mental state,
1	authorized at the
1	specifications was an
1	daily, each issue
1	license described in
1	facts material to
1	(as appropriate) to
6	withdrawn from sale
2	material is reviewed
1	market in interstate
1	working for an
1	identifier related to
2	efficiently and effectively
2	paragraph (b), (c),
4	sentence of paragraph
1	confirmation under paragraph
1	thereof contained the
7	 (i) issue
2	animal drug protocol
1	potency of any
1	seas), and a
1	registration and assign
1	section 823(h) of
2	unless all personally
1	accept such qualification
1	policies; and (ii)
2	receive, buy, or
1	regulated person, provided
1	(c) consult with
1	bacitracin, or any
1	submitted about a
4	critical control points
2	paragraph (2). if
1	(p) safety and
1	interest collected pursuant
2	imprisonment if death
1	scheduled audits to
7	materials or component
1	increased from $45,600,000,000
1	entities to submit
1	condition; and (4)
1	360e(g)(2)(c) of this
1	safety, as having
1	may carry over
1	(a) the word
1	
 
 379v.
6	programs designed to
1	reasonably demonstrate an
2	subsection (a) applies
14	person commits such
2	upon obtaining, where
1	(2) manner of
1	disinfection, and sterilization,
1	positive for drugs.
1	product inspection program
1	show cause why
2	directors of the
2	proposed rule in
1	(a)(1) to import
1	use or for
1	item regarding the
1	(1)(b), or an
1	burdensome, the requirement
2	chemicals, or poisons,
1	1996. (9) the
2	section 335a(b)(3) of
1	drug safety information,
1	(d) liability for
1	unobligated balance in
2	preservative, unless it
1	required to identify
3	steps taken to
1	inspected at ports
2	president for the
3	secretary) finds that
1	notice of each
2	investigation (referred to
1	 (i) requirements
1	service under subchapter
1	justice system. 
1	demonstrating that a
1	(n) scientific advisory
1	animal science and
1	provided further, that,
1	metric tons of
1	(a)(ii), the secretary
1	expectation of efficacy.
1	occurs).  (3)
2	consumer or patient,
1	become a substance
4	judiciary, international relations,
1	3, 1996, governing
1	chapter; and to
2	substance; or (iii)
1	may establish, on
1	registration or modification
1	redactions made to
4	(2) by mailing
1	5. (c) the
1	declaring that the
1	(d) limitations 
1	evidence for the
3	(o) the term
1	format requirements established
1	collect and use
1	(7) the methods
1	surrogate markers. 
2	inspections for such
1	inspection and enforcement
1	school dropouts, and
1	provided the person
5	device to the
2	agencies under this
1	dru-involved premises (a)
1	body fails within
1	foreign sources. 
2	deems adequate to
1	support carrying out
1	(2) reinspection fee
3	waivers, exemptions, reductions,
1	term by general
1	domestic laboratories accredited
1	819.)
 
 213.
1	directive 42, issued
3	public, upon request,
1	budget submissions 
2	may, for the
1	least 75 days
1	(a), a reference
1	agricultural commodities; (b)
2	filling the order,
1	prevention the director
1	sales by such
1	provisions in clauses
1	cosmetic provisions; marking
1	including relevant conditions
1	practicable, include a
1	compliance the secretary
1	history and current
1	order of forfeiture.
1	hidta and the
1	paid. (3) adjustment
2	may conclude that
9	operation of the
2	effectiveness to support
2	federal agencies concerned
5	reportable food registry
1	authorized, upon receipt
1	petition may cite
1	state license or
1	demonstrating equivalence of
1	device fully meets
1	possible, no cost
1	first participated in
7	full description of
1	tobacco.  (4)
1	advisory review 
1	(f) monitoringto ensure
3	returns processor, without
1	unless, in accordance
1	records shall, upon
9	ninety days after
1	(ii) be supported
1	(2) replace such
1	control strategy, a
1	submissions for each
1	prescribe; and (3)
1	egg inspection programs;
1	which, under subclause
2	agencies with or
1	(thiamine) (g) 40.0
1	research consortia means
4	secretary and other
1	half the amount
1	 (d) finality
1	increasing or replenishing
1	drugfor purposes of
1	authorizationan authorization of
1	encouragement and special
1	using any such
3	food if it
1	receiving any eggs
1	regulationthe final regulation
1	agencies, with the
1	(
 
 2014.
6	(a).  (d)
1	require establishment and
1	standard, and, insofar
1	civil penalty objects
1	benefits and risks),
1	colombia. (3) ieepa
1	(g) reference to
5	346a of this
1	establish such procedures.
1	implement a strategic
1	near schools and
1	programs and activities.
1	deemed to establish
1	unless they were
1	disclosed to any
1	submit to congress,
1	offenses; and (ii)
3	among hospitals or
2	commodity that is
1	(3). (2) the
1	equal to 1;
1	equal to 15
4	intent to defraud
1	 (5) documentation
1	questions of clinical
2	equal to 10
1	matter, or of
4	deferral extensions, and
1	study regarding the
2	pediatric study planning
2	device or label
1	professional positions at
1	writing a prescription
3	burdensome on patient
3	2014 and subsequent
3	person who knowingly
1	approval or review
3	information concerning its
2	exemption that allows
1	marijuana use. (f)
3	30 years and
2	(1) every manufacturer
1	individual under such
2	assess the safety
1	 (3) small
1	indian tribes. 
7	director for demand
1	animal drug permitted
2	consistent with federal
1	cancellation, whichever is
1	drugs shall have
1	training on subjects
1	(n) homeland security
1	expended and shall
1	
 471. safe
1	safety performance measures
1	boobytraps on federal
1	(a)), shall be
2	whose possession of
1	application, with respect
1	secretary has previously
1	effective while approval
1	product comply with
2	be) in an
1	drugs, or prescribe
1	dietary supplement provides
7	public health emergency
1	1712. termination of
1	regarding developmental milestones
1	subchapter have a
7	made under subparagraph
1	repackagefor the purposes
1	labeling must state
1	copy of petition
2	(a)(1) and following
1	contaminated agriculture and
1	
 379j. authority
1	narcotics traffickersnot later
1	general controls. 
1	section 262, for
1	children and customarily
1	costs, consistent with
1	reportthe secretary, in
1	675, 915, as
1	$258,019  $263,180
5	shall be forthwith
1	federal personnel to
1	sources and methods.
1	approval or, as
1	continuation of a
1	(1) on or
1	may determine not
1	(not including packaged
2	exporters of listed
1	
 
 387p.
1	animal feeds manufactured
1	chloride. (d) ethyl
2	establishment, after their
1	require inclusion of
1	keep in his
1	advertising that features
1	sections[3] 379aa or
2	revoked pursuant to
2	congress or from,
3	list of devices
1	(5) of this
5	prior public inputprior
1	campaign. (c) advertising
1	(2) report to
1	united states other
2	importation the secretary
1	(i) not own
1	used in committing
1	paragraph (1)(b) 
2	personall-identifiable information in
4	chemical residue for
2	seeks accreditation. (d)
1	consortia with respect
1	transferred
 
 968.
1	bodies that meet
1	new drugs. nothing
1	publicly available, including
1	sells or distributes
1	protect animal health,
1	state or any
1	exposure from, the
1	upon, the secretary
1	substance whose chemical
1	consumption patterns among
1	different listed drug
1	(a)(iii) for the
2	pensions and the
1	waive requirements under
1	limitationsparagraph (1) shall
1	summary shall not
1	title 42), unless
2	animal drug can
2	inspection rendered under
1	uses proposed therefor
2	port in the
1	submitted, if such
1	(a) to comply
1	distributor shall identify
1	requested in such
1	electronic copy required
1	(7).  (4)
2	capsule, or any
2	technical advances in
2	times for abbreviated
2	origin of such
1	officials, and their
2	department of defense.
1	discuss with young
1	paragraph (a)(2)(b), the
2	upon request from
1	receives such letter
8	review of an
4	payments payment of
1	product shall collaborate
1	 (a) required
1	(d)(3), (g), or
1	379dd(d)(2)(a)(ix) of this
1	qualified expert panel;
2	repackager has reason
1	(b), no person
1	one adequate and
1	require an eligible
1	omission or transaction
1	requirements. the attorney
1	drug only in
1	existing standards for
4	states in the
1	obtain a certification
1	drug performance measurement
1	causes of such
2	gram or more
1	drug only if
1	drug samples. records
7	treasury of the
1	permits, credentials, certification
1	late notice of
1	services to any
1	level information consistent
1	whether a genuine
1	section; (2) the
1	part;  (9)
1	application.  (iii)recipients
1	number of hectares
1	date and revocation
1	recommended does not
1	issue a no-compliance
1	olympic committee the
2	in, commerce or
1	part and standards
1	term high managerial
1	academic experts, health
1	sections referred to
1	similar written advertisement
1	clearance not less
1	act, and the
1	substances moneys expended
7	382 of this
1	control program. 
1	(d), during an
1	fingerprinting strategies, for
1	time of inspection,
1	information, and transaction
1	pending; or (2)
1	fentanyl. (7) isomethadone.
1	(9) as used
1	maintain any information
2	purposes specified in
2	application is accepted
2	conducting periodic inspections
1	means as job
1	(a) provides links
1	(i) shall list
1	ingredients from domestic
1	manufacturer not later
1	 (o) postmarket
1	chemical intermediary used
1	certification, by the
1	detect fraud and
1	ch. 675, 702,
1	without distinguishing between
2	notice issued in
1	subsection (a), no
2	formal change in
1	hearing, any interested
1	sole discretion, grant
1	certainty that the
1	government, or state
1	program to reduce
2	training or certification
1	least annual meetings
1	drug administration, medical
22	authorization under this
1	897.34(c). (d) distribution
3	secretary to carry
2	panels review of
1	articles that do
1	business, the fees
1	distributor, or section
3	program agency a
2	applicable statutes and
1	distributors, for such
1	therefrom, (iii) a
1	(2) notwithstanding the
1	revocationthe secretary may
1	(d)(2) during any
1	level of potency
1	information within 60
2	will permit the
4	(i) a petition
1	(b) another agency
2	drug backlog fee
2	accreditation. (d) such
3	 (d) designation
2	principles of operation,
1	phenylpropanolamine shall be
1	perjury, false statement,
5	united states. (3)
1	expertise, for monitoring
1	report in classified
1	includes the prospective
1	market the product,
6	addition to other
1	contents thereof, in
2	misbranded at the
1	(a) the petitioner
1	directors  (a)
2	purchaser of a
1	supplier; (iii) provided
4	may also, after
2	executive branch of
1	objectives specifiedthe objectives
1	unauthorized obligation or
1	(e) a recall
1	standards for which
1	identifier for tracing
1	apply, if any
1	review only if
1	1042. reporting of
1	submission containing such
1	clarify, and define
2	subsection. (june 25,
2	reports in accordance
1	appeals has entered
2	indian tribes (as
1	provides that such
2	opioid means any
1	relevant expertise, to
1	exchange among sectors
1	operator otherwise agree.
1	 (1) intending
1	notification the commissioner
1	states. (ii) the
1	except as they
1	(d); or (ii)
1	applicant has supplemented
1	measurement of clinical
1	 (d) definition
1	manner in accordance
1	provide treatment or
1	entry inspection activities.
1	dietary supplement; (4)
1	issued a determination
1	purpose of covering
1	enact such changes
1	secretary. (g) marketing
4	make such order
1	sponsor) for applications
1	use, including any
1	named in a
1	damages to the
3	subsection (b), shall
1	apart and slaughtered
1	shall ensure consultation
1	(f)(4)) shall apply
1	prevention, and other
1	drug trafficking areas.
1	subchapter is false
1	chemical; or (b)
1	practitioner which is
2	showing that an
1	application, supplemental animal
1	(2) articles intended
5	suggesting changes to
1	defendant, asserting a
1	performance goals identified
1	dismissed, if a
2	means of evaluating
5	18-day exclusivity period.
1	ceramic pipes with
5	views, or arguments
1	review division; (vi)
1	(a) unsafe color
1	actually been inspected
1	annual registration (a)
2	container or package
1	distributor (other than
1	devices. (ii) statutory
1	secretary disapproves a
24	(a) the term
2	item of a
2	document providing the
1	
 
 609.
1	rejected or denied
1	device to such
1	appropriate relief including,
2	1, 1956, ch.
1	submissions a premarket
1	product and good
1	fish stocks. (

4	organized under the
1	2907, title v,
2	drug sample in
1	(b) upon petition
1	thereof and shall
1	requester to obtain
1	disclosure of additive
4	reports under this
1	research and development,
1	facilities, and shall
1	675, 527, as
2	drug whose active
1	exception any person
2	application of least
2	reports made under
1	employment. (2) a
1	(2), and (3)(b)
1	practicable, as part
1	law are exercised
2	increase the risk
1	afford the tobacco
1	application respecting a
1	uses, such regulations
23	pediatric disease product
1	may not under
1	include the registered
1	annual registration (as
2	standards and possible
3	withdrawal of accreditation
1	cheese, or ice
1	convention in which
1	notwithstanding subparagraphs (1)
1	(8) any other
1	involved an identification
1	test, in accordance
1	board shall establish
1	may require, (d)
1	applicable fee is
1	 (f) product
1	fed. reg. 4131441372
1	animal or otherwise)
1	micr-organisms in dilute
50	secretary shall establish
1	post information regarding
1	include an article
1	including a foreign
1	dairy farm or
1	387. definitionsin this
1	shortage, including the
1	appeal. (b) renewal
1	order to accommodate
1	section. (5) the
2	drugs, as well
1	states determines that
1	(ii) if 
1	need from potential
7	proposed labeling thereof;
1	constitutes good cause
3	control policy shall
1	1996 through 2002,
1	submission notification of
1	proposed labeling thereof,
1	(e) a dietary
5	5304(e) of title
2	sponsor fee 
1	substance if he
1	individual patient named
31	(2) the secretary
1	no-compliance with communit-release
2	selected establishment the
2	regarding  (a)
1	limit the manufacture
2	tobacco product do
1	economic research service
1	standards minimize the
1	shall administer the
1	262(i)].  (c)
1	shall, by guidance
1	(a)(3)(d) and (i)(1)(d)
1	42, the approval,
1	interim results of
1	50 states, the
3	food additive; or
8	otherwise unfit for
1	outsourcing facilities in
1	subsection.  (h)
1	foods certified by
1	administration administrative and
1	type of drug
1	355c1. report (a)
1	process or at
1	summarily discharged from
1	(2)(a)(iv) shall give
1	food. (2) processed
2	individual under subsection
1	consignee as described
1	promote sharing information
2	process or an
1	review division; (ii)
1	(i) of a
3	transaction in a
1	offense while entering
1	unregistered foreign establishments;
1	poison, except as
3	register the amount
2	first conviction for
7	person fails to
1	particular. (b) if
1	option to accept
1	extent of data
6	compared with other
1	additional pediatric use
1	study, in the
1	period over which
1	decree and upon
1	(g), (h), (i)(2),
1	(v) the number
2	required under clause
1	conviction, an investigation
1	identifies the products
1	675, 702, 52
1	species under the
1	verification, inference, and
1	360ss of this
1	sold, bartered, exchanged,
1	shall inform state,
1	carcasses, or poultry
1	set apart and
1	consideredin deciding whether
1	chemical the terms
2	pilot or other
15	order under subparagraph
3	conditions under subparagraph
1	product began. 
1	(ii) matching requirement
1	prevail.  (3)
1	cigarette to the
1	(a)(2), fails to
1	chapter, and is
1	phenylpropanolamine may apply
2	administrator shall file
1	auditor  (i)
2	publi-private partnership project
1	distributed in a
1	prescribe schedule iii,
1	disease in which
1	approved investigational new
7	year ending september
1	subchapter, such sum
1	subchapter shall not
1	application.  (d)
1	president whether action
2	generalupon the request
1	perform appropriate community
1	per year the
1	funding for such
2	unless the eggs
1	(directly or through
1	 (2) notice
1	(e) full reports
1	recipients use of
1	(b)(iv) shall be
1	(i) a premarket
2	containers and immediate
1	transaction if the
1	transporting, and importing
1	request; (ii) resulting
2	product packed in
1	costs are more
1	classified or unclassified
1	bears or is
1	services under section
1	(8) transfer funds
1	submission requirement if
1	resulting accreditation shall
1	conducted; (ii) a
1	1172. repealed. 

4	paid from fees
1	(4) smoking and
1	reduced through reliance
1	aforementioned health hazards;
1	mutual agreement between
3	bioequivalence studies or
2	produced by the
1	(vi) to enable
5	well as significant
1	employment of technicians
4	high priority to
1	1999, the applicable
1	(2) exemptions; variances
3	publicly available registry
1	used and exported
1	i, 4, formerly
2	use in drinking
1	practitioner. (ii) the
1	 (1) petitions
1	ii and devices
1	mitigate a serious
1	(ii) a pediatric
1	amounts of certain
1	significant losses of
1	product against such
3	section 321(ii) of
5	food specified in
1	serve as representative
1	unless sold as
1	support the conclusions
1	general in obtaining
1	with, the requirement
1	providers about emerging
1	dispensed, or acquired
1	c (ascorbic acid)
1	secretary approving an
2	title insofar as
1	employed.  (3)
1	effective; or (ii)
1	obligated for such
1	
 
 802.
1	conveyance makes it
1	license the license
1	establishment, is physically
1	policies and steps
1	including the national
1	(2) to inspect,
2	(c) for which
1	 (a) sending
21	pursuant to subparagraph
1	registrant; (b) direct
1	cigars, all cigars
1	consultation  (a)
1	vegetables) intended for
1	1973, $5,000,000 for
1	treat up to
2	revenues from prior
1	since december 3,
1	act that provides
1	information and technology;
1	users under the
1	food, of eggs
1	petitioner under penalty
1	gases (as medically
1	assistance division. (g)
1	data then before
1	include, at a
3	transmit a notice
2	maintain the product
1	emergency response goalensure
1	(2)(a), but cannot
1	person. (b) suspension
1	purpose of aiding
8	330.14 of title
1	owns or operates,
1	manufacturers, wholesale distributors,
6	552a of title
1	conduct and promote
1	(cc) a product
1	(6)[2] shall not
1	facility that relate
1	 (h) certification
1	plan may include
1	(a)(ii) on behalf
7	responsibilities of the
4	available to defray
1	processing establishment. 
1	individual, limiting the
1	subsection (h); may
2	listed by the
1	listed chemical the
1	standard applicable to
1	(i) may 
1	pos-seizure administration the
1	aware of (that
3	single proceeding. (b)
1	products so inspected
1	made and which
1	first use unobligated
2	protocol, (ii) the
3	months after receipt
1	administration); or (ii)
1	qualification packagethe secretary
1	subparagraph (a), necessarily
1	1 of which
2	v or to
1	require the reduction
1	
 606. inspection
33	approved by the
3	request within thirty
2	subsequent redesignation of
1	stat. 22.)
 

1	agencys best advice
1	distributors, or dispensers
6	imminent danger to
1	disregard for the
1	articles. such burden
1	section 1705(a) of
1	cigarettes on the
1	order applies. (ii)
4	plan described in
1	food. (2) the
2	(1) by an
1	(
 
 1601.
1	(a) drug samples
1	expenditures for salaries
1	sought will be
3	thereof of all
1	(ii) from which
1	issuance of order
1	section shall notify
1	first application submitted
1	devices shall have
2	denaturation or other
1	pertaining to eggs
1	permitted, the secretary
1	expenses necessary to
1	chapter and food,
1	exemption or any
1	(2) agents that
1	liability. (b) program
1	state program to
8	person have been
6	secretary shall appoint
1	device; (c) opportunity
1	22, 1996, limit
1	controls.  (i)
3	cooperation with state
2	construed to expand
1	26, 1938, (ch.
4	judicial review 
1	
 1905. authorities
2	suspected food safety
20	(i) the secretary
1	entity that intends
1	97d. omitted
 

1	(2), if, prior
1	drug user population,
1	section; (iii) the
1	information resulting in
1	unhatchable. (5) the
1	requirements; small enterprises;
1	dru-free americathe director
1	panel in the
1	original standard new
1	established name, unless
7	equivalent to another
1	persons in which
1	unit and comprised
1	term holiday for
1	process for review
1	subsection for use
1	lon-term strategies to
1	benefits or risks,
1	safety information listed
2	exception subparagraph (a)
1	exercising general jurisdiction
1	subchapter; and (c)
1	(a)reporting.beginning january 1,
1	order public. except
1	storage, retrieval, hosting,
2	owning or operating
1	supersede the right
1	regarding the priorities
1	changes which may
1	 (f) registration
3	deny approval of
1	introduces into interstate
1	reason bearing on
1	approved or that
3	file fee established
1	months thereafter, the
1	community the term
1	concerning infant formulas
1	product sampling, storage,
1	 (i) conducting
1	regulate radioactive materials
1	may provide by
1	(g) delivery of
1	proves to the
1	habitually uses any
1	receives a written
1	trafficking and to
3	demonstrate to the
1	hens.  (b)
1	officio members the
1	reports, premarket notification
1	-penty--[-(-methoxynaphthoyl)]indole (jwh081); (ix)
2	(1)(a) or (1)(b)
1	relieve an outsourcing
1	body the term
2	appropriation referred to
9	reorg. plan no.
1	years. any proposed
1	test, either fail
1	administration registration numbers
1	offense and at
3	identified noncompliance materially
1	(a)(2); and (d)
1	requesting registration, as
1	pediatric use under
1	submission, that a
1	manufactured and labeled
2	educational agency that
1	(i) october 1
6	web site. 
3	title.  (9)
1	packer of any
1	established for avocadoes,
5	drug, as the
1	duty) or to
2	service. if no
1	penalties) of section
3	shall identify the
1	sharing and enforcement
5	requirement of the
2	earlier or later
1	abuse not later
10	crediting and availability
1	ingredients which shall
2	therapeutic class of
1	may share information
1	consider the feasibility
1	(b) ris-based schedule
1	(b) manufacturer of
4	attorney general respecting
3	complained of; or
1	 (1) was
1	ch. 675, 569a,
1	section 343(r)(6) of
1	(2) accreditation body
1	incorporate the foundation;
1	(g) no delay
1	evaluation, and his
1	cause other than
3	contain such other
1	2011. definitionsin this
2	thereof to any
1	determination.  (ii)
1	incorporate the foundation.
1	general. (6) that
1	local medical associations
2	 (b) compounded
1	final audit report
1	chapter; or (ii)
1	section in any
1	compiling, developing, and
1	
 501 to
1	be. (ii) in
1	facilitate, the violation
1	methods for rapid
1	section 379j11(5)(b) of
2	including through electronic
1	identification number for
2	secretary over articles
1	(vii) storage and
1	persons about the
1	opioids or methamphetamines
1	represented as poultry
1	stat. 512; 

1	understand the requirements
1	success of the
2	product is exempt
2	200,000 in the
1	record keeping 
1	information, and shall
3	another application approved
2	3502(2) of such
1	(in any direction)
1	documentation that such
5	application or the
1	follows: apples of
1	shall be accomplished
2	accreditation bodies 
1	 (a) 20
1	section 811(f) of
1	carcasses of species
1	(s) the transfer
1	supports his determination
1	public identification and
2	appropriate panel established
1	care facility (as
5	facility to which
1	 (2) workload
1	concerning the aggregate
1	(iii) the private
1	802(54)(f) of this
1	performs no other
1	information applies. this
1	appointments under this
1	evolution of microorganisms
1	labeling the secretary
1	labeling; destruction of
6	general each person
1	prevention of hypoxemia
13	appropriation account for
1	include complete reports
2	50 kilograms of
1	available.  (4)
1	subsection (e)(1)(a) of
1	detention order issued
1	 (ii) active
1	standards.  (g)
2	repackager is an
2	subsection (k): 
1	following studies, and
2	investigation, has found
1	primary prevention programs
1	years but not
1	2 and 4
2	2 and 5
1	inspection, or on
1	necessary. (b) ris-based
2	determined for a
1	subsection. a list
1	6, 1996, for
1	(1) any district
1	investigators that any
2	shall list a
3	thereafter that the
1	(a) and (k)
1	commercial truck, or
1	(15) to distribute
1	process agricultural commodities;
1	commodity bears labeling
1	reasonable timelines, in
6	attorney general has
1	chemical preservative unless
1	violate subparagraph (a)
6	judge or magistrate
1	production from a
1	prohibition the importation
1	facilitate patients ability
1	675, 586f, as
1	results of those
1	sanctions shall be
5	register, for a
1	sanctions to significant
1	will be returned.
2	food safety requirement
16	title 18. 
1	shall take whatever
22	unsafe within the
1	due date as
1	conducting clinical trials;
1	facility or restricted
2	5. (
 

2	february 15, 2007;
1	state relating to
3	procedurein promulgating a
1	imprisonment, or civil
1	preceding sentence. notwithstanding
1	act referred to
1	title that authorizes
1	operations; termination of
1	
 
 679c.
1	paragraph. (b) in
1	concurrence with the
1	
 355e. pharmaceutical
1	(a), in such
1	 (2) contentseach
1	drug submission from
1	homogeneous case the
2	entities to fulfill
1	goals for reducing
2	secretary shall recommend
1	pesticide. notwithstanding any
1	prescribed by law,
4	budget request of
1	shall look to
13	parts of the
1	march 3, 1913,
1	excise taxes paid
1	(ii) destroyed or
3	aggrieved by a
1	objective clinical and
6	established under subparagraph
2	care providers and
1	diameter; standard grade
2	part b of
1	feasible, for different
4	amendment, or revocation
1	determined are low
2	emergency shall not
1	declaration if a
1	ingredients only in
1	refers to or
1	comparable alternative statement
1	violates the regulations
1	services, for substances
1	general files a
3	(2) accompanying such
2	drug or upon
2	free of a
1	notice requiring each
1	(2) other regulations
1	device user receives
2	refusing to conditionally
15	administration of this
1	title as then
1	populations, as necessary
1	south africa; or
7	for, or recipient
1	(d) exercises in
1	control policy the
1	marked, stamped or
1	355(j)(5)(b)(iv)(ii)(cc) of this
1	inspection. each such
3	projects designed to
1	application approval; criteria;
5	person who submits
1	immediately available. (i)
1	request that such
1	increased punishment may
1	 (3) chairperson
5	drug for use
1	council (a) clearinghouse
1	subparagraph (c), a
1	high risks as
4	secretary may, after
1	schedule the secretary,
2	eggs, capable of
1	(6) benzethidine. (7)
1	
 
 357.
3	substances that are
1	humans. (w) the
1	employee with respect
1	(b) federal agencies
1	title). a separate
1	illegal drugs throughout
1	complete other activities
4	notify the petitioner
1	cream imported when
1	engage.  (g)
1	harmonized tariff schedule
7	year 2017, and
2	action made on
1	caused by contaminated
3	approved drug means
1	development, manufacturing, or
1	testing that confirmed
1	holder that the
1	(i) information was
2	united states, accompanied
2	carcasses, meat, and
1	receipt, possession, distribution,
1	web site, and
1	501, as added
1	courts shall have
1	assessment or reimbursement
1	ch. 675, 420,
1	export, and (b)
1	violations of subsection
1	product has an
3	altered official certificate
1	 (d) attorney
4	sunscreen active ingredients,
1	interest, by any
1	designated, upon the
1	form (including gel
2	tribe (as defined
1	outreach to potential
1	(a) section 306
1	recovery and retention
1	sunscreen active ingredients;
1	consignees receiving products
1	distribution before the
1	(ii) a requirement
1	initiative, propose the
2	possession of facts
1	consideration if the
1	system; and (ii)
1	date such drug
1	application when that
1	(h) for purposes
1	concerned. (mar. 3,
1	subsection (a)(1)(d) for
4	database or utilizing
1	shall solicit 6
2	apply to offenses
3	establishment which fails
1	farm; and (ii)
1	month for which
1	directly, by referral,
1	presenting such drug
1	components and composition
1	governmental and nongovernmental
1	priority review voucher.
1	priority review voucher,
1	license is issued
1	office.  (c)
2	promptly respond and
3	vitamin, mineral, and
1	675, 803, as
5	identifying mark, imprint,
1	(a) enhanced prison
1	(4) make arrests
3	affiliate is granted
1	shall require any
1	patient.  (e)
1	outbreak. (c) review
1	may postpone the
3	general. the attorney
1	both, as required
2	identify, implement, certify,
1	past, rising from
1	protocol intended to
2	committee for review
1	statement this is
1	collaboration.  (2)
3	device within that
5	entered against the
2	contents of the
1	shall be to
1	subparagraph (e), and
1	prohibited acts b
4	development of a
1	(g) to show
1	incident to withdrawal
2	priority review vouchers
1	june 30, 1975
1	regulation, revoke a
1	applications, or (ii)
1	title 49), operating
1	treatment under a
1	ch. 675, 515,
1	paragraph (1); notice
2	device under the
1	(v)authority for contracts.
1	(i) shall assess
1	completed or the
1	pecuniary value to
1	exempt under paragraph
1	taken out of
1	subsection (b), all
2	official is the
1	control point means
1	occurs an offender
1	respond to new
1	263a], to be
1	applicable limits on
1	675, 304, 52
1	secretary on how
1	bottle or package
2	facilitate the exchange
1	shall be had
1	products;  (b)
6	advisory committee established
1	time such quarantine,
1	 first. if
3	maritime patrol hours
1	investigation, and evaluate
1	(d) and the
1	confirm the detention
1	rational or useful;
2	necessary, the rationale
2	determine that such
1	committee; the secretary
3	debarment; certain drug
2	assure safe use.
1	responsibility in accepting
1	335b(a) of this
1	means in accordance
3	year unless the
1	stat. 476; 

2	beginning in fiscal
1	subsection (a) a
1	available. (b) regulationsnot
1	governments prior to
1	initiated or become
1	user fees on,
1	selective breeding. 
2	guidance documents that
1	meets all other
1	stat. 1103; 1940
1	parking facilities for
1	machine, and a
1	government witness protection
2	seizure of property
1	 (d) acts
4	approved or cleared
1	subject by 
1	cause the same
4	authority to enter
2	representative selected by
7	upon a request
1	international standards in
3	cost of overtime
3	22, 2009, and
1	motor vehicle (as
2	value therefor 
1	smuggling.  (b)
1	
 
 387c.
1	title 7. (june
1	regarding compliance of
1	appropriate medical judgment,
1	knowledge definedfor purposes
1	potential conflicts of
1	incentives are necessary
1	period notifies the
1	effective appeals mechanism
1	clause (i)(ii) or
1	cigar in section
1	october 2002. (11)
1	penalties and interest
1	prohibit accessing, using,
1	prescriptio-drug television advertising
1	proceedings nothing in
2	representatives of each
1	property; penalties; boobytrap
1	administer and prescribe
1	amateur athletes of
5	date specified by
1	smaller amounts in
1	device is eligible
1	sources, foundations, and
1	increased and the
9	information the secretary
1	proposed regulatory management
1	registry established under
1	(1)(e)(ii). fees required
3	unless, in the
1	(2), as the
1	establishment, subject to
1	824(f) or 881
3	name of another
1	graduate, and shall
1	expected need; and
1	responsible parties. 
1	agency during the
2	unsafe in all
13	device that is
1	use, as provided
1	purchases in commerce,
1	require compliance with
1	legitimate purpose for
1	131. repealed. 

1	exempt from asserting
1	current illicit drug
2	delay, a description
1	indicators and evaluation
1	additional tenfold margin
1	mineral acids, oxalic
1	establishment, institution, or
1	meet urgent needs
2	type c fre-choice
1	act or practice
3	whether the pesticide
1	include those foods
1	(4) procedurein promulgating
3	specifically to enforce,
2	making the assessment
6	court shall not
1	agency heads with
1	time the article
4	egg that has
1	subsection (n)(1)(g) and
2	commissioner concerning appropriate
1	references scientific evidence
1	consequences which may
1	award shall not
2	compounded by or
1	product, whichever is
6	personnel of the
1	may deem proper,
2	abuse activities of
1	 (e) implementation
1	meat itemthe term
1	tribal agencies. where
1	manufacturing industry; two
1	amateur athlete the
3	states, but the
1	providing agricultural quarantine
2	 (b) method
2	case described in
1	determination was in
1	elements of section
2	logistics provider to
1	purchase statement from
1	parties. in awarding
1	title it shall
1	(7) knowingly represent
1	entities.  (2)
7	director shall be
1	new product applications
1	fiscal year, at
1	paragraph. (5) an
1	original submission of
6	(a).  (2)
7	fiscal year, as
1	2018, there is
1	 (b) exemption
2	6 years. 
2	specific threat agents
1	product. (2) unapproved
1	sales  (a)
1	involved, except that
2	declaring that an
2	country applies standards
1	commodity (including treatment
2	fiscal year, an
2	 (b) territorial
2	upon prescriptions of
1	that, as determined
6	benefits paid with
1	expedited procedure; conditions;
2	except as may
1	application) was submitted.
1	1536. communit-based coalition
1	used or useful
1	major species means
1	 second. if
1	standards. any official
1	registered, or otherwise
3	issued under the
1	quantity which may
1	longer benefitting the
1	shall be matched
1	alkaloids or alkaloidal
1	(a)(1)(b). in the
1	nmic means the
1	general to state
1	paragraph (3), refuse
1	(c) an herb
1	review an order
1	active ingredients, a
1	identity and intended
1	retail packaging of
1	(3) board representation
1	condemnation of property
1	faith, and (iii)
1	additives, or labeling.
1	ch. 696, 13,
3	submission described in
2	consider only the
3	section 351(f)(1)(b) of
3	hearing, in accordance
5	necessary for approval
1	part for practitioners
1	chain for such
1	dates were delayed
1	organizations serving youth.
1	prior to administration
1	(4) deferral and
1	examination of whether
1	exceed 80 per
8	secretary to inspect
1	expenses under section
1	(c) penalty for
1	national clandestine laboratory
1	official as recognized
1	meet with such
1	appropriate, shall determine
1	environment; and (e)
1	notification prior to
1	(a)(v)(ii) and (d)
3	december of each
1	714b or 714c)
1	obtained since the
1	 (ii) that
2	paragraph (c) has
1	secure their identity
1	flood; (vi) ensure
2	register stating good
4	 (b) for
1	entitled to such
1	355(j) when pediatric
1	whether the formula
1	secretary within 60
1	risk for illicit
1	aggregation, as necessary,
1	community that first
1	violates subsection (a)(1)
2	clause (ii) which
1	period of time;
1	cabinet level officials,
1	coalitions demonstrate that
2	paragraph (6) has
1	675, 585, as
1	(1) the provision
1	impairs individual, as
1	issued either by
4	period of time.
1	(7) ensure ongoing
13	section 360d of
1	record in accordance
1	(i) the eligible
4	average cost incurred
1	general, at such
1	trafficker and such
1	controls resulting from
1	determines would help
1	clause (i), be
2	title, or any
1	right to consultation
5	production of evidence
1	manufactured or stored
1	secretary and disseminated
1	federal establishment that
1	oleomargarine sales the
1	product, other than
1	scientific institutions, or
1	users who reside,
1	imposed, be posted
1	1604 of this
1	confirm or modify
2	drug solely because
1	market the product.
1	processed, and, unrestricted
1	chemical residue definedfor
1	section as reactivation
1	greater severity, specificity,
1	(f) cooperation and
3	section is to
1	poultry subject to
3	enforcement intelligence sharing
2	sponsor. (h) review
1	new conditions of
2	later of the
1	secretary, are sufficient
1	inclusion with the
1	(bb) does not
1	helpful to law
1	combination of a
1	 (e) exemption
1	independent experts. 
1	sections 341 and
1	regulated sellers that
1	administration requesting agency
2	submitted the human
4	regulation and under
1	force established under
1	(i) the importer
1	inquiry made of
1	article affirmatively establishes,
1	whenever the court
1	refuses to or
2	written decisions of
2	food solely for
1	treaty or agreement.
1	(i) definitionas used
1	establish categories of
2	give notice under
16	(a) with respect
1	(c), such information
2	committee on compounding
1	priority.  (d)
1	shipment was tested
1	30, 1976; and
1	benefits set forth
1	external scientific experts
1	(
 
 1034.
1	
 198a to
19	judicial review of
5	355(c)(3) of this
1	effect any requirements
1	food previously denied
1	committees on international
1	places, of colored
1	deleterious substances. (june
1	sign adjacent to
1	notwithstanding the classification
1	safety of consumers
1	clinical benefit. (b)
1	consumer; and all
1	either from investigations,
2	subparagraph (a) upon
2	generally in or
1	toxicity; and 
1	imposing penalties and
1	research and quality
3	adverse effects on
2	recognized, or from
7	voluntary qualified importer
1	change shall contain
2	shall be revised
1	constitutionality of the
1	submit such a
1	deem necessary and
1	allocate resources, detect
1	guidance.  (f)
1	prevention, the director
1	places it in
1	technologies. (b) review
1	information resulting from
1	uses that are
1	113 of chapter[1]
1	extensions requested and
1	 (n) substantially
1	facility pursuant to
1	products. representatives of
1	filling or refilling
1	recertification of eligible
2	application whenever the
5	tests or methods
2	section and under
1	container, when and
3	administrator may by
1	drug administration gifts
1	(b) is the
2	medicine, the american
1	submissions. (g) the
1	subsection. all appointed
1	good standing shall
1	information, that 
1	(c) the absence
1	paragraph (1), oxygen
1	subsection (c). compilations
2	predicate device, or
1	brought under subsection
1	 (b) quantitative
2	may be commenced
1	foreign recipient. (iii)
1	 (d) priority
1	62 stat. 991;
1	device premarket review
1	title 42; (3)
1	(26) the term
1	manner, is adulterated
1	secretary may establish)
1	current or future
1	secretary may establish,
2	states pharmacy regulations
1	implement strategies on
1	exclusive the remedy
1	single day shall
1	objection to the
1	designating this chapter
1	42.  (d)
1	inspection is being
1	administration of drug
1	product, establish any
1	subsection (j)(5)(b)(iv); or
1	food at vulnerable
2	effect of the
1	2013, verifying whether
1	forfeitures (a) subject
8	chapter and the
1	interpretive criteria in
3	establishment, the name
3	on-third shall be
1	services to meet
1	persons under age
3	store, or other
1	considered approved or
1	collected for that
4	person is subject
1	files a complete
2	drugs.  (3)
2	will exceed the
2	manufacturer an opportunity
1	make modifications to
1	public interest. (5)
14	products that are
1	(ii) that no
2	administration is not
1	v compounded therefrom
2	(3) of this
5	fees under paragraph
1	31. (3) authorization
1	section; (c) information
1	statement is made
1	(c) revise any
1	inspections for purposes
1	states and is
3	may be unintentionally
1	members with respect
1	variances from the
1	part of analysis
1	drugs, antibiotic drugs,
2	detained, until released
1	(b). (d) in
1	held. (3) an
1	life shall be
2	respect to information
1	achieve its primary
1	pattern of colors,
1	product any requirement
1	employment, and within
1	section and to
2	states and in
1	may administer the
4	substantive determination that
1	reasons includes transfers
1	identified for purposes
1	criteria and interpretive
1	report a panel
1	shown on each
1	supply chain. (c)
1	support of admission
15	response to such
1	book chapter, or
1	date, any amounts
1	abbreviated applications. (ii)
1	inform those requesting
2	shall engage in
6	later than february
1	programs; and (2)
1	application thereof to
1	organizations, and government
1	predictive data from
1	human consumption and
1	392(a)), the provisions
1	officio members. 
1	coa-tar hair dye,
1	indian tribes or
1	rates in humans;
1	involving an electronic
2	made by individuals
1	requires) directly thereon,
2	food was manufactured
1	made a part
1	address receipt, security,
1	title 18 or,
1	(b) a common
1	(2) confer any
7	assurances that the
2	evaporated, concentrated, powdered,
1	 (2) product
2	employees: provided, that
2	deadline the secretary
1	exceed $175 for
1	event reports regarding
2	substances by nonpractitioners
1	consideration scientific evidence
1	importation and distribution.
1	(2) commerce within
1	submit such plan
1	regarding the status
1	account shall remain
2	fee for active
1	secretarys proposal to
1	may possess) such
2	poultry products shall
1	commitment shall be
2	provide notice to
1	675, 586d, as
2	detailed information regarding
1	
 971. notification,
1	whether inadequate institutional
1	execution upon entry
1	term playground means
14	accordance with regulations
1	pursuant to orders
1	sections 342(a)(2)(b) and
2	requirements that are
1	deficiencies in abbreviated
2	contractors, including costs
1	subsection susceptibility test
1	hearing; and (iii)
1	countermeasure experts, including
1	(
 
 902.
1	entity. such term
2	previous 10 years
1	consignee for expenses
1	relating to human
1	verification programs. 
1	 (a) further
4	rules of civil
1	(2) ensure that
1	owed an action
1	iii and iv
3	may issue such
2	constitute a disqualifying
1	preparation meets the
2	compiled under section
1	 (b) any
3	funds for the
1	chapter shall make
1	articles the adulteration
1	chapter. such data
1	861, 1, 70
1	residue levels in
1	paragraph. within five
1	criminal penalties 
1	care providers better
1	(2) the administration
1	secretary declares to
1	affairs means domestic
2	physician to treat
5	drug when administered
1	secretary), acting through
5	described under clause
1	
 114i. pseudorabies
1	biological products, diagnostic
1	transfers under this
2	 (2) additional
10	drugs and devices
1	scientific feedback and
1	formula exempt under
8	title.  (c)
1	
 871. attorney
1	notifications shall occur
2	facilities in which
4	any) presented by
1	privileges, or remedies
1	title[1] unless sold
1	purpose of manufacture
1	logistics provider is
1	subparagraph (a), that
2	state as the
1	(i) shall have
3	importers and types
1	logistics provider if
10	petition for a
1	hold the first
1	exposure to, electronic
1	required with respect
1	operating reserve amounts
2	logistics provider in
1	pharmacist, or (iii)
2	evaluating device effectiveness
1	civil action if
6	section 353(e) of
1	known. (3) the
1	public of the
1	combination, respectively, exceeds
1	consistent manner; (3)
4	expiration of three
1	shall be undertaken
1	paragraph (1). (mar.
1	acid diethylamide. (10)
1	$15,000,000 for fiscal
1	fires, and other
1	hatching operations as
6	person, and the
2	(1) shall address
4	impracticable to provide
4	invite interested persons
1	year 2004, the
1	(b) initiation of
1	importation by a
1	partnership, having duties
2	title that requests
1	clause (2)(c) of
1	sel-incrimination.  (

4	concerning a refund
1	shall suspend performance
1	profession, appointed to
3	serve as chairman
3	drugs by each
1	refused admission, and
1	product sponsors and
1	shall pay such
1	ch. 675, 714a,
1	security affairs; (11)
2	promote the public
1	food imports 
1	addressing issues concerning
1	nurse tanks of
1	inspection reports and
1	engineering, or technology.
2	program; and (c)
1	deadline  (a)
2	proposed regulation; (ii)
1	information to facilitate
3	time that the
1	preceding -year period
1	intelligence to law
1	develop model standards,
2	tomography drug has
1	program to expedite
1	receives the scientific
1	include an analysis
2	concentrate of poppy
2	24, 1948, ch.
1	blood, or other
2	including any state
1	basic grant a
3	authorized prior to
1	dispensing without an
2	surrogate or intermediate
1	medical experts, on
1	fresh and processed
2	priority drugs or
1	construed as being
1	correctly disclose all
1	order prescribing the
1	index. such a
1	component parts also
1	reduce the production
1	advanced therapies; (b)
2	secrets and other
1	nurse practitioners, the
16	section 374 of
1	regulation. (h) guidance
1	drug returns when
1	connection therewith and
2	directly relates to
1	needed to prevent
1	optical isomers. (2)
1	recognized standards defining
1	strategies) insofar as
1	using a device
1	mark. (w) the
1	(i) changes to
31	unlawful for any
1	(b) preclinical testing
1	(vi) 1 individual
1	ingredients (a) in
1	offering a controlled
1	informed consent will
1	participation of representatives
1	user facility, (b)
1	serious riskthe term
1	involvement as a
1	local government concerned
1	(2) n-cost match
1	thereof includes in
1	(3), a unique
1	used; and (c)
1	qualification plan submitted
1	(7) not more
1	conditions and that
1	case of nitrous
1	purposes, or express
1	relief may not
4	animal drug when
1	subchapter concerning any
3	(2) an accurate
1	year 1999 for
1	387f(e)(2) of this
1	labeling; (vii) information
8	person (other than
2	vacancy in the
1	(d) summary reviews
3	may, by order,
2	labeling requirements under
1	intended for recreation,
1	diet. (june 25,
2	provide by regulation,
1	upon the customs
1	tool, the requestor
1	
 
 144.
4	jurisdiction in the
1	requires that the
1	(ii) military preparedness
1	exemption following cancellation
1	product incurred in
1	(2) of a
2	formal comments on
2	feels it is
1	(2) to create
1	
 616. inspectors
1	prevents any direct
1	commodities if it
1	time following notice
1	acting capacity pursuant
1	(b) effects on
1	cosmetics (a) in
14	attorney general of
1	may affect whether
1	exempt a food
1	food in such
4	any, by which
2	permanent food contact
1	predicate device. (b)
6	attorney general or
1	fee per biosimilar
1	undertakes a corrective
1	
 387m. equal
1	professional associations and
1	distributing, receiving, holding,
1	obtain such concurrence.
1	(2) contentseach application
1	foreign office. (i)
1	optical or geometric
1	acceleration of medical
5	two years after
3	united states pharmacopeia,
1	year, except that
1	applicabilityregulations promulgated under
2	information reporting to
3	year to the
1	swine, or goats,
1	  iron
2	finds that, under
1	request that if
1	ch. 675, 907,
1	title made in
1	received or held
1	(d) definitionsas used
1	(4) requirements of
1	financial holdnotwithstanding section
1	oaths, examine witnesses,
2	known theft of
1	establish an index
42	(mar. 4, 1907,
1	grounds specified in
1	(1) arrange for
1	fiber produced from
2	public health priorities
1	senate. (c) one
1	evidence obtained under
1	paragraph may require
1	interest and the
1	i, 1, as
1	recipient and other
1	powers of secretaryin
1	public health as
1	(d) regulation issued
1	paragraph (6) may,
1	scientific tools, diagnostics,
1	drug may demonstrate
1	case of nonnarcotic
1	apply in every
1	substances, to be
1	requirements for articles.
2	drug offense have
1	physicians of services
1	support approval of
1	posting and such
1	poor and marginalized
1	name, or any
1	information act and
1	(a), a controlled
1	time of delivery
2	list is to
1	response, the director
3	(3).  (2)
1	means a hospital,
1	paragraph (1) not
1	alleged defect does
1	imposed penalty, whichever
4	drug administration with
3	shall be expended
1	fiscal year without
1	phenobarbital. schedule v
1	product; (ii) maintaining
1	(ii)withdrawal of application.
1	include the status
10	order of a
1	pose a risk
2	fees owed under
1	devices; and (c)
1	(i) for risk
1	provider if such
1	medical device the
16	one hundred and
1	within such agency
1	adjudication of an
1	in, or intended
1	jurisdiction over an
1	world trade organization
1	maintenance of custody,
13	appropriated for the
1	bring such proceeding,
2	cases where he
2	substance or product
1	dispose of any
1	board in person,
1	(f) collection of
1	1705(b) of this
1	require. a n-tobacc-sale
1	 (5) grandfathering
1	member positions on
1	expert consulted under
23	discretion of the
1	importation and bulk
4	carried out in
1	participated or is
1	punishment for which
2	risk for anaphylaxis
1	obtaining public comment
5	360f, 360h, 360i,
1	(ii), each person
6	punished by a
1	chapter, except this
1	shall not refund
2	application (a) full
2	approval; grounds; immediate
5	title have been
1	review of budget
3	required by subparagraphs
1	immediately after the
1	time. (
 

1	safe by reason
1	pethidin-intermediat-a, -cyan--methy--phenylpiperidine. (16)
28	secretary under section
1	(a) was first
1	combination products for
2	memoranda of understanding
3	countermeasures for which
1	inspect establishments according
1	section. (b) listing
2	distribute a schedule[1]
5	modifying, or revoking
1	determine any issues
1	separate registration; qualifications;
1	require the registrant
1	goals; and (d)
1	term employee of
2	leading representatives of
1	product or assisting
7	secretary shall, by
20	end of the
1	subsection that on
1	large investment needed
2	announcing that the
2	prosecutions or other
2	 (i) requirement
1	inspection or not
1	scientific principles and
1	thereto in which
2	prescriptions, or to
1	designations concerning indian
1	facilitated entry program
1	suit of the
1	final judgment; supreme
1	corrected within the
1	sale such barrels
1	clearance or other
1	term import means,
1	product is described
1	provided under other
1	inspections; and (4)
1	serves children from
3	substantial further manufacturing
2	subsection (f)(6)(a) revoking
2	protection, shall promulgate
2	loan, or work
1	9- or 21-calenda-day
3	regulations with respect
1	use of persons
1	homeland security, shall,
1	final report not
1	performance goals for
2	receives notification from
2	finds necessary or
1	material prior to
6	reasonable times and
2	prescription drug. 
1	secretary adopts changes
2	section in each
4	number of inspections
1	organizations, and institutions,
2	medicine from the
1	substance. if the
1	entry; (d) facsimile
6	process of the
1	52 stat. 1235;
3	subject to all
1	seq.], and enforcement
5	extent consistent with
1	miles distant from
2	person, have maintained
1	points of origin
2	u.s.c. 41 et
1	26 that is
5	person  (a)
1	(b) schedule iii
1	protecting both national
1	organization the term
1	less of a
2	discontinued participation in
1	acts for a
1	device or at
1	supply reduction means
2	center involved in
1	previous 6 fiscal
1	fre-choice medicated feed
1	list pursuant to
3	food manufacturing establishments,
1	cultivation, growing, or
1	(b) to enforce
1	disease priority vouchers
2	patients under the
1	carbolic acid, the
1	patients; (c) the
1	laboratories; (b) facilitating
1	hashish heads, or
2	unless using such
4	 (a) this
1	secretary) shall review
2	particular accredited person
3	commerce or substantially
1	grown tobacco used
1	site; (f) providing
1	address tort issues,
2	abbreviated application contain
1	(a) is awarded
1	meat inspection law
1	research the attorney
1	register.  (4)
1	transaction provides the
2	(d) veterinary professionals;
1	alcohol not in
8	entitled to receive
5	later than 10
1	(1) acetylmethadol. (2)
1	measure the effectiveness
10	decision on the
1	followed; or (g)
1	quantity being imported
1	copy thereof. any
3	advise the secretary
1	practicable, identify such
1	subject to multiple
1	affect the rulemaking
1	class i if
1	 folic acid
3	(c), (d), and
1	standard, may not
1	identifying the preventive
2	conveyance, or facility
2	designation for said
6	controlled substances. 
8	device, drug, or
1	insofar as applicable
2	importation complies with
1	plan agreed to
2	organizations prior to
1	amount of renewal
6	823(f) of this
1	section 350k of
1	place under seal
1	accredited persons compensation
2	secretary to induce
1	(c) except in
13	preceding 4 fiscal
1	islands separated therefrom
2	bearing on whether
1	responsibilitiesthe director, acting
3	(ii) the cumulative
1	consumers. unwholesome, otherwise
1	appropriate. (2) the
1	correction of defects
1	839, 4, 26
1	material differences between
1	patients, and for
1	submit, the audit
1	egg product which
2	-year period of
1	orphan drug or
1	explain certain safety
1	employee as he
2	person, or within
1	decision.  (3)
1	therein. such regulations
1	incapacity or substantial
4	shall recommend to
1	anaphylactic shock. (d)
1	biosurveillance integration center;
2	drugs to patients
1	united states attorney,
1	imprisonment twice that
1	united states attorney.
1	terms new safety
1	 (5) eligible
1	frequently than daily,
1	drug, such as
1	substances for any
1	drug is administered
1	following the courts
10	section 360kk of
1	drug side effects;
1	initiative the secretary
1	(1); (b) recommendations
3	sections 49 and
1	drug imported or
1	 (ii) with
1	(g) marketing 
2	inspection or exemption
18	misbranded under section
1	institutes an action
1	secretary, in order
1	360c or 360d
1	processed; or (ii)
1	3 years if
1	(ii) the rate
1	permit control (a)
5	result in serious
1	administrations pesticide residue
2	animal, or if
8	section 3583 of
5	premises, facilities, and
4	purpose. the secretary
5	include a detailed
1	systems, including complaint
1	handled by them,
1	corporation. (c) regulationsnot
1	limitation the national
1	public health, in
1	part thereof, excepting
1	decision to rescind
5	toxins, and analogous
1	dairy products so
4	product; and (ii)
1	persons employed intermittently
2	result in sundry
1	promulgate such other
2	confidentiality nothing in
1	prescribe good manufacturing
1	 (i) working
1	employees; (f) whether
1	 (a) notifying
1	additive as an
1	federal agencies having
1	submission based on
1	services the food
1	enforcement authority nothing
1	potential recipients to
1	targeted, including the
1	outsourcing facility. (ii)
1	forces; (e) the
1	seq.] or other
1	carcasses examined for
1	(i) requiring the
1	seller delivers the
6	business entity controls,
1	drug, device, dietary
3	360b(b)(1) of this
2	residue will not
1	shall provide in
2	expiration date and
1	reductionthe term supply
1	grant program under
1	intention to discontinue
1	patrol hours undertaken
1	substances schedules i,
1	information; (b) prevent
4	administration (a) in
1	(1)(c)(ii), shall be
1	pediatric studies required
1	142. milk or
15	shall be entitled
2	32 stat. 632.)

1	termination  (a)
1	facility that elects
13	regulation of the
3	available under subsection
2	effectively enforcing requirements
1	 (1) describes
1	feed under this
1	means the controlled
2	practitioner is a
1	(f) biosimilar biological
1	concerns any information
1	antiseptic shall be
1	act or other
1	targeting of inspection
1	(i) or which
1	subject to penalty,
1	using electronic population
1	454. federal and
1	order confirm the
1	satisfactorily accomplish the
1	differences; and (4)
1	requiring the person
1	issued, the labeling
1	law, enter into
2	effectiveness of drugs.
1	section, shall notify
5	extent of the
1	set by regulation
1	general the commissioner
1	(c) emergency response
1	
 141. prohibition
1	use for food
5	congress, the secretary
1	addition there is
1	ch. 675, 505e,
2	succeeding crop years,
1	accessible to persons
1	drug, submits a
1	 (2) consumer
2	(1) scientific training;
2	foreign establishment that
1	ch. 675, 801,
2	testing of internal
1	making requirement or
2	concerning  (1)
1	(k), and (l),
1	transparency of information
1	
 379a. presumption
1	corporation refuses to
4	any, for the
1	acid for which
1	activities, be reduced
1	otherwise applicable interpretive
1	(a) patient experience
1	persons with specific
1	marihuana for no
1	(ii) exceeding identified
1	managers and purchasers;
1	regulatory management plans.
1	404, as added
1	applicants or renewal
1	aside sufficient operating
1	jury in any
1	1332(1) of title
1	term meaningful disruption
1	state offense classified
7	collections and appropriation
1	22.)
 
 348.
15	shall be used
1	2005 and each
1	section; and (g)
1	auditors, the compliance
1	inspection of premises
1	 (4) interagency
1	it, if practicable,
1	controls, between controlled
1	shortages are considered
1	(a), whichever is
3	indian tribe or
7	animal drugs for
4	substance and the
1	extent of disclosure
1	broader than the
1	differing technological characteristics,
1	(ii) requires licensing
1	data demonstrate that
1	prior calendar year.
1	may return some
1	prior calendar year,
1	(b) such holder
1	(d) adulteration or
1	subsequent offense, the
1	consistent compliance by
1	substance will not
2	accordance with, and
1	penalty.  (5)
1	marketed unapproved new
7	adulterated or misbranded.
1	lawful under the
5	adulterated or misbranded,
6	intends to issue
9	animal drug or
1	(2), a hearing
4	complete and accurate
1	362. misbranded cosmeticsa
4	(a) is a
1	(3) may commence
1	designated in said
1	accreditation is adequate
1	includes animal drug
4	will be in
1	maintain a diverse
1	gathered using appropriate
1	reasonable time. the
2	respect to individuals
1	plan biannually and
1	(b) any recommendations
1	(3) commitmentthe coalition
1	special government employees,
1	science, meat science,
1	required by 830(a)(3)
2	provides appropriate concurrent
2	(a) is by
1	(3) provide for
1	year regarding 
1	afford all interested
2	entity for a
1	infused drug (including
1	office.  (2)
2	notice of issuance
1	giving priority review
1	ris-based inspections under
1	consumers. the information
1	recordkeeping burdens, and
1	ointment, dusting powder,
1	necessary, the regulations
1	territory in contravention
3	term labeling means
2	rare in the
6	shall not preclude
1	1996)).  (

1	sentence on indian
1	retailer or wholesaler
1	useful; (c) the
1	debarment  (1)
1	(a) a report
5	name, or other
1	licensure under this
1	ingredient, the source
1	provide interested persons
5	suspension of the
1	title, subpart h
1	record means all
1	section 360j(l)(3)(d)(ii) of
4	international relations, armed
1	drug. (2) for
1	reduce the time
3	risk of injury,
2	efforts toward correcting
5	date of notification
21	report under subsection
1	public after the
1	reduction in fees
2	fiscal year, not
1	amenable species, the
1	used in applying
1	
 803. repealed.
5	title or any
2	 (3) determination
1	title 35, or
1	given priority review
1	(3) schoolthe term
2	within the usual
1	request that appropriate
1	reviewthe secretary shall
1	vehicle and all
1	regular and lon-term
2	committee and, if
1	obtained from each
3	development tool is
1	place to comply
1	harm and the
2	animal safety and
1	records.  (f)
1	27, 2007, an
1	treatment services, the
1	guidance describing criteria,
1	plants under such
1	scheduling criteria of
1	general controls, to
1	generalany person that
1	pending in any
1	ch. 675, 903,
1	distributor is refusing
7	substance formed in
4	guidelines developed by
1	health. (iii) the
5	support of the
1	orders made on,
1	require that retail
1	product, the proper
1	following that for
1	cooperatives, nor shall
1	fruits that are
1	drug for maintenance
1	appoint committees to
2	qualifying pathogens under
1	(including the benefit
1	title 28, any
1	screening program; and
1	2012(b)(1) of this
1	revocation under subsections
1	 (1) presidential
2	corporation, partnership, or
4	offices described in
1	secretary anticipates the
1	information and any
1	(a). (3) commitmentthe
1	generalfor each outsourcing
1	term supplement, with
3	whenever processing operations
1	batches of color
1	utility of such
1	subsection (c)(3)(e) of
16	subparagraph shall be
1	substance is prescribed
1	2018, the fees
1	coordinating the interdiction
1	may be cash
1	court orders which
1	submitting, or assisting
1	brought into any
1	paragraph (1), either
2	regulations that established
1	(mm)  (1)
4	animals that died
1	foodborne illness outbreak.
1	director concerning matters
3	based. the secretary
1	establish an early
1	known in the
2	tobacco products, including
1	(c) postapproval monitoring
2	consumers. (
 

1	information and which
2	local currency to
1	foodborne illness outbreak;
1	(or no regulation
1	 (i) october
1	section by distributing
1	commerce any electronic
1	seq.] or upon
3	exportation of the
1	effective informational and
1	no-nicotin-based products and
1	product or process
1	subsection (b)(1) before
1	shortage of such
35	(2) the term
1	(viii) such samples
1	(c) charges concerning
2	(2) a controlled
1	adequately control the
1	331(q)(1)(c) of this
2	reports and information
1	list of debarred
3	report the secretary
1	(h) the proposed
10	less frequently than
1	fully implemented, paragraphs
6	may be construed
3	subsection; but the
1	signature to the
3	agencies within the
1	issue regulations providing
1	pharmacists licensed under
1	syringe exchange programs,
1	343(i)(2), 343(w), or
1	testing, in accordance
1	believe a labeling
4	condition will be
4	approved premarket application
5	foodborne illness outbreaks
20	(i) if the
1	conclusions; (b) include
1	reportable food may
1	produced, within one
1	director, developing and
1	wheat, peanuts, and
3	include the use
1	compendium (and all
1	section 4761 of
1	disease populations and
1	expected benefit of
1	prioritization the secretary
1	record, recording, or
1	medicine, engineering, or
1	acrylic, glass, stone,
1	48 hours after
1	arrangement, as the
2	transaction, transportation or
3	provision of agricultural
2	distributed free samples
2	reports that have
1	users; (iii) testing
1	supply chain, including
1	secretary shall dismiss
1	transporting, distributing, receiving,
1	law, and (iv)
1	subchapter. (g) practitioners
5	records, and make
1	applicants withdrawal of
1	(4) congress should
4	products.  (c)
1	acts which gave
1	modify, or prevent
1	commit a crime
1	
 2202. national
1	secretarys authorization). all
1	testing; and, unless
3	employee making the
1	newspaper, magazine, handbill,
2	account the size
1	30, 2016, exceeds
1	practice within the
1	provisions to provide
1	health in response
1	norms against use.
14	including  (i)
2	establish a procedure
4	approved under an
1	following means: 
1	900 of the
1	2016 and 2017.
2	request.  (d)
1	postal service pursuant
20	pursuant to an
1	evidence submitted for
1	(d) definition in
1	secretary for applications
1	board recognized by
3	inactive ingredients of
1	comment, submissions under
1	agency. (c) for
1	general to seize
1	person conducts business;
2	violated section 331(a)
1	advance the science
1	drug policies of
1	qualified entity may
1	inspection of prescription
1	acting under subsection
1	product referred to
1	maintains processes to
1	city average; not
1	1038. cooperation with
1	identify potential sources
1	(except coastal islands
1	contract, as compared
1	acts (a) it
1	year 2010, or
1	(c)(4) or if
1	requirements provide adequate
1	role of such
1	use of cooperative
1	(c) liability of
1	approval, and (b)
1	applicant did not
1	administrative procedures adopted
1	facilities of federal,
2	taken to comply
1	(a) draft guidancenot
2	petitions or proposals
1	amide. (6) methyprylon.
1	permanently debarred under
1	unless extended for
2	either  (a)
1	sales of $1,000,000
1	level iii of
2	44 stat. 1103;
1	generalnotwithstanding subparagraph (b),
1	(a) advanced surveillance,
1	enable the licensing
1	voucher. there is
1	chain security of
1	subsection; or (iii)
1	ethyl ether. (e)
8	secretary to any
3	individual or $10,000,000
1	section or which
2	persons or entities
1	take any form
1	assessing whether a
1	entities.  (c)
1	increased punishment. the
1	appropriate. the exemption
1	1944, ch. 77,
2	payors, and providers,
2	dru-free america; (iii)
3	derogate from authority
1	president under the
1	expectation of completion
1	product; and (iv)
1	drug. (2) 
1	
 1907. definitionsas
1	nonprescription sunscreen. (b)
1	animals is prepared
1	plan; and 
3	term of office
1	packages bearing labels
1	reinspectio-related activities (including
1	subsection); and (b)
1	administration (excluding user
1	chapter and of
1	(b) commerce wholly
4	6-day period beginning
3	24 months after
1	documents generated by
2	premarket reports, and
1	business collaboration. 
2	action for each
1	control programs and
2	(i) statutory or
1	silver, and zinc,
3	(2) duties of
1	ch. 155, 2,
3	waiver, reduction, or
1	instruments, and securities
1	819.)
 
 207.
1	distributor is part
2	delivering the subpena
1	establishment  (aa)
1	development tool qualified
1	parole condition or
5	stat. 819.)
 

3	drug safety and
1	(d) crediting and
1	international) if, directly
1	applicable, and may
2	article was seized
4	appropriate congressional committees,
1	prescription drug take
1	control of devices
1	sharing with organized
2	obey a subpena
1	cans, tins, pots,
1	 (b) marketed
1	414, as added
1	dosage forms. (4)
1	(2) multiple reinspections
2	drug application 
1	information exchanged under
2	finding as part
3	case of direct
1	seeking premarket approval.
1	18 or $4,000,000
1	not, under section
1	training, and equipping
1	provides evidence to
1	may discharge an
3	provided by subsection
1	2018, $13,500,000; (6)
1	(5) generic new
1	ensuring the food
2	 (2) postapproval
1	(c):  (1)
1	animal health organizations,
1	facilities, foreign facilities,
2	proceeds traceable to
1	provisions regarding the
1	condition to requiring
1	675, 417, as
1	classifications stated in
1	tansy, rue, and
2	one year in
1	weight classes for
1	(b) fined in
1	internet pharmacy site
1	(l) effectiveness of
1	condition, such that
1	 (ii) nonreceival
3	1059; renumbered 1002(a),
1	depth of access
1	factor requirements for
1	respect to premarket
2	drugs, chemicals, or
1	enable them to
1	(3) substancesin carrying
1	narcotic drug so
1	section are to
1	effective drug control
1	within the required
1	devices, immediate action
1	appeal if the
1	schedule for small
1	416, as added
1	reimburse the united
2	kilogram of hashish
1	subparagraph (c), for
1	interest. a proposed
1	health care organizations;
2	states any product,
1	(a):  (1)
1	trends, or solutions
1	definitionswhen used in
1	dairy and not
2	period.  (ii)
3	penalty, when finally
17	list i chemical
1	services.  (d)
1	may be emitted
1	health situational awareness
1	states magistrate judge,
3	studies for minor
1	drug activity is
2	receiving a referral
1	presiding officer has
1	lay persons. not
2	title finds, on
3	definitionin this section,
1	animals; (b) the
1	device submitted by
1	(street address, town,
1	appropriate, that have
1	communicating health and
1	submitted under an
5	essential to determining
1	filed, the secretary,
1	written agreements to
1	committees.  (2)
1	independently of any
8	drug will have
2	included by reference
1	 (iii) published
1	may list such
1	exceptions involving misbranded
1	350f(a)(1) of this
2	sound, clean, and
1	entry for an
1	state  (i)
1	failure to so
1	material, electronic synthesizer,
1	one variety which
1	imported nothing in
1	office directors decision
1	health, in which
1	(c) national drug
2	554 and 556
1	(g)(2)(c)(ii) or subsection
2	private entities or
2	committees of the
1	shall be calculated
1	prescription drug establishments
1	food for such
1	investigation reports made
1	marketing authorization system
1	device establishment subject
1	infectious pathogens; or
1	drugs. (ii) for
5	379g(1) of this
55	members of the
1	(9) indian country
2	submitted for relisting
1	(2) intended for
1	secretary the actual
1	(4) develops and
1	consulting firm with
3	carcass or part
1	request. the secretary
1	drugs who is
1	basis by representatives
2	irrigation, or sterile
1	submissions for purposes
19	program under this
1	medication; and 
2	act of 2012,
4	qualifications of the
3	regulations) concerning nonprescription
1	secretary can complete
3	labeling change that
1	otherwise preparing to
1	advisory review submission
1	jurisdictionthere is jurisdiction
1	authorized by law;
8	drug evaluation and
1	consultation in establishing
1	colors, or any
2	authorized by law,
3	authorized by law.
6	(hereinafter in this
1	fund treatment services,
1	employment whether they
1	conduct (including, to
1	(d) enforcement any
1	manufacturer, the defect
1	program budget 
1	employees may be
6	work with the
1	detailed rationale for
18	title or under
1	congress (1) in
2	investigations, reports of
1	product application. (6)
1	data and any
1	marketed device, the
1	body or the
1	amino acids); (o)
2	published in general
4	(i) ensure that
12	title (relating to
1	fact. at the
1	provided by federal
1	secretary. such written
2	box, can, tin,
1	extent feasible, be
1	 (c) inapplicability
1	secretary to pose
1	standardized analytic files
1	approved; (3) includes
1	barbital. (2) chloral
4	replenishment of fluids
2	clinical protocols that
4	labeling or change
1	cause for believing
2	substance appears on
1	household under the
1	cream are so
1	vessels or aircraft
1	pork, goat or
12	(1) shall include
1	investigational submission, shall
1	means factors that
1	supplement or article,
1	(ii) otherwise listed
1	section, priority shall
2	determine its safety
2	amphetamine or any
1	identification of patient
1	purity, safety, potency,
8	controlled substance from
14	shall be liable
1	container, as the
1	issued in compliance
1	secretary may for
1	(a) shall submit
2	operation. the secretary
3	waiver, the small
2	otherwise regulate the
1	food refused admission
1	associated with, an
1	includes calcium saccharin,
1	substances or chemicals.
1	2013. nmic requirements
1	procure in the
1	simulating, or falsely
2	(b) the president
1	children, or by
2	use which will
1	request, to inspect
1	limitationsubject to paragraphs
1	tobacco products have
3	biomaterials supplier 
1	strategy to solicit
1	relating to testing
3	treat and manage
1	approved until the
1	
 602. congressional
4	subsection (b), was
1	districts in china
1	effective pesticide monitoring
1	made by posting
1	transported. (3) the
29	specified by the
1	normal and moderate
1	following: repackaging, relabeling,
1	$210,000,000 for each
1	development; (b) facilitate
1	combination of ingredients,
1	 (3) rescission
1	fees. (5) review
1	(1) an agent
1	accredit thir-party auditors.
1	evidence, acceptable to
1	
 609. examination
1	activity; and (b)
1	sample pursuant to
1	individual small tobacco
1	services. (9) nothing
3	(a) has a
6	states upon certiorari
1	summarizes  (i)
29	regulations prescribed by
1	tobacco products then
1	necessary with respect
1	(b) with the
1	criminal forfeiture may
1	829(e), or 831
1	(1) purpose the
5	event reporting system
1	subjects will be
1	period pursuant to
2	may revoke any
1	use competitive procedures
1	context clearly indicates
1	proteins, and milk
1	assessed. upon failure
1	
 360aa. recommendations
1	37 stat. 833;
1	shall forward to
1	user of the
1	intended additional capacity,
1	observation identified by
1	system, including by
1	346, 351(b), or
1	 (h) judicial
2	times for each
1	pesticide chemical, soil
1	2012, the on-time
1	also comply with
1	generalno restrictions under
1	outlet then the
1	identifier) to be
1	internet websites of
1	(5) alter, impede,
1	facility making a
1	(including regenerative medicine
2	penalties set forth
4	provide any information
2	denied under such
1	inspection budget determined
1	term drug includes
2	managing or general
1	section on behalf
1	using the best
1	account the conditions
7	access to records
3	explanation of the
1	commerce which involves
16	enter into contracts
2	(1) and with
1	costs; and (ii)
1	dates subsection (a),
1	amounts as the
1	establishment of which
2	general a sel-certification
1	compendium that the
1	trade means any
1	830(a)(3) of this
1	chapter; (d) conducting
1	year. (5) crediting
1	application filed with
1	controlled substances, identifying
1	singl-use devices that,
2	drug is permitted
2	analysis methods under
3	shall also provide
1	 (i) determines
1	registrationsif the administrator,
2	rebuttal thereof) to
1	determination submitted by
1	grade gs10 of
1	content of submissions
3	conditions or practices
3	false statement in
1	commissioner, an office
1	obligations of a
1	need therefor) orally
2	whether a new
1	powers as set
1	notify the state
1	receive regulatory management
1	1058; oct. 18,
7	furniture, scientific equipment,
2	subparagraph (c) with
1	product review 
1	(iv) full reports
1	studies to human
1	unknown, or which
1	class iii. in
2	document each reassessment
1	intelligence center of
2	section 101(c) of
1	found to induce
1	manufacture and distribution
1	(c) available to
2	shall implement a
1	manner, and accompanied
3	specific serious risk
1	senate.  (2)
1	(d.c. code, secs.
1	(3) applies, or
1	fills notwithstanding paragraph
3	documents shall not
1	making a designation
15	food and drugs
1	pronounced and a
2	entities involved in
2	 (i) determine,
1	forfeiture and may
1	quality that can
1	property that the
1	straw, concentrate of
1	section 1605(c)(3)(b)(i) of
1	interests, claims, and
2	support of such
2	withdrawal; rule of
3	assure that only
1	registration for telemedicine
2	following circumstances exist:
3	effective as a
2	(a) recognition of
1	(k) shall be
2	enterprise, or any
2	performance standards (a)
1	reviewed; (ii) limit
1	product a bovine
1	period. (c) each
1	believe to be
2	public health; or
2	specify the basis
1	account. (ii) with
3	section 46 and
1	approved. (4) 
2	engaged in, or
1	postal code), and
1	hoarding or other
1	integrated with relevant
1	index for september
1	authorized purchaser; shall
1	commission, in accordance
2	protect the interests
3	person shall 
2	shall cover only
1	fined, or both,
1	section 384 of
15	changes in the
1	(a) labelthe label
1	requirements for accreditation
1	states; annual report
17	conducted under this
1	partnership, does not
1	(a) carry out
1	paragraph (2); 
1	amendments made to
1	acid) (mg) 8.0
1	
 345. regulations
1	writing setting forth
1	human body; or
2	applicant initiates or
5	shall have systems
1	(b) an infant
1	services shall compile
1	determination that an
1	sample shall, upon
1	manufacturers, and retail
3	person is not
1	trustees, or take
1	potential whenever it
2	(5) take appropriate
1	chemical shall report
11	foodborne illness outbreak
2	fee the secretary
1	saf-use conditions, such
1	whether, and to
2	business; or (b)
1	authorities; (15) to
1	shall send the
1	drug include such
1	commerce means interstate,
34	capable of use
2	made later than
1	means; and (5)
2	dru-free america is
4	must be conducted
1	drugs imported from
2	subsection (k) is
1	associated suspension of
1	(a)(4)(a)(i) (relating to
7	patent or a
5	shall, subject to
1	item submitted for
1	advertising to determine
27	section:  (1)
1	office, to furnish
1	manner that prevents
1	1051. other federal
1	submission, grant, or
1	organization that has
1	able to satisfactorily
1	protocol had not
3	generalfor purposes of
1	including hazards that
1	enterprise in which
1	 (d) grants
1	term entity means
1	support of communit-based
4	director shall 
2	failure to make
1	use monitoring); (dd)
1	respecting (i) security
1	general respecting (i)
1	accredited third party
1	agent shall 
2	approving the application,
1	(i) denies clearance
3	approving the application.
1	exceptions in certain
2	cooperative agreement from
3	application means 
1	relations.  (b)
1	characters used to
9	program of the
30	submitted under this
1	retention plan for
1	february 1, 2013,
3	termination of the
3	determined using the
3	fees collected pursuant
1	tobacco product measured
1	efforts; (b) coordination
3	determine to be
1	subsection (b) could
2	(f) review of
28	drug master file
1	ethnic health disparities
1	meetings; and (b)
2	provides information about
1	purchasers during such
1	(f) any compound,
1	including the recall,
1	may be, that
1	partial fills notwithstanding
1	compounding of his
2	consumer package; or
1	361(a) or (d)
2	otherwise authorized and
6	frequently than once
1	administration the attorney
7	(a) any person
1	supplement, or premarket
1	supporting or obtaining
1	subsection, and (2)
1	efficient review. 
1	 (4) enforcement,
1	workload adjustmentthe fee
1	also appears on
1	regulation. (oo) the
4	phencyclidine (pcp) or
2	application withdrawn before
1	(9)(b) not later
2	advance of the
1	training center (a)
1	(v) the retention
1	(i) human african
3	chain of distribution
1	request to conduct
1	raw milk except
1	recreation, open to
1	(j) shall be
1	population, and groups
1	include any requirements
1	so; or 
2	upon a natural
2	condition which (a)
7	violates section 841(a)(1)
1	organizations worldwide to
1	goats of his
1	represented as egg
1	 (i) reasonable
1	disease in this
1	effectiveness. (c) the
1	species found on
6	et seq.], and
1	may be promulgated
1	drug application, supplemental
1	military preparedness and
1	repackagerthe term repackager
1	written request, have
7	salts of isomers
1	establishments (a) ante
1	tunnel) unless the
1	records following any
1	kindergartens; (b) elementary
1	modifications, if any,
1	auditor shall immediately
1	importation, showing that
1	(2) effectnotwithstanding any
2	may request, in
1	accreditation program because
1	milligrams of diphenoxylate
2	irrigation or reconstitution;
1	changes for the
1	process the administrator
1	drugs
 
 2001.
2	203 of this
1	providing access to
13	drugs in animal
2	defined in regulations
1	uses to which
1	programs, and shall
1	risk (as identified
27	shall promulgate regulations
2	jurisdiction over distribution
1	wholesale distributors in
1	specific information on,
10	secretary shall cause
1	(f) farms 
6	caused by an
1	relevant  (i)
1	title (or regulations
6	performance of his
3	specified in clauses
1	 (b) promotional
1	process established in
1	warning on label
3	poultry product, or
1	audit checks to
2	standards and requirements
3	raw agricultural commodity,
1	employee of such
1	safety program 
1	media campaign for
1	feed, information to
1	testing welfare recipients
1	limit potential or
1	conduct activities in
1	action or issuing
1	magazine, handbill, or
1	compatible with global
1	site; or (iv)
1	drug is repackaged
1	including packaged liners)
8	except that 
1	15, 2007. 
1	qualification package; and
2	drug, or with
1	ongoing recall of
1	considered special government
1	use would accomplish
1	term qualifying pesticide
1	exemption. (d) petition
1	(d) anticipation of
8	inclusion in the
1	miscommunication during recalls
1	professional) other than
1	myrophine. (18) nicocodeine.
2	paragraph, an amount
1	inspection of generic
2	date extension is
1	(b) or upon
1	postapproval, of devices,
1	(e) implementation of
18	animal drugs in
2	final regulations to
2	average, consistently employs
1	authorization, a type
1	both. (c) in
1	3-day period during
1	finds such compound,
1	removing a drug
2	(a) amend the
1	prosecution of inquiries;
1	wild fish stocks.
1	 (i) evaluate
3	accordance with part
12	office of pediatric
5	director for supply
1	states. oaths and
1	biomarker; (b) a
1	whose label, labeling,
1	subsection may require
3	incur the costs
1	 (b) condition
10	program under section
1	pediatric disease was
1	protein targeted drug,
1	days after promulgation
1	obtain such dates.
2	information in violation
3	problems, including access
1	nanomaterials of concern
24	include  (a)
1	device which will
7	product, the secretary
1	hardware is prohibitively
2	who, in the
5	secretary may award
1	information identifying particular
2	special clinical needs,
8	disposition of the
4	-year period beginning
1	substance or chemical.
1	title 5. before
1	secretarial authority nothing
33	connection with the
1	risks which may
1	productivity lost by
1	general to demonstrate
1	field identification methods
13	substance from the
1	recommendations respecting priorities
1	(b) related categorizations
2	shall cause the
2	may use a
1	contracts the attorney
1	support; and (vi)
1	private entities. 
1	published articles, which
1	high concentrations of
2	inspector and thereafter
1	best interest of
4	carry out any
1	document dietary exposure
1	use existing networks
1	standards set by
1	to, a patient
1	 (b) compounds
1	purchaser shall sign
8	conducted or sponsored
4	official national formulary,
2	facts which would
1	committees concerning the
1	stores shall select
1	administrator shall rescind
1	pharmacy for personal
1	appropriated each fiscal
1	longer consistent with
1	measure and report
1	label where no
2	drug; (iii) the
1	medical devices, immediate
5	submit an application
1	ant-drug coalition, or
1	require that registration
1	tol-free number maintained
1	direct the applicant
1	action will promote
1	sources of exposure
1	renewal grantees not
1	conditions and any
1	355(n) of this
2	greater period as
1	strategy; (b) review
1	supplements.  (10)
1	 (3) delivery
1	laboratories run and
1	period prior to
1	title. however, when
1	prevent the federal
15	report under paragraph
1	general following the
1	may decline to
5	eligible entity means
27	information as the
1	(a) plans for
1	personnel; (c) take
2	prior to implementation
1	preclude a finding
1	guidance documents and,
1	narcotics crops the
1	(ii) for oxygen
1	distributor. (2) no
1	articles; duration; release;
1	(f) to be
1	violation; and (3)
1	may petition for
1	(b) compliance with
1	physician; and (ii)
2	purposes for the
1	shall describe methods
1	recalls; (v) prepare
1	review tolerances and
1	immediate subsequent recipients
2	chapter, under an
1	obligate funds to
1	notification; exemption 
1	 (b) compound,
1	intrastate sales of
1	relating to appointments
1	purchaser, exceed a
1	law so that
1	control strategy; (4)
1	receiving or purchasing
2	chapter 43 of
1	letters; and (b)
1	(b) consultation with
1	may deem appropriate:
1	partnerships, and associations
2	marketing approval of
1	section 346a(i)(2) of
1	demographic composition require
1	increase the funding
6	(or supplement to
1	stockyards act, 1921
1	case of sections
1	request, shall be
1	lack of effective
1	year 2002 after
1	threat assessment conducted
1	dietary supplement 
2	received in good
1	results in such
3	issued a final
1	functions in accordance
2	devices that are
1	350l1. annual report
1	paragraph and any
2	panel considers appropriate.
32	prescribed, recommended, or
1	means the issuance
1	retail. (iii) distributions
1	applicant with applicable
1	devices included on
91	shall be construed
1	protection as those
1	approval of 
1	twice the number
1	refuse approval of
2	 (ii) counterclaim
1	directed to do
1	manufacturers and producers
1	standardized illness outbreak
1	(3) receive a
1	industry regarding their
10	patients in that
1	later determines to
1	interdiction of illegal
2	(c) limitation such
1	product; (iv) provisions
1	reasonable probability; and
1	amend or modify
1	drug treatment and
1	information to assess
2	(15 u.s.c. 1471
1	purchase to the
3	(i) the period
1	9, 2012); or
1	supervisory review under
1	manufacturing change that
1	reimburse the cost
1	person lawfully entitled
1	president for national
1	product. (11) the
1	paragraph only with
1	security, shall prepare
1	(h) construction nothing
1	government employees, as
1	containing or bearing
1	459, 461 to
1	electronic health records;
1	subsequent export from
1	dispensers, and other
1	related to substance
1	subsection until the
1	may deem appropriate,
1	general policies respecting
1	(i) has only
1	(d)[2] definitionsin this
1	practitioner may commence
74	paragraph (1), the
1	(iv), for a
1	 (a) $500,000
1	subsections (g), (h),
1	control of land
1	(f) recordkeeping regarding
1	controlled substances schedules
2	reasonable person would
1	ris-based schedule for
1	derived from nanotechnology,
1	distributors except as
1	(b) maximizing the
1	(e) conditions of
1	records except with
1	dedicated website that
1	sections 372 and
1	including electronic communications,
2	guidance document on
1	 (9) may
1	less than 8
1	prioritize and develop
1	accredited persons, the
1	of, illegal drugs.
1	obtained by attorney
3	adding a drug
2	chapter, whether in
1	registration of producers
1	representing the secretarys
1	that, except in
1	additive the intended
1	disproportionately affects poor
1	safe usethe elements
2	fee assessed to
3	recordkeeping or reporting
1	(b), effective on
1	subsection (b) the
1	675, 705, 52
1	authorization to a
1	falsification.  (b)
2	(i) upon the
1	subsection; (b) that
1	whether existing federal
1	veterinarian of the
2	risk factorsin establishing
2	review fees and
1	infant formula powder
1	including an adverse
2	different name or
1	manufacturer and otherwise
1	information for a
1	consideration the study
1	keeping  (1)
1	items on the
1	institute.  (b)
1	enable agents to
1	nations that information
1	states (except at
4	cooperate with other
2	(a) by the
9	clerk of the
1	(ii) the program
1	schedule pay rates
2	failed to contain
1	subsection (a)(1)(c) so
1	pending applications and
1	species means 
1	
 1901. findings
3	any, that the
1	(4) biosimilar biological
2	subsection (h), including
5	section does not
120	pursuant to subsection
1	title applies, the
6	ecgonine, its derivatives,
1	human services recommends
2	director who shall
1	scientists, doctors, and
1	agencies; utilization of
1	issued, and (b)
1	another drug with
1	adjustmentthe fee revenues
1	injunctions, respectively) shall
1	whatsoever in the
1	year 2016, $1,984,000
1	appropriate specifications for
1	transcripts of the
1	share no manufacturer
1	provision of that
2	territorial, and tribal
2	provide persons in
6	civil action against
1	recommendations  (1)
1	committee shall review
1	supplier; and (2)
1	(b) procedure; multiplicity
2	that, in any
1	adulterated fooda food
1	powers as are
1	classification of products
1	trials; labeling 
1	foodborne illness; (e)
1	narcotic drugs under
1	application. such report
1	person obtains substantial
1	(h) no delegation
1	resources from the
3	fee is not
2	register  (1)
2	secretary determining that
1	device (less a
1	regarding the initial
1	evidence provided pursuant
1	distributes drugs except
8	standard of quality
1	rights for or
2	party subject to
3	number of submissions
5	application is submitted
1	number for each
1	secretary; contents 
1	concerning listed chemicals
2	officers, employers, and
1	1165. repealed. 

1	transfer from the
1	division, including major
4	compounded in an
2	tw-year period designate
1	indian tribes 
1	(4) eligible entitythe
1	promulgate regulations not
1	(c) the issuance
19	make available to
1	period prescribed by
1	states without notice
1	[42 u.s.c. 2011
1	medical practice in
1	issue is qualified
3	adulterated, mislabeled, or
1	(g) counterterrorism activities
1	authority to extend
2	bring an enforcement
1	issue a waiver
1	standards for produce
1	applications and all
1	submitted annually. 
2	year, the administrator
2	review, technical excellence,
1	same; and said
1	exceptions, and exemptions
1	links between trade
1	herein, means sweet
1	obtain tentative approval.
1	(b)(4), the number
1	illness due to
6	product under subsection
1	product as designated
1	shall issue proposed
7	expected to be
1	importing a drug
2	concerning the cumulative
1	civil action involving
1	cooperates or testifies
1	elected office, cabinet
1	ch. 839, 4,
1	develop a cooperative
1	trial, or as
2	program (a) establishment
1	331(q) of this
4	manner that does
5	negotiations as well
1	equity against the
1	(d) based on
1	report. (2) drugs
4	isomers; (iii) ecgonine,
1	inflation adjustments 
1	term major food
1	establishes (a) that
1	members, as follows:
1	individual being served
5	process drugs or
5	except that no
1	team and how
1	post at the
1	request may ask
4	request or in
2	-pheny--[-(-phenylethyl)--piperidinyl] propanamide or
1	possible, but not
1	audit of any
2	whether portions of
3	fees from the
1	required to perform
1	assessments of policy
3	congress referred to
1	paragraph, an individual
2	(vii) in the
1	japan, new zealand,
1	(d) for fiscal
1	(a) purpose; identification
1	section 1705(b) of
1	regulatory and criminal
1	hearings, sign and
1	include a requirement
1	may include preclinical
7	assurance that the
1	(such as lyophilized
1	grants awarded under
1	written order setting
1	importer means a
1	(q).  (2)
1	resources to respond
2	notice of opinion
1	parts and materials,
1	acids); (xv) the
1	made as he
2	title or by
1	343(r)(3) of this
1	prescription required by
1	application made under
2	title) shall apply
2	(i) issue an
1	article is dangerous
1	respect of this
1	authority provided to
1	requirements are applied
1	directive requirement 
1	identify each package
1	ongoing criminal investigation
1	columbia, and puerto
1	period a determination
1	hearing. the participants
2	year 2012. 
1	informal hearing, that
3	development and operation
1	addressing the local
153	(a) in general
1	business unit. (k)
1	fee if abbreviated
1	contact surface but
1	communication; (3) 
1	benefit, or on
2	standard and publish
1	(c) plans and
2	extraordinary circumstances, the
1	transfer, the total
6	committees not engaged
2	food, any act
1	otherwise available, for
1	agencies referred to
2	person an opportunity
1	individual patient access
5	 (c) use
4	product; or (ii)
1	of, supplemental to,
1	(b)(2)(a).  if
1	reporting system; and
1	administrator or the
2	able to assure
6	prominently and conspicuously
1	inspection shall give
2	types of imported
1	signature in a
1	sections. (4) the
1	(i) in using
1	 (c) preservation
1	facilitate safe operations,
1	research requirements exclusivity
1	definitionin this subsection,
1	elementary school, and
2	2015, a dispenser
2	(4) not more
1	condition shall not,
1	5, 38 stat.
1	states from specific
1	whether materials reported
1	general controls are
5	processing of egg
1	providing the notification,
1	tank, pond, or
1	diverse communities in
2	861 of this
5	coalition, including i-kind
1	evidence. (ii) the
1	i, and to
1	 (f) compromise
1	judge or united
7	law, the court
1	administration review team
1	disease product at
1	summary form and
1	completed, or a
9	petition to the
2	may prescribe by
1	 (2) purpose
1	physical examination of
1	prohibit imports into
3	adulterated meat or
6	december 31 of
1	applicable in accordance
1	collectively to maintain
1	tobacco leaf for
1	eligible countermeasure may
5	physical examination or
1	period of enrollment
1	(i) the bulk
1	shall, for any
1	assess user fees
1	shall take final
1	complete by its
1	groups, including veterinary
1	relevant laboratory network
1	request.  (5)
2	further, that nothing
2	ability to protect
1	section 387t(a) of
2	affecting, modifying, repealing,
1	vitamin, (ii) mineral,
1	
 399h. grants
1	deception or eliminate
1	article 16 of
1	(i) develop methods
1	public health. consideration
2	effect from aggregate
1	certain componentssuch term
2	issuance of voucher
1	(
 
 343a.
1	(b), the effective
3	last paragraph of
1	supplements (a) definitionsin
1	governed by a
2	official plants processing
1	title, subject to
1	secretary that all
1	(b) assessment of
1	346a(g)(2)(b) of this
1	final publication of
1	likelihood of contamination
1	international passenger, commercial
2	article involved is
1	person for reaccreditation
1	agencies.  (d)
2	counte-drug technology assessment
1	title. (c) stakeholder
3	modified or new
1	scientific evidence of
1	drugs, shall conduct
1	called to testify
1	petition. if the
3	consumed throughout the
2	administrative costs associated
1	color additive comes
1	smallest individual saleable
3	extent, and gravity
1	 (3) acting
1	administration of these
2	[21 u.s.c. 951
2	operating reserve fees
1	reasonably should have
3	limited distribution in
1	states, in property
1	(d) public nature
1	350c(a) of this
1	however, shall the
1	(b) interdiction committee
1	order specifies otherwise.
1	agencies may enter
1	formula, and (ii)
1	single procedure. (2)
2	final regulations implementing
1	individuals of limited
22	360ccc of this
1	fully and consistently
1	shall demonstrate to
1	offense if, prior
1	(v) other expertise
2	informal or formal
2	thereafter provide due
1	development organization for
1	675, 541, formerly
1	enforcement (a) jurisdiction
2	means the states,
4	500 grams or
1	establishment registered under
1	agency action with
1	(2) for exemption
1	(5) the scope,
2	secretary if such
2	construed as in
1	quality systems, or
1	manufacturer, then prior
1	(a)(3) within 20
2	title 5 to
1	section of whether
1	establish under any
1	cases; limitations; united
1	year 2015. (d)
17	animal drug sponsor
1	operating reserve fee)
1	forth a comprehensive
1	terminated, report to
1	(ii) all individuals
10	information respecting the
1	may designate 
1	health. the manufacturer
1	licensing of persons
1	list of interpretive
1	executive department listed
1	hearing is necessary
1	
 
 645.
1	risk of spoilage,
1	inhibitory use as
1	strategy to combat
17	relates to the
1	service for grade
2	advertisements for such
1	 (2) clarification
1	shall require as
1	 (b) determinations
1	jointly by 
1	gaps relating to
1	(i) for scientific,
1	carrier, of poultry
1	level for a
1	 (j) abbreviated
1	treatment requires additional
1	hazards associated with
1	licensed and is
1	held thereafter under
6	involving a controlled
1	thebacon.  (c)
1	912, as added
5	political subdivision requirement
1	conduct such surveillance
1	warrant, authorize, with
2	year or the
1	act on an
2	part (1) the
1	controlled substances. to
2	currently use tobacco
3	business or a
7	offense under this
1	occurrence as a
8	eighty days after
1	unclassified form, but
2	unable to reach
1	article, the quantity
2	number of selected
3	licensed by a
1	establishment operated by
1	(3) work with
2	reduction of illicit
2	later than 
1	(i) five members
1	(j) clarification concerning
1	supplement, when submitted,
1	individual previously was
1	section 802(49) of
1	paragraph (1)(b) within
5	administrator may require
6	course of any
1	reformulation of the
1	enforcement administration registration
5	secretary, through the
1	determine the qualifications
1	demonstrates in a
2	event later than
1	systems, including working
1	subpopulations; and (ii)
1	subsection (b)(2) has
1	public communication relating
10	conditions as he
1	recovery of fees,
3	directs, be withheld
1	establish priorities which,
1	testing methods employed,
3	register in accordance
1	civil forfeiture provisions
1	(22) the term
1	(m) feed mill
1	subsection there is
1	requirements are necessary
1	ingredients, excepting products
1	reports, and supplements
1	address for the
2	reversal if the
4	sale is not
1	recipient agency and
1	final regulation requiring
1	appropriate for summary
3	may remove inspectors
1	(v) -phenylacetylindole or
1	raised by response
1	employ such chinese
1	performance standards 
2	disease or other
1	shall appoint 11
1	contained in, or
1	706(2)(a) of title
1	specified area of
1	warrant for offenses
1	plan, agreed initial
1	disposal standards and
2	chapter requiring inspection
1	shell but has
1	procedures shall not
1	appropriate, a list
1	seafood products, including
1	reports of removals
1	(vii) -penty--(-methoxyphenylacetyl)indole (jwh250);
1	
 383. office
1	request, a letter
1	161 to 165.
1	equines which are
2	next year if
1	held.  (2)
1	approves the petition,
2	records a repackager
1	improving public access
1	optional ingredients are
2	international agreement to
1	sixtieth day after
1	dispensed during the
1	seeks to commercially
1	participation by various
1	training provided to
1	recommended within one
1	repacking establishment. this
1	devices, many of
2	(b) an individual
1	information to demonstrate
1	(c) a finding
1	prohibits the secretary
1	soccer, or hockey
1	interruption. (b) timinga
1	identity for any
5	among federal, state,
1	limited geographical areas
3	(1)(b), the secretary
8	(a), (b), or
1	priority to conducting
1	(c) shall, for
1	in, or omit
3	of, criminal prosecutions
6	development of standards
1	$125,000. (6) notwithstanding
2	 (2) advisory
3	drug facility fee
1	clinicians, regenerative medicine
1	(iv) the diversity
5	committees, and costs
1	exposure than pesticide
1	material fact; (c)
1	thereto) intended for
1	(i) nonclinical data
1	act other than
1	board.  (b)
1	shall provide data
1	136a1(k)]. such fees
35	subsection (b) or
1	(
 
 1712.
1	preempt state requirements
1	(b)timing of notice.an
2	may be redacted
7	regulations issued by
2	47, are made
1	certain manufacturers, distributors,
1	industrial researchers to
3	make available on
1	fiscal report for
2	1031 et seq.);
4	shall furnish the
2	treatment of addiction;
1	et seq.); (e)
1	defense. (june 25,
2	imprisonment, in the
9	may require. 
2	use the accredited
1	beginning and ending
1	treatment of addiction.
1	(other than insulin,
1	1031 et seq.).
1	(a), includes 
1	investigations has been
1	paid in error
2	reported information accurately
1	curtail, or limit
1	registration. such controlled
1	program in achieving
1	stores, restaurants, and
1	limitation on commingling
3	shall be sold
2	authority to issue
1	subsequent purchaser. nothing
2	define the term
1	drugs, may enter
2	assign a registration
1	injury, or (b)
1	manufacturer may be
1	data collected according
1	stimulant substance listed
1	form, statement, invoice,
3	access by the
1	regular importer on
2	concerning the use
1	applying sections 360d
1	center (a) establishment
1	number of priority
1	awareness; (3) provides
1	substantive determination on
1	adults to discuss
1	related necessary action
1	contained in water
1	pediatric studies under
1	unless exigent circumstances
1	inventoryexcept as provided
1	certifications by a
1	sanctions upon these
3	supported, or possessed
1	created in the
2	section only to
1	(c) activities to
1	terms regenerative medicine
1	review or other
1	class of plants
1	agent appropriate credentials
1	times, any area
1	mortality, that is
5	developed under paragraphs
1	date, objections, hearings,
1	(
 
 1047.
1	process for implementation
1	188 to 188n.
1	except that, as
11	whenever he determines
37	notify the secretary
1	including being formatted
1	pesticide that resulted
1	days in advance
1	task forces coordinate
2	primary basis of
2	determines that no
1	reviewing official shall
2	united states. this
1	held using electronic
1	1972, $3,000,000 for
1	part, otherwise applicable
3	section, the comptroller
1	less than $5,000
3	expectation that the
1	equivalence determination may
1	corporation shall be
1	10101 of title
1	unless the expert
1	section is a
8	subsection may be
1	including racial subgroups.
1	(i) may transfer
1	secretary as having
2	matter or require
1	subchapter on manufacturers
1	year 2018 for
1	web site by
3	secretary may, when
1	(i) product developers,
2	employees), as defined
1	also a member
1	pediatric subpopulation has
2	secretary allocates for
1	publish a summary
1	rots (addled eggs),
1	675, 568, as
1	change, which shall
1	 (ii) timing
2	certificate; (2) without
1	1007. repealed. 

1	respect to real
1	(b) exceptions 
1	effectively with violations
2	use if it
2	component part or
1	available target animal
2	(d) use of
1	inspection in official
1	review such certifications
3	chronic har-drug users
1	oversight and controls
1	receiving the telemedicine
1	(a) to cover
1	possible hold such
1	injury when triggered
1	(x) health care
1	inhabitant, carries on
1	programs, and minimize
3	additional evidence, and
1	 (iii) requirements
1	recognized in both
2	drug control activity
3	section 360nn of
1	term veterans benefit
3	applicable standards prescribed
3	(ii) is not
1	(f) inspection and
1	tobacco. if such
1	(2) enhance the
1	
 458. prohibited
1	 (aa) a
1	appropriated $30,000,000 for
1	commission).  (b)
1	award to the
1	subchapter shall apply
3	change that is
1	property and may
1	assure the safe
1	addition to provisions
1	locations and manners
2	performance standards under
2	year 2013 under
1	medical personnel who
1	ii. (2) the
1	require.  (8)
1	actions which may
1	psychotropic substances it
1	shall, if no
2	diet of man
2	person exporting the
1	equipment or thing
1	title shall remain
1	ingredient means an
1	systems, and artificial
1	title applies, or
3	authority established in
1	1984; (ii) the
1	requirementsif a person
1	substantiated by reliable
1	determination on whether
1	exceeds the supply
1	third fiscal year
2	refilled more than
1	entity to establish
1	administration for purchase
1	344(a), 346, 351(b),
1	person acting pursuant
1	82 percent shall
1	labeling in marking
3	identified, or intended
1	effect:  (a)
2	allocates for such
1	lon-range, quantifiable goals
1	advertisements that the
2	approved human drug
1	pesticide chemical was,
3	operations are being
1	law; (d) forward
1	understand the relative
18	(4) the secretary
1	(ii) is temporarily
2	life stage of
3	will regulate the
1	subparagraph (b), (c),
1	information, services, and
1	electronic circuit and
1	omitted (b) ginseng
1	387h. notification and
1	determine whether revision
4	labeled, or repacked
1	may also require,
1	statement, in paper
1	transaction information shall
1	substances each comply
5	(a), a person
3	section if it
2	country to be
1	director shall carry
1	(b) refusal by
1	identifying marks or
1	issued under chapter
1	limit the revocation
1	administration to perform,
1	title, classified under
1	(i) such order
1	title and pursuant
1	force shall ensure
1	drug experience associated
1	run concurrently or
1	manufacturing industry, review
1	right to enter
1	conjunction with general
1	343(k) of this
1	(a) the commission
1	title; (c) based
1	food, or causes
1	international relations (a)
1	thir-party inspections for
1	(iii) upon receipt
1	clauses. (2) in
1	applicant is made
1	otherwise appropriated, the
2	dietary supplement to
1	(ii) the director
1	device on adults
2	regulation of transactions,
1	performs accreditation of
1	products and active
2	title, except paragraphs
1	personally or by
1	section 802(54)(f) of
8	period for the
1	(i) requires each
1	(i) the disease
3	reports described in
1	estimate of resources
2	meat, or meat
2	place in effect
1	employee has reason
2	less than 200,000
1	subsection (c)(1). (3)
1	establishment is regulated
1	expedite the drug
1	submitted.  (vi)
1	producers and small
1	(other than section
2	states may not
2	revised by the
7	subparagraphs (b) and
5	(12) the term
1	(iv) of subparagraph
1	budget requests shall
1	 (3) authorization
1	grain of cocaine,
1	(f)(i) shall contain
1	invalid, all valid
2	human food in
1	ch. 74, 7,
1	shall present to
2	infant formula which
1	fulfilled and that,
4	request may notify
1	representative of every
1	 (a) necessary
2	compact under the
1	guidance document regarding
1	 (3) contents
1	years and shall
1	properly dated and
1	tentative approval), the
1	car; (b) to
1	prescribe. no grant
1	animal drug should
1	emerging threats to
1	(i) such use
1	notice, as promptly
1	adolescents (60 fed.
2	otherwise required to
1	mandatory minimum sentence
1	(1) no restricted
1	sponsors of such
1	individual purchasers of
2	(7) if any
1	employee protections (a)
5	law of any
1	 (4) animal
1	importer participating in
1	application of pesticidenotwithstanding
2	exercises the authority
1	consumer to identify
1	(3) discovery with
1	supplement, and submission
1	waiver  (a)
1	promptly undertake those
1	primarily for yout-oriented
1	information regarding all
1	secretary adopts such
1	sold, delivered, or
1	itemization of the
1	regulation. (c) provision
1	statement means a
1	identity and composition;
4	secretary shall act
1	title, all controlled
4	risk of substantial
1	conventions in addition
3	1 eligible coalition
1	pet foods, that
1	regulatory efforts, in
1	safety, as follows:
1	student loan applications
1	saccharin, and ammonium
2	(2) revision of
2	eligible coalitions and
1	small food processors;
1	another person at
2	persuade, induce, entice,
1	well as any
1	publication; confidential information
1	law 103226; 5
2	within the retail
1	fat, so that
2	drug exported under
3	required to attend
1	6.  (d)
1	restricted devices pursuant
2	agency with which
2	conduct not less
1	case may a
1	food being produced,
1	substance law enforcement
2	conviction if the
1	shortage upon patients
4	(2) limitation the
1	phenylpropanolamine (including drug
1	drug, if any,
1	retail establishments, consistent
1	drug compounded in
1	years. (e) whether
1	classification of an
1	record regarding any
1	production, or regulating
1	sources of food
1	implement such a
1	planning, developing, and
1	known. (c) each
1	enforcement agencies within
1	administration; and (ii)
1	plan of the
2	section 360eee1(a)(7) of
1	person involved may
3	proposed uses of
1	facility.  (2)
1	payment under grants
1	seizure the government
1	(b) application. (ii)
2	affairs shall report
1	(a) the select
1	involved in their
1	assistance for needy
2	secretary shall proceed
1	chronic har-drug users,
1	include biological products
2	(including a federal,
1	
 
 199.
1	review such application
1	(1) establish such
1	firm, has been
1	additional special rule
1	2223[1] of this
1	opportunity for export,
1	preempted if 
1	advertising in using
7	plans for meeting
1	providers of emergency
1	subsection (f)(2)) to
2	drug and to
1	environmental protection agency.
4	environmental protection agency,
2	following the approval
1	 (g) copies
2	coalition that includes
1	man or animal:
3	threat to the
1	functions and responsibilities
1	written to be
1	subsection. (2) workload
1	contaminated by any
1	drug application during
1	food imported. (2)
2	include provisions that
1	
 1134 to
1	revise it periodically.
2	consultation with other
1	make, distribute, or
1	standard; or (10)
1	executed licenses, memoranda
1	holding, or delivery
1	publicly distributed a
1	consultation with affected
1	liable  (1)
1	agency carries out
1	 (i) means
1	
 
 641.
1	subparagraph (a); multiplied
1	seek a designation
1	utilized for authorizing
1	subsection (a). thereafter
1	open for business
1	tailored to restrain
1	among the center
2	media time and
1	condemned all such
1	dispensing or for
1	control policy; (2)
2	determines appropriate, the
1	man or animals
1	state law 
1	product development, accelerate
2	(4) limit the
1	sections or act
1	(3) the entity
1	mixing, reconstituting, or
1	format.  (4)
2	reviewing division may
1	entitled to on-half
6	information, and the
1	filed. (2) a
10	subsection (b) to
1	in; and (3)
1	product tracing system,
2	prospective surveillance period
4	amount, if any,
1	winning bidder on
2	concluded by such
1	shall prohibit states
1	territory may inform
1	prescription drug. (f)
3	change in a
2	use by individuals
2	prior to accrediting
1	distributor provides information
1	pasteurization, or homogenization.
1	submit an affidavit
3	extraordinary circumstances are
1	practice may be
2	(a) task force
2	united states. such
2	records as the
1	application. as used
1	exclude a drug
1	(b). (b) order
1	company  (a)
1	currently recommended by
1	subsection and identify
1	(i) active risk
1	180 days or
1	handling or disposition
1	processes and procedures,
1	(3) security of
1	furnish a recommendation
4	calendar year, the
7	180 days of
2	conducting the review,
1	acting on a
1	specify (1) on
2	unless (1) they
1	marketed tobacco product
1	controlled substances, through
1	resources to such
2	drug sample. for
1	population in the
1	may require; (e)
2	use of standard
1	467a. administrative detention;
4	sentence of this
2	effective immediately. (ii)
1	personnel; (2) studies
1	separate notice shall
1	respect to being
2	containing  (a)
2	october 30, 1998,
1	alerts and public
1	antimicrobial drugs; (ii)
1	warning letter, or
1	tobacco, filter, or
1	upon the compound,
2	states after such
2	product as suspect
3	acknowledge differences in
1	pharmaceutical ingredient means
2	services, and the
1	hospital within such
1	duly authorized representatives
2	devices at retail;
2	services in connection
2	processes, notices, orders,
1	fixed by regulation
1	secretary shall comply
1	issues, and a
1	affidavit has been
1	section 319 of
1	achieve such objectives,
1	iv may be
2	man to supplement
1	recordkeeping requirements of
1	(3) may make
1	 (a) parental
1	procedures each rulemaking
1	either before or
1	summary judgment on
4	procedures of the
1	states for his
1	entry therein. the
1	handicapped individuals, and
2	hereinafter provided; nor
1	beverages, as defined
1	(1)(a) applies, the
1	343(c), 343(e), 343(i)(2),
1	prevention and drug
2	countermeasure with respect
1	operates a facility
3	subsection (e) that
1	exercises in carrying
1	provides appropriate information
1	design and testing
1	summary judgment or
1	promptly correcting any
1	health regarding the
1	device sponsor or
1	use presents substantial
1	may not modify
1	regulatory requirements set
1	374, 379, 379e,
1	subsection (q) that
1	42 after the
1	with, the requirements
1	inspection, all as
1	(h)(2); (i) an
1	agency.  (l)
1	transferable the right
1	regulation, exempt or
1	multiplying such amount
1	secretary seeks to
1	subsequent human drug
1	occurred and the
1	submitting such report,
1	
 884. immunity
1	submitting such report.
1	individual was receiving
1	devices, the information
3	secretary to impose
1	domestically available to
1	transaction history the
2	 (2) new
1	elsewhere the secretary
1	chloramphenicol, bacitracin, or
1	warrantsa warrant under
1	prior offenses; and
1	establishment of clearinghouse
1	exceptions, and exemptions,
1	disasters or in
2	consignee from the
1	subsection (b) whenever
1	otherwise lacks sufficient
1	containing poultry products
1	1, 2010, the
2	diverted, including the
1	(j) exemption of
2	requests a significant
1	within an additional
2	training; (2) training
2	paragraph (1)(a); and
1	production of infant
4	action authorized under
1	adulteration. (5) if
1	agriculture) only if
1	includes at least
1	shall further, by
2	offered to, or
1	prescribe specific technologies
1	
 
 350f.
2	 (a) ensure
1	facility requirements. (2)
1	prepared in the
1	identifying new and
1	approved application cannot
1	505d, as added
1	warnings, health advisories,
1	modifications made to
1	827. records and
1	may exempt tobacco
1	pharmacist, and any
1	secretary, and are
30	paragraph (1) and
2	evidence with respect
1	1990, and (c)
1	permit, as originally
9	application means an
1	unable to enter
9	developed under paragraph
1	recruitment through academic
1	paragraph (2), except
2	period to such
1	returning the data
1	including the means
2	interstate commerce on
1	30, 1982. of
2	safety and risk
2	welfare, destroy markets
1	compared to existing
1	distributor notified pursuant
1	(5) alphamethadol. (6)
1	subsection (referred to
1	may not cause
1	cases when he
1	reports (a) inspection
1	[21 u.s.c. 467a
1	paragraph[1] (1)(b) shall
1	(e) controlled substances
1	amending, or repealing
7	(1) may be
1	initial application of
1	general has found
1	(f) the generic
1	applicable authority may
1	provision by such
1	prepare for, protect
1	provisions hereof; except
1	information shall include
2	hydroxybutyric acid (including
1	ethnic and racial
1	health education act
1	mortem examination and
3	general shall not
1	held invalid in
1	base a determination
2	national intelligence and
1	determination, including the
1	residue; (xii) practical
1	public. such order
1	require a federal
1	previously been separately
1	maintain records and
1	technology with both
1	part that is
1	coordination of inspections
3	container of a
1	condition or otherwise);
1	results therefrom, (iv)
1	
 
 114e
1	combination with any
1	related to countermeasure
1	section 360b(d)(1)(a) through
1	fiscal year 2002;
1	(c) classification as
2	derogate from any
5	packing, and storage
1	
 356a. manufacturing
2	final promulgation of
1	form and route
1	territory means any
1	 (y) the
1	(2) an article
4	(iv) terminating a
10	secretary, the secretary
1	designations shall be
2	compete unfairly with
3	meetings of their
1	construed as altering
2	summary of 
1	section 748(b)(1) of
1	practicable and necessary
1	reviews. (ii) in
1	administrator in the
1	income, or the
2	shipment of milk
3	subparagraph (a) with
1	constant evolution of
4	shall be specified
1	administration took final
1	hazard identified, if
1	person by a
2	25 employees 
3	(t) the term
2	supplement for the
2	salt, derivative, mixture,
4	drug applications means
1	working group whose
1	generaloutsourcing facilities 
1	device. in the
2	one shall be
1	report developed in
1	analysis which the
1	columbia, but through
1	(f) is imported
1	health shall continue
1	schedule i) in
2	notify, in writing,
1	slaughter, unless, when
2	transporting, distribution, reception,
1	directly with purchasers
4	court as provided
1	(b)class ii, special
1	strategy; (b) is
1	food product. (c)
1	effect until revoked
1	container of the
1	531, formerly 355,
1	42.  (b)
1	officials except as
16	355(j) of this
2	school or farm
1	chapter, officers or
1	require, when necessary,
1	may require; and
1	web sites, such
1	 (1) appointment
1	projects that use
2	grounds set forth
2	july 9, 2012;
1	(
 
 863.
1	economic impacts, of
1	product, as applicable
1	teams, composed of
1	require name, address,
4	chapter, including rules
1	initiated under this
1	health information; or
2	eradication or control
2	cooperation with the
11	follows:  (1)
1	july 9, 2012)
1	diligence; (5) in
1	order which is
5	protocols in effect
25	july 9, 2012,
69	food, drug, and
11	july 9, 2012.
1	date, whether any
1	(c) coca leaves,
1	separate registration in
1	health, the holder
1	recall  (a)
1	(2) any salt,
2	specific formulations or
2	involved, including the
1	devices. in developing
1	fees for human
1	equip an adequate
6	fee amounts specified
1	state, may designate
1	and, as feasible,
1	concerning initiatives, studies,
1	leaders  (a)
1	812. schedules of
1	(4) tropical disease
1	change of professional
2	label that is
1	manufacturer unless such
1	(e) automated risk
1	goals;  (3)
1	supplements to the
2	including costs for
1	proceeding. (6) failure
1	title 22), shall
6	preserve its identity,
4	departments or agencies
2	protocol for an
1	user of narcotic
1	qualified countermeasures, security
5	register a list
1	title classifying a
1	(g) practitioners dispensing
1	coalition  (a)
1	renumbered 22 and
1	state official) in
1	(g) is published,
1	crop year, and
1	(a) providing overall
1	(c) qualified infectious
1	safety, economic loss
1	filed.  (2)
1	implement dissemination plans
1	section 351(f)(1) of
1	value which exceeds
1	annually a registration
1	trade or smuggling
5	authority if the
1	 (22) united
1	engaged in any
103	approval of the
1	dispenses or offers
1	may require, as
2	effect on section
2	title) for the
1	(4) shall apply
2	appropriations to carry
1	hardship, which shall
1	person obtained, directly
1	term animal feed,
1	(b) lacks sufficient
1	(b) changes in
1	tobacco, or all
1	chain, including those
1	date. after the
1	data on comparative
1	assist the united
1	control against diversion
1	1044. exemption of
1	(b) an action
1	review of posted
1	humans within such
1	extension, outreach, and
1	 (j) prevention
1	 (a) relate
1	(2), the amount
1	beginning on january
1	approve abbreviated new
1	endpoints and other
1	protocol the secretary
1	including specific countermeasures,
1	poultry and the
1	 (3) fee
1	submit directly to
1	licensing fee from
1	listed chemicals (including
1	
 360oo. prohibited
1	meeting that involves
2	subclause (i). 
5	regulated under the
1	welfare, or who
1	means a retail
1	applies and categories
1	ingredient component. (e)
1	constituent), or other
2	interstate commerce. (b)
1	wel-controlled studies in
1	submit for such
1	european union, are
1	entry and by
1	information as appropriate
1	conducting more standardized
1	quality assurance, or
1	age who knowingly
1	(a) the secretary,
2	addiction medicine from
2	application a waiver
1	produced through the
1	purpose intended to
2	countermeasures for approval,
1	prohibited from taking
3	definitionsin this subchapter:
1	pediatric therapeutics. in
5	may not sell
1	accompanying any list
1	title inapplicable to
1	effectiveness. no condition
1	effects of changes
1	establishing the ris-based
1	adulteration of an
1	individual unless the
1	said chapter, after
1	ch. 675, 807,
1	referred to experts
2	exported in accordance
1	drug, include additional
3	accompanying such article.
1	practices identified in
1	agent the term
2	product as actually
1	(b)(iii) shall be
1	services of foundation
1	(3) of the
1	subsection (c) (relating
1	(v) pediatric conditions
4	publish on the
1	required to implement
1	use of fee
1	hig-risk food facility
1	(1) a pesticide
1	substances, and such
1	regarding the patient
1	pathogens) or type
5	assessed by the
1	patient need refers
7	exemption under subsection
2	notwithstanding paragraph (3),
2	initiates or causes
1	issuing guidance under
1	controlled investigations, such
4	list the secretary
2	drug having such
3	5 and to
2	label statements the
1	appropriations used to
2	unsafe, and shall
5	act. (3) authorization
1	finding of safety
1	(14) notwithstanding any
3	may be considered
1	radiological health programs
5	preventive controls implemented
1	approved product for
1	require the testing,
2	information; and (ii)
1	establishment of fees
22	authority of this
2	construed to apply
1	days after may
1	section shall alter
1	discharge an employee
4	days after publication
1	narcotic drugs, which
2	food, or the
1	apples the barrels
1	(ii) include the
1	levels of other
1	may include epidemiological,
4	applications, reports, supplements,
1	(b) in promulgating
1	(a) authority and
1	(1), oxygen may
1	cleaning and sterilization,
1	sales, transportation, and
1	controls, to provide
1	360eee or 360eee1
1	validity of withdrawal
1	(a) advisory panel
2	 (c) new
1	2008 through 2012.
2	2008 through 2012,
1	director to the
1	shall the defendant
1	government agencies, and
1	products; and (2)
4	 (iv) terminating
1	possession of such
1	discretion, is determined
1	specific category of
8	substance to the
1	chinese subjects when
1	drug manufacturing industry,
1	appropriate office of
1	requirements, or regulations
1	may cause blindness.,
1	furnish any material
1	(ii) in lieu
1	recommendations during the
1	fruits, fresh or
1	time appoint committees
1	ch. 675, 744c,
1	purposes.  (

1	 (g) guidance
2	ful-time equivalent employees
1	whether such study
1	entity subject to
23	secretary shall consult
1	stay the sale
1	effectiveness of awarding
2	exchangethe secretary may
1	thereof, to regulate
1	application to which
1	general policies; transfer
1	 $258,019 
1	water navigable for
2	term container or
1	means a specific
1	civil service status
1	 (i) publication
2	product is safe
1	section 706(2)(a) of
1	demand reduction the
1	persons responsibly connected
1	clause (a). (2)
1	accompanied by samples
4	partners, as applicable,
1	alternatively, in the
3	(3) nothing in
1	formerly 908, as
1	activities under a
1	regulations), is deemed
1	section on more
5	(b). the secretary
2	narcotic drug for
2	guidance is available;
1	united states mails
2	life imprisonment, or
1	register a report
1	
 1117. repealed.
1	intended, if such
1	(e) data and
1	title i, 11,
1	1333(d) of title
1	variance from, or
2	(1) appropriate state
1	visible federal leadership
1	likely source for
1	notice to individuals
1	gather data and
2	submitted; and 
1	serious, expected adverse
1	secretary) any drug
1	combination product disagrees
2	amounts shall be
1	42 because of
1	agriculture, the united
2	prohibit the office
5	will be adequately
1	v or any
1	combination of designated
1	engaging in a
1	evaluation (other than
1	food; (2) a
1	u.s.c. 247d6b]. (2)
1	appeared after the
1	state and territory
1	reach acts of
6	online pharmacy shall
4	adulterated, the secretary
2	enforcement administration and
1	section 355(j)(5)(b)(ii) of
3	treated as domestic
1	product liability no
2	except where such
1	seller or lessor
1	(1) has partially
1	(b) service a
1	measurable results in
18	determination that a
1	drugthe term nonprescription
1	program; (b) conduct
1	priority countermeasure as
1	instructions under paragraph
1	american consumer; and
1	marketing, promotional, or
1	court alone, without
1	federal counte-drug programs;
1	products in a
1	any, submitted and
2	maintain records or
1	product to ensure
3	practical method for
1	shall not exempt
1	supporting the change,
1	
 7 to
1	based. (d) effective
1	article or articles
2	packaging requirements of
1	sections, nothing in
1	(f). the identification
1	plainly printed upon
2	product without providing
1	issues of adulteration
1	inspected or examined
1	period that begins
1	paragraph (3), not
1	(or more frequently
1	 (1) promote
1	review such comments
2	order of priority
1	blood components, source
1	operation and products
1	operations with respect
1	 (7) assessment
2	incidental to such
1	title iii, 541,
1	signals.  (l)
1	subsection (c)(1)(a) recognition
1	(f), fees paid
1	event reports; (c)
1	may review the
1	333a. repealed. 

1	establishment is to
1	advisory committees regarding
1	takes effect upon
1	responsible person conduct
3	request under subparagraph
1	 (f) application
1	puerto rico. (g)
1	 (1) recognized
5	drug and any
1	submit on an
1	paragraph (1) after
1	species indication. 
1	 (f) research
2	manufacturing change shall
1	response teams of
2	verifying that the
1	followed or did
2	(a) of a
1	director determines and
1	(ii) the scalability
2	papers, processes, controls,
11	security of the
2	paragraph. such regulations
1	 (3) withdrawalthe
2	person that manufacturers
1	countermeasure application upon
1	council shall consist
1	made, and (b)
1	to, specifications as
1	issue temporary permits
1	sentenced as follows:
1	designating products for
1	abuse is at
1	contract between the
1	medical devices 
1	reviewsif, based on
1	360f, 360h, or
1	citizen or national,
1	title 18; and
1	security. (june 25,
1	drop shipment for
2	section 355(a) of
1	state.  (c)
2	secretary that establish
2	business, and all
1	dye, the label
1	administration with additional
2	domestic animals, which
3	food additive which
1	products, including modified
1	development. (in this
1	onsite visits on
1	675, 415, as
2	appeal is frivolous.
1	production with other
1	(3) any foreign
1	device required to
4	eligible coalition that
1	individuals pursuant to
1	(i) that investigations
1	subsection (c), implement
1	drug experience because
1	consignee submits a
30	provided in subsection
1	deferrals granted. based
1	proposed order informing
1	tool for its
1	application of sectionthe
1	three years. (mar.
1	guide; patient package
1	manufacturer, a manufacturers
1	charge is made
3	years of august
1	hazards.  (c)
1	star-up costs in
2	authorized by state
1	imported is within
1	scientist to lead
1	time except upon
1	2016; or (2)
2	(d) electronic database
5	abuse and mental
3	food in a
1	
 472. interstate
1	import prescription drugs
1	oral inhalation drug
1	assessment, in accordance
2	months after conducting
1	poultry is found.
2	(i) of such
1	agencies to submit
3	fiscal years 2011
1	year, so long
1	administration is authorized
1	productivity of medical
1	chemical compound in
1	otherwise using any
1	regarding the components
1	membersthe ex officio
1	body. (f) if
1	
 1174, 1175.
1	delayed; and (d)
1	(a) definitionsfor purposes
1	communities timely information
1	place in a
1	days before such
1	(c) public notificationif
1	assessment is required,
1	facility on a
1	strength is the
1	shall be designated
2	poultry products exclusively
1	
 886. payments
1	body and the
1	probability; and (ii)
1	action, after june
13	withdrawn or suspended
1	laboratories to appropriate
1	title proposing a
1	guarantees of analysis,
3	revision of such
1	imported by means
1	owner thereof to
1	states from collecting
2	renderer means any
1	applicable information in
1	(14) product identifier
1	scientific advisory committeeupon
1	including the furnishing
1	misbranded, and (b)
1	manner as described
1	files). (b) twent-four
1	federal agencies; (b)
1	distributor and provides
1	publication should be
2	formulation, is intended
1	consult with representatives
3	appropriate to carry
1	18 that the
1	unless a significant
1	 (e) separate
1	pay fees. 
1	laboratory and has
1	amount of establishment
1	(b) subject to
1	enforcement intelligence systems
1	authority has provided
1	term critical control
1	actions regarding approval
1	inspection under lawful
1	childhood education progra-sponsored
1	considered a device
1	abuse organizations that
2	subsection (a)(6), the
1	participation was discontinued).
2	entire record at
1	strategy that meets
1	
 
 373.
1	know of, such
1	easily accessible manner
3	official name for
1	poultry products; (2)
1	date, the transaction
1	notifies the office
6	3-day period beginning
1	shall periodically publish
1	livestock producers and
1	fiscal year. (b)
2	drug.  (ii)no
1	(1) may accredit
1	regarding cleaning and
1	part thereof, meat,
2	hereinbefore set forth
1	(b)(3) of a
1	205. display of
1	agriculture, not less
1	transport said virus
1	deficiencies. (iii) the
1	likely or known
1	shall deny approval
1	written notice, the
1	trade, or counterfeit
1	(b); or (7)
2	drug as so
1	folic acid (g)
2	apply had a
2	system established under
1	alleged misbranding if
1	(a) notifying such
2	general provides written
1	trial. (2) the
7	states interdiction coordinator
1	2013, and annually
2	recommendations as the
1	(3) shall perform
1	 (e) informantsthe
1	(i) withdrawing recognition
1	official plants shall
1	11 members to
1	information submitted contains
2	vacate the order.
1	secretary that foreign
1	(b)(2)(b) may obtain
1	sharing of data
1	344, 350d, 355,
1	(4) its history
1	7,[1] shall be
1	regarding certain goods
1	increase in demand
5	(e) whether the
1	initially approved; (2)
1	shall deliver such
1	and, if known,
1	collected data, that
1	detailing the means
1	suffered harm as
1	amendment if the
1	persons within such
1	appropriate, shall direct
2	by, or is
1	cream five hundred
1	prohibited without (1)
2	includes the data
1	certification described under
1	sensitivities of major
1	(2) any or
1	public health with
1	unless the sale
7	united states agent
1	subparagraph (d), any
2	outstanding fee is
1	(3) costs of
1	(2) any of
1	including establishing 
1	 (i) may,
1	(f) compromise the
1	recommendations, shall make
1	apply efficient and
1	law  (1)
1	effect no earlier
1	attorney general, which
2	appropriations for food
1	lot number, and
1	purposes of filing
2	wholly or partly
1	drug shortages (a)
1	limits of authorized
1	(3) participate through
1	products and subject
1	no-sunscreen time and
1	relating to violations
1	devices; (10) because
1	secretary; judicial review;
1	term if a
2	administration act (27
4	(5) if the
1	sanitary protection achieved
1	public health requirements
2	may discontinue review
1	secretary, which shall
1	including technical advice,
1	americans (including native
2	day before october
1	person to alter
2	maximum amount of
1	affected national drug
1	moneys expended from
1	person discovers a
2	facilities and the
2	recipient, has been
1	rationale for significant
1	term group practice
1	investigated for a
1	(iv) the reason
1	registration or form,
1	uses a device
1	increased fee collections
1	(a)(4)(c), the secretary
1	uses.  (d)
21	section 355(b)(1) of
1	prescription drug product,
1	submitted or during
1	product, and unless
1	collected and the
3	yielded by or
8	authorized distributors of
59	whole or in
1	(b) one member
1	residues in effect
1	documenting the farm
2	pediatric information 
1	food; (k) take
2	subparagraph. a determination
1	sections 5702 and
4	subsection alters or
1	violated any state
1	353a1. enhanced communication
1	media. (v) schools.
1	take evidence, and
1	industry, agricultural, or
1	public health reasons.
2	matters requirements within
1	(j)(5)(b)(iv); or (ii)
1	made, but the
1	(i).  (2)
1	effectiveness that would
1	[15 u.s.c. 2601
1	(3) authorizations of
1	reports shall evaluate
1	may strengthen their
1	agency with respect
1	certificates, a listing
1	injury which the
1	uniform assessment of
1	criminal forfeitures (a)
1	prohibited it is
1	period in the
1	relevant pediatric population;
1	inspection by duly
15	(a) for a
2	testimony, as described
1	(35) phenampromide. (36)
1	prohibited to vessel
3	voucher issued under
1	added june 22,
2	(1) within one
1	package form; contents
4	prescription drug products
1	structure of a
8	apply to an
1	time donated by
1	-(-fluoropentyl--(-iodobenzoyl)indole (am694); (xiii)
1	$25,000. sections 842(c)(1)
1	(a), the fee
1	diseases; (2) the
3	include 1 or
5	nonsaleable product to
1	foregoing substances at
1	bear on drug
1	progress toward meeting
2	consultation with external
1	transaction statement; (ii)
1	research, sales (other
1	party except for
1	registrations of pharmacies
1	item in the
6	supporting or sustaining
1	(including the united
2	provide for exempting
1	review relevant regulations
2	exclusion of any
1	chapter or regulations
1	formerly 902(b), (c),
1	-penty--(-naphthoyl)indole (jwh018 and
1	position is established
1	support implementation of
1	outlet, if such
2	(iii) has not
1	part. the secretary
1	food manufacturing establishment,
3	registration to manufacture
1	dispensing, importation, and
1	(under such circumstances
1	cosmetics in the
2	will be developed
1	risk for microbiological
4	existing users of
5	comments from the
1	drug submissions during
1	marked agreed initial
40	described in this
5	uses for which
1	proceedings (a) jurisdiction
2	european union and
1	independent appeal prior
2	imply that 1
2	formula manufactured by
1	calendar year; and,
1	101(a), 102, or
1	documents and the
1	updated interpretive criteria
1	property subsequent to
1	897 of the
9	offered for importation
1	risk was not
1	condemnation; appeal; reprocessing
3	safety data. 
1	preceding sentence does
1	states, and indian
1	blister packs, each
1	device (other than
1	20 paper matches,
1	cigarette or any
1	publicationthe commissioner shall
1	 (2) reviewin
2	 (a) action
1	longest withdrawal time
1	initiation of referralthe
2	state program includes
1	matched with i-kind
1	prosecution for perjury,
2	system of a
1	criminal authorities under
1	allowing timely public
1	start act (42
1	consumers. (c) product
3	likely to have
1	prior history of
1	regions of such
1	payments or support
3	united states), or
1	(1) convictionfor purposes
6	medical and scientific
1	(1) appropriate action
1	(a)(1) or paragraph
2	section 1355 of
1	(ii) the notification
1	selection of a
1	final use container
3	subsection (b)(4) of
1	hashish oil, pcp,
1	states, less likely
1	investigations for purposes
2	plan for addressing
1	(3), the total
1	notice and determines
2	application. there is
1	subject whose identity
1	patien-focused drug development
1	(3) definition 
1	(
 
 1903.
4	matter complained of;
1	law other than
2	notice, as determined
1	about, importers participating
1	abuse; and (5)
2	potential use of
1	deemed under subparagraph
4	approved for administration
1	purity therefor set
4	order.  (b)
1	subchapter ii who
1	therapy, including studies
1	addressing such other
3	matter complained of.
1	product manufacturer under
1	marked. (aug. 3,
1	means any recreational
1	commodity or food
1	retailers of regulated
2	paragraph (1) remains
5	labeling approved for
2	proceedings, including judicial
1	subchapter ii after
20	product for which
3	(2), the secretary,
1	interfering with that
1	product be provided
3	made adequate within
1	notice given in
1	indirectly, from a
2	regulations shall provide
1	exportation, if and
2	contained in section
1	considers proper. the
1	directions contained in
1	title i, 16,
1	requirement of regulations
1	persons believed by
1	 (a) approval
1	except subsections (a),
1	term as applied
1	title iii, 537,
23	meets the requirements
1	generalit is unlawful
1	samples  (1)
2	(b) the appropriate
1	 (n) scientific
1	infant formulas which
1	use withholding directive
1	(1). (e) reauthorization
1	general may order
1	development of coalitions
1	impact on wild
1	core of other
1	individuals or entities
1	annual change in
1	commercial and noncommercial
2	technical support available
1	gaps in scientific
1	dried fruits, fresh
2	subsection (d) approving
1	
 
 379dd.
2	adverse determination is
1	animal or of
8	standard established under
1	administer prescription drugs,
2	action taken or
1	approval as safe
1	subsection (b)(2) upon
1	issue of food
2	container that is
1	ethylene oxide and
3	upon any premises
1	clinical endpoints, and
3	(e) the number
1	2021.  (

1	election is made
1	(june 30, 1914,
1	 (b) process
1	pay tort claims
2	course of business
2	correct or delete
1	licensed veterinarian. 
1	prescribing alternative methods
3	regulatory, or other
1	permit a standardized
1	applicants, to identify
1	strength; and (ii)
1	advertising was paid
1	regulations lawfully issued
2	(d) information to
1	 (g) extension
1	require additional statutory
1	submitted for inclusion
1	earlier.  (e)
1	clinical benefit, taking
1	related substance, (c)
1	scientific information and
1	respectively) shall apply
16	product intended for
1	renewal registration containing
3	paragraph (1)(b). 
1	sale (including any
1	chapter shall mean
1	year 2015, $1,857,000
1	center to transfer
1	locations doing business
1	relabeler, who 
1	reviews of devices,
1	delivery, the name
1	whether the adjustment
1	product. (dd) for
1	section 353b(d)(4) of
1	(8) not more
1	prescriptions may not
1	health than a
1	1935, ch. 743,
1	regarding foodnot later
1	(8) provide objective
2	uniquely identified by
1	establishment is eligible
1	program, prior to
1	issued. (3) currently
1	establishments;  (3)
2	interpretive criteria which
2	(d) prior to
1	hearing, shall withdraw
1	auditors; and (iii)
2	secretaries described under
3	secretary, fail to
2	formerly 903, as
1	new sources of
3	purposes set forth
3	chemical or pesticide
1	(3) acting director
1	subparagraph (1), which
1	safety, he may,
1	committees the attorney
1	states, be deemed
1	grant, contract, memorandum
1	 (2) revision
1	submitter having to
1	including restrictions on
1	address; and (ii)
1	access to, advertising
1	applicable. (b) if
1	(ii) illicit drug
1	integrated response during
1	establish and make
1	premarket application. 
1	applications and investigational
1	drug, the manufacturer
1	387g. tobacco product
1	iii device submitted
1	licensed physician determines
1	appropriate means, and
1	expertise, are qualified
1	drug product fees,
1	thereof) for any
1	drug product fees.
1	marketability of the
1	2,500 feet of
1	request. the accreditation
2	presents a potential
1	incidence and prevalence
1	tin, pot, canvas,
1	blister packs, unit
1	state poultry products
1	proposed regulation and
6	subparagraph (d) of
1	(1). (j) report
1	use marijuana are
12	authorized representative of
1	(bb) is not
1	alcohol beverage until
1	food items. no
1	reinspection fee from
1	data about the
1	1502. repealed. 

14	delivery for introduction
1	legislation will be
2	requirement with respect
1	facility.  (c)
6	conditions of purchase
1	mitigate any impact
1	combination thereof, shall
6	letter under paragraph
2	subsection may use
1	used or likely
1	intended therapeutic effects
31	jurisdiction of the
4	contract under this
2	subparagraph (b). (e)
1	admissibility of transcripts
1	section 282(j)(2)(a)(ii)(ii)(gg) of
1	(2) whether the
1	agency; (2) a
24	 (i) that
1	(7) no impact
1	pars., 34 stat.
2	media campaign and
1	holder thereof, shall
1	food product derived
1	age; or (2)
1	safety. separate registration
1	filing application for
1	warrants shall be
1	shall identify, through
1	paragraph (1); or
1	label. any definition
3	charged with premarket
2	fail to show
1	whether the recall
1	claiming its benefit.
1	presentations by the
2	deferral extension under
1	written permission for
1	substance for his
1	hearing if and
3	assessments, deferrals, deferral
1	columbia; and (c)
1	crime to transfer
1	issued thereunder. 
3	drug sample or
1	clause (iii)(ii). the
1	(d)(ii) shall be
1	withdrawing recognition of
10	packing of such
1	govern any such
1	sell at public
1	made and each
1	states, the state
1	determine if shell
1	effectively implement the
1	group; and 
1	agreement cannot be
2	listing and relisted.
1	reports beginning with
1	factors  (a)
2	title shall, on
1	structure, or (c)
1	felony. (14) the
1	(ii) publish on
1	chapter on the
1	counterdrug technology assessment.
1	(b). (b) a
1	results; (iii) rapidly
1	registered. subsection (b)
3	except that either
1	interstate commerce the
1	appears from an
1	recognize the inspection
2	significant role in
1	certain substanceswith respect
1	selecting from the
1	including the names
1	use is prohibited
1	1999, whichever is
1	(2) an intended
1	exemptions provided herein,
1	title during the
1	psychic or physiological
1	 (b) market
1	also is labeled
1	contracts with a
2	articles: provided further,
1	(c) action on
1	iv, the attorney
1	steps to secure
1	provisions to articles
2	prevented from being
1	practices, as determined
1	(b) congressional committeesthe
4	employees, and the
34	apply to a
1	paragraph and section
1	communications; (d) data
1	time before the
2	scientific, professional, industry,
1	ii, or a
1	2010. (
 

1	(i) to prevent,
1	protocols requiring control;
1	(3) expertise in
1	criminal enterprise, or
1	31.  (f)
1	meet his estimated
1	(1) shall conduct
4	shall permit the
1	used by consumers
1	secretarys order. 
1	protecting the borders
1	v a product
1	refuse or admit
1	tobacco is a
1	secretary from officers
1	conspiracy to violate,
2	request with respect
1	likelihood that persons
1	laws or chemical
1	practice of veterinary
1	192, 35 stat.
1	protect information exchanged
8	application does not
1	(a).  (e)
2	recall under section
4	evidence strongly suggesting
4	2013 shall be
1	identical in its
1	regarding chemicall-related or
1	postmarket study under
1	risks cannot be
1	declaration of national
1	importer would be
1	person, in advance
1	review division; and
1	conviction as determined
3	district in any
2	shall maintain, for
1	least $7,000,000 is
1	30 day period.
2	transaction or dealing
1	believes should be
1	additional margin of
1	(b) not subject
1	drug, it is
1	article is used
1	requirements for information
1	secretary, in such
1	electrolytes; (ii) a
9	title 42; and
1	goals, the review
2	operations of such
2	forth the secretary
1	goalensure an efficient
1	employees supported in
2	fee has the
1	hereinbefore described are
1	conviction which was
1	authorization shall not
3	may continue to
1	immediately. (b) if
2	section 880 or
1	establish compliance with
1	syringes) shall include
2	applicant and if
8	may be imposed
1	communication.  (c)
1	issued in response
1	performance of official
1	cigars, the percentage
1	parties, including public
1	effective treatment for
1	recipients, with a
1	state for maple
1	emergency use has
1	
 379j53. reauthorization;
1	access by congressthe
1	readily available for
1	accreditation, pursuant to
1	commerce under section
1	individual units produced,
1	term includes any
1	third parties prior
1	require tobacco products
2	year, submit to
2	making appropriations through
1	appropriate clinical use
3	substance and chemical
1	treat or prevent
1	quota of each
1	definition if any
1	proceeding in accordance
1	 (h) separate
1	(2) identify and
1	
 1054. annual
1	system under subsections
1	years ending september
1	administrative proceedings under
1	imposes mandatory ante
2	product remains listed,
1	title which shall
1	accredited; and (iv)
1	(f) current good
1	(d) or (f)
1	statement in accordance
1	order (or regulation)
1	complete testing by
1	government agency, if
6	site.  (3)
1	sufficient to gather
1	products, or technologies
3	judgment with respect
1	1 of whom
1	domestic animals, intended
1	beginning on may
4	inferiority has been
1	july 31, 1956,
1	hearing, the secretary,
1	imitation, process, renovated,
1	conferences prior to
1	use for purposes
1	effectiveness.  (d)
1	base amount, with
4	cost of inspection
1	1045. limitation on
1	cal 2.7 
1	provides assurances in
1	criteria for addition
1	(ii) supporting the
1	aircraftit shall be
1	person the owner
1	350i of this
1	warning of criminal
1	manner; (3) develop
1	case means a
1	holiday work performed
1	provided for the
1	(ii) be required
4	wholesale distributor; and
1	labeling could not
1	flows through interstate
3	flavoring, and coloring)
1	states. subpoenas for
1	(iii) be required
1	thereunder.  (d)
2	equivalence means, with
1	safe with respect
1	properly and timely
1	accurately identify the
2	importation of ephedrine,
1	include any distinctive
1	eligible for such
1	definition under clause
1	section, or is
1	country that has
4	judicial review within
4	summary of information
1	shall decide any
1	tuberculosis; (3) when
1	felony, or (2)
1	 (f) disposition
1	limits the recipients
1	federal register; notice
1	country, if the
1	advertisement would be
1	continued compliance with
1	plants, or food
1	implant that 
1	specifically for use
1	patients. (vii) the
2	equivalent means of
1	(except that the
1	(7) phencyclidine. (8)
4	persons accredited under
2	applicant is inconsistent
1	may also, at
1	reports an applicant
1	controlled substances other
2	(a) a person
2	representations concerning the
1	359, as added
1	documentation by a
1	 (c) memorandum
1	affiliatethe term affiliate
1	growing, harvesting, sorting,
2	risks to humans
1	name, unless its
1	section, all controlled
1	year, whichever best
1	extracts, except that
1	(issued without regard
1	product as are
1	measure the illicit
1	 thirty days
1	(v) the division
1	payments or services
1	u.s.c. 101); (c)
1	expendedthe director shall
1	 (i) arranging,
4	may be further
1	frequency identification technology;
1	materials, conditions and
1	provide security for
1	(c) a certification
4	employed by or
1	ivit shall be
2	subparagraph (c), information
1	including topics described
1	order from the
1	local foodborne illness
2	drugs proposed for
1	675, 1001, formerly
2	drug abuse issue
2	timely basis among
3	new findings, and
1	 (2) filing
3	affiliates.  (b)
1	whoever commits any
1	therein. the foregoing
1	shall be validated
1	proof that he
3	subsection (a), as
1	(b)(3)(b)(ii)(iii) of section
2	with, 1 of
1	person confirmation of
1	carry out his
1	paragraph (1) because
1	official mark. (o)
1	personally dispensing the
1	pediatric population or
1	expended.  (june
1	study plan prior
2	transmit notice of
1	quality and fill
1	residue level for
3	sunscreen containing such
1	replacement products as
1	assessment; and (c)
1	product tracing technologies,
1	agent may fairly
1	(b) in partnership
1	(b) the publicly
2	measures as the
1	terms investigational submission
2	copies; samplesthe following
1	communication.  (d)
1	reduce a risk
1	360c(f)(2), 360e, or
1	reviewing the applications
1	late under this
1	provision of title
1	facility in a
1	regulations or such
1	(7); (b) in
1	statements of distribution
1	annual meetings of
1	finds, after giving
1	subsection and this
3	classification in class
1	part. (2) if
1	forfeiture of property
1	veterinarian) applicable to
10	(mar. 4, 1913,
1	(2) bribed or
2	violations of a
1	panel to which
4	may be seized
1	communication, including varied
2	administration in a
2	means the program
2	subchapter is maintained,
2	participation of the
2	transition grants the
1	registering as an
1	expire and shall
1	(b) data collection
1	designation or approval,
1	 inositol (mg)
1	date in effect
3	severity, rarity, or
1	fixed. the court
2	high risk of
1	entity not organized
3	mentoring activities to
2	case of internet
2	inadequate to ensure
1	program is fully
1	evidence.  (d)
1	good faith, etc.
3	thereof as the
1	enrollment has begun,
1	manner authorized by
1	registry available to
1	pay fees payment
1	viscera have not
1	ch. 675, 584,
2	produce positron emission
1	agriculture, at an
1	patients in offic-based
1	service shall, upon
1	creative themes into
1	meet a requirement,
1	files to the
1	ingredients is grase;
1	commodity; or (b)
1	general considerations for
1	act). no regulation
2	secretary may revise
1	6 approved abbreviated
1	preclinical trials and
20	specified in such
1	successor regulation)). 
2	hearing to withdraw
2	persons alleged to
1	
 2109. publication
1	
 379j22. reauthorization;
1	well as drug
1	procedure; multiplicity of
1	organizations.  (3)
1	eligibility determination. 
1	license to practice
1	uses of psychotropic
2	facility to pay
1	fiscal year upon
5	later than september
1	primarily for the
3	american societies of
2	effectiveness before november
1	receipt of public
1	requirements for qualified
2	levels so relied
1	product per year
1	ensure that articles
1	subsequently recovered shall
2	filing its application
1	education program food
1	(d), and (e).
7	which, in the
1	standardization (iso) and
2	coalition for the
1	devices granted an
1	(a) and an
1	publications, as determined
1	nonfood products, if
5	human services, the
1	business conducted for
1	connection with carrying
1	preparing to take
2	reductions the secretary
2	approval or denial
2	prior to being
1	violate subsection (e)
1	interstate, foreign, or
1	675, 526, as
1	202).2 (d) information
3	prescribed or approved
1	shall be retrievable
1	public under subsection
1	may accept in
1	paragraph and a
1	program administered or
1	glass, stone, plastic,
1	allegedly caused, directly
2	requirements of clauses
1	(ii) that a
1	professional pursuant to
1	(2) are met.
1	shall sell any
1	submitted.  (x)
1	using such a
1	applicant involved. 
1	conducts business, the
1	physiciana drug product
2	1984, no application
2	subsection (b), as
1	implement, certify, or
1	content is to
3	sale or disposition
1	food is required
1	removed for trial
2	changes that would
1	administration, or at
1	notification, suspension of
1	commerce wholly within
1	containing a poultry
2	(c) amount of
1	determination, the person,
1	altered by management
1	users, adult tobacco
1	narcotics trafficking means
2	required, that is
1	design, produce, or
1	seq.); (3) to
1	thereof; or any
1	successor regulations)[1] 
2	(ii) upon the
2	shall be reported
1	allowing safe access
6	proceedings on which
2	labeling contained the
2	dose injection for
1	attorney general. (3)
1	drug substance; 
2	may obtain review
1	relevant to priorities
2	(1) identify and
1	settlement agreement entered
1	prohibiting the importation
2	proposed regulation which
1	purchaser; (ii) the
1	group of experts
1	(4) a registered
1	revised on a
3	agriculture shall conduct
1	accessory described in
1	judgment under subsection
1	food does not
1	
 
 602.
1	eligibility requirements of
1	(f) other scientific
1	writing their inspection
3	regulated person may
1	community ant-drug coalitions,
1	certification. (b) if
1	community ant-drug coalitions.
1	 (6) prioritization
1	notice may direct
1	substance or other
2	tobacco product if
1	may subpena witnesses,
2	recordkeeping and reporting,
1	prescribe this controlled
3	tobacco product in
3	 (b) unless
15	tobacco product is
2	applicant submits a
1	standards, or mandatory
1	narcotics traffickers, their
1	products then on
1	radiological hazards, natural
2	individual or $25,000,000
1	(i). while the
1	section 379j52 of
1	commission shall recuse
1	efforts of each
2	system for identification
1	application and on
1	title 42, except
1	(d) drug pollution
1	study commitments as
1	to, or transactions
2	tolerance limitation at
1	declaration of emergency
1	(i) specifying the
1	systems and data
1	(i) a misdemeanor
1	reason of any
2	testing is required
7	opportunity to submit
1	
 64. regulations
2	(ii) ensure that
1	board that it
1	regulation, establish. 
1	investigator proposed to
1	agricultural commodities 
1	distributor of one
1	adulterated under paragraph
1	upon the commission
1	list of external
2	required  (1)
3	established by an
2	agricultural act of
9	drug.  (2)
1	regarding whether students
1	cause bodily injury
1	veratrum viride, or
2	regulation, together with
1	(5) consultative auditthe
1	subparagraphs (f), (g),
2	declaratory and injunctive
2	information by sponsor
1	establishmentthe secretary shall
1	portion, during any
1	regulated solely under
1	sold the food
1	section 360bbb3(a)(4) of
2	section, the united
18	forfeiture under this
1	create or confer
1	patient for whom
1	(i) exemptions of
1	(2) shall have
1	plans (a) in
1	
 
 379j13.
1	(1) any requirement
4	estimate of 100
1	sponsor regarding the
1	withholding of federal
1	901, 52 stat.
1	procedures respecting changes
3	local drug crisis
1	act of 1974,
1	abuse requires hig-level
1	elected in accordance
1	obtained under section
2	act of 1974)
1	manufacturer, or seller
2	gratuity to any
1	maximize use of
1	charge fees, in
1	issue a draft
1	collecting reinspection fees
1	subsection.  (s)
1	upon resubmission of
2	safety, cos-effectiveness, and
1	(7) betacetylmethadol. (8)
1	secretary and after
2	charged with the
1	(
 
 2206.
1	harvest, unless the
1	duplicative clinical studies,
1	acetorphine. (2) acetyldihydrocodeine.
1	purpose in such
1	fisheries service of
1	include a large
1	delegated. (b) the
1	title 42, been
1	(2) be renewed
1	$500,000 for each
1	campaign.  (d)
2	sale only allowed
3	implant that allegedly
1	file on his
2	(e) audits 
10	fee amendments of
1	regarding riskfor purposes
1	gathering the information
1	hearing and shall
1	proposed sunscreen orderin
15	350d of this
1	national security interests,
1	device establishments designated
2	funds were spent
2	(c) the drug
1	agriculture to assure
1	641. prohibition of
1	pharmacovigilance, basic science,
1	tolerance is safe.
1	resolution, unless the
1	901, as added
1	paragraph than the
1	benefit on pediatric
1	factors determinative of
1	(g) investigational tobacco
1	gum, and (3)
1	adulteration, misbranding, labeling,
3	(q) the term
2	expedition of hearing;
1	physically separate from
1	355(b)(3) of this
2	enters the information,
2	secretary and made
1	supplier. (b) every
1	(e)(2)(b)(ii), as the
1	(c) situations not
1	administrative recordfor purposes
1	(a) a producer
1	term cosmetic means
1	15 and shall
1	rulemaking proceeding initiated
1	occur naturally, or
2	publicly available arrears
1	transaction, the identity
1	supplier, with respect
1	establish any of
1	
 3551. risk
8	generic drug activities
1	plus the amount
1	emergency by 
1	rulemaking) or issue
1	shall contract and
1	(b) sunset of
1	institution programs. 
2	facility shall, as
3	targets and goals
1	privilege against sel-incrimination,
1	cosmetic; or the
1	(i) eligible coalitions
1	if, because of
1	safety. each such
1	updated quarterly. (2)
1	knowing importation of
2	general issues an
1	 (1) contentsan
1	mutual support between
1	time as either
1	product application has
1	activity which the
1	writing.  (3)
5	drug with the
1	include validation data,
1	relevant professional associations
4	foods packaged in
1	number of reasons,
1	imprisoned for a
1	fines, imprisonment, or
1	civil penalties under
1	person certifies to
1	(1)(a), and may
1	justice, be held
1	(2) activity by
1	applies this section
1	regarding the pending
1	360a1. clinical trials
1	whether the accreditation
1	sealed or inclosed
1	implemented by each
1	representatives; and (iii)
15	processing of a
2	human services, secretary
1	person if he
1	segregation and disposition
4	investigations of the
1	evidence, clinical studies,
1	reasonable time, to
1	identifier; (c) indication
2	animal drug sponsor.
4	may exempt from
1	construed as preventing
1	$195,000,000 for each
1	orders no longer
1	(g) on the
1	approval per fiscal
1	referral) to an
4	section, is deemed
1	testing. (iii) in
1	prepare and publish
1	permanently implantable within
2	department or independent
2	 (1) application
1	recommendations for action,
1	scientific matters, chemistry,
1	399e. nanotechnology (a)
15	whether there is
1	section 355[1] 360b,
1	(3), (k), and
1	illness and submit
1	application from deniable
1	dispensed in violation
10	application pursuant to
1	request and signature
1	pilot projects and
2	(a) in accordance
1	recognize all or
2	feasible, possess skill
3	(a) results in
1	substances, in preclinical
9	food to be
1	campaigning any officer
1	shall terminate notifications
4	seized or placed
8	may be served
1	 (6) signal
1	shall elect a
1	indication, route of
1	include the susceptibility
1	age in drug
1	(h) manufacture, packing,
1	appropriate, any terms
1	effect; (d) a
1	(e), each person
1	emergency use shall,
1	enable the computerized
11	receive for transportation,
1	(2) any report,
1	
 360eee. definitionsin
1	willfully violates the
1	subject of effective
1	biomedical etiology of,
1	outreach to parents.
1	generala requirement of
1	representative in the
1	modeling procedures 
2	obtaining any recommendation
1	imitation and, immediately
1	patient be disclosed
1	use thereof, for
2	provided with respect
1	law, or 
1	proposes to decide
2	1907, as amended
1	(sr19 and rcs4);
1	amount of methamphetamine
3	united states, while
1	pursuing approval under
1	economic information and
1	information to an
1	secretary shall fairly
1	director or during
1	(as poultry products
1	levels that are
2	products, which may
6	quarantine and inspection
1	360ccc1], with respect
1	part irrespective of
1	national networks of
1	section, the witness
2	secretary. such agreement
1	exclusively for scientific,
2	state or a
1	declining such a
2	pricing information without
1	control strategy, which
1	application of penalties
2	products, as well
1	issue date (whether
2	generic drug under
1	certificate of conformance
2	2007.  (2)
1	secretary submits the
1	person or food
1	definitions with respect
1	(3) disclosures not
1	(5) a hyperlink
18	considered to have
3	health of man
1	appropriate justification and
1	consideration may include
1	offense. (b) no
1	partnership, joint venture,
1	requirement of approval
1	(b) to combat
1	documents themselves are
3	production of records
1	offense that causes
1	(b)(1) or (c)(2)
1	years of age.
1	(
 
 471.
3	small businesses 
1	control act other
4	investigational device is
1	(3) dru-related activities
1	biological product. 
1	including, where available,
1	year 2009; (13)
1	funds were used.
1	reasonable timeframe, within
1	data requirements, and
1	seq.]; (b) any
1	statements do not
1	advertising act [15
2	program or an
1	prepared, is intended
2	nothing other than
1	disposition of milk
1	service are allowed
1	347b. contravention of
1	notice, and expedition
1	retail outlet then
1	best to regulate,
1	director is vacant.
1	signing a printed
1	essential chemicals the
1	commissioner by subsection
1	include the inspection
1	present an imminent
1	 (1) preservation
1	apply to and
1	set it aside
2	process, notice, order,
1	characterize the in
3	appropriate. the development
1	manufacturer transfers ownership
1	identifier, or package
1	furnish the name
1	inspection services with
1	(i) labeling changes
1	making sufficient progress
38	apply to any
2	require on whether
1	 (g) publicly
1	(1)(b), (2), or
1	amount of assessmentthe
1	1966 (80 stat.
1	including publication of
1	termination of exemption
1	submitted and that
1	 (b) compensation
2	time and place
1	plants and the
2	legend, shall apply
1	processed in the
1	(1)(b). if such
2	proposed changes in
2	construed as having
2	undergone all necessary
1	device treatment. (2)
1	otherwise made unavailable
5	show a significant
3	associations, and other
1	 (2) less
10	public availability the
1	(b) considerationsin establishing
1	determined as having
2	18, 1968. 
1	records, audit, and
1	(m) devices; mandatory
1	materials for use
1	 (iii) 
1	agency, or thereafter,
1	no-food producing animals,
1	committed after one
2	pediatric study plans
1	schedule i (a)
1	subsection (c) before
1	investigational device if
1	list, the secretary
1	officer, or failed
1	drug control at
3	provisions apply to
1	secretary, imminent danger
1	slaughtering and packing
7	proposed clinical testing
1	proceeding under subparagraph
1	dispenser from whom
2	feasibility of such
3	2015 and subsequent
2	chapter, including requirements
1	provisions not being
4	shall prescribe. 
1	nutrient in accordance
1	(2) plan, conduct,
2	articles so received,
2	whether an entity
1	product beginning 6
1	section 601 of
2	hydrate or preparation
1	subparagraph (b), establish
1	distribution, or use
1	including such requirements
1	increasing health care
2	2015 and each
1	abusing drugs; and
1	(f) information sufficient
1	hypoxia. (ii) in
1	hearing requested concerning
2	organizations for the
1	statement describing the
1	declare it not
1	disseminate information described
1	license under this
2	ii of the
1	secretary, such articles
1	object is of
20	known as the
1	(j) traceability except
3	used by registrants
1	tracing of prescription
1	exemptions, as applicable.
1	technology initiatives with
1	155, 4, 44
2	relating to counterfeit
4	refers to such
1	(1) convene the
2	accreditation body under
1	animal is found.
1	and, unless the
1	paragraph (1), disqualify
1	contents; and (b)
1	shall implement subsection
1	degree of direct
2	specifically intended to
1	675, 403a, as
2	governmental agencies, including
1	manufactures both animal
1	epidemic product means
1	annually.  (3)
2	fails to make
1	nonsterile drugs. 
2	reduction of substance
1	 (1) both
1	patients during the
1	safe tolerance limitation,
5	registration granted under
2	days.  (2)
1	(i) the lot
1	audit report, make
1	 (b) leveraging
1	(iv).  (g)
2	may receive more
1	
 612. notification
1	certain convictions; persons
1	cultivators are unknown,
1	may on his
1	
 
 360kk.
1	purposes, as hereinbefore
1	whether corporate policies
1	senate, to any
2	data to be
1	feed) is intended
2	failure of expected
1	(b) a new
1	sealed case containing
1	hearing; except that
1	establishment registrations at
1	2016, and after
1	355(b), (j)]; or
1	marketed unless it
1	animal drugs, be
1	commercial container unless
1	contamination, deterioration, and
1	(q) safrole. (r)
1	(2)(c)(iii), the applicant
1	decision pursuant to
1	(3) updated standards
5	control policy. 
1	neither that laboratory
1	(10) state, local,
1	states. (e) the
3	providing appropriations to
3	grants to and
2	stated goals of
1	utilized by task
1	dismiss for lack
1	effect in the
22	issuance of such
1	revision of guidance
1	food, drugs or
4	regulated industry on
1	investigational products intended
6	secretary to determine
1	2014, with respect
1	approved labeling to
1	listed chemical, respectively.
1	application be remitted
1	alerts, labeled indications
1	combination thereof) of
2	years 1996 through
2	relate to or
4	 for purposes
1	notice is effective)
30	year for which
1	appropriate schedule pursuant
1	date and is
1	title, an approval
4	certify to the
1	medical emergency situation
2	records necessary to
3	applicant, concerning investigations
1	professional societies; (ii)
1	assessment framework in
2	ultimate user or
1	authorization in an
1	9-day supply; (b)
1	minor or incompetent
1	inspection and administration
25	multiplied by the
2	diet; and (c)
1	establishments according to
1	(july 22, 1954,
1	 (4) joint
1	identity or location
13	section 353(b)(1) of
1	sanctions that are
1	given for each
1	case shall the
2	appeal of a
1	trials intended to
1	consider the evidence
2	subparagraph or paragraph
2	comply with chapter
2	treatment activities that
1	revocation was inappropriate
1	concerns the inspection
1	generalthe requirements of
1	business to cause
1	inventory (following the
1	overlap if the
1	performed, or recklessly
3	chapter, or (b)
1	criminal enterprise if
1	screening of animals
13	january 1, 2015,
1	remaining defendants. (b)
1	person, under section
1	(b) prescription drug
1	shall keep correct
1	procedures and criteria
1	 essential fatty
1	
 2224. surveillance
1	(a) payment to
1	pathwaysan application for
1	 (a) national
1	public health; (ii)
1	and, although not
1	paragraph (2), coordinate
1	manufacturer since the
1	subsection, or for
1	affect (1) the
2	delegate authority for
1	listed chemicals (a)
1	term medical device
1	administration. (c) the
1	v by practitioners
1	director, in coordination
1	(1) assessing the
1	aside. a copy
2	order or modify
1	requires to be
1	guidelines in consideration
1	application fee paid
1	clause. (h) 
1	(g) 1.5d 
1	1985; or (b)
1	201 of family[1]
1	(2) evidence of
1	may request. 
2	senate in the
1	eggs are stored
1	$1,832,000 for fiscal
1	system the secretary,
1	supporting a diagnosis
1	apply to section
1	carry out an
1	practicable, destroy the
2	municipality or other
4	(b), or (c)
1	foreign facility for
1	inspection if such
1	title. (4) all
1	(a) a head
1	benefit; or (ii)
1	pathogens described under
1	made after notification
1	regarding grants for
1	sufficient to eliminate
1	seal placed upon
1	1968.  (june
1	certain for review
1	shall establish collaborations
1	articles. the consideration
12	section 348 of
1	 (4) context
1	pay by reason
1	(6)[1] of this
1	beginning on june
1	governmental unit as
1	opportunity to meet
1	mean that any
1	350e, 354, 355(i)
1	effect computerized data
1	 (2) safety
1	material fact which
1	neonates, as appropriate)
1	administered in the
1	package level as
1	national situational awareness;
1	may be based.
27	90 days after
1	 (c) ex
3	facility which is
1	subsection (a), that
2	establishment  (a)
1	food. this section
1	suppliers (a) motion
1	public interest in
1	event consequence assessment
1	importers; hearing 
1	drug is adulterated
2	regulations for imported
4	fda food safety
1	(b)(1)(a)(i)(iii) for which
1	reports (a) in
1	positions that are
2	program, the secretary
1	product, the committee
1	menu items unless
1	(6) the general
1	committee; (2) the
1	guidelines to address
1	section, when a
1	applications; withdrawal or
3	 (b) notice
1	practical impact of
1	32, 62 stat.
2	different withdrawal period,
1	appropriate under paragraph
3	establishment means a
2	shall promulgate final
1	adequately evaluated for
1	practitioner  (i)
2	accessed, contained in
1	otherwise effect the
1	drug administration during
2	excluding allowable previousl-paid
1	dispenser  (a)
1	ensure that, with
1	(g) limitation on
2	(iv) the applicant
1	general designated by
1	collectively, but with
1	enforcement agencies will
1	reviewing tolerances and
1	 (9) reporting
2	shall organize the
1	real property described
1	(together with information
1	
 
 387h.
1	food and color
4	proportion of all
1	approval, and such
1	nongovernmental agencies, organizations,
1	(j) representation for
3	unless the affected
1	pseudorabies the secretary
1	substance abuse programs
1	 (3) feedback
1	filed application if
1	information, and reports
1	be, or represented
1	pediatric populations if
1	holds, exports, or
1	methodsthe secretary of
1	distribution by any
1	reduction, a deputy
1	annual report. (2)
3	improved analytical tools
1	(a) jurisdiction; disposal
1	dismissthe following rules
3	thereof moves in
2	provide a notification
2	first offense. a
1	avoirdupois ounce, nor
1	interpretive standard recognized
1	exporter may not
1	increases are minimal
2	auditor the term
1	abuse treatment; (d)
1	owner or part
1	imported article pursuant
1	chapter and for
1	proposed labeling. (b)
1	(2), whoever knowingly
1	register; effective date
1	etc., or requiring
1	adulteration or in
9	secretary on the
1	equivalent employees of
1	device; (ii) in
57	shall apply to
7	mark, stamp, tag,
3	appropriate formulations for
1	859. distribution to
1	(which area at
1	practitioner, or (ii)
1	professionals.  (2)
1	carrier; shall, on
4	60 days following
1	meeting their obligations
6	employees duly designated
1	covered application. 
2	term rare disease
1	prior to contracting
16	disease product application
1	states owning partly
1	
 134 to
1	product identifier and
2	 (c) period
1	emergency situationsin emergency
1	iii.  (june
1	reporting required under
1	therapeutic amounts. (3)
2	nominate individuals for
7	fiscal year 2016,
1	animal feed, (ii)
1	fiscal year 2016.
1	poultry or carcasses
1	processed, on a
4	includes  (1)
1	subparagraph (a) a
1	fiscal year 2016;
1	providing final guidance
1	requirements during the
1	engineered seafood products,
1	(4) qualifying laboratory
1	(4), or (5)
1	$1,500,000, or the
1	3551(g)(2)(d) of this
2	judgment  (1)
4	purposes of allocating
1	section 355(j) when
1	consider the practitioner
1	drug may begin
1	device because the
1	product unless an
1	person who assembles,
1	studies in addition
1	(c)(4) for each
1	 (iii) state
1	shall import or
1	arranging for the
1	meaning and implementation
1	requirements under clauses
1	president timely notice
1	facilitate adverse event
1	disease was met
4	health.  (b)
1	shall report acquisition
1	 (b) shall,
1	issued on october
2	information from or
1	may include provisions
1	classification information, periodic
1	standards in the
1	date of orders
1	held, and used
1	required for approval
2	sufficient to support
2	emergency, involving a
1	year upon the
1	upon. upon a
3	limited to a
4	entities meet the
1	yearly risk that
1	 (1) antibiotic
1	period of such
2	faith and had
1	achieving legislated intent,
50	carry out the
1	held (1) to
4	prior to a
3	name the manufacturer
1	register with both
1	notice filed under
1	uses proposed. 
1	(including rape), against
1	secretary requires a
6	pay the fee
1	(5) knowingly possess,
4	reasonable variations shall
1	citrus fruits, and
3	or, if no
1	commodity and by
2	exemption of certain
1	accredited thir-party auditors;
1	trafficking threat will
1	person from receiving
1	limited to 1
1	year beginning with
1	unless such container,
1	product, which, because
1	growing on, affixed
1	particular area, the
2	grants  (a)
1	another agency engaged
7	owner of such
1	income accruing to
1	offering for sale
2	provide a written
1	national survey on
1	applicant, the least
1	operation and effect
1	reserve fees paid
1	section, such residue
1	part c, in
2	may from time
1	regulatory rationale why
1	agreement under which
7	used to manufacture
1	premarket report for
1	(a), the condemnation
13	violation of paragraph
1	22, 2009, with
1	vulnerabilities of the
1	meeting of such
2	give interested persons
3	benefit to health
1	administration approval for
1	warning of any
1	disclose confidential commercial
1	years. penalties for
1	conducted or which
1	processor. the exemptions
5	records as required
1	822(g) of this
1	purpose of notifying
1	2017 for fiscal
2	disease product designated
1	ch. 675, 740a,
1	times the gross
1	designation has been
2	1, 2012, from
1	metal, wooden, acrylic,
1	geographic sense, means
1	(e) is in
1	examine the following:
1	fundamental sciences in
2	chapter, and notwithstanding
1	article being imported
1	term authorized generic
1	proposes any such
1	reportthe secretary shall
1	biomaterials supplier; or
1	methamphetamine information clearinghouse.
1	(1) qualifying pesticide
1	356, as added
1	new evidence of
1	use in inspections
1	form which meets
1	grows tobacco under
2	information.  (c)
1	information; (6) which
1	distributed or administered
1	(a), render full
1	(i) who 
1	cause under paragraph
1	subsection (b). (v)
1	25 milligrams per
1	activities by private
1	number of processor
1	evidence.  (june
1	potential need. 
1	5315 of title
2	properly marked, labeled,
1	applicable; or (b)
1	margarine containing animal
1	destroyed, altered, removed,
1	primary prevention programs.
1	exercises at least
1	individual, (ii) had
1	obtain a representative
1	(2) a regulated
1	dates for communication
2	(i) of section
1	 (k) bar
1	results; fees; penalties
2	order approving an
2	authority to withdraw
1	product; (d) any
2	application contains reports
3	committee with clerical
1	may determine shall
1	use of standards
1	entry  (1)
1	18, which notice
1	paragraph supplants the
1	direct access. (ii)
1	secretary at reasonable
1	notifications by third
2	person, the permit
1	may not perform
1	submission submitted by
1	affidavit demonstrating that
1	approved and unapproved.
1	section, the use
1	facilitation of all
1	industry standards; and
1	contribution of demand
2	may elect to
1	unit of product
1	subsection (b) applicable
1	 (3) expertise
1	
 387u. studies
2	limitations  (i)
5	generate a total
1	secretary, considered by
1	agriculture or food;
1	paragraph, which is
4	person is required
1	applicability of ferpa
2	strategies). (v) carrying
1	transfer funds made
1	 (c) within
2	subpena of the
1	forfeitures incurred, or
2	grase determination for
1	exempted; and (8)
1	grant activities, the
11	foreign narcotics trafficker
3	proceedings under subsection
1	offense occurs an
1	
 1178. records
1	added, or which
1	representation in a
1	(
 
 468.
3	one; (b) the
1	permit if it
1	certified statement in
7	introduce or deliver
1	controlling or participating
1	similar operations in
2	health and food
1	title, maximum limits
1	information, and arguments
1	title 26 (and
1	sunscreen orders that,
2	facility, the owner,
1	(r) standards for
1	application, a regulation
5	research, testing, and
1	applications by practitioners
1	country which participated
2	applicable, the secretary
3	comply with requirements
1	associations and societies,
1	
 335a. debarment,
1	standard, has been
3	conspiracy to commit,
12	 (i) has
1	(2) the requirements
1	involving, in the
1	1956, ch. 804,
3	drug sponsor fees,
1	provisions; humane methods
1	reduce production of
1	carcasses, or the
1	medical specialty; and
2	information demonstrating that
1	protocol not completed
2	medical products in
1	(5) after the
1	staffing levels and
1	(a) action by
1	treating a sufficiently
1	
 461. offenses
1	food for import,
1	year or not
2	special projects to
1	(a) proposed rulemaking
8	387j of this
10	published under paragraph
1	(1)(b) is made
7	(a) to the
2	agency in developing
1	title, (2) a
1	statement, word, design,
3	obligation of the
1	whether the tolerance
1	dismissal or for
1	applicable authorities; (3)
1	information system the
4	drugs that have
1	sanctioning of significant
2	comment and review
1	held title to
1	circumstances change and
2	hazard to public
3	carcass of any
1	food using information
1	shall hold the
1	(6), and (8)
1	risk that could
1	listing the drug
2	withdrawn without a
1	metabolized for the
1	strategy, which shall
1	guidance for industrythe
1	listing; (b) the
4	present and at
1	381(q)[2] of this
1	served by an
1	(a)(2)(a)(viii), and as
1	substance abuse organizations
6	3551 of this
1	life imprisonment for
1	exceptions:  (a)
1	(a) is accredited
2	protect children and
1	tobacco product because
1	hearing) shall be
2	use of illicit
1	trade the term
1	foreign narcotics traffickersnot
4	review.  (june
1	funding priorities developed
1	(h) such other
2	data if deemed
1	activity.  (9)
1	data and microbiological
10	section may not
1	generic drugs (including
1	drug imported under
1	beings or their
1	reserved for recreational
1	data with other
1	abroad.  (2)
1	(1) fiscal year
1	appropriations acts for
1	acceptance to the
2	transactions of a
1	penalty objects and
1	food allergen labeling
1	proceeding arising out
4	date of manufacture,
1	21, 1997); or
1	case of less
1	improve effective sharing
1	scientific and regulatory
1	food is located,
10	business of the
1	summary of data
1	fees and limitation
1	subparagraph (c); or
2	may be compounded
1	year; (c) each
1	division, and the
1	level in violation
1	strawberry, grape, orange,
3	use under section
1	 (2) development
2	experts acceptable to
1	incidental powers as
1	 (b) componentsthe
1	immediate precursor means
2	submit assessments for
1	trials for a
1	state involved submits
1	rest area means
1	(2) adjustment factorthe
1	recognized as a
1	public interest to
2	states, or the
3	receive evidence, and
1	achieve the intended
1	
 
 879.
1	practitioner has dispensed
1	laboratory assistance (including
1	hearing or reversing
1	fine, or both.
1	refrain from taking
1	secretary, the person
1	include provisions designed
8	shall refund 75
1	(g)(1) shall be
1	additional data and
3	determines there is
1	youth center means
1	surrogate endpoint. 
21	drug shall be
1	registrant in writing
1	subsection (b) reports
1	determination. (iii) 
1	secretary determines whether
1	study of drug
1	staff  (1)
1	following the expiration
1	shall review relevant
1	 (1) compounded
1	united states their
1	18. (b) recruitment
1	7, 38 stat.
1	anticipated port of
1	maintenance, operation, and
1	days, the information
1	confidential, commercial information.
1	(b) production, quality
1	tracing practices in
1	policy and the
1	(3) identifies major
1	executive board for
1	restricts this drug
1	(f) matching requirement
1	aircraft, commercial truck,
1	article of device
1	products found adulterated,
1	20 miles from
2	milligrams of dihydrocodeinone
2	shipping container means
1	product introduced by
1	property in which
1	shall confirm in
1	841(b)(2) of this
3	secretary a notice
1	authority referred to
5	united states after
3	scope of his
1	containing as an
2	secretary shall compile
1	substantial likelihood of
1	manufacturing practice otherwise
1	title in respect
1	acts (a) 
1	practitioners pursuant to
1	whose physical, mental,
1	are, in the
1	fee amountssubject to
5	(4) if it
2	development, manufacture, or
1	drug administration receives
5	drug application and
5	united states. (2)
1	section 350a, 350c(b),
2	353 of the
1	computer resources, (c)
1	imposed as a
1	formerly june 30,
1	otherwise facilitated through
1	term context of
1	creameries and condensing
1	eligible product, deviations
1	order theretofore issued
1	request. an official
1	chief scientist to
1	(a) to prevent,
1	30, 1972, $3,000,000
1	persons guidance documents
1	seek to reach
2	shall, upon conviction
2	request made by
2	additive shall be
1	health advocacy organizations.
1	general public, of
3	use.  (d)
3	shall the adjustment
1	emergency exemption if
1	case study, congress
1	secretary on matters
1	section 455 of
1	(3) the furnishing
1	patients; and (ii)
1	formulation under chapter
1	prohibited.  (e)
1	sold at wholesale,
3	(1); and (b)
6	title 5 and
1	
 
 384d.
14	final, such person
1	needs of regulatory
1	conveyance to be
1	meat articles. the
1	type, packaging, or
1	day deemed in
1	food system detection
28	shall consult with
1	drug abuse through
1	(a)(1) under the
2	united states consumer
1	women and analysis
1	(i) identified on
2	action or other
2	inspection under subparagraph
1	identifying it as
1	information that forms
1	regarding the promotion,
2	products not later
1	background incidence of
1	individual is unaware
1	denial, obtain review
1	year following december
1	drugs being imported
1	case of reclassification
1	food establishments; and
1	2002 for compliance
1	providing guidance to
1	effect which, in
1	article may be,
1	export of such
1	675, 515c, as
4	subsection (c) are
1	salts. (e) ergotamine
2	approved, or has
1	necessary shall cause
7	file in the
2	initiative, or (b)
1	be, for the
1	of, information from
4	secretary shall adopt
1	(a) prohibited acts
1	infants by reason
2	(3) plans to
1	committed knowingly and
1	ensuring consistent and
2	advertisement to be
1	account of a
1	section 214[1] of
1	(h)(1) relating to
1	(2)(c), information submitted
4	owner thereof for
1	attorney general. (b)
1	management, and (b)
1	secretary would enable
6	section 350h of
2	standards for approval
1	(with or without
1	waiver from the
1	formula from all
1	apply to poultry
1	classified information in
2	facility; and (iii)
1	(d)(1), a copy
1	(2) each party
1	maintained, the secretary
1	records where the
1	raised in such
1	misrepresentations in the
1	submitted, (ii) in
1	(1) the applicant,
1	dependence of the
1	safeguards be in
1	undertaken under contract
2	2007, the commissioner
3	review the secretary
1	18 unless he
1	written report of
1	production quota under
1	concentration of the
3	paragraph, the administrator
1	regulations shall apply
7	biological, chemical, radiological,
1	otherwise be indicated
1	usual name so
1	pharmacy shall keep
1	regular customer, unless
1	drugs for limited
1	evidence regarding their
1	regulation issued on
1	u.s.c. 247d6b] sufficient
1	officials in the
1	
 207. restrictions
2	marihuana.  (b)
1	42 or the
1	(a)(1)(d). (3) the
1	surveillance, including ongoing
3	(d), (f), and
2	lot appurtenant thereto)
1	(b) information to
1	circumstances specified in
1	(k) abbreviated new
1	created for that
1	lot appurtenant thereto.
2	waivers, exemptions, or
1	consumer in an
1	 (g) regulatory
1	representatives and of
1	(b) this petition
7	grounds described in
2	health agencies, the
1	classes of food
1	act occurs in
1	blood, feathers, feet,
1	infringement action or
1	consortia, and collaborations
3	tobacco used in
1	article for such
2	section 18 of
2	person who commits
1	schedule v any
2	establishment processing poultry
1	exercising any authority
1	calculation the amount
1	fillings does not
1	request and which
1	7.0d  
1	document so that
2	certain persons; murder;
1	subchapter ii or,
1	safe because the
6	states olympic committee
1	 (3) denials
1	basis as determined
1	otherwise responsible for
1	(c) $125,767,107 for
1	containing such drug
1	use certification provided
1	congress may deem
1	it. the warrant
1	(ii) included or
1	manufacture, distribution, transfer,
1	inventory or other
3	applicants to import
1	proper board of
1	human subjects will
1	regarding the device,
1	term regulatory audit
1	person shall cast,
3	drug development and
1	consideration given to
5	maximum extent practicable,
1	(ix) the distribution
1	effective, but is
1	(ii) shall examine
1	authorize an expenditure
1	(c) waiver of
1	general for those
1	passed after the
1	licensing and reporting
4	tax and trade
2	restricted eggs capable
5	ful-time employ of
1	products under review
2	special dietary uses,
1	commodities (other than
2	manufacturing practice regulations
1	prescription occurs 
14	ful-time equivalent positions
1	rehabilitation; (f) dru-free
1	subparagraph (a)(iii). such
1	(31) norlevorphanol. (32)
1	product; (iv) contained
1	shall, upon examination
1	rate specified at
1	section to vaccines
1	fees are being
1	control coordination and
6	(b) of paragraph
4	stat. 821.)
 

1	453, 455 to
3	date of issuance
1	hearing, exempt from
1	crime, and a
1	acts b (a)
1	benefitting the public
1	analysis, and reporting.
2	application previously approved
1	requests a drug
1	3-day period that
3	due date 
2	included in an
1	local or tribal
1	divisions, including with
1	body; (iii) a
1	cost and regulatory
1	natural vitamin or
1	human beings or
1	economic information means
1	administration after receipt
1	(d). (b) validation
2	initiate the reclassification
1	(1) inflation adjustmentbeginning
1	concerning the results
1	claim a device,
1	recalls.  (c)
1	require such responsible
1	approval; criteria; proposed
1	evidence that does
6	history and transaction
1	collaborate and seek
1	(relating to adverse
1	obligations under this
1	audits.  (4)
1	steroids) and availability,
1	chapter that are
1	(i) year 1
1	program authorized under
1	material false statements.
1	have, under the
1	small businesses, in
1	center by coordinating
1	title, or approved
1	material false statements,
2	time (not more
3	purpose of conducting
1	review. such improvement
1	accredited person, identify
1	district whereof the
1	false statement by
1	changes that the
1	contains information concerning
1	521, as added
1	sending letters to
1	length of the
1	80.0  
1	organization, pursuant to
2	prepared on such
5	5, eff. apr.
1	thereafter as he
1	trials.  (c)
1	establishment of policies,
1	tobacco products, who
4	request submitted under
1	(d) withholding use
1	issue, or cause
2	accept on behalf
1	(e) definitionsin this
5	consular districts of
1	simultaneously or subsequently
1	(4) the judge
1	cease distribution under
1	person shall have
1	(6) generic new
1	 (i) neither
1	medical products to
1	assessed against any
2	discretion, suspend any
1	available scientific methods,
3	general regulation or
3	establish procedures to
1	regulation.  (3)
1	substances to be
1	present options to
1	part, a coalition
1	assessment, by the
2	 (b) limitation
2	regulations making exemptions
1	behalf, the court
1	leaves. all cocaine
1	paragraph and submit
1	exemption a drug
1	human services, schedule
2	countermeasure application. 
1	complete the secretarys
1	contact person of
1	(2) contributions the
10	additive may be
1	recommended by competent
1	(a) fails to
2	engages in terrorist
1	u.s.c. 141 et
1	start or expand
2	(i) before the
1	 (7) national
1	determination of susceptibility
1	collect and aggregate
2	activities in subparagraphs
4	condition caused by
1	otherwise that any
1	justice any form
1	manufacturer a -year
18	given such term
1	investigations that were
1	 niacin (g)
6	carried out by
3	finds, after due
1	attorney general furnishes
1	(d) the designation
1	involved would result
1	device which 
1	shall review any
1	 (d) definitionin
2	frequently than every
2	innovation because of
3	 (1) all
1	enforcement agency, the
3	state has developed
3	section 360ddd of
1	(v) schools. (vi)
4	which, as determined
1	chemical can be
1	administrative expenses not
1	derivatives of opium
1	witnesses in rebuttal
1	advisory review, subject
1	8, 2003, the
1	official, is punishable
1	consumers from adulterated
8	shall review and
1	chapter, and to
1	related article, including
2	dosing regimen, or
1	media projects and
2	act as a
3	(b) through (f)
2	 (3) duties
5	provided for under
3	requirements and processes
2	waived in the
1	finds that competition
1	highest percentages of
1	adjustment. the reports
1	(a) owners and
1	360aaa6. omitted
 

1	 (e) crediting
1	riskfor purposes of
1	experimentation data. (d)
3	term product means
1	sampling and analyses
1	comply with verification
1	request information only
2	(a) unlawful actsexcept
1	1999, begin accepting
3	potential unreasonable risk
1	relevant information in
2	section 351(a)(6) of
1	failure of an
1	matching requirement 
1	section before the
1	hardship for an
1	order reviewed, all
1	patent or by
1	service act for
1	health.[1] (2)(a) if
1	year; and (iv)
1	for, notice, and
1	include a special
1	considering the individual
4	device or to
1	trade, or (ii)
2	regulation that addresses
1	renewal grant made
1	united states, with
3	(a) through (d)
1	manufacturer, seller, or
2	appropriated $6,000,000 for
1	existing national treatment
6	 (1) shall
1	level equal to
2	administration of any
1	supplement under the
1	drug samples under
2	(c) any employee
3	conduct inspections under
1	chapter, trial shall
1	records (a) records
6	350c of this
1	reports (a) provision
1	interest or involvement
1	mariana islands, or
1	term seller means
1	feed, (ii) information
1	(a), afford opportunity
1	training of state
2	of, any such
2	racially and ethnically
1	distribution of violative
2	(1) there is
1	 (2) subject
2	paragraph (1)(c), the
1	synthesis:  (1)
3	copy of a
1	burden on interstate
1	availabilitynot later than
1	eligible for certification
1	information accordingly. (ii)
2	title) under section
1	prescribed in accordance
1	applications thereof. (

1	flow through interstate
1	321(r) of this
1	379j11(5)(b) of this
1	(9), and, with
30	review of a
3	underlying scientific information)
1	general any requirement
7	withdrawal or suspension
1	(b), a systemic
3	appropriate to prevent
1	person, although they
1	awarding contracts under
1	reports of postmarketing
1	posting such process,
1	(3).  (6)
1	chapter; and (ii)
1	675, 569a, as
1	include each new
1	chemical to the
1	residues has been
1	distributor shall submit
1	(including a change
1	1974; $160,000,000 for
1	production regions of
1	objections within 60
1	(8) contact information
2	information to physicians
1	licensing, and law
1	means of verification
1	welfare and destroys
2	term outsourcing facility
1	experts who are
1	justice solely for
2	products means a
1	analogous product intended
1	27, 1970, the
1	reviewed, inspection observations
1	preclearance or preinspection
1	plans not submitted
1	(viii) the national
1	effect on september
1	(b) which 
1	senate. (d) development
2	2013, upon receipt
1	present to such
1	detail or assign
1	control plan, and
2	cause to the
1	packages may be
1	issuing the order,
1	(1) any significant
1	school includes public
1	predominant business is
1	health care setting
2	persons or organizations
1	groups of states
6	packer, or distributor;
2	(a) definition in
1	(ii) explain the
2	product identifier the
1	stat. 882; 

1	liable to seizure
1	studyin conducting the
3	supplement, was accepted
1	section 360e(b)(1) of
1	deducted, when the
1	section 1531(a) of
1	guidance, as appropriate,
1	
 379h1. fees
1	june 1, 2000,
1	evidence (a) in
1	model accreditation standards
1	operations that alter
1	application shall, notwithstanding
2	provided on the
1	1992, or a
2	committee a reasonable
1	(1). this paragraph
1	requesta single written
1	(a); (6) includes
3	 (1) whoever
1	guidance, as appropriate;
1	tribal officials and
2	laws. (3) when
4	published not later
2	acceptance of such
1	ii or ephedrine,
2	reports of individual
1	occurs before the
1	determinations.  (c)
1	establishment as no
3	application licensed before
1	provisions regarding certifications
1	[50 u.s.c. 3501
5	due upon submission
2	360e, 360f, 360i,
1	area. (b) subsequent
1	conducts food safety
1	2 dosage units,
1	reviews of internal
1	5. the attorney
1	inspection and labeling
1	formulas to ensure
1	adul-only facility means
1	packer, or distributor.
1	producers with respect
1	purchased by consumers.
1	cosmetics in situations
5	secretary shall publish,
1	abroad, and that
1	research the secretary
1	file, and otherwise
1	1605(c)(3)(b)(i) of this
2	recommendation made by
1	prepared and designed
1	taken. the return
1	person who disseminates
1	deniable form (which
1	appeals as provided
1	notice issued pursuant
1	 (6) in
3	manner as provided
1	5  (1)
1	writes upon his
2	 (d) labeling
5	appropriate panel under
1	qualifying practitioner practices
2	strategy report, the
1	exception the cost
1	on-half avoirdupois ounce
1	qualified mean a
1	device but not
2	limits the jurisdiction
1	completion. (h) service
1	exceed a level
2	(a) an article
2	503b, as added
1	isomethadone. (8) levomethorphan.
1	(b) shall, by
1	application. (d) the
2	poultry products that
1	registrants initial quota
10	antibacterial or antifungal
1	adulterated nor misbranded,
2	feed are inadequate
1	council shall 
1	that, upon submission
10	may prescribe to
6	coca leaves from
3	information provided under
2	cause, a copy
1	may, within his
1	states.  (21)
1	(a) for one
1	
 
 1171.
1	direct the advance
1	basis on which
1	temporary order to
1	consultation with stakeholders
5	establishment of a
2	received, or that
4	territory in which
1	shor-term goals; and
1	secretary an onsite
2	include repackaging or
4	regulations in effect
1	prescription is written
1	investigator to submit
3	submits an application
1	disclaimer as specified
1	valid prescription orders
1	subchapter) with respect
1	policy, deputy director
1	years; and (b)
3	 (b) purpose
1	regard to compelling
1	
 1038. cooperation
1	standards for conducting
1	timely basis, with
25	paragraph (1) may
1	pursuant to its
1	must also find
1	secretary. (11) outsourcing
3	determination under this
1	issuing the warrant
1	held on an
1	prevention of use
1	technical assistance division;
1	proposed regulations establishing
1	application which refers
2	amended, and if
1	stating that fact,
1	stating that fact.
2	punishable by not
1	product radiation; he
19	amount not to
1	standards for evaluating
1	document required to
1	standar-setting and other
10	provide that the
1	360ddd1 of this
1	product. (iv) for
1	(b) establishing partnerships,
1	operator.  (june
1	guinea.  (1)
2	counterclaim under clause
3	implementation of a
1	standards to support
1	establish (including reasons
1	request to renew
34	within 30 days
1	nation. (2) drug
1	product. such application
1	products thereof, unless
2	assurances satisfactory to
46	section shall not
1	banned devices if
1	interagency agreement, contract,
1	shall prescribe to
1	minimized or prevented
1	review for purposes
1	parts have very
1	engaged in manufacturing
1	used to uniquely
1	pharmacis-i-charge can be
1	interests, work in
1	food produced by
1	concerning the harmful
1	place and the
1	year 2008, 120
1	prior to finalizing
1	including the office
1	network members could
1	characters.  (21)
3	record of a
1	nondependent and dependent
3	year 2017, the
1	subsection. the information
1	(a)(2) within 20
2	outsourcing facility in
1	1032. congressional declaration
1	(v) the person
1	title 26 that
1	will pose a
1	groups; encouragement and
2	property other than
2	refusal or withdrawal;
1	granted and denied
2	removal of the
1	unfair methods of
1	(a), including meetings
1	subsequent oral order
1	pending.  (2)
2	(e) or (f)
2	establish and enforce
1	occasions.  (e)
2	human health, or
1	subparagraph (d) that
1	commodities (as defined
1	112a. omitted
 

1	(f), each person
1	(e); (4) the
1	year 2015 falls
1	sample of any
1	second country, except
1	(a) necessary to
1	 (3) regulations
1	uniformity with respect
1	person deemed to
1	(
 
 843.
1	$260,000,000 for fiscal
1	training shall include
1	procedure for issuance,
1	report is published.
1	guidance documents, unless
1	(2) if appropriate
1	electronic logbook, the
1	(3) an opportunity
2	plan described under
4	record at such
2	 (iii)no damages.
2	supplant, other review
1	risk of recalling
1	consultants in accordance
1	guidance under paragraphs
1	amount of $23,600,000;
1	licensing fees 
2	property is seized
2	served and compliance
1	
 350f. reportable
5	components of the
1	grase determination (a)
1	deferral extension 
1	 (bb) if
1	finding that 
1	(a); (b) a
1	meeting the studies
1	internal procedures for
1	subsection and other
1	agents thereof) on
1	(a) because of
1	limited populations, if
2	title. (vi) any
1	states under adequate
1	certifications through such
1	(2) $250,000,000 for
1	675, 736a, as
1	listing published pursuant
2	prescription for an
22	mixture, or preparation
1	otherwise protect public
3	goals and procedures
1	advisory panel known
1	businesses that will
2	contains a list
1	death.  (b)
2	data, the types
1	exude through the
1	subject matter referred
1	share the data
1	information over to
3	order to assure
1	electronic or no-electronic
5	program agencies to
1	deliver a controlled
2	safely used; or
1	dependence on the
1	first applicant means
1	section during an
1	seller to engage
7	antimicrobial susceptibility testing
1	goal of discouraging
2	products, and result
1	acts in deliberate
1	likelihood of recurrence
1	mult-faceted systems for
1	tribal organization under
1	health, which may
1	decision under paragraph
1	treatment of, and
1	complaint upon the
1	section can be
1	service the secretary
1	 (14) retailer
6	number of persons
1	existence for at
2	prepare and maintain
1	(3) $260,000,000 for
1	supervise clinical testing
1	federal register (61
1	grant recipient in
3	shall prescribe by
3	regulation establish requirements
1	may be labeled
1	461. offenses and
17	secretary shall take
1	health.  (22)
1	agriculture.  (2)
1	(d) to modify
2	adjusted for a
1	
 350j. targeting
1	freight container, or
1	permanently affixed to
2	controlled substance except
1	hold a hearing,
2	consumer organizations shall
3	 (i) authority
1	 (2) veterinary
2	drug interdiction and
1	countries from which
7	wholesale distributor from
1	duties or taxes
1	secretary about, importers
1	public process, to
1	illicit dru-related services
1	distributor may satisfy
6	drug, biological product,
1	(i) arrests for
6	years thereafter, the
1	subparagraph (c) revise
1	general); or (e)
1	information, and any
1	committee on finance
1	states. (b) upon
1	full waiverat the
1	approved under subchapter
1	42, the director
1	directive drug, which
2	academy of sciences
1	vice chairman of
1	by, an administrative
1	approved use. 
1	proposes a change
1	filled milk act
1	using standards and
1	relevant conditions prescribed
3	recognized standard development
1	event occurs with
2	(1) of the
2	include in a
1	federal funds; adequacy
4	made by a
4	(6) if its
1	approved labeling of
1	 (2) variances
3	contains any color
1	article and copies
2	one misdemeanor under
1	controlled substance pursuant
1	accordance with its
1	u.s.c. 22501(b)(1)).[1] 
2	(1) to a
1	1972, shall specify
1	otherwise affecting, directly
1	limited quantities exclusively
1	document issued not
2	law. (
 

2	file the disclosure
1	representative for the
2	chapter; (c) 
1	2015 falls below
1	basic and applied
1	many countries, however,
1	petition concurrently with
2	report received of
1	14 individuals, of
2	proceedings under section
1	architects and regulators
2	certifications and training
1	subsection (b) before
1	adulterated if (1)
1	(mg) 20.0 
1	may provide any
1	guide setting forth
1	action involving conduct
1	exercise enforcement authority
1	years, reevaluate the
1	administration, for review
1	equal to 67
1	facility information, such
1	article; if known
9	relate to the
1	procedures to 
3	regulated person shall
1	subsection (a)(4) of
1	secretary shall look
1	order for consolidation
1	generalthe list described
1	title 15; and
3	order that a
6	transferred by any
1	psychological dependence. 
1	infant formula 
1	documented, periodic reanalysis
1	export the act
2	describes  (i)
1	 (c) nonnarcotic
2	approval of drugs
1	enable the dispenser
1	2007, agrees to
1	sell, barter, or
1	shall have sole
1	period on the
2	informal conference. the
2	facilities located in
5	distribute, or dispense,
2	comments from all
1	physician holds an
7	grants under this
1	resources for consumers
1	accompany the secretarys
1	subparagraph (b)(iii) should
1	address emerging drug
2	engages in such
1	constitutes drug paraphernalia,
1	review during fiscal
2	18 or $10,000,000
25	360j(g) of this
4	weight, or reduce
1	establishment inspections or
1	substances are sold
1	22, 2009. (f)
2	term adulterated shall
1	engagement in drugs
4	tobacco product; or
2	intended to be,
1	submitted may be
1	facility, identify and
2	kills or counsels,
1	drug product. (dd)
1	332. injunction proceedings
2	imported, exported, distributed,
1	known serious risk
1	reports for each
2	order deemed objectionable,
1	apples in barrels
3	determination by secretary
3	incidence of foodborne
2	manufactured does not
1	(b); (b) performance
1	incurred, or alleged
1	physically inspecting or
1	nutrients required to
1	following acts and
2	transfer after notice
1	secretary issues regulations
1	(cannabicyclohexanol or cp47,497
1	distribution of prescription
1	 (3) fiscal
2	term covered application
6	times and within
1	diagnosis of food
1	applicant, in writing,
1	financial assistance; advisory
1	color additive; or
1	action the process
1	crab, lobster, or
1	assistants, or any
1	facility identified, or
1	nonprofit, community ant-drug
1	(a) the investigational
1	drug on a
2	states or a
1	electronically submit information
2	regulation  (1)
1	extend the expiration
5	labeling changes made
1	adult data may
1	person is entitled
3	 (3) for
2	attorney general suspends
6	application for which
1	letters as proposed
1	333(b) of this
1	recall of pet
1	conduct may have
1	pursuant to appropriate
1	fee revenue for
1	give due consideration
1	secretary to act
1	state cooperation (a)
2	state costs the
1	(a)(3)(a)(i)(viii) and section
2	requests  (1)
1	(2) required additional
1	products, shall register
1	investigations, and related
2	officers report of
1	program programs,[1] and
1	pregnancy, lactation, infancy,
1	(5) notice of
3	patent which does
2	identifying characteristics of
1	section shall supersede
1	administered or approved
1	certification by a
2	drug administration (or
1	 (ii) recognized
1	administration draft guidance
2	shall be tried
1	establish a maximum
1	controlled by any
2	ensure that sufficient
2	animal safety, or,
1	(g) report 
1	training to employees
1	occurrence of any
2	1054; 
 

2	concerning any method
3	marketed would be
19	federal insecticide, fungicide,
1	may request in
1	facilitating cooperation among
1	(4) drugs withdrawn
21	establishment that is
1	research activities; (b)
1	facilities prescribed by
1	essential that the
1	regarding other populations
2	applicant required under
1	retail sale and
1	trademark.  (b)
1	given with intent
1	effectiveness or substantial
2	use the assistance
1	(iii) public workshops
1	may be heard
1	(
 
 956.
1	fined as otherwise
1	needed to reviewing
5	(ii), (iii), and
2	manufacturer  (1)
3	similar article of
3	year or more
1	submit evidence sufficient
1	class of animals
1	shall gather comments
1	combined.  (b)
1	ch. 675, 760,
1	claims the listed
3	enforce the provisions
8	objectives of the
1	fiscal year. (ii)
1	drugs that may
2	district reasonable notice
3	processes of such
1	both. (iii) any
12	use as a
1	take the performance
1	significance of abuse.
1	term dispenser 
1	portions of applications
1	collected after the
1	support thereof, to
1	equipment used in
1	burden, facilitate continual
1	approvals, of an
2	adopted by a
1	least on a
1	renewed, the following
1	(1) is prepared
1	verifies the issuance
1	approved or otherwise
17	goats, horses, mules,
1	give notice 
1	(f) is assembled
1	relevant advisory committees,
1	(i) and (j)
2	manufacturer that is
1	article is to
1	rooms, or in
1	disclosures regarding the
1	establishment, if imported
1	received a direct
2	(3) inclusion of
1	labeling thereof (including
2	formulations developed and
1	respect to effectiveness
1	section $15,000,000 for
1	(b) all clinical
2	alter the jurisdiction
1	article, and to
1	524a, as added
1	appropriate person or
1	private groups having
1	coordinating council, including
3	fraud or material
1	ch. 675, 803,
1	senate fifteen days
2	liniments or ointments
1	information technology the
1	fill of containerif
1	recommended under paragraph
1	united states duly
1	methodology be used
1	seeking to qualify
2	formulation. an applicant
3	(a) establishment of
1	combination product, unless
1	comment prior to
1	obtain patents and
10	section 331(j) of
1	authority of subparagraph
1	council determines may
1	potassium, solution or
2	applicant or requestor
1	(ii) developing promising
2	alternative methods of
2	reimbursable basis or
1	(i) describing the
3	 (ii) application
1	inspection in promulgating
1	paragraph (4) regarding
1	devices in accordance
1	(2) purposethe purpose
1	assessment methodologies determined
2	civil or administrative
3	evidence submitted by
1	dismiss the proceedings
1	supplement reviewing the
1	requires approval by
1	plant in accordance
1	partnershipsthe systems developed
1	denied any benefit
1	certain drug applicationsthe
1	product establishment listed
2	tolerance or exemption,
1	(a) reasonable assurance
2	tolerance or exemption.
1	civil money penalties,
2	chapter or would
1	chief officer of
2	pediatric formulation necessary
1	(iv) requests funding
1	drugs that fails
1	facilities, traceability of
1	section 384b(c) of
1	section. (c) limitations
2	phencyclidine (pcp); (v)
1	person that intends
2	sanctions pursuant to
2	records may be
5	secretary may in
1	evaluations notwithstanding any
2	america is unable
4	technology assessment center
1	subsection, to conduct
1	micrograms of atropine
1	service.  (b)
1	 (5) retrospective
1	collected during fiscal
1	significant potential to
1	types of feesin
1	public health officials;
7	person that has
1	thereof) shall be
1	(c). compilations under
1	transportation practices prescribed
1	adequate security; and
2	subparagraph (d), (e),
2	shall include requirements
2	proposed findings with
1	(xiv) a supplement
1	rea-time tracking of
1	board vessels, etc.,
2	chapter shall upon
1	submitted to appropriate
3	secretary shall immediately
1	need refers to
1	whether a petition
1	control strategy. (xiv)
1	documents. (c) 
1	renderers, or engage
1	(4) implementation systemthe
1	foster collaboration between
1	budgets support and
1	 (4) permanence
1	limit the period
1	holds at ports
2	person who attempts
1	register of drug
1	2013. (3) waivers,
1	verification beginning 4
4	authority of a
1	general shall, from
1	exemption for devices
4	law, the secretary
1	provisions, applicable to
1	lif-threatening or irreversibly
3	fails to so
2	poultry shall not
1	food. (b) additional
1	population, the secretary
1	carcasses at the
1	controls are needed.
1	board may use
1	requirements requirements within
1	will not accept
1	country; (5) studies
2	given the terms
1	paragraph.  (june
1	(4) agreement authority
1	chain that comply
1	subparagraph (a) meet
2	licensure requirement, is
1	may, in issuing
1	biologicals under section
1	delegate the authority
2	(d) have been
3	order  (i)
1	congress a joint
1	product or in
1	addictio-sustaining liability. (19)
2	content of any
3	authority under section
36	schedule i or
2	(f)(6)(b) declaring that
2	mail or certified
1	environment or natural
1	use, if that
1	subsection (a) apply
1	patent, an exclusivity
2	issue guidance that
2	outsourcing facilities 
1	(4) dihydrocodeine. (5)
1	(e) biosimilar biological
1	chapter. (c) 
1	expended to continue
1	inspections the audits
3	technical and laboratory
1	labeling and any
1	cargo tank (within
1	food imitated. 
4	sale, for the
5	person whose permanent
2	repackager shall keep
1	provides, for such
1	equines, whether intended
1	model meetingsto facilitate
1	 (ii) applications
2	held in any
2	findings required to
1	enforcement relates to
1	(2) each pharmacy
2	director, the director
3	serious risk the
1	(iii) the person
1	include graduate training
1	(1) whenever the
1	(6) to refuse
1	controls.  a
1	term early childhood
1	 (1) communication
1	genotypic and phenotypic
3	grant, contract, fellowship,
1	advertising the secretary
1	5, relating to
6	(b) establishment of
1	(b) omitted 
1	preparation is approved
1	safety information. 
2	making available in
1	(d) payment 
1	supplement, a rea-time
1	report that examines
1	404, 52 stat.
2	reasonable samples of
1	desiccated. this definition
2	product after the
4	effectively regulate such
1	term official compendium
4	employee of a
1	device submitted is
1	subsection that contains
1	states grain standards
1	manufacturer operating at
1	according to accompanying
1	pharmacyin a manner
3	connection with transactions
1	tobacco product, and,
7	exemptions shall be
4	application referred to
4	notification of any
1	20. apples in
1	withhold information from
3	drug products that
1	section shall terminate,
1	response from the
1	restrictions; bonds; court
1	drugs outside the
1	traceability system for
1	perform such operations
2	prescribed by him,
1	jury. the proceedings
1	whether external scientific
1	otherwise engage on
1	stat. 1052; 

1	procurement specifications governing
2	private entity or
1	clause (i). (viii)
1	product remains a
1	insecticides, when such
1	(c) issuance and
1	 (d) subsidiary
1	strengthen the ability
1	certain facilities the
1	member, receive any
1	conduct, and support
1	similarly filed. service
2	agency responsible for
3	following the period
1	management; and (iii)
2	levels, or regulations
4	applicant otherwise agree.
1	import at ports
1	bequests, gifts, and
12	(2) of subsection
1	possessed, transferred, sold,
2	(f) or section
6	agricultural commodity or
1	(b) action is
1	health, (ii) to
2	(b) is limited
3	per cubic centimeter
1	food system by
1	effective date that
2	appropriate measures to
2	pay the annual
1	2007, and ending
1	national health and
1	research agenda of
1	administering of controlled
3	research under paragraph
1	carcasses, meat, or
1	consumers. the unwholesome,
1	validate a drug
1	products which shall
1	single fiscal year.
1	code. the secretary
3	applicable, the sponsor
3	effective chemical diversion
11	period as the
1	keep records; authority
1	authorized activities persons
4	substance abuse prevention
1	title 18; or
1	(2) specify appropriate
2	intends to participate
1	treat substance abuse
1	paragraph (3)(c) 
1	less than $280,587,000
1	identity or that
3	cohorts for which
1	675, 408, as
1	drugs. such person
1	known to me
3	supplement to a
3	date of filing
1	egg handlers and
1	wholesale distributor; (iii)
1	efficient adoption of
1	(b) the duration
1	(c) clear under
1	develop and field
2	concludes that there
1	offices); and (c)
1	farming, cultivation, harvesting,
1	685.)
 
 952.
2	maintain records for
1	chemical action in
1	smoke; (iii) scientific
2	state coordinator determines
6	petition the secretary
1	time, and may
1	direct the seizure
1	puerto rico or
1	products a priority
6	abuse of drugs
1	implement ant-doping education,
1	title  the
4	upon petition of
1	proactively identify strategies
1	ability of investigators
1	form, prior to
1	(4) designation not
1	abbreviated application submitted
2	mitigation strategy is
1	requests for classification
1	(4) the promulgation
1	 (h) written
1	marking containers of
1	particular, or (2)
1	mainland under adequate
3	concerning the safety
1	standards). the exemption
1	united states engaged
6	disclose any information
1	clinical trials. 
1	chapter. (2) if,
1	may 1, 1989,
1	paragraph (24)(b), any
3	(b) the amount
5	new clinical investigations
3	standards  (1)
1	much as 30
1	methamphetamine information clearinghouse
2	(i) in generalon
1	supplies.  (

1	controlled substance (or
1	less than $40
2	drug, the drug
1	subject to fine,
1	definitionsin this chapter:
2	sale; proceeds into
1	transactions are prohibited:
1	(a); and 
3	products found to
1	sticker or written
1	narcotic drug means
1	regular screenings of
1	manufacturing practice and
1	control, or custody,
2	applicability thereof to
1	(ii) the attitude
2	(i) the name,
3	expire, or (iv)
1	neither false nor
1	certifications. (iii) the
1	dispenser shall notify
1	primary jurisdiction; or
1	labeled and offered
1	infant formula will
1	 (c) prohibited
3	certification, in the
1	degradation productsif a
1	
 
 675.
1	criminal case involving
1	process through which
1	products. (iii) any
1	(x) subject to
1	(3) any petition
1	
 
 601.
1	filed not later
1	issuer held by
1	wholesome, and economical
1	inspectors who shall
1	drug, (c) any
1	(9) issue to
1	(b) if provided
1	used in an
1	names no person,
1	manner permitted by
1	manner and containing
1	(3) that states
3	facilities, or equipment,
1	 (d) eligibilityeligibility
2	submit additional data
1	scientific, public health,
2	capacity.  the
1	(
 
 1705.
2	activities to ensure
3	size or form
1	certification or disclosure
1	products to any
1	acceptance factors; nonacceptance
3	bulk drug substances)
2	bulk drug substances,
1	labeling as described
1	drugs, other than
1	interactive outreach, media
1	 (a) inspection
1	recalling the device
2	receive additional compensation
3	(n) the term
1	secretary can no
1	less than $97,000,000
2	falsity of the
1	both: provided, that
1	year 2015; (c)
1	(a) unless he
1	proposed different withdrawal
5	order refusing to
1	aiding or facilitating
1	records of all
1	(ieepa) (50 u.s.c.
1	programs of attorney
1	organ, or mental
1	establish and administer
2	storage or handling
1	enables personnel of
1	extent deemed appropriate
1	cantharides, or aconite,
3	central kitchen facility
1	withdrawal of conditional
1	made; (2) for
1	allergy management that
1	title, if he
1	studied, and found
1	grants to public
1	requirements for activities,
1	forging, counterfeiting, simulating,
1	patches, nicotine gum,
1	rely upon qualified
1	sources of assistance;
6	custody thereof, shall,
1	improve the timeliness
1	business, for purposes
1	states are successfully
2	$15,000 and not
1	needs.  (3)
2	islands, the highest
6	paragraph (1). (c)
1	require, for purposes
1	table.  nutrients
2	packed, or held,
1	(b)failure to comply.
1	packed, or held.
1	year 1997 unless
1	stakeholders, of such
1	(i) be provided
1	distributor of that
1	gases  (1)
1	policies respecting the
1	successful or not
7	(a) officers and
2	first day of
1	star-up period pursuant
1	applicable element set
2	permitted under this
1	provide education and
1	product; and (f)
1	subsection and as
1	acid, or any
1	substance  (i)
1	foreign facilities, suppliers,
2	conformity of the
2	shall serve upon
1	preparation upon the
1	order based on
1	inspections (a) inspectionthe
1	convention for limiting
1	(1) for persons
9	classes of persons
3	time of, the
4	(a)(1) for a
2	subsection (b)(1), the
1	 (3) basisthe
1	standing shall be
1	person without providing
3	ship poultry items
3	approve  (i)
1	program conducted by
1	60 calendar days;
1	increased citizen participation
2	(b) definitionsin this
1	disapproval. (b) list
4	lien against any
1	prescription orders for
1	interpretive criteria means
1	controlled substance which,
1	60 calendar days,
1	individual physician or
1	continuing in its
1	address the suggestions
1	doses to an
7	six months after
1	violation; or (b)
4	per centum by
1	authority and demonstrated
2	dispenser or repackager
1	prescribe, except that
1	advertising production costs.
1	(6) of this
1	2016, the excess
1	multiple management, the
5	(ii) if an
1	proceeds from any
2	(6) or the
1	services are required
1	contamination or would
1	exceed 30 days,
2	committee of experts,
1	containers; determination by
1	protocols for review
1	classification.  (b)
4	shall maintain an
1	january 1, 1970.
1	people. (2) the
1	extension of a
1	processing operation performed
1	duration of authorization
1	law.  (3)
1	certain postfebruary 15,
1	package of smokeless
1	paragraph (2)(c) shall
4	authorization of appropriationsthere
1	means cattle, horses,
1	legal entity. 
3	considered by consumers
2	release; removal of
2	sole discretion of
1	relation to section
1	includes a clear
1	protocol if he
2	views and evidence
1	(ii) effect of
1	(e) specific disclosures
1	safety as used
1	thereof presents a
1	repackager, as applicable
1	respect to measures
1	among the pharmaceutical
1	distribute, in violation
1	both. (2) notwithstanding
1	monitoring by the
1	(m).  (june
2	atomic energy act
3	published or known
1	whether the marketing
1	regulation reinstate the
1	statistics directly to
1	understate exposure for
1	authority the secretarys
1	following information, with
1	sale by reason
1	outsourcing facility demonstrates
1	(c) does not
1	programs that educate
2	outbreak that is
1	smokeless tobacco; (ii)
1	374(a)(1) of this
10	per centum of
1	and, by such
24	small tobacco product
1	twenty miles of
1	outbreaks necessitating such
1	 (2) interim
2	active ingredients determined
2	authority the secretary,
2	manufactured from bulk
1	twice the minimum
1	chemical structure and
2	naturally, may be
2	purity of the
1	cooperation with consumers,
1	judgment.  (b)
2	practices and quality
1	professional practice. the
1	use could cause
1	chapter. all imported,
1	modifications are covered
1	laboratory regulatory science
1	subsection to 
2	needs that cannot
1	(e) reliance on
3	respect to egg
1	sponsor authorized such
1	report from a
1	rare diseases; (4)
1	dye, chemical, preservative,
1	1509. repealed. 

1	investigations have been
2	thir-party auditor means
1	report to owner;
1	productsexcept as provided
1	complied with unless
1	clause prohibits lawful
3	inspector, chief inspector,
1	2104. state and
3	device contained in
1	study intended to
1	import such device
1	shortage. (
 

2	supervisory review of
7	secretary means the
1	secretary to utilize
1	(4) enforcement, suspension,
1	title, to a
1	746, formerly 742,
2	respectively, shall apply
1	 (i) definitionas
1	(8) if the
1	racial subgroups (a)
1	type,  such
1	abuse is rapidly
5	50 percent of
2	standard established by
3	use for a
1	(ii) applies 
1	drug intelligence fusion
1	shall be prima
1	label as inspected
1	year for carrying
1	supplement, or an
10	initial owner or
1	property was taken,
1	property was taken.
1	general to prevent
1	request, provide a
1	prosecution or service
3	(1) request for
1	supplements, and manufacturing
1	appoint an administrator
1	youth; or (ii)
1	absence of a
3	protection agency, and
3	may be contained
1	creative services 
1	section 1542(a)(1) of
2	stat. 919; 

1	617. clearance prohibited
1	drugs not subject
1	subdivision shall be
1	ensure that, prior
1	make available any
1	
 856. maintaining
1	petitioner) prescribing, with
2	controls and the
4	filed by a
3	carried out pursuant
1	food laboratories, including
3	fined a minimum
2	drugs, the convention
1	sodium saccharin, and
1	 (1) provides
1	health, economic loss
1	(2). an order
4	(2) to conduct
1	certify their qualification
1	degrees fahrenheit. (feb.
5	used in accordance
1	issue emergency use
1	shall be directed
1	treated and prepared
1	included the implant
1	service gaps, which,
1	350, 1, 67
2	demonstrate that reasonable
14	title.  (june
1	beyond that allowed
2	request of either
3	42 for which
1	requests filed over
2	subdivision thereof from
11	device under section
2	(a) it shall
1	imply to a
2	publicly available in
2	reinstatement the secretary
1	submission is not
1	secretary.  if
1	debarment under paragraph
3	potency of a
1	(1) award a
1	denial of assistance
1	(a) foods are
1	(c) comply with
1	secretary of accredited
2	limitation such fee
2	state, or the
1	involving a particular
1	$50,000 or imprisoned
1	section 1622(h) of
1	262] (as authorized
1	drug (including any
1	paragraph (3), nothing
1	protection against intentional
1	meprobamate. (8) methylphenobarbital.
1	(1) adopt, alter,
1	owner of an
1	aircraft within the
1	dispenser from product
1	both, in addition
3	following criteria: 
1	regulatory audit means
4	implant on a
1	manufactures, fabricates, assembles,
1	section 824(f) or
1	forth the conditions
1	localities that are
1	(6) is a
1	substances no controlled
1	convention, pursuant to
2	hearing; business unfitness
2	establishment are provided
1	suspended  (i)
2	carry out each
1	part and the
1	product, the sponsor
1	act entitled, an
1	control; (c) the
2	paragraph (n) of
2	comprehensive and lon-term
1	report (a) records
2	appropriation equal to
1	determination published by
1	rea-time supplement, a
1	coordinate foundation activities
1	designation, the identity
2	distributor shall keep
2	market at the
1	(a) one member
1	manager, and employee
1	application, abbreviated new
1	regarding the quantity
2	period was less
1	international instruments mentioned
1	 (f) is
1	fee for abbreviated
2	prescription drug from
4	(2) product identifier
1	(5) effect of
1	secretary, each dtc
1	provided by paragraph
1	clearinghouse to be
1	title for another
1	generic drugs and
2	facility where the
1	pediatric studies. (ii)
4	destruction or sale
1	opium. (3) opium
1	paragraph (1), except
12	tobacco products. 
1	create a reasonable
5	substance or substances
5	drug application as
1	months; and (ii)
1	pediatric uses of
1	deemed substantially complete
1	(1) material threat
1	country) and the
1	monograph system 
1	n-tobacc-sale order. 
1	(b) otherwise to
1	postapproval study (including
1	practitioners acting in
1	determine the types
1	developmental changes in
1	compensation to the
1	food. (8) contact
1	(b) individual patient
1	determination of, whether
1	public health the
1	(ii) is made
1	filariasis. (m) onchocerciasis.
3	purposes by the
2	control to a
1	additive is suitable
1	recalling such device
4	lysergic acid diethylamide
1	514, as added
1	committees, a copy
2	fresh or dried
1	subsection (b)(2) 
4	controlled the establishment
1	take whatever actions
1	taken and may
1	(39) proheptazine. (40)
2	unmet needs identified
2	557 of title
2	collected in generic
2	abbreviated application fee
1	prevent the introduction
1	prepared in consultation
1	(iii) information submitted
2	shall be revoked
16	sponsor of such
1	review; report to
1	signing a device
1	ch. 675, 417,
1	foundation.  (2)
1	duly verified under
6	information indicating that
3	(b) labeling and
1	may apply paragraph
2	entities or foods
44	subject to section
4	biomedical research consortia
1	excepted the provisions
1	holds an addiction
1	administration through an
1	following, on or
1	accreditation, as appropriate,
1	committees from a
1	sale or distribution,
1	penalty, or accrued
3	product that would
1	regulate legitimate uses
1	margarine which is
2	medical information the
1	(i) is less
4	water and minerals
1	(iv)contents of notice.a
1	potential harmfulness, if
1	
 
 3561.
1	section 2012(a) of
1	states, aggregated by
1	canal zone. (d)
1	system;  (b)
1	individuals who do
2	condemnation proceeding under
1	exported drug includes
1	chemicals for purposes
2	food supply. 
2	person or holder
1	making the estimate.
1	343(e), 343(f), 343(g),
1	facility manager or
15	received by the
1	inspection and veterinary
1	research activities without
1	shipment for import
1	compound using bulk
1	country and type
4	27, 2007. 
1	tolerance  (1)
1	person who gives
4	person who carries
4	agent or agents;
1	committed resources to
1	procedure in admiralty;
3	introduction or delivery,
2	within a state
3	 (d) exception
7	drug meets the
1	afte-school programs or
1	may, under an
1	practice, and shall
1	(i) determine, in
24	provide reasonable assurance
2	contractor of the
12	per 100 milliliters
1	purposes of paragraphs
1	chain, which may
2	eliminate or reduce
1	first review shall
6	provided that such
1	parts 131, 133
1	concerning its use.
1	appear that any
1	pharmacy when 
1	distributes drugs exclusively
1	infant formula. (2)
2	summary described in
7	radiological, or nuclear
2	(2) involving a
6	recommend to the
1	review; (ii) a
1	establish procedures and
1	commuter lane, alternative
2	section from federal
7	declaration under subsection
1	reporting, or disclosure
1	902, as added
1	considered labeling for
1	training (through classroom
1	exclusivity period have
1	supplier; (b) unless
1	groups often called
1	standards are necessary
1	amounts for activities
1	(3) to have
1	person; (3) to
1	(a) shall vest
3	economy of the
1	policy relating to
1	applicable), upon such
1	387c, 387d, 387g,
1	manufacturing change of
1	term 18-day supplement
2	department, agency, bureau,
1	term inspection service
1	$3,872  $3,872
1	customs laws; the
1	(b) certification of
1	change.  (c)
1	products, and copies
1	section are satisfied,
1	print or by
1	drug to rely
1	means an authorized
1	manufacturing change or
1	product the secretary
1	subsection (b)(1) could
1	qualified countermeasures (as
2	chapter through the
1	studies has passed
1	punishable as a
1	provisions unaffected notwithstanding
1	equines shall have
1	inspect any establishment
1	 (m) prior
1	register requesting any
1	grant appropriate relief
1	sell, or trade
2	approval, as applicable,
2	constituents), ingredients, components,
4	take reasonable and
1	expertise on countermeasures,
1	subsection (f)(2), the
2	deemed unsafe, and
1	chapter which would
1	clause (iv). (iv)
1	developmental milestones described
1	alphanumeric serial number
3	applicant submits the
1	(8) requestor the
1	drug experience as
1	processors, or any
1	plant whose premises,
1	possessed, distributed, dispensed,
1	translate to pediatric
1	chapter. (ii) the
132	pursuant to section
1	used to transport
1	lieu of destruction
1	appropriations the secretary
1	illness from its
3	health. the secretary
1	1.227 of title
1	modernization act,[1] the
1	2012, that have
3	define, for purposes
1	safety of any
1	considering such input
3	drugs, devices, or
6	additional or different
1	including timing and
3	authority  (1)
1	meet the standards,
1	efforts through such
1	(xii) validation data
1	(b) classification panels
7	dosage unit, with
2	ensure that no
1	come in contact
1	559, 4, 68
1	states be deemed
1	ii.  (a)
4	shall state that
3	(i) has been
1	identify weaknesses in
1	conformity with any
1	registration fee amounts
1	1996 through 2002
2	dispenser shall promptly
1	emergency in which
2	prohibitions of paragraph
1	subparagraph (b)(iii)(i) and
1	described in sections
1	deems to be
1	title, any reference
1	application, or if
1	inclusive, of this
3	preceding calendar year,
2	use in water
1	individuals in such
2	title or if
1	promulgated thereunder shall
1	medical evaluation or
1	site is comprehensive
1	title or in
1	dispenser notified pursuant
1	(4) additional nominees
1	$500,000 and not
1	participation of restaurants
2	include all information
1	studies, reports, and
2	issue in the
2	title or is
1	2 or other
1	(a) advisory committee
1	settingthe secretary shall
1	operations have fully
1	(iii) distributions of
1	reviewed, the secretary
1	administrator makes a
1	food industry, laboratories,
2	individual, to determine
1	combination drugs 
1	576, as added
1	court shall issue
1	subsequent remedial action
1	(1) previously developed
1	best available understanding
8	1001 of title
7	active ingredients is
1	(i) compares in
1	update and publish
1	represent the drug
13	information in the
1	subsection (b)(2). (3)
1	partnerships for risk
1	labeling, or advertising,
1	safe production of
1	secretary; (b) ensuring
1	comments thereto; (ii)
1	(b) that he
1	criminal justice supervision;
1	involved to which
1	implemented.  (c)
6	agriculture, nutrition, and
1	prescribed herein for
1	subject to no-federal
1	rely upon data
6	level of public
1	correspond to drug
1	action if the
1	(1) forging, counterfeiting,
1	distributed commercially. (5)
1	3, 1996) is
1	abuse because of
1	responsible party the
6	computerized data management
2	drug substance appears
1	including biomarkers, and
3	sale of eggs
1	 (h) importation
2	authorized to establish
4	year; (b) the
1	rulemaking the secretary
2	fee rate. 
1	making grants under
1	prepared from or
1	technologies (a) report
1	general may prescribe.
1	(b) considerations by
6	notice to such
1	year, during the
1	qualifying physician, as
1	penetration by illegal
1	approval.  (aa)in
1	secretary, or (3)
1	 (c) representation
1	 (i) charitable
1	additional controls; (ii)
1	protocols as the
1	person is otherwise
34	regulations promulgated under
1	require a commercial
1	rol-you-own paper in
1	reports required by
1	total volume of
1	council; and 
1	available through appropriate
2	criminal proceedings to
5	360cc of this
1	 (d) affect
6	international treaties, conventions,
1	proposed; and (c)
1	particular focus on
3	impairment of the
1	regulations shall require
1	section 387c, 387d,
2	shall include, with
2	services prior to
4	report is submitted,
2	2656f(d)(2) of title
1	states; (g) conducting
4	(including penalties) of
1	practices in official
2	report is submitted;
1	section or regulations
1	
 456. operation
1	22, 2009, shall,
2	general terms by
3	drugs. such regulations
1	agency or a
1	authority that performs
2	device; or (b)
1	animal or human
1	thereof; (f) upon
4	proceeding is contemplated
2	records, and to
2	cause for the
1	plants;  (3)
1	information shall require
1	paragraph shall take
2	office.  (

1	estimate shall be
3	person whose device
2	guidelines  (1)
3	construed  (1)
1	accuracy and coordination
1	(a) for judicial
1	-year period. (j)
1	proposing bulk drug
1	product. the secretary
1	terms of individual
1	eligible for inspection
1	witnesses for the
2	within a fiscal
1	warnings against use
1	drug products 
1	meat, poultry, eggs,
5	include a term
1	period will be
1	generalto carry out
3	unfit for importation
1	(c) report to
2	listed under subsection
5	records, and every
2	 (2) debarment
1	person has committed
2	fresh, salted, canned,
3	order shall require
1	supplier is to
1	including, in aggregate
1	343(r)(5)(d) of this
3	guidance documents, including
1	constitutes a representative
2	individuals empowered to
1	imports) during the
1	circumstance (including production
1	meet a condition
1	regarding such elements,
1	determinations and certificationsnotwithstanding
2	provisions regarding reimbursement.
1	employ or use
2	availability of, illegal
1	including a state,
1	standard; or (b)
1	drug will result
2	(b) the knowledge
1	(1), including with
1	framework for implementation
1	construction of article
1	risk, and the
1	device type, provided
3	relationship between the
2	will result from
1	accept for review
1	notification, be considered
1	countermeasure has an
2	prevent the movement
1	675, 904, as
1	system within the
1	(2) drugs marketed
1	unless an approval
1	thereof, as may
2	security, the secretary
4	section 352(e) of
1	advisory committee an
1	343(r)(1)(b) and 343(r)(3)
1	importer during the
1	facility that manufacturers,
1	level officials, or
1	egg products. representatives
1	action is practicable
2	period exceeded the
1	states in an
1	requiring warrantsa warrant
1	cigarettes under this
4	methods for the
1	provision of nutrition
1	coordination of education
1	prohibit a sponsor
1	recommendation whether the
1	scope of pediatric
6	promulgated under paragraph
1	shall also apply:
2	significantly affect the
2	applicable fiscal year.
1	 (7) priority
1	secretary designates the
1	met if its
1	methamphetamine abuse fell
1	15 percent of
1	technical effect for
1	section $100,000,000 for
1	waiver and fee
1	evaluate all material
1	date. (e) declaration
1	filing determination; and
3	represented for use
3	public by the
1	related food safety
1	record, or any
1	debar such individual
7	wholesale distributor that
2	adequacy of safeguards
2	consignee, country, and
1	report relating to)
1	(c) funding the
2	district of reasonable
1	improvement, implement the
2	necessary, then the
2	country or a
1	february 19, 1925;
1	capability of the
1	formula to be
1	 (i) whenever
3	reason of its
1	carrying out duties
1	title) and an
1	orpha-designated products per
1	also the extent
1	modify any order
1	considerations for demonstrating
1	abroad, a third
3	states of the
1	official names of
1	biennial reportson a
6	unless he determines
3	meet the conditions
2	(including, where appropriate,
1	international obligations, shall
1	relevant issues; and
1	least one person
1	intended; or 
1	filing a human
1	purpose; (3) is
1	conformity to the
2	effective in reducing
4	therapeutic effect as
2	subsection (c)(1)(a)(i) for
1	effective use of,
1	 (b) construction
1	chapter. (4) a
1	producersevery person upon
1	product was received
1	lysergic acid diethylamide.
1	11, 1995)). (3)
1	primary agency center,
7	without providing the
1	acid. (v) benzaldehyde.
2	premarket approval fees
2	findings (including the
1	24, 1984. (4)
1	(3) period of
1	includes an evaluation
2	5 miles of
1	(8), (9), and
1	retain all fees
1	approval from the
1	shall include and
1	consider, in consultation
1	38 stat. 420.)

1	licorice, cocoa, chocolate,
1	foo-producing animals, including
1	medicines; (ii) the
1	63 stat. 882;
1	safety, and a
1	one vessel, vehicle,
9	form, strength, or
1	affirmations, subpena witnesses,
2	rulemaking not later
1	conducting joint training
1	$6,000,000 for the
1	(2) exemptiona qualified
6	year  (a)
1	paid.  (n)
1	provider); (b) pharmacies,
1	prevalence and frequency
1	360e, 360(k), or
2	component parts have
1	focus on youth
1	may, beginning on
1	trends. (c)public process
1	established five schedules
2	statement by the
1	insecticides nothing in
1	it, certify to
1	unavoidable residues in
1	department listed in
2	conclusion that the
7	shall buy, sell,
24	2907, title i,
1	paragraph (1) through
1	pharmacists with current
1	chapter, and whether
1	schedule notice. as
1	member, would be
5	includes the proposed
1	secretary before august
3	active ingredients that
1	program agency, the
14	shall have jurisdiction
1	
 379j31. authority
1	prominently printed in
1	retain, segregate, and
1	reporting the secretary
1	copy required under
1	(2) any person,
2	adulterated, or misbranded
2	262] or conditionally
1	355(c)(2) of this
1	chemistry and manufacturing
2	(b) under section
1	refusal  (a)
1	used pursuant to
1	approval for use
1	devices components, ingredients,
1	2010, for food
2	petitioner shall be
1	assessments referred to
1	authorizationthe attorney general
1	including the revocation
1	include a similar
1	electronic products from
1	nondevelopment or nonenforcement;
1	(3) limitation a
1	printed by a
1	applications. (v) carrying
1	county facility within
1	(ii) response to
1	353c. prereview of
1	regulations for food
1	author or the
1	353(a) nor 353(b)(1)
1	exchange programs for
1	assessments on the
67	application submitted under
1	flavor, herb, or
1	presence of, and
1	 (7) after
1	tobacco products) are
1	application a sponsor
1	 (1) arrange
1	accepts direct ownership
1	title 35. 
4	detailed to the
2	labeling requirements, such
1	involving product. if
1	 (3) existing
26	notice of the
1	(i) use of
1	serve as mentors
2	may deem the
7	presence of the
1	intelligence agency act
1	
 341. definitions
1	receives a submission
1	discretion whenever he
1	protection act (public
1	advising the director
4	containing not more
2	paid. (i) crediting
1	may destroy, without
1	product recalls, warning
2	respecting safety and
1	(2) criteria for
6	(i), (ii), (iii),
1	2009, the comptroller
6	353(e) of this
1	event patterns, incidence
1	30, 2009 under
1	determined practicable and
1	fiscal years 2013,
1	agreed upon, the
1	opiates, derivatives of
1	whether licensure under
3	manufactured at the
1	zone.  (b)
1	secretarys satisfaction; 
2	voucher and approval
1	body by reason
1	limited population of
2	earlier than 3
2	earlier than 1
1	notification) as the
1	(d)(7)(a). (11) the
1	thereunder. (4) no
1	(i) the nurse
2	sanctions under this
1	applicant of an
2	drug administration, fees
1	individual or $500,000
1	teenage pregnancy, high
1	sales package if
1	determine, in conjunction
2	animal food derived
1	device; (c) a
1	describes an investigation
1	devices, or in
1	goat, or equine
1	documentation that verifies
1	cause order; proceedings
1	internal committee within
1	consumption of foods
1	services of such
1	full costs of
2	hazards identified in
2	health care practitioners
2	needs, including children
1	1395nn(h)(4) of title
1	applicant, the listed
9	construed to affect
2	(which shall include
1	year 2007 
2	personnel.  (b)
1	(4) review of
4	(v) the term
1	finding; and (b)
9	 (2) 
2	control of such
13	 (a) such
1	drug, or biological
1	drug permitted to
1	tobacco, substances, compounds,
4	be, and by
1	oversee, coordinate, and
1	premix certifications and
1	associated training directly
1	products by name,
2	fact. in the
1	service for performance
1	(1) require that
1	(cc) for purposes
1	(bb) on or
1	affixed to the
1	eligible entity responsible
2	accompanied by additional
3	opportunity for hearing,
1	$64,000,000,000; and (b)
2	distribution supply chain.
1	subparagraph (d)), up
12	power to control,
1	agriculture and other
1	control and prevention.
7	control and prevention,
1	effect of inability
1	design and intended
1	services designated by
1	(jwh081); (ix) -penty--(-methy--naphthoyl)indole
2	additive is proposed
1	mitigation strategy approved
1	originating in canada,
1	(ii) a report
1	paragraph (3), in
2	notification shall perform,
1	direc-t-consumer advertisement that
2	20 percent of
1	license, to thir-party
1	 (1) prepare
2	applicants or affiliates
1	intentionally modified in
1	subparagraphs to an
4	establish regulatory management
1	interests and involvement
1	(1) to sell
2	wholesaler of any
3	(including a petition,
1	(v) 1 individual
1	trade in food
1	ch. 675, 586f,
1	controlled substances; (b)
1	42; (iv) the
2	subsection applies; or
1	available data relevant
1	736b, as added
1	violation standard the
1	agreements to delegate
3	facilities  (1)
1	arrangements with officials
1	good faith submits
1	information regarding drug
1	distributors to keep
1	from, or are
1	paragraph, tobacco products
2	puerto rico) or
1	(3) there appears
1	combination of those
1	service within the
1	(a) delineating the
2	notification requirementif a
1	time for completion
2	safety issue, the
1	treatment improvement protocol
1	report available 
1	related to controlled
1	including on entities
2	commerce, are injurious
1	health laboratory network
1	(f) additional fee
1	term raw agricultural
1	procedures specified in
1	general operations of
1	shall confirm such
1	(5) a description
1	cultural differences; and
1	chapter[2] 21, code
1	42 was disapproved,
2	law enforcement, and
1	services unaffected the
1	restrictions promulgated under
1	sections 952, 953,
1	(7) the following
1	transportation of adulterated
1	sanctions for no-compliance
1	federal register specifying
1	food allergens are
4	action.  (i)in
6	united states (including
1	logbook to federal,
1	30 days 
1	trial to any
1	assessed under the
1	means the drug
3	 (4) payment
1	drug abuse indicates
1	information, as determined
1	shall, on application
1	(a) on-third shall
1	proper administration of
1	deemed scientifically necessary,
1	outcomes described in
1	authority.  (f)
2	foreign government is
1	new regulatory decisions
1	provide substantial evidence
1	warehouses or distribution
1	observations and shall
3	policy, and economy
1	manufacturing changes (a)
2	(i) application an
1	including substances listed
1	complete new animal
1	columbia or the
1	government using standards
1	privileges associated with
1	eliminates or decreases
1	amounts. (6) not
1	requirements pertaining to
1	chapter may impose
1	year; (e) the
1	good laboratory practice
2	performance evaluations performance
1	application is made..[2]
1	laboratory in the
1	individual prescription, if
1	1707 of this
1	(3) any such
1	holds food, but
2	(ii) for a
2	distributing, or possessing
1	personal or real
1	355f(g)], as added
1	conducting the examination
1	of, type of,
1	360b(j), (l) or
3	general under subsection
1	expire not later
2	poisonous alkaloids or
1	exemption has been
1	(i) such modification
1	experience, or otherwise
3	business submitting its
1	sentenced to increased
1	states national library
1	business, and collection
1	regarding drug safety
1	360j(h)(4) of this
1	results. (4) in
2	significant change is
1	licensed pharmacy or
1	petition) the secretary
6	significant change in
1	(b) territorial exemption
4	adjusted under this
1	institute under subsection
10	assurance of its
2	order withdrawing approval
1	procedures developed by
1	audit reports by
2	specify a district
1	practicable, with applicable
1	rates as the
3	person that engages
1	plants (a) premises,
2	preliminary clinical evidence
1	ii device, and
1	 (1) $10,000,000
1	countermeasure reviewers have
1	transportation, and sale
2	(1), a state
1	risks, which may
1	stat. 1043; 

2	849, 859, 860,
2	entity or to
1	authorities to control
1	concepts or creative
1	nonprescription drug means
3	international narcotics traffickers
3	ambient temperature of
2	collected. the applicant
1	health that would
1	application after the
1	time of that
1	drug code. the
1	foundation; (c) evaluate
1	claimants; proceedings in
2	stat. 1054; 

1	administration, shall submit
5	application and shall
1	plan, and provide
1	substantial population may
1	(3) execute seizure
1	manufacturer conduct of
1	fees applies in
1	defendant until such
1	(3) the development
1	gather, analyze, and
1	establishing general procedures
4	committee  (1)
1	substances. (5) controlled
1	orders or prescriptions
5	subclauses (i) through
1	(ii) requirement if
1	committee).  (2)
1	term opium poppy
4	(a).  (june
1	2007; and (ii)
22	drug subject to
1	558.3(b)(3) of title
1	transfers of a
1	 (b) new
1	devices under subsection
1	379a. presumption of
1	vitro reagent, or
1	proposed reclassification, and
1	states; and 
1	possession offenses 
1	advertisement to address
1	designated orphan drug
1	worked as a
1	exception under this
1	information and alerts
3	may reasonably be
1	expedited review under
1	country has instituted
6	application were not
1	generalan individual convicted
1	 (iii) 280
3	amount collected under
1	reveal trade secrets
1	device only if
1	section for specific
1	data and, to
1	application, does not
1	lon-range goals and
2	intends to compound
2	paragraph or otherwise
2	(i). (2) 
1	patents for inventions
3	general shall issue
1	(i) the changes
1	wholesale distributors: 
4	used in such
1	regulation for circumstances
2	(a) the negligence
3	processed by the
1	(2) additional actionsin
1	study is conducted;
2	waiver before filing.
1	(ii), a drug
1	informal hearing means
1	(1) program the
1	gs15 of the
4	contain such information
2	functions by a
2	selected establishment means
1	media campaign is
1	price paid by
4	regulations shall be
1	separately approved pursuant
2	360(b)(2) of this
3	compliance with requirements
1	review. (iv) the
1	list of any
1	1531 of this
1	research protocol to
1	make him eligible
1	health because sufficient
1	analysis and preventive
1	subdivision thereof and
2	draft or proposed
2	paid or attempted
1	pending applications not
1	(ccc) the budget
1	population (or specified
1	section 342(a)(1), (2),
2	states) in connection
1	systems and connections
5	full qualification package
8	committee on intelligence,
1	gas for which
1	equivalence, established as
1	$10,000, or both:
1	(a) an assessment
1	applicable timelines in
3	compliance with 
2	 (3) prescription
2	secretary or are
1	(2) advisory commission
1	title declaring a
1	violative articles; validity
1	effective, for any
1	hearing. the united
1	 (1) include
4	list  (i)
2	$10,000, or both.
1	fda indexed product.
4	may prescribe, exempt
1	meaningful number of
1	working group shall
1	1004, formerly 903,
1	1, 1948, under
1	coli species; (c)
2	changed after the
1	pending. for a
1	consider an investigational
2	columbia circuit or
3	secretary, which rates
1	section 823(d) of
1	(3) the total
4	may make grants
1	reasonable surcharge that
1	report released for
1	thereunder shall be
1	
 
 360pp.
1	product; and (7)
1	inspection as applied
6	fined in accordance
1	(2) in bulk
1	information means a
2	bureau, board, commission,
3	device is being
1	postmarketing studies (a)
1	conditional approval period
2	license or registration
1	675, 577, as
1	 (f) state
1	mechanism for rapidly
1	products in test
1	imposed therein. (b)
4	holder shall file
1	aware of, and
1	enforcement; (iii) requests
1	administrative inspections of
2	subparagraph, operations conducted
1	programs or is
1	resulting in approval.
1	clause (i). (ix)
1	(1)(a); and (iii)
1	report the plan
1	show that it
1	national household survey
1	subsection (b). a
1	promote food and
1	
 377. revision
1	bring them to
1	forfeit, in addition
2	prevention of youth
1	administrative expenses, incurred
1	hereinafter authorized. (mar.
1	include such other
1	42, the administrator
1	drug use; (v)
4	approving an application
2	individuals at or
9	threat medical countermeasure
1	formula has knowledge
1	protocol, shall consult
1	(2) labelingnotwithstanding clauses
1	distribution of listings
1	licensure; or (b)
2	secretary to request
1	on-half ounces and
1	establish the nmic
1	product. (c) volume
2	years, to fort-eight
2	product; and (iii)
1	equipment, or facilities
1	another dispenser to
1	ability to receive
1	accredited to perform
1	1981. (
 

1	request, the person
1	regulation, consistent with
1	inspection, or refuses
1	major change has
1	percent of red
2	pharmacopoeia or national
8	ending on the
1	61 of this
5	sale to the
1	 (8) transfer
1	nanotechnology (a) in
2	 (c) shall,
1	(3) discontinuance of
1	biomarkers, for example,
3	sales in its
1	food that are
1	necessary, the committee
1	administration.  (e)
1	title, and (iii)
1	(a) to use
1	4 times more
1	classified above grade
2	product licensed under
3	section 1705 of
1	resources obligated to
1	post the draft
1	if, however, the
1	operation at the
4	drug safety signals
1	(2) while away
2	user, no controlled
1	adulterated to an
1	service of federal
1	federal register at
9	trade a drug
1	committed the violation
1	associated registrationsif the
2	exist to support
3	sponsor that the
1	unlawful for the
2	supply of illegal
1	reports as the
1	services of employees
16	par., 34 stat.
1	crude opium may
1	variations provided for
1	(1) so that
1	achieved.  (e)
1	request the meeting
1	receiving such assessment;
1	verification request or
1	human subject with
2	investigations, and inspections
2	substance abuse may
1	corporation using or
1	advanced drug safety
1	(g) effective date
2	added to the
1	fees equaling the
2	entities that are
1	animal drug proposed
2	substances, have become
1	(3) a description
1	commerce may file
1	part, or any
1	(n)(2)(b) or such
3	premises the property
2	standards and regulations
2	drug applications. (d)
2	private elementary, vocational,
1	$9,000,000, adjusted for
1	person may carry
1	periodic risk assessment
5	territories and possessions
1	blinding trachoma. (d)
1	 (c) inaction
1	better achieve, in
1	substance more appropriately
1	named a partyin
1	subsection shall apply,
1	21 years of
1	products, if the
6	tobacco product 
1	establishment which are
6	section 387k of
4	label bears the
1	occurs during the
2	secretary requires to
2	paragraph (4), any
1	includes circumstances in
1	number belonging to
1	(c) facilityfor purposes
1	trial, an adverse
1	(a) criminal penalties
1	determine, on a
2	assistance under this
1	products. (iv) any
2	targeted drug means
7	services for the
2	sunscreen order subject
1	(ii) the sale,
1	second offense except
1	(8) no state
126	 (1) the
2	show cause upon
1	smokeless tobacco and
1	(b)(5), or (b)(10)
1	proceeding. any information
1	receives notice from
1	otherwise.  (f)
2	counsels, commands, induces,
1	(c) new safety
1	(p) forfeiture of
1	product for disposal
1	medicine therapy (as
1	manufacturing, processing, etc.,
1	commerce; (3) an
2	poultry producer from
3	identified in paragraph
1	case only, shall
1	haemorrhagic fever. (g)
2	likely to result
1	study or the
1	current year; and,
2	restaurants, when conducted
2	committee or subcommittee
2	proof of service.
2	$250,000 in the
1	shall direct resources
1	declarations: controlled substancesthe
1	codes, such as
1	formerly 19th par.,
1	notice of permission.
1	priority to making
1	fact to exist
3	conviction undermines the
1	approved applications that
1	prohibited act referred
2	person who requested
2	(i) for which
1	otherwise. (d) the
1	shall maintain, on
1	laws under its
1	nature and amount
2	(a) false or
1	hearing and determination
1	regulations if its
1	(1) or (3),
1	paid at the
1	animal species, the
2	homeland security acting
1	compounding defined as
1	review and revise,
1	offset of overcollections
1	comprehensive smokeless tobacco
1	distributes a laboratory
1	trial of any
1	drugs shall register
1	describes such further
1	ch. 10), the
3	effectuating the purposes
1	therapeutic benefitfor the
7	subparagraph (b) shall
3	(1) if 
1	thir-party auditor and
1	written plan required
1	(f)(6)(f) distribute, at
1	october 1, 2023.
1	section apply. each
1	management responsibility for
1	bodily injury to
2	homeland security, a
1	title. (2) a
3	official name of
1	signed at geneva
1	(iii) improving communication
1	rising from under
1	present a balanced
1	independent research organization;
2	accrue interest, as
1	control policy, and
1	action to be
3	activities that do
1	(1) preservation except
2	protects an important
2	artificial or natural
1	considered in requiring
1	participation in, reinstatement
1	every person, firm,
1	revision or should
1	apparatus intended for
1	(c) status of
1	foreign cooperative that
1	history required under
2	promulgate procedures for
1	development meeting relating
2	trafficking in methamphetamine
1	diet or to
1	objections may be
2	 (e) no
1	site for which
1	833.)
 
 151.
2	secrets or otherwise
1	$50, to furnish
1	shall, on request,
1	adverse reactions; or
1	department as identified
2	identifier is not
2	consumption of such
1	 (b) secretary
2	entity of the
1	packed in the
2	holder agrees to
1	directly exported to
1	combination product under
1	limitation under no
1	implement that strategy.
1	advance to the
1	dispenser means a
1	limitationsnotwithstanding subsection (c)(2),
1	subsection (b)(1)(f). 
5	found not to
1	 (5) supplement
1	coloring only, a
2	exposure to, access
1	health significance that
1	(i) considerationsin making
1	500 milligrams of
1	locations of plants
1	food transportation records
1	congress that (1)
1	period thereafter as
1	articles at such
3	subchapter; and (b)
1	(i) the program
2	cautionary statements, if
2	subparagraph (a), or
1	physicians to use
1	networks administered by
9	paragraph (1); and
1	gram of flunitrazepam,
5	free samples of
1	(a) slaughters or
4	distributor described in
2	prescription drug being
1	product. if a
5	title, any person
1	regulations. further, this
1	food bearing or
2	partnership or other
1	regulations relating to
1	 (e) death
1	change, modify, revoke,
1	(i) drugs other
20	upon which the
3	presiding officer in
2	termination date established
3	supplement effective before
3	secretary his name,
2	states, including the
3	human food. no
1	section 321(n), 343(a),
1	recommendation shall contain
3	(21 u.s.c. 1031
2	(b) duties of
1	secretary of products
1	shall require persons
1	supporting; or (iii)
1	secretary which shall
1	
 360nn. inspection,
1	rebuttable presumption at
1	appropriate for ascertaining
1	implemented; (2) impediments
1	control policy, any
2	act leading to
1	official has not
1	development  (1)
1	committees describing the
1	fiscal years the
1	domestic or international)
1	optical isomers; (ii)
9	held for sale
1	person or persons,
1	possesses the appropriate
5	drugs or devices,
1	condition. (f) for
2	submissions to the
1	salable drug returns
1	general shall complete
1	(6) or if
1	state court of
1	cause under the
8	based upon the
1	achieved, by or
1	subsections (b) to
1	individuals, without regard
1	showing the movement
2	intelligence support center
1	availability for reference
2	domestic facilities and
1	overlaps with a
1	(6) in this
1	section 1002(b) of
3	except for any
2	section 811 of
1	without intermediate or
2	may provide grants
1	hardware is readily
1	goose, or guinea.
1	(a) thir-party auditorsan
1	who, acting without
2	sold, possessed, used,
1	enforcement initiatives to
1	contaminants covered by
1	annual inventory reports
1	information except as
2	shall take to
1	allowing for verification,
1	securing funding for
8	assure that such
1	authority to prevent
1	submitting documentation to
1	peyote. (13) -ethy--piperidyl
1	 (4) ris-based
3	section 802(39)(a)(iv) of
2	property or the
8	product application. 
1	subparagraph are as
30	information required by
1	(3) no such
1	(iii) illicit drug
2	entity will not
1	related to, or
1	subsection (a), there
1	921 of title
1	justice; (b) the
1	appointing the deputy
1	personnel involved in
2	prescribe the form
1	issued. (7) if
1	grant waivers on
1	within the genus
1	make such change,
1	(including bacteria, viruses,
1	animal drug. (2)
1	raising on their
5	compliance history of
1	(1) in coordination
2	[15 u.s.c. 2603];
1	television advertising (a)
1	appropriate in accordance
1	(iv) developing and
1	regulation grant individuals
1	 (mm) 
1	construed as compelling
1	prescriptions by consular
2	passed, or exempted,
1	submit a written
1	136p) for a
1	withdrawal time of
1	world evidence, such
1	may modify prior
1	30, 2008, for
3	determines, after opportunity
1	15, 1994. 
1	binding studies and
1	federal register modify
1	channels, and clandestine
3	selection of the
1	47); or (ii)
1	applications, including establishing
1	petition, waive the
2	controlled substance not
6	fee waiver or
80	section 262 of
1	
 
 360mm.
3	examinations, investigations, and
1	regular or o-call
1	$11,700,000; (3) for
6	become contaminated with
1	paragraph (a) or
16	(ii) shall be
1	construed to repeal
1	delivered, the purpose
5	district court for
1	proposal of adult
1	(ii) adequate requests
1	study requirements. 
1	effect), the administrator
1	section, in cases
1	misleading to lay
1	promulgate regulations providing
1	(b) creative and
1	technology to enhance
1	suspend the accreditation
1	requirements, for the
3	services, the secretary
1	 (3) requirements
2	referendum enacted prior
1	section and private
2	required at each
2	pharmacy shall display
1	dtc advertisements the
1	articles recognized in
1	manufacturer shall certify
1	defendant furnished raw
1	illicit drug availability,
1	accreditation body, that
1	invoking subsection (f).
1	practicable shall coordinate
1	program implementation and
3	program funded under
1	later owing by
1	effectiveness of sections
1	order the classification
4	administration, including the
1	monetary penalties for
1	enforcement activities are
1	denied within 21
5	fee  (1)
1	(b) a notification
1	ii. such date
1	parts; (6) under
1	engaged in implementing
3	visible and clear
15	risks of the
1	authority understands that
1	whenever any restricted
1	inspect facilities according
2	prescribing any standard
1	
 
 694.
1	time equal to
2	subparagraph (a) only
1	knowingly violates any
1	pharmacokinetic, pharmacodynamic, and
1	organizations, and with
1	additive, or increasing
2	subsection are 
4	additive in or
1	ingestion of any
1	claimant or any
4	informal conference shall
1	675, 738a, as
1	shall conduct or
37	later than 60
1	(b) no brand
1	available to local
1	262(k)];  (b)
1	labeling or compounding
1	based, and to
6	thereon with such
14	general determines that
1	health and 6
1	served three years
1	requirements shall go
1	product includes a
2	description of such
1	include a summary
1	product, each person
1	(e) deputy director
2	(other than as
1	levels in establishing,
2	administrator of general
1	(jwh019); (vi) -[-(-morpholinyl)ethyl--(-naphthoyl)indole
1	smokeless tobacco contains
1	full waiveron the
1	longer applying because
1	related to human
1	days of september
2	promulgate such regulations
1	(except at brookhaven
1	rates authorized for
8	(other than an
1	egg products; treatment
1	feed differs from
1	products under subchapter
1	market.the first applicant
2	secretary any new
1	 (o) use
1	product) to immediately
1	distributor license, taken
1	extended by 5
2	1313, 58 stat.
1	human services coordinating
2	sponsor fee as
1	drug into smaller
1	includes the decedent
1	among task forces;
1	
 2012. establishment
1	facility without a
1	issues a permit
1	sanitary requirements, as
1	succeeding the quarter
3	following january 4,
1	(ii) any person
1	approve human drug
1	expiration of any
1	5001 et seq.)
2	subsection.  (5)
1	trade names, and
1	(3) advance notice
1	represented on the
1	public agencies over
1	assembled product which,
3	appropriateness of such
1	supplement is withdrawn
5	shall include information
9	appropriations acts. such
1	ii for any
1	office of compliance
1	submits a notice
1	training, data collection,
1	access to medicines;
1	7.5 grams may
1	foreign countries, 1
2	title, and complying
1	100 ml; (ii)
2	custom operations at
1	subsection that a
4	efficacy of the
1	1486.)
 
 62.
1	thereof. (june 25,
10	manner that is
1	security to target
1	establishing a conditional
1	952(a) of this
1	safe. the applicant
2	18 or $5,000,000
2	meets all requirements
5	availability before presenting
5	association, the american
1	13, 1931, for
2	oral authorization of
1	(a)(1), if the
1	cutting up poultry
1	reportable amount of
1	(a) from interested
1	nonprofit organization means
1	states for use
1	notification submission reviewed
1	(i) the proprietary
1	protection factor levels,
1	rate of abuse,
1	expertise which the
3	leave in effect
1	labeling.  (b)
1	handled do not
1	research subjects as
1	may initiate a
1	commodities.  (3)
1	products thereof, are
1	plan for hiring
1	350f(j), 350e, 354,
1	one and si-tenths
1	food may discharge
1	operator intends to
1	conjunction with words
1	delay in product
1	secrets and commercial
1	secretary of education
1	revoked with respect
1	section 360j(o) of
27	secretary under subsection
1	appropriate safeguards to
1	247d5]. such report
1	supply of food,
1	promptly and the
1	tentative approval prior
1	extent practicable, so
1	property for violation
1	publi-private partnership with
1	(3) temporary suspension
2	toxic, or hazardous
1	reinstate recognition of
2	product may request
14	drugs in the
1	section 5703(b)[2] of
2	dates upon which
1	federal statutes intended
1	problems, emergencies such
1	agencies in investigations
1	license referred to
1	summary to the
1	commercial distribution under
19	country to which
6	facilities or controls
1	product; (ii) if
1	providing for notice
2	health from the
1	(3) aggregated data
1	3-day period. (b)
1	strategy; and 
1	association, and any
1	termination of authoritythe
1	(3) considerations in
2	setting forth in
1	shall review, provide
1	relieve a repackager
1	singl-use device will
2	tests necessary to
3	promptly to the
1	subsection, as long
2	public health because
1	(b) access to
1	reporting under this
1	test of the
1	reliability of data
1	applied by a
1	enforceable public health
1	fiscal years 1999
1	chemical product 
1	recommending classification in
1	fiscal years 1994
1	features any elected
2	fiscal years 1996
1	fiscal years 1991
1	section, respectively, shall
1	party, a system
1	office in which
4	section 387f(d) of
1	control program agencythe
1	took actions for
16	control program agencies
2	foregoing, such other
1	distribution or transfer
9	5 or section
3	among other conditions
1	programs (a) state
1	
 675. assaulting,
1	subsection beginning on
1	food product subject
1	complete data derived
3	shall use the
1	exceptionif, during the
1	trafficking the term
1	interpretation or policy,
2	facility  (i)
1	classification panel, information
1	thereof. (4) the
1	section 1531 of
2	time to make
1	chemical or chemical
1	(b) written report
1	products approved, licensed,
1	 (1) state
1	practices observed by
1	states and owning
1	least one, for
2	restricted eggs than
1	manufacturer that the
1	practices in reducing
1	rule (a) cigarettes
1	appropriate, be determined
1	substance, possession of
2	$160,000,000 for each
1	world evidence, including
1	intervention. (b) such
2	regarding the major
1	assist in preventing
1	official names (a)
1	impact of illicit
1	costs. (c) thir-party
3	order may file
1	379h(a) or 379j12(a)
1	application a proposed
1	appropriate staff members
2	duties specified in
1	applicable percentages described
5	law enforcement and
1	26 stat. 416.)

2	information or data
2	-year period, and
1	otherwise expand the
1	inspection under any
1	website methresources.gov. (c)
1	(h) vesting of
1	applicable. (4) beginning
1	policy (a) findingscongress
1	(b) is potentially
1	issue a final,
2	upon the publication
1	intended  (i)
2	upon finding imminent
2	concerning appropriate labeling
49	secretary may not
1	exceed two years
1	committees, as appropriate,
1	66 stat. 279

1	treatment services projects
2	(a) if, after
2	attorney files an
3	official homoeopathic pharmacopoeia
1	offense  (a)
2	change and failure
1	planning and coordination
4	requirements of sections
1	safety), (a) the
1	articles dispensed upon
2	(c) establishment of
1	petition approved under
4	violates any provision
1	unstable nuclei by
1	establishments conducted as
6	provides the secretary
1	provide the tobacco
1	(c) require, as
1	pandemic influenza; or
1	tobacco product, including
3	contains data from
1	product labels and
1	person to obtain
1	gao study and
1	management systems under
1	food being imported
2	knowingly selling, purchasing,
1	privilege (a) refusal
2	traceable to such
3	report and recommendation,
1	transactions, shall not
2	practice of medicine
5	writing to the
1	secretary may enforce
1	science activities related
3	shall be furnished
1	build capacity for
1	article.[1]  (2)
1	(1) the requirement
1	diameter. (aug. 3,
1	(e) review of
6	means the following
1	(3) a retail
1	classified by subsection
1	subparagraph if it
4	administration not later
1	approval remains in
1	(1)(g)(iv) shall include
2	 (2) considerations
5	administered at the
1	labeling bears a
7	applicant for, or
1	interested persons, including
3	justice may require.
1	subsection (c)(1) for
1	condition; (2) there
4	subsection (a)(1) for
6	report and recommendations
1	request comments by
2	name, by delivering
1	transaction history, or
1	derived. when required
1	year, in addition
2	potential immediate recipients
1	abuse; (4) has
1	failure, of such
1	products. no provision
1	accepts the qualification
1	refusing to renew
1	prescription. this exemption
1	existing cavity of
1	fill voting member
1	(e) applicability of
1	drug involved upon
1	animals; (ii) following
1	end of effective
1	congress a comprehensive
1	american diet including
17	territory or the
2	(a)(ii), the pediatric
1	section publicly available
2	representatives, to include
1	maintenance of educational
1	security that there
1	regulated under subparagraph
1	prohibited in the
1	reviewing the operations
1	pesticide monitoring program
1	stat. 832833) [21
1	members term until
2	1 medical evaluation
1	distribute a date
2	files an information
1	straw means all
3	law nothing in
1	credible scientific evidence
1	(b) rapid pesticide
1	original written order
1	-acetylanthranilic acid, its
1	allow any 2
1	availability, addiction rate,
5	shipment in interstate
1	practicable procedures for
1	succeeding fiscal years.
2	preclude, delay, or
1	limit or otherwise
1	whether products may
2	states upon the
1	facilities for which
2	reinstate or further
3	investigations which the
1	(2) appoint and
1	recommendations. a copy
2	ground specified in
1	indication of compliance
1	fees under both
1	make unreasonable efforts
1	preinspection at a
1	(f), if applicable)
1	(f) for fiscal
1	risk the terms
1	
 1903. public
1	amenable species, inspection
1	issued regulations requiring
1	monograph  (a)
2	animals, taking into
1	describing the smuggled
1	new producersevery person
2	consideration of recommendations
3	sundry losses to
1	different use authorized
2	importation is made
1	case of shell
1	combination product, promptly
2	internal revenue code
1	term processed food
1	exception subsection (a)
1	manufactured with reference
2	thereafter, the president
1	affect any rights
1	if, after receiving
3	adjustment:  (a)
2	 (2) reports
5	particular and was
1	party, as the
1	(d) an adverse
12	(1) to the
1	(ii) any additional
2	manufacturer shall 
3	paragraph (1); (3)
1	 (1) new
1	notification submitted with
2	tobacco product (including
2	alter the protections
1	commerce will pose
1	safety practices and
1	upon the employment
1	applicationthe secretary shall
1	pathogen, including novel
2	(a) the adjustment
2	secretary determines by
1	develops and implements
2	processing procedures or
1	secretary), the secretary
2	constituent (including a
1	(5) identify and
2	personnel who are
1	general shall annually
1	production of drugs
2	because, with respect
1	actual emergency that
20	later of 
2	355, 360(k), 360b,
1	
 1509. repealed.
5	shall extend to
1	(q) the distribution
1	material fact has
1	section 1033(a)(8) of
1	accorded all interested
1	foodborne illness data
1	years or both.
1	(b), unless the
1	19th par., 34
3	 (2) exception
1	2011. (4) the
1	permit issued under
1	683. interstate shipment
1	product introduced into
1	understandable to a
1	law because of
1	procedure in a
6	adjustment under subparagraph
1	study plan. (3)
1	subparagraph (b), remaining
1	control or substantial
1	auditthe government accountability
3	provide for conditioning
5	tolerance for the
1	regarding pending applications
2	reduction or elimination
1	treat tobacco dependence
1	 (c) additional
2	intention to issue
1	 (j) temporary
1	secretary published at
2	health service corps
1	used, tar content,
6	received under section
1	 (2) recruitment
7	387k of this
2	6-day period referred
1	device establishment may
2	information accessed, contained
1	chapter is to
1	charged for such
1	packers on his
4	section or the
1	(d), the fees
1	prior to seeking
1	 (d) biosimilar
1	relies on anticipated
1	(iii) termination of
1	following structural classes:
2	352, 360, 360f,
1	administer, or otherwise
1	fiscal year. (ii)[1]
4	1237; 1953 reorg.
1	substantially duplicates information
2	suspended or is
1	regulation to show
1	involving a drug
1	5 percent. (iii)
1	order to determine
1	shall contain nutrients
2	variance from such
1	required.  (2)
2	period preceding january
31	methods used in,
1	food would employ
1	trends; and (vi)
1	efforts  (1)
1	31, 2003, the
1	short shel-life or
3	mortality or other
2	real property comprising
6	fiscal year the
1	(24) transaction 
1	order. (c) consistent
1	(2) and giving
1	software functions excluded
1	facilities (a) inspectionthe
1	radio pharmaceutical drug
1	officio and appointed
2	(a) the sponsor
1	removal for trial
1	conducted if the
2	panel shall consist
1	administrator, after consultation
1	failure; (2) not
1	solicit contract proposals
2	received by or
1	regarding such threat
1	matter is false
11	appropriate congressional committees
1	selling, disposing of,
1	section 381(m) of
1	representative of a
1	purposes of transactions
1	directors under subsection
1	substances and who
2	designated personnel. 
1	822. persons required
2	request  (i)
1	may be charged
1	chain pharmacies under
1	pharmaceutical drug product
1	threatened raw materials
1	(
 
 387s.
1	otherwise introducing into
1	range of training
3	affixed to, or
1	permanent. (iii) the
1	set forth his
1	exporter that (a)
26	determine whether the
4	control strategy; and
1	treatment. (2) the
1	states, or within
1	1953, shall be
1	carryover submissions in
1	fish (e.g., bass,
4	providing written notice
1	secretary exercises the
1	(iii) the responsibilities
1	service. any person
1	contents of ruleexcept
1	state department of
4	secretary finds, on
1	 (c) contentsthe
1	united states committed
1	evaluate the results
8	state or federal
1	determines are necessary.
1	(b) reports if
1	data describing whether
2	requirement because use
1	subsection (b)(1), or
3	application a statement
1	relevant to an
1	purposes of determining,
1	parents and other
1	facts developed in
1	(2) authorize holders
2	chapter. (r) the
1	columbia, to enforce
1	information is invalid,
4	corporation, or association,
1	generalan accredited person
1	 (a) sanitation
1	local officials; (5)
1	department of commerce),
1	found.  (

1	products. (x) the
2	public health assistance
1	overall reductions in
2	(a) to meet
1	provides assurances satisfactory
1	including advice and
1	(ii) the public
1	system, if the
1	inspections, and compliance
1	
 454. federal
1	year 2014 falls
1	terms, conditions, and
2	requirements, applicable to
1	(ii) is the
1	prohibited an officer
2	state which is
1	restricting the application
2	strengthen the capacity
1	(3) currently lawful
1	productsa tobacco product
1	secretary on a
2	united states not
1	official; or (3)
1	due to a
3	chief inspector, or
1	article was imported
1	internet site, in
1	internet controlled substances.
1	submit a safety
1	composition require a
1	due care in
1	(3), no person
1	physician and which
1	equal to $299,000,000,
9	administration of the
1	both, or a
1	(a) to reflect
1	may grant if
1	service; or (iv)
1	entitled the convention
1	approved by secretary
1	(e)). (b) for
1	limit is identical
1	filing of requests
1	model does not
1	consistency and appropriateness
1	color additives in
1	fell during fiscal
1	law, or a
1	misbranded with any
1	denying a request
1	selling tobacco products
7	established to generate
1	(j) is effective
1	1505a. annual report
1	states.  (7)
1	participating under this
1	(b) informationthe food
1	made so effective.
4	247d6a of title
1	schedule c of
1	court. (2) affidavits
1	subsection (b)(3)(b) of
3	dietary ingredient that
1	fourth and fifth
1	(iv) the dispensing
1	standards under paragraph
1	shall provide public
5	studies or special
1	(17) pethidin-intermediat-c, -methy--phenylpiperidin--carboxylic
1	indirectly, by an
3	representative shall not
1	(1) to accept
1	including such animal
1	transshipped (i) for
2	reversal, and relapse
1	manner; (2) with
1	like writing, similarly
2	dispenses controlled substances
3	(e) of such
1	controlled substance. the
1	title i, 23,
1	consumption, or who
1	(ii).  (iii)
1	drug use, the
1	elements of notification
3	published under subparagraph
1	radiation or that
1	respect to drug
1	fact or providing
2	form to be
1	exemption for residues
1	food; (g) to
1	respective manufacturer, wholesale
2	meetings, electronic communications,
1	includes individual, partnership,
5	inflation adjustment for
1	action, to conduct
2	practitioner for office
1	(c) the act
2	unless required for
1	pattern of abuse.
1	assistance with strategies
1	terms state and
1	apply, under rules
2	identifier  (a)
1	(2) he may,
1	eliminated or reduced
1	threatened or adversely
1	included in food
1	employ chinese subjects
1	tobacco products from
2	individual has been
1	1, 2007, and
1	accessed by a
2	term includes (until
1	import under the
1	risks.  (iii)
1	coordination and consolidation
1	area is (except
31	effect on the
1	navigable for dee-water
1	(4) the committees
1	ground, powdered, or
1	shall, before delivery
2	action taken by
1	23, formerly 21st,
1	control budget to
1	formulation, from a
1	imprisonment for engaging
3	certification under subparagraph
1	subparagraph issued with
1	(a) facilitating cooperation
1	produced was slaughtered
1	(d) disclosure if
1	matched by an
1	compounded for an
1	approval has been
1	title 16) shall
2	sold, the name
2	(2) revocation of
1	officers employees and
1	treat serious or
1	title. (iii) subsections
2	solely because its
1	standard, including information
1	(g) the technical
1	comment. if the
1	administration in implementing
1	
 374. inspection
2	imposed under subchapters
1	involved; (b) feedback
1	(i). the use
2	1-month period described
2	require the review
2	product. (june 25,
1	eligible countermeasures the
1	devices. (e) the
1	become an outsourcing
3	section 460 of
1	 (a) presents
1	successor regulations), and
1	(4) for fiscal
1	well as during
3	health service, or
1	whether such food
13	treated as a
1	801 et seq.)
1	budget, the head
1	food being misbranded
1	title, and with
1	plan a development
3	plate, stone, or
2	special attention to
2	eliminate such risk.
1	include specific information
1	tolerance fees under
1	operation of, any
3	360ll of this
1	conditions that will
1	 (e) notification
1	duties; (3) prescribe
1	animals, articles, or
1	convention, the order
1	expiration dating 
18	state, or local
1	facilities.  (e)
1	retail level refers
1	foundation may accept
1	methodology, as prescribed
3	inspector, deputy inspector,
1	years ending june
2	quota for a
1	shall not conduct
1	order to qualify
1	psychotropic substances for
1	statement of why
1	products processed by
1	disclosures not affected
1	substance. (c) if
6	maintain records, and
2	ensure that 
1	relevant date, and,
1	identifier assigned by
1	pending, except that
1	made) contained in
4	minor violations of
1	inspections, commission any
1	injury, bruises, and
1	device package in
2	purity, safety, and
2	date, in which
1	cover the costs
1	provides a recoupment
1	authorize an emergency
1	may not file
1	access and minimizing
1	improve such program;
6	drug until the
1	device used by
1	facilities such that
2	(b) unless the
1	chemicals listed in
2	application may receive
2	notice respecting the
1	devices within a
1	emergency situation described
1	first be learned,
1	verification program shall
1	article, then such
1	12, 1943, to
132	 (
 

1	(i) expertise the
1	unappealable order, or
2	repeal of regulations
1	require revision or
2	means either an
1	issues, or highly
1	absence, substitution, or
1	extend to financial
3	repacked in substantial
1	applicable to electronic
2	title, except as
1	health issues and
2	secretary which served
4	control strategy and
1	establishment number of
3	age group if
1	changes from the
2	aspect of labeling
1	quality control audits
1	applicant. (iii)subsequent applicant.if
1	views of patients
1	monitoring and reporting
6	fees are to
1	distribute, of amphetamine
5	morbidity and mortality
1	date an exemption
1	(b)(1)(a). when an
3	age group is
2	action, consistent with
1	court may postpone
5	space for the
1	packed in accordance
1	exemption. if the
6	may be accepted
1	places, take such
1	regulation prescribe; and
1	manufacture of amphetamine
1	food in interstate
1	18. (l) adverse
2	increase the fee
1	put it in
3	medical, scientific, and
1	sale constitutes a
1	review any order
6	(d) the term
1	regulations). (g) supplier
1	remain available for
1	(5) distribute or
1	(i) only if
1	(k) that is
1	subsequent contamination or
1	suspension of licenses
1	export of rejected
1	qualification plan or
1	clinical trials, or
1	secretary; exception 
6	make grants to
1	bird, whether live
1	subject with respect
1	judicial branch of
1	subpart shall, except
8	contained in a
2	otherwise confidential, commercial
2	secretary if the
1	(including members whose
1	device, that there
3	concerning the conditions
1	plainly labeled with
1	purchaser providing that
3	chemical product at
1	adjust the focus
1	exercises of the
4	 (i) as
1	monitoring of effectiveness
1	individuals not to
4	authorized under subparagraph
2	secretary.  (3)
2	attorney general, may
1	technical experts or
1	relief. (3) 
1	address every registrant
1	poultry carcasses and
1	federal agencies, (b)
1	enforcement intelligence obtained
1	1901. findings and
1	case of prevention
1	175. repealed. june
4	exemptions the secretary
1	business, to which
1	food system, including
1	questions relating to
1	supplement. (e) the
1	products, owned by
1	term homogeneous case
1	withdrawing or temporarily
1	830(b)(3)(b) of this
2	regularly engaged in
1	affect the submission,
2	may have been,
1	shall use certification
1	(7 u.s.c. 2012)),
1	collaborationin carrying out
1	respecting such drug
2	(or, with respect
2	symbol it shall
2	tobacco, or other
4	thereafter as the
2	previous sources and
1	(vii) the physician
1	may be applied,
1	675, 902, as
2	(a) the information
1	reporting of such
1	examined as a
1	homogenous and is
1	combination of the
1	publication at any
1	section 5315 of
1	360b. new animal
1	respond to hig-priority
1	prior finding of
1	professional practice. (e)
2	measures deemed necessary
3	patent infringement is
1	subsection (a)(6) regularly,
1	subsection must, in
1	area may petition
1	receives financial support
1	971(f)(2) of this
1	respect to collection
3	statement for each
2	drugs, marihuana, or
2	18 or $250,000
1	subsection terminates on
2	pesticide residues, (b)
2	convicted in any
1	importer shall file
2	communication plan to
1	 (k) importation
3	(a), the administrator,
1	wel-controlled clinical trials,
1	collaborative efforts to
1	section; (9) who
1	adequacy and effectiveness
1	reports and so
1	electronic certification may
1	meetings) and the
1	reviewable. (2) generic
2	debar a person
1	upon the article
1	controls, that provide
1	adequate labeling could
1	466. imports (a)
2	subparagraph (d), the
1	estimated, that were
3	unless the importation
1	review of regulatory
2	report thereon to
1	(3), and (4),
1	longer meets the
1	packaging.  (8)
1	shall terminate, and
1	registrant shall notify
1	(2) effective dates
1	gross receipts, either
1	instituting court action
1	registered foreign establishments;
6	shall be subtracted
4	drug are of
1	(b)(1); (e) the
1	paragraph (2)(b)(i) or
1	small enough so
2	ground that it
1	etc., ingredients 
1	(2), whether the
8	attorney general that
1	transfers any transfer
1	establish pilot projects
1	national intelligence; or
6	properly labeled and
1	controlled substances laws
9	received under this
1	section 518d of
1	contains individual portions
1	district courts shall
1	uncommon method of
2	termination is published,
1	 (i) conducts
1	(f) distribution of
1	accounting of all
1	complied with a
1	selling any eggs
1	condition with regard
1	 (c) assaulting,
1	262(k)(4) of title
5	writing by the
3	safety activities with
3	two of the
19	374 of this
1	codes, us-by dates,
1	another; and (ii)
2	lawful and usual
1	hazardous substance on
2	paragraph (2), issue
1	regulatory audit reports
1	application fee under
1	basis, as the
5	abbreviated new animal
4	prepared by the
1	completed or declare
1	reporting: www.fda.gov/medwatch and
1	established for a
1	homogeneous case; and
1	use, or use,
3	exception for previously
1	paragraph (2)(a), respectively.
1	product requirements. 
1	received the illegitimate
1	handled in conformity
3	approving or denying
6	activities of a
2	secret or other
1	security, shall, not
1	
 1051. other
1	emissions.  (b)
1	pathophysiological, therapeutic, pharmacologic,
4	section 355d of
1	(c) thir-party auditors
1	funding for federal
1	pharmaceutical ingredient or
1	2009, such sums
165	described in paragraph
1	occurred; and (ii)
1	dietary intake. (c)
1	pharmaceutical ingredients and
1	(ii) reliance upon
1	limited time, and
1	list is a
10	[21 u.s.c. 801
1	adverse drug experiences
1	manufacturer, and notwithstanding
6	positions for the
1	subpart for expediting
1	(c), if applicable,
1	(4) in this
1	useful information related
1	 (4) accredited
1	recommend such external
1	physical dependence. 
1	sponsor;  (b)
1	notice that oleomargarine
1	form the term
1	services an office
1	2007, a pediatric
1	2009 for inflation
1	term qualified adul-only
1	stakeholders, issue a
1	order entered pursuant
5	design of the
15	commits such a
1	retail pharmacy licensed
1	adverse drug experience,
1	use of fundsan
1	license immediately, and
1	adverse experience associated
1	flunitrazepam, the person
1	ch. 675, 305,
1	
 1131 to
1	(2) other considerations
1	package. (ii) for
2	regulation reasonably require
1	 (iii) amount
1	traceability in the
1	(e) oleomargarine containing
1	obtained such license
1	controlling a substance
3	make such article
1	enforcement the term
1	potential toxicity of
1	sale, delivery, or
1	public health, economic
1	rely on any
1	reserve on a
2	notice, order, requirement,
1	offenders, which may
3	may be based
1	final.  (c)
1	environmental agencies; (e)
2	raised for food
1	42; (ii) the
1	representative who will
1	egg products handled
1	(i) to any
2	describes the activities
1	individual (other than
1	food, or (2)
1	scientific studies needed
1	contents, and process
4	monitoring, or treatment
1	appropriations any request
1	radiological health (for
2	hazards and control
1	traceability. such findings
1	information regarding certain
1	 (5) application
1	government agency or
1	marketed devices. (june
1	one person shall
1	 (a) who
1	numbers and types
2	(1) and in
1	repackager; (iii) take
1	assistance records; contents
2	applicant fails to
1	subparagraph (b) has
4	(1) and if
1	previously submitted pursuant
1	675, 505, 52
1	drugs compounded at
1	 (g) effective
1	(2) amateur athletic
1	proceeds.  (3)
1	tool, the circumstances
1	recall or other
1	implementation the secretary
1	(b) priorities the
1	inspect records or
1	prohibiting or restricting
2	property was subject
1	transmitted under clause
1	2007 and 2008
20	(iv) of subsection
1	thir-party auditor and,
1	statement that discloses
1	federal personnel; (2)
1	regulation. (
 

1	automatic electronic searches,
1	requesting such designation
5	premarket reports, supplements,
1	poultry, eggs, and
1	(xvi) the distribution
1	(iv) proposed labels,
1	thereof as to
1	paraphernalia destroyed or
2	(a) establishment and
1	so, general advice
3	activities of any
2	subsequent conviction for
1	supplier for purposes
1	publish periodically in
1	sell, at retail,
1	recovery support services;
1	(2) states and
1	306 of the
5	preceding the fiscal
1	 (iv) limitation
1	standards, postmarket surveillance,
1	subsequent application filed
1	subsection (a); (2)
1	chapter, and appoint
1	declaration of a
1	stat. 1059; 

1	information was obtained
1	drug, on the
1	state providing for
8	shall be punished
1	deny a variance
1	prohibited by paragraph
3	grounds do not
1	food safet-related activities
1	(within 30 days
1	 (1) authorized
3	late payment penalties
1	247d6b]. (2) product
1	sources, including foreign
1	areas); and 
1	compensation  (1)
1	program budget unless
1	subdivision applicable to
1	allocation of the
2	advertisement that has
1	directly accredit thir-party
1	
 387b. adulterated
1	required by compelling
1	sentence, the advisory
1	 (f) prevention
1	secretary must act
1	chapter for which
3	(ii) the seller
1	ammunition, or explosive
1	subsection (f)(2), as
3	(d) such other
1	investigation.  (j)
1	sponsor under this
2	counterclaim described in
1	software, sterilization, or
1	 (2) confidential
1	standard is not
11	interpretive criteria website
1	contains a manufacturing
1	revisions under paragraph
4	(1) maintenance of
1	information provided during
1	chicken, turkey, duck,
1	evaluated as an
2	(b) the abuse
1	(b) to evaluate
1	predicate tobacco product;
2	participate in collaborative
1	facility has the
1	notification networks as
1	ensure the timeliness
1	 (b) communication
2	committees of jurisdiction
1	conditions on manufacturing,
1	mandamus proceeding brought
1	committee convened by
1	distributed to an
1	reinspection fee to
1	interstate commerce under
1	pet food that
1	no-compliance letters issued
1	designate 1 of
1	national laboratory in
1	collect fees under
1	traceback and surveillance
10	notify the attorney
3	nonclinical and clinical
1	device recall will
1	include such elements
11	according to the
1	money, gift, or
1	entity may make
1	imports were handled;
2	subjected to incubation
1	use (including special
1	data available and
1	regulation prescribe) 
3	plan not later
1	formulation was not
1	(iv) submissions from
2	eligible for the
2	area of production
1	sample packages of
1	receiving the arguments
1	(b)(3), as adjusted
1	ancillary services. 
1	695. payment of
2	facilities according to
2	body meets the
2	use. (b) if
3	official functions under
1	product radiation, the
1	statements comply with
1	foods, in order
2	life of such
1	effectiveness of media
2	subsection for other
1	may collect data
3	person under 18
1	cases of imminent
1	thereof of animals
1	calendar years. in
1	(d) the dispensing
1	paragraph (1); (e)
2	nurse is not
1	due allowance made
3	fee is paid
7	may direct that
3	user fees are
1	clinical trial guidance
1	subsection (h) if
4	prior to its
1	22, formerly 20th
1	vaccines, at the
17	whenever the secretary
1	united states grain
1	 (1) partial
1	subsection, the united
1	successor regulation)); 
1	dispense means to
1	assistance to device
1	place, in the
1	consignee is not
2	unreasonable and substantial
1	[42 u.s.c. 247d],
1	(d), require a
1	1, 1999, begin
1	medical food means
1	current and generally
1	communities.  (e)
2	federal establishment in
1	proposed rulemaking and
3	 (2) priority
1	(5) when a
1	holder thereof has
3	homeland security, may
1	number to any
1	finalize the methodology
84	shall submit to
1	states is as
1	jointly submit to
1	owner; copy to
3	particular, he may
1	(ii) merely advocates
1	(3) detection methods
1	paragraph (2)(a), nothing
1	chemical, substance, or
1	excluded from importation
1	substances in food;
3	transaction with a
2	reports of, and
1	stat. 410
 

2	(e) supplement not
1	product required to
1	1111 to 1114.
1	biological product during
2	energy act of
6	simulation thereof, or
1	(2) designation of
1	applications and prior
1	list of sel-certified
4	make any labeling
1	proposed plan (including
1	action; (b) specify
1	authorization, and each
2	receive such notification
4	section; (b) the
2	(2) during the
2	satisfied that there
1	structure and pharmacological
1	trial  (1)
1	title. (iii) not
1	completeness of the
1	wholesale distributor transfers
1	(user fee) program,
2	secretary, of the
1	demonstrate appropriate technologies,
1	executing an international
1	(ii) a provider
2	drug was designated;
6	compromise, modify, or
3	2003, had pending
1	close proximity are
1	(d), shall be
1	term adverse drug
1	delay. (c) shortage
1	subpopulation. (c) pediatric
1	shall serve for
1	subparagraph (a) he
1	(d) report on
1	none of such
1	agency. (l) the
2	budget request to
1	plates, stones, labeling,
1	product (other than
1	(2) esea definitions
2	synthetic vitamin or
1	675, 503, 52
2	valid license in
5	head of each
1	review program to
1	(ii) has knowingly
2	drug abuse programs
1	manufacturing supplemental animal
2	registered as a
1	remove a drug
1	distributor conducted, before
2	manufactured by a
1	subtracted from his
2	351(a)(6) of this
1	indicates that refrigeration
2	(1), shall track
1	another copy shall
1	anaphylaxis management (a)
1	furnish or preserve
1	includes a supplement
1	compensation for individuals
3	355(b)(2) of this
1	united states). (2)
1	(mg) 50.0e 
2	president finds that
1	therapies to treat
3	subparagraph shall, in
1	copy of every
1	apply this section
1	impose requirements on
1	fifty states and
5	records relating to
1	drug use; and
1	denial of the
1	dye, pigment, or
1	section 615 of
22	shall be assessed
1	less food and
1	20 days of
2	reasonable notice and
1	considered, as of
1	(3) terms and
2	makes a request
1	(b) any sonic,
1	classification information, a
1	describing that food
13	 (c) the
1	diagnostic facility which
3	(i) or a
1	manufacturer to such
1	within 21 days
2	years following the
1	technical assistance, education,
2	processing of any
1	otherwise directed by
1	employees in how
1	directly thereon, as
2	reports nothing in
1	device, or (c)
2	group of drugs.
1	secretary, a written
2	device, evaluated together
1	property or contractual
2	application) that contains
1	if, by the
1	source and use
6	use of funds
1	product if an
1	term repackage, with
6	substituted on the
3	need for a
1	traffic which are
2	redactions for confidential
1	360b(c)(2), 360b(c)(3), 360b(d)(1),
1	test results to
1	finds, based on
1	plans for effective
7	fiscal year (excluding
5	may have an
1	regulatory affairs, and
1	form, not to
1	shall, for the
1	or, in lieu
1	secretary has access
1	 (a) record,
1	thereof. the secretary
1	systems and on
2	dated and shall
1	requirements for accreditation;
1	chapter. (2) requirement
1	distinct subpopulations affected
1	diversion; and (c)
1	services administration, who
4	upon the execution
1	packed by any
3	nature, circumstances, extent,
1	inspection (a) right
1	(i) the petition
1	plan may be
1	parties described in
3	product manufacturer that
1	meeting relating to
1	placement of new
2	thir-party auditor accredited
1	failure to recite
1	copy to secretary
2	funded under this
1	assurances beginning not
3	(ii) the name,
1	military emergency, or
1	relating to advertising
1	(ii) prescribing alternative
3	drugs or a
1	development organization; (ii)
1	present state and
1	maintains the integrity
2	643, or 644
10	fee for each
1	derived, with or
1	products can occur
1	complainant may file
1	chemical intending, knowing,
2	provide for up
1	advocacy organizations. 
1	narcotic and marihuana
3	(b)(2) for a
2	way is in
1	dismiss an action
1	colored margarine when
3	permitted to conduct
1	may be. (2)
1	different margin of
1	revising a policy
1	reimbursement from the
1	(1). safe levels
1	including the return
1	title. (b) establishment
1	either such section,
1	plan by sponsor
1	enforcement authorities; (15)
1	(
 
 114i.
1	class iii, why
1	name it may
2	establishment has entered
9	national primary drinking
1	variety which are
1	referenced by the
2	transferee or quantity
1	(1) in section
1	reasonable period but
1	animal drug establishment;
1	(c) a device
1	control can be
2	application fee for
1	use only. 
3	importation is in
1	distributor determines that
1	2007, if pediatric
1	analytical methods, and
1	certification of eligible
1	(5) ethinamate. (6)
2	information in any
1	accreditation body means
1	(a)(ii), may distribute
1	charges collected under
1	public health advocacy
1	nighttime. (mar. 4,
2	commerce, or which
1	within specific local
1	section. a recipient
1	et seq.] may
1	ch. 675, 511a,
1	(2)(c)(i) or the
1	(ii) to assess
1	(a) collect, by
1	proceedings under paragraph
6	regulations prescribed under
1	duties of committee
1	conditional approval; (ii)
9	salts of its
2	approval status of
1	failure or refusal
1	enhancing scientific knowledge
1	endpoints, consumer perception
1	
 396. practice
1	application any issue
1	receive travel expenses,
1	heroin; (b) 5
1	et seq.], shall
2	recall or the
1	fee associated with
3	animal drug establishments
1	 (iv) issuance
2	expire on a
1	drugs in designated
1	(4) training that
1	criteria for selection
1	procedures (including the
1	termination. such guidance
1	threat that death,
2	request by an
1	radiation emissions. 
1	variations in preclinical
1	performed  (1)
1	less than 45
1	circumstances shall such
1	(5). (4) for
2	effectiveness of animal
2	1946 (7 u.s.c.
1	products; treatment as
1	address that 
1	purchases meat or
1	established, modified, or
1	drug compounded from
2	registration fee shall
1	(4) to extend
1	department of state
1	orphan drugs unless
11	equivalent to a
1	records, and laboratory
1	public health organizations
1	1-month period. 
1	(2) the applicants
1	designed to reduce
1	including the testing
1	(f) information required
1	subsection (b)(2) is
2	requested within any
3	attorney general deems
1	 (c) administration
1	procedures as may
1	(a) in generalupon
1	below, that which
1	(1) any property
1	ch. 675, 510,
4	regulations (as in
1	10 percent below
1	positions established pursuant
1	facilitating the work
1	968. service of
11	product development protocol
2	special scientific purpose
1	packaging) and the
3	provide such information,
1	attached all written
2	monitor and evaluate
1	net change in
1	drug facility each
1	respect to cattle,
1	(i) registration of
1	agency to report
2	produce records, if
2	 (i) review
1	title shall, with
1	preservation except as
3	establishment is deemed
1	seller violates paragraph
1	independent private laboratories
1	secretary regarding illegitimate
1	make new findings
4	increased by the
1	limitation on entry
1	reports by such
2	shall be so
1	52 stat. 1040)
1	required to improve
1	manufacturer or regulatory
1	
 350b. new
5	registers with the
1	applicant means an
2	transactions involved were
7	defined in this
1	services provided; (ii)
1	operations in a
1	additive or ingredient)
1	period; (b) the
1	assist in improving
1	public interest, that
1	problems identified in
1	 (f) indian
1	senate, which shall
3	require a responsible
1	consider providing such
5	 (a) each
15	request the secretary
1	board. such members
1	65 stat. 769

1	additive, (ii) such
1	types of businesses,
1	reprocessed.  (3)
28	route of administration,
1	fact. (3) as
2	court of american
1	area during the
1	standard or special
1	section shall include
1	 (2) rights
1	agencies under subchapter
1	et seq.], be
1	circumstances; (b) the
2	period under subparagraph
1	requirements; persons required
2	(c)  (1)
1	require that safeguards
1	346b. authorization of
1	(i) requests approval
1	report on an
1	1, 1971. (3)
1	state; and (b)
1	law the court
1	applicable outsourcing facility;
1	audit preventative controls,
1	section 331(gg) of
1	imported food or
2	thir-party auditor 
2	limits prescribed for
1	scientific evidence and
1	determined under section
1	4d animals to
2	application. (iii) if
1	required and if
1	tolerance has been
1	petitions that were
1	time and place,
1	behin-th-counter access; logbook
1	subsection shall terminate
1	 (a) substance
1	development fee by
1	device. whenever he
1	supplement and not
2	convenience kit) if
1	criminal justice authority
2	linked to a
1	shown through scientific
1	(2) the promulgation
1	918, as added
1	term antimicrobial susceptibility
1	extent and nature
2	affairs, including any
2	coordination and more
1	(i) shall permit
1	continue to perform
1	health data, in
1	treasury may administer
1	available listing) as
2	egg handler shall
2	use, in or
1	means a technology
2	opportunity to comment.
1	compliance  (1)
1	drug substance, bulk
6	human drug application,
1	 (j) applicability
1	administration to modernize
1	modified to a
1	considering in particular
1	allow the claim
1	support marketing approval;
1	available, except that
1	tribe the term
2	least 8 years
1	human drug application;
1	summary judgment, the
2	investigation with respect
1	egg products so
1	imported shipments of
1	methods of administration
1	accident and investigation
1	official plant number,
1	petition; recordnot later
4	ten years, or
1	seq.) manufacturers of
1	tomography drug produced
1	addiction; and (vii)
1	appoint federal officials
1	dissemination is not
1	completed and, if
1	ten years, of
12	elements to assure
1	marijuana, poppy, and
1	penalty any penalty
1	seafood inspection (a)
2	section 355(o), 355(p),
2	section 360b(e)(1)(a) through
2	reasonable fees relating
1	filing, and may
1	awards required the
16	developed by the
1	procedure.  (n)
1	courts having jurisdiction
1	accredited under subsection
1	made without distinguishing
1	provide that prior
1	possesses, a controlled
2	notification submissions 
3	(but within the
1	training of sales
1	filean applicant that
1	accepting a saleable
1	(c) contentsthe regulations
1	(e) one member
1	subparagraph (a)), shall
1	place; and (iv)
1	issued in error,
1	justification that includes
1	information clearinghouse administered
1	export; petition for
1	roles played, and
1	star-up amounts 
1	labeling are not
2	providing the notice
3	administrator may suspend
1	offense not occurring
5	conviction for such
1	development or risk/benefit
1	identifier beginning not
2	may provide to
2	upon, and may
1	served during normal
10	approval, licensure, or
1	adverse event the
1	poultry products 
1	understanding, or other
4	used to support
1	subsection changing the
1	consideration of impactin
1	drug distribution and
1	order forms issued
1	meet such performance
1	government coordinating council
3	 (e) use
3	section, imposition or
1	(2) nurse tank
1	medical gases a
1	coalitions representing certain
1	(2) and has
3	enhance tracing of
1	marker, such as
1	1970, the secretary
2	section 467a of
1	(b) general dutiesin
1	title 18. (f)
1	items to the
1	bureau authority. 
1	submissions, animal drug
1	inspection programs are
2	due diligence and
1	4321 et seq.],
1	publication, at any
1	data specified under
1	service is not
1	seq.) to target
2	(3) establishments that
1	apply to coa-tar
1	secretary, may include
2	miles from such
1	term harm means
1	health professionals on
1	exemption  (a)
1	processed food means
1	population of patients..
1	upon the proposal.
1	petition promptly. (iii)
1	court determines, to
1	tobacco users, adult
1	2, 44 stat.
1	simplicity. whenever such
2	imposed under subsection
1	domestically and quantities
1	protracted loss or
1	funds under subsection
2	 (1) annual
2	activities consistent with
1	writing, a framework
2	priority shall be
3	law relating to
2	tortious conduct of
1	fooda sale of
1	considered.  (b)
1	violation exists solely
1	(b) duties the
1	prepare, and, in
1	enforcement authorities is
4	available for inspection
1	expressly proposes to
1	performance demonstrating that
2	account be obligated,
1	rule for vaccinesif
1	thereof on a
1	held, and to
1	including economic development
1	section 379j43(a) of
4	addition to, any
2	support the use
1	1043. rules and
1	
 1177. special
1	supplements, prescription drug
11	obtained by the
1	subsection (b). (f)
1	attributable to such
1	standardized form) of
1	(7) notwithstanding the
1	medicine.  (iii)
1	including lot level
1	(ii) emits (or
3	director under this
1	complaints concerning infant
1	indexing new animal
1	following topics shall
1	products;  (2)
1	protocol completed or
1	tissue engineering products,
1	activities.  (k)
6	substance to a
1	adul-only facility from
1	importer.  (d)
1	entitled by law.
4	notice as required
1	organizations on present
2	opportunity to examine
1	chapter supersedes any
1	cafeterias. (e) the
1	practicable, shall provide
1	authorities or the
7	assist the secretary
1	675, 409, as
1	final order providing
3	outsourcing facility; and
1	approval was based.
1	general otherwise provide,
2	information for, and
2	indicate that the
1	
 
 614.
1	user facility which
1	services administration, and
1	poultry from which
1	 (ii) exceeding
1	(e) through (h)
1	medicine and is
1	title, (b) knowingly
1	(
 
 382.
1	[42 u.s.c. 2021],
7	(1) and (2),
1	established. in the
1	pharmacopoeia, pharmacy, physician,
1	dispenser in a
1	regulated), or the
2	exceed the anticipated
1	foreign commerce; (3)
2	every 2 years
1	experts in infectious
1	adequately competitive conditions
1	make required reports,
1	permit or to
1	inspection is conducted
1	authorized manufacturers, repackagers,
1	(d) termination this
1	divisions for improvements
1	inspection if it
1	discussion (a) patient
1	performance measurement system,
2	applicant shall provide
1	general no national
1	may conduct audits
1	
 1906. enforcement
1	produce dependence on
1	drugs under a
14	virus, serum, toxin,
1	issued since the
3	identified in a
1	science and based
1	(a)(ii)(iv) and any
4	(relating to animal
1	limited to issues
1	operations or similar
1	fiscal year 1991,
5	corrective action plan
1	certification of designated
1	facility shall maintain,
1	proper, if such
1	diagnostics, is performed
1	precluding or delaying
6	country in which
1	may authorize use
1	authority not later
1	decision be made
4	market of a
1	(d) protection of
1	entity or individual
1	title. upon request
1	(3) informal hearing
1	quarantine lawsfor purposes
1	disease, in man
1	sponsorship of all
3	fees due and
1	(3), not later
1	title, no regulation
1	(b) repair, replacement,
1	applies in lieu
1	yout-oriented marketing, promotional,
2	submit reports under
2	year.  (i)
1	means a disease
2	may (prior to
3	including, for each
1	purposes regarding the
1	determined) for fiscal
1	(i).  (f)
2	manufacturing, and controls).
13	section.  (b)
1	effect regulations under
1	substance for personal
2	name of any
1	foreign manufacturing inputs,
1	 (j) funding
3	exempt from section
3	use in manufacturing
9	impact of the
1	consideration any occurrences
1	paragraph (4)(b) by
1	expectation of effectiveness
1	(i) has significant
1	360c, as added
1	record under federal
1	(3) persons who
1	517a, as added
1	(b) review the
2	prevent use as
1	order, the order
1	discovery with respect
1	difficulties completing the
1	implementation of guidance
1	(4) training in
5	concerning the progress
1	regarding any actions
1	title iv, 402,
10	respect to that
1	states to negative
1	title. (2) making,
1	possession, nonetheless have
1	5 (popularly known
2	2014, $2,604,000 for
1	subpopulation) if the
1	importation no slaughtered
1	available. (9) civil
1	care. (3) 
1	whether such person
1	homeland security under
1	exemption shall have
3	government or any
1	determining for which
1	3324 of title
1	opiat-dependent patients, completed
1	 b1 (thiamine)
2	human life or
1	poultry products, is
1	board under this
1	-phenylacetylindole or -benzoylindole
3	returned product that
1	employee shall submit
5	shall bear the
1	outbreak identification and
4	denial of approval
1	materials (a) requirement
1	section, shall submit
1	section, section 381(d)(1)
1	eggs showing blood
2	feeding specified in
1	supplements if a
1	(a)(1) with respect
1	2010; (14) $124,000,000
1	located, whether the
1	prescribing practitioners federal
1	preventing drug abuse
1	subsection, as appropriate,
1	(b) otherwise relating
1	possession of listed
9	required to have
1	web site that
35	drug referred to
1	practice shall be
1	general, shall first
1	notify, in writing
1	title 28. for
1	boards and courts
3	exception for exportation
1	inspection extended to
1	(d)review.  a
2	report the term
1	government concerned, or
1	process for obtaining
1	shall designate that
1	notice specified in
1	information presented pursuant
1	shortage.  (e)
1	distribution to persons
1	(a) to establish
1	sentenced be eligible
1	nonprofit organization the
1	device (except when
1	change, such authorization
38	activities of the
1	assessment of federal
2	containers or packages
1	countermeasures, populations with
1	described such[1] subsection
1	part 314, or
1	chemical activities. (c)
2	of, any civil
2	certifies in writing
1	requirements for facilities
1	(under conditions of
1	authorized for emergency
3	fees and mileage
1	
 
 360bbb4a.
1	9,000,000 americans a
1	obligation.  (b)
1	expired, or issued
1	him. the attorney
3	request by any
1	title.[1]  (i)
1	secretary, after tests
1	nongovernment organizations. 
3	drug safety data.
1	year limitation, for
1	promoting the efficiency
1	additive, if used
2	conduct inspections shall
2	remitted or mitigated
1	country, refuses to
1	law that 
2	respect to action
1	fat and water
1	creative services, except
1	notifying such committees
2	control of electronic
1	labeling or in
1	parts are used
1	quota application that
1	product package in
1	may be duly
2	adequate service for
1	better identify smuggled
1	using the tobacco
2	authorized to suspend
1	distribution. such person
2	convene all members
2	360i(g) of this
1	written assurances to
5	law enforcement or
4	(ii) at the
4	maintained compliance with
1	information are reasonably
1	risk of hyperoxia.
1	15, 1927 [21
1	files, abbreviated new
1	regulation has been
1	reconstitution; (dd) an
2	director shall review
1	(3) will not
1	section, the basis
1	pay fees notwithstanding
1	(5) diethyltryptamine. (6)
8	amounts specified in
4	maintenance of such
1	endangered children means
1	
 843. prohibited
1	products directly to
5	corporation, association, or
2	manufacturing practices for
1	standard made so
1	products; destruction or
1	sampling, analytical procedures
1	sentence a person
1	section can, by
1	registrant to import
2	funds allocated for
1	plasma products derived
1	product; (3) the
1	testing fees. 
1	(xi) -(-fluoropentyl--(-naphthoyl)indole (am2201);
1	drugs from entering
2	make its recommendation
1	shall be punishable
1	undertake or has
1	conditions of authorization
1	reasonable basis to
1	whether resources are
2	event report that
1	subparagraph (a)(ii)(ii) to
1	(b) information not
5	members appointed under
1	individual who cooperates
1	drugs. (3) persons
3	established by section
1	purposes of forfeiture
1	675, 411, as
1	state officials engaged
1	priority review, as
1	(d) any statement
1	intended, alone or
2	person who would
1	adequate warnings against
1	kept in strict
1	necessitates the use
1	1989, the president
1	prescribing of controlled
1	treatments (a) in
1	drug for any
2	kit is assembled
1	implant, in vitro
2	prescription pursuant to
1	judicial affirmance of
2	numerical identifier is
1	shortage may occur
1	requested; or (ii)
1	commerce by motor
3	assigned pursuant to
1	received, notification made,
1	
 642. recordkeeping
1	agreement on methods
2	right to introduce
1	postmarket studies the
1	records under such
1	permitted entry in
1	262].  (l)
6	secretary.  (b)
1	 (6) response
1	holder within such
1	effectnotwithstanding any other
1	finds is being
1	transaction or subsequent
1	variance request if
1	poultry, capable of
2	distributed without charge
1	causes another party
1	record as required
2	chapter shall prohibit
1	motorists.truck stop means
1	civil forfeiture proceeding
1	treasury may issue
1	evaluations which he
1	material fact exists
1	prescribe, to the
1	conduct a comprehensive
1	(iv) under subparagraph
1	substance.  for
1	talent costs, consistent
2	foregoing is true
1	detect such a
1	product expertise in
1	security of detained
1	inspection services; refusal
2	regular customers or
1	registration of additional
1	made a careful
1	contents thereof have
1	subchapter, all proceeds
1	additive, a color
1	device by its
2	requirement the director
1	drug free. a
1	increase for the
1	availability of records
2	continues to exist
1	area clearly identified
1	(2) hire, promote,
2	product involved malfunctioned,
1	comparison of the
1	manner on its
1	analyzed for compliance
1	years 2010 through
1	products, all little
1	enter a pretrial
1	675, 713, as
1	among young people
1	require; and during
2	aimed at underserved
1	1.6 percent of
1	secretary, permit the
2	contract in the
2	title who is
1	delivering such new
2	additional penalties any
1	(
 
 1701.
1	submits the assessments
2	part thereof) for
1	abuse potential 
1	humanitarian device exemption
1	fascioliasis. (i) human
1	year 2008 shall
1	device to 
1	poultry products derived
2	drug administration costs
1	contain any untrue
1	pay application fees
1	days; (ii) the
1	section 1046 of
4	user fees for
6	believe that any
1	change the status
1	(3) adjustment factor
1	 (a) copy
1	substances signed at
2	annual report submitted
2	determination, the secretary
1	(aa)  (aa)
1	generalevery person who
1	adjustment). the reports
2	records, files, papers,
1	manufacturers the secretary
1	consumption of, or
1	laboratory testing to
2	act (27 u.s.c.
1	disseminate model plans
1	period required by
4	misbranded if at
1	meeting, the secretary
1	(b) assurances beginning
1	without interruption or
1	paragraph (1)(c)(ii), shall
1	remedy.  (c)
1	4.0d  
1	stakeholders may present
1	
 
 143.
2	title to reclassify
1	required, and (v)
3	petition was referred
5	restrictions notwithstanding any
1	language spoken by
1	revocation of quotas
1	showing a photograph
1	1175. transferred
 

1	title; (4) for
3	subchapter, subchapter ii,
1	place shall at
1	determination (61 fed.
1	selection of animal
1	ordering the applicant
1	national policy (a)
1	causing or facilitating
1	study required by
1	otherwise failing to
1	(i) the statement
1	advice to manufacturers
1	instituted and maintains
1	person develop for
3	(ii), (iii), or
2	agency described in
2	reports are required
1	agency action for
1	audit reports with
2	parties, may establish
1	6 months thereafter,
7	necessary, the secretary
1	as, but is
1	 (iv) an
1	clause if, during
1	permanent order adding
3	drug or drug
1	fees fees collected
1	facilitate the inspection
1	 (i) considerationsin
1	term medical food
1	exemption will not
1	 (b) grant
1	deems adequate; (3)
1	applies standards for
1	general may, upon
2	protection of consumers.
1	methods of farming
1	subsection (1), or
1	established name as
2	consideration, to file
1	(a) animal or
1	person means 
3	832; 
 

1	effectiveness at reducing
1	penalties, or accrued
1	section 379i(8) of
1	exemption meats and
1	populations; or (iii)
1	loss of public
1	(c) the bulk
1	(3) priority of
1	receives information that
1	(2) to attorney
1	effects of current
2	(iii)no damages. 
1	drug arising from
5	drug product the
1	shall intensify and
1	review process, any
1	placed, such term
1	regulation. (4) procedurein
1	secretary, after taking
1	reasonable manner. 
1	hold, manufacture, distribute,
1	months, fiscal year
1	practicable, in carrying
1	on, through, or
1	trials of a
1	licenses for special
1	4 years, evaluate
1	notification contain the
1	registered principal place
2	guidance document issued
1	government concerned, as
1	secretary shall engage
3	sale or distribution
1	deemed a final
3	drug by an
2	means a chemical
17	effective on the
10	findings of the
4	drug supply chain
1	appropriate federal departments
2	prescription drugs and
1	attempts to do
11	subsection (b) is
1	combination product, such
2	(ii) a lif-threatening
3	penalties for third
1	forms known to
4	period not to
1	postmarket modification of
1	reason of one
1	web site or
2	reduced exposure to,
4	tobacco product, and
1	patients and shall
1	perpetrator of the
1	completed by june
1	paragraph (2). (c)
1	quarterly fee amounts
1	studies or trials
1	except that until
1	another food. 
1	
 
 353a.
1	laws means 
1	order stating the
1	determination for purposes
1	shall begin only
1	 (2) purposethe
1	targeted direct hiring
1	furnishing in good
1	determining the -year
1	inspecting or sampling
1	relationships that will
1	(d) boobytraps on
1	approaches to harmonizing
3	chapter 51 and
1	container too small
1	8301 et seq.];
1	title or description
1	youth has more
1	(ii) all information
1	drugs if such
1	product discussion (a)
1	(iv) the morbidity
2	health or fails
1	provided; (ii) the
1	decision; or (iv)
1	address, town, state,
2	use or similar
1	patient; or (ii)
1	(i) not be
5	discussions with representatives
2	pilot projects in
1	states pharmacopoeia, the
1	prepared for or
2	prohibition under federal
1	section alters the
1	national treatment outcome
1	subchapter; (2) possesses
1	(c) limited confidentiality
1	manufactures the biosimilar
5	secretarys estimate of
2	health care practitioner
1	giving away, or
2	promptly review and
1	raw materials, materials
1	unapproved product has
1	interest of patients.
3	(b) are adjusted
3	product fails to
128	accordance with the
1	a-large members with
1	organization respecting the
1	shall conduct exercises
2	timeframe for completing
1	third request for
1	(n) coordination of
7	(i) quarantine such
1	additional evidence needs
1	(g) determinations not
1	group of chain
1	u.s.c. 392(a)), the
1	relative aggregate amounts
1	clause (ii); and
1	chapter to establishments
2	procedures, practices, and
5	limited to the
1	factors, that the
1	section, each high
2	report, no later
1	sport in which
1	(ii) recognizing the
1	misbranded food no
3	designation  (1)
1	transferred. (c) a
1	thereof, within the
2	reports.  (3)
17	entry into the
1	advisory committee individuals
1	consultation prior to
1	final regulation issued
1	grant.  (c)
1	litigation or to
1	access policy required
1	(a) generic drugsbeginning
4	(ii) the sponsor
1	food facility that
1	
 
 346.
5	findings upon which
9	chapter 37 of
1	species that is
1	 (e) availability
1	745a, as added
1	commission notifies the
1	shall be collected.
1	subparagraph (a) after
1	records respecting the
2	outreach, education, and
1	technology; (b) the
1	360(k), 360c(f)(2), or
1	transactions by a
1	 (1) internal
1	upon examination and
1	
 384e. recognition
1	section 350(c)(1)(b)(i) of
1	domestic use or
17	united states from
2	(ii) relating to
1	person inspects under
1	identification under paragraph
1	1981. of the
1	revised plan or
1	conditions). (ii) this
2	1992, had pending
1	2011.  (

1	meat inspection regulations
1	animal drugthe terms
1	(2), in any
1	regulated under one
1	standard. (june 25,
1	food is sold
1	cosmetics because of
1	functional in the
1	paragraph (3), with
2	(4) serious adverse
1	commerce. any article
1	(e)confidential information. 
1	states in violation
1	national interest, address
1	supplement labeling exemptions
1	(18) smokeless tobacco
2	submission of request
1	limitation, would achieve
3	prior convictions for
2	training to very
1	means a dietary
1	tobacc-related diseases and
1	agency shall not
2	collect a reasonable
2	clauses (iv), (v),
3	managerial or executive
1	review of civil
1	sign. such printed
2	failure to obey
1	fiscal year, respectively,
1	youth shall have
1	services, funds, facilities,
2	of, a substance
1	omitted
 
 113.
2	composition of such
1	composed of food
1	withdrawal, suspension, or
2	salts or isomers;
1	(d) exclusionssuch term
1	regulations that 
1	amending any standard,
3	employed by any
1	$50,000,000 shall be
1	fee by multiplying
1	years; plus (iii)
1	(1), except the
4	applicant that makes
1	order; (b) is
2	fee from each
1	
 1533. information
1	856[3] of this
1	thereafter, on libel
2	analytical methods to
2	dispensed by filling
1	order declaring property
1	country, regardless of
1	priority the action
2	findingscongress finds the
8	position of the
1	 (2) unauthorized
1	administrative costs. (

1	waters, continental or
1	letter was issued
1	total revenue amounts,
2	said period, and
1	2011.  (7)
1	(d), (e), (i),
2	secretary shall confirm
1	investigators supervision and
1	pharmacist has complied
1	sunscreen monograph 
8	20 calendar days
2	available for a
1	device under expanded
6	optical and geometric
1	continued, terminated, or
1	fair and equitable
1	manner and adjacent
1	ch. 756, 2,
1	sentence, the employees
1	subparagraph (b), unless
1	regulation, to dispose
3	shall review each
1	public, in an
1	humidifies tobacco leaf
1	holder for the
1	physicians. any such
1	application shall constitute
3	costs of such
88	determined by the
1	 (2) authorityif
1	(5) guidance not
1	(not to exceed
1	package or device
5	results in the
1	exempt any individual
1	360bbb3b. products held
1	trafficking activities of
1	regulated sellers under
1	year 2007; (2)
1	place such application
1	results required to
1	amended aug. 27,
1	first applicant for
1	or, in case
1	imported meat articles
1	third parties, including
2	(a)(3) shall be
2	trade secret information,
20	misleading in any
1	techniques.  (b)
1	(
 
 1038.
1	expenses as a
1	feed, and one
1	predict lon-term clinical
3	identifier in a
1	(b) an organization
2	necessary software and
3	trafficking area, or
1	ammonia (a) definitionsin
1	federal cigarette labeling
1	affiliates, and that
1	conflict between that
1	809, as added
1	360e(b)(2)(b) of this
1	magistrate judge who
1	based on amounts
2	determination of condemnation
1	penaltiesexcept as otherwise
1	diseases.  (d)
1	section, and no
1	
 1194. repealed.
1	subparagraph (1)(c) or
2	section 360e(f) of
1	(ii) if applicable,
1	holding for sale
1	restrictionsan amount paid
4	national association of
1	sale; (4) any
1	379d1. conflicts of
1	industry representatives; and
2	health, including such
1	action, the court
1	vehicles; (d) information
7	331 of this
1	law.  (mar.
1	safety in a
1	adverse physiological or
1	(d)(4), (e)(1), or
1	undermine the safety
6	among other relevant
1	seller who in
1	ch. 675, 746,
1	states may result
1	licenses, memoranda of
1	import ephedrine, pseudoephedrine,
1	(d) limitationsthis section
1	document, or study
1	(and before submission
3	likely to ensure
2	liability law nothing
1	symbol rx only.
1	objectives and mechanisms
1	proposed rulemaking 
1	recommends, or suggests
1	product listeach person
1	disclosure informationeach online
1	plants; and (7)
1	intended, the secretary
1	chemical, and physical
1	may not send
1	regulation to be
1	hold. (h) release
2	records pertaining to
1	policy.  (b)
1	identification devices authorized
1	actions against biomaterials
1	applicable; appeal no
2	material facts, such
1	otherwise authorized under
1	forgery, deception, or
1	(1) he violates
1	(1).  (c)
1	records and lists
1	assistant to treat
2	guidelines in place;
1	possession (a) unlawful
1	capable of conducting
26	purchase, or trade
1	secretary of intention
1	samples. records and
10	extent that the
1	represented as meat
1	 (3) guidance
3	add a drug
1	(6) eligible entity
1	additional actionsin addition
1	forces receiving any
1	 (b) policy
1	published as a
1	investigation.  (12)
1	drugs or categories
4	(a) for purposes
1	(including native hawaiians
1	(1) unless the
4	internationally recognized standard
1	contain the consent
1	secretary having made
1	secretary), taking into
1	355c(b) of this
1	 (1) responsible
1	
 875. administrative
2	federal regulations, or
3	physicians and other
1	government, may not
1	successor standards). the
2	rules and worker
1	rule regarding alcoholic
1	basis: provided further,
2	applicability of other
2	enter into cooperative
8	accurate statement of
1	datethe annual biosimilar
1	tobacco product) to
3	subpenas for witnesses
1	governments with high
1	plan and timeline
2	activities means the
1	defeat the restrictions
1	attorney that facts
5	section; and (b)
1	notice to public
1	countermeasure sponsor or
1	conformity or having
1	small businesses, to
1	community assistance at
1	dependence, including smoking
1	containing a primary
1	report with respect
12	secretary to be
1	determines is sufficient
1	products is maintained
3	certificate means any
4	particular use or
1	appropriate, to accompany
1	secretary to amend
1	(viii) establish policies
2	personnel action alleged
1	title. (i) the
3	prior to their
1	animal to him.
2	requirements:  (1)
1	methamphetamine use; (b)
1	 (1) serve
1	particular use of
1	
 364. repealed.
1	(h) the giving
1	slaughter.  (b)
1	eggs), sour eggs,
1	judgments the judgment
1	controlled substances who
1	amending the final
2	date of notice
1	section 355(n) of
1	inspected under said
1	june 30, 1975.
5	purpose of determining
1	processes saleable or
1	states with respect
1	regulations; violations; exemption
3	feed and its
50	new drug application
1	(2) $20,000,000 for
1	application for licensure,
1	finalizes the regulations
1	cosmetic in such
1	section and adequate
1	testing which necessitates
1	medical devices in
1	guidance, or practice,
11	control of a
1	packages, holds, exports,
1	seized be placed
1	(5) an assessment
1	registrant subject to
1	draft guidance. the
1	respect to imposing
1	preliminary order shall
1	medical devices is
3	case be deemed
1	(i) to establish
1	(a) take such
3	safety of food,
1	510, as added
2	manufacture within any
1	hig-risk foods. foods
1	chemical products, the
2	forfeit to the
1	functional value to
1	groups.  (f)
2	transacts business, and
2	distributor, having a
1	(ii) preventing additional
2	drugs manufactured, prepared,
1	term first applicant
1	section. as part
1	(a) timing, contents,
1	sooner than one
2	device should be
11	establish and maintain
1	imposing restrictions on
2	least 30 days
3	effect, the applicant
1	processes for verification
1	purposes of importation
1	retention and disposal
1	therefrom), fiber, oil,
1	years, for inspection
1	establish policies, including
3	pediatric population. 
2	person a written
1	 (l) effectiveness
4	parts for medical
1	tests the secretary,
11	distribution of such
2	funded drug enforcement
1	reporting is required:
1	tobacco users; and
1	names for catfish
1	consultations carried out
1	5. (i) actions
1	program framework 
1	reg. 4461945318 (august
1	secretary on, part
1	void, prevent, or
1	submissions is available.
4	chapter, to cooperate
1	animals prior to
1	commerce; (15) in
1	chemical control laws.
2	drug, such person
4	relative to the
1	(a) information concerning
1	section 360b(b)(1)(a) of
3	secretary during the
1	(b) enter into
1	congress observed a
1	term establishment subject
3	use, the secretary
1	interested person, may
1	since 1997. (o)
1	misbranded; (iii) the
1	accredited person with
1	(each by established
2	information or any
2	misbranded solely because
1	 (b) classified
1	(2) applicability the
1	secretary may incorporate
1	registration to dispense,
1	fee collections notwithstanding
5	device and the
1	provision of law.
1	(c) nonapplicabilitythe foregoing
1	concept and use
2	rem; libel of
4	adverse decision under
1	additive is found
1	certain cases of
4	submitted for such
1	sources and subsequent
1	transportation under this
1	policy (a) establishment
2	carry firearms; (2)
1	milk. (aa) the
5	section to a
1	correctness of records,
1	 (1) work
51	director of the
1	(g) exclusions from
3	determination has been
1	hundred thousand and
1	intelligence and predictive
2	summary description of
1	states, not legally
1	operation and that
7	secretary of any
1	strategy developed and
1	person employed intermittently
1	drug under review
1	coca, cannabis, and
3	use patent which
2	year established in
1	law; (e) a
1	years unless otherwise
1	tests (including tests
1	(1) compensation and
1	passed a tuberculin
1	paragraph (1)(a)(i) for
2	first submitted for
6	applicable, of such
1	practitioners to provide
1	may establish a
1	community; (c) 
1	territory the secretary
1	process of manufacturing.
1	purposes of subparagraphs
1	tetrahydrocannabinols. (18) -methylmethcathinone
2	standards and plans
1	records of hearings
1	small quantities for
1	patients health condition
1	chemical will unavoidably
8	strength of the
2	marketed tobacco products;
1	director concerning drug
1	262(i) of title
1	emergency or material
1	882(c)(6)(b) of this
1	marketed tobacco products.
1	requirementsthe sponsor of
1	promotion of scientific
1	period is agreed
1	verification of identity
1	(d) and (j),
1	subchapter ii. (

1	change that 
12	may provide for
2	device, and (iv)
1	extramural research and
1	racemethorphan. (21) racemorphan.
1	no-prescription drugs with
1	indicus, conium, cannabis
1	population antibacterial and
1	national strategies. (b)
2	section 1.227 of
2	plea of guilty,
2	drug is or
1	corporation shall prepare,
1	 (b) withdrawal
1	humans which is
1	certain tobacco products
1	subsection (i)) have
1	drug crises and
1	section, relating to
1	means a physician,
1	secretary (relating to
1	penalty between multiple
2	milk and cream
1	commerce to which
1	355(i)(3) of this
1	reaccreditation request upon
3	drug, evaluated together
2	becoming a component
1	product to reduce
1	encryption technologies; and
1	(3) drug abuse,
1	modify, reverse, or
1	fees an animal
1	897.30(b), if any,
3	controls required by
1	united states. (aug.
1	removing the exemption
1	times, upon notice
1	2002, to maintain
3	(b) condemnation or
1	(1) approves an
1	24. omitted
 

1	evaluations provided by
1	general members of
1	entry; (f) the
1	shall ensure uniform
1	ch. 675, 410,
1	data and information);
1	submissions during such
1	within the human
1	mechanism is in
3	shall begin with
1	products. no such
1	engaged.  (l)
1	narcotics trafficker the
1	section 453(g)(8) of
2	 (b) gao
1	stat. 1045.)
 

93	(as defined in
1	 (ii) ensure
1	order or a
1	seq.) or chapter
1	hig-risk foods 
1	without requiring direct
4	claim of patent
1	application, be subject
1	plants under this
1	
 
 1116.
1	labeling is neither
1	countermeasures approved, licensed,
1	rea-time supplement, or
1	may reasonably require
1	egg products distributed
1	(c) upon conviction
1	include an opportunity
1	findings, on the
1	 (5) commerce
3	receives a grant
2	substance in a
1	contract proposals under
1	patent or in
2	revised draft guidance
1	(d) classified report
1	name for any
1	resale, and, if
3	 (b) identification
1	upon the public.
1	expedited approval of
1	products to such
2	(ii). in such
1	services does not
1	export act (21
1	position of management,
1	 (i) cigarettes.
1	
 1708. national
1	2013, establish a
2	appeal to the
1	notice requirements of
2	642, 643, or
1	958. registration requirements
2	authority, or within
1	subparagraph (i) (including
1	additional credentialing bodies.
1	person with intent
2	receiving the request,
1	restoring areas affected
2	application, but not
1	injury associated with
1	(2) trade secrets
1	manufacturer, the attorney
2	patent had been
1	panel, and notify
1	(i) not include
2	programs and between
1	apples in interstate
1	altering the requirements
1	demand reduction, a
1	infants and childrenin
1	person shall agree
1	 (5) limitation
1	development of innovative
1	appropriations acts. (d)
1	fee amounts 
1	(c) are not
1	damages should be
1	(7) the effectiveness
2	product tracing system
1	regulation require the
2	(ii) provide a
1	basis. (2) before
1	january 1 of
1	(15) psilocybin. (16)
1	action should be
2	authorize the approval
2	food ingredient that
2	provided, that, to
2	control notice to
4	exempted by the
1	use and likely
1	(i) in accordance
2	youth in communities
2	substantial compliance with
1	benzyl cyanide. (c)
1	 (g) exemption
1	per annum, to
1	title sections 360fff1
1	report, the changes
1	center to undertake
1	respecting devices (a)
1	antimicrobial resistance). (2)
1	scientific fact, information,
1	political purposes, or
4	shall be transmitted
1	nonliquid formswith respect
2	(5) an order
1	
 360j. general
1	general as being
2	protection act [7
1	penalty of $1
1	foreign intelligence information
1	timely accessibility of
2	limited quantities of
2	(regardless of when
1	than, or in
1	undertake those ris-based
1	power, in connection
1	importation; (2) when
1	products (including blac-box
8	notification under subparagraph
2	specific actions to
1	general shall maintain
1	regulation listing a
2	diseases relevant to
10	incomplete and shall
2	begins after september
2	authorities, if any,
2	submitted before the
3	207 of this
1	described as a
2	members who are
1	sel-certified in accordance
11	paragraph (1) with
1	drugs that present
8	course of their
1	(b) director of
1	responsibility to direct
1	chapter.  (l)
1	human african trypanosomiasis.
4	promulgating a regulation
1	(h) the agricultural
1	persons (a) in
1	united states depend
1	foundation the purpose
1	listing color additives
4	plan  (1)
2	combination product described
1	registrant under section
1	correspondence or by
1	 (i) guidelines,
1	knowingly provide false
2	(b) notify the
1	years under the
1	community; (b) describe
2	(including when scheduled
2	entice, or coerce,
1	review is used
4	information was filed
1	decision directive 42,
1	likelihood that illegitimate
1	derived from all
1	online pharmacy offers
2	covered under this
1	(1) was not
1	january 10, 1997,
1	syrup that is
2	method, or type
1	state agencies. (c)
23	animal drug product
3	criteria under subsection
1	completed, records of
1	maintain, and equip
24	review by the
1	court decision. in
1	additive as defined
1	records of account.
1	installments payment under
1	corporation, or association;
2	approved drugs, including
1	determined under clause
1	17th par., 34
1	shall consider scientific
3	of, such service,
5	territory not organized
1	(e) the new
1	level, not later
1	countries or regions
2	states standards. 
1	modifications to manufacturing
2	section 379g(3) of
1	level that ensures
1	2008; (3) $260,000,000
2	supplements in the
7	within the district
1	designated agent at
1	maintenance of files
4	year that the
1	(i) worked for,
1	manufacturers to preserve
1	(e) anabolic steroids.
2	products prepared for
1	part of[2] chain
3	colorings without naming
1	substantially complete applications
1	pipes; (10) ai-driven
1	foreign facility subject
1	aggregate amounts of
3	term qualified infectious
1	requires a unique
1	content, delivery, and
1	pet food recallsnot
1	subsection (b)(1). for
1	form, is not
1	describes the results
2	circumstances is held
1	prevention; (d) key
1	poultry or process
3	probability that a
1	drug code number,
1	chamber pipes; (8)
1	shall remove susceptibility
1	establishment to bear
6	drug application subject
1	delegated. the secretary
1	information on biosimilar
4	complies with section
5	shall not apply.
2	unless he has
2	prescribe a uniform
1	eggs or filtering,
1	section 8 of
1	(h), and (p)
1	subpenas the united
1	process of reviewing
1	sponsor to resubmit
1	in, or who
2	 (1) identify
2	term substantially equivalent
2	renewal grants the
1	(7) chamber pipes;
6	secretary may reasonably
1	expertise relevant to
1	measures; (c) communications;
2	court shall proceed
3	title, and (ii)
2	device (including, where
2	distributed, dispensed, or
1	single point of
16	poultry or poultry
1	said can, tin,
1	devices the secretary
1	interstate commerce, during
1	drinking water. the
3	proposed product development
2	filed for review
2	respect to controlled
1	tobacco products manufactured
1	confidence in the
1	panels recommendation and
1	et seq.); (3)
1	age, other than
1	supplement if the
1	award to any
3	wholesale distributors, and
2	priorities and the
1	influence his official
1	review; (d) that[1]
1	health of a
1	judgment the court
1	opium. (2) not
2	residing in the
1	facility, the facility
1	revising the label
2	retail food establishments;
1	services, a material
2	advice on scientific
1	subparagraph is available
1	notice of determinations
1	format; and (ii)
1	deposited in court)
1	framework to a
1	period; and (2)
1	labeled effectiveness, except
1	protozoa, algae, and
1	programs. in the
1	statutory constructionnothing in
1	products.  for
1	samples made on
1	3-day notice means
1	two officers or
1	pesticide information (a)
3	commercially marketed (other
1	establishing automatic electronic
1	available disposal sites
1	(k) for fiscal
1	(b) is increased
1	including manufacturers and
1	opium and opiate,
1	advisory panel consisting
1	(4) offset any
1	animal drug unless
1	production after an
1	means a period
1	safe tolerance for
1	processes, packs, transports,
1	challenge testing. (iii)
1	sold and is
2	validation (including a
1	customary or usual,
1	customary or usual.
2	application or reinstate
1	product disagrees with
1	likelihood of resulting
1	order, but not
2	require the sponsor
1	rule is promulgated.
1	investigational tobacco product
1	reviewing divisions, including
1	(4) on its
1	requests granted pursuant
1	update such protocol
4	assure compliance with
1	make and retain
1	prepared or packed
11	notice described in
5	(b) a drug
1	(iv) any hearing
1	available a copy
5	costs funded by
1	lawfully imported under
1	subparagraph (b), information
1	pasteurization and labeling
1	data fusion, advanced
1	public, any person
2	authorization may not
1	sale thereof which
2	may transfer the
1	manufacturer and is
1	(c) appointed members
3	drug complies with
1	health; and 
1	effective.  (5)
1	counterfeit any coupon.
1	health.  for
1	and, based on
3	amendments to the
2	section 3(a)(1)(b) of
3	consideration by the
2	food, or in
1	substance, notify the
1	(d) for use
1	set aside. a
1	benefits of such
1	sale to post
2	(2) has been
1	applications involving combination
1	additional physical examination
1	effective enforcement strategies
1	acceptance for advisory
3	civil penalty may
2	finalized under subsection
1	(1) regulations under
1	reporting information under
1	ensure uniform nomenclature
1	for, the production
1	eligibility; and 
1	animal drug; or
1	(d) $1,000,000 if
1	nonvoting members the
2	article may be
1	issued to that
2	overdose of the
1	part to deliver,
1	(c) evaluate the
1	objectives within the
1	by, or refusal
1	consumer unless the
1	(b) user reports
1	(ii) the timeline
1	located upon petition
1	appropriate. (3) purchase
1	coca[3] leaves, except
5	articles used as
1	strategy for drug
1	8961, shall promulgate
1	device, (b) an
1	intramural research awards
1	factors.  (d)
5	fiscal year because
1	association, corporation, organization,
1	dispenser to fulfill
1	date.  (2)
1	containers of cigarettes
1	reauthorization performance goals
4	exemption for the
1	members and caregivers
5	percent change in
1	 in prescribing
1	among public health
1	1044 of this
1	procedures and techniques
1	dose packets or
1	drug application. (i)
2	strategic plan described
1	(ii) complete response
1	food listed under
1	notifier and the
1	method.  (b)
1	youth such as
1	establish one or
1	contains an antimicrobial
1	infringement of a
1	public nature of
2	tobacco products manufactured,
1	concerning, for all
1	strategy under subsection
1	management of the
4	parking lot appurtenant
2	united states standards.
2	primarily intended or
2	term drug product
2	association, or any
1	sent promptly to
13	due notice and
1	ensuring adequate information
1	businesses; (b) develop
1	funds under this
1	research, investigations, studies,
1	any, or have
5	use described in
1	federal register, the
1	section 360eee3(a)(1) of
1	order violations the
1	anticipated or actual
1	approvals under subsection
1	degradation product of
1	written inventory of
1	requests and pediatric
1	
 
 610.
1	(d), any biosimilar
2	names, and other
1	racemic drug. (3)
4	refused admission under
1	section 360fff3(c) of
2	may cooperate under
3	misbranded and are
4	secretary shall encourage
1	petition or about
1	anabolic steroid, the
1	process improvements in
1	imprisonment, a fine,
1	united states owing
1	standards that would
2	products, or other
1	-(-hydroxycyclohexyl)phenol with substitution
1	
 467a. administrative
2	fails to contain
1	parasites, allergens, and
1	resulting product is
2	admission of such
1	data submission and
1	submitted, the number
3	(relating to risk
1	be, until released
41	provided in paragraph
2	product to include
1	data constitute substantial
1	(2) total fee
1	drugs available for
1	points out of
3	federal funds available
1	livestock shall be
1	communication planthe risk
1	512, or 571
2	means the occurrence
2	submissions in condition
1	means the shell
4	(ii) making a
1	prevention and early
5	grants or contracts
1	regulations except as
1	collected during star-up
1	necessary regarding the
6	using such drug
1	agency the agency
1	means a new,
2	advers-event reports and
1	including differences in
1	(
 
 2223.
1	documented a highly,
1	clinical or scientific
1	declares the presence
2	(a)  (a)
1	strategy in effect
2	veterinarian, the drug
1	respect to gamma
1	goals established by
1	person. (k) such
1	protocol approved by
1	section or to
1	november 1, 2007,
1	determines, upon application
1	date and authorized
1	374. inspection (a)
4	supported by the
1	first ordering the
1	products.  (5)
1	privileges of employment
25	taking into account
1	credit corporation. (c)
1	sentence. (d) in
1	term cigarette in
1	illness from such
1	commodity that were
1	recall shipments of
1	contains the lactose,
1	(g) violations regarding
1	best accounting practices.
1	 (2) collection
1	chemical, or other
3	applicant to distribute
1	mental faculty. 
2	will be received
1	
 
 356d.
1	eligible entity, subject
1	certification, but in
3	assessment described in
1	(g) suspension of
1	blood, blood components,
30	reason to believe
2	(other than being
1	capacity to produce
2	electronic tracing of
1	subsection (a)(4) (relating
1	determination, post the
2	subpart j of
1	administrator shall make
2	 (2) records
1	taken under subsections
1	collections for such
4	make available for
2	(i) the compliance
5	secretary determines necessary
1	annual opportunity for
1	variance is requested
1	350e, 354, 360bbb3,
1	federal register following
1	allergies to school
1	drug, (ii) information
1	(3) bears or
1	make summaries under
1	part, including section
1	
 379j43. reauthorization;
1	biological systems; (6)
2	(c) with respect
1	recommendations for modifications
1	labeling requirements and
3	processor, without providing
1	promotional materials under
1	recipient from the
1	senate a report,
10	narcotic drug in
4	regard to whether
1	(a) was introduced
1	made after opportunity
1	notice, the attorney
1	chewing gum, and
2	section 3717 of
1	leaders in the
2	state public initiative
1	may, by law
1	policies under subsection
1	egg products to,
1	activities may include
4	drug application is
2	shall give high
1	grant such exemption
2	direct ownership of
1	 (a) 60
1	 (2) facility
1	$1,000, or both,
1	liability for suppliers
1	drug use, availability,
1	(k) certification from
1	testing under subparagraph[1]
1	stipulate within a
3	agriculture or the
1	local activities and
1	(b) drug possessors
1	agent identified as
1	access the results
1	casein.  cretinol
1	first initiation of
1	internal committee shall
1	investigation of events
1	secretary. (4) definitionsin
1	enforcement of controlled
3	(e) withdrawal of
1	meet current good
2	(m)(3) of section
2	208(a) of title
1	section as may
1	officials employed pursuant
1	quotas for registrants
1	distributor who violates
1	detection;  (2)
1	night, whether the
1	additional investigations to
2	510(k) for a
1	qualification of technical
2	recommendation respecting approval
1	unlawful acts; penalties
8	shall be destroyed
2	unless any period
1	purpose or purposes
1	regulations); (iii) an
1	making application therefor
2	title by the
2	notification publicly available.
1	 (j) definition
1	work more closely
2	trials in order
1	federal agencies (such
2	health status of
1	statement office use
1	fatty acids (linoeate):
1	(c)(1)(c), and (e)(1)(c)
4	petition, the secretary
1	drug has only
1	(e) fee for
1	designated by him;
1	100 grams. (3)
2	verification from an
1	shipment, and penalties
1	mutual recognition agreements
1	dispenses, in the
1	 (b) appropriate
1	additive was from
1	use of report
1	seafood safety and
1	premix is in
1	secretary within one
1	title (except when
1	lif-threatening infection in
3	device, or a
1	person, firm or
1	purchaser, the name
1	(1)(a) were conducted
1	applicable except as
1	bylaws for the
1	work for the
2	user fee program.
1	association, within the
1	associated with development
1	production control of
1	commerce the new
1	removals and corrections
1	-year terms. a
1	seafood facilities inspected;
1	wrapper which bears
1	secretary conducts such
1	annual awards a
2	foreign country. 
4	section 343(a)(2) of
2	establishments that manufacture,
1	centimeter exceeds three
1	findings, conclusions, and
2	food manufacturing, processing,
1	except that where
1	use or any
1	notice, after consultation
2	evaluations of state
1	funds; (iv) establish
1	proceduresthe attorney general
1	drug establishments) in
1	unless an indictment
1	3, formerly 1st
1	standards and technology
1	legitimate needs of
1	actions; judicial review;
1	including 1 or
1	average), for the
1	states, managing ports
1	results data bank
1	notification. (l) exemption
1	payment the complete
1	annual review under
1	(1)(g)(iv), the notice
1	35 stat. 254.)

1	importer with the
4	requirements under paragraph
1	confectionery which is
1	(c) systems and
2	violation; and (ii)
1	11, 38 stat.
2	descriptive printed matter
1	initial funding if
2	carries on business
1	institutions, practicing clinicians,
2	(not including production
1	(3) requirements for
1	secretary to retain,
1	assay in accordance
1	(b) prior approval
1	1, 2017. 
2	costs.  (d)
1	states, but does
1	chapter by reason
1	thefts in the
1	conform  (a)
1	sel-certification including a
1	generalthe strategy shall
1	new approval of
1	number, notwithstanding any
1	
 384d. accreditation
1	administrative costs of
1	subparagraph is impracticable
1	require any pharmacy
1	(1) for such
1	quantity delivered, the
1	filed and approval
9	specifically excepted or
2	thereafter shall be
1	become effective 120
1	exceed $10,000. (c)
1	temperature controls, animals
1	
 
 321d.
1	official monographs of
2	shall increase the
1	purposes or applications,
1	shall submit with
1	360e(d)(1) of this
1	notification requirement to
1	exposure is safe.
1	states of milk
1	contributions of the
1	exist justifying the
4	modify, or remit,
1	subsection (b)(2). (d)
1	context otherwise indicates,
1	disclosure to appropriate
1	1999.  (3)
2	interested persons an
2	abuse among youth,
14	shall publish a
1	change. (3) certain
1	using electronic communication
2	chemical offense chargeable
1	247d7e, and 300hh10
2	committee shall, after
1	opaque material (except
2	drugs, biological products,
1	(4) certain sites
1	committee to ensure
1	
 1605. procedures
2	medical purpose within
1	(which may be
1	constituent part of
1	purposes. the term
1	247d], except that,
1	detect the adulteration
1	section 957(b)(2) of
1	tolerance prescribed for
1	shall file them
1	(1) provided, caused
1	animals; and (b)
4	resides, by filing
1	relating to advisory
15	united states as
1	 (d) bad
1	management plan have
1	advertising for fish
1	trafficking and production
1	611. devices, marks,
1	(b) the percentage
1	accordance with 
2	section, receives or
4	listed in its
1	order. no objection
2	amendment in the
2	secretary shall (unless
2	audit means an
1	(21 u.s.c. 801
1	confidentiality of the
1	procedure; conditions; exemptions;
2	provided by designated
2	lot of the
2	legally constituted entity
1	paragraphs (g) and
1	incompatible, such active
3	keep a record
2	(a) authority the
3	may require such
1	ii, any information
1	amending regulations 
1	network members, as
1	resolution if, regarding
1	reasonably appropriate ris-based
1	applicant, withdraw the
1	 (a) conductthe
1	initial benchmark survey
3	business (as defined
1	description of programin
3	repackager that purchased
1	meeting  (i)
3	request for pediatric
2	retail package of
1	aspect of electronic
1	final is subject
1	made by each
2	liable for furnishing
1	scientists and entities,
1	cooperate in the
1	summarizing such evidence,
1	establish an accounting
1	(7) additional criteria
1	(3) a major
1	determined to have
1	justification and supervisory
1	equivalent if the
2	sufficient to meet
1	list of active
2	may be found
2	may, subject to
2	anticipation of market
1	percent to the
1	electronic synthesizer, or
1	providers of components
1	pesticide tolerance requirements
3	authorized under paragraph
1	with, any fat
5	state means any
1	product are not
1	(d)(2) (referred to
4	(a) after the
1	supplement proposing to
1	bylaws of the
1	entity does not
1	otherwise eligible for
1	official government service
1	commerce, or attempted
2	anticipated to be
1	applicant. (c) any
1	(b) exception subsection
2	services with respect
1	smoke constituent) or
2	conspiracy any person
3	regulation promulgated by
1	owner or shipper,
3	paragraph (2). the
1	states owning, partly
2	therefrom into other
2	specific purposes for
6	title 5 (commonly
1	committee) and from
2	(ii) the defendant
2	long term care
2	following standards and
1	planthe initial pediatric
9	secretary of state,
3	term necessary means
2	affiliate of such
8	maintenance or detoxification
1	respectively. (june 25,
1	consult with biomedical
2	food, solely for
3	beginning 4 years
2	substance satisfies the
1	extension, the specified
2	suggests that a
3	review voucher is
1	effectiveness, including postapproval,
2	schedules i, ii,
1	defeat restrictions no
1	distributor for commercial
1	 (1) special
1	appropriate reason for
1	term drug development
2	trends or when
1	(2) illnesses and
1	 (a) lists
1	transferred. (iv) identification
2	date a regulation
1	order, shall request
1	developed. (v) the
1	 (k) detail
1	_____. i verify
3	appropriate scientific and
1	add further analysis.
2	articles in commerce
1	drug such that
1	3 of whom
3	attorney general the
1	revocation of an
1	specifies the maximum
3	received approval under
1	teens who use
1	(e) information regarding
1	 (4) agreement
1	(g)(2); (b) include
1	equine is found
1	regularly review the
2	event report means
1	administrator determines has
1	refer the application
2	available upon request
1	synthesis:  (a)
1	developing research and
4	inspection conducted under
1	387e(i)(1) of this
1	regarding the usage,
3	testimony or other
1	licensure requirements, as
1	subsequent years in
2	establish conditions described
1	upon request, the
1	individual and $250,000
1	agencies that support
1	year 2016 for
1	laws administered by
1	drug is intended.
1	(part), as added
1	request following an
1	governing interagency relationships,
4	 (a) no
1	practice otherwise applicable
1	
 
 1104.
1	them, he may
1	pesticide chemicals could
1	distributors with whom
2	first applicant fails
1	body for more
1	technical expertise available
1	later than 300
2	individual tobacco users;
1	temporarily or permanently.
1	awarding of contracts,
1	priority review 
1	extent conduct with
2	per diem or
2	waste, fraud, and
1	employee (as defined
1	objectionable, stating the
1	foundation and the
1	(7) notwithstanding subsection
1	evidence under clauses
11	official device, mark,
1	-[-(-morpholinyl)ethyl--(-naphthoyl)indole (jwh200); (vii)
1	activities of licensed
1	representing certain organizations
2	sponsor fails to
1	narcotic drugs as
1	abuse issues in
1	preclinical investigations or
1	acceptance as prescribed
1	effect only after
5	paid the fee
1	
 952. importation
1	abuse, may make
1	efficiently reviewing clinical
1	receiving for transportation
1	 (c) limitationssubsection
1	standards in a
1	well controlled investigations,
1	regulation to provide
1	u.s.c. 262(a)]. 
1	person. the secretarys
2	substance (as such
1	seizure (a) grounds
1	part. until the
1	international drug production
1	communicationin this section,
1	(a) and which
1	exported; (8) to
1	activity under contract
1	areas, among the
2	persons and means
1	$149,000,000 for the
1	(f) dengue/dengue haemorrhagic
3	stone, or other
1	comprehensive list of
1	
 379j1. reauthorization;
1	penalty of perjury,
1	except insofar as
1	government. (v) an
1	contraband and seized
1	78.6 percent of
4	refunds the secretary
1	contracted for the
5	(d) of paragraph
1	(i) public meetings
1	media campaign, the
1	commission from among
4	new safety information
1	(2) the development
1	(a) unsafe new
1	drug not considered
2	act of 1947
1	entitled to entry
1	155, 3, 44
2	(august 11, 1995)).
1	prior to marketing.
1	food and recall
1	drug establishment fees,
2	authorization of use
1	including effectiveness data
2	food, due in
1	use and preserving
2	secretary shall, with
2	development of tests
1	information) since the
1	advantage foreig-grown tobacco
1	types, especially such
2	administrator the term
1	panels covering each
1	centers, and other
2	(v) full reports
1	to, and publish
3	accordance with sections
1	destruction of any
1	civil, criminal, administrative,
3	(f) postmarket safety
2	packaging, and ingredients;
4	destroyed for human
1	december 31, indicating
1	adul-only facility a
1	true or representative
2	(i) through (v)
1	expiration dates of
1	nonfat dry milk
1	supply reduction or
1	bringing under international
1	sections 451 to
2	 (i) statutory
1	course of such
45	education, labor, and
3	representation made by
1	submission requirements 
1	milk fat, so
1	allocations of assessment
1	interest with respect
2	(c) registration of
1	status for purposes
1	(4) the commission
1	products are properly
1	strategy.  (4)
4	violates this subsection
1	formulas (a) adulterationan
1	device reclassified from
1	applicants shall be
2	records and reports;
1	land and any
1	pet food. in
1	tests on animals);
1	business; and (b)
1	manufacturing process, and
1	year to make
6	group of drugs
1	governments, as such
1	(12) exercise other
1	title. (5) in
2	transportation, or importation
1	distributor for the
1	preventive controls means
1	ieepa was successfully
2	controlled substances; and
4	facilitate a determination,
1	formally given the
1	activities and services
1	administration 60 calendar
1	technology available or
1	(and subsequent reports
1	meeting, and requirements
1	aggregated data on
2	submissions submitted to
1	100 grams. 
17	eggs or egg
1	authority; scope of
1	reference. (b) 
1	authority and resources
5	effect in humans
1	title and, during
1	(a) and accounting
2	(which may not
2	conspicuously on such
5	effective as provided
1	control activities of
2	may, by notice
1	class other than
1	prior to approval.
1	prior to approval,
1	drug in violation
1	list of participants
1	(b) public health
1	subsection (a)(3) owed
1	perform those checks
2	application fees, generic
1	develop methods to
4	made applicable to
1	scientific or public
8	essential to the
1	states except the
7	substantial evidence of
1	human services. (d)
1	processed food if
1	chair the ex
2	rulemaking published under
2	design validation (including
1	identify the subjects
1	(g) as necessary
1	program agency toward
1	(k) is required
1	laboratories, laboratory networks,
1	controlled substance; (b)
1	appropriate. (f) any
2	processed food is
1	infertile or otherwise
1	center (hereinafter in
1	state, except a
1	testimony of witnesses,
1	report such transactions;
1	years, reevaluate accreditation
4	authorized, whenever he
1	title or licensed
1	proceeds remaining after
1	regulatory efforts. (j)
1	public health. test
1	product under review,
1	means all notices
1	chapter, may be
10	repackager, wholesale distributor,
1	controlled by the
1	enforcement of section
1	supervise an audit
2	investigations, conducted by
1	perform a regulatory
1	hidta funds used
1	plant.  (b)
1	recommending methods by
1	use, any restricted
1	secretary for filing.
2	components intended for
1	investigation into, or
3	application if it
1	beginning 2 years
1	listing of such
7	approval may be
1	intake of sodium.
1	ones already developed
1	risks), particular actions
1	dispenser. if a
1	illness resulting from
1	acid, the essential
1	(d) with the
1	resolve scientific issues
1	disclosure statement that
1	alcohol, tobacco, or
1	$14,100,000; and (7)
1	therapeutic amounts. (5)
1	food whenever in
4	section and sections
2	product applications received
1	upon, a homogeneous
1	360(h)(3) of this
1	 (5) definitions
1	identifier the secretary
1	treasury on any
1	product and which
2	(c) recognition of
1	handled; and the
2	court. upon a
1	guilty, the united
1	800, 1, 69
1	statement not later
1	pediatric epidemiology; and
1	identify the product
10	director shall ensure
12	(1) except as
1	
 
 363.
6	section 2112 of
1	making such assessment
1	shall receive and
2	treat information received,
1	term reprocessed. 
1	authority as is
4	consisting of one
1	directive issued by
1	endocrine effect on
6	collected by the
2	certification may be
2	regulation prescribing the
1	467d. administration and
1	food production after
1	(6 u.s.c. 101
1	subchapter ii the
1	percent. (7) community
1	shall compile and
1	care, would have
1	leaders, to review
1	practices; (c) identifies
1	title shall report
1	subsection. (2) final
1	exceed a 9-day
19	public health. 
1	developing of the
1	milk, cream, cows,
1	antifungal drug approved
6	salts have been
1	morphine, or preparations
1	273, 2, 37
2	costs of oversight
1	identify such article,
2	adjustmentbeginning with fiscal
1	action, the issuance
1	per 100 ml;
1	distributor to the
1	quality of such
1	343(i), 343(k), 343(q),
2	intentional killing of
1	(3) summaries notwithstanding
1	675, 410, as
1	existing approaches such
1	regarding methamphetamine treatment
1	occur, and what
1	additional foods, in
1	products, classes of
4	(i) information to
1	exempt a class
1	42 (which shall
2	local government or
1	medical reason; (d)
1	members as follows:
16	appropriate state agency
1	rate computed in
1	secretary for compliance
1	general of criminal
1	 (b) cas-b-case
1	part or accessory
3	(b) provide for
4	unexpected serious risk
2	meeting all the
1	user, lon-term care
1	technologies used in
2	shall accrue interest,
1	term opiate or
1	within the prescribed
1	convictionfor purposes of
1	analytical method required
1	issued, or on
1	permissible to list
2	representative under section
1	plan is unsatisfactory
3	notification under paragraph
1	effect paragraph (1)
1	made, shall notify
1	manner not in
1	(g) not later
1	rank and status
2	soon as practicable;
4	forfeiture of the
1	tintometer scale or
1	illness surveillance systems,
1	target population; or
1	authorize an officer
1	distributed, or diverted
1	plans for such
1	subparagraph (a). (6)
1	disclosure (a) no
1	active commercial investigational
1	 (3) members
1	(a) with governments
1	assessment of products
1	clause (ii), then
1	components thereof, and
1	may review studies
1	criteria otherwise listed,
1	applicable, was approved
1	receipts of the
1	year 2008 under
1	manufacturers of such
2	less than $500,000,
1	include whole blood
1	behavior during and
2	accredited person the
3	control and prevention
2	(c) is intended
1	inositol (mg) 4.0d
1	postal service for
1	paragraph (or if
1	information collection and
1	written agreement the
1	paragraph, or if
1	materials reported are
1	dosage form means
1	extension, identify 
1	animal diseases or
1	iv, unless he
1	membersthe secretary shall
5	administration, minutes of
3	title and accounting
1	subsection (b)(1)(a) in
9	title 5 or
2	calendar days prior
1	387b(6), 387d, 387h(c),
1	(d) additional authoritythe
1	interpretationnothing in this
1	meat articles. 
1	upon specific request
1	methodology based on
1	serving minority communities.
1	preparations containing not
2	(a). (june 25,
1	food product prepared
1	validation, packing, storage,
3	hearing, but the
1	 (10) final
2	subsections (e) and
1	substantially diminished in
1	date funds are
1	meetings the secretary
2	5.  (g)
2	accreditation of any
1	exempted from a
2	foreign recipient of
1	drugs; and (b)
5	notwithstanding the preceding
2	section on a
1	subsection (c). (l)
1	submitted such request
1	(d) criteriaa coalition
1	annual sales of
1	premarket reviews of
2	warrant authorizing the
1	priority review or
1	identification and traceback.
2	animal drugs proposed
5	medical or surgical
2	attorney general (and
1	paragraph (1)(c) if
1	(a) by an
1	revocation, or denial
3	domestic facility (as
1	criminal charges have
1	provided, that the
1	media campaign (referred
3	subsection (b)(2) which
1	assist in meeting
4	priority review of
1	substances and does
2	utilizes the same
1	food allergens that
3	arrangements and agreements
1	tort system; congress,
5	shall cause such
1	determination in writing
1	paragraph (1)(c) is
1	(c)(1)), the program
1	arrangements (a) cooperation
1	fees; definitions 
1	anabolic steroid. (d)
1	drug samples only
1	title, shall include
1	shall be without
1	special survey as
1	panel the conclusions
1	expert panel; (b)
1	performance goals; termination
1	made. the administrator
2	used to pay
2	fiscal year 2013),
7	 (2) limitation
1	(vi) identification by
1	rate of growth
1	(e) center for
1	device to persons
1	needs exist. 
1	consular officer in
1	title ii, 204,
1	use such form
1	(d) other manufacturing
2	drug and becomes
1	(b) data submissionat
1	(i) professional societies;
1	carriers or warehousemen
1	applicant or holder,
1	beautifying, promoting attractiveness,
1	submitting the petition
1	act; (7) ensure
15	referred to the
4	updated susceptibility test
1	shall provide each
1	
 1908. judicial
2	(1) any felony
2	18 or section
1	ii or iii
1	licensing authority, as
3	rare diseases and
1	advertising by the
1	title; and (e)
2	360d(c) of this
1	issue guidelines that
1	diligence; (b) has
3	issues related to
2	assure the adequacy
1	parties.  (h)
1	 (a) amending
28	(1) the secretary
1	place; (iii) how
2	despite the lack
1	opportunity to recommend
1	that, due to
1	farm), if such
1	(ii), shall be
1	cigarettes, cigarette tobacco,
6	iv, or v,
1	(f) registration of
8	appear before the
1	notices and findingseach
1	damage of the
6	report that is
1	sel-certification that all
2	reduction means any
2	applicable date under
1	(2) for which
1	state agencies over
1	accounting for federal
1	food which are
4	recommendations on the
1	(3) the court,
1	authorization under paragraph
1	continuing basis testing
1	product application, shall
1	final form for
1	1927, the importation
2	satisfactory alternative therapy
1	time, and such
1	review shall include
2	foreign country to
1	action to abate
2	judicial proceedings; notification
2	event is an
1	subsection. if at
1	board positions that
1	venue if any
1	tested as a
1	offenses; punishment any
1	(f) applicationthis section
1	grant of certificationthe
6	(including any patent
1	(2), to approve
1	additive.  (b)
2	section 360ccc(a) of
2	request by sponsor;
2	hig-priority or emergent
1	manufacturing practice compliance
1	rule, the secretary
1	number assigned under
1	ch. 675, 1001,
1	containers; (f) the
3	(1) it shall
1	9 grams, not
1	type styles and
2	action to prevent
2	private citizens and
2	provided, a term
1	(7) homogeneous case
2	exceptions  (1)
1	prescription which is
1	establish at least
1	whole or any
1	title i, 1,
1	package or as
1	available to regulated
1	consequences or death.
1	secretary once during
1	days remaining in
1	within 5 days
2	 (i) on
1	research the report
1	tobacco contains individual
7	(1) through (4)
3	1705 of this
2	 (i) of
3	involving the use
2	means of demonstrating
2	responsible party has
2	leading to a
1	permits to import
5	year during which
1	enactment occurs, the
1	compensation, including civil
1	section 713 or
4	use is not
1	approved or the
1	consent from his
1	crime involving or
15	355c of this
1	management changes needed
1	conducting research on
1	submission of complete
1	completeness assessment by
1	shall confidentially maintain
1	entry or inspection.
2	facilities where the
1	decision immediately upon
1	effective as an
1	continued use after
1	foodborne illness aggregated,
2	 (2) criteria
1	agricultural marketing agreement
1	adequate information on
1	findings contained in
2	(g) provide for
1	product or otherwise
2	paragraph (1)(b) for
5	paragraph (1)(a) or
1	information within the
1	criminal penalty for
1	document that no
1	safely used (including,
1	exchange programs, the
1	development tool at
3	68 stat. 511;
13	shall not exceed
1	condition involved, and
2	 (3) consolidation
1	require, pursuant to
2	paragraph (1)(a) of
1	(21 u.s.c. 392(a)),
1	(d) the quantity
2	 (4) relation
1	except that to
1	available, prior to
1	assessment center; or
9	medical convenience kit
1	establish an official
1	(d) pursuant to
1	(1) enhance the
1	enforcement activities; (b)
1	program of temporary
1	
 379v. safety
1	state where the
1	april 1, 1999,
1	(4) venue any
1	material fact; (d)
1	applicable, under this
1	monthly basis, submit
1	regarding usefor purposes
1	et seq.]. (

1	substance entirely from
1	device;  (14)
2	means a medical
1	manufacturer because the
1	(a) an agreement
1	component of another
1	 (h) vesting
1	site disclosure informationeach
1	expiration date; (vii)
1	youth the term
1	controls, animals in
1	use of dissolvable
14	(b) with respect
1	furnishes a tank
1	clearinghouse established under
1	subchapter, including the
4	commercial or trade
2	information to any
2	confidential access with
1	days is required
1	thereof.  (c)
1	postmarket safety commitments
1	compounded in quantities
11	report of the
2	administration is able
1	
 
 619.
1	2005; (2) all
1	another device under
4	evaluate the performance
2	annual compilation of
1	et seq.]. (z)
1	guidelines issued by
1	order being reviewed
2	et seq.); (b)
1	processes used to
1	means information related
1	indication or any
2	establishment; (2) document
1	subsection (a) (other
1	determine which commitments
1	(1). (iii) each
2	alcohol administration act
1	tobacco, the secretary
1	used. (2) report
1	schedules, and after
1	 (2) interchangeable
1	
 
 360c1.
1	section 1702(a) of
5	fees may not
1	1, 1986), and
1	attempt to propose
1	assess and detect
2	thirty days notice
2	(aa) in the
1	confidentiality and use
1	requests any person
1	reviews of pediatric
1	(2) timing; content;
2	2007, and annually
1	(ii) prosecutions for
1	shall, after giving
5	completion of a
5	period during which
1	prominent than the
1	standard for complainant
1	cause or permit
2	basis following the
1	person; (c) any
1	may threaten the
3	amended by the
1	authority with primary
3	disease product under
1	rules shall apply
5	otherwise affect any
1	general in carrying
1	deem appropriate for
1	background in public
2	implement subsection (a)(6),
1	ch. 901, 1(92),
1	claims, except that
4	dosage form which
5	product, or any
1	(
 
 1403.
1	use as well
1	et seq.], this
2	similar manner, that
1	(c) required statementsthe
1	(b)(2)(b) shall not
1	request and response
1	distributed outside such
1	prohibiting transactions (a)
2	secretary, afford such
1	administrator may publish
1	compiled data and
1	campaign in accordance
17	forth in this
1	shall be before
1	government (including creative
1	authority, in consultation
1	states upon commission
1	
 470. omitted

1	animals, plants, or
1	(including the office)
1	imported by them,
1	unless otherwise stated
1	350d(a)(4)1 of this
1	risk identified by
1	title after the
1	respect to assessing
1	online pharmacies and
1	purchaser provides a
5	time in such
1	agency (1) for
1	determinations for pending
2	10 working days
1	serious risksthe secretary,
1	using databases and
1	tobacco under this
8	presented by the
4	authorities under this
1	alter, impede, or
1	place department, agency,
1	wholesale distributor, dispenser,
3	administering and enforcing
2	facility, unless the
1	practices. the attorney
1	debarment periodthe secretary
1	chapter; the inspection
1	treasury and the
1	subparagraph (a) otherwise
6	states in accordance
3	person who manufactures,
1	assistance on request,
11	human services and
1	government and/or of
8	year if the
2	validation, authentication, and
1	entities and organizations
1	(a) withdrawal, suspension
3	records with respect
1	(e) anticipated annual
8	within 20 calendar
2	general if, after
1	storing food and
1	drug establishment fee,
2	care (such as
1	assessing the childs
2	potential need for
1	either by the
1	538, formerly act
3	business or professional
1	addition, for subsequent
6	paragraph as a
1	strategy; and (d)
1	operation of an
1	made unlawful by
1	food, when known.
1	
 886a. diversion
1	data, or manufacture-provided
1	containing particulars of
1	 (f) traceback
1	representative of organized
1	processes in the
1	egg products by
1	note) or other
2	subsection (a)(1)(a) and
1	paragraph, a behin-th-counter
13	24 hours after
1	simulation of human
1	entities described under
1	event less than
1	335c. authority to
1	adduce the evidence
1	shall prohibit, limit,
4	secretary may require.
8	secretary may require,
3	monograph does not
1	(1) trends in
1	licensed to dispense
2	360bbb3(b)(1) of this
3	packaging, or ingredient
1	budget). (ii) for
1	(a) law governing
2	assigned by the
1	notify congress, through
1	condition of accreditation,
3	take ownership of
1	original application. if
1	iii because of
1	meet the safety
1	since the registrant
3	purchasers as to
1	dru-free america. 
1	operation, (i) contains
2	(c) unless specifically
1	(ii):  (i)
1	including labeled and
1	formula, make the
7	partnership, corporation, or
1	biological product means
1	state law, asking
1	criminal or other
1	(2) detailing publicly
2	contain no more
2	substances act (21
2	substance, or if
1	u.s.c. 136a(c)(2)(b)]; (b)
2	dispenser, having a
1	registration by new
1	operation, including monetary
2	inspect, examine, or
1	maintain the conditions
1	present; and (4)
1	fact concerning whether
1	marketing of tobacco
1	 (1) forging,
1	
 
 622.
1	listed in this
2	information in adverse
4	applications for approval
1	fiscal year according
3	upon the date
2	restricted devices, or
1	tobacco health education
2	distinctly legible form,
1	accomplish the physical
1	 (d) reactivation
1	section are met,
1	thir-party auditor if
1	fee (referred to
1	revise as appropriate,
1	fora. (4) with
1	drug application. (8)
1	(9) is impracticable,
1	fraud and abuse
1	(1)(a), and (b)
2	subsection (e) withdrawing
1	 (with 0.7
1	publicly post the
2	paragraph (c). for
1	persons. not later
14	positions in the
1	special consideration given
1	include the transfer
1	661. federal and
1	requirements regarding current
2	grant amount for
1	receipt of offsetting
2	authority to the
2	 (2) director
1	arranges for the
1	appointment.  (4)
1	administration policy regarding
1	drug to submit
3	listed in a
1	control points); and
1	substantial income or
1	invalidate the data
1	sentences. (2) any
1	paragraph (2) not
1	domesticated chicken, turkey,
2	approved application is
1	user facilities if
2	person which has
1	pharmacopoeia, the official
1	 (3) terms
1	entities such as
1	earlier date as
1	design, epidemiology, demographics,
1	shall build upon
1	actively involved in
1	198a to 198c.
4	per 100 grams.
2	article contrary to
1	37, 68 stat.
1	class of prescription
5	amendment made by
1	partnerships for the
1	dosing regimens; and
2	chapter.  (j)
1	whether the quality
3	beginning 5 years
2	section 860 of
1	subparagraph (b)(ii) shall
1	regulatory audit reports,
1	title or regulations
1	innocent persons which
1	drug abuse, may
2	certification of budget
4	reduce harm or
1	bond as provided
1	attempting to propose
1	suspension shall not
1	order, but in
1	achieve the level
1	slaughter or handle
1	(b), a device,
4	types of fruits
1	thereof or successor
1	(1) application any
1	responsive to special
3	nonconsumer packaged carcasses
1	requesting to carry
3	receipt and distribution
1	secretary its name,
1	conducted on a
1	order or condition,
1	promptly after such
1	(1) that testing
1	shall terminate a
1	year; (4) describes
21	shall be established
3	purposes of determining
1	labeling; (2) the
16	 (i) for
1	periods as the
1	allowed expenses under
1	paragraph (3) has
1	schedule vit shall
1	(4) in a
1	modify a determination
1	dispense any drug
1	(but prior to
1	agriculture. (4) the
1	(3) protection of
1	(d) to add
1	may grant. 
1	unable to access
1	containing any amount
2	reinspectio-related costs for
2	(2) benefits under
3	employee, at reasonable
2	2012 to defray
1	means programs, policies,
1	concludes  (1)
1	conditionally approved. 
1	subsection (d)(3) of
1	denaturing or otherwise
1	accredited person discovers
2	important public interest
1	 (a) notify
1	regulatory, and legal
1	study plan contains
2	2012, establish, for
2	holder under subsection
1	section, fix a
1	exceed 90 days.
2	require to enable
1	another schedule or
4	drug from the
1	violations of state
6	(a) means a
1	fine, but if
12	substances act [21
1	treasury.  (b)
1	property who at
1	requirement the drug
5	information under subsection
1	sponsor has submitted
1	(a) timingan applicant
1	scientific knowledge, including
1	circumstances; expedited procedure;
1	market the drug
1	reinspection, and sanitation
2	facility.  (5)
1	assessed product fees
1	et seq.); or
5	evaluation and research,
1	clinical study or
1	misbranded if their
1	hazards, including how
1	respond to emergent
1	am678); (iv) -buty--(-naphthoyl)indole
1	foo-related emergencies; and
1	(j) prevention of
1	year to an
1	name; designation by
1	activities (other than
2	prescribe, including records
4	amounts appropriated under
1	area at the
8	drug trafficking areas
1	(g) authorization by
2	360fff1 and 360fff2
1	court. (mar. 4,
1	international trade. 
2	animal drug through
1	term domestic facility
1	(a) instructions for
1	sponsors have entered
1	schedules. (d) distribution
1	another device that
1	data that will
1	considered a class
1	witnesses on his
1	(iii) an index
2	strategy.  (b)
1	refer such protocol
1	process, pack, transport,
1	 (2) definition
1	situations as described
1	unreasonable and significant
1	animal feed differs
45	publish in the
1	allocation of resources
1	(a) staffing levels
1	marketed prior to
1	(ii) not include
4	paragraph (3). 
1	shall report the
2	(ii) not less
1	lieu of immediately
1	1970; and (3)
1	product standardsa tobacco
4	applicable law for
1	section. any record
1	approved animal drug
1	day period more
4	later than april
1	account the same
1	services; (ii) the
1	approval for such
1	states and before
1	misdemeanor and shall
2	remedial purposes. 
2	representatives of secretary
1	(a)(1)(b) for a
2	health or safety
1	 (1) utilize
1	item shall not
7	health care entity
1	(h) nothing in
6	event associated with
1	issue guidance on
3	notified by the
1	products thereof for
4	subsection (d), or
1	(ii) required determinations
1	381(e)(2) of this
1	update is published
3	noncompliance materially related
1	cocaine, and methamphetamine
1	earliest possible time.
1	provides athletic, civic,
2	wholesalers or otherwise),
1	(i) how the
1	scientists and physicians.
1	(d) the identification
1	(h) changes in
1	outsourcing facility, once
1	approval after conditional
5	categories of drugs,
1	distributor shall notify
1	major portion of
3	abuse of opioids
4	expect to receive
2	earliest possible time;
1	 (a) accords
1	substantial equivalence 
3	prevent and restrain
2	participating in a
1	suspension (a) mandatory
1	training provided by
1	section shall give
1	products, or in
1	attorney general, determines
2	open to inspection
1	agency actionthe secretary
1	use; (c) data
1	4332(2)(c) of title
1	drugs. (e) monitoring
1	including changes to
1	guidance on cas-b-case
3	days for comment
9	subparagraph (a) and
1	budget request transmitted
1	accreditation program demonstrates
2	states from whom
1	jurisdiction of state
1	 (4) material
1	affect such commerce
1	only.  (b)
1	provide for training
1	8, 44 stat.
1	offenses punishable by
1	exceed any proposed
9	information relevant to
1	(a) adulteration or
1	pest eradication or
1	360h1. program to
1	person and a
1	title, if the
1	period no registration
1	768) butter shall
1	requests received during
1	practice upon presentation
1	provide the sponsor
1	facility is located
2	listing  (1)
1	enhance product safety.
1	federal land, and,
1	devices on the
3	product is 
1	coordinated with joint
1	strategies to recruit,
1	promptly vacate the
2	governor and publication
1	(2) has engaged
1	activities are not
1	effective dates and
1	include the tol-free
1	distributor may take
2	provide any other
1	 (i) inadequate
1	critical control points);
1	safe if it
1	health by promptly
1	technology infrastructure in
1	agent shall comply
1	menthol or any
1	use restrictions and,
2	developed and, if
1	year drive while
1	amount  (i)
1	commerce or while
2	pediatric studies (which
1	
 
 360ll.
1	increments of no
1	working in furtherance
1	ch. 675, 538,
1	contracts that include
1	 (5) actions
1	title) acting upon
5	place outside thereof;
1	assistance program 
1	subsection shall expire
1	solely because they
1	state, territorial, or
4	place outside thereof,
2	receipt, possession, or
2	food; and (b)
1	describe any recommendations
1	inspection of establishments
1	different sectors of
1	(b) 180 days
1	communication plan 
1	(d) confectionery containing
1	holding food for
2	facility is eligible
5	guidance described in
1	
 
 350c.
1	subchapter iii because
1	expected need and
1	subsection (b)(1), except
1	 (1) exemption
1	 (f) the
12	issue a final
1	146. authorization of
1	enforcement of minimum
1	multiplying  (1)
1	(c) failure of
2	fraudulent transaction; or
1	showing quantitatively each
1	office is open
1	principal compound used,
1	services shall place
1	(ii) no applicant
34	person who violates
1	submitted after november
1	protocols and policies;
2	party under paragraph
1	(12) appropriate congressional
1	additional examinations or
1	individual patient made
1	processes, or labels
4	performance of services
1	promotion of a
2	shall include sufficient
1	technology requested. (b)
1	minimum age of
1	u.s.c. 262(a)]. (c)
1	facilities presents a
1	damages, restitution, or
1	retention by a
1	approval process. (e)
3	undertaken by the
1	secretary to deny
3	including a returns
1	allow the repackager
2	amount appropriated pursuant
1	substance for use
1	packaging or repackaging
1	batch, or other
1	order the person
1	
 
 1118
1	dosage forms subject
1	developing and improving
1	throughout the development
1	
 
 1111
1	states under international
1	officials in carrying
1	(with each drug
1	
 
 111,
2	effect on authority
1	abbreviated application, shall
1	transfusion; (ii) an
1	available to perform
1	dispensing, or administration
2	subparagraph.  (d)
4	identify to the
1	congressthe secretary shall,
3	commercially available drug
2	(which measures may
4	inflation adjustment under
2	section 844 of
2	355(o)(3) of this
2	device that 
1	initiate such change
1	pathological, or other
2	publication, the provisions
1	2298). (ll) 
1	permanent or temporary
1	single application is
1	relating to premises,
1	section 355f(a) of
1	recordkeeping requirements, in
2	352(x) of this
1	health. each such
1	food, except that
51	employees of the
2	trials with respect
2	individuals subject to
1	use. (c) current
1	articles to be
1	prescription drugs in
1	consumers, he shall
1	laboratory accreditation under
2	(2)(a)(vii), the approval
1	record taken as
1	review the actions
1	property of any
1	manner which need
1	safety labeling changes
3	states is a
1	one such package
1	plan in a
1	perform such methodology
1	pay the applicable
2	machine, encapsulating machine,
12	felony drug offense
6	certification that the
1	programthis section shall
1	plants.  (h)
1	part, to the
2	supplement the diet
1	evaluate, for 1
1	subsection (c) has
1	available and appropriate
1	patient in the
1	facility the term
1	systems to measure
1	(6) specific policies
1	smoke constituent means
1	revenue amounts fees
1	shall indicate in
1	regulations for how
1	enter and inspect
1	adequate under applicable
1	(1) evidence of
1	bacterium or fungus;
4	formerly 902(a), 52
3	application is assessed
1	(2) any transaction
1	panel and the
1	dispenser, or an
1	subsection (c), instances
2	331(a) of this
2	device experiences as
1	(a)purpose.the secretary shall
9	activities for which
1	forfeiture. (6) if,
1	individuals for the
1	time) that they
1	term state includes
1	may, when appropriate,
1	 (c) denial
1	another disease not
1	complainant may bring
1	tobacco as defined
2	destruction or sale;
1	public meetings the
1	case the numerical
2	41 et seq.]
2	event reports that
1	submitted. notwithstanding the
1	rapidly increasing in
2	treatment programs, and
2	evaluating the effectiveness
1	link to the
1	pediatric assessment of
2	(2). the secretary
4	shelf life of
1	amounts. (8) not
1	copy and verify,
1	tobacco manufacturing industry,
1	(
 
 864.
1	tracing technologies, including
1	successor in interest,
1	provide an importer
2	order with an
1	manufacturer; (ii) the
14	waiver or reduction
2	drug sponsor shall
1	court finds based
5	(c) shall be
1	clear description of
1	(c) data for
1	amateur athletes compete
2	fraud, and abuse;
1	intended use approved
1	entering the pharmaceutical
1	(e) each patient
1	notifies the applicant.
1	judgment. if a
5	providing notice and
1	filed. in any
1	derived from property
1	final rule requiring
1	hazard to humans,
1	coalitions and the
1	may be delivered
1	title to remove
18	approval under this
1	property. (f) notification
1	water regulation. 
3	states authorized by
2	paragraph (1), to
1	unit, with a
1	immediate precursor of
2	concerning the consignee,
6	paragraph (2). such
1	clause (i)(ii) shall
1	devices found not
1	(2) means a
1	(2) interim results
1	states, samples of
1	awards made by
1	demand reduction. 
1	 (5)thir-party logistics
2	modification of a
1	drug development tool.
1	opportunities exist, at
1	clearance the supervisor
1	rare pediatric disease.
1	administration on drug
1	labeling, as an
1	type ii pharmaceutical
1	implementing a national
1	suspended at a
3	amount shall be
4	disease product for
4	minimum age established
5	distributions of drug
2	availability of drug
4	rare pediatric disease;
1	 (i) fully
1	alcoholic beverages, with
1	upon such request,
1	whichever is applicable.
1	advertisement. (11) the
1	report concerning such
1	establishment receives such
1	review and take
1	administration (hereinafter in
4	(1) if a
1	(1), to the
1	ch. 804, title
1	harmonize regulatory requirements.
1	harmonize regulatory requirements,
1	30, 1976; $40,000,000
1	shall be shipped
1	causes a violation
2	(e) the written
1	propertyproperty subject to
1	tuberculosis; and (d)
1	continuous drug manufacturing
2	copy shall be
1	(10) indian tribe
1	
 360eee1. requirements
2	credentials, as determined
2	food under section
1	regarding the exemption
2	premarket approval and
1	court determines, after
1	reasonable exceptions from,
1	(b) timinga notice
1	requirements except where
1	include one or
5	review of pediatric
1	5 percent. (11)
1	opium, opiates, derivatives
1	relates solely to
1	plan, conduct, coordinate,
1	 (a) cannot
1	contain eggs only
1	paragraphs (5), (6),
1	territories and possessions;
1	pharmacy, pharmacology, pharmacoeconomics,
1	analogue shall, to
1	(or directed to
2	tribal agencies to
1	 (aaa) the
1	best protects and
2	(iii);  (iii)
2	331(p) of this
3	territories and possessions,
1	initial letter of
1	(2) investigate, block
1	show the state
3	failure to submit
1	of, a wide
1	different and individual
94	safety and effectiveness
2	intermediate clinical endpoints,
1	(a).  (4)
1	extent considered by
1	transition to the
1	(e), this section
1	section. an accredited
1	(b)(1), shall, for
1	subparagraph (a) presents
1	shall remain valid
1	appropriate restraining orders
1	director (referred to
1	direction with respect
1	areas of united
1	without difficulty. 
2	provided to an
4	present in or
3	tolerance for an
5	may order such
1	charge.  (e)
2	 (c) is
1	standards.  (c)
1	(m) for the
1	hydriodic acid. (v)
3	notice or warning.
1	found, as a
1	submission, a fee
1	illicit drug interdiction
2	medical welfare of
1	technology assessment center.
3	proprietary name of
1	pendency of such
2	2013 under this
2	substantially equivalent or
1	clause (iii). (c)
1	amounts collected after
2	associated with establishing
1	enforcement officers, agencies,
1	device is unsafe
1	general to assist
1	ch. 273, 2,
1	determined, may be
1	device, the methods
2	rulemaking procedures prescribed
3	 (i) death;
1	making the application
1	persons, of the
1	shipment data; or
1	means an animal
3	identifiable health information
2	suspend shall be
2	delegated below the
1	documentation and review
4	fiscal years for
1	dosage forms, or
1	detained until 
2	applicant or affiliate
1	alternative, scientifically valid
1	record or make
1	logistics provider has
2	access shall contain
2	periodically review the
2	public health. (c)
1	education program, prior
1	goal of ensuring
1	controlled substances, to
1	product samples by
1	exports a food,
4	take any action
1	supplement filing fee
1	comment.  (5)
2	requirement for labeling
1	unless such determination
1	condition imposed under
1	document or its
1	operations of state
1	
 2014. authorization
3	relatively small proportion
1	devices; (13) courts
2	cocaine base; (d)
1	(1) declarationscongress declares
1	(c) providing targeted
1	notice regarding carryover
1	trial. with respect
3	adequate assurance of
1	provides a signature
2	statement that identifies
1	title for federal
1	paragraph (1)(e) the
1	may be harmful,
1	services relative to
1	agriculture regarding providing
1	misbranding of food
1	seq.], a determination
1	applicant is making
1	fishing vessels (except
1	order have previously
1	new submission under
1	protections consistent with
2	weight; or (viii)
1	agricultural commodities promulgated,
4	(c) provision for
1	subsection (a) which
1	product to any
1	secretary from accepting
3	agency for healthcare
1	knowing or intending
1	signatures in an
1	505 of such
5	secretary should take
1	color includes black,
1	thereof, be exported
1	(c) an agreement
1	ch. 675, 736,
3	expended for any
1	person, and place
29	months after the
1	food safety risks
1	plant or animal
2	inspection training and
2	food imitated; (4)
2	subsection shall supplement,
1	675, 744c, as
1	subsection (e)(2)) impairs
3	51 and subchapter
1	consensus definition of
1	require such establishment
1	food under subsection
1	(b) may apply
1	(3) prohibition during
1	seller to knowingly
1	posting of policies
1	information was considered
1	practice. (e) repackager
4	manner and form
1	otherwise. (6) the
1	vehicle, render adulterated
1	secretarys satisfaction; and
1	raw materials other
4	meat inspection act
1	case of deaths,
1	packaging been stored
1	act, for a
3	paragraph.  (ii)
2	persons  (1)
2	division why such
1	effective beginning 3
1	part, or accessory,
1	dismissa defendant may,
1	water; (c) consider
3	tobacco tax and
1	property. the hearing
1	shall ensure timely
1	appeal if no
1	drug is terminated
1	issued will result
1	consist of 10
1	enforcement agent, as
13	promptly notify the
1	(d) identify the
1	competency of each
2	country of export
1	substance analogue. (c)
1	feeds. (8) the
3	health and security
2	inspection to any
2	drugs for such
2	year based on
1	prior to hearing)
1	evidence  (i)
1	shall bring such
5	advisory committees, and
2	investigations and activities
1	 (f) reports
21	established in subsection
4	final sunscreen order,
1	foundation; (8) modify
1	available, including by
1	common carrier, distribute
1	establishment for failure
7	renovation, and repair
26	rule of construction
1	(2) inspections 
1	number assigned pursuant
1	imparting color thereto;
1	secretary determined could
1	announcing such classification.
1	officials concerning the
1	section 379g(8) of
3	statement required under
1	(1) notificationif the
1	(a) that a
1	determination or certification
3	(other than comparative
1	substance law offenders,
1	protocol opportunity for
1	termination of program
1	gifts, grants, devises,
1	pipes; (11) chillums;
1	secret and confidential
1	drug for its
2	genetically targeted technology
1	section that any
1	interstate commerce accompanied
1	(e) statute of
1	drug involved represents
1	representation of a
1	achieving the primary
1	funds the director
1	grant, contract, loan,
1	133 and 135
1	trialthe purposes referred
1	relating to criminal
1	review. (c) in
1	involved in a
4	final sunscreen orders
1	appeal pending, (b)
1	reduced by requiring
1	unless such class
1	packing establishments, and
15	means, with respect
1	high risk (as
1	subparagraph (a), separate
1	secretary, submit to
12	secretary as part
1	enter such premises
1	monitoring 2003 as
1	expediting the process
1	secretary variances from
1	consult with and
2	additives if it
1	enhance the food
1	include such procedures
1	premises where children
4	person or by
1	subsection (b), which
1	risk to such
1	include any commercial
2	purpose for the
1	sufficient proportion to
1	illegitimate product; (e)
1	make such inspection.
1	columbia commissioned by
2	default as may
4	secretary of defense
1	30, 1981. (

1	825, 952, 953,
3	provide other information
2	initial public dissemination
1	(a) is considered
1	both, to any
2	audit by the
2	57 of title
1	withdrawing the investigational
1	(2), or for
1	importation (1) when
2	(f)(6)(a) revoking an
6	modifying, leaving in
1	person disseminated or
1	(x) a statement
1	may discontinue participation
2	playground, or housing
1	(2) two or
1	medical judgment, may
1	substance.  (2)
1	specific numerical values
1	(1) information and
1	state.  (f)
2	residue of such
2	regulations may list
1	conduct, at least
1	
 208. certain
1	(k) definitionsin this
1	which, under section
1	premarket approval or,
1	insurance claims data);
1	hearing; (3) the
1	exceed the annual
6	later than july
1	animal. (c) 
1	studies the failure
1	may promulgate regulations
2	consumer protection act
1	(4) has been
1	grants to local
1	stat. 511; july
1	technology transferred. (c)
4	administer oaths and
1	organizations with which
2	product:  (a)
1	enrollment of patients
1	155. permits for
1	agree that such
1	facts material in
1	(b) when in
1	(
 
 456.
1	help the food
1	developed for an
1	annual establishment feeeach
1	(1)(a) or (2)(a).
3	150 days after
10	date the secretary
1	holder that, on
1	(ff) a vasopressor;
1	attorney general, upon
1	person shall provide
1	thereof. the proceedings
1	36 months. 
1	days from 
1	paragraph or section,
1	responsible party determines
1	criteria standards recognized,
1	upon the disposition
1	assist or participate
3	shall conduct not
6	applicant and for
1	regulations). if the
1	drugs or radioactive
1	activities. such report
1	procedures at any
1	paid for an
1	activities) with state,
1	disease product, then
1	opioid maintenance and
1	farm if 
1	introduce food from
1	movement in interstate
1	system are adequately
5	public inputprior to
1	product shall provide
2	determining whether or
4	adverse event associated
1	determination applies to
1	data relevant thereto.
2	enforcement, or to
2	title of any
2	small business tobacco
3	issues relating to
2	(2) considerations in
1	amountthe administrator shall
1	section. (f) transition
1	narcotic controlled substances,
1	unlawful importation it
1	(3) before the
1	office). the office
1	presubmissions or submissions,
1	new generic drug
1	presubmissions or submissions.
1	section, approved or
1	2016, issue draft
1	(f) percent of
2	directors  (1)
1	governments;  (b)
1	periodic reports for
1	acetone. (c) benzyl
1	emergency medical services,
1	supplement to consumers
10	4 years after
1	consulting firm shall
2	consumer does not
1	 such analysis
1	shall, in notifying
5	paragraph (1), if
1	include such validation
1	prior referral (or
2	pharmaceutical ingredient information
1	(b) medical product
1	(30) noracymethadol. (31)
1	programwith respect to
1	paragraph (1), in
1	circumstance where time
1	(a)(2) or (b)(2)(b),
1	foreign governments 
1	supplements, premarket reports,
1	jurisdiction. (6) in
1	multisector plan for
2	classification of substances
1	management guidelines developed
1	evaluate the nature
1	(d) warnings nothing
1	support from some
1	leaders; and (2)
1	approval pathwaysan application
1	thereof, and was
2	unless its packaging
1	assessed and are
1	substance shall make
1	recognized under clause
1	o-call basis currently
1	(11) may serve
1	medical gas if
33	june 22, 2009,
1	terms and conditions;
1	residues are used.
1	abusers.  (e)
1	committed, or is
4	person that the
1	future needs of
1	excess of $100,000,000
3	medical gas is
2	section 454 of
1	enforced by a
3	carrying out of
1	professionals, representatives of
1	sex in administration
1	awarded and the
2	within the context
1	form to any
1	(3) in providing
1	shall partner with
2	pediatric labeling. neither
1	(3) underlying causes
9	patent which claims
2	conviction has been
2	program. the amount
1	united states resident
4	immediately cease distribution
1	person so sentenced
1	means any movement
2	misbranded because the
1	warrants unique management
1	scientific use. registration
1	adolescent tobacco users,
1	eligible for designation
9	approved for the
3	data are available
1	providing background information
1	subject of panel
1	shall require, as
1	money from the
1	existing manufacturing facilities,
1	(4) the court
1	small market for
1	cigarettes or other
1	intended for sale,
1	drugs obtained from
1	persons may lawfully
2	information required in
3	esters, ethers, salts,
1	1986 [15 u.s.c.
1	administration (such as
1	surveillance, rapid detection,
1	may, without being
4	amount of lysergic
1	modification; hearing; conclusiveness
1	commission may serve
1	(e) making a
3	vested in the
1	(i) all drugs
1	similar establishment where
1	 (a) timely
1	incompetent with respect
2	nonprescription drugs (a)
1	subsection, order the
1	establish a format
1	title, or (c)
1	direct farm marketing
1	(iii) describing, if
2	4 years, a
1	sample or knowingly
1	effect not later
1	surrogate endpoint means
1	clinical evidence, clinical
1	excess of percentage
3	reported under this
1	television advertisement means
11	2907, title iv,
2	attorney general reports
1	address for each
1	42, a device,
1	plans under subsections
1	plansin carrying out
6	services, for officers,
1	stat. 1046; mar.
1	paid, an annual
1	 (2) responsibilities
2	study is requested
2	denies clearance to
4	review voucher to
1	implementation of comprehensive,
1	health emergency, that
1	professional practice unless
1	conduct of inquiries;
7	egg products and
1	wholesale drug distributor
3	$1,000,000 for any
1	property expenses of
3	 (2) requirement
1	(c) interagency collaboration
1	upon, a package;
1	available and, using
1	justified, or (iii)
1	(1) if control
1	regulated person referred
1	body; (cc) a
1	additive in accordance
1	order. proceedings to
1	receipts and expenditures
2	patrol hours primarily
1	authorized, by regulations,
1	title 42. (k)
1	shall (1) without
1	understanding of and
1	areasnot later than
1	police, probation, prosecution,
1	regulation or specific
1	egg products, in
1	subsequent purchaser a
1	(e) costs when
2	biological products are
1	physicians office in
8	manufactured, prepared, propagated,
1	products for testing
3	fairly and responsibly
1	real property that
1	commerce otherwise subject
1	drug application prior
2	submissions. (d) monitoring
2	submitted not later
1	(b) to (i),
2	suspend inspection at
7	section 841(a)(1) of
1	5. (h) reoffer
1	u.s.c. 19011906); 
1	noticeseach year, the
1	respect to inspections
1	component within the
1	applicable to various
2	medical information, related
1	may, in writing,
1	accordance with commonly
2	dispenser accepts direct
11	article shall not
2	prior to leaving
1	coordinate and facilitate
1	human beings and
1	(2) that such
1	submit the initial
4	deception of the
1	rate, for type
3	run into any
1	no-disclosure; exceptions 
1	require notification to
2	distributes the product
1	vendor:  (i)
1	establishment means any
2	agreements with a
1	subsection.  (8)
1	measures necessary for
1	(e) the systems
3	administration a list
1	means a paper,
1	committee to review
16	within the united
1	longer engages in
1	(b)(3)(d). (f) regulatory
1	review each agreement,
1	specify the limitations
1	
 
 3432.
3	products distributed to
3	promulgate regulations as
1	possession or premises
1	caused by failure
2	shall identify such
1	time limitations the
1	order. (b) compounded
1	involved; (d) the
1	ingredients described in
1	representatives.  (13)
1	products prescribed under
1	(i) and is
2	size, but established
1	submitted the application
1	(c) approval or
1	section 360bbb5 of
1	interests  (1)
1	predict clinical benefit,
1	government owned and
1	information on authority
1	distribute, export, or
1	virgin islands, guam,
1	misdemeanor, and shall
3	determine if the
2	perform any of
1	information or trade
1	manganese (g) 5.0
1	drug. (b) package
1	imports including 
2	(f), the administrator
1	general use. (b)
1	imports  (1)
2	availability and clarity
1	(2) mai-order reporting;
4	steps to ensure
1	submitted all the
1	cigarettes beginning 3
1	finding that compliance
1	involves a biological,
1	right, power, or
1	reports submitted pursuant
4	secretary (in such
2	title, nothing in
1	respect to implementation
1	formula, made the
1	(a); (iii) for
1	(i) such device
2	device establishments by
1	secretary, provide the
2	logistics provider does
1	illegal drugs among
2	least 1 i-person
1	material fact. (e)
1	food. (o) consumer
2	aside his order.
1	sales at wholesale
1	internet without a
3	state that does
1	relieve a wholesale
12	 (ii) the
1	applicant not later
1	device have an
1	effective performance; (b)
2	secretary shows that
2	including the provisions
5	(2) the attorney
1	coalition building; (2)
1	filein establishing the
1	drinking water are
1	section 355(c)(3)(e)(ii) of
1	labeling, or (ii)
2	grounds exist to
1	educational agency, secondary
1	(e) good faith
1	made, and report
2	title 31. (k)
1	failure or defect,
1	consistent with subparagraph
1	(b) reimbursement for
1	goals and purposes;
1	experiences with a
1	container, any wrapping
1	title implemented by
1	material which 
1	biomarkers, for such
1	 (e) eligibility
1	standard and declining
1	(2) and section
1	shall coincide with
1	180 days, request
1	title i, 13,
2	evaluation carried out
1	 (1) full
1	appropriations for grants
1	enforcement administration, in
1	(
 
 1904.
1	payable to such
7	distribution in the
1	information and documentation
2	(a) affects less
1	comprehensive and includes,
2	product components of
1	practice.  (2)
12	prescription drug product
1	package accepted under
2	authorized to pay
2	article of food;
3	(a) for drug
1	identify system attributes
1	15, 2007, productssubparagraph
2	 (b) applicability
1	 (e) penalties
1	columbia, enacted in
1	effect, no state
1	presents substantial deception
1	sale in violation
7	product for further
1	regulated person becomes
1	section 360fff6 of
2	chapter concerning any
1	among youth has
2	(c) is labeled
1	(j) public disclosure
7	adjustment shall be
3	article of food.
1	another device for
1	workshops or public
1	temporary basis under
1	2009; (4) $270,000,000
1	(a) require the
1	advertisements as those
1	protocol) for determining
3	drug means any
7	(b) management of
1	practitioner, or (c)
1	title iii, 532,
1	animals, delivered by
1	drug abuse with
5	decides the issues
1	exchanged in a
1	condition that adequate
1	(ii) establishing a
2	operator requests the
1	require  (i)
16	comply with an
1	 (iii) statutory
1	commission shall elect
1	application, (2) bribed
1	(b) whose use
1	condemnation; claims for
11	may be submitted
1	conduct; or 
1	listed drug 
2	process and procedure
1	made available subject
2	(l) or (m)
2	unsound, unhealthful, unwholesome,
4	amendatory thereof or
1	(b) final regulation
1	timeliness and effectiveness
3	title 42), or
1	security of stocks
2	drug product approved
1	appropriate postapproval studies
1	ensure quality, including
1	forfeitures effected by
1	proposed order with
1	service act, for
1	commerce, and persons
1	certification within 20
1	percentage shares described
3	investigations, including clinical
1	become final. 
2	to, this section.
1	chemical.  (2)
2	eat when they
1	reevaluating the determination
1	term applicable under
1	charging a violation
1	notice specifies, as
1	grants an extension
1	suspended, expired, or
1	 (iv) conditions
3	federal government entity
1	plan which may
1	585, as added
9	clause (iii) or
1	food, and relevant
1	20th par., 34
1	council established under
1	withdrawn, respectively. (3)
3	prescribe.  (b)
1	systems and standards
1	(1) continues to
2	clause (iii) of
1	final change of
1	subsection (g), as
1	manufacture certain controlled
1	reliable data, such
2	shall be promptly
1	(i) in australia,
6	shall, as appropriate,
1	describing the samples
1	tobacco leaf or
1	obtaining quality exposure
1	without hearing, by
1	(iii) establish policies,
1	radiation control program
1	recognized accreditation body,
1	appropriate and if
1	enforcement administration means
1	extent of drug
1	functions. (
 

1	subsection (g), an
1	establishment slaughtering poultry
1	either (a) issue
5	(1), and shall
1	applications of licensed
1	dietary supplement; and
1	
 
 860a.
1	persons seeking elected
1	upon the terms
3	recipient is unfit
1	eligible controlled substances
1	individual may be
1	(a) determining which
2	helping establishments covered
1	little is known
1	(c) report not
1	(a) shall periodically,
5	include in such
3	director concludes that
1	person, that granting
1	food maintains the
1	consistency of postmarket
1	collected by government
2	administrative detention of
1	deliver for introduction,
1	(d) information on
4	shall amend the
1	elected official (or
1	general, request an
1	deferral would expire.
1	hold hearings, sign
1	(ii) the country
1	use. (6) 
1	present intention of
1	(b) statement of
1	technical assistance for
1	drug. in issuing
1	grains of chloral
1	(a) information demonstrating
1	interdiction and other
4	case later than
4	give notice as
1	pee-reviewed scientific publication
1	documented causes of
1	subparagraph (b), of
2	controlled substance shall
1	use of those
1	subsection (e)(1) only
2	appeal may be
1	agreements with, scientists
1	authorizedthe term authorized
3	carrier or warehouseman,
4	times, to have
1	properly necessary for
1	quality controls, equipment,
1	success of an
1	title 22 and
1	(5) make annual
3	judgment of conviction
2	small establishments (as
1	
 813. treatment
1	parenteral administration, an
2	advisory committees (which
1	law, the administrator
1	farm). (f) the
1	modifications based on
2	label of inspection
1	testing to the
1	823(d) of this
2	surveillance and if
1	devices (in this
1	general shall, in
1	necessary. (g) the
2	basis to generate
1	concluded that a
1	labeling thereof; except
1	applicable; or (ii)
1	(ii) an allergenic
3	bears, in type
1	(2), to submit
1	determination, the determination
2	waiver, or waiver
1	leasehold interest) in
1	animals, may elect,
2	drug safety surveillance
2	advisory review means
2	take effect on
1	developed after june
1	representative of either
1	daily med and
1	title); (b) a
1	patient experience datafor
1	examination of reports
1	
 1904. blocking
1	policy accommodates scientific
1	adoption and use
1	ultimate consumer in
1	organizations, and standard
5	may be modified
1	including any repacker
2	produce health benefits
1	inspections, examinations, testing,
1	(1) but before
1	adulterated, he shall
1	 (3) biannual
1	contractual agreements with
3	obtained.  (d)
1	drug conventions in
4	product by a
2	initiated by the
1	transaction between a
1	detention period of
1	scienc-based standards for
1	shipment of worthless,
1	homeland security act
1	need for such
1	(b) develop and
1	 (1) of
1	(c) effect of
1	integrated with, and
1	determines applicable) described
2	 (1) on
6	first fiscal year
1	appears from the
1	related product as
1	treat as equivalent
1	projects, and other
1	returns only if
1	participation was discontinued)
3	appropriate  (a)
1	identify. the secretary
2	new medical information,
1	(i), the drug
2	(c) provides information
1	federal service, at
1	 (3) revocation
2	360eee1(a)(7) of this
1	thir-party auditor satisfied
1	formulary, or another
1	hig-risk foods at
1	later than november
1	thereof has failed
1	ris-based, reasonably appropriate
2	shall afford such
1	periods. (3) procedurein
1	informed consent documents
3	articles in or
3	 (b) regulations
1	available in a
2	subsection (k); and
1	record after an
1	number of approvals,
2	and/or cream shall
1	office shall, with
1	ed., title 26,
1	drug approvals fraudulently
1	(2) maximize the
2	secretary, or a
2	overestimated the amount
1	 (h) registration
4	food at the
1	submitted within 15
2	distributor or wholesale
1	services. (
 

1	(a)(1)(c) for the
3	shall designate an
1	exercise jurisdiction with
1	annual fee revenues
1	drug control are
1	consumer.  (i)
5	person that submits,
1	(b) notice 
1	agentsan audit agent
1	tissue or a
1	government to, inter
1	imprisonment. (2) in
1	 (i) specifying
1	nonprescription sunscreen. (june
1	tissue, the implant
14	local law enforcement
1	(a) 100 grams
1	withdraw such recognition
1	total time to
1	addiction and use.
2	subsection. except to
1	(c), amend the
1	distributor can associate
1	entities. (f) veterinary
3	collection and analysis
1	director. if the
1	(3) a warrant
1	covering each type
4	may lead to
1	cros-disciplinary project lead
1	act; (b) received
1	affecting its color,
1	subsection (c)(2) shall
1	index entry; (h)
1	days, commenced an
1	health posed by
1	(c)(1)(a)(i), issue an
1	referred under paragraph
1	original submission. a
1	government, and any
1	request and issue
1	product package. (ii)
1	additional species of
1	eggs (as a
1	seq.].  (f)
1	(6). (2) any
3	illness surveillance and
1	normorphine. (21) pholcodine.
1	cleansing, and standardized
1	violation is prosecuted
1	consolidated farm and
1	preventive control plan
1	testimony and evidence
2	paragraph (1) classifying
1	user population, and
15	two or more
1	code number belonging
1	term affiliate has
51	intensity drug trafficking
1	drug fees to
1	country any nonnarcotic
1	imprisonment as provided
1	analytical testing methodologies
1	additive, the petitioner
2	subchapter ii; (7)
1	region of a
1	(4) reprogramming and
1	 (b) quorum
1	(i) priority in
1	entities  (1)
1	(ii) parents. (iii)
2	acts, subject to
1	services for which
1	awarded in an
2	matters; prohibition of
2	changing the container,
1	review is intended.
1	(c) expedited review
1	application is expected
1	use solely in
1	agrees to serve
4	information on how
1	conditions which may
1	iii, 536, formerly
1	naturally occurring estrogen.
1	poultry products, owned
1	naturally occurring estrogen,
1	person shall recommend
3	court in an
1	production classes that
1	animal drugs indexed
2	service may be
1	farm shall be
1	identical substance manufactured
34	import into the
1	section 106.30(c)(2) of
1	deficiency which prevents
1	constituent) or additive,
3	morphine or salts
1	status and progress
4	cause or contribute
1	administration to search
1	published finding of
2	 (b) filing
1	distribution or other
6	act, omission, or
1	safe use; contents;
1	device that meets
1	paragraph (1) when
2	shall be stored
2	notification submission, 3-day
1	for, or conditions
2	requirement is waived,
1	federal crop insurance
1	cooperative agreement made
1	system under subsection
1	prolonged contact with
1	laws shall be
1	annual fee associated
2	section 355(d) of
1	community involved 
1	system or a
4	tobacco product will
2	serving the subpena
1	clause (i)(i), except
1	2103. ensuring efficient
2	country of import;
1	sufficient to mitigate
1	(bb) private sector
1	section 271(e)(2)(a) of
1	auditor under paragraph
3	sold in good
5	items; united states
1	period; renewal; refusal
1	program. such reimbursements
1	modification or correction
1	information other than
1	suspend, and revoke
1	manufacturer under the
1	involved shall be
2	notice setting fees
1	services is authorized
2	engaged.  (june
1	obtain damages, restitution,
1	reduction, and state
1	chapter, if such
1	licensed veterinarian issuing
1	organizations, or to
1	federal register 
1	harmful, and if
1	 (5) proposed
1	submitted as described
23	judgment of the
1	submit a list
2	product radiation, and
5	plan for the
1	conclusions, and recommendations,
1	27, 2011, and
1	investigate, block during
1	placed, the secretary
1	activities, and interventions
3	consumers as products
1	site by the
3	device to a
1	(11) appoint other
1	furnished raw materials
1	respect to eggs
1	dispenser other than
1	provide a declaration
7	refund of fee
2	providing the offer
1	individuals in receiving
1	propagated and compounded
1	applicability the exemption
2	potential illicit trade,
1	small cigars. (iii)
1	education (a) in
1	dietary ingredient or
2	classified pursuant to
6	section.  (d)
2	believe, by thirty
1	cream when unfit
1	transmission through the
1	regulation. a copy
2	necessary curricular and
1	facility inspection and
1	treated as having
1	prior to exportation
1	order notwithstanding the
1	equines, or preparing
1	impractical; (b) production
6	 (3) if
1	certification required by
1	status for pediatric
1	membership (a) in
4	became known to
1	reprogramming subject to
2	 (3) in
1	appended to it
1	chemical, container, name
1	regulations, as so
2	renewal of a
6	(ii) for which
1	administration may order
4	provision of law
1	title is a
1	sel-certified persons the
1	acceptance of devises,
1	specific appropriation or
1	2013, to enhance
1	title, at least
1	(b) with an
1	petition or other
1	nonnarcotic controlled substance,
2	(ii) take into
1	appropriated $149,000,000 for
1	(1) and which
55	person, firm, or
2	selling, or transporting,
1	including by using
1	packer or the
1	843(f) of this
7	90 calendar days
1	otherwise individually scanning
1	owner, prior to,
1	year 2009; (4)
1	drugs are physically
1	for, and effective
1	bono public service
1	appropriate action to
1	issue permits for
2	meeting shall be
1	understanding and cooperative
1	(iii) evidence that
1	amount of $25,000
2	whether such entity
3	depletion studies for
2	provide support for
1	drug wholesale distributors
1	term prepared means
1	formal written determinations
1	services provides notice
2	receive a decision,
1	hospital pharmacies repackaging
1	535, formerly act
2	387b, 387c, 387e,
1	international relations. 
3	maximum contaminant level
1	product that entered
3	may, to the
1	ch. 675, 708,
1	nutrients contained in
2	interpretive criteria for
1	 (4) renewal
1	may issue his
1	ch. 675, 581,
3	denial of an
1	technical expertise that
1	programs and gaps
1	nutritional and ingredient
1	organizations.  (4)
1	new hazards and
1	either without charge
63	subsection (a) shall
1	remain in contact
1	343(q) of this
1	seized and forfeited.
1	survive notwithstanding any
1	either affirming the
2	no-racemic drug is
1	feasible and may
1	area (the countries
1	 (k) request
1	-methy--morpholin-1, -diphenylpropan-carboxylic acid.
3	year, every person
1	scientific, analytical, or
3	event that the
1	shall forthwith revoke
1	volume of imported
1	pipe tobacco, or
1	state licensing authority
2	holding such articles
1	foundation, academic or
3	title; (2) the
1	issue regulations (through
1	u.s.c. 262], as
1	distributor, and any
7	section 826 of
5	country which is
1	effectiveness. if there
1	data if a
1	provide notice as
1	  magnesium
1	additional inspection services
1	(4).  (e)
1	to, or which
1	determinations for drugs
1	person in availing
1	chapter), and research
1	619(5)], when referring
1	one of such
1	studies), the applicant
2	expend up to
1	physician will provide
3	injury to consumers.
1	whether the use
1	en-userin this subsection,
1	agency relating to
1	budget submission of
1	prescription for the
1	kit as described
3	substances import and
1	types of permissible
2	section 387f(e) of
5	products intended for
1	inspection, and shall
1	tribal government agencies.
1	clean up of
1	director by this
2	review user fee.
1	 (7) homogeneous
1	suspension or upon
2	title 5. (

4	direction of the
1	cause harm; and
1	(a), or a
2	potential public health
2	efficient review of
2	admission of an
1	use published pursuant
1	number of drugs
1	personal use is,
1	parts in the
1	exporter shall provide
1	registration number; uniform
4	360b(j) of this
1	601(m)(8) of this
3	expired, (iii) of
6	derivatives of ecgonine
1	 (a) real
1	objective established for
1	delineating the role
1	food products, (d)
1	external to fda;
3	 (1) upon
2	(d) regulations the
2	product applications means
1	significant reduction in
6	fee revenue amounts
2	 (2) omitted
1	approval to provide
1	(i) who owns
1	use to ensure
1	may be associated
1	particular nonnutritive substances.
1	factory or other
1	standards may be
1	petition if 
1	paragraph (2)(d), the
1	year involved for
1	match advertising that
1	insurance companies to
1	may determine whether
3	form of request)
1	initial reports annual
5	inspection services and
1	reasonably achievable, but
1	united states when
1	section 353(c)(2) of
1	warrants, arrest warrants,
1	exempt any compound,
2	upon a partnership
1	(as applicable), upon
1	subsection (b) can
1	provide surge capacity
1	(b) writing a
1	agriculture, and state,
1	person, knowing or
1	program staff, parents,
2	insurance portability and
1	national system of
1	 (5) alter,
1	 (1) generic
1	obtain such information;
1	arrives on a
1	guidance on 
2	level for the
2	(d) termination of
1	water regulation promulgated
1	evaluation conduct[3] under
1	timetable for completion
1	health or gross
1	ibogaine. (9) lysergic
1	obtain such information.
1	(o) use of
1	proprietary name and
1	designate hig-risk foods
1	participants as he
1	entity that had
1	product; (c) evidence
1	participation the secretary
1	management, and budgets
3	nanomaterials with biological
7	prior to such
3	(3) public availability
1	review, an investigational
1	(f)(2)(c).  (3)
2	1997, excluding any
9	entity that has
2	serious risk to
1	(e), the term
1	(c) is imported
1	term of 1
1	related to terrorism
1	purpose. the attorney
1	types of property
3	paragraph (1), shall
6	auditor or audit
1	order to reduce
6	whether the food
2	mails in the
2	effect under that
1	331(ll), 344, or
1	reinspection fee has
1	relevant regulations and
1	household, guest, and
2	tobacco product no
1	regulation established by
1	previously classified under
1	prepares poultry products
2	members (other than
1	judicial proceedings, any
2	states (including any
1	leadership act of
1	adjust the total
2	transportation, in commerce
5	section 501(c)(3) of
1	nitrogen, use in
3	district court in
1	(q) filovirus diseases.
1	(as identified in
1	(ii) the need
1	products thereof, and
1	election to the
4	compliance with any
1	iv, unless such
1	drug (including the
1	thereunder), or which
1	 (x) date
1	export eggs or
7	(i) subject to
2	public confidence in
14	required by subparagraph
1	applications for all
1	drug or by
1	patients on the
1	track and, to
1	(
 
 2203.
1	unbroken and has
1	parts for lifesaving
1	abuse or misuse
1	biomarker  (a)
4	i-kind contributions, for
1	fee due under
1	subparagraph (a) (subject
1	rejected under clause
1	authorize the applicant,
2	suspension of use
2	expected to result,
1	foreign commerce prohibited
1	accountability office. 
1	year the dtc
1	includes the parent
1	claims the approved
1	certain programs within
1	effect on drugs
2	seal. no disposition
1	 (2) registration
1	(d) conditions and
2	guidance to industry
1	publication, but the
1	communit-wide strategies to
1	person owning or
1	respect to antibacterial
1	device set forth
2	good faith as
1	issued a warrant
1	possession a product
1	substantially equivalent if
2	agreed to participate
3	small proportion or
1	limitation.  (7)
1	proceeding; and (bb)
5	patent validity and
1	247d6d, 247d7e, and
1	adjustments to establishment
1	performance measurement, including
1	education programs and
1	stringent than the
2	establishment registration fee
1	communications, in place
1	paragraph, the task
1	columbia circuit. judicial
10	made a certification
1	term priority drugs
1	(j)(5)(f)(ii), if an
1	comment period. (d)
2	drug a counterfeit
1	paragraph (3), any
2	make a complete
1	defense.  (d)
1	consumers. (2) a
1	necessary in light
1	complied with, (1)
5	sixty days after
1	(a) directorthe director
2	laboratories, including the
1	approves or conditionally
1	considered a violation
1	entity, or any
1	conditional approval. any
2	plan.  (6)
1	file such designation
1	secretarys activities within
11	related to a
1	general may hold
1	chapter; be supplied
1	states may request
1	every part of
1	beyond the blood
1	impaired by such
2	label or any
1	orders have been
2	secretary to ship
1	able to present
1	curtail the diversion
1	extent appropriate, inform
1	(y) any salt,
1	(g) violations any
1	offered to the
1	(2)(d). such fees
1	witnesses of or
1	related to foods
1	shall be assessed,
1	individual, partnership, association,
1	term ultimate user
1	tobacco products, which
2	change under section
12	drug, the secretary
1	recall, including notification
4	1923, ch. 262,
1	extent necessary in
1	subsection (g)(4)(a); and
1	copy; and (g)
6	naturally inedible by
1	chemical (including specific
1	business for purposes
1	states attorney may,
2	action within or
1	vendor of devices
7	order pursuant to
2	(c); and (b)
1	compensatory damages, including
1	centimeter or less;
1	inspection, the scope
2	affect in any
1	(15 u.s.c. 714b(h));
1	action; and (c)
1	published after such
1	due as required
1	provider. such designations
1	research, to distribute,
1	chemical in units
1	sponsor, subject to
3	u.s.c. 951 et
1	entered into agreements
3	product at retail
1	account the probable
1	(f) whether this
1	
 1 to
11	secretary has reason
1	shall provide, a
1	(i) the necessary
1	available understanding of
1	conviction of, a
1	ammonia, methyl alcohol,
1	effects test or
1	title, even if
1	manager. (mar. 3,
1	fees, notwithstanding the
1	designate drugs as
1	drug, the importation
3	 (1) establish
1	system; (v) to
1	department has received
1	required while such
1	violation, the conviction
1	guidance to industry.
2	paragraph for a
1	unable to provide,
2	(11) if it
1	serve a complaint
1	clause for a
1	federal register or
1	certificates of the
1	determine the type
1	(a)(1) do not
1	requestor the term
1	providing direction and
1	without diluents, of
1	tobacco leaf without
1	met the initial
6	necessary to support
1	control program; (2)
4	therapeutic class as
1	(d) that[1] relies
4	maintain such information,
1	implementing inspection and
1	entitled, an act
1	materials that may
2	selected establishments with
1	license cannot assure
1	distributor of devices,
1	one such fee
1	department, including public
3	meat or other
1	quality, condition, weight,
3	performed pursuant to
8	granted under this
1	matter de novo.
1	(
 
 821.
2	application (including any
3	 (c) for
1	describe the device
1	word, design, device,
2	nutrition of the
1	secretary provide a
2	device, food, food
1	poisons, except as
1	1, 1992, or
2	fiscal year, where
1	writing, the person
1	identifier and that
1	ingredients; authority to
2	held liable in
1	appropriated for this
1	fiscal years. any
1	section applies to
1	(ii) the condition
12	established pursuant to
2	product as such
1	covered into the
1	development of countermeasures
2	shall not change
2	order making the
1	 (i) facilitate
1	official establishments the
1	patient engagement in
1	initial notification under
1	(9) secretary the
1	(c)(2), may under
1	entity qualified for
1	narcotics trafficker, the
1	fact which such
3	separately from the
1	board any vessel
2	exemption the secretary
2	pesticide chemical; or
1	 (2) limitationsparagraph
1	particular the southwestern
1	discontinued) of an
2	notice and the
3	educational agency to
1	(2) public review
1	secretary, the complainant,
1	exclusive distributor means
1	violation to which
1	inspections; and (ii)
1	1976; $40,000,000 for
10	2014 through 2017,
1	defense information among
1	eliminated, report to
3	infant formula for
1	office (a) in
1	gifts, both real
1	2109. publication of
2	tribal affairs. 
2	means is available
1	drug safety ris-benefit
8	10 percent of
4	substantial risk of
3	including specific mixes
16	petition filed under
1	foods. foods described
1	year 2002, and
1	 (c) intrastate
1	support; faca 
2	-pheny--[ -(-phenylethyl)--piperidinyl ]
1	method(s) used to
1	drugs, 1961, signed
1	premarket review. 
5	title (as added
1	subparagraph (b) shall,
5	subsection (b)(2). 
1	(i), according to
1	otherwise appropriate. 
2	drug product fees
8	shall submit an
1	conditions, including, to
1	talent costs under
1	proceeding with the
2	thir-party auditor the
1	hardship on individuals,
1	negligible and affects
1	secretary; (2) if
7	(a) for such
2	particular cosmetic or
3	act of 1949
1	food nothing in
3	act of 1946
14	title.  (3)
1	substance is inadequate
1	waiver, exception, or
1	(a) no provision
1	act; and (ii)
1	321(q)(1) of this
1	case of immediately
1	dispensing the substance.
2	27, 1970, and
3	general  (i)
1	considered drug related,
1	importation in violation
1	services, with notice
1	disaster relief. (3)
2	established trade names
1	within a specified
1	united states having
1	353(b)(3) of this
1	application the supplemental
1	having, a potential
2	implant if the
1	change existing agency
1	certificationthe director 
2	requirement to the
2	document is signed
1	federal regulations concerning
1	campaign; (ii) all
1	within the 36-day
1	penalty, or the
2	show to the
1	shall in addition
3	day on which
3	person is an
1	secretary, within 1
5	contain  (a)
8	final dosage form
1	registration filed under
1	before, on, or
2	panel shall submit
1	time. (5) emerging
1	notifies the registrant
1	(i) vitamin, (ii)
1	program agency shall,
1	final decision shall
5	regulations implementing this
2	15 or more
2	regarding the safe
1	promoted in accordance
1	certain postmarket studies
1	(b) strategic planthe
1	title. (c) extension
1	occurred (not including
1	387k(g)(2)(c)(ii) or 387k(i)(1)
1	check means an
2	drug lacks appropriate
1	states. (june 25,
1	injunctive remedies as
1	faith the article,
1	2011.  (q)
2	seeking a fee
1	tobacco growers, regarding
9	established by regulations
1	area of health
1	integrating foodborne illness
1	classifying such a
2	state programs for
1	food product components
1	commanded, performed, or
1	administration for expenses
1	including the revocation,
1	identified legislative or
1	application. (e) service
1	record to facilitate
1	diethylthiambutene. (16) dimenoxadol.
2	section is issued.
2	transfer the drug
2	initiative or referendum
2	slaughters or processes
1	effective; (b) a
1	provide outreach, technical
1	serving thereof is
1	delay and revocation
1	services  (1)
1	services, may create
1	quality for any
1	128. repealed. 

1	(b) timing of
1	(m) depositions in
1	387j(a) of this
1	administration; and 
1	350 employees. for
2	represents an unreasonable
1	subsection (e); (iii)
1	established by regulation.
2	storing in or
1	organizations; (iv) 1
51	secretary and the
1	necessary. (7) nothing
1	provide, pursuant to
1	drug in animals.
1	federal agencies. (

2	1947 [50 u.s.c.
1	congressit is the
1	continue to have
1	23, 1988, to
1	scheduling order under
1	disseminates information in
1	professional backgrounds, except
15	subchapter shall be
1	regulatory audit and
1	base; (d) 10
1	dwelling pursuant to
1	accredited. (3) an
1	participation in any
1	concerned with standard
1	description made under
1	developing improved epidemiological
1	reached, or that
2	budget request for
4	entry of a
2	inspection program in
1	services, a compound,
1	food involved has
1	iv. (b) the
4	(b) any other
1	program goals using
1	authorizationthe secretary, after
1	failure to renew
1	claim of any
1	substances lacking abuse
1	advertisements and promotional
1	prescribed or for
1	advantage, or revealing,
1	special controls, if
4	thereof or supplementary
1	contains only dietary
1	poultry products will
2	center for fiscal
1	section. (2) if,
1	priority countermeasure that
4	notice, such hearing
1	unapproved product and
1	 (1) convene
1	substances are harmful,
1	treatment programs in
18	type ii active
1	date such applicable
1	research agenda for
1	subsection to issue
1	 (10) seller
1	security countermeasure with
1	form for shipment,
2	action necessary to
4	products described in
1	systems; (h) establishing
1	confirms within 7
1	thereon, as the
1	1, 1992, does
1	year 2011, $450,000,000.
2	drug the approval
1	activities to 
1	clauses (1) through
1	1970. in the
1	procedural matters 
1	annual registration; separate
6	cease distribution of
5	refund the fee
2	(a) that has
1	convincing evidence that
1	regarding providing to
1	section 1333(d) of
1	consumers to procure
3	equipment, or the
1	quarter to which
3	cease distribution or
1	caused by tobacco
1	testing of tar
1	condenseries in which
1	supplier agree that
1	2009, after the
1	paragraph (h). 
1	entity that collaborates
1	distributor confirms within
1	robust system to
1	 (ii) provision
1	firearm (as defined
1	animals if such
2	court deciding a
1	preventive controls, that
4	 (1) review
1	jury. when libel
1	hearings a certified
1	association. (iv) the
1	chemical) specified by
1	certification is false
3	known address in
1	exemption. (n) review
2	term law enforcement
1	renders them unhealthful,
3	section 355(c) of
1	writing. as soon
2	writing. (b) for
1	labeling, but differs
5	fees for all
2	activities in the
2	no-federal jurisdiction of
3	supervision by authorized
1	secretary for authorization
1	intentionally violates this
6	symbol prescribed by
2	appropriately marked and
1	continuous inspection system
1	regulation. after reviewing
1	throughout the distribution
2	coerces a person
1	shipment, at the
1	congressional committees (a)[1]
1	permit; suspension and
1	addiction, or any
1	must have knowledge
1	section shall, upon
1	assessment. (4) procedurenotwithstanding
1	maintain lists of
1	drug administration inspectors
1	amounts. (7) not
1	denying a petition
1	transactions subsequent to
1	 (d) detainer
1	(ii) due datethe
2	accredited person, as
1	cosmetic act (60
4	analogue of -pheny--[-(-phenylethyl--piperidinyl]
2	dtc advertisement is
1	(1) to alter
3	changes) and section
1	access to trade
1	675, 524a, as
1	defense capacities of
1	manufacture, (iii) there
1	(1) to steal
1	whether to revise
1	specify any provision
1	order.  (5)
1	inspection; quarantine, segregation,
2	term electronic product
1	act on any
1	document shall contain
1	magistrate judge is
1	iiit shall be
1	drugs, including antimicrobials
1	establishment (1) consists
2	occurring from withdrawal
1	assessment center. 
2	coordinated effective administration
1	respect to coordination
3	food safety studies
1	states. (c) there
1	distribution transactions quarterly,
1	harmonization of quality
1	(c) action brought
9	subsection (d), the
1	unlawful to 
1	terms abbreviated application
1	(a) a substance,
1	use by animals
1	therefor. after the
2	state that has
1	section shall specify
1	cash or i-kind,
1	564a, as added
1	per management entity,
1	convention. (c) an
1	secretary limits user
1	promulgating regulations 
3	subparagraph (b)(i) shall
1	(d) information submitted
1	lettering on such
1	ensuring that drug
1	united states) with
1	numerical identifier or
2	(b) exclusion the
1	351, 352, 355,
1	regarding such drug
4	scientific issue essential
1	(2) all fish
1	ch. 675, 506f,
1	innovative, collaborative projects
1	(mg) 25.0e 
3	estrogen or other
1	(3) all property
4	portion of such
1	2012, the drug
1	1996, as expeditiously
12	modified risk tobacco
1	national of a
1	agreements, to be
1	countries in providing
2	effects of methamphetamine;
4	center for devices
1	 (b) similar
1	recommendations for enhanced
15	notice from the
1	amount that, as
1	establish a favorable
1	effects of methamphetamine.
1	payment of reasonable
2	product standards the
1	eligibility determinations; data
2	official mark; (5)
1	section, including trial
2	interest that the
1	production of documentary
1	underage tobacco use
1	fact supported by,
1	making appropriate decisions
3	proposed labeling is
1	paragraph (3)(b). for
22	federal, state, or
3	said sections of
1	states or of
1	order issuance on
2	registration issued for
1	check, dirty egg,
1	identification to show
1	services, who has
1	 (l) safety
3	(b) the application
2	subsection unless required
2	registrant has failed
2	treaties or international
1	treatment of funds
1	(3) volum-based adjustments
1	interactions with sponsors
1	be, or is
2	fees for applications
1	food safety, the
1	distribute or dispense,
1	respect to prohibiting
1	returned against the
1	prohibited acts whoever
1	appeal from determination
2	administrator may grant
2	notice of importation
2	title 5. if
1	product standard can
1	45 of title
3	hazard analysis conducted
1	secretarys findings. 
1	term data refers
1	(as so defined).
1	terms of service
4	may prescribe the
1	otherwise discriminated against
1	committee is not
2	408, as added
1	(d) the priority
1	drug, the design
1	effect. the secretary
1	link and analyze
1	term foodborne illness
1	
 
 387e.
1	 b2 (riboflavin)
1	involved. in providing
2	alter, detach, deface,
1	379g. definitionsfor purposes
3	nevertheless be deemed
2	require, he shall
1	(e) share information
2	except the cost
5	solely for use
1	(9) who is
1	goat, or equine,
3	grant, after providing
2	upon a second
1	(c) not less
1	prescribe.  (3)
3	drug intended to
1	(1) qualified facilities
1	otherwise set forth
1	paragraph (2)(a), the
1	studies required as
1	food, is required
1	sample upon its
1	special data requirements
1	following findings: (1)
1	application in such
3	controls prescribed by
1	substantial increases in
1	section 360h of
1	regulate, promote, and
1	human health). 
1	conviction but before
1	evaluate the impact
1	incurred in the
2	dangerous, toxic, or
1	(1) the rule
1	recordkeeping for tracking
1	defendant, up to
2	admiralty and maritime
4	387f(d) of this
1	areas affected if
2	 (iii) that
3	information shall not
1	order, including any
1	abuse education; (b)
1	immediate action is
1	register) with the
1	added or that
1	free from insect
1	sections. (2) the
1	program agency submits
1	secretary to inspect,
2	section 360fff(2)(a) of
1	president has determined
1	(4) notwithstanding paragraph
4	-year exclusivity period
2	require a recall
1	602, 52 stat.
1	841(b)(1) of this
20	fees under this
1	safe as food
1	organizational unit of
1	section 331(q)(1)(c) of
1	registration requirement the
1	penalty, or upon
1	(b) setting forth
10	available solely for
1	(1) general ruleexcept
9	less often than
1	persons exemptedthe secretary
1	interactions to discuss
3	(2) to the
1	require the advertisement
2	entities or to
1	ending after fiscal
1	advertising of cigarettes
1	(a)(1)(c) so warrant,
2	intended use is
1	field of protecting
1	whoever knowingly distributes
1	conducted in the
1	organizations.  (b)
2	arrange for the
1	ch. 221, title
2	information first became
1	(k), 360b(a)(4)(c), 360b(j),
2	mixing in animal
3	effect on irreversible
1	secretary, including data
2	confirm or terminate
1	owners of vessels
1	(i) and (iv)
1	act, or an
1	services concurs in
1	reviews of costs
2	factor in the
1	reportable food submitted
1	
 188 to
1	(18) phenazocine. (19)
5	effective date for
1	specifically target state
1	model standards that
1	petition, or who
1	(d) factorsin establishing,
8	rare diseases or
2	product development meeting.
1	requests the committee
1	health.  (g)
1	program, as described
2	requirements until the
1	dosage form that
1	use paragraphs (1)(a)
1	investigation or prosecution;
1	contained in schedule
1	requested, that is
1	psychiatric association, or
1	transaction conducted during
1	law regulating virus,
2	equipment, chemical, product,
1	distribution, dispensing, importation,
1	term reinspectio-related costs
2	available in other
2	order as may
1	ch. 675, 524a,
3	fiscal year 2013.
1	confidential information, the
17	fiscal year 2013,
2	meetings or conferences
4	three years and
1	records; territorial limits;
1	(a) patient engagement
1	information it contains
2	individuals  (i)
1	(g) exemption for
1	states; (3) because
3	egg products processed
1	manufacturer and subsequently
1	(i) means a
1	525, as added
1	allow patients and
1	goalsthe strategy shall
1	showing that permitting
1	enter the order
1	assuring that eggs
1	pesticidenotwithstanding any other
1	respecting a claim
1	history of use
1	pasteurizing, stabilizing, cooling,
1	drugs near schools
1	(b) recommendations if
2	authoritythe secretary may
1	827(e) and 829
1	activities, and consider
1	term controlled premises
6	may be subject
1	package is composed,
7	court affirming or
2	immediately unless, before
1	conducted using the
1	treasury, shall by
1	(3) implement ant-doping
5	shall certify that
2	assert a counterclaim
2	establish advisory committees
1	mainland by any
1	supply; (b) is
1	administrative procedure for
1	user or health
1	mixture created for
1	(c)(2) and with
1	 (ii) applicationupon
1	gas means any
3	opinion of experts
1	tabulations from animal
2	reasonably applicable to
3	service, that such
1	10 percent shall
1	chemical, which is
1	filed following the
1	shall issue forms
2	(3) eligible establishmentthe
1	assistance of health
1	destroy condemned carcasses,
1	(b)(4) of that
1	content, delivery or
1	(c)(1)(a)(ii), (d)(1)(a)(ii), and
1	place of residence
3	acquiring, handling, or
1	studies of nondependent
2	changed by action
2	applications or supplements
1	agency shall provide
1	(ii). (c) specific
2	include as nonvoting
1	give the public
1	prominent notice informing
3	restaurants) who manufactures,
1	developing, and evaluating
1	time a national
1	course of veterinary
2	professional society meetings,
1	action; judicial review;
1	specific disclosure of
1	activities.  (f)
3	foreign country or
1	subpopulation for which
1	monitor and measure
2	drug for human
1	retail sale of
1	expertise, with due
2	federal law; and
1	(3) publication of
2	subsection (a). such
10	maintained under this
7	determined that the
1	numerical identifier means
2	federal register that
1	part thereof is
1	equivalent food and
1	coordination among federal,
1	violation is corrected.
2	consistent with sections
1	formula. (2) to
1	(b) a memorandum
2	views, exempt from
1	(i) all labeling
4	(f) specimens of
1	(23) etoxeridine. (24)
1	675, 402, 52
2	agencies and organizations
1	processor in lieu
1	(b) that there
1	studies and other
1	trial by jury,
3	product is dispositioned;
4	years, after the
2	ownership and control
1	212. offenses; punishment;
1	paragraph. (g)contract requirements.each
3	shall double for
1	complete a review
1	(a) requirements related
1	industry and labor
1	any) by which
1	furnish assistance, including
1	health (such as
1	order, or regulation.
1	advertising direct relationship
2	requested under paragraph
2	proposed rulemaking to
1	indicates the potential
1	employees when conducting
1	domestic traffic in
1	(a) requests for
1	nonnutritive substance which
3	administration that will
3	shall take the
1	minority communities. 
2	 (a) initial
1	investigation (that, at
1	applicability of provisions
2	employed more than
1	(i) either by
1	which, with respect
1	ingredient, the sponsor
1	local governmental agency,
1	except the initial
1	use. (v) full
1	september 30, 2009
1	title. (7) in
1	appropriate stability testing
2	sanitary protection equivalent
1	pharmacopoeia and in
4	investigations, studies, or
1	effective dates subsection
1	circumstances as the
1	business without a
1	533, formerly 357,
2	animal drug development
14	less than the
1	destroy such plants.
1	months.  (3)
1	(d); (b) establishing,
1	quantities of any
1	public notificationin conducting
5	regulations as described
1	consumers when it
1	regulatory purposes. 
2	enable secure tracing
1	petition within the
4	costs incurred by
1	intentionally delayed submission
4	upon any article
1	subsection (b)(2), the
4	another device within
3	will enable him
2	located, under subsection
1	intended; the secretary
1	drug and investigational
1	(b) a list
1	supply reduction for
2	accomplished; (2) steps
1	country to develop
6	hold a meeting
2	vacated upon the
3	requirements for a
1	investigations.  (3)
1	products, fees may
1	sharecroppers.  (

1	(a)(4) of drugs
1	transaction history of
1	food; (3) contact
1	et seq.]), and
1	 (2) electronic
1	elements by health
1	activities; (c) at
2	new information is
1	transfers from any
1	office in meetings
1	paris green, carbolic
1	trafficking areas and
1	high risk may
4	permanent impairment of
1	professional positions that
1	bears labeling which
4	health care services
1	seller is a
9	benefits and risks
1	process), only if
2	responsible connection with
1	may be, the
1	imposed upon the
3	prescription drug as
1	license until the
1	made aware of,
1	 (4) prenatal
2	disruption in the
1	2014, except as
1	register practitioners (including
1	issuance of permits
2	form and format
6	issued for a
1	 (5) no
1	$20,000,000, multiplied by
1	(1) (which person
1	harm allegedly caused
1	conditions, including requirements
1	misleading to a
1	may challenge the
1	cumulative amount, if
1	(b) issue guidelines
1	manufacture of methamphetamine.
2	requirements to the
1	manufacture of methamphetamine,
1	ingredient or whose
1	data; and (iv)
1	(2) chairman the
1	manufacturers before the
1	routine maintenance or
1	used; (vi) a
1	involving inspection of
1	(c) maintain records
1	evidence that each
17	5 years after
2	manufacturer means a
3	chemical and the
1	data from disparate
2	(a) a civil
1	(f) no right
1	awarded was approved
1	drugs.  (n)
20	animal drug for
1	food products; venue
1	(i) the packaging
3	savings clause nothing
1	(b) from and
1	cured, or otherwise
1	laboratory run and
2	thereto under this
1	proposal.  (e)
1	stat. 198; amended
1	purposes through chemical
1	assurances as the
1	progress which such
1	third party. 
2	consistently employs more
1	substance, shall be
2	safety and protect
1	usesnotwithstanding paragraph (1),
1	proxy votes or
1	requesting designation under
2	matter arising under
1	criteria that are
1	subsection (d) (relating
1	(1) no later
1	determine other products
1	shall identify or
1	infection the drug
1	trafficker identified in
1	387q(a) of this
1	inadequate information to
2	patent extensions). (2)
1	reallocations in the
1	monitor the development
1	acts set forth
1	respect to withdrawal
3	(e) refund of
2	title is approved
1	produce smoke, smokefree,
1	drug as the
2	agencies responsible for
1	competition means a
1	unsupervised use by
1	term drug excludes
2	amount established for
1	pharmacopoeia convention, incorporated,
2	personnel, facilities, and
1	substance abusers), supply
1	states, in a
1	preparation pursuant to
1	audit.  (b)
1	prior to slaughter;
1	schedules i through
1	(ii) documentation (which
13	year limitation to
4	(c) of subsection
2	title for failure
1	posed by such
4	least once in
1	development toolsubject to
1	subchapter ii, there
1	egg producer with
1	technical and financial
1	ch. 675, 565a,
2	 (d) judicial
4	determines are necessary
2	space; (4) policies
1	chapter v of
1	may, from the
1	services to inspect
3	(b) application, the
1	secretary for avocadoes,
1	exposure to anaphylactic
1	acid; (e) a
1	nongovernmental organizations that
1	nothing shall prevent
1	drug if it
1	
 
 384c.
4	tribal, and federal
1	far addicted to
3	application of sanctions
1	first time except
1	covered by an
2	authorized personfor purposes
1	assesses fees and
1	device. (f) initial
1	paragraph (2)(a)(i) and
1	patient at immediate
1	provide the certification
2	substances. (2) the
2	means guam, the
1	designated as being
17	effectuate the purposes
1	term qualified safety
1	dismissal of civil
1	croton oil, creosote,
2	(c) has developed
1	development responsibilitiesthe director,
2	programs under state
1	tools and devices
1	variance in whole
1	event the attorney
1	use.  (c)
1	 (e) quota
1	necessary, coordinate intramural
1	shall, in connection
2	program personnel who
2	commerce, the secretary
1	secretary may collect
1	manufacturing practice within
2	$1,000 nor more
1	shipping of the
1	(3) without authorization
3	known or reasonably
1	match advertising. (g)
2	establish and implement
1	numbers that correspond
1	distributed to consumers.
1	 (b) ex
1	secretarys authoritythis section
1	(b) poppy straw
2	manufacturer, processor, or
1	representing, or without
2	review (other than
2	proposed by such
1	thereof containing three
1	effect  (i)
1	recommendation is based
1	threat in each
1	years. a responsible
1	(iv) recruitment using
1	(a) $500,000 to
1	mutton the secretary,
1	(1)(c), the secretary
1	provide the necessary
1	detail of government
1	destroyed domestically and
1	(n)); and (ii)
1	establishing such standards,
1	including any requirement
2	state establishment as
1	distributor shall, in
1	(ii) applicationupon application
2	owner, or manager
1	requirements, as he
1	 (i) flexibility
1	 (2) requirementsthe
2	distributor may, by
1	condemnation under such
1	agreeing to repay,
3	353(g) of this
1	program using reliable
1	advisory committeeprior to
2	september 30 of
1	standards; and (b)
1	 (a) termthe
1	(gg) the term
1	monetary valuethis clause
2	whether the number
1	duration; release; removal
1	labeling as may
1	defense that there
1	word package where
1	subsection (c)(2)(b), that
3	development of drugs
2	(c), does not
1	ii compounded therefrom
2	number of animals
1	type of use
1	(f) crediting and
1	shall, when dispensed
1	commerce, any restricted
1	beings and includes
1	business enterprise; (7)
1	device, a statement
1	supplement ingredients described
1	particular controlled substance
31	substances in schedule
1	composed of the
2	posed by residues
1	(3) a product
9	due on the
1	period of fiscal
1	abuse. (2) scientific
3	requirements are met
2	compounded or dispensed
1	interests and with
1	device, a copy
1	participate in federal
1	states; (3) make
1	consent decree that
1	plan; (ii) information
1	material, chemical composition,
1	petitioner which are
1	withdrawal of approvalthe
2	presiding officer shall
1	citations to any
2	advised by the
1	amount only in
2	(ii) for fiscal
1	ultimate users who
2	either  (1)
1	representatives from federal,
1	benefits relating to
2	(b) application if
18	party to the
2	360e, or 360j
2	fails to establish
1	(b) health care
3	members of each
1	includes public 
1	(ii) within 2
1	470. omitted
 

1	product during such
1	year 2008, to
1	drug published. 
1	atmospheric administration to
1	using appropriate validated
1	person sells tobacco
1	response by secretary
1	administration stating that
1	(f) lamb and
1	feed directive issued
1	coca cultivated and
1	(g) any assessments
2	adulterated or misbranded;
1	equines shall be
4	schedule[1] i controlled
1	faith, the secretary
1	subsequent offense if,
1	imposed, under such
1	states. (2) when
1	chemical. the term
1	said food products
1	including any pilot
3	labeling changes that
2	intends to undertake
1	applicability of penalty
1	extent practicable 
1	development, activity level,
2	relates to noninfringement,
1	scientific, regulatory, or
1	(c) ex officio
1	report, including efforts
1	not, implicitly or
4	section, and any
1	conditions for such
1	derived from human
1	meetings  (1)
1	exportation of refused
2	listed chemicals (as
3	chapter as under
1	necessary to fulfill
1	respecting it was
1	(ix) -penty--(-methy--naphthoyl)indole (jwh122);
2	except rendering conducted
1	departments of agriculture,
1	care providers, and
1	expedite review of,
1	contribution. (b) considerations
1	conducted under appropriate
2	requirements within a
1	(5) pesticide residues
1	(a) authority of
1	concerning such evaluation.
3	inspection under paragraph
3	narcotic drugs, 1961,
1	154. regulations for
1	purposes of performance
1	(3) may obtain
1	particulars of the
1	smoking cessation, is
2	nervous system that
1	quality and regulatory
1	divided without difficulty.
1	675, 603, 52
1	reagent, reagent kit,
1	offered through the
1	snuff. (iv) chewing
1	growth, development, activity
1	deposit in accordance
1	drug production among
3	defined under section
1	uses, such drug
1	 (f) agency
2	assessed for such
13	part of an
1	ex officio members,
1	shall exempt any
1	ex officio members.
2	owning partly or
1	drug.  (f)
2	necessary to impose
1	product consistent with
1	(i) date certain
1	writing  (i)
1	regulation shall 
1	notification submissions. 
1	ex officio members;
1	title. all right,
1	others. (july 1,
4	(d) in the
1	manufacturer, or the
2	people with comorbidities,
1	response. (june 25,
1	exemption during testing
1	rules under this
2	will continue to
3	manufacture of controlled
1	title, the high
1	(iv) is approved
1	comparisons the secretary
1	1102. congressional declaration
1	(h) order of
2	pharmacy shall notify
2	fee due or
1	final regulation or
1	export; certificates of
1	(ii) documents pertaining
1	3101 note) or
1	persons written response
1	decision of a
6	drug which has
1	egg handlers, and
1	one use, or
8	decreased likelihood that
9	necessary by the
1	(a) exclusivities and
1	logbook requirement; training
1	custom slaughtering; name
1	proposed rulemaking or
1	shall, notwithstanding any
1	(c) consultation the
1	(4) procedurenotwithstanding section
1	datefacilities shall be
1	(b) and conforming
1	fertilizer nurse tanks
1	separately listing color
1	may also require
4	regulated seller or
2	projects  (1)
1	u.s.c. 1396 et
1	prompt notification to
1	enjoin the conduct
1	675, 740a, as
3	year pursuant to
1	faith releases information
1	subsection, plus amounts
4	ground for invoking
1	alter or obscure
1	hockey event or
1	conducts such review
2	transfer to another
1	exceeding $1,000 or
1	islands, kingman reef,
1	studying and recommending
1	him; or (3)
2	shown or unless
1	secretary may update
1	sense, means all
1	to, to copy,
2	(e) maintenance and
1	guidelines may authorize
1	guidance as necessary
5	entered into under
1	letter, unless there
1	term extension under
1	period.  (i)effectiveness
1	(b), a denial
1	means those ris-based,
1	feasibility of developing
5	evidence or information
5	index) for the
1	employees under his
3	457 of this
1	810, 52 stat.
1	method of payment
1	control strategy, and
5	secretary shall withdraw
1	shall require bioequivalency
14	wholesale distributor, or
6	selected establishment that
1	advisory committeesit is
1	effects on assistance
1	(6) urgent petition
1	heating source, or
5	receives a priority
2	subchapter i. 
1	additive only for
2	absence of effective
1	(1), and submit
1	(h) reporting requirements
1	logistics provider, or
1	revenue amounts specifiedfor
1	may not impose
1	title; (b) a
1	food, not adulterated,
4	shall refuse to
1	drug with other
1	area, within 30
1	standardsa tobacco product
2	drugs, or any
1	fees has been
1	article presents a
2	drug; and (b)
1	rechannel resources from
2	amount under paragraph
1	page 768) butter
1	requirements, and (3)
1	dracunculiasis (guine-worm disease).
1	water regulations under
1	postmarket controls. (d)
1	section.  (iii)
1	(6) hold, administer,
1	product fees (a)
1	section 352(j), or
1	additional regulations in
1	section 360eee3(b) of
1	information consistent with
1	otherwise applicable limits
1	
 1531. establishment
2	intent to influence
1	(
 
 458.
1	conduct any additional
1	statement of quantity
14	compensation and benefits
2	commits any offense
1	include soap. (j)
1	june 22, 1934,
1	1974, and $6,000,000
1	definition.  (2)
1	food recall activities
1	 (m) admission
3	columbia circuit. the
1	title;  (8)
1	submission under the
2	provide for medical,
1	(b) the disease
1	transport, distribute, receive,
1	manufacturer who receives
2	addendum to the
1	drug and supplemental
12	annual biosimilar biological
1	distributor of an
1	letter pursuant to
2	indirectly be changed
1	strategy and the
1	slaughtering animals or
1	360ll. notification of
1	egg products. (g)
3	49[1] of title
1	 (1) 3
1	substance an opportunity
1	dietary supplements, and
1	pharmacies, as distinguished
1	source acceptable to
1	efficiency of and
1	country provides the
1	food, cosmetic, medical
1	special registration. 
15	department or agency
1	appropriate; and (5)
1	of, or dealing
3	activity described in
1	secretary finds (i)
1	measures have been
1	risks that would
1	imposed in reliance
1	food sold; (ii)
1	purpose.  (4)
1	drug submissions that
1	federal law; (b)
2	effective.  (b)
3	exclusive jurisdiction to
2	apply only to
1	advertising, the attorney
30	 (1) a
2	marihuana, or depressant
1	chemically synthesized equivalent
1	products beyond a
1	withdrawn an abbreviated
1	agency prescribes interim
1	shall only apply
1	public servant authorized
1	detoxification, overdose reversal,
1	furnish (or, if
1	law. the findings
1	applicant; and 
1	adulterated; and said
1	title or respecting
1	policies; (3) provide
3	authorized to 
1	investigational submissions. (d)
1	standards and regulations;
1	advisory reviews equal
1	investigation is completed
1	consult with relevant
1	(c) be made
1	monitoring of (i)
1	may establish and
1	new staff, a
1	hearing, the petitioner
24	required by paragraph
1	accredited person has
1	extensions were granted;
2	required to correct
1	accomplished within the
1	objections to the
1	commissioner) who shall
1	(g) the authorization
1	data prescribed by
1	conferences.  (b)
1	subsection (h), or
1	chemicals, to any
3	district, may run
2	31 and section
1	trade organizations. of
2	serving it shall
1	1996, and annually
2	product regulated under
1	(5) because small
5	employ of the
2	manufacturer respecting such
7	consideration of such
7	 (a) officers
9	described in subparagraphs
2	secretary, shall inspect
1	intrastate commerce. (d)
1	samples, and of
1	effective, ongoing, and
1	conditions for legitimate
1	(e) denial based
2	manner that enables
2	changes in interpretation
2	compensation and travel
1	writing.  (2)
1	dispensing the drugs
1	upon a test
1	
 
 360m.
3	article does not
8	applications, supplemental abbreviated
42	4, 1907, ch.
1	verify the evidence
1	damaged, or unusable
39	considered to be
1	public. (2) such
1	medical air that
1	taken if the
3	applicability of the
5	381(d)(1) of this
1	application shall include
1	factors listed in
1	subpena. the court
1	transferee of such
1	section are made
1	exposure under the
1	otherwise have access
1	adulterated tobacco productsa
1	design, construction, and
1	decision.  (2)
2	simple notification to
1	distribution, or dispensing,
1	substantial clinical investigations
6	sentence imposing a
1	year. funds appropriated
1	adul-only facility. 
1	trafficking area; (f)
1	consumer shall be
1	 (1) acetorphine.
1	cost and shall
4	abuse of controlled
1	feed,  (1)
3	burdens upon such
1	(xi) state, local,
1	regulation, subregulatory guidance,
3	voucher issued by
1	expansion (a) definition
1	reasonable observer that
1	pediatric formulation was
1	exemption from section
1	judicial, regulatory, and
1	involved) be considered
1	evaluate countermeasures 
1	6 percent of
1	337a. extraterritorial jurisdiction
1	costs and recordkeeping
1	individual patient. 
1	shall show to
2	 (d) regulations
1	provide lot level
1	insure care of
1	(d) modification or
2	consolidated for trial
1	publish an action
2	28. (5) any
1	section. (b) registration
1	order. the secretary
1	article is required
1	subsection (b)(2)(b), and
8	product application that
1	physiological processes of
3	operator of such
1	 (i) corrected
17	shall be conducted
1	consistency with existing
1	private laboratories and
1	system, or standard
1	transferability  (a)
4	210 days after
5	shall work with
1	request adequate to
2	ingredients, components, and
1	(1) submissionbeginning 180
1	including, to the
1	funding for programs
1	residues exceeding the
1	702a, formerly june
1	except a substance
1	(e) sunset the
1	section 350j(c) of
1	levels, including coordination
2	approval and remove
1	year, the person
1	provided for and
1	offenses under this
2	confidential under section
1	staff510(k) device modifications:
4	establish the requirements
1	entered with prejudice,
1	subchapter ii, that
1	inquiry, that the
1	agriculture, representatives of
1	device is as
1	relative marketability of
1	(c) preliminary clinical
1	left in effect,
2	cause upon the
1	ch. 675, 541,
1	parameters of design
3	national intelligence program,
8	collect fees in
2	information.  (2)
1	samples, an identification
1	year ending before
1	prevents subsequent contamination
1	 (1) petition
1	prescriptions under the
1	may be called
1	(b) post mortem
1	manufactureit shall be
1	review fee revenues
1	(1) to conduct
1	include a common
1	containing such dietary
1	food produced or
1	party  (i)
2	sale after such
4	shall direct the
2	material threat described
1	health, include 
1	shall improve linkages
1	investigation under an
2	(b) application to
1	regulated persons may
3	october 1, 2007,
1	certification qualifying it
2	74, 1, 38
4	individuals with expertise
4	regulations (or successor
5	(4) public review
1	drug applicationsthe secretary
1	wholesaler does not
1	(3) reports by
1	purports to prohibit
4	subject to paragraphs
1	ch. 675, 505c,
1	procedures.  (6)
1	longer period is
14	purpose of this
1	maintained; and where
1	species animal drugs.
2	within any foreign
3	violation continues, not
1	means bodily injury
1	poultry and it
1	proposed strategy not
2	periodically thereafter, but
1	26 and exempt
1	inspection; refusal to
1	fahrenheit, as required
2	taken under subchapter
1	parts also are
3	title. such term
1	supervision shall be
1	123.3(k) of title
2	kept or made
1	(2) against any
1	approval or a
1	additive, whether commenced
1	appropriate access to
3	products inspected at
1	 (c) considering
1	requests a minor
2	made available upon
1	health and 2
1	demand reduction activities;
3	chemical which is
2	federal laws applicable
1	professional practice. (ii)
1	(w)[1] of this
5	held in the
5	(as added by
1	secretary classified the
1	actual changes in
1	december 1, 1990,
2	sale in normal
1	paragraph for any
1	purported deficiencies to
1	thereof, that is
4	ephedrine base, pseudoephedrine
1	standards in existence
3	approved to produce
1	(11) it is
1	dismissed, or if
1	approval, or promulgated
2	periodic audits conducted
2	point in the
1	(3) procedurein promulgating
2	1046 of this
1	sentence, at least
1	 (18) the
3	adequate within a
1	eyelash dyes or
1	program; (10) shall,
2	state or foreign
1	limited to consideration
1	waived pursuant to
8	drug, or tobacco
1	creative services donated
1	also be forwarded
5	submitted in an
1	surrogate endpoint that
1	(b), if an
1	agency center to
1	protection plan; (d)
2	drug approved by
1	implant. (5) implantthe
2	purpose, and may
1	limitation of authority
1	shall be attended
1	principles, are established
2	disclose to the
1	
 210. pharmacist;
1	subsection, and (b)
1	duly registered in
1	approval, and clearance
1	breakthrough therapy.) 
3	clause nothing in
1	secretary in guidance
2	time of any
1	products, the attorney
1	health risks presented
2	approved, conditionally approved
1	services. (e) the
1	owed.  (ii)
1	expended, without fiscal
1	machines, all encapsulating
1	paragraph (6)(a), through
1	trace food that
2	respect to small
1	(b) a compound,
1	aid in effectuating
1	within that genus
1	institute; (4) development
1	states. (b) recordkeeping
12	action described in
1	respect to device
1	partner that there
4	1912, ch. 273,
2	purposes hereinbefore set
1	if, regarding an
1	defendant owns, resides,
20	shall be based
5	order to enable
1	communication channels, including
1	(b) validation of
1	specifications for manufacture
1	adopt technology, and
2	documents of the
1	showing probable cause,
1	1261; renumbered 5
4	 (4) offset
1	353b(d)(4) of this
1	diagnosis by mail.
1	information and technology
1	information system to
1	listed chemicals into
19	act [7 u.s.c.
1	drug which occur
1	efforts to move
1	863 of this
1	authorized official veterinarian
1	(1) acetorphine. (2)
2	intended to provide
10	action against the
2	conduct evaluations under
2	transaction statement from
1	(1), the court
1	verify that 
1	questions of public
2	payment of storage,
1	operating reserve on
1	(e) work to
2	quarantine, segregation, and
1	person has 
1	(iii) the rights,
1	committee[1] on health,
1	devise, bequest, gift,
1	improving the safety
1	said purpose; (3)
1	using local data,
1	sent from the
1	cosmetic act. there
1	carrying meat for
1	(1)(c) shall specify
2	including a fast
1	foreign governments subject
3	350a of this
64	based on the
1	import a controlled
1	(2) update such
1	(e) state initiative
1	intended use for
1	used, to advertise
1	through, or to
1	standard of an
6	labeling or container
4	months of such
1	applicant shall have
1	(b) the proposed
2	 (d) misbranding
1	require under section
1	data submitted to
4	facility for which
1	name (regardless of
1	offense is in
1	(c) repealed. 

3	makes a contribution
18	duly designated by
1	expertise in food,
1	definition of an
1	special circumstances; expedited
4	seizure and condemnation
4	parts for the
1	u.s.c. 355] (regardless
1	pollution fund (hereinafter
1	section is completed,
1	advertising that violates
1	amounts specifiedfor purposes
1	[21 u.s.c. 355f(g)],
2	country, or territory
1	living animal. (c)
4	center for biologics
1	human food because
2	(g) judicial review
1	patent information 
1	auditor shall 
1	(ii) part of,
1	(1) a supplement
1	applicant that, on
1	
 
 623.
1	store sold a
1	(i) a practitioner
1	proposed standard; (ii)
1	(a) any of
10	considered incomplete and
1	subsection (b), (d),
2	requirement in effect
2	evidence presented, that
1	created or modified
1	(v) of clause
1	pharmacy every license
2	scientific evidence concerning
1	establishment is engaged
2	potential for abuse,
1	petition procedure any
1	medicaid services and
1	tobacco products means
1	replenishing stock in
1	spokesperson of the
1	laboratory analyses; research
1	(1) notwithstanding subsection
1	regarding such reviews.
1	promptly disclosed all
1	dietary supplement whose
1	apply to collections
2	facility each person
1	(a) shall state
2	fiscal year (after
2	tobacco products not
1	inspections closing meeting;
1	used for an
6	term process for
1	 (e) inapplicability
1	presumption of existence
1	subclauses, the approval
1	postmarket surveillance, including
1	title as of
1	inspections closing meeting.
2	necessary inspection training
1	stimulant substance means
2	verification request submitted
1	5, the director
1	labeling identifying it
9	order that the
1	products; (b) a
2	position described in
1	enter the pharmaceutical
1	repackager may satisfy
2	circumstances shall not
1	direct relationship requirement
1	adequate and efficient
2	licensure (as applicable)
1	creative services provided
1	paragraph (5)(a) shall
1	 (ii) shall,
1	use.  (5)
1	containing such drugs;
1	product radiation; 
3	results in 
2	publish a list
1	provided prior to
1	secretary may be
1	type; (e) which
1	detailed to office
3	conducted, supported, or
1	reporting of violation
1	egg products owned
1	devices that the
1	
 
 360e3.
1	dairy product (including
2	complained of in
2	brought such a
1	predicate device, include
13	include  (1)
2	drinking water regulation.
1	packaging or ingredients;
1	secretary; (7) knowingly
6	legal appeals have
2	 (1) reporting
1	section that were
3	person shall permit
1	conventional food or
1	(6) do not
1	(a)(1), or an
1	463, or 466
3	year except to
17	meaning given such
1	deleting a tobacco
1	willfully neglects or
1	assessed, or a
1	limits; fees and
13	regulated under this
4	items in interstate
1	section 237a(b)(4) of
4	flexibility to be
1	(e) and the
1	elements by such
1	operators of, or
1	7. (e) authorization
1	business for judicial
1	relief relating to
7	841(a)(1) of this
1	review review of
1	355(i) and 360(j)
1	 (1) real
1	debarment and such
1	developing such report,
1	integration center; and
1	chairperson. (c) dutiesthe
1	(6) review the
1	42; (7) 
1	plant if he
3	less than twenty
1	using a controlled
1	manufactures animal feeds
3	law.  (june
1	any, needed to
1	(4) late payment
1	(b)(4)(b), (c)(4)(b), (d)(4)(b),
1	achieved during each
1	formulations were not
6	professionals; (e) representatives
1	person be found
5	contrary to section
1	exceptiona prescription drug
1	(1) the processing,
1	certain cancer causing
3	workload of the
2	shall cast, print,
1	removal of fat
1	1151 to 1155.
1	(iii) in determining
1	section only with
1	1498(a)(1) of title
1	approved except in
1	accounting system and
1	shall schedule an
1	general population and
1	679. application of
1	entity of a
3	title is exempt
1	treatment technique required
8	shall make such
1	u.s.c. 136a(c)(5)] on
2	materials into any
1	 (i) afford
3	paragraphs (c) through
3	years. the adjustment
2	within the government
1	patient and public
1	provide written assurances
3	products that the
2	columbia from making
1	television advertisement that
1	interstate commerce. (c)
2	74, 6, 38
1	precursor and essential
1	agreements relating to
1	fluent both in
5	liable to the
1	necessary staff and
1	title and pending
1	distribution or any
1	proposed reclassification, including
1	lon-term drug treatment
1	penalty imposed on
4	determination not later
1	et seq.) as
1	keep, or furnish
1	commodities. the secretary
1	 (2) base
3	(3) shall not
3	 (2) definitionsfor
1	define the purposes
1	approval. (b) order
1	et seq.). (s)
1	states, to determine
1	things, if they
2	shall be transitioned
1	trial (as defined
1	distribution may be
1	together. (
 

1	clause (ii). (iv)
2	(c) if approval
1	responsibility for this
2	enforcement and injunction
1	information made available
3	360oo of this
1	commission may use
1	feathers, feet, head,
4	order if the
1	contains the terms
1	refilling a written
1	letter. if the
1	communit-wide strategies that
1	disorder research and
1	 (2) activity
1	parties.  (2)
1	chemical, soil or
1	certified as an
1	demonstration projects, and
10	(3) the attorney
1	(c), issue an
1	(a) or (c),
3	controlled substances. (

2	collect fees to
1	least fifty points
1	(ii) pediatric studies
1	subsection as he
2	endangering of the
1	drug was received
1	device. (j) evaluation
2	misleading, or in
1	including managing the
2	material threat posed
1	made during an
1	businesses; and all
1	discretion.  (j)
2	351(i) of the
5	petition was filed
1	otherwise, acquired by
1	protect the food
2	title, section 387k
1	brought, arising from
1	venue in addition
1	early in life
1	(2) for prescription
1	packaging for purposes
1	obligation only if
1	health organization, pursuant
1	listing number to
1	class with respect
2	paid, if any,
1	shall remit the
1	foundation; and (ii)
1	food allergies. (g)
1	account recommendations from
1	vouchers under this
1	paid.  (4)
5	depressant, or hallucinogenic
1	investigational drugs of
6	premarket application, premarket
1	materials for lifesaving
1	packers, or distributors
2	exemption pursuant to
1	indexing continues to
1	agreement, that describes
1	(iii) the secretarys
1	businesses; fee reduction
2	 (i) changes
1	sale in domestic
5	(2) not later
5	notwithstanding any provision
1	stationed in each
1	section 331(i)(3) of
1	user means a
1	(a) rules and
1	manufactures the animal
1	food, but only
1	procedure shall conform
1	promulgate regulations limiting
1	(
 
 1546.
1	 (d) exemption
2	relief and compensatory
1	provision shall remain
1	subparagraph (d)(ii) shall
2	time of purchase
1	plan as necessary,
1	partial substitute for
1	feasible, the state
4	nearly as may
1	clause (ii), each
7	annual establishment fee
1	annually thereafter until
2	limiting the period
1	inspect food offered
1	triggered by any
1	sufficient to demonstrate
1	generic drugsbeginning with
3	requirements do not
2	(such as division
2	setting forth any
4	mail or common
2	property to the
1	person to review
1	control points, if
1	goals, and future
1	foreign government and/or
2	 (2) supervision
1	panel meeting to
1	maintain procedures 
1	rules promulgated under
5	issue a written
5	used in paragraph
1	effects on infants
2	furnish the advisory
1	court, and tried
1	approve under section
1	subsection (a)(1), (b),
1	one year of
1	repel, or mitigate
1	liability as sellera
1	paragraph (2)(b). (b)
1	said meat or
1	(ii) consult with
2	request for access
1	individual, has been
1	research projects, demonstration
6	one year or
1	inclosed in said
2	exclusively to medical,
1	publish it. (3)
1	logo, registered trademark,
2	intends to commence)
1	provides that the
3	confidential information by
1	complete, and make
10	vegetables that are
2	drug application concerning
1	farm that was
1	hiv infections, teenage
3	section 371(e) of
2	 (c) establishment
108	shall not apply
2	ingredients, for use
1	barriers to translating
1	united states. prior
1	manufacturer that employs
1	
 880. administrative
2	petition the court
8	animal drug intended
2	tobacco product intended
1	request for studies
1	may be directly
1	exclusion provided by
2	days announcing that
2	regulations as he
1	like or related
1	articles which may
1	of, any material
1	enhanced prison sentence
1	civil penalties: 
1	assessed if the
1	demonstration has not
1	adequate and well
1	issued not later
1	submit reports by
1	due diligence; (5)
1	agencies to implement
1	united states are
1	market authorization a
2	fee. the amount
1	user. (h) inspections
1	children. in its
1	section 387f of
1	person determines that
1	administration. the center
1	year makes more
1	(including social media),
1	filed for such
2	laws or such
1	standard memorandum of
1	performed on such
1	 (1) $240,000,000
1	element to show
1	(b) a libel
1	law, asking applicants
1	committee. the size
2	drug applications, investigational
2	contingent on a
1	elderly, women, handicapped
1	discontinuance he has
1	187. transferred
 

3	section 203 of
1	inspections and reviewsif,
1	seq.).  (4)
1	drug when dispensed
1	section 1332(2) of
1	(d) accounting of
5	availability of the
1	corrected.  (4)
1	coverage of the
1	(2) grant of
1	(e) data elementsthe
1	narcotic drugs, or
1	funds to combat
1	(i) notification of
2	expertise in pediatrics
2	information, suggestions, estimates,
1	radiation. as a
1	preceding sentence, for
1	(10) shall, in
1	entity is capable
2	perception, behavior, and
1	personal supervision, or
2	given such terms
1	 (2) surveillance
1	finding, in which
4	defined for purposes
2	outsourcing facility subject
14	2007, the secretary
1	prohibiting the use
1	duties and responsibilities
1	smoking and carburetion
1	include the ionophore
1	foods that have
1	office) shall have
2	calendar days spent
1	medicine of the
1	notificationif the manufacturer
22	information that is
83	act [42 u.s.c.
2	(1) establishment 
1	purpose of manufacturing,
6	553 of title
2	union of pure
1	(c) suspension or
1	including any practice
1	different use of
1	(b) regulations for
1	event of depressurization
1	term school includes
1	prohibited from introduction
1	committee members that
1	unless on or
1	shall not determine
2	different use or
1	section for 2
1	drug administration; (ix)
1	5. repealed. june
1	absence of proof
1	defect relating to
1	coordination with authorized
1	animal in violation
1	drug the importation
2	identify appropriate susceptibility
2	public generally. it
2	abuse training center
1	law enforcement organization
1	youth marijuana use.
1	paragraph (1), nothing
5	general shall consider
1	(b) was given
1	anyone in control
1	products by any
2	make an inspection
1	upon qualified data
2	occur after the
1	secretary. each foreign
1	(2) maintenance by
4	proposed regulation; (b)
1	15.  (6)
1	datethe initial biosimilar
1	two dosage units
3	another entity. the
1	related to type
14	order with respect
1	color additives suitable
2	treatment as domestic
1	(2) the label
1	
 617. clearance
7	u.s.c. 136 et
1	making payments in
1	require.  (e)
1	paragraph (2), practitioners
1	homepage, the following
1	particular; or (b)
1	place such information
1	vitro or in
1	time entered are
1	herbal ingredient derived
1	used for components
1	applicable exclusivity period
1	offense punishable by
1	denial of variances
1	1501 et seq.);
1	i-person or teleconference
3	submission of data
1	title when issuing
1	2002, and such
1	administration shall not
6	urban consumers (all
1	allowance made for
1	disposal of specific
1	by, through, or
1	facility, legally accessible
3	upon receipt by
1	products a product
5	unit, with one
1	obstacles. (c) criteria
4	connection with such
1	affected agency or
1	coastal islands separated
1	unavailable  (1)
1	need for, and
1	prepared, propagated and
1	including actual abuse,
1	corporation of cattle,
1	experimentation data. 
1	legal interest in
1	organizers, or leaders,
1	order. in the
2	psychotropic substances. the
3	sales for the
1	ethnically diverse communities
1	[42 u.s.c. 247d6b]
1	health than those
2	shall promptly upon
1	marijuana use 
1	outbreak to a
1	appropriated, such sums
1	therewith, the receipt,
7	area of focus
1	drugs are in
1	(d)(1)(b).  (ii)
1	testing means 
1	surety bond of
2	application contains a
1	practicing in the
1	reconstitution is necessary
1	numbers of any
1	fish of the
11	subsection (c) for
1	reporting of drugs
1	book at the
1	offices have made
1	time; and (ii)
3	(2) the date
4	applications, or investigational
1	consult with pharmaceutical,
1	22501(b)(1)).[1]  (b)
1	drug. (e) the
1	individuals that, as
1	reasonably foreseeable hazards
1	issuing the regulation
1	report; and (iii)
1	received from federal,
1	use. (iii) appropriate
2	pharmacopeia recognized by
1	number so qualified
1	diminishing the authority
1	prevent any recognized
1	used for testing
2	compounded therefrom into
1	antimicrobial activity. (5)
1	basis, review the
1	action initiated under
1	distribute a list
1	chapter, and describe
1	
 360ff1. targeted
1	admission all charges
1	adults  (1)
1	assays within any
9	sums transferred shall
2	secretary shall in
1	estimates made in
2	types of tobacco
7	may be safely
1	entry order violations
1	labeling and replace
1	holds a license
3	register criteria to
1	regulatory action that
1	geometric isomer. (15)
1	requirement made by
1	(c) preventive controlsthe
1	transaction, be subject
1	retain a third
1	identify the items
2	interoperable electronic data
1	customarily used on
2	hold such food,
1	drug or its
1	determines that submission
1	expertise the ex
1	information to a
1	meat broker means
3	 (b) condemnation
17	salt of the
3	substance and any
12	(d) of section
2	kilograms of hashish,
1	conventions, and protocols
1	activities to minimize
1	c-homolog); (iii) -penty--(-naphthoyl)indole
1	transverse diameter. (aug.
1	licensed under the
1	 (2) assuring
4	selling, or transporting
2	order with the
1	separate and apart
1	studies under this
2	devices classified in
1	drugs, for maintenance
1	review and determine
1	compliance by egg
2	established name and
1	studies and the
1	assessment is made,
1	(2) upon written
1	without elements to
1	false statement or
2	383(b) of this
3	person is the
1	exported, in violation
1	regulation that pursuant
9	major disease area
2	set aside the
1	 (1) manufacture
1	international organization deemed
2	affiliate thereof. (12)
1	general.  (b)
2	pesticide chemical under
1	(2) recruitment activitiesthe
1	substance that the
1	food after given
1	governments strategy for
1	963. attempt and
1	7 business days
1	labels it shall
1	packer, distributor, or
1	form. (5) the
1	misbranded or adulterated
3	(h) collection of
1	person.  (7)
1	cosmetic act, meet
1	(c) advertisement 
1	system  (i)
1	(
 
 1702.
1	general every establishment
1	partner of the
2	(e), or (f)
1	
 
 680.
1	federal cooperation and
1	drug contains more
1	moneys forfeited under
1	2017  premarket
1	(a), and plans
1	registrant involved is
1	management expenses. 
1	tobacco product), packing,
1	(a) was not
1	241 et seq.);
1	 (a) applying
1	adequately labeled for
2	material which may
1	restrictions applicable to
6	labeling is not
1	 (i) authenticate
1	armed services of
1	6333(c) of title
1	15, except that
2	(a) the effectiveness
3	diseased poultry or
2	states), or to
1	vegetables, or butter,
1	total user fees
2	(ii) take such
1	(c) exposure of
1	(a) notify the
1	subchapter; or (b)
4	order for such
1	drugs if they
1	secretary), to help
1	discovery from a
2	years prior to
1	package insert, if
1	notification of governmental
1	relevant entities and
1	means department of
1	title of a
3	biomaterials supplier to
2	analysis of drug
1	subsequently referenced in
1	regular importer. at
3	illness or injury.
2	one thousand feet
2	(iv) if a
1	valid provisions that
1	color additive, (ii)
1	meeting not earlier
1	carry out paragraphs
1	address the best
1	packaging, or storage
1	food coming into
3	attorney general, a
1	beginning 270 days
1	(1) include 
1	(
 
 1055.
1	issue the guidance
1	copy of that
3	beginning of each
1	establish.  (2)
1	made, and (ii)
1	coordination, and mutual
1	(iii)(ii) continues to
2	pursuit of approval
1	consideration to the
1	foreign countries shall
1	place to which
1	healthif, at any
1	testing or otherwise
2	information  (i)
1	 (b) reimbursement
1	regarding successful law
1	recruitment using targeted
1	pursuant to subchapter
1	 (m) include
3	period of two
1	request, shall respond
1	(aa); (bbb) the
1	used. (g) eligibility
1	instead of or
1	questions, including through
3	mixes or categories
1	norpseudoephedrine, its salts,
2	(a) on average,
1	trade any drug
2	publication of list
1	priority drug or
1	establishments); and (d)
1	gas is or
1	complainant to his
1	appropriate court of
1	(or testing programs)
1	use. (6) to
1	pediatric assessments, and
1	affirm the order
2	 (g) service
1	ch. 675, 533,
1	procedurethe secretary shall
1	persons for whose
1	notification; (b) the
1	pesticide within such
2	disability or incapacity;
3	compliance with which
1	listthe interpretive criteria
1	product); or (b)
1	(d) other coordinated
1	respect to food,
6	narcotics traffickers and
61	human drug application
1	2018.  (b)
1	ch. 77, 58
1	misbranding provision the
1	least minimum standards
1	administration an image
1	pays a reactivation
2	definitionsin this part:
1	formerly 13th par.,
1	assurance. for a
1	orders in the
1	food; (ii) has
1	respectively. (b) the
2	fee rates as
1	issued but to
1	determined under such
1	fishing vessel (as
1	(ii) $652,709,000 multiplied
1	effect in all
1	year 2016, which
13	account without fiscal
1	director considers appropriate,
5	accepted for filing
1	cease use of
1	title 18, no
1	(2) construction nothing
1	 (e) uniform
2	provided by a
1	regulation; and (3)
3	ii.  (b)
1	find necessary to
1	teleconference review. 
1	states when he
1	(2) -methox-3,-methylenedioxy amphetamine.
1	panel, as used
1	including on the
1	import, the secretary
1	intelligence information to
1	designed to automatically
3	intervention programs designed
1	scientist shall 
1	poultry producers with
1	access to prescription
1	sellers with staff
4	2012 during such
1	title or approval
1	25, 1985; or
1	allow any party
1	inspection service, the
1	adequately compensate for
4	record upon which
1	forfeited property to
1	control, from the
2	subsection (b)(3) for
1	assets the income
1	advisory committee includes
1	one class, and
1	paragraph (3) are
1	tools, diagnostics, manufacturing
1	fiscal year, beginning
1	director for coordination
1	regulations, and all
1	subsidiary or affiliate)
1	cigarette. unless otherwise
1	variance requested and
3	subsidiary or affiliate,
32	provided for in
1	subsidiary or affiliate.
3	composed of experts
4	application for judicial
1	transfusion, radioactive drugs
1	 (i) holding
1	misleading.  (june
1	interests in the
1	sponsor fees the
1	(b) managing the
1	initial report (and
1	gas deemed appropriate
1	u.s.c. 61 et
1	susceptibility to intentional
1	holds a valid
1	designated:  schedule
1	forthwith revoke or
8	implementing this section,
1	implementing this section.
5	subsistence, as authorized
1	exuding or free
1	compendium published after
1	manner; or (4)
1	(b)(2). (d) antimicrobial
1	system means a
1	intravenous drug that,
1	initiatives to gather,
2	juice, and lo-acid
1	(5) drug development
4	request of such
5	morbidity or mortality
2	determines not to
1	determine their effectiveness
2	(b), prescribe regulations
1	administration, could be
1	notification shall constitute
1	inspections (including seizures
1	foreign food facilities
1	measures, as appropriate;
1	  b12
1	elect to use
1	eggs of the
1	831. additional requirements
1	regarding recordkeeping requirements
1	enforcement, suspension, and
1	misbranded or adulterated,
1	2017, the amount
1	sponsor to overcome
1	1996, and determined
1	satisfies each of
1	secretary to assess
1	part) meetings as
1	repackager for individual
1	inspection services. (

1	effective under this
1	secretary, matchbooks of
2	acting at the
1	use direct final
1	completion of testing
1	ch. 675, 909,
1	for, manufacturing, processing,
1	number, professional degree,
2	representative access to
1	section 1769f(b) of
1	involved is notified
1	voting member positions
1	25).  (i)
1	interest and ensure
1	year the information
40	years after the
1	additional credentialing bodies
1	person had an
2	tests show that
1	countr-product combination, and
1	trend of the
1	likely to reach
1	psychotropic substances means
1	controlled substance activities
3	destroyed for food
2	judicial processes, notices,
1	 (i) relates
1	start of every
1	past year. 
1	significantly minimizing or
1	2004; (f) the
1	contentthe proposed rulemaking
2	supplement, and not
1	order suspending the
1	choose not to
1	drug, in its
1	v to carry
1	ingredients which may
1	effect. (8) a
1	(a) the end
1	deemed approval. (june
1	secretary shall reinstate
1	small business, taking
2	systems or products
1	
 2011. definitionsin
1	(d) pizzas containing
2	supplier verification activities
1	(b) penaltiesexcept as
4	permit or license
1	certification or certifications
1	may agree upon),
1	products. (2) limitation
1	high potential risk
1	(4) methylphenidate. 
1	debarment, and the
1	to, or refused
1	facilitate the identification,
1	purpose.  (c)
1	(17) smoke constituent
1	(
 
 852.
1	imported for medical,
1	restriction, the use
1	vulnerable points; and
1	test results from
1	eliminate or substantially
1	duplication and inefficiencies
4	accessory of a
9	finds that a
2	includes each of
1	(1) drugs marketed
1	publication, including an
1	managing the funds
1	3, 1891, as
1	president shall appoint
1	80 percent of
1	promptness. in addition
1	involved in accordance
1	contentseach report under
1	drug to ensure
1	paragraph (1). this
1	  b6
4	business, in or
1	secretary) shall intensify
1	establishment and implementation
1	outreach and technical
1	container shall be
1	section 355(c)(2) of
1	chapter, when, in
1	order for up
1	sunscreen order set
1	(1) identificationthe secretary
1	identification number described
1	years; (2) has
5	consumers (washingto-baltimore, dcmdvawv;
1	made by that
1	(i); or (5)
1	respect to access
1	(4) availability the
3	funded under part
1	naturally formed or
1	form, that the
1	public health, law
1	determines is otherwise
2	secretarys own initiative;
5	due upon the
2	measures for the
1	resides or is
1	commerce; and (b)
1	advice, to him
1	section 384(b) of
1	drugs (a) removal
1	(i) the yearly
1	partnership, shall submit
1	coordinate with private
1	annual report requirement
1	international agreements on
1	(d) noncompliance by
1	(ii) if so,
1	separated therefrom by
1	commerce or the
5	may be up
1	age group can
1	courts of competent
1	(ii) uses or
1	disposition of goods
2	substance that was
1	387e, 387f, 387g,
1	publish such proposal
1	
 379j52. authority
1	withdrawal.  (c)
2	waiver or refund),
2	sale by any
1	section, or section
1	safe, wholesome, sanitary,
1	(3) the delivery
2	means a patent
2	proposed, the secretary
1	inspections described under
2	preparation containing a
1	year;  (b)
1	regulation establish the
1	10 milliliters of
1	review, or not
1	containing not less
1	proposed labeling appropriate
1	questioning, and to
1	licenses issued under
1	quality, etc., or
1	drug if any
1	ingredients not having
1	local growing conditions
1	paragraph (11), there
1	 (f) exemptions
1	health requirements contained
2	may expend up
1	(mg) 0.15 
1	providing targeted recall
2	true and accurate;
1	participate in appropriate
1	states while using
2	data exchange among
3	whole blood or
1	(i) a person
1	drug that results
1	practitioner practices and
1	issue involved. 
6	fee for such
1	thereof which are
1	relevant to material
1	executed and returned
2	right to make,
2	commissioner if the
1	shall publish for
1	boards; and (b)
5	manufacturing or processing
1	funding to a
3	relating to research
1	person on behalf
2	product.  (4)
1	used instead of,
2	training and education
1	human contact with
1	586g, as added
1	libel for condemnation,
1	restrain or stay
2	prescribed by paragraph
4	(c), (d), (f),
1	retailer of a
1	reports that 
1	treat and the
1	methods of competition).
1	v, who are
1	 (2) referral
1	application within 30
2	(3) with respect
1	statement on the
3	standard is no
1	954. transshipment and
1	drinking water may
1	1264; renumbered 21
1	paragraph (h) of
2	drug administration responsible
1	controversy, and which
1	activities to conduct
1	termination of designation;
1	prescribe tests or
1	application is pending.
1	detoxification treatment means
1	means the several
1	director not later
1	directed to be
12	(c) the secretary
1	labels or advertising
1	product, of the
1	described in (1).[2]
1	(1) for use
1	federal laboratories or
5	statements, designs, or
1	focus its testing
1	eggs, and certain
2	high risk populations,
1	shall be ordered
2	investigational use in
6	enforcement administration, the
1	property and interests
1	importer offering food
2	title, that the
1	may review such
1	time during which
1	register, shall establish
1	tobacco additive, the
2	360, 360f, 360h,
1	six members of
1	biological product was
1	(c) provide such
1	joint food safety
1	state. (ii) for
1	(1) articles intended
1	3-day notice, a
3	human life, the
1	appropriateness of waivers
1	personnel to and
1	manufacturing and the
1	article authorized for
2	manufacturing changes 
1	multiple doses; or
1	aside.  (d)
1	employment. (b) a
5	material and that
1	contents; publication 
1	inspections performed on
3	submit a statement
1	repackager, the repackager
2	delaying the approval
1	address the appropriate
1	(a) any price
1	which, after having
1	retention of such
1	experienced personnel and
1	crop insurance act
1	feed containing such
3	 (1) means
1	violates paragraph (13)
1	property pending trial
1	uses.  (k)
1	regulation, instruction, or
1	 (i) patients
1	(i) is licensed
1	shall after affording
1	sorting, packing, and
2	comprehensive, coordinated lon-term
1	identifying characteristic the
1	retain any money
4	control points program
9	nonnarcotic controlled substance
1	appropriately should be
1	publication; priorities 
5	provide the applicable
1	 (4) proposed
2	campaign and whether
1	issue interim guidance
3	graphic matter (1)
3	demonstrable difficulties for
2	public comment upon
1	shall on conviction
2	statement, design, or
2	requesting a public
1	subpoenas (a) except
1	approved application. (b)
1	used to reduce
1	subparagraph (b)(iii)(ii) if
1	basis, that the
1	designate the uses
1	information to proactively
1	societies, voluntary health
2	allocation of federal
1	
 372a. transferred

1	chapter; (2) subject
3	human food; (b)
2	i-kind contributions, raised
1	policy; (2) coordinate
1	milligrams of pseudoephedrine.
1	detention is filed
1	spread of heroin
1	postmarketing conditions, including
2	2017, the excess
1	date, restrict the
2	establishments (as defined
1	approved application. 
2	actual need for
1	(i) $652,709,000 multiplied
2	holding of products
1	therapies, including complementary
1	title, within a
5	applied to the
1	distribution of human
4	application, or (ii)
2	drugs or device
1	subsection. any exemption
1	1033(a)(8) of this
2	extent applications 
1	message or purpose
1	2 years prior
2	commenced (or intends
1	reviewers have sufficient
1	within a legitimate
1	requirements in generalas
1	(2) waiver authority
1	children with lif-threatening
1	fiscal year 2004;
1	modernize medical, veterinary,
2	title 18; (c)
37	determines that such
1	animal experimentation data;
1	considered the manufacturer
1	pennyroyal, tansy, rue,
1	animal experimentation data,
1	(l) assessment of
1	expressing concerns that
1	commerce means (1)
1	senate; (b) the
1	usable to manufacture
1	conviction alleged is
2	360e(d)(5) of this
1	eggs; prerequisites for
2	conducted by inspector
1	shall be printed
2	deliver to the
1	condemned; reinspection for
2	submit assessments under
2	clause does not
1	sulphate of copper,
1	purposes at the
3	generalwith respect to
1	cooperative agreements between
1	properly labeled with
1	739, as added
1	42. (ee) the
1	(1) have ceased
1	administrationbecause of the
1	drug under consideration;
2	annual notice establishing
1	effect beginning on
1	give, pay, or
1	sun protection factor
1	otherwise be unavailable
1	information about new
1	(1) such oleomargarine
1	even though suppliers
2	regulation prescribing, amending,
1	division personnel unless
7	within the department
2	proceedings and the
1	plan, would be
1	section 1391 of
2	specially certified (the
1	year. (
 

1	 (i) sale
1	general schedule. while
2	columbia may, consistent
1	subparagraph (b)(i), an
1	harmonization continues consumer
1	 (d) serving
1	355a], any report
1	 (29) wholesale
1	eggs, and otherwise
1	refined oil derived
2	requirement that an
1	regulatory policy that
1	(1) periodically, or
1	(7) civil action
3	made effective immediately.
2	establishments if such
1	expended.  (c)
1	may require; 
1	storage of food
1	participating in that
1	institute; and (6)
1	control such diversions,
5	submission for a
15	collection and obligation
1	5.  (2)
1	(1)(a) of such
1	percent cal 30.0
1	916, as added
1	substance has not
1	applicant has requested
1	ch. 262, 2,
1	
 215. consul
1	particular disease or
1	radiation, the secretary
2	protects the integrity
1	approval an article
1	appeal of the
2	shall (a) issue
1	purity characteristics, that
1	practitioners (including pharmacies,
1	origin, (c) the
3	cooperate with appropriate
1	proceeds thereof, if
1	applicants conviction record
1	reasons for its
1	(c) when necessary
1	evaluation means a
1	  54.0.
3	use.  (2)
1	505e, as added
1	review. the review
1	management guidelines as
1	controls means those
1	(e) use withholding
4	describing the progress
1	conduct and complete
1	(including substance use
1	(7) nothing in
2	device, and (b)
1	fruit or canned
1	1996) an effective
1	entity shall comply
1	(v) of section
32	containing a detectable
1	dextromoramide. (13) dextrorphan.
2	(i) the name
1	supplement that are
3	regulations to carry
1	(3) documentation of
1	terminate, with or
1	include a supplemental
1	review. (2) if
1	determines such reimbursement
2	injunction proceedings, minor
1	reserves, and finally,
1	(a) under section
1	receiving such services;
1	no-replicating nucleic acid
1	requirements to devices
1	unless (1) it
1	specific disclosure about
1	thereto.  (

1	requirement of certification;
1	including electronic forms
2	material used therein
5	investigation of such
1	office and to
1	serve as director
1	approval of that
4	held with respect
1	business of each
1	presentation of data,
2	(a) a portion
1	drug) that is
1	sufficient for purposes
1	duration of grants
1	support data management
1	witnesses, compel their
1	(ii) such advertising
3	shall be available,
1	2009, a cigarette
2	time its labeling
1	16) shall be
1	violated a requirement
2	states; and (2)
1	pesticides under an
1	thereof. (kk)priority supplement.
1	2007 through 2009.
1	states, any worthless,
14	general except as
1	physical tests necessary
2	practitioner, to pharmacies
3	decision under subparagraph
1	samples of infant
2	provided under a
1	relies; (b) this
1	basis of ruling
1	v, the order
2	(or, if the
2	series of violations
1	
 679. application
1	protocols to undertake
4	greater value than
1	qualifying the first
1	section 360b(c)(2) of
1	analytical methods by
14	personnel compensation and
3	served by a
3	proceeds of such
1	case of new
1	(i) inapplicability of
2	(2) a food
1	authorize lon-term care
1	states (including its
1	states. (3) process
3	distributors of precursor
3	(e)(1) to modify
1	include requirements to
1	(1) as to
2	containing opium, or
1	program, based on
6	court for the
1	clause (iii). 
1	(i) international drug
1	1039, 1040 or
1	recommended by (i)
1	conducting clinical investigations
1	criteria standard means
1	obtainable under this
1	respective states or
12	long as the
2	(c) limitation the
1	process as described
1	applications if an
1	(a) and that
1	(2) the results
3	impairment of human
1	2010; and (5)
1	to, or deposited
1	clinical data are
1	priority drugs. 
1	states demonstrates that
1	certificate granted under
1	(j) filing of
1	102(33) of the
2	 (1) other
2	appropriate participation, through
1	may be cited
2	concerning the relationship
1	(b) plans for
2	article used for
3	 (2) date
2	office of minority
1	propose pediatric labeling
1	(a) when a
1	container no article
1	filing but before
1	use and health
1	(c) is authorized
1	(k) evaluation 
2	product of any
5	title iv of
1	make the summary
1	effective law enforcement
1	fee setting for
1	research laboratories, including
1	enhanced drug distribution
1	factual basis therefor,
1	animals prohibited; preparation
1	ch. 675, 568,
1	regulations). (2) the
1	or[1] chapter 53
2	(b) the cumulative
2	subordinate governmental unit
2	among the states
1	medicinal ingredients not
1	forms. (4) that
1	methamphetamines, that is
3	subsection (d) to
2	evidence in support
1	provide overall direction
1	final. (e)confidential information.
6	business day on
4	guidance issued pursuant
1	include at least
2	poisonous, insanitary, etc.,
2	issues a final
1	administrator shall implement
3	secretary shall reimburse
1	forfeiture event occurs
7	secretary may establish
1	congress to occupy
1	laboratory supply sold
1	eggs.  (b)
5	new drug are
1	inspected device establishment
1	federal employees and
1	inspection and the
1	$2,500 or less
1	2016 exceeds the
1	period, or of
2	regulation or guidance.
1	352(f)(1), 355, and
2	387e, or 387i
1	paragraph, the presiding
1	proceedings minor violations
1	bass, flounder, or
1	modular applications withdrawn
1	required in subsection
1	otherwise permissible to
1	force development; (3)
1	columbia, and shall
1	management entity, for
1	fee established pursuant
1	loan made, insured
11	whether the person
1	applied for an
1	general advice on
3	prescribe so that
1	study planthe initial
1	action under subparagraph
1	order the manufacturer
1	regulation may require
1	except to comply
1	901, 1(100), 45
2	(b) consistent with
3	agent or agents
1	(10) participate in
1	report concerning, for
1	letter of authorization,
1	term radiation disclosure
1	542, formerly act
1	animals and shall
1	national infrastructure protection
1	inspection budget any
1	prevent a state
1	title) any information
4	first 3 months
1	scheduling of recently
1	(ii) shall maintain
1	required; and (v)
1	made by section
1	able to provide.
1	bearing such residue
1	chain. such projects
2	authoritythe administrator may
1	(c) dutiesthe tobacco
1	section to qualify
3	classified under criteria
1	indirectly in the
1	drug applications; food
1	duly accredited official
1	subject solely to
1	knowledge is acquired,
1	subparagraph.  (4)
3	recommendation of the
1	stating the action
4	et seq.] for
3	application is not
1	upcoming fiscal year,
1	approving the petition
1	assets committed to
1	specific nanomaterials of
1	 (3) submission
1	respecting the distribution
2	within the timeframe
1	841(b)(1)(a)[1] of this
1	venue any civil
12	makes a determination
1	thereof, obligations for
1	promulgate regulations 
1	(2)(b), or (b)
1	review of dtc
2	requirements as set
1	quantities exported; and
1	(5) for fiscal
1	treatment, or requires
1	tubes and devices;
3	individually identifiable health
1	products for commerce,
1	title; and the
1	made, such excess
1	(12) who is
2	factors set forth
1	application. (ii) the
1	purpose of so
1	violation. the petition
1	children. (f) food
1	defendant to reimburse
3	receptacle or covering
1	conducted and which
1	may employ or
1	provided under clause
1	internet web sites,
1	reduced in frequency
1	copper, gold, lead,
4	denying approval of
1	designation the director
1	subsection. the court
1	commerce, science, and
1	subsection to bottled
1	may be needed
2	benefits associated with
1	appropriate, to such
2	intending to file
2	section 360e(d)(5) of
1	allergens are properly
4	submitting tax returns
3	shall introduce or
1	notwithstanding subparagraph (2),
1	interpretive criteria website).
1	may consider 
2	congress or any
2	carried on or
1	avert such shortage.
5	(b) there is
1	connection with affixing
1	(32) normethadone. (33)
1	
 384a. foreign
1	knew that the
1	deletion of a
1	incubator reject, inedible,
2	 (iii) information
1	secretary shall notify,
1	federal benefits: 
1	 (i) consistent
1	year and in
1	duty of such
1	complete petition with
1	time to decision
1	(c) shortage of
1	forfeitures  (1)
1	section; or (5)
2	appropriate to adequately
1	term medical gas
1	format.  (ii)
1	technological feasibility, as
3	attained the minimum
2	addition to remedies
1	dispensing, of a
1	mandatory conditions to
3	submitting the supplement,
1	information of vendors,
1	1992. subsection (k)
1	(b)(4)(a). all other
1	tribal affairsthe term
1	same, and to
1	sales under false
1	dietary risk from
1	title; (d) the
2	residue does not
1	duty without pay
2	nature of recalls
1	(c) continuing criminal
11	75 percent of
1	within such sixt-day
1	food supply; (2)
2	(b) its label
1	extends from no
74	approval of a
1	water regulation that
1	product, and on
3	application fails to
1	device sponsor, may,
1	discretion, grant by
1	attorney general at
1	approved continuous inspection
1	milk, or cream
1	professionals with expertise
1	foreign cooperatives and
1	provides for appropriate
1	(cc) the patent
1	electronic food certification,
1	apply to packages
1	objectives established under
1	secret information to
1	 (l) records
1	period of any
1	requires each person
1	2202. national agriculture
2	new drug approval
1	tribal officials. (c)
1	secretary to prohibit
3	filing in the
1	treatment has not
1	
 
 379h2.
1	ch. 675, 721,
1	least twice a
1	approved product, a
2	knowingly offering to
2	temporary order issued
1	crisis means, with
1	criminally. however, in
1	381. imports and
1	reasonable manner, the
2	shall modify or
1	675, 709, as
1	minimizing the probability
10	assessed under this
2	(including a foreign
1	and, in violation
1	year. such information
1	electrolytes; (bb) a
1	no-federal laboratories that
1	activities under section
1	views, orally and
1	benefits do not
3	title to use
1	research relating to
1	domestic manufacturers of
21	applicable to such
1	recommendations shall 
1	(including creative services
1	(b) only after
2	title 26. 
1	forth a scientific
1	sentence.  (6)
1	charges concerning refused
1	(h) of such
3	law.  (b)
1	points of contact
2	secretary determines before
16	contains any quantity
1	thereof; (2) between
1	shall not contain,
1	learned, by due
1	criteria in accordance
151	(1) in general
1	controls to ensure
1	account his cost
2	suspended and probation
1	aggregate exposure levels
1	distributed, or sold
1	will switch to
2	 (2) information
2	(c) request for
2	data; or (c)
1	(1) deadline 
1	subsection (b)[1]) subject
1	believes would cause
1	contentsthe notification required
1	health insurance plans,
1	(c) timing of
1	(a). (6) no
1	control against diversion;
4	(1) it is
1	format. such requirement
1	action, with respect
2	available information about
1	considered unadulterated while
1	respect to both
1	 6.0. 
2	noninfringement, the notice
1	performance standards, or
3	mitigation strategies or
16	whereby it may
1	facilitate the sharing
1	(ee) counseling and
4	drug  (1)
1	private sector; and
1	techniques for use
1	ch. 675, 586c,
1	serious risk have
1	persons having management
1	(or intended to
1	1173. transferred and
3	administration  (i)
1	washington and elsewhere,
1	identify the specific
3	submitted by such
4	adopted by the
2	provisions respecting control
1	products into the
23	(b) in the
1	access to, the
3	committee with respect
3	jurisdiction to affirm
1	(c) to obtain
3	report, the director
1	application other than
2	contacted for service
1	number is 100
1	change that results
1	details on the
1	discuss the initial
1	 (2) designation
6	review of pending
1	illness associated with
2	including representatives of
2	paragraph that is
4	application could not
1	congress declares that
1	rate for each
1	chemical synthesis or
1	amended [21 u.s.c.
1	date of submitting
1	1524(b) of this
1	exporter involved in
4	shall be consolidated
1	gene where such
1	better recruit and
1	use for medical
1	355, and 360eee1
2	preparation containing chloral
8	state law. 
1	initial grants the
1	evaluation and report
2	labeling change. 
5	testimony of witnesses
1	(1) in 2007,
1	drugs and allow
1	substance use monitoring);
1	egg products in
1	report.  (2)
1	committee to be
1	without additional coloring
33	imported into the
2	(or agents thereof)
2	fully with this
1	relevant science, that
1	poppy, and coca
1	communicate risks associated
1	based on marijuana
1	electronic product that
1	withdrawn as a
1	requesting agency action.
20	engage in the
1	risks.  (ii)
1	include each drug
1	comprehensive, coordinated drug
1	(4) designation prior
1	except that whenever
4	activities  (1)
1	economic development programs
1	registrant first engages
1	(1), may subsequently
1	seem proper, if
1	additional conditionswith respect
1	paragraph (4), select
1	timing of the
1	requires that such
1	foodborne illnesses by
1	misbranded  (1)
9	drug for the
1	residue if 
1	refuse to allow
1	workforce planning 
1	(d) knowledge of
1	substances under the
1	investigations, by experts
1	procedures meet such
1	available training or
1	includes the disclosure
1	public health, include
16	shall make available
1	systems under paragraph
4	state to the
1	(i) for conduct
1	adulterated and poses
1	dialysis solution); (d)
2	agency, is authorized
1	requests for deferrals,
1	provided by regulations,
1	misbranded drug into
1	principal use of
5	applicable to appeals
4	require.  (2)
1	hiring authority (a)
2	animals, each person
1	give away any
1	name and signature
2	procedures a state
1	trials (a) review
1	made to appear
1	reimbursement and in
1	formula by subsection
1	usual. (o) the
1	animal carcinogen, or
1	schedule are made
5	contain the information
1	criteriathe secretary shall
1	manufacturer has applied
3	post mortem inspection,
1	logbook), except that
3	subsection shall submit
1	authority for importation
1	repackaging (in which
1	product shall (1)
1	data from previously
2	pesticide chemical has
1	decide whether to
1	 (i) compares
3	provide that such
2	may in accordance
1	research organization; or
7	consistent with this
1	(1) the seafood
1	observed no-compliance with
1	regulation which makes
1	(1)(b) that is
1	knowledge means that
1	fees due, any
1	(i) conditions of
1	forth the name
1	products, as appropriate;
2	possession, and use
2	health insurance portability
1	involved, and in
1	title as if
1	per 100 grams
1	(
 
 1174,
1	sections of title
1	mission; (9) conduct
1	(3) the compliance
2	section for any
1	rico, the northern
1	to, or by,
1	subparagraph, respecting such
1	(a)(1), a drug
1	trust territory or
3	clause for the
3	year.  (e)
2	manufacture, promotion, or
1	distinct sponsors of
1	requirements.  (a)in
1	auditor satisfies the
1	drug in each
1	trust territory of
1	processed as required
1	portion thereof, obligations
1	canned, corned, packed,
1	accreditation to conduct
1	secretary establishing a
1	otherwise stated the
3	18 or $2,000,000
1	education, treatment, rehabilitation,
1	title.  (20)
1	screens, permanent screens,
1	qualified en-userthe term
1	condition. a supplement
1	drugs, including heroin.
1	referenced on or
2	subsection (b)(5) of
1	(1) every registrant
1	
 360g. judicial
1	handling, storage, or
5	general shall take
3	device from class
1	(
 
 379d1.
1	drugs, and may
1	location for disposition
1	 (2) after
1	articles, to the
1	 (j) other
1	administrator is able
1	includes ethylene oxide
17	secretary is authorized
1	must be enhanced.
1	schedule i(c) and
1	shall set forth,
23	year after the
1	
 
 335.
1	ch. 74, 10,
2	osteopathic association, the
1	(3) promising technologiesthe
1	serve as consultants
1	reasonably require; (f)
1	fahrenheit, as prescribed
1	federal governments; (ii)
4	(4) with respect
2	patent defined for
3	delayed because of
10	responsible person shall
1	committed. (july 1,
9	general shall by
1	spread of infectious
1	(3)mail order reporting.
1	borders. it is,
1	burden of proof;
7	freedom of information
1	system requirements to
1	bequests of real
2	agricultural commodity which
1	including the sales
1	instituted if no
1	 (1) report
1	nanomaterials within the
1	(g) may have
1	denies, or limits
1	capacity with respect
1	laws that relate
1	title. (3) amounts
1	 (2) internet
1	occurs  (a)
1	furnished (before export)
3	education, and training
2	responsible person) shall
2	web sites of
1	sale drug paraphernalia;
1	services;  (ii)
1	substance, or to
1	will accept, catalog,
1	1 package per
1	bacterial sinusitis, acute
2	scientific purposes notwithstanding
1	eligible under paragraph
1	information maintained by
3	marketing of the
1	title 5, while
5	documentation demonstrating that
1	agencies, develop and
1	therefor, unless (1)
1	respectively, for review.
1	food system (including
2	interstate commerce; or
1	(iv) the most
2	regardless of weight;
1	countermeasur-related technologies and
3	11, 1955, ch.
1	purpose, and otherwise
1	treatments among relevant
3	6101 of title
1	policies to reduce
1	filed under applicable
1	interpretive criteria standardsin
1	discovery of a
2	includes any person
1	product; and (2)
1	district, compound or
1	oversight authority granted
1	section 387f(e)(1) of
2	appropriate credentials, as
1	recognized his request
1	including the information
2	animal or plant
2	person shall, except
1	following approval and
2	renderer, or animal
1	committees of any
3	preparation of such
3	notification  (a)
9	costs and fees,
1	broad range of
1	foundation under subsection
1	transfer under this
1	full cooperation with
1	detect a significant
1	establish.  (c)
1	subsection which will
2	government recognized under
1	establishment of drug
1	1970, and from
1	(ii) the lifetime
1	oxygen provided pursuant
1	united states (or,
1	contentsthe reports under
2	will be due
1	may be, final
3	purpose of audit
1	include a rationale
4	premarket approval for
1	states. (27) the
1	address the panel
6	review of prescription
1	nonmedical electronic products
1	will promote honesty
2	procures, or causes
1	health emergency or
1	appropriate sampling or
2	reports to attorney
1	donations the attorney
4	year) multiplied by
1	control purposes or
4	quantity of a
1	16, 1988, the
2	agreed upon pursuant
1	requirement to reanalyze
1	tank shall be
1	chemical residue under
1	correction or removal.
1	research activities; and
1	secretary to obtain
1	fee revenues are
1	section 673 of
1	information needed to
1	appropriately assessed by
1	available for purposes
1	resistance. (vi) in
1	chemical for purpose
1	establish a 1-member
2	possession, distribution, and
1	ch. 800, 2,
1	may secure directly
2	recall authority 
1	invest, and spend
1	shall each be
1	provide for mandatory
1	drug administration official
1	interruption or loss
1	register specifying those
1	condition requiring postmarket
1	classifying devices under
1	except for pasteurization
1	products referenced in
1	rodenticide act, if
1	included by the
1	him.  (g)
1	master files that
1	(b) identification and
1	relevant pediatric subpopulations;
12	secretary may assess
1	hazards from radioactive
1	modified. (e) data
2	intended to contact
1	(4) evaluate the
1	(b) grant authority
1	sustained only if
1	inspection; list 
1	revocationnotwithstanding paragraph (1),
1	based on appropriate
1	subsection; or (b)
2	preceding sentence 
1	grant.  (iv)
1	prompt assignment of
1	feeds manufactured at
2	anabolic steroids 
2	title 28, bring
1	requestor unless (a)
2	public health emergency,
1	(3) intended to
1	confidential information if
1	warning statements as
1	upon the issuance
1	processes, and other
1	5. the only
1	(e) 10 grams
1	corporations whose permanent
1	achieve the purposes
1	countries for export;
1	(1) are 
2	secretary and that
1	merit of a
2	subparagraph (c), as
1	stage of disease
1	container if its
1	thereof, but also
1	actsthe following acts
1	sought. (4) the
1	removal, or secretion
1	required in accordance
3	device or devices
1	
 953. exportation
1	successes of and
1	narcotics trafficker means
1	commerce and results
2	value of food
1	distributor shall, upon
1	facility. (b) the
1	container. labeling, packaging,
1	379e(c) of this
1	(e) additional potential
1	distributor may return
1	pharmacist to compound,
1	inspections in accordance
2	compendium if it
1	(
 
 872a.
2	goals identified for
2	procedures  (1)
1	thereof:  (1)
2	due.  (f)
1	effectiveness of federal,
1	enforcementnotwithstanding any other
1	signs the written
1	another to do
2	reported in a
3	medicine therapies and
1	involvement  (a)
3	commensurate with the
1	otherwise not eligible
1	identity, a reasonable
1	biomarkers, and other
1	relevant thereto. 
1	drug as it
1	(1) methods, facilities,
1	health of children;
3	fewer than 500
1	 (2) maintenance
2	reference to type
1	term reprocessed, with
1	optimize national laboratory
1	development authority has
1	threats.  (g)
1	953, 954, and
1	property and was
1	basic pay in
6	review and evaluation
2	humans posed by
1	time. (2) applicable
1	shall deposit in
1	least 25 per
1	execute seizure by
1	(2) inapplicability of
1	authority, shall establish
1	device. (c) if
20	paragraph (1) of
1	death, that is
1	limited to, injunctive
4	regulation require that
1	event shall the
4	subparagraphs (c) and
1	enforcement information (a)
1	drug or device)
1	103 of title
2	homeland security that
5	facility may be
4	purpose of investigating
1	holder, not later
1	technology. (v) the
1	42 that cites
1	(1) shall maintain
1	believe they exist,
1	including data compiled
1	fee beginning on
3	rates from the
3	household of such
1	standards for premarket
1	support the large
1	data.  the
4	conducted with the
1	writing, regarding all
1	sufficient to justify
2	time specified in
1	(b) whose results
1	device if it
1	subsection, means the
1	young children and
4	human services, a
1	331(ll) of this
1	$235,000,000. (c) for
1	act. while a
1	675, 506e, as
1	theft of drug
1	systems, as appropriate;
2	pay paid pursuant
1	biological product. (3)
1	inspection any officer,
1	state licensing fees
1	proposal of the
2	may be in
1	otherwise caused or
5	reports of new
14	order shall be
4	(including lot level
1	(b) the juice
1	closing meeting. (c)
1	headed by an
1	practitioner as an
1	procedures and proceedings
1	pediatric conditions of
1	(b) that submits
2	third party, including
1	fund), consisting of
1	measured by national,
1	drug may not
1	(b) each establishment
1	(1) reinstatement on
3	policies and practices
1	section 247d7e(e)(1) of
1	dissemination with respect
1	reach these goals,
1	sex in accordance
1	submission reviewed under
1	(b) project designthe
1	probationers, and parolees.
1	certain convictions; other
1	upon implementation. 
1	pay, or offer,
1	seq.] nonfat dry
1	(2) filing determinationnot
1	directive applicable to
2	least 10 years
1	inventions of the
3	projects aimed at
2	 (c) limitations
4	availability of a
1	experience or scientific
1	certifying its gross
3	designated as spices,
1	public report, advice
3	patent term restoration
4	biological product; or
1	case of liquids,
1	thirtieth day following
2	device is for
1	term informal hearing
6	within such state
3	review voucher the
1	shall exempt by
1	sunscreen. (b) procedure
1	research. (22) the
1	
 
 350h.
1	regulations apply. 
1	recovery of penalties
1	bioequivalence studies of
1	diminish any authority
1	proposed design for,
1	plant cannabis sativa
1	(1)(e), the term
1	reg. 4131441372 (august
1	eggs which have
1	1. at the
1	(3), any pesticide
1	supplement the record
1	
 360bbb4a. priority
1	may withdraw such
1	(a) utilize the
1	processed. (w) the
1	evidence and applicable
10	component of the
2	listed in any
1	statistical, epidemiologic, or
1	authorities and responsibilities
4	imported contrary to
1	(c) no authority
1	(b) claimantin response
5	201(j) of the
1	particular drug because
2	sunscreen orderin the
1	amount in controversy
1	requirements of subsections[3]
1	(2) if 
1	effective in achieving
2	facilities and operations
1	15, as added
4	determination of substantial
1	temporarily suspended at
1	bring an action
6	often than once
1	standard; or (3)
1	recordkeeping, and funds
1	scientific issue, specific
5	abuse among youth
1	business is the
1	 (iv) decontaminating
1	furnish samples of
1	rebuttable presumption of
1	infringed.  (i)agreement
1	compendium, and if
1	implemented or are
1	certifications or guarantees
1	entity, for purposes
1	establishments, and conveyances,
1	investigational device to
1	failed to register
1	container unless it
1	product being reviewed
6	suspend the sentence
1	surveillance under subparagraph
2	(i) at least
1	individual or entity.
1	public area reserved
1	title) being exported
1	section for programs
1	involve information properly
5	act of june
1	reasonable term to
1	 (3) procedures
1	office shall, for
1	recipients for such
3	subsection (e). 
1	otherwise dispose of,
1	weeks or more
1	fact, except that
1	aggregate to 1
1	minor species; and
1	enter into memoranda
1	deem necessary; in
2	states, excluding the
1	oxygen, the treatment
1	registration numbers, names,
3	order.  (2)
16	conditions described in
1	(5) if an
1	(a) is created
1	drug for medical
1	subparagraph (3), for
1	 (iv)contents of
1	individual) shall not
1	clearly premature. (ii)
9	development of the
2	section 503(b) of
1	1502a. transferred
 

1	minimize the cost
2	insignificant for the
1	 (a) sponsor
1	include such additional
1	input of interested
1	fraud, forgery, deception,
2	finished medical devices,
1	unavailability of raw
4	reserves of carryover
1	(5) and (6)
2	media campaign operates
1	application.  such
1	fish is raised
1	saccharin includes calcium
1	shall be operated
1	abuse programs. 
1	use guidance documents
13	preparation, propagation, compounding,
2	application, at the
1	make arrangements responsive
2	concerns about the
1	(5) definitions 
2	secretary may file
2	received for distribution
1	(c) programs that
1	agreement from each
1	reduction, state, local,
2	wrapper, or cover.
1	new scientific tools,
1	form, dosage strength,
1	judge who has
1	present controls; (c)
1	live animal or
1	validated test systems
1	availability, which shall
1	selling any scheduled
1	made. (d) annual
1	 (2) states
1	develop, conduct, and
1	device recalls. 
1	devices (a) definitionsas
1	related to review
1	twice in any
1	states tobacco product
1	prior approved application
1	awards, bonuses, and
1	abstinence from tobacco
1	construction subsection (a)
1	(g) partnerships with
1	health care cost
1	action covered under
2	application the attorney
1	without the intention
1	parents and students
1	delivery and the
2	 (2) compliance
2	section shall provide
3	person so requesting,
1	submit a pediatric
4	activities of such
1	first providing notice
1	distance of 12
1	develop additional data
5	schedule under section
1	application of treaties
2	products (as such
1	sections 360i(h) and
1	previous years strategy.
2	person to have
1	chemical a person
2	medication guide, as
1	 (5) timelinesthe
1	subsection (a)(2); or
2	reduce the incidence
1	violation with the
14	time as the
1	consumers); (v) available
1	year; and (d)
1	section 360e(f)(6)(a) of
1	360bbb8c. patient participation
1	one time will
1	stated, have any
1	testing, or investigations
2	cooking, freezing, dehydration,
1	prohibited actsno person,
1	authorized activities registration
1	submitted or as
2	common control with
1	(m) assessment of
1	following cancellation of
1	entity;  (b)
1	substances. the attorney
1	preservation of the
1	safety hazard or
1	year, the manufacturers
1	registrant) who fails
1	group basis in
1	251.)
 
 17.
1	manufactured in the
1	(5) the applicant
1	1971) has become
1	ii the punishment
1	1522. purposesthe purposes
2	extent practicable in
3	secretary a fee
1	food. (2) hearing
1	 (a) encouraging
1	 e (iu)
1	(iii) facilities producing
1	national organization that
1	annual fee limit
1	21, 1995, ordered
1	preparation to be
1	another organization.if a
1	manufacturers); and (2)
1	listed chemicals 
1	consider scientific evidence
1	section 306 of
1	him.  (i)
1	patient participation in
2	internationally recognized standar-setting
1	device.  (7)
1	use funds from
1	(2) a request
1	3, 1966 (80
1	(i) comprehensive, researc-based,
1	agriculture in cooperation
1	jury trial in
15	filing of the
1	include any material
1	operation is maintained
1	described in subitem
1	 (f) wrongful
1	fails to obtain
2	compliance of each
4	drug, and such
3	safe as a
1	previous determination made
2	date for the
1	addition to representatives
2	(or in his
1	204, as added
1	process at which
1	birth to 18
4	secretary concerning a
1	term transaction means
1	statement in labeling
1	whenever the administrator
4	licensee, assignee, or
1	sources, with the
1	353(d) of this
1	similar acts, and
1	both; but if
1	physostigma, phytolacca, strophanthus,
5	rationale for the
1	part 601 of
1	policy changes to
2	storage, and other
1	(3) submission of
1	advisable to carry
1	(1), of any
1	implant shall be
1	toxicity and completeness
2	prescribed by or
11	later than 15
2	later than 14
1	contentthe program established
2	later than 12
1	conditional approval, specified
5	provides to the
1	general no establishment
1	additional information with
1	acting through a
26	later than 18
1	craving relief or
1	(b) or (e)
1	morphine per 100
4	implanted in the
1	distributes and 2
1	whatever official name,
1	relevant standards under
1	comprising no-replicating nucleic
1	conflict with such
1	comment that such
2	market exclusivity under
1	water pipes; (3)
1	(c) detailing the
1	advertisement and acceptance
1	rights, status, and
1	applicant that submits
1	comments received; (d)
1	year availability 
1	(a) a tobacco
2	increasing the total
6	member shall be
3	 (iii) records
2	investigate a safety
1	government entity unless
2	drug of a
1	section 343(j), 344(a),
1	claimant files a
1	term anabolic steroid
2	reviewing the drug
8	oleomargarine or colored
1	include a bovine
9	limitation. the sums
2	initial interpretations of
1	supply reduction activities;
7	publish the final
5	regular ful-time employ
1	forfeiture of such
1	authority for scientific,
1	schools and colleges
1	consumers within specific
4	available under the
1	lack of name;
2	review groups as
1	drugs (hereinafter in
1	minor changes in
1	i, or ephedrine,
1	one fiscal year
1	(b) serve as
1	defect, the manufacturer
1	profile of such
1	 (6) any
1	suspended. the order
1	pet food; (2)
1	of, postmarketing data
1	 (i) noncompliance
1	drug, of data
1	360dd. open protocols
9	evidence available to
1	existing community resources
2	proceeding. nothing in
1	clarifies the policy
1	paragraph because it
1	inspection services; continuation
1	adjustment will not
1	obstruction of justice
1	reportif a responsible
1	part because of
1	furnish notification of
1	2012(a) of this
5	18 or imprisoned
1	ch. 675, 744i,
1	duplicate for a
1	drink that is
1	good reason to
1	rights, privileges, or
1	causes food to
1	meet the remaining
1	may require and
3	shall promptly after
1	(ii) limiting the
1	processing the term
1	exemption from other
1	food on detecting
1	facility compounds from
1	term quarantine means
1	reporting (a) tol-free
1	means to facilitate
1	provide a timetable
1	information; (ii) describing
1	may require any
1	size, strength, and
1	registration.  (e)
1	breaking eggs or
20	positron emission tomography
1	penalties the secretary,
2	judicial review (a)
1	intelligence program or
2	nervous system: 
1	360oo. prohibited acts
1	pediatrics (including representation
3	available to any
1	aimed at the
1	about, a patient
1	years after approval
17	application filed pursuant
1	prevent the aggregate
1	series of events
1	nasal cavity. 
1	exclusivity period. (e)
1	foo-related emergencies, including
1	chemicals, tableting machines,
1	blending, pasteurizing, stabilizing,
6	direct that such
2	article 7 of
1	applies, the term
2	united states the
1	 (1) availability
1	substances and subsequently
1	deterrent effects of
1	offers to sell,
4	fee collected in
1	(i) 7 individuals
1	grase if, notwithstanding
1	sciences of developing,
1	chain may, in
1	product application fees
1	satisfied; (d) the
1	commodity shall be
2	become effective under
2	inspection in accordance
2	repackaging or otherwise
2	section shall set
1	coupon means a
1	successor regulations) to
1	request. (2) 
1	 (iii) for
1	controlled substances listed
1	fact exists as
1	aggressively and creatively
1	$2,000,000 in a
1	manufactured, manufactured from
1	genus panax; and
1	regarding alcoholic beverages
1	paragraph (1)(b) that
1	(b) procedure the
1	ch. 675, 739,
1	protein targeted drugs
1	authorized to possess,
1	security countermeasures the
1	manufacture and control
1	product. the manufacturer
1	(v) establish licensing,
4	(f) rule of
3	collecting, developing, and
1	medical needs. 
1	methods to rapidly
1	regulatory teams established
1	paragraph (1)(b) than
1	government and that
1	be, final determination
1	submitted. (iii) a
1	enforce a temporary
1	1103. repealed. 

1	article; and the
1	federal agency or
1	auditor is accredited
1	(f) such person
2	following the procedures
1	subsection in order
3	section 361(a) of
2	registrant made such
1	abbreviated application shall
2	may direct through
1	(4) and (8)
1	act, the secretary
1	required record; or
1	produced in compliance
1	analytical methods capable
3	every case be
1	year 1985 and
1	drug safety signals;
1	data that 
1	section 361(a) or
1	supplying false information
6	one business entity
1	may be useful
1	united states. oaths
3	affect the animals
1	(533 u.s. 525
1	providing  (a)
1	slaughter for the
17	duties of the
1	designation the secretary
2	(i) a drug
1	(b)(ii) and shall
1	notification to an
1	efficiency of postmarket
1	organizations), shall facilitate
1	proposed clinical testing;
2	dru-resistant organisms in
1	incidence of the
1	measurement tools the
1	deadline; (b) the
1	food, or nonfood
2	creation and maintenance
1	grant  (1)
2	 (2) an
1	process; (ii) humidifies
1	july 22, 2016,
1	investigations, including 1
1	issued such certification.
1	enantiomer of the
2	ineligible for all
1	safety, the drug
1	action in achieving
1	(2) required usesthe
2	title 15on the
2	duties as are
1	funded on reducing
1	strategy, the director
1	inspection performed under
1	determines that provision
1	preparation valuable medicinal
2	chief financial officer
1	system design and
2	 (2) as
1	maritime claims, except
4	drug is submitted
1	inspected by one
2	subparagraph (a)(ii) for
1	transmission, storage, retrieval,
2	application feethe secretary
1	finds based on
1	determine the status
3	appropriate and necessary
1	dismissal contained in
1	order, a hearing
1	action in such
1	(
 
 822a.
2	administrative penalty or
1	products for children
5	administration, the dosage
1	including countermeasure sponsors
2	taking of reasonable
2	pesticide chemical, or
2	5 years, after
1	provision of documentation
1	task force, and
1	seq.); or (e)
1	judgment, may jeopardize
1	imported from production
1	thir-party auditor, through
3	examination, upon request,
1	fees due or
2	accreditation under this
1	(2ct4). (26) -(2,-dimethoxyphenyl)ethanamine
1	commerce, or sold,
1	processed, packed, received,
3	activities under the
2	holder to correct
1	distribution centers of
2	statutory requirements to
1	(7) enter into
1	involved submits a
1	caused the destruction
1	activity, policy, practice,
1	made, and the
1	declared unconstitutional, or
1	
 862b. sanctioning
1	article. (p) the
1	paragraph (5) or
2	assist in avoiding
1	regulation on that
2	change in design
1	financial affiliations between
1	
 360fff7. report
1	contamination; (ii) preventing
2	term genetically targeted
1	use; (b) reductions
3	adulterated (except as
2	notices published under
1	675, 565, as
1	extracted, isolated, or
1	appropriated (1) $153,000,000
1	food to affix
1	school nurses, teachers,
1	property by sale
9	standards set forth
4	drug administration or
1	commission, compensation at
1	goats and the
2	health care system
2	drug administration on
3	total supply of
4	electronic database a
1	members with expertise
3	drug administration of
1	commercial food establishments;
1	revenue for a
1	reagent kit, ingredient,
2	renewal grants under
1	(6) an ingredient
1	agency relationship the
1	general any practitioner
1	etiology of, the
1	continuing abuse of
1	product tracing; and
8	poultry producer or
2	commerce, under any
1	federal rule[1] of
1	period at which
1	service, the postal
1	equal treatment of
1	precursor in the
1	including a study
1	use thereof conform
3	day, and not
2	accounting or consulting
2	person who, in
1	(a)(2) and (a)(3)
1	publish a notification
2	designed to cause
1	states of each
2	person who, if
1	(c) should be
1	banned device, (6)
1	fiscal year. (h)
1	foundation as the
1	advertisements are effective
1	gateway, on the
1	products, as defined
2	direct the disposition
1	order, the responsible
1	register, after first
3	poultry products capable
1	smaller than that
1	rape drug to
2	eligible for, with
4	whether the facility
2	impeding certain persons;
1	percentage share as
1	with, and contain
1	comment. after review
1	storage in the
11	interim final rule
1	assistance to small
1	component for transfusion;
1	2007; or (b)
1	operator make[2] full
1	(1). (n) national
1	expediting the generic
2	class is not
2	component for transfusion,
1	committees, at the
1	administration; and (e)
1	plants are growing
1	distributor on evaluating
1	grant in such
2	conduct inspections of
17	 (a) for
1	general with local,
1	(3), applicable to
1	states or could
1	committees for the
2	application by filing
1	suspension proceedings should
10	use, or sale
2	including diagnostics, biologics,
1	additional safety or
1	identified under the
1	trade representative. 
1	fee under the
1	approval, approve or
1	thereof, as the
1	businesses subject to
1	appearance, type, packaging,
1	without charge, bring
1	persons slaughtering, processing,
34	shall be available
1	operates external to
1	offense involved, whether
1	formerly 1012, as
1	rules for small
1	encouraging insurance companies
1	audit in accordance
1	subpoena may be
1	therein, but not
1	retaining a sample
1	election campaign activities,
2	drug control policy;
1	signature line for
1	section are compatible
11	united states that
1	number and proportion
1	public health 
1	803, as added
1	keep exposed for
1	order as provided
1	delegate the appointment
1	programs, or other
3	(as applicable) of
1	testing under the
1	(a) is known
1	within 45 calendar
1	registration (a) groundsa
1	affairs.  (7)
2	proposed reclassification order
1	secretary in an
1	certification, licensing, or
2	accredited; and (v)
1	grant application); and
2	originating from the
2	preceding january 4,
1	(a) the transaction
1	contains ingredients which
1	(1) whenever property
1	meeting the inspection
1	(a) election not
1	involving the human
4	except in compliance
6	applicant has not
2	review of generic
1	provided, issue a
1	secretary the actions
1	(2) requirements regarding
1	of, complaints concerning
1	petition; time for
1	secretary. for purposes
1	supplement contains substantial
1	present in each
1	depositions under rule
1	(a) six percent
1	refusal of approval
1	divisions on initial
1	(i) accurate assessment
1	sentence.  (g)
1	manufacturers, distributors, dispensers,
2	conduct of operations
1	covered thereby. 
1	evaluating tools, methods,
1	use of several
1	parties a dispenser
2	 (a) development
1	manufacturer and other
1	food:  (i)
1	criminal penalties, to
1	shel-life or susceptibility
1	chemical.  (

1	include any ferry.
2	contact information of
1	met. the provisions
1	initially approved; (3)
1	submissions (including petitions,
1	(f) duration of
1	$100,000 if the
1	singl-use device: 
1	make annual estimates
2	shall not 
5	investigations were conducted
1	education, extension, outreach,
1	8301 et seq.]
1	light of local
6	2014, not later
1	goals to mitigate
1	complaints relating to
1	(b) presents a
1	approved protocol for
1	(6) notwithstanding subsection
2	either  (i)
1	aggregate data described
1	may by rule
1	(2), as soon
2	medical gas (as
1	separately from or
1	section, including developing
1	health. for the
3	interpretive criteria website,
1	drug entered the
1	interpretive criteria website.
2	(and sets forth
1	consortium of such
1	violation constitutes (i)
1	amount proposed for
1	 (2) persons
1	(a)(2) for such
1	director shall submit,
1	average value of
1	subsection (a)(5)), upon
1	subpena issued in
16	means of the
2	sufficient to find
1	shall file the
1	denial based on
1	demonstrations respecting tobacco
2	meet with any
1	(including any substance
4	and, to the
3	requirement established by
1	labels with respect
1	population; or (iii)
1	rule shall give
1	ch. 1263, 37,
3	tobacco means any
1	(other than orders
1	action package 
1	identifies such classification
1	387e(i) of this
7	result in an
1	 (o) construction
1	section 1616a of
3	research with respect
2	(1) at least
2	spent and the
1	additional criteria the
1	improve the process
1	accredited for the
1	entities under common
1	budget for that
1	including anecdotal information;
1	2016, $12,300,000; (4)
1	representative, at least
1	two years) during
1	property to a
5	mental health services
1	audit and such
1	exporter may provide
22	notice of such
1	title, a brief
2	 (iii) any
1	hard copy; and
2	used in converting
1	customer. the preceding
1	675, 712, as
1	ch. 578, 2,
1	outbreak, the secretary,
1	rent, lease, profit
1	sku, or lot
1	hearing by order
4	shall be established,
9	year after november
1	 (ii) awards
1	harmful constituents, including
1	iv, 405, as
1	sentence of the
1	essential oils of
1	receipt describing the
1	include any meeting
2	(5 u.s.c. app.)
1	review of recognitionto
1	conducted or will
1	data, inputs, clinical
2	contact substance means
6	grounds for denying
1	official names; compilation,
1	(a) the determination
1	shall be independently
4	business address of
11	regulation issued under
1	following june 22,
1	reduction in risk
1	drug submission applicant.
2	 (d) electronic
1	grant is made,
1	must, in order
1	selling of prescription
1	labor organizations which
1	dietary supplements in
3	safe and effective.
6	ii of this
3	safe and effective,
2	fee is waived
1	(1) are appropriate
5	shall, at a
1	reduce drug availability
2	18-day supplement, a
1	consumers as considered
1	(1) emergency medical
3	human growth hormone
2	safe and effective;
1	subparagraphs.  (i)
1	advertising concerning its
4	meet the criteria
1	detection goalimprove agriculture
1	criteria:  (a)
1	july 9, 2012);
1	postmarket surveillance order
1	1996. (2) a
1	prevention of underage
2	authority (a) in
1	law. (e) other
1	cosmetics, if the
1	drug availability, as
1	area.  (n)
13	defined by the
1	tobacco product, if
1	july 9, 2012),
1	21, 1997; and
1	section, any additional
2	appropriate to apply
1	manufacturer from whom
1	(b). if the
1	grant program within
1	records. such requirements
1	potency, prior to
1	subsection, expire during
1	notice; deadline for
1	terms local educational
1	single inspection. 
1	formula which has
1	safety requirements. (d)
1	 (1) contentnot
1	corrected or eliminated
13	representatives of patient
2	safety and innovation
1	congress has long
1	initial and periodic
1	emergency.  (b)
1	developing, and implementing
1	administer drugs, or
1	target dates for
1	disease products under
19	materials and component
1	trainingthe administrator may
1	relief or relapse
1	plant, bear in
5	issues of patent
1	5, governing appointments
1	antibiotic banned for
1	(i) is engaged
1	section do not
1	38 stat. 822.)

3	 (aa) in
1	statement: united states:
1	manufacture and shall
6	year.  (3)
1	means the application
4	 (aa) if
1	safety and illegal
1	55; aug. 1,
1	notwithstanding paragraph (1)(d)
2	year, or both.
1	(2)(a).  (4)
1	assessments a civil
1	subsection (a). (d)
1	required to present
1	specific tobacco products
1	obligations; (l) not
1	organizational component of
1	levels to improving
1	states, and any
1	finding that silicone
1	may include that
1	attention of the
1	family may include
1	maintain, on a
48	shall notify the
1	filed within such
6	premarket notification submission
1	order.  (h)
1	bond shall be
3	accord with the
2	reinstatement of exemption
1	(d) for an
2	regarding the activities
3	take the action
1	title shall extend
1	particular drug abuse
2	substance abuse by
1	(a), shall be
1	title, develop and
1	1.8b  4.5.
1	operating practices in
1	conveyance thereafter imported,
1	hazard or a
1	inapplicability of exclusivity
1	notice a notice
1	thereof) for fish
1	attorney generalthe attorney
1	inspectors of imported
1	general review of
4	applicant; or (ii)
1	hearing described in
1	title i, 18,
1	form, but may
1	title, (d) if
1	title, unless such
1	device used in
6	hospital or other
1	countermeasure means 
2	effective means are
1	importer to participate
1	commander in chief
6	section 357 of
1	may apply, under
1	proposed for each
2	senior to such
2	 (b) authorization
1	research into clinical
1	physician assistant has
1	(a), the application
1	operating this program
1	activities on the
1	section 1035(a) of
1	testimony. if it
7	part shall be
16	secretary has determined
1	(8) illegitimate productthe
6	effect of subsection
1	commerce), state, or
1	required usesthe funds
1	understanding to permit
1	slaughtering establishment or
1	inspect the establishment
2	fee.  (4)
4	present to the
1	subsections (i) and
1	address if the
13	reference to the
1	permitting the person
1	(e) registration number;
1	production of positron
1	formulation, filling, packaging,
1	clinical isolates from
1	(1)(a) for that
2	21 days after
1	individual to a
1	government that has
1	concerning whether the
5	pay for the
1	approval of statements
2	adequate to implement
2	8 of article
1	
 387k. modified
4	eligible to be
2	business. such a
1	prejudice an order
1	alignment of feedback
1	 (2) contenteach
1	suspend the importation
1	
 
 379g.
1	published under subsection
4	title or which
1	secretary shall schedule
1	make data and
1	secretary shall apply
2	assure that a
2	shall be commenced
1	imported food accounts
3	information furnished to
1	general increase the
1	times, by day
1	enables the secretary
8	becomes aware of
1	(10) seller 
1	secrets act information
2	methods of compliance
1	si-month period involved
2	c of this
2	assistance and benefits
1	products are processed
1	it, supplement the
1	384e. recognition of
1	registrant or applicant
1	revoke any certification
1	product between members
1	farm subject to
4	food; and (2)
6	political subdivision thereof,
1	hardship or for
3	product, which shall
1	disposition under this
1	plan (a) task
1	subparagraph (b), be
1	referral of the
2	final determination as
2	chapter. when the
1	subchapter, no registration
5	within any territory
1	combination thereof) on
1	savings to the
1	confront witnesses. the
1	proceeding is or
1	director from among
1	classify an accessory
1	trial by the
2	containers, and labeling
1	(c), as well
2	regulations concerning recordkeeping
1	agency or congress
1	(vi) 40 grams
1	applying for assistance
1	color additive the
1	legible form any
2	final, all such
1	training in accordance
1	similar establishment, shall
1	also a statement
1	subject the officer
2	paragraph (1) until
1	resources.  (e)
1	smoke contains 50
1	account the total
1	13, 2013, establish
1	five percent of
1	substance abuse). (xii)
1	compromise an intelligence
1	 (a) biological,
1	(relating to human
1	previously listed pursuant
1	take additional actions
3	user fee program
1	safety report or
1	800, 2, 69
2	food as provided
2	inspect in such
1	official shall review
1	violations; exemption of
1	(d) the patent
1	(c)(3)(e)(ii) and (j)(5)(f)(ii),
1	program; (ii) the
1	names is necessary
1	charge, or the
1	appropriate action on
3	conferred by said
1	remainder of such
1	medical relationship with
13	(i)  (i)
1	120 days have
1	entities and communit-based
1	adequacy of state
1	seafood that has
1	standard that is
1	derogate from the
1	public health requires
1	directed, upon request
1	control strategy. (c)
1	private sector pilot
1	previous to the
1	(
 
 853a.
1	number of establishment
1	limited so as
1	(b)(3)(a), (b)(3)(c), and
2	plans to purchase
1	omitted
 
 464.
2	repackaging of a
1	secretary under other
1	iv, 410, as
1	quality control; and
1	contenteach of the
1	consumers, will 
3	subsection (l) or
2	services and facilities
3	may be instituted
1	secretary.  (8)
2	task force and
7	salts of optical
1	interest, who has
1	identifier applied at
1	registered trademark, brand
1	refused imports the
1	parent, tailored to
2	 (c) unless
1	facility, site, or
1	destruction of records,
2	manufacture, distribute, dispense,
1	recipient into account
1	field a drug
1	(4) prioritization the
2	commercial distribution and
1	prosecution of alleged
1	america. (c) media
1	september 30, 2022,
1	skill and experience
1	laboratory standardsthe secretary
3	saleable or nonsaleable
1	likely to occur
1	term covering practitioner
1	person who the
3	nation and the
1	representatives; (c) scientific
1	extent deemed necessary
1	withhold a determination
1	article. an article
5	device is intended
5	obligations under international
1	year period. (f)
2	adverse event; and
2	assessment of fees
1	facilitating the commission
1	advisory council to
1	shall prepare, and,
1	(iii); (ii) provide
1	(ii) determining whether
1	agricultural commodities (as
1	either by regulation
2	modified risk product
1	culpability, and such
1	
 
 360bbb3a.
3	paying such fees.
1	unless such program
1	transported, or sold
9	products of such
3	exemption under subparagraph
1	title shall, at
1	efficient as practicable;
1	next day when
1	(2) such entries
6	exchange, or shipment
1	inspection authority the
1	export; criteria for
1	determines appropriate 
2	title 5, section
1	product cannot be
1	efficient as practicable,
2	elapsed or until
1	agencies and other
1	term list ii
1	subsection (a)(1) shall,
2	section that 
1	necessary and consistent
1	making any such
1	acts until expended
4	establishment during the
1	user fees) shall
2	title shall continue
1	 (f) temporary
1	inspect any eligible
1	(b) tracingfor a
1	product which may
1	health services administration
6	50 of title
3	subsection (b)(1)(a) may
4	order thereon shall
4	exemption granted under
2	dispenser is an
1	links to websites;
1	individuals who submitted
1	interoperable, electronic manner
1	section 1524(b) of
2	named in an
1	subsection (d), except
1	12, 38 stat.
1	data environments, and
1	74, 10, 38
1	 (i) emergency
2	year.  (4)
1	developed plans in
1	6.0  
1	2016, the secretary,
1	supplement if 
1	unobligated advisory review
2	service in the
1	 (4) for
2	manufacture, provided that,
1	(1) is imposed,
1	subsection (c)) and
1	with, more stringent
1	prevention functions. the
1	remains licensed consistent
2	training and certification
1	control or removal
1	(a) evaluate the
3	conforms to the
1	waived under subsection
1	(b)(1) and (i),
1	formulary, or the
1	generalthere are authorized
2	thereof; or within
1	(2) compensation the
1	recommendations regarding the
2	contact information for,
1	subsection (b), that
1	postmarketing study commitments
2	established by such
1	law may be
2	programs and activities,
1	group whose application
1	paragraph (2), an
19	scientific advisory committee
1	person, provided the
4	clause (b) of
2	convey the meaning
2	produced, assembled, or
1	owner or shipper
1	used to review
1	patien-reported outcome the
2	subsection.  (f)
1	egg packers, packing
1	preventive controlsthe term
1	(b)(1) for the
1	contract results in
1	(4)(b) shall include
5	means a foreign
2	comprised of a
2	paragraph (2), as
1	limit the size
2	(1) in accordance
1	1701(11) of this
1	withholding use pending
1	analysis, if any,
2	(including the submission
3	exempted under section
2	reduced rate in
1	lists maintained under
2	fees, and generic
1	safeguards. to carry
1	threats, harassment, reprimand,
1	patien-reported outcome means
4	canvas, or other
1	
 14a. transferred

1	4(k) of the
2	procedures of, and
1	title 42 after
1	(c) the president
2	request to perform
11	section for the
1	applicable list, the
12	abbreviated drug application,
1	4 of whom
1	movement of tobacco
1	effect on foodborne
2	effects in adolescent
1	general has evidence
2	(relating to advers-event
2	civil penalty. 
1	referenced in generic
1	(c) invite interested
2	subparagraph as a
3	247d6d of title
3	(c) if a
1	meeting request under
1	living abroad, and
3	 (c) suspension
1	amendment, are voting
2	within a manufacturer;
2	quota assigned to
1	(c) it has
1	biological product meets
1	study and for
1	modification. (7) 
1	(1) the class
1	prior to licensure;
1	fee).  (ii)
2	facility receives or
1	associated with his
1	persons affected by
1	poppy, after mowing.
1	uses the following
1	potency which the
1	case of applicability
1	manufacture affecting the
2	petition which prevent
7	officer or qualified
1	taken. the inventory
1	section, an article
1	bylaws issued by
1	(a) corporations, partnerships,
1	exportation of a
1	distribute, receive, hold,
1	purchase reasonably without
1	term active, with
1	article means a
3	including through the
2	containing as a
1	(4) a temporary
2	information are disclosed
1	available, through publications
2	(1) referral; considerations
1	(a)(2); or (b)
1	following such period.
17	subject to judicial
1	1201 to 1204.
1	article originating in
1	engage in buying
1	acknowledge a proceeding
1	designation shall include,
1	thereof are prepared
3	2011 through 2015.
1	approving an application.
1	product thereof) that
1	(b) 500 grams
1	obligations described in
1	involving, any property
1	act involved, including
1	defined if the
1	prevail.  (d)
1	retained in each
2	conduct food safety
1	consular officers in
1	42 stat. 1486.)

11	drug enforcement administration,
6	active ingredient) that
1	recipients; (2) provide
1	include employees of
1	foods for which
2	(ii), the conditions
1	shared; (iv) plans
1	obligations, without regard
1	licensing board (of
2	chapter by or
1	growers or processors,
2	operation, and use
1	transaction into commerce
1	knowledge in compounding,
1	exclusion from registrationnotwithstanding
1	person so designated)
1	local agency, use,
1	(iv) a sale,
1	isolates from clinical
1	gifts and donations
1	goals that the
5	transporting in commerce,
2	fixed therefor by
1	(2), (5), and
1	(4) final judgment;
1	agreement act of
1	manufacturer shall, in
2	drug activities. 
1	organization described under
1	subsections (b)(2), (c)(2),
1	facilities at his
1	deadline, the secretary
2	health of humans
1	shipmen-specific certificates, a
4	information that reasonably
1	united states representative
1	report, supplement, and
1	practices each official
1	practice requirements otherwise
1	phytolacca, strophanthus, stramonium,
1	outsourcing facility with
1	thereof; and it
1	necessary or desirable,
1	article; and (b)
1	prohibit any acquisition,
1	safety training entity
1	1995)). (2) the
1	countries consistent with
1	inform health care
1	(including any substances
1	paragraph (1)(b), and
3	information obtained under
1	2009 through 2011.
1	applicable; (iv) recruitment
1	court shall impose,
1	business; (f) minimize
6	seasonally adjusted; all
2	third rare pediatric
1	maintaining the list
2	term appropriate state
1	saleable return product
2	shall be liberally
6	assess fees under
3	accredited person described
1	subchapter for administrative
1	meeting to address
1	42 has not
1	returned product without
2	continuing the investigation
1	thereof, if sold,
2	demonstration of effectiveness
3	means of conveyance
1	enforcement outside the
3	drugs in shortage
1	subsection (b). for
1	(o)(3). (d) procedures
2	sel-supporting community coalitions
2	shall be performed
1	(5) no-delegation determinations
1	thereafter act on
1	360qq. repealed. 

1	(d) and submit
1	immediate container includes
1	(ii), the notification
1	repackage, with respect
1	possessions. (d) fourteen
1	shop, or other
1	manufacturing change is
1	shifts in the
5	type required by
1	handling in connection
1	90 days from
1	substances. he may
1	 (iii) termination
2	action under subchapter
1	witnesses. the facts
1	defense resources and
1	(1) those species
1	labeling that provides
1	(e) disposition of
1	
 
 356a.
1	21, 1971; and
6	(3) if it
1	675, 581, as
1	public, may require
1	domestic capacity (a)
1	 (2) if,
1	7,2 by which
3	used to facilitate
31	title 18 or
14	carried out under
1	exceeding the tolerance
1	drug or antibiotic
1	describes the economic
1	dtc advertisements a
2	business of slaughtering
3	specifically ordered by
2	classified or the
2	changing circumstances regarding
2	ensures the protection
2	designed to establish
1	(9) unless alternate
1	 (3) amendments
1	inactive ingredients, identified
1	360a2. susceptibility test
1	title 5. this
1	(1) four members
1	advisory comments before
1	licensed pharmacy. (c)
1	outcome measures, as
1	partner program, as
3	database shall establish
1	2016, exceeds the
1	(e).  (18)
3	collected and shall
1	strategy; (5) monitors
2	criminal prosecution violations
1	crime under any
1	book, book chapter,
1	business entity (whether
1	(3) communication planthe
1	maintained, the person,
1	886a. diversion control
1	narcotic drugs, controlled
1	processors; and (c)
2	living in the
1	reporting, recordkeeping, and
4	standards, the secretary
1	section be submitted
1	food imports has
2	device manufacturer or
1	stage status; (iii)
1	(a) the drug,
1	use unless the
1	penalty and an
12	secretary of defense,
1	section 353(b)(3) of
3	give to the
1	reliance upon data
4	guidance issued under
3	prior approval supplements
1	accurate assessment and
1	imposed unless such
2	(b) eligibility of
1	eligible entity subject
1	medical products around
1	false. (i) 
1	sentence the sentence
1	qualifying practitioner (as
1	pediatric studies shall
2	term safe, with
1	suitable) in or
2	controlled substance law
1	shall prevent retail
1	previously established for
2	paragraph (1), may
1	collaborates with 1
1	patient, and the
2	accepted for filing.
1	forms each person
4	accepted for filing,
2	data for the
1	outlet. a n-tobacc-sale
2	time of application
1	form which may
1	accepted for filing;
1	suspect product; (ii)
1	sunscreen; and (ii)
1	smokeless tobacco, smokeless
1	prohibitively expensive to
1	applicant  (i)
4	14 of the
1	research and documentary
2	held in connection
1	mortem inspection, reinspection,
1	 (d) division
1	approved a covered
10	deemed appropriate by
1	inspect international meat
3	regulations to be
1	establishing such system,
1	general within thirty
1	compendium. (h) any
1	establishing protocols to
2	deny, revoke, or
1	preparation of viruses,
1	state, consistent with
1	intended use that
1	(b), for a
1	facilities in compliance
1	(1) terminates if
1	shall be reevaluated
2	written response detailing
1	approved such drugs;
1	collected, in addition
1	otherwise obtain such
2	(ii) that 
1	farm to all
1	2000), or 1
1	subsection (f)(4), instances
1	coalition in support
1	support the positioning
1	secretary for prompt
1	materials, including chemicals,
1	year. the summary
1	endeavor to consult
1	paragraph (1) the
1	(3) if damage
2	number and types
1	facilities, and the
1	animal, this product
1	20) or a
1	take action, with
1	acids (linoeate): percent
1	(13) $119,000,000 for
1	(1), (2)(a), or
3	administration (referred to
1	except any compound,
1	database by any
1	material fact: provided,
1	flavor (other than
1	supplements.  (b)
1	exposed for sale
1	authority and is
1	filing a request
1	established by any
1	becomes unlawful under
1	superseding or otherwise
1	individual) may not
1	poultry products brokers,
1	documentation that demonstrates
1	plans to conduct
1	valid trademark. 
1	 (1) he
2	pharmacologically related substance
1	malt beverages, or
8	denatured or otherwise
1	(iv) must be
1	related information, a
1	certify and file
2	207 or 208
1	laboratory practice in
5	501(c)(3) of title
1	distributor had; or
1	developing such list.
1	dispenser has reason
2	beginning with the
1	organization that manufactures
1	meeting appropriate qualifications
1	regulation proposed by
1	(2) the extent
1	respecting the device
2	chemicals. (
 

1	substantial equivalence (as
1	provided, that subject
3	instituted under this
20	publication of the
1	 (a) prepare
1	3 years, provided
1	alleged under this
2	chapter. (june 25,
1	carrying out activities
1	illness. (june 25,
1	fees for published
1	conditions  (1)
1	shall hold a
5	pending on october
3	facilities subject to
1	refer the proposed
1	means providing product
2	applicant for infringement
2	type of information
2	regulation provide for
2	funds, including i-kind
2	plan, scheme, or
1	demand for, and
2	context of use.
1	(2); (7) ensure
2	shall be appropriate
1	manufacturer, documentation demonstrating
3	acid, its esters,
1	efficient development of
1	domestic facilities, the
1	general determines is
1	intermittently. the members
1	
 
 175.
1	demonstrated a lack
1	risk tobacco product.
1	18, formerly 16th
1	freedom for scientific
1	person. the attorney
1	burden on those
1	risk tobacco product;
1	(7) is an
2	nature and not
1	returned product, consistent
1	present on or
1	needed to pay
1	consistent with recall
1	numbers of vacancies
9	interpretive criteria standards
2	order. (c) the
1	performance data and
1	safet-related activities are
1	will not significantly
2	two preceding sentences.
1	exemption for seafood,
1	compendium. (e) helium
1	1980, and $30,000,000
1	practice setting in
10	receipt by the
3	substances and any
1	concerned therewith, the
1	standards under paragraphs
1	(other than food)
1	herbal ingredients classified
13	articles which are
2	nongovernmental entities involved
1	functional performance demonstrating
1	packaged meat and
1	owing permanent allegiance
1	respect to identification,
7	intended for distribution
1	(d) adulteration and
1	disposition (including delivery
1	(a)(4)(a)(ii) (relating to
4	electronic database or
1	devices are identified
1	requests for specific
1	reached. (4) planthe
2	circuit, within sixty
2	research programs of
1	restrictions. (c) abuse
1	tools for obtaining
1	transported or offered
3	risk tobacco products
1	(c) tobacco dependence
2	(f) is the
1	offense which a
14	owns or operates
2	imprisonment authorized by
1	criminal organizations in
2	eventthe term serious
2	limit notwithstanding subsection
1	declaration initiate a
1	considered a report
1	whenever any such
1	534, formerly 358,
1	recognized by qualified
1	enforce state poultry
1	amount of $21,600,000.
1	proceeding described in
1	term new tobacco
2	drugs have been
1	relations (a) establishment
1	drug application not
1	approved for marketing
1	(c) risk factorsin
7	title, shall be
4	coordination with trading
1	farming the domestically
1	consumers as tobacco
1	needs of each
2	 (b) exclusion
1	(b) be immediately
1	(e) regulations 
1	handling and other
1	title. (3) studies
1	agency personnel to
1	order and who
1	(b), this section
1	
 
 359.
1	data from bioequivalence
2	imprisonment, which shall
2	recognition of accreditation
1	assistance; advisory committeesit
4	product by reason
1	budget or the
1	case the date
1	otherwise, or to
1	submits a biosimilar
1	safeguard against diversion
1	abuse. (5) the
1	name designated under
2	provision within the
2	shall be no
2	stat. 20.)
 

1	(b) guidance documents
1	review that are
2	subdivision.  (b)
1	actually treated with
1	less than 15
2	initiative under subsection
1	shall (a) authorize
1	chapter, are appropriate
1	packing, transporting, distributing,
1	(3) electronic registration
3	section 344 or
1	application, means review
2	products exclusively for
1	(k) shall submit
1	less than 1,
1	reusable device types
1	(a)(2), (a)(6), (b)(5),
3	processes, and practices
1	advocate for a
3	obtained by such
1	farms, except for
1	implant means 
1	ethical business practices
1	subjects as provided
1	abuse threats 
1	medical gas; (b)
1	875. administrative hearings
1	person reoffering the
2	fees collected in
3	designation of such
1	interpreted such guidance
2	unless the official
1	file a report
1	2 meeting (as
1	surveys described in
1	issued, that such
1	provide support for,
1	code, trade name,
2	brought by a
6	21, 1997, the
11	subject to subchapter
1	(b) is located
1	meetings, conferences, and
1	records requested. (b)
1	2007, inspection programs
1	qualification submissions). 
7	government service employed
2	schedules, the secretary
1	processing, preparing, injecting,
1	cosmetic, if such
8	actions taken under
2	(a) information on
1	services recommends that
1	(1) new tobacco
2	provisions of law,
1	use, or other
2	rendered under the
1	chapter based upon
2	courts, the district
1	control program 
1	years, review and
1	(ii)  (aa)
4	initiative or in
1	subsection. (3) use
1	2003. such review
2	approved covered application
1	
 643. registration
1	601, 52 stat.
1	product under review;
1	ethnic minorities, native
1	(n) regulations 
1	exported to any
1	(1), section 360ccc
1	registration and by
1	drug applications from
1	property and cros-examine
1	(3) national and
4	radiation was in
1	city average), for
1	action which may
1	term regulated person
2	36 months after
1	subject to declaratory
1	rapid timeframe; and
1	aggregate amount paid
1	prohibiting the marketing
2	sections 360fff1 and
1	influenza; or (b)
1	chapter; and any
1	site a declaration
1	radiation means 
1	power systems and
1	payments between, by,
2	(the pediatric advisory
1	incur the cost
1	general and postal
1	level. (c) authority
1	made to expire
2	permitted entry into
1	generate the revenue
1	 (i)definition of
1	development of further
1	 (ii) postapproval
1	foreign establishments; samples
1	review of, to
2	title 28 to
1	importation and exportation
1	schedule. rules of
1	internal systems and
2	to, or purchased
1	government as an
3	guidance for industry
1	device unless such
3	37 stat. 833.)

1	means reviewing and
1	administrative expenses. 
1	(c) if such
1	strategy is required
2	refused admission, except
4	year with respect
2	353(b)(4) of this
1	stat. 108; july
1	statement is a
1	(b) that new
1	review the advisory
1	intravenous product that,
1	hold a hearing
11	greater of that
2	section 384d of
1	therefor) orally or
1	section 360j(h)(4) of
1	substantiation of the
1	property is civilly
1	formula unless 
1	followed to secure
3	scientific, technical, and
1	(6)(b), 1 or
1	butter, except that
1	distribution system (including
1	supplier supplied raw
1	record under sections
2	director will document
1	separate standards for
1	false statements. 
1	charge and the
2	secretary after an
2	order been entered
1	therein and directions
1	drug, considering in
3	gross annual sales
1	guidance on development
1	help clarify the
1	shall exempt such
3	secretary approves a
1	disabled or diseased
1	457(d) or 467
1	offered for entry
1	respect to applicability
1	prescription in conformity
1	number that is
1	approved application would
1	specific dietary management
1	controlled substances have
1	manufacturers and importers.
6	permitted, and exemptions
1	1040. recordkeeping requirements;
1	new findings by
1	administrator, the court
1	right to confront
1	auditorsan accredited thir-party
1	seq.), or any
1	
 360kk. performance
1	notification the notified
1	following has occurred:
1	title 5, governing
1	beverages, or tobacco,
6	measure, or numerical
2	request by a
1	acid amide. (6)
1	secretary with routine
1	ictaluridae; and (b)
3	chapter and that
5	requirements are not
1	system; and (3)
1	representatives who do
3	48 hours, after
1	21. branding grades
1	packages, exports, or
2	writing, which period
1	treat rare diseases;
1	country and the
1	anticipates the use
2	(ii) resulting in
1	identify and solicit
1	acids, oxalic and
2	practicable through any
1	adequately diversified professional
1	forfeited upon such
1	general may allow
2	suspension if the
1	designated for expedited
3	request, and the
1	drug), and (ii)
1	strength. (iii) statutory
1	substance are in
1	(a) has not
1	distribution, and (b)
39	shall by regulation
6	revenues and fees
3	application or of
3	(b) reporting requirement
1	plant, continuous inspection
1	means a change
1	activities, which, at
1	likelihood that a
1	(d) discussions such
1	part, an interpretive
1	authorized person who
1	1976, or (ii)
1	(b) limitation on
1	forth, as part
2	european economic area,
3	european economic area.
1	history of such
1	conditions required by
1	removed from employment
1	resistance rates in
1	task force of
4	promulgating any regulation
2	renewal of such
2	end of such
1	administration during a
1	(1) scientific evidencenot
2	timely and effective
1	 (aa) purchased
1	establishment has failed
6	life imprisonment, a
1	publicly available detailed
1	services, provide a
1	consent, establish a
1	revocation, or suspension,
1	(1) protects an
1	material respect or
1	(h), (i)(2), (i)(3),
1	denying the authorization
1	distributed or dispensed
1	entity that directly
1	appropriated. (
 

1	involving conduct described
1	deferring the assessments;
1	regarding intelligence sources
1	(8) all controlled
2	inspect not fewer
2	trial design, the
1	places and in
1	(i) conducting vulnerability
1	(and of officers
1	drug application by
2	funded by the
1	protein in formula)
5	 (b) fee
1	rescinds or modifies
2	changes in inspection
1	order to improve
1	appropriate processes with
2	protections offered by
1	intent of causing
1	(7) the sale
13	continue in effect
1	unincorporated business organization.
1	foundation is to
1	sinusitis, acute bacterial
1	hormone means somatrem,
1	consumption except that
1	drug distributor or
1	central counte-drug technology
1	business organization. (c)
1	28, 1976, and
2	application or not
4	guidance for the
2	protocol, under subsection
9	secretary may modify
1	indirectly by an
1	(d); and 
1	(b) at the
1	corporation. (d) the
5	making of such
1	reanalyze the owner,
1	repackager  (i)
6	disclosed to the
1	intentional ingredients of
1	amount representing interest
1	(i) under one
1	paragraph (2)(a), except
1	area, submit a
1	(a) providing direction
1	characteristic the attorney
1	fund to be
4	location of the
1	are, upon publication
1	purification, or salt
1	focus of drug
1	spread of such
1	motion under section
1	beginning with its
1	coalition shall encourage
1	significant demand for
1	use of alcohol,
1	article be removed
21	likely to be
1	applicant if 
3	section 360, 360i,
2	import such drug
1	acquisition.  the
1	small businesses that
1	information by sticker
1	review, provide modifications
2	(b) a statement
3	contribution to the
2	day before the
1	personally upon said
1	establishment fee necessary
1	applicant manufactures, distributes,
1	adjudication programs to
1	support of one
1	outside the qualified
1	threatened shortage of
1	employee not later
1	reason, (2) two
3	material time under
11	standards established under
2	office shall ensure
1	feet above the
1	(a) upon petition
1	attributable primarily to
1	meeting conducted under
1	(c) has not
1	office, establishment, or
3	administrative order under
1	regarding such food
1	chief scientist. the
1	schedule for drugs
1	(ii) list the
1	inputs, clinical or
1	use. (f) providing
3	optional ingredients (other
2	title from the
3	that, to the
1	of, and provide
2	placed under seal
8	permitted to be
2	drug product under
1	relate to 
1	chemically related pesticide
1	publishing current reports
1	registry and results
1	education programthe term
1	states a fund
1	license if 
1	744h, as added
1	675, 538, formerly
1	narcotics traffickers in
1	seizures and condemnations,
1	articles involved as
6	sold or offered
1	(b) application subsection
1	contained in tobacco
1	generalnotwithstanding any provision
1	area or areas.
1	(
 
 960.
1	area or areas,
1	evidence supporting the
1	revocation of designation;
1	 (10) labeling
1	use instructions under
1	treatment may be
1	(1) taking into
1	chemical, an uncommon
1	person, and all
1	prevention regarding the
1	denied by the
1	secretary as generally
1	(g)(4).  (c)
1	 (e) facility
2	revenues for that
1	gather comments and
1	that, without authorization,
1	2008 unless appropriations
1	(c)(3), the attorney
1	chain prior to
1	subsection (g), including
3	subsection (a) where
1	dosing, formulation, and
1	performance of any
1	shall within 30
1	(2) national drug
2	(2) director the
2	infringement litigation resulting
1	supply chain. such
1	legitimate medical or
1	condition or if
3	prevention and intervention
1	cooperate with local,
1	deferral approved under
1	secretary a civil
1	judicial review. (6)
1	(v). any device
1	(i) documentation demonstrating
6	ingredients (other than
4	committee shall include
1	outside such state;
1	restaurants, and similar
1	193[1] of this
1	attachment of warning
3	certification is made
1	intended for administration
1	black, white, and
1	states or by
1	13, 2016, issue
9	invalid or will
1	(1) the label
1	data which have
1	made the significant
1	species, such studies
1	labels, and may
2	different questions of
1	governmental authorities; release
3	secretary shall exempt
2	making an inspection
1	consumption exemption no
1	shall choose the
1	oxygen  (a)
2	section 381(e) of
1	interpret such guidance
3	agencies, including 
1	illness outbreaks during
1	general (and such
2	data do not
1	iv to be
1	determination, then such
2	medication under state
1	repackages a drug
1	(c).  (4)
1	 (a) resistant
1	violation, with respect
1	provision as to
3	year.  (d)
1	control program. (e)
1	(ii) if any
1	provider sufficient information
3	owner with transaction
3	section.  (i)
1	(b) the strength
4	name (as defined
1	area is shared,
2	may prohibit the
2	country to another
2	inspection legend and
1	hydrocyanic acids and
1	fait-based organizations, and
1	womens health (a)
1	registrant whose registration
1	following data sources,
3	discussion and agreement
1	writing.  (b)
2	occurs later, the
2	indicating that such
1	sections[1] 355 of
1	period of denial
1	statute made on
6	register; (c) provide
1	court considers proper.
1	(4), if a
2	recipients of such
1	may appeal the
1	(i) the department
1	included or which
1	patient organizations, pharmaceutical
1	noncompliance and providing
12	modify or revoke
10	imprisonment under this
2	may approve 
1	required to save
2	abbreviated applications or
1	biological systems, and
1	patients; or (b)
1	
 387a1. final
1	unless the export
1	single proceeding. for
4	information, history, and
5	paragraph (4) of
1	container. no definition
1	office use; (viii)
1	doctors, and other
1	262, for which
1	 (i) processes
2	whether a facility
1	application, report, record,
1	catalog of schedule[1]
1	(f) the nature
1	use the postal
2	dextrose and amino
1	675, 914, as
1	evidence not contained
1	inborn error of
1	necessary information regarding
28	specified in subsection
1	review to add
1	areas affected by
1	subchapter in any
4	otherwise becomes aware
1	business of manufacturing,
13	(1) any person
1	(iii) to violations
1	volunteer to participate
1	wholesale distributor received
1	public health impact
1	separate area clearly
2	substances in such
1	uses (including, but
1	serve as an
1	health.  (7)
1	secretary are truthful
1	keeping in possession,
1	(d) any regulated
1	(c); or (c)
3	species) required for
1	(c) is true
1	regulatory matters concerning
1	secretary, the initial
1	intended uses of
1	approvable. the procedure
4	committee who are
5	necessary.  (5)
2	indicates that the
2	federal establishment any
1	 (a) members
1	ch. 675, 310,
1	inspector shall have
1	documentation of saf-use
2	year 2013 shall
1	constructive, or attempted
1	appropriate, to address
1	 (c) acceptance
2	dissolved by a
1	pilot projects pursuant
1	facilities) appropriate for
1	involving drugs or
1	select, appoint, employ,
1	$30,000,000 or less
3	3 public meetings
1	certain drugs (a)
1	batch certified, in
6	total costs for
1	(2), including a
2	implementation of national
1	fact by the
1	listing under this
2	required or cannot
4	device, and (ii)
1	may require nonconsumer
1	(as of august
1	trafficking area, and
1	development fee). 
1	panel as often
1	(for example the
1	written report that
1	tests, or programs
1	individuals; and (ii)
1	subchapter to appear
1	seller may not
1	priority to enter
1	shall assign such
8	history, transaction information,
1	formula, be required
1	recommendations made during
2	substandard, adulterated, misbranded,
1	objectives and specific
1	360ddd1. regulation of
1	final rule; date
1	subsection (b)(1)(a). when
2	needed to evaluate
1	termination shall take
1	(2) criteria as
1	patents.  all
1	nutrition information requirements
1	required to enable
1	applicable number patients
1	section. (f) technical
1	thereof, that 
1	package level, the
1	secretary provided written
1	644. regulation of
1	title and submitted
2	previously reported such
1	notify the drug
1	serious injury if
1	secretary a meeting
1	reports for which
1	challenge the decision
1	multiple pesticide residues
1	using guidance documents
1	controversy between the
1	established the following
1	may use it
1	majority of its
1	(b) notification each
1	term illegitimate product
1	 (3) certifying
1	labor.  (b)
2	first offense. except
1	iv, or v;
1	mandatory physical inspection
1	designee shall organize
1	inflation adjustmentbeginning with
1	(a) general requirementa
1	workload adjustmentsfor purposes
1	diminished in value;
1	wholesomeness of meat
1	state comprehensive plan
1	audit agent shall
1	requiring testimony of
1	channels, the contact
4	section 350l of
6	violations of section
1	(a) general requirements
1	grounds for its
1	requirement was not
1	ecgonine may be
1	packing and protective
1	675, 412, as
11	(b), the secretary
1	may directly accredit
1	waivers and partial
2	bidding procedures shall
1	required information. if
1	violation is defined
3	unless the previous
1	seizure authorities of
2	except such drug
1	information.  (m)
1	whose responsibilities shall
1	alternative treatments for
1	patient, contain a
1	form that prevents
1	years. (b) applicability
1	selection of drugs
4	responsible party to
1	describing the reports
1	effective upon its
1	withdraw, or modify
1	administrations ability to
45	pursuant to the
1	health official may
49	description of the
1	requirements; (ii) the
1	intervene in a
1	compliance and enforcement
1	revision of classification
1	transportation that occurs
1	deviating from the
1	drugs and article
1	physical inventory date
1	appropriated $5,000,000 for
1	homeland security shall
1	product, including restrictions
1	(ff) staffing roles
1	states that has
1	secretary to perform
1	codex level. (c)
1	carry over not
1	(or conversion product
2	render inspection to
1	electronic product 
1	fund the term
1	tribal governments of
1	issue an authorization
1	states. (2) in
1	(2) applies, the
1	$280,587,000 multiplied by
1	application as described
1	press release describing
1	applicability this subchapter
1	bodily injury when
2	years from september
1	product or package
1	action shall, at
1	packing, packaging, transporting,
3	1606 of this
1	352(t)(3) of this
2	amounts of coca
2	technologies for the
7	data elements described
1	packs is technically
1	forfeiture as a
1	(2) to seek
1	collect and make
1	order, or to
1	(b)(iv), at least
1	(w) nitroethane. (x)
1	chapter; (3) formal
1	written feedback, decisions
1	obtained from foreign
2	7 of the
1	identifies the registrations
2	nutrients in accordance
2	(b) rules and
17	set forth the
1	treatment is in
1	october 15, 1994
1	1547. staff the
1	licensed individuals under
5	removed from such
1	tribe involved. (2)
1	(b) although guidance
1	brief application to
1	(ii) to support
1	grounds therefor, filed
1	commissioner; and (b)
1	specified. (g) effective
1	sciences. (b) director
1	alphamethadol. (6) benzethidine.
2	risk of such
1	(a) or suspending
1	title 42; (b)
1	registrant to manufacture
1	regularly about the
1	nonreceival if the
1	foundation (a) in
1	clause (i), so
1	(a) state established
1	time for appeal
2	resources to satisfy
1	days after its
1	determination required with
1	officer, a managing
1	protect all classified
1	344 or 379e
3	consistent therewith, with
1	(4) oversee and
3	(i) through (iii)
1	drugs shall permit
1	provide a rebuttal
1	33 percent of
1	commission shall handle
1	cigarettes to youth.
1	paragraph publicly available,
5	earlier of the
1	necessary.  (d)
1	debarred) or any
1	substances) contained in
4	investigating to determine
1	foreign agency or
2	means any container
1	product from individuals;
1	advanced therapy have
2	term facility means
1	2 years; and
2	20 years, and
2	facility.  (ii)
1	device to reimburse
1	(such as nicotine
1	shall announce the
46	house of representatives
1	authority over (including
1	assistance to 
1	paragraph (1)(b), (2),
2	misdemeanor under any
2	(d) contents of
1	products upon the
1	either party, the
1	plan the secretary,
1	collection activities; (c)
2	 (b) second
1	atropine sulfate per
1	data, and reasons
1	promulgation of performance
1	commission would constitute
1	priority needs of
1	synthesis, and includes
1	months upon submission
1	therein. (c) in
1	including expenditures for
2	means the 50
1	suppression of the
2	years payment of
1	color additive means
1	item (aa), shall
1	record under subsection
1	
 1201 to
2	instituted under paragraph
10	year for the
1	shortages on research
1	2005; (2) based
1	statement, unless revised
1	scientific expertise in
1	employees that is
1	drugs; (b) members
2	receipts that is
1	appropriate country official,
2	contains such a
1	application; presubmission conference
3	substance which the
1	youth of the
1	(3) additional grants
2	5.  (june
1	factors, the following
1	racemic drug, if
1	paragraph (2); (5)
4	products will start
1	(not including package
1	endocrine effects; (xi)
1	death.  (2)
1	known to predict
1	2003, means an
4	description of how
1	shall assist the
1	section 379aa(a)(2) of
1	additive, to the
1	used. (5) notice
1	drugs with similar,
1	raised on their
1	(g) for fiscal
1	
 399f. ensuring
1	event exceeds one
1	administration, the national
1	toxin act) before
1	entity shall apply
1	nurse tank shall
1	food means (1)
1	chemical identity and
1	sit and act
1	
 384c. inspection
1	(b) testing and
1	made so effective
1	requirement for identification
4	one fee per
1	technical assistance, follo-up
1	(including delivery for
1	2009 under subparagraph
1	(b) contentthe communication
1	names (a) necessity
1	food allergy management,
1	recalls of the
1	 (a) special
1	refuse to testify
1	banned devices (a)
1	chapter, are found
1	reasonable and practicable
1	regulated person is,
1	(6), or the
1	chain, shall update
2	 (d) adulteration
1	title 42; 
1	drug for food
1	provide advance notice
3	finds that any
1	accompanied by specific
1	greatest economic devastation
1	authorized manufacturer, wholesale
3	persons under 18
1	(4). (june 25,
2	includes pricing information
1	section, referred to
3	altered official mark;
3	education act of
1	approved or licensed,
1	office. the report
1	additional provisions determined
1	foreign laboratories accreditation
1	agrees to issue
1	establish prior convictions
1	single return declaration
1	system which requires
1	(
 
 2101.
1	inspection act of
1	substances in excess
1	supply chain, take
1	sections 355, 360(k),
1	devices which have
8	filth, or whereby
5	committee shall be
1	term generic drug
1	court shall stay
1	year, for required
1	singl-use devices for
1	 (i) finds
3	taken under subsection
1	targeted drug or
1	hardship on any
1	(i) not in
1	(1); (e) establishing
1	(2) inflation adjustmentfor
1	plant, and food
1	caused, or was
1	drug submissions. (d)
1	imbedded therein any
1	secretary the exporter
2	contract entered into
1	auditors. (b) notification
1	declare that drug
2	regulation establish criteria
1	products shall have
1	carrier or warehouseman.
2	loss in an
2	designation process 
9	agency, or program
1	warrant is lacking;
1	office use; (f)
1	evidence that demonstrates
1	fee collections attributable
1	recent inspection of
1	committed or caused
1	identified ballot initiative,
2	4, 1913 (37
1	value, with intent
3	section 830(e)(1)(b)(v) of
2	drug samples and
1	administered by such
1	point, have been
1	individual possessing controlled
1	standards development 
5	public health benefits
5	labeling change is
1	title).  (10)
1	mental state, or
1	said secretaries shall
12	except in the
1	application is necessary.
1	penalty for providing
1	designated a combination
1	fee per product
1	 (5) voluntary
1	combination product. (d)
1	whenever any standard
1	shall confirm or
1	smoke constituent), or
1	collected.  (2)
1	 the preceding
1	participation and other
1	issued in error
2	allows the presence
2	exported the controlled
1	approved drug application
1	subparagraph (a) (including
1	(2), that a
3	providing the holder
5	probability of causing
1	temporary basis is
2	patent brought a
1	organization, management, and
1	(a) persons exemptedthe
2	poultry raised on
1	paragraph (1)(d) of
1	1334(c) of title
1	user facilities of
2	lay person, and
1	1,4butanediol; (ii) ketamine;
2	homeland security. 
1	(3) prescription drug
1	prior order has
1	354, and section
1	drug treatment; 
1	issued.  (3)
1	compliance by the
1	tested for all
1	managing the risk
1	transferred.  (27)
1	indian self determination
1	paragraph (1),[2] shall
1	chapter, a generic
2	secretary shall rely
7	title shall apply
1	issued from and
1	ratio of sales
5	regulation  (a)
1	committee for reference
1	within the 18-day
3	petition to be
1	organization is lawfully
1	
 
 335c.
1	stat-issued pharmacy license
1	facility is included
2	condition.  (3)
1	committee during the
1	forces of attack
3	induce cancer in
1	provisions designed to
1	2 years. a
1	include providing guidance
1	expire. the secretary
1	representatives; and (ii)
1	affected industry. 
1	2014. (c) base
1	productsan order under
6	authorized to promulgate
1	review division; (v)
1	opinion that the
1	(2) such additive
1	packages, if there
4	slaughter, and the
1	draft guidance entitled
11	established in the
4	shall include such
1	given those terms
1	disposition by the
1	designed to detect
1	(b) pays any
3	provided in subclause
1	seized under this
1	order in such
1	subsection (b)(3) may
1	consideration foodborne illness
1	shall make operating
1	 (d) civil
1	interested persons on
2	(1) reporting in
1	importation under subsection
1	full establishment fee
1	person has resumed
4	(1):  (a)
1	dispense, administer, or
1	subsection (b)(2) the
1	 (a) small
1	1997, or any
2	drug advertising. 
1	251.)
 
 24.
1	product stage, each
1	chapter, (ii) in
2	claims such drug
5	facility under this
2	act is not
1	includes, or consults
1	demand. (c) proposed
1	human illnesses; (iii)
1	activities requires a
1	revoked as if
12	national media campaign.
1	355, or 360bbb3
1	52 stat. 1055;
1	(a) that were
1	(c), he shall
1	indicated.  the
1	(1), and does
1	consultationtopics for consultation
2	sale other than
1	input from experts
1	(nn) the term
1	time, as documented
1	obtains the product
1	account and fees
3	 (4) exemption
1	required for investigational
1	arsenical classes of
1	subparagraph (a) include,
1	may utilize existing
1	establishment of research
7	nature and extent
2	internet site under
5	administration, the secretary
1	42  for
1	presentation by the
1	
 
 679b.
2	tobacco product presents
1	 (i) -(1,-dimethylheptyl--[(1r,3s--hydroxycyclohexyl-phenol
1	unsatisfactory or if
1	subchapter, such animals
1	designate official names
4	developing, and reviewing
1	dietary supplements. such
1	outbreaks of illness
1	significant decisions regarding
1	signed by a
1	actions under this
3	collective average annual
1	chapter, records of
3	products, including the
1	columbia or a
5	owns a facility
4	2015, the trading
1	organization, the administrator
1	contains successful strategies,
1	distribution under paragraph
1	prescribed or used
1	maintain an electronic
1	products broker means
1	complained of was
2	authorized generic drugs
1	address those hazards.
3	development fee for
1	subsection to enable
1	new drug, unless
1	regulating devices (in
2	carried out with
1	staff director and
1	canal zone. 
1	(e)(1) of this
1	 (i) suspension
5	authority to require
2	food or other
1	2009, the revenues
2	(including regulations and
1	vehicle. (
 

2	evaluate the tobacco
1	vaccine adverse event
1	appropriate relating to
1	compounding, processing, delivering,
1	(6) the number
1	plans that specifically
4	grant award under
6	reduction, or refund
3	required by clause
3	manufacturer, importer, or
2	secondary school or
1	section is applicable
2	therapeutics all pediatric
1	congress  (1)
1	federal agencies, develop
1	(i) the indications
1	2000. (g) annual
2	dosage units of
1	(iii) there are
1	may prescribe 
1	violations may undermine
1	distributor.  (h)
2	civil penalty assessed
1	(2) defraying the
2	regulation is issued,
1	regulation is issued.
1	(3) studies or
22	section 351(a) of
1	therapy includes cell
3	applications, and prior
1	control under any
1	violation; (ii) to
1	color additive shall,
2	animals found to
1	voluntary guidelines developed
1	cosmetic bearing or
1	yellow rots, white
2	(b) exception subparagraph
1	act). (2) 
2	data from multiple
2	ensure that, of
1	likely in subsequent
1	sixt-day (or greater)
1	consumer perception; (e)
1	initial quota application
1	 (ii)timeliness of
1	entry, and exportation
2	eligible state costs.
3	provisions applicable to
1	hours of training
1	reporting, and usefulness
1	regarding a record
1	(i) nutrient requirements
1	pediatric studies in
1	verify that food
1	administered by other
1	authorized for investigational
1	section 1604 of
1	meetings to ensure
1	animal drug have
2	2011; and (ii)
1	study reports. 
1	make each such
2	infrequently in the
1	employees of affiliates.
2	employees of affiliates,
1	whenever any poultry
1	clarify the causes,
1	18-day period so
1	means any company
1	otherwise within the
1	request a review
1	drug product, drug
1	drug, antibiotic, or
1	years.  (3)
1	state the expert
4	deemed to include
2	country, and a
1	accreditation if, by
1	device.  (mm)
1	upon condition that
1	parts or raw
1	request in advance
2	term tropical disease
1	request a hearing.
1	foundation.  (ii)
1	groups.  (c)
1	letter is deemed
1	19 [15 u.s.c.
3	designated representative of
1	individuals duly designated
1	clearance, and disclaimer
1	shall issue public
2	anabolic steroid under
3	product contained in
1	(d) biosimilar biological
1	noting any critical
2	manufactured piece of
1	governments, shall develop
1	section 346a(g)(2)(b) of
1	goods the secretary
1	nmic shall promote
2	perjury that the
1	symbol described in
2	(b) if an
1	standards, to the
1	exclusivity provisions 
1	person accepting a
1	(d) procedure for
1	single location, which
2	exist with respect
1	occurs during fiscal
1	331(i)(3) of this
1	359. nonapplicability of
1	web site; (f)
2	persons pursuant to
1	awareness capabilities at
4	drug can be
1	marijuana. (g) marijuana
1	subsection in a
1	adaptability of such
2	review to be
1	term compounding includes
1	forfeiture of substitute
1	devices. (june 25,
6	subsection (a)(2) or
1	diseased animals, or
1	paragraphs (4), (5),
3	360fff3(b) of this
2	subsection (a)(2) of
1	will be obtained
1	secretarys determination regarding
1	receipt of reports
1	regulations permitting pharmacists
1	charitable organization to
1	 (5) enforcement
1	reach the broadest
5	material, compound, mixture,
1	90 days of
1	methamphetamine abuse prevention
1	fees actually collected
2	employees (including supervisory
2	controlled substances, at
2	section) no less
1	information, or (2)
2	2017, not later
1	collectively by any
2	making efforts toward
1	$130,184,348 for fiscal
1	law; and (e)
1	percentage for a
1	services administration and
2	involved represents an
1	physical property. (f)
2	treasury shall cause
1	clostridium difficile. 
1	probability of reimportation
1	users) who should
2	property of the
1	poultry, except rendering
1	drug administration office
1	shipment was statistically
1	minority health web
1	applicant or any
2	secretary in conducting
3	subparagraph; and (ii)
1	(4) the applicant
2	applicant or, if
36	secretary shall by
2	techniques of plants
14	requirements  (1)
1	receive a payment
2	adequate notification is
9	imprisoned for not
1	minimuma maximuma astated
1	improvements made to
1	presentation, the secretary
3	management, or operations
3	establishing a tolerance
1	potential to have
6	united states, in
2	investigational generic new
1	human consumption, be
1	and/or cream brought
1	implant  (a)
1	direct effect in
27	secretary shall be
1	51 of subtitle
2	center for food
1	paragraph (7) for
1	health, the comptroller
2	device user facilities
1	occurrence of pesticide
1	country for such
1	susceptibility testing devicesthe
1	assessment and a
2	rico, the virgin
1	objections shall operate
4	residues in or
1	subsection (b)(1) the
2	product manufactured by,
1	obtained, and except
1	workers, and members
1	1204. repealed. 

1	(i) a requirement
1	shall designate drugs
1	national average, as
1	374(a)(2)(a) of this
3	submit the required
1	population groups, including
2	failed to develop
1	first applicants forfeit
1	industry to examine
1	title 15. (b)
4	audit agents of
1	longer surveillance for
1	 (i) expertise
1	2017for each of
1	(a), during the
1	information, to enable
1	basis to accommodate
3	obtained under the
1	accountability  (a)
1	canned fruit or
1	devices to enable
1	labeling and prescription
1	350i. protection against
1	transfers all right,
64	prior to the
2	serve an order
1	requirements for manufacturer
5	makes a certification
1	establishmenta petition under
1	operations thereof as
4	property subject to
2	excluded under this
1	ethinamate. (6) methohexital.
1	whether the standard
1	(d) a bioequivalence
2	substances; (4) past
2	therefor, within 30
1	(c), and exercising
1	investigator conducting or
1	secretary a true
1	provider licenses until
1	(as meat brokers,
1	vehicles, food, or
1	healt-related purposes, and
2	provisions only under
1	lon-term commitment in
1	practitioners and other
1	associations and private
1	drug is unrecognized
1	subparagraph (a)(ii)(iv) and
7	based on new
1	employees, the annual
1	flow, such as
1	8 of part
1	loss or loss
1	nations; (iii) request
2	natural or synthetic
1	auditor, except that
1	knew or should
1	statistical information, and
1	subchapter, or rules
1	ch. 675, 415,
1	inference, processes that
1	(7) to remove,
2	secretary is satisfied
4	(iv) the number
1	biennial registration renewal
1	chain of establishments
1	reporting, and illustrating
1	basis for its
1	compensation the compensation
1	countermeasures by facilitating
1	gel caps) at
1	thereof and other
1	total appropriations for
1	means to the
1	gram positive pathogens,
1	article an order
3	filed over protest,
1	association) if the
4	secretary providing the
2	reports; and (ii)
4	applicable transaction information,
1	declarations: psychotropic substancesthe
1	investigation. (b) regulations
1	seasonably made to
1	water from milk,
1	proposal contained in
1	 (b) recovery
1	(b) reauthorization 
1	training regarding the
3	title, the attorney
1	industry; two of
1	response to significant
1	matter that the
1	laboratories, including independent
1	determining bioequivalency under
1	enforcement participating in
1	(c) proposed standards
1	disclosure restrictions established
1	applicable food, the
1	section 360j(g)(2) of
1	title 18) any
1	higher amount as
1	acid to the
1	
 
 360k.
1	proposed strategy 
1	title 28, except
2	significant disability or
2	respect to another
4	shall conform to
2	reference in section
1	procurement, and dispensing
1	united states. subpoenas
1	issue his proclamation
1	notice by the
6	drugs, devices, tobacco
2	chemical preservative, unless
1	(i) were violative
1	distributes animal feed
1	hashish, or one
1	agencies. (c) inspection
1	jurisdictional authority that
1	(b) procedure for
1	matter in controversy,
1	additional indications for
6	adopted under subsection
2	drug, narcotic, or
1	(2cp).  (d)
1	panel, and which
13	food, drug, device,
1	sources the disclosure
1	responsibilities shall include
1	 (i) generic
1	item that, in
1	authorize that the
1	plant disease or
1	date no later
1	(a)(1). (c) limited
1	restricts visibility but
1	deferred upon filing
2	portions of smokeless
1	cleanup associated with
3	containing (1) the
1	eligibility determination submitted
1	(iii) the defendant
2	conducting drug interdiction
1	secretary stating that
1	helium, the treatment
1	information on patien-focused
3	substances in the
3	applicant of the
1	appropriate agency of
2	therein in such
1	promulgate amendments to
1	675, 305, 52
1	(c) the actual
1	costs pursuant to
1	(1) registration and
1	differences between the
1	application requirements; contents;
4	better or of
2	clauses 2 and
1	(d).  (

1	treaty, statute, executive
3	45 days from
1	 (i)in general.
2	food is misbranded
1	recognition or accreditation,
1	cost of providing
2	chemicals and supplies.
1	(d) small businesses;
1	law, states shall
2	proposed regulation, and
2	guarantee of access
1	columbia, or other
2	continuation of distribution
1	(2) allylprodine. (3)
1	secretary, after notice
1	2, 70 stat.
2	like circumstances or
1	programs may include
1	summary judgment 
1	respectively;  (b)
1	authorized federal officer
1	 (i) accepted,
2	reason of administration
1	promotion of unapproved
1	hospital or of
1	allocated as needed
1	tobacco smoke. 
6	fiscal year following
3	report its recommendations
1	applicable the provisions
1	request to add
1	render it expedient
1	analyses conducted to
1	disposal under the
1	solely for intrastate
1	information is needed
1	section colored oleomargarine
1	resources to drug
1	causes of foodborne
1	(i) because of
1	tobacco productsa tobacco
1	aforesaid of any
1	formerly 360, as
2	(b) is capable
1	approved designated new
1	(4) as used
1	photograph and is
2	subchapter i, or
1	withdrawal period which
1	article or articles;
2	 (g) biennial
1	(f) upon the
1	(c) condemnation of
1	 (c) waiver
1	credible. (2) discovery
1	retail in such
2	3, 1996. the
27	appeals for the
2	move in interstate
1	take such security
2	list of countries
1	means a material
1	 (a) identity[1]
1	appropriate documentation or
1	reserve fees combined,
1	variety, the name
2	conduct 1 or
1	food. (f) the
1	behin-th-counter placement of
1	 (i) annual
1	chemical residue as
2	state may be
2	adequate protection of
1	ful-time employees when
1	compounding that such
6	specified period of
1	[42 u.s.c. 247d5].
1	amendment of order
1	(n)(3), information submitted
1	federal agencies the
1	(iii) establishing a
1	(b) manufacturer requirements
1	applicable request and
1	(4) withdrawal, suspension,
1	distinct enclosed area
4	infringed (including any
3	initial list under
1	annual submission the
1	file means a
3	devices solely for
1	states, irrespective of
2	drug, based on
1	 (d) suspension
1	360e1. pediatric uses
1	country, and the
1	30, 1981. of
1	act of 1937;
1	review if a
9	described under subsection
1	year, conditionally approving
1	care providers, if,
1	pests.  (2)
2	human services. in
1	submitted based on
6	adjustments  (1)
7	drug enforcement task
1	use in 
1	brought in a
1	extensions of time,
2	referred under this
1	1, 2023. 
1	(f) the action
2	 (iii) firms
1	subsection (a)(3)(b), including
1	may, after consultation
2	application therefor, may
1	traced. the individual
1	regulation, any state
1	colored oleomargarine (a)
1	interventionexcept as provided
1	reporting of violations;
14	fiscal year that
2	review the progress
1	relating to labeling,
1	tobacco product described
1	 (i) 1;
1	organizations commit to
2	research and development.
14	amount provided in
1	taken that affects
1	transgenic animal.[2] 
1	appropriate acute pharmacological
1	relating to marketing
1	360aa. recommendations for
1	health presented by
1	budget submissionsas part
1	research organizations; (iii)
1	warranted and submit
3	(a) involving a
1	thre-year period subsequent
1	included with other
2	establishment fees under
1	rulemaking finding that
1	commerce or burdensome
1	institution programs of
1	compliant companies and
1	order direct that
1	trial guidance for
1	distributor whose name
1	(b). clauses (iii)
1	 (a) only
1	improving an automated
1	members of high
2	regardless of weight,
2	biological product named
2	applications and, where
2	new drug protocol
3	employee is acting
1	key barriers at
1	
 683. interstate
1	hearing is held,
3	congress to provide
1	destruction or reprocessing;
1	 (iii) fiscal
1	(5) use to
4	order such additional
1	proposal, the secretary
2	services provided is
1	public health advisories
1	limitationsfor purposes of
1	subsection (f). (m)
2	chemical diversion control.
1	enforcement and restraining
1	attaining the intended
3	general schedule, for
36	control program agency
1	tobacco use in
1	derived from studies
1	  copper
1	trade bureau authority.
1	diversified professional backgrounds.
1	fees assessed shall
1	terms lif-supporting, lif-sustaining,
1	concluded, except that
1	prescribed, or, if
1	violates this subchapter
1	561, as added
1	diversified professional backgrounds,
1	moved from such
1	authority or by
1	numerical identifier, lot
1	may be produced
13	subsection for a
1	person. (2) information
2	age to violate
1	(1) review beginning
1	child by school
1	[15 u.s.c. 1333]
2	may require; (f)
1	immediately, or (ii)
22	60 calendar days
2	applicant, unless that
1	addition to conditions
1	(ii) all surrogate
1	enforcement sensitive information
1	27, 2013, to
1	protocol to determine,
2	supplement was filed.
1	one age group
1	requirements for data
1	media campaign. the
2	criteria used by
1	represented as 
1	issuance; execution; probable
3	excess of a
13	report to congress
1	term narcotics trafficking
1	calendar days following
13	july 1, 1944,
1	resources necessary to
1	respect to studies
1	airway resistance. (vi)
2	agency, shall not
1	practitioner has the
2	availability in the
1	(b)(3) of section
3	fiscal year 2013for
2	mariana islands, the
1	information not described
1	review if, prior
1	(5) review 
1	on-half fluid ounce
3	 (c) registration
1	(a) contain (i)
5	relating to drug
1	coordination through national,
2	summary under subparagraph
4	device would be
1	media campaign; (ii)
1	devices for a
1	grants, in whole
1	part. (b) rules
9	removed from the
1	inventory.  (b)
1	based solely on
1	time periods specified
6	drug administration. (b)
1	application; minus (ii)
2	authorized the emergency
1	regarding any gaps
2	performance of functions
2	several states not
1	
 
 347a.
1	regulatory auditthe term
2	year, or a
8	excess of 3
1	(iii) the address
1	2017.  (

1	405, as added
1	otherwise, notify the
1	exporting country achieves
2	furnish each advisory
2	30, 2013, for
1	drug or active
1	decision. the secretary
2	subsidiaries or affiliates,
5	funded by appropriations
1	rules agreed upon
1	packaged in blister
1	inspection if the
1	bioavailability means the
1	judicial district whereof
1	representatives for violations
1	eligibility for approval
1	device exemption if
1	plants; authority to
2	evidence of diversion
1	regulation that matchbooks
2	indian tribe involved.
1	intended for consumption
1	(including judicial review
1	order shall designate
1	means expenses incurred
2	information which is
1	 (i) designate
1	consist of such
1	presumption at trial
1	finds there is
3	require, as a
1	822.) [1] see
1	thereby.  (c)
1	(1) the licensed
1	(iii) testing of
1	(i) based on
1	smok-free, without smoke,
1	federal international and
1	use involved. 
2	writing, with regard
1	income derived, directly
1	(i), a fee
1	petition make a
1	scientific societies in
1	picked, of good
1	whenever he finds
2	electronic data (such
1	made, and no
1	involved before taking
2	preparation of any
1	crime and criminal
1	center.  (c)
1	section 346a(a) of
1	(14) -methy--piperidyl benzilate.
3	fee revenues to
2	drug; (c) a
1	documents and revisions
1	(a) which are
1	harm reduction, and
1	sharing in high
2	21 of the
1	person may obtain
1	record maintenance and
2	entities, which may
1	262], for diagnosing,
1	 (1) identificationthe
1	containing such article
1	handicapped individuals in
2	sentence for the
3	healthcare research and
1	(2) availability 
3	pending action under
1	certification with respect
2	introduced, or may
1	proceeding, the administrator
1	place unless a
1	food additives (a)
1	(b), (b) if
1	 (a) foreign
1	disclosure could reasonably
1	years of (1)
2	preempts state, local,
1	number and operation
2	authorized representatives, shall
1	(d) establish minimum
1	expansion to additional
1	(3) application the
1	year by this
1	any, filed with
1	disseminate specific standards
1	paragraph). such plan
1	substance if 
94	shall be considered
1	1971, every registrant
1	area; (c) the
1	full and accurate
1	
 
 399.
1	objections has expired
1	report. (
 

1	coalition meets the
1	drug, prior to
1	filter, or other
1	if, after tests
1	formation and execution
1	har-drug users, including
1	(i) the strategy
1	sealed as required
1	harm as a
1	notification or receives
1	and/or of any
1	official compendium in
1	paragraph (4) for
1	made use of
2	30, 1890, ch.
1	official compendium if
1	(3) such regulations
1	(10) an assessment
1	packages or 10
1	person has paid
1	standards).  (2)
1	(m) authority with
1	4-day comment period.
1	
 356g. standards
1	consult the policies
3	public meetings in
1	(g)(2)(c), for a
1	model standards shall
1	(iii) for a
1	section[3] 350c of
1	aircraft. any such
1	license issued by
1	risks and special
1	device; (b) in
1	(d) annual fee
2	american osteopathic association,
2	title that were
1	resolution the responsible
2	limit, to the
2	permit granted prior
1	section, until an
1	 (j) delayed,
1	cooperative that aggregates
2	appropriate pediatric labeling.
2	tobacco products containing
1	including the topics
2	respecting control of
4	administrator, in coordination
1	including civil penalties
1	consultation the action
1	advertisement. the advertisement
2	made under the
1	number, or device,
1	marketed only if
4	given the term
8	times to have
3	entities and individuals
1	certificates, and of
1	facility and all
9	fails to comply
1	procedures for food
1	consumer; or fishing
5	state agency of
1	(c) confidentiality of
3	origin, or independently
1	violation after 1
1	(2) it has
3	proposed labeling thereof.
2	specification of (i)
1	(
 
 2224.
1	unauthorized access to
1	met. (2) timelinesthe
1	shall revoke such
1	(b).  (f)
1	valid public interest
2	paper book shall
2	establish scienc-based minimum
1	operation performed by
1	tolerance established under
1	agriculture, and human
1	fact.  (5)
1	representatives annual reports
3	u.s.c. 300g1), the
1	general each manufacturer
1	expertise for the
1	technological characteristics means,
1	physician. the secretary
1	made such notification
2	already given notice
1	(i) limitation the
1	act or causing
1	outbreak in this
2	bribery, payment of
1	review, and update
1	(ii) improve the
1	weaknesses in the
1	reimbursed to the
1	least 85 percent
1	(c), such device
1	section shall prohibit
1	imposing conditions on
1	(4) new tobacco
1	submitted a registration
1	pictures, or sounds
1	wholesale distributors, dispensers,
1	following the submission
2	secretary issued under
1	treatment, education, or
1	assure that appropriate
1	review if an
1	debarment. (b) individuals
5	act relating to
1	secretary any such
1	site outside the
1	(4), the person
1	plant classified within
1	(iv) reallocations in
1	order; (b) proposed
1	containing such additive
2	subsection for 1
1	standard new drug
1	without modification, shall
1	submission submitted under
1	taken or proposed
1	product recipients, recordkeeping,
1	food found to
1	collectively, of any
2	regulation of meat
1	section, and not
1	approve had been
1	liability shall be
4	use to reduce
1	manufacturing process or
1	chain to convey
2	review in accordance
1	documents are properly
2	duration of awards
1	become effective, and
1	 (b) income
2	seeks a priority
1	subparagraphs (m) through
1	barbituric acid, or
1	secretary, refer the
2	additional year, he
3	supplemental nutrition assistance
1	manufacturing process of
1	providing reliable law
1	privileges of his
1	subchapter i, to
1	term qualified entity
8	secretary for review
1	
 350. vitamins
1	clinical data derived
2	updates to such
1	general to produce
1	eating place unless
3	action of any
1	order deny or
1	pathway has functioned
1	(c) secondary schools.
1	product manufacturers, wholesale
3	advertisement prior to
1	 (f) advisory
6	patient access to
2	(b) be disposed
1	subsections (b)(1), (b)(2)(a),
1	(f)(i) the person
2	reporting for all
1	inspection requirements 
1	year, and require
1	section by any
2	title; (ii) a
1	third parties a
1	data, rates of
1	modifying or revoking
1	evaluating new or
1	(1) no state
1	work assistance; and
1	(ii) is authorized
2	 (g) authorization
2	made to a
1	poppy and poppy
2	another application submitted
2	assessment shall be
3	drugs under this
1	subsection (c)(4) or
1	transfer, and use
1	505e(g) of the
1	stay of civil
2	document titled regulations
1	gum, and nicotine
1	extent that this
2	foreign animal diseases.
1	establishment within canada
1	co. v. reilly
1	586b, as added
1	designate drugs, categories
1	pregnant individual except
1	branded as to
1	devices utilizing updated,
1	applicationthe term material
1	characterizing flavor of
1	section; and (3)
1	coordination relates to
3	section shall permit
1	poultry products as
1	establishments to ensure
1	samoa. (june 25,
5	within 30 calendar
1	available; and (ii)
1	costs.  (4)
1	trial that any
3	subsection (c) shall
1	containing foreig-grown tobacco
1	(2) surveillance protocol
1	321(p)(2) of this
2	investigating potential illicit
1	population or the
1	mitigation or remission
2	among youth in
1	persons registration number
3	last known address
1	addict means any
1	paragraph.  (

1	lead, mercury, silver,
1	area task force,
2	pharmacy that is
1	organizations, and academia.
1	biomaterials supplier moves
4	business of dispensing
1	criteria website, a
1	scope of grants
1	agreement between attorney
2	requirement adopted by
1	member shall serve
1	sonic, infrasonic, or
1	(by order in
1	coordination of law
1	coordinator  (1)
1	harvested at such
1	expire not more
1	relating to) this
1	nutrients, and (ii)
1	103226; 5 u.s.c.
1	respect to products
1	398 of this
2	term wholesale distributor
1	unavoidable.  (5)
2	generala person that
2	valid prescription issued
1	adds or increases
1	clause (vi) and
4	secretary shall seek
1	issuethe term emerging
1	language and english
1	carcass, or meat
1	(6) miniature spoons
22	later than 120
1	equipment, punches, dies,
1	research training for
3	request, unless extraordinary
1	substance and that
4	omitted or abstracted
4	active ingredient is
1	health. a tobacco
2	active ingredient in
1	consumers for information
1	determined necessary to
1	section shall make
1	division director), as
8	first sentence of
1	determined could be
14	acting through the
1	submits a second
2	substances.  (b)
1	chair of the
1	(c) upon a
2	may appear before
1	comment. within 120
3	authorized by or
1	speech, print, or
1	(iii) scientific evidence
1	food for shipment
1	section. (june 25,
1	revise, or eliminate
1	serious risk associated
2	(3) the report
1	proposed regulation. 
2	labeling thereof. 
1	states, to 
2	authorized to inspect
1	increase; and (4)
1	human services designated
1	(3)  section
1	issue regulations allowing
1	liquid eggs, with
2	1621 et seq.);
1	title, or 856[3]
1	971(c)(1) of this
5	authorized by their
15	milk or cream
1	november 10, 2005,
1	whether the individual,
2	amount of food
11	(ii) with respect
1	prevention programs. for
2	contains (by reason
1	paragraph (2); plus
1	must be no
1	grant at a
1	 (b) criminal
1	identifier, lot number,
1	trial shall, upon
1	(c) and shall
1	omitted
 
 16.
1	title;  (b)
1	(5) explanation by
2	laboratory accreditation bodies
1	2, 48 stat.
1	(a)(4).  (

1	(1) each disease
1	testing under this
1	1948, ch. 613,
1	fees received by
2	budget proposal to
1	holding of alcoholic
1	on-page summary; (b)
8	develop and implement
1	received a manufacturing
2	processed at such
1	 (a) exhibits
1	usual name and
1	may be the
1	(c) holding public
1	completed video production
1	tolerance; and (xiii)
1	detoxification treatment requires
1	requirements for licensure,
1	reviews the steps
1	federal natural resource
1	showing required under
1	audit and investigation
1	subsection (b)(1) with
1	(h) authorization of
1	describing whether the
1	transportation, in any
1	(c) each device
1	42 for an
1	provided without a
1	open participation by
2	(2) reporting in
1	ready or suitable
1	-(-naphthylmethane)indole by substitution
1	harvestable acres, income,
1	(ii) the placement
1	certain commodities are
1	secretary, that appear
2	operates an eligible
1	furnish the notification
1	clinical, or both)
2	distributed in accordance
1	(5) make, prior
1	(
 
 955.
1	programs by eligible
1	practicable in accordance
1	reserves for the
1	(c) preservation and
1	0.60; and (ii)
1	period.  (i)definition
1	regular customer. the
1	(b) policy it
2	information related to,
1	term new animal
1	option to carry
1	consolidation is so
1	electronic portal, from
1	criteria to determine
3	shall be headed
2	application is eligible
1	circumstances:  (a)
1	postpone sentence to
1	(ii) documentation of
1	identifying potential immediate
1	reveal the existence
1	offered for importation;
5	ingredients or drugs
1	reaffirmation of the
1	biosimilar to a
2	withdrawal of approval;
1	domestic commerce. 
1	offense. and it
1	recognition of an
1	statement that, because
1	displayed thereon: cautionthis
1	(1) was enrolled
1	practitioner of the
1	food products regulated
4	refusal to permit
1	standardsthe secretary shall
1	appropriation. (6) use
1	(m) requests for
11	investigation of a
3	section 1604(c) of
1	scheduling decision pursuant
1	appropriate, shall contract
1	declaration within 30
1	clause (ii) may
1	prior convictions, unless
1	attorney general (1)
2	manner designated by
1	mail or other
1	enterprises; slaughterers or
1	secretary. (d) no
14	violation of the
1	regulated products in
1	information available; (e)
1	delayed submission of
1	sufficiency of assets
1	congressional committees, to
1	enter upon any
1	extent a sponsor
1	smokeless tobacco, or
2	year on creative
1	attorney generalnot later
1	iii. (b) a
1	alphameprodine. (5) alphamethadol.
7	risk of tobacc-related
1	trials cannot be
1	may also assign
1	pivotal animal studies.
1	 (f) rules
11	information necessary to
1	 (2) oxygen
2	large volume biological
2	animals, human food
1	dispensed only (i)
1	(e) recordkeeping; and
1	regulatory activities under
1	coordinate with each
2	extract product, or
3	safe or effective.
1	treatment are based
1	term illicit trade
1	ch. 675, 915,
1	protocol, or device
2	shall track and
19	(b) for a
6	shall maintain a
1	applicable regulations governing
1	(2ct2). (25) -[-(isopropylthio-2,-dimethoxyphenyl]ethanamine
1	safe for the
2	government entities engaged
1	making contributions to
1	stat. 1101.)
 

1	term youth center
1	means the committee
1	meat articles from
1	(through notice and
2	(b) before the
2	drug, means a
1	school, and parent
1	355f].  (2)
1	administrator, including 
1	ammonia will be
1	defense, the director
1	laboratory tests); or
1	industry, with health
4	relabeling or other
3	secretary shall, within
9	request described in
3	capture the transaction
1	organization. (c) the
1	assistance (a) definitionsin
1	
 
 360n1.
4	seek approval of
1	related to securing
1	property which has
1	applicable; (f) disclose
1	cattle, sheep, swine
5	requiring the secretary
1	experience, can be
2	establishment of such
38	salaries and expenses
2	conditions on an
1	intent, purposes, and
1	management guidelines 
1	whether the conditional
1	one prior i-person
1	 (d) review
1	needed to monitor
1	opportunity as the
1	warehousemen no carrier
2	matters to be
2	review fee shall
2	mitigate or prevent
2	 (b) refusal
2	208 of this
1	enhance the resources
1	effectiveness of devices,
1	travel expenses the
1	device for investigational
1	devices that, under
1	(xiv) -cyclohexylethy--(-methoxyphenylacetyl)indole (sr18
1	budget requests and
1	number of voting
2	may, if shipped
1	plan developed by
1	including guidance regarding
1	(b) to remedy
2	20 days after
1	establish such a
1	drugs (as amended
1	animal or edible
1	blackmail, extortion, falsification
2	enjoined from engaging
1	distribute does not
1	establish recordkeeping requirements,
3	section 881(e) of
2	authorized to prescribe
1	(12) no later
1	secretary, and shall
1	new drug. (2)
60	intended for use
2	use, or the
1	sharing of such
1	january 1, 2015
7	person required under
1	error or, after
1	reportable food; (c)
1	(i) whole blood
26	united states for
1	prescription drugs, including
1	document the nature
1	year 2015 
3	substantially not in
2	18 or $20,000,000
1	 (f) applicationthis
2	uses of a
1	regarding the handling
1	might contribute to
14	request that the
1	supplement to be
2	united states; (3)
2	use the grant
2	advisory committeethe secretary
1	person has at
1	written policies and
2	101(c) of the
1	may include disposal
1	person has an
1	active ingredient; (b)
1	party; (c) has
3	request, in writing,
1	scored; (4) in
1	promote, compensate, and
1	filed to an
1	scientifically insignificant for
2	reasons why such
1	children; (b) would
1	date for pediatric
6	prescription drug user
1	extent provided by
2	subsection (f)(6)(b) declaring
1	title, including progress
2	1, 1992, an
1	application. (b) payment;
1	full time equivalents
1	suspect product means
1	moneys and proceeds
1	said article is
2	device under paragraph
1	grant year, provide
1	summary judgment under
1	data showing the
1	beings; (c) the
1	(including a peritoneal
1	including nicotine replacement
1	upon under subsection
1	ch. 675, 405,
1	population.  (7)
1	882; 
 

2	drug at the
1	(3) the thermally
1	develop and use
1	cas-b-case waivers the
1	guidance. the secretary
1	foods. (f) exemption
3	conclusive unless, within
1	matter listed in
1	 (3) interim
1	act. (g) supplement
1	auditor; (ii) in
1	clinical data necessary
1	summary means a
1	552(a) of title
1	account the material
1	356. expedited approval
1	bloody white, large
3	matter of the
1	manufacturer requirements 
1	pendency of an
2	preparation of carcasses,
2	food, including the
2	information regarding data
1	including pharmacokinetic, pharmacodynamic,
1	physiological condition that
36	comply with the
5	safety and defense
1	reasonably practicable to
3	when, in fact,
4	active ingredient, information
1	removal such manufacturer,
2	fiscal years; and
1	definition  (a)
1	label with any
1	 chloride (mg)
2	equivalent review employees
1	standards for regenerative
1	1048. administrative detention
1	detentions, seizures and
2	account, among other
2	debarment under this
1	prescription to that
1	statements.  in
1	payment to informers
4	list in effect
8	transportation, in commerce,
1	ready for serving
4	 (2) contents
1	takes to share
1	impact notwithstanding any
1	title. (25) transaction
1	valid microbiological surrogate
1	avoided, the secretary
1	paragraph, since february
1	title 18 unless
1	(v) the length
7	(c) leasing, maintenance,
1	(e)(1)(b), (f)(2), (n)(3),
1	annually thereafter, submit
1	 (g) scope
1	(6) tracking of
1	include the product
1	take such comment
1	may request, at
1	food products, by
1	regarding prior convictions
6	section 360(i) of
17	shall prepare and
1	discretion to prevent
1	office for purposes
1	basic pay paid
1	2009, the executive
1	processing of food
1	access and commenteach
1	general during the
1	(c) registration by
1	misconductno person, firm,
1	used; and (2)
1	services, for loss
1	both. (6) any
1	support the approval,
1	medical training that
1	information is available)
1	filler, or its
3	nutrient required by
1	state that the
1	regulations governing computer
3	drug, or an
1	new determination, the
2	handling and distribution
1	1, 2010; and
1	wooden, acrylic, glass,
2	delete from any
1	clearance includes 
1	sciences, qualified in
1	(c) reduced fees
2	adverse device experiences
1	proposals and awarding
1	chemicals. (2) notwithstanding
1	two sentences of
1	granting or denying
1	systematic approach to
1	transactions involving an
1	reporting requirement the
1	issue originated, as
1	accelerate foodborne illness
5	income tax return
1	2nd par., 34
1	path initiative of
1	855. alternative fine
1	
 379d1. conflicts
1	(b) exemptions 
1	from, federal requirements,
1	sel-executing, and the
1	material not privileged
1	 (c) wholesale
4	(ii) a fee
7	classification of a
1	(3) opium poppy
2	7 of part
1	preceding the applicable
1	product as these
3	filed. the secretary
1	966. authority of
1	administration and update
3	criteria  (1)
1	advisory board composed
1	applied at a
2	otherwise than in
2	affiliates.  (iii)
1	manufacturers.  (2)
1	effectiveness of another
1	iii devices, which
1	description of production
1	identity has been
1	stat. 2298). (ll)
1	practitioner authorized by
1	individuals who were
1	pane-track supplement means
1	seq.); (b) the
1	describing the numbers
6	title or to
1	campaign. (b) in
1	2003 to 2007.
3	earlier than the
4	apply:  (1)
1	require. (2) notwithstanding
1	intending to provide,
1	activities as provided
1	period for new
1	conform to tobacco
38	required under subsection
1	 (c) coca
1	initially approved without
1	health; (2) bears
1	processed produce, so
2	either that the
1	states or abroad,
1	limitations specified in
1	pharmacist, and the
1	coordinating councilsthe secretary
1	product application (as
1	appropriateness of an
1	(f) relation to
1	(f) forfeiture and
2	retail a scheduled
1	limitations established in
1	date an action
1	response to report
6	section, there are
4	applicant elects to
1	least $6,250,000 in
1	may not thereafter
1	inference, and inform
2	certifies to the
1	capsule, powder, softgel,
1	thereby affecting its
1	party shall confidentially
1	fine imposed under
1	lif-threatening; (b) modulates
1	purposes of service
2	appropriated for new
1	modified, revised, or
2	kilograms of marihuana,
2	shall, upon obtaining,
3	infectious disease products
2	(3) termination of
7	order to ensure
1	verification activities for
1	body spaces during
1	bioequivalence studies needed
2	distributors of such
1	encouraging all national
2	serve upon the
1	secretary in any
1	definition as used
1	forms to be
1	subsection (e).[1] the
1	documentation that establishes
1	year, the annual
1	emergency that is
3	section shall in
1	precautions, or adverse
1	title, or (iii)
3	unless the administrator
1	plan process the
1	may cite the
1	unless such objection
1	title which are
1	lon-term care facilities
2	products for export
1	clinical testing involving
1	shall refer a
1	infectious disease product.
2	infectious disease product,
1	shipment shall be
1	new records. (g)
8	receiving a request
1	statutory, regulatory, ethical,
1	2008, to continue
1	standard, for consideration
2	 (c) scope
11	appears on the
1	1 or both
1	(d) availability for
1	2013 through 2015
1	supplement and nonprescription
1	nonprofit organization; or
2	orders, decisions, and
1	(i) a nonprofit
1	protocol will result
1	interpretation and application
9	immediate trading partners
5	adequacy of the
1	relevant endpoints, and
1	action and, upon
1	implement the provisions
1	(b) by petition
1	alkenyl, whether or
1	claimant would be
1	animal safety grounds
1	labeling, recordkeeping, records
1	advance or by
2	consultation with respect
2	morphine, or any
1	thousand and in
1	prescription drug shall
1	legitimate channels; (2)
1	required to gain
1	schedule for each
4	product was purchased,
1	(b) contain labeling
1	specify the scope
1	safe access to
1	assurances to the
1	(iii) any individual
4	provide sufficient flexibility
1	interest in this
1	2016. (e) $130,184,348
1	petition; (2) any
3	shall be consistent
1	(a), if a
1	given or substances
2	day), by written
1	professional organizations, representatives
1	categorization of the
2	interest that would
1	space that is
2	publicly available or
1	area, thereby indicating
1	free trade association)
1	cause for such
2	best suited under
2	animal drug) the
12	notice of completion
1	hearing was held
4	set forth for
1	protocols for investigations
1	(3) exceptionthe secretary
1	prescription medications; (3)
8	paragraph 7 of
1	individual patient, which
2	persons under section
1	three years after
30	 (a) to
11	publicly available on
1	title, section 360c(a)(3)(d)
3	assets of the
3	may impose recordkeeping
1	(iii) enhance the
3	implementing and enforcing
1	trials for rare
1	(4) all penalties
1	expunged under this
3	enforcement of chapter;
1	(ii) is an
1	device and has
3	repackagers, wholesale distributors,
1	donated funds; (iv)
1	may defer submission
1	(ii) is at
2	involved, to all
1	person claiming that
1	c of title
1	voluntary. nothing in
2	public health such
2	will facilitate an
1	protect the interest
1	forth the various
1	supply reduction shall
1	drug for another
1	programnot later than
1	individual shall not
1	official) with a
1	ensure adequate review
1	(c) the question
3	emergency, or a
1	corporation preparing said
1	offer, directly or
1	secretary. (7) the
1	(b)(1) with respect
1	release and fined
1	prior to becoming
1	use (a) classes
4	either party may
1	i, 16, formerly
1	performance of each
1	design or manufacture,
2	clause 4 of
3	formula or an
1	(b) exception if
1	percentage of individuals
1	food products unaffected;
1	ending  (i)
6	public review of
9	regulations under section
1	15, 1967. 
1	675, 582, as
1	proposed labeling for
2	committee  (a)
2	united states, excluding
2	understands each of
1	written decertification of
1	abuse prevention functions,
2	abuse prevention functions.
2	building, or conveyance
1	required by recognized
1	export shall apply
1	manufacture, many controlled
1	authorizes any official
1	report are submitted
2	law, including any
1	title and take
1	petition. (3) no
1	inspection budget). (ii)
1	876. subpenas (a)
1	catalyst for increased
1	presented, or is
3	require periodic reports
2	relief, including interim
1	collectively; and (ii)
1	purchase of media
1	exemption already granted
1	
 
 387a1.
1	section, publish an
2	revokes a registration
10	represented to have
1	offices for the
1	activities (including compliance
1	substances mentioned in
1	
 873. cooperative
1	residue (in excess
5	information and trade
1	legal disadvantage based
1	address each of
1	confidential under such
1	advertising restrictions applicable
1	used within a
1	homogenization. (e) exemption
1	paragraph (1) best
1	1534 of title
1	change such applicable
5	united states ant-doping
1	(b) tolerances for
1	(a), as appropriate,
3	exemptions, reductions, or
5	(iii) the number
2	may withdraw accreditation
1	temporary period of
2	(1) the biomaterials
1	
 337a. extraterritorial
1	either a new
1	materials, constitutes an
4	pseudoephedrine base, or
1	place the facility
1	1337 of title
1	recall order that
2	license number of
1	material threat pursuant
1	slaughtering any cattle,
1	practitioner licensed and
2	meeting with such
2	scientific, and industrial
2	reclassified as class
43	cosmetic act [21
28	without regard to
1	analogous products. 
1	subchapter unless controlled
2	tolerances  (1)
1	applications the administrator
1	states pharmacopoeia, pharmacy,
4	standard referred to
1	(iv) available information
1	below, the standard
3	(1) modified risk
3	may, without regard
1	maintain the display
3	following requirements shall
1	 (2) partnershipsthe
3	(c) in any
2	products were not
1	shipment. the secretary
1	 (i) report
4	available for use
1	(i) publish the
2	activities of which
1	care professionals. (xi)
1	level  (1)
1	homeland security applications
1	drug sponsors, and
2	reviewing division why
1	 (2) nonprescription
2	governments and nongovernmental
1	information about patients
1	performance audits and
1	18-day supplement means
1	(7) within 90
1	subject (or his
4	owner or holder
2	antibiotic drug an
1	statement concerning the
1	labeled and of-labeled
1	deny the application,
1	ch. 675, 1006,
3	section 409(l)[1] of
2	distributor or manufacturer
1	(i) the amount
2	premises where it
1	case containing only
1	
 
 381.
1	listed drug application
2	technology research and
4	united states internal
1	article under any
1	or, as applicable,
1	useful to fulfill
1	director, may 
1	removed from all
3	congressional committees information
1	distribution; (ii) be
1	61, 6, 64
1	states by 
1	(i) determine, on
2	system.  (b)
1	(2) requirements 
1	(f) incidental production
1	request the sponsor
2	waiver), the submission
1	either to establish,
1	paragraph. (6) 
1	later withdrawn modular
1	ghb, including gamma
1	(d), as applicable
1	establishes standards for
3	permitted under the
1	meat; and (b)
2	transactions within such
2	good cause to
1	alleging such prior
2	(5) past experience
2	applies to any
1	used (or intended
3	subchapter.  (2)
1	operator may make
1	poses a significant
1	(2)(a). (dd) tentative
2	holds a permit
1	(or, in his
1	list of nominees.
1	
 
 379j21.
1	 (d) protection
4	deliver, distribute, or
7	approved for safety
1	fewer than 3,
3	distributor shall provide
1	intent to commence
1	675, 910, as
1	dispenser shall, not
3	ninet-day period beginning
1	adulterated.  (3)
3	days of november
1	603, 52 stat.
1	manifestations primarily affect
1	
 360bbb5. critical
1	cigarette tobacco means
1	clause (i) only
3	separate standards that
6	present the recommendations
1	states prompt notice
1	preparation for an
2	direction issued under
9	consignee of the
1	effective date) notify
3	safety.  (c)
9	secretary shall establish,
5	regulation under subparagraph
1	donor intends to
5	designs, or devices,
1	importer) who distributes
1	products owned by
1	projects in research,
1	united states, unless
1	milk except for
1	manufacturers that were
1	inform the issuance
2	prohibition act of
1	hydrate, except upon
1	upon thir-party inspections
1	definitions the terms
1	(2) acetyldihydrocodeine. (3)
1	made would have
1	(c) certification the
1	issued a sum
9	procedures prescribed by
1	food, including residue
1	(b) contracts the
1	yolks, moldy eggs,
6	written, printed, or
1	persons and corporations
1	use, or on
1	(g) 1000 kilograms
1	victims of drug
2	referrals under subparagraph
2	filing date but
1	(7) whether the
1	imposed on him
1	administration, including functions
8	title 42, the
1	(1) the cooperative
1	publish the reports
1	list created and
1	either of them.
1	codeine methylbromide. (5)
1	states. (mar. 3,
1	drug immediately; (b)
1	properly designed or
2	processes the products
3	grounds that it
1	outside territorial jurisdiction
1	effect; (d) which
1	received $10 million
1	impleader under subsection
4	refused admission into
1	condemnation under this
1	formula is homogenous
1	january 1, 1958,
3	(a) unless specifically
1	compilation of notices
1	services. amounts provided
1	foods are safe,
1	identifier beginning 6
2	(c) service of
1	publicly the presidents
13	initiative of the
1	means a statement
1	recognize all, part,
1	(f) state enforcement
1	evidence properly and
1	2011; or (b)
1	exists an agency
1	subsection (a)(2). (iv)
1	 (a) contrary,
1	relate to milk
6	(b) and (c)
1	processing, packing, holding,
2	person to any
1	 (8) rules
1	subsection.  (13)
1	statement from a
2	effective by experts
1	identity[1] opportunities to
1	(ii) and request
3	shall be obligated
1	government, or the
1	indicated. (ii) with
4	importation of such
1	device modifications: deciding
3	(e) monitoring of
1	-year periods as
1	specialized training and
1	poisonous substances sold
1	violation of paragraphs
1	paragraph (1)(a)(i), the
1	adul-only facility (as
2	paragraph (2), a
1	(c) returns 
1	excess of yellow
4	substances manufactured and
1	territory for the
58	part of the
3	control under this
1	review of full
1	following applies with
1	administrator, including consideration
1	prices of which
1	activities of grant
1	individual schools or
1	renewed for additional
1	facility demonstrates to
1	livestock industry of
3	borne by the
1	paragraph the secretary
1	poppy straw, and
2	youth center, public
1	including the prevention
1	communicable diseases if
1	(b) a substance
1	sponsor; and (cc)
1	request means each
2	reports, and recommendations
2	 (b) application;
1	subsection (f)(6)(h) distribute
1	(1) fees authorizedthe
1	1396 et seq.].
1	determined de novo,
1	sales direct to
7	qualified by training
2	pursuant to subparagraphs
1	annually for up
1	pharmacology, addiction, or
1	required; (ii) identifies
1	net assets the
1	chapter: (1) biomaterials
1	tribal demand reduction
1	extracorporeal membrane oxygenation
1	acquired by the
9	adjustment for fiscal
1	triple those authorized
1	sell, or transport
1	(b) upon receipt
1	renumbered 309, 

1	thereof, to establish
1	timely communication with
1	(c) paymentthe fee
2	purposes.  (b)
1	valid basis to
1	effective methods to
1	format that can
2	manner of handling
1	title 42 at
6	terms are defined
1	manufacturing in the
1	1260; renumbered 3
3	881(e) of this
3	transmitted pursuant to
4	may 1, 1971.
1	informal conference. a
2	registrant who is
1	food; and 
1	international, border, and
1	sizes; definitions and
1	auditor becomes accredited
1	(1) rare diseases;
1	(3) formal changes
2	employ, hire, use,
6	design and size
1	42, any such
1	ii and narcotic
2	product, the agency
99	pursuant to this
1	number so employed
3	(including by sale)
1	arcade facility, is
2	subsequent years payment
1	education program regarding
1	675, 542, formerly
1	monitoring in accordance
1	$599,000,000. (i) for
1	compounded drug 
1	applicable, for each
1	fda authority over
1	ii, or title
1	subchapter;  (3)
4	section.  (5)
1	summary level review
2	united states except
2	public hearing for
1	360e, or 360j(g)
2	respecting the quantities
5	supplement submitted by
1	qualified manufacturers in
2	201 et seq.)
1	finds that clauses
1	comparable approved drug.
2	services. in issuing
1	medical countermeasures. 
1	(including scientific matters,
3	business if he
2	water regulation under
1	 (b) discoveryif
1	means an applicant
1	ch. 675, 565,
1	provide, a substantive
1	serious injuries. (b)
1	taken during the
1	manner of notification
1	general, may request
2	list in alphabetical
1	methicilli-resistant staphylococcus aureus,
1	possession, sale, or
1	(1), the advisory
1	described by subsection
4	notification under such
1	 (a) collect
2	services the secretary
6	order of forfeiture
1	
 360ss. state
1	749, formerly 746,
4	presents a reduced
2	combination product. if
1	activities relate to
2	pediatric study conducted
1	director shall make
1	secretary after notice
1	42); and (e)
1	shall make an
1	extent not intended
1	chemical for use
1	act, (b) it
2	(iii) a person
1	examination of data;
1	violation but not
1	transfer to a
1	qualitative or quantitative
1	aggressively to the
1	commodities, including persons
1	ensure safety and
1	information and statements
3	components, ingredients, and
1	device imported does
3	claim a use
2	determinationnot later than
6	information submitted by
1	concerning the dietary
1	determines appropriate, update
1	in, or to
2	use in medical
2	drug applications (adjusted
1	
 
 355d.
7	201 et seq.]
1	periods of such
1	commission by secretary;
1	nonusers of tobacco
1	disposing of, or
1	coca leaves, and
1	(8) it is
1	reduction is necessary
1	means. (3) the
1	established relationship between
1	paragraph (a)(2) or
1	(b) liability of
2	(f) any other
1	paragraph (e) the
1	(1) includes an
1	paragraph, no grant
1	actions will not
1	permanent. (ii) the
1	complete such study
1	exempt tobacco products
1	(2) determinationnot later
3	time, on a
1	(b) grant of
1	supplier who is
1	concludes that the
1	conviction; (b) at
1	2012, and a
1	device so identified
1	(3) chairperson the
1	shall prescribe. no
1	approval.  the
1	vegetable, animal, mineral,
1	benefit as described
3	necessary or appropriate
5	notification  (1)
1	fish and shellfish;
1	1264; renumbered 22
1	mail) as approved
3	specifications, as provided
1	parties no fee
1	services or to
1	change determined by
1	swine populations. 
1	regulation of dietary
8	data (other than
1	use are used.
1	regarding premarket notification
2	performance report 
2	review and provide
1	(2) the application
1	task force resources
1	requirements. (d) coordination
1	(7) residues from
1	(i) 1 kilogram
1	activities not affected
1	local advertising concerning
1	(f) exemption for
1	institutions. (mar. 3,
2	diversified professional background,
1	chapter.  (m)
1	obtained prior to
20	experts qualified by
1	(ii) any illness,
1	shall become final
1	frequency as necessary
2	united states while
1	commercial purposes. the
1	health consequences; (ii)
2	action alleged in
1	health impact caused
1	action taken upon
1	interstate commerce; 
1	(ii) timetable; periodic
4	adduced upon the
1	diversion from legitimate
1	(d) review of
1	(b) the products
1	fees fixed by
1	(a), a requirement
1	protection, or to
9	may by order
1	particularly underrepresented subpopulations,
1	drug substances is
1	level is established
1	interviews. (c) strengthen
1	facility within 100
1	$50,000 for each
10	person sentenced under
2	relate only to
1	meat food industry,
1	requests; and (3)
2	years after its
5	paid by such
1	component parts are
1	capable of adequately
3	containing any official
1	questions; and (ii)
10	(iii) if the
1	component is or
1	requirements the substantive
1	official sample for
2	establishments are subject
1	subsection of the
1	identifier for the
1	third person, this
1	(b)) that will
1	brought by that
1	limit or interfere
1	petition, the petitioner,
1	(i) postmarket surveillance
3	postmarket safety activities).
3	deferral or deferral
1	material in the
1	revoke any priority
48	provided in section
2	upon the secretarys
1	additional evidence and
3	commodity bears or
1	(s) referral to
1	drug containing one
1	prior owner of
1	extent possible, that
1	entry of false
1	health organizations and
1	feed be deemed
2	grams of codeine
1	evidence exists, establish
1	314, or subpart
1	establishing the safety
1	methamphetamine abuse and
1	section; (c) for
1	produce, and the
3	board shall be
5	pesticide chemical that
1	prerequisite to receiving
1	identity for purposes
1	secretary submits to
1	expiration of 240
1	(a) would not
1	(d) commissioner 
1	qualification plan, or
1	taken.  (3)
1	(relating to opportunities
1	biological responses to
1	(2) rights of
2	maintain liaison with
1	
 901. severability
1	considered because of
1	inspected by 1
1	1171. drug abuse
7	826 of this
1	379h1. fees relating
1	communicable disease under
1	previous 24 months;
1	special susceptibility of
1	chronic bronchitis. such
1	administrative, legislative, or
1	standard a standard
1	good faith protection
1	including postapproval, of
1	(a) enables personnel
1	(c) contemporary research
1	receives, packages, holds,
1	review fees due
1	title. (c) exception
1	(2) working groupthe
1	pay an operating
1	exercises described in
1	substances possessed commonly
3	(c) publish the
6	informal hearing on
2	(d) judicial review
1	act. (9) the
1	believe that grounds
1	advice. (c) disclosure
1	functions; (b) laboratory
1	food would cause
1	 (5) advertising
1	fed. reg. 4439644615
1	dextrorphan. (14) diampromide.
1	general a drug
1	
 851. proceedings
1	year 2009. (4)
1	days after conducting
1	supplant, local community
1	 (b) on-year
1	(3), or an
1	mature stalks of
1	sales of food
1	cosmetic act. (june
1	 (b) scope
1	title xviii of
3	lieu of a
2	 (2) includes
1	including from toxicological
1	official action, or
1	formerly 356, as
1	purchasing organization or
1	(iii) data showing
1	1264; renumbered 20
1	following phrases to
1	nurse tank the
1	42, the person
1	including foreign governments,
3	congress finds that
1	(i) the record
3	823(g)(1) of this
2	denial of federal
1	thereof; the resin
1	(d) to obtain
1	delegated to the
2	subparagraph, the secretary
1	contractual agreement under
1	testing capacity that
3	states of a
1	administrator shall terminate
1	publication shall be
1	afforded opportunity for
1	regulation) shall also
1	title. (b) for
1	risk when available
1	secretarys action; judicial
2	applicant involved meets
1	(or regulation) provides
1	(obtained prior to
1	(l) of subsection
6	section pursuant to
1	isomers on premises
8	may by regulations
1	to, and fair
1	administrations communication plan
1	undertaken solely under
1	therefor is submitted
1	subsection (m). (2)
1	performance standards, to
1	(iii) chair the
1	section 379dd(d)(2)(a)(ix) of
1	resources required to
2	product, a repackager
1	subsection to an
1	(ii) the government
1	every 3 years,
1	conducted for one
1	administration, with expertise
1	message. such message
1	(9) sulfonethylmethane. (10)
1	animal drug; contents;
1	justification that explains
1	university consortia, publi-private
2	order, the court
2	commerce any new
1	shall be falsely
1	systems are placed
1	254l et seq.],
1	reviewers prior to
1	(3) refusal to
7	secretary determines, based
2	solution or water
1	agent or agents,
1	42; (iii) the
1	(h) temporary scheduling
1	(
 
 1402.
1	consultative affiliation) with
1	develop metrics to
3	requests and may
1	pharmacy, hospital, or
3	article, means of
2	new findings, by
1	(b), and subject
1	section to programs
1	law enforcement agency;
1	president is satisfied
1	(c) scope of
1	16(b) of such
1	printed by the
1	share responsibility for
5	product application for
1	services to continue
1	delegation any responsibility
1	misbranded or (b)
1	(g) plants 
1	small group of
2	stocks thereof on
1	law enforcement agency.
1	concerning nonprescription sunscreen,
3	foreign country from
1	seq.]. (2) shor-term,
1	paragraph (3), of
1	submit the deferral
1	cooperative agreements the
2	article will cause
2	subject to debarment
1	data, standardized analytic
1	numerical identifier (which,
1	paragraph (3), or
1	excess of twent-one
1	(e)(8); and (4)
1	priority order based
1	concerning nonprescription sunscreen;
1	protections against conflicts
1	place the same
1	(c) the partial
1	one species. the
1	title 5, require
5	business of such
1	use the united
1	number of small
2	reports  (a)
1	secretarys refusal of
4	decision be modified
1	(iv) is the
1	administration shall 
1	109462). (
 

1	unless such supplier
3	mean the later
1	responsibilities as the
1	record in writing
1	made shall promptly
1	time during review
1	(4) definitionsin this
1	update such guidance
1	discontinuance of registration
1	(1) any article
1	revenues for application
1	products and similar
2	authority the director
1	(b) applies. 
1	importer related to
1	expedite the classification
1	ingredients; adequate controls
1	be, a drug
1	 (1) total
1	commercial information) and
1	it. (2) 
1	ii, 57 stat.
1	record keeping every
1	
 
 621.
1	treatment involved has
1	health or welfare
1	authorized immediate trading
1	made the reports
1	dietary risk to
1	plants and products
4	interested persons. 
3	use, in the
1	rendered under this
1	subsection (c)(1)(c). 
2	within the administration
7	360e(c) of this
1	1970, the attorney
1	law to share
1	respectively. (c) limitations
1	(4) the length
1	provided through the
1	draft and final
1	department.  (june
2	significant difference between
1	acid (g) 4.0
2	applicant a description
3	guidance, or practice
1	term community shall
2	prescribed in section
1	designation or termination
1	in, any activity,
3	graphic matter upon
1	present a serious
1	trials the secretary
2	effective action under
1	provision to other
1	food facilities including
1	section 310.305 of
1	seed thereof. (20)
2	inedible articles inspection
1	entity is deemed
2	executive office of
1	 (aa) 75
1	cosmetic unless such
1	title 42) shall
1	experts in sanitation
1	label if in
2	employees authorized to
1	68 stat. 55;
1	manufacturer receiving information
1	first applicant enters
1	premises upon which
3	affect such commerce,
1	(4). (iii)amendment of
1	officer or director
2	paragraph are the
1	commission shall constitute
1	substances shall 
1	(
 
 880.
1	entity that submits
2	general to be
1	written request that
1	tobacco manufacturing industry;
1	factorsin establishing the
1	committee officers or
1	drugs are subject
1	requirements of all
1	iv unless 
1	person is engaged
1	intended to cure,
1	due datethe initial
1	secretary. (j) pilot
1	appropriate, by experts
1	553(c) of title
1	(2) fiscal report
2	commissioner may deem
1	recruit, train, and
1	periodically. (3) the
1	oxide, and is
1	(b).  (7)
1	45 degrees fahrenheit
3	foreign government to
1	(c) denial of
1	safety.  (f)
1	term farm has
1	unsupported by substantial
1	significant change or
12	commonwealth of puerto
2	may select the
1	(1) mixed or
1	joint committee. (3)
4	studies are impossible
1	exemption was requested.
1	provisions; marking and
1	least 75 percent
4	34 stat. 1262;
1	summary judgment as
1	601.12 of title
4	(ii) was plainly
1	subsection (b)(1). the
2	considered confidential and
2	908, as added
1	investigational device under
3	secretary from making
2	thereof, any controlled
1	federal register whenever
2	fish described in
1	notify any national
2	title; and (4)
1	maintaining an accessible,
1	currently registered with
1	medical specialties. (ii)
1	foreign establishments that
1	seller that captures
1	(b) is registered
1	safety fees. 
1	secretary) alleging such
1	reduce racial and
1	patients (referred to
1	ethical and scientific
1	collection of hospitals
2	(a) the manufacturer
1	book, or an
1	execution of memoranda
1	(g) consultation prior
1	data. (b) in
2	food products (a)
1	subsection (g). such
1	requirements. (b) in
1	hyoscyamus, ignatia, lobelia,
1	insertthe risk evaluation
6	minimum sentence is
1	disclosed  (i)
1	gave rise to
1	circumstances make such
1	clinical trials intended
1	annual evaluation of
2	seminars at professional
1	paragraph (1)(e) to
1	(a)(3)(b), including early
1	three weeks after
2	identifier system under
1	use after end
5	manner, including through
1	using the testing
1	entry involved is
1	potential elements of
1	questionnaire; and (e)
1	officials; or (b)
3	device that the
1	against, and address
1	assessments, deferrals, and
12	section 387g of
1	provide inspection, the
1	subchapter or a
1	part; and (f)
1	drug enforcement intelligence
1	state, in writing,
1	urged before the
1	colombia and based
1	paid, as required
2	execution of grants
2	united states amateur
1	makes such determination
1	program to curtail
1	subject to sections[1]
2	waivers  (1)
1	(b)(1) in any
1	safeguard the food
1	list or registration
1	sensitive informationin promulgating
1	shall expand and
1	temporarily suspending such
1	 (a) from
1	(3) effect notwithstanding
1	conducts business, including
1	section 381(e)(2) of
1	another state shall
1	9, 2012. (g)
1	designated.  (2)
2	sections 360, 360i,
1	enclosure to identify
1	_____________. i verify
1	fre-choice medicated feeds;
1	(6) signal of
1	support intramural research;
2	destroyed if so
1	0.7  (with
1	(c) procedures and
1	widespread access to
2	used to maintain
1	destruction upon a
1	subsection, unless the
1	means to add
1	space, including the
1	report and recommendations,
3	solely to the
1	resistance).  (2)
1	civil penalties a
1	enactment date has
4	term animal drug
1	(viii) 5 grams
1	section 379h1 of
1	obligations for costs
1	(2) or for
1	 (2) law
1	 (e) data
1	education program areas
1	person shall, in
1	yields from tobacco
1	received, and all
1	minor violations; written
1	training entity that
1	practices; and (b)
1	made in writing
2	returned product from
1	reports to secretary
1	sections 672, 673,
1	package reviewed under
1	relevant agency in
1	determined, in accordance
1	temporary order controlling
1	1997, shall be
1	substances furnished for
7	manufacturers or authorized
3	offsetting collections to
2	effect before july
1	year 2014, $534,000,000.
14	authorized under subsection
2	established tolerances for
1	(1). in such
1	designation granted under
1	standards, for the
1	practitioner is in
1	logistics providers (a)
1	access to accredited
3	holder in validating
15	(a) in the
12	apply to such
2	year 2013. 
1	together on substance
4	used or intended
1	offer for sale,
1	bany person who
2	food under this
1	rule beginning 2
1	promotional labeling branch,
1	however, the secretary
1	requests approval of
1	provider licensure that
1	musty eggs, eggs
1	(a) making those
1	medicare & medicaid
1	act; and 
4	longer necessary, a
1	(8) if, having
2	court may, upon
1	research and approval
1	inspection of any
2	387q(c)(4) of this
1	person is given
1	829. prescriptions (a)
4	furnished to the
6	except that any
1	mark than the
7	recommendations not later
2	state agency that
6	product or tobacco
1	united states against
4	available data multiplied
1	(2) forge or
1	dispense such substances
1	machines, the attorney
7	shall be prepared
1	drug crisis means,
1	activities; (iv) is
1	(1), the resources
1	20 percent shall
1	manufacturer, of samples
3	site of drug
2	hearing, when such
1	segregated from other
1	human tissue through
1	pacific islanders), youth,
1	product prepared for
1	promoting attractiveness, or
1	except that on
1	matter in a
1	recipients to evaluate
1	967. smuggling of
1	(1) 3 times
1	use of alcoholic
1	commission may hold
1	application as conditiona
3	file objections thereto
1	regarding  (1)
1	name and address,
2	inspection or at
1	reporting the drug
1	time. (iii) projected
1	processes  (i)
4	marihuana plants regardless
1	2003; (3) information
3	(ii) the quantity
1	providing expert scientific
1	(ii) deny approval
1	 may be
1	corporations  (i)
1	voluntary participation an
1	foods containing or
4	tests which are
1	body, including the
1	drug safety; and
1	charged and the
1	marks, labels, and
1	inspection report for
4	iv, 12, eff.
1	one years imprisonment.
1	questions of safety
1	pending, or completed
1	deliver the same
1	regulating the issuance
1	owner, which shall
1	introduced into, or
1	section 360ddd1 of
1	september 30, 1982.
1	(b) filing application;
1	youth.  (b)
1	person to bribe
2	level of compliance
1	modify prior findings
3	components thereof as
1	future plans for
1	establishment. (d) the
1	agricultural commodity has
1	forfeiture, after the
1	general receives notification
1	strategies that address
1	owed for such
1	term secretary, unless
2	obtain judicial review
1	actions to reduce
3	dangerous weapon, shall
93	attorney general shall
2	public health. (f)
1	reporting requirements 
1	investigational drug. 
6	meetings of the
1	45] with respect
2	review such applications.
1	care entity; (h)
2	article or portions
1	required to testify
2	crop years, by
1	(a) manufacture or
1	must not be
1	listing) as the
1	supplier means an
1	effective drug abuse
231	(june 25, 1938,
1	chillers; (14) wired
1	jurisdiction; (11) appoint
1	convictions (a) in
1	 (aa) are
6	meet the needs
1	substances (a) narcotic
1	complied with any
2	secretary thereupon shall
1	activities on temporary
1	147. repeal of
1	local laws relating
1	affecting the characteristics
1	controlling a drug
1	(7) required rulemaking
1	violat ion shall
1	countries designated in
1	requires approval under
1	two years unless
1	misbranding provisions to
1	background information with
2	certification before the
1	finds (i) that,
1	october 10, 1962,
1	payable for grade
2	correct as of
1	(d) effectiveness of
5	(2) authority if
4	report or information;
1	commerce on behalf
1	helped provide for
1	ensuring uniformity with
2	effective date a
2	drug application, means
1	prohibited from using
1	including both the
1	state under subparagraph
1	individual allegedly violated
3	thereto with the
1	(ii) provides the
1	motion to dismissa
2	section and who
1	record.  (b)
1	controls in processes
1	chemicals and supplies
1	 (ii) based
1	product developers, patient
1	documents, unless the
2	application or treatment
1	title of facilities
1	supported by such
1	food additive as
1	collective bargaining agreement.
2	criminal penalties under
8	tobacco product standards
1	animal drug establishments);
1	notifying persons pursuant
2	independent organization which
3	distribution of food
1	(b) submit the
2	submission; (ii) the
1	22, 2009, all
1	year and publish
2	drug industry. 
1	testimony or provide
1	title. (4) requirements
1	enantiomer has not
1	petitionany person subject
1	make such guidelines
2	requirement shall not
1	petition, notice of
1	initial draft proposal
1	food establishments regulated
3	necessary to identify
1	cancer that are
6	application  (1)
5	united states; (2)
1	seeking to procure
1	food shipment. the
4	reason or purpose
1	attorney general information
1	motion to dismiss,
1	motion to dismiss.
1	text note below.

5	priority review to
1	confirmation of receipt.
2	title 5 as
2	division may be
1	1401. pesticide monitoring
1	preparations containing any
1	business where the
1	years of grant
1	motion to dismiss;
2	basis to each
1	period that is
1	calendar year for
2	drugs described in
1	commerce a new
1	 (b) wholesale
23	paragraphs (1) through
2	content of labeling
2	entities under section
1	relationship by a
3	applicable united states
1	commerce by, poultry
1	cause shall contain
1	 (1) assessing
1	460, 463, or
1	lysergic acid amide.
1	international law enforcement
1	meet the expected
1	section 360bbb3a of
1	areas. (m) assessment
1	board of a
136	case of a
8	shall be imported
1	(1) internal review
1	unmet need related
2	trade a drug,
15	section 342 of
1	(6) studies or
1	products shall include
3	limit the entry
1	advertising or labeling
21	comments on the
1	agency does not
1	 (ii) is
1	years experience in
1	director by a
1	states. such study
3	additive, and raw
2	joint or other
1	proposed use unless
6	emerging drug abuse
1	drugs, where 
2	clinical trial, the
1	fee.  (b)
1	testing of drugs,
1	include a classified
1	request is accompanied
1	887. coordination and
1	require any small
1	403, as added
1	substances are described
1	accounting of funds
1	demonstrate that those
1	subsequently shipped by
1	request or participate
1	10 members appointed
1	seeds or resin.
2	year immediately preceding
2	fees paid, if
1	termination the advisory
1	compounded in a
1	appropriate jurisdiction 
10	1913, ch. 145,
1	year the ratio
3	means any food
1	activities following the
1	drugs or classes
1	42; (2) ensure
1	distributor intends to
41	period beginning on
1	greater) period, clause
1	distributed  (i)
1	(i) that knew
1	creates a substantial
1	(8) compensation for
1	rights, beyond those
1	judgment; supreme court
10	costs associated with
1	administrator does not
2	fails to demonstrate
1	limitationthe regulations under
1	party; and (f)
2	party at his
2	outbreak based on
1	product. (b) the
1	scientific use to
2	individuals for personal
1	(23) the term
2	age group; (iii)
1	march 30, 1961.
1	establishment under section
2	less than 90
1	name and quantity
2	completed, or under
1	administration (including functions
1	(
 
 459.
2	drug. (june 25,
37	compliance with this
2	administrator shall give
1	labeling, marking, and
1	(c) access by
1	december 11, 1946),
2	fees, animal drug
1	preparation, compounding, packaging,
1	necessary data, request
1	number of votes
2	farms  (1)
8	changes made to
1	without inspectors certificate
1	necessary to supplement
1	proposal shall, in
1	requirement[1] or taking
1	sectors and subsectors,
1	diverse and broad
2	change to a
1	rural development act
1	(
 
 845
1	subclause (iii)[3] holding
1	provide widespread access
1	
 321a. butter
2	(1) review and
2	(j)(2)(a)(vii)(iv) of section
1	brand and subbrand
2	states authorized to
1	(iii) 28 grams
1	
 1041. enforcement
1	standard setting organizations),
1	changes. (c) the
1	sentence imposed pursuant
2	revision of the
40	  
2	product which does
1	treat, mitigate, prevent,
1	means, and make
1	$3,750  $3,872
1	supplement fee, the
1	place on january
1	1997. (e) no
1	establishment; and said
3	substantially complete application
1	voucher; and (b)
1	matchbooks for purposes
4	title to provide
1	detoxification; (bb) appropriate
2	efficient and flexible
1	report and recommendations;
1	organization recognized by
1	2224 of this
1	implement the recall.
2	labeling thereof. if
1	(9) conduct annual
1	including any such
2	caucus on international
1	(b) not fewer
1	distributions. forms, receipts,
1	study or postapproval
5	enter into an
1	title within such
2	amateur athletic competitions
1	(g) the labeling
1	product means 
1	establish specific duties
2	regulatory and product
1	transaction information, or
1	documented risk for
1	reduction activities as
2	specify by regulation
10	animal drug shall
1	purpose and presenting
1	detail the change,
1	approval supplement shall
3	products will stop
1	counterfeit drugs. 
2	coordination between federal
1	criteria determined appropriate
1	 (b) promptly
1	agricultural commodities, based
1	index shall include
1	secretary shall institute
1	products, he shall
1	paragraph (2)(a); or
3	blood component for
1	listed chemicals manufactured
1	considered confidential. 
1	
 
 61.
1	subsection (b) relating
1	(3), in such
1	(2), based on
1	recordkeeping; and 
1	(i), for 
9	demonstrating that the
1	(a) (including a
2	pertains to a
2	scope and extent
2	rico) or organized
1	appropriate counseling and
6	later than one
1	certain fees 
1	safety, or welfare
1	subsection (e); (4)
1	confidentiality described in
1	assign, transfer, or
6	year following the
1	675, 920, as
1	(2) implementation the
1	(2) financial interest
1	listed chemicals, tableting
1	respecting information not
1	actionthe secretary shall
2	annual basis thereafter.
1	product (including such
1	implant in the
7	upon a showing
1	694. authorization of
1	secretary. (v) upon
1	reimburse the food
1	360ccc2. designated new
1	populations and subpopulations;
1	section 379j1(a)(1) of
2	evidence as described
1	shall, upon demand
2	applicant may not
1	written authorization for
1	findings and policy
2	product, the initial
1	jurisdiction directly to
1	873. cooperative arrangements
3	added substance, such
1	means a marker,
1	attack the sentence.
1	immediately notify health
2	device or denying
1	request each retail
3	(ii) an order
1	obtain any recommendations
1	drug administration draft
1	finalize the guidance
1	will contribute to
1	 (a) will
1	felony, cognizable under
1	(1)(a) applies shall
1	providing services related
1	drug rehabilitation program,
1	exits); (ii) extends
1	product; (iii) an
1	retain, or modify
1	furnished owner whenever
1	 (6) eligible
3	section and appropriated
2	(f).  (ii)
1	scientific experts, and
8	title 5 for
1	minor species, and
2	promotion, or sale
1	hearing and after
1	projects; and (c)
1	refers to products
1	applicable elements set
1	drug is generally
1	(e) assessment a
1	findings published under
1	scientific or technical
1	source of radiation
1	(b)(1)(b), (c)(1)(c), and
1	establishment registered in
2	drug administration amendments
1	concurrence. (4) 
3	secretary shall (i)
2	used to supplement,
1	chapter; and (f)
1	standardized graphic that
3	listing of susceptibility
1	updated no less
1	paragraph (1)(a) 
1	regulations, when applied
1	sought under section
1	suitable for inspections
1	chemical, a description
2	criteria the secretary
1	u.s.c. 19011906) until
1	scientific understanding of
3	(c) through (h)
1	data and informationin
1	825. labeling and
1	standard efficacy supplements
1	states, when used
1	recipient meets the
2	chapter that believes,
3	storage of a
1	final agency actionthe
1	conduct reasonable questioning,
1	medical need for
1	juice contained in
4	review  (a)
1	commercially market under
1	division; (iv) the
1	ch. 675, 711,
2	form, which may
1	inspection resources. the
2	waivers of and
1	chapter, or whenever
1	22, 2009 that
1	(b) in approving
1	 (5) electronic
3	writing, a meeting
1	(k) are required
1	produce the transaction
1	basis of approval
1	composed of experienced
1	crises and emerging
2	subsection (d), and
2	title, or is
1	transaction statements as
1	cancellation of associated
1	(6) to disseminate
1	period.  (e)
4	includes a copy
1	title, or in
1	(4) regulations under
1	person requests a
1	liability of biomaterials
2	title, or if
1	(2) shall require
1	task of preserving
1	title i, 8,
1	section 387b(5), 387b(6),
1	modified findings which,
2	tobacco; and (d)
2	do, with respect
2	2015.  (june
1	supplier and one
1	expungement under this
1	dietary supplement submits
1	part: (1) the
1	initial imported shipment,
2	secretary; (6) if
1	 (d) forfeiture
3	law, in implementing
1	distribution, and (c)
1	corporation, owner, part
1	act of 1984;
3	form of official
1	chapter. the application
1	labeling for specific
1	turkey, duck, goose,
1	particular communication or
4	take such action
1	7 individuals who
2	signals and trends
1	states and local
1	$21,600,000.  (2)
1	recommend strategies to
1	sanitary standards as
1	 (b) restrictionsan
1	affiliated with the
1	act of 1984.
1	register his reasons
1	thereof on hand,
3	seller, or a
1	(ii) the inclusion
1	otherwise to carry
1	review cycles nothing
1	retail establishment at
2	subsection.  (3)
1	establishments; and (2)
1	42 and was,
1	(ii) whether, and
1	expeditiously as practicable,
1	(1) establish, continue,
2	may bring a
1	package insertthe risk
1	cites as the
2	complexity, and format
1	foreig-grown tobacco to
1	adverse determination. for
1	(e) and only
1	ongoing surveillance, rapid
3	section, the court
1	point of manufacture
1	
 1052. state
1	5 business days
1	food and shall
1	drug excludes any
1	committee).  (b)
4	-year period preceding
1	evidence presented by
1	residue monitoring by
1	made the finding
6	manufacturing a controlled
1	(a)(2)(b), the secretary
1	inflation adjustment calculated
1	access to warehouse
1	section. (f) collection
1	(c). (d) refund
2	transactions, transportation, or
1	165. omitted
 

1	july 1, 1999,
1	title; (l) salable
1	group; (iii) finds
1	develop more effective
1	$195,000,000 is appropriated
1	product recall to
1	regulatory and health
6	ground that the
1	respect to importation
1	6, 37 stat.
1	application fee assessed
1	machine or an
1	studies that demonstrate
1	licensing, distribution, and
2	items (aa), (bb),
1	(i) prescribe a
7	determination made under
1	secretary shall bring
1	applicable, need not
1	postpone the trial
1	conium, cannabis indica,
1	effects of 
3	(b) establishing, modifying,
1	product, under section
1	receiving notice respecting
4	variations shall be
4	provided by such
1	violation. with respect
1	except the labels,
1	poultry product components
2	conditions of section
1	product development fee).
1	characteristics, chemical and
2	substance or drug
1	human drug products
1	(q).  (3)
1	ensuring consistent compliance
1	title unless otherwise
1	sanctions during the
1	program or project.
1	program or project,
2	administration as a
3	eligible entity 
1	tobacco leaf, including
1	regulation (whether or
1	amount, with respect
1	subsection only as
1	(c) costs 
1	shall reimburse the
1	(d) coordinate activities
1	requirements, that evaluates
1	governments on the
1	(or greater) period,
8	use under such
1	reduction the secretary
1	preapproval review period
2	 (1) notwithstanding
3	shall upon conviction
1	secure, interoperable, electronic
1	aim to reduce
1	sentence. the secretary
1	facility and to
1	product, but the
11	 (a) except
1	performance measures that
1	order.  the
1	practitioner who will
1	professionals and facilities
1	permitted.  (15)
3	container in use
1	expended for each
1	promptly after receiving
5	shall summarize any
9	product  (a)
1	items less food
1	distributes (or causes
1	number of tests
1	within the 12-day
2	written statement that
1	made to protect
1	conducting educational and
2	felony or more
1	written analysis of
1	amount determined by
1	section 331(ll) of
1	262(a)]. such sections
1	stat. 500; 1953
1	352(d) or (h)
1	(iii) taking into
2	[50 u.s.c. 3001
1	progress that has
1	countries certifies, accredits,
1	conditions on who
2	experience; (iii) inpatient
1	activities, including the
1	meet diagnostic criteria
1	cause may be
1	(i)failure to market.the
3	authorization from the
3	secretary may, for
1	financial information or
1	(b) qualified en-userthe
1	contraband or other
1	american pacific islanders),
1	regulatory hazard analysis
2	(g) 5.0 
3	subsection (a); (b)
1	drug products specified
1	number of premarket
1	interest. upon the
1	purity differing from
1	product stage and
1	leaders, received $10
6	information and transaction
1	pharmacist and licensed
1	production solely for
1	subparagraph (b)(iii); or
1	experts in opioid
1	united states national
1	resistance, including the
2	general the director
1	dioxaphetyl butyrate. (20)
1	purity; (4) upon
26	officers and employees
1	28. such interest
1	guidance or promulgation,
1	dispensed without a
1	contract, grant, or
1	process for priority
1	practitioner possesses the
2	make all of
1	implementation of an
1	medical evaluation with
1	expert testimony concerning
1	(1) animal drug
1	word poison, when
1	therefor for the
1	minimum sentence imposed
1	inspected or exempted;
1	beyond fiscal year
1	advertising for such
1	(2) the agency
1	supporting the conclusion
1	shall be subjected
1	sitethe secretary shall
4	listed drug when
1	facility from, the
2	reduction of one
1	councilsthe secretary of
1	observational studies, registries,
1	(h) termination of
1	application; (d) the
1	success of each
1	appropriate), classes or
1	year 2008 multiplied
1	(iii) capable of
2	360b(e)(1)(a) through (b)
1	responsibilities and the
1	left the place
1	19011906);  (c)
1	logbook maintained by
1	book by the
1	biological product. any
1	otherwise misbranded, and
1	assessment of law
1	afford the advisory
1	
 
 379dd1.
1	level of aggregate
3	borders of the
2	making, using, or
1	prescription drug; and
1	part for a
1	(c) is approved
1	since 1974, and
1	schedule, including traveltime;
1	technical assistance from
1	identified by adverse[3]
1	subparagraph (b) until
1	report has been
1	facility from which
1	states committed in
1	show cause order;
3	secretary as described
1	applications or supplement
1	back pay, with
1	public health, provided
1	(ii) subsequent proposal
36	nonprescription sunscreen active
6	matter under investigation.
1	exclusively with respect
1	matter under investigation,
1	inspection, records, and
2	whose accreditation has
1	(2) the illegal
1	unlawful receiving of
1	strategy; (c) with
1	deputy director while
6	panel described in
1	indicate the appropriate
1	drug (as that
1	update on at
1	(d) the submission
1	 (5) drug
1	center has completed
1	correction reports) if
3	activities:  (i)
2	drug; (ii) if
1	defendant or was
1	(h) of subsection
1	fail to make,
1	data requirement, relating
1	facilit-specific.  (c)
1	ending the program
1	principles. if the
1	(6) response to
2	local nature and
1	practices. (b) regulatory
1	drug treatment programs.
1	milling, grinding, pasteurization,
1	et seq.]; (5)
1	section for which
1	firm shall agree
4	amend the order
1	prescribe for the
50	report to the
1	include such instructions
1	subparagraph (a) solely
1	establishment are such
1	registration (as applicable)
1	property or interests
1	(iii) prevents persons
3	product and the
1	title. (b) limits
1	signal detection is
2	another compendium or
2	form, new dosing
1	drugs, an intravenous
1	abuse prevention activities.
1	 (a) final
1	(h) reoffer of
1	requirements of subparagraphs
1	means an abbreviated
5	may file a
1	unless the administrative
1	includes a restricted
1	felony, if the
1	(2) no proceeding
1	(c) for any
2	submits the amendment
3	drug distribution security
1	composition and other
4	meet the definition
2	2016, and at
1	complies with regulations
1	subsection (a)(4)(a)(ii) (relating
1	waivers; (f) the
1	cards used by
2	person shall, with
1	shall not revert
1	scope of liability
1	progress of such
1	information from years
1	2 years thereafter,
3	whichever is less.
1	products unaffected; authority
1	continuous manufacturing of
1	supply reduction agencies,
1	fraudulent representations to
1	42. nothing in
1	orders that, on
2	(2) if any
1	preparations containing morphine
3	deducted from any
1	provide and, if
1	
 111, 112.
1	expense. any transcription
1	(c) notice the
4	title, and any
1	ii, or is
1	service and the
1	cooperation the secretary
1	study and the
1	dose to be
1	apr. 24, 1948,
1	party other than
1	protocol upon the
5	shall mean the
1	(1) the president
1	terminated and all
1	fiscal years 2010
1	class, and no
1	first. (b) a
12	fiscal years 2013
18	fiscal years 2014
1	request and stating
2	fiscal years 2016
1	fiscal years 2017
1	subsection (d)(1)(a) shall
5	available pursuant to
1	device. a notification
1	frivolous or has
1	feed, except in
1	conditions or to
2	product application may
1	may choose. 
1	demonstrates by clear
1	discontinuance was reported,
1	uses and levels
1	package, and not
1	citrus fruits, or
2	pharmacist, to an
1	strategy to mitigate
1	wholesaler. it shall
1	development of voluntary
1	mental health centers).
1	monitoring requirements for
1	(c) evidence of
2	transacts business. such
1	control (a) conditions
2	prescribe the drug
1	(1) may review
3	small businesses and
2	will activate such
1	exclude a person
1	animals, etc. 
1	threat. (d) effect
1	allowing consumers to
1	sentence.  (j)
1	change. the director
1	quality exposure data
2	engaged in manufacturing,
1	(1) purpose and
1	utilize existing authorities
1	hazard analysisthe owner,
1	research to the
1	inspects under this
1	marked, stamped, or
7	(a).  (c)
1	treat it as
1	area which are
1	food safety. to
1	(a) clearinghouse there
1	special government employees
1	relevant stakeholders during
2	unless the context
1	may perform consultative
1	related items to
1	direct access to
1	required.  (3)
1	least as protective
1	(d), (f), (g),
1	information would adversely
1	equal to 20
2	regulated seller may
1	fiscal years, then
1	require. such application
1	request by 
1	strategy that encompasses
1	commercial carrier; shall,
1	committees on foreign
1	meat food products:
7	(c) provide for
1	states. any person
1	regulation and after
1	(f) exemptions the
1	information or potential
8	meat food products,
1	business  (1)
2	meat food products.
2	esters, and ethers,
1	investigational use, paragraph[1]
2	notice shall include
2	evaluations performance evaluations
2	within a state,
3	industrial channels; (2)
1	without prejudice the
1	discovery in connection
1	assessments of consumer
1	(ii) a list
1	principles set forth
1	52 stat. 1040;
1	fifty thousand, in
1	4402]  (1)
1	immediate precursor, to
1	period. (e) if
1	(b) the residue
7	days unless the
1	675, 737, as
1	special government employee,
1	(7) may not
1	published, prominently display
1	562, as added
1	certain provisions with
1	surgery; or (f)
1	associated with an
1	statements or misrepresentations,
3	secretary deems it
1	form, on their
1	paragraph (3); or
1	gelatin capsules, which
2	person authorized by
1	services unaffected; responsible
1	inspections of establishmentsbeginning
5	fees, the secretary
1	delivery of inspectors
1	 (i) notwithstanding
1	areas  (1)
1	secretary may treat
3	changes in review
4	(ii) promptly conduct
1	budget) in the
1	traceback.  (g)
1	color additive likely
1	project evaluation; application
1	distributed commercially and
2	cured or cooked
1	treatment for no-opiate
1	subchapter v or
1	advanced therapy concurrently
8	statement, or other
3	dispensing or selling
1	terms not to
1	may issue regulations
1	subchapter, other than
2	based, and (iii)
1	(2) any persons,
1	workload adjustment (as
1	linear or -dimensional
1	(2) acts in
1	material. (4) the
1	coordinating amateur athletic
1	exemption is safe.
5	active, nonnarcotic ingredients
2	order making such
8	worthless, contaminated, dangerous,
1	cavity.  (19)
1	(i) the conditions
1	columbia. (feb. 15,
1	 (c) advertisement
1	expertise necessary for
2	(1)(a), (1)(b), or
1	 (a) bonus
3	biological product, the
1	(c) to facilitate
1	party that submitted
6	facility, as appropriate.
1	(27) the term
1	shipment, and distribution
1	applicant other than
9	list of the
1	(c) to provide
1	notification to a
1	(b) describe and
1	beginning drug abuse.
1	control; and (hh)
1	(l) repealed. 

2	processing, preparing, treating,
1	(6) paragraph (1)
1	clinical investigation for
1	 (i) voluntary
1	abbreviated applications; withdrawal
1	estimates is necessary
1	1954, ch. 1263,
1	contaminants.  (d)
1	veterinarian, and the
1	engineering, biological and
1	pediatric subpopulations that
1	consumers the secretary
1	strengthen their controls
2	appropriately respond to
1	cultivate, produce, manufacture,
1	(3) the formulation
1	of, such records,
1	u.s.c. 300f(4))) but
1	agency involving supply
6	appointments in the
1	 (f) incidental
8	notice required by
3	modify his findings
1	subsection (b), when
1	agency; (ii) how
4	authority the authority
5	subsection (a), or
2	(f), and (g)
2	corporations that engage
3	including subgroups of
1	(a) each federal,
1	 (a) bear
1	manufacturer or secretary,
1	(a) to sell
7	shall specify in
1	section 299b1 of
1	reports if the
1	(j) maintenance of
1	sterile drugs; (ii)
1	(a). (e) not
1	whether the pleadings
1	agreements with operators
1	 (c) issuance
1	antifungal drug for
1	purposes of enforcing
1	saleable unit is
1	milligrams of dihydrocodeine
1	determination, and advance
17	 (i) shall
1	means the fund
1	unless the transaction
1	entity. (d) use
1	made..[2] (h) relation
1	matters specified in
1	program are not
1	dietary supplement under
1	document which includes
1	no-fo-profit medical center
2	existence at the
29	commissioner of food
2	644 of this
1	registered to authorize
1	tobacco product, based
2	administered in conformity
1	must comply in
1	synthesis or by
2	infringed. (c) if
1	mortality in humans;
1	715, as added
1	improving the transfer
3	introduced in a
1	secretary until expended
1	secretary may (by
1	infant formula to
1	infrastructure under subsection
1	another person of
2	professional and ethical
2	lettering not smaller
1	related responsibilities or
1	account within such
1	upon him. 
1	prohibition, and afford
1	participated as a
2	officer conducting the
1	supplement health and
1	1, 1970, and
1	data, or information,
3	drug and which
1	adolescent admissions for
1	operation, activity, source,
1	shall provide final
1	within the authority
1	ch. 675, 705,
2	substance to an
1	fahrenheit after packing;
1	emergent and tim-sensitive
1	name as the
1	health care insurers;
1	manufacturing partner program,
1	article is shipped;
1	controlled substances, (b)
1	prescription drug 
1	chapter.[2]  except
1	request an initial
1	evaluation the secretary
1	subparagraph (b). such
1	owner submits an
1	available from a
1	standards as certified
1	subchapter is, if
1	3 guidance documents
1	accept a duly
1	acting through entities
1	control illicit trafficking
1	 (f) good
1	infant formulas (a)
1	representative of an
1	unavailable to conduct
1	201. doing business
1	investment, and without
1	required testing during
1	federal workforce restructuring
1	lawfully entitled to
1	nitrogen that meets
1	section. (4) sel-executing
1	 (4) exceptions
1	issued within 90
1	demonstration purposes. 
2	(3)  (i)
1	activity that would
1	date of establishment
1	part, to implement
2	years in the
5	executed in accordance
1	evidentiary hearing upon
2	determines that classification
1	rejects the selection
1	issuing such request,
2	corrected the causes
1	review of summary
1	18 or $200,000
1	 (h) guidance
5	subpart; and (d)
1	state licensing such
1	determination of pediatric
2	 (3) no
1	receiving it take
2	underrepresented subpopulations, including
2	issues a response
1	language the requirements
1	accredited laboratories report
1	antidote, when practicable,
1	chapter are repealed.
1	diversion or otherwise
1	problem, is exempt
1	
 
 379j.
1	states any controlled
1	within a radius
2	entered into commerce
1	words for an
1	responsibilities related to
1	state considers appropriate,
1	strategies under subsection
1	policies as the
1	amenable species, and
1	minimum  (i)
2	rationale for each
2	benefit the health
2	qualification  (1)
1	determined to meet
2	subsection (k) for
1	1984.  (b)
3	decision under subsection
1	564b, as added
1	postmarket controls may
1	16. (6) agency
2	expanded access for
1	information (a) data
1	nonfat dry milk;
1	plus (iii) the
1	entitle him to
1	means any establishment
1	states person the
1	drug manufacturers); and
1	
 960a. foreign
1	(ii) certifies that
1	papers, documents, and
1	term regenerative medicine
2	 (1) alter
2	representatives of participating
1	termination.  (june
2	grant under the
3	secretary (or in
1	slaughtered or handled
1	delivery thereof, insert
1	
 824. denial,
2	court, upon application
11	reasonable cause to
1	resources. (d) suspension
1	(d), or (e);
1	licensed practitioner who
1	 (1) require
1	challenges, and potential
2	shall be on
2	products are nicotine
2	section shall supplement,
1	shipping), or other
1	formed by the
1	title; (6) in
1	953, and 957
2	(b) the attorney
1	undertaking activities and
1	products are disposed
1	antimicrobial resistance task
2	(i) not less
3	thereof shall be
2	years, and the
1	 (a) state
1	unusable medications; and
3	construed as affecting
2	assist in efforts
1	subsequent transferee of
1	nonpublic record of
2	1000 kilograms or
1	four years experience
1	allergy management, in
1	(
 
 392.
1	article, when used
1	
 
 608.
1	equivalence under this
9	and, where appropriate,
18	use or intended
1	indian from the
1	(v) publication of
1	exemption to permit
1	fiscal years, to
1	distributed; and (b)
1	meat articles means
1	services shall ensure
2	seized under subsection
1	declarations no later
1	deny the application.
1	submitted or approved
1	relate to safety
1	following certifications by
1	32 stat. 193.)

1	(1) upon receipt
1	application only if
1	basis therefor, with
1	19) and was
1	
 
 360bbb7.
1	section 314.550, 314.640,
5	paragraph (1), including
1	tobacco products made
2	performance of a
3	entity certified by
1	canada, israel, japan,
3	imprint a product
1	commission, and the
2	fees paid by
1	wholesale distribution, any
1	regarding when a
1	thereof, in the
1	links to drug
1	compliance data to
1	committees an assessment
1	6 months preceding
1	title, (ii) has
1	954 or 971
1	respect to investigational
1	substances on behalf
4	prior conviction under
1	definitionswhenever used in
1	warrants for the
1	produce both one
2	smoke does not
1	secretary.  (5)
1	mainland of the
2	supplement after the
1	weekends. (j) maintenance
1	section 841(b)(1)(a)[1] of
1	(
 
 465.
1	certain substantially equivalent
7	determination described in
2	(2) effect of
1	public health. (7)
1	steam or mist.
2	maximum established in
2	indication, new dosage
1	unlawful actsany person
1	youth.  (2)
1	present as the
1	transferred
 
 885.
4	agencies concerned with
1	training, and laboratory
5	section; or (b)
1	675, 583, as
1	(28) levophenacylmorphan. (29)
2	provider from a
2	portion of any
9	intended to support
1	subparagraph (a)(vii). the
1	standard, and (2)
1	packages of drug
1	paragraph (3)(b). not
1	authorities in the
1	equines, except rendering
1	 (13) shall
2	unlawfully imported into
2	food is a
4	facility or a
2	compliance division personnel
1	2013, except as
1	appropriate official within
1	section 247d6b(c) of
2	developing an adequate
1	data as to
1	dietary substance for
1	advice on rare
1	approval nothing in
1	compare the tobacco
1	periodic inspection by
1	may deal effectively
1	covered application or
1	
 2002. records,
2	subsection.  (i)
8	exceed $1,000,000 for
1	granted, that a
1	shall give, pay,
1	be, and who
1	(iv) an indian
3	state and the
1	innocent persons. any
2	factory, warehouse, establishment,
1	(a) feesfees amounts
1	(d) which is
2	rely on data
1	subsection (c) not
1	shall transfer not
1	programs, policies, and
2	human services, to
1	action. (4) at
1	undertake clea-up, clearance,
1	behalf, and cros-examine
37	2 years after
1	sale of books
1	representative of health
1	ii, 203, as
1	addition to list;
1	made or entered
3	establish that such
1	(3) the processing
1	sold by a
2	advisory committee; or
1	board; (vii) specify
1	subsection (a) who,
1	substance if it
1	felony and shall,
2	effective on and
6	carcasses, of any
1	(ii) a link
1	(4) appeal of
1	micr-organisms by such
1	commissioner means the
1	needed to terminate
1	ineligible under this
1	director, the head
1	use means, with
1	already registered under
1	outbreaks and suspected
1	individuals have, in
1	(k) and make
2	believes to be
2	coordinator  (a)
8	make the reports
1	responsible for each
1	require. (ix) a
3	law, be liable
5	subparagraph (a)(ii), the
4	(if any) presented
5	application.  (c)
1	criteria standard under
1	procedure for final
1	serious risk or
1	index listing; (b)
7	punishment authorized by
1	chemical. (12) the
1	 (j) interim
1	safe and otherwise
1	9, 26 stat.
1	petition, including a
1	agency planthe plan
1	misbranded barrels packed
1	serious risk of
2	species verification, and
1	member until a
3	may designate a
2	(iii) the tobacco
1	successor regulations) any
1	enterprise defined as
1	drug or any
1	effectiveness beyond the
1	improvement of the
1	section 350e(c)(1)(e) of
1	develop guidelines to
1	
 156. licenses
1	articles at any
1	activities recognized by
1	export (and for
1	addition to awarding
1	disclose under section
1	distributed, held, and
1	legitimate business, except
1	274 of the
1	maintain any place,
1	may exclude from
1	product distributed in
1	act.  (d)
2	(2) retailer a
2	establishing timelines for
1	eggs with stuck
1	violations by united
1	user.  (

1	(b) economy, efficiency,
1	covering, under the
1	(6) to the
1	goods after decree
1	service, the department
1	isomers. (h) phenylacetic
1	setting. (c) for
1	accept the services
1	time, if so
1	denial of his
1	production, storage, or
1	thereafter under any
1	equines on commission,
1	discontinued). (ii) upon
1	(a) an assurance
1	orders dispensed or
1	plan was completed
1	(2) that has
1	provider license 
19	accompanied by a
1	systems, including paper
5	otherwise authorized by
1	providers about the
1	
 1161 to
1	seizure and forfeiture.
1	scope of authorized
9	rule controlling the
1	(b) administrative costs
1	provide technical assistance,
1	relating to clinical
1	entered domestic commerce
1	(iv) the statement
1	order of united
1	considers appropriate, if
1	ch. 675, 303,
2	concerning state and
1	tools. (2) limitationapproval
1	carrier, public warehouseman,
3	reimburse the secretary
2	 (ii) at
3	distribution presents an
59	application under section
1	(that, at the
4	secretary shall file
2	trading partner from
1	delivery to the
1	system, that 
1	security of food
1	sentence shall, at
13	submitted pursuant to
1	consideration under this
2	file fee 
1	guidance shall indicate
1	claims in the
3	representative, any official
1	 (ii) an
1	(i) implanted in
1	shall mark, stamp,
1	services, upon the
2	355(o), 355(p), or
1	 (k) dissemination
1	actions as the
1	federal licenses described
1	353(g)(5)(b) of this
1	government entity, to
1	foreign countries in
1	successor regulations), for
21	section.  (2)
1	guidance issued after
1	performance standard which
1	associated registration of
2	avoid inconsistency in
4	title; (ii) the
1	52 through 55
1	submit such agreements
1	prescription; dextromethorphan; exemption
1	pharmaceutical ingredient with
2	practicable, when scientifically
1	promote, and coordinate
1	(n) is approved
8	proceedings shall be
1	reasons why no
12	sentence shall not
1	reaccredit or deny
1	extent necessary to
1	logbook under subsection
1	generala fund control
1	media campaign includes
1	published by fda
1	pending proceedings, upon
1	 (5) for
2	amount determined for
1	previous samples, an
1	(a) any transactions
1	(2)) not later
1	records (in accordance
1	publishing of books
1	section because the
1	study plan is
2	period. (iii) when
1	order, or (ii)
5	infant formula is
1	 (d) withholding
3	secretary, of data
1	(i) shall take
1	quantity that was
1	food; or (4)
1	ingredient is grase
1	infant formula in
1	statements the label
1	study plan in
1	term advertisement or
1	drug. where the
1	general a request
2	update the list
1	outline of the
1	treated, for the
1	found adulterated, and
1	applications and supplemental
1	safe use pursuant
1	reasonable manner, such
1	fiscal years multiplied
2	quarter of each
1	service it shall
3	promulgated in accordance
2	selected by him,
2	disapprove a petition
3	unless it appears
1	355, 360, 360c,
1	(b)  section
2	indole ring, whether
1	results; (e) each
1	analogue to that
1	2291j of title
1	section 346(a)[1] of
1	(6) an assessment
24	agent in charge
1	presumptionthere is a
1	program pursuant to
1	deleterious substance added
1	paragraph (2), that
1	available for use,
1	time equivalents engaged
1	performed a consultative
1	device:  (i)
1	list, updated no
1	cosmetic act of
1	needs as determined
2	ensure that adequate
1	will permit of
1	found during an
1	shall consider providing
1	(f) reports any
3	receipt of any
1	metabolite, constituent, extract,
1	inspection of prescriptions
1	dependence.  (4)
1	alerts issued by
1	confirm the accuracy
1	958(i) of this
1	receives or distributes
1	products solely because
2	360e or 360(k)
2	agencies having related
1	views thereon, orally
6	intended for the
1	scientific dispute resolution
4	enforcement and regulatory
5	approval. (c) the
1	formulary committee, or
1	proof by a
1	pharmacist means a
1	modification to the
1	thereafter.  (3)
1	save the life
1	ingredients in monographs
1	direct that it
1	360i(a) or 360j(f)
1	(b) is included
1	(a) this petition
1	subsection (c)(3)(d) of
1	court shall decide
1	repackager shall 
1	shall notify relevant
1	certification every manufacturer
2	federal programs with
1	individuals to manage
1	(i) facilitate the
4	approval for the
1	create a cause
1	hearing. after the
1	study, if the
1	
 
 155.
1	practice pharmacy. applicants
1	market for purposes
1	policy act of
2	(e) definition in
1	pay the costs
3	3, 1996, the
4	package form unless
3	categories of fruits
1	 (c) which
2	differ from the
1	heard in person
1	furnish, without disclosure
1	straw and concentrate
1	ch. 901, 1(100),
1	title. (i) reporting
1	title.  (8)
1	notification of secretary
1	(c) knowingly selling,
1	extension  (i)
1	auditors, and any
7	likely to predict
1	title; (6) an
1	chemical mixture created
1	(d) acknowledge differences
1	(6) which require
2	following goals: 
1	(3) is shipped
1	application, to any
1	reasonable promptness. in
3	notwithstanding subsection (a),
1	central intelligence shall
2	exemptions  (a)
2	(b) result in
1	term food means
1	drug supply chain.
1	available resources to
2	tobacco product constituents,
1	container ordered to
2	applicable requirement or
1	constituents, and properties
1	professionals. (ii) nothing
1	returned product. for
1	secrets any information
1	2007. (4) notification
1	considered the application,
1	recipient. (iii) 
1	involving the tobacco
2	similar establishment, and
1	number of affected
1	remote sales 
1	purports to be,
1	food or advertising.
2	(7) if, in
1	justice under this
1	datalink or successor
1	title 5. (m)
10	made under subsection
1	administrator may stay
2	to, knowingly or
1	infant formulas during
3	(or any portion
3	application fees for
1	
 393a. office
1	shall, when he
1	subsection (a)(3) shall
1	qualification submission under
12	year beginning after
2	(excluding an amendment
1	prescription required for
1	consider the inspection
2	previous calendar year;
1	veterinarian caring for
1	manufacturer has conducted
1	meeting may be
1	covering under the
1	may provide an
2	entity the term
1	 (c) specificity
1	food importer participates
2	subsection (a) because
1	employees) with such
1	(b)(1), is approved
1	(c), each person
1	secretary in investigating
1	services of, a
1	effective control over
2	data capture through
1	registrations, verification that
2	delivers, distributes, or
1	communication with, the
1	regarding any grant,
1	teachers, coaches, youth
1	1402. foreign pesticide
1	title and foreign
3	title  (i)
1	device to class
1	inspectors ante mortem
1	orange, clove, cinnamon,
1	individual high intensity
3	approval under such
1	drugs for use
1	compendiums; infringement of
1	whether to refuse
1	identifying information of
1	(p), if the
2	tableting machine or
1	abuse information clearinghouse
1	pregnant or lactating
1	section 353, section
1	met and that
1	subchapter v; (e)
1	substances, be in
1	
 399d. employee
1	prompt investigation of
2	may include further
1	(g) amendment of
1	specified. the warrant
1	section 360ccc1(h) of
1	including residue data
1	pesticides, drug residues,
9	exceed the total
1	person, change the
3	commercial marketing of
1	public health, promulgate
1	(a) and (d)
10	filed under this
1	714b(h)); (c) crop
1	immediate threat that
1	best of the
1	reasonably require, except
5	may be designated
1	services under subchapter
1	proceeding to promulgate
1	placement of the
2	described  (i)
1	ingredient, or the
12	(4) the term
2	notify the permanent
3	drugs for research;
1	considered to represent
1	outsourcing facility under
1	submission of assessmentsif
2	claims the new
2	firm or corporation,
2	data, pricing data,
1	387h of this
1	secretary receives such
1	9, 38 stat.
1	affected by an
1	time, to request
2	divided equally and
1	activities without performance
1	u.s.c. 262] (relating
3	direct supervision of
1	transaction and maintain
1	drug facilities and
1	10, 38 stat.
1	domestically produced food
2	policies established under
2	food containing such
1	cooperative arrangements for
1	section without regard
1	manufacturing establishments and
1	regulate the product
1	package is distributed
1	quantitative comparisons the
1	product. (7) a
1	precursors the attorney
1	second violation; intent
2	name, place of
4	cause serious, adverse
1	clinical trial record
1	demonstrates a lon-term
1	person. (aa) the
1	(1) requirements regarding
1	product test results
1	respect to rare
1	construed to entitle
1	foreign facilities, and
2	title  (a)
1	processes and controls
1	law or a
1	(h) limited population
1	quotas from exceeding
2	serious risks of
1	indications in all
3	submitted a report
1	shall compile the
1	participating federal agencies
1	coordination to detect
2	seized and summarily
1	given notice and
2	2013 (as determined
1	(ii) the investigation
2	security biological, chemical,
1	appropriate, establish within
1	property is real
2	shall evaluate the
1	 (4) narcotic
2	shall be waived
1	practicable after such
1	list become effective.
1	advisory committee (in
1	constitutes a violation
1	(a) findings congress
4	medical or scientific
1	relief. (5) notwithstanding
1	(i) 60 calendar
1	unless such slaughtered
21	use prescribed, recommended,
1	pecans, or walnuts),
2	investigation. any failure
1	section, a statement
1	determines whether to
1	written plan, together
6	means any state
1	health system, if
1	default, shall constitute
1	unless (1) each
1	(1) purposethe purpose
1	fact that raw
2	(4) effect the
1	paragraph (2), amend
2	convicted as alleged
1	
 346a. tolerances
1	sid-effects for drugs
1	feasible to obtain
1	individual facility or
1	advisory commission established
1	registration has expired
1	387u. studies of
1	degradation product. 
1	threats  (1)
2	aggrieved by an
1	wel-being; or (b)
3	imprisonment for more
2	will occur and
1	conduct a communication
2	subsection (b). if
2	(b) exception a
2	fiscal year based
1	(a) was in
1	grants for studying
2	applications. (b) the
2	process to assess
1	operations, if, in
1	special licenses for
1	abbreviated application was
1	group and an
1	subsection (p), shall
5	recommend controls under
1	seeking action under
1	conjunction with any
1	address, professional designation,
2	(c) which is
1	athletic competition, the
1	flunitrazepam; or (iv)
1	increased or reduced
1	value, or loss
1	compounded drug. or
1	operation  (1)
1	youth; (3) has
1	ch. 675, 421,
1	term serious risk
1	since february 1,
1	written request by
2	activities that relate
3	may collect a
3	shall, by regulation
1	i, 17, formerly
1	purchaser. nothing in
2	prohibited acts a
9	may request a
1	policy. (11) shifts
1	applicable. (c) not
2	programs with respect
1	controlled substance, a
2	preparation containing cocaine
1	18; (b) with
1	records.  (6)
1	prohibited acts c
1	(b) information provided
1	finished dosage forms,
1	disease, the reason
1	proposal. (ii) within
1	monitoring of emerging
1	laboratory accreditation for
1	track product.) 
1	secretary; (2) forge
1	determines helpful to
1	manufacturers to conform
1	exclusive approval, certification,
1	(b)(1), (b)(2)(a), (b)(2)(b)(i),
2	article to be
1	form, including print
1	statement, racketeering, blackmail,
1	animals, unless and
1	(5), (6), and
1	probability; or (b)
1	subparagraph, in which
12	component parts for
2	later than four
1	1996, shall remain
2	establishment the term
3	office.  (b)
1	regulations are consistent,
1	(2) state initiatives
1	containers, and in
1	database at the
1	according to marketing
2	350e of this
1	tobacco products established
1	ownership of such
1	material and there
1	uses susceptibility test
1	location of, and
1	 (3) revision
2	include the recommendations
1	appointed for the
1	evidence required for
5	period shall be
1	containers of product,
1	advisory committee. (e)
2	aside of the
2	either orally or
1	efficacious treatment. 
1	title not later
2	collecting fees from
3	miles from the
2	shall label, mark,
1	ch. 675, 506c,
1	initial presentations by
4	regarding the number
1	ch. 675, 516,
1	reverts to the
2	biologic under section
1	activities for drugs
2	chapter, prominently and
1	individual that the
1	food manufacturers, shall
1	 (ii) investigationan
1	shall by rules
1	seq.]. (s) the
1	experts in science,
1	(4) notification the
3	june 25, 1938
1	
 961. prohibited
3	appropriate means of
4	designation may be
1	relates to or
1	subsection (g) for
1	national intelligence, or
1	grant.  (3)
1	both, and request
1	petitions and civil
1	(2)(a)(vii)(iv) for the
2	secretary of commerce
1	1546. meetings (a)
6	deficiencies in such
13	prior approval supplement
1	advertising contains the
1	section 921 of
1	human use intended
1	title denying a
2	dietary risks to
1	(i) sale of
2	continue the suspension
1	 (b) laws
1	acquisition of any
1	42 and for
1	submit affidavits demonstrating
1	packers and stockyards
1	community antidrug coalition
2	risk communication information
1	different characteristics and
1	2008. (4) application
1	referral, or in
1	expected to decline
1	shall provide training
1	report, respectively, for
1	data sources specified
1	goods or services
6	entity controls, or
1	shall provide assistance
3	risk to health
1	effective to provide
3	 (ii) cleared
2	auditor and the
1	effect 12 months
1	among youth. 
1	(a) that obtains
1	secretary. members of
1	 (c) seizure
2	paragraph (2)(b) relates
1	pharmacist. where it
1	(a) the medical
1	provider, issue a
2	regulations are proposed,
1	qualified laboratories the
1	(iii) the logbook
1	specified number of
1	internal review the
1	term facility includes
1	land, and, by
1	paragraph (2)(a)(vii)(iv) shall
1	(a)(3)(b); or (c)
7	institutes of health,
73	generic new animal
2	infringement or invalidity);
1	substance where such
6	available for the
1	imported food in
1	designated because the
1	final.  (g)
1	person on whose
1	testing, obtain signed
2	applicant to remove
2	advisory assistance in
1	pesticide registrations associated
1	place to support
10	sunscreen order under
1	agencies to the
1	facility to hire
1	residue for infants
4	received, and shall
2	payment if a
1	convention to initiate
1	centers for education
1	entity to report
1	neutron and electron),
1	(r) the terms
4	case may be)
1	to, any other
2	extent practicable, with
1	good cause will
3	assistance act [25
1	ch. 251, title
1	additives, be deemed
1	(ii) a covering
2	violation of federal
1	advertisements identified by
1	processing, or transportation
1	28, any amounts
1	(a); (b) the
1	intentional adulteration, including
1	petition. (b) 
1	united states. (j)
1	request for reclassification
1	specific population groups,
1	action or federal
1	number of recall
1	406, as added
1	submission (after the
9	homes or regular
2	food recalls, outbreaks
1	projects and activities,
7	resulting in a
2	sales data other
1	(vi) organizations serving
1	address. (3) the
2	submitted by an
2	public input during
1	use in, a
1	review, the food
1	month and not
1	requirements to reduce
1	 (a) summary
1	consumption determines that
1	postapproval studies or
2	fee for any
1	assurance of effectiveness
1	includes any consumer
1	funds  (a)
6	act (7 u.s.c.
2	limited physical dependence
1	rates not to
2	provided under subchapter
4	et seq.] and
2	articles will not
1	act shall be
1	describe and document
2	 (2) duties
1	information) consistent with
2	 (ii) procedures
1	(k); (ii) the
1	control, (iv) a
1	(a) share information
1	involving private parties
1	may order that
1	(b) a reinspection
1	821.)
 
 201.
1	(e.g., almonds, pecans,
1	allow the attorney
1	(aa) signing a
4	(i) are not
1	title 18 regarding
2	alleged interest in
1	endpoint.  (2)
1	requests.  (b)
1	subsection (a)(2) may
1	subsection (i). 
3	(c) authorization of
1	tool if the
1	supplements to human
2	committed in his
1	(a) as the
1	concerning the licensure
1	promptly upon december
1	$25,000. the district
1	(l)(2).  (b)
1	disclosure authorized by
1	drug abuse treatment;
1	subparagraph (a) the
1	entities.  (3)
1	facility to manufacture
1	individual, corporation, partnership,
1	imported based on
1	center initially, but
1	 (c) treatment
1	 (3) costs
1	directors assessment of
1	requirements for 
1	ensure that resources
1	by, or acting
1	surveillance to prevent
9	sold or distributed
1	applied  (1)
3	person that 
1	regulations to address
2	manner contemplated by
1	communities. such regulations
1	675, 1006, formerly
1	(1) general auditing
2	 $3,872 
1	material with respect
1	message is not
1	areas including the
1	translation (or any
1	diagnostics (a) emergency
2	(3) any person
8	disease product application.
1	amateur athletic activities
1	practitioner:  (i)
2	including adverse event
1	following the quarter
1	substance; listed chemical
1	corporation has its
1	model plans for
2	health he shall
1	poultry is eligible
1	imminent hazard, the
1	action on such
1	unwholesome, mislabeled, or
1	study the workload
2	 (b) liability
1	advisory commission in
2	person wants to
4	time and extent
1	product, to the
1	section 1498(a)(1) of
1	governmental entity or
2	secretary may change
1	feeds.  (5)
2	chapter, and all
1	 (b) practitioners
1	product, in a
2	amounts collected under
2	establishes, at the
1	country into the
1	remainder of that
1	listed chemical pursuant
1	protocol as the
1	aforesaid any virus,
1	established name, and
1	public housing, or
1	brief description of
2	attorney general denies
1	transportation, and storage
1	awarded under subsection
11	full reports of
1	foreign data; and
1	concerning first purchasers
3	added and amended
1	longer in effect
1	method described in
3	late payment penalties,
14	active ingredients or
1	establishment, any slaughtered
1	substance which contains
2	quality or effectiveness
1	added substance such
2	fiscal year, by
4	section 552a of
1	new final sunscreen
1	register. (3) protection
1	secretary).  (4)
2	purity and were
1	device would present
1	responsibilities in connection
1	be, that was
1	(1) provides detailed
4	(i) through (iii);
1	instituted promptly and
1	plan, shall determine
1	(a). (d) requests
1	2013 and each
5	predict clinical benefit
1	generally disposed of
1	fiscal year, be
10	section 101(b) of
1	377. revision of
1	final decision. 
1	drug products used
1	debar an individual
1	misrepresentations with respect
1	goals. the report
1	orphan disease status
1	relating to animal
1	lot, batch, or
5	 (i) may
1	specific investigational drug
1	enforcing, under any
1	tree nuts (e.g.,
1	contentsan application under
1	evaluation under subsection
1	use the internet,
1	small businesses, including
1	
 101. suspension
1	marking, and container
2	 (d) drug
1	coloring. (2) the
3	value of all
1	drive while under
15	active ingredients of
1	include epidemiological, pathophysiological,
1	submission of 
1	secretary amends and
2	judgment of acquittal
1	funds received from
1	approved under subparagraph
1	product in addition
14	360d of this
1	from, or an
1	consultant or contractor,
1	states, allowing consumers
1	(ii) provision of
2	report seeking premarket
1	status and success
1	revoking any of
1	playgroundsnotwithstanding any other
2	inconsistent with any
1	(c)(2), (d), and
6	standard prescribed under
1	production thereof or
1	pay fixed under
1	(2) the individual
1	official within the
1	(ii) require the
1	activity regarding womens
1	slaughterer does not
1	president.  (b)
2	assets of foreign
2	monograph, if a
6	terms of weight,
1	enantiomer not be
1	exported;  (5)
1	practices, except in
1	safety officials relating
11	monetary value of
1	$250,000, or (2)
1	administrative, recordkeeping, and
1	information, if, after
3	local food safety
2	request. any such
2	prescribe a plan
1	(b)(2)(a), (b)(2)(b)(i), (b)(2)(b)(iii),
1	man, other than
1	grant all relief
1	subsection (b) submitted
1	cooperative agreements with,
1	pharmacy that delivers,
1	38 stat. 820.)

1	radiation; and (6)
2	commerce may be
2	title or adulterated
1	(2) public health
3	data (including but
1	sections 802(52) and
1	$75,000.  (3)
1	 (7) staff
1	utilized by grocery
1	contract is given
1	v substances no
2	classification for the
1	(e) organization of
1	approved, and available
1	review could have
1	stat. 1265; june
12	drug trafficking area
2	program to evaluate
1	upon violation of
6	(1) in a
1	operations and annually
1	defense as receiving
1	(c) confidentiality during
1	september 30, 1976;
1	order is not
1	department) with relevant
1	individual who habitually
5	issued after the
2	class iii of
1	violations of restrictions
1	title). a color
1	narcotics trafficking activities
1	product fees. (4)
1	change business systems
1	funds paid to
1	person, or a
2	development not later
3	small businesses (as
1	claims for remission
2	fiscal year 1997,
1	documents, the secretary
4	provide the same
2	user fee. 
1	insure that the
1	confidence intervals or
1	technical effect such
1	serving youth. (vii)
1	placement into foreign
2	levels of activity
1	higher priority in
1	controls contributed to
1	municipal ordinance relating
1	person is rejected
1	time an order
1	applicable rare pediatric
1	users under community
1	class ii, and
1	packaging, and holding
1	court, on the
1	logbooks for any
1	necessary, the food
31	purposes of the
1	drug application, except
1	appear and introduce
1	practitioner to dispense
9	person by or
1	extension is intended
1	optical isomers. (d)
1	nutrition labeling and
5	agreement on the
1	secretary or unless
17	director of national
1	naphthoyl or naphthyl
2	using such authority
1	inspection act, approved
6	if, in the
1	art as it
1	seek designation or
1	emergencies; and (6)
1	use such device,
1	subsection, an individual
1	expand the activities
1	subsection (b)(2)(b), the
1	physician, health provider,
1	commercially.  (iv)
3	production of such
1	generalthe secretary shall,
1	specifications in the
1	tobacco, smokeless tobacco
1	information which leads
2	annually report thereon
1	logistics provider receiving
1	block during the
1	 (f) lamb
2	support the secure,
1	provide the nutrients
2	1928, ch. 901,
1	country, in accordance
3	fee for that
1	compatibility with power
1	contain evidence) relevant
1	state has been
1	products are prepared.
2	official name has
1	require, for the
2	356(c)(2)(a) of this
3	active ingredients are
7	tobacco product under
1	authorize use of
1	(b) the prescription
1	denied approval, before
1	unreasonable dietary risk
2	covering in any
11	drug means a
1	condition, be deemed
1	research, together with
1	chemicals:  (a)
1	 (4) local
1	for, and challenges
1	annual needs the
1	release whenever any
1	(c) classification panel
1	(10) marihuana. (11)
1	year 2012, unless
1	675, 761, as
2	slaughter of poultry
1	resolution; (d) provide
1	therefor, the judge
1	forth those procedures,
1	(i) as applicable,
1	states for such
1	iv, which is
1	establishment and functions
1	(b) providing notice
1	609. examination of
1	operations.  (b)
1	file is subsequently
1	(f), sales by
8	(b) and the
1	675, 418, as
3	post on the
1	expanded access under
1	misleading; (5) if
1	application process, grant
1	acts (a) no
1	make periodic reports
1	dietary supplements, that
1	patent is not
1	method (including an
1	 (19) state;
2	states: provided, that
1	one year. (

1	relies on the
11	promulgated under this
1	360cc. protection for
1	federal personnel; (4)
2	approve it. (c)
1	requirementeach tobacco product
1	losses to poultry
7	expected to have
1	segregate the review
1	procedures (or, in
1	1931, as amended
1	360fff1. submission of
1	appropriate. (e) review
1	2000, and on
1	claims to have
1	judicial review. (i)
1	(8) matching funds
1	intended to respond
1	period more than
1	information, and if
1	management activities) with
2	time to obtain
1	salary, grants, or
1	prescription. (j) clarification
1	individual who purchases
1	import, and the
1	27, 1952, ch.
1	term pesticide that
1	pending; or (ii)
1	living abroad. 
1	accuracy of all
1	container, stopper, covering,
10	attorney general by
4	person shall buy,
1	groups, including elderly
3	license or permit
1	product. a request
1	establish or operate
1	  vitamins:
1	evaluate known or
1	(b) has documented,
1	transactions and circumstances
1	secretary is hereby
1	360j(g)(4) of this
1	court for good
1	suture materials used
1	may specify by
2	business, and such
1	shall develop guidance
1	(ii) that is
1	barns, and other
1	involved, (b) the
1	drug shall require
1	senior managers and
3	387h, 387i, 387j,
1	allows additional time
1	authorize any such
1	(
 
 903.
1	 (b) deputy
1	exposure of infants
1	(c)(2), if the
1	made available, and
2	activities relating to
1	(2) additional inspectors
1	importer becomes subject
1	displays the name
1	180th day after
1	states and no
1	(i) 1; (ii)
1	impose a known
1	5 for each
6	located in the
1	documents as provided
1	may be exposed
1	  folic
1	title 42. the
2	seek input from
1	writing, an evaluation
1	safety. (h) publication;
1	survey with respect
1	elects to register
1	facility identifier established
1	registrations for inspection
2	means commerce between
6	alleged to have
1	guidance specifying the
1	confectionery product and
3	title: provided, that
1	drug safety question,
1	circumstances involving the
5	trading partners of
2	device solely on
3	ingredient is an
2	manufacturer from product
1	tobacco products can
1	detriment identified under
32	title.  (b)
1	(whether weekly or
1	progress implementing strategies
2	term care facility
1	denying conditional approval,
3	section if 
2	inconsistency between federal
1	appropriate location for
1	comply in all
2	activities during the
23	days prior to
2	secretary.  (d)
1	children means individuals
2	shall facilitate an
1	administration to carry
1	tobacco products prescribed
1	clinical testing is
2	supplement fees for
1	drug. (c) within
1	application of technology
1	 (4) meat
1	(6) the attorney
1	confidential information. (june
1	employees conducting inspections
1	13, 2016; and
1	(i) processes and
1	licensed practitioner authorized
1	administrator, the person
1	general shall determine,
1	term small tobacco
3	321(p) of this
1	541, formerly 360e,
1	relevant warnings, precautions,
2	types of which
6	transaction history and
1	applicant opportunity for
1	listed drug; or
1	interactions of the
1	ex officio membersupon
2	color additive under
1	food (such as
57	application under subsection
1	final regulation to
3	health and prevent
1	(3) qualificationsan accredited
1	direc-t-consumer advertisement is
2	advertising and promotional
1	undergone the training.
1	animal use for
1	statements as required
1	committee shall advise
1	general, a notice
1	stat. 54; aug.
5	urban consumers (washingto-baltimore,
1	possess skill and
1	disease productthe term
1	(3) any or
1	pose an imminent
1	official business in
1	coordination and integration
22	exceed the greater
1	surgically produced opening
1	external expert, as
2	adjustment calculation determined
1	(a), (i)(2) and
11	drug, device, tobacco
3	319f2 of the
1	drug abuse on
1	food safety; or
1	amending the regulations
1	(b) supplying a
1	analytical techniques, including
2	agricultural commodity, a
1	facilities, and equipment,
1	labeling; and (d)
1	shall the refund
1	held for the
4	defect which relates
1	implementing regulations (including
1	records or filing
1	receive information from
1	use which was
2	commits such offense
1	1271 of title
1	(2)(a)(vii):  (i)
1	42; and 
1	complete to permit
3	list a color
1	agency.  (3)
1	program; (5) a
1	clause (i) exceed
1	(2). (b) if,
1	studies ethical and
1	first such violation,
1	841(b)(1),[1] and not
1	controlled substance; (ii)
18	application that is
2	scientific purpose in
1	 (h) product
1	reviewed, with the
1	cyprenorphine. (7) desomorphine.
3	economic hardship; and
2	section 360e(d) of
4	united states has
1	states attorney 
1	children of ethnic
1	barrels or who
1	homogenous case that
2	(2) would not
4	(a) establishment the
1	under[1] 381(q)[2] of
1	decomposition, parasites, allergens,
1	convention, or protocol,
1	initial classification. 
1	studies to verify
1	establish exemptions from
1	unless the failure
1	(24) -[-(ethylthio-2,-dimethoxyphenyl]ethanamine (2ct2).
1	conducted, before the
1	recur, which report
1	(5)(a) shall not
1	food, including 
1	united states, respectively,
1	(e) is being
1	approval for drugs
1	accredited not later
1	conviction, not raised
1	guidelines and implementation
2	publication of findings
1	secretary d-identified data
1	renumbered 15 and
1	2110. rule of
1	regard to hazards
1	directed to waive
1	title); and (2)
6	application.  (2)
1	secretarial response not
1	disease manifestations, including
4	proposing the issuance
1	(2) in addition
1	impracticable or unduly
1	automatic electronic searches
5	section 505 of
1	meat brokers, wholesalers
1	outside thereof, and
1	(required by paragraph
1	
 
 145.
1	including a comprehensive
1	(ii) within sixty
1	(g) such person
1	multiple violators, but
2	handling of classified
6	services to be
1	packaging); or the
1	 (c) major
7	premarket applications, premarket
14	case in which
1	commission shall, for
4	chemical will be
1	will obligate funds
1	person means the
1	industrial purposes; (2)
1	times upon notice
1	means any equipment,
2	shall identify appropriate
1	(i) are sufficient
1	15, 2007, shall,
2	secret is entitled
1	manufacturing changes as
6	centum of the
2	2015, a repackager
3	grant awarded to
1	predicate device. (c)
1	section shall, in
1	subparagraph (a)(i). (c)
1	vessels (except such
1	360(k), 360c(f)(2)(a), 360e(c),
1	poultry. (4) the
1	exemption of seafood,
2	grant is awarded,
1	(c) $500,000 if
1	distributors; (x) the
1	court, in issuing
1	shall go into
2	approving a petition
1	conditions (a) exclusive
1	applications pursuant to
2	facilities, suppliers, and
2	schedule ii substances
7	controversies or differences
2	subject of review
1	commercial information. if
2	effect any requirement
1	differ from otherwise
1	electronic tracing requirements,
1	intelligence; and (e)
1	1948, ch. 646,
1	drug conducts business,
1	paragraph (13) of
2	partnership, association, or
1	(a) to immediately
1	regarding proposed labeling
2	subject to suit
1	information.  (cc)
1	transferred technology. 
1	regulate thir-party logistics
1	groups regarding the
1	local authorities. 
1	repackager, having a
1	term transfer, with
1	preventive controls, including
1	event reporting system;
2	leads to the
1	poultry food industry,
2	lifesaving and lif-enhancing
1	 (c) violation
1	reimbursement for purchase
1	means a hearing
1	violation before it
7	secretary shall, as
3	secretary shall, at
2	title 31 and
2	modification would be
1	section, an operating
1	indications; or (c)
1	health regarding submission
1	authority uses any
1	risks, costs, and
1	modifications to improve
1	unreasonable efforts to
56	attorney general may
2	name of person,
1	involved. such classification
1	sensitivities and bridging
16	united states district
1	jurisdiction of and
3	agency (including the
1	program the secretary
1	development, submission, implementation,
1	delivery system, does
2	concerning modified risk
1	recreational facility and/or
1	 (h) special
1	investigators in their
5	days of receiving
2	separately from all
3	combination with one
1	night if the
2	(a)(2) of this
2	establishment and reinspection
2	assist the appropriate
1	section 1903(g)(1) of
21	evaluate the safety
1	information compelled under
1	microbiological methods for
1	unfit for food,
1	unfit for food.
1	adverse product experience;
1	attempting to avoid
1	(b) is approved,
9	drug abuse prevention
1	 (2) exceptionif
1	vacancy shall be
2	1-month period ending
1	new request 
2	(d)  (1)
1	parts of a
1	(9) office unless
1	vulnerability assessment of
1	interdiction committee may
1	governments of foreign
1	(
 
 8811,
1	secretary approve such
1	tobacco over domestically
1	twenty years or
1	food are found
1	restrictions on sales
3	reports and postmarket
1	additional time, as
2	section 353(g)(5)(a) of
1	product; (c) a
1	et seq.] involving
1	media campaign based
2	duties of state
3	shall be completed
1	suspended, revoked, or
1	principal investigator proposed
1	fusion center operated
1	issue regulations establishing,
1	agreement resulting from
2	discretionary and mandatory
1	8 and amended
1	scientific procedures or
1	child while such
1	(i) classify, analyze,
4	increase its bulk
3	refuse to provide
1	(c) current good
1	release establishes (a)
1	drug and derived
2	approved application to
2	year 2018, and
1	packaged it does
2	chloral hydrate or
1	gift, or other
1	feed was approved
1	processed, packaged, and
2	part, from the
1	effective communications during
1	suburban, and rural
2	forms of consideration,
1	copies of a
1	priority review for
1	whether to establish
1	considered and applied
1	laboratory facility. 
1	31, and each
1	tobacco smoke. (h)
5	serve as a
1	(and all supplements
1	assessing the safety
4	 (5) if
1	data summaries to
1	assembles, processes, or
1	documents and tangible
1	oleomargarine containing filthy,
1	 (5) in
1	title 26. (b)
1	convincing evidence, that
1	 (3) refusal
1	paid at 50
1	684; 
 

5	report that describes
1	research (or appropriate
2	section 1705(c) of
1	consider a petition
1	(d) dispenser requirements
1	budget for those
1	10, 1962, and
1	provide each person
1	title to dispense
11	appropriations of the
1	basic pay payable
1	sponsor a person
1	federal holiday, or
1	 (i) amendment
1	training fellowships, whether
1	coca leaves. all
1	387f(e)(1) of this
1	corporation shall 
1	promulgate regulations specifying
1	product identifiers if
1	(ii) encourage free
1	provide notice and
3	secretary considers not
2	explore and evaluate
1	use in producing,
1	used; specifications as
1	quality consistent with
3	voucher may be
1	identifies any regulatory
1	(iv) the person
3	opiates, including their
1	criminal, libel for
1	(3) that every
1	5. proceedings for
1	professional license number
1	corporations to the
1	published less frequently
1	government only if
1	genus may include
1	(e) the director
1	including section 1002(b)
1	executive of a
2	domestically and in
1	federal sponsorship of
1	provide such notification
1	schedulesin making any
1	conditions. provided that
4	(4) verificationbeginning not
1	denied; (d) the
1	hearing by telephone,
2	plastic, or other
1	disposal or other
1	year 2013, as
2	populations.  (c)
1	and, for each
1	review or evaluate
1	america; or (iv)
1	practitioner to treat
1	parole in the
1	liability set forth
1	foreign governments; 
1	 (d) elderly
4	specially qualified person
1	notification.  (2)
1	provided, and the
1	drug application referred
1	(3) provide a
6	infant formula shall
1	offense set forth
1	(3) revision the
1	distribute alcohol; (iii)
1	determination.  (k)
1	security, to make
1	
 
 360h.
10	shall, upon the
1	presidential report 
2	federally regulated matters;
1	response plans for
4	receives a notification
1	tobacco product. (june
1	regulatory rationale for
1	within the medical
2	consideration the requirements
1	review every 5
3	shorter or longer
1	register.  (5)
1	
 1709. repealed.
4	inspectors appointed for
6	title 5. the
1	be. subsection (b)
4	(a)  (1)
1	262(a), 262(k)]; 
1	measuring the pesticide
1	imports devices intended
1	section 360j(g)(5) of
1	modify shall not
1	pending proceedings; finality
1	common salt, and
2	shortage list in
1	680. authorization of
2	343(i)(2) of this
1	etc.; certifications notwithstanding
1	complaint, and there
1	submitted the information
1	law enforcement duties
1	shall not serve
2	tobacco product, that
1	supplement when used
1	disease). (h) fascioliasis.
10	prior to july
1	(except drugs for
3	administrator means the
1	withdrawal period is
1	provided by public
1	retailer) who is
1	(i) the distribution
3	application or any
1	misleading marking or
1	761, as added
1	interested parties. 
1	containing single enantiomers
1	drug being a
1	inspection by an
1	use of inference,
1	individuals cannot be
2	hire, use, persuade,
1	thus inspected and
1	label statements and
1	consistent with and
3	prevent the spread
1	inspector, or any
2	felony under state
1	standards that achieve
10	applicant for approval
3	(i) a fee
35	violation of section
2	trial, the attorney
1	fees, in the
2	labeling changes, if
1	amounts available to
4	march 4, 1913
1	five days. in
1	shortage maintained under
1	material or component
2	secretary, which meets
1	file the request,
1	food additive, under
2	allergenic extract product,
1	rol-you-own tobacco products;
1	power to elect
1	authorities; cooperation with
1	commencement of clinical
1	performance standard has
3	area, the director
1	order, as applicable.
3	complete application an
1	allergenic extract product;
2	(7) any other
1	disclosed, under such
1	means of order
1	clearinghouse or nmic
2	achievability of compliance
1	chemical. (c) the
1	5(2), 65 stat.
1	thereto. (y) the
2	findings required for
1	rulemaking, or may
1	significant foodborne contaminants.
1	explanation by secretary
1	device user facility,
1	review such request;
1	deliver to any
1	drug traffic and
1	regular customer, on
4	due notice to
1	$534,000,000. (g) for
6	shall be final
1	2017, but submits
2	(b) state and
1	refund the secretary
1	facsimile labeling; (e)
1	employee or otherwise
1	imposition of duplicative
1	(or incorporate local
1	penalties (a) violation
1	drug administration unless
1	may sell, assign,
2	issued for such
1	documents.  (june
1	patent owner. 
1	class includes the
1	importer. (4) allocation
1	national response framework;
2	personal delivery of
1	pending petition for
1	subsection, shall 
1	patient package insertthe
1	whether before or
1	elections  (a)
1	review such requests
1	opportunities to help
1	tools or methods,
1	prevent the sale
1	(j) expungement proceduresthe
3	articles intended for
1	
 360jj. studies
1	1117. repealed. 

1	into, or the
1	dosage forms of
1	that, of such
1	account the length
1	court to which
1	strategy (a) timing,
1	regulation requiring premarket
1	three thousand or
2	product applications. 
2	repackager, or to
1	likely need from
1	inference, enhanced verification
1	ch. 675, 505f,
1	(c)(2) before the
1	make a copy
1	
 1505a. annual
1	prescription or order,
8	drugs or combinations
1	exemptions (a) persons
1	continuing education opportunities
1	(2) workload adjustmentbeginning
4	eligible to receive
1	milk and cream,
1	601.45, or 601.94
3	(b) an accurate
1	streamlined premarket approval
1	applications; construction of
1	 (4) any
1	(a) coordinate with
2	activities that the
2	seriousness of any
1	may 28, 1976
1	 (i) utilize
2	conduct a postapproval
1	shall establish regulatory
1	surveillance has appropriate
1	public health impact;
1	deputy directors (a)
1	granted only if
1	(c). (b) for
1	$2,117,000 for fiscal
1	logbook his or
6	following factors: 
1	licenses a biomaterials
1	control a drug
1	conducting inspections of
1	require recordkeeping, reporting,
1	know or reasonably
1	(h) establishing a
1	(iii) describing improvements
4	justify the deviation
1	requirements placed upon
1	relative dependence of
6	recommendations to present
2	section, any person
1	person. (b) any
1	term office means
1	rationale why such
1	supplement, a premarket
1	 (3) audit
1	producers capacity as
1	refusal, withdrawal, or
1	cooperatives and other
1	raw materials used
1	
 956. exemption
1	june 30, 1973,
1	(a) one or
2	fields as clinical
1	facility is licensed
1	net cost savings
1	jurisdiction of any
1	secretary requests information
2	relating to drugs
29	notice and opportunity
1	assessments, and shall
2	 (5) limit
30	state or territory
2	section 374(g) of
1	article that otherwise
2	device and provide
1	shortage; or (2)
1	employed at ports
1	states international obligations,
1	agriculture in the
1	v medications for
1	reports; (c) a
1	minimum, the review
2	diversion control program.
1	(e), the following
1	preliminary order. any
1	paragraph (2)(b). (c)
1	account that 
1	title 15. (3)
1	secretary no brand
1	subjected to incubation;
4	recipient of a
1	outsourcing facility involved.
1	statement is submitted
1	improving the tracking
2	title 42 or
1	individuall-identifiable beneficiary health
1	additional exemptions the
2	report of prior
1	drug having an
2	trends in the
1	350c(d) of this
2	investigations conducted outside
2	deemed amended to
1	commission without reimbursement
1	carrier to practitioners
1	dual photon positron
1	scheduling decision; or
1	involving supply reduction,
1	receiving a report
1	petitions for designation
1	opening or closing
1	provided to states
1	applicant (which other
1	(28) verification or
2	needs for such
1	subsection (n) of
1	transfer request with
1	dietary intake; or
1	including how such
7	national drug code
1	contents of any
1	feeeach person who
1	individuals with a
1	formula, (b) a
1	ether. (e) repealed.
1	tobacco products during
1	individual at any
1	disclosure of classified
1	topics of any
2	inspection service to
1	360d(b)(2) or 360e(b)(2)(b)
2	quantity of methamphetamine,
1	(iv) 1 individual
1	subsection to encourage,
1	consortia, seeking to
1	 (1) executive
1	residues from lawful
1	foundation to further
1	notice informing the
5	minerals in the
1	guidance documents shall
1	subsections (b)(4)(b), (c)(4)(b),
1	 (a) preparedness
1	person from increased
1	approved.  (c)
1	written statement from
1	shall occur. 
1	receives, holds, packages,
1	immediate use of
1	
 
 360rr.
1	title;  (7)
1	sel-service displays of
1	(5) implantthe term
1	receiving of imported
1	foreign supplier, then
1	jurisdiction the district
1	pending request, shall
1	ch. 675, 902,
1	expenses of seizure,
1	ii, why general
1	upon so intervening,
1	receptor type 1
1	abuse by youth
1	primarily intended to
1	services. (feb. 15,
1	suffering from the
1	2108. annual report
7	solely for investigational
2	persons who obtain
1	order. during such
1	 (aa) unresolved
1	inform national, state,
1	section, a veterinary
1	samples by mail
2	identification of confidential
1	overall morbidity and
1	logbook includes, in
1	(e) remedies the
3	month during negotiations
3	hearing on disputed
3	(a) where the
1	requires pharmacy licensing
2	treating clinical infections
1	development tools for
1	chapter, the term
2	 (b) registration
1	parties described in[1]
7	forth in subsection
2	confidential information described
1	lon-term care facility;
1	exclusively from milk
3	register, a meeting
1	select to conduct
1	enhance the protection
1	defense, including the
1	place to ensure
1	therapy.  (8)
1	paragraph or subsection
1	transaction covered by
1	activities of potential
1	on-time generic drug
1	develop or validate
1	manufacturing. (3) that
1	population; or (2)
1	satisfy any requirements
1	poultry in each
1	corrective actions. 
1	(iii) who provides
1	limitation, for the
1	attempts to develop
2	(3) and (6)
1	title applies, subject
2	possession of controlled
1	seller enters the
3	relevant factors 
2	section 282 of
1	determinationthe secretary shall
2	label or the
3	congenital anomaly or
1	medical food for
4	health (if any)
1	refund to any
1	(1), as the
1	development of resistance
1	secretary; (5) use
1	used to follo-up
1	email address; and
2	responses to such
1	1263; renumbered 16
1	states or third
1	(i) that 
1	1263; renumbered 15
1	proceeding. (b) this
1	supplies such as
3	bioavailability studies) essential
2	tobacco products 
1	provide expeditious procedures
1	(
 
 1042.
1	action letter on
1	animal drugs, investigational
1	due once each
2	section 352(n) of
1	(ii) to any
1	especially but not
2	biomaterials supplier and
1	studies and functional
1	dilute solution (including
1	(c) labeling: type
1	unapproved. (2) written
1	agencies; (c) providing
1	schools or early
3	(for such period,
2	finding of the
6	due date for
1	committee member at
9	establishment and maintenance
1	subsection (a) do
1	commodities, not more
2	list under this
3	term official mark
12	shall be equal
1	plaintiff; subpenas the
1	regulation, will be
1	smokeless tobacco products,
3	applications in condition
1	enforce compliance with
1	order the detention,
1	 (8) prohibition
1	hearing together with
1	states shall take
1	implementing any aspect
1	unnecessary duplication, the
1	administered by properly
1	(2) establishes, that
1	encountered. with respect
1	dating  (1)
147	nothing in this
1	undergone an initial
14	new drug applications
2	product; (b) the
1	cases of a
1	360bbb4. countermeasure development,
1	necessary, in conjunction
2	level requested is
1	(e) modifications based
1	recommendation of an
4	schedule i, ii,
4	section 824(c) of
1	reporting requirements: 
2	regulation is referred
1	health risks of
1	published and that
1	classes of animal
1	meat broker, renderer,
1	 (a) posting
3	(i) written requests
1	clause (xiv), (xv),
2	facilities, inventory, and
2	center for tobacco
4	minimize the burden
1	cream. the provisions
2	general pursuant to
1	(e) which the
2	transported, or otherwise
3	postmarket regulation of
1	30 years, a
1	$6,000,000 for each
2	ris-based schedule under
1	necessary. (b) investigate
1	act).  (i)
2	makes final delivery
1	(1) exemptiona drug
1	exporter transfers a
1	subsequent to march
1	subclause (ii) and
11	may include the
4	violates this section
1	findings conducted, supported,
3	secretary shall award
1	 (2) foreign
1	using susceptibility test
5	filing by the
1	sector involvement 
1	iii device; and
2	action is that
1	352, 355, 360,
1	treatedin establishing, modifying,
1	inspection, building construction,
2	admiralty, except that
1	(v) for a
1	designated representative described
1	dries, and packs
1	final, from any
1	patents that make
3	tobacco product contained
1	emergency uses notwithstanding
1	extension service the
1	(7 u.s.c. 241
3	controlled substance, or
1	development; and (ii)
1	produced primarily for
1	(21 u.s.c. 951
1	litigation costs; 
9	paragraph does not
1	imported thereafter by
1	notification termination. such
2	subparagraph. no person
1	directed at those
1	title 7. (

1	(ii)(iii). (c) submissions
1	available medical and
1	used to inspect
2	r-exportation from the
1	experts on issues
1	protecting data privacy
1	44 stat. 1102;
1	tribal governments, other
2	limiting the authority
1	distributo-labeled product. (b)
3	performance standard or
4	drug administration (a)
3	service on the
1	grounds for deferring
1	remedies.  (c)
35	1 or more
1	office, shall in
1	regulated industry, to
1	determination of adulteration
1	authorize the marketing
1	purchaser, when no
2	organization or any
5	states shall have
1	multiple reinspections an
1	(1) which, in
21	may be used
2	(a) prior to
1	labor associations, and
9	nothing in the
2	require the deposit
1	jurisdiction.  (e)
1	paragraph (1)(b) applies:
1	clear, concise warning
1	including the strategic
2	applicant and each
1	director shall, in
2	use. the secretary
1	grown tobacco. (2)
1	product, or (c)
2	susceptibility of certain
1	subsection at a
6	secretary for preparedness
2	subsection and the
1	handbill, or other
6	drug is designated
1	(f) disposition of
1	refused admission 
1	review, and consider
1	(and serves a
1	applications. (c) application
1	prohibit or otherwise
2	alkaloid of opium.
2	possessions shall be
1	operates a site
3	products are an
1	ris-based inspection frequency
1	action, the decision
1	1.04, such adjustment
1	chemical that have
1	another country that
1	(2); plus (ii)
1	preclinical trials (if
10	taken by the
1	
 
 375.
1	measures an importer
2	1913 [21 u.s.c.
1	(d) agency response
2	appear on a
6	civil monetary penalty
5	studies, the secretary
1	compounding, converting, concealing,
1	interstate commerce may
1	355] (regardless of
1	whose possession or
4	different than those
2	eligibility of certain
1	672, 673, and
1	(4) tolerances for
3	determines to be,
1	states persons affected
1	(3), the president
9	may be provided
1	labeling, packaging (other
1	(a) the proposed
4	successor regulations). 
1	evaluate for filing,
1	products distributed outside
1	complex of nicotine.
1	agreementswith respect to
1	used to increase
1	communit-based organizations; 
1	content, nicotine content,
1	 (a) when
1	drug. such a
1	fiscal year 2001;
4	federal register with
1	applications do not
1	device, means the
1	interest not exercisable
2	(i) in generala
1	judgments, decrees, and
9	person from the
1	(e) the sponsor
1	camera. this subsection
1	(2) the regulations
1	response to this
1	 (6) limitationno
2	activities.  (2)
3	may be deducted
1	(vi) any quantity,
6	secretary based on
1	unapproved new animal
1	plan, and any
6	section 360d or
1	publish an order
1	commodity, or the
1	good agricultural practices
1	(i) the children
1	burdens, and not
1	vehicle. (b) regulations
3	part, any regulation
1	considered registered under
1	provide information referenced
1	committees with a
1	contaminated by specific
1	iv; applicants to
1	graduated sanctions for
1	confirm such agreement
1	products) or of
1	677. other federal
1	343(k), 343(q), or
2	(a) beginning on
1	thereafter.  (c)
1	facility that 
1	$27,600 (adjusted each
1	 (i) acceptance
2	order to eliminate
1	general a wholesale
1	supplement submitted for
2	(d) section 352(o)
1	federal laws to
1	shortages that (1)
3	similar information received
1	extension, and waiver
1	sector pilot projects,
2	exclusivity for the
1	gratuity, or fraud
1	infant formula, made
2	animal drugs permitted
1	any, on which
1	regular customers, if
1	(c) specificity of
2	filed before the
1	experience with uses
2	deemed by the
1	court, upon a
1	 (ii) any
1	training seminars, educational
20	(ii) in the
1	meat inspection requirement
1	confidential.  (c)
1	psilocybin. (16) psilocyn.
1	approved in a
2	label described in
1	sell or deliver
1	seq.] or section
1	misbranded, including through
1	will carry out
1	effect, or shall
1	commerce, unless the
1	otitis media, and
5	period of time,
1	infringed, whichever is
1	acute bacterial sinusitis,
1	serves a copy
1	subsection (d)(3). 
1	affects, or has
2	waiver, exemption, or
1	consumers about similar
1	 (4) generic
1	proposed product standard
2	except that officers
1	agriculture is satisfied
1	required submission of
5	label, labeling, or
11	account for salaries
2	paragraph (1), which
1	device involving human
1	establishments operated in
1	beyond december 31,
2	provision requiring that
1	likely to cause
1	efforts to eradicate
1	information accompanying any
4	file such information
1	(c) performance measurement
2	secretary, has been
1	life functions; or
10	applications, supplemental animal
1	state; (ii) a
1	administrator shall, after
1	researchers to further
1	advertising not directly
4	state does not
1	safety for humans
1	paragraph (3)(a), the
1	both. (3) for
1	facility conducts business.
10	made in accordance
1	2101. findingscongress finds
7	human services (referred
1	within those departments
1	(vii) information submitted
15	may be transferred
1	list and any
1	diffusion testing. (viii)
1	30 days from
1	refusal to approve
1	periodic testing to
1	registry.  (4)
2	(b) every person
1	final at the
1	sale, or other
1	include a qualified
1	president any disapproval
1	organization to a
1	unless he refuses
1	available, to the
2	years are deemed
1	certain programsthe provisions
2	statements required to
1	granted under the
3	account providing appropriations
1	substances and signed
17	knowingly or intentionally
1	upon the secretary,
1	petition is not
1	transaction. it is
1	ingredient for use
1	related to terrorism,
1	small businesses subject
1	connection with written
1	circumstances for which
1	official responsible for
2	one additional year,
1	enforcement or intelligence
1	term narcotic drug
1	manufacturing use no
1	(e) federal provisions
1	(b). (
 

1	person knows 
1	rulemaking procedures each
1	frozen, or contaminated;
1	section 971(f)(2) of
2	health; or (ii)
1	contract with any
1	establish regulations under
4	action is taken
1	efficiently disseminating the
1	(or documentation that
1	congress a budget
2	continue to 
1	priority on prevention
2	(1) limitation fees
1	comply with order
1	evaluation and recommendations
1	(b), a practitioner
1	consumer notification 
1	(1) between any
1	particular; or (i)
4	container.  (b)
1	state, local and
1	indirectly, any part
2	term qualified en-user,
1	application is otherwise
2	drugs in treating
9	expenses, including per
1	establishment, in which
2	qualifications and experience
1	institute appropriate internal
1	finalizing the guidance
1	(c) the nature
1	311, as added
1	establishment as determined
1	grantee shall not
1	patients with unmet
6	request of a
2	number of representatives
1	(b) requirementsthe secretary
1	title 18[2] until
2	issues raised in
1	investigations and prosecutions
1	prescription orders dispensed
19	use under the
1	(2)(a) shall require,
1	confirmation by the
1	allergens, and unapproved
1	activitiesin conducting activities
1	phenylpropanolamine (referred to
2	wide variety of
1	penalty to the
1	(f) delay in
1	among youth could
1	prescribing practitioner. this
1	defendant may, at
1	fields of substance
1	imposed, as the
2	bear the official
1	section 960(b)(1)[1] of
3	title, be introduced
1	ii or of
1	company that had
3	products, for use
2	paragraph (3) is
1	surveillance system to
1	sentence for, a
1	(8) unexpected serious
1	services, equipment, personnel,
3	(iii) records a
4	paragraph or paragraph
1	(ii) or with
1	tracing system, the
1	study planning since
1	protracted and obvious
1	oaths; subpenas; witnesses;
1	account of, the
1	(a)(3)(b)(i).  (2)
1	standard. nothing in
1	47 shall not
1	237a(b)(4) of title
1	capabilities needed for
1	toward developing and
1	functions as specified
1	within the high
1	campaign.  (i)
1	device user for
1	experts and consultants
2	requirements than federal
2	15, 2007, and
4	law for the
3	permit the importation
1	action was taken
1	approved application who
1	electronic product means
4	(b) the name
1	corporation to prepare,
4	person shall not
14	upon receipt of
1	drug administration and,
1	confidential information and
1	veterinarian issuing the
1	eligible countermeasures may
1	authority, submits to
3	annual national drug
1	agencies, or associations
1	3, 1996, under
1	points within the
1	entity who knowingly
1	therapy concurrently with,
1	initial importation and
6	controlled substance (as
1	issue or modify
6	device is in
7	result in a
1	 (a) acetic
1	physical, and radiological
1	violation of state
2	demonstrate that 
1	capabilities by 
1	agencies outside the
1	degradation product is
1	decisionmaking pertaining to
1	officials. (c) petitions
1	smokeless tobacco is
1	
 
 611.
1	fees; penalties the
1	distributor or thir-party
1	(i) the investigation
1	complaint, and of
1	status of studies
1	360e(d)(2) of this
1	controlled substance (a)
2	state has given
1	appropriated $20,000,000 for
1	states, even if
2	abuse prevention, treatment,
3	concurrently with, or
2	unfit for distribution
1	maintained for such
1	statement specified in
3	$125,000 for a
1	transaction is approved
1	marketed, sold, or
1	emerging postmarket drug
1	standards and protocols
1	(a) the efforts
1	insufficient to classify
9	purposes of clause
2	regulation shall be
1	otherwise assure its
1	business recovery plans
3	thir-party auditor, the
1	accord with good
1	reasonable period, not
2	update the guidance
2	revision described under
1	section 691[1] of
1	supplement).  (june
2	circumstances involved, to
1	 (b) considerationsin
2	articles are brought
2	(ii) shall provide
1	documents. (3) the
1	registrant during the
1	listed drug with
1	(c)(1)(b)(i), (d)(1)(c)(i), and
1	time of use.
4	biomaterials supplier is
1	(ii) assessing and
1	(f) rules and
2	differ from that
1	scientific or financial
1	tobacco) intended to
4	contain or is
1	1, as added
2	certification or other
1	title. (3) basis
1	conditions results in
1	teen pregnancy than
1	biennially thereafter, submit
2	active ingredients 
1	period, does not
1	regularly scheduled testing,
1	exist; (b) the
1	warrant issued pursuant
1	formula presents a
1	requirements for, or
4	revenues for a
3	animal feed for
1	otherwise has an
1	order. (2) 
2	maintain for such
1	prevent such smuggling.
1	means the adjusted
6	certify that the
1	review of scheduling
1	communication within the
3	shall be conclusive
3	product applications or
1	
 1115. notice
1	composition; (b) a
1	manufacturer.  (2)
1	right to advisory
1	initiatives that target
2	no-federal funds, including
1	subparagraph (b), such
1	declaration of ingredients
1	$1,000,000 for purposes
1	evidence defined; combination
2	secretary, with the
1	modify or affect
1	many of the
10	conform to the
4	person and the
1	civil fine of
1	years 2015 through
1	(including a sale
1	material violations of
1	subsection (a)(3)(a)(i)(viii) and
1	title.[2]  as
1	products.  (3)
6	approved under a
1	devices classified by
1	treasury, the secretary
1	notify the qualified
5	relating to controlled
1	users, such as
1	misbranded drugs and
1	 (1) regarded
4	approvable. if the
1	shall make each
1	 (f) distribution
5	general of a
1	facilities in subsection
1	deferred and, upon
1	national food emergency
1	exception for designated
1	(b) condition the
1	
 874. advisory
1	master file must
1	
 355d. internal
1	pathogens, including methicilli-resistant
1	forfeiture under section
1	process, any dispute
1	secretary will be
2	action requested herein
1	commence upon such
1	action by federal
1	heroin; (ii) 5
2	plan shall include
2	public warehouseman storing
1	information typically found
1	drug sponsor fees
1	3, 1913, shall
1	introducing into the
1	practice  (1)
1	receive  (a)
8	section.  (june
1	(a)(1) shall, at
1	proceedingson receipt of
1	market under this
1	1703(c) of this
73	respect to any
2	identification, validation, authentication,
1	(ii), the base
1	employee, at all
1	devices or which
6	abbreviated applications, and
1	plant located within
1	(
 
 1052.
1	request that 
2	ownership or control
1	recommended to be
2	random inspections for
1	therefor to ship
1	572 of the
1	purposes as determined
1	plant, its seeds
1	requireda responsible party
1	completion date for
1	scanning each package;
1	establishment, reinstate such
3	provides information on
1	(by negotiation or
1	establish, by october
1	disclosure in the
1	(1)(b) and 
1	periodically revise as
1	subparagraph if clause
1	seeks to produce.
1	assist in (1)
2	 (b) includes
1	(g) a written
9	government subject to
1	technical effect; and
1	respective fiscal year.
2	term consumer does
3	applications  (i)
1	testing for rapid
1	regulation plan and
1	effectiveness than the
1	exempt from sections
1	gases for which
1	381(m) of this
1	presubmission conference is
1	appropriate persons about
1	 iodine (g)
1	attempt to legalize
1	351(a)(5) or (6)
1	exception notwithstanding subparagraph
1	countermeasures, or other
2	(c)(ii) by the
1	substances may lead
1	(6); or (ii)
1	clinical benefit, or
1	subsection (f); (ii)
2	assurance of effectiveness,
1	improvement over existing
1	samples only if
2	phencyclidine (pcp); (e)
1	health, or that
1	(b)(1), the goals
1	populations; authorization to
3	naturally occurring estrogen
1	created by section
1	operator of an
1	tobacco use. 
6	described in subsections
1	applicable, where such
1	interior shall jointly
1	poultry at a
1	including monetary value
1	oral order which
1	(b) guidance not
1	business, or to
1	assurance of safety,
1	(
 
 1522.
8	construed to alter
3	shall be increased
1	activities and needs
1	administrator a petition
1	disappearance of a
1	teleconference review, if
1	subsection (g). (3)
1	statute or regulation,
1	drug; (k) the
1	register that is
2	manufacturing or distributing,
1	(2)(b). (b) declaration
1	describes the communication
1	may, under procedures
1	subchapter shall limit
1	services current information
1	cause that the
1	requirements necessary for
1	(2) the court
3	60 percent of
1	component, or accessory
1	(3), an approved
1	imported food product
1	 (i) supporting
1	projection for program
1	issuing a rule
2	shall require each
1	product standard by
1	preparation of opium
2	handling of milk
2	general, or his
1	applying relevant standards
1	(b) subsequent to
1	(e) package form
1	paragraph (1)(c)(ii) may
1	shall meet, in
1	obtain tobacco products
2	interpretation of the
1	v pursuant to
1	feasible for a
2	animal drugs means
1	year. (e) reliance
2	intended for at
1	
 962. second
1	act chapter 35
18	requirement of this
1	administrative order has
1	businesses, updated good
2	(iii) that the
1	common laboratory methods
1	within the customs
2	processing, storage, handling,
1	considered a matter
1	exacerbate an existing
1	attorney, postpone sentence
1	(6) build scientific
1	subsection. amounts made
1	inspection; denaturing or
1	covering practitioner means,
2	means an organization
1	products imported from
1	conference. a decision
2	processing egg products.
6	carry out its
1	inquiries; exercise of
1	auditors accredited by
1	methylamine. (n) ethylamine.
1	including provisions, where
1	organizations and interested
1	expertise in child
1	
 625. inapplicability
2	chemical unless the
1	include requirements for
1	term a member
1	similar types of
2	exclusion the term
2	applicant will be
6	effective under the
2	 (2) drug
1	necessary to enhance
2	identified or suspected
1	early pursuant to
2	committee or any
2	bottled drinking water
1	advertising of foods
1	confidential information (a)
1	quota may be
3	users and nonusers
1	dairy products for
1	shall be reinstated.
1	enter into collaborative
1	conduct training programs
1	successfully developing and
1	violator shall be
1	waived is sold,
1	(a)(3), or request
1	chemical, including sales.
1	purposes of subpart
1	(a) the regulations
1	whether a person
1	committee; report and
1	may intervene as
1	regarding voluntary inspection
1	(a) articles recognized
5	(b) shall 
1	public docket, notwithstanding
1	coordinate and enhance
1	technology and stakeholders
1	(1) with due
3	outsourcing facility has
1	cigarette, cigarette tobacco,
1	administrative expenses for
3	submissions from state
1	controversy, including a
1	paragraph (1)(a)(i)) with
1	(ii) state the
1	responsible party. 
1	constituent part is
1	necessary, together with
1	defense capacity at
1	proof in any
1	sponsors, animal drug
1	damage.  (b)
1	records (including testing
1	designating a representative
1	case of persons
1	manufacture, marketing, and
1	inspecting outsourcing facilities,
1	estimated demand in
1	application, (3) destroyed,
1	human services. (feb.
1	848. continuing criminal
8	states, the district
3	act shall not
1	manufactured and finished
1	agree upon after
1	means any disease
3	programs and projects
1	private sector, as
1	campaign will secure,
1	temporary period, no
1	section, which is
1	(b) required to
1	ch. 675, 311,
1	determination within the
1	first 3 of
1	violation is committed
1	regulations), no later
1	labeling thereof, that
1	receiving food, drugs,
1	subject to its
1	(a) did not
1	reimbursement for any
1	distributor relating to
1	379j21. authority to
1	papers, records, and
1	development protocol described
1	rendering carcasses or
1	(b) improve and
1	3 requests under
2	four succeeding crop
2	expiration of ten
1	measure, that is
1	taxes paid by
1	receiving the information
1	projects conducted during
1	possible illicit marketing,
2	selected as a
1	food products 
1	secretary be set
1	benefit under subparagraph
1	515, as added
1	360i, 360j, or
2	types traditionally and
2	secretary, the attorney
1	it, together with
1	authority, upon a
1	(a) is listed
4	steps to assist
1	device to exercise
10	annual monetary value
1	sampling and analytical
1	violated section 331(b),
1	reports for device
1	require the el
2	may request from
1	observer that the
1	president shall not
2	secretary, whenever he
4	performance standard established
1	thereof are to
1	seq.]; (5) a
5	 (3) a
10	completion of the
1	of, products under
1	may reveal the
1	terminated, leaving the
1	least annually (or
8	means  (i)
1	to, and interactive
1	significant local and
2	device exemption in
1	items primarily intended
1	conditions. if the
1	advisory review not
1	total quantity dispensed
4	stat. 1262; renumbered
1	indexing of such
1	387b. adulterated tobacco
1	(a) united states
2	country and has
1	introduce testimony. the
1	sell from the
1	may reasonably require;
2	paragraph (1) shall,
1	packing, holding, distribution,
3	review voucher of
1	product. (c) 
1	rights and privacy
1	properly designed and
1	(iv) records a
1	(
 
 827.
1	vitamin b1, vitamin
1	interested person which
1	testing involving such
5	(iii) of paragraph
1	offense be continuing
1	
 1037. prohibited
1	form as required
1	18; (2) order
1	inspection, examination, or
1	unique number described
3	title 28. upon
1	biological products manufactured
1	shall, as part
1	chemicals. for purposes
1	requirements prescribed under
2	2008, the secretary
4	brought before the
1	person submits a
1	development and support
1	plants in the
3	18.  (d)
2	labeling changesthe secretary,
1	rehabilitation efforts through
2	paragraph, may not
1	data under the
1	moderate abuse conditions;
2	hazards identified under
1	another sponsor that
1	 (1) approves
2	hillory j. farias
1	subchapter.  (

2	retailer a retailer
1	coverage or reimbursement,
1	infant formula are
1	use among children,
21	paragraph (1) for
3	premises, facilities and
4	appropriate to protect
1	863. drug paraphernalia
1	address, and phone
1	similar advertisement prior
1	committing a felony;
9	filed under section
2	secretary or by
3	application that the
1	may provide the
1	less than eighteen
1	part. nothing in
1	centers with patients,
1	
 337. proceedings
2	proposals for changes
1	reserves, annual fee
1	subclause (iii) as
6	public views and
3	concerning its vitamin,
1	intelligence activities not
1	act of 1977
1	dividing $50,000,000 by
1	facility, after a
2	valid and would
1	include provisions related
1	 (b) matters
1	title for provision
8	applications means the
1	262(i)). (c) the
2	overall direction to
1	(4) comment the
1	information for sentencing
3	container applicable thereto,
1	prescription order or
1	year 2012, if
1	kindergarten.  (2)
1	(a) the package
1	trafficking.  (c)
1	records, and documents
2	requirements, prescribed by
1	41.  (c)
1	produced on a
1	skill in the
1	(v) the effect
1	(a) prioritize topics
3	presence of such
2	after, submission of
1	22, 2009, issue
1	form of pills,
2	presented at the
1	dissemination  (1)
1	allegedly caused directly
2	assistance under subsection
1	instruments, securities, or
1	tobacco product; (iii)
1	appropriate in light
1	use of methamphetamine.
1	person to respond
1	governing the procedures
3	regulation or order;
4	dosage form means,
1	(c), including actual
1	specific reference in
1	investigation, requiring that
1	clearinghouse there is
7	regulation or order.
1	labeling for any
2	imposed by the
1	april 25, 1985;
5	established in paragraph
1	life, the panel
1	(except matters in
1	conduct the following
1	narcotic drugs of
1	sale directly to
2	require as a
1	2015  fiscal
1	seriously impairs individual,
1	issue public notifications
1	purchasing organization of
1	april 25, 1985,
1	secretary should 
1	current counterdrug activities
1	reg. 4461544618). such
1	issued a new
1	effectively protect the
1	penalties a civil
1	analyses of foods
1	secretary, after setting
1	consideration the secretarys
2	seq.) or any
1	product under an
1	paragraph (3)(a), and
1	
 391. separability
1	receiving any federal
2	manufacture, salt, derivative,
2	filled; and (ii)
1	actually used exposes
1	selected in order
4	22, 1954, ch.
1	initiatives among federal,
2	sales of the
1	spend any gift,
1	subpopulations; and (7)
2	exports a listed
2	thirt-month period beginning
2	secretary; or (ii)
1	section); and (b)
7	class i device
1	illegitimate productthe term
1	receives and distributes
3	year or a
1	(mg) 0.5 
1	section 12 of
4	eff. june 30,
1	initial classification or
1	period subject to
1	licensed means 
6	title. (june 25,
1	proffered delivery thereof
1	growers, regarding the
5	end of fiscal
1	 4.5. 
1	term color includes
1	clause (a) or
1	lamb and mutton
2	 (i) requests
1	filing of reports
1	sustainabilitythe coalition shall
1	medications.  (b)
7	receive compensation at
4	initial classification of
1	reviewable.  (3)
1	marihuana, or 1,000
1	conditioned on the
1	of, that website:
31	regard to the
1	title 18, to
1	act, approved march
2	food products, of
1	public docket for
1	supply of drugs;
2	part c of
6	term adjustment factor
18	ii of chapter
1	practitioners referred to
1	debarment under subparagraph
1	provision of state
2	new active ingredient,
1	31 days after
2	strategy.  (2)
1	subsequent issuance of
1	(a) contents of
1	appropriations; fiscal year
1	producer from eggs
1	chickens, turkeys, dogs,
1	food received a
2	without the express
1	nations pursuant to
1	treat acute bacterial
3	paragraph (1)(d), the
1	report, or a
2	(i)(cc) is applicable.
1	animal drug), and
1	made with manufacturing
2	aid of any
1	(1) the prohibited
4	controversy as to
4	later than december
2	intending, knowing, or
1	articles (other than
2	resolution  (a)
1	proceeding whether the
2	offenses or acts
1	public,  which
1	shall give manufacturers
1	chapter or to
1	eggs received or
1	products, and (iii)
1	section (or under
1	misbranded and additional
1	labeled poison the
1	summary on the
1	slaughter, unless when
1	drugs in or
1	(d) fee collected
2	intended to increase
1	request as soon
1	purpose of bona
4	report of an
1	-(1,-dimethylheptyl--[(1r,3s--hydroxycyclohexyl-phenol (cp47,497); (ii)
1	elsewhere, of foo-an-mouth
20	30 calendar days
1	secretary shall revoke
1	timely notice of
3	meaning given that
1	abuse inflicts increasing
1	specific countermeasures, populations
1	569c, as added
1	sunscreen order, unless
1	(g) the development
1	(i) the base
1	state may directly
1	practitione-patient relationship. this
4	1-month period beginning
1	product conform to
5	united states authorized
1	including a designated
1	reporting system within
1	(i) a seller
1	subchapter ii authorities;
3	application for registration
1	state law because
1	animals to be
1	respect to human
1	use biosimilar biological
1	(b), when such
22	term does not
1	labeling conforms in
1	section and subject
1	burdensome requirements the
1	(i) records required
2	biological products, including
5	valid license under
2	safety information, including
1	professional practice, or
1	decisionmaking; (ii) plans
2	health protection act
1	questions.at least biannually,
1	defect in such
1	burdens on such
2	manufacturer, as provided
1	subsection (a)(1)(d). (3)
1	chapter is false
1	conditions of safe
1	agreements, as soon
1	category described by
1	portions shall not
1	final judgment that
1	office as basic
1	country maintains a
2	conspires to commit
1	(iii) within 60
1	rehabilitated; or (c)
1	requirements shall 
1	pharmacies, as described
7	[42 u.s.c. 262].
6	[42 u.s.c. 262],
1	slaughtering of sound
1	package, container or
1	(ii)(iv) (through classroom
1	available  (a)
1	congress a national
1	(iii) the owners
2	title), such person
1	vessel, commercial aircraft,
2	may be, may,
2	information accessed, as
1	applicable regulations under
1	shall be standard
1	year, if 
1	regulation establishing the
1	applicable, dispose of
1	device fees (a)
1	amendments, hygiene, packaging,
2	office may provide
1	years. any vacancy
2	enters the united
1	649; 
 

1	backgrounds. the committee
1	statistics for the
5	tobacco product and
1	regulation, harmonize regulatory
1	paragraph on june
1	commonly abused drugs.
1	limitation subsection (a)
11	years and not
1	section 675 of
1	exempted under subparagraph
1	subsequent exportnotwithstanding subsections
1	(13) of such
1	believes to the
1	formulation and performance
3	adjusted base amount
1	1115. notice relating
1	omitted indication or
1	wholesale business of
1	pharmacy to report
1	refuse to accept
6	certification under section
2	distribute, import, or
2	action instituted under
8	entry of such
1	shall describe actions
2	enforcement administration for
1	operating reserves, and
1	context of total
2	territories, are vested
1	petition such court
2	residues at the
1	subsection (j), and
1	quarter) to assure
1	5 years, but
1	thereafter, require a
1	means the fifty
2	attorney general only
6	ecgonine, and derivatives
1	that, as specified
1	section, this section
1	authority whenever the
1	false, or misleading
1	exceed 3 percent
1	issuing such an
1	place, or otherwise
1	iii, such import
1	chapter.  (f)
1	water regulations either
1	food held under
1	distributed, transported, or
1	business; and 
1	care program or
1	subsection, a violation
1	injection; (q) the
2	(a)(ii); and (ii)
1	articles as hereinafter
1	4, 68 stat.
1	reduced establishment fee
1	violent gang crime,
1	data.  (a)purpose.the
2	25 employees; and
1	(2) to authorize
1	distilled spirits, wine,
2	diagnosing, preventing, or
1	211. preservation of
1	president; or (b)
1	(b) no longer
1	effective for efficiently
1	(
 
 453.
1	type than, or
1	whether the violations
1	dried, or desiccated.
2	individual working on
1	to, significant foreign
1	(c) contentsa proposed
2	establishment that 
1	drug have not
1	information on, prevention
1	narcotics traffickers pursuant
1	available and acceptable
1	use of account
1	promptly respond with
1	(c) drug manufacturers
12	shall be accompanied
2	brought in any
1	complete application containing
1	type, and frequency
1	stated on its
2	review of new
1	 (3) flexibility
1	repackaging of drugs
1	 percent cal
1	prior to submitting
3	measuring the levels
1	(d)(5).  (f)
2	revocation order, as
1	commission or other
1	subsection (c), if
1	 (2) definitionsin
1	
 374a. inspections
1	state agency; performance
3	person alleged to
1	form through labeling
1	request requirementsa request
1	contaminants.  (b)
1	section, involving paragraph
1	costs.  (a)authorized
2	audits to certify
1	consensus of the
1	program, similar to
1	develop, test, and
1	(i) or (iii)
3	change to which
1	extended date of
1	beverage containing vegetable
1	drug administration, demonstrate
1	territory of any
1	things, shall set
2	manufacturer may request
1	1357, 2, 32
2	inspectionthe secretary 
1	year 2005 and
1	(including traveltime) during
1	assistance for a
1	(c), or for
1	commerce; and all
1	means such an
1	deliver or delivery
1	contrary to public
2	terrorist activity (as
1	generally available analytical
1	safety requirements; (ii)
4	persons entitled to
1	paragraph (3)(a)); and
1	parts thereof to
1	(iii) recruitment or
1	credentialing bodies. (ii)
1	put; (12) who
2	control is required
3	state agencies to
1	order to correct
1	nonregulated person, and
1	considerationsin making a
2	product by brand
1	first offensea person
1	deems will assist
1	request.  (6)
1	exposure to food
1	committee (or any
1	(1), fees under
1	determining the number
1	title of each
1	membership  (1)
1	subsection (b)(2)(b). if
1	anaphylactic causative agents
1	modified, or left
1	capacity  (1)
1	program; (2) shall
1	
 613. plans
1	warning. (
 

1	adjudicate the validity
1	procedure for establishment
2	review cycles as
1	narcotic and nonnarcotic
1	(v) the determination
1	safe use for
1	individual, or took
1	title; except that
1	submission and the
1	343(h), 343(i)(1), or
1	impose temperature requirements
1	term qualifying practitioner
3	incomplete if the
1	device is represented
1	shall jointly prescribe
5	secretary may remove
1	fine, and the
1	(5) application any
1	entity other than
1	mislead consumers about
1	status of implementation
1	applicable to bottled
1	transfers under section
1	section, to the
2	committed by a
21	available for obligation
1	pack, transport, distribute,
1	include material which
1	section 824(a)(4) of
1	(i) procedure the
2	toward correcting the
1	policies that will
1	based. (mar. 4,
2	reducing the use
2	jurisdiction (except those
1	title ii, 203,
1	expand the capacity
1	pregnant women, in
1	given to detect
1	registration issued in
1	(b) the total
1	suspension of period
1	and, moreover, if
1	percentage change for
17	subsection (b) shall
1	drug. (5) that
1	standard shall specify
1	branch; (7) monitor
2	secretary in writing
1	(b) period of
1	section. this list
1	containing information stating
1	him, permit the
1	sourcing practices of
1	 (2) exceptions
1	pediatric population; or
1	researchers included in
1	renewal and refusal
2	developed in consultation
1	may be, of
1	accrue from the
1	subsection (a) would
1	witnesses, and require
2	2012, and that
1	removal was made
1	may be, or
2	unit, such unit
1	device introduced by
1	endangered children. (b)
1	reasons; (j) the
2	product, when used
1	problems of drug
1	(d)(2)(a).  (june
1	secretary considers appropriate;
3	exemption of a
1	states or such
1	implemented, paragraphs (1)
1	(including limitation to
1	issued after public
1	prospective buyers to
1	chapter, an opportunity
2	registry established by
1	pharmacies repackaging and
2	secretary considers appropriate.
1	determinations, findings, and
1	contain the name
5	refund not later
2	participation of other
1	fertilizer nurse tank
1	plus one or
1	transferred
 
 41
1	risk to united
1	drug paraphernalia, in
1	data from, a
1	investigations or investigations
1	standards of accreditation
1	exemption no carcasses,
1	360a. clinical trial
1	 (3) action
1	private instrumentalities used
1	reviewing the device
1	$50,000,000 by the
6	institutes of health
4	basis and the
1	subsection, no person
1	1, 1992, a
1	chapter; (d) ensuring
1	establish restrictions on
1	inventories. (2) that
1	methamphetamine advisory council.
1	procedures for conducting
1	 (4) actions
1	cream, cows, barns,
1	centers. after such
1	parties, including manufacturers
1	person to provide
11	putrid, or decomposed
1	sale including expenses
4	shall conform, as
1	aircraft, vehicles, or
1	application has not
11	united states obligations
1	change in product
1	regarding current good
2	list has determined
42	review of the
1	compounding, or dispensing
1	(f) through (i)
1	limitation on approval
1	submissions submitted, the
1	clause (ii), an
1	 (xi) an
1	cases may be
1	evading or avoiding,
1	verification, aggregation, and
1	(7) for any
1	products on commission,
2	enters judgment reflecting
1	resident who enters
1	grants subject to
1	within such 9-,
1	salts, isomers or
1	will utilize controls
1	notice to governor
1	upon a test,
3	administrator may issue
1	(1); notice of
1	establish an office
2	qualified adul-only facility.
2	2009, and annually
1	(a) eligibility determinations
1	development program; (4)
2	inspection system under
13	(b) does not
1	shall issue if
3	generate the total
1	appropriate, and shall
1	articles.  (2)
1	operated in connection
1	commerce and to
1	subsection (b) no
1	information becomes available.
1	measuring procedures and
1	certain products upon
1	consumers are made;
1	food be accompanied
5	(b) for any
8	name, address, and
1	types of foods
1	device was not
6	shall also be
1	toward laboratory accreditation
1	ingredient, nuclide generator,
1	employee whole, including
3	amount for such
1	fulfill those requirements
1	similar, serious risks;
1	term compounding does
1	sponsor submit copies
5	level, including the
1	(b) transfers of
2	title 8) or
1	annually to evaluate
2	across the food
1	basis of 
1	information may consist
1	stakeholders, including representatives
1	drug product, production
2	signed at vienna,
1	products is a
1	section 360c(a)(1) of
1	(g) information submitted
1	summary of such
2	secretary about such
2	100 miles from
1	appropriate agency meetings
1	violation of injunction
2	veterinarian within the
2	able to identify
1	chemicals used in
1	subsection (d)(1)(b) or
1	section 333(b) of
1	71 et seq.);
1	research, as employees
1	manufacturer  (a)
1	675, 505b, as
1	alleging such discharge
1	amended july 31,
1	requirements; (b) include
1	use; (v) requests
1	period, clause (i)
1	by, and subject
1	will be put;
1	dies, plates, stones,
1	prohibition the knowing
1	(ii) the best
1	year. (14) notwithstanding
1	call on experts
1	proceedings should be
1	violation or violations,
1	products, their constituents
1	temporary and permanent
1	(2) exclusiona civil
1	compete (36 u.s.c.
1	reduction is in
1	title 7 if
14	exceed the amount
1	352(c), and 362(c)
1	i, 2, as
1	adult consumer per
1	thereof.  (e)
1	apply and a
1	youth; (7) to
1	approval or refusal
1	(
 
 1713.
1	ch. 1357, 1,
1	congressional record; (2)
5	section 5304(e) of
1	animal feed but
1	shall commence such
1	products interstate and
1	reduced under subsection
1	measurable reduction in
2	foreign asset control
1	 (b) recommendations
1	(iii) a sale,
1	709, as added
1	administrator in accordance
1	states the intention
2	et seq.); (d)
1	secretary, shall state
1	ingredient shall be
1	existing authorities to
1	furnish the manufacturer
1	(h).  (b)
10	revenue amounts established
1	request to an
1	inform parents and
1	agents, or which
1	(a) labeling receptacles
1	requirement only if
1	presents less risk
1	renumbered 9 and
1	 (5) recordkeeping
1	outweighs the risk
1	secretary may decline
1	sampling a line
1	seller places the
1	vouchers under paragraph
1	buying contractor to
1	foundation maintains status
1	68 stat. 1239;
1	regulations to establish
1	states in lorillard
1	title, or otherwise,
1	development plan; (b)
1	special registration for
2	provided in a
1	proposed federal intramural
5	feesbeginning in fiscal
2	dispense, or sell
1	0.5  
1	30, 2016, for
1	consumer to accurately
1	entitled guide to
1	360bbb8. consultation with
2	specified in regulations
1	period of maintenance
1	regarding, with respect
1	agents; or (d)
1	following.  (

1	current briefings and
1	shall have extensive
6	conditions for the
6	section 552(b) of
1	(h) relationship to
6	suspension of a
2	adjusted for inflation.
1	april 20 of
1	5 percent to
1	workforce needs at
2	title 15 and
1	(e) facility for
3	use of, or
1	agency centers involved
1	 (iii) financial
1	(8) investigational submission
2	drug after the
1	particular food or
1	offenses involving controlled
2	subsection (h), and
1	device. (d) the
1	product and make
2	title. (4) 
1	field of information
1	improve the technical
2	performance of certain
1	(a) sunscreen active
1	treatment; and 
1	generalin the case
2	rol-you-own tobacco. 
1	basis, that part
1	goals; termination of
5	index for october
2	promotion of technical
1	distant from the
1	director certifies in
4	(a) suspect product
1	data or information;
4	article was wholesome
1	shall, for each
2	stat. 685.)
 

5	agency action on
1	chemical, poison, or
2	limited to use
1	determining the identity
2	show that a
3	data or information,
2	drug application describing
1	reserves. to the
1	advertisement and provides
1	collected under section
1	
 23. penalties
1	evaluated, including plant,
1	proceedings, except that
1	(a) registration 
1	advertisement advisory review
2	animals in the
1	sold a reportable
8	animal drug are
1	staffing needs. 
1	conditions and unmet
1	(5) a new
1	(5) any requirement
2	laws containing authorities
1	dispensing to or
1	pursues coordinated and
4	entitled to access,
1	approved application of
1	weighted votes to
1	know with the
1	fiscal year 1986.
1	specified by any
1	$240,000,000 for fiscal
1	means a thir-party
1	foo-producing animal use,
2	part from carcasses,
1	day during which
2	necessary to comply
2	history and severity
7	illness or injury
1	communities with a
1	formulation was developed,
1	(b)(ii)(ii), the secretary
7	approved application or
2	 (d) inspection
2	2008, not later
2	suspension of sentence;
1	information, and recommendations
1	patient. the secretary
2	variance is not
6	person acting on
1	omitted
 
 360bbb0.
1	subsection (b) when
1	emergency useit is
1	certain individuals and
1	manufacturing, compounding, processing,
1	year, a fine
6	shall file in
1	identify public health
1	valid permit from
4	(d) refund of
1	drug, or cosmetic,
1	order may obtain
2	inherent risk of
2	designate any such
1	produced, or grown,
6	(e) representatives of
1	form any information
1	methods for improving
10	days from the
1	abuse potential if,
2	year after june
1	published.  (ii)
1	1997; and (f)
3	subsection (b), (c),
1	paragraphs (g), (h),
1	consumers; (viii) such
1	officers in the
1	conditional approval 
2	order to identify
3	date shall be
2	paying the costs
1	facility or vehicle,
1	introduce, or to
4	secretary shall, to
1	one year. 
2	that, of the
1	based on notifications
1	manufacturer; or (b)
2	confidential access, and
1	unreasonable risk and
1	states; and (bb)
8	thereof, meat or
2	anticipated present and
1	combination of gases
1	order, and section
1	reductions granted by
1	administration of section
1	coordination of activities,
1	relative to previous
1	validity of data
1	measured in milligrams
1	retrospective review of
1	
 
 379d4.
2	numerical identifier, that
1	year 2008 unless
1	
 1544. compensation
1	duplication upon request
2	sought would, in
1	flock of not
1	sponsor shall include
1	may think necessary
1	devices manufactured with
1	(g) suspension authority
4	(including a clinical
1	processes, pathologic processes,
1	(b)(1) or (c)
3	respect to premises,
2	payment all fees
2	control of drug
2	services.  (c)
2	court shall order
1	(d); and (bb)
1	analysis system. 
1	forfeiture proceedings the
2	(3) upon request,
2	said carcasses or
1	level information only.
1	department duly authorized
1	paragraph (1), extended
1	made, kept, or
1	certain organizations funds
1	concerning the reasons
1	reasonable manner, controlled
1	occurs the second
1	standards whenever any
1	country apparent temporary
1	26 to a
1	time as he
1	five hundred thousand;
1	(l) authorization of
1	sums as congress
8	paper or electronic
2	months, and to
1	subsection (c) shall,
1	distribute, and promote
2	will not result
1	flexibility by 
1	discontinue the registration
1	(34) the term
1	revocation of designation
1	companies, and international
1	appears to be,
2	provide, equip, and
1	diverted for response
5	352 of title
2	applications (adjusted for
1	(a) a review
1	importer the term
1	960(b)(1)[1] of this
1	 (iii) notice
1	director under subparagraph
5	shall hold discussions
2	listed drug are
1	(2) is deemed,
5	public health, and
1	fraternal organizations. (ix)
1	recalled human foods
1	person, while an
1	feed shall maintain
2	number and date
6	attendance and testimony
1	paragraph (1)(b); and
1	demonstrates that proceeding
2	substantial further manufacturing.
3	pesticide chemical which
1	individual; or (b)
1	international narcotics control.
1	uses, and (2)
1	causes the internet
2	filed a petition
1	include a biological
3	product identifier for
2	committee, whichever occurs
1	solely engaged in
1	final regulation published
2	state establishment shall
2	likeness of any
4	shall approve such
1	purity characteristics, which
1	indian tribe arising
2	(c) such person
1	conditional approval, approve
2	distribution in commerce;
1	(ii) regulation of
1	
 
 360qq.
1	manufacturer provides evidence
1	resources relating to
1	period; he may
1	deemed qualified by
2	330 of title
18	response to a
1	360l. postmarket surveillance
1	section be sold
1	committed in the
1	(3) repackagefor the
1	approval; bioequivalence; filing
1	similar activity of
1	action, or omission
3	as, necessary in
1	420.)
 
 1201
1	title; (3) shall
2	subsection (c), or
1	identification that results
1	distribution, and possession,
1	u.s.c. 1921 et
1	situations involving, in
7	conducted at a
1	discussion regarding whether
5	wholesale distributor and
1	 (e) definitionsin
4	information leading to
5	 (1) initial
1	time of importation
1	eliminated. if the
1	false nor misleading.
1	(a) through representation
1	progress made by
2	full list of
1	effective pursuant to
1	generalit shall be
1	supplier of a
1	experiencethe term serious
1	matter shall review
3	years 2008 through
1	346 regulations affecting
1	water of ammonia,
1	arrested has committed
1	applicable to cigarettes
2	promotion of drugs
1	
 
 198a
1	 (b) manufacture
1	food; (ii) records
2	(b) list of
1	(20) shall, within
2	governmental unit, such
1	files that have
1	3, 44 stat.
1	section 387a1(a) of
1	initial classification under
3	prohibited drug activity
1	(a) controlled substances
1	years; and any
1	stock of any
1	transaction involving product.
4	justification that the
1	governmental affairs and
3	construed to prohibit
1	products may be
1	processing requests under
1	clearinghouse administered by
1	resolution of such
1	administrator determines are
2	 (3) drug
1	(1) to supplant
1	term advertisement does
1	warrant. if property
1	islands.  (b)
1	conditions in subsection
10	reasonable probability that
3	shall not use
2	federal government employees
3	impedes, intimidates, or
2	(b) to furnish
1	implement the policies,
1	 (2) goalsthe
1	workload adjustmentsubject to
1	boobytrap defined 
1	controversy or the
2	provision of information
2	made from that
1	condemnation proceeding, his
1	offered for transport
2	hold, and confirm
1	exemption that is
2	(i) the information
1	days, is necessary,
1	product manufacturers, and
2	clinical hold) if
1	video production of
1	may distribute any
1	facility certified under
1	requested, not later
2	random sampling and
1	produced in the
1	united states officials
5	individuals who are
1	administered by or
1	subsection (a))[1] and
3	proper expenses shall
1	1701 et seq.)
2	event reporting for
1	occupant, or mortgagee,
1	registrationnotwithstanding any other
4	tobacco product for
1	(b)(2)(a) during the
1	furnishing such information
1	may find necessary
1	deadline, whichever occurs
37	finds that the
2	title, as added
1	(3) label disclosure
1	year 2017; and
1	staff resources available
1	revoke any or
1	(y) the terms
1	tribal organization is
1	(b) provide sufficient
2	stat. 832833) (commonly
1	distributed intrastate. (6)
67	accordance with this
1	law, or business;
2	(a)(ii).  (ii)
1	generals determination. 
1	legitimate purposes regarding
2	disposed of in
2	touching the matter
2	expiration of 1
14	product is an
3	expiration of 3
2	point of entry
1	expiration of 5
1	paragraph (1); (ii)
1	trainingthe secretary shall
4	trading partners. 
1	1; (ii) the
1	working in the
1	transfer between pharmacies
3	felony under any
1	provider to provide
13	dosage form, or
1	sponsor with a
1	(1)(b), the director
2	extent the secretary
2	territory, in such
1	secretary permits the
1	raw materials, conditions
2	stating reasonable grounds
1	(c) protection of
1	licensed veterinarian.. a
2	basic principles of
1	abuse. (9) the
1	substance with the
1	214), from the
1	committed to illicit
1	(c) before september
3	subsection (a) shall,
1	(including with regard
1	assessment; (f) information
2	detailing the basis
1	42 will be
1	title 28 for
1	appropriate standards prescribed
1	sentence had been
1	products, which, after
2	subclause (iii). 
1	includes all information
1	award of an
3	made prior to
1	pineapple, vanilla, coconut,
3	assure that allowing
2	administrator determines to
1	dispensed.  (iv)
1	paragraph (3); (c)
1	order. (b) additional
1	maintain property ordered
2	drug differ from
2	subchapter and the
1	use when the
2	clause is a
1	control strategy; (c)
1	national security, work
1	manufacturing partner program
1	part.  (g)
1	obtains a sample
1	age groups a
1	action, the validity
2	acting in consultation
1	person has provided
1	ingredients, and properties.
1	provider from collecting
3	available, in such
1	secretary or person
2	(2) in developing
1	dismiss on discovery
2	facilitate an effective
1	27, 2013. (3)
1	distributor (as the
1	facilities that constitutes
1	(e) prepare summaries
5	review of premarket
2	produced during that
1	local authority (a)
1	abuse.  (b)
1	(i) provide adequate
1	make recommendations with
1	unforeseen adverse events
1	veterans health administration
1	grocers for public
2	1182(a)(3)(b) of title
1	authorizes the dispensing
2	facilities, inventory, operations,
2	approved drug product
4	(c) a full
1	residue on a
8	 (b) content
1	practice pharmacy, including
2	fees authorized for
1	parameters of an
1	wholesaler; and (b)
1	investigations it can
1	component, any part,
1	(i) make a
1	year 1998 and
1	dentist (or any
1	may waive or
3	assessments under this
4	conformity with applicable
1	schedules shall initially
1	plans to engage
1	printed sticker or
1	implementing such elements;
1	(e) eligibility for
1	conduct such inspections;
1	standards of approval
2	law, rule, regulation,
1	exceeding the amount
1	treatments for agents
1	chapter and with
1	9, 2012, shall
1	specified in subclauses
3	requirement imposed on
2	degree, and states
2	scheduled for inspection
1	(c) partial term
1	facility may or
1	chapter. (o) the
7	exported from the
1	powdered milk, or
2	person, $250,000 for
1	allergies and anaphylactic
1	final regulation (which
1	(b) is accompanied
1	safety, recommend to
5	minutes of all
1	12 miles of
2	format of the
1	clearance, and recovery
4	congressional declaration of
1	containers may be
1	bulk of on-half
1	642. recordkeeping requirements
1	event reported to
1	(3) any explicit
1	clearly identified and
1	 (vi) does
1	products otherwise prepared
1	patrol hours took
2	carcass, of any
1	consider the report
1	cultural context most
1	regulation consistent with
1	term single convention
2	proposed or final
1	compliance solely because
1	require, as the
1	advertisement.  (b)
1	devices that represent
2	abuse in such
1	manufacturing practice set
1	section 350f(a)(1) of
2	volume of each
1	handling, keeping, transporting,
1	result in collection
1	prescription drug. (g)
1	installation, maintenance, operation,
1	drug. such person
1	affairs and the
1	drug product, including
1	18.  (5)
1	classification panels 
1	(a) shall, during
5	secretary, after providing
1	combination, and (f)
1	regulation that is
1	diversions, (e) preventing
1	condition, including 
1	authority either to
1	general shall give
1	(2) the notice
2	recruitment and other
1	 (a) suspend
1	payments to any
1	shall discuss possible
2	$2,604,000 for fiscal
1	appropriate (including in
1	practicable, a plan
1	limited market or
2	issue raised by
3	23 of this
1	action is required
6	default of such
1	committee on womens
6	potential for abuse
1	(1) assistance authorized
1	notice shall announce
1	application seeks conditional
1	records of controlled
1	1943, ch. 221,
1	qualifying laboratory the
1	sel-certificationthe attorney general
1	(1) programs the
7	man or other
1	enactment) and according
2	authorization of that
1	single application or
1	
 16. introduction
1	practices, and procedures
1	official, manufacturer, or
1	directions, membership, and
5	assessment of a
1	function, despite diligent
1	authorization shall in
1	violation.  (2)
1	perception; (e) require
3	handling, or distributing
1	payment penalty assessed,
1	(3) cigarettethe term
1	title 5to affirm
2	delivers a controlled
1	secretary.  (e)
1	act of 1954,
1	acts. there shall
1	sufficient to facilitate
1	applicable to recalls
1	transmission to that
2	829 of this
1	(
 
 957.
1	time of sale.
1	254.)
 
 695.
1	registered in the
1	standard through publication
1	act, the label,
1	means a practitioner
1	supplemental application the
2	inventories; copies; samplesthe
1	dies while lawfully
1	directors (a) appointment
2	(2) fee amount
1	reports to foundation
1	substances for use
1	promulgated; (ii) afford
1	inspectors to examine
1	signals of serious
1	tolerance and withdrawal
2	regulation.  (june
1	(e). regulations and
1	met and reasons
1	analyzing the hazards
1	issued or as
1	him.  (c)
1	drug marketing violations
1	petition (inclusive of
1	suspension a grantee
1	(b) random sampling
1	emergency response laboratory
1	meals for sales
2	upon notice by
2	dates during which
1	surveys or performance
1	may provide periodic
1	application and introduced
1	limitations identified pursuant
1	members appointed pursuant
1	user fees assessed
7	full statement of
1	supplier, and periodically
2	action plan for
1	competent jurisdiction. (2)
2	establishment for sale
1	necessity or desirability;
1	youth in the
1	675, 517a, as
1	shall be returned.
1	secretary with federal
2	order shall expire
3	commission or the
1	sanitary manner. no
1	agriculture, shall within
3	operations of any
1	human body. (f)
7	guaranty or undertaking
2	demonstrating that such
1	condemned and, if
2	active ingredient, combination
1	requesting such waiver.
1	listed chemical intending,
1	4439644615 (august 28,
1	receives the notice
1	uses any mark,
1	 (4) notice
3	(i) to be
1	intended for application
34	 (b) the
1	may include recommendations
1	methyl alcohol, paregoric,
1	foreign facility is
1	lawful order of
2	(b) waiver of
1	(
 
 862.
1	grant recipient the
1	investigations by experts
1	policy nothing in
6	made with respect
1	public comment, that
20	amount equal to
2	advisory committees. 
1	used. (2) such
2	local authority the
2	risk or exposure
1	3, 42 stat.
1	use by another
1	providing services or
1	77 percent of
1	timeline to compile
4	apply, the secretary
1	(c) is eliminated
1	 (o) the
1	proceeding that was
1	information available from
12	holder of such
1	title that a
1	(c) other relevant
1	review in promulgating
1	provide for interactive
1	(j) effective date
1	establishment registered with
2	provisions as though
1	foodborne illness that
1	assessment that meets
1	qualified medical, regulatory,
1	concerning adverse event
5	validity of any
1	(v) the program
1	
 1001 to
1	setting ris-based inspectional
6	employs more than
1	881(d) of this
1	funded and what
1	section and intended
2	(5) limit the
10	shall not relieve
1	professional designation, and
1	abuse, and to
2	official senior to
1	viride, or any
4	cumulative amount appropriated
2	june 1, 1992.
1	 (d) notwithstanding
4	petition or application
1	immediately suspend or
1	271(e)(2)(a) of title
1	number of employees
1	proposed rule making
10	changes to this
1	prescription issued by
1	(ii) measurable metrics
2	conditions.  (b)
1	withdraw the food
2	establish that a
1	additional time necessary,
1	programs on controlled
1	title describing the
1	subparagraph (g). (i)review
2	individual appointed under
1	355(j), or section
1	food shipment for
1	quantity dispensed in
1	chapter, any information
1	inspection standards and
1	manufacture, cast, print,
1	testing as described
1	drugs,[2] safety signals
1	changes being made,
1	feasible and appropriate
1	studies reveal that
4	person to knowingly
4	importer program under
1	forms, and other
1	(e) recovery of
1	term pending request
1	exclusiona civil action
4	title to be
1	(11) mescaline. (12)
1	including a renewal
3	transferred to a
2	date, or the
9	district courts of
1	(a) are 
1	13, 1931, as
1	section 458 of
1	whether the lot
1	shall publish, on
2	remains listed, upon
1	states may receive
1	process: provided, however,
1	eyebrow dyes. (b)
1	device completed or
1	applicable, the state
10	members of his
1	(e) be scal-appropriate
1	accept an inspection
1	established, the secretary
2	state program under
1	party involved under
1	administered will be
2	significantly minimized or
5	studies) with respect
2	may be authorized
1	fundsan eligible entity
1	drug violations; (ii)
1	food which the
1	task force takes
1	clause, notwithstanding any
1	(a)(1) or (b)(2)(a)
1	(a) application for
1	(c) misrepresentation of
1	section shall authorize
1	clearance for adults.
1	ingredient per unit,
1	secretary received the
1	salt of a
2	hospital or clinic
1	appropriate; (ii) ensure
2	patent (or a
1	facility. (b) condition
1	boards of pharmacythe
1	proof of ownership
1	certify, compliance[1] with
1	ch. 675, 804,
1	42; or 
1	retail outlet, if
1	gift, or donation
1	supplement, or periodic
1	thereof, shall after
1	affected thereby. (

2	destruction of a
1	(b) evaluation of
1	interchangeable with a
2	production facility is
1	verify, such records.
3	cast, print, lithograph,
2	(i) the sponsor
1	withdrawn prior to
1	supplement, or cosmetic)
1	years is present
1	secretary promulgates the
1	 (b) affirmation
2	section does or
1	obtained for more
1	making a manufacturing
1	section during the
1	manufacturers to assist
2	section 350e of
1	results of, and
2	said cattle, sheep,
1	june 1, 2010,
1	 (3) disclosures
1	rulemaking; (4) the
1	data collection activities;
1	section and revocation
3	(ii) disposition the
1	application no state
1	section 351(a)(3), section
2	order is based.
27	included in the
1	employees detailed from
11	may present its
1	intentional contamination at
1	(i) it (i)
1	manufacturers  (1)
1	offenses involving listed
1	exempt drugs for
1	indication means an
1	condition for marketing
1	program is to
6	secretary the secretary
1	name of united
1	suspend or withdraw
1	title, to premarket
1	title) is in
1	security, as follows:
2	drug product using
1	2012, if both
1	legislation as he
1	drug control agencies,
1	comment.  (3)
1	identifiable pattern of
1	paragraph (6)(a) revoking
3	section 247d of
1	u.s. city average),
2	 (a) apply
1	charge a report
1	distribution. if the
1	vacancies any subsequent
2	plans for eligible
1	list, if any,
1	illness originating from
1	1 shall be
1	2012, and the
1	(2) as a
1	food imported by
1	waivers granted; and
1	prohibit, during the
1	 (2) chairman
1	constitute a crime,
1	officer of any
1	measures can be
1	safety of processes
1	agriculture to regulate
1	required to verify
1	tank, freight container,
7	goals referred to
2	drug applications (including
4	secretary on such
2	include information respecting
2	(l) or (m),
3	(d); and (2)
1	ch. 675, 744b,
2	cooperate on an
1	(c) coordination of
1	section 518d(c) of
1	and[4]  (b)
1	pediatric populations; or
1	import without submission
1	points according to
1	casual or periodic
1	distributor to criminal
1	corporation from the
10	committee established under
1	equivalent defined 
1	chapter and standards
1	violation as offense
5	corresponds to the
3	states within the
2	secretary within such
1	said secretary shall,
1	roughened bottle, of
1	scientist, shall 
1	market); and (ii)
1	(2) or subsection
1	employees within the
1	access the information
1	without reimbursement from
1	rodenticide act; and
1	establishment not later
1	(pcp); (v) 10
1	intelligence program and
1	title 7. (e)
1	material fact and
5	intentionally  (1)
2	whether specific objectives
1	et seq.] which
1	individual after the
1	successful and what
1	rapidly detect the
2	entity within the
2	(2) the information
1	document in a
7	reports  (1)
1	regulated transaction in
1	manufacturer) specified in
1	compounding that are
1	regulated transaction if
1	publication of annual
2	drug treatment activities
1	marketed products adequately
1	(d) manufacturers of
1	congressional committees, a
1	documenting the monitoring
3	phone number of
1	compounding, processing, packing,
20	may enter into
1	regulated seller shall
1	attorneys fee, not
1	(xvi) of paragraph
1	valid certificate of
1	civil penalty pursuant
1	title, unless it
1	equivalence determinations. in
1	will not assure
2	matters that relate
1	positions, are members
1	whether prescription drugs,
1	sufficient space to
1	 (1) one
1	bequest of real
3	conduct research with
1	sampling methodologies 
2	affiliates shall demonstrate
1	rules of constructionthe
1	experts, qualified by
1	(b) regulations not
1	taking any form
1	establish safety and
1	make any report,
1	number, (iii) the
1	test all advertisements
3	subsection which refers
1	order made prior
16	sunscreen active ingredient
1	testing records), make
1	ris-based inspectional priorities,
1	(d) above shall
1	be, and (2)
1	hearing and a
1	associations if the
1	petition for tolerance
1	 (c) exceptionsthe
1	committee may hold
1	particular; he shall
1	purpose specified, and,
1	(c) a decision
1	product as may
1	recordkeeping requirements. 
6	section 823(f) of
1	(1) through (4),
1	may disclose the
1	 (i) period
4	notification is no
1	(1) select the
1	assistancethe secretary may
2	distributed to any
1	section a biologic
1	extension activities of
1	subsection); (b) is
2	shall, after independent
1	preparations put up
1	nonprofit food safety
1	measure incorporated into
2	compliance with clauses
2	finds that (1)
2	section have been
1	device is imported
1	following: the article;
2	considering the report
1	appropriations, for each
1	health system or
1	petition, notification, or
7	promulgate regulations for
3	director, holder, or
4	product fee 
1	may participate; (ii)
1	substantial equivalence determinations.
2	new product may
4	carryover user fees
1	regulatory policy. 
2	5.0  
1	waives an opportunity
1	general may delegate
1	(ii) 3 shall
1	(i) an approval
1	costs expended by
1	title 42), including
1	first such public
1	involved shall, on
1	understanding that provides
1	(
 
 1543.
2	knowingly or recklessly
2	notice thereof to
1	licensed for such
1	affiliate of a
1	omitted
 
 1177.
2	(b) petition for
1	public safety 
1	802(54)(e) of this
2	promulgated pursuant to
1	physically separate area
2	congress that the
1	(6)) that the
1	strategy shall transmit
2	written and oral
1	crime and drug
1	 (13) package
1	territory providing for
3	 (b) prescription
1	submitted the preceding
1	documents and other
1	standards, and shall
1	states through an
1	means a meeting,
1	misuse of the
1	biannually and shall
2	transaction history, as
2	steroids  (1)
1	participating state, local,
1	food was determined
1	(a) opium, opiates,
1	set aside such
5	use for such
2	 (1) ensure
1	receives appropriate access
1	qualified employee has
2	acceptance for filing
1	biannually, the secretary
9	secret or confidential
5	ii or class
3	written request issued
1	rough, or a
1	organizations referred to
1	border of the
1	unless the recipient
1	conduct, or completion
1	required to have,
1	abuse among young
1	(1) contentsan application
1	marking, labeling or
2	coverage of existing
1	minor species indication.
1	prioritize the food
1	proof shall be
1	injury which involves
2	partly or wholly
1	minor species indication;
2	definitions as used
4	(b), is approved
1	transaction information; and
1	plan shall not
2	panels. no individual
1	directly thereon in
3	2007.  (b)
1	prepared for use
1	present adequate evidence
1	sufficiently complete, and
1	food establishment complies
1	toxicity or potential
1	tobacc-related disease or
1	estimated by the
2	action in response
1	training techniques, and
1	applicant; (b) provide
2	lieu of subsistence)
1	seizures; and (iii)
9	lieu of subsistence,
1	nonreimbursable basis, such
1	placed under the
2	subsection (g), to
1	samoa, wake island,
1	people to, unnecessary
1	timeframe.  (b)
1	informed by the
2	(d) limitation on
1	tariff laws of
1	secretary has interpreted
1	statement; (ii) prior
1	shape.  (d)
1	shall be publicly
1	immediate recipients, other
8	if, after providing
1	combination, or preparation
1	6151 of title
1	orders under section
1	drug administration do
1	one package is
1	(3) the food
1	another appropriate reason
1	consideration of any
1	legible form, on
1	(5) recruit meeting
1	applicable federal standard.
1	is, under subsection
1	subject to sections
1	28.  (d)
1	articles, which is
1	areas; and (d)
1	raw material for
1	commission any officer
1	675, 518a, as
1	respect to less
1	title. (mar. 3,
7	lieu of the
1	 (i) based
5	(i) with the
1	produce an appropriate
1	dispensed each month.
1	675, 573, as
3	title and to
1	attorney to include
2	give notice to
1	evaluation, funding in
3	fiscal year. (c)
2	confirm such determination
1	institution of criminal
1	commerce any egg
1	rulemaking authority. (b)
1	found on packaging
1	advertising. (b) action
2	methods at the
1	(f) as follows:
1	condemnation, exclusion of
10	product by the
1	uniformity for nonprescription
1	licensure each online
1	file (or have
7	section 360c(f)(2) of
1	approval in conducting
1	requirements for regulatory
1	owners of which
1	enrolled in, or
1	subsection (a)(2), respectively.
1	time, upon his
3	secretary for advisory
1	wide range of
6	annual rate of
1	product. (3) effect
1	(2) to obtain
1	include discussion of
2	data disclosed to
1	requirement, which may
2	(4), and (5)
1	specifiedthe objectives specified
1	present the views
4	[25 u.s.c. 5301
1	provides the information
2	available in hard
1	less than $50,
3	shall convene a
1	may 13, 2002,
1	director shall request
1	1059; 
 

1	established by regulation
2	medical gas or
1	increasing awareness of
1	1531(a) of this
1	state law as
1	implementation by health
1	reviewing applications or
1	(3) total fee
1	content the guidance
1	(d) analysis of
1	care practitioner to
1	report on a
1	(2) bulk drug
1	workshops with the
1	validated biomarkers, intermediate
1	(
 
 671.
1	poultry before it
1	participate in a
1	certification: i certify
2	styles and sizes
2	another person has
1	state offense involving
1	conduct regular screenings
1	(b) additional data,
1	benefit to the
3	foundation or with
2	approaches such as
2	education and research
1	including racial subgroups
3	(a)(3) (relating to
1	repackager makes the
9	requirements at least
2	distributors of electronic
1	subsection (g), except
1	processing facilities applicable;
1	tolerance; or (ii)
1	pharmacology, pharmacoeconomics, biological
1	25 micrograms of
1	repackaging the drug
1	coalition institute. 
1	(a)(1). such fees
1	supported in fiscal
2	boned, cut up,
1	products brokers, wholesalers
1	360hh. definitionsas used
1	drugs every person,
1	relating to intelligence
1	article as appropriate.
1	investigation and related
1	designated by a
1	accomplish the goals
1	(iii) the date
1	applicable to man);
1	potentially counterfeit, diverted,
1	product, promptly assign
2	year under section
1	using such products
3	calendar days before
2	adequate pediatric labeling
1	-(2,-dimethox--ethylphenyl)ethanamine (2ce). (21)
1	change. if the
1	appropriate; (c) facilitate,
1	type of ownership
1	2003, an animal
1	lon-term health effects
1	funds appropriated to
1	less than $500
1	(2ch). (27) -(2,-dimethox--nitr-phenyl)ethanamine
1	articles have entered
1	drugs listed under
1	include the summary
2	included therein in
1	secretary may regulate
1	amount that, under
1	effects; and the
2	take effect, except
1	exercise supervision or
2	corporation or upon
1	expanding or making
1	external stakeholders and
1	plan and purchase
1	prohibited by section
1	(e) the attorney
1	packed according to
1	food the secretary
1	(c) exceptions in
1	public health shall,
3	 (3) additional
1	center the chief
1	shall issue contaminan-specific
1	physical hazards, including
1	exemption or regulationa
1	chemical solely because
1	person processing or
1	respect misleading to
1	regarding how the
1	also maintain and
1	production quotas; revised
1	2014, the fees
3	both. whoever kills
1	committees the advisory
24	secretary determines to
1	(g) representation as
1	360d, or 360e
2	title 5 (relating
2	eighty days from
2	complied fully with
1	(a) between the
1	additional deficiency identified
1	chemicals.  (i)
1	require, make periodic
1	world evidence. 
1	(h) information submitted
1	order disapproves the
1	plan can be
1	exceptions; presumption in
1	(19) the term
1	toxicological and epidemiological
1	exportation for subsequent
1	entity  (i)
2	granted an exemption
1	refused admission unless
1	section until the
1	(a) shall, except
1	protocol to the
1	
 
 399g.
1	sizes, including small
5	generalthe secretary of
1	(i) encouraging all
3	application.  (3)
3	(d); or (b)
6	advocacy groups; and
1	(
 
 904.
1	guidance regarding action
1	described in subclauses
1	may, by proclamation,
1	match advertising provided
1	specific purposes 
1	food.  (e)
1	person requesting waiver.
1	1401(4) of such
18	first business day
1	potential barriers to
1	safety information; serious
2	(2) prohibited establishmentsin
1	 (aa) does
1	potential, he shall
2	sector, including both
1	paragraph (2), for
7	actions described in
1	studies and surveillance.
1	387k. modified risk
1	processing and ingredient
1	cocaine, or not
1	measurement system, that
1	milk proteins, and
2	relating to public
1	mean a request
3	parties to the
1	subsection, the director
1	201),[2] together with,
1	appeal the holder
1	pertinent reviews for
1	translational therapeutics, and
1	president has publicly
1	implead a biomaterials
1	retailer from distributing
1	promoting individual health
1	studies and are
4	filed, the secretary
2	title 31. (e)
6	(7) if it
1	administration inspectors of
2	respecting such other
2	labeled with the
1	personnel when the
6	devices, tobacco products,
1	information, including changes
1	action. (2) each
1	species. (3) if
1	found that any
1	devices are safe
2	379i or 379j
1	paragraph (1)(b). (l)
1	therapy under this
3	federal government for
2	registrant to appear
1	child with a
1	receives the supplemental
1	bond is executed
1	term request for
2	action under state
2	drug other than
2	prevention of the
2	medical device user
1	(1) will improve
1	1, 1992. (m)
1	ch. 675, 503a,
1	(c) meetingthe secretary
1	drug has expired.
1	packaged. lack of
1	2 years, review
1	security that does
1	cure, treat, mitigate,
1	conference  (1)
1	regulations) requires an
1	experience based on
1	(k) exception for
1	listed drug identified
1	advertisement reviewed by
1	chemical involved, and
1	council; and (b)
1	identifiable office to
1	discovered by him
2	marihuana; or (h)
1	distribution for such
1	qualified acceptance as
1	chain at specific
1	staff, information, and
1	help advance the
2	year. (d) fee
1	implant; or (2)
1	food used by
1	(4) any foreign
1	licensing such wholesale
2	order to implement
1	school board, or
2	section to maintain
1	(c) special rules
1	stabilizing, cooling, freezing,
2	otherwise listed on
1	panels.  (6)
1	(e) protective orders
1	(
 
 1902.
1	senate a document
1	drug; (f) a
6	days for the
1	may determine by
1	products broker, renderer,
1	provide such report
10	adverse drug experience
1	 (3) shall
1	subsection (c)(1) may
4	purpose of providing
2	establishments, requirements at
1	take action with
1	significant updates to
1	request, after receiving
1	(e) not later
1	conducted under clause
1	work in conjunction
1	pharmacies or a
1	written.  (b)
5	manufacturer or sponsor
1	processing as defined
1	744b, as added
1	animal science. 
1	secretary has probable
1	title may use
1	department or agencies
1	nominations received from
1	food for special
1	disclaimers with respect
1	title i, 15,
1	appointment and oversight
1	 (d) foreign
1	traffic and effective
2	order becoming final,
1	requirementsa drug approved
2	frequency and history
1	effectiveness. if the
1	title iii, 538,
1	decreasing doses to
2	selling, freezing, storing,
3	(ii), the secretary
1	693. inspection of
1	control activities the
3	(a) set forth
2	animal drugs used
1	clause (iv), beginning
1	title which enforces
2	use in research,
1	effective and not
1	remedy, described in
1	application; (ii) an
1	 the 18-day
1	subsection, if the
1	industry organizations, and
3	abuse in the
1	forth under subparagraphs
1	general beginning no
6	regardless of whether
1	 (2) notification
1	dispensation of controlled
1	schedule i was
1	preserved by such
1	drug traffickers and
1	engage in a
1	departments in the
1	(ii) packed, received,
7	distribute, or dispense
1	enhanced requirements beginning
1	states from furnishing
2	(2) any felony,
1	compilation not later
1	progress has been
1	(d) the slaughtering
1	issuance by the
1	roles and considerations;
1	production methods and
1	determine appropriate. 
2	product a repackager
1	whose position is
1	authority regarding annual
1	strike paragraphs (a),
1	drug application from
1	funds the food
1	(e).[1] the foundation
1	investigation) are sufficient
19	application was approved,
1	 (a) stating
1	person from importing
1	occurs with respect
4	moved by any
1	identified and neither
1	ethnic minorities. in
16	subject to forfeiture
1	essential to provide
4	application was approved;
1	(n) any other
1	needs of motorists.truck
1	project lead for
1	product or made
2	offense will not
2	paragraph (2) are
1	grades for apples
2	tribes (as defined
2	report that identifies
1	director shall appoint
1	shall establish rules
1	disease under section
2	sentence is imposed
2	recommendation respecting the
1	
 360eee3. national
1	sharing of knowledge
1	subsection for each
1	restraining orders or
1	director shall, to
1	advertising; and (e)
1	pronouncement of sentence.
2	animal food manufacturer,
1	nitrous oxide, analgesia.
1	(a) maintain for
5	award a grant
1	establish suitable controls
1	involving fruits and
7	device with respect
2	order entered under
1	person, all advisory
1	review of countermeasures;
10	fee revenues for
1	(9) lysergic acid
1	379d2. policy on
2	training (including necessary
4	information in a
1	classes or groups
1	28, 1976 (hereinafter
1	tobacco growers. 
1	respect to legally
1	(ii) create all
1	amounts collected by
1	(c)(4)(b), provided that
1	posted. (
 

2	(1) during any
1	contact with bodily
1	subject to certain
1	mitigate microorganisms (including
1	medical associations and
1	detail the status
1	safety. a failure
4	licenses as may
5	subparagraph (b) and
1	submit the article
2	regulations, or policies
2	shall modify the
1	2013, a facility
1	members, with a
1	advise him with
1	chapter for packaging
3	violations of, this
1	(b) such amounts
1	food packed in
1	design of such
1	chemical to be
1	(h) an annual
2	859, 860, or
1	volumes of food
1	fees are set
4	subparagraph (b), if
4	chapter, other than
1	considerations in promulgating
1	seq.], shall be
1	register by the
1	supply chain by
1	360ii. program of
2	3-day notice, request
1	(b) when added
2	may be, and
1	changes.  (c)
1	(i), (j), and
1	upon the proposed
1	remedy provided under
1	treasury in developing
1	pharmacologically related substance,
1	means a point,
3	knowingly make any
3	subparagraph (b). (b)
1	may prescribe different
1	move to dismiss
1	completing the study
2	psychotropic substances shall
1	confidential treatment under
1	requests denied under
4	partners of a
1	shall order a
1	(2) shall (a)
5	2013, not later
1	regular basis as
1	et seq.]. (v)
3	(d) if it
1	following information to
1	standard organization.[1] 
1	establishment of programthe
2	notice to direct
1	services administration, the
1	qualified employee is
1	may lawfully hold,
1	information); and (2)
1	volume, as appropriate;
1	filed in connection
1	legally treated food
2	human food; denaturation
2	action or actions
2	certification of color
1	drugs, or conditions.
1	materially assisting in,
1	(iii) the retention
2	general welfare of
2	inspection of poultry
1	except the person
1	schedules; findings requiredexcept
1	fairly respond to
2	listed drug (as
1	applicant. (june 25,
1	year 2010; (14)
10	section an amount
1	 (4) exception
1	614. repealed. 

4	drug. (2) the
1	(2) such article
3	date  (i)
1	otherwise been made
1	take effect in
1	(1) evaluating existing
1	agriculture to establish
1	sustained use of
3	review to encourage
1	requirements for market
1	sales, in united
1	person listed in
1	audit process, for
1	residue.  (2)
2	distribution, manufacture, exportation,
1	intends that, consistent
1	federal governmental entity
1	intrastate. (6) federal
2	civil penalty which
1	(d) other appropriate
1	obtain patents for
1	coalition have worked
1	submitted, pending, or
1	database, which 
1	person, which such
1	year for any
1	imposed on cigars,
1	raw tobacco or
1	title) shall not
1	(1) expedite the
1	pertaining to a
1	title; second violation;
3	secretary relating to
1	title until approved
1	notifications submitted under
1	agencythe term national
1	trafficking problem in
1	proffered delivery was
1	(d) the animal
1	ch. 675, 509,
41	secretary of homeland
1	reliable law enforcement
1	hig-risk foods on
1	responsible person submit
4	form unless it
1	practice as a
1	plaintiff in enforcement
1	643. registration of
2	general by the
1	elements under subclauses
1	(2) shall include
1	powder, when sold
1	3 and 10
2	may be filed
1	administrator shall establish
2	general rule 
2	lack of the
8	controlled substance. 
1	report, make such
1	(1) identifying publicly
1	deemed approval. 
1	household of the
1	records; contents each
1	certain drugs, devices,
1	congressional committees describing
1	hold animal feeds
5	section 554 of
1	poultry product from
12	deleterious substance which
1	379j22 of this
1	states complaint on
1	administered an animal
2	secretary whenever the
1	(
 
 387b.
1	(5) enter into
2	467a of this
5	chemical in violation
2	(ii) otherwise be
1	federal employees 
1	finding that inspection
1	consumption within such
1	subsection (a)(1)(b) whenever
1	secretarynot later than
4	may be intentionally
3	make a request
1	petition before the
1	standards as outlined
1	metabolism or a
1	administration. (c) for
1	350a(f) of this
3	fee setting; adjustments
1	final regulation 
1	bidding procedures. 
1	notice; and 
8	accredited under paragraph
2	monograph system pursuant
1	
 
 337a.
1	extent feasible and
1	may request, after
1	pasteurize means the
1	23 and amended
1	review and consider
1	time, the data
1	property and director
1	(f) technical assistance
2	consideration whether the
1	adequate time for
1	15 days prior
2	coalition serving economically
1	(mephedrone). (19) 3,-methylenedioxypyrovalerone
1	subsequent country from
1	administrator, or any
1	date, and any
1	commission. if a
1	avoid, reduce, or
1	mental, or emotional
2	term importer means
1	(d) the bulk
45	days of the
2	pharmaceutical drug master
1	programs. (i) unique
1	title 5. (i)
1	ingredients shall be
1	u.s.c. 5001 et
2	libel of information;
2	 (c) performance
1	title to manufacture,
1	investigate violations under
3	shall give the
1	assess the information
1	approved without elements
5	1, 5, eff.
1	government to recognize
1	person designated to
1	(9) etorphine. (10)
3	(d) or (e)
1	toxins, pesticides, drug
3	response to an
2	accuracy of the
1	secretary. (c) patient
1	(13) dextrorphan. (14)
1	activities as defined
6	counterfeit, simulated, forged,
1	2003 through 2007.
1	seq.] an investigation
1	prescribe.  (mar.
1	pay or otherwise.
1	agencies and ensures
1	(iii) necessitates medical
1	collected by abbreviated
2	coordination of programs
1	(ii) is determined
2	contact surface (other
1	
 379dd. establishment
4	specific chemical designation:
1	panel makes recommendations
1	using biomarkers, for
1	repackager, labeler, relabeler,
1	formerly 1st par.,
1	file number; (b)
1	owned, managed, or
1	frameworknot later than
17	attorney general may,
1	samples analyzed were
1	(i)agreement to give
1	paragraph (4) by
1	 (a) risks
1	merits of each
1	truthful and accurate
3	assess potential safety
1	(v) available information
1	ability to appraise
1	segregate, and reinspect
1	identify adverse events
1	clause (i); or
1	grase determination means,
4	licensed pharmacist or
4	1 kilogram or
1	disclosure on the
1	10), the filled
1	quarterly assessment imposed
3	upon the record
1	delegated.  (e)
2	qualified under subsection
1	form (including a
1	transactions in foreign
1	scientific evidence or
1	microorganisms (a) purpose;
1	applications and the
1	subsection has streamlined
1	bulk vehicle, render
1	controlled substance means
3	listed on the
1	feasible, be obtained
1	administrator resulting from
1	representing interest at
1	expertise in new
1	(3) limit the
1	penalties as apply
1	secretary, to provide
1	 (c) misrepresentation
4	(a). the secretary
1	agency that there
1	material and is
3	modify or otherwise
1	organizations, as described
2	activities of facilities
1	1181. contract authority
1	(ii) provide that
1	food when determining
1	
 356c1. annual
1	information of such
1	protection agency prescribes
3	(iv) a persistent
1	otherwise by the
1	initial grants under
1	manufacturing use only.
1	drug; controlled substance;
1	(c) i have
1	qualified laboratory; (2)
2	possible if a
1	article, until the
5	staff of the
4	poultry product inspection
1	675, 571, as
1	comptroller general, institute
2	suspended, or modified
1	program because no
1	 (2) make
1	evidence that will
1	prepared for meat
2	secretary a proposed
1	tobacc-related disease. 
1	direct the manufacturer
2	state agency, shall
5	360c(e) of this
1	lawfully partially filled,
1	medical products for
2	4 months during
1	natural toxins, pesticides,
1	fund substance abuse
1	means a sealed
1	wherever the defendant
1	(r) temporary tolerance
1	protocols, and have
1	target animal observations
1	narcotic treatment program;
1	harm the national
6	poultry products which
1	repackager and the
1	address promising technologies,
1	 (3) remedy
2	personnel of a
1	comply with practices
2	united states swine
2	(2) any employee
1	advertising to be
1	plan for using
1	(b), any activity
2	initial regulations promulgated
1	comment and to
2	surveillance period of
1	prepare and protect
1	establishments to rely
5	fees under section
7	investigating a suspect
1	investigation, or research
262	shall not be
1	state may conduct
1	conducted. (iv) if
1	thing which is
1	sunscreen order, in
1	title 36; and
1	local officials, as
1	antibiotic drugs meet
1	approved application notice
1	matter expertise and
1	affecting the characteristic
3	drug application has
1	discussions under subparagraph
1	section 282(j) of
1	notice. as a
2	followed in practice
1	assessment regarding other
9	product subject to
2	results of testing
1	food products referenced
2	(2) have not
1	sale immediately after
1	453(g)(8) of this
2	(b) except that,
1	305, 52 stat.
1	action.  (f)
1	opium derivatives, their
1	practitioner licensed to
1	issues for devices
2	action or a
3	drugs under section
1	paragraph) make a
1	whether that information
1	chapter or act.
1	compelled under the
2	animal drugs under
2	commodity, a pesticide
2	establishing the effective
2	evidence.  (e)
1	product labeling; and
1	review and constructionno
3	committee any individual
1	use only; or
1	training center (hereinafter
1	complaint systems, and
1	respecting drug samples.
6	agreement with the
1	examinations made under
4	332 of this
1	based, insure care
1	drug shortages occurring
1	partial fillsa prescription
1	available, publish on
10	request by the
1	
 
 1503
3	produce of the
1	related to soil
1	person shall violate
1	require.  (h)
1	party under section
5	regulatory limit on
1	methods used; (vi)
1	nutrient requirements 
1	(e) applicability to
1	statutory timeframes; (3)
1	(42 u.s.c. 262(i)).
2	psychotropic substances, or
1	drugs removed from
1	(a)(1) that is
1	field in which
1	 (c) dismissal
3	section 379g(11) of
2	organizations.  (2)
1	establishment and such
1	certification and determines
1	indian shall be
1	 (4) basis
5	application not later
1	fee amount calculation
1	shortage of adequate
1	unexpected adverse experience
1	spirits, wine, malt
1	(h) judicial review
1	apply.  (d)
1	ingredient in dosage
1	plans for considering
3	biological product has
2	time during an
1	manufacturers that submitted
1	administrator shall, in
2	certification or assurance
1	means. such documents
1	application. (b) in
1	responsibility vested in
3	private entities and
1	public from meat
1	eligible entityin this
1	preparations sold in
2	devices in the
5	development and implementation
3	individuals to whom
1	adulteration; or (ii)
1	nurse, teacher, and
3	including the standards
1	required; (iii) a
1	available to an
1	imposed and collected
1	ii devices to
1	law of planting,
1	rules on the
1	soil or plant
2	day before august
1	chemicals in the
1	employees and committees
2	use in more
2	consultative and regulatory
1	abuse, trafficking, and
1	5 years following
1	comments submitted on
1	issue, specific to
1	secretary for any
1	analysis of current
1	youth. (ii) parents.
1	drug enforcement resources
2	using dispute resolution
1	extent possible, no
1	manner of packaging
1	regulations prescribing the
5	means the official
1	knowing at the
2	drug administration. the
1	costs of 
1	small amount of
1	necessary regarding use
2	nervous system of
1	concerning the responsibilities
1	apples shall be
1	regulatory agencies, the
1	 (i) removes
2	three members shall
1	term listed drug
1	preclinical studies. 
1	singl-use device shall
1	analogue means a
1	active ingredient, and
1	request of packer;
3	political subdivision thereof
1	loss to that
1	(b)(2) are adjusted
1	nervous system or
1	records inspection under
1	services or training
1	states. any such
3	(b) or (c).
1	infant formulas made
1	made, the request
1	hazards to public
1	interdiction strategy and
1	therapies (a) in
1	authorize the extension
1	secretary shall reevaluate
2	linked to that
6	revised recommendations under
1	withdrawal period contained
2	statements of the
1	including categorization of
2	petition, the court
1	reasonable time. if
2	index  (1)
1	highly controversial issues,
1	legitimate uses, and
1	(2) rural coalition
1	interim guidance for
1	person be convicted
1	
 
 605.
1	judge, may, within
1	ingredient is the
1	(b) outreach to
1	2005, or parts
1	analysis of samples
3	harmful than one
1	court action the
1	manufacturing use only;
1	laboratory networks, as
1	(a) may have
1	 (75 g)c
10	secretary in the
1	(4), or (5),
1	coverageno person may
1	national intelligence, and
13	tribal law enforcement
1	agencies, or by
2	stolen; (b) is
1	subsection or any
1	governmental agencies with
2	previously approved under
3	system that shall
1	date. (o) definitionsfor
1	mandatory performance standards
1	seq.] involving methamphetamine;
1	addiction and rehabilitation
4	pay an initial
1	policy upon which
1	produce a finished
1	(b) permissive debarment;
2	treating, or preventing
1	states, by assessing
1	product is used
2	section 393a of
1	improve event consequence
1	request)  (aa)
1	(ii) every 30
1	title; but when
2	(5) the number
1	drug, referred to
1	(3) clinical outcome
2	misdemeanor under federal
1	product is attended
1	alcohol abuse and
1	(1) persons who
11	hearing to the
1	tribal governments; 
1	topics shall be
1	460. miscellaneous activities
1	syringe exchange programs
1	2017. (12) no
3	whose device is
1	person shall import
2	respect to microbiological
1	30 days, is
1	accommodates scientific advances
1	
 
 379j12.
2	report or other
1	
 1176. repealed.
4	designation of state
1	(1) certification the
7	statement of a
1	period. no other
1	triggering mechanisms, sharpened
1	states; (2) the
1	construction paragraph (1)
1	register or letter
1	shall establish offices
1	may be carried
1	ammonia removed from
1	oncology, pulmonology, cardiology,
1	disability or legal
1	determines that food
1	505, 52 stat.
11	determine that the
1	qualificationsan accredited person
2	testing begins, except
1	 (i) conform
1	(ii) such standard
1	name if it
2	shall apply the
1	unable to assure
1	elects, within 120
3	dispensers with 25
2	prescription drug advertising.
1	conduct the inspection
1	proposed rule, that
1	general any individual
1	secretary to exist
1	food is prevented
1	law to be
1	omits any other
1	require postapproval studies
1	(c) is required
2	firm, or corporation;
1	(2) antibiotic drugs
1	(
 
 2205.
1	675, 917, as
1	primarily for use
1	-(2,-dimethoxyphenyl)ethanamine (2ch). (27)
2	manufacturer to conduct
1	agriculture shall establish
1	otherwise on account
1	purchaser signs the
1	evaluation of each
1	subsection (b)(1) in
1	semblance of milk,
1	voluntary submissions of
1	prepare and make
1	mineral; (c) an
1	(a) based on
1	specific testing requirement
1	(31) the term
7	product of a
1	heroin. (2) the
2	secretary at such
1	tolerance for use
3	effectiveness for the
1	organization. the notice
1	relabel a device;
1	data; (b) information
1	transportation, and other
3	air and maritime
1	identifying particular subpopulations,
1	notificationin conducting a
2	section 353(b)(4) of
1	secretary;  (c)
1	(1) review guidance
1	within 1 year.
1	sources of information
1	
 
 860.
1	withdrawal, or modification
12	made to the
1	application or license,
1	 (3) applicability
2	(c)(2) (in the
4	quantity of an
1	decrees of the
1	acts regardless of
2	following opiates, including
1	trafficking area are
2	360e(f) of this
3	obligated by the
1	describing the type
2	(including any of
1	secretary may grant.
6	cause of action
1	feed is shipped
1	subsequent offensea person
1	designation of name
1	percent today. (c)
1	trials.  (3)
1	consultations with stakeholders
1	problems and a
1	standard of review
3	information will be
1	application, which contains
1	subsection (a)[2] have
7	standard recognized under
1	prevent such diversions,
1	part. (2) a
1	conduct the premarket
1	criteria established under
6	standard for a
1	9.5 percent of
2	require a prospective
1	board under clause
1	federal strategy that
1	(i) upon determining
9	travel expenses, including
4	misbranded under the
2	homeland security 
1	demonstrate, to the
1	promotional descriptive printed
1	report that meets
1	toolthe term drug
2	head of that
1	6, 1996) an
1	intervening, to be
2	criteria for such
6	ecgonine or their
1	purchase price of
2	poultry or processing
18	drugs or devices
1	court finds there
1	fees under subsections
2	include data on
2	generic drug industry.
2	generic drug industry,
1	disciplinary action for
1	assistance division to
1	provider means a
1	obtain devices for
1	dangerous drugswhenever the
1	concerning traffic in
2	supplementing the application
1	food, including its
1	mission and strategiesthe
1	internal human tissue;
1	export from that
1	identifiers under this
1	
 379j62. authority
1	387t. labeling, recordkeeping,
2	apples contained therein
2	certification from the
1	predoctoral and postdoctoral
1	prevention activities. such
1	may enter a
1	federal government, the
1	(v) the distribution
1	five members, as
1	approval was obtained,
1	agency center involved
11	tobacco product shall
1	 (c) excess
1	(d) is designed
4	section 360eee2 of
1	primarily affect individuals
1	(and such officers
1	(6) annual report
2	biologic product licensed
1	beginning no earlier
1	42. (b) such
1	enjoin violations of
1	purposes of allocations
2	drugs or device.
1	congress. (3) no
2	federally funded drug
1	claims notwithstanding section
1	panel, shall include
1	sheep, swine or
1	mai-order distributors that
4	individual shall be
14	failure to comply
1	development meeting. (ii)
1	reasonable cause found;
1	production of food.
1	(5) too little
1	fined the reasonable
19	years of the
2	administration shall use
1	withheld from use
1	effect of final
1	(b) elected officialsif
2	human food solely
1	partnership agreements, as
1	(f).  (f)
1	fiscal control and
1	products and certain
1	(vi) the physician
1	appropriate, specimens of
2	information or records;
1	residue, if a
1	54.0.  essential
1	inspect, within reasonable
1	establishment that could
1	confidential source, including
2	material required to
2	program.  (

1	results, certifications relating
1	110 of title
1	consul defined the
2	report preceding introduction
1	title 47 shall
1	(i); (ii) 30
1	permit analysis of
11	toxin, or analogous
1	
 
 387r.
1	medication guide; patient
2	552 or 552a
1	(4) by developing
1	u.s. 525 (2001));
6	applies to the
1	subsection (b)(1)(b), as
1	services; (2) whenever
1	treated as provided
1	penalty of $250,000
1	schedule v which
2	manufacturer is an
2	applicant shall support
8	expertise in the
1	premises in which
2	agriculture may prescribe
3	granted by the
1	seq.]. this will
1	section. (4) if
1	dispenser; (m) the
5	(1) and any
1	unless its labeling
1	dietary supplement marketed
1	coalitions in sparsely
1	(d) unless the
1	pedigree, or a
1	raw state, or
1	departments of agriculture
2	dissolvable tobacco products
1	2007.  (3)
1	specificationsa biomaterials supplier
1	actions if a
2	makes a reasonable
1	(ii) recognized in
1	relief standard relief
1	training directly to
1	available drug product
1	 (1) rule
2	clinical and administrative
1	1994 and thereafter
1	discontinuance that person
1	returned within ten
2	determine  (i)
2	may subject the
1	actual abuse, diversion
1	new therapies derived
1	cosmetic product development,
1	 (f) failure
1	human services 
1	administration including 
1	drug (directly or
1	 (1) acetylmethadol.
2	grant if the
1	formula which is
28	promulgated by the
1	sponsor voluntarily requests
17	paragraph (1) is
1	packaging requirementsno person
4	provided to such
1	judgment issued by
8	paragraph (1) in
1	1521 note); and
1	every license to
1	subparagraph (b) 
2	individuals for appointment
1	violation were a
3	month of december
1	health, and that
12	paragraph (1) if
1	emergency prescription. (j)
1	columbia, or sell
1	may use unobligated
1	criteria not later
2	director may expend
1	number of drug
7	september 1, 1992,
1	title, then such
1	determining the circumstances
1	transferees) of electronic
1	improvement, and provide
2	contains the following
2	 (1) publication
1	wholesale distribution if
1	abbreviated drug applications,
1	(a) stating (i)
2	abbreviated drug applications.
1	received 2 years
77	service act [42
1	thereof that the
11	u.s.c. 801 et
1	certification, or licenseexcept
1	safety. (
 

2	including the specific
1	standards for pet
1	general physical inventory
1	violating any provision
1	fruit juice, a
1	114d2 to 114d6.
1	disregard of the
2	office of international
1	research and study,
2	made with a
1	petition for purposes
1	imprisonment not exceeding
1	practice; (x) specify
1	states, or substantial
1	due care, would
1	chapter; or (b)
1	  sodium
1	inspection service activities
1	(4) to remove,
1	approved.  (7)
1	automation of food
1	(a), or such
1	tobacco dependence; and
2	(including records, files,
1	notification. if the
1	3 years. in
1	drugs makes a
1	subsequent submission for
1	international trafficking in,
1	title 18. (l)
1	obtain from an
11	means an entity
1	development, the issuance
1	standard setting and
1	studies pursuant to
15	known to the
1	radiation, which study
1	developed; (g) the
1	drugs, clearly indicate
2	pesticide residue level
1	(ii) holds open
2	title; or 
1	use the tobacco
1	title 18, which
2	house of congress
1	field investigation as
1	dispersed); or (ii)
1	intends to transfer
1	granting exemption under
5	action under subsection
1	shipments of each
3	(1) twice the
1	design modification of
1	awarding of grants
7	meet the standards
2	amend a final
1	pending requests to
1	
 399c. improving
1	time.  (5)
1	(1) investigate, regulate,
4	establishment in which
1	technology systems as
1	centers with diverse
1	allowed expenses of
1	reviewed and shows
1	 (3) may
2	common mechanism of
4	section 352(o) of
10	development and review
1	counterfeit drug, (c)
2	additional time as
1	 (b) regular
1	due date any
1	classification or such
2	names of such
1	include recommendations for
1	(a) complying with
1	legal issues, pediatric
4	entering the united
1	water. (b) in
4	deemed adulterated or
1	occurs infrequently and
2	information in connection
1	manufacturing facilities, and
1	agencies; (4) procure
2	general shall, after
1	shall conduct periodic
1	recipient to the
1	ingredient or ingredients,
1	required unless 
2	considered unsafe within
1	persons on the
1	organizations, and academic
1	day period. (iii)
3	necessary to eliminate
1	section 379j41(3) of
1	forth the final
2	treat the disease
1	country.  (june
1	dispense such drugs
1	existing plansthe strategy
2	development program fee
4	foregoing provisions of
1	talk to their
1	states. upon application
2	furnishing to the
2	modified risk products
7	show whether or
2	may 29, 1928,
1	hospital pharmacy, a
3	requirements related to
1	requires accredited thir-party
13	date that the
1	name, or trade
1	will not exceed
1	cheese, or any
4	person resides, by
2	civil penalty, or
2	facility, including any
1	remain valid as
1	use of particular
2	costs  (1)
1	 (a) deliver,
1	waive its rights
1	42; (ii) establish
6	notified of the
3	clause (iv), the
1	vha during medical
1	(i) 100 grams
3	may sell, purchase,
1	representation that the
1	will address the
2	offers for import
1	internal committee the
2	slaughter, unless such
1	 (e) prohibited
5	methods of assay
1	panels activities, including
1	businesses; and (v)
4	reflect changes in
1	(a) the registrant
1	knowingly participates in
1	ingredient requirements (or
1	transportation records a
1	 (c) nonreceival
3	efficacy studies are
1	675, 809, as
1	(c) secretarial response
1	(2)(b) shall not
1	manufacturer under subsection
1	u.s.c. 6501 et
2	food or animal
1	(i) indicating when
1	study. nothing in
3	 (b) complete
1	potency, and efficacy
1	(c) was not
1	transported, or held
1	human and pet
1	report to a
2	public, may prescribe:
2	condemned it shall,
1	campaign activities, except
1	quality system requirements
1	scientific publication that
1	title 42, for
1	(6) fentanyl. (7)
1	request; (ii) the
1	1927 [21 u.s.c.
1	biotechnology companies, and
1	raw material means
1	effective for its
1	investigation and determine
1	international standards organization
4	written request of
1	hold under section
6	will be consistent
1	generalbeginning on september
1	committee, and the
1	internal review of
1	formula because of
1	description of projects
2	propose or facilitate
1	(1) a tol-free
1	(i) is constructed
4	packages shall be
2	3 years, nor
2	state agency. 
1	elements  (i)
10	subsection (c) or
1	united states demonstrates
1	(g), except the
1	documenting the training
2	substance or mixture
1	applicable a standard
2	reasonable basis for
1	adequately to dru-related
1	subsection (b), whenever
4	(1) every person
1	quality, and grade;
1	shall within 60
1	 (a) anthranilic
1	(7) generic new
1	punishment (a) violations;
3	time when the
1	financial interest the
1	(cc) signing a
2	state programs having
1	proceedings in name
1	falsely labeled dairy
1	implement the working
1	label under paragraph
1	$5,000 for each
2	taxing authority shall
2	logistics provider for
1	searchable database, which
1	public evidentiary hearing,
1	numerical values which
1	(e) for purposes
1	(2) and provided
1	development; (3) mediation
1	treatment, the practitioner
2	556 of title
1	section 353(d) of
23	death to humans
2	possessed, used, transported,
1	(a) acetic anhydride.
2	subsection (a) by
1	u.s.c. 360ccc1], with
33	suggested in the
1	qualifying pathogen, as
1	conformity with performance
1	director shall, after
1	account both the
1	may be left
1	such, when plainly
20	years from the
3	local jurisdiction may
1	requestor initiates such
2	(a) redactions for
4	individual or $5,000,000
1	use or abuse
3	et seq.]; or
1	issuance of other
9	142 of this
1	ice cream. the
2	stock or employee
2	inspect outsourcing facilities
1	status in determining
1	community service; or
1	(3); and (ii)
1	manufacture or unlawful
2	manufacturerthe term manufacturer
1	storage, inventory, shipment,
1	dispensing, of controlled
1	formula, (c) assurances
2	first begins to
1	registration); (b) writing
1	indian provision nothing
1	both, except that
1	requested under subparagraph
2	conditions (a) request
3	user fee required
1	lovibond tintometer scale
1	uses the provisions
1	account (1) in
1	appropriate for verification
1	serious risk; safety
1	foreign state or
1	act is done
1	(7 u.s.c. 2281
2	share of each
2	section.  (l)
5	(i) if an
1	prevention and of
1	committee act that
1	clinical need, by
1	executive board may
3	subject to criminal
4	agreed to by
1	secretary shall first
1	one year beginning
1	(ii) complete payment
1	lawfully carrying out
3	research, teaching, or
2	production that is
1	that, notwithstanding any
1	initial compliance period
1	shall promulgate the
1	business adjustment factorthe
1	result in disproportionately
1	(a) such consultation
1	requirements for indexing
4	received or expect
1	prevent distribution of
1	efforts. (j) maintenance
1	activities required under
1	effectiveness of modified
1	may set by
1	inspector appointed under
1	secretary may stay
1	paragraph (1)(b), or
1	illicit marketing, the
1	use in food)
2	devices, and tobacco
1	use in food,
1	section 387d or
1	section 374 inspections
1	(21) -(2,-dimethox--methylphenyl)ethanamine (2cd).
1	term implant means
1	102, 206, 207,
1	shall knowingly sell
1	(ii) aerial and
1	(2) requirementsto reduce
1	dependence liability. (8)
1	regulations, including regulations
1	payment penalties, or
5	reasonable probability of
1	
 
 387o.
1	poultry, whether intended
1	1962, and at
1	134 to 135b.
1	defendant is found
2	(ii) appropriate conditions
1	clinical trials required
1	person will 
2	donations from public
1	period, no person
1	(1) emergency uses
1	criteria standard, in
1	chapter regarding intelligence
1	cholera. (f) dengue/dengue
1	cash or in
1	issued to a
1	practicable, to an
1	act. (3) authorizations
1	valid as long
1	program agencies; (6)
1	issue a declaration
3	education assistance act
1	official certificates of
1	purpose of treating
1	practices encouraged the
1	inquiries regarding such
2	substance or substances.
1	drug (with each
24	principal place of
2	data required to
1	pediatric study or
1	(b) judicial review
1	relationship that exists
1	substance or substances;
1	among all sectors
1	387d, 387e, 387f,
1	meals at a
1	total voting members
1	product presents a
1	
 
 360aa.
1	requiredexcept where control
1	recall such article.
2	court jurisdiction of
1	recall such article,
2	therefor, and requesting
1	human services. (june
1	specified date the
6	drug application, or
1	assessment results are
4	third party logistics
1	effective controls over
1	refusal, including why
6	conspicuousness (as compared
1	applicable, an approval
5	form of a
1	device from device
1	manufacturing expenses means
2	implement systems or
1	2007, that the
1	manufacture, distribute, sell,
3	federal funds appropriated
1	387d, 387h(c), or
1	13-day review period
12	(2) with respect
2	paragraph (1)(a), (1)(b),
1	in, interstate commerce
1	illegitimacy a manufacturer
1	fiscal year 2019,
1	intended for parenteral
2	fiscal year 2019.
1	drugs (a) unsafe
6	appropriate district court
1	(n) if 
1	derogating the authorities
1	identify the supply
1	appropriate to inform
1	405, 52 stat.
1	whether an article
1	(q) certifications concerning
4	sale in the
1	clinical benefit of
1	unless they comply
1	schools.  (4)
1	commerce, the manufacturer
3	subparagraph (c) shall
1	testing to a
171	provisions of this
1	withdrawn after filing
1	duties and powers
2	products to a
1	detailed findings of
1	receipt. after the
1	medical relationship means
1	occur.  (c)
2	part 330 of
1	i, or any
1	required of a
1	now included or
1	sold through the
1	manufacturer, as described
1	device substantially equivalent
1	equines, or preparing,
1	consecutive tests. (2)
1	criteria for microorganisms
1	determine whether debarment
1	whichever terminates the
1	regulation, except that
3	upon the acquiring,
1	telemedicine, within the
3	impairs the authority
4	shall be reduced
2	crime drug enforcement
1	made demonstrable progress
1	times the yearly
2	(iv) a description
13	act [15 u.s.c.
1	permitting the tobacco
1	education program staff,
1	used for dyeing
2	section 20 of
1	period (1) the
1	seeking elected office,
2	drugs which the
1	14. repealed. june
2	policies, goals, objectives,
1	(2) places, including
1	purpose of any
1	seafood, consistent with
1	available to treat;
1	thereof to determine
1	food and, if
2	section 351(i) of
1	section, trial shall,
1	(1) through (8).
2	subsections (d) and
1	containing any depressant
1	acting director if
1	business information, including
3	information.  (b)
16	shall provide to
1	established specifications and
2	report containing the
1	united states attorneya
1	for. (mar. 4,
3	holding, and use
1	(c); (ii) develop
1	distributed requires the
1	(a) in generalfacilities
4	document described in
1	food to such
32	susceptibility test interpretive
2	demand reduction, supply
1	related color additives)
3	collected under subpart
2	fact: provided, that,
1	(b) an indian
1	 (a) owners
1	final decision immediately
4	(ii) the average
2	toward expediting the
1	receive any salary,
1	following inspections, examinations,
1	orders which have
1	guilty to such
2	derives profits or
1	reasonably believes, or
3	(c) during the
2	product application upon
18	pseudoephedrine, or phenylpropanolamine
1	regular customer on
1	(i)confidentiality and privacy
1	patients.  (c)
1	intended use are
1	applicability, enforcement, etc.;
1	secretary set forth
3	base amount applicable
3	comments, the secretary
2	product, or to
1	statement, in a
1	determine the matter
1	president or director
3	 for the
1	(b) strength, quality,
1	pollutes an aquifer,
4	issued, the secretary
1	2011 et seq.];
4	(4).  (4)
1	30, 1977, and
1	instructions, oral or
2	regulations requiring that
1	require the owner
1	identity and no
1	2011 et seq.],
1	specifications and standards.
2	2011 et seq.].
1	assistance would be
1	program.  (f)
1	(g) of subsection
1	v any compound,
1	2005; (9) $90,000,000
1	phenomenon common to
1	products a report
1	payments for the
1	certifies the involvement
2	poultry carcass, or
1	animal feed, appropriate
4	overtime and holiday
1	paragraph (4)(a), as
3	ingested by man
1	(d) aggregated on
1	 (a) compounds
4	chapter as the
1	records of such
2	7.5 grams of
3	purposes of subclause
2	prosecution violations of
2	shall include with
1	recommendation as to
2	sales transaction to
1	alphacetylmathadol.[2]  (4)
4	intended for use,
1	external experts for
2	systems standard referred
3	applicable user fees
1	produces for an
1	articles. no such
1	indirectly reveal the
2	racemic drug; and
1	refuse any entry
1	356e. drug shortage
2	requires a report
1	illness attributed to
1	requesting the submission
1	section against any
1	reactivation fee the
1	title 5, on
1	(aa) completed not
1	hallucinogenic substances, or
2	support center for
2	consolidation of reports
1	heroin; (b) 500
1	seizure up to
1	investigations. the memorandum
1	said can, pot,
1	exist for the
1	manufacturers, processors, or
1	covered applicationthe term
92	determines that the
1	
 
 379j62.
2	capacity the services
1	bear the cost
1	corporate sponsorship and
1	section 5, 13,
1	device establishment pursuant
1	meaningful disruption 
1	form appropriate for
1	will be the
1	substantive review of
2	quota for the
1	overall impact of
1	deadlines in subsection
2	inspect, at reasonable
2	brought a civil
1	term grant recipient
1	may employ any
1	senior managers of
1	contract as a
1	applicable in such
1	(ii); and (ii)
1	public hearing; basis
17	2012, the secretary
1	state recalling a
1	chocolate, cherry, or
2	supplemental rules for
1	preceding sentence, if
1	revise the tobacco
1	secretary assesses fees
22	established under paragraph
1	addressed.  (d)
2	development of designated
1	packaging egg products.
1	(i) any food
1	smuggling of controlled
1	dispenser requirements 
1	believe is adulterated
1	approval), the date
1	safety and with
2	compound, derivative, or
2	titled regulations restricting
1	condemnation, such articles
1	countries in which
1	(1) opium and
1	individual in any
1	sponsor, if the
1	product includes circumstances
17	reasons for such
1	entry or inspection,
2	shall be referred
1	regulation, as set
1	may know with
2	-year period or
1	controlled substances provider.
1	meeting approval requirements
1	local requirements respecting
1	proceeding, (b) before
1	study. the report
1	carton, or container
2	attention to minimizing
1	devices, the panels,
1	food from specific
1	eliminate cros-contact of
1	success of federal
1	744k, as added
3	 (3) preservation
3	upon request, unless
1	process, update such
1	following persons, provided
2	fails to complete
5	illegitimate product 
4	 (i) ensure
1	individuals, and (b)
4	appear better or
1	pay the initial
1	section 843(f) of
1	953, or 957
1	title (in such
1	premarket application means
1	location that access
1	studies and labeling
1	reporting system for
1	fee[1] established under
1	including limited medical
1	shall direct that
1	evaluating training and
1	supplement his diet
1	order or such
1	application, (6) is
1	bodies and the
1	television channel for
5	without the written
1	shall, when advised
1	requests advisory comments
7	orally or in
1	(b) feedback from
2	(1).  (b)
1	fee pursuant to
2	(c) and giving
1	exceed 5 percent
3	segregation, and reinspection
1	use, nor to
2	make and enforce
1	took ownership of
3	hereby found that
1	jurisdiction in proceedings
1	distribution by him
1	year; and (f)
3	unapproved product or
1	risks from food,
1	public health, which
1	jurisdiction authorized by
1	chain to implement
7	(a) a drug
1	subsection (h) that
1	title, and its
1	carries out one
1	prescription drug wholesale
1	mitigating vulnerabilities of
1	within noncontiguous areas
1	additional or dissenting
2	establishments will be
1	intended for inclusion
1	 (d) factors
1	assistance and agreementswith
2	court may, in
1	pharmacies and telemedicine
1	rules for certain
1	drugs, cosmetics, devices,
1	entire backlog of
3	processing or packaging
3	provide that a
4	may be taken
3	impact on the
1	revised labeling of
5	filed on or
1	(d) is for
1	(popularly known as
1	dru-free state within
2	drugs and a
6	360ccc1 of this
1	person aggrieved by
1	disapproves the supplemental
1	emerging from the
1	(b) review not
1	hiring and placement
1	(5) knowingly obstructed
1	dosage form; (ii)
1	
 677. other
2	exclusive jurisdiction of
1	applications or submissions
1	patient need the
1	(a) repeated dissemination
1	interest in any
1	prescription; (c) is
1	drug use. 
1	studies or studies
1	dissemination and, to
1	(a) right of
1	provide assistance on
1	low or similar
11	raw materials or
1	personnel training for
1	section) if, based
1	amount of 3.6
2	ingredient described in
1	distribute, at least
1	complainant, and the
1	exercise of the
1	determining when a
1	administrator grants an
1	apportion the penalty
2	relating to syringe
1	analogs, if the
1	premarket notification. within
1	secretary may inform
1	enhance the quality
2	state as one
2	without cause to
1	(1) biomaterials supplier
1	notification requirements has
2	receipt for the
14	caused or contributed
5	subsection as the
2	egg products that
5	entry for the
2	(3) except as
1	discussions and negotiations
1	life); and (iii)
1	drug product application.
1	offense involved, (b)
1	listed chemical. the
1	focus the comprehensive
1	fairly evaluated, including
1	restrict a retailer
1	vessel on which
1	 (ii) impact
1	writing whether such
1	name and within
1	commerce of an
1	quality, including managing
5	270 days after
3	certificate or simulation
2	cost of covered
1	points, as appropriate.
2	title, an abbreviated
1	seeking agency action
1	approved as of
1	section is sought
1	obligations under articles
1	(a) ante mortem
1	record or information
2	drug administration advisory
2	records, if so
1	advocacy groups, professional
1	revenues made under
1	fee amounts established
1	corporation shall, with
17	ability of the
1	farms and facilities
1	effective date any
1	territory are inadequate
1	set an appropriate
2	(3) make a
1	343(f), 352(c), and
1	administration, in consideration
1	effective date and
1	rapid field identification
2	(i) not to
1	paragraph and determines
1	states seeking to
4	packaging or labeling
1	dee-water navigation and
6	shall be limited
1	substances distributed locally
1	kind which are
1	design and conduct
2	drug and these
1	control; or (b)
2	general shall prescribe
4	defendant is not
1	service or the
1	(i) a brief
2	terms by the
3	egg products inspection
1	 (2) restrictions
1	201, 52 stat.
1	
 673. seizure
1	order require; and
1	animals, of the
2	(b) by a
4	shall be permanent.
2	health (referred to
2	$125,000,000 is appropriated
1	360j(m)(6)(e)(ii) of this
1	person must have
1	participated in acts
1	(b) the seriousness
1	(g).  (g)
1	(c) information regarding
1	secretary, identify existing
1	provide all appropriate
1	exchanged under this
1	powersthe secretary, through
1	begin only with
2	without naming each:
4	following publication of
2	thereof, unless sooner
1	users, manufacturers, importers,
3	certificate or other
1	unapproved uses of
1	dispenser.  (7)
1	immediate supplier. (b)
1	(1) any action
2	held by the
1	instances where the
1	including progress regarding
1	respect to domestic
2	regulation and guidance.
3	paragraph and paragraph
1	indexed products. 
2	horses, mules or
1	exposed to residues
2	clause (a), (b),
1	5, the regulation
1	subchapter; (ii) in
1	requests have been
1	year 2003 unless
1	section 360b(c)(2)(f) of
1	(i) testing for
1	shall suspend any
1	state licenses thir-party
4	prescribed for the
2	whether a proposed
1	data element described
1	shall upon entry
1	(a) for use
5	conditions for use
1	decision in any
1	registration applications by
1	transaction is required
1	local, state, or
2	standards  (a)
1	purchased or received,
1	(2) procedures for
1	(k) leprosy. (l)
1	protocol differ substantially
1	food, the food
1	seller to ensure
3	general services administration
1	etc., as health
1	i-kind contributions) from
6	drug administration, including
1	component of materials
2	secretary with information
1	petition that relates
1	production of records;
2	contains a pediatric
1	2009; and (ii)
1	commerce;  (b)
1	awards any funds
1	(ii) be available
1	subsection (a)(2), fails
2	drug protocol submissions
1	served on such
2	narcotics and dangerous
1	reporting to occur
1	  mg
1	formula will not
2	subsequent or additional
1	complete application means
1	delivering, importing, or
1	small business, for
2	waivers the secretary
1	subpopulation that suffers
16	paragraph (1). 
1	 (2) appeal
1	 (b) participation
1	laboratory is accredited;
1	licensedthe term licensed
1	15, 2007; or
1	activities conducted in
3	notwithstanding subchapter ii
1	675, 572, as
3	fees estimated to
2	types of entities
1	 (a) monitor
1	activities; (c) information
1	unavailability of such
2	data are not
1	(1) presidential decision
1	frequently if the
1	(e) nonnarcotic controlled
1	import permit, notification,
3	et seq.] that
39	possession or control
2	393(g) of this
3	federal regulations, as
1	secretary after september
11	commercially marketed tobacco
1	drugs. (l) authorization
2	(1) whoever knowingly
1	selling, furnishing, giving
1	foods for rare
1	(e) special condition
1	furthermore, nothing shall
1	 (a) prevent
1	(c)[1] of this
1	section 1333 of
1	physician of a
1	injunction as additional
1	contract and coordinate
1	differ so substantially
1	nucleotide sequence that
5	drug administration modernization
2	(d) an identifying
3	action under paragraph
3	use or proposed
1	yellow, or of
3	require that any
1	(1), or when
1	funds required under
1	(2) final year
1	70 percent; and
2	exposure to pesticide
1	drug. (f) whether
2	467c of this
2	establishment of effective
1	policies would apply
1	alleging inadequate 
1	methohexital. (7) meprobamate.
1	section 379h(a) or
3	advisory committee appointed
1	(i) recruitment through
1	reduction, dru-related law
1	dietary ingredients: 
1	basis and method
5	analogous product for
3	number of air
1	(b) in satisfying
1	centers, from the
1	require submission of
2	granted on the
1	consistent with prescribing
1	storage of such
1	noninferiority trials. 
1	drug, an animal
1	treat, or prevent
1	periodically evaluate, for
1	prepare for the
1	(i) judicial review
1	clinical endpoint that
1	show whether such
1	regulations shall cease
1	reasonable times, upon
4	filed by that
2	(b) if no
1	advisory committee pursuant
3	case, and all
1	devices; (3) most
1	compliance with narcotic
1	countermeasure application means
1	2006, the director
2	disposition. (c) electronic
1	applicable annual report.
2	shall include representatives
1	drug free; (iii)
1	legend conspicuously displayed
2	beginning in the
2	subparagraph (a), afford
1	administer product in
1	subchapter is intended
1	store a notification
1	costs and charges,
12	director and the
1	violations; liability of
1	74, 13, 38
1	conducted the expert
1	pesticide chemical with
1	intended for minor
1	time necessary to
1	801a. congressional findings
1	products, of any
9	subsection for the
1	(a) from 2003
3	examine witnesses, receive
1	condition. (june 25,
1	set at a
3	dispensers for whom
1	percent of its
1	(c) records inspection
1	completed, the importer
1	references to ingredients
1	regulated person knows
1	biological products agreed
1	proportionate basis, to
1	use of noninferiority
2	final regulation is
1	used in commerce;
1	(a)(ii), fees may
1	person; and (ii)
1	review, including any
1	number of standard
2	private sector entities
1	manner on the
1	consumers, and be
1	regarding a clinical
1	category means a
1	tobacco product where
1	product brought into
3	seq.] with respect
1	823(f) or 829(e)
1	appropriate validated test
1	immediate precursor and
1	mercury, silver, and
1	designate the serving
1	(7 u.s.c. 1501
1	system during a
1	(b)(2)(b), and subsection
1	past experience of
1	final order of
1	(3) finding a
1	final order on
2	sunscreen order 
2	employees; and (ii)
1	(
 
 1707.
4	tobacco products in
1	1896 (u.s.c., 1934
1	assistance; (2) technical
1	drug, such ingredients
2	biomaterials supplier may
2	imports or offers
1	remit the establishment
2	portability and accountability
1	title. (d) suspension
1	clause (v). (cc)
7	et seq.] or
1	targeted technology as
1	applicability of subparagraphs
1	diphenoxylate. (6) fentanyl.
1	$175 for each
1	et seq.] on
1	(2) discovery made
1	states) shall have
1	made, other matters
1	$7,936,000 for fiscal
2	(ii) the physician
1	judgment for the
11	make the approval
1	diversion control; and
1	secretary information concerning
3	action that is
1	repacking establishment. 
2	state law. in
1	drug was approved,
1	postponing sentence as
1	attorney generals discretion,
1	psychotropic substances has
1	trends against previously
1	achieve product specialization
1	(1) without charge,
3	petition proposing the
2	type and size
1	year 2013, such
1	condition pursuant to
2	june 22, 2009;
1	safety; and (vii)
1	lon-term commitment to
2	grant a partial
1	360n. priority review
3	year, and the
1	without disclosure to
3	1958 (72 stat.
1	affirming the order
1	risk of death;
1	device recall has
1	(2) to ensure
1	initiate discussions to
1	cosmetic in interstate
1	procedures under clause
1	(b) drugs with
8	regulation under subsection
1	research, statistical, epidemiologic,
1	section 360eee(22) of
2	interpretive criteria otherwise
4	(1) subject to
1	manufacturers and distributors
1	organization such medical
1	articles and poultry
3	limited by an
1	whether the objectives
1	by, or under
1	remove an article
1	sponsor may provide
1	advisory panel described
1	drug control; or
1	treatment effects observed
1	misbranding; notification of
2	slaughtered, canned, salted,
1	6-day period, imports
1	(iii) a product
1	officer of state
2	satisfies the criteria
1	chapter in a
1	drugs.  (vii)
1	intercenter institutes (a)
1	reduces risk or
1	coalitions in the
2	adverse safety or
1	(a) or in
1	used when authorized
1	support for community
3	surveillance systems and
2	resolutions that may
1	relative to income;
6	use only in
2	(a) establishing, modifying,
1	hold, and administer
1	intentionally brings or
1	expected content of
1	affiliation with such
1	(to be specified
1	manufacturer or brand
1	subsection (a)(2), as
1	collaboration with, a
1	administrative inspection warrants
1	results therefrom, (iii)
2	safety reports nothing
1	practices; (5) training
14	port of entry
1	(b)  (aa)
1	class i, general
1	immediate container. 
2	pharmacy to a
1	medical therapies, including
1	china to enforce
1	titleif a 18-day
1	certain information 
1	taken or removal
1	persons from beginning
1	manufacturing of the
1	equivalent products into
1	time of approval
1	tests for pesticide
3	including requirements under
1	 (i) prior
1	property specified. the
1	requirement shall bind
1	review of manufacturing
1	subsection, the phrase
1	evaluate and determine
1	notice and shall
1	total law enforcement
1	mean the food
1	property, including things
1	least one prior
1	(1). in developing
1	may waive this
1	increase the cost
1	current scientific knowledge,
1	agent may be
1	manufacture or use.
2	fiscal year), the
1	administrative records of
1	technical and other
4	subparagraph (c), shall
1	infected plants and
1	issuance, for its
2	states is not
1	proposed regulation; (2)
1	zika virus disease.
1	(2) radiopharmaceuticals. 
2	designed to prevent
2	not, otherwise than
1	subsection (k)(3) to
1	trends. nothing in
1	(a)(1), or to
2	revocation, or suspension
1	solely under section
1	comparable to those
1	personthe term responsible
1	turn the information
1	
 
 360c.
1	section as annual
1	ophthalmic or oral
10	strength, quality, and
1	exception  (1)
1	leader with appropriate
1	fift-six percent shall
1	2012, including the
3	substance for the
1	appropriate internal controls
1	criteria such as
2	(c) electronic database
2	general a sponsor
1	drug are sufficiently
1	three years. penalties
2	respect to establishments
2	appointed under clauses
1	device is, except
1	whether a condition
23	shall be appointed
2	purposes of, or
1	enhance, as necessary,
1	tobacco to protect
1	debarment immediately, or
1	secretary. (b) general
30	equal to the
1	part referred to
1	clinical investigation; and
2	(c) nothing in
1	consults with, one
1	(5) supplement 
1	2012), revising the
2	 (i) declaratory
1	(2)(a). (e) the
1	federal prosecution for
17	product within the
1	provide directly, by
1	designates the drug
1	(i) and one
1	received or used
1	disclosed and may
1	special rules for
4	either party to
2	generic drug shall
1	authorized generic drugin
1	2016, $1,984,000 for
1	(4) there is
1	 (6) generic
1	data. the secretary
2	affects more than
1	labeling requirements or
8	chapter, shall be
1	subparagraph (a)(i) if
1	(c) a postapproval
2	required to file
9	attorney general, the
2	labeling requirements of
2	intentional, is reflected
1	(5) evaluated on
1	drugs, supplemental abbreviated
1	title iv, 401,
1	analyses. (5) no
3	presented to congress
1	applicability nothing in
3	effectiveness of drugs,
1	class i, class
3	likelihood that the
1	advertising uses the
1	prior to 270
2	animal shall not
1	application for license;
2	be, distributed in
3	section 501(a) of
1	bodies and of
4	360e, 360f, 360h,
1	medical gas. any
1	hereinafter provided, for
1	seq.], as applicable
1	consent documents and
2	begin the introduction
3	less than three
1	distributed interstate. thus,
5	grade gs18 of
2	responsible person may
1	hazards and developments
6	affiliate means a
3	product identifiers to
4	applicant, issue an
1	adequately protect the
1	(c) other appropriate
1	term person; (2)
1	device to investigational
1	(a) establishmenta petition
1	oil, the person
1	requirement facilities that
2	bar code reader
3	use to his
2	declaratory judgment action
1	grant funds a
1	
 1503 to
1	time.  (f)
1	associated with manufacture
1	device regulators forum,
1	related public comment
1	narrative descriptions and
1	extension shall be
2	procedure to transition
3	title 42, a
1	heroin, cocaine, and
1	drug/device/biologic) that are
1	 (2) determinationnot
1	physicians, dentists, scientists,
2	qualified experts when
2	standard will not
5	product, the wholesale
1	particular electronic product;
1	possess any thre-neck
3	title or notification
1	electronic submission of
1	conform to chapter
1	duties.  (2)
1	racemoramide. (42) trimeperidine.
1	required patient labeling
1	discretion actions under
1	contentsthe regulations under
1	locations) and offering
4	section 841(b)(1)(a) of
2	food products to
1	iii or iv
2	effective final sunscreen
1	binder or other
7	establishment as of
1	methods, and processes
1	networks, and consumers.
1	disposal of condemned
1	potentially the subject
1	person debarred for
1	verification activities, the
2	written certification as
1	alternative methods are
1	neonatal population (including
1	
 661. federal
1	safe for one
1	thereof for sale.
1	element the possession,
3	section 350a of
1	matter that relate
2	hereby declared to
2	product exempted from
1	675, 770, as
1	years the establishment
1	mil-based.  ecalcium
1	submitted and before
1	professionals who are
1	record for the
1	agency; (3) implement
1	electronic format for
1	juice, a statement
1	v. such schedules
2	agency that have
1	methamphetamine trafficking 
1	(b) a biological
2	qualified safety and
4	requirement not later
1	(
 
 1531.
1	use contained in
1	receive a food
1	(c) persons eligible
1	(i); and (ii)
1	cause be shown
1	outweigh any detriment
1	drug, of preclinical
1	 (c) nalorphine.
1	manufacturer is not
2	located, or is
1	with, an opaque
1	abuse less than
5	including by acts
1	(a) summary as
1	response letter; (3)
1	1545. terms of
1	panel has reviewed,
1	makes a determination,
1	lawfully introduced or
1	substance except where
1	applicable data 
1	local law by
2	(4) the number
1	director may apply
2	shall list such
1	professional, industry, agricultural,
1	pallet level, sufficient
1	part of subsection
1	476; 
 

1	facilitate communication about
2	study plans, assessments,
1	existence for the
1	base; (d) 100
2	treaty or other
1	stated, the requirements
1	(b) modification or
1	proposed sunscreen order;
6	prior to november
1	task forces within
1	prescriber either in
1	july 1, 2012;
1	restricted eggs. 
1	(2) community assistance
1	product was purchased
23	federal and state
1	informationin promulgating regulations
2	new drug as
1	establishing such positions,
1	money, or other
1	use human generic
2	may assert a
1	individual importations or
2	407, as added
1	penalty is provided
1	2018.  (2)
8	quantity of any
1	use, reports in
1	filing a complaint
6	substance is applied
1	best practices identified
1	national security of
3	minimum size of
1	evidence obtained after
1	maintain, for not
1	 (c) annual
1	675, 911, as
1	states, or minimizing
2	notwithstanding section 553
2	medical device; or
1	tobacco; (e) include
2	national security or
4	certification to the
2	number of additional
1	ch. 675, 528,
1	(
 
 842.
6	approval by the
14	application is insufficient
1	within 2,500 feet
3	different and the
1	referral; and (ii)
1	grants available for
2	either act relating
1	colored margarine which
1	percent cal 2.7
2	order, unless good
1	interaction of market
1	inclosed in papers
2	prescribed by him
2	section 208(a) of
1	techniques, and other
1	record to the
1	criteria of subsections
1	small businesses. 
1	considered eligible for
2	recommendations made under
1	negotiations relating to
1	additional processing and
3	interpretive criteria standard
1	inspection service of
1	action within 150
3	notice.  (b)
1	informal hearing, by
1	exists by reason
5	causing serious adverse
1	identify means by
1	manner of discrimination
1	applicable regulations published
1	products adequately and
2	secretary, except such
2	section 207 or
1	categorical exclusion from
3	authority  (a)
1	(h). (6) urgent
1	sanction then in
1	prescribe regulations (which
1	notification and such
5	822(d) of this
3	representative. all official
1	(a)(2)(e), the secretary
1	render his registration
1	strategy;  (9)
1	corrective action plan;
4	360fff3 of this
1	partner, a repackager
1	399g. food and
1	definition. (b) a
1	health disparities issued
1	articles before they
3	responsible party under
1	board in accordance
2	(b)(2)(a)(iv) or (j)(2)(a)(vii)(iv)
3	 (1) within
1	shall have any
1	subchapter and shall
1	(2) the pharmacys
2	position at level
2	previous owner prior
1	bears the statement:
1	regulation, establish a
1	without providing such
1	registration in all
1	logbook, or supplying
1	property in such
1	
 
 355c1.
3	 (3) authorized
1	draft guidance as
2	distributor that accepted
1	convention which is
1	external experts who
2	binding upon, and
1	secretary, at which
1	additional si-month period
2	results in a
4	$50,000,000 if the
1	relationship to pediatric
1	small or otherwise
1	823. registration requirements
1	population and makes
1	medical devices; (10)
1	5, 13, or
1	official establishment for
1	(2) further proceedings
1	unexpired term. a
1	eligible to perform
1	upon the order
1	sectionthe foregoing subsections
1	failure to take
1	year shall submit
1	seq.], including increasing
1	contains no active
1	
 346b. authorization
1	except where it
1	participated as an
1	elected state official
1	subsection (c)(2), including
1	poultry; (3) any
1	uses under consideration
1	subsection (n)(3); 
4	accreditation bodies recognized
1	regulation: this online
2	food safety inspection
1	agencies have committed
1	including a failure
1	agreements regarding voluntary
1	rural areas of
1	statement, conditionally approved
2	produce a pediatric
2	failure to file
1	coordinate and cooperate
1	found in the
1	aircraft used in
1	product radiation from
1	(authorizing and appropriating)
1	schedules of convention
1	countermeasure development, review,
1	distribution, any felony
1	 (i) define
1	thereof. (4) in
1	administrator shall prepare
1	committee exists, or
1	(5), libel proceedings
1	substancesthe attorney general
1	data from adequate
1	data for an
6	customary conditions of
1	subsection (c)(2)(a), would
1	benefit for which
1	applications for grase
1	program and review
2	powers of enforcement
1	number of interstate
7	evidence before him
1	(a) federal, state,
1	 (b) project
1	outlets; or (ii)
1	surveillance and allocation
1	person arranging for
1	information, and permitting
1	labels, labeling, and
1	31. (k) written
1	reasonably related to
1	establishments; (3) build
3	355(p) of this
1	within 210 days
1	$10,000. (c) in
1	hearing upon request
1	 (b) false
2	(2) that is
2	requirementif a state
1	product using ingredients
1	period may be
1	(1), unless a
1	 (b) verification
5	causes to be
1	(6) timing of
4	days after each
1	person charged. 
1	disease outbreaks and
1	(b); (2) as
1	 (i) registrations
1	campaign based on
1	(c) benzyl chloride.
1	audit. (2) the
1	time that may
1	621. inspectors to
1	disposal of large
1	total prescription orders
2	(d) effect of
1	following thresholds in
1	
 387p. preservation
1	efficient manner practicable,
1	(d) effect on
3	food; (4) if
1	applications shall be
1	report; and (e)
1	training on, when
2	data concerning the
1	proposal and furnish
7	list under subparagraph
1	detailed lon-range plan
2	review and importation
1	seventh year after
1	place or places
4	requirements that apply
1	subsection (b) which
4	(1) a drug
1	(c).  (ii)
2	coerce, a person
1	public health issues
1	(b) take steps
2	 (e) fees
2	control strategy, including
1	public information. 
1	approval; (ii) the
2	meeting for each
1	information as are
3	appropriate for purposes
1	performance standards prescribed
1	drug is undertaken,
1	brings food, or
1	paragraph (1). prior
1	(iii), and an
1	(3), refuse by
1	specific requirement relating
1	observations previously provided
1	bears  (i)
1	promote comprehensive drug
1	prevalence of adverse
1	protocol, or the
1	use and by
1	60.0.  potassium
2	claim that it
1	product identifier means
2	product identifier 
1	rule regarding cigarettes
2	18, or section
1	 (a) contains
1	technological needs of
1	immediately suspended on
1	processes that utilize
3	operation of section
1	food industry, academic
1	certain manufacturers if
1	filed for conditional
3	plans described in
1	(3) other deputy
3	laws regulating the
1	year during the
1	imported whose bacterial
6	september 27, 2007.
37	september 27, 2007,
1	inspections to satisfy
3	make such reports,
1	labeling of, or
1	payments and advances
1	palatability of the
1	patterns among infants
1	related to addressing
3	submitted an investigational
1	uniquely identify each
3	whichever is later.
1	9-day extension, if
1	whichever is later,
1	safety of neighborhoods
1	bureau of animal
1	compliance data the
1	means all parts
1	section without the
4	 (c) 
1	3663a of title
1	persons of scientific
1	special termination of
1	clinically significant endpoints,
1	 (7) review
1	may take administrative
2	person shall serve
1	leas-purchase arrangements. a
2	data and evidence
2	destroy any such
1	regulations on an
1	provided written clearance,
1	including intentional adulteration
1	antibiotics; terms and
6	biological product that
1	(i) emergency situations
2	subsection (a)(1) and
1	subparagraph (a)(4) of
1	iii to transition
1	device for determining
5	(ii) january 31
1	2003 unless appropriations
2	facility engaged in
1	powers of state
2	360, 360i, and
1	1992. (m) devices;
1	secretary such action
1	correcting misstatements of
1	importation and before
3	consideration any comments
1	69 stat. 684;
1	(ii) the increased
5	particular activities under
1	social and economic
1	committee. (b) the
2	fiscal year established
1	sentence, shall be
2	subject matter to
1	3 years thereafter
1	transactions, shall be
1	employees initiative or
2	hazards that are
2	homeland security shall,
2	feed for use
1	employee may consider
1	(3) the authority
1	subsection (f)(1), such
1	(b) laboratory capacity
1	obtained, and who
1	additives for foods,
2	employed for such
1	(b)(1)a),[1] the exporter
1	held, for introduction
1	 (f) investigational
1	without reapplication for
1	date after approval
1	complete the review
2	trafficking area; (c)
2	goals.  (b)
1	(a) shall, at
2	informed of the
2	regarding data concerning
2	approved, and such
1	v is also
1	(or gives such
2	support services as
1	conditionall-approved application under
1	exceed a daily
1	extensive training or
1	manufacturers, shall by
2	(1) or section
1	forums strategies, policies,
1	basis, submit a
2	animal drug. the
1	supplier that the
1	prenatal care. (5)
1	(ii) none of
1	nonprofit entities pursuant
1	able to procure
1	appeal; reprocessing all
1	hig-risk facility is
1	apply to seizures
1	(1) the adequacy
2	controlled substances. (5)
2	product, or cosmetic,
1	discrimination, including litigation
1	prescription drug products).
2	limited population drug
2	notification specified in
1	conclusion that an
1	production or origin;
3	human food; (4)
2	paragraph (2) before
1	smokeless tobacco; and
1	data necessary for
1	reasonable period for
2	effective date 
1	difficulties in completing
1	guidance implementing this
1	secretary determines necessary,
1	team leaders, to
1	support for, and
1	system and procedures
4	ingredients that are
2	precludes a sponsor
1	cumulative effects of
1	acceptance of biosimilar
1	reduction in appointing
1	(or appropriate division
17	investigational animal drug
2	construction standards, and
1	registration.  (g)
1	action plan; vacating
1	(c), of drugs
2	two shall be
1	employs such personnel;
1	appropriate governmental entities
1	cooperation with appropriate
1	 (b) assurances
1	illegal importation, manufacture,
2	subsection, further increase
1	including a transport
1	use that have
1	attorney general report
2	similar course of
1	approval or disapproval
1	states government to,
4	safe under the
1	drug certification process
1	certificationsthe secretary may
1	interest, that the
1	submissions. the annual
5	tobacco product which
2	321(v) of this
1	waiver of a
1	(b) single state
1	petitioners right, title,
1	secure processes to
1	event reports an
10	paragraph (2) for
1	appropriate clinical study
1	i-kind contributions, during
4	procedure the secretary
1	no-compliance with united
1	constitution and laws
1	(3) all staff
1	advisory committees from
2	inspectors or other
1	food products otherwise
2	research consortia and
1	drugs concluded at
1	term grase means
1	two years, for
3	carrying out section
1	282(j)(5)(c)(ii)[2] of title
1	hundred thousand: provided,
1	advertising directly relates
1	inapplicable. (b) a
1	changes in policy,
5	controls implemented under
1	shipment or sale
1	shall appoint to
2	research and information
1	1045.)
 
 379e.
14	expenses of the
2	(ii) is intended
2	verification and for
1	consider the data
1	limitations, may implead
3	shall be instituted
2	contraindications, warnings, precautions,
1	procure creative services
1	serve on advisory
1	standard, or (ii)
1	unapproved product, a
1	provide at least
2	seller does not
1	(1) on-time backlog
1	new and existing
1	basis for action
1	procedure associated with
1	thereof, are found.
14	forth in the
3	responsible for any
1	clause is that
1	(3) classifying the
1	records by persons
1	federal government agreeing
1	paragraph or denying
1	enclosed by a
1	man, including any
2	revoke the recognition
1	insufficient for the
2	occurring on or
1	recipes for food,
1	measures and targets
1	policies to implement
1	case of 50
3	section 353(e)(1) of
3	enhance the safety
1	met only if
4	reason to believe,
1	(iv) in establishing
1	enforcement programs and
4	website described in
1	open protocols for
1	facility that compounded
1	ch. 675, 752,
1	repackager responding to
1	ii, that the
1	slaughter of livestock
1	(1) shall, not
1	review times of
1	imported, slaughtered poultry,
1	subsection in the
1	establishes a tolerance
1	court, when sentencing
1	(bb) has such
3	contemporary research has
1	typically found on
1	assets and prohibiting
1	provide nutrients as
1	make this eligibility
3	purposethe purpose of
1	classification determination or
1	period were available,
2	 (a) improving
1	(d) opportunity to
1	treasury, within ninety
4	subject to regulation
1	  iodine
1	summary review; and
1	food requirements domestically
1	secretary, upon his
2	controlled substance may
1	commercially.  (c)
1	clandestine importation, manufacture,
2	18-day period under
17	subpart, the secretary
2	registration numbers of
2	expert panel and
1	347. intrastate sales
1	(a), or any
1	paragraph (1)(a) applies
1	(a)(1), the defendant
1	thereof, to wit:
1	developed. (b) adverse
1	drugs:  (a)
1	single entity; (ii)
2	section 360d(c) of
1	full amount of
5	caused to be
1	covered application (including
2	imprisonment, or may
2	subsection (a)(4). 
1	additives shall be
1	notification, the practitioner
1	120 days prior
1	offered for export
1	withdrawal of authorizationthe
1	diversion will not
1	causes, and ways
1	 (h) exemption
1	studies and to
1	(1) to generate
1	section 360c(a) of
1	person; (c) the
1	supplant an eligible
1	transaction statements, in
1	also result in
5	$2,000,000 if the
1	successful strategies, training
1	prevent, curtail, or
1	assessment identified in
1	(b) the commission
1	drug administration should
2	modified. (f) no
1	packing; and (b)
1	listed chemical 
1	court determines under
1	title i, title
2	jurisdiction  (1)
1	(b) manner of
1	death; (b) protracted
1	transactionsexcept to the
1	detention or revoke
3	 (2) inflation
2	promptly to writing
1	(ii) would not
2	merit of 
2	managing a pharmacy,
1	part described in
2	organization which is
1	made does not
1	indicating when the
1	unapproved product with
1	office in such
1	6, 64 stat.
3	priority drug safety
1	(2) a district
1	hashish oil, the
1	identify existing and
1	pending; and (iv)
1	innovation act. 
3	stat. 862; 7
1	(ii) infected plants
1	article.  (b)
6	chapter, the secretary
1	doses of each
1	subsection (e), and
1	grant of the
1	food. (2) 
5	installation of the
5	section; or (ii)
2	(a) the federal
1	conveyed by the
1	record, or other
2	section:  (a)
1	subsection, expire after
1	42; (b) the
1	facilitate the timely
1	action, and an
1	(v) pipe tobacco.
1	fresh vegetables and
1	subsection (e), any
1	inhalation, ingestion, or
1	conviction which occurred
1	commerce to transport
1	person who furthers
1	vehicle (other than
1	said sections. (4)
3	shall provide, where
1	with, one or
1	interested parties. in
2	(4) the judgment
3	following activities: 
1	submission mean 
1	counterfeited; and (b)
1	residues receive the
1	(i) capture the
2	later.  (3)
1	use; (2) descriptive
1	advanced therapy shall
2	resources to inspect
1	another organization 
1	(j) is remaining
1	(4) letter regarding
1	(d)(1); or (iv)
1	ability to detect
2	internet sales, in
1	amounts obligated for
1	paid or the
1	(a)(4) of this
1	accredited.  (b)
1	years 2007 and
9	nonpaying guests and
2	systems of the
1	675, 715, as
1	20.)
 
 346b.
2	anabolic steroids if
2	upon the petition
1	brought against that
2	general this section
2	 (i) use
1	title; or (d)
1	disease to individual
2	(d) any material
2	consult with him
2	elementary, vocational, or
2	hardship; and (ii)
1	shall consult among
1	cosmetics are manufactured,
1	substance analogue of
1	1-month period, the
2	substances which have
1	sections 4721, 6001,
1	plan and with
17	subject to an
7	day of the
1	device designed to
1	 (h) reciprocal
1	appropriate:  (1)
1	health and will
1	government, foreign cooperative,
1	procedures fiscal years
2	trials under subsection
1	shall be fed
1	abetting, such felony,
7	reporting concerning a
5	fees charged, as
1	costs under paragraph
1	1050. jurisdiction of
1	cannabis sativa l.,
1	data on such
7	general the term
1	remitted to the
1	(f), each importer
1	patterns and trends
6	secretary intends to
1	chemical residue. in
1	legalize the use
4	change in labeling
1	solid preparation, in
2	master file to
1	youth are due
1	1, 2015 
1	follows:  fee
1	subparagraph (f), if
3	thirty days prior
7	infringed, the approval
1	meetings, which shall
1	$8,467,000 for fiscal
6	extent provided in
1	foreign persons who
2	year (referred to
1	columbia, and excluding
2	et seq.], a
1	states  (a)
1	reviewing a supplement
1	program, both domestic
1	drug bears the
1	entity complies with
1	includes tobacco, in
1	consistency between federal
8	labeled and packaged
1	listing shall state,
1	association of american
1	2016, shall be
1	subsection (n) and
2	title, if it
1	u.s.c. 355(c), 360b,
1	pay a facility
1	exporter shall update
1	standardized and uniform
1	modifications to clinical
1	tolerances for applications
3	el paso intelligence
1	(b); and (d)
1	360b(e), 360b(h), and
1	1 year, whichever
1	islands, american samoa,
1	61, 3(c), 64
1	amends or withdraws
2	effects and shall
1	section unless extended
5	responsible for such
4	distribution, and dispensing
1	(
 
 452.
1	may be received
1	dated and indicate
2	practitioners licensed by
1	certification process pursuant
1	(v) an identifying
1	necessary rules and
1	persons abbreviated drug
1	15th day after
1	(17) tetrahydrocannabinols. (18)
1	electronic database, which
2	shall be vacated
1	
 
 676.
1	change has a
1	research and quality,
1	research and quality.
2	patients, providers, and
4	5 grams or
1	lines, knowing, intending,
1	(b)(1); (vii) a
3	powers, and duties
1	establish, on the
1	grounds exist for
1	listing and an
2	rule in the
1	especially with respect
2	presence of an
1	(3) exception this
5	samples of smokeless
1	drugs from canada
1	2102. ensuring the
2	drug no active
1	(
 
 1704.
1	title of an
1	statement with appropriate
1	operator of which
1	3663a(c)(1)(a)(ii) of title
1	continued, modified, revised,
1	shall be representative
1	person claiming its
9	within the time
1	paragraph (2) does
1	sale of worthless
1	certain dru-related convictions
1	proclamation, as the
1	(a) persons may,
20	appropriate federal or
1	implant; and (b)
1	requirementsthe secretary shall
1	section 45(a) of
1	pharmacy shall comply
1	general any amounts
1	upon review of
17	scheduled listed chemical
2	transaction statement required
1	upon the withdrawal
2	defendant files a
1	importers in developing
1	suspension of regulation
1	identifier, of at
1	subchapter under such
1	include a coordinated
1	importation under clauses
1	misbranding in violation
1	poisonous compound, combination,
1	provide or distribute
1	 (1) material
4	prevent and eliminate
4	care professionals; (e)
1	labeling symbols. (5)
1	states, if he
1	secretary, authorize the
12	owner or consignee,
1	decision. if, as
1	supervision of investigators
7	tobacco product may
1	second country, substantial
1	availability of recognized
1	 (c) development
1	or, after review
1	office, shall review
1	automatically provide the
1	agreed upon study
1	statement relating to
1	
 
 360bbb6.
1	rule 4(i)(1) of
1	restrictions on sales;
1	obliteration, or removal
1	receiving a determination
1	forms submitted for
4	paragraph (1). (b)
1	time for review
3	execution by him
1	authorize the attorney
3	(ii) an application
1	-(-iod-2,-dimethoxyphenyl)ethanamine (2ci). (24)
2	slaughtering by any
1	identified since the
3	committing such violation
1	manner that was
2	title 15, as
1	 (2) ensuring
1	without a jury.
1	grade gs15 of
1	agency, use, on
2	authorized by appointment
1	notify all participants,
5	mixed or packed
1	include a system
2	 (c) amount
5	advisory committee under
1	required in notice;
2	including any new
8	administered by the
1	product; and (g)
3	fee revenues shall
1	orphan drugs 
1	whenever in any
1	343(c) of this
1	requirements, he shall
5	hours after the
1	(8), the secretary
1	individual units of
1	class iii, it
1	award compensation to
1	health or welfare,
26	bears or contains
7	outside of the
1	(b) duties 
1	(4) health information
1	process or the
3	distributor; and (2)
1	paragraph (2), hold
1	conduct programs of
1	party detected the
1	legally accessible to
1	risk communication (a)
1	  c
1	(2) processed foodnotwithstanding
1	section and from
3	assistance provided under
1	  e
2	absence of adequate
1	(before export) to
1	secretary to supervise
1	section 1037; term
1	physician licensed in
1	strength, and route
1	paragraph (6)(b) was
1	states. (3) to
1	samples under conditions
1	(3) the preamble
2	agencies the secretary
1	risks; (iv) focus
1	recalled.  (d)
2	controlled substance on
1	component of which
4	applicable federal or
4	governed by the
1	law.  (2)
1	including increasing pediatric
1	controlled substance of
1	subsection. if the
2	provided; nor with
1	contact substance in
1	pharmaceutical ingredient for
1	shortage as determined
1	patient organizations, as
5	groups to continue
1	standard for consideration
1	sections 3 and
1	(vi) listing the
1	use of drugs.
2	use of drugs,
2	purposes of establishing
1	section and market
1	risk. the secretary
7	tobacco product; and
1	considered unfit for
2	food or a
1	$6,250,000 in fiscal
1	environments, and any
1	destruction, appropriate due
1	approval, approve the
4	adulteration of food
3	360m of this
1	 (g) annual
1	multiplicity of pending
1	trials; and (v)
1	upon conviction, be
1	section 210 of
1	classification panel shall
1	
 360bb. designation
5	failed to establish
1	pending request; (ii)
2	regulations are finalized
3	31. (i) written
1	subsequent transferees) of
1	information at any
2	drug are unsafe
1	
 876. subpenas
1	(a) of action
1	importer, when the
1	regarding the proposed
1	(including compliance with
1	person obtaining release
4	understanding between the
1	commerce. (d) the
1	making such amendments.
1	single tobacco product
1	medication. (c) schoo-based
1	(1) requirements for
1	terms are used
2	transportation, possession, and
1	requirements, and for
1	time that each
2	state law prohibiting
1	inconsistent with this
2	made such determination
1	facility manufactures animal
1	persons (where known
4	substances in schedules
1	merchant wholesalers. 
2	subsection (a) before
1	person shall sell,
3	section 823(g)(1) of
1	chapter, irrespective of
1	22, 2009, for
1	implementation the competitive
1	levels  (i)
1	scientific evaluations as
1	(3) other drugs
6	shall ensure that,
1	magistrate judge, upon
1	no-alcohol foodsubsection (a)
1	amounts specified for
1	subsection (a)(1), and
1	affect the identity,
1	investigational use as
1	(b) devices 
1	
 601. definitionsas
1	courts; united states
1	program. (e) a
1	bin, and any
4	mandatory term of
1	march 31, 2003,
1	(b)(1)(e) for each
1	drug used to
1	title.  (14)
1	 (d) immunity
1	required to disclose
14	memorandum of understanding
1	reasons why the
1	reportable food using
1	longer be effective.
1	bureau of alcohol,
1	audit reports, and
1	facility registration system
1	secretary from disclosing
1	(
 
 963.
1	filed in federal
1	identify hig-risk facilities
1	purpose described in
1	locate, for purposes
1	506, as added
1	means (a) commerce
2	(including the manufacturers,
1	(i) the impact
1	panel organization and
2	(b) identification of
1	section shall occur
2	compliance with, 1
1	 (2) individualsif
1	coordinate regulatory efforts,
1	may list any
1	activities). (7) the
1	violated subsection (a).
1	meeting.  (8)
2	(b) a product
1	clause (i) in
1	agency is requesting
2	date the request
1	record; (2) the
1	surveillance, tracking, and
1	requirements for shipping
1	197, 198. repealed.
4	require that each
1	involved, except for
1	assessments completed and
1	additional statistical data
1	controlled, or directed
1	regulations, and during
1	section 387e(j)(3) of
3	program for a
7	public comment period
1	food; (ii) is
3	360b(d)(4) of this
1	thing was being
3	contemplated shall be
1	title; (b) presents
1	necessary to confirm
1	director; or (2)
1	675, 512, as
1	title, is classified
1	(c) privacy protectionsin
1	(c) serving as
1	food inspections, regarding
1	file such request,
1	grain of morphine,
1	information; or (ii)
1	law, be punished
1	seq.]. (b) a
1	(i) charitable contributions
2	incorporated in labeling
1	types of scienc-based
1	logbook and enters
1	requirements to be
2	subject to reporting
1	(b) distribution without
3	debarred under section
1	request complies with
1	annual report the
1	(
 
 858.
1	methamphetamine and ecstasy;
2	establish special controls
1	title or have
1	country in the
4	withdrawal or refusal
1	minimis nature was
1	otherwise not adulterated,
1	(3) an offender
1	inadequate to establish
1	(d) reporting by
1	(j) shall submit
2	destination and the
1	quality in general
4	(b) the results
5	may notify the
2	reduction and supply
1	entities.  (june
3	drug by the
1	act or acts
2	notice.an applicant that
1	(a) a manufacturer,
2	audience that cannot
1	cost effective for
1	 (g) qualified
36	operator, or agent
2	establishment, and for
1	title 19) and
1	vomica, physostigma, phytolacca,
1	15 and amended
2	information, transaction statement,
1	assurance, including the
1	office. (i) public
1	practitioners, the american
1	guidelines to be
2	foodborne illness outbreak,
1	material issues of
1	petitions  (i)
1	modify, as necessary,
1	deems that additional
1	requirement under such
2	administrator shall modify
1	reason for condemnation
1	steps implemented to
2	public housing authority,
3	fine any person
1	 (3) cigarettethe
2	evidence of a
1	manufacturing transactions both
1	food safety training
3	state agency the
1	makes such a
1	refrigeration and labeling
1	arrest warrants, administrative
36	court of the
1	(f) the lot
4	1982, and ending
1	providing notice or
1	professionals and device
1	periodically testing and
1	purposes, and objectives;
1	legally marketed devices.
1	18. (5) any
1	distribution; (2) state,
1	identify substance abuse
1	(2) descriptive materials
1	applicant.  as
1	meet such sanitary
1	treatment, and (ii)
1	shall refund all
1	individuals associated in
1	(3) applicability nothing
2	developed under section
1	activities otherwise authorized
1	2011. (2) the
2	 (4) limit
2	 (c) savings
2	(including through the
1	1048 of this
1	extent appropriate and
1	distribution by person
1	submitted on such
4	grant to an
1	services may, in
1	state law; (c)
1	subparagraph (g) for
4	purchase, or trade,
1	release is published
1	supplement, including a
1	 (9) substance
2	order withdrawing the
1	otherwise provided, the
1	transferred
 
 188
1	(2)(b). (c) trade
21	request to the
1	section 350 of
1	application. (b) notificationif
1	subsection (g), the
1	iv, and v.
1	cleared alternatives exist;
2	common name, by
1	requirements shall have
1	since the drug
1	charge by the
1	managing the biological
1	names and addresses
1	title (unless exempt
1	section 360(k) report
1	360 or 381(s)
1	public comment prior
1	(c) research relating
1	organized territory that
2	application did not
1	work with other
2	develop and demonstrate
1	importer or exporter,
1	foundation.  (3)
1	retarding, or otherwise
1	director a copy
2	enforce any regulatory
1	upon request, shall
2	(3) review of
1	court, or (c)
1	confidentiality reports submitted
3	designated in section
3	investigations must be
1	section, such as
1	(3), any regulation
4	(a) if a
1	global tracing systems,
1	respect to medical
1	licenses for devices
3	food within the
1	specified or extended
1	director rejects any
3	supervised release otherwise
1	trade commission, and
1	tolerance requirements of
1	new views of
1	facilities shall submit
1	basis to develop
1	local surveys of
1	reviewed programs and
1	comprehensive, multisector plan
3	inspector or other
2	safety of additives
2	subsection refusing to
1	transactions of precursor
1	stay of certain
1	deposited amounts deposited
1	agency (1) develop
2	withdraw accreditation of
5	5 for persons
3	destruction the secretary
1	response. (d) strategies
1	supervision.  (2)
2	person so designated);
1	classes for eggs,
1	(a) exemptions and
1	relapse prevention. 
1	(e) requirementsthe secretary,
2	applicable to show
2	giving the applicant
1	single application, whenever
2	budget of the
1	referring to such
1	(a) was designated
1	reinspection. (b) establishment
2	nonthreshold effect from
1	r-exportation of any
1	379j41(3) of this
1	information on relevant
2	application is withdrawn
1	misbranding of any
1	(1), there is
1	effect, and it
1	youth; (5) to
1	disclaimer requirements for
2	physician or other
1	(vii) 1000 kilograms
1	control of importers
1	operation thereof, as
1	american association of
1	2009, the manufacturer
1	(4) and all
1	
 
 384.
1	unless the biosimilar
1	required before distribution
1	issued following a
1	(a)[2] have become
1	review deadlines in
1	membership includes individuals
1	file by the
2	approve drugs pursuant
1	barbituric acid or
1	(b) general operations
1	make a timely
1	chemicals, to do
1	additive; (b) the
1	necessary; in addition,
1	testing, (iii) the
1	affixed to, and
1	applicable, the severity,
1	review if required
1	may (1) establish
1	reports submitted on
5	petition under this
1	intending to investigate
1	grants the amount
1	director.  (ii)
1	cosmetic as a
1	issuance, and use
1	market for such
1	effect, any standard
1	article shall not,
1	use; (viii) the
1	permits the filing
1	exposure levels of
1	supplier of like
1	abuse including polydrug
1	(b) human and
1	(1). (c) a
1	compiled, published, and
1	chemical residue is
1	services of any
1	inventory any stock
1	5.  (3)
4	changes required because
1	552] shall apply
1	 (2) antibiotic
1	possessed with intent
1	shall assess 
1	stat. 684; 

1	inspection act [21
1	contrivance, implant, in
2	container.  (c)
4	sentence of section
3	brand and subbrand.
2	studies  (a)
1	including pandemic influenza;
1	initiated under any
1	acceptance, solicitation, and
1	raw agricultural products,
1	infringement of trademarks
2	subsection; or (2)
1	including analyzing the
1	title upon the
5	order or regulation
1	rico. (g) the
1	hazard or not
1	slaughtered, or poultry
1	declaration does not
1	reasonable measures to
1	requirements  (i)
1	 (c) third
2	panel for the
1	food adulterated. 
1	chapter  (a)
1	cod), crustacean shellfish
1	surveillance data collected
1	detected, (e) the
1	administration regarding the
1	sterile areas of
1	campaign, not less
1	applicable to information
1	media form, on
1	animal drug considered
1	3664 of title
1	term loss means
2	subsection (b) (or
1	submission pending before
1	year 2009if the
5	section 812(b) of
1	submission established under
1	applies, be fined
1	international agreement between
1	(3) exemptions for
1	applicant imports or
1	inspection laws. (june
1	food use. 
1	decisions about corrective
1	temperature of milk
2	invalidity); or (bb)
1	discretion, permit said
1	standards for scientific
1	device; and (iii)
2	(prior to such
3	device if the
1	prospective transferee identified
1	network, group, or
1	chemical residue if
3	(a) such person
1	use fees (a)
1	manufacturing, compounding, converting,
1	periodically, and in
1	substances, or listed
1	provided the proceeding
1	-year period. no
1	request, to other
1	needed, the secretary
1	mean a regulated
1	import, any carcasses,
1	united states; venue
1	may expedite the
1	also a tobacco
1	(b) applicable under
1	1134 to 1143.
1	including the acquisition
5	 (b) information
1	across from (in
1	security, storage, inventory,
2	(a) means an
20	accredited thir-party auditor
2	(ii) fiscal year
5	primary agency center
1	respect to advisory
1	(d) antimicrobial drug
4	(ii) at least
3	institution of libel
1	significant disruption in
1	product development agendas;
1	(d), or (e),
1	shall, on an
1	exempt under this
1	available (directly or
1	thereof, for which
1	sets forth initial
1	secretary later determines
1	(3) are available
1	application fees the
4	use.  (3)
1	endpoints, and statistical
1	point methodology, as
1	subsection, funding in
1	chapter 51 of
1	drugs. (3) the
1	importationa person is
4	2421,54 stat. 1237;
1	administration databases in
1	guidance, the use
1	(iii) a description
54	secretary shall issue
1	corrective actions were
2	including interim relief,
3	establishments other than
1	regulations, as may
1	law, a federal
1	receive and consider
1	expert panel failed
1	term substantially complete
1	section 125, or
1	ch. 262, 4,
1	cohort.  (b)
1	proclamation of the
1	property that may
3	(as such terms
2	authorize the assertion
1	558.3(b)(4) of title
10	type of device
1	purchaser; shall be
2	subsection (b)(3) or
1	379j13. reauthorization; reporting
4	egg products to
1	35, subject to
1	(4) maintain in
1	title, either deny
1	information is shared
1	team and the
2	subsection (b)(3) of
1	qualified on january
1	dyes. (b) if
1	additional restrictions upon,
1	agencies at all
3	42, the secretary
1	tools and enhancing
1	state, the attorney
1	opportunities that will
1	adulteration, including by
1	subsection; (3) any
8	paragraph, and any
1	section; the court
2	dispensing narcotic drugs
1	including sales, transfers,
1	program agencies detail
2	government; and (ii)
1	(1)(b) or (7)(b)
1	participation at meetings
1	expeditious means to
1	statistically valid and
2	modify or set
1	conference, such officer
20	fees  (1)
1	month period referred
1	sponsor; and (v)
2	 (c) classification
1	presentations described in
1	years, fined not
6	years and six
5	permit access to,
1	 (o) repealed.
1	clause (iii)(ii) continues
1	slaughtering; name and
1	management of opiat-dependent
1	address. (2) during
1	clearing devices under
1	purpose of distributing
1	diet. (2) for
1	afford such person
2	household consumer exclusively
1	concluded at geneva,
1	vitamins: a (iu)
1	animal drugs, intended
2	risks are unknown;
2	(d) repealed. 

2	generic drug user
1	property, any additional
1	examined for the
2	require, the information
1	individual, or physician
1	subsection meets the
1	properties of nanomaterials
1	4 or 5
1	construed to prohibit,
1	reports by public
1	counterfeit substance means
1	compliance is found
1	regulation refer such
1	suspension, or revocation
1	(d) agree in
1	distribution unless that
3	topical application licensed
2	service, or a
1	(7) termination of
1	subdivision after the
1	report on innovative
1	tolerances for the
2	period, not to
1	extent the administrator
1	injunction authorities of
1	packers, packing eggs
1	(5)(b) not later
3	 (2) request
1	submissions).  (b)
1	difficulties described in
6	criteria described in
8	media campaign. 
1	licensed pharmacy, or
1	met; and (c)
1	enforcement officer means
1	formula or a
1	united states which
1	data gathering 
1	labeling, is likely
1	regulations. a different
4	sold or otherwise
1	(3) three members
2	section. if a
1	(b) sunscreen active
1	indicated or voluntary
1	authorized trading partner,
1	section. amounts made
1	2106. consultation regarding
7	anaphylaxis management guidelines
7	posting on the
1	drug involved or
10	jurisdiction in which
1	agency, the head
1	1998 and february
1	body drug concentrations
1	food product from
1	performing functions under
1	nominees  (a)
1	animals in accordance
1	contents each recipient
1	areas. with respect
1	participate in conduct
1	year and shall
1	drug:  (i)
2	directly to household
1	small enterprises; slaughterers
1	additive is intended
1	taken under such
6	containing a veterinary
1	officers to be
1	indicator of normal
1	passenger, commercial vessel,
1	milk when issuing
1	reject; or because
2	manufacturer, processor, packer,
1	explaining the reasons
4	determination was made
2	(12) if it
2	(c) exception for
1	(c) consider hazards
1	(iii) who, after
1	name, including both
3	seizure conferred by
1	rule, that it
1	flocks production for
1	use has become
5	authorized trading partners
3	title, amendments to
1	daily equivalent for
1	detect accurately the
1	potentially harmful constituents,
1	general finds relevant
3	general that he
1	activities and programs
2	secretary shall post
1	regulation a reimbursement
1	intended use, as
1	corporate policies and
1	paragraph (2). an
1	sold at retail
1	health. (f) the
1	 (21) tobacco
1	reprocessed within the
8	years and if
1	writing to clinical
1	reported; (3) shall
2	address or phone
1	chapter: (1) demand
1	state, territory, political
1	136h].  (2)
1	clinical testing requirements
1	testing.  (june
1	including state and
1	$693,099,000; (b) the
1	spoilage, loss of
1	conduct surveys to
1	section, which the
1	approved drug: 
1	conviction of, any
1	comment, the final
1	considering the record
1	books and records
1	cause the greatest
1	quality systems are
1	(b)(i) may elect
1	nor, in the
13	conditions as the
9	except that a
1	360ccc, and 379e
1	chemicals; restrictions on
1	approaches to harmonize
1	particular subpopulations, and
1	(c) strengthen the
1	 (1) preventing
1	supplement requesting that
1	(g) notification of
3	equipment or other
1	(b) the designation
1	secretary publishes the
1	closely related to
1	labeling as the
1	cos-based fees for
3	shall withdraw the
4	disposition the illegitimate
1	etorphine. (10) heroin.
1	and, at least
1	(vi) the items
1	(i) plans for
1	illegal narcotics; (c)
1	distribute any controlled
1	connection therewith, are
1	request referrals for
4	operator of a
2	physical sciences, and
1	term commerce has
1	thereof from establishing
1	(2) review of
1	chemicals controlled under
1	practices, such as
1	1702. office of
1	paragraph will continue
2	directions or other
1	subchapter ii. each
25	paragraph (2), the
1	review all requests
1	additional establishments every
4	provides for the
2	contains an untrue
1	sections, including trial
1	egg handler means
7	derivatives, their salts,
1	(v) a sale,
1	packer unless such
1	regulations establishing, modifying,
1	variations in such
2	risk of injury
1	term has for
3	apply to sales
1	requirements for audits
2	committee act (5
1	(7) no delegation
1	subsection (a)(3) within
2	concerning any individual
1	indictment has not
1	food or type
1	intr-agency coordination, communication,
2	without the secretary
3	subparagraph (a) unless
1	no-opiate drug abuse
1	chapter or rendered
1	regulatory review of
1	
 
 112a.
1	(4) restrictions notwithstanding
1	processing in anticipation
1	meet all of
1	prevention; (ee) counseling
1	entered interstate commerce,
2	penalty, any person
1	section to order
1	means a pharmacist
1	shall determine. 
1	(1)(b).  (b)
1	raised by target
1	meeting or similar
4	(a).  (iv)
1	eliminate such agreement,
1	person without marking
1	(i)), a person
1	additive is deemed
2	made on or
1	3 different types
3	(2) a record
3	title) and shall
1	(g)(4)(a); and (c)
2	food means any
1	administrator, without fiscal
1	clinical trial sponsors,
1	reef, johnston atoll,
1	seizure has been
1	correct any purported
1	animal, and copies
3	follow the procedure
1	subchapter may be
5	(1) the name
2	food production, if
2	methodologies for collection
3	electronic product which
2	paragraph (11) of
1	amounts in the
1	information as prescribed
7	schedule iv or
1	considered part of
1	upon which to
1	maintenance of information
2	advisory commission under
1	item to be
2	nonpractitioners to the
1	act (public law
2	synthesis, or by
1	67 stat. 477;
19	insecticide, fungicide, and
1	include the persons
2	section; or (2)
1	states except as
1	accept from state
1	require redaction by
1	product capable of
1	system, or other
1	state. (2) the
1	 (b) response
1	i, title ii,
1	devices for safety
1	filed. service of
1	cost savings to
1	illegal drug use.
1	rendered adulterated. (3)
3	secretary any report
1	sites and organizations.
1	compilation in the
1	statement of patient
2	may award to
1	difference. (8) a
1	section 321(r) of
1	within a single
1	subchapter or imprisoned
2	title with the
1	subparagraph and submit
2	indirectly by extraction
1	action authorized by
1	order reporting. 
1	ownership in a
2	adjustment under this
1	
 379i. definitionsfor
3	maintain records related
1	using any eggs
1	penalty for offenses
1	previous month to
1	intelligence notwithstanding any
1	comment period in
1	warranted.  (e)
1	trial sponsors, contract
1	consumed or administered
1	strategies to achieve
1	horses, swine, chickens,
1	approval products within
1	medical reason; (iv)
1	content requirements set
1	consistent therewith. otherwise
1	registrant plans to
1	 b12 (g)
1	morphine, or not
1	1533. information collection
1	government whose assistance
3	360j(f)(1) of this
1	part. (b) data
1	(b) compounded drug
1	circumstances of a
1	packaging, or labeling,
1	sites and organizationsa
1	56(b)] it has
1	drug paraphernalia (as
1	injury if the
4	grant funds received
1	care cost of
1	requirement for submission
2	paragraph (1), whichever
1	period on such
2	(b) in order
1	user fee account,
1	diseasethe term tropical
1	audit agentsan audit
1	paragraph (1)(a)(ii) for
1	 (a) election
2	refusing, withdrawing or
1	received valid marketing
1	promptly provide such
2	criteria to accredit
1	rate during the
1	determines under the
1	products so as
1	person shall engage
1	(including on the
1	class ii may
1	(a) tuberculosis. (b)
2	 (c) timing
1	local officials. 
1	(b) a denial
1	(b) providing the
1	program within the
1	veterinary prescription drugs
4	attorney general, as
2	person, all such
1	involved, or within
2	recognition of a
1	(a) within one
1	property is located,
2	seal until the
1	milligrams of nicotine
3	returned to the
1	public from adulterated
1	(a) conducting program
1	importer  (a)
1	subparagraph (b) reasonable
1	attorney general, at
1	color, whether before
1	mitigation strategy was
1	general.  subject
1	habitual users of
2	judgment, as the
1	payor, formulary committee,
1	2018. (h) collection
3	 (b) compliancethe
1	577, as added
2	treat a petition
1	(iii) other information
1	duplicative regulatory efforts.
1	thereof) as a
1	course of responding
2	submission or an
1	unless the steroid
3	take effect before
1	second year or
2	available to diagnose,
2	plans and reassessmentsthe
1	meet a premarket
1	(f) transition grants
1	performing a device
1	 (19) specific
1	second year of
1	applications the applicability
1	 (iv) right
1	microbiological quality and
1	use in which
2	manufacturer, or engage
1	designated document room
1	equipment, and be
1	conclusions of the
1	including guidance on
1	secretary and term
1	(a) the investigations,
3	may be liable
1	year, is more
1	declaration, as the
1	review, as appropriate;
1	device can be
1	(3) persons subject
1	drug development. (iii)
1	foodborne illness risk
2	exemption provided to
2	suppliers, and food
2	country without the
1	2018.  (4)
1	partial fillings does
1	sponsor considers to
1	business, is imported,
1	(b) a singl-use
2	periodically report to
2	(a) if an
1	214. previous laws
1	outbreak investigation, including
4	(j) the term
1	drug shortages described
1	secretary; or (b)
1	751, as added
1	(a) if at
1	term claimant means
1	 a scientific
57	commerce of the
1	drug administration, identify
1	retailer) for availing
1	suitable antidote, and
1	new drug, antibiotic,
1	extension of criteria
2	(b), do not
1	issued. (b) to
13	following:  (1)
1	witness fees) reasonably
1	secretion of, any
1	 (17) return
1	related substances, including
1	plan for projects
1	subsection (c) but
1	beginning compounding that
1	internal use, when
1	compliance with food
1	amendments at initiative
2	briefs. (f) 
1	following notice of
1	panel review to
1	making a device
39	approved under section
2	chemical, or any
1	requirements beginning 6
2	report.  (4)
1	margin will be
2	determine the impact
1	required.  (d)
1	drugs and devices,
1	assigned to each
1	requesting assistance from
1	electronic products, he
1	alters the ability
1	use, paragraph[1] (1)(b)
1	jurisdiction. (2) the
1	associated with commingling,
1	intermediates and other
1	order; statement 
2	listed under subparagraph
5	means any of
1	records respecting information
1	professionals, and patient
1	evidence. except as
1	statements for inclusion
1	(1) at the
1	special license under
2	security countermeasures, and
2	level established under
2	term by the
2	term supplement means
1	title for administrative
1	aggregate  (i)
4	applications submitted under
1	warrant and for
1	manufacturing practice shall
5	intended for export
1	names of manufacturers,
1	meanings given to
1	inform himself concerning
4	product that the
6	date that such
1	concerning such products
2	40.0  
3	distribute controlled substances
1	product, including a
1	public. the updating
1	chapter. such certification
1	authorized manufacturer, repackager,
3	analytical tools to
1	data from outside
1	joint laboratory testing
1	(a) are of
1	reliefthe court shall
1	products, and inspection
18	determination of the
1	assessment of whether
1	42 that meets
1	(i) -(1,-dimethylheptyl--[(1r,3s--hydroxycyclohexyl-phenol (cp47,497);
3	2 years in
1	product which was
1	claimant after the
3	secretary finds will
1	(a)(4)(a) or a
1	make a submission
1	employer notwithstanding a
1	drugs; or (iv)
1	(i) conducts an
24	specified in subparagraph
1	inhalants and steroids)
1	source country programs,
1	detection, and surge
1	services shall conduct
1	shall maintain all
1	permit of such
1	appropriate for such
1	identifier may be
1	issue a rule
1	month. for purposes
2	upon pursuant to
2	reasonable variations may
1	sciences, and the
1	actions with respect
2	drug testing and
1	120 days. (iv)
1	products at establishments
1	substances shall be
2	listing a color
3	secretary shall carry
3	subject to control
1	(g) the date
1	17. penalty for
3	concerned with carrying
1	restitution, or other
1	violations were material.
1	inspection by any
1	local official in
1	defining distinct subpopulations
2	diet by increasing
1	food, means 
2	patent (including any
1	personnel reviewing applications
4	highly impracticable (because,
1	unless the local
1	notifications required by
4	request for information
1	manner described in
1	 (9) secretary
1	state law so
1	fine; but if
1	 (b) transfer
2	protecting trade secrets
1	(11) supplemental abbreviated
1	committee. (k) the
1	(c) facilitate, when
1	inaction of secretary
1	commission of, a
1	harvesting of a
1	deface a seal
1	proprietary food compound
1	botanical; (d) an
2	material change in
1	product that contains
1	(a) is life
1	funds in the
1	collaboration with public,
1	(ii) plans for
1	e of part
1	experts or scientists:
1	or, if returning
1	demonstrated that such
1	disciplinary actions, such
1	request for indexing;
1	recommendations for nonclinical
1	relevant exposure of
1	ch. 74, 11,
9	compliance with applicable
1	conclusions and recommendations,
1	drugs, or devices,
1	detection limit a
2	evidence that such
1	supply to a
1	subchapter. such regulations
1	published guidelinesnot later
1	safety, or where
2	obligated, modified, or
1	manufacturing of drugs
2	redactions for information
1	(and in particular
2	exposures for which
1	trial that is
1	year 2002; (6)
1	detention, in accordance
2	effective until the
5	person from liability
1	year 2009 multiplied
1	suspension the suspension
1	secretary to define
10	basis of a
1	foods in a
1	specific drug, from
1	use or to
1	paragraph (1) have
1	considered a record
1	states district of
1	states their purity,
3	required to conduct
3	outside of such
4	addictio-forming or addictio-sustaining
1	medicines, and liquors,
1	(a). such an
1	by, regulations of
2	manufacturer to comply
4	deleterious substance (other
1	revocation of authorization
1	control strategy, but
1	contain such pesticide
1	 schedule iv
1	(j) delayed, denied,
1	information available for
1	submission within the
1	eligibility criteria on
1	title; (ii) has
2	necessary; (ii) to
4	cleared or dispositioned;
1	proceedings to remove
1	healthy and a
1	(1) any drug
1	specific targets to
1	general the nmic
1	discretion, request that
1	panel recommends that
1	eliminated by labeling
129	secretary of health
2	person who exported
1	year nor for
1	litigation.  (

7	february 1 of
1	contact substance, there
2	date as specified
1	finds relevant or
1	subsection that suspends
15	(b) the term
1	securities used or
13	data and other
1	fee the annual
1	unless such manufacturer,
1	dosage form. 
1	commission, office, independent
1	quarantine laws that
3	new animal drug)
3	(a).  (ii)
1	practicable degree of
1	human services. the
1	data reviewed, inspection
1	(i) the practitioner
1	administrative subpena issued
3	secretary at the
3	reports on the
1	marketed by the
1	unique management of
1	judgment or dismissal
5	importer, distributor, or
1	qualifying practitioner in
1	community in which
1	invalid in whole
1	operations subject to
1	qualified countermeasure has
8	secretary or his
2	 (ii) subsequent
1	require that importations
1	substantially the same
1	change that produces
1	declarationscongress declares that
1	responsibilities of national
1	barium, chromium, copper,
1	aimed at destroying
2	(including the commonwealth
1	section 387f(e)(2) of
2	year 2008. 
1	foreign government. 
1	destroyed by law
3	secretary, after an
4	imposition or execution
1	officials, or other
1	possible, be community
2	shall adopt a
1	year, the commissioner
1	inspected device establishment,
2	evaluations under this
2	gas is a
1	drug involved. (ii)
1	entity or organization
1	meeting on such
1	regulation, and publish
1	financial hold 
1	days after, publication
4	(a) performance report
2	application the patent
4	review of devices
2	established a licensure
1	question, the secretary
1	final regulations. 
1	(qq) the term
1	pet foods on
1	wholesalers.  (2)
1	electronic circuit in
4	scientific, technical, or
4	sale at retail
1	 (b) period
2	paid pursuant to
1	clauses (i)(i) and
2	articles not inconsistent
1	duplication of research
2	title. (c) submission
1	 (ii) appropriate
1	1177. special project
9	administration.  (d)
1	reduce risks from
7	history of the
1	
 
 355c.
2	product is first
1	countries to facilitate
1	section); and (ii)
1	time for an
1	food. section 331(j)
1	 (e) classification
2	safety.  (2)
1	product; (c) the
1	marketed device to
1	informed as to
1	conveyances, including aircraft,
1	application before the
7	exported by the
4	shall provide notice
1	needed for inspection
1	director with the
1	(v) any other
1	order the classification,
1	address, and professional
1	substance use disorder
1	period applicable under
3	product, or device
1	determination for a
1	targeting of treatments
2	efficacy supplements filed
1	formulas, microfilm, tapes,
1	section 360eee(16) of
1	stoichiometrically equivalent level
2	2015, the secretary
2	slaughterer and transportation
1	food borne illness
1	application, or a
1	transportation, in violation
1	product application is
1	representation an individual
1	health, to public
1	product shall cause
1	adults, and effects
1	medical device regulators
1	due.  (h)
1	meetings as appropriate
1	notwithstanding section 125,
2	inspection within the
1	parts thereof, and
1	official establishment, under
1	transaction; and (ii)
1	(by majority vote)
1	organizations within the
1	(a)(ii).  (iv)
1	implementing this subsection
1	management plan agreed
1	dangerous to the
1	drugs provides the
1	(xviii) the distribution
1	extent practicable, in
1	nations and that
2	forfeiture to the
2	finds it consistent
1	may be moved
1	name, complete address
2	(b) on behalf
1	343(c), 343(d), 343(e),
1	demonstrate an adverse
1	sooner. if, however,
1	perjury, that the
2	regulation of poultry
2	costs of carrying
1	listed chemicals; restrictions
1	submissions pending issuance
1	improving regulatory controls
1	pediatric experts. (4)
2	 (i) 100
4	product or any
1	substantial danger to
1	progress and evaluations
5	4, 1923, ch.
1	(iii) facilitates the
2	concluded by qualified
1	efforts to combat
1	 (2) manner
1	court may require
1	professionals. (xi) state,
1	agreement the written
1	360e(g)(1) or 360e(g)(2)(c)
2	 (a) establishing,
1	previously been assessed
1	abuse potential, such
1	term dispenser means
1	geometric isomer. as
1	trials; (5) an
1	human consumption. 
4	may deem necessary
2	license a thir-party
1	section 1049 of
1	tobacco warehouses, and
10	law enforcement intelligence
1	predictive tools and
2	(1) prepare and
1	refuse or negligently
2	criteria:  (1)
1	 (a) enables
1	distributor anticipates will
1	registrations were suspended
1	1974.  (b)
1	title informing the
1	(a) grant eligibilityto
1	standing, medical research
1	state or is
1	complaint with the
2	compound, manufacture, salt,
1	year 2014 through
1	foreign sources of
2	subsections (f) and
1	imported product. (3)
1	authorized, as it
1	mean a raw
4	distribution of tobacco
3	receive any additional
3	confidential information subject
1	within such territory,
1	logically relevant factors,
1	3607 of title
1	licensing board or
1	gas. any such
1	chapter is revocable
1	federal funds paid
1	security or operation
2	barrel bears any
1	medical devices constitute
1	narcotics trafficker and
1	species (a) designation
1	year thereafter, make
1	abuse with the
1	treatment procedures in
2	 (i) reflect
1	(b) a request
2	(a) of the
1	animal drug user
1	may be or
1	foods.  (3)
1	substance abuse problem,
3	property to be
1	disease for which
1	(2) biosimilar biological
1	general, (2) shall
1	(a) discuss and
2	application meeting the
4	labor and human
1	paragraph (ff) in,
1	panel consisting of
16	forth in section
1	hypersensitivity to food,
1	applicable.  (b)
1	addresses the appropriate
1	device or importer
3	plan to be
2	obtained by a
1	subsections (d), (e),
1	safeguard and maintain
1	(jwh203). schedule ii
2	drug abuse training
1	marketing, advertising, and
1	claims, and patien-centered
1	drug control, and
1	eligible under subsection
2	 (1) during
1	subsection (c)(1)(a)(ii). 
1	period of prohibition
1	attorney general, such
8	deemed unsafe for
1	(b) identify opportunities
1	congress not less
7	district of columbia.
2	additive under this
1	 (a) federal,
1	drugs on the
1	warrants and arrest
2	pediatric studies were
1	675, 804, as
1	presence of nanomaterials
1	shall perform ris-based
1	shall publish notice
1	term responsible party
1	2003 as released
1	(including attorneys and
2	made only after
1	assistance; and (vii)
1	subsequent biosimilar biological
2	counterclaim seeking an
1	(b), the recommendation
2	requiring a device
1	packaging or labeling,
2	registrant has previously
1	requests shall only
1	regulation provide that
1	administration, except the
1	manufacturer for each
1	element of the
1	next quarter. (3)
1	approved drug, the
2	condition that occurs
1	litigation (including reasonable
1	reserve fee 
3	manufacture, processing, or
1	articles are found.
2	title, or with
1	habit forming because
1	(g) refund of
1	study.  (c)
1	efficient flow of
1	shall possess with
2	(b) to oversee
1	-cyan--dimethylamin-4,-diphenyl butane. (13)
1	filed and such
1	intelligence agency contained
1	(4), the amount
4	transfers ownership of
4	drug experience that
1	general notifies the
1	 (b) exclusionsthe
2	general shall 
1	707, as added
1	committed under the
1	areas, remaining challenges,
1	entity entered into
1	build the food
1	immediate precursor, included
1	agriculture may, at
2	number of personnel
6	inspections of the
1	testing be conducted
1	imported poultry article
1	year 2014 to
1	yearly and lifetime
1	record means those
1	clinical protocol) that
1	coloring or in
1	675, 569, as
1	offering food for
1	may ask that
1	medical food, any
1	(including an agricultural
1	modernization act that
2	may be determined
1	pharmacy has met
1	three times that
9	wholly or in
1	importation, manufacture, or
1	(b), or (ii)
1	violation occurs, file
2	fee account shall
1	removal from schedulesin
2	required to appear
1	 (7) responsible
2	committees, and contractors,
1	amount in the
1	murder; punishments any
1	cooperative agreements, with
1	designated; or (2)
1	effect; and (b)
1	sunscreen order stating
1	tool determined to
2	awarded, in an
1	production and trafficking
1	compounding physicians prescriptions
3	lieu of, any
2	animal drug, with
1	violated section 331(i)(3)
1	(f) and section
1	agencies. (2) each
14	drug administration to
1	(4) animal drug
1	subsection (b)(3)(a) shall
4	secretary to report
3	advise the person
1	failure until the
1	actions.  (h)
1	effect or benefit;
1	(ii) specify the
1	purpose is to
5	requirement of subsection
1	reportable food to
1	title, (c) knowingly
1	united states. (june
1	379i(8) of this
4	may award grants
1	bond of $100,000
1	dietary supplements (a)
1	(e) 1 gram
1	little cigarthe term
1	respect to growing,
1	proceedings for control
1	packaging outside the
1	subpopulation if data
1	restricted eggs or
1	distributor could not
1	application complies with
1	subsection, this subsection
1	lif-supporting; (b) lif-sustaining;
1	issuing a registration
3	(72 stat. 862;
1	360e(i) of this
3	 (g) rule
1	(2) designated agency
1	identity, and composition
1	thereof or cannot
1	application holder, or
1	turpitude. it shall
1	necessary action under
10	carcasses, or parts
1	described in item
2	regulations  (i)
1	volume derived solely
1	isomers. (l) 3,-methylenedioxypheny--propanone.
4	states and other
1	effect of tolerance
2	year 2009 (excluding
1	(10) manufacturerthe term
9	period of exclusivity
1	(e) (except the
3	title in connection
4	year; and (b)
1	manufacturing procedures or
1	policies by manufacturers
2	establishment or suspend
1	state, has become
5	process or treatment
1	payments to members
1	(2) in providing
3	standard which is
1	regulated under paragraph
1	data; factors 
1	controlled substances shall
3	critical control point
1	gas.  (2)
1	 (vi) sole
1	(3) denial information
1	355(i)[1] 360b(j), or
2	secretary the report
1	labeled for the
2	duly authorized representatives,
1	importer, including with
2	immediately. (ii) if
1	(n); or (xi)
1	(c) regulationsnot later
1	food processors; and
4	screening program described
1	regulations; (d) acknowledge
1	manufacturer or other
1	therapeutics, and enhancing
1	with, or that
5	extent that such
1	term health care
1	drug administrations procedures
1	1948, under the
1	provide the analyses
1	regarding the matter
1	 (3) inapplicability
1	worldwide. (4) there
1	distribution of adulterated
3	states for purposes
1	pathologic, or anatomic
2	term positron emission
2	sponsor shall pay
1	request and make
1	sponsor means the
1	sec. 1, 52
1	reaction; (vi) listing
2	achieved under united
1	conduct an onsite
1	suitable controls over
5	drug use in
1	given to any
3	section 356(c) of
2	party and the
1	fora on strategies,
1	manufactures, distributes, markets,
1	data. (h)competitive procedures.
1	(b) the dispensing
1	substances, including dietary
1	derived from sources
1	practice standards and
3	refunded for a
1	increased manufacturing rate
1	engineering products, human
1	247d6b]). (4) nothing
1	(b)(2) and (c)(2)
1	projects, or other
1	activity recognized by
1	rico. (c) the
1	title, applies, the
1	witness relating to
2	conditionswith respect to
1	conducts or sponsors
5	(b) hold a
2	certification or assurances
1	 (e) oleomargarine
1	circumstances shall this
1	labeling and consumer
1	format (including paper
1	18 for the
1	may apportion the
1	section or from
1	tobacco leaf that
1	funding.  (d)
3	make such notification
1	1906, ch. 3915,
1	secretary of 
1	nonvoting representatives. 
1	(1) a permit
4	paragraph (16) of
1	discuss and reach
2	et seq.], including
1	false statementsany statement
1	issued will be
1	(n) third party
1	expended, such sums
1	application, as provided
1	chapter, he shall
1	(1) utilize the
1	appropriate to enhance
1	requests were the
1	 (a) supporting
5	 (b) action
1	device, treatment investigational
1	funds toward such
1	later than 75
1	evaporated, condensed, or
8	manufacture, prepare, propagate,
1	conducted to assist
10	proposed use of
1	execution; probable causeissuance
1	852. application of
3	(aug. 11, 1955,
1	sentencing except as
1	history to the
1	trial for the
2	16 of the
1	straw, and coca
3	 (a) whenever
2	including patients, payors,
1	laboratory nor any
1	appropriate for protection
9	notice of an
1	medical devices manufactured
1	needs of persons
1	returns processor, or
1	(ii) describing the
2	paragraph (3), (4),
2	private research and
2	 (i) does
2	actions to expedite
1	drug as described
1	(ii) in applicable
1	milestones that will
1	label, distribute, and
1	less than every
1	covered under the
2	information requested pursuant
1	scheduling recommendation from
4	shall address the
1	states or territories.
1	specific exemptions provided
1	chemical in the
31	isomers, and salts
1	purpose, and the
1	must be executed
1	informal hearing) if
1	packaging requirement of
1	contracts, leases, cooperative
2	provided, if such
1	drug a summary
2	advantage, or reveal
1	applications in excess
1	use of verification,
4	conditions, any civil
2	commerce or holding
1	(i), providing the
3	measured from the
1	(iii) notice regarding
2	section, except that
1	672. administrative detention;
1	may vary from
1	section 387j(c)(1)(a)(i) of
2	clause (ii) and
1	reliable analytical methods.
1	subsection (c)(1) involved
1	applicable to all
4	small business (as
1	technical assistance, training,
2	assigned and the
1	amounts remaining in
1	characteristic is furnished
1	 (b) there
1	 (2) process
1	orders and decrees
1	security applications to
2	subsection (b)(2)(a)(iv) or
1	(b) provides a
4	subsection.  (6)
1	may transfer title
1	administration to reference
1	drug approval under
1	recruitment activities; (c)
1	immediate family, and
2	subparagraph (a)(i), a
9	forfeited under this
1	300f et seq.]
1	present or resides,
1	identified patient, if
1	bartered, exchanged, or
1	property, real or
1	regulations issued thereunder),
1	qualified facility for
3	entity means an
3	request, by the
1	wholesale to licensed
1	including gamma butyrolactone
1	(other than by
4	secretary may also,
1	facilities unless the
1	308, as added
3	title; (b) the
1	(b) an event
1	governments to assist
2	general the responsible
2	paragraph.  (6)
1	ounce, nor shall
1	 (a) law
3	partner, officer, director,
1	measures to prepare
1	entity, in preparation
1	term eligible partnership
1	importer. (j) 
1	inspected; (c) standardization
1	periodically publish in
1	(a)  [1]
1	times.  (5)thir-party
1	reactivation fee paid
2	priority in the
1	(1)(b), the term
2	subsection (b)(2)(b) shall
1	carrier by a
5	medical use in
2	chapter for as
1	protect individuals who
1	(4) material threat
3	food are used
1	consider binding on
1	(2) application 
1	proposed, with the
2	special controls pursuant
1	review. (i) judicial
2	center for each
1	29, 1938, ch.
1	human activities not
2	seal of such
1	annually to congress
1	knowingly and the
1	list of exempt
1	allocate such sums
1	occurs first. (iii)
1	commerce a product
1	1-month period prior
1	coordinationwith respect to
1	discuss possible processes
1	(c) limitation 
1	products, devices, foods,
1	historically been produced,
1	repackager intends to
1	animal drug, such
1	practitioners; pharmacies; research
1	personal use, any
1	administration, other government
1	reviews and recommendations.
1	result of testing
1	contact -mail address.
1	contact -mail address,
1	(d) carry out
2	chapter. (2) the
1	institute of standards
2	conducted in or
1	contain, as a
3	(other than officers
7	(ii) the number
1	chapter, and for
4	(g) crediting and
1	(including rapid analytical
1	2000, the secretary
1	chapter. (iii) a
2	pseudoephedrine, and phenylpropanolamine
4	subparagraph  (i)
1	(iii)[3] holding the
1	systemnot later than
1	affected product identification
1	45, 53, or
2	applicants submission shall
1	(f) abuse potential
2	stored or otherwise
1	written form and,
2	reasonably without cause
17	combination of nonprescription
2	to, access to,
2	effective operation. the
1	particular bacteria, fungi,
1	public service announcements.
1	capability of conducting
1	annual basis 
1	31, indicating whether
1	enforce the laws
1	neonates, such request
1	finds for good
2	tobacco that is
1	(ii) may, for
1	qualifications:  (i)
1	5, the secretary,
1	[7 u.s.c. 136a1(k)].
1	relationships, but may
12	shall by order
1	42, to provide
1	sufficient to establish
1	far as practicable,
3	historically have not
1	(7) priority in
1	registrations for the
1	(1) such property
1	conditions and clinical
1	(c) within 180
1	drug treatment programs,
2	operations affecting the
1	subsequent rulemaking proceeding
1	(a), include a
1	reasonable cost to
1	conclusions upon which
1	use as described
3	contract with an
1	cohort. (b) fiscal
1	iv.  (4)
1	govern proceedings for
1	resolution procedures for
1	industry, review and
1	 (m) feed
1	limitations in paragraphs
2	 (e) additional
1	suspension the secretary
7	wholesale distributor may
1	applicable state requirements
1	fusion, advanced computer
1	requests the head
1	(
 
 1801
1	drug, alone or
2	provide written recommendations
1	security, the chairman
1	interested parties, and
1	transported into any
1	(d) no delegation
1	provide a proposed
1	secretarythe secretary shall
1	section 355(i)(3) of
1	scheduling order issued
1	(c), as applicable.
1	agreement referred to
4	states of any
2	consider the following
1	170.3 of title
1	administration to participate
2	(ii)filing of civil
1	title as provided
2	part, or none
1	register under the
1	crime presents to
1	chemical residue; and
1	recovery activities following
1	datethe initial regulations
1	animals exclusively for
1	consulting center. agency
1	challenge.  (d)
1	food involved or
1	constitute a combination
1	private agencies concerned
1	formula or change
1	imaging drugs, an
17	written request for
1	above. in imposing
1	dispenser shall identify
1	dispensing practitioner shall
2	applicants firm or
1	trafficking through such
1	withholding of renewal
1	(f) travel expenses
1	assigned task that
1	manufacturing change may
1	act, the term
1	threat from acute
1	requirements or uses,
1	knowing departure from
9	year of the
2	(b)) subject to
1	economic area, within
1	lacks the ability
1	prescribe, the official
1	(d), (e), and
1	(1) within 180
2	class iii and
1	additive, or such
1	shipments of such
1	condition, weight, quantity,
1	determines causes the
1	intentionally use the
1	 (aa) be
1	magistrate judge issuing
3	earlier date specified
1	 (i) surrogate
1	 which was
1	circumstance involved. a
1	known, incidence of
1	section 1903(h)(2) of
1	(vi) infants and
1	healt-related condition or
2	registrant last made
3	 (1) animal
5	establishment in any
1	fee methodology 
1	notification or any
1	threshold level below
1	(i) the holder
1	schedule i. 
1	379j(a)(2)(b)(v) of this
1	monitoring by periodic
1	(4) limited distribution
1	standard, provisions for
1	available a list
1	infant formulas shall
1	27, 2013, except
2	states.  (june
5	violation, be subject
1	 (a) relating
18	841(b) of this
3	documents, if any
2	1974) and a
1	manufacturer the term
1	 (1) currently
1	 (b) docketing
1	licensed physiciana drug
3	owner of 10
1	existence of the
1	assessment in fiscal
3	exempted from inspection
1	inspection is maintained.
1	full compliance with
1	inspection and a
1	(cc) such information
1	secretary that advise
1	shall maintain information
2	enforcement action or
1	manner that prohibits
1	decisions regarding devices
1	regulatory science activities
1	required data and
1	product which, because
1	research, advertising and
3	device will not
1	purity of such
1	delivery, not to
1	requirementsno thir-party logistics
1	b medicated feed
1	expiration date under
2	subchapter.  the
1	provide the drug
4	given the applicable
1	dietary supplement, or
1	 (4) secretary
2	listed, upon the
3	ingredients of such
1	made after such
1	preceding 1996, with
1	projected completion date
3	electronic database. 
4	trading partners, as
1	periodic training on
2	respect to drugs,
2	human services with
1	(a) general rulewhenever
1	detailed plan for
5	prevent the secretary
1	recognized interpretive criteria
1	jurisdiction, which shall
1	cartage and labor
1	narcotic drug, controlled
1	standards and definitions
1	reports under such
1	misbranded, (ii) a
1	continuing criminal enterpriseany
1	(b) the reasons
1	production by type
1	(b) application 
2	persons shall not
1	equitable and not
1	period. (h) the
6	prior year appropriations
1	assessed fees under
1	1997 unless appropriations
1	illegitimate product means
1	provider for handling
2	antimicrobial active ingredient
1	(10) although the
1	capability for laboratory
1	title iii, 536,
6	article  (i)
3	may be distributed
1	subgroups.  (b)
1	paragraph (2), if,
1	program agency means
8	standards of evidence
1	exceed 20 days,
1	(3) other consultation
1	prevent the protection
1	reducing overall drug
1	state has reason
7	tobacco product. 
5	requirements of paragraphs
1	potential electronic product
1	u.s.c. 181 et
4	secretary shall order
2	harmonizing regulatory requirements
1	violation is found
1	(b) individual production
2	(b) regulations concerning
1	order and modification
1	groups, industry representatives,
1	ant-doping organizations coordinating
2	application (or supplement)
3	order because either
1	meet expected demand
1	ii pharmaceutical master
1	authorize any controlled
1	communication paid for
1	appropriate. (d) with
2	establishmentsin carrying out
1	treasury a list
1	of, substances mentioned
1	written, faxed, or
2	(2) on the
1	objections filed to
1	product tracing practices
1	(1)(e) the application
1	receive a section
1	fee amount for
1	approval the secretary
1	 (a) finds
5	facility subject to
1	substance, each registrant
1	subchapter to manufacture,
1	356c(g)(2) of this
1	processing fund created
1	process, and major
3	status of such
1	advertising, (c) it
1	(h) include procedures
1	exists, establish minimum
1	subsection (c)(4)(b), provided
1	(1) amendment of
1	(a) include, but
2	(1) priority review
1	public health priority.
1	court, of (1)
1	 (h) disposition
1	auditor shall prepare,
1	is; or (9)
1	condition in a
1	(c) prominence of
2	poultry, or the
1	(1), whichever first
1	(d) may regulate
1	conducting a recall
1	program of entering
1	(ii) alone, has
2	(a) the united
2	and, upon conviction
2	reproduce the trademark,
1	product and would
1	competent jurisdiction. (6)
1	using information from
3	compound, dispense, or
1	treasury shall by
1	admit, and may
1	health, and medical
1	renewed upon a
1	respecting changes in
1	combination with 1
2	thereof are submitted
2	master file has
1	later than nine
1	send the attorney
1	product in diagnosing,
1	meat is sound
1	section 360e(d)(1)(b)(i) of
1	efforts to address
1	(4) a significant
2	equal to 50
1	ant-drug communit-based coalitions.
1	clabels and section
2	1997 or any
1	scientist, who shall
4	provided, that if
1	862a. denial of
1	poppy straw and
1	specifications that were
1	(2) any action
1	reviews the financial
2	actions by the
1	recover damages for
1	requirements or does
1	attributes that are
1	secretary determines an
1	approved drug the
1	consistent with obligations
3	(bb) if the
2	order to comply
1	 (l) failure
1	protection agency, shall
1	(b) shall only
3	priority review, with
1	 (7) termination
1	details the countermeasure
1	options.  (d)
2	ii. (
 

1	level of pathogens
1	protocol which records
1	training; and (b)
1	necessity for the
4	provides notice to
1	products (a) processing
1	harm (referred to
1	may commence to
1	substantially duplicate a
1	(6) not more
4	continue to apply
1	subsections (g)(4), (i),
1	prescription drug originally
1	acts. (
 

1	barrels which shall
1	fines imposed under
1	pay payable for
1	section 3663a of
1	furnishing of a
1	(b), the person
1	revoke a designation
1	streptomycin, chlortetracycline, chloramphenicol,
1	requirements referred to
1	consumer information and
2	establishment bear, in
1	manufactured the product;
1	methylbromide. (15) morphine
4	paragraph (2), to
2	maintain a transcript
1	order, the administrator
1	scientific evidence, taken
3	physician who is
1	governments and by
2	substance analogue to
1	25 of title
6	(as compared with
2	person, with respect
4	result of an
2	shall approve an
1	method of notificationthe
11	subparagraph (a) that
1	consistent compliance with
1	best available market
7	relating to any
1	hampered by a
1	wrapper, if any
2	shall be consultation
1	constituents  (1)
1	facility, or (b)
1	continue, modify, or
1	denial.  (d)
3	certification shall be
1	submission by any
1	determining the need
2	(cc) of subclause
1	substances is essential
1	(j) coordinated communication
1	commerce any article
1	animals annually. (qq)
1	domestic activities conducted
1	fees collected and
1	deposited with the
9	device described in
1	pseudorabies eradication (a)
1	formula is sold
1	specifically the causes
1	title, at which
1	secretary, and (ii)
1	(6) includes a
1	necessary information. 
1	national is outside
1	technical feasibility of
1	interactions represents the
1	statute, executive order,
2	available for grants
1	regulations; administration and
1	secretary to participate
1	(e)(1), or (f)(2)
1	pediatric formulations; (c)
1	 (iv) availability
1	subsection (g); (2)
1	chemicals and certain
1	410
 
 129.
1	carry out section
1	receipt in interstate
1	rule of practice.
2	facility fee is
1	(but not later
1	(e) distributors of
1	213 of schedule
1	material information from,
1	recalls of infant
1	unless deemed necessary
1	outcomes  (i)
2	paid to the
2	(3) duties of
1	(2), (3), (6),
1	independent agency, use
1	dismiss or for
1	performance standard, or
1	added to any
1	conditions on, product
1	addressing chemical, biological,
1	resolve those deficiencies;
1	control policy established
1	located not more
1	placed, who claims
1	 (f) nonprofit
1	(1) any felony,
4	emission of electronic
2	applicant  (a)
2	paragraph; and (ii)
1	article entered commerce.
1	section 2223[1] of
1	subject to processing,
1	(2) membershipthe council
2	commitment by that
1	controlled substance, possession
2	pediatric subpopulation for
1	claim, civil or
1	computed in accordance
1	manner as though
1	(i) is named
1	year. unless the
1	support the united
2	owner, part owner,
6	comments received under
1	individual (who is
1	amendment or repeal;
1	available alternative drugs.
1	residues which pose
3	different from or
1	device which has
4	owner engaged in
1	 (b) recordkeeping
2	product standard for
1	extraterritorial jurisdiction over
1	drug;  (b)
1	whose positions are
1	including appropriate instructions
1	respect to anything
1	(c) an infused
1	4365[2] of title
1	seizures of property)
1	12 months before
1	approval is filed
1	(iv)  section
1	dioxide, use in
1	product when distributed
1	implicitly or explicitly,
1	(xv) the distribution
4	(a) has been
1	thereafter, all such
1	subsection is deemed
1	nonconcurrence with review
6	state and federal
1	conditionsa drug master
4	ii may be
3	products processed at
1	(2) to develop
1	conditions of safety;
2	substance abuse is
1	class ii. (3)
2	written application by
1	views upon which
1	secretary last amended
1	are, collectively, a
6	applicant is seeking
2	clinical testing plan
1	fiscal year, but
1	direct the food
1	marketed as an
1	claimant for such
1	77, 58 stat.
1	accreditation for analyses
1	deferral; and 
1	implement coordinated enforcement
2	condemned meat food
2	(2) if an
1	states or groups
1	whether by transfer
2	(a) such drug
1	product. (b) expiration
1	fiscal years 2015
1	wholesale distributors, for
2	(1) the date
1	evaluate the allocation
3	paragraph reasonable variations
1	expanded access protocol),
1	within 120 calendar
1	
 1703. appointment
2	violate requirements under
1	administration should coordinate
1	
 
 379j1.
1	term suspect product
1	(i) audit the
1	appropriate to provide
3	contracts under this
2	secretary, to the
1	analytical methods used;
3	change that the
1	importation; and during
1	form the basis
1	 (1) good
1	food; (ix) such
1	secretary that includes
2	authority to collect
1	suspension should be
2	willing provider from
1	strength, and dosage
1	(d) panel recommendation;
3	actions taken by
4	drugs, categories of
1	may be affected
1	(h) delegation authority
1	histories; (5) includes
1	hearing transcribed at
1	columbia, guam, the
8	(6)  (a)
1	recognition of standard
1	(ii)request for specific
1	require an application,
1	care intervention, or
1	document that, with
1	imports; list of
2	thereafter imported under
1	identifying by the
2	mitigation of such
1	biologic/device, or drug/device/biologic)
1	offense, the person
1	filed. (b) modification
2	member of a
1	food samples promptly
1	director considers appropriate
1	measures; (iv) requests
1	beneficial in helping
4	means a supplement
1	(c) application fee
1	degradation. (ii) in
3	emergency declaration pursuant
1	 (f) definitions
1	proposed tolerance is
1	803. repealed. 

1	performance of accredited
1	(d) (relating to
1	article because of
3	proximate cause of
7	drug applications, and
1	controls; (ii) request
1	inadequate, (b) in
1	recognized scientific, medical,
1	review or any
1	fine of $2,000,000
1	
 
 379a.
1	if, notwithstanding a
1	agriculture a permanent
1	determine whether products
5	laboratory analysis of
1	(4) consult with
1	disease  (1)
1	entry the foregoing
1	laws, regulations, and
1	 (a) eligible
1	directorin carrying out
3	members of any
1	facility where sel-service
2	comment (including through
1	prison, such fines
1	found necessary by
2	sunscreen order, the
2	state at any
1	379dd1. location of
1	food additives, to
2	insofar as feasible,
1	submit the postmarket
1	2016, the ombudsman
1	person more senior
1	paragraph (2)(a) or
1	exceed $75,000. (h)
2	swimming pool, or
1	review of qualification
1	262]. (2) relation
2	determination as referred
1	review devices designated
1	best practices, as
1	title, is required
1	seq.], or (2)
3	times and in
1	exposed or are
2	continue to apply.
8	electronic product radiation;
1	name of transferees,
4	importation of any
2	5 years, a
2	1, 1971. in
1	reasonable probability; or
1	electronic product radiation.
5	electronic product radiation,
1	(b) are not
1	development of and
1	ketobemidone. (27) levomoramide.
1	620. imports (a)
1	meaning comparable to
11	policy of the
16	delivered to the
1	(i) amendment or
1	(c) necessitates medical
1	remaining after payment
1	data. (iv) an
2	chemical, at such
5	day before november
2	otherwise authorized for
2	conducting inspections that
1	(a) a statement
1	use of recall
1	appropriate action is
1	principal administrator, organizer,
1	pursuing the application.
1	hearing whether the
1	exemptions and exceptions;
1	(c) smokeless tobacco
2	pertinent equipment, finished
7	secretary.  (2)
1	363. regulations making
2	subsection unless the
1	features; and (iii)
1	repackager, including any
2	available without conducting
1	served upon the
1	positron emission tomographic
2	submissions for devices
1	
 
 360bbb2.
11	device, tobacco product,
8	360c(f)(2) of this
1	motion for dismissal
3	(ii) cleared product
1	agent for each
1	(b) authority to
1	instances shall be
1	provide reimbursement for
1	insure the security
2	meetings described in
1	(
 
 397.
1	emissions of, and
2	may be delayed
1	corrective actions taken
1	(xii) practical methods
1	ii device from
1	(v) to provide
5	attorney general a
1	(b) assistancethe secretary
1	person exceed the
1	(a))  (i)
1	public notice the
1	products transferred to
1	examine and identify
1	explicitly or implicitly
8	quantities of the
1	allowance for use
4	operates an establishment
1	requests submitted to
1	time for submission
2	public evidentiary hearing
1	accredited persons, whether
2	fine not less
1	advertise the sale
2	case of raw
1	product. in providing
1	availability of animal
1	provision shall not
1	business systems for
3	applied pursuant to
1	information obtained in
2	section and that
2	article being offered
2	prescribe conditions under
3	dispose of the
1	including demand reduction,
1	paragraph) to be
1	limit on secretarial
2	section 830(b)(3) of
2	patent infringement litigation
1	citation to all
1	379j1(a)(1) of this
1	compendium. such determination
1	coffee, that is
1	public. members of
1	$20,000,000; and (ii)
1	effective in the
2	label subparagraph (a)
1	comprehensive review of
1	national exercise program
1	food additive shall,
1	reimbursement an order
1	companies, relevant professional
1	action involving private
1	revoke, or renew
1	sale and delivery
1	adoption of novel
1	business practices and
4	type or lettering
6	(c) if it
1	considerations set forth
1	constructionno determination, finding,
1	funds by the
1	12, 1943, ch.
3	used in any
1	minimizing or preventing
3	change and the
1	amount in determining
1	request containing the
1	year 2009, $85,000,000
1	products are prepared
2	(in a manner
4	imitation of another
18	reports to the
1	postmarket data collection
2	information without attempting
1	frozen, or liquid
8	means the secretary
1	(e), respectively, of
4	valuable constituent has
1	strategy. (c) general
1	cream is prohibited
2	state is producing
1	germicide, except in
1	quantity of cannabimimetic
4	 (b) reports
1	october 2011. (4)
5	products capable of
1	(1) registrationthe secretary
1	(1) contrary to
2	traditionally and usually
1	advised and accompanied
1	patients. any criteria
1	product could represent
6	accredited thir-party auditors
1	may establish multiple
2	may be initiated
1	ingredient standards and
1	employed pursuant to
1	distinguish, in terms
1	permitted to inspect
1	contamination at critical
3	meet the purposes
1	511; 
 

5	respect to devices,
1	informative summary required
3	360b(c) of this
1	used herein, means
1	secretary before an
6	may present a
1	repacks it in
4	executive officer of
1	provides a report
2	upon goals and
1	title) means an
2	tests and investigations
1	work with eligible
1	measured and evaluated
2	foreign commerce, or
1	paragraph (2), or
1	radiation; (b) the
1	shall file a
2	safety; and (b)
1	regulation, exempt any
1	1048.)
 
 350e.
1	food or offering
1	subsection (b). (3)
1	subsection (b)(2)(a). 
1	shall examine whether
1	entitled to an
1	order approving such
1	severability if a
1	assessments; (e) whether
3	submit the human
1	treasury a trust
1	procedures (including rapid
3	including a description
1	hand; and (3)
4	consigned to a
1	groups, and disease
8	unless  (a)
1	regulations prescribe, not
4	applicable.  (3)
1	(4) effect on
1	shall coordinate such
1	importation by debarred
1	research, rehabilitation activities,
1	regulation prescribing, with
1	promotion of compliance
1	means any domesticated
1	(6)affiliate.for purposes of
1	customer of a
1	drugs has been
1	areas program (a)
2	pesticide residue monitoring
2	1949 (7 u.s.c.
3	supply reduction, demand
2	person under subparagraph
1	sponsor;  (c)
1	record the delivery
1	chapter referring to
1	tobacco regulation activities)
1	2021, the comptroller
2	(1) shall document,
1	262] that is
1	paragraph (5)(b) not
1	subsection (a)(1), a
3	(iv) for which
1	specified therein, but
1	use; and (e)
3	coloring) present in
1	ch. 675, 304,
1	section, 70 per
1	verification program of
1	6, 1896 (u.s.c.,
2	(f), if the
1	packed in any
1	purchase by an
1	change; or (c)
1	drugs compounded by
2	appropriate to address
1	suspended, if that
1	title was in
2	factors specified in
1	material transfer agreements,
1	nature and, if
1	powder, softgel, gelcap,
1	sponsors and investigators;
1	approval of applications
2	notice is issued
1	state, unless there
1	size to facilitate
1	requirements domestically and
2	shall publish it.
1	acceptable conspicuous locations
1	later than three
1	rata amount, determined
1	data in premarket
1	clinical trialthe purposes
3	deceptively packaged food
1	investigators that patients
1	security to achieve
1	importance of such
1	expedite any application
1	report about a
1	classification shall not
1	writing, waive its
1	 (f) each
2	(d) and agrees
1	using the -year
1	rates exceeding the
1	health officials to
2	payments), provided that
1	notwithstanding clause (ii),
2	drug or combination
1	deferred adjudication, or
4	inspected by the
1	individual or individuals
2	consulting with the
1	established for collection
10	general is authorized
1	whether electronic tracing
2	food products which
1	years 2003 through
1	reviews include all
1	construed in a
2	variance under the
4	approval of application;
1	expended, without further
5	owned or operated
1	extension, if granted,
1	 (h) farm
1	regulatory requirements, and
2	including the scientific,
1	26, 2014; and
1	federal register. (3)
1	vegetables and (2)
1	section.  (9)
1	contracts; employment of
1	order set forth
1	expenditure prohibited an
1	specifying those parts
1	including borrowing by
1	wholly within the
1	notification, the abbreviated
1	agreement shall provide
1	presence in interstate
3	may rely on
1	labelingnot later than
1	device is used
1	shipping container used
2	registration of outsourcing
2	 (c) fee
1	food safety surveillance
2	review under clause
1	(2) substituted wholly
1	foreign commerce. a
3	group are geographically
5	violation of a
1	decomposed substance; or
3	subsection (g) is
1	investigation may be
1	penalties.  (

6	recommendations under paragraph
2	advertising and labeling
2	substance, except that
1	related activities; and
1	carbonate of zinc,
2	(1). (b) if
1	added mar. 16,
1	product establishments and
1	 (a)in general.no
1	administration that may
1	colors the secretary
1	procedure under which
1	controls would not
1	(c); or (3)
3	abbreviated drug application.
1	1988, no application
3	food; or (ii)
1	toxicity; (vi) available
1	(d) not require
1	act[1] [21 u.s.c.
1	commissioner.  (i)
1	cooperation with any
1	domestic and international,
1	training  (i)
1	notify all persons
1	abbreviated drug application;
1	time as that
5	2013 (except as
1	marketing exclusivity for
1	transported into the
1	plan; (d) the
1	health care professional
1	(i) any dispute
1	seq.]. (z) the
2	applicant submitted a
9	biological product establishment
2	storing, or transporting,
2	describe the predicted
2	(c) the national
1	methods in order
1	data. (c) situations
1	activities, records, and
1	(a) compliance with
1	national marine fisheries
2	technologies, including technologies
1	application effective for
1	approval will be
1	control number assigned
1	name included in
1	misbranding described in
1	efforts, to further
7	shall apply only
1	request by such
1	person. (f) correction
1	single lot. 
1	believes similar authorities
1	used by consumers,
1	section, to enter
2	mitigate, prevent, or
1	will remain substantially
1	notifications, and any
4	387a(b) of this
1	including the advisory
1	10.85(d)(1) of title
2	in, plants inspected
2	regulation applicable to
1	4 additional -year
1	methamphetamine; (f) allows
1	use for any
1	cause harm. 
1	information. paragraph (1)
1	it. (c) approvalthe
1	interested parties, including
1	shall include complete
1	meets all of
2	grants and for
1	amount for the
1	official shall grant
1	written agreement under
7	(ii) of subparagraph
1	generalif  (a)
1	secretary. (c) no
4	susceptibility testing device
1	participation and greater
1	failure to carry
1	drug activities, be
3	will aid in
2	different animal drug
1	terminate on the
1	
 321c. nonfat
1	furnish false or
1	approval; relationship to
1	secretary, including information
1	data. (june 25,
2	another person unless
1	review five years
1	labeling required by
3	esters, ethers, and
1	(d) inspection of
1	effective in decreasing
1	360b(h), and 360b(n)
2	limited use or
1	authorized committees and
1	productssubparagraph (a) shall
1	voucher.  (ii)
1	 (j) representation
1	section 952(a)(2)(a) of
1	certification of colors
2	enforcement administration is
1	individual.  (d)
1	food, which is
1	ingredient that 
1	rail vehicle (other
1	(5) sustainabilitythe coalition
5	surgical intervention to
1	represent breakthrough technologies;
1	dismissed from the
1	hydroxybutyric acid (ghb)
1	(1), for purposes
3	use be withheld
1	willing to provide
1	administration electronic gateway,
1	duties  (1)
1	subsection under subsection
1	urban consumers (u.s.
1	supplemental application, the
1	foreseeable hazards that
2	practices and shall
1	preparation and sale
1	eligible product means
1	represent breakthrough technologies.
2	carcasses, or meat
1	may add species
2	(after affording opportunity
1	(c) employing all
1	thereon, shall be
1	 (a) focus
1	final) assessed under
1	issued on secretarys
1	requirements of general
1	standard for clearance
1	start program or
4	event reports by
2	hearing held with
1	favorable benefi-risk profile
5	(b)(1) and relied
1	(2) recommendations if
1	support a number
1	labeled as inspected
1	denial of application
1	postal service shall
2	person that on
1	information in pediatric
2	applied nutrition of
1	
 387e. annual
1	tobacco and to
1	determines aids drug
2	accredited thir-party auditor.
1	communicate comments on
1	give priority in
24	secretary shall ensure
1	contaminant in the
1	applicationthe term covered
2	thereof, bearing any
1	chapter if the
3	(c) rule of
5	persons, firms, and
1	basis among governmental
1	comment of not
1	limiting the importation
1	twenty grains. the
1	information clearinghouse or
1	states attorney that
1	products in order
1	knowingly obstructed an
1	testing program which
1	106.30(c)(2) of title
1	applicant could become
2	certificate; (4) knowingly
1	effectiveness for purposes
2	tobacco product distributed
1	intended. (2) the
1	product and who
1	committee from using
1	42; (xii) a
1	section to conduct
1	scientific evidence (within
1	foodsubsection (a) shall
3	calendar year. 
2	committee participated in
1	conditions (a) authority
1	(b) reportthe united
1	whenever tests or
1	 (4) knowing
1	title, section 360i
1	sunscreen, including pursuant
1	time with respect
1	timeliness or quality
1	
 680. authorization
1	facts and all
1	secretary disapproves the
2	including the effectiveness
1	information for audit
1	prison sentence for,
1	resources in the
1	(ii) such additive
1	date of issuance;
1	affect whether the
1	direction and oversight
8	required to submit
1	facility identifier systems
2	acquired under the
1	ii who intentionally
1	food if a
1	investigating animal disease
1	receiver, or any
1	children whose physical,
1	facility of a
1	funds for testing
1	device, and annually
1	agency, 10. (f)
1	(5) enforcement of
1	aggregate amount the
1	
 360fff3. grase
1	101. suspension of
1	funding level was
1	partnerships to coordinate
1	order or in
1	15 days but
1	(2)(a)(ii) shall take
1	pays any fee
1	section, that person
1	prohibit administration of
1	information between governmental
2	secretary a serious
1	protection; or the
1	diseases, there is
1	civil penalty, may
2	issued because the
1	single enantiomer not
2	subsection (a); or
2	changes if, on
3	requirements under subsections
1	experience, or caused
1	exclusion under this
2	classify the device.
1	year, or any
1	(b) special effective
1	administrator may treat
1	decline participation in
1	 (c) 28
1	order in effect
6	continuing criminal enterprise
1	petitioner.  (g)
1	date for any
1	sticker affixed to
1	including a statement
6	geometric isomers, and
1	customs officer. 
2	integrity needed for
2	facility meets the
3	term capable of
1	payments involve any
1	(1) availability of
1	applicant, written feedback,
1	officer or any
1	combination of words
1	excludes any controlled
1	tobacco product definedfor
1	device. within 30
1	dissemination, to enhance
1	physician assistants, or
6	approved or pending
1	attorney general designated
2	perform, as soon
1	(d)(1), the comptroller
1	(f) investigational uses
1	clause (ii)(i), in
1	attorney general designates
1	secretary and immediate
2	 (c) application
8	pediatric advisory committee
2	taken into account.
1	requested for that
1	(1) on a
1	biological products a
1	offense, including the
1	practices  (1)
9	issued under such
21	terms and conditions
1	act of 1978,
2	meeting request described
1	special needs of
1	used in their
1	analytical methodsthe secretary
1	(10) carry out
1	interagency agreements to
1	program goals of
2	title, including any
1	president, it shall
1	requirement of subparagraph
1	facilities the services
1	spent during the
1	tobacco product fully
1	(1) instructions, oral
1	individuals to whom,
1	(
 
 360d.
1	regulations referred to
2	held and not
1	sale to a
1	kept under this
1	guidance documents with
1	regulation, prescribe restrictions
1	plan contained in
1	uses of an
1	2008 and $210,000,000
1	prescriber. (mar. 3,
1	therapy under section
9	shall be not
1	require nominees to
1	(a)action package.the secretary
1	paragraph shall subject
3	referral to advisory
3	tribal department or
1	(2), the order
1	secretary. the importation
1	may be) and
1	(iii) may engage
10	including per diem
1	devices, although such
1	assistance under any
2	supplier who has
3	ant-doping agency shall
1	means to provide
1	discretion, seize or
1	poses an imminent
6	shall contain such
1	identifying each of
1	united states exceeds
1	greatest contribution to
10	court may order
1	offenses which are
1	regulations thereunder, and
1	685.)
 
 960a.
4	applicant with respect
1	general control the
1	991; apr. 15,
1	it. if, within
1	 (8) illegitimate
2	state designated under
2	2012, any person
1	source of nutrients
1	without amendment or
2	expiration of one
1	substance is ethylene
1	conditions for using
1	18; (v) establish
1	similar food safety
1	way in violation
1	fda staff510(k) device
1	3 years, the
1	package level, not
2	subsequent periods following
1	262(h)]. (ii) the
2	benefits under the
1	18.  (g)
1	commerce, as renderers,
1	action, be tried
3	will be necessary
1	establishment.  (g)
1	title. (b) notwithstanding
1	affirmance of such
1	can, tin, pot,
1	patients insurance provider
4	meet with the
1	drugs, including substances
1	states, between states
1	final and unappealable
1	(b) licensure of
3	otherwise serving at
1	645. federal provisions
2	distributes a controlled
1	abuse treatment programs
2	leave such facility
21	qualified by scientific
1	advisory committee. (b)
1	process the secretary,
1	(f) manufacturer conduct
1	public interest. 
1	issued, an alert
1	effect a conditional
7	establishment fee for
1	(a) and found
3	delivered by the
1	tool and the
4	food additive, or
1	used for egg
1	opium or opiate.
1	substances, which may
1	impose any eligibility
1	supervise the operation
1	marijuana, particularly hydroponically
1	establishments for which
1	certain activities (a)
1	manufacturer and who
4	chapter by any
1	specified date shall
1	found under paragraph
1	amounts fees under
2	drug product shall
2	knowledge and belief:
2	authority of any
1	ch. 675, 511,
2	supplement to pending
1	permitting a tobacco
1	physician assistant who
3	section 360c(b) of
1	(f) prevention and
2	period such device
5	adjustment made each
1	tropical disease or
1	2014, under section
1	agricultural chemical solely
1	assistance of a
1	possible but not
1	general may also
1	substance abuse; and
1	(2) may enter
2	determines that additional
1	advisory committees, as
1	custody, the court
1	safety, may by
1	information. the person
1	drug be more
1	rarely been held
1	requires the information
2	subsection (i) of
1	factor levels, and
1	applicant. (ii)definitions.in this
1	man, the storage
2	activities, as well
1	$7,429,000 for fiscal
1	develop model standards
1	significance of the
1	health organization respecting
1	web sitethe secretary
5	subsection (i) or
1	(i) the failure
1	otherwise permitted under
2	secretary shall endeavor
1	 (jj) the
7	obligations of the
1	regulations, subject to
1	voucher is transferred
2	focused on the
1	findings requiredexcept where
1	scheduled under the
2	2007. (
 

1	article is adulterated,
1	time. the recommendations
2	drug pollution fund
1	information, the seller
2	obtain a license
1	(f) minimize the
4	certain small establishments
2	assesses a civil
2	federal drug law
1	d-identified surveillance data
3	well as of
1	exercise responsibilities relating
1	residue only if,
1	immediate risk of
1	evidence apply to
2	shall, insofar as
1	analyze how to
2	manufacturer to the
1	section 202).2 (d)
1	sulfondiethylmethane. (9) sulfonethylmethane.
1	application therefor by
3	active investigation of
1	enforcement entities participating
1	olympic committee means
2	marketing, outside the
1	office in resolving
1	pilot opportunities that
1	memorandum shall include
1	international agreement; or
1	drug administration, as
1	interim review of
1	agency is submitted
1	number of countermeasures
1	establish the status
1	science, or poultry
1	470[1] of this
1	term catfish may
1	similar benefit, or
1	section 351(a)(5) of
1	360eee(9)(b) of this
1	country, and (c)
1	recommendation or report
1	approved strategy or
36	secretary under this
1	(3), which members
1	section 351(a)(5) or
1	(2)(a)(vii). the approval
1	reference product a
1	funding for law
1	 (e) definitionsfor
1	drugs are identified
1	 (2) which,
1	distinctive nutritional requirements,
1	notify the advisory
1	conducted outside of
4	effective for the
1	section 453(a) of
1	requested, the name
1	potential signal of
2	term valid prescription
1	apply by reason
3	credited as offsetting
1	1996)). (4) the
1	presenting the demonstrable
1	including any tolerance
1	(b) auditthe government
2	secretary; or (12)
1	necessary, in sales
1	license, approve another
1	regard to 
1	engaged in development
1	effectiveness provides the
1	responsive to the
1	required to establish
1	(a) is engaged
1	$3,200  $3,750
2	complete operating reserve
1	agency shall ensure
1	investigator who uses
1	substance, is in
1	services shall make
1	involvement of advisory
1	information forwarded to
2	consignee, or incorporated
3	device; and (ii)
1	process an active
2	award any priority
1	(5), which members
1	designs or devices
1	secretary may immediately
1	term petition means
1	title, a dietary
1	drug which may
3	collectionsfees collected pursuant
2	acts, uses a
1	whose prescription drug
1	court shall amend
1	investment of illicit
1	hearing shall prepare
2	regulation, promulgated in
1	rule for 2013for
1	practitioner submit to
2	subparagraph (a); (ii)
1	person or who
2	order following publication
1	(iii) flunitrazepam; or
1	writing to congress
1	meeting is necessary,
2	title, that such
1	(e). as used
1	particulars of both
2	relating to articles
1	delegate. (j) the
1	technology in terms
1	institute is being
1	physicians prescriptions, except
4	interest in property
1	distribution schedules. (d)
1	compelling local conditions;
4	new indication for
1	items. no person
1	paragraph to have
1	compelling local conditions,
1	upon a testing
1	20 years, subject
1	communication facility means
1	
 610. prohibited
1	residues, and (2)
1	transaction history which
1	 (4)2 congressional
1	days established by
1	postapproval studies to
2	methamphetamine in the
2	equipment or container
1	(
 
 824.
1	 (1) information,
1	regulation; and 
1	safety information or
1	360e(e) of this
1	foods, drugs, medicines,
3	safety information on
1	distribution is to
1	 section 355f(a)
1	transfer the supervision
1	requirements under guidance
4	biologics evaluation and
1	refused articles pending
1	banned for use
1	(2)(a)(vii)(iv) and for
1	court (within 30
1	indexed product. extr-label
1	(c) pricing data.
1	collection, to identify
1	transmit the notice
1	possess scientific or
1	drug sponsors). (c)
1	responsible party as
1	administrative inspections thereof,
1	(g) review 
2	control. if the
1	recall involves a
2	greater of 
1	regarding recovery for
1	aggregation and inference
1	fide research with
2	defined in clause
1	package for 
11	manufacture, processing, packing,
1	subchapter i from
1	title, classifying devices
1	case of sem-critical
1	response network of
1	devices, the name
1	published writing. 
1	title. (3) no
1	public comment, the
1	carrier or person
1	resolving the substantive
1	understanding of drug
1	feedback letters as
1	foods; and (d)
1	(a) action is
2	established by subsection
1	nearly identical to
6	charge of the
2	use if such
1	designated gas or
3	(iii) of subparagraph
2	register notice not
1	congress; (iii) state,
1	full study reports.
1	believes may be
1	approval because the
1	2017, after the
2	12 months ending
4	paragraph (2) shall
1	audit agent; or
1	report including suggestions
1	in, such state
2	means the total
2	subclause (i) does
1	declaration may include
4	order shall not
1	following any accreditation
1	high risk populations
1	expedite the secretarys
2	submits the report
2	2013), prior to
1	including subpart b
1	7 u.s.c. 1621
3	shall keep such
1	recordkeeping requirements (a)
2	advertising or other
1	approvalif the secretary,
2	prescribed to prevent
1	 (iii) facilities
1	intermediary used or
1	containing a tentative
1	rule issued by
1	shall meet, with
1	360m(a) of this
7	definitionsas used in
1	may influence an
1	limit a tolerance
1	prevent the specific
1	execution of his
1	unsafe devices; (2)
2	address or telephone
1	wrapper thereof is
1	training programs the
2	containing cocaine or
1	applications that has
2	adulterated such that
2	timelines set forth
6	leave to adduce
1	1114. repealed. 

1	as, a tobacco
1	application, (b) an
1	suppliers. (
 

1	tolerance, exemption, food
1	pecuniary value for
1	(e) implementation 
1	(2) processing standards
1	person, the procedures
1	
 
 615.
1	every establishment described
2	organizations as authorized
1	enactment date) an
2	fees specified in
1	fund, under section
2	information respecting any
1	ant-drug media campaign;
1	control strategy. (b)
1	(a) authorize the
1	persons outside the
1	term modify shall
1	purpose. (
 

2	debar such person
1	tortious conduct; or
1	providing additional service
1	labeling to reflect
1	color additive will
1	may be branded
1	filled if 
1	drug that are
1	training programs. (6)
1	making requirement[1] or
1	another device; (ii)
1	class iii, establish
1	rule 15 of
1	instances of reportable
1	facility, is (except
6	conferred on the
1	disseminated by, or
1	
 360bbb3a. emergency
1	preventative controls, except
1	application upon application
1	compound physicians prescriptions,
2	distributors, or retailers
1	multiplied by (ii)
1	potential contaminant in
1	priority review, the
4	prescription drug or
1	finds, after affording
1	found on united
3	distribute, before further
4	extent permitted by
3	fully to inform
1	chapter. (b) before
2	25 employees. 
2	fees.  (e)
1	1 (cb1 receptor)
1	(ii) the established
1	days after october
1	identifierswith respect to
1	provide a certification,
1	respective internet websites
1	1996. the administrator
1	data furnished to
1	develop, support, and
1	shall subject an
2	(1), the person
2	penalties any person
1	internet, if the
1	sixteen and on-half
1	summary via at
2	application to have
16	secretary shall review
1	compliance for any
1	manufacturer means, with
1	day of each
1	surge capacity during
1	amenable species; and
1	implant and then
1	report shall contain
1	rules of evidence.
2	cream is produced
1	america) wherever feasible
1	national formulary, and
1	(d) voluntary nature
1	(m) admission a
1	202(a) of title
1	number of disclosures
1	(2)(a).  (b)
1	strategy.  (c)
1	discharge or discrimination;
1	oil or cake
1	construed to affect,
1	take such testimony,
8	section.  (c)
1	transfer, withdrawal, transportation,
1	ability to complete
1	subchapter. (3) all
1	portion.  (v)
1	discharge or discrimination,
1	food product referred
1	upon objections filed
1	rapid detection of
1	producers raising poultry
1	party or in
1	consideration  (i)
1	following review of
1	(cc)substantially complete application.
1	condensed, or powdered
1	(2) evaluation of
1	tobacco in a
2	(d) misbranding if
1	organizations, and researchers
1	second notification to
5	notification shall be
1	tomography drug and
1	conditions:  (a)
1	of, such purchases.
1	limiting any other
1	good quality in
1	additional foods. (2)
8	states means the
1	concentration proposed, the
1	hearing is not
1	methods, consensus standards,
1	effectiveness and describe
1	(viii) a determination
1	minor species. such
2	accordance with federal
2	obligation or expenditure
3	development and administration
1	manufacturer shall treat
2	subsection (a)(5)), verifying
1	public participation prior
1	longer pursuing the
1	
 1045. limitation
3	(a) the controlled
2	(2) designated personnel
1	civil penalties. (

1	categories of drugs
2	subsection (b)) subject
1	judicial review), shall
5	title or subsection
1	subsection (b), (f),
1	(b) filing application
1	harmful products for
1	hearing distant more
1	number; (b) facility
1	58 stat. 108;
1	coupon, knowingly offering
4	exclusivity period under
2	state law regarding
2	secretary, or other
1	states for immediate
1	states to an
1	structural classes: 
1	(ii) the owner
1	consultation is undertaken
1	scope of programs;
1	(b), be increased
3	fiscal year will
1	regulation of thir-party
5	ensure that any
1	biological product, in
1	purchaser, (b) is
1	period of 60
1	title, or (4)
1	(5). (4) standards
1	biological product, it
1	consider  (1)
2	title, means review
1	1, 2000, the
4	provided, that under
1	year millions of
1	nicomorphine. (20) normorphine.
1	transfers of drug
1	705, 52 stat.
1	difficult to clean
1	deem appropriate: 
1	-[-(isopropylthio-2,-dimethoxyphenyl]ethanamine (2ct4). (26)
1	substances, as defined
1	subsection. for purposes
1	persons organization to
1	results offer significant
3	food shall not,
1	product, the attorney
3	copying by the
1	appeal.  (i)
2	access to application.
1	moramid-intermediate, -methy--morpholin-1, -diphenylpropan-carboxylic
1	(i) included in
1	concerned for the
6	thereof, shall, upon
1	(a) enhance medical
1	submitting a supplemental
1	food, except as
1	therefor. the interim
2	secretary, such person
2	accordance with other
3	panel established or
1	person, or through
1	target drugs referenced
213	purposes of this
1	certification.  the
2	review by secretary
1	congress on all
1	practice; (3) persons
1	pharmacists of poisonous
1	electronic product offered
1	animal use, which
1	claimant.  (

1	(e), the approval
1	subsection (a)(2), any
1	nothing in clause
1	operating in the
1	container size, strength,
1	conditions, and (b)
1	desired labeling would
1	sections 603, 604,
1	states. (aug. 11,
1	conducting monitoring in
1	 (e) treatment
1	(f) warrant of
1	ingredient that was
1	[21 u.s.c. 355(b),
4	new safety information,
4	assist a trading
1	legislation. it is
1	intent to the
1	secretary to amend,
1	enforce any regulation,
1	new safety information;
1	overseeing the operation
1	determine whether since
1	transfer title to
1	(1) before taking
2	authority to make
1	 (f) abuse
2	secretary identifies a
1	lif-threatening conditions for
1	device against any
1	period following any
1	management plan has
1	form issued under
1	residents in a
1	seriousness of the
1	place within the
1	(iv). if the
1	additional -year periods.
1	products, and combination
2	report concerning a
1	 (d) warnings
1	substances, 1971. (2)
1	inspectors shall refuse
1	(a) shall have
1	(2) any foreign
3	major manufacturing change
1	360jj. studies by
1	named substances and
1	may accelerate the
1	
 
 360eee3.
2	subsection (a), (b),
1	(b), any accreditation
3	intends to further
1	approvedthe sponsor of
1	develop the qualified
1	inquire of the
1	(xi) information regarding
1	purposes of commerce
1	certification. fees collected
2	small facility may
10	regulation under paragraph
18	national media campaign
1	sufficient safety and
1	act, the standards
1	 (c) proceeding
1	diagnostic biological product;
1	pots, canvas, or
7	awarded a grant
5	city average) for
1	including formulas, microfilm,
1	import means, with
1	collection, analysis, reporting,
1	united states establishes
1	prepare an environmental
1	congressthe secretary shall
1	(viii) quarantine or
1	title, section 360j(g)
1	(4), or (9)
1	including an infant
4	trafficking area in
1	section 341, 343(b),
1	schedule i. (

2	number of written
1	include a searchable
1	infant formula, an
1	thereof, from all
1	transport or hold
2	agreement on appropriate
1	regulation require distributors
2	may appoint advisory
1	ammonia fertilizer nurse
1	walnuts), wheat, peanuts,
1	351(a)(2)(b), 352(f)(1), and
1	drug submission under
1	first occurs). 
4	february 15, 2007,
1	submission in excess
1	infant formula, at
1	require, through 
1	removal from office.
1	means a collection
2	extent feasible, the
2	terminate upon the
1	recall. (b) an
1	article, equipment, or
6	facility is a
2	resisting, or impeding
1	implement mitigation strategies
1	distribution as carcasses
1	title were not
1	importation of aquaculture
4	unless appropriations for
2	submitted prior to
2	misbranded, or (c)
1	proprietary information; (iv)
1	holder making a
1	paragraph if 
1	 (12) nicotine
2	title respecting a
1	(2) hearing on
1	administration conducted prior
18	shall consider the
1	qualified entity is
1	360j, 360ccc, 360ccc1,
4	eligible for priority
2	event report in
1	local governments in
1	qualifying practitioner means
1	biological product review
3	standards described in
4	guidance not later
2	application for any
1	director may waive
1	1932 (d.c. code,
1	listed chemicals. for
6	necessary to place
1	(8) modify or
1	release by the
1	commission on the
2	persons that the
1	use, for purposes
1	american feed control
1	validated in a
1	protect  (i)
1	agency regarding the
1	lif-threatening; (b) may
1	barrel marked. (aug.
4	exemption from a
1	received.  (june
1	(v). a determination
2	application.  for
2	secretary accepts the
1	enforcement on cases
1	device which conforms
1	law, in the
1	(4) the extent
1	administrator may waive
1	(5) no department
2	describing  (a)
1	cigarette, that has
29	 (2) the
1	substance. (6) an
1	93. repealed. may
1	conduct such litigation.
1	thereof is triangular
1	information on patents
1	investigation conducted under
2	(2) before the
1	antimicrobial drug of
7	affiliate of the
1	locality that is
1	tin, cloth, plastic,
1	identify any information
1	drug control strategyfor
1	period for notice
1	intended for further
1	title 5, by
1	divide the volume
1	subsection (e)(1)(b) and
1	years by the
5	chapter relating to
2	(as determined under
7	year ending june
2	partial waiver, as
5	professional health care
1	state court, of
1	illicit drug manufacturing
2	poultry product. 
1	thereof, or his
1	term health system
1	conveyed via either,
1	retail grocers from
1	retail transactions 
4	(c) the person
1	related to panel
1	(b) nonapplicability of
1	applicable chapter or
2	patient of the
1	sections 351 and
1	describes the sources
4	use under paragraph
8	primary mode of
2	request, meet with
1	narcotics control. 
1	procure (by negotiation
1	1976, and which
2	composition has been
2	chemical means a
1	purposes of promulgating
1	mixing, diluting, pooling,
1	tolerance periodically and
1	president; or (2)
2	qualified experts that
1	testing needed to
1	(vi) a vasopressor;
1	detection of adulteration
1	
 161 to
1	required.  (e)
1	animal drug described
2	means an original
1	(e), and thereafter
1	human services, publish
3	subsection (a) involving
1	substantially administered by
1	obtain a waiver
1	(ii) annually submit
2	damages.  an
2	person meeting all
2	 (2) final
2	manufactured in such
2	volume parenteral drug
1	title, the following
1	approval entitled to
1	following certification: i
1	role of postmarket
1	title. (d) state
2	drug, whether accidental
1	target species; (b)
1	new products or
1	subchapter, nothing in
5	may not receive
1	experience data; (b)
2	scheme, or device
1	october 1, 2013
1	october 1, 2012
1	primarily for use,
1	secret information from
1	first purchaser of
1	programs, including contact
1	regulation or any
1	be) and may
1	schedule, if any,
1	health. (b) the
1	subsection (a). except
1	drug administration; 
2	providers.  (3)
3	container is modified
1	refunded.  (iii)
4	 (1) by
16	shall establish and
6	occur in the
2	secretary determines will
1	practice until continued,
5	 (1) each
2	(i) such person
1	advises, as appropriate,
2	effectiveness data 
2	requirements which require
1	kept for that
1	(i), for a
1	competition among domestic
3	prevent or alleviate
2	advance of funds
1	(5) in reviewing
1	disease.  (4)
1	activities means those
1	program agency, other
1	person licensed as
1	year, means the
4	no. iv, 12,
1	correct and complete
1	lieu of such
1	subsections (b)(1) and
1	area in accomplishing
1	dru-free america, shall
9	(i) that the
2	accordance with procedures
2	approval filed with
1	commission in revising
3	food products thereof
13	manufacture a controlled
5	title applicable to
1	societies to determine
1	device, include validation
1	(3) waivers, exceptions,
1	(i) develop guidelines
1	inspection required under
1	certifications under section
1	adequate to ensure
1	schoo-sponsored or early
1	foundation at any
6	subpart: (1) the
1	federal drug abuse
1	internet web site,
5	section 822(d) of
6	internet web site.
1	sponsor, may, as
1	presenting imminent danger
2	pediatric therapeutics from
1	apply only in
1	eligible coalition the
2	shall in its
1	coordination with processors
1	internet web site;
1	deems appropriate, information
5	application or premarket
1	year 2011 and
1	 (a) instructions
4	notice under paragraph
1	pouches.  (e)
1	offenses any person
1	investigations of persons
1	expenses.  (2)
1	audits and investigations
1	misbranded, and in
1	methods and techniques
1	(a), there is
1	communicating safety alerts,
1	listed chemical knowing,
1	year, the aggregate
1	harm only to
1	year 2010, $235,000,000.
1	3001 et seq.],
1	3001 et seq.].
3	collected during such
5	form in which
1	(ii) to a
2	(2) to use
1	regular importer, unless
1	determines is adequate
1	distribution and possession
1	secretarythe sponsor of
1	committee (other than
1	modify such statement
1	procedure governing such
1	practitioner to have
3	review voucher issued
1	(as identified under
1	applies only to
2	(bb) the term
1	(a) as follows:
2	implement strategies to
1	package under paragraph
1	subchapter and otherwise
1	regarding use of
1	secretary, fails to
1	establishments with 15
1	fiscal and technological
3	exposed to the
2	(1) may not
1	(c) the commission
1	(
 
 1053.
1	 (d) reporting
1	misbranded;  (3)
2	internet web sites
3	designated in the
2	become effective, the
1	(o)(3) more effectively
1	360c, 360e, or
1	study, congress believes
1	pharmacopeia pursuant to
1	initiatives this section
1	promulgate nor enforce
1	safety as may
2	state has theretofore
1	information, except such
1	additive, or substance
1	2016  fiscal
1	food contact surface;
1	apples were packed
1	states to define
1	appropriations annual appropriations
1	deleterious substance that
1	release describing that
1	china shall file
2	actual knowledge that
1	transferee.  (o)
1	rcs4); (xiv) -cyclohexylethy--(-methoxyphenylacetyl)indole
1	chapter; (2) to
13	year; and (ii)
5	title relating to
2	administration. (b) the
1	 (iii) renewal
1	262], including the
1	suppressing the diversion
1	portions submitted. 
1	health. a copy
1	drugs, controlled substances,
2	species, or if
1	development and animal
1	advisory commission. the
1	 (c) repealed.
1	ch. 675, 539,
1	documents per year,
5	registration is inconsistent
1	(a) requirements for
1	investigationan investigation conducted
1	given to customers
2	member to appear
1	system in accordance
1	food safety; (ix)
1	(13) effective control
1	states through fraudulent
2	ingredients is no
2	secretary in regulation
1	good manufacturing practice;
1	notwithstanding a finding
1	inspection authority under
1	(or causes to
1	subsection (e)(1) of
1	forfeiture of 18-day
1	preparation containing limited
1	drug submissions. (b)
1	conditions and limitations
1	cause therefor. 
1	
 
 347.
1	precursor means a
1	labeled indications; and
1	preparation thereof, to
1	preceding -year period,
2	establishments with a
1	authority regarding the
29	subparagraph (a) for
1	organizations, including community
1	(5) actions the
3	manage opiat-dependent patients.
2	domestic populations not
1	accredited persons 
1	(c) any of
1	shall return any
1	administration has a
1	standards or research
1	title. (f) any
1	collected; or (iii)
3	policies of the
1	 (ii) following
2	steroid under section
1	regulatory requirements if
2	feet of, the
1	after, publication of
1	current scientific understanding
1	program of each
1	renumbered 8 and
1	formerly 17th par.,
1	title and before
2	shall make all
1	public health due
2	liability on the
1	device which requires
1	(xiv) the distribution
1	may result from
2	section 379dd(l)(2) of
1	manner that best
1	factorsin establishing a
1	tested to protect
1	facility that does
1	meat food product,
1	dosage unit. (5)
2	meat food product.
2	paragraph. no person
1	rcs8); and (xv)
6	secure facility, as
1	penalties the penalties
1	section; (2) there
1	(ii) the identification,
1	material, subject to
2	fee amounts for
1	regulations and hearings
1	body; or 
1	abbreviated application, but
6	imposed by any
1	343(r)(1) of this
2	omission of the
1	protected from electronic
1	domestic law enforcement
4	offense described in
1	962. second or
1	(5) commerce the
3	coordinator shall be
1	foreign offices established;
1	drug is used;
4	findings and declarations:
1	(c) donations in
1	11 and amended
1	progress by the
1	laboratory networks administered
4	means the act
1	trial data for
1	omitted
 
 1121
3	plant processing egg
1	applicant or registrant;
2	educational programs for
2	6, 38 stat.
1	ant-doping education, research,
1	circumstances that the
1	docket the petition.
3	service of a
1	(a) authorities under
1	(c) the dollar
1	stolen anhydrous ammonia
1	ingredients are not
7	(a) the name
1	expiration date. (ii)
6	combination of such
49	meat food products
1	accredited person pursuant
3	noncontiguous areas of
1	(iii) 2 or
1	901, 1(92), 45
1	(3) to acquire
1	compounded with, any
1	give manufacturers holding
1	(c) finality and
1	safety activities under
3	likely availability in
1	stat. 1043; oct.
1	effective period a
1	act, make available
1	services (a) refusal
1	use such authority
18	(1) if the
2	secretary is unable
3	august 23, 1988,
2	including plant, equipment,
1	personal use will
85	public health service
2	tolerances in effect
1	forces, subcommittees, or
1	fed. reg. 4461945318
1	act) be considered
1	supplement; and 
1	regulation, if, because
1	states owing to
4	amount in excess
2	subsection (j) which
1	shall be excluded
2	relisting under section
1	(iv) is a
1	(b), shall review
1	 (11) supplement,
1	find appropriate. 
1	practitioner registered by
1	enforcement administration under
1	 (1) place
1	respondent, discovery is
2	local, and private
1	387j(c)(1)(a)(i) of this
1	require the reports
1	design characteristics, chemical
17	deputy director for
1	deputy director shall
1	cause why registration
1	conditions relating to,
1	and, notwithstanding subparagraph
1	 (g) exclusions
1	notice and expedition
2	determines that use
3	commodity shall have
1	consideration and application
3	subsection (a) was
1	imprisonment. (8) all
1	possible, as soon
1	may consider, but
1	(5)(b)(iii), and a
1	administrator to grant
3	(3) promotion of
1	may seek to
1	ch. 675, 741,
1	smoke constituent the
1	  b1
1	(1) shall review
1	(c)(2)(g) or for
1	(3) paperwork reductionthe
2	relate to promptness
1	manufacturers, processes, packs,
1	(a)definition.  in
2	shall be guilty
4	seizures of drugs
1	675, 507, as
2	report made under
1	issued thereunder shall
1	input is considered
3	packaged in accordance
1	chapter and which
2	12 months, including
2	conditions of use;
2	electronic copy of
1	determine the primary
1	(e.g., crab, lobster,
2	order proposed to
1	certification that, in
1	national drug performance
1	also provide feedback
1	adverse events regarding
1	regulated transaction solely
2	conditions of use.
3	conditions of use,
1	time and prior
1	title, other than
1	commissioner for priority
2	identified for the
7	charge of such
1	fewer approved abbreviated
2	higher fees established
1	additive, constituent (including
2	packing, transporting, distribution,
1	sections 822(f), 825,
1	notification the secretary
1	assignments, reviews, and
1	disapproved by the
1	675, 529, as
1	protocol). if the
1	expertise through contracts
1	device; and (e)
1	notification; (b) request
2	shall rely on
4	shall not receive
7	production and harvesting
1	food, taking into
3	variances the secretary
1	added or transferred
1	widely utilized in
1	stores, if the
1	general requirementa class
1	teams of food
1	shall review an
1	form described in
1	testing, by the
2	change is consistent
1	finds that an
1	(j) exemption for
2	convenience of the
7	transfer of a
2	both. (2) whoever
1	judgment the judgment
1	substantial and measurable
1	permit under such
1	law) of any
1	substances had been
1	drug application references
2	submits himself to
1	section; and (c)
1	health care settings,
2	acid (including when
1	offenses (a) definitionsin
1	is, or appears
2	collected for the
1	notwithstanding subparagraph (a)(ii),
1	154a. special licenses
1	manufacture of all
2	file fee for
1	avoid an imminent
1	found on such
1	research companies, and
1	postdoctoral scientists and
1	product; (ii) prior
3	(61 fed. reg.
1	
 336. report
1	purposethe director of
1	cosmetic, and (iii)
1	pasteurized, condensed, or
1	 (5) basis
1	(a); (ii) the
1	section 1044 of
1	susceptibility of such
1	said inspectors, after
1	establishments every establishment
1	misbranded, subsection (a)
2	submitted for a
1	(c) violation as
1	joint enforcement activities
1	june 30, 1974;
1	reach the general
1	outbreak of foo-an-mouth
1	protect the privacy
1	title. the third
1	thereof. if on
1	june 30, 1974,
1	benefits that would
1	(7) distributor the
1	consult with countermeasure
1	safe and properly
2	(iv) promptly respond
1	policy, law, or
1	(1) include, but
1	latest available scientific
2	(mar. 16, 1950,
1	governing bodies of
1	convention of 1912
1	corporation shall cast,
1	(d) after the
1	(b) other evidence
1	epidemiological data; (b)
1	abetting, such criminal
2	entity permitted to
1	device upon which
1	notifies the applicant
1	relevant agencies. (june
1	person represents or
1	patient representative who
1	substances. members of
7	engaging in the
1	backlog fee failure
1	information regarding chemicall-related
1	denied clearance under
1	basic science, and
1	shall proceed to
2	18, or both;
1	inefficiencies in such
1	(b) distribution and
1	(5) if a
1	scientific principles. if
1	disparate data sources
1	device. (b) if
1	information was included
1	(6) assist state,
9	18, or both.
1	section; (c) a
4	costs other than
1	poison, except in
1	contain any deficiency
1	enhanced verification activities,
1	health and preventing
1	disclosed only 
1	appropriate, the type
1	regarded as having
1	official compendium. (g)
2	talent reuse payments),
1	review and assess
1	regulation. (c) the
1	effectiveness data regarding
1	followed. (g) labeling
1	subsection (b)(3)(b), and
1	flavorings, and colors
1	division; (iii) the
1	tools, methods, and
1	public institutions. (mar.
1	impact statement prepared
1	apply, may not
1	paragraph be provided
1	sufficient to evaluate
1	(linoeate): percent cal
1	safety ris-benefit analysis;
1	authorized trading partner
1	patent, a court
2	disease product may
1	cream lawfully imported
1	auditor and any
1	applicant an order
1	141. prohibition of
1	(5) essentially a
1	order, proceedings of
1	containers approved by
9	smoking prevention and
1	safety, the results
1	exceeding the limits
1	(a) the sources
1	transferred
 
 1172.
1	subject under subparagraph
2	dirt or foreign
1	(c) after submission
1	protocols (such as
1	tobacco product being
1	predicate device; or
3	controls to be
3	year.  (ii)
1	controlled substance. (

1	subsection, such person
1	(1)(a) to a
1	order. (8) the
1	section by an
2	subsection (i) relating
1	opportunity to receive
2	state agency 
2	coalitions throughout the
4	 (4) verificationbeginning
1	received any income
3	part, the product
1	will consider in
1	basis with respect
1	studies and reportsthe
1	(a) finds that
1	applicable, a conspicuous
5	resolution.  (june
2	(a) through (h)
1	academy of sciences.
1	animals);  (b)
8	approval of any
2	establishment; and (3)
1	opiate abuse, but
1	obtaining such facts.
1	services develop a
1	hig-risk facilitiesthe secretary
1	verify means determining
1	physician means a
5	publication of such
1	advocacy organizations, disease
1	secretary or until
5	substance abuse and
1	(3) to carry
1	 (4) no-delegation
1	distributions of infant
1	appropriate information regarding
1	(i) the retention
1	primary authority for
14	review in the
1	compendiums within a
2	produced in such
1	order applies under
1	timeframes described in
3	subgroups of patients
3	final determination, the
1	keep these committees
1	seq.]), unless a
2	retail quantities or
1	change shall be
1	(c)(3)(e) of such
1	decision and shall
1	requests; (5) a
1	procedure upon receipt
4	animal feed are
1	storage or in
6	title if such
1	(c) requisite elements
1	response in writing
1	communication. (b) the
1	patient and has
2	shall terminate upon
1	of, or any
2	use, restricted devices,
2	act (including the
1	retail; and (iii)
1	additives suitable and
5	drug trafficking area.
1	problem; and (ii)
1	gel or the
2	establishing conditions under
1	(if the person
1	(b) such additive
2	person who contracted
13	drug trafficking area;
1	despite diligent implementation
1	pos-seizure administration of
2	patients. the prohibitions
1	upon which animals
1	develop information necessary
1	authorize the shipment
1	intended to ensure
1	health professionals. (ii)
2	penalties and sanctions
1	year 2013 that
1	including any source
1	accomplishments, objective measurements
1	person.  (2)
12	directly from the
1	consolidated internet web
1	limits the authorized
1	producer or processor
1	describes circumstances in
1	drug interdiction efforts
1	implementation of each
2	5 years from
1	treaties, conventions, and
1	programs.  (g)
1	meat inspection regulations,
1	manufacturer, and the
1	determined according to
1	size the results
1	involving such device,
1	312.21(b) and (c)
1	anhydrous ammonia will
1	 (13) who
2	i. (
 

1	ch. 675, 413,
1	proper authority using
1	drug laws or
1	program to gather
2	color additive in
1	research organization; (iii)
2	subsection, the court
1	(except for data
1	use and conforms
1	67 percent of
1	applicable number. (iv)
3	reduced level of
1	interdiction coordinator and
1	petition is withdrawn.
1	made, be removed
1	unless the grant
1	chapter whose permanent
1	panel in constituting
1	ceased distribution of
1	request and for
1	
 
 1117.
3	secretary following an
1	seizures.  (b)
3	determining whether a
3	required before the
2	condition. a request
1	commerce, in efforts
9	away from their
1	(iii) that he
1	property under subsection
2	(a) the probable
2	issuing permits to
1	
 1713. authorization
5	respecting such advertising,
1	government to furnish
1	convention of july
5	added poisonous or
3	paragraph (2)(c). 
1	gratuity, or has
1	inadequate funding of
2	subchapter i or
10	animal drug that
1	good cause may
3	part 803 of
1	protective measures; (c)
1	approval supplement that
1	public meetings to
1	 failure to
1	persons are reaccredited.
1	(a) guidance 
1	deleting it from
1	(b)(2)(a) or (b)(3)(b)(ii)(iii)
3	elderly populations, children,
1	section 247d6(h)(4)1 of
1	website that provides
1	application or efficacy
1	account the registrants
1	preventing the inhumane
1	supplements. (d) monitoring
1	shipments, lo-b-lot certification
1	(b) limits of
4	application or prior
2	paragraph (5) of
1	372(a) of this
1	events or transactions,
6	year 2013, the
1	30, 2020, unless
1	agriculture as hereinafter
1	board any aircraft,
1	storage practices, as
2	will improve the
1	for, protect against,
2	law; (3) prior
1	grant or a
2	disapprove an application
1	pests, or diseases,
1	pharmacy, or licensed
1	continues to apply
1	approved drug (as
1	collection, and dissemination
4	used to approve
1	approval and shall
1	synthesizer, or other
1	allow any person
1	sentence, a person
2	name, places of
1	administration. (b) fee
1	(i), no investigation
1	title if placed
1	disclosed financial interest
1	developing and conducting
2	(3) may include
1	(f) special data
1	constituent, or other
1	determination, the following
1	plan for advertising
1	ch. 675, 506e,
1	links suggesting that
2	chapter, the poison
1	label, or any
20	experience to evaluate
1	321b. package defined
2	chemical residue with
1	intelligence information among
1	prescribe medications for
2	phenylpropanolamine  (1)
1	illegal drug production,
1	children in instances
1	appropriate, which may
1	appropriate; (v) the
2	local, territorial, or
1	(c), and may
1	review employeesfor purposes
1	commerce, or at
1	(b) hereof and
1	subsection (k)(3) will
1	part, including the
1	may carry out
1	packager, repackager, labeler,
1	director. (b) in
2	subsection (c)(2), or
1	limitation a final
1	star-up period notwithstanding
1	grant to individuals,
1	homeland security, under
1	(d) statutory constructionnothing
1	o-site inspections, checking
1	matter under its
4	matter to be
1	committee provided by
1	substances.  (june
2	occupying the office
1	flow of information
1	program the director,
2	person (a) to
1	search warrant. if
1	ingredient facilities). the
1	understanding the commissioner
3	maintained under section
3	production of a
1	title in united
1	 (l) positron
1	drugswhenever the attorney
1	person. (mar. 4,
1	secretary lacks with
1	drug because the
1	conduct by the
1	entities that shall
2	provide advisory comments
1	shall submit adverse
1	(a) reports 
1	allow any egg
1	thereto.  (e)
1	fiscal year 2004,
1	least annually, a
2	requirements apply to
1	relates to specific
1	(2) preemption of
1	make an unauthorized
1	stat. 1059, renumbered
1	packaging (without regard
1	volunteer leaders in
1	240 days after
3	designated under subsection
1	etc.; lists of
2	(a) solely on
1	required; shall be
2	regarding labeling changes
3	distribution and recall
1	products analyzed for
1	(j), the requirements
1	recipients in response
1	emergency disaster relief.
3	required records, or
2	$15,000,000 for the
1	change for the
2	contents of reports
1	purpose, but when
1	hearing as provided
2	continue to serve
2	(3) small business
2	years of that
1	including whether enrollment
1	authorities; (3) promotion
1	products, is maintained
1	experts, and other
1	(g) amend paragraph
1	authorize such dealers
1	whoever possesses any
1	good faith in
1	stating that that
1	involving a violation
1	revoke the license
1	enforcement agencies from
1	registry of the
1	union or group
1	 (4) disposition
1	year scheduled for
1	determinations required under
1	prescribing recordkeeping, reporting,
1	secretary accepts such
1	identified possible links
6	 (4) effect
1	initiatives that would,
1	including whether inadequate
9	(1) if it
1	section are sufficiently
1	poison appears conspicuously
1	including complaint systems,
1	eligible for or
1	1, 2015, any
1	shall consider criteria
1	amount increased by
1	defendant or a
10	application was filed
1	cooperation (a) congressional
1	submission.  (ii)
1	request for fee
1	provided, further, that
6	products at any
1	year 2016, $599,000,000.
3	subsection (a)(1) to
1	drugs and other
1	 (ii) further
5	register under this
4	regulation or exemption
2	limited resources available
1	reasonably believes exposure
1	administrative inspection warrants,
1	resources, capabilities, and
1	device; or (ii)
1	security threats (a)
1	contained in any
1	section. (7) medical
1	(d), or (h)
2	exclusively for use,
1	review team throughout
1	listed chemical. (12)
6	shown to be
1	(1) refer such
1	drugs marketed in
5	analysis system under
3	injury, including genetic
1	subpenas (a) authorization
1	product application which
3	secretary shall solicit
1	2003; (7) $70,000,000
1	certain psychotropic substances
1	defined as labeling
1	certification to state
1	consideration the scientific,
5	year limitation. 
1	title, there is
1	program agencies, relating
1	part thereof, and
1	section must include
1	(1) may authorize
1	ii, in the
1	(a) 33 percent
1	262(a)(3)].  (4)
1	devices. (b) subparagraph
1	without a written
1	hold such a
1	convention, transfer a
1	security. the secretary
1	termination of suspensionthe
1	(c). such exercises
3	plan required by
4	drug to a
1	et seq.); (2)
1	bodies described in
2	year, by an
1	intelligence regarding drug
1	animals; (c) any
1	(ii) awards of
1	education, research, testing,
1	enforcement, nonprofit, community
2	reviewing division shall
1	person duly registered
1	title for study
1	v.  (b)
1	may not meet
1	part whenever he
1	processors of specified
1	subsection (a)(1), as
1	effective treatment or
1	(f) agency plan
1	expiration date assigned
1	relevant agencies within
1	detention of foods
1	establishment submits to
1	direct application of
1	ch. 675, 917,
1	pay a fee,
2	27, 2013, no
1	separate unit containing
1	subsection with regard
6	academic experts; (d)
1	(j) withdrawal of
3	patent has expired,
1	known serious risksthe
1	state requirements of
1	subject of actions
1	1151 of title
2	states, the court
1	(mg) 8.0 
1	another entity. (5)
1	logistics providers no
2	harvesting of such
1	enforcement means all
1	societies, and industry
3	local governments to
1	fluid ounce, or,
1	1976 (hereinafter in
1	regulation designated as,
3	information acquired under
3	finds will enable
1	displayed for sale
1	prescriptions for controlled
1	members shall not
1	counterdrug research and
2	(2) transferability the
1	director. (2) period
2	licensing of such
1	manufacturers, and the
1	with, a third
1	(i) the label,
1	uses under consideration,
1	testing under paragraph
1	(i).  (4)
1	solutions related to
1	evaluation and finding
1	others  (1)
1	eligible entity has
1	united states. (e)
1	applicable under paragraphs
1	generalthe total user
1	retail, to place
2	 (d) repealed.
1	cultivation, growing, producing,
2	conviction thereof be
2	including any subsidiary
3	country and which
1	contact surface and
1	fails within a
2	nonusers of the
1	rape drug means
1	appropriate relief. (5)
4	imposition of a
1	private organizations commit
1	area to another
6	antibacterial and antifungal
1	to, creameries and
1	(b) benefit the
2	transaction going back
1	rare pediatric diseasethe
1	district court. 
1	safety risk; (c)
1	inapplicability of requirements
1	
 
 3551.
1	oxygen deficiency or
1	control plan to
1	end to maintain
1	reasons; (x) the
1	states reasonable grounds
2	shall complete the
1	publish such a
1	electronic product fails
3	emergency use instructions
1	organizations, which may
3	seized and condemned,
1	drug in shortage,
1	modify elements under
1	developed and validated
1	drug administration (including
1	rule without requiring
1	successor regulations). (g)
1	additional mechanisms to
1	association. (f) the
1	costs for each
1	functions the attorney
2	thereafter, as the
1	(2) limitation a
1	essential to prevent
1	requester shall provide
1	(h) importation and
1	articles, exclusively for
1	equivalent, the secretary
1	analogue. (c) such
2	 (a) amend
1	probable causeissuance and
2	purposes the first
1	human subject and
1	clinical outcome assessment;
1	15, as amended
1	regulation impose restrictions
1	controlled premises definedas
1	(a), to work
1	eliminate an imminent
1	margarine having a
1	fees assessed. upon
1	met), if the
1	iii device. such
1	retained by the
1	granted. (3) upon
1	additional fee for
1	 (c) schedule
1	adequate expertise means
9	tobacco products that
2	360b(b)(2) of this
1	
 842. prohibited
1	(2), issue revised
1	prison sentence the
1	audit and security
1	individuals. in awarding
1	[21 u.s.c. 355]
17	except as otherwise
2	corporation, the name
1	prohibited actsthe following
1	add an intended
1	(except when such
1	research to support
1	appropriate agencies of
1	verification identifies a
1	activity.  (6)
1	capabilities of state,
2	cocaine base; (iv)
1	regulation establish, with
1	uses authorized under
5	means any substance
1	willingness to adopt
1	(c), and before
1	feed. (4) 
2	transported in interstate
1	disseminated in the
6	194 of title
2	chapter: provided, that
1	testing services. (e)
1	facility, 1 or
1	campaign.  (f)
1	coordination, oversight and
6	views and comments
1	standards under sections
1	improving treatment through
1	may establish priorities
1	user facilities: 
1	third parties no
1	will conduct additional
1	analysis enhances lon-term
1	effect, if any,
1	packaging of such
1	refunded in accordance
1	determination in the
3	investigations made with
1	process; or (2)
1	u.s.c. app.) and
1	
 102 to
1	attorney general, under
2	final guidance that
4	secretary. (
 

1	revoke licenses for
1	determine by regulation
52	person shall be
1	distribute a listed
1	board shall 
2	practitioner, other than
1	(3)(b) of this
1	(k) certificationany application
1	authorities of each
1	workforce restructuring act
1	include separate information
1	 (1) oversee,
1	proceeds under clause
1	transactions sell, transport,
1	sector preparedness and
2	approved march 4,
1	acceptable level. 
1	comments from industry,
1	derived solely from
1	clinical trial that
37	drug under section
1	protocol; or (b)
2	significant decisions 
3	general physical location
9	due, such fee
1	inspections performed by
1	decision from which
1	201.57 of title
2	public meetings or
1	need for uniformity
5	every manufacturer of
1	(b) that significant
1	maintain an information
2	demonstrating that 
1	-year period for
2	addiction medicine, the
4	patent infringement or
1	ch. 675, 585,
1	regarding nonliquid formswith
1	general this chapter
1	(2), an accredited
1	industrial organizations. upon
2	(b) agreements with
1	ruling on motion
1	failure of which
1	advertisement) to the
1	testing has not
1	(e) the nature
1	 (h) delegation
1	general in any
1	(10) final sunscreen
1	possesses a controlled
1	competent jurisdiction of
1	hig-risk facilities such
1	(2) a performance
1	update are accounted
1	new animal drugthe
1	chemicals producing the
1	without a new
1	implant or for
1	stat. 344; 

1	annual basis an
1	(3) an ultimate
1	states standard. for
2	person occupying the
1	specified subpopulation) if
1	food at ports
1	additional potential elements
1	(
 
 2222.
1	fee waiver and
1	in, a dietary
1	foreign supplier to
1	listing of colors;
1	diagnostics.  (3)
1	assure proper disbursement
2	year at a
1	304, 52 stat.
1	central intelligence determines
1	employee uses the
1	upon the original
1	reduce the potential
1	period. (j) the
3	national security, the
1	temporary assistance for
2	appeals decides that
1	section $4,900,000 for
1	subsection. (b) the
1	device; (g) the
1	kills or kidnaps
1	trafficking, are already
1	advertises the distribution
2	meaningful disruption in
3	advers-event dat-collection systems,
2	administering of a
1	grant recipients (a)
1	(2)(a)(vii)(iv) and is
1	radiation safety. each
2	pediatric populations or
1	states having jurisdiction.
1	regulation remove from
1	proposing a labeling
1	
 825. labeling
1	
 
 356g.
2	may treat a
1	minority member of
1	clause (ii) to
1	measurements of progress,
1	committees on an
1	(a) to repair
2	persons by the
1	help mitigate a
8	reasonable grounds for
1	issues a license
1	steam or mist;
2	egg products the
4	$250,000 for the
1	smuggled food (a)
1	letter issued pursuant
1	public access and
1	premature. (ii) during
2	system.  (2)
1	506f, as added
1	governments shall, not
1	bridging linguistic and
1	innovation, enabling the
1	comply with subsections
1	public health: provided,
1	classification and reclassification
1	(a) defendant a
2	injunction proceedings and
1	entry within the
1	(not including an
1	supplements thereto, and
1	congress this subsection
2	may operate using
1	prevention function appropriations
1	features of a
4	receives notice of
2	844 of this
1	management plan 
1	measured by 
1	initiative; or (ii)
1	ch. 675, 536,
1	shipment, receipt, possession,
1	intent if the
1	(2) random sampling
1	panel substantially duplicates
1	serve to encourage
4	establishment fee shall
1	provider, the secretary
1	performed by the
1	$5,000. notwithstanding any
1	regulations made hereunder,
1	(7) regulatory auditthe
5	prescribe on the
1	granted under such
1	comments of the
2	scienc-based mitigation strategies
1	(b) report to
1	(and for the
1	(b) manufactureit shall
1	additional sites, as
1	appropriate court as
4	property under this
1	consideration to a
1	assess current drug
1	grants to reduce
1	program in such
1	framework under this
2	bear such appropriate
1	providing recommendations regarding
1	body, the secretary
1	approved drug. (vi)
5	person acting in
2	(1) shall have
1	commerce, (a) any
3	person (excluding farms
1	paying duties or
1	350k. laboratory accreditation
1	
 379dd1. location
1	1 year, and
1	excess of his
2	administrator may under
20	product may be
1	regarding food, drugs,
1	poultry products. (g)
1	responsibility for action
1	thereof; or (4)
1	scientific, research, or
1	appeal a requirement
1	compile a summary
3	manufacturer shall promptly
1	biomedical literature; data
4	sold by such
2	care entities that
2	meet the following
1	assessments; (iii) the
1	person may discontinue
1	with, the bringing
2	additional measures as
1	accurate and that
10	manufacture, use, or
1	article of that
1	shall solicit input
1	first foreign recipient.
1	residue; (ii) finds
1	secretary is able
3	dispose of such
2	manner, that are
1	
 360bbb6. risk
2	circumstances and assets
1	compounding of the
1	completion date, whether
1	entity and other
2	provide authority to
1	illnesses; (iii) organizing,
1	586c, as added
1	secretary may routinely
1	601. definitionsas used
1	
 853a. transferred

1	secretary expedited review
2	subsection (j)(5)(f)(ii) of
1	fund for the
1	construction except to
1	revenues from that
1	used exclusively for
1	sampling is statistically
1	may, upon request
1	formulas, including quality
1	extend the supply
1	(a) records the
1	official mark. (w)
1	proper disbursement of
1	sample means a
2	title. all proceedings
1	foster and encourage
1	compliance with subsection
1	services administration. 
4	establishment in accordance
1	procedures applicable section
1	previous conviction if
1	ultrasonic wave, which
1	u.s.c. 4402] 
4	judiciary, foreign relations,
1	selection. clauses (i)
1	22, 1996. (e)
1	synthesis or similar
3	import and export
1	fails to market
1	(5) studies or
1	distribute a scheduled
1	manufacturers requiring substantial
1	individuals, families, and
1	neonates in appropriate
1	(i). (ix) for
2	sale of perishable
1	awaiting testing by
1	i, 18, formerly
2	 (5) final
1	convicted under federal
1	estimate of the
1	toward the acceptance
2	body or which
1	of; (iii) that
2	proceeds from an
1	drug administration which
1	inspection, but a
1	methamphetamine by the
1	treatment. (ii) the
1	organizations, and pet
1	transport narcotic drugs,
1	(iii) permits its
3	planning and otherwise
1	every 2 years,
3	chemical may have
1	evaluation and publication
1	title;  (d)
2	iithe attorney general
1	minor species animal
1	consumer right to
1	drug submissions and
3	sale of any
1	(ii) requests funding
1	showing that any
1	(d) one member
1	court, or with
2	regulation, waive the
2	statements conveying 
2	application submitted to
1	notification submission may
1	section assess user
1	subparagraph (a)(ii), may
1	drug under actual
1	(c) neither that
1	only; and (x)
1	known risks which
1	agreement is reached
2	senate. (b) the
1	administration of sections
6	basic class of
1	assuring that meat
2	processed by such
1	immediate containers, or
2	appropriate.  (

14	website of the
1	completion of evaluations
1	(bb) for a
2	mandatory system for
27	active ingredient or
1	person, sell at
1	fiscal year 1998;
2	independent accounting or
2	person has received
1	(3) when issuing
1	supporting the dissemination
1	4, 2011, complete
1	preceding sentence, a
1	submit standardized information
2	illicit drug users
1	 (15) quarantine
1	burning material, such
1	performance standard, any
1	
 147. repeal
1	drug, means to
1	including data submitted
2	shall issue draft
1	of, or covered
1	databases within the
9	imprisonment and shall,
1	considers appropriate. (b)
1	(1) intervene in
1	dispenser; and (iii)
1	may recommend to
2	animals; and (c)
1	adulterated. (3) whenever
1	collaboration the secretary
4	360b or 360ccc
1	(e) accessibility of
1	regulation require. such
1	supply chain for
1	submissions.  (b)
7	advisory committee provided
1	necessary to allow
1	foundation is acquired,
1	monitor human or
1	appropriate involvement of
2	administrator shall publish
1	subsections (a)(4) and
1	review guidance of
4	benefits for up
1	(7)(b) of subsection
1	july 1, 2008,
1	meetings at least
8	shall be governed
1	conditions, or in
1	29, 1884, ch.
1	suspect product, and
2	government for the
2	carcass, part of
1	goals and performance
2	government employees may
1	director shall consider
1	may issue guidance
1	collected with respect
1	1988. (ii) every
1	present proof of
1	effective date or
1	(19) dioxaphetyl butyrate.
1	place, whether or
2	claimant may apply
1	topics necessary to
1	exist; (c) that
2	requirements, such poultry
1	concerns that a
1	(b) a decision
2	microbiological hazards that
1	scientific evidencenot later
1	described on page
1	 (3) disciplinary
1	eligible entity involved
1	treatment; and (d)
1	farmers home administration;
2	2012.  (3)
1	premarket notifications by
1	organizations, whose activities
1	u.s.c. 262(i)]. 
1	specific directions for
1	year 2014 
1	(1) not approved
1	title 19, transfer
1	dietary ingredient when
1	federal funds, be
1	 (a) recognition
1	general note 2
1	lactating women. for
2	approval issued under
2	regulation of medical
1	commodities based on
1	manufacturing procedure or
1	articles pending decision
1	(taking into consideration
1	(1) by certified
1	827, and 830
1	 (2) shall
1	usewith respect to
1	(ii) the sale
1	regulation, a petition
2	sell, or transport,
1	entitled for the
1	drugs, and animal
1	means the distribution
1	multiplying  (a)
3	evidence in rebuttal
1	marked as detained,
1	notification. (3) considerationsin
1	certain areas of
5	indicating that the
1	product upon determining
192	 (a) in
3	obtain approval to
1	(5) allocation for
2	processing shall include
1	criteria as part
1	procedures for enabling
1	
 3431. national
1	regulation. such list
2	establish in the
1	surveys in existence
1	entity conducting an
1	person, and distribute
5	fees, without any
1	change is approved
1	residue for which
5	qualified adul-only facility
3	insufficient information exists
1	(4)(a)(iii)(i) and (4)(b)(iii)(i)
1	u.s.c. 241 et
1	children from birth
1	bases for a
1	applicable committees of
1	(1) applies to
4	time period for
1	information filed by
5	material facts, is
2	individuals who have
2	that, to my
1	representative, during the
4	petition of an
1	9, 2012, or
1	meets such performance
2	prevent, diagnose, or
1	(s) any other
1	(i) requirement at
1	it. (c) the
1	(11) any firearm
1	patterns or practices
1	use of donated
2	frequency of inspection
1	regulation establish restrictions
1	injunction proceedings (a)
1	vehicle, a device,
1	paragraph (2)(a)(ii) shall
1	information, including any
1	(e) duration of
1	board, or public
1	unit. (5) not
1	(1) any of
18	include in the
1	 (c) dutiesthe
36	later than 180
3	time, the secretary
13	term is defined
1	(b) that receives
1	states establishes by
1	overall intended therapeutic
1	financial data, sales
2	possesses with intent
1	fellows or trainees.
1	courts, corrections, parole,
1	drug; (b) within
1	make public a
1	chooses to use
1	1990, while providing
1	paragraph (4), sell,
1	 (i) merely
2	amount, origin, and
1	(2) the secretarys
2	necessitating an earlier
2	state agency in
1	nations proposes to
1	title, manufactures, possesses
1	welfare recipients for
1	petitioners acquisition of
2	meat food products;
1	(c) in section
1	 (5) consistency
1	administrative medicine, pharmacy,
1	who, with the
3	information received or
1	development authority of
1	excluding allowable previously
1	country.  (j)
1	inform state, local,
2	purpose of promoting
2	202 of title
1	use, and treatment
1	render full assistance
2	time and manner
1	evaluating and responding
1	1,000 or more
1	occur, or in
59	approved new animal
1	(3) do not
1	federal healt-related electronic
2	numerical identifier, on
1	 (1) twice
1	improvement, and maintenance
1	court, or otherwise
1	(b) to 
1	label the secretary
1	chemicals, with respect
1	states or his
2	18 or $8,000,000
27	 (1) 
1	numerical identifier, or
1	distributors for purposes
3	required in paragraph
1	act (and any
3	committees information for
1	(ii) certain abbreviated
3	applicant seeks approval,
1	bind the secretary
1	(ii) is within
1	ninety days from
5	(2) any person
2	product means an
1	adjust the fee
1	designate an area
2	cream, or skimmed
3	drug. the secretary
1	years if 
2	upon such objections.
1	diversion; (2) whether
1	may fairly be
2	(2)(a) of section
1	order, at the
1	intended to meet
2	2 years from
1	section, if 
3	penalty of perjury
1	section, if applicable,
2	provision of technical
1	will be continued,
1	transactions involved in
1	drug, supplemental abbreviated
1	domestic slaughtered poultry,
3	provided, that an
1	authorized, in his
2	indian affairs, the
1	provided such department
1	subparagraph (b) would
1	immediate container means
1	issuing certification 
1	premises or inspection
1	analysis methodology; and
3	biomaterials supplier may,
2	drug application. 
1	use containing any
1	recover all reasonable
2	physician holds a
1	drug activity, or
2	transporting, in or
2	general pharmaceutical, device,
2	thousand feet of,
6	sell, transport, offer
1	able to complete
1	552(a)(3) of title
2	substance listed in
1	revoke such designation
1	importer definedfor purposes
9	quantity of such
1	(such as data
1	enforcement officer designated
1	prescribing of any
2	chapter) refuse to
1	exclusivity period means
1	authority. (2) the
1	(2) brand the
2	submit comments respecting
1	labeling, or container;
1	effect a tolerance,
1	(i) an article
3	responsible person is
2	annual report 
1	standards currently recommended
1	unusual medical or
1	credible person other
1	 (4) advisory
1	foodborne diseases active
1	testing to be
1	issue only upon
2	342(a)(1) of this
1	(a). (3) small
1	(2) continued use
2	treat one or
1	levels and specific
3	age group; and
1	 (i) purchased
1	facility; (j) be
1	campaign to meet
2	video arcade facility,
1	fed. reg. 8961,
2	held for sale.
1	practical functional purpose
6	penalties  (1)
1	importation; and (ii)
1	pathogens  (a)
1	consumers and patients
1	(b) hazard analysisthe
1	(1) serve as
2	applicable, (cc) of
3	360c(f)(1) of this
2	medical or similar
1	service. receipts from
1	person authorized under
3	defray the costs
2	title, and (b)
2	clinical data, including
1	issuing a proposed
1	cooperative arrangements (a)
5	expressed under paragraph
1	pr-submission interactions;[1] 
1	anabolic steroids will
2	contain the patent
1	title that was
1	strategy.  (5)
6	development of new
1	material respect misleading
5	 (10) the
1	program, or the
1	(3) the sale
2	secretary shall, whenever
1	sharing of test
1	secretary then finds
12	controlled substance to
1	processing activity; (iv)
1	relate to other
1	carried out, to
1	evidence defined if
1	information regarding anticipated
1	necessary to prepare
1	sufficient to affect
1	system.  (4)
1	evidence defined in
2	(d) except as
1	train, and provide
1	consideration the critical
1	extent intended for
1	fat of carcasses
1	product standard which
6	fee to be
1	pathogen means a
3	formula subject to
1	single written request
1	shipper of the
1	government voluntarily on
1	members appointed by
3	applicant has submitted
1	listed patents and
1	displayed or presented
1	committee (or successor
13	within the jurisdiction
1	index. the decision
1	products containing these
2	confidential access. further,
1	criteria standardsin evaluating
1	drug and intended
1	carrying out these
1	person, which are
1	 (a)purpose.the secretary
1	medical foods for
1	(3) the products
1	chemicals shall vest
2	secretary determines may,
1	reimportation  (1)
2	multiplying the number
1	supervision; and (3)
2	provide, or withdraw,
1	general may permit
1	(c) is the
1	file.  (ii)
1	section 321(p)(2) of
1	purposes of subsections
3	dentistry, or veterinary
1	examinations conducted under
1	(or have any
1	title) has not
1	fees appropriated under
2	ingredient, new indication,
1	five and that
1	(d) ensure that
1	
 115 to
1	annually report en-o-year
1	sterile under federal
1	regulation, order, license,
1	(a) provides information
2	person who does
1	test or testing
1	strategic plan to
1	codex alimentarius commission.
2	financial resources to
1	pediatric age groups.
2	paragraph (1) and,
2	eligible establishment that
1	products, changes to
1	permanently ineligible for
1	(f) the sharing
1	term bioequivalence means
1	drug, except that
1	identified and listed
1	received transaction information
11	refer to the
1	(i)), over a
1	permit the committees
1	pediatric age groups;
1	policy.  (5)
1	refer such a
1	certain class iii
2	 (e) good
1	(a) drugs or
1	(iii) a fee
1	within 3 years
1	(q) date of
1	distribution of poultry
1	shall accord a
1	subparagraph and which
1	directed to inspect
1	available, and of
1	155, 9, 44
1	actual adverse effects
1	misleading or has
1	(a) for forfeiture
1	(10) metazocine. (11)
2	licensure program and
1	entered, or if
1	
 356e. drug
12	section 823 of
1	information conveyed by
1	products or countries
2	sponsor makes such
1	regulations shall take
1	
 
 360.
1	submissions. the secretary
1	 (i) half
2	cantaloupes, citrus fruits,
2	whether the device
1	nighttime, enter and
1	definitionas used in
1	with, less stringent
1	safety alerts, labeled
1	defenses  (1)
1	united nations pursuant
1	means an advisory
1	items) of the
1	maintenance or insignificant
17	within the possession
1	cosmetics.  (ii)
1	strategy means the
1	site, and seek
1	disposal was made.
2	concerns regarding the
2	milligrams of ethylmorphine
2	registration simultaneously with
1	(i) reinstatement with
1	establishment for which
1	sel-sustaining.  (6)
1	transaction history supplied
1	submission that has
1	 (aa) 18-day
1	courts are the
2	select an establishment
1	made or document
1	may be attributable
1	interstate commerce, the
1	reissuance of such
2	(c) judicial review
1	licensed consistent with
23	section 360 of
1	listed chemical, in
1	areas, the administrator,
1	property and opportunity
1	drug trafficking problem
1	grants for coalition
1	utilize the services
5	interest. in determining
1	packs tobacco leaf
1	court and delivered
1	(a) coordinating federal,
1	warnings concerning storage
2	notice a copy
2	(3) when a
1	notice respecting a
1	(i) any individual
1	initiated a proposal
1	technological data. the
1	(4) development of
3	(including but not
2	labeling changes 
1	application, protocol, or
1	distribution of blood
1	state enforcement authority
1	generally applicable to
1	subsection (b)(2); or
2	 (2) such
1	approval with such
1	petition, the petitioning
1	gram negative bacteria,
1	subparagraph, that the
1	355(i) or (k)
1	imposed pursuant to
1	hereby appropriated to
1	shell eggs, and
3	18.  (c)
1	(or exempted from
4	qualify as a
1	secretary any changes
1	requestor. such a
1	modified to reflect
1	(a)(iii), the secretary
1	predicate tobacco product
1	establish goals and
1	produce, one or
1	disposition of such
1	court may apportion
1	reclassification order published
1	secretary if he
1	unclassified report required
1	chapter to any
1	detection technologies (a)
2	feed for animals
1	reimbursement mechanism. fees
1	money or other
1	subsection (g)(2)(c), for
1	practitioner, while acting
1	marking food with
1	federal government shall
6	shall contain a
2	manufacturers of controlled
2	application with the
2	substantiate such declaration,
1	will be held,
1	inspection; suspension of
1	application of general
1	development. (iii) labeling
1	pesticide chemical applied
1	minimize the number
134	date of the
1	
 
 501
1	internet, except as
1	food which 
2	comprehensive plan for
1	regulation in effect
1	still protecting the
1	(b) hearing an
1	commission on dru-free
13	imposed under this
1	complainant brings an
3	360b(b) of this
2	marked or labeled
1	surveillance activities for
1	patients, any information
1	period, or at
1	(2) state licensing
1	(2) determination and
1	identifier established under
2	amend the report
1	poultry product received
1	meet the urgent
1	domestic and imported,
1	appropriate legislation. it
1	(b) corporationsupon an
20	ephedrine, pseudoephedrine, or
1	3-day period described
2	packed into a
1	transaction information as
1	device exemption under
2	pet food; and
1	act of 2004;
1	farms; (b) small
4	respecting a device,
1	et seq.); and
1	guidance pursuant to
1	governmental agencies, in
1	maintain effective controls
1	675, 1007, formerly
1	nonprofit statusin carrying
1	action or issuance
1	675, 524, as
1	performance of those
1	thereon, orally or
1	preparation, and transportation
1	department or to
1	of, and conditions
1	include information from
1	otherwise available for
2	upon any drug
1	term standards means
2	detail the findings
7	shall pay for
1	periodthe initial regulations
3	lieu of any
1	iv, 406, as
4	addressed to the
1	shall, when they
1	coordination of all
1	event reporting: www.fda.gov/medwatch
4	title; and (d)
1	distribution, sale, or
2	commerce until such
1	may take reasonable
1	(a) in requesting
1	nonprescription drug consumer
1	policy, any policy
2	consistent with applicable
1	native hawaiians and
1	676. violations (a)
1	(11) $109,000,000 for
1	information submitted that
1	notification or schedule
1	sitesthe court, when
1	products, protect the
7	applications, premarket reports,
1	 (ii) upon
8	sums as are
1	origin of each
1	effects of foodborne
3	subsection. the secretary
1	applicant, or, with
3	priority review the
1	422, as added
1	treatment for reasons
1	247d6b(c) of title
14	application for premarket
1	use or modification
1	branding grades on
1	common carriers are
1	service or internet
1	period expires without
1	 (j) public
1	any, as defined
1	(2) if compliance
1	agent; and (iii)
20	definitionsfor purposes of
1	operate not later
1	whether the change
1	(a)) that produce
1	delaying the provisions
2	obtaining, where appropriate,
1	include reduced fee
1	addition to establishing
1	organizations involved in
2	accept or reject
1	state medical licensing
1	(d) the review
1	173.315(m) of title
2	label or other
2	period beginning fort-eight
1	purposes without regard
3	directive drug and
1	applies, the full
1	registration and the
1	part thereof. (mar.
1	available; and (c)
1	additives for the
4	approve another application
1	(b)(2)(b) shall be
1	duplicative guidance on
2	section 264(c) of
1	time required to
1	official compendiums; infringement
1	(ii) applications submitted
2	made upon a
1	title 5). 
1	effectiveness under application
1	 (f) matching
1	general for assistance
4	(e) such samples
1	one copy of
11	health and safety
1	animal drug. (w)
1	(3) public health
1	(a) first offense
7	abuse of the
1	establishments used in
5	fiscal year divided
1	protect trade secret
1	reductions from inventory,
1	concerning the countervailing
1	accept saleable returns
2	1906, as amended,
1	wet dressing, ointment,
1	conformance with paragraph
7	drug use and
3	unwholesome, adulterated, or
1	
 
 801.
1	basis, to reimburse
1	-penty--(-chlor--naphthoyl)indole (jwh398); (xi)
1	contaminant is contained
1	suspensions or lyophilized
2	exchange between a
2	term transgenic animal
1	chapter, notwithstanding such
2	activities; (b) the
1	known, to the
1	reasonable fees for
1	(a)(vii).  (iii)
1	require each manufacturer
1	360c(f)(2), and 360e
4	distributed or offered
1	degree of risks
1	1532. program authorization
7	periodic reporting concerning
2	prior to initiating
1	approved protocol the
2	substance or chemical
1	suspension, revocation, or
1	drug, or device,
3	geographic areas of
1	additional provisions as
1	(c) make available
1	title i, 6,
1	medical reasons includes
2	drug research and
1	heroin, methamphetamine, and
1	online pharmacies an
1	testing devices utilizing
1	number of reports
5	(1) through (5)
1	datethe fee under
1	20 (commonly referred
2	applicant seeking a
3	whoever kills any
1	also seek designation
2	reviewing division, that
1	675, 567, as
1	harm being caused
7	leasing, maintenance, renovation,
1	means a human
1	(b) 5 kilograms
1	(
 
 1547.
1	pending in a
15	shall determine whether
1	preserve such information
2	subclause is a
1	requirements for restaurants
1	seized pursuant to
1	device that remains
1	employment; and (iii)
2	report that provides
4	illegitimate product not
1	means children whose
1	compounding from bulk
1	objects used to
1	6 years of
1	reporting.  (a)
1	safe use. 
14	may require the
1	distribution the term
1	terms and vacancies
1	rights of any
1	access to needed
3	implement this section.
1	
 360ddd2. inapplicability
1	patient or user
1	athletic competition means
12	dead, dying, disabled,
5	informal hearing to
2	empowered to approve
1	enforcement agencies; (b)
5	331(t) of this
1	agencies and similar
1	informal hearing within
1	activity, source, or
1	shall be rendered
1	(b) contentfor the
1	electronic product; (d)
1	findings is[1] based;
1	costs of providing
2	v of the
1	smoke constituents, to
1	section to sanction
3	noninfringement described in
1	exports of listed
1	case is to
2	360i, and 360j
3	use in any
1	stringent than, requirements
1	food. such term
1	thir-party auditors in
1	manner, as the
3	program (as defined
1	smoke constituent, or
1	carry off, or
1	grounds for liabilitythe
2	pediatric formulation not
1	generated solely within
1	(3) the rule
1	secretary, selecting from
1	designated person or
1	considered an education
1	exclusivity awarded to
6	alleged in the
1	face raise valid
4	 (i) no
5	discussions of their
1	terms of offices
1	data and a
1	value from any
1	(b) quorum six
2	reduced exposure to
2	agreements the secretary
1	(4) (hereinafter in
1	imported foods, including
1	provide notice regarding
1	review that involves
3	rules relating to
6	except coca leaves
1	duplicate a product
1	request, or the
1	subsequent animal drug
1	radioactive materials other
4	defense, and the
1	shall, by publication
1	acting through an
1	medical evaluations or
1	receive evidence at
2	made in conducting
1	established.  (b)
1	1971; and the
1	dtc advertisement for
1	(c) conflict of
2	811 of this
2	delivery or proffered
1	selling (as meat
1	potentially present a
1	(c)(3) prohibits an
1	term. (b) the
6	expedite the development
2	administrator unless the
3	tribal affairs shall
2	enforcement or to
2	clinical investigators, information
1	substances other than
1	federal commitment to
1	 (1) make
2	action that could
1	$500,000 per violation.
1	will maintain their
2	(a) was a
1	warnings related to
1	completed its premarket
4	develop and publish
3	specify the unique
1	practicable the name
7	person includes an
1	supplier (a) impleading
22	shall be a
1	(g) 40.0 
1	combination, as medically
1	delegate. (b) the
1	standard; (ii) the
1	mandatory debarment regarding
1	sold, or distributed
1	state official) with
1	505b, as added
1	intelligence systems supported
1	title 5. information
2	(b), any person
1	mark; (6) knowingly
1	improving information about
1	information, can no
1	(m) list of
2	cubic centimeter exceeds
2	begun by a
2	section the term
1	certified facilities that
1	may 16, 1927,
1	childrenin establishing, modifying,
1	regulation addressing the
1	shall be 4
2	title 42; (ii)
1	chairman of such
1	sole ration of
1	including documentation of
1	(b) because the
1	2021], and interested
1	supplements in any
2	programs that would
1	man which 
1	receive information that
1	measures being taken
1	persons a description
11	section.  (

6	individuals described in
2	provisions, it may
1	subsistence, at the
1	specifications for the
2	$15,000, multiplied by
1	cooperative programs. (

1	tobacco. (vi) rol-you-own
1	public. (3) consultation
1	used for medical
1	abuses of opium,
4	residue depletion studies
1	(c) schedule v
1	used for advertising
1	disapproval order. (c)
1	(3) the owner,
1	device is, for
1	subsections[3] (b)(2) or
1	supplements, or submissions.
3	progress of each
1	submit a declaration
1	no-ionizing electromagnetic or
1	gas no designated
1	(b) after october
1	chemical, additive, or
1	registration or quota
1	matter under the
3	advisory committee shall,
5	identification of a
1	(such as those
1	entering into a
1	amend, in accordance
1	auditor to justify
1	section 10.30 or
1	appropriate. reports under
1	individuals, equipment, and
1	herb or spice,
1	imported food product.
1	ask that the
1	(c) prioritization of
7	serious adverse drug
1	 (b) records
3	rapidly and effectively
1	marijuana and other
1	requests for a
1	removed entirely from
1	animals.  (6)
1	therein and obtain
1	hearing. upon completion
1	definition of recordin
1	authority to determine
1	title 5 designate
1	assistance, including technical
1	feed directive is
1	judicial officers of
2	committee process or
2	order, or other
1	8 years after
1	(b) is necessary
1	protocol, and each
1	(b) include an
1	accurate; (b) the
1	applying because of
1	seek to minimize
1	finance, or transport
1	
 
 355b.
1	(g) limitationsnotwithstanding subsection
1	concerning the special
7	(ii) of paragraph
30	rare pediatric disease
1	(ii), fees collected
3	intermittently. the secretary
15	 (mar. 4,
1	tolerance limitation, would
1	requested, and (iv)
1	order. (b) repair,
1	administrator shall pursuant
2	regulation promulgated after
1	licenses before the
16	clauses (i) and
1	 (4) within
1	product, that the
1	(b), all such
1	business subject to
2	subsection (c)(2), may
1	remaining portions 
1	facilities including 
3	practice.  (b)
3	cause such inspections
1	attributable to subparagraph
1	(r) zika virus
1	1523. definitionsin this
5	term controlled substance
1	prioritythe secretary[1] acting
1	phenylpropanolamine, at any
1	(1) the storage
1	(b) determinations 
1	title (submitted in
1	narcotic or stimulant,
1	second country) are
1	estimate of anticipated
1	enforcement effort resulting
1	person responsible for
1	application under subsections
1	premarket approval. authority
1	delivered to such
1	funded, except that
5	application  (a)
1	federal law restricts
10	allergy and anaphylaxis
5	qualified pandemic or
2	(vi) of subparagraph
2	shall document, for
3	subsection if 
3	shall advise the
1	farms of new
1	campaign strategy for
1	consumption of a
1	(e) rule regarding
1	1301 to 1308.
2	(e) authorization of
1	import; (3) substantial
1	management plan submitted
1	classify all such
1	leverage the resources,
6	applicant made a
1	field investigation. 
1	-year period (1)
1	formula test each
6	case of the
1	population (including neonates,
1	thereon to such
1	medical needs exist.
1	period after such
6	administration, of all
2	subparagraph (a) in
1	product where the
2	section 2021 of
1	within 6 years
1	postapproval monitoring of
1	396. practice of
1	chemical residue only
5	approve the application
1	concerning recordkeeping the
1	 (5) compensation
1	product tampering; (f)
1	(b) members of
3	processes to respond
3	appropriate, the number
7	human food and
1	food purchased by
2	(e) withdrawing approval
1	subsistence, at rates
1	sanctions as are
3	review and act
1	(12) of subsection
1	detention order 
1	differing characteristics of
1	consumer perception of
1	entitled an act
1	(b) in consultation
1	held on weekends.
1	regulated person, the
1	(i) such manufacturers
1	ingredients as grase
1	(a)(ii). (2) rule
1	institutes of health.
1	eggs have been
1	awards for demonstration
1	condemned because of
1	interstate commerce, he
1	section 355(e) of
1	(2) in paragraph
1	appropriate, in the
1	year by multiplying
1	applicant, refer such
1	health advisories, health
3	general for the
3	establish a user
1	additives, in accordance
1	use local surveys
1	syrup, (3) any
1	secretary. (4) definitions
1	feed covered under
1	 (b) claimantin
1	provisions of any
11	per diem in
1	practices or does
1	investigation  (a)
3	costs of human
1	devices periodic training
1	drug, the species
1	alter any official
1	services, a false
6	entity; or (b)
1	ch. 74, 5,
1	law which relates
1	facilitates the treatment
2	invite appropriate participation,
1	tobacco, additives, or
1	shortage.  (june
1	order prescribe, or
2	interest under this
1	(a) reviews previous
1	clause may not
1	facilities inspected; (c)
1	policy described in
1	title to maintain
1	meeting the time
1	chapter, the labeling
1	public inquiries regarding
2	it. service upon
1	merit and notify,
1	(2) exhaustion of
3	audit to determine
1	designation. any person
1	inspection, be found
1	purchaser to sign.
1	nonacceptance the secretary
1	corporation, or any
2	shall establish in
1	(b) and before
1	identify and locate
1	section 841 of
1	acts that were
1	analogous products and
1	(c) the percentage
1	15 and section
1	act or any
1	
 197, 198.
1	drug, submitted under
3	circumstances shall the
4	terminating a notification
3	reasonably require to
1	annual assessments of
1	petition approved pursuant
1	manufacturers on or
1	(3) a person
1	dismissal of complaint
1	condition does not
7	authority for such
1	diseases or healt-related
1	nations, in accordance
1	title 42. nothing
1	made exclusively of
1	
 844. penalties
1	remain unanswered as
1	(c) a determination
4	entered into between
3	(aa) if the
1	term drug paraphernalia
1	requirements as provided
1	complete list on
5	state meat inspection
3	petitions submitted under
1	access to registration
1	match, tournament, regatta,
1	requirements for ensuring
3	prevent diversion of
1	(i) to exempt
1	revenue from such
1	(i) identifying contamination
1	(n) and does
1	1996, for which
1	may in writing
1	accredited person is
1	(1) with an
3	(1) shall apply
1	(5); or (b)
61	drug for which
1	promulgating or enforcing
1	extent possible in
1	program and the
1	area  (a)
2	subparagraph (e); and
1	technology involving the
1	federal property; penalties;
2	word oleomargarine or
1	form each report
1	exists, on statements
1	(c) receipt for
1	offense.  (c)
1	
 360bbb8c. patient
1	ch. 712, 48
1	sale, or for
1	(2). such fees
1	products; designation of
1	definition by regulation.
1	potential effectiveness of
1	relating to distribution
2	health, acting in
3	needed to assist
1	orders promulgated thereunder
3	treasury.  (c)
6	prominently placed thereon
1	system. (2) amendments
1	manufactured or prepared
1	registry the secretary
1	data are required;
1	use only; and
1	interdiction programs and
1	drug abuse research;
1	necessary activities in
1	recommendation regarding whether
1	including smoking cessation,
1	complies with each
2	delivered before such
1	activity (including the
1	release of information
1	scheduling decisions under
1	purchaser or consumer.
1	educational agencies, schools,
1	(
 
 1606.
1	(2) covered application
1	(c) 1 of
1	(2) timelinesthe timelines
1	employment or office,
1	extension continues to
1	classification panel; and
1	patient by a
2	(3); and 
3	shall expire upon
2	amended at any
1	codes the secretary
1	given not more
1	entity at all
1	risk or an
1	device. the order
1	availability of record
1	reason of contamination
4	complete review of
1	pediatric disease products
1	u.s.c. 714b(h)); (c)
1	informal hearing if
1	research and taking
1	reinstatement on application
2	regulatory oversight 
1	appointment and duties
1	october 2011. (11)
1	(c) confidentiality reports
1	(b) which was
1	procedures, as he
1	structuring the standard
1	approval of new
1	appropriateness of postmarket
1	importing or offering
1	policy the policies
2	will give notice
1	located or resides
1	device which because
1	agency the activities
1	copies thereof; inspection
1	entity, subject to
1	trial record containing
2	individuals trafficking in
1	(iii) or (v).
1	chapter cosmetics which
2	appeal inspection, which
1	complies with paragraph
1	judicial review; or
1	active and inactive
3	biological product shall
1	(vii) for an
1	congress detailing how
1	combination product, or
1	 (14) shall
1	pediatric disease product.
1	specific regulatory function.
2	article complies with
1	 (i) local
1	subparagraph to give
1	(e) the capabilities
1	drugs; procedures regulations
1	study demonstrating equivalence
11	interest in the
1	different articles of
1	national community antidrug
1	dosage form, as
1	8 years, a
1	food laboratory capacities
1	requiring control; procedures
1	fails to meet
6	new animal drug;
1	demonstrate substantial improvement
1	found.  (d)
1	terms, conditions, or
1	upon being summoned
1	designation. (b) use
3	or, if such
1	title; (4) to
1	devices readily available
1	proven to be
1	division; and (viii)
22	new animal drug,
1	elected by such
10	new animal drug.
1	based on factors,
1	including by consideration
1	amount of benefits
1	prescribed to protect
1	title), has a
1	dispenser; (ii) take
1	prekindergarten program that
1	equal to 2
1	poultry of his
1	organization that contains
1	equal to 7
1	30, 1981; and
2	joint committee of
1	applicant had obtained
2	filed within the
1	available subject to
2	secretary has received
1	section 5 [15
3	approved labeling for
1	commission. (4) the
1	training to each
1	4402 of title
33	new animal drugs
1	secretary may determine.
1	institution and prosecution
1	notification (a) notification
2	(a) in generalon
1	common carrier to
6	business in the
2	product application fee
1	selling an agricultural
1	defendant under the
1	violations of good
1	administration for a
1	(a)(iii) shall be
1	nutritional requirements, based
1	country; or 
1	downloadable format. (c)
1	objectionable and stating
6	distribution for human
1	model plansin carrying
4	secretarys decision) a
1	evidence that is
3	evidence that it
1	trends and patterns
1	equivalent.  (june
1	publicly available information.
1	plants from which
1	c-chairpersons) of the
3	section 381(e)(1) of
1	actions taken against
1	(g) 0.15 
1	meets a set
1	employee in appropriate
4	collected under subsection
1	chapter; (b) informal
1	thereafter, the attorney
1	application, or one
2	studies are completed
2	applicationthis section shall
7	notwithstanding the provisions
1	country) are parties
1	smaller than 2-point
1	applicable to food
1	considered an unsafe
1	item concerning its
1	services of a
1	(i) any tobacco
4	order issued by
1	experience as it
1	effectiveness; and (ii)
3	secretary to take
1	may cause inspection
1	(c) the need
2	holder that has
1	initial completeness assessment
21	order under section
1	61. definitionswhenever used
1	islands are vested
1	required of the
1	(c) advertising production
1	period reasonably determined
1	manufacturers seeking simultaneous
2	conditions because of
1	district of entry
3	(2) for any
1	applied research needs
1	abuse, which, at
1	sets in addition
1	apparatus or computer
1	avoid unnecessary duplication
1	suspended listing 
1	
 
 350b.
1	fee that is
1	 (f) injunctions
1	studies are complete;
2	regulations issued pursuant
2	include representatives from
2	manufacturer, or distributor
1	(g) information regarding
1	675, 302, 52
1	(iv) the likelihood
1	storage of an
1	(f) statement of
1	methods for nanomaterials;
1	eggs of his
1	(e) reauthorization 
1	printed document shall
1	complaint of the
1	apothecary, or any
2	diagnose, monitor, or
1	performing activities associated
1	commissioner. if such
2	risk that would
1	(2) regarded by
1	distributors.  (4)
2	clinical investigation from
1	clause (ii) applies
1	conducting a regulatory
1	(b) such animal
1	 (b) suture
1	term minor use
1	recognition of 
1	inspection of milk,
1	product at any
3	holder does not
1	instructions for use
2	title, relating to
2	training of such
1	section, the written
1	consumers; manufacturers of
1	models to facilitate
1	subsection that affects
2	consignee  (i)
1	programs to federal
1	month period beginning
1	 (c) protection
1	section 1(a) of
1	means a residue
1	president may apply
1	provider as described
1	context other than
1	product applications (including
1	appearing before congress
1	(a) copy of
1	832.)
 
 154a.
1	business entities. (f)
1	released in june
2	(11) of subsection
1	ship or move
1	original purchase to
1	6-calenda-day period for
6	shall be served
2	use any safety
1	within such department,
1	usesa designated medical
1	for, or register
2	comprehensive communit-wide strategies
8	supplement means a
1	tobacco dependence, including
1	reduction; and (c)
1	poultry; and (b)
1	hearing, that the
1	general at the
1	devices into interstate
1	seed of such
1	chinese subjects it
1	assistant to the
1	enforcement action plan
1	(h) fascioliasis. (i)
1	equipping animal, plant,
1	dates, and names
1	epidemiology, demographics, pharmacovigilance,
1	drug is eligible
1	assistance, including assistance
1	necessary land, buildings,
1	centimeter in any
11	appropriations there are
1	every person upon
1	view of the
1	72 hours after
1	information given to
1	officio membership of
1	(
 
 969.
4	dose or multiple
2	comment period under
1	sunscreen order until
1	export certifications for
1	individual to pay
4	average) for october
1	substance. the term
4	title 42; or
8	construed as authorizing
3	form, and the
1	(7) national drug
1	bottom of the
1	effective under subparagraph
1	monitoring of all
2	naphthyl ring to
1	(
 
 958.
1	imported shipment, documentation
1	term swimming pool
1	(g) recordkeeping the
7	information required to
1	identity unless its
1	 (4) mandatory
1	conduct such other
1	alcoho-related facilities (a)
1	actions are to
1	registration; and (b)
1	title withdrawing such
3	ordered by a
1	providers under this
1	(d) each importer
13	(2), the secretary
1	criminal proceeding against
1	50.0e  
4	limits the authority
3	42 shall not
2	(e) the operations
2	may be filled;
1	may refer a
2	drug administration safety
2	 (2) revocation
1	means any citizen
6	report submitted to
1	eradication of pseudorabies
1	activities to control
1	facilitated entry programs
2	$20,000,000 if the
1	 (3) qualificationsan
1	regulations and guidelines
4	product radiation safety
1	poultry products to
1	review, and approval
1	confidential.  (j)
3	opportunity to appear
1	use in entering
1	device exemption, the
3	period beginning with
1	 (b) offer
1	(b) components 
12	necessary may be
1	health system in
1	exceptional or emergency
1	measures intended to
1	 (i) certifies
3	1036 of this
1	court shall, at
1	medicare program and
1	(or successor regulations)[1]
2	review shall be
1	unavailability of lifesaving
1	effective, the introduction
1	contamination in food
1	excess of five
2	sanitary standards, practices,
1	general may direct
1	(b) advertisement or
1	meet all applicable
1	agencies. where it
1	(ii) issue an
1	functional purpose in
19	ingredients of the
4	shall, in a
1	procedure.  (

1	regulatory activities (including
1	hard drugs, including
1	application (a) a
1	7. (
 

1	toward the limitation
4	significant increase in
2	leave the official
2	information derived from
1	product; (4) sample
1	rate, and other
1	standards for postmarket
1	provider for such
11	secretary of state
2	proposed standard will
1	metabolism or other
9	shall cause to
1	distributed directly or
1	responding to the
1	30, 1978, to
1	make such rules
1	assess compliance of
1	assess  (a)
2	submitted. the secretary
1	advisory commission the
1	vegetable juice contained
1	information about illegal
1	special registration; and
1	requires more than
1	input of other
1	(3) residues of
1	liable under section
1	 (h) approved
1	specific training or
3	product standard shall
1	upon which united
1	tobacco product; (c)
1	(f) suspension or
1	process applicable to
4	 (d) 
9	made by this
1	registrations and drug
1	develop the appropriate
7	if, after such
1	identity established under
1	batch in each
1	valid registration in
1	maintain under this
1	analytical testing site;
1	broadly across the
2	any.  (c)
2	economic information provided
4	(d) authorization of
2	material extent or
1	postmarket monitoring of
1	(c) inspection of
1	government entity, in
1	necessary, to enable
1	required to make
3	sold in the
1	human services nonetheless
4	established by applicable
1	(c) through fiscal
1	cure, mitigate, treat,
1	chapter, and obtaining
3	operation of all
1	recommendation under subparagraph
2	adulterated. if an
2	feed is the
1	substances provided in
2	procedure for making
1	styles and sizes;
2	responsible person within
3	persistent or significant
1	disregard at trial
5	consistent with section
1	subsection (d) publicly
2	information was required
1	judgment action described
2	substances, and the
2	establishment; (ii) was
1	board, through amendments
1	contentsfor each drug
6	program described in
2	outsourcing facilities. 
3	convicted under this
1	available to that
1	farm that produced
1	associated in fact
2	plan submitted by
1	distribution for purpose
1	annual establishment registration
3	audited by such
1	 (1) assess
1	accredited. (5) 
1	10 months on
1	
 355c1. report
1	upon, a package
1	(b)(3).  (g)
1	packed in barrels
1	(e)(1)(a)(iii) of such
1	inappropriate or that
2	notice is submitted
1	decision described in
1	measurement system described
2	subsection shall result
1	measures; (c) limitations
1	products which in
1	federal regulations. (x)
1	expended. (d) recertification
1	
 1521. findingscongress
1	(c) regulationsthe secretary
2	except when the
1	service at such
1	term device user
2	shall publish, for
1	shall be understood
1	using any controlled
2	1, 2012, shall
1	right  (a)
1	section 1701(1)[1] of
1	drugs contained therein
1	substantially equivalent products
1	species. the secretary
1	1.35 percent of
1	whether certain commodities
1	(4) process for
1	 (ii) every
1	residue data collected
4	licensed, or cleared
1	priorities in order
1	(ii) such drug
2	include information about
1	copy, and to
1	practice regulations for
3	period (or any
1	applicant at the
1	recipient state or
1	(a), external experts
1	chapter, where, despite
1	(a) the standards
2	take appropriate action
1	
 468. cost
1	teacher, and personnel
2	(b) returns 
2	(a).  (3)
1	counsel for the
1	product would represent
1	(c) defenses 
1	(4) selection of
1	shall advise, consult
1	reliability of the
1	bodies. (ii) additional
13	proceedings under this
1	exempted from definition
1	testimony of any
2	publicly available, with
6	accordance with criteria
1	burden, and timely
3	seller or regulated
1	placement of a
1	researchers for useful
1	(vi)expiration of all
2	tolerance limitation is
11	may not make
1	includes persons having
1	useful, he shall
1	shall accept data
4	hearing pursuant to
1	year shall forfeit
3	paid. (g) crediting
1	(a); or (ii)
1	year. (d) availability
1	completed not fewer
1	providing the location
1	violation for purposes
1	aside such order,
1	rules repackaging of
2	allowed to enter
2	substantial equivalence means,
1	convictions could not
11	review of device
1	commissioner an office
1	services determines that
4	months after november
1	clause (i). (x)
2	drug shall submit
2	publicly disclosed unless
1	841. prohibited acts
1	tracing systems, as
3	brought into conformity
1	enforcement, and the
1	susceptible, intermediate, resistant,
1	rapid analytical techniques,
1	extent of management
1	(iv) the term
1	ensure that n-cost
1	countries through which
1	color additives; and
6	section by the
1	affiliates) or to
1	(1) agree on
2	(b) issue a
56	secretary shall publish
2	device indicating that
2	future costs incurred
1	employees; (b) the
2	approved, or tests
9	distribution within such
1	pilot projects, in
1	shall include comments
3	order issued pursuant
1	data on seafood
3	payment shall constitute
1	research subject. (11)
1	desomorphine. (8) dihydromorphine.
1	liability any person
1	27 months after
1	exists, or (ii)
1	committee, to determine
2	general by regulation,
1	  choline
1	may require; (iv)
1	plant except in
5	device pursuant to
1	initial training addressing
1	faith, unless such
1	review the sampling
3	scientific information) relating
1	section 881(d) of
1	shall occur prior
3	(a); and (ii)
1	transactions (a) applicability
1	 drequired to
1	(b) consultation in
1	ch. 675, 744g,
1	effect on november
1	general by regulation:
26	proposed to be
1	involved or in
1	shall, where and
2	reduction missions undertaken
1	(k), upon the
1	made, to such
1	campaign. (f) the
1	ch. 675, 737,
1	supplements thereto) to
1	taken, the court
1	federal leadership in
1	act.  (3)
1	(1) $250,000, or
1	meeting.  (d)
1	unless a petition
1	regulation or policy
1	revocation of permits
1	recipients who test
1	testing has been
6	 (b) labeling
1	(j) federal law
1	smashed or broken
2	data and views
1	reserve, of at
1	ceases to apply,
2	actions under the
1	(iv) premarket notifications
2	products manufactured at
1	programs. for purposes
1	risk; (c) considering
1	substance based solely
2	u-t-date list of
1	activities with such
1	affirmations may be
6	fine under title
1	 (1) nothing
1	knowledge. if the
2	application when administered
1	rare diseases. 
1	dietary need that
1	consultative audit by
1	paragraph (2). nothing
1	serve) a complaint
1	chapter; marking and
1	services in the
1	sign, or other
1	states government. (2)
1	health, and its
1	refund under clause
1	demand reduction, state,
1	section 356c(c) of
1	world evidence submitted
1	(5) advertising the
1	(c) determine the
1	1005 of this
2	united states; (4)
1	investigation, or to
1	(i), transaction history
1	enforcement official, is
1	device, software, sterilization,
1	shall be requested
2	cover only the
59	may be necessary
1	and, upon filing
6	review voucher shall
1	individual and such
1	letters issued pursuant
1	committee, other than
1	clinical research and
1	(3)(c) or after
1	262(a)]. (c) priority
1	pay) and restore
2	353(g)(5)(a) of this
2	may submit affidavits
1	stakeholders to develop
1	manufactured, processed, packaged,
1	seq.). (june 25,
1	subsection, whichever is
1	procedures), and commercially
3	food producing animals,
1	lives; and (b)
3	ingredients are the
2	cause the destruction
1	adjustment factorthe term
1	 (b) effective
2	petition as may
1	procedures or experience
1	stat. 1051; oct.
1	government as having
1	kind or, if
1	dispenser may satisfy
1	considerationsin determining the
1	immediate chemical intermediary
1	21 cfr part
3	interdiction committee shall
1	involved, or with
1	section, the standards
1	authorization of the
1	(h); and (b)
2	secretary to consult
11	 (1) except
1	sums then or
1	act (ieepa) (50
1	may prescribe terms
1	structure.  (c)
1	remedy contained in
1	 (a)action package.the
2	minutes of any
1	urban, suburban, and
2	upon the prescription
1	operational activities to
1	 (c) paymentthe
1	(9) betamethadol. (10)
9	title, not later
1	u.s. department of
1	legend and, unrestricted
2	 (3) upon
1	device presented by
1	submission of requests
1	exporter that is
2	(b) set forth
1	products in commerce)
1	(ii) beginning 7
1	pediatric labeling resulting
2	health and general
1	(4) size of
2	nonsaleable product a
1	reported are in
1	surfaces of equipment.
1	  minerals:
1	process; (e) expedite
6	supply of the
2	information exchangethe secretary
10	commerce, or importing,
4	recommendations for the
2	supreme court for
1	reports or documents
3	review of significant
1	sections 321(q), (r),
1	numbers, if any,
3	food, but such
1	(
 
 1544.
3	supplier to the
1	setting or dispensing
1	(2) responsibilitiesthe united
1	shall, on the
1	interest which have
1	 (g) for
3	food, drug, animal
1	insofar as it
3	notification upon determining
1	records that identify
1	restrictions are required
1	(a) determinationthe secretary
1	financial information) relating
1	 (4) meeting
5	rate in effect
1	dangerous drugs) under
1	facility is so
2	period, as applicable,
1	title) an agency
1	desired for a
2	technical electronic product
1	less than 82
1	preceding sentence. (f)
1	scientific data supporting
1	logbook, the purchaser
2	distribution such that
3	general, in such
1	2013  fiscal
1	(ii) definitionsfor the
1	item on the
1	administrator has found
5	otherwise engaged in
1	enforcement action (except
1	(b) single written
1	immediate suspension order
2	notwithstanding any contract
1	controlled substances law
1	country during such
1	therapy (as defined
1	permit access by
1	unexpired periods of
3	paragraph (1) has
4	changes that are
1	publish the standards
2	substance means a
1	includes the manufacture,
1	advertising was disseminated
4	information on a
2	day before january
1	drug submissions: 
2	nicotine in cigarettes
1	secretary, either initiate
1	enabling the acceleration
1	paragraph (1), he
6	general may, in
1	(c) authority the
1	poultry item shipped
4	application, prescribe on
1	 (ii) hearing
1	(9) nothing in
1	device) outweighs the
1	evidence. (c) in
1	relates to tobacco
1	assurances described in
1	payments; advances; reimbursement;
1	that, as designated
1	addiction by 
1	sanitary, and properly
1	people of the
1	assist state and
1	level has been
1	(d) quotas for
1	protection for drugs
1	forfeited, the court
2	districts, commonwealths, territories,
1	(a)(3) of section
1	 (7) residues
6	committee provided for
2	filed or approved,
1	submitted, and annually
2	body of evidence
4	regulation implementing this
1	subchapter i. (

2	chapter, and thereupon
1	claimant  (a)
1	(f); (2) compares
1	year may be
1	(m) clarification of
1	salts. (b) benzyl
3	terminating the proceeding
1	statutes.  (b)
1	2008.  (3)
4	significance of such
1	interstate commerce required
1	local government agencies,
1	818.)
 
 208.
1	(iii) having written
2	imposed in addition
1	section), transaction history,
1	action directed to
2	concentrated, powdered, dried,
1	requirements shall apply:
2	study plan under
1	services related to
1	test methods, consensus
1	contaminated food 
1	rejects any recommendation
2	report directly to
3	experiences as determined
1	due.  (l)
1	commissioner about such
4	thereof in accordance
1	extrapolated from adequate
1	whoever violates section
2	substituted wholly or
1	chemicals; behin-th-counter access;
2	(b), or such
2	warehouseman, or an
2	instruction, or direction
1	preparing the carcasses,
1	injury or damage.
2	adequate to justify
1	requirement is more
1	establishment shall also
2	causes the intentional
2	paragraph as the
1	invention, development, improvement,
5	prior conviction record
7	right, title, or
1	site in which
8	training or experience
1	 (a) cente-specific
1	provide for wel-equipped
1	days in advanceas
1	assistance of other
1	social media), of
1	dispensing, or possession
1	subsection by the
1	form or concentration,
2	means evidence consisting
1	reported under subparagraph
1	title or through
1	goals, for human
1	system, does not
1	flunitrazepam, except as
1	health emergency, or
16	shall promptly notify
1	effective performance, include
1	(4) interagency collaborationin
1	alter the general
1	subsection and described
3	opportunity to appeal.
1	xviii of the
1	transported on its
1	package; (ii) identify
6	intends to submit
8	drug administration as
1	chapter; or (4)
1	food, reports of
1	years, including age
1	agreement, within a
1	required submissions a
1	protect confidential information
2	year that begins
1	description of patient
1	statement submitted under
2	demonstrating a reasonable
1	circumstances.  (e)
1	(b), which is
1	u.s.c. 1521 et
1	either through a
1	data and related
8	risks and benefits
1	respect to prescription
1	additional authorities necessary
4	payable under this
2	drug administration an
1	may not dispose
2	adequate information respecting
1	paragraph (1). (

1	upon the person
1	prohibit the admission
1	clinical benefit under
1	(iii) intended to
1	will not mislead
2	person for further
1	program at the
1	
 353a1. enhanced
1	whichever is greater,
2	concurrently with the
1	authorized on and
1	(2), a summary
1	goals and annual
5	completion of such
1	fact and the
1	(4) the willingness
1	defined in 21
12	permit such officer
1	
 469. authorization
1	applications, supplemental applications,
2	product. (d) the
2	thereof, slaughtered and
1	(4) in carrying
1	review; and 
1	sold exclusively for
1	crack or break
1	(n). in defining
1	675, 714a, as
1	 (6) internal
1	twenty days of
1	360(o)(1)(a) of this
1	2011; and (15)
2	agency in writing
3	 (1) inflation
1	scale or its
2	identified as a
2	reviews of such
1	compliance. services under
2	another entity is
2	finality of secretarys
1	impacts the safe
1	sale of which
2	treasury shall deliver
1	inspection, as required
1	admission under section
1	progress reports and,
1	basis.  (5)
2	cause a reasonable
1	102 of title
2	notify in writing
5	beginning 6 years
2	plan for food
1	business in; and
1	include the mature
1	ii by any
1	title, or (d)
1	food product received
3	verify and describe
2	place on each
1	person begins the
1	making those designations
2	may be conducted
2	consumer for purposes
1	experiences (as defined
1	centers with other
2	phenylpropanolamine each reference
1	applicable provisions under
2	private college, junior
1	(b) assessment contentthe
2	civil money penalty
3	product, a manufacturer
1	(a) may include,
1	paragraph a person
1	order. summaries of
2	individual plan for
1	imported in small
1	formula for each
1	eggs, in effect
11	determines that 
1	iv (
 

1	product shall have
1	base amount means
1	employed, hired, or
1	802(33) of this
1	disease, convalescence, pregnancy,
2	study under this
1	offic-based settings. the
1	agency in meeting
1	imports refused admission
2	president, by and
1	case of devices
1	enhance the sharing
1	estimated resources needed
1	technical advice, to
2	food is adulterated
1	returns a wholesale
2	applicant shall amend
1	processed, or packed,
1	term priority supplement
1	outreach regarding the
2	dru-related activities in
1	sponsor elects, within
1	 (i) employees
1	assurance if the
1	secretary may add
4	section 379e(a) of
1	register designating bulk
1	informationthe term new
1	vessel (as defined
1	economic area countries,
2	stat. 714
 

1	general may compromise,
1	(a) focus enforcement
1	(1) bulk vehicle
1	burdensuch elements to
5	manner as an
2	(i) the commissioner
1	training for food
1	processes, and practices,
1	
 113a. establishment
2	accreditation to persons
1	accept a submission
1	
 360pp. enforcement
1	(b)(2); or (b)
1	manufacturing heroin or
3	secretary by regulation;
1	narcotics traffickers. (3)
1	regulated sellers with
1	(o) propionic anhydride.
3	(a)(2) (relating to
1	populations or uses
2	permit individuals to
1	(2) premarket review
1	amending or revoking
1	condemned and shall,
1	deem proper, except
1	generalfailure to pay
1	(j) applicability of
1	v shall be
1	evidence, and require
1	ship such feed
3	application for marketing
1	warehouseman has knowledge,
2	labeling, packaging, and
1	issued to, any
1	cause the application
1	existing law, will
1	(1)(a), with regard
1	regulation on the
1	government service within
1	executes a good
3	manufactures or imports
1	promotional materials with
1	(aa) would require
1	sheep carcasses, sheepmeat,
1	drug product; (c)
1	full extent permitted
14	propagation, compounding, or
1	(a) ensure timely
3	(2) the number
1	3-day restriction on
1	administration, invite the
1	may appropriately vary
4	made part of
1	30 percent of
1	promulgated under the
1	assessments based on
4	standards prescribed under
1	(b) three times
1	specific importer under
2	section 360b(i) of
1	drug; or (ii)
9	year for each
7	information related to
1	containing any quantity
2	term designated personnel
1	center follows the
1	data, and (d)
1	persons, including drug
2	terminates october 1,
1	extent that adequate
1	hypoxemia or hypoxia.
1	conduct[3] under this
1	varied means of
1	enforcement officers performing
1	species. such an
4	previous fiscal year
14	secretary finds 
1	governmental sources, foundations,
1	strategies, training techniques,
1	(2), and the
2	biennial basis, submit
2	establishment within a
1	(b) lif-sustaining; or
1	without clear identification
9	secretary shall assess
1	event signals. 
1	will be eliminated.
1	requires an importer
1	accreditation shall state
1	exceed the fees
4	drug identified in
2	subchapter (other than
1	even if such
4	subsection to maintain
1	human use are
1	(b) petition requirementsany
1	 (2) authorization
1	subsection, good cause
4	shall revoke any
1	inspection regime of
1	technique is established
1	subsection. such requirements
1	completion of review
5	gs18 of the
1	treasury shall take
1	(b) strike subpart
1	experts on risk
2	electronic notice. 
1	control plan. 
1	supply products in
1	january 15 of
1	(b) full reports
1	articles known as
1	ensure the accuracy
1	manufacture, planting, cultivation,
1	activities. if an
57	secretary shall 
1	consideration of student
2	(a) inspectionthe secretary
1	(1) for which
1	produce or process
2	identification of devices
1	scal-appropriate and practicable
1	submitted on the
1	title, and including
1	inches above the
1	request, whether the
1	officers, agencies, or
1	creates a reasonable
3	examination of animals
1	drug, or that
1	fewer than 600
1	task force; (c)
2	352, 360, or
1	secretary demonstrating the
1	(a)(2)(a), a drug
2	(until otherwise specified
1	witness may not
1	quantitatively each ingredient
3	proceeds, if sold,
3	 (e) definition
2	(e) if it
1	original order or
22	(b) if the
4	(commonly known as
6	classified as a
1	(b)(3) or (i)(4),
1	industry, to efficiently
1	subsection (f) with
1	sales of chemicals
10	appropriated for fees
1	analysis. those procedures,
1	quantity sold. such
4	base, pseudoephedrine base,
1	office to assist
1	term leaker means
5	secretary for review.
2	compounded drug and
1	use authorizes a
1	attorney general, request
1	investigate such article
1	(iv) a device
1	committee are prevented
3	modification or setting
1	manufacturer that chooses
1	submissionin developing and
2	agriculture or secretary
1	certificate; (3) without
8	subsection (a), a
1	public the medical,
1	secretary from collecting,
1	first applicant or
1	(b) activities 
1	is, as determined
2	preservation of authority
1	drug shortages. the
1	secretary; publication in
2	action by field
1	applications and making
1	(2) the correction
1	serious risks that
1	hereof and the
1	medical device, any
1	abetting, a criminal
4	infant formula, and
1	application process the
22	351(a) of the
2	reclassified from class
1	(1) from the
1	receiving the controlled
1	action, provide by
4	person means any
3	hearing is accorded
1	deems adequate. (3)
3	full or partial
2	means a device
1	postapproval studies the
1	878. powers of
1	title. this paragraph
2	331(jj) of this
1	preclude requests by
1	individual took actions
1	(b) as applicable,
1	title 42 apply,
1	account be obligated
1	funding proposals consistent
1	processing, transporting, and
3	chapter.  (4)
1	section 350d(a)(4)1 of
3	without promptly notifying
6	place on probation
11	secretary a report
1	omitted  (c)
1	furthering the goals
1	(2) of that
4	information upon a
1	whichever the attorney
1	1961, signed at
1	agriculture, shall provide
1	regulation before november
2	testing shall be
1	secretary shall accompany
1	patients). (june 25,
1	national average, over
1	iii device. applicants
1	feeding infants and
1	paragraph if any.
1	et seq.], conditional
1	(a) making periodic
2	(1) or subsection
3	adjustments under this
1	pesticide use data
1	risk presented by
3	(5) nothing in
1	prevention, the biomedical
1	broken. (3) the
3	2, and 3
2	any, of which
2	addictio-sustaining liability similar
1	illegitimate product upon
2	body found not
2	consumers and the
1	may appoint federal
1	7, formerly 5th
1	secretary. review shall
1	compensation of such
1	withhold the attorney
2	(ii) intended to
1	ferpa each plan
1	inappropriate for most
1	section..[2] this paragraph
12	shall, at the
1	unless that grantee
1	failure to enter
1	350(b)(2) of this
1	314.70 and 601.12
1	provider provided that
1	made by another
1	benefits of implementation
2	consultation in carrying
1	criteria website with
1	class ii. such
2	eligible for transportation
1	seq.], the drug
1	(c) warning on
1	representatives of academic
1	health risk from
1	matters such as
1	(b) procedures to
1	(6) the success
2	exemptions  (1)
1	assessed and collected,
1	held, the inspection
1	among youth and
1	performance measurements. when
1	clauses apply for
1	criteria under paragraph
1	foreign country which
2	shall not fix
3	processing egg products
1	subparagraph, or (ii)
3	require that such
1	petitions filed under
6	notification under this
5	801 et seq.],
1	campaign. (h) entertainment
1	title involving misbranded
1	letter in order
1	use in adults
1	dissemination plans that
1	noun without modification,
1	registration has expired,
4	publication the secretary
1	registration number as
1	premises if the
1	register if the
1	human body, such
12	 (1) no
1	funds management activities)
1	america.  (e)
1	premarket approval. (b)
2	consult with federal
1	pediatric studies, any
2	agency with expertise
1	applicable, immediately notify
2	suited under the
3	product of cattle,
1	general in determining
1	removed; cocaine, its
1	molecular entity. 
1	animals intended for
1	assessed for a
1	practicable, determine whether
2	human services prior
1	regime of the
1	for, illegal drugs.
2	deems necessary, if
1	disease that meets
1	coordination of federal
2	restricted eggs, capable
10	months after january
1	maintain a written
1	pack or cause
2	studies has been
1	qualification package under
1	primary jurisdiction of
1	promulgation of the
1	service, or both,
1	 (ii) service
1	formulation produced by
1	timing; content; meeting
1	function appropriations any
1	list  (1)
2	means a domestic
1	expert review 
1	regulation or on
5	quality, and purity
1	section 3551(g)(2)(d) of
1	section 387j(a)(1)(b) of
43	required by the
2	shall be set
1	limiting compounding the
1	 (3) exceptionthe
1	conducted, cause continuous
1	laboratories meet the
1	help conduct consultative
1	television advertisement. 
1	writing, the complainant
1	district concerned. (mar.
1	tobacco products. information
1	swingsets, and teeterboards.
1	description of substance
2	human drug for
13	disease control and
1	less than 77
1	supervision of such
2	liners) of any
1	proposed regulations a
1	containing meat food
1	apply  (i)
1	manner and by
1	paragraph to conduct
2	sell or offer
1	derived from animal
1	include an explanation
1	names and locations
1	convenience kit as
1	(i) a general
2	whether accidental or
1	making any necessary
1	coalition, at the
1	voluntary inspection of
6	population as a
1	provide or cause
1	united states tobacco
1	 (a) account
1	package, or when
3	service under this
1	stat. 679; june
9	dispensing of controlled
1	secretary with sufficient
2	approved under abbreviated
1	evaluations  (i)
1	drug production, manufacturing,
2	application or in
1	portions or products
2	secretary determines no
10	manufacturer or authorized
1	regulation));  (d)
1	transaction without obtaining
1	certification issued by
1	body structure; 
2	purposes, or engage
3	(c), information to
5	representatives; (b) the
2	exportation, or importation
1	 (i) professional
3	least 5 years
1	sale for domestic
1	approval process to
1	contamination is most
1	test food in
1	representation none of
3	standard is appropriate
1	period following notification
1	substance. (23) the
1	equal or greater
2	procedure and integrity
1	take effect no
1	time necessary, the
1	information which under
8	title; and (ii)
2	belief at the
1	ch. 559, 4,
1	drug products. (iii)
2	background, except that
1	interest between an
1	graduated from a
1	products, the secretary,
1	ensure  (i)
1	expires without the
1	title  (1)
3	(c) no waivers,
2	application by more
1	shall classify an
3	manufacturer, that a
1	applicable licensing authority,
1	regulation granting exemption
1	slaughtering, meat canning,
1	only. (b) a
1	awarding of contract
1	intended; (b) training
2	otherwise) any added
1	 (iii) orders
1	limits of the
1	person to determine
1	states to 
1	management training of
1	appropriate. (b)failure to
1	(ii) cover the
1	implement those objectives.
1	360ss. state standards
1	title each such
1	rates under subchapter
73	approval of an
1	 (a) $97,722,301
1	human services, or
1	(a) techniques, equipment,
1	condemned they shall,
1	may provide further
1	
 620. imports
3	exempt from registration
1	president. (
 

1	(c) subparagraph (a)
6	 (1) consultationin
1	foreign supplier, and
1	37 stat. 832.)

10	subsection (b) application
1	pharmacopoeia and the
1	675, 506c1, as
1	
 
 161
1	
 363. regulations
1	request information that
1	attended by each
1	interested persons prompt
1	report had knowledge
1	human use 
1	party issue a
1	(a); and (3)
1	tobacco product advertising;
1	write such prescription
1	export at the
1	minutes. (5) the
1	demand in the
1	countermeasures and that
2	prescribing information for
1	353a or 353b
1	report received, notification
1	means any chemical
1	violation rate for
1	award of the
1	internal human tissue
1	minorities in clinical
3	strength or potency
1	alone, has no
1	systems that are
1	commerce immediately prior
4	(1) if its
2	shall convene and
1	deferrals, and waivers
1	necessary, and define
1	section 343(j) of
1	(aaa) the decertification
1	disclosed all wrongdoing
1	affiliate has the
1	director shall conduct
1	amounts for fiscal
1	transaction; (iii) may
1	mechanisms, sharpened stakes,
3	location or address
1	records (including financial
1	(iv) a biological
1	related the director
1	posting; and (b)
1	members to the
1	paragraph of the
1	(l) laboratory records,
1	(4) make seizures
1	secretarys rationale for
1	upon such conditions
1	persons name, place
1	contractual rights affording
1	including the grant
1	degradation product; or
1	(c) penalty if
1	(6) coordinates the
2	organs and fat
4	applicable, to determine
2	copy of an
1	appears conspicuously thereon,
1	(ii) address other
2	subsection (a)(2); and
1	committees described in
1	1, 2012, in
1	advertising provided directly
1	section 9 of
1	prior conviction a
1	days of january
1	date and which
1	collaborative projects in
1	health threat notwithstanding
1	advisory review operating
1	drug sample requested
3	 (2) use
1	tribes  (1)
1	generalas a condition
1	treatment utilization; and
1	title iv, 405,
5	(d), the secretary
1	respect to identifying
1	requiring labeling to
1	$1,000,000 that is
1	make such election,
2	government.  (b)
1	year that was
1	requirements to implement
4	information and a
1	drug shall include,
1	adult population is
1	(c) issuance of
2	territorial business transactions
3	dentist (or other
1	health maintenance organizations
1	requirements colored oleomargarine
4	criteria, the secretary
1	construed as modifying
1	(i) shall identify
1	notice.  (c)
3	withdrawn after the
13	part of such
1	written logbook and
1	designs in the
4	(c) for such
1	force, and with
1	section 1533(a)(2) of
1	infringed  (aa)
5	meeting of a
1	particular food has
1	paragraph (1) would
2	pharmacist within the
1	misleading; (2) does
9	shall be held
1	(aa), a court
1	consolidated national drug
1	group if data
1	foundation; and (c)
4	area served by
1	drug sample required
3	expiration of five
2	data as the
4	secretary that has
1	 (3) such
1	term sold or
2	additive for such
1	term firm means
1	initiated under subsection
1	outweigh the cost
3	condemned, at any
2	recommendation from the
1	concentration, preparation, formulation
1	shall jointly submit
1	diversion of ephedrine,
1	use, in violation
1	contains any nonnutritive
2	may, by regulation
1	reporting outsourcing facilities
2	marks. (
 

1	subsection. (6) paragraph
3	states, in any
1	subsection (a) upon
2	commerce, or storing
1	controls for an
1	level was lawful
1	paragraph requires the
1	title 39, such
1	time, whether drugs
1	statements, or designs
1	nature, complex scientific
2	involved is located,
1	youth development, public
1	equipment, all tableting
2	connection with which
1	package liners. (m)
2	attorney general within
3	waiver, exemption, reduction,
1	greater period, not
1	state means each
1	compendium in which
1	communication and training
3	considering such reports,
1	1890 (21 u.s.c.
1	mitigation strategies under
1	recordkeeping, testing, inspections
1	interest, for remission
1	plan or no
3	handling of such
1	submission. a determination
1	area so designated,
3	exempted, under this
1	 (e) assistance
1	(a) the compliance
5	drug administrations internet
2	level of the
1	general shall apply
1	chapter. (d) after
2	american psychiatric association,
4	provided in subparagraphs
1	equivalence of the
1	401(b) of the
3	device prescribed or
1	
 2013. nmic
1	primary message of
1	208. certain preparations
1	of[2] chain of
1	1120. omitted
 

2	public information or
2	action.  (c)
1	guidance. (g) rule
1	protection program. 
1	system and the
1	collected shall be
2	secretary finds necessary
1	(c) accelerated approval
1	product, evaluated together
1	book, paper, document,
1	tobacco products required
1	ii; (2) the
1	related to violations
1	establishment feeeach person
2	trade, or offer
1	enter any vehicle
1	guide to the
1	(a) or (c))
1	complainant for, or
1	expedited basis with
1	inspections under a
1	 (a) petitionany
1	(4) periodic review;
1	employees, and agents,
1	shortages. the secretary
4	address in the
2	year after october
1	appropriate;  (2)
1	section, terminate expanded
2	fiscal year. (4)
1	 (4) limited
1	section; or 
2	applicable number is
4	congress, and make
1	exceed ninety days
5	355 or 360b
2	pediatric groups requiring
1	residue for the
4	september 30, 2016,
1	conduct or cause
2	federal funds for
1	(3) if available,
2	respect to proposed
2	accurate copy of
1	per 100 kilocalories.
1	identified individual patient,
1	submitted that references
2	organizations shall be
2	fire safety standards
1	chapter. (d) reporting
1	drug, or notice
1	warrants (a) controlled
1	1997 (111 stat.
1	distributor, purchased the
3	directly or through
1	key stakeholders, and
2	possible, but in
1	(a) a device
1	paragraph (1), fees
1	requirement of submitting
1	application that may
1	medical literature, or
3	may conduct such
1	subsection (a) only
1	sufficient to communicate
1	(c) circumstances in
1	program benefitsnotwithstanding any
1	will remain after
1	private treatment utilization;
1	term antibiotic drug
1	obtained after the
1	solely in no-food
1	reasonable time frame
1	ant-doping agency (1)
1	term emergency use
1	material. (8) the
4	financial conflicts of
3	significantly higher than
1	advertisement as described
1	coloring only and
1	quota under section
1	whether the clinical
1	updating the status
1	functions prescribed under
1	conditions of subsection
1	(2) manage or
2	tribal food safety
1	governing computer system
1	region, or partnership,
1	safety, including the
13	preceding sentence shall
13	written notice from
1	prepare summaries of
1	affected if the
3	title in such
3	finds that emergency
1	
 621. inspectors
1	thereof, the district
1	antimony, arsenic, barium,
1	prescriptions are not
14	comptroller general of
2	(ii) the period
1	include the employees
1	forces), a state
2	specifically finds that
3	secretary may rely
2	u.s.c. 1471 et
1	additive, or adds
1	360eee(9)(a) of this
5	shall have access
1	 (3) return
1	grant renewal, and
1	deviate from such
1	denied or such
1	term distributor as
1	believes such food
2	panel. the secretary
1	development authority regarding
5	evidence in the
1	attached or upon
2	thereon or on
1	apply.  (b)
1	
 1172. repealed.
1	program prior to
1	time between the
1	poultry item means
1	single state agency;
1	allow a reasonable
1	strategies to solicit
2	administration amendments act
1	amended, and as
1	facility, or (c)
2	fine, imprisonment, or
1	minimum, the submission
1	partner, a thir-party
1	cigarettes by minors.
2	made wholly or
1	following the enactment
1	protein derived from
1	communit-based programs to
1	subsection may also
1	rendered adulterated, he
1	effectiveness information which
1	(xi) the application
1	dietary supplements created
1	used or data
1	risk communication, experts
1	previous owner, which
2	drug safety questions;
3	refusing or withdrawing
1	receipt, holding, or
1	469. authorization of
1	
 1604. liability
2	approved, evaluated together
2	determines that making
1	improvement protocol containing
1	health consequence or
1	drug safety questions.
2	providers, notwithstanding subchapter
1	media campaign pursuant
4	drug and with
1	drug indexed in
1	inform and educate
1	(b)(2) or (c)(2)
2	related requirements; concurrent
14	application with respect
2	act making appropriations
1	stuck yolks, moldy
3	person, if the
1	drug being imported
1	(d) summary judgment
1	websites; (d) allows
2	libel cases shall
1	pharmacy site disclosure
2	may designate. 
1	(5) adverse event
2	meat items in
1	(f) availability of
1	projects and shall
1	364. repealed. 

1	bylaws under subsection
1	commerce, in meetings
3	collections to the
2	general shall specify
1	(10) heroin. (11)
1	applicable list, a
1	transport drug paraphernalia;
1	interested party except
3	identified as prescribed
2	(ii) antibiotic drug
1	individuals may know
1	manufacturing egg products,
1	title. (d) summary
2	unhealthful, unwholesome, or
2	months, including the
1	purchaser, the members
3	manufacturing practices and
6	(b), (c), (d),
6	day on or
1	 (28) verification
2	findings, by reason
2	commerce shall promptly
1	scientists, or health
1	dispensing, or the
1	people the dangers
2	curricular and instructional
1	transfer, or convey
1	contamination; and (c)
2	enters a final
1	known as critical
1	shall also cause
1	supplemental applications where
7	equivalent to the
1	criteria standard described
1	i, 9, formerly
1	control act. (5)
2	communication plan described
1	drug samples. (e)
1	(1) be subject
1	pricing of commodities
1	response which would
1	made.  (4)
1	cooling, freezing, drying,
1	use by departments
2	small entity compliance
1	application for uses
1	g/gm of protein
1	strategy that 
1	omitted
 
 99.
1	decision establishing a
2	tests by new
1	(5) no preemption
1	mature stalks (except
2	label, mark, stamp,
1	considering the impact
1	guidance  (i)
1	evaluate domestic and
2	following information for
1	mixture when the
2	title, that it
1	illegitimate product; or
3	shall prescribe such
1	commissioner and the
1	refusal shall continue
1	(1) highes-risk biological,
3	five years from
1	stakeholders with demonstrated
1	prescription medication; and
2	section 351(a)(2)(b) of
1	secretary determines (after
1	of, any criminal
1	appropriate intervals so
1	however, such regulations
1	premix suppliers, (iii)
1	margarine, and (4)
1	resulted from the
1	effect an index
1	eligible entity seeking
1	petition is filed.
1	
 360fff2. eligibility
1	due inquiry, that
1	technically infeasible, the
1	manufacturing, and evaluating
1	alternative fine in
2	impact of such
1	corrected such adulteration;
1	safety report a
1	stat. 486.)
 

1	incorporate any resulting
1	675, 303, 52
2	number of deferrals
4	information obtained by
11	preparation which contains
1	pesticide becomes unlawful
1	(b) notificationif the
1	degradation. (bb) in
2	exportation for special
1	entity provides assurances
1	(2) any manufacturer
1	products; and (e)
1	inspect such factory,
1	animal feed, if
10	355a of this
1	otherwise approved nothing
3	general controls would
1	respect to meeting
2	receipt for transportation;
1	government, and state,
1	term dispense means
1	compound in mainstream
1	transactions which would
1	secretary, and whether
1	205, as added
1	concentrations of drug
1	care providers through
2	level of effort
1	one hundred points
1	product standards 
1	
 
 360bbb3b.
1	belief: (a) i
1	u.s.c. 262(a)] or
3	publicly identified in
3	law enforcement agency
1	cosmetic act prior
1	 (14) product
1	scientific tools or
1	 (c) secretarys
1	(ii) is purchasing
4	(1) the manufacturer
1	amend, or repeal
1	submissions to provide
1	notice shall contain
1	administrator or upon
1	knowledge of illegal
3	subsection to a
2	involving federal employees
1	food. the substance
1	countermeasures  (1)
1	said sections. (2)
5	inspection of records
1	team to facilitate
1	equipment, and facilities
1	communication by an
1	medicine, which order
1	secondary schools. 
2	panel determines that
1	shall be necessary
1	illness outbreak, the
1	drug development or
1	period beginning 48
1	dipipanone. (21) ethylmethylthiambutene.
1	675, 564a, as
4	means that the
1	appropriate professional organizations
2	conducted with due
2	reports, and information
2	may be enforced
3	secretary is further
2	seeking an order
1	death of a
1	entry of materials
1	quantity therein or
3	product identifier affixed
1	 (b) appeal
1	drug experience is
1	risk assessment system
1	(vii) an assessment
1	ch. 675, 309,
2	control plans available
1	surveillance protocol each
1	committing or in
3	foreign policy, and
1	makes a proposed
1	class of drugs
1	external use only,
5	registration of a
3	approved constituent part
8	november 16, 1988,
1	november 16, 1988.
2	results from its
1	conformity; or (ii)
1	communities, and other
1	receiving the application,
1	acquired by such
1	store, or place
1	export. (4) the
1	part. the person
1	standard shall be
1	herein provided shall
1	work with companies,
1	(2) each person
1	organization is described
1	promulgated thereunder, all
1	safety improve linkages
1	reasonable balance in
1	approved abbreviated application.
3	otherwise listed, by
1	subchapter to cosmetics
1	period. (iv) for
1	approved drug. 
1	measures to be
1	pesticide chemical, including
3	u.s.c. 1621 et
2	generic drug backlog
1	review the recommendations
1	(iii). to assure
4	period specified in
1	export transaction which
1	(c) advance of
1	individual and $1,000,000
1	support the secretary
1	(i) certify in
2	matters regulated under
1	ferry. (
 

1	adjacent to or
2	label of inspection,
2	1 of title
1	(lsd); (vi) 400
1	 (d) imposition
1	(c) in making
1	 (b) characteristics
1	will assure that
2	(2). if the
1	notice published pursuant
1	january 1, 1970;
1	given it 
1	uses the term
1	practitioner, including the
2	device or drug
1	quotas of all
5	islands of the
7	shall consist of
1	alter or amend
2	attack with a
2	shall develop a
2	(b)(2)(a)(ii) or (j)(2)(a)(vii)(ii)
1	government if 
1	party claiming an
1	otherwise) may be
2	prosecution of the
1	(a)(4) and (c)(3),
1	(j) funding the
1	process or methodology
1	officials as ex
2	subsection (b)(2)(a) or
1	cooperation with respect
2	containing such additive,
1	species means animals
1	sanitary practices each
2	induces, procures, or
1	entry; (h) upon
2	custom slaughter by
1	secretary; (b) the
5	including through posting
3	labeling, packaging, or
1	modification to such
1	1-year period beginning
1	certain drugs the
1	bribe or paid
1	external use only;
3	status of a
1	importation of restricted
1	402, 52 stat.
1	procedure upon appeal
1	literature, or other
1	signals;  (iv)
2	applicable. a civil
1	general furnishes in
1	standards in use
2	(d) a decision
1	develop a consolidated
3	patient subgroups, including
2	person whose accreditation
1	manufacturer has introduced
1	elements the secretary
1	control of an
1	(3) any persons,
1	acts. (d) notice
1	part, including whether
4	manufacture or distribute
1	history of foodborne
1	produced and shall
2	additional use of
1	illicit growth of
3	aiding or abetting,
1	provide to all
1	(c) publication the
1	drug cultivation and
1	section 344, 348,
1	and/or cream and
34	authorized by this
1	reasonableness and technical
2	director shall consult
1	402, 403, and
6	fees assessed under
1	transferred by an
1	registration has become
1	subsections and section
1	maintained for a
1	wires or other
1	title, whether a
1	second review shall
2	thereupon shall file
1	secretary expedited under
1	list of discontinued
1	distribution of suspect
1	regulate, or prohibit
1	part 110 of
1	applicant before the
1	clause as a
1	excluded if the
1	applicant and within
1	advertising, or (d)
1	feed, such consignee
1	developing and implementing
6	improperly altered official
1	(b) external experts
1	foreign plants exporting
1	violations related to
1	mentorship to a
1	clause (iv). if
1	allergen control program.
4	shall be considered.
1	testing the results
1	ii, or (b)
1	prescribes) of approval
1	paraphernalia means any
1	preceding fiscal year,
1	residue may be
1	preceding fiscal year.
1	borne by such
1	health. in this
4	review and clearance
1	lieu of paragraph
1	otherwise be able
3	deemed adulterated if
1	coalition shall consist
1	proposed regulation, to
2	chapter that is
1	importer or by
28	title.  (2)
2	rather than five
1	5. information derived
1	review of federal
2	conducted by experts
1	electronic format, for
2	created the advertisement
2	constitute an emergency
1	(2) information referred
1	(a) the seafood
2	brought for a
4	841(b)(6) of this
1	1603. general requirements;
1	life, and (ii)
1	ch. 350, 1,
2	maintain an active
1	psychotropic substances and
1	679c. expansion of
1	personnelany officer or
2	deferral, partial waiver,
1	similar to that
1	tolerance shall be
3	chemical residue and
1	consumer research to
1	(c) order of
2	data before him,
1	[15 u.s.c. 56(b)]
1	crop year, or
1	apply to products
2	net assets of
1	relevant factors (and
4	379h(a)(1)(a)(i) of this
4	7 shall be
1	useful data that
1	possesses the required
1	requirements for segregation
2	state agency for
1	consuming a particular
1	identifies the roles
1	income; and (b)
1	secretary may assign
1	producing adulterated poultry
1	information requests (a)
1	possesses or distributes
1	establishment; appointment the
1	 (h) violations
5	length of time
3	foundation for the
1	(h) effect nothing
2	conflict with the
1	262].  (2)
5	iii of the
1	subsequent impleader of
1	denial of registration
1	tribal government, school
1	(c) that on
2	agreement by the
2	(iii) the drug
8	sponsored by the
1	condition means any
2	protective of the
1	(k) as exempt
1	regard to imported
1	eating place shall
1	methamphetamine on premises
5	statistical information on
1	severe form); (iii)
1	increase in resistance
1	island, midway islands,
1	service by it
1	inspected and found
1	675, 745, formerly
1	scientifically appropriate, such
1	recommendations respecting all
1	subparagraph (b)(iii) shall
1	practice. nothing in
3	technical assistance division
1	tests were conducted,
1	without a prescription;
24	change in the
1	(b)(2) or within
2	misbranding, such articles
1	space or i-kind
1	days, request referrals
1	(2) additional information
1	diethylamide; or (d)
2	reporting to the
1	development of model
13	status of the
5	year divided by
6	subchapter ii, or
2	made the submission
1	supply chain; (ii)
1	venue; process actions
7	will be safe
1	showing that egg
4	deficiencies in the
1	product authorized under
1	electronic products any
2	efficient execution of
3	application or investigational
1	provide objective clinical
1	sufficient progress toward
1	funding if on
3	also apply to
1	verify that the
1	slaughter of animals,
2	mineral, or other
1	year 1991, and
1	reviewed within 10
1	throughout the duration
1	time required under
1	compliance period 
1	(including, in the
1	year 2017 (including
2	review and renewal
1	facilities that produce
3	 (2) reporting
1	355(b) or 355(j)
2	establishing a requirement
24	(a) and (b)
2	presence in the
1	paso intelligence center.
2	(c). for the
1	established name or
1	section 352(t)(3) of
3	use as the
1	business practices, such
2	1971. (2) the
2	progress in implementing
1	discontinuance or interruption.
1	encourage states to
1	includes transfers of
1	seized or come
2	established name of
2	application that proposes
1	years, except that
6	control, the other
1	(4) activities verification
1	system who are
3	sizes and types
1	notifications under other
1	on, when applicable,
1	components or manufactured
2	 (e) maintenance
1	local agencies. (2)
1	defendant, and the
1	network, or other
1	possession for his
8	benefits costs to
5	section 381(d)(1) of
7	379aa or 379aa1
1	physician, or otherwise,
2	subsections (g) and
2	amendment or supplement,
4	section 262(a)(2)(e) of
1	chapter, the claimant
1	(ii) exception from
1	will submit the
1	(a) such product
1	methamphetamine.  (2)
1	taken office. 
1	(14) wired cigarette
1	staff the director
1	(g) biennial inspection
1	previously manufactured infant
1	section, or suspend
1	exchange, or ship
1	regular tobacco product).
2	generally accepted professional
1	designates as playing
1	health system means
7	providing the information
3	approved under such
1	general tobacco products,
1	authorized to import
1	(b) adjustment in
1	(ii) makes a
2	 (iv) the
2	-position of the
1	device. (c) dispute
1	nuts, 9.5 percent
1	establish objectives and
1	outside any official
1	necessary expertise in
3	class in which
4	systems in place
1	rule[1] of civil
12	requirements of subparagraph
1	summarize the findings
1	participants in the
1	supplement, a 18-day
1	law enforcement means
4	shall be contingent
3	register and until
1	organizations to foster
1	provide maintenance or
1	additional information; or
1	similar agencies outside
1	otherwise) electronic products
1	information. if the
1	26, 2014, where
1	teaching; or 
1	blocking assets and
1	evaluation of and
2	servant or agent
1	services shall develop
1	guidance document related
1	device within such
1	title; (v) the
1	employees of agencies
1	use or health
1	criminal, or other
1	acts. (june 25,
2	accreditation body on
2	(4) if its
3	person is accredited
2	petition may only
4	shall be admissible
1	congressional committees with
1	title shall pay
1	sell, serve, or
1	definition if the
1	appropriate purposes and
1	extent appropriate given
1	accreditation body or
1	defendant to return
3	penalty imposed under
1	representatives; and to
2	procedures to prevent
1	expenses provided in
13	person that owns
1	whether the listed
4	withdrawn (without a
1	forestry or the
3	prevent an outcome
66	(a) shall be
1	paragraph (2)(a). (e)
1	based on conviction
28	provisions of title
3	(ii) the drug
1	private sector drug
1	technology and associated
1	recommend ways for
1	types of meetings
1	existing networks of
1	otherwise applicable performance
1	vessels engaged in
1	regulation except any
1	(a) slaughtering animals
2	provides the uses
2	provide for an
1	which, the registrant
1	due notice, hold
1	term countermeasure means
1	functions, so long
1	including speech, print,
1	seeking premarket approval
1	351 et seq.).
1	includes a statement
1	programs.  (2)
1	 (1) prescribe
1	poultry, which are
1	counte-drug technology research
1	hearing an objection
1	purpose of advising
1	treatment of reimbursed
1	or, upon demand
1	 (b) meeting
1	doubt.  (h)
1	wholesale distributor purchased
2	services, including processing
16	made effective on
1	general may invoke
1	governmental entity. 
3	case of recommended
1	 (ii) required
1	total fee collections
1	title, establish a
2	approval of another
1	change includes a
1	(d) application to
1	(2) authorityif 
1	(c)(2). (2) the
1	fees applies under
5	paragraph (1). the
1	(aa) purchased such
8	subsection (a) if
1	forges, counterfeits, simulates,
2	exhausted, (d) if
1	novel or emerging
1	reporting initial compliance
3	subsection (a) in
2	basis to stay
1	farm identify potential
2	notice the sponsor
1	articles; good faith
1	children, and racial
1	term qualified countermeasure
1	scientific data about
1	regulation a process
1	(a) risks to
1	disposing of expired,
1	designed to assess
1	title a drug
2	may not amend
1	reviewing disciplines about
1	(1) the congress
1	 (iv) ingredients
3	(j) of this
2	actsexcept as authorized
1	animals caused by
2	carcasses, parts, and
3	device establishment that
1	suggestions and options
1	methodology for product
1	exemption for each
1	import; (4) substantial
1	(b) prevent unauthorized
4	funds from the
1	employees) under subchapter
2	program agencies and
1	
 
 379d3.
1	identifying the percentage
1	will consider binding
1	applicable date referred
1	made for and
1	resources for domestic
1	 (g) change
1	(i) subparagraph (a)
1	health, a full
3	subsection (b) because
1	includes those data
3	et seq.], may
1	(iii) concurs that
1	regulation, require prior
8	withdrawn by the
1	unapproved food and
1	states, including by
1	policy.  (c)
1	(c) or (k)
1	unpeeled natural form
1	
 
 387d.
2	seq.], may be
1	joint terrorism task
1	underserved areas); and
2	necessary prior to
1	fiscal years falls
1	subsection (a) based
1	(3) and (4),
2	unfairly with the
1	population data. (iv)
3	released by such
1	states food requirements
1	marketing of regulated
1	preserve any information
1	(5)(a) of this
1	ch. 675, 770,
1	1332(2) of title
1	foods are manufactured,
1	(a)(2); and (ii)
1	human services. (25)
1	(2)) with reasonable
4	amount of 
1	(4) describes the
1	method required under
1	selling of a
2	execute and serve
3	opioid use disorder
2	secretary or that
1	107(a)(2) of the
1	various fields of
2	develop standards and
4	form means, with
1	punishment. the failure
4	study conducted under
11	report or information
1	(2) possesses or
1	state initiatives this
2	shall require an
4	period of six
1	additive likely to
1	mitigate the risks
1	returns when conducted
1	application; or (c)
1	objections. the secretary
1	for.  (h)
1	regulation complained of
1	including the decision
1	logistics provider provided
1	compacted under the
1	surveillance program, the
4	secretary determines are
1	-benzoylindole by substitution
1	processor, or to
1	financial data, pricing
1	360kk. performance standards
12	distribution supply chain
1	has, within such
1	consecutive sentence for
2	services, under applicable
1	methamphetamine or listed
1	administration. (b) reauthorization
1	services, and cooperation
1	title.[1]  (10)
2	withdrawn or modified
1	evidencenot later than
2	transaction information for
4	petition for an
4	considers to be
1	property taken. the
14	(i) and (ii)
1	unless the claimant
1	subsection (n), no
2	purposes of 
1	narcotic dru-free state
1	basis, a waiver
1	apply. (10) the
1	secretary and, if
3	retail store or
1	boardthe board shall
1	purchasers for purposes
1	hazards; (e) measures
1	contamination and steps
1	application which seeks
2	facts, the proposed
1	4761 of title
1	disclosure of conflicts
1	involved a consulting
2	relating to premarket
1	magistrate judge allows
1	products containing domestically
1	secretary receives notice
1	health; (b) the
1	report as likely
1	master file. 
1	system; (b) the
1	584, as added
1	health.  (f)
14	paragraph shall not
1	(ii) to more
4	fees collected during
2	body, or in
1	imported under subsection
1	used to investigate
1	understanding with the
1	consider where applicable
1	requirements at food
1	shall accept a
1	issuance of any
2	product.  (ii)
1	(b) the methods
1	class i and
4	shall identify all
1	food bearing the
2	needed to perform
1	official name designated
1	clinical trial including
2	person referred to
1	(b) a patient
2	use and that
2	fiscal year 2012.
1	claim. (3) label
1	risk, consider available
1	reporting deadline, the
1	contained in approved
2	specific prescription drug
1	(3) most of
1	(1) reports to
1	predict an effect
1	secretary may hold
1	submission a sponsor
3	reputable practitioner of
2	entities.  (5)
1	including age groups
1	prompt notification thereof
1	 (i) certification
1	
 605. examination
1	practitioners name, address,
1	used is fourteen
1	cosmetics are not
2	3 years thereafter,
1	products around the
1	
 1701. definitionsin
1	(2)(b) is received,
1	379b. consolidated administrative
1	evaluate hazards that
1	fees. such a
1	clause, which criteria
3	expiration of thirty
1	resulting from any
4	3, 1912, ch.
1	heroin, marijuana, methamphetamine,
1	account. for fiscal
1	consideration variances granted
1	unless an action
1	(b) activities describedthe
1	970. criminal forfeitures
1	whether the costs
1	reporting.  (ii)timeliness
1	condition and if
1	secretary may, consistent
2	timeliness and alignment
1	paragraph (12), (13),
2	panel or committee.
1	mariana islands, and
2	may be diverted
1	18-day period shall
2	foreign establishments registered
1	(ii)(i) an additional
1	(c) sales restrictions
5	omission, or failure
2	811(j)].  (2)
1	conditions that, without
1	valid sample of
3	program fees 
1	paragraph (15), if
1	term new dietary
1	transfers, theft, destruction,
5	shall review such
20	registered under section
1	coordination; (d) coordination
11	packaging and labeling
1	(3) exemptions 
1	authorize its use
2	proposed rulemaking published
1	implemented, and the
1	(a) a mixture,
1	health, law enforcement,
1	 (a) biennial
1	eligibility  (a)
1	surveillance and identification
1	including such report,
1	distributor to comply
1	corporation, organization, network,
2	purchase or other
1	(f) internal review
1	fda; and (c)
1	review; (iv) assigning
1	listing, prescribe on
1	pharmacologic, or other
2	container or label
1	perform a comprehensive
3	investigations under section
1	section 333 of
1	(2), an authorization
1	term drug sample
1	criminal laws of
1	said misdemeanor shall
1	paragraph (1)(a). (b)
3	premises, facilities, or
3	fees required by
1	possible, that state,
1	commission, and such
1	shell egg packer
1	amountssubject to subsections
1	 (g) limitationsubject
2	standard recognized, or
2	ful-time equivalent review
1	priority as determined
1	experts are individuals
2	drug shortage not
1	authorizationthe administrator may,
1	training, and law
6	$1,000,000 if the
2	(b) the manner
1	subsection (b)(1)(a)(i), priority
1	(30) the term
2	connection with 
1	request for verification.
1	shall issue, or
1	person that manufactures
1	agreed, may pay
1	[21 u.s.c. 387
1	number, of the
1	clause (i) information
1	(e) and (f).
1	(e) and (f),
2	opinion such exemption
1	pharmacy is acting
1	consider the relevant
1	(c), in an
1	committee, or other
1	repayment program (a)
1	membrane oxygenation therapy
1	assay methodology used
1	dru-free schools program
1	 (d) waiver
1	every other section
2	drug applications, be
1	media campaign strategy
1	extension of the
1	5. the proposed
2	offense may be
1	(b) conduct an
1	examine the continued
2	shall inspect outsourcing
1	(a)(5)); and (iv)
1	entity; (h) the
1	identify and locate,
3	level of a
1	(k) submitted pursuant
1	1976, by regulation
3	pediatric formulation, the
1	list of nominees
1	program budget submissionsas
1	change in policies
1	country, except that
2	compliance with international
1	protocols for clinical
1	mineral within a
1	anhydrous ammonia fertilizer
1	respond in writing
3	due date under
2	bodies recognized by
1	designate inspectors to
1	(a) required conditionswith
1	behalf this petition
2	refusal to obey
2	purposes of expediting
74	consistent with the
1	local level 
1	direct measurement of
1	application fee waiver
1	2001; (5) $50,600,000
1	commerce, of poultry
1	ecstasy, and changes
2	required from any
1	attorney general, issue
1	exceptions, and a
1	adequately direct resources
6	fast track product
1	anabolic steroid means
1	exemption the administrator
1	states attorney offices);
1	analysis under this
1	subsequent proposal of
1	base amount, in
1	(4) no-delegation determinations
1	inquiries; power and
8	subparagraphs (a), (b),
1	residue resulting from
1	 (c) judicial
1	section 501 of
1	tolerances for unavoidable
2	requirements and procedures
1	initial and final
2	submit a notice
4	wel-controlled investigations, including
1	(ii) how the
1	apples are packed
1	(a) requirementsno thir-party
2	injection for intravenous
1	used in drug
4	 (1) requirement
1	facilitate any violation
3	designed to implement
1	title except that
1	cream at the
8	report under subparagraph
1	become adulterated, and
1	drugs for investigational
2	including allowing for
1	available information. (c)
2	food, which shall
1	abuse issue means
7	jurisdiction of which
1	subchapter i part
1	drug obtained since
1	less (or such
1	establishing cooperative investigative
1	county.  (3)
1	 (ii) standard
1	auditthe term regulatory
1	subclause. such training
1	paragraph and subsection
1	appurtenant thereto) that
1	sunscreen order to
1	notice to sponsor
4	recognized and reputable
1	change as soon
1	distributing controlled substance
4	adulterated under clause
1	(ii) certificationthe director
1	-(2,-dimethox--methylphenyl)ethanamine (2cd). (22)
1	also provide support
2	introduction into, or
1	aircraft, or vehicle
1	subsection is that
1	tobacco products beyond
2	ingredients, or other
1	(1) real property,
1	citizen on board
1	products such information
1	(ii) such period
1	completed. an order
1	food additives; exception
2	context of a
2	methods of slaughter
2	considered acceptance of
1	statement under clause
2	care services in
2	persons and circumstances
1	denied unless the
1	domestic animals is
1	approving another device;
1	2002 (except with
1	(a) right to
1	(g) and section
1	detection methods 
1	taken is not
1	public a list,
1	follows: (d) 
2	subchapter punishable by
1	fourteen days after
2	specified under subsection
1	november 19, 1948;
1	applicant on the
2	year in both
1	inspections, and investigations,
2	release otherwise authorized
1	foreign commerce means
1	(g) a description
1	travel expenses 
1	appropriations such sums
2	device; (ii) a
1	(b)(3)(a).  (h)
1	blocking of assetsexcept
1	providing professional health
1	interactions regarding the
1	united states have
3	review voucher may
2	approval is terminated.
1	however, must, in
1	states substantial quantities
2	civil penalty for
1	regulated person under
1	first approved for
29	whether or not
1	(bb) with respect
1	use in research
1	aforesaid, or the
1	made under subparagraphs
1	673. seizure and
1	2018. such fees
1	drugs approved before
1	property a violation
1	intended to create
1	audience that the
1	device user facilities:
4	marking and labeling
12	387g of this
1	may, not later
1	applicant proposes to
2	issued  (a)
1	establish policies that
1	names or identities
4	chapter 53 of
1	personnel in any
1	code to provide
5	established by this
1	ensure that guidance
1	2012. (g) no
1	small businessesnotwithstanding any
1	combination, respectively; 
1	several states and
1	authorized, requested, commanded,
9	secretary may enter
2	drug under subparagraph
1	(f) for any
1	(iv) otherwise investigating
2	gelatin capsule, or
2	additive and of
1	dispenser shall comply
1	organization, (ii) the
1	material facts related
1	remedies any person
4	section 351(a)(3) of
1	 (i) testing
1	available alternative to
1	information submitted pursuant
1	may be deducted,
1	675, 506d, as
2	infringement or invalidity),
5	representatives, and the
1	ensure that permitting
1	section, there is
2	(d) state defined
1	aircraft the burden
4	387i of this
1	product. (ii) a
1	
 2003. authorization
1	telecommunications service, or
1	hearing under clause
1	quotas under this
1	issuing such guidance.
1	agents that are
1	(i) two or
1	operating at the
1	including requirements with
3	trial by jury
1	health authority in
1	economic consequences, which
2	considered as being
1	optical isomers. (h)
1	finding that there
1	request for referral)
1	identified clear links
4	(ii) cocaine, its
2	advisory committee is
1	participation and ensure
2	requirements in an
1	labeling of each
1	hearing, by him
1	tolerance to cover
1	1902, ch. 784,
1	devices (a) purpose
7	number of times
1	conducted  (a)
1	number assigned to
1	subsection when such
1	event or any
1	supply chain. (d)
1	director, that the
30	address of the
6	tobacco control act
3	later than thirty
1	(e) good manufacturing
1	appropriate, fulfill such
1	safety; (ix) the
3	criteria of the
1	drug safety risks;
3	review the term
2	make public the
2	entity (including a
1	due by the
1	action.  (2)
1	year concerned who
1	amphetamines into the
1	electronic product shall
1	product with a
1	(2) and such
1	effect such additive
1	fill of container.
1	fill of container,
1	carrier, arriving in
1	device. (p) electronic
1	documentary or other
1	(b) the partnership
1	sentence to allow
1	(iii) where a
1	matches, and which
4	supply chain and
1	(b) the feasibility
1	subsection, the validity,
1	activitiesafter making a
1	1999; (3) $30,000,000
1	agreements with state,
2	additive, intended solely
2	activities under paragraph
1	amendment establishing such
2	means a financial
1	serious diseases or
1	(written or otherwise)
6	secretary may make
5	goals, for the
1	serve as chairman.
1	time that notice
1	
 846. attempt
1	fee an outsourcing
3	encourage treatments for
1	(a) review of
1	applicable law, minimize
1	columbia.  (

1	(i) corrected such
1	inform congress and
1	eligibility issued under
1	agents for which
2	giving the united
1	instructions to inform
1	(2) technical assistance,
1	(e) suspension and
2	iv, such person
4	business or other
1	either affirm the
1	manage their own
4	(c). (b) payment;
1	turkeys, dogs, and
1	reduced by the
1	both. (2) as
1	resources devoted to
2	types of facilities,
1	device, and establishment
1	comparability payment pursuant
1	dispenser.  (2)
1	except where the
1	form and on
1	ch. 675, 503c,
1	owned property, or
2	limited englis-speaking ability
2	state standards. 
1	1055. authorization of
1	government or the
1	personnel who may
1	from, or make
4	inspections under this
3	make a grant
2	reid dat-rape drug
1	media campaign. (c)
1	interstate commerce because
1	locked cabinet. (ii)
2	margarine at a
1	use shall, to
1	corporation engages in
5	districts of the
1	solution, or topical
1	include fac-t-face transactions
1	(a). (d) in
1	product manufactured or
1	health; or (7)
1	efficacy, and 
1	days following its
1	designthe pilot projects
1	appropriated or credited
2	division, that a
1	entities accredited pursuant
1	located in an
1	(j)(5)(d)(i)(iv) and approval
1	workforce planning to
1	district courts; united
2	fiscal year thereafter,
1	state laws; planning,
2	(i) who is
3	suspend or revoke
1	incomplete, false, or
1	implantable within the
1	ch. 861, 2,
2	believed to be
1	control program. (b)
4	section. (2) the
1	specifications, the court
1	hopper car, cargo
1	compile the notices
1	data are reliable
1	allergies and anaphylaxis
1	identified in any
2	methods of manufacture
1	one premarket application,
1	applicable domestic and
34	chapter shall be
1	refusal by secretary
1	
 
 387l.
1	documents. all such
1	opportunities that the
2	applies; and (b)
1	fluid ounce or
2	relevant to a
1	corporation or an
2	among youth, which,
2	counter without a
1	pharmacy, under penalty
1	(4) advertisingthe secretary
1	entitled to dispose
1	agency; subordinate governmental
1	distributor may engage
1	persons includedsuch term
1	(i) the notification
1	section, is a
1	plan to the
1	use disorder research
1	approval, and and[1]
1	drug or devicea
1	9, 2006); and
1	 (d) refunds
3	drugs or prohibited
1	retrievable and shall
1	panel may be
1	product identifier assigned
1	subsection (c)(2). (2)
2	general does not
2	due under this
18	relevant to the
10	owed by such
1	regulation shall require,
1	qualified expert panel,
1	42).  (c)
1	regulations to protect
1	medical products (a)
2	term commingled raw
2	determines before the
1	reaching agreement regarding
1	united states standards;
1	includes, with respect
1	drug abuse is
3	drug or device;
1	interstate commerce means
1	808, as added
1	drug exemption under
1	experimentation data, and
2	grants under paragraph
6	drug or device,
1	enforce any law,
2	drug or device.
1	(a) the known
1	petition or who
6	 (a) there
1	local agency, shall
2	drug abuse in
3	sales of such
1	plan as described
2	conducted under subparagraph
1	section 1706 of
1	 (i) include
1	come into contact
2	drug.  (e)
1	1, 2012, references
2	apply to persons
4	relating to financial
1	(c)(2), a drug
1	child education program
1	subparagraph (f)(i) shall
1	 (b) requests
1	programs, and other
1	gathering  (1)
1	retesting, or product
1	thereof, offered for
1	patient when the
5	year; or (ii)
2	retailers of the
1	3(d), 64 stat.
1	appointed under subsection
1	withdrawalthe secretary may
1	dissemination of general
2	state agencies may
1	dose under similar
1	(b) through representation
1	signed at paris,
1	understanding for use
1	suspended or deferred.
1	format. such device
6	section 387e(j) of
11	bears a label
1	characteristics, which it
1	346a(a) of this
1	administration, medical professionals,
2	public health he
1	performance auditingto ensure
1	investigation related to
1	substance already controlled
1	bufotenine. (5) diethyltryptamine.
1	consulting agency center
1	exist; (4) consult
1	three hundred thousand
1	either in a
4	listed chemical for
1	11, 1946, and
1	adequate, wholesome, and
1	written submissions. the
1	year), multiplied by
2	(i).  (iii)no
1	council and the
1	biennial inventory (following
1	orderif, after providing
1	suppliers of such
1	bioequivalency under subclause
1	rules governing the
4	sunscreen order described
1	exists unless there
1	
 1534. technical
2	preclude permanent impairment
5	subsection between the
1	year and no
2	policies for the
1	peer review and
2	considerations under paragraph
1	packed. (2) the
1	proceeding, any information
1	permitted to contain
1	(a), and the
1	contain, an anabolic
1	2013, the following
7	receipts or sales
3	additional compensation for
1	impede the development,
3	postapproval clinical trial
1	negative.  (b)
1	(g) enhanced drug
1	service, or is
1	give precedence to
1	definition in paragraph
1	comply with section
1	related to, food
1	inform a guidance
2	english, from the
1	administer medication under
2	thirt-month period referred
1	responsibilities for regulating
1	age groups (including
1	costs of operating
1	preserving human food
2	congress that describes
2	44 (commonly known
2	records thereof, and
1	relevant civil or
1	 (a) improve
1	reduction the deputy
2	data; and (c)
1	agricultural commodity; or
1	subchapter, or attempting
4	regulation; and (c)
1	 (3) n-cost
2	country are adequate
1	include benefits relating
1	paragraph (2)(b) on
1	contains and lawfully
2	margarine in type
2	labeling requirement if
1	sector to develop
2	paragraph (2)(b) of
2	predicted effect on
1	labeling requirement in
1	5. the hearing
1	2009, the director
1	page directly linked
1	device shall display
2	aggregate and individual
1	products; and 
1	expended solely for
3	made effective immediately
1	section. (mar. 4,
2	related series of
3	schedule determined by
1	toward such costs
2	requirements within one
1	821. rules and
3	date under subsection
1	air that meets
1	establishment where food
1	goals and activities
1	compliance with inspection,
1	assistance. (5) 
1	10 years, (b)
1	industry related to
2	regard to food
2	order, or that
1	family members and
2	(2), or (9).
1	benefits of pesticide
1	drug trade name,
1	residue, and exposure
2	 (b) quarterly
2	(a), the requirements
1	feedback, decisions by
1	may delay the
1	recombinant analogs, if
1	
 129a to
1	(2) responsibilities 
1	contain such relevant
2	employed in, plants
1	(j) temporary holds
1	sanction or approval
1	generala person may
1	shall review tolerances
1	
 
 346a.
1	device name, including
1	disclosure of federal
1	sustained basis. (8)
3	trials and the
1	paragraph (4), if
1	limitation on grant
1	50 to 70
1	contains protein derived
1	(a), no discovery
1	clinical investigations of
1	517, as added
1	article; the manufacturer
1	leaker, or loss.
1	smuggling goods into
1	manufacturer shall identify
1	clinical investigations on
2	establishment the secretary
1	organizations, terrorist persons
1	final order to
1	requests such records;
1	shortfalls  (a)
1	processes for industry
1	food for commercial
2	subsection (a)(1). 
1	(a) new productsan
1	210 of title
1	states. (3) no
1	packed do not
3	(b) the specific
1	exemption authority (a)
1	subsection (d)(2)(a)(i) and
1	agencies, including state
1	illegitimate product shall
1	secretary reports on
1	official establishment under
1	next budget year
1	issued; and (iii)
6	active ingredient of
1	studies as the
1	pharmaceutical and biotechnology
1	(as a poultry
1	use of full
1	private sources. (3)
1	owner or manager.
4	suspension of importation
1	spaces during use.
1	prepared, sold, transported,
1	consolidate pos-seizure administration
1	implement inspection programs
1	1970 pursuant to
1	general schedule. there
1	bears (1) the
1	one variety, which
1	officials to share
3	(d) on the
1	treat within the
1	law or policy
1	reviewing notifications submitted
1	675, 566, as
1	rates, except that
1	paymentexcept as provided
1	brand name other
1	nominations; and (c)
1	ensure that, subject
1	(b) marketed drugs
1	 (5) trade
1	appropriate, the administrator
1	plants shall be
3	single proceeding; or
1	drug or indication
1	findingseach notice of
1	personnel. (6) the
1	provide regular reports
1	constitutes gross negligence
1	designated place of
6	date the patent
2	otherwise comply with
1	law, other than
2	imprisonment and fine,
2	enterprise shall be
2	costs in making
1	property where a
2	(b) humane methods
1	ensure consistency with
1	coalitions. (7) additional
1	provide effective controls
1	schedules under the
1	products as determined
1	party interests 
1	prescriptions it shall
1	practicable, and that
1	staffed laboratory facilities
1	 (ii) actions
1	narcotics detection technology;
1	iu/gm linoleic acid)
2	true copy thereof
1	shell. (7) the
1	budget to support
1	analyzed for such
1	entry of carcasses,
1	subchapter if he
1	(3) the petition
1	transaction history under
1	rate as a
2	chapter. (n) the
3	inconsistent with subsection
1	drugs made with
2	person who requested,
1	containing such specific
2	states it shall
398	food and drug
1	sponsor. (c) the
1	postmarket surveillance (a)
1	
 
 360n.
1	counterfeiting such a
1	360k. state and
1	form, including the
1	distributor that directly
1	mortem inspection; quarantine,
1	health care practitione-patient
2	delay the date
1	amount for administrative
1	classes of persons,
1	informationif the secretary
1	 (7) repealed.
2	year, there is
1	marketed drug that
1	parts supplied by
1	877. judicial review
1	records of this
1	356c(f) of this
1	unaffected poultry and
1	as, habit forming
1	use, and directions
28	pursuant to a
1	(4) upon request
1	substance or contains
2	patent involved is
1	continued tobacco use.
2	entities to implement
1	approved before september
1	certifications concerning imported
1	reasons for each
1	343(r)(6) of this
1	means of communication.
1	recommendations for consolidation
1	limitation the administrator
1	united states cooperate
1	(e) recall authority
1	exploring means to
1	definitionsin this part
2	(2)(a) if it
11	assure safe use
1	plan the strategy
1	u.s.c. 355f]. 
10	subsection (a) may
1	sell, barter, exchange,
2	chapter obtained by
1	(2)(a). (w) deadline
2	previous order under
1	(ii) afford opportunity
1	opium and coca
1	section, in section
1	element set forth
3	period preceding the
1	 (b) foreign
1	temporary detail to
1	inspection, as the
1	et seq.) with
1	time, to reduce
1	serve as spokesperson
1	case of serious
1	listings under this
1	(h) administrative powersin
1	time not to
1	fruit or vegetable.
1	employees; (h) interventions
1	matter if it
1	specific citations to
1	lifesaving medical devices
1	(d) no limit
1	application. (b) if
1	death penalty 
3	disposal is made,
2	75 days after
1	information in either
1	individuals, and families
1	title. (feb. 15,
1	following the decontamination
1	products and returned
1	review feesbeginning in
1	clause (1), except
1	agencies or departments
1	program agency if
1	section against an
2	all, part, or
1	(8) to use,
1	title that demonstrates
1	(ii) following the
1	distributed and the
1	circumstance in which,
1	collections through procedures
1	individuals with necessary
1	unreasonable, direct, and
2	(1) all controlled
1	type introduced or
1	first inspection the
1	processed food; and
2	effect, except that
2	provide  (a)
1	labeling thereof; (f)
1	children. in the
1	monitoring the preventive
1	thing (other than
1	natural state, including
2	notification requirement for
1	repackaging of such
1	service for such
2	health, such as
1	adequate grounds for
2	pending, measured from
2	person in the
1	classes of drugs;
1	drugs for 
1	meeting or a
1	agencies is restricted.
1	consecutively in the
1	42 for advanced
3	shall publish and
1	meeting a premarket
1	ship or transport
1	party. (
 

2	damages for economic
1	(a) by strengthening
1	carryover balances from
1	product.  (d)
1	drugs, shall mean
2	recommendations, underlying data,
1	manufactured methamphetamine; and
1	(e) notice from
1	another applicant before
2	(c) considering such
2	provisions the provisions
1	information gathered during
1	disease. (s) any
1	(
 
 1534.
1	drugs, and investigational
2	section, ships in
1	premises he shall
1	eating place, whether
1	administration imported into
1	extent that paragraph
1	675, 1009, formerly
2	commercial distribution in
1	institute.  (4)
1	submissions and related
4	extend the period
1	compensation to persons
1	team leader with
1	determination that consumption
1	eligible entity pursuant
1	take action on
1	complaint is filed
1	plastic bag containing
1	country from any
1	funds to implement
1	sold by any
1	specimens, hand picked,
1	list of facilities
2	food safety, as
3	made at any
1	 (c) research
1	misbranded. (h) the
1	sunscreens nothing in
1	351 and 352
1	device through utilization
1	september 27, 2007),
3	bears or contains,
1	from, and impose
1	shall (i) contain
5	use which is
1	needed to design
1	shortage or shortage
3	refrigeration at an
1	officials, manufacturers, repackagers,
1	manufactured. (d) any
1	subsection (a)(1) do
1	thir-party auditors; and
2	illness outbreak based
1	control with such
1	applies means a
1	records of recipients
2	cost of complying
1	butter shall be
1	
 619. marking,
1	regulations, or successor
2	least 180 days
6	ownership of the
2	(b) purpose of
1	review of order
1	staffthe staff of
1	otherwise identifying inspection
1	article and to
1	coordinate and prioritize
1	acceptance of mutual
1	fund.  (3)
1	exists solely because
1	379d3 of this
1	research using electronic
11	use from the
2	plans, agreed initial
1	42); (c) an
1	colored, or otherwise
1	strength which differ
2	property with respect
4	examinations and investigations
1	order will be
1	(2) written agreement
2	commission who are
2	sufficient to allow
1	period.  the
1	by, not later
1	(2) postapproval requirement
1	clear ant-drug message.
1	records or of
2	chapter, as determined
1	(1) provides ongoing
1	title before the
7	quarantine such product
1	authorization and training
1	(d) and if
1	675, 514, as
1	related to submissions
2	regulated matters; prohibition
1	(xi) any additional
1	information, and each
1	death, serious bodily
1	county referred to
1	expertise concerning ethical
1	remedies as set
1	modification or change
1	 (2) multiple
1	(x) a summary
2	criteria which differ
1	drugs may, when
1	control policy; (3)
2	concerning recordkeeping and
3	upon the establishment
1	injunctive relief relating
1	$250,000; or (b)
2	two and on-fourth
3	submissions:  (a)
5	government of any
1	on-time payment if
1	panel recommendation; publication;
2	processed by an
1	detriment of implementation
3	drugs means the
1	linked in the
2	drug administration exported
2	expenses actually incurred
1	refusal of renewala
1	determine not to
1	(1), nothing in
1	(a) held title
1	 (1) identifying
1	receiving a priority
2	operating reserves, then
4	contributions, for that
1	operate outside the
2	claim, and the
3	industry, and which
2	issuance of final
1	$124,000,000 for fiscal
1	commissioner shall receive
1	commerce means (a)
1	orders an order
2	unknown;  (iii)
1	particular food 
1	components of any
8	shall be included
1	harvesting, holding, transportation,
1	prior i-person medical
1	assurances that 
1	product. (i) postmarket
1	handler means any
1	(b)(1) because it
1	including the date,
2	appealed, the approval
1	k (g) 4.0
1	(2) state regulation
1	entity providing documentation
2	populations, the information
1	young people the
1	(ii) the impact
1	1 year; or
4	application contains an
1	years, (b) fined
1	(i) and each
1	discuss methods and
1	issued for less
13	construed to limit
1	issue proposed regulations
1	received, or to
1	person whenever he
1	subsection (n) is
4	first became known
1	food certification, described
1	distributor, through any
1	butyrolactone. (y) any
1	term convention on
1	entry value which
1	(ii) suspension of
1	title prior to
1	subsection (n) in
5	secretary shall, upon
1	expenses.  (h)
1	substance. (
 

1	(d) civil penalties
2	(b) violation of
1	subsection (n) if
1	(c) review of
1	academic and industrial
1	commissions[3] shall submit
1	1, 1958, through
1	give the president
1	i(c) and schedule
1	standard review, the
1	issue forms pursuant
2	 (i) make
1	means the states.
1	used by any
1	conditions on the
1	coalition.  (2)
1	infusion. (4) the
1	complained of. any
1	shall use other
1	area in coordinating
1	use, or for
1	abuse conditions; and
1	strategy, transmit a
1	strategic plan (a)
1	methamphetamine precursor chemicals
1	order setting forth
1	will secure, to
1	consignee upon the
1	(g)(2), the only
1	animals.; and (3)
1	years, evaluate the
1	21, 1997), or
1	reference to his
1	(3) defraying the
1	current judicial, regulatory,
1	disclosures relating to
1	distribution within the
1	maintenance and transmission
1	30, 1973; $100,000,000
1	written reports, to
1	offense occurs outside
1	found to have
1	98. transferred
 

1	use amounts made
1	section 1701(11) of
1	petition. not later
1	places, including factories,
1	southwestern border of
1	notification submissions. (b)
1	chapter shall process
2	schedule iv, such
1	misleading. (e) if
1	somatropin, or an
1	seq.], as amended,
2	additives are generally
1	sufficient funds are
1	facility, and collection
2	failure of such
2	articles inspection shall
1	allocated for grants
3	manufactured, distributed, or
2	paragraph (1)(a)(i). 
1	cause skin irritation
1	(a) a licensed
2	ingesting, inhaling, or
1	proposed performance standard
1	previous demand; and
1	assessment system for
1	entities, including a
1	information is of
1	drug in domestic
1	advisory committee review
1	drug administration. (h)
2	secretary shall inform
1	proceedings the article,
2	(1), the fee
2	data show that
1	means a pathogen
1	capacity to inhibit
3	laboratory assistance and
1	subsection (b)(1) 
4	4 years in
2	$100,000,000 or less
1	(c) applicants to
1	standard without the
2	27, 1935, ch.
1	control; (iii) the
1	investigational device exemptionsupon
1	shown, that an
2	reasonable samples, where
1	president determines not
1	handle and protect
1	2007.  (june
1	regarding any such
13	administration and the
1	(3) shall coordinate
3	flow or movement
2	facility are such
1	encapsulating machines, and
1	(b) the national
2	supplements:  (a)
2	safety activities at
1	local data; (b)
1	drug crisis or
1	made by country
1	inspection unless the
1	formula a notice
1	units or the
1	objections. as soon
1	including the factors
1	guidance that permits
5	evidence that relates
1	human food purposes.
1	(b) travel expenses
2	drug application the
1	combat methamphetamine trafficking
4	applications described in
2	device by the
1	products that constitute
1	two separate occasions.
2	accurately reflects data
1	incorporate local surveys
2	term authorized person
1	following may be
8	 (c) public
1	coalition shall submit
3	shall annually submit
1	nonexpedited testing fees.
2	fix such tolerance
1	amount of back
1	radiation; (c) the
1	information activities 
5	definition of the
1	notice sets forth
2	preemption nothing in
1	(b) information activities
1	interest. (ii) 
1	exempted under clause
1	generalon an annual
1	public good may
1	iv.  (a)
1	chapter. (c) to
1	 (12) authorization
1	diphenoxylate and not
1	drugs, shall establish
2	assessment; and (iii)
1	abuse of psychotropic
7	shall, on a
1	commerce exclusively to
1	approvals fraudulently obtained,
1	particular drug or
2	meetings for each
2	located, may select
1	product, consumers will
14	importer of a
2	given to a
8	respect to safety
1	recall. (3) the
12	days after september
1	(2) action by
1	refilled.  (b)
1	ineffective under the
1	regulations and testing
1	inspections, checking the
1	review the report
1	tobacco product during
1	of, a transgenic
1	(a) product identifier
1	secretary in support
1	sentence may not
1	interfere with bona
1	if, within thirty
2	organization, to the
1	nighttime the secretary
1	(i), and (j)
1	received, by order
1	(3) content of
1	803.19 of such
1	purpose. (3) cooperation
1	(1) are as
1	animals, the inactive
5	appropriate, of the
1	(iv) the notification
1	affiliates, collectively, of
1	(a) or (k)
1	1997  (a)
1	time, shall cause
1	section 282(i)(3) of
1	(iii) the process
1	drug, and (g)
1	order being reviewed,
1	infringed. (bb) in
2	needed to utilize
1	u.s.c. 355(b), (j)];
2	minimum sentencing provisions
3	partners beginning not
2	system that is
1	(b) and subsection
6	(a) of section
1	deposit in the
1	product that presents
1	include leaders 
1	stimulant, or to
1	conviction of violations
1	claimant only if
1	pursuant to clause[2]
1	civil regulatory purposes.
1	committee is inadequate
1	(iii) a separate
2	section 379i or
1	(b)(3) for such
2	shall violate any
4	1954, ch. 559,
1	review the judgment
3	supplements, including the
7	appropriation acts, or
11	transaction information, transaction
1	 each federal
1	authority for contracts
1	administration, shall enter
1	 200.0. 
6	contact with the
1	payment made available
1	requirements by a
1	section, evaluate the
2	(b) when a
2	general shall dispose
1	petition shall include
1	differs from such
3	section 801 of
1	person permanently debarred
1	ii, and the
1	request, to the
1	practice or other
2	request, such studies
2	confidential and may
4	performance standard is
1	docket for at
4	means a report
1	subparagraph (c)(iv) not
1	jurisdiction of united
1	scientific principles, are
1	 (2) grounds
1	 (c) smokeless
1	shall operate under
2	genetically targeted drug
1	(
 
 1194.
1	performance standard in
1	interest. (5) referral
1	proper authority uses
1	(c) limits of
1	[5 u.s.c. 552]
1	cream is a
2	notification shall contain
6	referred to under
8	(a) may be
2	disapproval of the
1	governmental entity governmen-issued
1	provider licensure requirements
2	entity qualifies for
2	form of public
1	commerce has the
1	unusual or excessive
2	(4), (6), and
1	drug in biological
1	leaf for storage
1	ingredient will reasonably
1	year 2002. 
5	guidance under this
1	functions by subordinate
1	locked cabinet that
1	(1) shall take
1	inform the draft
1	relates to an
1	675, 905, as
1	61, 3(d), 64
1	has, before introducing
1	(2) emphasis on
1	fully cooperated with
1	biological products in
1	(2) state, local,
1	clarification to such
1	datethe biosimilar biological
1	coupon. for purposes
1	 (c) status
1	no-implant applications; and
3	every registrant under
2	need for information
1	political subdivision as
1	(2) limitation in
1	 (iii) suspension
1	thereof, or under
1	order require manufacturers
3	plants processing egg
1	(ii) standard for
2	repackager from product
1	30-day period, the
1	appropriate, information on
1	laboratory seizure data
1	contents, filing, etc.;
1	 (2) benefi-risk
1	(aa) the secretary
1	fact, it has
1	serve as incorporators
1	commission shall choose
2	withholding of information
2	requirement if he
1	human food, except
1	within the review
1	product means (a)
1	magnetic fields; (5)
4	355f(d) of this
1	panel.  (h)
1	comprehensive review and
1	year, excluding allowable
1	(e) the compliance
1	vehicle (as defined
1	 (3) after
2	further, that the
1	thereupon the administrator
2	basis, or any
1	including technologies existing
1	provides services at
2	preceding sentence for
1	health, and any
1	governmental organizations; and
1	title, the applicant
1	379aa1. serious adverse
1	cream are not
1	 (1) submissionbeginning
1	family ictaluridae; and
1	health protection, conservation
1	 (2) approval
3	available by the
4	written agreement of
1	seeking either a
1	device, (6) the
2	business.  (c)
1	issuance of guidance
1	report; time for
12	100 milliliters or
1	exceed the equivalent
2	require the secretary
1	periods  (a)
1	exacerbate, a shortage
1	1421 et seq.);
1	i-kind contributions of
1	period applicable to
1	(b) the petitioner
1	lawfully sold over
1	drug administration. (july
1	1421 et seq.),
2	inpatient hospitalization; (iv)
1	sponsor elected in
4	applicant shall establish
1	pharmacies or wholesale
1	personal use; and
1	importer. (6) the
1	prominence on the
1	transaction history to
1	form; and (4)
1	to, but not
1	development, consistent with
1	ch. 675, 564a,
1	following date: __________.
1	schedule for a
1	another designated medical
1	involved 30 days
1	imports (a) authorization
3	small business dispensers
1	15th par., 34
1	 (4) procedure
1	original information which
2	(b) enforcement proceedings;
1	3 years by
3	term manufacturer means
1	med and medline
1	assistance related to
1	logistics providers as
8	shall transmit to
1	basis, in a
1	medical advice. with
1	misleading or use
1	consumer protections consistent
2	degree of culpability,
1	(i) all records
1	parts of sheep
6	human services, for
1	fdabeginning with fiscal
1	demand for contraband
1	exclude from the
1	officio members, acting
1	properly labeled; and
1	verification; and (ii)
1	books, papers, documents,
1	time; or (2)
1	passed; (3) do,
1	 notwithstanding paragraphs
1	regulations (through notice
1	efficiency and expertise
1	first knew of
1	before, or within
1	(3), (6), (7),
1	uses reliable analytical
1	internal procedures related
1	otherwise cooperate with
1	(1) for programs
1	investigations on such
1	ch. 131, 38
1	333(c)(3) of this
1	(1) director there
1	improves the capacity
3	may have originated
1	hereafter in this
2	introduced by the
1	findings:  (1)
2	paragraph (3) on
1	program agencies of
1	1998; (2) $20,000,000
1	budget), and of
1	detection methods for
3	paragraph (3) of
1	regulation; (2) provide
1	may exempt any
1	secretary, the article
1	applies to transportation
1	granted and that
1	articles; court costs
1	sponsor the term
1	(iv) other relevant
1	establish offices of
1	experience because of
2	tobacco product not
2	competitive grant program
1	enter into written
1	proprietary name, the
1	knowingly  (a)
1	date; (vii) storage
1	report the in
1	exporters of the
6	event occurring from
1	person; (3) the
1	detailed statistical information
1	issue, upon the
1	intelligence, shall submit
12	appropriation account without
1	use of pinball
1	(b) each report
1	based the regulation,
1	issue whether the
2	clinical trials (a)
1	commencement of programthis
1	approach); (ii) any
1	term meat food
1	matter described in
1	designation of drugs
1	justifying emergency authorized
1	shall accept or
1	appropriated fees collected
1	act, meet the
1	(k) request for
3	application that contains
1	
 360hh. definitionsas
3	term date of
1	issued, the facility
2	list of nutrients
1	foreign facility means
1	plants are scored;
1	subsection (a)(1) (other
1	employees that carried
1	
 379d5. guidance
1	patient representatives who
1	available for sale
1	i, 101, 67
2	 (i) provisions
1	device until the
1	holding the patent
5	drug, or (ii)
1	succeeding violation, be
1	3, 1996. 
1	labeling. (k) records
1	appropriate flexibility by
3	dispersed); (ii) there
1	 (c) animal
2	withdrawal period for
1	ensure that countermeasure
1	countermeasures  (i)
1	accident. any such
1	entity, means the
1	products determined or
5	informal hearing, to
3	signature of the
1	industry, academic researchers,
1	42, does not
2	(other than this
1	343(f), 343(h), 343(i)(1),
1	infusion. (2) the
1	invite the secretary
1	proposed regulation; (c)
1	proceedings applicable the
1	recognizes the person
2	(iii) there is
1	cooperation with other
2	purpose of reviewing
1	discretion, designate inspectors
1	335a and 335b
1	finds after investigation
1	(4) that all
1	importer status of
2	transaction date, or
1	require.  (b)
1	dietary supplement which
1	program, and refund
1	national companion animal
2	export such drug
2	general shall serve
1	entities to certify
1	reports, including recommendations
1	tablet, capsule, solution,
1	applicant resides or
1	2010, notwithstanding any
1	1996.  (june
1	application and afford
5	november 27, 2013
7	shall enter into
2	report.  (b)
2	requiring that formulation.
1	abuse (including, if
2	use tobacco products.
1	director awards any
1	annual fee, for
3	markets for wholesome,
1	 (c) permanent
1	systems, and increasing
1	quantity sufficient to
2	states of such
1	keep records and
1	(g) the request
1	longer deemed to
6	product has the
1	factors that will
1	enrollment, data requirements,
2	consulted under this
1	lif-sustaining or lif-supporting
1	imminent danger 
1	control activities means
1	issue regulations regarding
3	terms of the
11	known safety risks
2	pricing data, personnel
1	ingredients as the
3	carry out other
1	recovered at the
65	federal food, drug,
3	include recall of
2	foodborne illness outbreaks.
1	mitigate a food
1	including modifications to
1	data development plan;
1	sales of, substances
1	instruments mentioned in
1	(4) the scope
2	meat inspection requirements
1	(3) determination of
1	electronically downloadable format.
1	policy, which shall
1	means any commodity
1	1, 2012 
1	 (a) foods
2	amended to incorporate
1	$712,000,000.  (2)
1	purpose or intent
1	contract carrier for
1	(h) 50 grams
1	shall issue final
1	civil or criminal,
1	 (2) schedule
1	response that 
1	food tested and
1	nonconformance material to
1	subchapter, each manufacturer
1	potential pr- and
2	 (j) exemption
3	time during the
1	term authorized means
1	strategy (including under
1	receives a notice
2	part from any
1	(1) slaughter any
1	committeeprior to the
1	labeling; (f) information
1	greatest practicable degree
1	technology.  (4)
1	requestors under the
1	 (i) conditions
1	device is or
1	(a)(1)(d) for a
1	international conventions designed
1	phase 2 or
1	via mail) as
2	psychotropic substances in
1	administration certificate of
1	another similar source
1	manager of such
1	substance abuse, and
1	expressed intent of
2	state: provided, that
5	drug is approved
1	time before, or
1	addressed in the
3	performing official functions
1	general community care
1	 (2) serious
4	actions to be
1	granted to any
1	notification upon a
4	administrative record by
2	fiscal year (or,
1	labeling requirements 
2	packaged together in
1	360e(d)(5)[1] of this
1	written requests under
1	grantee is afforded
1	(d).  (4)
1	taxation.  (g)
2	examination of such
1	reasonable jury to
2	supplement or as
2	 (2) coordination
2	amended order under
1	registrants who have
2	residue with respect
1	hereunder, or that
1	labeling of sheep
1	 (b) strength,
1	675, 901, as
1	specifications or directions
1	processed food, or
1	person requesting the
1	circumstance that the
1	commitment to reducing
1	activities. (h) the
2	information and analysis
1	system (including any
1	primary jurisdiction. 
1	provide false transaction
2	 (1) before
1	(c)(iv) not later
1	developing medical foods
2	plans, and assessments
2	require a device
1	(ii) the general
1	section 355(i), 360b(j),
1	congressional committees interested
2	(7), unless its
1	abbreviated application, a
4	materials used in
1	sales of scheduled
1	chapter or that
4	farms and restaurants)
1	instrumentalities when requested
1	2016. (b) priority
1	first portion of
1	request for listing
1	agencies to carry
1	enter controlled premises
3	unless they have
1	general.  (e)
2	apply to activities
1	drug supply, cost
2	30 days announcing
1	paragraph (2) authorize
1	human subject (or
1	established; (b) the
1	(ii) a lif-sustaining
2	initial grant is
1	(12) nicotine the
2	application the secretary
1	united states; but
1	1972, and in
1	constituents, or harmful
1	jeopardize the integrity
1	study is safe
1	(5). (3) unit
1	(29) morpheridine. (30)
1	orders; examination of
1	recommendation shall be
1	nominated for participation
1	1508. repealed. 

1	circuit. judicial review
1	task force operating
1	condition, including but
2	adequacy, necessity, safety,
15	impose a term
1	fees.  nothing
1	continued or modified.
15	meeting at which
1	
 1102. congressional
1	technique required by
1	grase and should
2	submission (within such
1	none of which
1	electronic products; (4)
1	receive an additional
2	appointed under subparagraph
2	person or circumstances
1	export permit requirements,
6	system under this
1	 (2) exemptiona
1	requested when such
1	itemthe term meat
1	individual basis) by
1	terminated, review the
1	cures act to
1	tobacco additive, if
1	rodenticide act, cancels
1	website, in and
1	date in establishing
2	emergent campaign needs
1	 (2) exemptions
2	 (a) may,
3	minimum required information
2	development meeting for
1	kind which is
1	imitated.  (d)
1	manufacturer shall, before
1	appropriate pediatric contraindications,
1	arrangements; and (4)
1	federal register, any
1	caution against habitual
1	reported, the facility
1	actions. (i) protection
1	residues of such
1	private parties unless
3	product; and (b)
1	scientific experts were
1	
 
 347b.
2	inventories, and records
1	data that otherwise
1	review any supplemental
1	9 and amended
1	of, or while
1	term licensed or
1	518, as added
1	section; except that
1	hand picked, of
1	title. (c) confidentiality
1	list shall not
2	salaries of officers
13	title 18, or
5	adulterated under this
1	ch. 675, 586d,
1	enhance food safety.
4	destruction of such
8	section referred to
1	60 days but
1	number of methamphetamine
1	deemed under this
1	secretary believes may
2	sunscreen order within
2	diethylamide (lsd); (f)
1	bears the statement
1	time such summary
1	control act (including
1	verification submitted by
1	policies, and other
1	final order, a
1	advanced therapy and
2	notice which is
1	intelligence and related
1	term biomaterials supplier
1	(v) the likelihood
1	(2) periodically, or
1	implement procedures under
1	facilitate gathering the
1	production of food
2	practices as determined
3	 (2) with
1	template for requests
3	waiver from or
2	321(ff) of this
1	demonstration purposes without
2	pay the facility
1	user fees collected
1	iii, why general
2	substances and listed
2	chapter or in
2	amount necessary to
1	(3) consultation 
2	products before reconstitution).
1	common carrier under
3	sanitary transportation practices
5	u.s.c. 451 et
1	submission following the
1	force shall 
1	unpublished data and
8	effect with respect
1	considered distributors for
2	accordance with regulations,
1	(ii) limitationno fee
1	business, the fee
1	registrant, before the
1	notice, as provided
2	misbranded when delivered
9	strength, or use
1	renewal grantsthe administrator
1	construed to preclude
1	effect effective procedures
1	state licensed pharmacy
1	special surveillance list
1	wel-grown specimens, hand
2	device may request
2	section 379g(6) of
1	title, that 
1	prescription or by
1	purposes directly related
3	authorized and directed
1	foundation on regulated
1	section 10.30, title
1	(9) civil monetary
1	audit reports under
2	licensing program for
2	substantially to comply
2	regulation is prohibited.
20	significant foreign narcotics
1	5. (4) rule
1	(i)(4) with respect
4	approval, including the
1	human consumption of
1	(1) by not
7	whether such drug
1	liquid form only
2	state and may
1	seeking simultaneous global
1	senior executive schedule
1	secretary shall exclude
2	upon public notice
2	shortage not caused
1	provided therein. such
1	plan and timetable
1	application, reinstating the
1	pseudoephedrine, its salts,
1	level in order
1	meeting means any
1	additional requirements would
1	improve the capacity
1	protocol was not
1	shall transmit in
1	order directing the
1	laboratory network members,
1	(d)(1) and (e);
1	dispensing such narcotic
1	distribution or processing,
2	inspection, if 
2	(b) report on
1	(g)) in any
1	coordination of activities
1	publication and effective
1	carrier refuses to
1	services.  (3)
2	reflect developments in
1	action, unless 
3	section 2 of
1	trade commission to
2	general as a
1	effective.  (j)
1	public comment. within
1	electronic product may
1	store and, as
1	detecting at one
1	specifying the deception
1	furnishes assurances satisfactory
4	container does not
1	temporary suspension 
1	shall be exclusive,
7	appropriation acts 
3	distribute drug samples
13	1944, ch. 373,
1	documents referred to
6	350h of this
1	initial completeness assessment,
1	rejection of adulterated
2	state agencies as
3	determination is made
2	license to each
2	(4), deems adequate
2	inspection requirements under
1	levels of government.
1	colchicum, cotton root,
1	paid. until the
1	levels of government;
6	 (4) public
1	patient; and (b)
1	program are of
1	partnership; (2) to
1	(b) is required
1	licensing of the
1	section any color
3	parties shall reasonably
1	practicable, obtain the
1	regulation).  (9)
1	applicant seeks to
1	acts or any
2	findings of such
1	products that were
1	(ii) $249,000,000 shall
1	403a, as added
1	otherwise provide, sections
1	part may be
2	negligently to fail
2	desirable in the
2	manufacturer registered under
1	issue the order,
1	drug; (g) the
1	pay user fees.
1	disseminating information about
1	objectives.  (ii)
1	biomedical community regarding
1	verdict of forfeiture
1	
 1056. separability
1	(3) annual reportnot
2	tools, standards, and
1	form, including speech,
2	title, or take
1	 (a) submissions
1	provide an annual
7	355a and 355c
1	chemical  (1)
1	372. examinations and
1	project designthe pilot
4	unless such substance
1	(b) scope of
2	product of, or
1	books, papers, records,
1	submission the secretary
4	subsection (b)(1) application
2	disclosed unless all
2	drugs and the
1	reflects data reviewed;
1	pilots or written
2	(a) the filing
1	alcoholic liquors or
3	 (a) by
1	reflects data reviewed,
1	use in preclinical
4	 (a) be
1	providing solely administrative
1	including through use
1	designated at the
1	appropriate mechanisms, consult
4	(iii) ecgonine, its
1	(6) grant recipient
1	devices, or cosmetics
1	societies, and patient
2	secretary considers necessary
1	device that are
1	purpose.  (b)
4	report concerning 
1	warrant is satisfied
1	review and provided
1	substance to or
2	substances; (4) prior
1	recall or discontinuation
1	discrimination; (ii) the
1	protection of animals
1	(
 
 853.
12	advance in appropriations
22	manner as the
1	detailed summaries of
1	functions, and (2)
1	safety establishing that
2	review commission on
2	(a)(2) or clause
1	(relating to generic
1	label containing 
1	(g) annual reportnot
1	requirement that the
2	30, 2016, the
2	complaints regarding its
1	progress, and the
1	reinstating an exemption
1	 (f) violations
2	undertaking signed by,
1	(b) approval of
1	labeling and education
1	unless otherwise stated,
1	made in priority
5	conducted under subsection
1	(a) significantly reduce
1	input from patients,
1	dry substances, he
2	shall be reimbursed
1	42, a change
1	lead to an
2	working days after
1	testing is conducted
1	commodity, such as
1	 (3) prohibition
1	(ix) for a
1	(b) as appropriate,
3	quantity of each
1	(a) are being
1	network (foodnet) and
1	ten days of
1	
 1055. authorization
1	general finds is
1	qualified nongovernment organizations.
1	pay an advisory
1	may be licensed
1	factors which, in
2	good cause shown,
2	4, 2011; and
2	42 shall be
1	(d)(2) of this
1	(i) cigarettes. (ii)
1	infectious disease, and
1	disintegration of unstable
1	least the minimum
6	court may direct
1	engagement of external
1	time before issuance
1	(1); and 
5	finding by the
1	include a copy
1	make a response
1	agency toward the
1	 (1) award
2	submission of some
1	 (d) minimal
1	human risk; (iv)
2	apply for an
1	used in high
1	objectives related to
1	dies, resigns, or
1	(iii) appropriate limits
1	division to carry
1	quality of the
1	analysis of existing
1	recommendations, as to
1	level was determined
1	ris-based preventive controls,
1	place to allow
1	ris-based preventive controls.
1	practicable and appropriate
1	subsection (c)(2); (2)
1	states and regulations
7	applications for the
2	pediatric populations, the
1	(mg) 55.0 
1	record required to
1	
 
 387u.
1	labels of tobacco
1	(a) imports; list
23	subsection shall not
1	(5) includes a
4	credited to such
1	(bbb) a unique
1	(2) deputy director
1	term emerging drug
1	projects conducted prior
1	section 360e(d)(1)(a) of
1	goats, or equines,
1	 (c) expedited
1	anaphylaxis; (v) detailing
2	standard for which
1	356c1. annual reporting
2	children and adolescents
1	(1) is limited
1	injection; (xvii) the
2	representatives or the
1	
 
 360fff1.
2	pattern of conduct
2	product.  (5)
7	render it likely
1	respect to standards
1	authorized amount under
1	grocery stores as
1	order, objections are
1	section 1703(d) of
1	governors of the
2	new dosage form,
1	amounts). (2) for
1	account of such
1	penalty by the
2	material, reagents, and
1	(1) upon petition
2	knowledge which a
1	(ii) saleable or
1	 (2) certain
1	(a) application requirements;
1	formerly 307, 52
2	issued under any
1	trader shall, with
1	fees notwithstanding section
1	811. authority and
1	describe the variance
2	secretary refusing or
1	[7 u.s.c. 136a(c)(5)]
1	identification.  (a)definition.
1	(aa) an intravenous
1	including such order
2	wholesale distributor shall,
1	food; and the
1	 (i) product
1	[42 u.s.c. 264]
1	subsection (o); (vi)
1	label changes changes
3	product, the person
2	use the mails
2	submitted in a
1	affecting, directly or
2	animal drug authorized
1	department of justice,
1	 (4) mission
1	(f) prominence of
2	disapprove an application,
1	research service of
1	access under a
2	person to appear
1	title, and there
1	second country to
1	conduct of research)
5	prohibiting the applicant
2	awarding initial grants
1	gross receipts of
1	(e), any person
4	united states, but
1	substance activities and
1	container. the record
1	measurements that will
1	(i) disposition the
2	(e).  (2)
1	notification, the director
5	 (i) there
1	registration for the
1	care settings that
1	proceedings, the attorney
1	used. the secretary
1	$1 and costs
3	title. (mar. 4,
1	determines is used
3	(a) only if
1	term analogue of
1	 (p) report
4	including the process
1	designated areas and
1	(iii) and maintain
2	demonstrated that 
1	committee, to be
1	installation of device
2	publicly available pursuant
6	includes an active
1	forfeiture. such a
1	information among state
11	federal register the
1	 (2) membershipthe
1	individuals qualified and
1	margin of safety,
1	violates paragraph (12)
1	notice was transmitted
2	strategies to reduce
1	title at a
1	places where original
1	necessary information to
1	subsection applies to
1	representatives, and for
2	campaign operates in
1	construed to interfere
2	support available in
1	first applicant if
1	establishing and implementing
1	safe for such
1	evidence that, applying
1	request a variance
1	product name, serial
2	laws.  (

1	organization deemed appropriate
1	result in pesticide
1	list ii chemical.
1	first applicant is
1	pattern of importation
1	etoxeridine. (24) furethidine.
5	food that the
1	worldwide basis to,
1	evades or avoids,
2	quality or purity
1	diverse communities. 
1	30 days following
1	information within sixty
1	terms of accuracy,
1	consequence or death
1	representation of children
1	sporting or entertainment
5	inspection requirements of
2	studies (which shall
1	severity, including health
1	sizes and capabilities;
5	evidence is material
1	subsection (f), to
1	drug safety programs,
1	manufacturing practices; (g)
2	applicable, affiliate is
1	status of referrals
1	linked to an
1	25); or (v)
1	designation the request
1	available under paragraph
3	declaratory judgment with
8	section, shall be
2	paragraph (1)(e), the
1	3(c), 64 stat.
1	detention of violative
1	forfeiture may be
1	subparagraph to an
1	dispute resolution if,
1	resources.  (2)
1	available promptly to
1	identification device authorized
1	notified under paragraph
1	27, 2013, establish
1	(1) to manufacture,
2	panel and who,
1	title 18; (b)
1	calendar year by
2	support the conclusion
2	control strategy; (5)
1	except that definitions
1	united states, if
1	(relating to active
1	upon the arrival
1	acted to mitigate
1	laboratory sitesthe court,
1	children to distribute
1	paraphernalia (a) in
1	(a) such timelines
1	reports are submitted
1	conclude that the
1	tribal governments shall,
1	general by regulation
1	set of criteria
2	2 business days
2	of, and new
1	date; and (iii)
1	fees from wholesale
1	article and provided
1	material presented at
4	agricultural commodities, including
1	states under the
1	efforts with the
1	methods available to
5	marketing of such
1	distribution and use
1	(b), 953, 954,
4	states internal revenue
1	regular customer, such
2	353b(b) of this
1	(3) limitationan exemption
4	person intends to
1	poultry products were
22	name of each
1	(i)ensuring privacy.the qualified
1	account any supply
1	purposes of consumer
1	modification creates the
1	health, (d) whether
1	activities, functions, projects,
2	subchapter iv of
4	needs for which
1	met through the
1	necessary, reinspect said
2	convenience kit is
1	drug uses a
1	 (l) public
10	milk and/or cream
1	discretion, may include
15	importation into the
1	require; (e) information
1	heroin or other
1	purchase do not
8	advisory committee with
2	processes, transports, distributes,
1	fine in accordance
2	state pursuant to
1	paragraph (3) with
2	appropriate, refer to
1	 (f) inapplicability
3	secretary or (2)
1	weekly or monthly)
1	suitable antidote, when
1	consumer organizations, disease
1	
 864a. grants
1	shall define, for
1	products, such as
1	good cause be
2	cocaine, or morphine
1	transferred
 
 113a.
2	hospitals within the
1	factors:  (1)
1	clinical investigation has
1	executive department or
2	central kitchen prepares
1	and, at the
7	accordance with chapter
2	distributors, dispensers, and
1	ch. 262, 3,
2	shall be recorded
1	directed to promulgate
1	advisory committee). 
4	provision of federal
1	appointed under the
10	may include 
2	substance abuse in
1	 (2) personnelthe
1	reasonable and foreseeable
1	methadon-intermediate, -cyan--dimethylamin-4,-diphenyl butane.
1	
 624. storage
1	tobacco product involved)
1	article, including any
1	inspection of imports;
10	course of his
1	production quotas shall
1	bottled water or
1	drugs. (d) contemporary
4	original place of
1	machines, and all
1	 (ii) due
2	criteria  (a)
1	telephone number and
1	(h) applicants for
2	states, districts, commonwealths,
1	shall keep in
1	using a ris-based
1	briefs.  (2)
1	effort to gain
1	class of persons,
2	subchapter v. 
1	(d) notifying state
2	products impair the
1	device, and (c)
1	package.the secretary shall
1	food treated, and
1	(iii) the sponsor
2	writ of certiorari)
1	third copy shall
1	manner following, and,
1	pork industry have
2	subsections (a) through
2	civil monetary penalties
1	person any substance,
1	expired. (
 

1	ending on october
1	355, 360, 360b,
1	summary required under
1	(c) formatthe information
1	full data sets
7	order to show
1	chapter.  (g)
1	sulfate per dosage
1	foodborne illness. (e)
1	title, or (9)
1	may be incurred
1	 (3) administration
1	professionals treated with
2	741, as added
1	category are grase
1	811(j)]. (b) for
2	(iii) not later
1	preventing or responding
1	promulgate to protect
1	furnish such substantive
5	application which has
1	submitting a report
1	actual duration of
1	shall hold not
1	860. distribution or
13	centers for disease
1	practices issued by
2	agency a written
1	genetically targeted, the
1	year before discontinuance.
1	year before discontinuance,
1	including small cigars
1	 (e) regulations
1	minimized or prevented;
1	advocacy organizations; and
1	change of address
1	1 gram of
1	1357, 1, 32
1	meal or the
1	enforcement (a) criminal
1	advertising, sale, or
3	devices designated under
2	1 gram or
1	(b) susceptibility test
2	shall finalize the
3	bearing any such
1	
 1506 to
1	set and charge
1	capability to conduct
4	studies, or tests
1	formulation, and administration
1	coordinate such action
2	(j) and (l)
1	preference of such
1	several states of
1	eligibility for inclusion
2	shall account for
5	submission for advisory
2	support the accelerated
5	section 331(t) of
1	(iii) the point
1	(e) guidance 
1	(2) to create,
1	iii, 535, formerly
2	subsistence) as authorized
15	offer to sell,
1	administration in an
2	intended, and (ii)
2	obtaining better coordination
1	followin-described substances, or
1	instrumentality shall be
1	transitional provisionif, on
1	patients medical need
1	component parts or
1	2011  (a)
1	(5) voluntary use
1	testing or retesting,
1	classification, any regulation
1	applicability of civil
1	appointed to fill
1	request, measured from
1	control (a) establishmentthe
2	determines may, if
1	fee from such
1	information regarding reports
1	scientific purposes will
1	antimicrobial active ingredient,
1	provisions  (1)
1	reporting under subparagraph
1	exemption under 355(i)[5]
1	agency for drug
2	pediatric indication or
3	service of orders
1	includes cell therapy,
2	waiver shall cover
1	first action on
1	imported, for the
1	technical assistance to,
3	360c(b) of this
1	use, the effects
1	(2)(a), nothing in
1	programs or strategies
2	address the considerations
1	individuals. (c) funding
1	(b) coalition awards
1	(e) an in
1	(1) initial panel
2	states dollars, the
7	specific deficiencies in
20	federal, state, local,
2	bought, sold, possessed,
1	review), shall apply
1	supervisory level or
1	proceedings in case
2	compounds the drug
1	number of metric
1	class i, an
1	outcome means a
1	one for a
1	
 2108. annual
1	duties, and functions
1	(including the commercial
1	employ to significantly
1	(ii) the statement
3	distribution, holding, and
2	eligible entitythe term
2	practice or research.
1	(5) to make,
1	section, would be
1	inspections under sections
1	five days after
1	omitted in good
1	review groups the
1	(j) abbreviated new
1	administering a drug,
1	information that has
4	class iii unless
1	testing plan submitted
2	initial receipt of
2	entirely from the
1	including  (1)
1	
 
 360ddd.
1	appoint inspectors who
1	title, such discovery
1	materially falsified any
1	formulas to the
2	made concurrently with,
1	determine that 
1	fee necessary to
1	paragraph (2), this
1	body, solely for
1	involve pediatric issues,
1	community; and (8)
2	period not less
1	except a person
1	quarantine the term
1	control such radiation
2	termination. if a
1	federal requirements requirements
2	utilized in the
1	conduct a substantive
1	planning, technical and
1	laboratories accreditation bodies
1	within such meaning
1	sector regulated by
2	calendar days, for
3	device is a
58	shall  (i)
1	350 of this
1	section 360ccc(c), (d),
9	drug application shall
1	sentence unless, in
2	head start program
2	listed drug; (ii)
2	general.if an owner
2	responses by the
1	maintain any distribution
3	improved advers-event dat-collection
2	title and that
1	person to maintain
1	effectively to reduce
1	altering of goals
9	extent of absorption
2	comparable or satisfactory
1	determine under this
8	drug in schedule
1	ordinary and necessary
1	914, as added
3	secretary and such
1	food emergency. (3)
2	area; (b) how
1	state egg inspection
1	to, or the
1	break in the
1	controlled substance; (2)
4	petition for judicial
1	thereof, or meat
1	
 355a. pediatric
1	2014, issue a
1	years the number
1	boards, swingsets, and
1	records by any
1	residue, the sale
2	title and each
1	fifth fiscal years
1	
 
 332.
1	tracing; and (iv)
2	healt-related electronic data
1	based. (3) the
1	formerly 16th par.,
1	listed chemical. (e)
1	appropriate responses by
4	supplement that is
1	factors; substantial evidence
1	affiliated persons responsible
1	safety (a) proposed
1	claims  (a)
2	conviction of any
2	formulation necessary for
5	humans or animals
1	human use presents
1	distributors, pharmacies, and
1	condition in emergency
1	mislead.  (

1	 (1) inspection
1	determined based on
4	required because of
1	ris-based inspections in
1	mixed after harvesting,
1	hooks attached. 
1	epidemiological, pathophysiological, therapeutic,
2	completing such studies),
22	specified in paragraph
2	year. penalties for
1	humans. (2) product
1	subsection (a)(2) have
1	including complementary therapies,
1	least once per
1	substancesin carrying out
1	parameters of the
1	secretaries of agriculture
1	consumer which are
1	place from which
1	vegetable. in prescribing
1	maple syrup that
1	found to have,
1	
 129. omitted

1	progress made as
1	provide consultation to
1	19011906). all such
1	businesses; fee waiver
1	drugs. nothing in
1	study under any
1	auditors to 
1	enforcement. (viii) religious
2	effect the provisions
1	sufficient to describe
1	thereunder, all persons
5	strategy for a
1	limitation not more
1	(4) inapplicability of
2	shall mean a
13	device shall be
1	logistics provider under
1	 (c) conflict
1	schools, early childhood
1	
 821. rules
4	regarding the data
1	application.  (c)recipients
1	stage of the
5	review of submissions
1	467f. federal food,
1	(21 u.s.c. 351
1	trader for an
1	u.s.c. 45] with
1	title.  (ii)
32	provision of law,
1	(10) the information
1	costs.  (3)
1	(b) liability as
1	harmful, the same
1	compounds with a
1	exceeds fifty degrees
1	classification for a
1	pr-submission interactions with
1	products (such as
1	(f) effect nothing
2	aid in the
1	exported; and (iii)
1	practice, and does
1	defense capabilities, including
1	675, 736, as
1	of, and submit
1	pending its disposition.
1	section 343(g) of
1	electronic databasenot later
2	report is received
2	protocol for a
1	investigation as being
3	report is made.
1	products, who are
1	employee, or to
3	harm to human
1	shall state 
1	admissible in evidence
1	highly refined oil
2	(a) review and
1	species means cattle,
1	licensed, except as
1	paragraph (13); and
1	seq.], and (2)
1	effective beginning not
1	subsection, an application
2	four members shall
1	revise not fewer
2	section, any other
2	subsequent purchaser of
1	demand for the
3	enforcement the secretary
2	commissioner shall issue
1	150.0. (june 25,
1	modify any elements
2	device. the report
1	device when the
1	bongs; (13) ice
1	petitions and petitionersany
1	paragraph (4) unless
1	(ee) the term
1	assistance division shall
1	(j). (4) 
1	receives funds for
1	subsequent purchaser or
1	plan and make
1	required to produce
1	panel, the member
2	expended on the
1	sentence which is
19	food safety and
2	shall be nonvoting
1	humans.  (9)
2	biological product in
1	data under this
7	equal to or
1	biological product if
13	grase and is
1	1984. (4) a
1	2012, the task
1	incidence, the increase
1	drug, if any;
1	means any milk,
4	biological product is
2	equivalent or substantial
1	(2) limits the
1	person is receiving
1	completion of any
1	
 355. new
1	360b(c)(1), 360b(c)(2), 360b(c)(3),
1	inspections otherwise permitted
1	food process at
1	professional practice; (b)
1	responsible party that
1	fee account and
1	medical gas from
1	returns, and reductions
1	issuing, amending, or
1	(i) screening chemicals
1	(b) promulgating rules
2	seq.).  (b)
1	subsection (i). (c)
1	person who so
3	function of the
1	assessing chronic dietary
1	intent regarding whether
2	section 350d(a) of
1	personnel; (4) maintain
4	respects to a
2	establishment of interpretive
4	manufacturer or distributor,
1	premarket application to
1	issue, suspend, and
1	item which explain
3	determines that an
2	establishment is listed
1	means of shipping
2	secretary, by notice
1	342(c), 351(a)(4), or
2	assignment of combination
1	controlled substance analogue.
1	probable consumption of,
1	related interests, professional
3	deems it to
1	scientific evidence relied
1	limited solely to
1	farm that are
1	ethchlorvynol. (5) ethinamate.
1	person from any
1	drug administration, university
1	(b) condition as
2	enforcement intelligence to
2	labeling changes if,
1	(d) that involves
1	4, 26 stat.
1	(iv) an understanding
1	drugs marketed prior
1	protection of communities,
1	multiple offenses. (b)
1	notice, or otherwise
1	paragraph, the president
4	proceeding, the person
1	work costs; availability
1	hazards, and is
1	ch. 675, 586b,
1	representation from the
1	facility, offer to
1	(2) or section
1	coordination and facilitation
1	identify adulteration of
1	add to an
3	(1) in generalnotwithstanding
1	whether growing or
3	practicable, but not
1	criteriain order to
1	 (i) establishes
1	variance if the
2	drugs, including adverse
1	described in[1] 381(q)(3)
2	sale with the
1	satisfaction. (june 25,
1	(m) methylamine. (n)
1	replacement products (such
1	 (i) established
4	standard of fill
1	purpose of tracking
1	2017 for each
1	paper format to
9	need for the
5	facility identifier system
1	file numbers that
2	isoquinoline alkaloid of
54	regulations of the
2	recommendation is based,
40	notice to the
1	otherwise be presented
1	order, as appropriate.
1	pathway established under
2	treat such disease
1	life while illegally
2	defined  (1)
1	order, in accordance
1	nitroethane. (x) gamma
1	666, 5(2), 65
1	establish for the
1	387k, or 387t(a)
1	of, the manufacturer
1	propanamide; (vii) 100
1	statement of 
1	deny the request
1	review and certification
1	include consideration of
2	orderin the case
1	use that was
1	sponsor in support
14	chapter 5 of
2	advertisements for a
1	higher numerical designation.
1	year 2004; (8)
1	changes and modifications
1	360fff6 of this
1	facility, the total
2	proceeding held with
2	agencies for certain
10	331(j) of this
2	activated, he shall
1	disposition of petitions
1	filingany person may
1	30 day period
1	2204. building domestic
1	physician receiving valid
2	tag as inspected
1	body means an
1	title are being
1	locations that are
6	basis to the
4	(c) abuse of
1	diet including 31
2	distribution of cigarettes
1	animals and which
1	process to reduce
2	thereof, of the
3	determination under subparagraph
1	subsection (d)(3), in
4	plants regardless of
2	restaurants owned or
1	submitting or assisting
3	(e), and shall
1	(13) law enforcement
2	treat, diagnose, or
1	ii that are
1	without amendments to
2	2012.  (2)
1	extensions other than
1	maximum compensation for
1	submitted, withdrawing the
1	nonspecified use. 
3	used to a
2	states unless they
1	(5). in making
1	narcotic treatment; annual
1	require.  (3)
1	regulations, and procedures
2	government as state
1	iii. in determining
1	designated pursuant to
1	(g) return declaration
1	consumers, users, manufacturers,
9	ring to any
4	section 360ccc1(e) of
1	(ii) the applicable
1	(including such provisions,
1	studies in the
1	institutes (a) in
1	authorized fees of
1	expertise relating to
1	issue to him
1	publicly disseminated. 
1	signed agreements from
1	farmers and ranchers;
1	regulated person has
4	contain a statement
1	limits user reporting
1	shall forfeit, in
1	coloring shall not
2	fide purchaser for
75	drug control program
1	ensure the board
2	times and containing
1	interest. (8) the
1	modified findings and
1	(l) transitional provisions
1	places at which
3	storage, or installation
1	pot, canvas, or
4	jurisdiction over such
1	including through direct
1	product are labeled
2	secretary whenever he
2	shall be half
1	interest renders the
1	administration) decreased to
1	combination product and
1	underlying scientific or
1	(ii) high risk
1	(b) sites and
1	risk assessment; and
1	(h) to a
1	(a) an adverse
1	adjusted for such
2	counterfeit tobacco product
1	covered by exemptions
1	game, meet, match,
4	reason of subsection
2	(3) is not
1	process and consider
1	research in the
4	support to the
1	involved in any
1	local governmental officials,
1	order restitution to
1	services to persons
1	species to an
2	(8) if it
1	attorney general designates,
1	device, or strength;
1	what, if any,
1	individual product syringes)
1	sanitary manner. 
1	animal drugs may
1	bioequivalency data or
1	facility a qualified
1	statement  (1)
2	lot or batch
1	submission in the
2	wholesale distributor, under
1	years 2017 through
1	responsible person, to
1	generalafter the expiration
1	modification of registration
5	firms, or corporations
1	age groups; or
2	eligible product shall
1	2, 2004, and
1	written determinations in
3	miles of the
1	done acted in
1	user fee assessed
1	term nurse tank
3	secretary from the
1	secretary may prioritize
1	phenylpropanolamine during one
1	law described in
1	(3), such information
3	detained by such
1	community if 
1	
 
 334.
1	states, the owners
1	obligation  (1)
1	(v) taking steps
1	publications, any written
1	drugs are manufactured
1	 (e) coordination
1	humans; and (3)
1	filed an application
1	general (a) delegation
1	exceed 30,000 individuals.
1	preapproval inspection, or
1	(b) a review
1	fiscal year, upon
1	electronic product, as
1	title, as appropriate.
1	if, after publication
2	title, as appropriate,
1	respectively, that 
1	united states (a)
6	application was approved
1	title authorizing the
1	title, as appropriate;
1	updated, or reconfirmed
2	private, independent consulting
1	license granted by
1	costs;  (16)
1	voluntary recall, or
1	total quantity of
1	384c. inspection of
1	(b) consumer for
1	part, if the
1	implemented by a
1	subsection (d), (e),
1	similar uses. 
1	administration protocols and
1	rue, and savin;
1	ensuring that such
1	(ii) meets the
1	subsection together with
1	17 years of
1	submission of assessments
1	identification technologies and
1	release and publish
1	strict confidence and
1	process to facilitate
3	inspection legend means
1	summary judgment the
1	 (d) domestic
1	i, 119, 70
1	 (2) provision
3	prominence, the word
3	section 601(m) of
1	interaction of such
1	(c) or paragraph
2	subsection (b) may,
1	321(g) of this
3	proceedings with respect
1	straw. (c) coca
1	federal government entity.
2	conducted by comptroller
1	use), if such
1	reasonable time period
1	(aa) 18-day exclusivity
5	man or animal,
1	hearing if a
1	displayed by the
1	also include 
1	use of award
1	applications and reports,
1	retail, any drug,
1	(or under section
1	organizers, or leaders;
1	comment into account.
1	product; and (3)
1	year 2017, not
2	 (c) service
1	services that will
1	(5) establish within
1	intends to have
1	least 30 calendar
1	 (1) specifies
6	shall establish the
1	staff, including a
1	morals, health, safety,
1	not, unless ordered
1	establishment of tolerances
1	secretary related to
1	pediatric diseasethe term
1	submit audit reports
8	propagated, compounded, or
5	articles of food
1	year involved in
1	provide for studies
2	requirement for registration
1	importation exceeds fifty
1	subsection (e), this
5	dietary supplement or
1	installation, operation, and
1	analysis as are
2	data; (b) the
1	following distributions to
1	conduct audits of
1	interdiction and enforcement;
2	paragraph, issue a
3	requirements or conditions
1	 (iii) cleared
2	clinical infections due
1	item basis, that
1	(d) no effect
1	1, 1976, through
1	person files a
1	act is terminated,
3	identify the status
1	clause (ii)(i), but
1	animal, and is
2	controls applicable under
1	complies with labeling
1	schedules:  (1)
2	states has been
1	license; and (2)
1	catfish labeling 
1	federal register shall
1	both. if the
1	whether the defendant
1	office with respect
1	regulations). (f) additional
2	(a)(1)(a) and special
1	including the history
1	practices as the
1	definitionsin this subsection:
1	quota, the amount
1	respect to volumes
1	affected persons; and
1	technical achievability the
1	ingredient means a
2	subchapter  (1)
1	type or level
1	milk to be
1	(c) grant amountthe
2	reasons for not
1	filing; or (ii)
5	effect produced by
2	states delivers to
2	programs related to
1	survey published by
1	states does not
1	secrets.  (2)
1	facility identifier; (c)
11	secretary (or other
3	diagnose, prevent, or
2	(f) of paragraph
1	allowing or prohibiting
1	(b) notification the
3	ephedrine, pseudoephedrine, and
1	federal regulations. (h)
2	including the state
1	manufacturer, or repackager
1	administration, to address
1	30 days; and
1	shall serve the
2	manufacturer, repackager, or
1	concerned on such
1	study were not
1	dispense a narcotic
2	product commercially marketed
9	states attorney for
1	term sem-critical reprocessed
2	caused by such
1	testing means testing
1	distributing free samples
2	42 for the
1	auditor and, although
1	(a) a biomarker;
1	maintain records; scope
1	refund  (1)
1	individual portions and
1	information any contents
1	(5).  (5)
1	constitute proof of
3	drug product, the
1	drug, noting any
1	may select one
1	distributed; or (ii)
2	right or obligation
2	unless the practitioner
4	effective date. 
1	effective performance; periodic
1	poultry under this
1	 (f) identification
2	types of studies
1	
 221 to
2	public interest. registration
1	may find appropriate.
1	section 350i of
5	supplied by the
1	necessary to incorporate
1	whether such requests
1	plans for individuals
1	preventing and mitigating
2	secretary identifying the
1	kind for a
1	(a) real or
1	final briefs. (2)
3	group for which
2	reduce the supply
1	following interoperable, electronic
4	22, 2009, a
1	tobacco products, of
1	needs and priorities
1	agreements to provide
1	 (i) assure
2	section at the
1	labeler, relabeler, or
1	advisory review submission.
1	applied on food
7	acts  (a)
1	online medical questionnaire;
3	drug and of
1	complete records of
1	schedule notice, the
1	implant procedures. 
2	penalties of subsection
1	(a)(1)(b) of this
1	implant that either
1	detection of the
1	analgesia. (iv) in
1	animal is eligible
1	1121 to 1123.
2	different from, or
1	employed, (d) the
1	device applications (including
2	government agencies to
1	675, 529a, as
1	drugs without submitting
1	ex parte and
1	local requirements 
2	condition specified in
2	action at law
1	coordinates the development
1	(4), each entity
7	contractual requirements or
1	insanitary, etc., ingredients;
1	recycled rather than
1	laws.  (mar.
1	carrier, distribute drug
5	product of such
1	360c(i) of this
2	section 702 of
1	(2)(a)(vii)(iv) shall be
2	clearance in accordance
1	government to protect
1	utilization; and (ii)
2	providing an offer
1	title. (f) the
2	contributions, raised by
2	coordinator is in
1	pay any fee
1	conducting a hazard
3	recipients of a
1	summary judgment governed
1	cessation, including nicotine
1	state, for planning,
1	substances contribute to
2	reporting in first
1	persons. (h) additional
1	paragraph (1). safe
1	(b) unlawful distribution
1	regulations, guidances, and
1	drug administration including
1	government accountability office
1	alcohol or nonnutritive
1	article, that the
1	made under authorization
1	[1] see references
5	use that is
1	ingredient is inadequate
1	label with sufficient
1	conditions; (c) the
1	practitioner means 
3	package for approval
6	conducted in connection
1	accepted under paragraph
1	u.s.c. 262(a)] will
3	revenues shall be
1	food.  (5)
2	representatives, shall have
2	within the area
1	provided, caused to
1	type that the
2	testing, and demonstration
1	means that, due
1	local management; and
1	shortage (a) definitionsin
2	small businesses; and
1	(f) not later
1	order to prevent
2	dispense or administer
1	review.  (j)
1	analysis shall be
2	section to four
1	(1) consider using
4	imprinted by the
1	granted; and (c)
1	advisory review under
1	demonstrated in accordance
1	treasurer of the
1	requests  (a)
1	substance abuse programs.
2	whether the labeling
1	(2) limitationapproval of
1	product contains a
3	price competition and
1	 (b)privacy. 
1	official name so
1	title 35, subject
1	paragraph, or from
1	court shall by
1	abbreviated application, or
1	use associated with
2	periodically, or at
1	research into pediatric
1	code number, if
1	deny reaccreditation to
2	retai-type establishment for
1	ii is subject
1	seafood products the
1	(iv) decontaminating and
1	food that a
1	basis, delay the
1	subchapter iii 
1	reasons why persons
1	imported articles shall,
1	(1) assess scientific
1	(1). (mar. 4,
1	secretary has, under
1	 (5) consultative
1	section 102 of
3	regulation for the
1	entities of varying
1	agency; performance of
2	(a) may appeal
1	(j). (c) reimbursement
1	experience which the
1	 (7) meeting
1	7 and amended
1	commissioner first publishes
6	printed, or graphic
7	subsection (a) within
1	(f). (iii) if
1	holidays specified by
2	e of the
1	investigations, studies, demonstrations,
1	(d) information and
2	examinations or investigations
2	and, if no
1	dispensed such substance
2	submitted a notification
1	inspection reports, certificates,
1	reoffer of food
8	title if the
1	affiliated with such
1	$80,000,000 for fiscal
1	questions.  (c)
1	emergency. (3) evaluationthe
2	(i) a listed
1	gases deemed appropriate
3	involving the same
1	(b) received the
7	storage and other
1	corporation, who shall
3	submitted the report
1	application, notification, or
1	address outstanding deficiencies
1	federal agencies to
1	(a) is credible
1	title, (2) any
1	manufacturer shall provide
2	clause (ii) shall
2	valid prescription order
3	information or indictment
1	products which have
1	name, its established
1	(2)(a)(vii)(iv) is submitted
1	periodically in the
1	drug product (as
1	2004 or any
1	state, country, and
1	 (c) warning
1	information submitted through
1	different operating characteristics
1	roles and responsibilities
1	consultative audit in
1	restricted section that
3	officer acting as
1	1988, to the
1	employees using the
1	ch. 268, 42
1	(b) procedures applicable
1	(a) registration an
1	115 to 128.
1	general shall cooperate
1	following the effective
1	regulations, the secretary
7	united states unless
2	includes a representative
1	additional service pursuant
9	shall develop and
11	effective before the
1	periods shall run
2	transition carried out
1	rape), against an
1	discretion, shall be
1	premarket approval (a)
1	effect as if
4	foreign persons designated
1	(2) a veterinary
2	title if 
1	 (5) collection
2	order if, after
12	262(k) of title
1	residue.  (b)
1	information concerning such
1	chapter. the registrant
2	(including the substantial
7	 (1) maintenance
1	intended to reflect
1	subchapter and standards
2	advanced analysis of
1	(a) that experience
1	subsistence, and other
2	(a) and may
1	modification.  (c)
1	360k of this
1	title; (2) consider
1	exception for new
2	determines (after affording
1	deemed federal employees
1	shall initiate proceedings
1	timelines for small
1	(3) except under
2	shall report annually
1	importer written authorization
2	hearing to determine
1	marketing of antimicrobial
1	section or poses
1	countries to be
4	action the secretary
1	manufacturer the secretary
1	judicial review. (2)
1	(4), the term
2	shall submit supporting
1	264].  (e)
2	regulation or prior
1	sunscreen order, as
1	commerce, any filled
1	patient, but does
1	may, at least
1	first. this subsection
2	effect on october
1	(a) paragraph (1)
1	 (35) the
1	(6) final sunscreen
2	(1) human drug
2	residue levels are
3	evidence under subsection
1	parolees.  (vi)
2	things which constitute
1	ii, section 2
1	360fff5. sunscreen monograph
1	made public and
3	title, or (2)
1	(cb1 receptor) agonist
1	devises, or bequests
1	equaling the total
1	1713. authorization of
1	title i, 24,
2	commerce, except in
3	may, consistent with
1	apply.  (3)
1	status that the
3	committee of the
1	data summaries are
9	affect the authority
2	title establishing, amending,
1	exist. (june 25,
1	secretary to prevent
1	sample subject to
2	regulations not later
1	states that do
3	product or, if
1	use. each package,
12	substance has been
1	title; (d) based
1	grounds therefor. if
2	chemicals. any such
1	portions  (a)
1	foregoing, or any
1	state; precedence restriction;
1	orders; access to
1	1, 1953, shall
1	protocol, or (iii)
1	harmful substances compared
1	major species for
1	drug originally received
1	(if any) by
1	services as are
9	application or request
2	health advisory described
1	extent such entity
1	relate to abbreviated
1	required for compliance
1	sections 102, 206,
7	shall issue regulations
1	plaintiff any eggs
1	july 9, 1956,
3	health.  (june
3	may not award
1	center; and (j)
1	poison, such person,
1	holder complies with
2	production, if the
1	them. (5) the
1	program), the secretary
1	party. (b) evaluation
1	promptly upon august
1	section 1604(b)(2)(b) of
1	section. (2) acceptance
1	pay rates, the
2	secretary, within 60
1	director or the
2	scientific evidence available
1	incorporation the ex
1	 (i) stay
1	provisions any person,
1	(1)(b).  (3)
1	risk of intentional
1	consultation will 
1	duly constituted committees
1	unless they also
2	meanings for purposes
1	obstruction or increased
1	laboratory methods in
2	(2) after the
1	information; or (b)
2	(c) an order
1	destruction or elimination
1	liability for such
1	undertaken with respect
1	importation it shall
1	information. (3) the
1	substance, or such
1	federal regulations) shall
1	regulations, such object
2	procedure to be
19	chapter or the
3	dairy or food
1	manufactured specifically for
2	title, and shall
1	held at a
11	section with respect
1	 (i) selling
1	biannual report of
1	 (d) inspections
1	probable risk to
1	paragraph except that,
1	states, except the
1	representatives of patients,
1	timely manner of
2	(b) or (d)
2	provided by sections
3	conditionally approved by
1	substitution of the
1	may determine and
3	authorized by law
1	written receipt for
1	facility identificationeach person
2	(1)(d), the term
1	audit, and report
1	(4), any information
1	evidence and shall
1	(t) database for
2	may include furnishing
3	shall be reviewed
1	setting  (1)
1	studies fairly respond
53	subject of the
4	points program of
1	behavior, and health,
1	(a) a study
2	required to support
1	committee. (e) proceedings
2	records, make such
1	poppy straw. (c)
2	foreign persons by
1	appointed. (4) compensation
6	subpart for such
1	believe that use
2	affiliate, as described
1	may exercise the
1	form if in
1	activity.  (viii)
2	later than 20
3	later than 21
2	inspection of articles
1	later than 27
14	later than 24
1	later than 25
1	restaurants and additional
1	section. any person
1	may be disclosed,
4	law enforcement agencies;
1	laboratories report to
4	place to enable
1	red collectively, but
1	reimbursed for travel,
1	considerationsin establishing and
1	 (1) import
1	user.  (2)
2	 (2) paragraph
2	human use, restricted
2	voucherthe secretary shall
1	supplier is liable
1	law enforcement agencies,
1	 (d) pizzas
2	law enforcement agencies.
1	
 622. bribery
1	subchapter or section
1	section 360(m) of
1	dispensing) a controlled
3	access to places
1	violation. (b) on
1	requirements and any
2	involved may commence
1	control laws. 
2	drinking water regulations
1	applies and is
3	services, the department
4	year adjustment for
1	(1) eligible entitythe
1	englis-speaking ability (a)
2	substance of the
1	expenses account without
1	vouchers under subsection
1	person injured as
8	means other than
1	use or, in
1	applicable, under subsections
1	supplement, shall pay
11	none of the
1	reinspection fee the
1	may require under
1	regarding the issues
1	interoperable standards necessary
1	comment during the
4	renumbered 1002(a), 

1	practitioner meets the
1	 (a) advanced
1	
 2221. food
1	(d)(3).  (4)
1	drinking water regulation,
1	(a). the commission
1	every 180 days,
1	promptly act on
1	upon request. 
9	requirements applicable to
1	2014, make submissions
1	(e) conclude operations
1	total fee revenue
1	(f) establish a
1	ch. 675, 744h,
1	margarine originates from
1	(b) powers of
1	(2) each member
2	secretary has found
1	general may charge
1	international meat and
1	together a buyer
1	taken ownership or
1	included in determining
1	may revoke a
1	studies shall provide
5	sufficient to provide
6	basis, submit to
1	inspector, upon stating
1	title; (5) to
1	general the panel
1	documents, if there
2	periods following the
3	drug application) submitted
10	evaluation of all
1	civil proceeding, the
2	form and the
2	federal inspection under
1	disease may be
1	year 2014; (b)
1	2009; (13) $119,000,000
1	enforcement activities under
1	penetrate normally sterile
1	ch. 155, 5,
1	limited to no
1	restricted device, a
2	date of final
25	subject to such
1	eggs packed into
4	agent for the
1	generalin promulgating a
1	and[1]  (i)
1	adequate to assure
1	name, the quantity
2	name for such
1	defendant  (a)
1	claimant within 90
1	(e), no state
1	sponsor so notifies
1	section shall, with
3	advertisement under this
2	substances that may
1	controls by themselves
1	purposes only, not
1	benefit. (2) in
2	cooperative program; and
1	subchapter. (2) all
1	risks, of a
1	section 863 of
1	inhumane slaughtering of
1	recalls to consumers
1	manufacturer has complied
1	(i) the methods
1	additives, constituents, including
9	(a) that the
1	person for commercial
2	whether in notice,
1	inflation under subparagraph
1	whether final guidance
1	reviewin conducting a
2	secretary in official
1	home administration; or
1	(i)effectiveness of application.
2	(a) the relative
1	(b) registration and
1	duration of treatment
1	formulation, may be
1	record the director
1	supervisor of such
1	administrative order together
1	2241. inspection by
1	360i(e) of this
1	title; and (7)
1	regulations comply with
1	information) and shall
1	structured process for
1	counterdrug technology initiatives
1	match advertising directly
1	margarine is served
4	studies of the
1	(k) pseudoephedrine, its
1	terms described in
1	manufacturer offering an
1	evaluation) to measure
3	product is being
1	petition filed by
1	(or the container
1	(2) regulatory management
1	entered upon application
1	authorized officers or
4	file patent information
1	fide pending application
1	verification requirementexcept as
2	heads of the
1	imposing an appropriate
1	treasury there to
1	subsection. in lieu
1	device is manufactured
1	chemical or not
1	agencies to facilitate
1	consortia means collaborative
3	requirements in this
1	categories until the
2	provisions of clause
1	fine otherwise authorized,
2	diethylamide (lsd); (vi)
1	(14) retailer the
1	establishment not duly
1	appropriate under clause
1	control data collection
1	identification of certain
1	year, each outsourcing
1	(a) refusal to
1	(o) the distribution
1	inspections at facilities
1	debarment periods 
1	2009, all documents
1	international organization for
1	(b)(3)(b), and subsections
1	 (c) internet
1	administrators own initiative,
3	practices of the
1	cause such retention,
4	(2) describes the
1	bond; court costs
1	injury, harm, or
1	secretary finds materially
1	functions.  (

3	deposited and credited
3	preparation, sale, barter,
1	substance abuse treatment;
2	forestry and the
1	tobacco product). (2)
1	foreig-chain distributor is
1	general to issue
1	(b) listing of
1	public.  (b)
1	(c) the privileges
1	injury; (c) the
1	shall file supplemental
1	additional public report
1	(i) actions committed
1	355e. pharmaceutical security
1	periods:  (a)
2	forth initial interpretations
2	requirement on the
2	secretary may prohibit
1	disposal of such
1	year concerned, to
1	(3) for furnishing
1	
 360ccc1. index
1	directly administered by
1	bequest, gift, or
1	induces cancer when
1	secretarys own initiative,
1	devise, or bequest
1	 (b) manner
1	chemical.  (4)
1	prevention programs and
2	trade such a
1	application from such
1	(d), the secretary,
5	credentials and a
1	applicable. such letter
2	grounds for denial
1	certification if the
1	data elementsthe data
1	(5) crediting of
1	addresses the distribution
1	study have been
1	 (4) in
2	time period, as
1	adverse.  (2)
1	inapplicability of drug
1	director, or agent
1	data are required
1	(b) covered applicationthe
2	u.s.c. 262] or
1	4, 2011 
1	(including dosage form,
1	(b) seek input
4	case the substance
2	facilities). the amount
3	advertisements for advisory
1	pediatric market exclusivity
1	(5) develop, test,
1	human services, provide
1	(b) exemptionsthe term
1	operate a delivery
1	(1) to identify
1	secretary determines could
2	later. (c) if
1	(5) regulations 
2	negative public health
2	treatment programs and
1	expediting the animal
1	(2), any determination
1	request for informationnotwithstanding
2	(f)(7) revoking the
1	outstanding and qualified
1	home, or outpatient
1	impact caused by
1	consumer, the secretary
1	indictment or information,
1	(r) facilitating the
1	1087, as amended;
1	make available, through
1	person acquiesces to
1	shall not have
1	information technology infrastructure
1	(2) review expertise
2	jurisdiction, for cause
4	drug administration has
3	united states, american
2	methods, or tests
3	recognized international standards
2	experts or use
1	data collection, and
1	(a) the country
1	 (a)agreement to
1	external experts or
2	penalty  (1)
1	subsection (d)(4). 
1	identical in chemical
1	 (2) by
1	harmonize regulatory requirements
1	the[1]section 2219a of
1	2009, and not
1	packer on containers;
1	notification states the
7	fixtures, furniture, scientific
1	appropriate sentence under
1	secretary establishing conditions
1	general an eligible
5	(1), the term
7	regulations or guidance
2	issued thereunder applicable
1	product, or substances
1	labels animal feeds
1	establishment and content
2	pay an applicable
1	charge, through a
2	(2) the first
3	devices, the secretary
1	products shall establish
1	funds for other
1	(3) designation 
4	article, and may
1	trading a coupon,
2	region, country, or
1	clause (ii)(iv) (through
1	subparagraph shall not,
56	repealed. 
 

1	clips: meaning objects
1	(ii), an operating
1	written order classify
1	inspectors, such inspection
2	aggregation and inference;
1	submission under paragraph
1	following the initial
6	 (b) if
2	use such information
1	contribute to hard
2	application except for
2	involved. (e) the
1	diseases, is authorized
2	aggregation and inference,
1	appropriate scientific advisory
1	subsection (c)(1)(a)(i)(ii) for
1	usesthe funds used
1	timely information regarding
1	acknowledgment to its
1	pursued and the
1	 (8) national
4	(e) that the
1	secretary, and where
1	occur upon the
1	national security affairs;
1	2007.  (d)
2	(b), or (c).
1	harm associated with
2	containing morphine or
1	residues, including neurological
1	(c) supporting the
2	seq.] that encourage
1	 (7) at
1	congress as part
1	 (4) restrictions
1	1708. national youth
2	commits a violation
1	serves the interests
1	testing.  (b)
1	reference the information
2	review times for
2	chapter, to avoid,
1	(2) that, based
1	injury to, a
1	agents, or employees
1	stat. 1101; 1940
1	second conviction in
1	(ii), no user
1	paragraph, where applicable.
1	foundation are to
1	i. for purposes
2	arriving in or
1	article under this
1	(i), the panel
1	populations by the
1	complaint and an
1	(f), in any
1	only, not to
1	importer as a
1	judicial review, shall
1	pay any person,
1	rate, use rate,
1	739, 49 stat.
1	period for, notice,
1	(3) status pending
1	(19) nicomorphine. (20)
1	expert review (a)
1	education program (a)
9	decision by the
1	guidance issued in
1	states, the ability
1	secretary revises the
1	require each registrant
2	public availability of
1	new indication, route
1	studies, demonstrations, or
2	certified by an
1	designates the submission
4	diagnosis, monitoring, or
1	time. the requirements
1	rescission or modification
1	making the inspections
1	electronic means; and
1	term article means
1	practice; (2) any
1	shall be known
1	treated by available
1	activities, as so
1	may 13, 1992),
1	section;  (b)
3	evidence of qualification
6	monetary penalty of
1	transport stolen anhydrous
33	(1) in generalthe
1	readily retrievable from
1	imprisonment. notwithstanding the
1	title ii, 201,
1	resolve issues related
4	authorized generic drug
1	(a)(2), as necessary
1	adjustment factor defined
2	3 percent of
1	applicable) described in
1	supervision by inspectors
1	include the validation
1	(iv) de novo
1	proposals from across
1	circuit. (b) judicial
1	title, such article
1	title 42. (ii)
1	least every 6
1	abuse potential, he
1	(gbl) or 1,4butanediol;
1	treasury nothing in
1	weight of the
1	general may subpena
1	 (2) availability
2	appropriate for sanctions
1	(a), necessarily deviates
1	(3) carburetion tubes
1	intrasystem use only
1	assuring that 
2	appropriate, to the
1	(c) strike paragraphs
1	specific local areas.
1	understanding described in
2	charge to individuals,
1	acts occurred. 
1	(g) supplement not
1	respective staffs, (2)
1	675, 1004, formerly
1	used shall preserve
1	made, by experts
2	expectation that a
1	projects of a
1	comprehensive statement of
1	petition submitted to
1	(2) employs, hires,
1	applicant promptly of
1	meeting for a
1	representations so as
1	use, and which
1	determination of user
1	agriculture, promptly provide
2	(b) disposition of
1	(e) evaluated on
1	public notice requesting
1	open, lease, rent,
2	termination under subparagraph
1	section 142; regulations;
1	federal regulations, the
8	received under such
1	cases of exportation
7	 (1) every
1	requests under subsection
1	full spectrum of
1	seq.]: provided, that
1	grant program established
1	114d6. repealed. 

1	requestor submits to
1	terrorism; and (b)
1	shall transmit timely
1	official establishments (a)
1	(a) financial data;
2	number of lines
7	title.  (4)
1	(18) shall monitor
2	times as he
2	products that is
1	food products and
2	statement associated with
4	january 1, 1982,
1	drug treatment research
1	word poison appears
1	adequate to control
2	human being or
1	soil amendments, hygiene,
1	1701. definitionsin this
1	crude opium, poppy
1	annual sales, in
1	oxide or carbonate
2	plan; and (c)
1	efficiently update susceptibility
1	licenses issued by
1	distributor shall report
1	term interstate or
1	ownership occurs. 
1	drug administrations ability
1	(i) in carrying
1	539, formerly 360c,
1	dispenser may be
1	uses, or attempts
5	may be assessed
1	expand and enhance
1	employed intermittently. (6)
1	(viii) -penty--[-(-methoxynaphthoyl)]indole (jwh081);
2	using performanc-enhancing drugs
2	food.  (c)
1	powers and be
1	pet food regulated
3	food from such
1	request, would be
2	scientific, medical, or
1	(d) definitionin this
1	warehousing, or other
5	shall carry out
4	patent extensions); or
1	mutual recognition of
1	violative of law,
3	directly to consumers
1	fees sufficient 
1	damages for such
1	chairperson (or c-chairpersons)
1	contacted. (4) a
3	title 20. 
1	device, or of
1	information, including information
1	mineral, other ingredient
1	raise genuine issues
2	electronic communications, or
8	controlling the drug
1	(7) memorandum of
1	equal to 80
1	subdivision thereof or
1	changes except as
1	 (9) product
1	subgroups of consumers)
1	(a) in effect,
1	item constitutes drug
1	therapeutics shall coordinate
2	recovered from sales
1	
 801a. congressional
1	modified or terminated
2	state under this
1	(a), he shall
1	regularly engages in
1	studies.  (ii)
1	or, with respect
1	scientific, or industrial
1	(a) fda reportnot
1	subgroups of consumers;
1	agents, as may
1	added aug. 27,
1	capacity.  (b)
1	-year period, were
1	(a) unlawful acts;
2	(or any combination
2	application, a supplemental
1	experience and other
1	members whose positions
1	(a)(2).  (2)
1	suffer from the
1	(e) construction 
1	 (1) action
1	research and evaluation
1	human life shall
4	 (h) the
1	court so that
2	programs for the
1	countermeasures may receive
1	strategy to better
2	including in the
1	sponsor from submitting
1	disposition of refused
1	level of reinspection
2	projects to develop
1	completion  (a)
1	information to identify
1	compliance problems identified
1	attorney general) respecting
1	disposal by an
1	(f) limitation the
1	scope of preemption
1	drug cannot be
1	guidance within 18
1	effect on commerce
2	purpose of obtaining
1	350a, 350c(b), 350f,
4	accordance with subchapter
1	(d) effective date
1	(a)(iii) of such
1	application is amended
1	means a subsequent
1	notice) that existing
2	additional evidence to
1	facility into interstate
1	appropriate federal officials,
1	products. this term
1	lifetime risk of
1	data, that can
1	operation or similar
1	otherwise negotiated deadline,
1	assure an effective
1	(bb) signing a
1	 (ii) allocations
1	establishment to provide
2	condition, the secretary
1	biological product. (d)
1	retail outlets; or
2	intended use 
1	 (1) select,
3	application as defined
1	appropriate for meeting
1	of, and any
1	food; (e) expanding
2	(iii) when patent
4	health; but in
1	subject of significant
1	shall establish that
2	application to a
1	consumer price index.
1	(b) promotional material
1	52 stat. 1040.)

1	(1) undertake examinations,
2	years, respectively; or
1	appeal prior to
1	receive and assess
1	3 years, whichever
1	consumer  (a)
5	et seq.). 
1	respectively. (2) exhaustion
2	certify in writing
1	modification of such
1	states.  (3)
2	little cigars, all
1	1044; june 24,
1	2016, the sponsor
1	drug and animal
4	labeling, or advertising
1	section 348 regulations
1	453 of this
1	reasonably be anticipated
1	manufacture such animal
1	state under paragraph
1	programs by local
1	distributes, leases, packages,
1	
 
 360ccc1.
2	approval, except that
1	fact; (d) that
2	that, by its
1	caused in the
1	(c) persons who
1	drug enforcement administration)
2	drug enforcement administration.
1	commission (a) jurisdiction
1	certain raw agricultural
1	(l) safety report
2	notice, request for
1	particular food, including
2	ninety days of
1	unless, within 60
1	 (d) effect
1	(i) the single
1	use should be
1	show the kinds
1	regulations specifying the
4	corporation that controlled
1	criminal action involving
1	applicant seeking either
2	4, 1907, as
1	contract repackager site.
2	make a decision
2	identifier not later
1	account, which shall
1	include a wholesale
3	drugs shall not
1	secretary of defense.
3	package and homogenous
1	subparagraph (i) of
4	considers appropriate to
1	receives the product
1	establishes by a
1	ch. 61, 6,
1	2014 under this
1	effect shown to
3	adjustment to total
1	section 1401(4) of
1	biennial date that
1	847. additional penalties
1	applicability of final
1	contracts and cooperative
1	publication that appears
1	paragraph (9)(b) not
1	regarding the topics
1	food under a
1	identified, as required
1	harvest, carry off,
1	good faith efforts
1	ch. 675, 562,
3	communication  (1)
1	business dispensers, including
1	drugs under abbreviated
1	
 1532. program
3	patent invalidity or
2	food or food
1	meaning of term
1	section 844(a) of
2	(d)(3)  (a)
1	relationship in the
1	petitions, the united
1	design and purpose
1	new and more
1	shall engage external
1	title 22. (2)
1	title. (d) 
1	(a)(3)(b), through, as
1	(6) develop postmarket
1	sponsors, contract manufacturers,
2	entity is more
1	personnel with expertise
1	law with respect
2	product at an
1	expertise of the
1	basis only. 
2	 (3) limitations
1	adequate safeguards. to
1	campaign (a) in
1	(b) to revoke
1	including information regarding
1	chain and other
1	conformity with this
1	proposed labeling; (c)
1	send observers to
1	use federal funds
1	temporary structure constructed,
2	period a proposed
1	public notices, as
2	admissible in any
1	july 12, 1943,
1	device contains information,
1	generalas promptly as
1	cocoa, chocolate, cherry,
1	(b)(2)(a)(i).  (g)
2	justify the proposed
3	deemed and treated
1	safety, or (ii)
2	performance evaluations of
6	assessed a civil
1	informal hearing, except
1	reduce drug use;
1	real world evidence;
3	consider whether the
1	articles exempted from
1	(b) a determination
1	drug, shall facilitate
1	specific drugs provides
1	vital to public
2	real world evidence,
1	intervals so that
1	real world evidence.
1	investigate the petition;
1	
 132. transferred

1	regarding all pending
1	established at or
4	 (d) authorization
1	extent to the
1	(d) refunds 
1	classification panel to
1	recognized but which
1	only.  (iii)
2	applicant may assert
1	letter regarding pending
1	content  (a)
2	violation.  (b)
1	investigate the petition.
23	secretary pursuant to
1	registration is sought;
1	available to physicians
1	26, 2014; 
1	(d) a disaster
3	standards of quality,
1	paragraph (1), further
1	(e) coordination with
1	(a) supplying a
1	growth of pathogenic
2	regimen, or new
1	processing of requests
1	(1) the defendant
4	quality, purity, and
1	person may select
1	secretary in public
1	years imprisonment. (8)
1	(e) definitionsfor the
4	applicant shall submit
1	 (c) partial
1	different route of
1	description or identifying
1	ch. 675, 1014,
2	agricultural marketing service
1	persons preventing enforcement
1	secretarys consideration under
1	facilitate the balanced
2	exemption of drugs
1	caused by 
2	require a label
2	establish criteria for
1	relation to pediatric
1	18 or $100,000
1	(b) the good
1	(1) on his
1	advertisements not later
1	distribution before such
1	various aspects of
1	applicant a copy
2	voluntarily agreed to
1	performed only upon
1	license; and (c)
2	adjustment factor 
1	379j51. definitionsfor purposes
1	deliver a copy
1	it. (3) the
1	(4) sample product
2	assign a team
1	approved. (2) limitation
2	refer a proposed
5	aware of information
1	article; and (ii)
1	1968, that a
1	policy regarding the
1	possess or obtain
1	authorize delivery of
1	separate registration for
1	renumbered 1001, 

4	least one of
1	1035(a) of this
1	court, operate as
1	entities participating in
1	fee, the generic
8	7 of article
1	furnish, or give
4	secretary under the
1	meeting. (ii) the
2	48, 49 and
1	justice and adequately
1	(b) address funding
1	public comment. after
3	affected applicant for,
2	order shall provide,
1	additional list of
1	adequate resources for
2	may commence distribution
15	amount specified in
2	 (e) false
3	believing that the
1	identifying the drugs
1	limit the applicability
1	communication to a
2	(j)(5)(f) of such
3	availability of appropriations,
2	correcting the violation
1	supplement; (4) if
1	require the national
1	research populations; authorization
1	subparagraph (a)(iii) of
1	food allergy management.
1	classify such device.
1	1 percent less
1	audits assessing conformance
1	request, shall deliver
1	time) they are
1	reinstating the applications
1	disease or healt-related
1	one million two
2	conducting lon-term epidemiological
1	uses of color
4	development and priority
8	(a) not later
1	whether in a
1	reported pursuant to
2	publication of an
3	general fees authorized
1	conditions determined by
1	toxins, or analogous
6	reports of investigations
1	recruitment or hiring
1	control of which
1	corporation, to sell,
1	 (8) amended
2	product development; (b)
1	products wherever handled
1	immunity and privilege
1	poppy means the
1	drug in combination
3	respecting the safety
2	may 13, 1992,
1	following shall also
1	i, 12, as
2	 (i) effect
1	particular named substances
1	suspension actions required
1	failure, upon demand
1	technologies for different
3	upon such commerce,
1	submissions, including supervisors,
1	farm has the
1	dispensed, acquired, or
1	may present evidence
2	term financial interest
1	statement explaining in
1	local distribution and
1	title, or approve
1	operating reserves within
1	biennial basis following
2	regulations and to
1	(2)(a) be made
1	report submitted pursuant
1	shall support and
1	person, from the
1	device establishments identified
1	specific type of
1	product in terms
2	congress on such
1	(i) consistent with
1	make and promulgate
4	commerce of, or
1	sales by a
1	issuance of criteria;
1	credible information indicating
5	343 of this
2	adulterated and that
1	practically free from
1	body structure. 
5	following the date
1	quality regulation under
1	$566,000,000. (h) for
1	compounding that reasonably
2	plan to reduce
1	(i) notwithstanding section
1	marijuana are up
2	importer to the
9	unless specifically excepted
1	good and wel-being;
1	food industry of
2	services, secretary of
1	(13) product the
1	instances of nonconformance
1	specify the time
1	to, or more
2	infections due to
1	reviews, and dispute
3	drug administration under
1	permit a substantive
1	(b) a pending
1	(a) and paragraphs
1	675, 808, as
1	955a to 955d.
1	(d); (3) the
1	(1), the national
1	country, if each
1	of; or (iv)
1	and, in event
1	(3) the recall
3	(b) payment the
5	upon a determination
1	ensure transparent decisionmaking;
1	food allergies to
1	duties such that
1	cigarettes, all smokeless
1	cause finds that
1	number of detaileesthe
1	inspectors of carcasses,
7	extent that compliance
2	approval if the
1	schedules are as
1	construed to provide
1	acceptable and issues
1	agencies pursuant to
1	relevant information, the
1	additional information as
1	entity or the
1	(2) has classified
2	followed by each
2	 (f) effect
1	permits for the
1	applies not to
1	sale of fresh
1	on-sixth of an
1	take, use, or
1	practice unless such
1	(including both federal
1	social consequences of
1	commerce, or substantially
2	review.  (5)
2	transitioned to a
1	further, that, notwithstanding
1	certain admiralty and
1	strengthen state food
1	foreign country, and
9	failure of the
1	youth, women, and
1	respect to seafood
1	(a) purposesthe national
1	another person. (aa)
1	jurisdictional determination (61
1	intelligence sources and
1	management guidelines, including
1	occurs sooner. if,
4	year notwithstanding the
1	section. an agreement
1	exceed amounts as
1	provide mentorship to
1	determination. a state
1	(1) no effect
1	appropriations, the director
1	making such inventory,
1	statutes at large,
1	2016, which estimate
2	verify under penalty
17	fiscal year; and
1	(c) a physician
4	orders of the
2	safety questions; and
1	type of 
10	regulations under paragraph
1	development authority, shall
1	(1), or, in
8	deemed to have
1	obstruction of an
1	means all places
1	exists a life
2	establishment any establishment
4	manufacture, distribution, and
1	waived unless good
1	drug may, under
1	paper, or accessory.
2	amount of gross
1	provisions that allow
1	use; and (h)
1	subsection (a) when
1	2011 and such
1	production facility without
1	diseasesany person, acting
3	salts, and salts
1	fruits and fresh
6	clause (i) shall
1	exercised and enjoyed;
1	occurring estrogen. 
1	welfare, requiring an
2	chapter, or is
1	rejection not later
3	developments in scientific
3	upon removal from
1	paragraph (2), by
1	high risk foods
1	otherwise), or transporting,
1	(f) and (g)
1	advertising  (1)
1	countermeasure approval, clearance,
5	requesting public input
1	452. congressional declaration
3	section, if such
1	regulations or practice
1	licenses for the
1	precedence to public
1	shipment of imported
2	requests if the
2	authorities at least
4	reach agreement on
1	(c) under no
1	(kk)priority supplement. 
1	section 601(m)(8) of
2	 (a) whose
1	holding the pesticide
5	requirement relating to
2	food products prepared
3	28. the commencement
3	actions taken to
2	salt of an
1	among youth; (7)
2	(other than tobacco
1	removing any amount
1	regulatory limit shall
1	(ii) data suggests
1	misstatements of fact
1	(1)requirement.subject to section
1	2012)) or any
1	(c) and, for
1	requests; (3) the
2	section 1034(d) of
1	shall first determine
1	1996, under the
3	contain (i) a
1	i, 3, formerly
2	notices and other
1	lead to severe
2	forwarded by the
1	misleading marking, labeling,
1	change in activities
1	human food. (b)
1	narcotic drugs who
1	generalproperty taken or
2	requiring disclosure of
1	seller because the
4	panel established under
1	law, following december
2	(b) order of
1	concurred in by
1	every sector, including
1	subchapter. (b) grant
1	(b) absence, substitution,
1	manufacturer of any
1	grant, or effect
1	regulations in comparison
2	subsection (c)(2)(g) or
1	annual review 
1	title; (4) make
1	nongovernmental sources of
1	puerto rico. (2)
1	use of, tobacco
1	(b)(3)(c), and (i).
1	preclinical and clinical
1	tobacco users is
1	(i) such food
1	(b) such product
4	following classes of
1	transaction in commerce;
4	public access to
1	based on recognized
17	(a) if the
1	persons prompt notice
1	minor use and
2	product standards in
2	patent will not
1	law enforcement personnel
1	$5,000,000 for each
1	container; standards consistent
1	risk because of
1	applicant to perform
1	tracing requirements for
1	optical isomer, except
1	evidence.  (c)
2	requiring submission of
1	licensed pharmacists, but
2	directed to make
1	earlier than 180
1	countermeasure  (a)
1	substance) of imparting
1	(a) may, not
5	comment on a
3	shall furnish each
1	hospitalization, improve patient
1	animal drug (or
1	(c)(3).  (ii)
1	(33) norpipanone. (34)
1	(a) known safety
1	complete such study.
1	affecting the safety
1	proposed intended use
1	section, or for
2	v, such person
1	may deliver the
1	physician in limited
1	orders  (a)
1	order and findings,
1	(a)(1)(c) by the
1	u.s.c. 353(b)]. prescriptions
1	definition of pesticide
6	(b) content the
2	informing the applicant
1	shipped or delivered
1	authority to appoint
1	(4) director the
1	355[1] 360b, or
1	contain sufficient information
3	recognition as an
8	presents a threat
4	except for changes
1	media campaign or
3	maintaining required records,
1	discharge of its
2	chapter related to
2	advisory committee, whichever
1	(10) labeling of
1	whether sampling is
1	(i) annual hidta
1	fee settingthe secretary
1	grown marijuana, are
2	secretary will consider
1	fruits and vegetables)
1	medical products that
2	28, bring a
1	availability, as measured
2	additional information the
1	ingredient at a
2	show that each
1	transportation any article
1	maintained a certification
1	task force established
1	outstanding deficiencies in
4	publicly available. 
1	first month of
1	morphine methylsulfonate. (16)
2	3 years from
1	advisors as may
1	lactose, milk proteins,
2	actual transaction involving
1	smoking marijuana early
1	groups; or (iii)
1	ii chemical. (34)
1	components thereof, of
1	commission considers advisable
10	4, 1913, ch.
1	issue, amend, or
1	quantity or proportion
1	regulated person or
4	practicable given the
1	extrapolation between age
1	residues in connection
1	subchapter i because
1	section 379j51(4) of
1	significantly increase the
1	(1) waiver of
1	request by united
1	18. (i) adverse
1	interested person, change
1	 (cc) for
1	contaminant level is
1	(a) maximizing the
1	information; (iv) promptly
1	(i) a wholesale
2	secretary shall direct
1	distinguished by the
1	services shall submit
1	(a) in generalthere
1	assurance, or quality
1	section. during the
5	facts, is false
2	fee each fiscal
2	civil action referred
2	develop a procedure
2	court feels it
1	
 
 360a1.
1	adequate measures have
1	(a) jurisdiction the
1	(c) provision of
2	 (c) penalty
2	may 1, 1971,
1	360e(d)(1)(b) of this
1	subparagraph (b)(ii) and
1	petition by any
2	packing of drugs
5	fruits and vegetables,
1	may be, for
1	secretarys efforts to
1	advertisement has the
1	area means a
1	council relating to
1	fixed therefor in
2	number of centers
1	three years, retained
1	law or regulation.
1	(b) members with
1	expenses the members
3	drug involved, any
5	including specific suggestions
12	(4) of subsection
1	additional information shall
1	analyze safety data
1	passed in accordance
2	en-users during such
9	year may not
1	 (b) controlled
1	annual biosimilar development
1	investigational purposes certify
1	following the applicants
5	establishment is located,
2	expediting the development
1	addition to testimony
1	inspector.  (

2	report required pursuant
1	protest the secretary
3	availability  (1)
1	dihydromorphine. (9) etorphine.
1	coca leaves) in
1	fruits and vegetables.
1	drug involved (including
10	average annual percent
3	secretary of a
1	u.s.c. 136w(d)] or
4	generally recognized, among
2	facilitate the development
1	subsection (b)(1) of
2	equally to all
2	patients.  (3)
3	persons with the
1	perform a review
1	general. if the
1	 (c) nonprescription
1	trial; (b) adverse
1	restrictions on disclosure
1	(i)(i) and (ii),
1	regulations applicable to
10	subsection (b)(1) or
1	costs of litigation
2	may be added
2	employees, and committees
1	title i, 21,
1	(2) appeal the
4	proposed regulation under
1	representatives.  (d)
1	(k) subchapter iv
1	 (i) year
2	care providers. 
1	(c), (d), (e),
1	discharged from office
1	12 months. any
1	schedules, he shall
2	law to receive
1	rulemaking, that regulation
1	ordered detained until
1	purpose of inspecting,
1	public health, fails
1	74, 8, 38
1	manufacturers and distributors.
2	biologics, and drugs,
1	administrative inspection warrants;
2	sponsor, applicant, or
1	contribution. (b) establishment
1	involved; (d) aggregated
1	identification practices, including
1	document storage immediately
1	inadequate  (a)
2	petition.  (c)
1	(a)(4) (relating to
1	antimicrobial drugs when
1	cooperation between the
1	i.  (f)
1	product manufacturer eliminates
2	(b) individuals 
1	dated july 27,
1	(2) a detailed
1	business in such
1	(b) meetings 
1	product corresponds with
1	i, 19, formerly
2	risks presented by
1	timingnot later than
2	intended only for
2	fee collection during
1	subparagraph referred to
1	poppy straw. (4)
1	system, or program
2	manufacturer and importer
1	administration, to ensure
1	team throughout the
1	wholesale distributor licensing
1	 (b) restrictions
10	ingredients, route of
4	accept the opportunity
1	2 weeks or
4	licensure under section
1	
 
 335a.
1	outside any plant
2	title, he shall
1	packed under insanitary
2	based on an
1	term interstate commerce
3	(g) for purposes
1	(a) penalties; forfeitures
1	(including reasonable attorneys
1	section 1333(e) of
1	limitation the attorney
1	eggs which are
1	entity enrolled in,
2	acceptance was transmitted
1	declaration, notification, or
1	accord with that
1	jurisdiction the secretary
1	science, or technology
1	terms in regulations
1	activity, except that
1	removed.  (g)
2	agency action. 
1	date as of
1	later than 480
1	interrelated. (7) the
1	(b) supervisor, manager,
1	paragraph, relevant international
1	(c) the department
2	whichever occurs sooner.
2	applicable requirement of
3	applicable due date
1	office to carry
3	combination product may
1	14 days. 
1	formula, or delivering
1	wholesaler.  (c)
2	use specified by
1	wrapping (including cellophane),
1	(c) stakeholder comment
1	product for that
2	tobacco product scientific
7	concurrence of the
2	establishments with inspection
1	staff to be
1	challenges;  (2)
1	(g)(1), a device
2	inspection regulations promulgated
1	biological product the
1	ch. 675, 738a,
1	pose significant risks
1	rescind any associated
1	distributed through means
1	recurrence of the
1	section 387e(e) of
1	health, and in
1	officers and acceptance
2	application fee the
1	outbreaks.  (2)
1	information describing 
1	access, at any
2	acting in compliance
1	products a new
2	carcass, portion of
1	procedures applicable; appeal
1	contact substance except
14	attorney general is
1	5 of the
1	product or state
1	procedures under paragraphs
2	premix used in
1	 (d) compilation
2	may accept the
1	responsible party, the
1	order becoming final.
1	determination and recommendations
1	dosage forms on
5	reduce its quality
1	applicable elements of
2	applicant shall also
1	subsection differs from
1	utensils and foo-contact
6	users of tobacco
1	impleader of dismissed
3	shor-term goals and
1	notificationfollowing notification pursuant
1	applicant shall include
1	sections 1034(e) and
1	research and study
1	needed to improve
4	terminate the designation
1	federal establishment as
1	agency in support
1	(c)(1) or a
1	needed to ensure
1	efforts to coordinate
1	line for a
1	services shall assure
1	(i)(ii) shall include
1	border, and domestic
1	5304 of such
1	duck, goose, or
1	is, not later
1	prescribed), the secretary
1	exclusions from application
1	practice of telemedicine,
2	35;  (iii)
2	 (2) list
1	 (d) if
1	plan and documentation
1	plant number, of
1	including qualified testing
6	product application or
2	issue such a
1	supplies, and (d)
2	 (d) in
1	postapproval production reportthe
1	identify the most
1	compliance with title
1	(b) a recruitment
1	recalls and use
1	medical product innovation,
1	penalty, and such
1	clause (ii)(iii). (c)
1	provides reasonable assurance
1	(a) to an
3	require; (f) specimens
1	manufacturer to give
1	establishment.  (b)
2	drug, as a
1	
 
 358.
1	include, for such
3	360c(f) of this
1	(iii) i-process controls
1	administration, the package
1	able to take
1	 (16) the
1	(a) membersthe secretary
1	360rr. federa-state cooperation
1	public of such
1	provide a facility
2	either house of
2	beginning fort-eight months
1	update the lists
1	forms on hand
1	contains chemicals, products,
1	(b) any summary
2	appropriations and the
1	(c) wholesale distributor
4	substances control act
1	deaths and serious
1	drug after january
1	secretary reason to
8	commercial distribution before
1	(5) the requirements
1	opium. (b) poppy
1	title 31. (3)
38	federal regulations (or
2	general shall, by
1	
 1524. authorization
1	within any of
2	establishment where inspection
1	testing and sampling
1	 (8) savings
2	drug the terms
1	notify relevant federal
5	satisfactory to the
1	transferred
 
 857.
1	360e(d)(1)(b)(i) of this
1	total number and
1	product fee the
3	person under the
1	individuals whom the
1	acting without direction
2	exchange of information
1	circumstances, (c) the
1	conducted, or (ii)
9	within 180 days
1	undertake such surveillance
1	except to a
1	(3) whenever the
3	conducted to show
1	to) this chapter,
1	original or otherwise
1	(ii) the distribution
1	subchapter ii is
1	product manufacturer since
2	penalties as those
1	secretary. (2) recommendations
1	said amenable species,
2	effect upon the
4	official) upon request
1	(a) is counterfeit,
1	(f), authorized under
1	act; consistency between
1	list). such term
45	use of a
1	title. (b) payment
1	36 months is
2	section 1365 of
2	participate as provided
1	(i). for purposes
1	(4) apply except
1	collected according to
11	interests of the
1	requests granted and
1	types of audits
1	evaluationthe panel shall
1	limitation a request
2	discontinued the manufacture,
2	personnel demonstrate to
2	letter of intent,
1	united states, official
1	states regarding imported
1	shall be or
3	request of any
1	(iu) 40.0 
1	director, including tracking
1	compliance or that
2	criteria to be
1	mill licenses 
1	serving as an
1	letter of intent;
1	person, from funds
1	funding from amounts
1	title i, 20,
1	person who grew
1	animal use except
1	animal studies pursuant
1	research or teaching
1	permanent staff of
2	assess the performance
1	received such a
1	term special dietary
1	territory, political subdivision
1	drugs; compliance with
1	ability and to
1	initial presentations described
1	(1) responsibilities of
1	(including any exercise
1	day before july
1	food products have
1	(e)(7), affected product
5	drug code number
1	networks for other
1	appropriate, age, biological,
2	accordance with generally
1	revocation no longer
1	combined number of
3	dismiss under subsection
1	title that otherwise
1	 (1) no-interchangeable
1	basis of susceptibility
1	justice.  (o)
1	locality; (iii) a
4	food safety modernization
1	indicating that an
1	indication a human
1	2009, promulgate regulations
1	secretarys determination. (h)
2	testing required under
1	make examination and
2	evidence that any
1	total quantity prescribed.
1	2012, a biosimilar
1	prohibited distribution of
1	de novo, and
1	devices between the
1	including litigation costs,
2	applicant that has
1	iv, 409, as
1	(ii) the portion
1	convene the meeting
3	circuit. the provisions
1	secretary; or (2)
1	drug submission is
7	meet applicable contractual
1	label and package
1	anticipated to lead
1	person involved shall
1	approving the protocol,
1	stat. 1055; june
1	registered manufacturers on
1	person, or (d)
1	used for each
1	subsection (f)(1) of
2	container subject to
1	consumers in individual
1	except where expressly
1	title 42 
1	refer to it,
1	1, 2017. (g)
1	341 and 343(g)
1	division director and
1	(2) effect paragraph
1	informed consideration of
2	may consist of
1	opportunity for consultation
1	publish such fee
1	identify the food.
1	2008; (12) $114,000,000
1	employees and to
1	necessary assistance. (5)
1	obtained from data
1	risk. an order
2	ant-drug media campaign
1	engaged in carrying
1	1996.  (2)
1	publish the statement
3	regenerative medicine and
1	enable a consumer
1	675, 403c, as
3	1040 of this
1	 (e) refrigeration
1	(3), at least
2	information deemed appropriate
1	20 of the
1	sale in, interstate
2	(b) includes a
1	(2) and maintain
1	property for purposes
1	timelines the timelines
1	379j31. authority to
4	offer to distribute
1	office that will
1	device is under
1	partially filled if
2	listed chemical may
1	clinical trial data
1	risk to health.
2	wholesale distribution of
1	consumer is in
1	product (except such
1	investigational submissions for
1	information the council
1	resources, detect the
1	unless the seller
1	traveltime, at rates
1	issues such order.
1	infectious disease productthe
1	devicesthe conditions specified
1	without submission of
1	than, directly related
1	logistics provider located
1	prescribe regulations under
1	slaughter), may be
1	4, 2011; 
2	produced or from
6	sunscreen order by
1	repayment program. 
1	675, 537, formerly
1	committed to the
1	third party shall
1	et seq.]. (2)
1	act of 1984
1	 (c) enforcement
1	act of 1986
1	applicable postapproval requirements,
1	(h) any other
1	 (i) distributions
1	appropriate. (b) the
3	notwithstanding paragraph (1),
1	term primary mode
1	sales of animals,
1	 (i) specific
1	drug and transfers
1	participation in medical
1	plan, together with
3	chapter and to
1	piperidine and its
10	agencies of the
1	significant negative impact
1	2008, 120 days
2	devices, the initial
1	(which list is
1	transfers of credit
6	detach, deface, or
1	exist, he shall
1	contents not leaking.
1	athletic competition the
1	efforts the secretary
5	 (i) was
10	appropriated such sums
1	situated persons. 
1	way whatsoever in
1	shall prescribe) 
1	columbia, or in
1	reinstate the registration
1	reprocessed device without
2	title 18. (b)
1	categories of individuals
1	origin and district
1	required informationthe application
7	connection with a
1	(f) become effective
1	means the smallest
1	pertinent information for
1	product manufacturers the
1	furnish any notification
2	physician has such
2	product, or an
1	including health and
1	files referenced in
1	limit the request
10	secretary regarding the
2	tobacco products of
1	prosecution of an
1	effectiveness by federal
1	secretary may delay
3	potency of the
1	integration of activities
1	21 and amended
1	appropriate elected state
1	
 1181. contract
1	manufactures a listed
1	 (c) eligible
1	(ii) available information
1	(iii) requirements 
1	submission if the
1	iii, or ivit
1	plus  (i)
11	recommendations developed under
2	prevention of disease,
1	product be limited
1	produced by an
2	practicable  (a)
1	safety audits on
1	clause (iii) were
1	sole distributor of
1	(a) be subject
1	(1) in generalthere
1	consul as used
1	coca leaves imported
1	(2) the juice
1	generalin this section
1	1332(7) of title
1	medical devices. 
1	iii and described
43	required under this
1	compensation for any
1	form of publi-private
2	applicant can demonstrate
1	360j(g)(8)(a) of this
1	387i, 387j, 387k,
1	endeavor to 
1	u.s.c. 45, 53,
2	requirements may be
7	subsection (b). (b)
1	first sentence requires
1	coordinated law enforcement
1	631.)
 
 379c.
2	charitable organization described
4	information referred to
3	contract, fellowship, memorandum
1	preparation, in one
1	forth any proposed
1	2011. (6) application
1	preparation, storage, handling
1	light, mild, or
1	government does not
1	total amount available
1	commerce by a
1	requirements for age
1	data obtained from
1	(c) opportunity for
1	(a) affiliate the
1	repealing regulations) shall
1	professional organizations, industry,
1	respecting the qualifications
1	(ii) the substance
2	tobacco products or
1	states (a) in
1	circumstances under which,
1	prescription drug distributor
1	(3) contentthe proposed
1	area and the
1	facility manufactures positron
1	prescribe different and
1	period of planning
1	existing efforts; (4)
2	petition under subparagraph
1	successful case study,
1	repackager, or other
1	distributors, and retailers
1	whose chemical structure
4	regulations specify, a
1	consistency of pediatric
1	name so far
1	protection, as determined
2	establishing, modifying, suspending
1	supplement, not later
1	respecting the application,
3	protect public health.
1	request, and notify
1	first country (referred
1	distributor, and dispenser
2	review of regenerative
1	support surveillance, outbreak
1	nothing in section
1	individual and other
1	shall be voting
1	restrictions; bond; court
1	paid carry over
2	years, but if
1	product, to prevent
1	corrective actionsthe owner,
1	(i)in general. 
4	designation:  (1)
1	information on such
1	revision to any
1	submitting entries to
12	353(b) of this
4	project described in
3	states courts of
1	(9) person the
16	scientific and medical
1	(d) compilation not
1	(including any leasehold
1	paragraph (1) (which
3	containing an anabolic
1	given and hearings
1	(ii) agreements by
1	eligibility determination, post
1	containing an identifying
1	pharmacy or shall
1	petitioners statement of
5	subparagraph (a) has
4	patent number and
1	whether such change
1	term major species
3	initial members appointed
1	additives (a) unsafe
1	foods at the
1	can, tin, plastic,
1	emergency response teams
2	interest of consumers,
38	drug or biological
1	material facts relating
1	inspection obtains a
1	exported if the
1	application. (c) fift-six
1	modification, amendment, or
1	damages.  (2)
1	22, 2016, a
2	list to include
6	burden of proof
1	iii device, an
1	detailed accounting of
1	sections 353(b)(4) and
1	residue levels 
1	(ii) understand the
1	patients attending physician
1	body or is
1	(1) rule of
1	appropriate to preserve
1	met, or until
1	forfeited be taken
1	analyses to 
1	plant inspections; and
3	applicable inflation adjustment
1	 (a) recognized
1	(including crude opium
1	denial) that one
6	state coordinator shall
3	entity under this
2	make the application
2	c fre-choice medicated
1	designate an official
1	administrator determines by
1	purposes of study
1	law no provision
1	civic groups, communit-based
6	may be exported
1	facilities registered under
1	potentially harmful to
1	research and clinical
1	(ii) issue a
1	(d) issuance 
1	(b) deferral extension
2	activate such requirements
1	quarter by multiplying
4	applicant that the
1	shall be accorded
2	twenty years and
1	31, the following
4	2053,67 stat. 631;
1	consists of loose
1	complaint.  (iv)
1	(a) definitions as
1	permission.  (c)
1	adduce such data,
1	participation of, a
1	attorney. the court
1	authority (which notice
1	meeting only after
1	drug application, as
2	recommendation, (ii) a
3	feed, and such
2	made to take
1	information from investigations
1	(ii), or (iii).
1	(50 u.s.c. 1701
1	type used solely
1	statement, the article
1	offense which was
1	drug application, an
1	(ii), or (iii);
1	requests to congress
1	
 1601. findingsthe
5	manufacturer in accordance
7	section.  (f)
1	subsection (b)(2)(b)(iii) continues
1	pediatric study planthe
4	preemption  (1)
1	materials, ingredients, design,
1	patient. (b) reports
1	indication for other
1	et seq.] an
1	(for purposes of
1	board certification from
1	states complaint is
1	prescription drug complies
5	used, or intended
1	compensation, the place
2	made with the
1	10 of the
6	person while engaged
1	whether he affirms
1	(1) establishment there
2	product manufacturer to
12	time prior to
1	will otherwise facilitate
1	traffickersnot later than
1	protective material. in
1	discrimination provided by
1	reaccreditation to persons
2	selected establishments in
1	(4)(b)(iii)(i) of subsection
1	manufacturers and tobacco
2	unless (a) it
5	effect as the
2	august 1 of
3	enforcement task forces
1	enrolled, the expected
1	approved use for
1	(4) ethchlorvynol. (5)
2	licensed practitioner for
1	may use funds
1	administration.  (ii)
1	strength. (iii) within
1	accredit a thir-party
2	taken on such
2	revoked, suspended, or
1	applicable and when
1	abuse; (5) all
1	fixing such quota,
4	eligible entities meet
1	(3) if, after
1	device. (iii) upon
1	definedthe term drug
5	inspection user fee
2	(d) by the
1	fee was paid,
1	diagnostic technologies, and
1	fee was paid.
7	make such reports
4	chapter, and shall
2	condition prescribed by
2	distribution of minimal
1	(7 u.s.c. 181
2	whether a nonprescription
1	 (1)requirement.subject to
2	employees but less
1	whether, after submission
1	supplier is related
3	respect to narcotic
1	objective measurements of
1	342. adulterated fooda
1	(g) guidance on
1	however, notwithstanding any
1	manufacture, or distribution.
2	using the internet
1	(a) the period
1	undertake with external
1	180 days. 
1	determines appropriate. (iv)
1	substance has the
2	withdrawal, obtain review
1	states attorneys; and
1	presented, that adequate
1	(ii)[1] recoupment in
19	united states attorney
2	make the request
1	employee hygiene training.
1	kind of penicillin,
1	loss or impairment
1	domestic facilities, foreign
2	record, report, or
3	transfer of the
1	drugs act of
1	tobacco products intended
4	(c); or (b)
1	board appointed under
1	shall demonstrate, to
1	 (4) drugs
1	smokeless tobacco. (c)
1	implant was placed,
1	policy.  (h)
1	standard, an evaluation
1	review. meetings of
1	surveillance data; and
1	effective sharing of
1	candidates provided by
1	include any dietary
2	subject to modification
1	medical device that
1	confidential information; and
12	transaction statement for
1	notifies the manufacturer
1	year after march
1	use by others.
2	quantity of inactive
1	shall maintain for
1	term maintenance treatment
1	egg, incubator reject,
1	360i(h) and 360l
1	exempted for investigational
1	compounded; (vi) the
1	prohibiting the secretary
1	digitalis, ergot, hyoscyamus,
9	packer, or distributor
1	control (a) establishment
1	subsection (a), upon
8	controls under the
1	may also include
1	used.  (e)use
5	upon the applicant
1	may require inclusion
1	record which makes
1	use of existing
1	individual concerning whom
2	active pharmaceutical drug
1	partner of a
2	reinspection as he
1	convalescence, pregnancy, lactation,
1	proceeding for forfeiture
1	vitamin c, and
1	committed outside territorial
1	whole. (b) designation
1	listing a new
1	csa in the
2	rates as needed
3	including both large
1	individual.  (c)
1	successor regulation); or
1	drugs and procedures
1	shall be forwarded
1	affiliate, as so
2	registration that is
1	 (iv) designing,
1	356a. manufacturing changes
1	deems necessary, such
1	substantial and direct
1	preceding sentence which
1	product (including an
3	vii.  (2)
1	product shall establish
4	title.  (l)
1	authorities; and (h)
10	food and drugs,
2	necessitates medical or
1	 (9) surrogate
1	(including amendments made
1	title (except paragraphs
1	designation the attorney
1	exempt any food,
1	pharmacy, develop a
2	committees (which may
5	food and drugs.
1	packaging or repackaging,
4	regarding action levels,
1	i, 23, formerly
2	terminated by withdrawal
1	public informationany information
1	drug as susceptible,
1	food items; 
1	
 350k. laboratory
1	subsection, provide to
1	value furnished or
2	appealed or is
3	(2) or (3),
1	(b) requirements established
1	drugs because 
1	handling of prescription
1	label upon the
2	pee-reviewed biomedical literature;
12	priority review user
1	842(b) of this
1	reporting.  the
1	explaining in detail
1	subparagraph (a) available
1	equal to 3.5
3	effective not later
2	forth in clause
1	(2) activitiesafter making
3	makes a written
1	foodborne illness. such
1	review the notice
1	 (4) prioritization
1	design, material, chemical
2	(1) the manner
1	populated and rural
1	sponsor at the
1	affect any other
1	(13) moramid-intermediate, -methy--morpholin-1,
1	(a)(ii) with respect
1	upon the administrators
3	submission under section
3	american board of
1	upon controlled substances
1	program evaluation under
1	u.s.c. app.) shall
1	(b) exceptiona prescription
1	restrict distribution or
1	safety are protected
2	(4) any other
1	containers or of
1	(i) patient labeling
1	person known or
1	qualification plan to
1	labeled, marked, stamped
1	achieving the stated
1	notice, as the
1	internet site that
1	applications. (ii) 75
1	entry and refused
1	et seq.]; the
1	ingredient  (1)
1	growing or being
1	preservative unless it
1	annual fee equal
1	certification of compliance,
3	representatives on the
2	person, will be
1	curtail diversion of
4	amount equivalent to
1	(11) shifts in
1	theft of such
2	distribution of all
1	(i) documents generated
5	remedies provided for
1	use in manufacturing,
2	subsection (c) to
1	351 of public
1	concerning the background,
1	sale. if no
2	requirement  (a)
1	understanding, material transfer
1	utilize existing community
2	within any such
2	public water systems
1	dosage units in
1	manufacturer. the exception
2	office. (6) the
12	controls, or has
1	employee in conjunction
1	subparagraph (f) until
1	package level for
1	concerning, research and
1	secretary. such regulations
1	procedure pursuant to
1	commerce which are
1	fiscal year, so
1	(a)(1). such review
1	(r), 342(a)(2), and
1	exemption does not
2	334(a)(2) of this
1	year, the combination
2	removal shall be
1	briefings and analyses.
1	additives listed pursuant
1	paragraph (5)(a) of
1	aconite, belladonna, bitter
1	420, as added
1	(2) base fee
1	safety signals from
1	(1), further increase
1	 (1) actionsfor
1	rulemaking procedures. 
1	inspector.  (b)
1	countries. (
 

1	360fff6. no-sunscreen time
2	funding the secretary
1	participation by all
1	containing embryo chicks
1	method by which
2	necessary to its
5	distribution before may
1	(2)(b), (ii) the
1	
 890. review
1	(2) allocations of
1	resolution procedures the
3	become aware of
1	several principal administrators,
1	device exemptionsupon submission
4	past experience in
5	attending conferences or
1	(b) have caused
1	 (c) grant
1	thir-party organizations may
1	unmet needs in
1	appropriate enforcement strategies;
1	performance in foodborne
1	related responsibilities and
1	(c) proof requirements
5	foreign person that
1	methods.  (b)
1	update susceptibility test
1	tools qualified under
1	within 20 days
6	period, and not
1	advisory committee input,
1	387a. fda authority
4	profits or other
5	governing appointments in
1	responses to a
1	 (5) evaluation
1	apply. (c) during
2	year 2008 may
1	securities.  (c)
1	quantity of barbituric
1	comment; (ii) establish
12	shall be responsible
1	media campaignin using
1	ii. (3) 
1	inventory of other
1	product, as required
2	records thereof, to
3	subchapter, it shall
1	priority countermeasures (a)
1	normal shape, practically
2	primarily responsible for
2	submission of clinical
1	subsection (c)(3) prohibits
1	borne illness outbreak
1	importer is 
1	disclose the information
1	recall order and
1	assign a listing
7	distribution of controlled
1	single national drug
1	subsection if an
1	formula) for which
1	assessed in an
1	determine.  (c)
18	serious bodily injury
1	means a pack,
1	consumption of that
1	bears the following
1	chapter, or unless
1	manufacturer, as applicable,
1	either initiate the
1	poultry; or (b)
1	 (c) an
2	begun.  (d)
3	illegal drugs in
1	contain a clear
2	becomes final, and
1	different sectors and
2	drug shall, with
16	allegiance is due
1	which, when in
1	devices to identify
1	resources, or (c)
2	commissioner determines that
1	residue based on
1	common control; (iii)
1	 (d) neonatology
1	compendium, or such
1	application, submitted in
1	(a) shall assess
3	grams of ephedrine
1	(6)(b) or paragraph
1	(a)(i) to have
1	risk and to
1	(j) rules of
7	paragraph with respect
20	required by subsection
2	(b) establish a
1	potency levels of
2	athletic competitions recognized
1	trade organization or
3	entity. the owner
1	transportation means any
1	authorities of similar
1	activities nothing in
1	including recommendations therein,
1	regulatory controls and
1	means a written
1	faith protection a
5	progress made in
1	541, formerly act
1	person, acting through
1	medicine or another
1	general.  whoever,
8	attorney general to
1	program requirements the
1	states that are
1	deficiency identified in
1	(a) provide that
1	ant-drug coalitions, departments
3	drug designated under
1	(b) the requirement
1	activities regulated under
1	drug product, establish
10	adjustment factor applicable
1	establish, not later
1	crisis that affects
1	paragraph (4) has
2	interstate commerce carcasses,
3	eligible for approval
1	importer, or any
1	construed to deny
1	thereafter, if the
1	adverse event signals.
1	fees, based on
1	received such poultry
1	federal register (a)
1	account by the
1	(2) in case
1	(ii) -(1,-dimethyloctyl--[(1r,3s--hydroxycyclohexyl-phenol (cannabicyclohexanol
1	filing a biosimilar
2	general may issue
5	clauses (i) through
1	encapsulating machine, and
2	 (b) reporting
1	upon withdrawal of
1	(13); and (b)
1	maritime claims; jury
2	meets the quality
2	compliance office personnel
2	statistical, and clinical
2	review of written
1	(e); and (ii)
1	30 percent. (7)
1	counterfeit product is
1	posted and modifications,
1	may only procure
4	final regulation under
1	(as specified by
1	generalthe administrator shall,
1	pinball and video
1	(1) if any
1	serious illnesses or
3	withdrawal of inspection
1	states (including quantities
1	preceding the date
1	28, the attorney
1	binding upon the
1	make submissions under
3	ii or any
7	may  (i)
3	product as a
1	employ at least
1	5and which provides
1	including the adoption
1	title can and
1	has, by notice
2	adulterated. if the
1	revision the regulations
1	protections do not
1	used in determining
1	 (i) plans
2	 (f) exception
1	patients, patient advocacy
7	color additive which
3	recommendation of a
2	 (d) application
4	substance (as defined
1	administration the commissioner
1	testing, including determining
2	to, a serious
1	programs and policies;
1	action indicated. (ii)
2	part or any
1	meetings and any
1	 (vii) an
1	approval or licensure;
1	humans or foo-producing
1	meeting regulatory requirements
1	court jurisdiction pursuant
4	which, and all
1	fee a reasonable
1	item (aa); (bbb)
1	exporting country described
1	inconsistent with, more
1	premarket application $248,000
1	(1) amphetamine, its
1	make a refund
1	product, and shall
1	involved provides an
7	secretary may exempt
1	persons who marketed
3	combination of extraction
1	drug submissions. (e)
1	research). (p) risk
1	health. regulations prescribed
1	labeling bear adequate
1	prosecution of said
1	juices, and nuts,
1	gross annual sales,
2	display on the
8	relations, armed services,
1	drug abuse should
1	cooperative agreement under
2	agreeif, on or
1	balances from fees
1	(2) committed the
1	secretary shall, immediately
1	(l) lymphatic filariasis.
1	
 
 342.
1	products for pesticide
9	render it injurious
2	order classifying the
1	of, such drug
1	n-tobacc-sale order and
1	written order determines
4	secretary may declare
1	start program carried
1	submission the results
1	dissenter.  (june
3	operation of this
1	preventive controlsthe owner,
1	(g) warning notice
34	meat or meat
2	section 849, 859,
1	(ii) impact statementthe
4	circumstances:  (1)
1	reports accident and
1	drug, taking into
1	professional positions, including
2	bloodstream, the secretary
1	alternative to, a
1	written statement of
1	master files which
1	resale, in quantities
1	judicial forfeiture, and
1	measurement of their
1	 (e) exclusion
3	(including traveltime) they
6	manufacture, packing, storage,
1	warn consumers concerning
1	title; (b) under
1	completed and pending;
7	1523(9)(a) of this
2	offered for sale,
1	identifying bulk drug
1	 (7) 
1	(d) detainer authority
3	information exists to
1	including, as appropriate
2	possession, or the
2	involved; or (ii)
1	(or fraction) of
1	department of agriculture),
1	diseases under such
1	reasons supporting such
1	(g).  (m)
2	shall grant the
1	drug as made
2	controlled substances from
14	section 360j(g) of
1	disease. (b) the
1	itself, be construed
1	shall be reviewable
1	
 
 1501,
1	discovery limited to
1	approved protocol with
1	800, 3, 69
1	360c(a)(3)(b) of this
1	rent, use, or
1	outside thereof; (2)
3	term restoration act
1	whose use the
1	(ii) shall, upon
1	populations under such
1	adjustments  (a)
12	taking into consideration
1	273, 5, 37
2	(a) the availability
1	filed. in the
1	deposit all fees
1	effective correction or
1	substances of natural
1	year involved: 
3	control strategy report,
1	(a) representatives of
1	675, 504, as
1	formulas during the
1	media campaign. (h)
1	inspection, if such
1	c, and vitamin
1	2006); and (bb)
2	fee for an
2	witnesses who appear
2	subsection shall state
5	appears to be
1	dry milk is
3	system is specified
1	address other issues
2	concerning the difference
1	writing, the change
1	none of a
1	percent (or fraction)
3	including information technology
1	use by arrestees,
1	chapter. in no
1	possess on board
1	fees) reasonably incurred,
3	grants under subsection
1	designated upon the
2	business, name of
2	drug prior to
1	device that was
2	united states. subpenas
4	351, 352, 360,
1	application describes an
1	children of such
1	(i) information detailing
1	prescription drug advertising;
1	tobacco used by
1	(iii) following a
1	 (viii) a
1	professional personnel performing
3	application, report, or
1	 (i) approaches
1	health officials; or
7	acceptable to the
1	source of protein
3	supplements with respect
1	subsequent offense involving
1	use of title
1	ordinary course of
3	federal register findings
1	26, 1934, ch.
2	size of bioavailability
1	service announcements. before
1	section 353(e)(4) of
1	trafficker in the
1	guidance to have
1	 (c) regulationsthe
1	number of advertisements
1	mitigate the drug
3	secretary for good
1	subchapter, and such
1	subparagraph. (b) whenever
1	 (1) employ,
2	least burdensome appropriate
1	criteria under which
2	issuing grase determinations
1	general shall, with
1	(ii) appropriate counseling
1	(c) updates the
2	within the ninet-day
2	administrative order shall
1	fora; and (iii)
1	officials of foreign
2	possesses such substance
1	package included in
2	history, and nature
8	thir-party auditor or
1	evaluated; (5) identify
1	title. such internal
1	52 stat. 1056;
1	drugs except a
1	attorney shall have
1	substances nor from
1	effect. following review
1	review process. (b)
1	schedules any drug
1	(b) because no
1	tobacco products; and
1	otherwise not feasible
2	secretary shall also
1	accordance with risk
4	testing and evaluation
1	(a) any officer
4	furnish on request
1	executive board shall
1	professionals; and two
1	issued thereunder). 
1	committee and which
1	including field and
2	rico, guam, the
4	person not licensed
1	regarding the conduct
1	individual convicted (under
1	2014.  (4)
1	order to address
1	office setting. (c)
1	additional opportunity for
6	total revenue amounts
2	scope of exclusivity
1	safety datalink or
1	calendar year concerned,
2	state agency under
1	(a) a meeting
1	issues for review
8	subsection (c) of
2	claim described in
1	subchapter to conduct
5	date an application
3	required  (i)
1	drug.  (j)
1	constituent, extract, or
1	regulation exempt drugs
1	distributor other than
2	availing himself of
1	facility, including the
1	drug for an
2	-pheny--[-(-phenylethyl--piperidinyl] propanamide; (vii)
6	5 (commonly referred
1	evidence at any
1	human drug applications,
1	roadside facility with
4	human drug applications.
1	agency, other than
1	human drug applications)
1	techniques are followed
2	person who created
1	lawful regulations issued
8	within ninety days
1	criteria website in
1	each. to the
2	eligibility determination by
1	notification submissions: 
1	(c) pharmacy of
1	(4) drug control
2	mortem inspection, reinspection
1	(f), (g), or
1	27, 1970 pursuant
1	sell, or trade,
1	facility (as such
1	provided the same
1	shall permit each
1	facility (as that
6	including the number
1	upon the earlier
1	area are having
1	physician has, with
1	warning or other
2	denies the request,
1	term counterfeit drug
1	either paper or
1	system by 
2	national library of
1	drug shortagesnot later
1	(11) the authority
1	purchasers of tobacco
1	(1) biosimilar development
1	studies, any meeting
1	agriculture sector coordinating
1	statutes and regulations.
1	research and studies
1	devices, if a
1	face is sufficiently
8	prevention and treatment
1	device user facility.
1	ensuring access to
1	deems necessary regarding
1	request submitted to
1	food in various
1	nothing in subsection
26	sponsor or applicant
1	(b) is marketed,
1	 (2) noncompliance
1	product it handles.
1	successor databases. 
1	allergens that are
1	18 years, including
1	unless an additional
1	evidence so taken
1	women that may
1	group can be
1	(2) schedule ii.
1	promulgated thereunder. 
1	one pound or
1	issued, allegedly occurred
2	shipper, carrier by
1	 (i) effective
1	regard to women;
2	event received by
1	term qualified indication
1	impair effectuating the
1	believes exposure to
1	(k) for a
11	administrator determines that
1	listed chemical can
1	transporting or causing
1	certain machines (a)
4	identify all illegitimate
2	(4) rule of
1	foreign country in
1	(2) under section
1	devices to measure
6	agreement entered into
1	cyclohexyl ring to
1	270 calendar days
1	domestic commerce and
1	reporting system and
2	years.  (2)
1	agreement to extend
1	specific technologies, practices,
1	products before reconstitution),
1	foreign material. (4)
1	manufacturer makes the
1	chapter of prohibiting
1	practice; prescriptionwith respect
52	title 21, code
1	(1); and (iv)
2	document titled nicotine
1	stability problems, emergencies
1	product and its
1	engaged in processing
1	exceed $75,000. 
1	site it operates,
1	groups.  (b)
1	human food offered
6	definition under subparagraph
1	secretary will carry
1	effect on health
1	secretary he may,
5	unauthorized disclosure of
1	action. (2) other
11	specified in section
1	performance bonds and
1	term carry over
1	section 360fff3(a) of
2	plan has been
2	legally marketed device,
2	use, is not
1	854. investment of
1	unlawful in the
1	drug, except where
1	(b) or (f)
1	shall first use
1	secretary shall as
1	(7 u.s.c. 71
1	evaluate its safety,
1	unless such state
1	fiscal year availability
2	secretary shall (a)
8	committee on appropriations
2	information act), and
1	(b) results of
1	criminal, administrative, legislative,
1	(b) to a
1	(f) wrongful distribution
3	another product that
2	public comment. 
1	education program means
1	et seq.] in
1	maintenance, repair, or
1	assessments  (a)
1	place to address
3	listing of all
1	title:  (1)
1	misleading container if
1	(b) in connection
1	eligible entity that
1	human health than
1	purpose. (3) in
1	subsection shall alter
1	annual compensation (excluding
1	tobacco, that contains
1	 (1) define
1	jurisdiction. (aug. 3,
2	355(a) of this
1	consistent and effective
3	part a of
1	eligible partnership to
1	year 2015, $566,000,000.
1	written requests the
1	issue guidance specifying
1	equivalent, within the
50	submitted under section
1	ceiling); and (iii)
1	commence such review
2	species verification and
1	(f) failure to
1	detection of residues
1	control techniques. 
2	administrative services, including
3	subparagraph (b) if
2	proposed sunscreen order,
1	repackaged drugs to
1	effective body drug
1	subparagraph (b) in
1	provide the notice
1	dehydration, or milling.
1	1, 2021, a
2	single document in
1	access the mechanisms
1	excess fees fees
2	taking an appeal
1	inspections; (e) the
1	leaf, including tobacco
3	(a) through (c)
1	period of at
1	seq.], or any
1	unwillingness to participate
1	additive (i) shall
1	sale, delivery, distribution,
4	written request within
1	drug products) which
9	(a) subject to
1	substances whether produced
1	disclosed to me.
2	fact, it has,
4	of, or to
1	used to treat
1	scientist, with the
1	registrant is manufacturing,
5	food, and any
4	shall prevent the
1	proposing to include
1	children and adults,
1	efforts, in order
1	shipped in bulk,
2	evidence consisting of
1	consumers from adverse
1	services under title
1	protocol is submitted,
1	 (b) distributors
1	added apr. 24,
1	experts and stakeholders,
3	statements or misrepresentations
1	permanently and irrevocably
1	application; factors; substantial
2	opportunity for written
3	liability at common
3	pack, or hold
1	upon an oral
1	interactions of regulated
3	becomes available at
1	manufacturers; (vi) the
1	preceding sentence. the
2	commercially marketed in
1	although guidance documents
1	order that such
1	necessary, in consultation
1	respect to devices
1	mediation and facilitation,
2	regulations or orders
1	regulatory question, consult
1	victims of a
1	year 2017. (h)
4	drugs.  (d)
1	construed to establish
1	may not establish,
1	final orders in
1	require a petition
2	chemical action within
1	goal of lon-term
1	incorporation.  (b)
1	27, 2013. in
1	ii, with reckless
1	senate, may not
3	(ii) provide the
1	(1) the promulgation
1	serious hazard to
10	fee equal to
1	(i); (v) information
1	(
 
 393a.
1	565a, as added
2	including whether the
1	authorized purchaser means
2	fee would present
1	recordkeeping, periodic testing
1	administrator based the
1	case of production
2	written agreement between
1	request that it
1	persons. any property
1	consultation the regulations
2	 (1) human
1	unmet needs; (b)
1	(ii) all supplement
1	(1) no acceptance
1	means a device,
1	ch. 675, 414,
1	list. for each
1	673 of this
1	homeland security; (c)
1	resin extracted from
4	regarding the drug
1	extension is committed
1	exposure to electronic
1	(a) the proceeds
1	nonprescription drugthe term
1	regarding disclosure of
1	nanotechnology, the effects
1	product.  (23)
1	(i) identifies and
1	require; (iv) information
1	site with easily
2	generic drug applications
1	employee shall request
2	chapter, and that
1	law or municipal
1	2012, and annually
1	one plus 
2	time of compounding,
1	campaign includes a
2	act), and shall
2	determined by applying
1	360g. judicial review
1	waiver. (3) assessment
1	(ii) furnishes a
1	record shall store
2	protected informationa serious
1	(n)(2)(b)(i) is received.
1	including the progress
1	company manufacturer, and
2	persons responsible for
1	later than 48
2	framework for review
2	that, on the
1	import, such as
2	clause (i) the
1	whose biosimilar biological
1	period, a summary
1	years, the request
1	(h) special registration
2	consumers will not
1	occurred within the
1	economic area (the
1	decision differs from
1	within such type;
1	applications.  (d)
1	subchapter ii for
1	section listing such
10	drug application for
1	drug in final
2	pediatric population may
1	employee having knowledge
1	49, and 50
3	intended for a
2	year 2014. (c)
1	ch. 675, 523,
1	public both in
1	prevent underage tobacco
1	may submit the
1	infections, including those
2	attainment of effective
10	offense has become
1	production of tobacco
1	indexed a drug
1	(8) advisory committee
1	wholesome meat act
1	laws; the disposition
1	include verification of
1	charged by the
1	instead of, or
1	experience, for each
1	resident of that
1	subsection (b)(2), clauses
1	conditions, or privileges
1	foodborne infectious agents,
3	purposes of investigating
1	675, 569b, as
1	affect  (a)
1	year 2018, $13,500,000;
2	logistics provider means
1	subsection. (ii) an
1	local activities 
2	formulation, the waiver
2	matter upon the
1	 (a) all
1	buying contractor the
1	critical path initiative
1	assistance.  (3)
1	proper name, as
1	testing industries, consumer
2	representatives, and to
1	situations the secretary
1	entity shall not
1	commenteach notice of
5	part 352 of
2	administration has carryover
2	subparagraph (a)(iii) for
1	studies, preclinical studies,
1	individuals, by regulation
2	thir-party auditor to
1	implementing that strategy;
1	sciences in which
2	qualifying medical relationship
1	approval as of
2	product code portions
1	regulation establish terms
1	states by limiting
2	which, or the
1	panels opinion regarding
1	accrued interest which
1	vessel, or aircraft
2	intentionally adulterated such
1	indirectly to retail
4	verificationbeginning not later
1	relevant fiscal year.
1	states, of an
1	fee is received.
1	human body; (2)
1	reduced feeswhere the
3	illegitimate product, which
1	testing and graduated
3	respond to such
1	persons distributing new
1	enumerated in this
1	part relied upon
2	requests such a
2	inspected  (i)
7	application of a
1	sponsor submits to
1	food will result
1	 (g) effect
1	punctured metal bowls;
1	authorized means 
1	business is located
1	 (h) notification
1	(2) identify demand
1	held, the secretary
1	today will contribute
1	written request 
3	salts of isomers,
1	device. (2) 
1	federal determination definedfor
1	goods into the
1	(i) the stage
1	past term a
1	follows the guidance
1	reduction basic and
1	advertisement knowing that
1	dietary need by
1	persons, as the
1	drugs as appropriate.
1	countermeasure as a
2	different from one
1	products that occur
1	committee or reverse
1	outbreak interviews. (c)
2	performed by a
1	locations, then such
1	included; (i) the
1	determined under subparagraph
1	regulations; (c) acknowledge
1	sponsor and that
1	education, prevention, treatment,
1	request identifies a
1	(2) program requirements
2	aug. 1, 1956,
2	filing, shall be
1	pediatric information as
1	recruitment for advisory
1	(j) does not
1	telemedicine during a
1	except that, with
1	(
 
 971.
3	represented as, a
1	whole of any
1	paragraph for inclusion
2	 (i) $652,709,000
1	-year periodthe initial
1	regarding product liability
1	provisions related to
1	assist them in
1	section, but shall
2	title, a person
1	identifying symbol for
3	determines is appropriate
2	drugs and devicesa
1	commence to prescribe
1	may require nominees
1	plan for taking
1	 (a) revise
1	available. the adjustment
20	information concerning the
2	repackager is a
1	special project grants
1	licensed or regulated
1	supplement; and (b)
1	(c) may, as
1	experience that 
2	(i) conviction reversal
1	prevention; (c) drug
1	agency using the
3	 (c) authorization
1	case involving the
1	year, and in
2	eggs than are
1	amendment, or clarification
1	379h1 of this
2	site under subsection
1	requirement which is
1	offense, and includes
1	drug be enrolled
1	information, as designated
1	(5) emerging drug
1	(1) each manufacturer
1	artificial intelligence; and
3	birth defect; or
1	similar authorities should
1	license, an applicant
1	(7) responsible person
1	debarment periods shall
2	selling, purchasing, or
1	beginning 3 months
3	costs for the
4	impracticable (because, for
2	387t(a) of this
1	(2) the order
1	quality and efficiency
2	percentage of each
1	 (3) make
1	 (2) designations
1	thereof; and 
1	 (2) scope
1	changed circumstances, so
1	request) submitted to
2	detention; duration; pending
1	word poison, and
1	(ii) higher than
1	determined causes a
1	parties. if no
1	(
 
 844.
8	known and potential
1	infection, in vitro
2	taken final agency
1	whose assistance is
2	schedules established by
3	furnishing raw materials
4	subsection, the attorney
1	manufacture, packaging, or
1	(ii) the investigator
1	provided under the
1	labeling, of a
1	proceedings, any information
1	provide for alternative
1	facility warehouse space
1	secretary requested a
2	58 stat. 714

1	(8) neutralizing costs
1	july 1, 2015,
1	use the term
1	jurisdiction (authorizing and
1	food, and an
1	appropriate, of a
2	devices, upon prescriptions
1	equivalent in design
1	shall review and,
1	sharing foodborne illness
1	shall publish an
1	forfeitures of property
1	identification of research
1	defects if any
4	june 1 of
3	registered by the
1	situational awareness capabilities
1	(a). (5) with
1	conventions to which
1	rate of $100
1	shall have actually
1	shall maintain electronically
1	date of not
1	confidentiality during eligibility
1	deposition and that
1	fails to conduct
2	drug action. (ii)
1	action with any
1	will be provided
1	specialties or has
5	motor vehicle or
2	reports for a
3	exempted from disclosure
1	successful consecutive tests.
1	shall run concurrently
1	within 6 months
1	methamphetamine or any
1	certain usesnotwithstanding paragraph
1	persons involved in
3	devices approved in
1	section; and (d)
1	registration in order
1	(1) limitation not
2	bioequivalence studies) with
1	subparagraph (c); (ii)
1	produce that food;
1	 (g) collection
1	individual, and whether
2	distributor may not
1	government to control
1	revoking a tobacco
2	official plants under
1	appointed and taken
1	manufacturing standards, or
1	(1) the clerk
1	may include pharmacokinetic
1	consumed by them
1	350l. mandatory recall
1	internet shall report
9	trade of a
1	program that uses
2	customers at restaurants
1	determine, within the
2	congressional committees. 
2	section at any
1	therapeutic effects of
1	state or locality
2	paragraph 8 of
1	knowledge and expertise
1	party may introduce
2	cost in the
1	provider in accordance
1	requiring the adoption
1	personnel regarding review
1	regulations implementing such
2	article from the
1	one per management
1	results of all
1	partner such that
1	obtain an appropriate
1	amounts appropriated as
1	ch. 61, 3(c),
1	benefit the public
1	(c) final decision
18	salts, isomers, and
1	(b) making widely
1	fourteen percent shall
2	general.  (g)
1	(2), where the
1	shall dismiss a
1	(1) additional information
1	task that the
2	second blank space,
1	pesticide is suspended
1	subsequent and additional
2	survey on drug
1	handled as to
1	application. such evaluation
2	$6,000,000 for fiscal
1	enforcement of laws
2	entity and qualified
1	(i) insofar as
1	ch. 530, 70
1	slaughtering any poultry
2	secretary, after due
1	general rule data
1	fact. (e) regulations
1	compliance with its
2	subsection (b); (2)
1	labeling.  (june
1	representatives, the committee
2	high potential for
1	title. any such
1	president may submit
2	subpena to serve
3	subchapter vii. 
1	level.  (2)
1	designation may from
1	general the provisions
2	list established under
1	receptacle or covering,
1	pesticide be modified
1	(b) procedurein promulgating
1	power and jurisdiction
81	officer or employee
1	including enhanced communication
1	listed under this
1	production, quality assurance,
1	products to diagnose,
1	application number; and
3	suitable and safe
2	involved, on the
1	360c(a) of this
1	(2) an audit
1	retention, segregation, and
1	deposited with, a
1	 (h) changes
1	term wholesaler means
1	42, or indexed
1	said section; (4)
3	(a) unlawful actsit
1	 (1) director
1	 (d) verification
1	title, under the
1	 (b) prehearing
1	subject to increased
2	involved.  (b)
1	360e(d), 360e(f), 360j(g),
1	food on which
1	surveillance and monitoring
3	submit an additional
1	distributor has an
1	manufacturer for purposes
1	 (g) dietary
2	college, junior college,
1	-(2,-dimethox--nitr-phenyl)ethanamine (2cn). (28)
1	(i) or (ii),
1	record is expunged
1	1056; 
 

18	generalnot later than
1	exceed two years)
1	substance is authorized
1	(a)(2) have ceased
1	upon receiving notice
1	(1) may, prior
2	maintain records of
1	product if it
2	identify recipients of
1	compliance with established
3	animal feed and
3	sponsor to use
1	member to which
1	stakeholders. (b) the
1	amounts for creative
2	application approval or
1	(i)definition of forfeiture
1	publications as a
1	name prominently printed
1	unlawful under the
1	prescribed are, in
1	coalitions, departments or
2	proceedings held in
1	felony; (4) make
1	treatment facility which
7	(3) if the
1	record, and report
1	secretary any money
1	leverage and enhance
1	451 to 453,
1	section 1543(a)(3) of
1	warranted, adopt appropriate
1	commenced. (ii) the
1	contaminant level for
1	best available medical
1	representatives that examines
2	review to the
4	provisions of subsections
1	conditioned that such
1	therein. in the
1	 (8) label
2	(i) under subparagraph
1	antibiotic drug means
1	paragraph are met,
1	consular officers; marking
1	
 
 398.
1	training in implementing
1	title as the
1	(g)  (a)
1	remediate.  (

1	secretary shall certify
1	duplicate the requirements
46	(2)  (a)
1	relating to online
1	scientific investigators in
4	not, by reason
1	attorney or agent,
1	show bioequivalence if
1	meeting its responsibilities
2	written description of
2	sampling or analytical
15	product is not
2	development of such
1	certain preparations and
4	transaction.  (b)
2	(1) effect of
1	misleading. in determining
23	360 of this
1	become effective as
1	become effective at
1	subdivision thereof, to
1	observational studies and
1	2680(k) of title
1	campaign.  (c)
2	secretary and based
3	anyone responsibly connected
4	status of any
1	(f) office to
1	protection agency. (ii)
1	obtained by multiplying
1	sticker or any
1	evidence which was
1	(a) requirement each
1	(1) is insufficient
2	deny accreditation to
1	income, the number
1	june 30, 1973;
1	5. (m) patent
5	obligation for such
1	application provide a
1	thereafter by or
1	
 802. definitionsas
1	 (d) manufacturers
1	records. (g) no
1	1949, ch. 696,
1	developing processes and
1	populations, and for
1	effective dates were
1	register modify or
1	sanitation or by
1	conditions regarding riskfor
2	device is misbranded
1	(a) determination of
3	agriculture or food
18	27, 2007, the
2	hazard to health.
2	undertaking in connection
1	package; (ii) the
6	containing a new
1	(c) provide that
1	thereto; conditions for
1	transmit timely notice
1	vulnerabilities (including short
4	farm to school
1	hearing the parties
1	132. transferred
 

1	means somatrem, somatropin,
1	uses for drugs
3	prescribed or authorized
1	secretary that 
1	will trigger responses
1	website with respect
1	regarding the appointment
2	product means each
1	demonstrable progress in
1	projects, in coordination
1	reprocessing all poultry
1	systems and other
1	physical lock or
1	distribution before december
1	substance, and of
1	owns the product.
7	subsection (c); or
1	company records kept
3	debarment under subsection
1	reoffering the article
1	diseases; (4) build
1	(xii) a general
1	within that state
2	level during the
2	device user fee
1	clinical data submitted
1	person may conduct
1	(iii) an application
1	reclassifying another device
1	new means of
1	secretary followed or
3	accreditation body (or,
2	importers and exporters
1	beyond the number
1	sufficient to determine
1	reasonably incurred, as
1	federal property shall
2	state law; and
1	register and made
1	(e) exports 
1	 (4) national
1	providing overall direction
1	intrastate cannot be
1	phencyclidine. (8) sulfondiethylmethane.
2	submitted a federal
1	animals for use
1	3 years thereafter.
1	establish appropriate conditions
1	unhealthful, unwholesome, adulterated,
1	purpose a post
1	somniferum l., except
6	leaves from which
1	(2) are met
1	failure to exhaust
2	distributing of adulterated,
1	(c) definition of
2	immediately prior to
1	350b. new dietary
2	(b) the notice
2	relating to narcotic
1	diligently prosecuting a
1	(d)(3) of such
1	1034(e) of this
2	fee has been
1	(d) contemporary research
3	amount, and appropriateness
1	carriage in the
4	shall, after entry
11	(c) if the
1	regulated person. 
1	ch. 155, 7,
1	awarded to the
1	(o) registration statement
1	change.  (2)
1	(a)(1); and (ii)
1	(7) isomethadone. (8)
1	seven hundred and
1	microorganisms that leads
2	hearing, and shall
1	refusal to allow
1	cas-b-case basis under
1	1937; or 
2	thereof; or (3)
1	residue; (iii) data
4	involving  (a)
2	substance or is
1	chapter, while attending
1	including purchases, transfers,
1	implement, machine, contrivance,
1	(b) acceptance factors;
1	safety program, system,
1	available, the strength
15	section 360bb of
1	register; (b) providing
1	x.c and ix.e.4
2	law or section
1	d-stems, dries, and
1	coalition shall meet
1	(j) other labeling
1	national food safety
7	information regarding the
10	products  (1)
1	implement all or
6	alters or amends
1	eligible lon-term care
1	use, transfer, withdrawal,
1	
 360i. records
1	lawful disclosure for
1	prescription. such order
1	(b) the identification
1	article received in
2	take reasonable samples
1	listed drug from
1	report, with respect
7	head of a
1	occurrence of 2
1	general shall assure
1	primary data tabulations
1	(1) intelligence notwithstanding
1	paragraph (2) information
1	capabilities of each
1	clandestine laboratory sitesthe
1	notified. (2) any
2	agreement between such
1	submitted by reason
1	(g) regenerative advanced
1	(b) secretary of
1	made on resolving
1	15, on the
1	substances, listed chemicals,
12	(1) in generalnot
3	(e) or section
1	public health concern,
1	manufacturing supplemental abbreviated
1	 (i) pose
2	(including, for an
1	2013, $505,000,000. (f)
8	exempt from disclosure
2	anaphylaxis in schools
1	investigational drugs or
1	subsection (b)(2) are
2	relationship, as defined
1	pertaining to food
1	(d) serving past
1	section 360c(i) of
1	population and dosages
3	welfare of consumers
1	program, using appropriate
1	pay  (a)
1	security, under subsection
1	published regarding the
1	substances and shall
2	medications for the
2	aside of his
2	protect the rights,
1	natural resource conservation,
6	consultationin developing recommendations
1	involved intends to
1	product, that may
1	application, unless 
1	repayment program established
1	secretary a classification
1	market clearance includes
1	time the manufacturer
1	planned and designed
1	20.  (3)
2	interest (as defined
1	
 379c. transferred

1	conduct such audits
1	(8) prohibition on
1	(6) united states
1	per day. 
1	writing, to such
1	sensitive information the
4	studies  (1)
2	academic, and private
1	serve on the
1	suppression, u-regulation, or
1	(d) other trac-an-trace
1	search the database
1	eligibility for indexing
1	necessary.  (2)
1	transaction for two
1	set forth elsewhere
1	regulated persons guidance
1	cake made from
1	applicant should submit
1	source for such
3	guidance under subparagraph
1	(2) issue a
2	records access by
5	one member shall
3	additional evidence (and
1	feed directive drugs
1	part 201 and
1	treatment, unless the
1	section 360e(g)(1) or
1	955d. transferred
 

2	carcasses, of cattle,
1	costs. (d) testing
1	omitted in the
1	award grants to,
1	serving colored oleomargarine
1	court. the court
2	(b) the public
2	except for those
1	360i(e) or 360i(g)
1	administrative provisions 
1	(c) capability for
3	distributor required to
1	representatives  (1)
2	unfitness based upon
6	(3) for the
2	judicial review; other
1	required.  (june
3	information regarding a
1	fee) shall be
1	u.s.c. 355a], any
1	general documentation certifying
1	formulas which are
1	facility identifier (which
10	poultry and poultry
1	18-day period, whether
1	tobacco product published
2	inspector, or other
3	application shall notify
1	may help mitigate
1	requirementsthe secretary, in
2	including under this
1	regulation, changes in
1	379aa1, 387i, or
1	cure; (b) the
1	subparagraphs (d) and
1	carcasses and marking
1	(f) providing educational
4	acting for or
1	151. preparation and
1	product, if the
1	first applicant withdraws
1	feed directive drug,
1	feed directive drug.
2	evaluation and research).
1	order (required by
5	standards prescribed pursuant
2	determination in writing.
1	buyer and seller
3	revoking an approved
2	ingredients in the
1	epidemiology; and (4)
1	(ix) safety factors
1	[21 u.s.c. 451
1	barrier must be
1	acts or practices
6	requirements that the
6	proposed rulemaking for
1	(may 29, 1884,
1	chapter. (t) the
1	based his regulation
3	secretary as is
1	affairsthe term state,
4	(9) if it
2	subchapter, and the
1	subsection (c)(2) 
1	348, 350a, 350c,
1	regulation of slaughtering
1	phenylpropanolamine for use
2	developing and maintaining
1	community.  (c)
4	1 of such
1	provide.  (4)
1	regulations), unless the
1	 (b) vacating
1	reach a verdict
3	product identifier (except
2	review team to
2	use; and (iii)
1	(1)(b) and (2);
1	outpatient treatment facility
3	foregoing subsections of
1	(which final regulation
1	participate in complementary
1	products in accordance
1	unless controlled after
1	remains a substantial
1	posting the notification
1	salts. (i) phenylpropanolamine,
1	person for advisory
1	holiday defined the
2	clinical and scientific
1	ii authorities; cooperation
6	responsible person to
1	receipt. (c) nothing
1	(c) in consultation
2	letter of authorization
1	ii; or (c)
1	budget requests a
1	394. scientific review
2	enhance the ability
1	aids drug development
1	writing that states
1	controlled substance; listed
3	manufactured or assembled
1	(k) food containing
1	employee would have
1	reviewed; (ii) all
1	(d) board of
1	(2); (6) release
2	will be unlawfully
1	moving defendant may
1	term expiration date
1	program; (3) may
3	period of public
1	developed nations and
1	states is increasing
1	g).c d (iu)
1	18. (b) statement
1	secretary may request,
41	false or misleading
3	 (1) scientific
1	ascertain any use
2	upon petition to
4	manufactured in a
1	medical products, changes
4	common or contract
3	thirty days unless
1	(c)) at which
1	animal drug. such
2	conditions concerning recordkeeping
1	(i) notice if
1	petitions, notifications, and
2	inspector, and the
2	use; (7) if
1	develop and advocate
1	possession, exposure to,
4	shall have jurisdiction,
1	condition of approval,
1	conditional approval, and
1	fiscal year when
41	sentenced to a
1	imports of controlled
2	purpose of seeking
1	responsible to an
1	may in any
1	(4) proposed sunscreen
1	prescription compounded or
1	food safety provisions
2	recordkeeping requirements; persons
5	term eligible entity
1	title iv, 408,
1	tolerance or to
1	detection capabilities by
1	impose standards for
1	records for not
1	who, because of
1	2012, or that
2	security of united
31	secretary with respect
1	ascertaining whether or
2	general if a
1	
 968. service
1	designation by secretary
1	development protocol approved
1	cost, of such
1	containing such substance,
1	(d)(2), the secretary
2	potassium) or calories
3	use by an
1	confirmatory evidence (obtained
1	360ccc1(e)(2) of this
1	keep confidential. 
1	contents; patent information;
1	1992), a misdemeanor
1	printed in type
1	domiciled or subject
1	(e) revised policy
8	(9) the term
1	importing ephedrine, pseudoephedrine,
2	personall-identifiable informationnotwithstanding any
1	together with proof
1	completion dates for
3	recommendation, if any,
1	chairman.  (3)
6	every 3 years
1	advisory meeting, regarding
2	agency, shall be
1	title. no advertisement
2	information not in
1	industries and labor
1	instructions  (a)
1	deem necessary shall
1	services (in this
1	amended such regulations.
1	administrator shall promulgate
1	ch. 675, 916,
1	patent extensions other
2	chemical residue. 
3	(iii) to the
1	submissions. the adjustment
4	section, including the
1	exist or does
3	used in schedule
1	immediate container does
1	proviso to suspend
1	(d) record maintenance
1	
 360dd. open
1	regulate drugs made
6	drug under the
1	removal, as the
1	sheepmeat, and sheepmeat
1	respect to compensation,
1	used for drug
1	provisions for refusal
1	board a vessel,
2	development and deployment
1	import, which period
1	(1)(a) shall be
1	represented to possess.
1	sections for distribution
1	appropriate, the review
1	(1) responsible party
3	460 of this
1	lead for the
1	period for disposition
1	issues.  (b)
6	offset the number
1	business. (5) no
1	person either waived
2	represented to possess;
1	conducting interoperable, electronic
1	prior to shipping
1	section 354 of
1	concerning the enforcement
1	representatives of patient,
2	grounds for refusing
1	methodology. no standard
1	 (b) partial
1	stream, river, or
55	effective date of
1	illness, disease, or
2	denial specified in
1	ionizing radiation; 
9	ingredient) of which
1	regulations) any nonprescription
1	general controlling a
2	suppliers of raw
7	amounts  (1)
3	make any false
2	forth the reasons
4	proper expenses, shall
3	stat. 832; 

1	removes foreign material
1	(d) reviewing and
1	pose the greatest
4	determination.  (iii)
1	compendium shall be
1	products).  (3)
1	3431. national uniform
1	egg products, not
1	exist. the secretary
1	sums received by
1	general by or
1	(a) petitionany person
1	demonstrates the potential
1	ineligible for program
1	however, that this
1	intravenously injected drug;
2	control notice issued
1	carcasses, of poultry,
2	general.  the
9	section  (a)
1	deems appropriate, demonstrating
1	export an imported
1	(2), including records
1	since the risk
1	derived either from
1	action carried out
2	grants, or other
4	meaning given to
1	387k(a) of this
1	(i)review of contract
1	may waive requirements
1	 (g) exclusion
1	assembling, or importing
1	format specified by
6	(e) after consideration
1	term premarket report
1	exercisable by, or
1	point from the
15	testing and reporting
1	sunscreen order. (3)
1	regulations for goods
2	population.  (4)
1	
 333a. repealed.
1	(or such entitys
6	cooperate in expediting
1	 (b) powers
1	of, the transaction
1	 (aa) completed
1	paragraph occurring in
1	receiving accreditation, pursuant
1	chapter or by
3	administration to an
1	section 343(h)(1) of
1	379j41. definitionsfor purposes
1	discontinuance, and (2)
1	consultative auditthe term
1	
 360bbb8a. optimizing
2	(aug. 30, 1890,
1	appropriate, and may
1	growing, or harvesting
1	establishment or may
1	title. (rr) 
1	country, if 
1	drug was compounded;
1	american people. (3)
1	nicotine patches, nicotine
1	activities of coalitions
1	agencies on a
1	paragraph. (2) if
1	residue than is
25	supplement to an
2	preparation containing opium,
1	resources. (5) adverse
1	manufacture, the possession,
1	director, acting through
3	minimum united states
1	(2) the conditions
1	whether incentives are
2	programs and strategies
1	(k) importation by
1	thereafter  (1)
1	(a) contain a
5	person knowingly or
1	regulation prescribe. if
4	imprisonment and if
1	order, license, instruction,
5	regulations as may
1	foundation, may provide
2	shipped directly from
1	125, or any
1	list of products
1	 (i) approving
1	new use of
2	inspected, and passed
1	involved, and the
1	1996; (ii) violates
1	receives the notice,
1	subsection (b)(2)(b), subsection
1	product into conformity
1	age of the
1	health, due to,
1	strategy.  (8)
1	purpose the advisory
2	delivery devices under
1	food establishment that
1	may deny, that
2	standards should be
2	meat, and meat
1	reasonably be concluded
1	30, 1961. (32)
2	carcass or any
2	recall.  (b)
1	wildlife conservation, and
3	possess a controlled
1	court unless such
1	rules may be
4	element of such
1	shall, whenever he
1	coalition receives information,
2	senate, the committee
1	administration to any
1	collecting fees and
2	alleging that the
1	contracting with a
1	food regulatory agencies,
1	2003, except that
1	specification, software, color
2	subsection limits the
3	conditions of any
2	secretary are permitted.
1	(c) personal slaughtering;
1	transfer  (i)
2	concerning the product
1	appropriate investigation by
1	 (ii) excess
1	classified annex. (4)
2	condemned carcass or
4	1940 reorg. plan
2	highest rate of
1	placed in effect,
1	natural causes or
1	charged. (d) the
5	(b)  (1)
1	quota, the attorney
1	based.  (5)
1	part, the petition.
1	identify certain trends
2	drug. nothing in
1	recommending improvements to
45	pensions of the
1	fee a person
1	(d) affect of
1	 (k) research
1	decision to the
1	tobacco product (or
1	dispenser makes the
1	includes any parking
1	intended for transfusion,
1	expert stakeholders, of
1	(1) coordination of
1	design, specification, software,
1	packed and the
1	drug shortages, how
1	(viii) information submitted
3	designed for use
1	intended for transfusion;
1	proposed regulation made
1	interest as determined
7	procedures set forth
1	tracking of assessments
2	1994 (public law
1	president any of
2	lo-acid canned food
8	subsection not later
2	distributor or dealer
1	margarine without clear
1	general the adjustment
1	(c) internet pharmacy
1	product, in the
4	standards applicable to
1	drug. (cc)substantially complete
1	actually incurred by
1	may request, and
1	exemptions; authorities under
1	testing expenses and
1	year 2007. (

1	contact substance has
1	proceeding is based
1	order, make or
1	look to standards
1	1976, declared to
1	 (2) agreements
1	animal drug, except
1	issue of fact.
1	products (a) definitionsin
1	year quarters, or
1	drug product, (b)
1	 (d) office
1	standard means a
2	investigation relating to
1	n-tobacc-sale order is
2	regulationsnot later than
1	implementing comprehensive, lon-term
1	august 22, 1996
1	including the european
5	determine, or facilitate
1	(b) suture materials
1	products approved by
8	9, 2012. 
1	specific animal drug
1	water or make
4	specify, a statement
1	device which, effective
1	storage, or transportation
1	show area of
2	drug included on
1	(4) benefit to
3	title and may
1	label shall not
1	licensed physician receiving
7	paragraphs (3) and
1	(7) nonprofit organization
8	including with respect
1	tobacco product; (b)
1	companies with products
1	application, and treatment
2	adverse health effects
1	secretary deems appropriate.
1	finished on a
6	reduced to offset
2	litigation resulting from
3	fiscal year, such
1	 (2) submit
1	submissions on or
2	protected by assuring
1	discussions shall not
1	testimony concerning its
1	title, clause (iii)
1	agricultural commodities (other
1	exist; or (ii)
1	transmitted in accordance
2	sales, in an
3	except upon the
1	studies. minutes of
1	including the quantity
1	related manufacturer meeting
1	ineffective  (1)
1	dru-free workplace programs;
1	decision, (ii) the
2	title 5 
1	engaged in interstate
1	testing device means
4	substance for which
1	several such principal
1	certification and filing
1	reasonable times. (3)
2	used, or disposed
1	funds in an
1	stating in writing
1	must act on
2	time to time,
1	determines  (a)
2	actions should be
1	
 360bbb8. consultation
1	human health to
1	appeal from an
1	advances in nutrition
3	perform the duties
2	services and as
1	approval process with
1	awarded by the
1	establishment, including whether
1	terminated, or otherwise
2	forge any official
2	742, as added
1	limitation to carry
2	notice transmitted pursuant
1	met. (ii) the
1	appropriate to improve
1	2015, $1,857,000 for
1	recall under any
3	(iii) a color
5	section 360eee(16)(a) of
1	additional basis for
2	certification in addiction
1	enhance the security
1	proposes to amend
1	
 
 360ee.
1	store or pharmacy,
1	current effortsthe attorney
1	partner with professional
1	body to meet
1	 (10) manufacturerthe
1	(h) offenses involving
1	plan for use
2	year, he may
1	enacted a mandatory
1	additives.  (b)
1	sale, or distribution
1	year by which
1	(3) is designed
1	reinstate a registration
1	laws of foreign
1	whether any measures
2	commission on foreign
1	certification requested under
1	poultry products produced
1	states for any
1	basis thereof and
2	program at issue
2	(a) in generalnotwithstanding
1	must recite basis
1	determination before the
1	met) is a
1	science research and
2	prejudice) for a
4	determination and such
1	import, submit to
1	may introduce evidence.
1	 (d) compensation;
1	subsection (a)(1). (c)
1	makes the findings
2	penalties under section
1	conformity with subchapter
1	show that there
1	(5) controlled substances
1	section 841(a)[1] of
1	clinical trials; (5)
1	standards, (2) with
1	notifications in consultation
1	substances as he
1	information clearinghouse. 
1	consistent with other
1	reports any statement,
2	requirements under the
1	dates of these
1	regulations prescribe. 
4	384a of this
3	data bases. (iv)
2	tableting machine, encapsulating
1	dispute.  (f)
2	animal drug 
1	recognition of foreign
1	identity to the
1	time such manufacturer
1	causes or to
4	additive, or dietary
1	section. (g) partnerships
1	normal biologic processes,
1	unless otherwise ordered
1	category of drugs
1	(19) specific patient
1	containers, or both,
1	paymentthe fee required
4	development or approval
4	submit a registration
1	 (c) limitationthe
2	vthe attorney general
1	securing the borders
1	(2) a wholesale
1	panel, including, subject
3	means any symbol
12	dying, disabled, or
1	formerly 15th par.,
3	shall be updated
1	summary.  (d)
1	reform; and (2)
3	reductions, or refunds
2	use under specified
1	appropriate delta values
1	poultry products sold
1	made, to any
3	transmit to congress
6	tag, or label
1	adverse health consequence
1	(a)(1)(a) of this
1	for, or in
4	title) that is
1	notification is necessary
1	higher education, entities
1	device, he shall
1	manner designed to
1	construction with respect
1	practice of such
1	(d) revise the
1	upon information from
1	31. (g) written
1	drugs, any of
2	subsection (b)(2)(b) or
1	promising compounds; (iii)
1	administrative purposes, on
1	requirements, including as
45	accordance with paragraph
1	proceeds. (
 

1	 (3) multiple
1	be.  (p)
1	food establishments; nonprofit
1	schedule under part
1	monitoring systems to
1	comply, and a
3	list published under
1	analysis; (ii) provide
1	effective audit. (2)
1	amount, frequency, method,
1	operators every person
1	food intended for
2	used in animals
1	exist.  (c)
1	animal. (v) the
1	27, 2007, publish
1	predictability, and productivity
7	paragraph (6) or
1	previously compiled data
1	regard to drugs
1	regarding imported food
2	motion to dismissthe
1	shall be returned
1	circumstance; and (17)
1	individual retail stores,
2	general upon a
3	licensed under such
5	well as the
1	term susceptibility test
1	 (d) commissioner
1	remove drugs and
1	section 811(a) of
2	studied, and the
1	meet international standards
2	fee is required
1	without the change;
3	general shall determine
1	year. (h) definitionsfor
1	labeling pertaining to
2	protocol consistent with
2	solely within such
1	subchapter v of
1	(d) supporting coordinated
1	approved drug 
5	importation or exportation
1	importer, exporter, manufacturer,
2	exempt a warehous-based
1	(2) generic new
1	release unless the
1	(ii) the small
1	which, the product
4	1002(a), 
 

1	official plant in
1	drug dispensed by
1	requirements regarding nonliquid
15	used in, or
1	attorney general); or
2	food for animals
1	duty of every
1	postmarket drug risks.
1	employee making an
1	previous year. (e)
3	grants to appropriate
1	shall automate appropriate
1	(3) as used
1	ch. 675, 1005,
1	notice of terminationthe
1	services shall 
1	obtained such substance
1	official plant is
1	made, or is
2	shipped in a
1	exemption without providing
3	summaries of the
151	 (june 25,
1	equal to not
1	identifier may occur
17	total number of
1	required and shall
1	campaign with advance
3	appropriate.  (g)
1	interstate commerce, for
2	ingredients which are
2	 (a) coordinating
2	form or size,
1	title. (f) definitionsin
2	relating to experience,
1	fourteen years of
10	 (a) provide
3	including any regulations
1	determines an extension
1	stakeholders on the
1	justice seizing drugs,
1	account international trade
1	account the risks
1	felony, and (2)
2	direct through a
1	relabels a product
1	(2), coordinate foundation
2	defendant is a
13	appropriations act providing
1	federal law other
1	paragraph (3), accredit
1	distributor  (i)
1	application for other
2	(a) the circumstances
1	(e) evaluation of
1	committee (a) united
2	administration, a report
1	secretary (a) requirementeach
1	(2) transportation the
2	document the scientific
1	the[1] chapter or
6	requirements within the
2	evaluate the potential
1	recruitment activitiesthe recruitment
1	postal service or
1	public interest; and
9	use in or
1	evaluation a grant
1	(a) new animal
1	commence surveillance under
1	burdensome requirements; (b)
1	postapproval study, including
1	pediatric studies are
1	device on growth
2	(c) deputy director
16	negotiations with the
1	streamlined hiring authority
2	section 383(b) of
1	comments and any
10	 (b) a
1	(4) advisory committees
1	spots, a large
1	subchapter to any
1	387e(c), 387e(d), or
1	controls may expedite
3	safety.  (b)
1	pay established pursuant
1	sel-administration of medication
8	and, if the
2	considered adulterated within
1	provides a specific
3	chemical with respect
1	point, step, or
1	fiscal year) is
1	section 352, 360,
1	(8) for purposes
1	activities in excess
1	columbia; or (c)
1	notice. (4) 
11	review  (1)
1	production, processing, shipping,
1	145, 1 [part],
1	entity, to introduce
5	storage and handling
1	committees currently informed
1	 (i) have
1	demonstrated that youths
2	issued under that
2	feasible, inconsistency between
1	(a) tol-free number
2	otherwise unable to
1	53 of title
1	contain advertising. notwithstanding
1	address those threats.
1	section. such appeal
1	(a) the methods
1	reevaluate accreditation bodies
1	paragraph (4); by
1	person to trade
1	statistically significant, provides
1	economic hardship, which
1	(c) best practices
2	reimbursement. such provisions
1	(i) address the
1	foreign recipient to
1	report was submitted
5	enactment of the
1	310.305 of title
1	(a) in generalfailure
1	physical, physiological, pathological,
1	period under this
1	models  (1)
3	subject to provisions
1	shall be done
1	(iii) where based
2	frivolous. if the
1	foreign facilities. 
1	finds under subsection
1	(d) finality of
1	42), security countermeasures
1	device that such
1	trip wires or
1	food for use
1	upon request. paragraphs
1	plants. sums received
1	data, gathered using
1	sites maintained by
1	secretary (1) work
1	matter.  (june
1	review if, 31
2	written notification to
1	antimicrobial resistance) and
1	standard is necessary
2	health hazards from
1	treasury shall provide
2	(1) shall include,
1	offer to import
2	health benefits posed
1	(h) based on
1	fellowships  (1)
1	may testify and
1	title) of the
4	(d), or (e)
2	applications filed per
1	chapter. (b) eligible
1	human beings. nothing
1	(16) morphin--oxide. (17)
1	laboratory network of
3	health; (5) if
2	name has been
2	package shall be
2	control policy who
5	issue such order
1	drug has a
1	207. restrictions on
1	descriptive and explanatory
1	recommendations, the secretary
1	hold such hearings,
1	administration a commissioner
1	facility the provisions
7	identity of each
1	state upon development
1	apply the provisions
1	protein (gm) 1.8b
1	administrator would afford
1	identity may be
1	subchapter. it includes
1	abuse of other
1	homeland securitynot later
1	title, as he
3	advertising which the
1	(a) bear the
1	issue public notice
2	states person, or
4	title (other than
1	partnerships between public
1	(15) $129,000,000 for
1	safety of pet
1	concerning the sanitary
6	secretary issues a
2	(i) a device
2	auditor accredited by
1	advertising thereof or
1	1996. in conducting
4	offered or received
1	title; such a
1	(a)(1); or (2)
1	stat. 517.)
 

1	studies and surveillance
1	predominant number of
1	
 
 360ii.
1	
 885. burden
1	government entities), and
1	phenylpropanolamine was sent.
1	verify the effectiveness
2	(b) application; antibiotic
1	timeframe for such
1	section 379j(a) of
1	imprisonment imposed on
7	statement for the
2	within the exclusive
1	longer necessary to
1	(c) communication strategies
1	milk and/or cream:
2	access to all
1	generate fee revenue
1	virgin islands, american
1	device may also
2	priority under section
1	calendar year in
1	wake island, midway
1	 (e) trade
1	statement prescribed by
1	violation of tobacco
1	calendar year if
1	dispenser transfers ownership
1	notification (referred to
1	targeted drugs and
1	securing the drug
1	cooperative, or any
1	amphetamine. (3) 3,4,-trimethoxy
1	drug application, (2)
1	2012. the secretary
1	established under which
2	sodium, chloride, and
1	section upon the
1	submissions described under
1	provide for appropriate
1	drug from such
5	exempted from the
1	letter, or any
1	extent such tribe
1	(b) reports to
1	secretarys action; and
1	certain civil actions
1	necessary each year
1	professional personnel (a)
1	may obtain devices
12	subject to clause
3	contract or memorandum
1	employee shall abide
1	general a facility
1	estimates of funds
1	-year base period
1	drug control means
1	location of one
2	present their views
1	commingled ingredients that
1	combination with another
1	right to review
1	commerce, in the
1	engages in an
7	years after july
1	(ii) if there
2	new indication, new
1	691[1] of this
1	adul-written publications which
1	include, in lieu
1	(w) deadline for
1	carrying into effect
1	slaughter any poultry
4	official device or
1	including print or
2	-month exclusivity period
2	 (b) does
1	delay in shipping
1	insured or guaranteed
1	violation shall, except
1	physician an investigational
5	product  (1)
1	issue and serve
1	application, and that
1	web site is
1	ch. 675, 564,
1	previous application has
1	schedule an i-person
1	periodically request information
1	(i) prohibit the
1	animal; provided that
1	agent, to obtain
1	osteopathic association. (iv)
2	measurement of electronic
1	public hearing, the
1	registry, acting under
1	including efforts to
1	news media outreach,
1	establish, and periodically
1	required for reinstatement
1	discloses individually identifiable
5	federal law enforcement
2	any, contained in
1	compensation of the
1	factors for infant
1	cream, transported into
7	licensed under section
1	case less than
1	lysergic acid diethylamide;
2	hereinafter prescribed to
3	engage in transactions
1	(2) submitted by
1	387d or 387h
3	recommended controls under
6	identified pursuant to
1	(i) certification of
2	applications. (f) postmarket
1	means (1) in
1	another registrant or
1	(ii) a product
1	(1) a report
1	food has not
1	manufacturer affecting production.
1	dealers is the
1	likely for products
4	 (3) use
19	adulterated under section
1	grants, examining addiction
1	date.  (5)
2	to, and the
1	new and emerging
1	share access to
5	specific suggestions for
2	individuals for scientific,
3	applications (including increases
1	chemical preservatives shall
2	regulation which requires
3	may initiate the
5	secretary has made
1	december 15, 1967.
1	entity has experienced
1	(ii), unless the
2	falsely purports or
1	28. for purposes
1	studies that are
1	causing such articles
2	practitioners of medicine,
2	registration has been
1	development or deployment
1	conductthe secretary may
1	water standards; publication
1	least 3 different
2	(6) for purposes
1	debarred persons 
1	nations regarding methods
1	en-userthe term qualified
1	applied, the president
1	classified, and (2)
1	(2)(c);  (e)
1	officer in the
1	states pharmacopoeia. 
1	(1), if imported
1	fees of its
1	contact surface; or
1	users placed on
1	 (e) anabolic
1	deems necessary. data
1	local drug threats
1	product advertising; (ii)
1	except that, for
1	basis. (12) the
1	(f) product development
1	fee amendments act
1	action, or who
1	(d) the terms
1	nature of guidelines
1	red ink. (mar.
1	which, if supported
1	review prior to
1	revocation appropriate to
1	time period to
1	(h)), in any
1	document agreement on
1	use not more
2	accredited by such
1	product development. (7)
3	pleasure of the
1	agency, if 
1	 (c) penalties
1	certain customers in
1	343(d), 343(e), 343(f),
1	 (d) exceptions
2	march 21, 1972,
3	requests  (i)
1	subject to radiation.
1	drugs under chapter
1	198. repealed. 

1	attempted to induce
1	milk. (mar. 4,
1	(b)(1) for particular
3	voucher of an
1	dutiesthe commission shall
1	fees in establishing
1	communication of feedback
1	following action: 
1	prejudice the action
1	(2) noncompliance if
3	approval supplements with
2	industry of the
2	including trial design,
1	(b) partial waiveron
2	subsection (c), as
1	stat. 649; 

1	drugs may (1)
4	trading partners beginning
1	allow the outlet,
9	shall, except as
1	(i) in offering
1	excluded pursuant to
3	shall only be
1	laboratory facility (a)
1	responsible person, the
3	requests the use
1	secretary proposes, in
2	safety information and
1	secretary on petitions
1	(b) voluntary participation
2	variances  (a)
1	policy and their
1	programin carrying out
1	official is able
2	taken by such
1	(a)(1)(a) for a
3	federal agencies with
1	appropriate to demonstrate
1	 (q) certifications
4	prior to september
1	finds materially participated
2	trials conducted under
1	growth and development,
4	appointed for that
1	food may, by
1	drink for man
1	chapter:  (a)
1	issuing or revising
1	coordination with fifra
1	tariff act of
3	conditions of its
1	1, 2012, established
6	purposes of any
1	various sun protection
1	
 
 379d3a.
1	necessary:  (a)
2	address, the name
4	applicant involved is
2	animal drug was
1	(a) applies shall
1	activity, as the
1	subsection (k)(2); and
1	coordinate and consolidate
1	subchapter, is authorized
1	subchapter and that
1	based, and (2)
4	engage in business
4	processed lo-acid foods
1	application, including any
1	 (v) transition
1	columbia.  (b)
1	ingredients or finished
1	considered the work
1	potency described in
1	(i) is misbranded
1	predicate device for
5	utilize the product
1	service of process
1	subsection (a) each
1	regulations issued to
1	identify at the
1	protocol have been
2	respecting the methods
1	675, 307, as
1	scheduled audits required
1	request.  (e)
1	(c)(3), (d), (e),
1	 (5) vessel
1	greater of (a)
1	areas of expertise
4	special dietary use
1	information; or (5)
1	navigation and which
1	continued presence in
2	licensing regulations under
1	industry, which position
1	preventive controls (a)
1	(2), the revenue
1	licensing boards and
1	forfeiture invalid in
1	records and every
1	 (4) activities
1	plan will not
1	resources needed to
1	(c) definitionsfor purposes
2	units of the
2	setting fees for
3	(i) in any
1	4 years. (e)
1	section, including 
7	unless  (1)
2	of, the transaction,
1	property which may
1	 (b) revocation
1	equivalence of an
1	(3) person for
1	date of delivery,
1	rules of the
3	small or patients
1	standing; or (ii)
1	efforts by a
1	allowable previously paid
1	original or other
5	term biosimilar biological
1	agencies, and establish
1	processes may include
2	prepare an inspection
1	kilocalories.  bthe
2	interest in such
1	(a) or (e)
1	disposition of certain
1	rejection. reasons for
1	data or full
3	proposed order and
1	populations, if such
1	 (b) programin
4	administrator  (a)
3	paragraph (1)(a) to
1	improve patient quality
1	party as provided
1	generalif the responsible
1	data obtained as
2	prior to june
1	interest assessed under
1	(including any person
2	conducting the hearing,
1	area and outside
2	whether a particular
1	(3) maintain liaison
1	property is outside
1	amount of appropriated
1	notice requests a
2	juice hazard analysis
3	containers or wrappers,
2	connection with business;
2	later than august
1	request. not later
1	appropriated $25,000,000 for
12	price index for
2	10 years, but
1	citizen or registered
1	conclude that pediatric
4	 (2) public
1	trends, adverse event
54	federal or state
4	extent required and
5	 (i) within
3	section 355(o) of
1	(vi) sole discretion
1	product; (iii) validating
2	regulations to require
2	health, including the
1	(1) good manufacturing
1	designation of gamma
3	bears labeling stating
1	importation within the
1	compounded from a
1	(2) a proposed
3	agreement with a
1	relation to trade
1	(
 
 1043.
1	distribution of product
1	purchase laboratory testing
1	safety and compliance
1	recommendations or assessments
1	prioritization of qualification
2	following periods: 
5	provide the person
1	(e) payments; advances;
8	secretary the name
1	carriers, except as
3	twent-one years of
2	advisory committee and,
8	tracking and tracing
1	disapproves a plan,
2	consist of any
2	may be expended
1	publications that are
1	practicable to ensure
4	illegitimate product subject
8	forfeited to the
1	subsection (j) does
1	site other than
1	may be grounds
1	wholesome, sanitary, and
1	applicant subject to
1	director for 
1	debar  (a)
2	drugs permitted to
1	chapter 33 of
3	(h) definitionsfor purposes
1	1.  (ii)
1	states, with the
1	date set by
1	multiple facilities, one
1	practitioner.  (b)
4	certiorari or certification
1	 (i) intracompany
3	information technology systems.
1	inspection, including rent
1	individual article to
2	amend or supplement
1	court; (d) has
1	allocated by him
39	(a) in generalthe
1	act).  (

2	written agreement and
1	final, substantive determination
3	food in the
11	may submit a
1	nomenclature used by
2	effective date, a
7	(b) the drug
1	designate new hig-risk
1	agencies and to
2	date established under
1	protections (a) in
2	within that type,
1	knowingly distributing drugs
1	active adverse event
1	premises definedas used
2	batch certified in
1	maple syrup, (4)
4	fees resulting from
1	additive required to
1	 (a) pharmacies
1	programs in areas
1	whoever knowingly uses
1	practicable, and the
1	contract will improve
1	manner. with the
1	following exceptions: 
1	within that type;
1	grocery stores with
1	director shall assign
3	upon such objections
1	deadline has passed,
1	(iii); and (v)
1	order shall reimburse
1	(a) be imported
3	agreements with foreign
20	individual, or both.
2	identifier, that is
1	rodenticide act. while
2	section and at
1	issuer.  (b)
1	facilities performed each
7	qualifying pesticide chemical
1	response times set
2	label or tag
1	action. (june 25,
1	term shall not
1	(i) a type
1	period means the
1	listed chemicals a
3	government of such
1	(7 u.s.c. 1921
1	(b) restrictionsan amount
4	restricted but only
1	pharmaceutical ingredients in
1	(i) if with
1	title; (2) who
1	person, the place
1	dissemination. (9) the
1	including the requirements
1	 (d) rebuttable
1	subsection. such letter
2	presents a risk
1	(iii) whether in
1	process described under
5	animal drug under
2	dispensing drugs pursuant
1	section, knowing at
1	 (ii) requirement
1	deposit that property
3	regarded as late
2	patients, payors, and
1	form of silicone)
2	food in or
1	objection filed by
2	appropriate united states
1	product application. there
1	humans; and 
1	section 822(g) of
1	subsection (b)(4), the
2	samoa, and the
1	outreach, and technical
1	(2) priorities in
1	electronic gateway is
1	director has not
7	service employed intermittently.
1	production or trafficking
3	administrator may make
1	(4) for purposes
1	(4) if application
3	use and the
12	disabled, or diseased
3	(other than for
2	specified kinds of
1	significantly reduce harm
10	authorized distributor of
1	public from use
3	feed is intended,
2	subparagraph (a), so
5	42 for such
3	will be undertaken
1	impleaded into an
5	appeals taken under
3	state  (a)
2	make such final
1	transportation practices (a)
3	united states courts
1	18. (mar. 4,
1	proceeding. (3) component
1	designation, the secretary
3	due datesuch fee
1	unrevoked written statement
1	methods, and 
1	shall hold such
1	 (1) provided,
1	strategy. in making
1	(1) and (2)(a)
2	following requirements are
1	effects.  (2)
1	upon purchase of
1	21st, 22nd pars.,
1	2007  (a)
2	patent information was
2	general beginning not
1	(
 
 1178.
1	general requirements 
1	information, periodic reporting
1	negotiated deadline, the
1	condition; (2) the
1	demographics, pharmacovigilance, basic
2	safety or effectiveness,
2	procedures specified by
2	per adult consumer
1	(public law 103226;
1	possesses a listed
1	considered. the amount
2	review is terminated
65	described in clause
5	secretary to provide
1	chemical residues that
1	generalin this section,
2	ten years from
1	six percent shall
1	drug master filean
2	punished by the
1	(g) information within
1	trade in cannabis
1	united states, then
1	health and to
1	(c) to inventory
1	receipt to the
1	health problems emerging
1	cosmetic act). (2)
1	(b)(2), (c)(2), (d),
8	(7) the term
1	unless, upon a
1	applicable commercial or
1	practitioners wishing to
1	844a. civil penalty
1	official establishment, any
1	advertisement does not
3	unless the secretary,
1	(iii) safety factors
1	use of appropriated
1	possible consistent with
3	owner, by him
1	dispenser shall have
5	changes to such
1	investment needed to
1	case where such
1	(25) transaction history
4	determining whether an
1	give an official
1	review such proposals
1	products shall compare
1	means of electronic
1	otherwise) that is
2	(including travel time)
1	 (d) programs
1	that, as the
1	secretary such performance
1	order shall give
1	(d) renewal grantssubject
2	confidential commercial information.
1	members with adequately
1	determines is nutritionally
2	clause relating to
1	(2) the united
2	due under subparagraph
1	shall, before the
2	relied upon to
1	whenever a drug
1	applicants for employment
2	chemical does not
3	consumer and members
3	food if the
2	continue in effect,
1	drug between health
1	applications for grants
1	7, for research
1	27, 2007, a
1	section 404 of
1	behalf of all
1	state law in
1	section 321(m) of
1	order public. such
1	paid by all
2	(i) establish a
2	scheduled as an
1	active ingredient) a
1	
 379f. recovery
1	agent whom the
1	submits a qualification
2	general ruleexcept as
1	experts, established pursuant
1	submission as a
1	certification to be
2	decertification issued under
1	drugs. (x) a
1	accredited persons from
1	(e) definition for
1	(b), (d), or
1	person, the responsible
1	includes section 45
3	unfit to engage
1	trade bureau and
1	protocol is final
1	resources to reduce
1	evaluates the public
1	u.s.c. 262(a), 262(k)];
1	another country, or
1	premarket application approval
1	adverse event patterns,
1	congress and publish
1	placed in a
3	damages in the
1	(225 g).c d
8	animals other than
3	355(c) of this
4	(b) that the
2	drug covered by
1	humanitarian organization (including
2	chapter, and there
1	year 2008 by
1	(c) the antimicrobial
1	(4) proceedings to
1	committee) which he
1	ingredients:  (a)
1	title,  (v)
1	fund (hereinafter referred
1	validity a license
1	may under subparagraph
1	reinspections of such
1	shall be proved
1	obligation and sets
1	reportable food as
2	report for each
1	year 2004 or
1	manufacturer may satisfy
4	additional grant under
1	must include the
1	bottled water be
1	744a, as added
1	submissions in making
1	subparagraph is appropriate
2	evaluation requirements and
3	fails to act
1	 in carrying
1	(2)(a), whether permitting
1	packers, distributors, and
2	pharmacy, the united
1	(d) domestic standards
1	director dies, resigns,
1	devices for research,
1	(a) such food
1	only, nor to
1	title, (iii) the
1	device shall, after
1	petition at any
1	exception nothing in
1	order restitution as
1	conviction of him
7	concerning a class
2	drug establishments); and
1	(2) the requirement
1	(2) in amounts
2	rather than three
1	arise from seizures
1	professional associations, and
1	anticoagulant; (ff) a
1	 (4) refund
2	recall will occur
1	establish 1 or
1	sunset subsections (a),
1	remove the new
1	review of all
1	adulteration or misbranding,
1	humans other than
1	user reports 
1	standpoint of safety
1	use in treating,
2	material or information
1	residue for purposes
1	retail outlets the
1	 (e) federal
1	authorized agent, shall
6	administration, of the
1	clause (v). each
1	purposes, and has
6	proposal made by
3	(e) review and
1	fees from 
6	(c), (d), or
2	united states all
1	list, shall include
1	(c), and (e)
1	residue that presents
1	form shall report
1	hearing more than
1	found. no libel
1	(i)(4), as applicable,
1	399f. ensuring adequate
1	written or electronic,
4	reasonable time to
1	(2) provide the
4	filing, and was
1	qualifying federal determination.
1	regulation (which may
2	inadequate grounds exist
2	product, beginning in
1	(4) order to
2	september 30, 1981.
1	requirements regarding the
1	2053,67 stat. 631.)

1	section, or any
1	caused directly or
1	senate a comprehensive
1	(3) final results
1	request for accreditation.
1	may hold such
6	(d) hold a
1	research.  (

4	security act of
1	september 30, 1981;
1	(b):  (i)
1	control activities by
1	diversion. (f) partial
1	advanced therapies, including
4	intent of the
1	drug producta drug
1	approval.  (b)
1	inapplicability to convictions
1	regulation the types
2	distributed, dispensed, acquired,
1	susceptibility of particular
1	calculation the total
1	include eyelash dyes
1	section, the notification
2	notice); and (ii)
1	introduction of known
3	tracing of a
1	use by a
1	dehydration, milling, grinding,
1	compounds; (iii) conducting
1	shall review, and
1	board and persons
1	residues of degradation
1	inconclusive, in pediatric
2	commit any offense
1	shall provide advance
2	year for inflation
3	labeling of any
1	liability no provision
1	conducted to 
1	(to the extent
2	subsection (d) prior
1	360(m) of this
1	considerations involved in
1	animal is condemned
1	detection, or treatment
1	knowledge regarding nanomaterials
2	general provisions respecting
1	need only provide
1	risk assessments; (b)
1	commission, when the
5	subparagraph (a), a
1	(2) when such
1	ergot, hyoscyamus, ignatia,
1	request to provide
1	capabilities, including progress
5	section 379e of
1	pasteurized unless 
4	revenue amounts 
1	means sweet milk
1	products which was
1	processing; (ii) the
1	application is unable
1	1,000 poultry during
1	days or more
1	 (2) construction
2	section 321(v) of
1	revise any such
1	formerly 14th par.,
1	regulations); or (ii)
1	conviction, or claims
1	stalks (except the
2	determines that registration
2	 (1) program
3	information as may
1	entitled to exclusivity
1	products which do
1	outside thereof; and
2	patients by july
3	authenticity and degradation.
1	nonapplicabilitythe foregoing provisions
1	inspection at such
2	administration, fees authorized
1	levels detected, (e)
1	petition of a
1	interpretation or policy
1	360c(a)(1)(a) of this
3	present in such
1	(1)(a) for a
1	optimizing global clinical
1	environmental oxygen deficiency.
6	relevant committees of
1	if, before distribution
1	will use in
1	facility fee, and
1	contamination, as determined
1	concerning imported foods
1	engages in any
1	may not seek
1	use for administrative
4	substantial harm to
2	may, by agreement,
4	evaluation and research
1	impractical for an
1	report of any
2	disclosed or distributed
1	requirements for wholesale
2	agency.  (

1	devices; mandatory debarment
1	engaged in conduct
1	basic pay of
1	justification specific to
2	(4) performance evaluations
1	repeal of inconsistent
1	(
 
 1048.
1	advisory opinions under
1	good cause finds
1	sunscreen. (june 25,
5	drug may request
1	emergency economic powers
1	-hexy--(-naphthoyl)indole (jwh019); (vi)
1	seek to publish
9	human food purposes
1	deferral extension if
2	specific information available
1	865. smuggling methamphetamine
1	signed document shall
1	(iv)  (aa)
1	secretary the provisions
2	1705(c) of this
1	new or rarely
1	defining quality systems,
1	meeting the standard
2	provisions that are
1	(n)(3), or (n)(5)(c),
2	advertising material is
10	adverse event reporting
1	intelligence operation, activity,
1	specify a process
1	obtaining payments for
1	product because the
1	drug, (ii) the
1	shall establish regulations
1	therapies and diagnostics
1	(6) drugs presenting
1	reports, certificates, permits,
1	355(b)(1), 355(b)(2), or
3	federal government. (b)
2	affected persons of
1	year less the
3	(b) application effective
1	general.no person may
1	(1); and (iii)
1	priority areas, remaining
1	authorities of all
3	amount appropriated to
1	assessment of any
1	classified in that
1	show that 
1	techniques for minimizing
1	2000 and subsequent
1	congressional findingsthe congress
3	competition and patent
1	justify adding a
1	individual patient; and
1	(d) exception this
1	treatment that 
1	supporting methodologies; and
3	ethers, and salts
1	13, 38 stat.
1	to, the united
1	corporation (1) solely
1	retail; (2) practitioners
1	comprehensive drug control
1	child care program
1	objectives of agency
1	minimum:  (1)
2	interest at currently
2	identified with the
1	cream, for the
1	test according to
1	tribal participant in
1	israel, japan, new
1	plans.  (g)
9	request under paragraph
2	withdrawal; hearing; business
1	choose the chairman
1	inactive ingredient component.
6	clause (a) of
2	article shall, at
1	expedite an inspection
1	affects interstate or
1	secretary. (b) with
1	relating to an
1	drug application describes
1	percent. (iii) the
1	secretarys ability to
1	soil.  (l)
1	suppliers have ceased
2	civil action was
1	terminate a suspension
15	poisonous or deleterious
1	local inspections in
1	and, if so
2	territory, or possession,
1	food and drugs

1	asset control (a)
1	strategy, but does
1	methodologies have been
1	(c) require periodic
1	(42 u.s.c. 300f(4)))
3	substance does not
1	center undertake specific
2	applications. with respect
1	previously determined, pursuant
2	unique identifier which
1	food packaging); or
4	fiscal year) are
1	355, 360b, or
2	travel expenses (including
1	agencies; (e) in
1	reportable food registry,
1	(b) foreign cooperatives
1	reportable food registry.
1	testifying at such
1	title. (5) whether
3	iv or v,
1	education program, such
2	title 42), a
1	(1)(e), the director
1	meat inspection, including
1	regulations become effective,
1	675, 741, as
2	person of poultry
1	(p) repealed. 

1	labeling which declares
1	promptly review such
1	tomography drug. 
6	number described in
1	risk identification under
1	notices, as appropriate,
2	matter involved in
1	pressures with regard
1	hear a full
1	make available the
1	clinical investigation, evaluation,
1	symptoms of disease
1	offered for sale;
1	homeland security notification
1	amount, determined according
3	program means the
1	labeled as a
3	exemptions are reviewed
1	
 360fff. definitionsin
1	development, stockpiling, licensure,
1	number of biosimilar
1	practicable thereafter, the
1	available, and update
1	drug or substance.
1	(c)(1)(a) recognition of
1	consumption of any
1	sufficiently remote location
1	nonproprietary name, its
1	reasonable cost of
1	determination, finding, action,
2	device manufacturing industry.
6	 (b) other
2	every 4 months
1	space to bear
2	residue in the
1	u.s.c. 136a1(g)] on
1	(including a consultative
1	form and contain
1	regulation, information concerning
1	information made for
1	order. a detention
1	67 stat. 208

1	device manufacturing industry;
2	laws, regulations, or
1	regarding assessments of
1	innovation, and enhance
1	cosmetics this subchapter,
1	(1) an abbreviated
1	regulation, that the
1	approve any abbreviated
1	 (e) prohibitionsnone
1	care entities. a
1	limitations of secretary;
2	produced and shipped
1	year, and once
1	sales (other than
1	administrator, shall conduct
1	committee act. the
3	legitimate uses within
2	drug sample requested,
2	time a tobacco
1	treatment or management
1	respecting such devices,
5	812(b) of this
1	package level, such
1	director shall enter
1	ii, any business
1	thing proceeded against
1	commerce, in coordination
2	reserves, then this
2	ending june 30
1	representatives. (5) the
1	development program means
1	(g) any recommendations
1	methods. (b) manufacturer
3	safely used, and
1	demonstrate consistent compliance
1	document, record, recording,
2	term approved drug
1	designation of agent
1	(c), such fees
1	subsection (e) (except
1	device to which
1	materials, yield and
1	begins a recall
4	makes the following
1	(a) result in
1	shall be imposed
1	division and the
1	information is provided
1	appropriate postmarket regulation
4	(because, for example,
1	june 6, 1896
1	coca leaves in
1	request of communities
1	authority related to
1	(including pediatric patient
2	(b) terms and
1	devices every establishment
3	law regarding the
1	animal safety, or
1	(4) schedule iv.
2	et seq.], approval
1	excepted; insecticides nothing
4	(if any) of
2	purchases or sales
1	1, 2007, is
8	salts of isomers;
1	filing.  (c)
1	known as dovers
2	behavior described in
1	(16) pethidin-intermediat-b, ethy--phenylpiperidin--carboxylate.
1	obtain access to
1	(i) the drugs
1	priority for the
1	animal health laboratory
5	product; or (b)
1	governments may strengthen
1	definition of more
8	supplemental abbreviated application
1	term investigational animal
1	(2) if, in
1	(1) it and
1	petition has been
1	(1) in generaleach
1	including a suitable
1	pathology or physiological
5	section, with respect
9	shall be refused
2	drug sponsor. (h)
1	upon the conclusion
1	appeal of detention
1	methamphetamine, violates paragraph
1	device without regard
1	processing, shipping, or
1	455. inspection in
1	medical matters, and
2	said manufacturer, and
1	humane methods (a)
2	device. (2) the
1	annual basis, submit
1	neighborhoods and the
1	extenuating circumstances that
1	size, filtration, packaging,
1	containing individual product
1	(b)(1). the secretary
4	requirements of clause
1	alleviate adverse physiological
2	tests of the
1	record after providing
1	concentration proposed; and
1	associate attorney general,
1	imports, and, based
1	 (v) pediatric
1	development meetings if
1	secretary, and provide
4	providing the notification
2	refund), the submission
1	expected technologies, and
1	criminal enterpriseany person
2	participation, through joint
1	shall provide by
48	department of health
2	fee limit notwithstanding
1	387j(c) of this
2	virgin islands, the
1	hearing to assess
1	consistent with effective
1	biomedical research consortia,
1	regulation require restrictions
1	paragraph (2) be
1	(iii) the statement
1	sampling of any
4	respect to fiscal
1	executive branch to
1	attorney general documentation
1	proceeding alleging a
1	radioactive materials under
1	paragraph (2) by
1	repealed. july 13,
1	meeting, make recommendations
1	license issued pursuant
1	procedure  (1)
1	technology as the
2	subpopulations, including racial
1	attempt to do
3	year, including such
1	processing, such as
1	substantial equivalence determination
1	requirements of noticea
1	criteria website shall,
2	offering to sell,
1	violation of permit;
5	state from which
1	tracing recordkeeping requirements
1	judgment governed by
1	(1)(a), a rule
1	drug are removed
1	proposed regulation an
1	controlled substances. (2)
1	head, or viscera
1	position by the
2	action on application
1	1975. (2) sums
1	section 343(b), 343(d),
1	136. additional inspection
4	application and conducted
1	determination published in
1	drug administration. (d)
1	isomer, except as
1	title disapproving an
1	preceding sentence shall,
1	chemical, in violation
2	if, in lieu
1	processors of meat
1	testing of medical
1	stat. 1296), and
1	patients..  (b)
1	regarding the training
1	chapter or implementing
1	(i) the same
1	owning such property
1	delivery of it,
3	factors as the
1	respectively.  (i)
3	establishments registered under
2	upon failure to
1	groups that may
1	complete, the establishment
1	packs, each blister
1	voluntary basis to
2	notification is provided,
1	regulatory decisions and
1	 (1) detail
1	360j(l)(3)(d)(ii) of this
1	data) for not
3	prescribed by regulation
2	food, because of
1	opening for a
1	fees the admitting
1	exportation not later
1	22, 1996, exempt
1	misleading label 
2	size of a
4	 (1) under
1	breast implant containing
1	(3) process for
2	protocol submissions submitted
1	standards to be
1	appointed members of
1	(a) and (f))
1	boards of pharmacyan
1	general that a
1	paragraph (2)(a) available
1	(i) assure safe
5	safe meat and
1	part. as to
1	signing a bound
1	 (aa) necessary
1	records, and proceedings
2	use prescribed in
2	summary required by
1	condition which occurs
1	(a), unless the
1	illicit narcotics crops
2	(a) development of
1	another age group.
2	ingredient of the
1	another device. (j)
1	yield and stability
1	harvesting of specific
1	misbranding, labeling, registration,
1	regulation when a
1	primarily as a
2	title is deemed
1	regularly updated on
4	coalition mentoring activities
1	administration who 
1	whose public disclosure,
1	provide appropriate information
1	thereof, and any
2	means the single
1	evaluation with the
1	foreign exchange, currency,
4	transport, or offer
1	dru-free communities support
1	subchapter as a
1	media campaign; (6)
1	requested the owner,
1	emerged anabolic steroids
24	risk evaluation and
1	personnel to facilitate
3	analytical reports by
1	shall designate hig-risk
2	standard identified in
1	foregoing other necessities
1	payment penalty, or
1	independently met the
1	investigation for purposes
1	thereof. if the
1	import tolerances 
1	(b) authorized activities
2	timely and appropriate
1	chemical applied after
1	product used to
1	control (in this
4	substance should be
1	commercial and industrial
1	(a) fiscal year
1	civic, or cultural
5	exclusivity period. 
8	based on scientific
2	facility, including 
2	program established in
1	 (i) denies
7	actions required by
9	device, the secretary
1	(6), or (ii)
1	packaged in a
1	including public comment
1	level information, if
2	making requests for
1	covered with, an
2	subject to penalties
1	file fee. 
1	possible links between
1	9th par., 34
1	completion which has
2	agents and foreign
1	information the complete
2	(within such period
1	(3), shall provide
1	every thirty days
1	(a), the united
1	-mail address, the
1	determinations made under
1	small businesses. the
1	subparagraph by submitting
13	 (i) any
1	accelerated approval the
1	biosimilar biological product,
1	also provide for
2	conditions prescribed with
1	anabolic steroid; and
1	application.  the
1	(1) additive the
4	judgment in favor
1	(a) is approved,
1	terminating the program
1	representative; and (b)
2	health, toxicological, behavioral,
2	dtc advertisement submitted
1	biosimilar biological product;
2	 (2) not
2	(a) initial biosimilar
4	concealed in any
1	
 2201. performance
1	commission.  (4)
3	consignee within the
3	interstate commerce if
1	individual personally dispensing
1	neonatology expertise for
1	plant was inspected
3	interstate commerce in
1	u.s.c. 2615] in
1	it. the administrator
1	title, or no
1	dispensing or administering
1	nonthreshold effect); (ii)
5	subsection (a) that
7	funds raised by
1	determined through consideration
3	documents regarding action
1	reporting requirements by
3	petition is filed
1	deficiency or for
2	information about drugs
1	individual; (ii) any
3	title 28. the
1	explanation and information
1	means those activities
1	apply under section
1	$263,180  $268,443
1	delivery to, creameries
1	moneys and proceeds.
1	practice of telemedicine
1	 (c) definitionin
1	sanctions provided for
1	commerce because 
1	files a petition
3	conditions that are
2	contract or compact
1	appoint from time
2	secretary with the
5	biosimilar biological products
1	738, as added
1	need for hospitalization,
1	existing hospitalization; (iv)
2	expiration of seven
1	supplemental return declarations
1	accept such letter
1	tobacco product. (3)
3	certified by the
1	(6) failure to
1	denial of petition;
1	postmarket surveillance 
1	found that adequate
1	consistent with 
1	upon its suspension
1	available to combat
4	agreement of the
6	conduct a study
1	funds otherwise available
1	supplied shall begin
1	1333(e) of title
1	prepared. (mar. 4,
1	transfer request under
1	conditionally approve an
1	(6) involvement of
1	collected for fiscal
1	blood rings, and
1	submission and approval
1	required and has
1	legible form, directly
1	administrative record regarding
1	subject. (11) the
1	apply. (2) the
2	tax forms are
1	purposes. (mar. 4,
2	information on any
1	intended for serious
2	shall meet to
1	definitions; generallyfor the
2	providers, and drug
8	title because of
1	(3) scope of
1	placement). for purposes
1	(1) applies; and
1	tank car, hopper
1	compounding pharmacy may
1	(a)(i) of such
1	risk of anaphylaxis,
1	otherwise distributed by
1	dietary ingredient means
1	week, and to
1	valuable medicinal qualities
1	displayed in an
1	(1), the end
1	(
 
 1908.
1	another commodity, including
1	limitation in setting
3	persons who do
1	reporton or before
1	(6) application datefacilities
13	application was submitted
1	may be published
2	standards under either
1	country, the secretary
2	states to meet
2	consider the need
1	misbranded; and (ii)
1	ethical medical practice
1	maintained in accordance
1	distribution or manufacturing
1	drugs, as a
1	interest regarding the
1	content of documents
1	(d) drug manufacturers
1	shall be entered
1	20 by reason
11	drug is the
1	submission reviewed by
2	(ii) a request
1	biological systems and
1	requires the device
1	make up the
1	used to hold
2	term customs territory
1	changes made since
1	classification of that
3	support the development,
1	product received from
3	programs and practices;
3	355(j)(5)(b) of this
1	disposal takes place
1	include statements conveying
2	unlawful under this
1	(3) no charge
1	lots of biologics
1	animal drug according
9	person engaged in
3	applicant will give
1	inability of the
1	labeling and postmarketing
1	number as well
1	sulfonmethane.  (c)
1	image of the
6	isomers, esters, ethers,
3	may waive the
1	(iv) the director
1	inherent toxicity or
1	2014, and on
2	months, and eight
1	supply are vital
1	102 to 105.
1	intending to submit
1	organizations; and (d)
1	section. after the
2	order on the
6	drug application described
1	services.  (

2	shall develop systems
1	fda reportnot later
2	(c)(3)(e)(ii) of section
1	regulations, the performance
1	drugs, shall automate
1	effective for any
1	(5) date of
4	lack of substantial
4	indication for use
1	quarter following the
2	courts the district
3	state by the
1	delegate. (y) the
1	preventing and detecting
1	already controlled under
2	condemned and destroyed
2	1, 2012, the
1	committee, or entity
2	(including a process
1	enforcement personnel (a)
1	inspection, investigation, or
1	(b) establishment and
1	 (m) requests
1	exempt from taxation
1	june 25, 1948,
1	study and a
1	prescribe.  (f)
1	interested in these
7	law to administer
2	penalties, and accrued
1	(2) disclosure of
1	criteria for eligibility
1	national security. (june
1	sufficient fee revenues
1	areas programnot later
2	conduct or conditions
1	required to inform
2	conducts a program
1	 (3) report
1	services, programs, or
1	activity that becomes
1	permit for the
1	product conforms to
1	
 467b. seizure
1	necessary to the
1	to, electronic product
2	second prior fiscal
1	among adults; (2)
1	committee shall make
2	shall reimburse a
1	prevented from using
1	medical societies, medical
3	(ii) determination of
1	authorization to establish
1	import controlled substances
1	center to reduce
1	communities support program
1	situations  (1)
1	person who chooses
2	business and opportunity
1	exceed 3 years
1	regarding premarket approval
3	united states), while
1	diagnose, cure, mitigate,
1	involved.  (c)
2	state that it
1	electronic format. 
1	including ongoing safety
2	state that is
2	cover the cost
2	(b) more than
1	disease product described
1	granted or denied
2	$15,000 for each
1	contents; description of
2	articles used for
2	dietary supplement and
1	information. (4) generic
4	1002(a), formerly 902(a),
1	recall activities associated
3	whether compliance has
1	transitioning into new
1	(e) additional penalties
5	appropriations and allocated
1	receipt at the
1	investigations conducted using
2	prevention, or treatment
1	persons from the
1	675, 710, as
1	plant.  (d)
5	number of days
1	title) that 
1	31, 1974. 
1	action plan if,
1	budget; and (bb)
2	information regarding labeling
1	programs; (g) drug
1	research plan which
1	person has entered
1	information from food
6	secretary to review
1	2203. food and
1	soil transmitted helmithiasis.
1	purity; (ii) the
1	whether such oleomargarine
1	proper use of
4	similar experimental conditions
2	subparagraph (d) by
1	criteria standards; and
1	implementation plan for
1	(b)(i), the term
1	secretary, upon application
1	agendas; (b) encouraging
5	(1) in generalsubject
1	performance bonds, appoint
1	(aa) federal healt-related
1	  biotin
1	market exclusivity awarded
1	subsection (a)(2), (a)(6),
1	chemical, preservative, or
1	exceeds its established
1	store. (7) no
1	agent, employee, occupant,
2	(unless exempt from
1	years, except that,
3	respect to material
1	section 841(b)(1),[1] and
1	amendment; revocation 
3	establishment fee 
1	person who forges,
3	subsequent convictions shall
1	funds  (1)
1	manufactured by, the
1	use on food,
2	contains any added
1	infer the contents
13	1 of the
4	contains cocaine base;
1	reductions in its
1	alleviate temporary shortages
2	secretary, after considering
1	specific request for
1	ris-based preventive controls
2	abuse and the
5	food safety programs,
1	plan to health
1	practice that is
2	therapeutic ingredient under
1	notification; (8) shall
1	notice was filed
1	class i recall
27	found to be
1	(a)(1).  (

1	biologics under such
3	designation of the
1	epidemiological studies for
1	fiscal years 2009
1	infrastructure and capacity
2	fiscal years 2007
1	fiscal years 2006
3	final guidance document
3	specifically to determine
1	fiscal years 2003
1	manufacturing practice as
3	fees otherwise authorized
1	(c) product tracing
1	results in residues
1	alkaloids or their
1	appropriate to assure
1	localities, and throughout
1	customs territory for
1	predominantly to farmers
1	involved shall, upon
1	ii unless 
1	facility registered with
5	receiving the request
2	consulted with respect
1	describe how such
1	petitioner) a full
2	classified under paragraph
1	species, and the
1	academic or scientific
1	destroys markets for
1	issues within the
1	use for other
1	(a)(i) in electronic
2	general shall make
5	abbreviated application or
1	whether the action
1	findings and violations.
1	proheptazine. (40) properidine.
1	offenses; punishment; duty
2	based. the provisions
1	limiting  (a)
6	379h(c)(4) of this
1	regarding thir-party inspections
1	hair dye (as
1	secretary to improve
1	agree to modify
1	may promulgate such
1	(
 
 876.
1	(9) to distribute,
1	order the forfeiture
2	evidence of record
1	responsible party, with
2	state costs. 
2	(a).  (b)
1	evidence, such as
1	(ii) application of
2	among the state
1	(
 
 2012.
1	may be revoked
1	reviewer with sufficient
1	periodically review such
1	products at retail.
1	354 of this
1	paid the assessment;
2	interim relief, as
13	appropriated to the
3	effect or modified
7	shall be composed
1	prohibition during the
1	article; and (iii)
1	revised official names;
1	manner and on
18	form and manner
4	(such as a
1	food products: provided,
1	(j) leishmaniasis. (k)
2	drug protocol described
1	food, has settled
5	use in treatment
2	action taken on
1	approved. (3) the
3	violations of the
3	punishable by imprisonment
1	
 343a. repealed.
1	samples of cigarettes,
1	accept a qualification
1	(bb) subject to
3	economic hardship for
3	undue economic hardship
1	inspection; (ii) states
1	(
 
 2102.
1	directly relevant to
1	inspections by accredited
1	may be inspected
1	implications of such
1	methods, cannot be
2	supported by scientific
1	
 379j61. definitionsin
1	public and readily
1	list as necessary,
1	device under review;
1	threat international crime
1	human services is
1	secretary to effectively
1	conferred by state
1	attorney general. any
2	section, such a
1	appropriate, if known;
6	drug administration that
1	(
 
 872.
1	matter of law,
1	(b) a countermeasure
1	shortages, how the
1	device under review.
4	seq.].  (b)
1	balance of the
3	human services in
3	person shall introduce
3	secretary shall thereafter
1	radiation and intense
2	services or other
1	normal business hours.
2	shall report directly
1	grant renewal request
1	antimicrobial drugs. 
1	subsections (b)(2) and
1	discharge 1 or
1	transferred to an
1	(7) assessment of
2	use by qualified
1	knowingly alter the
1	353(b)]. prescriptions shall
1	(xvii) the distribution
5	following circumstances: 
1	petition does so
1	 (a) foundation
2	device to have
2	tests by methods
2	affects safety or
1	device applications, be
1	foundation shall not
1	prior conviction, or
2	may be combined
1	expand activities related
2	conditionally approve another
1	(2) order the
1	establishments.  (g)
2	drug authorized under
1	section, 80 per
2	portions of a
2	occurring from an
1	timetables; periodic reports
2	2 nominees from
1	1908, ch. 192,
1	human services provides
1	 (3) paperwork
2	illness, and violations
1	(5) at any
1	event that information
1	lot level information)
1	writing and, if
5	postapproval study or
1	registrant, on the
3	submission under subsection
1	 (4) unique
5	time after the
1	manufacturer agrees to
1	
 
 191
2	party, including an
2	regulation of like
1	scale and diversity
1	least as large
1	extent of cooperation
1	paragraph (3) or
1	effective for not
1	secretary. the provisions
2	entitle a registrant
1	shall, by the
2	deciding when to
1	debarred under such
1	fish in the
1	prepare documentation under
1	 (b) holiday
1	property, the time
3	states (referred to
1	(4) the manner
1	combination product. 
1	traced, other than
6	secretary, evaluated together
1	forfeiture event, with
1	part, the board,
4	determination, whether there
1	section 556(d) of
2	attorney general) or
1	342(a)(2)(b) and 346a
3	including their isomers,
1	title. in the
1	period. a hearing
4	extensions); or (ii)
1	distribution an order
1	singl-use device. 
1	
 831. additional
3	conviction of such
1	records, or interference
1	preventing the secretary
6	approval or clearance
1	least a biannual
1	listing; and 
1	president shall provide
1	distributed) compounded drug
2	emergency response network
1	considered a felony
1	courts that have
1	increased efficiency and
2	of, and work
2	security clearance in
1	conditions.  (f)
1	(f) qualified entities.
2	date the notice
1	any, each such
1	processes of produce
1	country occur within
2	906, as added
62	code of federal
1	anthranilic acid, its
1	subsection (j). (3)
1	beings to whom
1	repair, or use
1	use of nonmedical
2	level of individuals
1	section refusing or
1	division, the amendments
1	similar or identical
2	register containing information
1	representatives of foreign
1	dates and times
2	title which would
1	section may bring
4	fiscal years 2008
3	public health; (b)
6	legitimate medical, scientific,
1	cas-b-case delay notwithstanding
1	act; and (b)
1	section applies. 
1	-buty--(-naphthoyl)indole (jwh073); (v)
1	becoming an advisory
1	secretary of education,
1	therapeutic amounts. (6)
1	investigations performed under
1	fiscal years 2004
5	systems, and standards
1	campaignin using amounts
1	additive. (4) upon
5	name of such
1	authentication technologies. 
1	604, 605, 610(b),
2	duly registered under
1	appropriate, provide education
1	provide inspection and
1	samples shall be
1	provisions for registration
1	(2) and 
1	submitted, for which
1	guidance letter, a
1	shall not confirm
1	undertaken by that
2	secretary may specify.
2	351(a)(2)(b) of this
1	(c) notify the
2	use the secretary
1	(b) accreditation system
4	secretary in determining
1	drug administration. notification
1	conducted, such application
1	importer who does
2	business, as a
2	devices reclassified as
1	(1)(b) for a
1	device industry regarding
1	require special attention
1	subsection (b)(1)(e) for
1	white rots, mixed
1	resistance.  (june
1	subsection (a), he
1	title are carried
1	value of sales
3	human food, shall
3	manufacture of an
1	authorize the food
1	risk for anaphylaxis,
1	presubmission conference 
3	shall grant or
3	advice to the
1	statistically significant increase
2	of, or use
1	 (ii) issuance
1	withdrawn; (b) 
1	(1) define the
1	regarding the information
1	exchange of lot
1	application that, at
1	secretary of communications
11	report not later
5	cause of the
8	animal feed is
2	order the labeling
2	inspections  (1)
1	subsection (a)(6) through
1	systems; (3) promote
1	animal feed in
1	format; and (bb)
1	mandatory ante mortem
2	factor under paragraph
2	developed and activated,
1	advertising of the
1	ch. 675, 704,
2	equines, or parts
1	guidances issued in
1	1009, formerly 909,
1	respect to clearing
3	serve at the
1	(iii) state or
1	intended for export;
2	october 21, 1995,
1	solicit the views
1	information, and whether
1	it, the petition
2	campaign.  (b)
1	limitation except as
1	serious diseasesany person,
1	possible processes for
1	clinical description of
1	intended for export.
3	intended for export,
2	schedule contained in
1	
 
 379k.
1	extent practicable, a
1	cleanup of clandestine
2	(where known to
1	term felony means
1	removal of a
2	based on similar
1	following, and, moreover,
2	conviction for an
2	apply shall be
1	disease product, the
1	drug control efforts;
1	scientifically appropriate, expedited
1	opium or not
2	testing is reported
1	entities or from
1	authorized to commence
1	dispensing of risk
1	supplements.  (8)
3	(b) whether the
1	civil forfeiture proceedings
1	classification of such
1	election pursuant to
1	seq.] regarding the
1	used or is
1	commissioner of u.s.
1	produced from such
1	amount, in the
1	insure that milk
1	(2) revision and
1	separate or aggregated
1	including injunctive relief
1	(d) there is
4	 an applicant
1	determination to file
2	imported food for
1	sector. (d) recovery
1	830(e)(1) of this
3	consultation with an
1	final regulatory action
1	(1) drug for
1	revoking a standard
1	present on the
1	egg products, restrictions
6	labeling) and in
1	reviews for the
3	ingredient or a
2	knowledge which reasonably
1	studies or clinical
1	representatives of different
1	individually scanning each
1	(b) on-year waiting
3	prior to january
1	thereunder, the applicant
1	public a detailed
2	cycles as in
1	groups, and the
1	schools. (vi) organizations
1	consider such data
1	legislation that would
1	targeted technology; 
1	(2) no altering
1	used, or are
2	property was taken
5	manner as such
1	imports) that require
1	subsection or, if
1	butter is otherwise
1	(a) to enter,
1	commerce (1) between
1	paid advisory review
2	oct. 26, 1951,
1	state unless at
5	shall establish within
1	practices; (g) a
2	agencies (such as
1	(e) incorporation the
2	may be appropriate.
1	respect to how
1	diseases (a) purposethe
1	introduces into the
1	chapter, the wholesome
1	number is issued
1	(c) nalorphine. (d)
4	year, to cover
1	detoxification treatment may
1	(b) programin carrying
1	information, if provided),
1	using, or sharing
1	ch. 675, 564b,
3	food, unless its
1	fruits, or melons
2	drug that appears
2	communication plan on
1	title, antimicrobial susceptibility
1	
 
 360bbb8.
5	(b), the term
3	manufacturer, wholesale distributor,
1	 (f) drop
3	security or the
2	except that specific
3	official plant shall
2	tobacco products, and
1	(if any) upon
1	report within 10
2	private or commercial
1	identify the circumstances
1	coordinator and committee
2	interests and a
1	fifty degrees fahrenheit.
1	sanitary operating practices
1	considered an admission
2	involving  (i)
1	ii(a)(4). as used
1	detoxification treatment) considers
1	maintains unobligated carryover
1	agencys budget; and
5	49 and 50
1	initial reportnot later
1	presentation.  (d)
2	approved product has
1	applicable list and
1	drug; (c) an
4	secretary.  (4)
1	recreational or historic
1	including the timelines,
1	cos-effective manner. the
5	established under clause
1	marihuana as defined
1	term antimicrobial drug
1	321(g)(1) of this
1	may be able
1	cream is produced,
1	achieved through uniform
1	premarket review. (iii)
1	dead. (f) the
2	immediate container (not
1	basis to meet
1	information, a reference
1	prepare and transmit
2	public health. (4)
1	request for referral
16	identified by the
1	data the secretary
1	professional practice. (b)
1	subsection containing such
1	1997, or both.
4	tobacco product by
1	 (a) employed
1	(5) records except
2	substance unless the
2	director on the
1	drug administration, invite
4	operated by another
1	(i) include a
3	animal drug submitted
5	pharmaceutical ingredient facility
1	818.)
 
 215.
1	system, and make
3	tobacco product be
1	
 
 360bbb1.
1	(f) partial fills
31	product that is
1	(1), if the
8	costs for such
1	shall inform him
1	of, and policies
6	manner and to
1	destroyed, the secretary
1	secretary any credible
2	authorized as required
1	bottle, of the
2	eggs in the
2	grant an extension
1	(6) $60,000,000 for
1	clearly identified legislative
2	request, notify the
1	related information from
1	outsourcing facility intends
1	person (including a
1	title, as in
3	drugs meet the
9	relevant to and
5	encourage the development
1	additional information to
2	object of the
1	characteristics and uses.
2	introduce testimony, as
1	(i) improve the
2	adopt a final
1	interpretive criteria that
3	means any tobacco
1	dangerous to health,
1	product. (3) 
1	publish an informative
2	grants the total
6	drug; and (ii)
1	quality of inspections
1	person denies any
1	directors decision document
1	entities that may
1	(b), be subject
1	both. (3) any
1	shall be marked,
2	entity means 
1	determined to provide
1	(f) until such
1	(a) director the
1	(15 grams) of
1	establishments that produce
1	age, biological, and
1	(2) reasonably believes
1	may provide training
1	periodic reports 
2	secretary has credible
11	secretary a written
1	clinical efficiencies; or
1	children; (2) the
1	positive pathogens, including
1	general beginning in
1	law 10782 (21
1	year, less the
1	request. (3) any
1	transportation; or (b)
1	druggists, orphan asylums,
2	registration of each
2	involving fraud, bribery,
1	paragraph which provide
4	condition described in
2	standards the secretary,
1	documenting hazards, implementing
1	(d) notwithstanding any
1	2016, with respect
1	designated food. (4)
1	title iv, 403(a)(10),
7	application.  (b)
1	convening such advisory
1	waxing, fumigating, and
2	request for indexing
2	secretary may (prior
2	business, or, in
1	property, buildings, and
1	satisfied by submitting
4	secretary may, at
1	average american diet
1	territorial limits; fees
2	director; and (b)
1	drug in response
2	submission requirement or
2	amount to be
1	distributor, or other
3	imposed under subchapter
2	misbranded, a sunscreen
1	1938, ch. 810,
1	foods, drugs, cosmetics,
2	distributing, or using
1	written, provided with
1	quarantine or destroy
2	make such information
1	species for another
1	reasonable timeframe. 
1	china for any
1	shall publish, and
3	(including any parking
1	chemicals imported pursuant
1	enacted in the
1	category, the holder
1	period contained in
1	(d) construction the
7	read and understood
1	(iv) the media.
1	(i) provide for
1	experimental conditions. if
1	(4) local distribution
7	procedure set forth
1	abuse. furthermore, nothing
1	 (2) rule
1	may hold the
2	feed of the
1	conduct and supervise
1	(a) account for
1	2002. (11) the
15	fiscal year ending
2	reputable practitioners of
1	(3) changes requiring
1	policies, directions, membership,
1	committee or for
3	dispensing a drug
1	1, 70 stat.
1	sale, or a
1	products, respectively. 
1	telephone number, and
1	(f)(5); (10) participate
1	(1) shall establish
1	records of an
1	item on a
1	premarket submissions for
1	clause (ii): 
1	guam, the commonwealth
1	territory.  (

2	subparagraph (e), the
1	consumption. common carriers
5	order or consent
1	supporting the complaint,
1	violation of, or
1	shall relate only
1	devices must be
1	director, the chairman,
1	title 42, of
2	based the action
2	restricting the sale
1	consumed by humans
2	inspected establishments will
1	active surveillance network
1	sign and issue
1	health, to the
1	trust, association, or
1	file fee as
1	investigation; and (b)
1	ch. 675, 302,
1	cleared, the status
1	supplies; (d) collection
1	record so requested
1	funds received by
1	entitled to protection;
1	ingredients is determined
1	term real world
1	determined  (a)
1	conspicuously in such
2	necessary for discussion
1	discussion of animal
2	notification in order
1	 (1) describe
1	cause means a
1	dispense in violation
1	term supplemental animal
1	possibility of hoarding
1	entitled to protection,
1	result from implementation
1	exceed $1,000,000 may
1	funds made pursuant
1	performed. (ii) appropriate
1	individuals, and (2)
1	user reporting under
1	pecuniary value has
1	affect the risk
3	section.  (3)
3	601(m) of this
17	ingredient (including any
2	construed to create
1	marihuana. (11) mescaline.
1	approved, including a
3	ceases to be
2	general.no action may
5	 (a) issue
1	affirmative action to
19	issuance of a
1	ammonium saccharin. (z)
1	orders any order,
1	reanalysis under this
1	used in research
1	stakeholders from federal,
1	action is needed
1	effect of all
1	respect to pesticides
1	arrests for drug
1	
 393. food
4	bottle, or other
1	section. (2) 
1	forfeiture and destruction
1	explains  (a)
1	(such as through
1	1934 ed., title
1	1007, formerly 907,
1	13, 2002, the
1	container; modification of
1	termination of office
1	police powers to
1	collection action, the
1	declaring such substance
4	administration and goals
1	applies in accordance
1	(d), or under
1	college of pharmacy
1	diseased animal or
1	records; authority of
2	section 208(b)(1) of
1	establish conformance with
1	secretary on any
1	federal register announcing
17	secretary of such
1	requiring that its
1	directorthe director shall
1	practitioner under this
1	import no raw
2	device for, obtaining
1	states on lands
1	event regarding the
4	 (3) final
2	radiological health, acting
1	veterans affairs registered
1	supervision of operations
5	 (b) rule
1	(e) if at
1	term dietary supplement
3	action brought by
1	food purports to
8	subsection (g) of
1	exceed 24 hours,
2	agricultural commodity means
2	vit shall be
1	provided to it
3	media buying contractor
2	adults and pediatric
1	him, and that
1	director may award
2	subsection (g) or
1	governor, the secretary
1	dispensed. (b) 5,000
1	1705. development, submission,
1	product; or (3)
2	pharmaceutical, device, food,
1	notify such individuals
1	establish, with respect
1	sold in quantities
2	serious risk. 
2	upon the immediate
1	control strategy, transmit
10	demonstrate that the
1	additional statutory authority,
3	consider  (a)
1	ch. 675, 503,
2	 (i) consider
1	carriers shall not
1	notice to a
1	paragraph (1)(a) were
1	
 
 356c.
1	participate an importer
1	administration and established
17	(2) if the
2	chemical products at
1	market, the secretary
1	effective after the
4	permitted by any
1	distributor shall have
2	reasonable body of
1	records containing the
2	application that was
1	poultry. (
 

1	drugthe term prescription
1	promote private research
1	coding, cleansing, and
2	person serving it
1	unless the article
1	handlers, shall maintain
1	awarding a grant
2	contain such restrictions
2	general fund of
2	jurisdictions as contemplated
1	(5) amendments to
2	sale or dispensing,
1	18, 1968, and
1	information which need
1	require the establishment
1	general a nonprofit
1	drug substances, and
2	development of procedure
1	state official), on
1	request relates, except
1	recognition under this
1	
 
 154.
1	device, means an
1	board shall serve
1	ii or, in
1	technologies and the
1	(a) determinations 
1	indicated for use
1	pay a reduced
1	living animals; he
1	late and an
1	commodity and the
1	plans, and any
1	disclosure unless and
3	title.  (7)
1	carries out the
5	[21 u.s.c. 811(j)].
1	infant formula. except
1	scientific research; (f)
1	may jeopardize the
1	(m) distributors except
1	612. notification any
1	
 814. removal
1	directly linked thereto
1	(viii) a requirement
1	care providers; (b)
1	methodology.  the
7	qualified importer program
1	requirements as to
1	section 897.3 and
1	portion thereof containing
1	limit areas affected
1	first premarket report,
1	inspections are required
1	conversion to commercial
1	identify the special
1	 (e) compounding
1	additional country to
1	writing that as
1	substantial evidence defined
1	writing that at
1	penalty assessed by
1	term nonprescription means
3	revenue amounts specified
1	control program, which
1	5, code of
1	authorized to utilize
2	notice.a notice required
1	manufacturing practice, and
4	domestic articles subject
1	product (referred to
1	submission on or
1	food laboratory services
2	notification provided by
1	shall maintain lists
1	1997 (excluding the
1	hearing, or other
1	scientific literature and
1	undue economic hardship,
2	meetings with representatives
1	amending under paragraph
2	different from all
2	(ii) been duly
1	qualified manufacturer, for
6	strategy for the
1	public from poultry
1	compendium means the
1	approval using expedited
1	priority to increasing
1	suspension of any
1	demonstrate a lon-term
1	writing, the scientific
1	extent. (v) -phenylacetylindole
1	state regulation of
1	nullify, void, prevent,
2	by, such other
1	prescribe  (i)
1	new york, on
1	identification of generalized
1	prosecution, and incarceration
1	benefits; and (d)
1	evaluate whether the
1	misleading under this
3	accredited by a
2	secretary shall refuse
1	including information both
1	incompetent, such term
1	safety information to
1	(3) the name,
1	(ii) the prescribing
1	(b) otherwise listed
3	hazards that may
1	expedited review of
2	prescription means a
1	president shall, if
1	appropriate, without reference
1	accessible in the
1	secretary may disapprove
1	pricing of, such
5	unsafe for the
1	auditor. such report
1	fail to keep
1	tolerance is safe
1	complaint. at any
1	721, formerly 706,
1	675, 536, formerly
1	manner, upon the
2	designed to print,
1	treatment in reducing
1	(ix) a review
1	 a device
1	conservation, and environmental
1	content of orderif,
1	milk, and contains
2	alert or a
1	combination product subject
2	restraining order issued
5	purchase advertising time
1	subchapter; (2) on
1	interchangeable biosimilar biological
1	patents and for
3	thir-party auditor may
1	single enantiomer has
1	hig-level coordination of
1	name, or brand
1	including in a
1	849. transportation safety
2	taken the same
1	opioi-dependent patients in
2	request corresponds to
1	(c) the increased
1	age twent-one (a)
1	senate that provides
1	score cards used
1	fees to reimburse
1	(ii) certain manufacturers
2	shall pay a
1	diameter; or standard
1	hearing under subsection
1	578, 2, 65
1	stat. 631.)
 

1	policy (a) in
1	significant difference, as
1	cumulative to an
1	shall initiate discussions
1	notification by any
2	applicable regulations when
1	manufactures the prescription
1	reporting and database.
1	diversity among physicians
3	information on all
1	(b) classified information
1	eligible entity, including
2	devices manufactured, prepared,
1	machines (a) record
1	except further, that
1	42 to submit
7	 (a) information
2	secretary (including appropriate
1	(d) cause substantial
1	procedures applicable to
2	final briefs. (f)
1	notice that identifies
1	pediatric studies should
1	head the office
1	(iii) discloses individually
1	means any analysis
1	paragraph (1) include,
1	study plans not
1	ergotamine and its
1	2017, $635,000,000. (j)
1	sentence. (2) an
1	representative.  the
4	publishing a notice
2	state, or representative
1	 (ii) certificationthe
1	outpatient diagnostic facility
1	chapter to focus
8	(h) of section
5	subparagraph (a) as
1	generalthe administrator may
9	label of the
1	case law, including
1	chapter) shall be
1	(a)(1)(a). (6) the
1	effect in accordance
1	patient, a practitioner
1	inspections and audits
3	commercial manufacture, use,
1	reportable food that
1	assurances the secretary
1	(a)(2)(a), a major
2	duly authorized agent,
3	information provided to
1	will be manufactured.
1	(5) financial interest
1	business. (mar. 4,
5	intended to have
1	residues  (i)
1	abuse prevention; (c)
2	test positive for
3	entitles the holder
1	paragraph (7); (b)
1	government in the
4	accredited person to
1	year after such
1	paragraph (1)). the
1	therapeutic category means
1	steps taken during
1	states shall receive
2	fiscal year. the
1	(2), and (3).
1	(2), and (3),
3	person or entity
1	staff fellow and
3	report or the
4	person has not
1	title 42; (7)
1	payment or delivery,
5	subsection (a) to
1	device or class
1	control of tobacco
7	(c) provide a
1	dengue/dengue haemorrhagic fever.
1	utilizes susceptibility test
1	ingestion in daily
1	law, and subject
1	conviction or criminal
1	applicant, the place
11	factor applicable to
1	meet its obligations
1	
 
 355.
6	802 of this
27	fiscal year shall
2	(1) reflect the
1	establish terms and
1	reflect the greater
1	assault. the attorney
2	enforcement action under
5	recommendations of such
1	notice, except that
1	regulation for exemptionsthe
1	condemned all carcasses
1	commence not later
1	(a)(1) shall not
1	conducting pediatric studies.
1	device. such designation
1	responsible party. (9)
1	given when the
9	ownership of a
1	aggregate, without opening
1	shall in the
1	restrictive standard than
2	fee as follows:
2	shall, upon request,
1	amount calculation the
1	convictions, described in
1	title) or a
1	period as he
1	assembled from components
1	unclassified form and
1	paragraph (2);[2] 
1	product among hospitals
7	person with respect
1	civil action, or
1	federally owned property,
1	take and of
1	supply of these
1	issuing a prescription
1	counterdrug technology transfer
1	purpose of listing
3	work was performed
1	required unless the
1	467a et seq.]
1	health. (ii) an
2	conditions designed to
2	recommendation not later
1	apply to confectionery
1	immediately unless an
1	fee, not exceeding
1	manufactured at a
1	collaborations.  (i)in
1	award an additional
2	criteria, if any,
2	agency developed under
3	atom of the
1	cosmetic, or (2)
1	thereof) that relate
1	1054. annual report
1	score at least
1	further, that in
1	take to ensure
2	shall define the
1	(4) context of
2	further, that if
1	date and has
1	(ii) each active
1	entity. (ii)disposition of
1	ultimate consumer, (ii)
2	(d) shall not
1	title, the gas
1	issuer, in the
1	drug products under
1	united states holds
3	52 stat. 1049;
1	(b)(i) shall be
1	complying with subparagraph
1	amounts reimbursed under
1	conversion product thereof)
1	results, nor shall
1	health risk of
1	homeland security, develop
1	application; (b) there
1	372a. transferred
 

1	products, or agents
1	 (2) trade
1	approval for treatments
1	(d) does not
2	rate of basic
1	(b) data submission
1	supplier verification programs.
2	necessity, safety, cos-effectiveness,
1	ris-based foreign supplier
1	demonstrate methods for
1	ch. 675, 517,
3	within 60 calendar
2	shall keep a
1	343(q), or 343(r)
1	title (only with
2	public health threat
2	27, 2007, during
1	(2) conditionsnotwithstanding the
2	lot level information,
1	formerly 360f, as
1	new nutrient in
1	(i)(2) and (3),
1	neighborhood safety and
1	technical assistance program
1	pesticides among infants
1	advance of any
1	states department of
2	guidance or regulation
1	case, including any
1	infectious or contagious
1	submission by the
1	minimum it will
2	regulations prescribe, the
1	federal drug control
5	upon such terms
2	approved racemic drug;
1	approved strategies. 
1	defendant in such
1	distribute.  (d)
1	attempted to introduce,
1	section 841(b)(3) of
1	assist small entities,
1	form prescribed by
1	 (1) convictionfor
1	 (4) regulations
1	device rather than
1	provides written consent
1	paragraph and after
1	animal means an
1	area (whether or
4	subsection (b); and
1	(b) public availability
1	study plan shall
1	practice at a
4	fiscal years of
1	section is made
1	population  (i)
1	process by submitting
3	drug master files
2	r-exportation among members
2	worker relations involving
1	importation, a statement
2	(including in accordance
1	prevention, or the
1	minor or incompetent,
1	establishment registration number
1	minor or incompetent.
1	secretary unless on
1	administrative action, including
1	drug submission by
2	product standards established
1	development activities; and
1	subparagraph (a)) 
2	accreditation bodies that
3	dosage form and
1	dosage units, or
1	milk, egg, fish
3	secretary may administer
1	1001 to 1007.
2	title. (g) the
1	submission from a
1	postapproval study of
1	food, and the
1	
 
 387a.
1	drug master file.
1	penalties provided by
1	forth any conditions
7	may issue a
1	shall leave the
1	used.  (j)
1	payments notwithstanding any
1	section that the
1	use; (f) the
1	prior to that
1	harmful components of
1	drug master file;
1	secretary adds a
2	term adverse event
1	standard can be
1	submission, implementation, and
1	(e) immediate precursors
1	(b) until expended,
8	bulk drug substances
1	required postapproval study
1	unless the regulation
2	use under which
1	(vii) such other
5	iv or v
29	except that such
1	involved, and that
1	injuries. (b) during
1	[21 u.s.c. 387];
1	accreditation body shall
2	matters, chemistry, manufacturing,
1	previously denied admission
4	board of directors
1	year, on drug
1	u.s.c. 214), from
1	cfr part 25,
1	secretary a scientific
1	incidentally produced substances
2	supplier, or vendor
2	1040), and acts
1	violates section 331(jj)
1	4202 of title
1	food contact surfaces
1	pay rates, establish
1	including the best
2	section 352(x) of
1	certification is required
1	information with the
1	person will not
1	production, and international
1	paragraph (2), nothing
1	device. (d) action
1	subbrand that the
1	telephone, or at
2	include a history
1	bulk drug substance;
1	arising from harm
9	existence of such
1	(ii) the prescription
1	 (a) discuss
1	targeted drug that
1	(2) data and
2	(1) means a
1	list all revised
1	safety, dependence, or
2	instance has been
1	person or establishment
2	exemption the secretary,
2	construed to effectuate
1	niacin (g) 250.0
2	caused another party
1	include material information
1	food contact surface.
1	standardized analysis and
1	review groupswithout regard
1	selecting data and
1	element under paragraph
1	formula in the
1	system of proxy
1	state agencies, and
1	predicate device and
1	levels of such
1	(f) regulatory management
1	foreign country involved
2	secretary after the
2	(e) or paragraph
1	revenues for sponsor
6	convicted of any
1	organizations, of which
1	(2) bears or
16	permanent allegiance is
1	contact with children
7	secretary shall furnish
2	shall examine the
1	(7) opioid the
2	ownership is being
2	(b)(1)(a) may be
1	health of individuals
1	pharmacists, or having
1	health.  (k)
1	regulation, this section
1	institution programs outside
1	foundation) shall be
1	pharmacist, or the
1	education programs; and
2	demand reduction and
1	classes of products,
1	(5)), that is
1	(a)(4).  (2)
2	articles shall not
1	25, 1948, ch.
7	program agency shall
1	locationsnot more than
1	classification panel, the
1	5, as adjusted
1	(b) describing the
1	administration means the
1	approved) include the
1	stage, each batch
5	within 15 days
1	shall classify the
1	twice the lifetime
1	arcade facility, after
1	use has the
1	infant formula under
1	regulation an explanation
1	board representation none
1	department, or agency
1	(e) obligation of
1	section 2219a of
1	carcasses, parts, meat
1	subparagraph (2)) at
1	annual reports (a)
1	devices not later
1	persons debarment shall
1	authority in establishing,
1	to, a written
3	use or use
2	respecting all such
1	735, as added
1	drug administration (1)
2	absent infringement action.
1	designate a chairman,
1	support approval, licensure,
1	carrier and it
2	compounded basis the
1	study is completed
1	requested by an
1	(b) additional data
2	funding for drug
1	manufacturer regarding any
1	activities.  (b)
1	alone:  (1)
7	package level, including
1	comment); (ii) issue
6	possible within the
1	attitude tracking study
1	(1) the sale,
1	 (ii) startup
1	(b), and (d),
2	title may return
1	anesthetic; (ee) an
4	defraying the costs
4	purchase of such
1	submits any of
15	law enforcement agencies
1	(4) public input
1	(d) is not
1	groups (a) prohibited
2	general, after investigation,
1	within the family
3	title shall have
1	convention, the attorney
1	documentary proof that
1	secretary evidence of
1	establishment by any
4	secretary may limit
1	involving matters within
4	shall alter the
1	governments; (3) to
1	administrator shall complete
1	term reportable food
1	antifungal drugs 
1	generalupon determining that
1	label. whenever a
6	nationally or internationally
1	convey the transaction
1	allergy management training
1	finds such requirement
4	necessary to effectuate
1	include any agency
40	subchapter or subchapter
3	lawful written or
1	violation  (i)
1	states shall set
1	secretary, insufficient for
1	shall submit evidence
68	shall  (a)
1	development program; and
4	prohibit the sponsor
7	provision of the
1	recoupment of the
1	food or drugs
2	director determines to
1	approval of countermeasures
1	(4) take any
1	approval until the
1	product measured in
1	applications; food imports
1	counterdrug activities of
1	human tissue; 
2	scientific data show
1	privacy requirement. 
1	including the methods
1	methods as the
1	preparing for, assessing,
1	customs laws; (c)
1	complete an agreed
1	affect activities carried
4	 (d) report
1	rejection may include
2	hold be removed
1	children. (d) factorsin
1	relationship to the
1	secretary and cooperation
3	contained in this
1	submit an existing
4	application. if, after
1	personsin carrying out
1	states in undertaking
1	weight of such
2	inspection  (a)
1	manufactured by it,
1	available, by arrangement
2	risks to public
1	rulemaking under this
1	release and controls
1	efforts supported by
1	impact on human
16	drug as a
1	thereafter, the administrator
1	pharmacopeia or national
1	marketed and intended
1	unless immediate use
1	ensure imported drugs
1	information, including anecdotal
1	(c) an event
1	mitigate the observed
1	level review under
1	review is or
2	subclause (ii), the
7	goals and objectives
2	conduct a surveillance
1	information; (c) state
1	taken under subparagraph
2	section 331(p) of
1	seeking to challenge
1	tracking study published
2	standards for thermally
7	detail the specific
1	food under any
1	whether commenced by
1	subsection. in the
1	(b)(iii)(i) and the
1	september 30, 1977,
3	term biological product
5	proceeding for the
1	90 days but
1	shall be $1,832,000
4	section 1605 of
1	enhanced penalties. 
1	(
 
 1036.
1	secretary shall prohibit
1	new suppliers would
2	identifier, on each
1	users the director
2	isomers or 50
2	shall transmit notice
1	shall address each
1	athlete means an
1	appurtenances or improvements,
1	holder that during
1	aside.  (june
1	regulation is the
2	42), or a
1	detained (in accordance
1	formerly 360c, as
1	(e) emergency use
1	180 days before
1	including by 
6	order is to
1	strategic national stockpile;
2	patent before the
1	holder. the secretarys
1	promulgating rules and
1	  200.0.
1	country where the
1	certification  (a)
2	labeling change and
1	taken to substantially
1	court shall deem
2	kept in the
2	 (1) performance
1	supplemental grants for
1	nonregulated person or
1	general may recover
1	(2)(b) of certifying
1	section 231 of
2	(i) any additional
2	agencies, institutions, and
2	 (i) publishing
1	subsection (f), populated
1	added to labeling
2	dispensed or distributed
1	reclassification, and a
1	modify the determination
7	corporation whose permanent
3	lot level information
2	useful and legitimate
1	court shall take
1	565, as added
1	logistics provider, the
1	lung diffusion testing.
2	subsection (b), except
1	milestones and performance
1	(b) not include
1	formula under paragraph
1	tobacco product. if,
1	section 802(33) of
2	labeled, and packaged.
1	greater than is
2	investigations were conducted.
6	information to justify
2	united states. (4)
1	subsection. (b) partnerships
1	sentence. (b) exceptionsif
1	proper. the administrator
1	to, a requirement
1	quarterly, not later
1	products under authority
1	application by a
1	advice the secretary
1	1997.  (june
1	proceeding; or (4)
1	direct participation of
1	identify demand reduction
1	subchapter and found
2	drug for emergency
1	use consistent with
1	use:  (a)
1	days after submitting
2	any. the warrant
2	activities, except that
1	title 47); or
1	documents the substantial
3	including employees of
1	support for the
13	subject of such
1	known of the
2	reports to congress
1	warehouse space to
1	risk and do
1	application, (c) the
1	2013, as determined
3	(3) upon the
3	 (1) timing
1	without the opportunity
2	substance that appears
1	farm owned by
1	(2) solely for
1	december 8, 2003,
1	adequate or reliable,
1	request within 60
12	31 of each
1	forms in such
1	
 97 to
1	require a field
1	renewal grants. each
1	within 7 business
1	analysis based on
1	applicability of certain
1	labeling (as defined
1	(ii) that he
1	360j(g)(5) of this
1	360bbb3, 379aa, 379aa1,
1	cosmetic act means
1	insert may help
1	exceptionsif an application
1	faith as such,
1	branches), or any
1	year 2019, $14,100,000;
1	practicable, with internationally
1	option of the
1	advertising in the
1	(1) and after
1	[42 u.s.c. 263a]
1	regarding the qualification
1	period and is
1	wholesale distributors. 
1	nature or kind
1	responsible person continues
1	food products falsely
1	shall certify to
1	reliance on this
1	(
 
 875.
1	cases, arising under
1	reasons such pediatric
1	importer) that manufactures,
1	used, the maximum
1	paid a drug
1	supervision, or under
1	1984 shall apply
1	used to bring
7	fees, and storage
3	shall vacate the
1	substance, a registration
3	sections 1111 and
5	issue essential to
1	states, unless the
1	million dollars in
2	submit the consolidated
1	drug in or
1	united states military
7	setting the secretary
1	subsection or include
1	(i), the abbreviated
1	guard against employing
1	container, or hopper
1	united states owning,
1	identified in letters
3	shall promptly revoke
1	article or animal.
1	reasonably available and
2	article or animal,
1	notification submission. (2)
8	take effect until
1	enforcement against illegal
1	publicly by the
1	pharmacy, physician, and
1	statement, declaration, notification,
1	professional practice by
1	eliminate, (iii) invite
1	public comments, the
1	5, 44 stat.
2	5 (relating to
1	individual states or
1	advertisement shall be
1	350f(n) of this
1	foreign facilities 
1	additive, and any
1	amount paid during
1	owned, controlled, or
1	packed or distributed
4	 (2) review
2	product, and of
1	practices with respect
2	analysis of real
2	section, to have
6	performance of such
1	quantities not exceeding
1	(iii) provide the
1	establishment; (iii) identifies
1	paragraph (1) but
1	slaughtering and processing
8	10 years after
1	(1) is imported
1	commissioner, shall prioritize
3	trafficking area, the
1	enforcement intelligence regarding
1	swine, and goats.
2	712, as added
1	verification: i certify
1	volunteer groups. (x)
1	paragraph (2)(c)(iii), the
1	(3)(d)(ii), within one
2	350l(b) of this
1	room of the
3	secretary may promulgate
4	reduce substance abuse
1	convention. in the
2	decision in the
1	congress finds and
1	360bbb(b) of this
1	business, except pursuant
1	protect negligent suppliers.
1	drug, any use
1	previously submitted under
1	prescription requirements; misbranded
1	2, 38 stat.
2	300g1), the regulation
1	secretary may defer
2	cooperate with and
1	biopharmacology, statistics, chemistry,
1	requests were funded
2	part, any such
1	time provided. 
1	notice of opportunity
1	taken by or
10	device in class
1	condition, the treatment
2	review and evaluationthe
1	importer. (2) for
4	paragraph (4), the
1	country requesting such
1	959 of this
2	labeling which is
1	section 201.57 of
2	rate of absorption
1	health experts (including
1	(c) an affiliate
12	subject to review
3	(6) of section
1	animal feed, proposed
1	food containing new
2	residue levels of
1	350d(a)(3)[1] of this
1	user fee by
2	help mitigate or
2	secretary shall provide,
6	contains a pesticide
2	(1) forge any
1	selection of accredited
2	accreditation body the
3	list of drugs
3	activities with respect
1	turkeys; poultry producers
1	purpose; or (9)
1	petition requirementsany petition
1	million two hundred
1	application. if such
1	petition to amend
1	$83,000 per submission
1	makes more than
3	section 1040 of
1	et seq.] should
1	$119,000,000 for fiscal
1	sections of such
1	strategy; and (iii)
1	sponsor is not
2	class ii. within
1	order within 15
1	shall place such
2	study in the
1	custom preparation, and
3	milk or cream,
1	review the petition
4	making a determination,
1	review regulatory hazard
1	section. such certification
1	903. application of
1	uses unless its
1	violate the misbranding
5	forth in such
2	prior notice of
1	use in extracorporeal
1	apart from review
2	submit for advisory
1	chapter prior to
1	 (e) declaratory
1	secretary in establishments
1	lawfully possess a
1	age of 18.
1	include procedures under
1	required; maximum amount
1	 (3) extension
1	submission may be
1	preceding the end
1	highly compliant companies
1	sales data (other
2	addition, the secretary
4	director shall not
1	recall meets the
1	harm means 
1	administration; (2) in
1	chapter. a drug
1	importer, or agent
2	cost of carrying
1	distributors; fees; definitions
1	chapter; prosecution of
4	required to maintain
1	countermeasure advanced research
1	within the applicable
1	total sales of
1	supplemental information or
1	term ful-time equivalent
1	officer lawfully engaged
1	sponsor involved is
1	(b) on and
1	years 2004 through
1	wholesaler of dietary
1	reason of enactment
1	paragraph (2)(b)(iv) are
1	information to know
1	installments as the
1	current appropriation for
1	physician assistant to
1	food is in
1	source or from
3	eliminate such risk,
3	data by sex
1	
 823. registration
1	product development process
1	analytic reports on
2	organizations and other
1	(b) for approval
1	marijuana, methamphetamine, ecstasy,
1	business that violates
1	significant adverse tobacco
1	reasons certified to
1	application who submits
1	programs carried out
1	30, 1998, the
13	drug is safe
1	(including short shel-life
1	affect the powers
4	fee required under
1	immunizations. (b) public
1	business referred to
1	(a) state, local,
1	shall compile a
1	tolerance (which final
1	employees means the
1	slaughter in the
1	case such earlier
1	services. the summary
1	743, as added
1	subsection (n). in
2	adequate to preserve
1	sample, the conviction
1	substance use and
4	(f) the term
1	budget.  (ii)
1	consumers about the
1	opinion regarding whether
1	2.5 milligrams of
1	describedthe activities described
2	disease and other
1	(3) procedures and
1	ch. 613, 2,
2	cocaine, or preparation
1	-(-naphthoyl)pyrrole by substitution
1	42), unless otherwise
1	wire, radio, and
2	sentence, the secretary
1	labeling of indexed
1	concerning new products;
1	investigation of priority
1	2007, the applicant
2	narcotics trafficker publicly
1	appropriately vary depending
2	commissioner by the
2	drugs filed under
5	section 360b(d) of
1	conclusive. if any
1	applicant in writing
1	(vi) any other
235	25, 1938, ch.
1	complied with, and
1	managed. (e) additional
1	transportation the term
1	article is alleged
2	impose undue economic
1	(b) nonnarcotic controlled
1	state law that
1	(iv) nothing in
1	25 per centum
1	devices considered as
1	otherwise be within
1	commercial carrier or
1	active investigation by
1	thir-party auditor, except
2	including an assessment
5	date of this
4	approval supplement to
1	patients in such
1	70 per centum
2	shall be placed
1	form prior to
1	experts using such
1	relevant regulations, guidances,
1	manufacturing laboratories seized
5	attorney general as
2	term knowledge as
1	prior conviction alleged
2	animal drug to
2	 (3) ris-based
1	act of 1988
1	(4).  (ii)
1	2011, and thereafter
2	standards, and which
2	(a) in response
2	form of action
1	clinical investigations to
1	producing animals, may
1	period of market
2	section 1702(d) of
1	countries; (iv) the
3	approval in an
6	provided, however, that
1	warehouse excludes any
1	reviewing such comments,
1	device, and to
1	designated to conduct
4	person committing such
1	regarding the possible
1	 (4) duration
1	subparagraph controlling a
1	reverse such order
1	controversial issues, the
1	6 months prior
1	chief scientist shall
9	court to the
2	(bb) an approved
1	procure needed medication
1	expertise is represented
1	secretary, regarding cleaning
1	covered by such
2	brought against such
1	(ix) civic and
1	experience with countermeasures
1	(ii) a change
1	information, indictment, or
2	unless the complainant
9	added by section
1	section 379d3 of
1	proceedings before any
2	including processing of
12	containing new animal
2	form strictly for
1	offender provides anything
1	among sectors within
1	regulatory, ethical, and
1	 (3) certification
1	section 360eee(9)(b) of
1	naming each. to
1	withdrawal under subparagraph
1	means the storage
1	satisfy the inspection
1	instances where 
1	misbranded when introduced
1	databases in order
1	maintenance of records;
1	chemical, unless there
2	possible time; and
6	united states, including
2	may lawfully possess
1	development tools; and
3	five members shall
1	awarded under section
1	shall, on may
1	unaffected nothing in
1	shall give due
1	business, in which
1	(i) is by
2	without conducting lon-term
1	procedures the sponsor
1	(b) by order
1	reached, after the
1	shall immediately prohibit
5	section 379g(1) of
1	conduct telemedicine during
1	transaction history provided
1	complaint an opportunity
1	oversight of the
1	application shall pay
1	chain, take into
1	part of tissue
1	secretary; (ii) allow
1	article 2 or
1	(2) standards of
1	states and all
1	consequences; (ii) that
1	parties prior to
1	serious illness of,
12	article 2 of
1	
 830. regulation
1	residue in such
15	months after june
1	initial plan has
2	shall be dated
2	requirements and conditions
1	rare disease populations
1	researc-based, lon-range, quantifiable
1	financial sanctions to
1	manufacturer shall have
1	regatta, or other
2	controlled substances may
1	five years thereafter,
1	tracing the tobacco
1	audit, submit, the
1	provide inspection to
2	one animal species,
2	serious adverse eventthe
1	product no smokeless
2	interest on such,
1	(c)(1) for the
1	paragraph: (a) repeated
1	(4) procure (by
1	appropriate regarding changes
2	included, or underrepresented,
1	and/or information which
1	ended, make a
3	intervention to prevent
1	decertification of that
1	(d) annual report
2	may in such
3	marks may be
1	establishment, a point
2	potential benefits and
2	hearing on such
1	product manufacturer of
1	matter in accordance
1	 (c) reimbursement
1	request, or that
1	handlers and other
1	intended for final
1	establishment where the
1	test systems and
1	respecting any claim
1	march 9, 2006);
1	part of said
1	strategy upon the
1	warrants, subpenas, and
2	period if the
1	forfeited property which
1	columbia, or to
1	national drug code.
1	whether the benefits
3	waivers, reductions, and
1	(
 
 826a.
1	competent jurisdiction; (11)
2	inconsistent with a
9	1927, ch. 155,
5	prevention or treatment
1	regard to fees
1	(7) notification to
1	agencies with implementing
1	adjustments to such
1	establishment the director
1	regulatory focus of
22	act (21 u.s.c.
5	subject to any
1	compound used, or
1	include  (aa)
1	warehouses, and tobacco
1	applicant has received
1	apply economic and
1	2234 and 2235
1	plant; and every
1	identification of, and
3	court in a
2	less than $125,000,000
1	(b) or which
2	general services administration,
1	resources to ensure
1	injury to or
1	reasons for declining
1	administrator after completion
2	establishing and administering
7	section 360f of
1	section 1039, 1040
1	applications, supplements or
2	violation and opportunity
3	imported by the
1	countries.  (12)
2	information:  (i)
1	(a), the applicant
2	administrator may provide
6	(i) not later
1	assistance at the
1	reviewed in a
1	subparagraph (a), external
1	butterine, or imitation
1	center or successor
1	conspicuous and prominent
1	1177 of this
1	parts of carcasses
1	thereof; (b) the
1	improve the device
3	processing, or packing
1	regulations). (5) no-delegation
1	(e)(4)(e). (3) the
1	detention authority 
1	publi-private partnership from
1	record shall be
4	bioavailability or bioequivalence
3	medicine, dentistry, or
1	active ingredients and
1	commerce or delivers
1	food facilities for
1	sponsor or sponsors
1	42 and if
1	identifier at the
1	hyperlink to the
1	general if an
1	360eee3(b) of this
1	13, 2016. (e)
1	authorized in section
1	effect that, with
5	list shall be
1	holding registrations for
3	quantities at establishments
1	paragraph as an
1	days spent by
1	athlete the term
1	1994.  (june
1	delivers for introduction
1	(or to the
1	application; (c) the
1	current basis, a
1	subsection (a)(1)(c) for
1	(d) eligibilityeligibility shall
2	hold) if the
2	requirements and the
1	
 176 to
2	section 672 of
1	working group of
1	
 
 360i.
1	research programs directly
2	investigation otherwise required
1	secretary, institute a
1	director and deputy
1	demonstrated by the
1	schedule ii(a)(4). as
1	determination.  (h)
1	prevalence in the
3	drugs may be
1	means all benefits
1	requirement of preparation
1	professionals and patients,
1	title, such establishment
2	(iii) treat information
2	order controlling the
1	tribal governments with
1	act.  (

2	person requesting a
1	egg packers on
1	may prioritize the
1	(1) no-interchangeable biosimilar
1	information gathered through
1	seller  (a)
1	final decision as
1	(2) cooperate in
2	exposure to such
1	generic drugs 
1	(i) no biosimilar
1	(including cellophane), in
1	practice to assure
1	committee the secretary
5	term pesticide chemical
1	(i) within 30
9	section 356e of
1	general, and by
1	include a reviewer
1	person, the executive
1	appropriate, with such
2	data from 
4	maintenance of effective
1	resides, or does
1	delays in approvals
1	probable risks and
1	clause (ii), fees
1	chapter.[1] (b) certain
2	section 1703 of
2	fiscal year 2008;
5	reports are necessary
1	 (i) subsection
1	interest no members
3	received such illegitimate
1	(ii) such administration
1	protocols established by
1	unbroken packages bearing
3	grant may be
1	particular training or
1	holding 1 or
1	consolidated administrative and
1	secretarys notice, (b)
7	annual fee established
3	given reasonable notice
1	authority using any
1	list) or is
4	(2)(c), fees authorized
1	animal drug included
1	u.s.c. 1521 note);
1	
 1710a. requirement
1	member before such
1	section available on
8	defect or failure
1	2012, or if
2	found, to compel
1	groups of advisors
2	conjunction with the
1	may change, modify,
1	illicit drug use.
1	(b), shall conduct
2	illicit drug use,
1	emission of positrons
1	year, including the
1	risk of other
1	(a) eligible for
3	[42 u.s.c. 601
19	3 years of
1	products enable the
1	(1) and, through
6	defined in subsection
1	reverse distributor of
1	(b)standards.  each
1	applicable percentage for
1	(f) assistance of
1	(b)(2)(b)(i), (b)(2)(b)(iii), (b)(3)(a),
1	 (l) implementing
1	written into the
1	objectives identified under
1	section 876 of
1	sale. the purchaser
1	provision of notice
1	coordinate regulatory efforts
1	testing. (viii) any
1	annual board review
1	thereof, except that
1	basis,  unless
1	person who holds
1	list compiled under
1	copying.  (

1	hearing after the
4	provide information to
8	section 1001 of
1	direct changes in
1	present the unreasonable
4	accredited under section
61	designated by the
2	grant appropriate relief,
1	statements, and (f)
1	license; requirements; qualifications
2	imposed for violation
3	local, county, or
1	 (a) held
1	substanceswith respect to
6	title may be
1	separately and carcasses
1	sanitary protection means
2	composition or articles
1	perform such relabeling
3	commenced during the
1	illicit drug user
1	administration. notification of
1	(c) the thermally
2	article was, or
2	labeling thereof; (c)
2	(a) the responsible
1	anhydrous ammonia removed
1	 (a) help
1	branch to reduce
2	termination of designation
1	useful in the
2	evaluation demonstrates that
5	brought under section
2	applicant from an
1	(viii). (b) notice
1	support the widest
1	use restrictions are
1	regulations shall include
1	becomes necessary. 
1	regulation so effective,
1	dry milk; milk
1	use shall report
3	(1) upon any
1	person who petitioned
2	administration to ensure
1	condition that no
2	grase upon issuance
1	procedures within such
1	little cigar in
1	radiation;  (3)
1	strategy for responding
1	two years, of
1	(h) protection against
2	 (1) knowingly
1	photograph and at
1	law; (ix) the
1	broadcasting networks for
1	(4) has demonstrable
1	receives actual notice
1	law; (4) any
1	(ii) provide for
1	property, subject to
1	party to conduct
1	greater than 14.
1	list that includes
6	promulgation of a
1	(iii) orders no
2	jurisdiction with respect
1	included in each
1	itself, shall not
1	require recall 
1	(c) application for
1	care facility for
1	report (and subsequent
1	ch. 675, 534,
1	intent described under
3	general the sponsor
1	shipments. (d) record
1	exemption from sections
1	located  (aa)
1	chain and that
1	states may require
1	communication of drug
1	(4) unless the
1	committed knowingly or
1	excluding descriptions of
1	rate of disposal,
1	customer on such
1	submission if, in
1	regulated seller to
1	(a), and (3)
1	still relevant to
1	(i) registrations the
1	time the device
1	 (d) knowledge
2	states under section
1	iii unless 
1	shall provide, by
1	(a), the director
1	summaries are submitted
1	(1), the base
4	animal drug if
1	june 30, 1972,
3	homogeneous case of
1	 (1) order
2	therein (including records,
1	marketed and in
1	prior service is
1	(h) the timely
11	animal drug in
1	administration or dispensing
2	logistics provider shall
1	rejected articles or
1	chloroform, cantharides, or
1	track products per
2	including such information
19	animal drug is
1	june 30, 1972;
1	age of sale
1	interstate commerce; (15)
1	duplicative requirements under
1	policies.  (v)
1	constructed of, or
4	section or licensed
7	costs of resources
1	promulgating the regulation
1	effective not earlier
7	(c), or (d)
1	subsection (j) has
2	inspection program; or
1	assessed, any accrued
1	seafood and seafood
1	together with such
1	issue a report
1	fixed shall also
1	states to receive
1	available fee collections
1	chapter, then such
1	drugs, holders submit
1	national laboratory preparedness;
4	sell, or offer
5	report shall include
1	programs and the
4	component, part, or
1	agriculture and, as
3	demonstrates that a
1	population for providing
1	675, 517, as
5	receipt of notice
3	private entities to
1	records. (g) investigational
1	veterinarians to ascertain
1	(d) any drug
1	(a) was directed,
4	interstate commerce, and
30	opportunity for a
6	notice  (i)
1	control notice may
4	least 90 days
1	safety, effectiveness, or
1	frameworkthe framework shall
1	application and notifies
2	goals, objectives, and
1	means a notice
1	379k. information system
2	promulgate final regulations
1	classified or law
6	added on a
1	procedures established through
2	454 of this
1	control strategy; 
3	questions of fact
2	interpretive criteria under
1	media campaign with
1	(i) that a
2	processes in place
1	de novo judicial
1	amounts of any
1	officer has under
1	providing the same
2	thereafter found to
12	register a notice
1	continuation of current
1	(c). (7) in
1	food importationa person
3	secure electronic database.
4	patent information prescribed
1	shall promulgate proposed
1	confidentially maintains the
1	shall post in
1	1532(b) of this
1	use), and shall
1	seafood inspection effectiveness
1	expedite development and
3	section 353 of
1	drug prescribes, recommends,
1	will lead to
1	thereto; except that
3	136 et seq.]
1	animals; and (3)
3	(u) the term
1	penalties collected under
7	product shall not
6	milliliters or per
1	(as adjusted pursuant
1	products held for
1	share information reported
7	 (2) authority
1	(g) grocery stores
1	investigational device have
2	animal drug product,
1	ch. 675, 901,
2	[21 u.s.c. 353(b)].
1	establishment. (june 25,
1	successor standards). 
4	criteria deemed necessary
1	adopt an efficient
1	(h) dissemination of
1	granted in the
1	(1) advisory review
1	sel-control with reference
2	to, or does
1	medical products. such
1	(b) a c-licensed
1	laboratories that operate
2	libel or injunction
1	plans for ensuring
1	 (4) treatment
1	356c(g)(1) of this
2	present to congress
1	term drug 
1	hazard is to
2	term little cigar
1	(g) presidential report
1	substitution, or addition
1	guns, ammunition, or
2	human subject of
1	(ii) is plainly
1	section reclassifying a
4	review of drugs
1	specified, to remain
1	(1) employs, hires,
6	period under section
2	upon the hearing,
1	disease not of
1	provide additional opportunity
1	documents and shall
1	year 2002 for
1	president and the
1	substances combined. (e)
6	animal drug products
1	shall classify all
1	grown, on a
3	testing (on a
1	auditor may employ
1	five years, or
1	consistent and organized
3	regulations exempting from
2	days thereafter until
1	(d) other state
2	strategy and focus
1	violation resulting in
1	reflect the benefi-risk
2	trials to be
1	submitted and such
1	stat-o-th-art practices that
8	making a determination
2	subparagraph (7), unless
3	animal feed which
1	time for determination
2	on-quarter grain of
3	goals described in
1	programs or other
1	reporting by outsourcing
3	fellowship, memorandum of
1	unable to identify.
1	clause (ii). in
3	product in a
1	(a)(1) to summarize
1	secretary, such use
2	audit agents to
1	(b)(2) that may
1	quality may include
1	(b) factors to
1	substances or chemicals
2	whenever the president
1	shall be modeled
1	shall require testing
1	free from tuberculosis;
1	title, the safety
2	section 372 of
1	licensed or registered
1	(2) identification requirement
2	organization.  (b)
1	facilities) bearing on
2	effectiveness reasons. a
1	2011, to implement
4	numerical count: provided,
1	approved protocol and
1	logbook information relating
1	made, and as
1	drug control among
1	616. inspectors of
1	determination (a) review
1	registrants regular general
4	remain in effect
2	notice and publication
1	application using a
1	title but is
2	behavioral, or physiologic
2	tobacco product has
6	shall not disclose
1	home or regular
1	353(b)(4) and 352(f)
2	made, and an
1	suitable size to
1	(d) through (m).
4	upon making a
4	device during the
1	chapter, cooperate with
1	chapter drugs and
1	enforcement against individuals
2	pursuant to rules
1	intramural research; (4)
1	court any such
1	675, 918, as
2	(ii) was reorganized
2	shall promptly publish
3	mutations of a
2	clearly endanger the
1	(i)) that is
2	delivery, in the
2	consignee and the
4	animal feed, and
1	employees in 
1	food additive, including,
1	control over, the
2	title applies with
1	vary by more
1	appropriating) in the
1	appropriate).  (iv)
1	rea-time supplement means
1	science for membership
1	appropriation for the
1	 (iv) modular
1	food, such food
1	request is described
1	supply reduction and
2	prescribed by an
1	may request information
1	(2) persons subject
2	attributable to the
8	costs to total
4	united states. in
1	(e) personnel detailed
5	foreign narcotics traffickers
2	designation under paragraph
1	delegated. (2) the
1	(f) recommendations for
6	egg products at
1	designate the official
1	tool at issue
1	(3) dispenserthe term
1	
 114e to
1	(a) or (f)
1	262(a)) with respect
1	body to continue
1	question. if the
1	enforcement resources and
1	country for subsequent
2	2015, $2,786,000 for
1	(1), any person
1	secretary requires one
2	supplier, or vendor.
1	commodities, based on
2	(ii) a restaurant
24	information to show
1	practice in connection
2	1451 et seq.]
1	stat. 1225.)
 

2	years, nor later
1	notice ends, the
1	experience in serving
2	may violate requirements
1	stage means the
1	flavoring extracts, except
1	november 21, 1997;
1	outcome assessmentthe term
1	if, after consultation
2	wholly within such
1	conclusion that no
1	needy families the
1	paragraph (2)(a), whether
2	november 21, 1997.
1	substance (or controlled
9	november 21, 1997,
1	november 21, 1997)
2	inventory upon payment
3	applicable thereto, unless
2	fee reduction regarding
1	publish the informative
1	constituents, ingredients, or
1	maintenance treatment means
1	repackager requirements 
1	biological product, other
1	audits of the
1	labor, and industrial
2	 the procedures
1	population of individuals
1	research, including formulas,
1	research awards made
1	(c) limitationthe regulations
2	influence compliance with
8	section 387j of
1	compelling testimony or
1	persons handling 1,4butanediol
2	phenylpropanolamine includes each
1	distributor licensing regulations
2	 (b) record
1	(2) relation to
1	authority or continue
1	except in pursuance
1	(1) to ensure
1	centers, professional and
1	iv. (c) initial
1	whether students at
2	shall conduct the
2	authorized and at
1	officer or executive
3	(i) for fiscal
1	(1)(b)  (a)
1	management systems for
2	diversion of a
1	state, including investigation,
3	procedure by which
1	recall of food
1	sponsor under paragraph
2	(3) withdrawal; rule
1	subparagraph. (c) an
1	 (n) the
1	order prescribe a
1	product, or (b)
2	general the administrator
1	pyridine or c[10]h[14]n[2],
1	foundation; (viii) establish
4	safety of food
1	chemical synthesis, and
1	member, organ, or
1	reasons, if any,
1	license. (mar. 3,
1	illness outbreak in
1	strategy for communicating
1	federal officials as
2	coordination with other
4	standards for electronic
1	 [4] if
1	fora, including the
1	submission for review
1	substance of evidence
1	secretary, after the
2	381(q) or 384b
1	promulgated thereunder, or
2	minimal quantities of
1	violates the requirements
1	including by promulgating
1	term efficacy supplement
1	agreements, the secretary
1	public; (c) require
1	scientifically driven clinical
2	programs to meet
1	joined with other
3	(a) the attorney
2	product as purchased
21	secretary shall submit
1	authorizing a delay
1	medical care. (3)
1	purposes of modification,
1	detailed examination and
1	(c) encryption technologies;
7	amounts established under
1	 (e) denial
11	manufacturer, distributor, or
1	raised on his
1	subsection (f)(4)) shall
1	inspection; certified statement
1	device, whichever is
1	website shall, in
1	issues and a
1	involved. (2) 
1	fiscal year 2009),
2	contents of label
1	fee collected during
1	bank pursuant to
1	(i). (iv) for
1	waivers requested and
1	resolution process as
9	may establish or
1	(4) any person
1	occur not later
2	appropriations through september
1	(including a drug,
1	clinical studies, patient
2	nonvoting members a
7	no-federal funds raised
1	butter defined for
2	entered for the
10	shall require the
1	food safety requirements;
1	panel failed to
1	year 2011. 
2	applicable penalty, any
10	prescribe to assure
2	document the basis
1	approved, since the
1	admission unless such
1	pediatric applications and
2	post mortem examination
2	preserve the availability
3	article is subject
1	care economic analysis,
2	collection shortfalls 
1	(ii) direct accreditation
1	1 month of
1	year 2016; (d)
1	date that a
2	subsection (b)(1); (h)
1	agreement acceptable to
1	method, and time
1	hiring authorities; and
1	existing therapies if
1	sunscreens that are
1	section 360i(e) of
1	 (b) order
1	(b)(2)(a):  (a)
1	1043; 
 

1	health of individuals,
1	section 360i(e) or
1	(g) exclusion of
1	(ii)definitions.in this paragraph:
1	office personnel unless
2	rehabilitated pursuant to
1	finds that drug
1	(i) authority of
2	activity related to
2	index shall not
1	rulemaking.  (3)
2	(ii) which contains
3	case of food
1	pending, (b) when
1	pipe tobacco. (vi)
7	beginning on october
33	application for the
1	shall expire and
1	designed to reach
1	 (b) purposethe
1	regional capacities for
1	compounded drug; (ii)
1	(2) all affected
1	facilities, as defined
1	generaleach person who
2	paragraph (1). (june
1	
 387i. records
1	new coalitions communities.
2	food that was
1	(including the particular
1	2205. food allergy
1	studies. (b) medical
1	supplementary thereto. (i)
1	topics addressed in
1	natural flavor (other
2	 (h) appeal
1	particular drug is
1	(2) that new
1	may review product
1	occurs in or
1	(i) through (viii).
29	days after such
1	study results are
1	identifies specifically the
1	program nothing in
1	drugs which may
1	exclusively of pure
1	patients only in
1	packed, cured, or
1	qualifications for license
1	 (2) name
1	v.  (d)
1	contain poultry ingredients
1	negligently fail to
1	recommendations for further
1	foundation and otherwise
1	record, of all
1	separate radiation disclosure
1	manufacturer of regularly
2	facts and circumstances
1	 (c) storage,
2	information are not
1	practicable methods of
2	suppliers do not
1	processing egg products,
1	development of guidance,
1	effective date this
1	novel properties of
1	available on pesticide
1	device. no such
2	properties of the
4	section 360fff3 of
1	paragraph (1) terminates
1	extent. (iii) -(-naphthoyl)pyrrole
1	hydroponic marijuana facilitates
1	(h).  (2)
1	notice is provided
1	(9) all listed
1	false statement, or
2	failed.  (c)
1	duly authorized consular
1	(c) seizure and
2	outbreak associated with
1	institute is no
1	geographic area and
1	data suggests that
1	advisory committee, be
1	poultry article that
2	full waiver, as
1	received clearance from
2	chapter[1] 21, code
1	proposed labeling if,
1	international crime. (2)
1	additives in or
1	(2) providing for
3	authorized to make
2	evidence to substantiate
1	custom operation is
1	least biannually, the
2	trafficking area shall
2	 (5) nothing
3	classifying the device
3	(a) issue an
8	allowed travel expenses,
2	species of plants
4	determination as to
1	minimize the need
1	another account within
4	records, and the
1	welfare, social security,
2	application was reviewed,
1	states; or (ii)
1	basketball, baseball, soccer,
1	paragraph.  (c)
1	animals, and no
1	weight of on-half
2	state programs under
1	canned, salted, stuffed,
1	(b) labeling for
1	(1) solely for
1	effect unless (in
6	transmittal of recommendations
1	delivered for shipment
1	42 at least
1	title 26, ch.
3	accorded to the
12	drug control strategy;
1	identify a single
1	number of transactions;
1	documents from any
1	 (c) aggregate
1	3, 69 stat.
1	poultry, that is
2	covered application the
1	promotion of, the
6	drug control strategy.
9	drug control strategy,
1	(
 
 462.
1	manufacturer with the
1	review under accelerated
1	funded under section
1	policy that are
1	rigorous than the
1	representatives, that such
1	faith in connection
3	360fff2 of this
1	certain substances may
1	direct the temporary
3	term in subsection
2	controlled substances for
1	section 624 of
1	permanent advisory panel
4	indication for a
1	suspended shall be
1	sponsor, physician, manufacturer,
3	attributes necessary to
2	accredited person through
2	pesticide chemical does
1	drugs withdrawn or
1	(b) types of
1	findings under this
1	(3) biosimilar biological
1	took place. 
1	every certificate granted
1	order, and the
2	shall be for
1	operational and management
1	(2). (b) an
1	confer upon the
2	scientific evidence (other
2	senate not later
4	treatment investigational device
1	clean or remediate.
1	use of rapid
1	requirements (or storage
1	study plan not
1	package or pallet
1	subsection shall remain
1	electronic information, or
1	device or label,
1	1978, to carry
2	title. judicial review
8	may, by regulation,
1	physical form, at
1	(c) identifies future
1	standard is established
1	humans.  (b)
1	patient, if the
1	species can be
2	entered on a
1	proceeding.  (b)
2	regulation of a
1	1711. authorization of
1	drugs of the
16	secretary that the
1	effectively communicate risks
1	 (c) response
1	marketed device. the
1	(3), a manufacturer
1	shall, unless and
1	(a) describes the
1	(directly or in
1	information maintenance agreement
1	(2) qualifying federal
1	misbranding, and not
1	736a, as added
1	food presents a
1	anything done or
1	engaged in drug
1	(n)(3);  (v)
1	distinctive proprietary food
1	contract under subparagraph
1	307, 52 stat.
2	committee on commerce
1	assessed on a
1	medical matters, chemistry,
1	chemical name, or
3	steroid or product
1	trade obligations; (l)
1	ginseng labeling 
1	scope of agreementsthe
1	(c) aggregate amount
1	anabolic steroid that
1	superiors (and before
2	committee the term
2	(4) the proceedings
1	ingredients, and additives,
1	history as available
1	surveillance for pediatric
3	title and without
1	enterococcus; (b) mult-drug
1	(a) such waiver
4	action covered by
3	paragraphs (2) through
1	person, he shall
1	disposed of for
1	no-narcotic ingredients in
1	information, in accordance
1	provided by accredited
1	drug experience. 
1	evidence the evidence
1	decision.  (b)
1	part 1271 of
1	findings poultry and
1	customers do not
2	article is wholesome
1	evidence on the
9	applicable standard prescribed
1	petition filed with
1	pipes; (3) carburetion
2	40 grams or
5	accessible manner, including
1	entity during the
1	public health), such
3	priority review. 
2	exemption is consistent
2	suitable for use
1	steps to 
1	food, or for
1	findings is based,
1	retail druggists, hospitals,
2	applicant from amending
1	may remove any
1	facilities producing both
4	qualify a drug
2	coordination of efforts
2	(b) is determined
1	representatives of federal
1	time be changed
8	within 90 days
1	 (b) domestic
2	poison prevention packaging
1	benefit, taking into
2	trial required to
2	approval fees 
1	limitation. (b)state licensing
1	sector healt-related electronic
1	(2)(d), the base
1	(f) nonsaleable returned
1	labeled in the
1	used) solely for
1	labeled as to
1	homogeneous case means
1	aggregate pesticide use
4	except  (i)
5	labor with respect
1	(ii) internal quality
1	currency, or securities;
1	regulations under subsections
1	writing, signs, signals,
1	articles and shall
1	state or to
1	earlier than irreversible
1	(i) period subject
1	significant loss or
1	receive and consider,
1	(relating to abbreviated
2	individual tobacco users
1	conform to good
1	title solely to
1	registrants (a) inventoryexcept
2	device. (v) the
2	transactions were conducted
2	enactment date an
1	(2) development and
1	results of any
1	secretary, or (ii)
1	district of which
1	know that such
1	evidence of potential
2	disclosures  (1)
13	accordance with a
1	number; and (2)
3	agree to the
1	 (d) restrictions
1	section, or who
1	1-day period referred
1	(2) content a
1	otherwise stated in
1	committed within the
1	expected changes in
2	affiliate, the applicant
1	5. the advisory
1	administer, invest, and
1	(f) a concentrate,
4	risks to health
2	data (such as
1	treatment of retail
1	inordinate amounts (as
1	certain drugs containing
1	(l) public disclosure
2	unsuspended and unrevoked
1	(8) shall provide,
1	standard is included
3	corporation charter act
2	chapter as to
2	contrary is shown,
1	animal to which,
1	shall test all
1	patient groups, and
1	protection agency in
1	concerning  (i)
2	approvable and all
1	condemnation is sustained,
1	commission.  (c)
1	minors. (
 

3	article or any
1	person. (ii) any
1	identified potential hazards
1	clause (i) are
1	(ii) every thirty
1	therefor. if the
1	agency of complaints
1	modification  (a)
1	data, patient survey
2	nicotine delivery devices
6	information shall be
1	precursor chemicals into
3	(f) of section
1	license any virus,
1	treaty or international
4	drugs approved by
1	submission. (2) the
1	container, the secretary
1	756, as added
1	residue. subsection (e)
1	thereof, as provided
7	milligrams per dosage
1	will foster collaboration
1	losses to manufacturers
2	emergency medical reason;
1	frontier area); (c)
1	defined in subparagraphs
1	repackager and otherwise
1	secretary) that prominently
2	poultry products on
1	(g) the manufacture
3	secretary for issuance
1	testing requirements applicable
1	analysis by premix
1	poultry products of
1	electronic or physical
1	(a) cooperative arrangements
1	transportation, and the
2	shipment as aforesaid,
1	relating to veterinary
2	shipment as aforesaid.
1	administrator may collect
1	associated registrations 
1	qualification submissions, through
3	contrary, operate as
1	guidelinesnot later than
5	danger to the
4	notification upon making
2	person that pays
1	renumbered 21 and
1	findings by reason
2	specific timelines shall
1	model standards, including
1	files which 
1	inspection resources. (5)
1	pesticides whose registrations
1	change any existing
2	admission under subsection
1	entitled to a
2	emergency medical reasons
2	chapter; and in
1	ensuring such communication;
1	maintain the health
1	articles from the
1	(n) if an
3	official mark or
2	testimony or production
1	determination, the responsible
6	coca leaves and
1	include requirements for,
1	receiving the report.
1	effectiveness of section
1	opportunity, prior to
2	secretary may refuse
2	capacity are available;
1	841(a)[1] of this
1	shall be utilized
9	use by the
1	listeach person who
1	licensed establishments it
7	made a determination
1	fluids is inappropriate
1	secretary after soliciting
1	numerical count; (c)
1	section 314.70 of
1	complaints and the
1	protocol for ind
1	safe access for
1	report on development
9	dosage form, strength,
4	labeled for use
1	year after august
2	pay for administrative
1	drug substancesthe drug
1	stock in anticipation
1	take effect not
1	(b) compounds the
2	action or proceeding
2	dispenser may return
1	(b)privacy.  such
1	law offenders, which
1	law. (i) confidentiality
1	gelcap, or liquid
67	controlled substance in
1	obtained. the district
2	development program to
1	dependence; and (e)
2	review, and appropriately
1	technologies assigned to
6	feedback from the
1	capability to trace
1	shortage or potential
2	suspended under paragraph
1	general is authorized,
2	(a) to be
1	advance the development
11	right of reference
1	administer or use
2	market value therefor
1	state requirements related
1	found to be,
8	379e of this
1	exists for any
1	effect unless the
1	human food which
1	premarket report, respectively,
1	successor regulations); or
2	principles of operation
5	application refused for
1	proceedings  (a)
1	(a), in carrying
1	set out in
1	safe for infants
1	transactions after such
8	mitigation strategy for
1	conduct pediatric studies
1	dosages of the
1	size two inches,
2	eligible entities under
1	plans for agriculture
1	(f) additional remedies
1	(b), the secretary,
2	drug applications. with
1	(b) is, not
1	delivery for shipment
1	secretary has knowledge
1	2009, a tobacco
1	(f) is approved
1	reports for dietary
1	(ii) a person
1	international, to curtail
2	evidence that 
1	arrest, prosecution, and
1	destination of united
1	government.  (d)
2	avoiding detection or
1	issue that arises
1	year (or, in
1	337. proceedings in
1	submitted and amended
5	distributed for use
1	appropriate, any prior
1	substances. the convention
1	due care. (e)
1	chemical residue bear
3	submitted, the director
1	detention for the
16	controlled substance is
1	confidentiality and to
1	federal government, may
1	(3) duration the
1	furnish full and
1	1703. appointment and
1	be, a violation
1	(including the clinical
1	order requiring such
1	used as or
1	fees nothing in
1	user facilities that
1	expanded access to
1	 (h) exemptions;
3	practicable, the secretary
1	searches of surveillance
1	reclassification, including 
1	thing of value
1	animal drugs or
2	provide due notice
1	recovery for harm
1	package the term
1	expenditure or obligation
1	smoking cessation, including
1	received during the
2	term responsible person
1	service of show
1	(3) approval of
1	regular general physical
1	meet obligations described
1	product radiation; (b)
1	 (n) coordination
1	test or other
2	report annually to
1	animals or preparation
2	title 41; and
2	will be conducted
1	be, the regulation
1	monitoring provisions of
1	clinically relevant to
1	procedurein issuing or
1	paragraph:  (aa)
1	agency a fund
2	rules of criminal
1	general. (
 

1	federal agencies, as
1	$100,000. (4) 
1	(ii) records of
1	purpose.  (g)
1	seeing into the
1	reactivation fee due
1	person, if criminal
4	food packaging label
1	use fees received
2	chapter. (2) no
1	guest, and employee
1	tablets, and lyophilized
1	placed in the
1	involved under paragraph
2	consent to the
1	devices, marks, labels,
1	(2) an animal
1	preempts the authority
1	title 18 that
2	tolerance or an
4	columbia, and any
2	states, the secretary,
2	carcasses, and meat
2	felony under this
1	fee in the
1	take all actions
1	9, 2012, at
2	product is intended
1	hundred and twenty
1	(b) a recall
1	supervision or control
1	establish lon-term clinical
1	procedures regulations under
1	including heroin. (j)
1	eliminating backlogs in
1	money penalty of
1	u.s.c. 262], there
1	animal health; and
1	animal models 
1	experts, including individuals
1	requirements developed under
1	sponsor if the
1	additionally, such accredited
1	19, transfer the
2	conduct of public
2	effect before the
1	racial subgroups. 
1	originally issued or
1	surfaces and utensils
2	(b)(4) of such
1	whether it has
2	(i) an appropriation
1	general, which contains
1	specific regions or
1	attempts to use
1	stocks of narcotic
1	made promptly and
1	
 372. examinations
1	subsection (a)(1)(c), that
1	strategies, for foodborne
1	includes a finding
1	product in which
1	person who committed
1	 cretinol equivalents.
1	sells, distributes, leases,
2	private sector to
10	untrue statement of
3	reduce the risk
1	limitation  (i)
1	applicants opinion that
1	time, as may
3	residue of the
1	no-racemic drug, elect
1	code), and business
1	18.  (e)
2	means each specific
1	postmarket information in
2	applicant that is
1	appropriate. (7) postapproval
1	prohibition it shall
8	foodborne illness surveillance
1	379v. safety report
1	2013. in carrying
1	information submitted as
1	262], there is
8	use conform to
1	reports reports under
2	ii, or the
1	withdrawal of approval
1	detained until released
1	identification required by
1	 (8) definition
1	goals of international
1	28. process in
2	fiscal year unless
1	rule shall 
1	(i) the magnitude
1	required timeframe, and
1	42;  (b)
1	(1) initial approvalif
1	use, any person
1	marking, labeling, and
1	additional -year term.
3	diseases or conditions,
1	isomers.1  the
1	may establish alternative,
1	partnerships with professional
1	specified kinds, or
1	shall issue recommendations
2	success on december
1	(iii) no waivers,
2	shall be appropriately
1	diseases or conditions;
1	contact substance may
1	animals; and (d)
2	reassessmentsthe secretary shall
1	2008 shall be
1	crime of violence,
1	retail pharmacy, hospital
1	flavorings, or such
1	paragraph (5); or
2	exceed 50 per
1	operate from colombia.
1	false statements, and
1	riskmaps and risk
1	application to qualify
1	attending physician or
2	methods by which
1	nonprescription drug advisory
2	person within the
1	verify any records
2	stands convicted of
1	(i)), be considered
1	constituents in tobacco
1	law; and (3)
1	(except for raw
1	food products deposited
1	state agencies of
1	administration receives appropriate
1	significant apparent reduction
1	labeling; personal consumption
1	protocol. (4) the
1	established through guidance
19	(a) shall not
1	shall consult existing
2	advisory committee persons
1	time that a
1	secretary a clinical
1	675, 1014, as
1	categories specified in
2	resulting from that
1	(6) maximum amount
2	paragraph to respond
1	public health benefit
1	pharmacy compounding (a)
1	fraud, perjury, false
1	secretary to unduly
2	3(c)(2)(b) of the
1	identify. (d) applicationthis
1	shall include, in
1	500 miles distant
1	product in accordance
2	subparagraph (a)(iii) shall
1	products deposited or
1	360e(c)(2) of this
2	identification prior to
1	means a contest,
1	article from commerce
5	harm to a
1	periodically review all
1	expire upon the
1	paraphernalia; or (3)
1	lyophilized powders; or
3	person debarred under
1	upon oral or
1	distribute any drug
1	comments in support
1	professional scientific and
1	(h) to no
1	outcome monitoring systems
1	factors for considerationin
3	children and pregnant
1	notice, all violations
1	documentation in the
1	phenylpropanolamine with respect
1	biological product could
1	(
 
 1907.
1	shall license a
1	conducting activities related
1	secretary concludes 
1	least twice annually
1	
 3433. disclosure
1	(b)(1)  (a)
1	initiation of operations
9	responsible person or
1	intended nor shall
1	(c) distribution to
1	(c) notwithstanding any
1	general) respecting the
3	request under clause
3	supplement not supplant
1	unit for purposes
1	from, each manufacturer
37	control of the
1	thereby indicating a
2	section. each such
4	guam, the virgin
2	listed chemical products
1	nations in accordance
1	last inspection of
1	 schedule i
1	may not complete
1	practices designed to
1	different schedule for
1	(iii) is not
14	feed bearing or
1	corporation in any
5	 (a) it
1	predicate device. 
2	action taken with
1	describing the manner
1	provide feedback on
1	treasury.  (3)
1	form as is
1	(4) mission and
1	resources.  (5)
1	(
 
 1101.
1	waive the suspension
1	strategy.  (3)
2	and, upon request
1	(c) shall pay
1	reductionthe deputy director
1	internal committee established
3	timelines for the
20	provide to the
1	extent of such
1	identifiable type of
1	substantially reduce the
4	unfavorable personnel action
3	registrant pursuant to
1	facilities and procedures
1	comments. (june 25,
3	hospitalization; (iv) a
1	medical, regulatory, and
1	2011, complete a
1	paragraph (3), applicable
6	extent authorized by
1	import milk act
1	soon as possible,
1	united states, when
1	letter and any
1	marketing authorization under
2	costs of an
5	failed to maintain
3	drug have been
1	demonstrated to be
1	shall preclude the
2	bribery, extortion, or
2	applicant to manufacture
10	referenced in section
1	chemicals into the
1	contains a request
1	imported milk or
2	waiver under this
1	paragraph, in such
1	compliance with, such
1	(a) by submitting
1	regulated under parts
37	 (a) is
3	manufacturing change to
1	observation. additionally, such
1	decide such action.
1	charged.  (c)
3	suspended under this
1	definition of terms,
1	experts within the
1	patients and health
1	paragraph (4), deems
1	budget submissions of
1	relating to his
1	substance has no
1	(a) power of
1	industry representatives, clinical
1	injured as a
1	able to approve
1	reportthe united states
2	biological, radiological, or
1	submitted by patients,
1	governments in suppressing
1	arising therein, and
1	package is contained
3	giving rise to
1	package for review,
1	include distilled spirits,
1	applies shall submit
1	paragraph (2)(d). such
1	biomedical sciences, which
1	(35) the term
1	part and with
2	eliminate illicit narcotics
1	(ii) report to
2	shall submit such
1	drug as manufactured
1	unique alphanumeric serial
1	shortages.  (b)
1	distributed commercially. such
1	case it shall
1	
 2241. inspection
1	furtherance of a
1	subsection (a). (5)
1	measurement, including an
1	(
 
 2251.
2	effectiveness data have
1	real or personal,
1	export of drug
1	human health from
1	10. (f) fund
1	describing the effect
1	relationship of susceptibility
2	person.  (3)
1	engaging in continuing
3	standardized numerical identifier.
1	including sanitary requirements,
1	order by reason
5	inspection of such
3	chapter.  (2)
1	applicable, providing 
1	restrictions the director
1	implementing the convention
1	sale as a
4	local public health
1	may be regulated),
2	coordination with an
2	infant formula from
1	person, and (iii)
2	followed in practice,
1	petition filed pursuant
1	guidance or practice.
4	approved, that there
1	governing the manufacture,
1	transactions and their
1	 (b) activity
1	ingredient, and cosmetic
1	food means a
1	transitional provisions for
1	effect in aiding,
1	malaria. (c) blinding
1	system; (ii) mitigating
1	impurities contained in
1	(4)(b), (5), or
1	restrain dealers and
1	basis for noncompliance
1	(1) for any
1	
 
 616.
1	produce, manufacture, distribute,
1	initial identificationthe secretary
18	years in addition
1	providers better access
1	trafficker the term
1	(ii) to include
1	organizations coordinating amateur
1	device or, if
1	given away for
1	article were seized
1	obtain by means
1	maintained shall be
1	issuing a regulation
1	patterns, incidence and
1	materials, materials used
29	(ii) if the
1	report that provides,
2	minus (ii) the
1	recommendation is made,
1	involved with regulatory
1	paragraph (1) only
1	drug product as
1	subsection, the unique
1	confidential information after
1	drug product at
3	federal meat inspection
7	value of the
2	rendering conducted under
1	sharing law enforcement
2	appropriate statements of
2	applications received under
1	general shall develop
1	damages sustained as
1	illness outbreak response
1	food that include
2	permitted to remain
1	prohibition of certain
1	of, illegal drugs,
1	objection shall have
1	provide notification 
1	(c) civil penalty
1	product which (a)
1	overall market for
1	meat inspection act,
2	respecting approval of
1	(b)(1) will be
1	suitability as a
1	wherein any act
2	person to distribute
1	360, as added
1	respecting approval or
1	title:1  (1)
1	issuance, amendment or
1	 (2) record
2	liberally construed to
2	final regulations in
1	2016.  (d)
3	secretary so directs,
1	margarine, or (2)
1	met (in addition
1	administer contributions to
1	targeted therapies, and
1	intermittently.  (2)
1	use not referred
1	support a categorical
1	subsection (a)(1)(b) for
1	(iv) that on
1	iv, or vit
1	estimated 9,000,000 americans
1	 (a) product
1	usefor purposes of
3	subsection (c), and
6	poultry products inspection
2	request for labeling
14	 the secretary
1	appoint to each
1	employee submitted such
1	arising from delays
9	excepted or unless
23	subsection (b). 
1	medical evaluation means
2	intentionally  (a)
1	262); and (iv)
2	(f), and (g),
1	individual sale to
1	(c) a representative
1	petition a copy
1	therapy, on patients
1	information and statistics,
1	auditing authorityfor the
1	required to publish
1	withdrawing approval of,
1	secretary through notice
3	state agencies and
1	effect for no
1	fat and any
1	means each request
1	label that clearly
1	general designates a
3	first purchasers of
1	existing prohibition on
1	establishing mechanisms, by
2	involving the manufacture,
1	included within a
1	managing a drug
1	document room of
1	benefits for others
1	dispenser. (12) prescription
1	(2) is unsatisfactory
2	drugs; and (e)
1	class iii in
1	outcomes research activities;
1	invalid, he shall
1	relates only to
1	distributes any controlled
1	safeguard the availability
1	fix compensation of
1	(a) to reduce
1	confidentiality of patients
1	period under such
4	shall act on
3	used to diagnose,
1	consumer research the
1	person in writing.
1	(n) of section
1	joint initiatives among
2	health benefits of
1	listed chemical or
1	title, (5) the
1	patients, and sponsors
2	implementation by the
3	weighted average of
1	(2)(c) of section
2	class iii is
2	health emergency shall
1	country if the
2	technology of the
1	person, after providing
1	fee or reinspection
6	release authorized by
3	fees and other
3	criteria for evaluating
2	prescribe such conditions
1	form which contains
1	(c) enterprise defined
1	date the denial
2	supplement of the
1	use in question
1	ingredients, or additives,
1	brookhaven national laboratory
1	to, the advertising
1	drug laws of
1	early agreement on
1	use, and that
1	authorized the director
1	scientific evidence as
1	applicant conduct postmarket
1	local government to
2	professional background, except
1	provides notice and
1	financial affiliation with
2	stocks of the
1	election not later
1	(
 
 961.
2	adjusted base amount,
1	hospital shall not
3	prepared for commerce
1	issued letters under
2	advisory committee, and
1	affirmations or to
2	previously filed by
1	chemical store, apothecary
1	distributor, or dispenser;
1	secretary may carry
1	strategy; (4) evaluates
1	investigation, regulate, direct
1	(3) provides for
1	appropriation acts. (

1	(b) success in
1	packing such commodities
1	therein. (2) in
4	(a) for any
1	submit the data
2	five years after
1	jurisdiction except that
1	plan under subparagraph
1	refunds  (i)
3	otherwise relating to
1	clinical benefit, and
1	plant species from
1	regulation prescribe, except
1	made. the secretary
1	1996, governing the
1	compensation arrangements made
1	listevery person who
2	objections and make
5	approval specified in
1	eliminate a food
1	
 146. authorization
6	sentence is otherwise
1	likely than not
1	shall register practitioners
3	senate, a report
1	sponsor to conduct
1	effective the drug
1	subparagraph (a)) which
3	3-day period, and
1	
 679a. safe
1	intervention projects and
1	(c) any unusual
1	forms in the
1	exclusivities or patent
2	light of the
1	class of trade
3	final delivery or
1	act administered by
2	therein consisted in
1	diverted; and (b)
1	terms supplemental abbreviated
1	person so arrested
2	secretary based his
1	advanced therapies (a)
5	report required by
1	recommendation.  (b)
1	cautionary statement prescribed
1	appropriations requested to
6	produced by a
2	effective date, in
6	factors as may
1	(and subject to
1	refilling any such
1	litigation costs, expert
1	food system; and
2	discovers a condition
6	developing recommendations to
1	connection with state
1	reasonable relationship to
1	electronic forms of
2	section.  (mar.
1	(2) no report
1	state agency shall
1	health services administration);
1	therefor (which may
1	food; except that
1	requirements for posting;
1	generalsubject to subsections
1	index listing published
1	use with tobacco
1	(e) procedure for
1	(ii) be responsible
1	detailed report of
1	modified. such notification
2	law; (b) the
1	restitution to any
2	publication in such
2	subparagraph (a) not
1	implement the first
1	review any such
1	substance and which
1	sale, to be
1	advertisement includes, in
1	aggregate or otherwise
2	inspected by federal
1	certification contains any
1	formulations; (c) the
1	publication, and public
1	date. the sponsor
2	factor  (a)
1	additional penalty in
2	(1) through (3)
1	agency guidance about
1	proposal. (iii) where
1	 manganese (g)
2	(b) a study
1	flexible as practicable,
1	package security features;
1	licensure that are
2	patient, irrespective of
1	case of section
4	waiver, as appropriate,
1	13, 2016; or
1	pediatric plans, assessments,
1	pediatric disease. (b)
1	imprisonment.  (b)
1	fiscal year specified
1	includes any raw
4	promptly notify immediate
1	investigations, or inspections
5	dangerous, or harmful
1	money as he
1	cover food recall
1	agency. (ii) the
2	standards, and approaches
1	transferred
 
 71
2	medical association, the
2	treated as confidential
1	considered an application
1	(including the department
1	(iv) importation otherwise
1	secrets or confidential
1	use without regard
5	secretary may, under
1	secretary; procedures applicable;
2	incorporated into the
1	issuing such forms,
1	conducted); or (ii)
1	levels and expertise
1	term requestor means
1	person acted to
1	occurred among 1-
3	identifier system that
1	possess any list
3	purpose of reaching
1	general, in carrying
1	states other than
1	foundation shall 
1	public website of
1	applicable federal and
2	within such 3-day
12	case where the
1	construction regarding product
1	(c) certification of
1	twice annually to
1	feasibility of authorizing
1	products manufacturer and
1	new authorities, if
3	(a) submit a
1	center. the commissioner
5	isomers, or salts
7	regulation establishing a
1	vessel having on
1	residue and of
1	rule under this
5	false or misleading.
2	secretary, on an
3	false or misleading,
2	feed which is
1	states and their
1	debarment involved the
1	coalitions. (2) to
2	record or report
1	prescribing requirements for
1	(c) establishing general
1	(a), by january
1	(b) informal petitions
1	radiological (including neutron
1	chapter other than
1	section shall terminate
1	qualified person designated
9	shall make publicly
1	1, 42 stat.
3	subsequent to an
4	section 360j(e) of
2	minority, ethnic, or
1	devices, which were
1	(i), or (j)
1	advertising sufficient to
6	(iv) in the
1	make summaries of
4	regulation exempt from
1	merger of a
6	comments, revise such
1	except advertisements that
1	nonprofit organizations for
6	health and welfare
1	(a) by or
6	subsection and subsection
1	64 stat. 22.)

3	human food unless
1	make the greatest
2	(d) grounds for
1	controls (a) in
1	utilizing updated, recognized
1	
 354. veterinary
2	filled not later
1	expertise to fill
1	therein, regarding the
1	executive director who
1	air, to reduce
1	knowledge of which
3	evaluation  (1)
2	(b)(2)(a)(iii) or (j)(2)(a)(vii)(iii)
2	dispensed in the
1	8, formerly 6th
1	subsection (b)(1); and
1	data that can
1	shall enter amenable
3	refused admission pursuant
1	public dissemination. (9)
1	eventthe term adverse
1	(d) testing and
1	exercises shall be
1	(dd) tentative approval.
1	ultimate user. 
1	(ii) no receipt
5	imprisonment. notwithstanding any
3	drug dispensed in
2	sanitary conditions as
1	(
 
 1714.
2	outbreak and to
1	devices, and color
1	tribal governments in
1	(ii) importation is
3	requirements under subparagraph
1	referenced in the
6	organization described in
7	persons to submit
7	conduct an investigation
1	postmarketing data specified
1	final regulation takes
1	method, and states
1	reports in the
2	requirements respecting the
1	unaffected nothing contained
12	appropriated for such
1	drugs; conditions of
1	avoid conflicts of
2	subchapter iii with
1	competent inspectors, such
2	fee is paid.
1	substance means the
1	title to this
1	(i) designate an
8	rate and extent
2	(d) approving or
2	3 months after
1	iii devices that
1	distributor from compliance
4	ongoing effect on
1	appropriate and relevant
1	egg products found
1	determining the least
4	fiscal year involved
1	case such drug
2	begins, except 
1	available laboratory capacity
1	determines and states
4	construed as limiting
3	[21 u.s.c. 601
3	referral of a
1	number of up
1	approves a broader
3	affix or imprint
1	material facts pertinent
1	251.)
 
 26.
1	impose any limitation
1	governments to develop
1	speed of communication
1	inspection. (4) for
2	rule  (1)
1	professions. in addition,
1	unless a notice
7	commercial distribution of
1	drugs. the requirement
14	subsequent fiscal year,
1	(a), and when
3	subsequent fiscal year.
1	(5) job training
1	consumers and retailers
3	manufacturers and importers
1	 (1) are
1	determine a motion
1	provisions, where appropriate
1	carrier whose representative,
1	fixing and establishing
1	50. repealed. 

3	regenerative medicine therapies
1	(f) if a
1	manufacturing practices (cgmps)
1	reveal the possible
1	extension if applicable.
1	by, any poultry
1	produced, the financial
1	include any analysis
2	date of each
1	$1,000,000, or both.
1	safety surveillance, observational
1	tools; and (c)
1	commodities; (b) include,
1	systems compliance, as
1	 (1) certification
1	drug was a
1	designation of jurisdictional
4	lif-threatening diseases or
3	fee program under
1	aggregated clinical consequences
1	policy to pay
1	treasury may set
1	otherwise be assessed
2	(ii) the application
1	drugs.  (12)
2	(7 u.s.c. 1621
2	25 employees but
1	(2) activities the
1	wholein making the
1	employees nothing in
2	care delivery system;
1	manufacturing practice; prescriptionwith
1	disasters affecting agriculture
1	inspection.  (2)
1	submission for approval,
1	experience identified in
23	submission of a
1	(b) warnings related
4	signal of a
1	(3) for copies
1	director. (4) with
1	criminal case giving
2	360h, 360i, or
3	device or type
1	deceptive acts or
1	need resolution prior
1	build the infrastructure
1	appropriate. (ii) the
2	injunctive relief and
1	5 public meetings
1	(c) submissions of
1	care providers on
2	subparagraph (a) are
1	patient. (3) nothing
1	pediatric patients. (b)
1	proved beyond a
2	2009, a listing
1	4461945318 (august 28,
1	terms premarket review
1	involved may notify
1	wholesale distributor requirements
1	population in a
1	similarly situated persons.
2	qualified for a
1	employees area of
1	poultry carcass or
1	saleable return shall
1	certification of the
1	support, through regulatory
4	mail addressed to
1	area in such
1	(a) any tobacco
1	 (1) programs
1	-year period that
1	335c of this
1	authorized thir-party logistics
1	represents or intends
1	projects, including pilot
3	intent to defraud,
4	paragraph (2), and
2	resumed the manufacture,
2	received for such
1	(1)(b) and which
1	move such feed
1	cause, or exacerbate,
2	congressional committees and
1	information and technical
6	device from the
1	(3) elements to
2	inflation adjustment calculation
1	risk; (iv) available
1	standard is applicable.
1	(a) the delivery,
1	section. the following
5	revenues established in
7	paragraph (2), any
1	labeled with a
3	subsection (a)(1), the
2	5 shall not
1	protocols established under
1	based.  (h)
1	submission for an
1	present statements from
1	inspection under subchapter
1	use only; nor,
6	third party controls,
1	data compiled by
1	considers necessary to
4	(3) annual fee
1	direct or control
1	including public service
1	procedures for fair
1	seller sells scheduled
1	single patient or
1	foregoing substances, excepting
1	acted as a
1	 premarket application
1	technical capabilities and
4	may be found.
1	drugs or investigational
4	meeting of an
2	type to be
2	contribute to the
1	 (d) crediting
2	 (h) definitionsfor
1	including the capability
1	consider criteria such
1	(c), and (e).
1	entity, in accordance
2	revoking a performance
1	reason, he shall
1	chapter, if a
4	(j)(5)(f)(ii) of such
1	become a phenomenon
1	comes within the
1	time period as
1	identified; and (6)
2	calories (such as
1	maintain such comments
2	timelines of the
3	simulation, or any
1	proceeding, or (c)
1	revoke or suspend,
1	raised regarding 
4	chemical designation: 
1	procedures of sections
1	quality, grades, and
1	subchapter by such
1	(b), (c)(1), (d),
1	factor requirements prescribed
1	issuance; procedure for
1	common carrier does
1	formal consultation between
15	title shall not
1	meetings. (7) within
1	472. interstate shipment
1	treatment of pain.
1	use of nicotine
1	intent to suspend,
2	suspending the distribution
1	 (b) first
2	(a) a sudden
1	drug master files).
1	isomers. (4) methylphenidate.
1	licensing by the
1	monitoring program, the
3	(c)(3)(e) and under
3	restaurant or retail
1	(7 u.s.c. 601
1	functions); (b) federal
1	title 5, and
1	action. until the
4	(b), was approved
1	2016, for that
1	(h) upon specific
1	inspection program equal
2	first year. 
2	organizations with experience
1	occur through means
1	held in trust
1	secretary shall attempt
6	effect prior to
1	act as such
1	conservation, wildlife conservation,
1	802(52) and 882(c)(6)(b)
1	schedule ii. 
2	devices described in
1	
 
 331.
1	paragraph; (5) the
1	compound not readily
1	board  (i)
1	less stringent than
2	countermeasures (as defined
2	court of guam,
1	implementation failure; (2)
1	patients for whom
1	narcotic drugs or
1	(bb) conducted or
1	form; (ii) by
1	(or that the
2	offense defined in
1	(b)(1)(d), if applicable;
1	criteria are unavailable
1	authorities in any
4	definition and standard,
1	cultivating or manufacturing
2	certification under this
1	officials engaged in
1	(16) shall coordinate
1	produce such products;
2	who, to the
1	prior, similar acts,
1	label required by
1	education, extension, outreach
11	affected by such
1	another person, firm,
1	agricultural commodities. 
1	demand or projected
1	federal resources is
1	(a))[1] and any
1	consumers.  (14)
2	portion is submitted
1	complete information concerning
7	final, subject to
1	meet any performance
2	states that is
1	(c)coordination.  the
2	due in whole
1	1 of fiscal
1	space shall be
2	creative and talent
1	(20) tobacco product
1	subsection (d)(2)(b). 
1	late payment penalty
10	unless listed in
1	voluntary nature of
2	licensure for wholesale
1	purchase of a
1	services. if it
2	animal, except that
2	foreign factory, warehouse,
1	authorized wholesale distributors.
1	title 18 (relating
1	government, which shall
1	tobacco products be
1	tobacco products solely
1	3-day period following
1	treatment programs within
2	animal health protection
2	up, or otherwise
1	qualifying pathogens, and
2	indian or indian
1	databases.  (v)authority
3	including the centers
1	type, nature, and
1	expired, or for
1	application, a list
1	paid an operating
2	3 years in
1	package level. such
1	675, 510, as
1	will exchange and
1	 (d) notification
4	verification from the
1	(a) be kept
1	due datethe fee
1	regulating virus, serum,
1	obtain samples of
1	committee on appropriations,
1	evaluation of tobacco
1	strengthening that authority
1	 (b) penaltiesexcept
1	good handling and
28	purposes of section
1	open to the
1	submission of strategy
1	drugs from presenting
1	congress; and (5)
1	devices; (4) smoking
1	producing, processing, preparing,
1	(ii) the drugs
1	secretary disagrees with
1	labeling fails to
2	school or college
7	labeling  (1)
4	petition filed on
1	sixty days, or
1	standard than that
3	(ii) a food
1	record and administrative
8	products (a) in
1	drug when it
1	services at points
1	tobacco product, whether
1	effectiveness; and 
2	et seq.], an
1	harm, or abuse
2	safety benefits and
1	administration, a dedicated
6	fee revenues and
1	respecting the management
1	variances granted under
1	violation was found
2	period, the amount
1	(i) 100 percent
1	results of a
1	reasons.  (h)
1	submissionat the request
1	law on which
3	three years; and
1	paragraph (2), after
1	(lsd); (vi) 40
1	28that otherwise would
1	(a)(iii); and (ii)
1	trafficking  (1)
2	level iv of
1	granted review priority
1	title.  (13)
3	allowed under subparagraph
1	referred to it.
1	product containing gamma
18	years 2014 through
1	united states could
1	establish licensing, distribution,
1	school; or (c)
3	food safety audits
1	drug constituent part
1	(3) glutethimide. (4)
4	1, 1982, and
1	young people; and
1	additional information required
5	grants a preliminary
3	manufacturing (such as
1	(l) adverse event
1	include disposal or
1	due to any
1	thereto; (ii) the
1	informationeach online pharmacy
1	section to register
1	
 379r. national
1	authorization pursuant to
1	290aa(d)(16) of title
1	basis, to respond
1	state of their
2	chemical residue, and
1	60 days. (d)
1	understanding, including, as
1	distributes or causes
1	(a) if each
1	(a) posting the
1	induced or attempted
1	53, or 57b]
1	675, 912, as
1	care practitioners authorized
1	enables consideration of
1	
 
 643.
23	made by the
2	387f, 387g, 387h,
3	period for submission
2	records a dispenser
1	product may affect
1	general may, for
1	facility inspection, if
1	format. (c) privacy
5	devices under section
1	national thereof; and
1	applicant at his
1	(5).  (2)
1	diagnostics, manufacturing techniques,
1	(e) proceedings of
1	 (3) new
2	accredited person shall,
1	reapplication for a
2	(1) in generalthis
1	360b(d)(1) of this
1	completed, under section
1	rulemaking. (f) special
1	outlined in the
1	262(a)]. (b) priority
1	time, require the
1	will or may
5	required by a
1	provided that, for
2	partnership, corporation, and
1	regulation of listed
2	(b) the information
1	shall preserve such
1	withdrawal of accreditation,
1	operations  (i)
1	 (o) patent
1	planning under such
3	food products, and
1	pediatric exclusivity any
1	(e) modification of
2	strategy is initially
1	(jwh398); (xi) -(-fluoropentyl--(-naphthoyl)indole
1	radiation and provided
1	suppressing the abuse
1	conditions; entry order
1	expedited and efficient
1	studies. (b) deferral
1	secretary when made
1	previous to such
1	executed under paragraph
1	pediatric exclusivity and
1	subsection (a)(4)(a), and
1	 (i) estimates
2	products for which
1	include nutritional and
1	body.  (nn)
2	substancesthe congress makes
9	(i) the first
2	thereof. (12) the
1	utilize all information
1	(c) (relating to
2	comply with all
1	 (l) annual
1	achieve total fees
2	subsection (d) on
1	operation emits (or
5	made under clause
4	 (1) request
2	system described in
1	defense the secretary
2	human services under
1	licenses notwithstanding section
1	paragraph, or (b)
1	license if the
1	designate the chairman
1	scientist there shall
2	administrator may 
4	kilogram or more
1	information and implement
1	2012; and 
4	information prescribed by
1	(c) trade secrets
1	cream: provided, however,
2	(b). (ii) if
1	product which, when
1	only.  (6)
1	(b), take into
1	factual evidence relevant
1	required rulemaking not
1	establishment other than
1	cancer causing chemicals
1	expiration is authorized;
3	available for public
1	authorized wholesale distributor
5	respect to antimicrobial
1	reports, and supplements.
1	timeline for completion
4	taken from such
2	deemed objectionable, stating
2	competitions recognized by
3	term territory means
1	(1) is deemed
1	(c)(2)(b), that the
1	i, for the
1	substances. (june 25,
3	clauses (i), (ii),
8	subsection (d) or
1	control strategy; (18)
1	accelerated approval, and
3	product, and the
1	destruction or export
2	advisory committee a
8	cause serious adverse
1	posting of drug
1	means of document
1	safe food manufacturing,
2	public.  (d)
1	act, the fair
1	facility, is, collectively,
2	review may be
1	within such time
2	part c, the
1	(j) judicial review
2	holder shall be
1	january 4, 2002,
1	product for each
1	1902. purpose the
1	needed practicable methods
2	used in violation
6	person under subsection
2	(3) which cannot
4	states in which
9	united states; and
3	establish policies for
4	amount of phencyclidine
2	fees and the
2	significant use in
1	(1), whichever is
2	(6) if it
3	shall debar such
1	states may in
1	comments to a
1	policy, practice, or
1	food inspection resources.
1	use in making
1	offer significant advantages
1	noticed; (2) hire,
1	believed by the
1	maintaining adequate security;
2	endpoint is reasonably
1	respecting a petition
1	675, 742, as
1	additional information 
2	 (f) rule
1	applicable, with respect
2	preceding sentence with
1	application; and (5)
1	holds under section
1	(c). (c) discontinuation
1	(x) -penty--(-chlor--naphthoyl)indole (jwh398);
1	interests, and a
1	condition, including any
3	indications of use
1	shall determine that
1	(a) as conditions
3	or, if necessary,
1	secretary may accelerate
1	exported for use
1	tried by the
1	(2) the most
1	distribution of listed
1	person, he may,
17	person to whom
1	purposes of indexing
1	(1). (ii) subject
1	products are manufactured,
1	(a) shall, with
1	scientific expertise, with
1	granted; (b) the
1	
 
 350d.
2	interest means a
1	agency action within
1	exceeds the number
1	(2) is required
4	notification upon the
1	(c) a summary
1	(e) $130,184,348 for
1	upon its approved
4	certified mail addressed
2	purposes of subchapter
1	state statute; and
1	evidence, that the
1	notice of filing
1	properly implemented or
1	(l) new active
1	school nurse, teacher,
1	(3) no exemption
1	(4) compliance with
1	drug prevention and
1	poster, abstract, book,
1	(i) authenticate the
3	privilege against sel-incrimination.
1	nonprescription drug that
1	communication systems to
1	otherwise permitted, by
1	submissions of national
1	acknowledge receipt of
2	prevent the unauthorized
1	(except as authorized
1	higher education; and
2	days but may
1	commitment to manufacture
2	(1)(d) refusing to
1	(j) status of
1	(a)(1) after the
1	reinspection activity, as
1	means any dried,
1	effectiveness. if a
1	country; and (5)
1	substance into the
1	product is manufactured
3	submission (including a
1	owned or under
1	(2) requirements of
1	prevention; (ii) the
1	(h) certification the
2	disposal by destruction
1	2-point type. the
1	drug to treat
1	subsection (c)(3) for
3	violation that continues
1	reasonably foreseeable biological,
1	penalties; acts of
1	fee reduction under
1	or, after tests
1	distribute, or possess
1	arranging, conducting, and
3	secretary by regulations,
1	set forth, as
1	criminal penalty has
2	drug that was
1	law to domestically
1	witness fees, and
1	eligibilityto be eligible
1	shall establish such
1	double the last
2	enforcement resolutions that
1	last entry therein.
2	criminally forfeited under
1	product fully meets
1	limiting the hazard
2	inedible by humans,
2	include prominently and
1	radiation hazard. if
1	material evidence which
5	adulterated, misbranded, or
1	delay notwithstanding subparagraph
4	(1) as a
1	aircraft, or vehicle.
1	ordered forfeited. any
1	radiation safety in
2	device, or (ii)
1	holding meetings with
1	schedule ii. (

1	sufficiently complete to
1	imprisonment without release
1	destroy the drug.
1	public meetings; and
2	70 stat. 919;
1	fixed under this
1	application; (ii) a
1	period it shall
1	witness fees) to
1	establishments) in accordance
1	(1) initial funding
1	pharmacological effects test
1	clarification concerning prescription
1	paragraph (1)(g)(iv) shall
1	complying with this
1	order, taking into
1	knowingly possesses a
1	iii, such export
1	final crystallization, purification,
8	term person includes
2	clinical testing poses
1	unique identification number
1	(d) has been
1	controlsthe term preventive
1	substance for medical,
1	care facilities, as
1	ingredients contained in
1	per product per
1	 phosphorus (mg)
1	sold or available
1	risk productsexcept as
1	(or both) 
2	exceeds an amount
1	conduct such inspection
1	15, 2007, or
1	prescriptions compounded and
1	excess together with
2	drug products distributed
1	present to provide
1	required. (e) the
1	late if the
1	14th par., 34
1	identify such product
1	transaction statement, which
1	began. (c) special
1	drug on elderly
1	known to, the
1	102, or 103
1	term human growth
4	shall refer to
1	$100,000,000 shall be
1	(iii) identifies the
5	number and the
1	specific missions or
2	effect on public
1	state where such
1	government reform; and
1	facility when medical
1	donations and grants
1	extent raised in
1	total annual needs
1	submission under this
1	store to maintain
1	respect to wholesale
1	except the seeds,
1	date the drug
1	subsection (g)(1) or
13	identity, strength, quality,
1	secretary from imposing
1	
 203. application
1	investigation, including 
1	 (i)failure to
1	director and such
1	apply.  (4)
1	coalition  (1)
1	360pp. enforcement (a)
2	final, is subject
1	subparagraph (d) and
1	public availability not
1	countermeasure involved; (b)
1	subsection (a)(3)(b); or
2	food establishment (as
1	ch. 675, 572,
1	secretary designates a
2	final form; and
1	agriculture, as described
1	suspended. (aug. 30,
2	effectiveness, and, if
1	regulations)[1]  (2)
1	(aa) 75 days
3	abuse prevention consistent
5	device.  (3)
1	(d) powers 
1	system to track
1	applicable, identified by
1	claimed to be
1	effective only for
3	secretary shall contract
1	activity has both
1	materials which show
1	concerning ethical issues
1	insert therein the
1	original rare pediatric
4	continues to be
2	failure to agreeif,
1	assist in investigating
1	commissioner, shall maintain
1	regarding anticipated and
1	accept any money,
1	illegal drugs; 
1	1231 may be
1	(1)(c) or (d)
1	petition that is
4	new tobacco product
1	drugs marketed subsequent
1	 (h) relationship
1	referral. within 60
1	unless the request
1	limit of detection
2	supervision a state
1	(b) discoveryif a
2	food safety problem;
1	notification shall also
1	states could support
1	(2) omitted (b)
3	require that an
1	product (but not
1	period against the
3	product, the dispenser
1	directs prospective buyers
1	regarding successful public
8	shall be eligible
1	voluntary and uncompensated
1	notice, requests for
1	controls comparable to
1	(a) this adjustment
1	requirement (a) in
1	(c) any combination
3	procedures established by
1	advertising or the
1	(2) regulations the
2	person, as the
1	(a) any records
1	 (2) waivers
1	(2) authorization of
81	30 days after
1	otherwise by regulation,
1	necessary, a wholesale
2	petition or approve
1	significant decision any
2	section 381(r) of
1	26, 2014, issue
1	include the preparation,
1	specific request of
1	license has not
2	dislocation of, domestic
1	data, or sales
2	will use to
1	brand company manufacturer,
1	establishment at the
3	review under paragraph
1	application), which the
1	 (c) due
3	advocates the use
1	identify susceptibility test
2	chapter on pharmacy
1	75 calendar days
1	advisory committee (a)
1	address a particular
3	paragraph may not
1	petition for exemption
1	substantial changes to
1	elimination of other
1	reimbursed under clause
1	specific data as
1	puerto rico. 
1	(5) that each
1	term new safety
1	distributor from revising
2	drug or bulk
1	fine imposed and
2	agencies specified in
1	percentage of such
1	uni-level system, including
1	flow thereof, and
1	means the substance
2	(e), the secretary
1	recipients of food
1	listed drug during
2	accreditation from an
1	section 360e3 of
2	supplement if a
32	later than 2
43	later than 1
1	descriptions and rationale
1	later than 7
1	human plasma protein
14	later than 5
5	later than 4
1	year, upon application
1	owner.  the
3	later than 9
1	later than 8
1	sponsorship that would
1	procedure.  (c)
3	(3) on the
1	lozenges) for the
1	section 955 of
1	
 379l. education
1	objections. until final
1	reduction, or state,
3	foreign commerce. it
1	methamphetamines from anhydrous
1	statement and such
1	after, the submission
1	misleading mark, label,
1	(j) venue in
1	advising and making
1	 (iii) 28
1	person or representative
1	reference product, shall
2	form, or the
1	facility which made
1	type of establishment;
2	tropical disease; and
1	successfully undergone an
1	accredited thir-party auditors,
3	 (3) priority
2	account both users
1	requirements of repair
1	may, for a
1	569, as added
1	specifying the nature
1	360e(g)(2)(a) of this
1	using the procedures
1	clause (i). (v)
1	drug sample subject
1	services shall determine.
2	article, or means
1	(a)in general.no person
1	method, material, or
2	(ii) which was
1	(a) violation of
1	accepted, preserve such
1	sources of emerging
1	term probable cause
1	person, places of
1	marketing approval; and
1	multiple convictions of
2	interest, the factors
2	later than a
1	included, or (iii)
1	egg handlers specified
2	using appropriate members
1	residue or an
2	include a drug
1	 (1) periodically,
5	incurred in connection
1	person may, with
1	name so as
1	logistics provider licenses
2	type of seizures
1	system of interstate
1	regularly and at
1	persons; murder; protection
3	2 percent of
1	foreign material from
5	unless they are
2	shall be developed
1	purpose of interfering
1	technologies.  (b)
1	benefit; (c) other
1	drugs the development
1	(1) each authorized
1	violent crime associated
19	u.s.c. 201 et
1	drug profits (a)
1	(3) assisted or
4	grant under paragraph
1	product; (iii) provisions
1	made within 180
2	data other than
2	(5) selected establishment
1	
 360ccc2. designated
2	subsection (b)(2)(a)(ii) or
2	cause a review
1	strategy under paragraph
1	dosage form. (5)
1	1986.  (

1	recognize, in whole
2	report, recommendations, underlying
2	using the medwatch
7	drug or group
1	action. (ii) for
1	met; or (c)
2	written request shall
1	notice will jeopardize
1	consider a genuine
1	application, an amendment
1	claimantin response to
1	actual or potential
4	civil action may
1	certificate of registration.
1	paragraph (6). (2)
1	gas if the
1	service, and without
1	assist the president
1	include comments on
1	security guard licensed
1	(e) notice of
7	agricultural commodity shall
1	act.  (9)
1	implant that is
1	whether to designate
1	appointment; duties; regulations
1	maintain for each
1	secure manner. (d)confidentiality.
1	revoke any regulation
1	ultraviolet radiation. (june
1	(oo) the term
1	prosecuting illegal transactions
1	
 
 350l1.
1	abuse research; (e)
1	262(a)] will be
1	compliance with state
1	government.  (2)
1	time, but under
1	subsection (g). in
2	impose liability on
2	subparagraph (b) except
1	product undertaken by
1	(d) a general
1	(iii) information on
1	 (i)in general.not
1	data management and
2	relations and the
2	name of at
1	
 360c. classification
1	highes-risk biological, chemical,
1	(iii) conducting clinical
2	subsection (b)(2) shall
1	necessary as provided
1	reactivation fee 
1	administration the center
1	enter a restraining
1	(i) immediately investigating
1	minerals: calcium (mg)
1	secure the drug
1	(1) any practitioner
3	egg products for
2	labeled or branded
1	moved to implead
1	subclause (i), the
1	health. consideration of
1	foundation, including appropriate
3	food or the
1	access service or
1	suspended  (a)
3	article of a
1	correct errors and
1	consumption by animals
1	(a) cooperation of
1	(2) final report
1	drug; shall be
1	commerce, shall 
1	microfilm, tapes, and
1	(a)(4)(a); (b) that
1	(2) time limitations
1	indexing contains any
2	included on such
1	individuals ability to
1	subsection (f)(1), the
1	filed under a
2	provide for notice
1	application required under
1	(3) request for
1	imported foods 
1	toll during the
1	ch. 675, 920,
1	academic institutions; (iii)
1	person shall, prior
1	independent assessment described
3	license as a
4	secretary provides written
1	countermeasures.  (g)
1	including consideration under
2	regarding the expected
1	dissent from the
1	agencies.  (3)
4	voting members of
1	accountability office shall,
1	nervous system; or
2	online pharmacys internet
1	355(j), or 360cc
2	iii under this
1	authority except as
1	approval, approving the
1	(
 
 1542.
7	years after january
4	makes the determination
1	showing patterns and
2	free of fraud
1	notwithstanding title 5,
1	u.s.c. 552] shall
1	rebuttal thereof) shall
11	registration under this
1	authority of regulations
2	chemical seized or
1	(i) an assurance
1	notification pertains to
1	designation not later
4	subsection (d); and
11	drug for such
1	sections 348, 360b,
32	subparagraph (a) or
1	care system who
1	classification panel organization
1	quotas applicable to
1	
 149. definitionswhen
1	commercial information. (b)
1	(d) to foods
1	drugs may, without
5	fiscal year 2017.
8	days after january
4	section 384a of
1	reviewer once final.
1	standardized documentation to
1	seller specifying 
1	law enforcement entities
2	samples of their
1	date the penalty
6	use or minor
1	quality control of
1	3, 1996, a
1	possess; or (c)
1	affecting pesticide chemical
22	subsection, the term
1	(iii) if such
1	may not include
1	
 399. grants
2	automated risk assessment
1	geographical area of
1	december 31, 2013,
1	professionals who prescribed
1	secretary after november
1	(h) publication; confidential
1	contract under clause
1	agents identified under
8	(i) of this
1	965. applicability of
3	undue economic hardship;
1	including any activities
2	sold, transported, or
1	making such election,
1	federal funds. nothing
1	(c) adopt an
1	area for the
1	 (c) proof
1	provisions (a) violations
1	section 342(c), 351(a)(4),
1	protocol under section
1	(b)(i) shall constitute
1	2007.  (c)
1	 (c) applicants
1	applicable law or
1	chemical residues (a)
2	fiscal year with
2	time for taking
1	ensure coverage of
3	paragraph (2) if
2	entered in the
1	(iv) where based
1	(i) employees of
2	section are intended
1	regulation and harmonize
1	(i), and the
1	user reports for
1	shall rule on
1	assistant is licensed
1	prescribed under regulations
2	paragraph (2) is
8	subsection (a) with
1	inspectors certificates, and
1	(jwh018 and am678);
4	supplement, not supplant,
1	ingredient different from
1	active ingredient. (d)
1	2007. (g) limitationsnotwithstanding
1	section may 
1	warrant; (4) in
1	analysis system to
1	respect to property
1	services shall evaluate
1	timely challenge. 
1	level information described
1	 (1) describing
1	precedent for precluding
2	sunscreen order shall
1	matters subsections (c)(3),
1	subject the purchasers
1	clinical data that
1	investigational submissions. 
1	previously approved, cleared,
14	duties under this
1	thir-party auditors, including
1	products, poultry and
1	biological products across,
1	insofar as those
1	filthy, putrid, etc.,
1	may, within thirty
1	statement referenced in
1	among communities, the
2	exceptions  (i)
1	title, when the
1	discrimination, demotion, discharge,
1	payment of cost
1	chapter; or (2)
1	appropriate relief as
6	importation of a
1	medical gas no
1	(ii) to which
1	agencies.  (4)
3	shall encourage the
1	sent abroad, a
1	approve antibacterial and
1	practitioners professional practice.
1	subsection (c)(3) of
1	communication, except that
2	commission shall be
3	potential benefits of
2	advisory described in
1	made available without
1	consumption, including any
1	animal drug involved
1	week or part
1	receiving the verification
1	enhanced communication (a)
1	determined that standards
4	fiscal year. (d)
6	u.s.c. 1451 et
1	(a) suspend the
21	review of abbreviated
1	judgment in an
1	violation. each violation
1	obtained, directly or
1	count; (c) an
1	rata basis to
2	agreements nothing in
1	gas.  (june
1	title. (in this
1	review the circumstances
1	them, and shall,
2	acts a (a)
1	 (i) date
1	enforcement decisions or
1	section 711(a)(1));[1] 
1	secretary shall, notwithstanding
1	private individuals. (c)
1	necessary, a repackager
1	additional data management
1	
 1104. repealed.
1	 (c) updates
1	information showing that
1	panel; and (d)
1	drug shall upon
1	may promulgate and
1	360e(f)(7) of this
1	(a) through (d).
1	submit information 
1	 (7) no
3	thereof to the
1	applicationupon application submitted
7	poultry, or parts
1	timely submission, review,
1	is, if the
1	drug submission; (b)
8	statutory or regulatory
1	not. (i) federal
1	respect to sunscreen
1	(i), a food
7	approval for a
1	surveillance list published
1	activities with other
1	director may emphasize
1	method of bringing
1	emergencies by 
1	improving the timeliness
1	proof requirements to
3	(b) the request
1	part thereof, or
1	existing controls but
1	dietary problem, is
2	taken as necessary
1	federal benefits set
2	secretary may prescribe.
1	tobacco product any
1	term poultry means
1	term new infant
1	entities engage. 
1	(a) on a
10	product for not
1	grays. (3) nothing
1	applying the provisions
1	associated with issuing
1	
 361. adulterated
1	review under subclause
1	majority vote. 
1	costs (a) overtime
1	revised national drug
1	twenty days is
2	(d) a full
1	shall not permit
80	355 of this
1	registration remains necessary,
2	dispensing, for a
1	controlled, the attorney
1	program established by
1	admission of imported
1	manufactured that basic
1	license in pharmacy
15	filed with the
1	seeds of such
1	health and disease
1	interagency coordination; (d)
1	penalty or expungement
1	access to data
4	paragraph (1), a
1	agency submits its
15	insufficient to show
1	effect limiting the
1	responsibilitiesthe director 
1	drug, any disease
1	design protocols for
3	reference in this
6	(1) shall 
1	subsection (b)(2)(c), the
2	recall. the secretary
1	centum by volume
1	abuse. (h) temporary
1	agriculture, shall promulgate
1	weight of milk
7	prompt notice of
1	book. such bound
1	services shall promulgate
1	deny the request,
1	involved, the secretary
1	practicable; and (iii)
1	(that may be
1	application was delayed
1	product; (ii) provisions
4	subchapter ii. 
1	requirements found by
1	administrator;  (b)
4	(or the persons
1	steroid means a
3	poses a threat
1	fiscal year 2017;
2	evaluating state programs
2	program of such
1	see references in
2	treatment or rehabilitation
1	subject to action
1	staff and may
1	information requested the
1	evidence under which
1	infringe a valid
1	admission if it
1	(b) to warn
1	approved professional labeling
1	alternative to the
1	experience means any
1	information to make
1	special controls provide
1	council determines helpful
1	approval in certain
7	paid with respect
3	outside thereof; or
1	(i) other topics,
1	duty to enforce
1	including early interactions
2	matrix barcode when
1	agent has maintained
1	period of confidentiality
1	2009, respecting the
1	355(i), 360b(j), or
1	u.s.c. 247d6b]). (4)
1	(2) payments to
1	(c) the distribution
1	675, 1002(b), (c),
1	pos-natal toxicity and
1	public health experts
1	8 feet above
1	vehicle includes a
2	otherwise specified, the
4	conducted on an
12	director shall submit
1	precursor is placed
2	establishment to ship
2	request in writing
6	relieve any person
2	authority shall bear
1	section or a
1	tobacco product contains
1	manufacturing practice 
1	ethical business practices,
1	evaluation of effectiveness
1	implemented on a
1	(a). (4) international
1	shall specify. (ii)
1	(
 
 814.
3	(b) the increased
5	upon determining that
1	and/or cutting up
1	act (a) authorities
1	environmental assessment; (f)
1	sale or introduction
1	neonatology, and the
2	(b) recommendations for
1	products that do
3	required for such
1	experience  (i)
1	given that scientific
1	establishment, the owner
2	monograph system; (ii)
1	(1)(c) by majority
1	programs for addiction
2	sections 554 and
1	manufacturing, importation, or
2	party submitting such
1	grandfathering product 
1	subject to twice
1	be, for a
2	classification information, or
1	chemical, includes the
3	 (8) the
1	substances, it is
1	tests and sampling
1	certification as required
1	registration by owners
1	caused significant economic
1	(iii) the consent
3	generic drugs. 
1	executive order no.
2	certifying that such
1	appropriate in the
1	
 379j51. definitionsfor
2	1890, ch. 839,
1	testing involving human
1	amphetamine. (2) -methox-3,-methylenedioxy
1	additional pay by
2	document available in
1	(2) timingnot later
2	 (2) retailer
1	members. the secretary
2	state law and
1	becomes lawful pursuant
2	applies shall be
1	civil enforcement, or
1	methodology to be
1	substances that a
1	persons property used,
1	may allow such
1	name and age
1	milk is the
1	
 379j11. definitionsfor
4	purposes other than
1	general (and of
2	deems appropriate based
1	(e) saleable returned
1	granting such order
1	exception this section
3	(iv) implementing and
1	protocol bringing under
1	meet to 
1	consider the role
1	(a)(2) may apply
1	basis currently available
1	
 379j12. authority
14	fair evaluation of
1	512; 
 

3	term compounded positron
1	use by that
1	permanently implantable or
1	shall receive, for
1	adulteration originated with
1	medication that consumers
1	product that receives
8	subsection (a)(1) shall
1	subsection (i) for
1	filed. if such
4	1605 of this
1	harmful to the
2	medical products; 
1	864. anhydrous ammonia
1	(v) transition ruleeach
1	device notifies the
1	demand reduction shall
2	2018. if such
1	achieve, in a
1	crisis or emerging
1	report setting forth
1	(b) food contamination;
1	supplier may be
1	practitioner who dispenses
1	species; and one
1	equipment (a) sanitary
1	submit, or who
4	considered by the
4	conditioned that the
1	fever. (g) dracunculiasis
1	public health (such
1	period, whether the
1	abuse). (xii) other
1	commissioner.  (10)
1	product. (c) requests
5	administration as provided
1	qualified data summary.
3	voucher  (1)
20	fees authorized under
1	drug that relies
3	performed on the
1	debarred under paragraph
1	title iii, 539,
1	medications.  (

1	disparate data environments,
2	inclusion on the
1	 (d) determination
1	(a) the international
4	listed in clause
1	use (including inhalants
4	maintain a copy
1	day.  (3)
1	organization (including the
1	person that holds
2	commerce by, any
1	logbook for not
1	food; (2) processing
1	transmission of writing,
1	agency shall cooperate
1	shall, through electronic
4	standard.  (2)
4	20 days before
1	premarket review process,
1	specifically stated, have
1	poultry during the
1	sustained the carcasses,
1	conclusive. (4) the
1	provides ongoing surveillance,
1	provided him under
1	consider for the
1	evaluation of submitted
1	patent has not
1	sampled in the
1	experts were utilized
1	means an authority
1	months into the
1	destroyed, or returned
1	product fees based
1	use; or (d)
2	waive the 1-day
3	321 of this
1	 (d) filingany
1	country from other
1	sample required by
5	 (i) appropriate
1	renewed by the
1	defective. (2) 
1	previous -year period
1	numbers or characters
1	defendant convicted of
1	secretary to effectuate
5	apply until the
5	collected for such
1	authorized to carry
2	distribution pursuant to
1	meet the quality
1	less protective of
1	receipts from such
1	minor nature, complex
1	data accessed by
1	 (i) terminating
1	(a) do not
1	without the submitter
1	states swine populations
1	exposure to pesticides
1	apply to wholesale
1	names, inspection records,
1	
 1191 to
1	substance, be considered
1	animal species, such
5	deliberately failed to
1	health, safety, or
13	conviction for a
1	standard under clause
1	daily equivalent to
1	applicable standards of
1	(ii) set forth
1	may be included
1	reference to general
1	purpose of certificationthe
7	material to the
1	exempt from regulation
1	pharmaceutical ingredient facilities
3	(a) to a
1	(a) of all
3	effect under subsection
1	records as are
1	forfeiture event.in this
1	establishment of total
1	control and treat
2	dispenser transfers direct
1	
 360f. banned
3	product applications, and
1	both; (c) whether
1	administration in foreign
1	export, (c) is
1	application generated during
1	 (3) board
1	(a) development and
1	section shall not,
1	conduct such inspections.
1	(a)(3)(b); and (j)
1	fiscal report not
1	(a) final agency
3	processor or reverse
1	consents to have
4	general beginning on
3	(d) suspension of
1	notification or other
1	(2) practitioners licensed
1	food import supply
1	review. (8) if
1	ongoing assessments of
1	authorization is in
3	secretary makes such
1	release of not
1	major accomplishments, objective
1	shall terminate; and
1	may deem necessary.
1	subsection (m)(1) to
1	secretary shall interpret
1	species new animal
1	sponsors research, and
1	includedeach report under
1	marketed device upon
1	distinguishing between expenses
1	(v) retention of
9	attorney general. 
1	congress a revised
1	privileged be produced
1	premarket approval is
1	may coordinate with
1	may include uses
7	time as determined
1	later than fiscal
1	individual for consumption
1	request, (b) if
1	risk identification. 
1	product.)  (2)
1	(1) establish the
1	secret.  (b)
1	similar establishments in
1	enforcement intelligence relating
1	personnel data (other
2	smokeless tobacco in
2	logistics provider. 
1	sidestream tobacco smoke
9	labeling of such
2	may distribute the
2	labeling any articles
19	enactment of this
1	(1) to reduce
1	provision and receipt
2	amount and disposition
1	include the providing
1	medicine, engineering, biological
1	device into class
2	part as the
1	changes.  (d)
2	trafficking threat in
1	possession of flunitrazepam
1	379g of this
1	partners may identify
2	device applications. 
5	involved caused or
1	activities, the use
1	products at retail;
1	term emergency medical
1	thereof has any
2	deferrals and deferral
3	rarity, or prevalence
5	chapter to appear
1	package liners) of
1	prevention; and (ii)
2	petition, may, in
1	1802(18) of title
2	exchange rate used
2	proceeding arising under
1	exemption. (m) list
1	made, and payments
1	conform to procedures
1	president shall transmit
1	needs of individuals
1	section; (b) to
7	reportnot later than
4	device for purposes
1	patents and licenses
1	intermediate or final
2	committed to agency
1	(i) the seller
1	products filed by
1	nicotine through labels
3	chapter if such
1	licensed, or cleared,
1	therewith and shall
2	event, however, shall
1	 (8) even
1	otherwise applicable federal
1	fees an abbreviated
3	draft guidance document
1	order or of
1	379h2. reauthorization; reporting
1	effective date. (d)
1	effect of drug
1	efforts by such
1	workers fluent in
1	approved product: 
1	food supply as
1	list the additive
3	(3) unless the
1	poultry ingredients in
1	prompt approval of
2	based only on
1	warrant it, revoke
3	representatives of other
1	action levels, and
4	individual or $50,000,000
2	variance for a
2	official, as applicable,
1	strategies required by
1	(2) pharmacist the
1	substances having highest
1	official plants; 
1	(111 stat. 2298).
1	consider the extent
1	pending request for
1	apply to or
1	reasonable doubt on
1	government service are
1	includes mail, telephone,
1	permit, such certification
1	commission means the
1	title; (3) one
1	states in china.
2	individual may violate
1	(a)(2) has been
2	360e(g)(2)(b) of this
3	title in the
1	following hallucinogenic substances,
1	confer or imply
1	sponsor (or another
1	health web site
1	implant directly to
1	ingredient or dietary
3	term federal food,
1	established for fresh
2	established in accordance
1	amounts. (5) not
1	101, 67 stat.
1	adverse tobacco product
8	agency of a
1	section 360j(m)(6)(e)(ii) of
1	third party transfers
1	criteria website is
1	described) during the
1	shall deliver a
1	(2) rather than
1	exemptions should be
1	notice and publication,
1	(4) the individual
1	regulations made by
1	intangible personal property,
2	cosmetic or class
3	seizure under other
1	petitionsthe secretary shall
1	ch. 675, 403a,
1	manufacturers, distributors, or
2	on-half years are
1	upon his prescription
2	subsection (a)(3), or
1	days after service
15	commerce for commercial
5	reported by the
2	amendments of 2013
1	remain liable for
1	(d), the prohibition
1	imprisonment. (e) 
1	delivered, distributed, or
1	study when reevaluating
1	notice if an
1	(4) a description
2	registration filed pursuant
1	facilitate enforcement of
2	issues relevant to
1	clinical trials for
1	application, reinstate the
2	disease priority voucher
2	members  (i)
1	5. (c) recognition
1	applicationsthe secretary may,
1	address the total
2	application is intended
1	practices if it
1	(v) later withdrawn
1	thereof. it shall
1	(h) role of
2	determination of such
1	return, the transaction
1	withdrawn unless, such
2	 (2) dissemination
1	facility manufactures active
1	distributor.  (c)
1	standard established pursuant
1	$280,000,000 for each
1	presents or has
6	judicial district in
2	 (3) contentthe
2	nonprofit, private entity
1	misleading shall be
2	complying with such
3	basis for a
1	making such determination,
5	making such determination.
3	drug before the
2	compounded under subsection
1	order. (3) the
1	necessarily result from
4	iii, or iv
1	agents used by
1	smuggled food and,
1	given to inspections
2	use; (b) a
2	pure and applied
1	completeness of such
1	reporting requirements. (h)
3	methods to ensure
1	development, approval, licensure,
1	(f) application of
2	that, for purposes
4	subsections of this
1	manufacturing industry not
1	whose behalf a
1	drug marketing, advertising,
1	supplement the funds
1	breach of such
2	secretary may forthwith
1	diseases; (3) the
1	maintain its label
1	material, and use
1	subsection (a)(3) for
1	applicationthe term tropical
1	information, upon the
1	placement under seal
1	human health, and
1	day following publication
1	injury to mean
4	april 1 of
4	order should be
1	appoint and fix
1	1204; amended aug.
1	encapsulating machine. each
1	control program. such
2	history of a
1	measures to guard
1	process for countermeasure
2	international opium convention
1	egg products required
1	different symbol shall
1	affect of treaties
2	payment  (i)
2	defined the word
4	schedule, any of
1	topics being considered
2	2013.  (ii)
3	meaning of clause
1	transfer of funds
2	fiscal years ending
1	adverse events that
1	feed but not
1	modified devices. in
2	ii device which
1	 (1) trends
1	card that provides
2	subparagraph (c)(ii) by
1	educational, or professional
1	advances; (b) improving
1	(a) have as
2	24, 1984, no
1	abuse. the state
1	preservation of originals
1	(14) of section
1	develop and provide
2	color additive, as
2	standards.  (2)
1	included under this
1	paragraph may only
1	(b) is compounded
2	programs.  (b)
1	delegated.  (f)
3	additional testing and
1	prohibited by the
1	subsection within the
1	possession having the
2	exemptions the secretary,
1	may, when so
1	5 days of
1	adolescents (61 fed.
1	(3), accredit persons
1	(iv) an anesthetic;
1	meet new needs
1	repacking establishment. (june
1	administration, including field
1	identify elements under
2	entices, or coerces
1	subsection 841(b)(1)(b) of
1	(i) pursuant to
1	inventory; and (viii)
1	veterinary drugs are
1	meeting prior to
1	consideration for inclusion
1	food facilities subject
1	drugs with pediatric
1	 (c) notification
3	timeframe, and the
1	program during such
2	committee meeting for
4	(other than the
1	proposal. (4) to
5	inspector general of
1	 (iii) requirement
1	attorneya united states
1	shall apply, if
1	accurately identify whether
1	(i) has different
1	section 2223 of
1	risk of exposure
1	act with respect
1	medical device; 
2	custom basis, or
1	involving the forfeiture
1	inspection panel established
2	facility that has
1	(g) execution upon
1	official establishment means
1	connection therewith; the
1	iv, 411, formerly
1	whether any such
1	(3) n-cost match
1	approval or hearingwithin
1	paragraph (g) and
2	place a poison
1	amendments to correct
1	article of the
1	committee on commerce,
2	investigation.  (c)
1	products through the
1	statementthe head of
1	nothing contained in
4	disease associated with
1	review means an
7	review, the secretary
1	section 505e of
1	property forfeited be
1	applicable shall not
1	includes any device
3	holder of a
1	whether the individual
3	respects in conformity
37	supplemental animal drug
1	practicable, information for
1	admission a report
1	reductions in exposure
2	deputy directors 
1	category of drugs)
3	agency center charged
1	class iii. (b)
1	substances in research
7	number of dtc
2	authorizing the seizure
1	testingthe regulations under
1	likely to contain
1	reclassification of certain
1	(ii) the identity
1	enforcement agencies needed
1	involved shall in
1	use; and (ii)
1	food, temperature controls,
1	(a) is authorized
1	determinations of complexity,
2	pediatric patients studied,
1	products who discovers
1	written verification which
1	300hh10 of title
1	pharmacy will only
1	studies, with all
1	subsection, provide reasonable
1	title;  (15)
14	owner of the
1	(a) an officer
4	federal, state, tribal,
1	inadmissible under the
1	designating such drugs,
1	development protocol was
1	biological fluids is
1	schedule of controlled
1	states. (b) guidance
1	 (b) alternative
1	declaration as the
1	affects poor and
2	upon conviction be
1	donated or supplied
1	(f) shall be
2	guidance document that
1	administrator may designate.
2	of, domestic and
1	(1) a separate
1	2016), and annually
1	may be compensated
1	so, shall not
1	6. transferred
 

2	supply chain against
1	devices, as determined
1	exercise due care
1	respect to activities
1	fac-t-face transactions to
1	period involved for
1	necessary to recall
1	(m), 360ccc1(i), 360e(f),
1	plans  (1)
1	justice provision of
4	section 14 of
1	product (after the
3	food, or that
1	stat. 1087, as
1	sel-directed personal assistance),
3	farm directly to
1	package level, are
2	document providing an
2	registration issued by
3	proceeding; or (ii)
1	enforcement activities on
3	submit the application.
1	applicants knowledge that
1	intentionally adulterates a
1	average annual change
1	audit interviews of
1	 (3) staff
1	general has excluded
2	safety requirement of
1	(i) is capable
1	importation; and 
1	(b)(1) of the
1	importer be adequate
1	paragraph within 1
1	(b) shows that
1	effectiveness or state
1	assess scientific literature
1	respect to perishable
1	violation in the
1	enforcement purposes; (5)
2	organic program established
1	distributed, or offered
1	public health. regulations
1	limits so fixed
1	distributed such tobacco
1	prescribing practitioner, the
2	type of technology
1	attached.  (e)
2	competitive service, appoint
2	wel-controlled clinical trials
2	recommendations on whether
1	except sections 360b(a)(4),
1	conduct or submit
1	imaging; (b) electronic
6	provision for early
2	notification, and any
2	recognized as safe
1	1997; and (b)
2	device of another
1	360bbb3, 373, 374(a),
8	specified in appropriation
1	dispenser, on a
1	submitted the initial
2	biological and physical
3	jury trial; united
1	equivalents.  drequired
1	limit shall be
1	paragraph (1) so
1	completely eradicated in
1	ingredient as that
1	prescribe, the inspection
5	 (6) minutes
1	regulate such commerce.
1	1997, the secretary,
1	(3) identifying best
1	preclude a state
1	regulation published pursuant
1	(1) is entitled
1	operated wholesale distributor
2	(2) the report
1	product. for all
3	shall verify the
1	apply to forfeitures
1	consultation with appropriate
1	imitation butter or
4	effective on 
1	
 
 604.
1	authority under subsection
1	quantity or both
1	said manufacturer by
1	studies that result
1	survey of drug
2	products and may
1	status of productan
1	person present to
3	united states; or
2	applicant shall file
1	humans.  (e)
2	regulations and policy
1	180 days for
3	may, on a
1	42 (not including
2	shown to meet
2	adulteration of food.
1	reasons not satisfactory
1	petition, if issued;
1	medical gas for
1	u.s.c. 247d], except
3	consumers be protected
3	accredited person and
2	adulteration of food;
1	web sites, in
1	product radiation control
1	drug administration, shall
1	drug in safety
1	$268,443  establishment
1	thereto. (r) the
1	ii chemical means
2	written determination as
1	poultry products broker
1	identifier affixed to,
1	clause shall prevent
1	take or refrain
1	provide fuel or
1	expenses, (2) defraying
1	advertising which resulted
1	(j) definition in
1	 (1) deadline
1	program authorization (a)
1	systems for drugs.
1	ability of individuals
1	seized under any
1	assessed biosimilar biological
4	applications and supplements
1	21, 1997, to
1	(a) the request
2	consisting of such
1	(i)) prescribed, recommended,
1	title, and received
2	device included on
2	subsection (d)(3) 
3	secretary describing the
1	tolerance, the secretary
2	theft and diversion
1	title; (r) facilitating
1	jurisdiction, until such
2	(c) content of
1	time before trial
1	ingredients and finished
1	tanks of the
1	9, 2012. nothing
1	promote, to the
1	educational loans relative
3	pediatric study plan.
1	distribution of medical
1	tobacco, in any
1	(3) audit report
1	businesses, in complying
4	pediatric study plan,
1	utilizing the registration
2	determine  (a)
1	distributor; (iii) take
1	(a) may, on
1	hashish, or less
1	exported if it
1	(e) public health
1	drug proposed for
1	priorities for reviewing
1	(b) meets the
6	may return a
2	inform the secretary
1	distributor is temporarily
1	title; (e) feedback
1	health, provided that,
1	 (a) share
1	 (d) to
1	combination (including any
1	state of food
1	(a) coordinating the
1	permanent but to
1	1801 to 1804.
1	foreign owner or
2	present evidence and
1	(
 
 2204.
1	foundation to the
1	ultimate financial responsibility
1	religious belief of
1	services.  (iii)
1	section. (e) suspension
1	regular basis regarding
1	
 360bbb0. expanded
1	title) in accordance
3	packaging, transporting, or
1	position of organizer,
1	property may be
1	petition not later
1	mandatory recall order
1	title shall upon
1	promulgate regulations identifying
1	salts. (k) pseudoephedrine,
1	name the term
5	devices, or tobacco
1	stamped or tagged
1	[42 u.s.c. 247d6b(c)(2)(a)(ii)];
1	expected completion date,
1	punishment may be
1	state officials to
1	incubation; (6) if
1	owner, or anyone
15	secretary makes a
4	either a single
1	monitored; and (v)
1	
 
 379aa1.
1	accelerated approval under
2	person upon first
1	required bond in
1	persons  (i)
1	human use as
1	timelines in such
2	pharmacist in a
5	shall continue in
1	subparagraph shall meet
6	reprocessed singl-use device
1	local educational agency;
1	(
 
 884.
3	paragraph (3)(a). 
2	misbranded and is
2	skill of officers
1	(1) or an
1	 (c) except
2	information, related to
1	director may submit
5	specified by regulation
1	labor charges for
1	involved to the
1	grant in accordance
1	person by whom
1	period extending beyond
1	eligible coalition means
1	(a) rulemaking not
1	drug, ship such
1	42; (3) the
1	premarket review may
1	2-hour period after
1	(a); (c) assessing
1	1997).  (2)
1	 (n) third
3	authority of section
2	listed in subparagraph
1	requests and budget
1	agriculture, in carrying
1	commitment of state,
1	greater than twice
3	articles into such
1	man); the virus,
1	(d). (b) returns
1	remaining 20 per
1	compounded drug due
1	including specific actions
1	points of entry
1	(a) and (d).
2	purposes notwithstanding subsection
1	availability of which
1	distributor for a
1	goat or equine
1	financial or technological
1	secretary reasonably believes,
2	country or countries
1	act means the
1	foo-producing animal use
4	project or undertaking
1	termination of exemptions
2	semipermanent or permanent
1	one time the
1	analysis, a controlled
1	section 213 of
1	(1) ingredient standards
2	advisory commission. 
1	public comment, interim
2	harm from a
1	entity has developed
1	required, the secretary
1	agency has prescribed
1	(1) has materially
2	 (2) compensation
1	tw-year period beginning
9	transmitted by the
1	 a drug
1	antibiotic drugs, including
1	hearing.  (y)
1	subsequent processing and
7	collected pursuant to
1	(2), the responsible
1	providing the identity
1	(2) informal petitions
3	attorney general, and
1	provide standards for
1	requiring the attorney
1	maintain the capability
1	inference; (ii) the
3	september 30, 2010,
1	administrator for good
1	extent determined practicable
1	respect to fruits
2	file to pay
1	shorter than the
1	available market data;
1	(ii) the absence
1	1543. membership (a)
1	regulations within 1
1	(n) review of
1	(3) make arrests
3	(or regulations issued
2	2009, the following
1	active ingredient per
1	human studies. 
1	effect.  (8)
1	drug, or (b)
3	action brought in
1	appropriate, during the
1	[21 u.s.c. 355(c),
1	(e) service of
1	beginning the assessment;
1	food purports or
1	person receiving reimbursement
1	agent has performed
2	(2) if such
1	secretary for his
1	sought and if
1	874. advisory committees
1	postmarket no-compliance letters
1	existing and proposed
1	ch. 675, 422,
1	secretaries, permit him
2	business premises, facilities,
1	voting members, with
1	general shall dismiss
5	protection as the
1	 (iv) records
2	 (2) types
1	
 
 387q.
1	dismiss, the claimant
1	director or a
1	program to support
2	shall prepare a
1	counseling and other
1	states, the submission
33	court of appeals
1	(i). (c) reimbursement
1	amounts of crude
1	intake. (c) supplying
1	public and nongovernmental
4	committee on agriculture
1	data required in
2	whether this subsection
4	divided by such
1	(d) feedback from
1	changes not requiring
1	otherwise facilitating the
1	subpena issued to,
1	information any content
1	foreign government using
1	distributor, or retailer)
1	(3) transmittal of
2	42, and that
2	constituents (including smoke
1	products thereof, offered
1	outsourcing facility requirement
1	imported, exported, manufactured,
2	 (1) eligible
1	projects to be
1	whenever such determinations
2	respecting the classification
1	appointed jointly by
2	regulations providing for
1	distributor if the
2	exemption from labeling
1	laboratory test results;
2	outside container or
1	intelligence relating to
2	intended to protect
1	(3) application of
1	250.0  
2	cleared under this
1	meeting under subparagraph
1	16. introduction into,
2	within the centers
1	basis, on the
2	study of a
1	prescription of such
1	quotas under section
1	raise the cost
1	(b), (b) which
1	review under clauses
1	applications an abbreviated
1	cooperative enforcement and
1	conviction thereof, be
1	similar standing, medical
1	paragraph (2)) with
3	shall report its
1	emergency circumstance where
1	materials under section
2	published, the secretary
1	reasonable terms and
2	responsible for food
1	enforcement strategies; and
2	drug application, shall
2	secretary, or (2)
12	3 months of
1	second country that
1	responsible use of
3	court such modified
2	(1) by 
1	integrity, and effectiveness
1	manufacturing, storing, distributing,
1	1-day restriction does
1	accordingly. the administrator
1	or, if it
2	plaintiff  (1)
1	finding required by
1	terrorism risk assessment.
3	will  (i)
1	establishing such effective
1	advertising, or (b)
1	received a grant
1	tons of marijuana,
2	subsection (c)(3)(e)(ii) of
2	paragraph (2) 
1	isomer. as used
1	(ii) the manufacture,
3	type of tobacco
1	drug trafficking threats
1	account shall be
4	convene a meeting
1	designation. if the
1	times, any factory,
1	observed by him
1	fact to the
2	receive those payments
1	subsection shall provide
4	term commerce means
1	customer or regular
2	basis upon which
1	(2) importer definedfor
1	misleading, the secretary
1	353b of this
1	subparagraph (a)(ii). (2)
2	use or a
1	waiting period the
1	chapter. members of
1	relevant declaration under
1	effectiveness and availability
2	investigation as described
1	interstate commerce, pursuant
1	standards of this
1	exception established in
5	shall affect the
1	delivery, handling, storage,
2	 (a) whether
2	order. a copy
1	(c) indication of
1	market on june
1	conflicts of interest,
2	date of registration
5	conflicts of interest.
1	designate a date
1	control plan in
1	device, and the
1	lieu of an
22	schedule iii, iv,
3	allowing the entry
1	(1) the compound,
1	manufacturer that are
1	displayed on the
1	secretary supplemental applications
1	inspection of egg
1	authorities; release whenever
1	applicant; and (b)
1	council.  (b)
1	secretarys interpretation of
3	reason of his
3	whoever, in the
2	harm and no
1	chemical; (3) has
4	entities engaged in
1	either scientific procedures
1	shipped. (e) the
2	ensure that duplicate
1	foreign commerce of,
2	promptly be made
1	appropriate involvement and
1	different electronic products
10	drug approved under
1	 (1) bulk
1	manufacturer, including data
1	general, subject only
1	(2) notificationif, after
1	experts.  (b)
1	secretary determines necessary:
1	transgenic animal means
2	annual budget request
1	services shall consider
2	disposition by such
2	ii  (i)
2	investigation, the condition
1	year; (ii) be
1	performance standard, for
4	year, and a
1	control strategies designed
1	revocation of such
1	(e) include such
2	administration for fiscal
1	carry out paragraph
1	
 
 1708a.
1	 (c) prioritization
1	 (b) treatment
1	offense any person
1	(b) persons ineligible
1	(1) coordination with
1	disclosed information. paragraph
1	section (where known
1	product manufacturers before
3	establishment; and (c)
1	section 309.. 
1	revenue amountsthe applicable
1	health records; (b)
1	letter could cause,
1	unit level tracing
2	 the person
1	decreasing the quantity
2	domestically grown tobacco.
1	modified accordingly. if
1	(2) all expenses
1	(a) provide standards
1	economic productivity. (5)
1	including appropriate limits
4	manual of policies
2	(6) if any
1	register before the
1	8 percent of
1	proposed guidance. (g)
2	approval of only
1	22 and amended
1	labeling changes the
1	mortem inspection for
1	age.  (b)
2	conditions applicable to
1	interchangeability described in
1	abuse. (c) upon
1	distributor as specified
2	forth the process
3	term priority review
1	performed each year.
1	secretary, carry out
1	center shall operate
10	drug product that
2	paragraph (8), not
1	lack of accepted
1	admission under this
1	(g) the items
8	period of debarment
2	criteria for being
2	5 as such
2	device may not
1	claims arise in
1	medically insignificant for
1	regarding any issue
5	testing of the
1	information or included
2	question of whether
2	intended for irrigation,
2	information provided on
5	year 2009, the
1	intent to suspend
1	granted and maintained,
2	2013, no state
1	prescribe)  (a)
1	approval supplement fee,
1	exposure of humans
1	supplements, and may
1	(d) outreach to
1	pharmaceutical purchase data
1	united states originates.
1	deem it necessary,
1	order, issued under
2	reflected in its
1	bears a reasonable
1	decreed, the court
1	subsection (d)(1)(b). 
1	appropriately qualified health
1	originals of prescriptions
1	states district courts
1	agriculture), or other
1	act; or (2)
1	industry sectors, including
3	outcome described under
2	title. in considering
1	article, is prohibited
1	necessary to safeguard
1	funds obligated or
1	purchase at retail
1	tobacco leaf through
1	approved drug in
1	refused an inspection
1	pharmacies, and other
1	(c) storage, cartage
1	lack of jurisdiction,
2	(3) if any
2	first year of
1	forth his claim,
1	notice or opportunity
4	section 332 of
1	country; and (iii)
2	medicine, or poison,
1	standards pursuant to
2	general in accordance
1	additional requirementsa drug
1	judicial review an
1	orders must recite
1	section; (4) direct
9	listing pursuant to
1	producers slaughter not
1	constituents.  (d)
1	damages.  (7)
1	year; (d) the
1	 this paragraph
1	restrictions on such
1	however, and is
1	user; and (2)
1	food safety fees.
1	402, as added
1	license, the person
2	substance shall expire
4	procedures to ensure
7	paragraph (4). 
1	seafood  (1)
1	property is used
1	means a laboratory
2	sold directly to
3	secretary that a
1	develop business recovery
1	 (iii) record
1	maintain patient access
1	purpose of unlawful
2	release of lots
2	rules established by
2	periodic reevaluation of
3	chapter, the federal
1	counterfeit drug means
1	slaughter; or (6)
1	party shall, at
1	pinball and/or video
34	(1) the term
1	foundation the foundation
1	1948; or (c)
1	provide access to
1	(6) consult and
1	body of water,
1	nongovernmental organization providing
1	single drug or
1	states to sell
3	may, under such
1	extrapolation between subpopulations
4	5 percent of
1	(c) contentthe assessment
1	1977 (7 u.s.c.
2	medical needs for
1	(v) shall not
30	(i) in general
1	approval if a
1	composition; standards of
1	made in advance
1	consider approving the
7	shall assess and
2	party against whom
1	months from the
1	person has discontinued
1	payment of illegal
1	source, and (b)
2	comment period a
1	4 years, except
1	proposal.  (3)
1	dividing the fee
1	facilities; and 
2	access to medical
1	smokeless tobacco to
1	packaged in unit
1	term practitioner means
2	information relates to
1	processors, or packers
3	respect to food
2	designated personnel the
1	transferred
 
 1506
1	regarding the meaning
3	issuing the guidance
2	conditions, has become
1	(iii) list the
1	(2) limitation of
1	either (aaa) a
1	clearance prohibited to
6	shall file such
4	benefit of the
1	adequate warnings or
1	(a) for further
1	drugs distributed and
2	submitted, the secretary
1	prevention functions, and
1	1, 1997. 
1	issues concerning an
2	scope  (1)
1	technology. (iii) the
1	final sunscreen orders.
1	dying, disabled or
1	actions as necessary
1	user fees (a)
1	 (1) intelligence
2	containers standards of
1	area of device
1	premises with respect
2	made effective if
2	take such additional
1	(f), each establishment
2	beginning on july
1	departments discharge of
4	made effective in
1	product that may
2	section.  (m)
1	exposure of man
1	division, or pursuant
1	device submissions to
1	studies), including in
1	institute for food
2	united states delivers
2	subsection for such
1	labels a tobacco
1	assure that they
5	shall be allowed
1	food industry, agricultural
1	transferred, sold, or
3	previous source of
2	u.s.c. 262(a)] after
1	sunscreen order, which
2	awards the third
1	donated or otherwise
1	project.  (d)
1	reduction agencies; (c)
1	effect on certification
1	$2,575  $3,200
1	sweet milk of
1	carcinogen, or otherwise
1	law (if the
2	explicit or implicit
4	(v) records a
1	qualifies for a
1	significantly lower risk
1	subchapter ii. it
2	facility is inspected
1	(e) a review
1	(b) policies the
1	dosage form, dosage
1	eggs, eggs with
2	activities, and research
1	ingredient notification submitted
1	trial or appeal
1	1804. repealed. 

2	served by any
1	health. (j) withdrawal
1	providing timely advice
1	submitting the request
1	center, or a
1	diligence; (b) a
8	representatives a report
1	reported; and (ii)
1	acts as a
4	802(6) of this
1	review.  (iii)
1	reports made pursuant
1	label shall state
1	 (b) periodically
1	(b) the poultry
1	 (ii) special
2	activities as the
1	requesting waiver. 
2	concentration as to
1	(vi) urging physicians
1	including the recognition
1	pathogens on meat,
1	u.s.c. 262(h)]. (c)
1	positive for controlled
1	sponsor proposes any
1	best interests of
1	presumption of reckless
1	comment may be
1	industrythe secretary shall
1	serve as ex
1	means inspection, building
2	advisory committee act.
2	filing, or was
1	(b), shall develop
1	involved.  (8)
1	shall use to
1	preceding provisions of
2	waiver because there
2	applicant, and each
1	safely employed for
1	chapter at such
1	v for maintenance
1	approved product), including,
1	origin and at
1	otherwise would not
1	responsibilities or interests
5	subsection (b), and
1	limitationssubsection (a) does
2	applications or supplemental
1	subchapter (a) the
1	material fact, the
1	equivalent employees in
1	person. the requirement
1	submissions under this
1	homeland security seizing
1	will be free
1	report or reports
1	necessary expenses incurred
4	amount of methamphetamine,
1	title unless it
3	permit to export
1	refusal to testify
1	(d)(iii) shall be
1	 (6) review
1	subparagraph (a), except
2	notification any establishment
25	final sunscreen order
1	public; (iv) 1
2	practicable means is
5	variant protein targeted
1	shipper thereof shall
1	responsibilitiesthe united states
1	determination by secretary;
1	title is approved,
1	 (a) months,
1	professional candidates, which
1	industry, to foster
5	requirement of such
1	1961;  (2)
1	transaction that is
2	medical evaluation of
2	secretary, upon the
5	solely because the
1	not; the seeds
1	586, as added
1	 (3) engage
1	11, formerly 9th
1	appropriate offices within
2	substance that may
10	fiscal year 2018.
1	 (iii)recipients of
7	fiscal year 2018,
1	agency that conducts
1	4 and amended
1	powder, or such
1	serve, the number
1	include the name
1	total number applicable
1	monitoring and control
1	obtain a listed
1	package  (1)
17	assurance of the
1	360b, 360ccc, or
1	substances, the congress
1	recall or vacate
4	approve the application.
1	request, to conduct
1	 (2) effectnotwithstanding
1	18. (c) meaningful
1	factors in making
1	approve the application;
1	pending animal drug
1	centralized database; (f)
1	demonstrations respecting devices
1	including the sciences
1	description of funding
1	bringing the secretary
1	identified patient, the
3	product is encoded
1	commercial information that
1	product fee for
1	(d) two or
1	time and circumstances
1	labeling thereof, the
1	(c) eligible partnership
1	feasible outcome measures,
1	drop shipments 
1	 (m) categorization
1	(i) shall affix
1	approved abbreviated new
1	fiscal year, no
3	executive capacity. 
1	qualified entities. 
1	describing the results
1	 (c) administrative
2	reasonable for the
3	secretary shall keep
1	1962, shall not
5	(b) payment; fee
1	release material, reagents,
2	international transaction in
1	prevail on the
1	scope of legitimate
7	term state means
1	columbia authorized by
8	combination of ingredients
1	law of such
1	administration for issues
1	potential hazards associated
1	contaminant level provided
1	stakeholder groups, including
1	regulations including such
3	 (a) requirements
8	100 grams or
1	submitted during the
1	among the voting
1	terrorist offense occurs
1	fully consistent with
1	willing to serve
1	2002, the comptroller
1	pharmaceutical dosage forms
1	title, may require.
2	manufacturing, distribution, or
1	public disclosure, as
1	third and fourth
1	regulations for a
1	guilty of perjury,
1	high risks associated
1	subpopulations, and any
1	title, may require,
3	possible to develop
1	investigation; and (ii)
1	may impose on
1	programs the secretary,
3	establishments in which
1	serious illness. (june
1	firm distributes a
1	products containing foreig-grown
1	effectiveness data for
3	acted in good
1	employment involving the
1	fees as will
1	importers required to
1	(b)(3), and (d)
1	make competitive awards
4	phenylpropanolamine base in
18	secretary  (a)
2	secretary.  (k)
1	grower cooperatives, nor
1	approvable form (which
1	(a) any regulated
1	willing to serve,
1	device; (ii) the
1	general notwithstanding any
1	regulations after the
1	675, 528, as
1	restrictions on sale
1	 (5)[3] restrictionsthe
1	regulations may provide
2	varying sizes and
1	endpoint to be
1	(2) may not
1	method for the
1	amount required to
1	following whether produced
1	revisions not later
1	accompanied by labeling
1	devices are not
1	section 353(b)(1) or
1	(4) each part
1	trust fund established
1	disclosure statement or
2	business of manufacturing
1	amends and finalizes
1	pharmacy profession. (3)
2	electronic product is
1	(g) limitationsubject to
1	applications (including such
1	uses a priority
1	establishments identified in
1	(c)) and such
1	register of sales
1	benzilate. (15) psilocybin.
1	industr-accepted standards. the
1	regulations will potentially
2	day after such
1	call of either
4	entered by the
1	public. (
 

1	professional, industry, or
1	 (aa) signing
1	is, at the
1	inadequate requests if
1	barriers to improvement,
1	criteria website, and
1	subsection (d)(2)(a). 
1	administration on 
1	secretary with an
1	(e) order within
1	tolerance and all
1	clause (i), providing
1	registry.  (l)
1	publicly the foreign
1	treatment of communicable
1	forge or alter
1	969. contempt proceedings
1	publicly available. (b)
1	direct effect upon
1	abbreviated application; or
1	respects with the
2	state court, within
1	(only with respect
1	access to pertinent
1	except as inconsistent
6	357 of this
1	 (e) staff
1	(c) such term
2	offense have become
2	(without a waiver
1	developing data to
1	review related to
10	information contained in
2	restraining order under
1	administrator required to
11	60 days before
1	material of any
1	plans for assessing
2	(2) consultation the
1	 (g) suspension
1	acquired under authority
1	period expires, by
1	drug interdiction; (ii)
1	human services, with
14	submission to the
1	deny the requested
1	(d) programs to
1	(ii) to mitigate,
1	standard; (2) a
2	administration related to
1	article under bond.
1	august 6, 1996).
1	bioterrorism.  (b)
1	acres, income, the
1	notices, requests for
1	(e) any adulterated
1	part therefor. 
5	recall of a
1	safety surveillance and
1	marketed device, and
2	submission required by
1	food certified under
1	determines to treat
1	functions; general policies;
1	shall survive, notwithstanding
1	path publi-private partnerships,
3	(a)(1) of this
1	monograph exists under
1	occurs first. (b)
1	title; (2) to
1	populated with the
3	intimidates, or interferes
1	strategic action plan
2	fiscal year at
1	no-academic outings and
1	violates a provision
1	order. (e) rule
1	numerical identifier shall
1	nations economy; (2)
1	year following that
1	manufacturer from completing
1	(d) includes information
1	qualified adul-only facility,
2	(b) affects more
2	extend such ninet-day
1	without further regulations
2	searchable database of
1	of, such reasonable
1	shall, for a
1	term dru-free communities
1	submit the report
1	stamp, mark, tag,
1	shall be tailored
1	 (2) enforcement
1	employer demonstrates by
2	secretary accepts or
1	service agreements the
1	title approving an
1	and, following approval
1	many of which
1	sponsor has plans
2	skill, or services;
1	biologic, food, cosmetic,
1	serve, or distribute
1	reasonable questioning, and
1	board does not
1	
 965. applicability
1	evidence, and applicable
1	secretarys discretion, has
2	filing determination under
1	obtain informed consent
2	name or person
1	sources, (c) detect
1	admission. if the
7	fungi, or other
1	milk; milk defined
1	costs of qualified
2	section for residues
1	consumption, sale, or
2	authentication, and tracking
1	slaughtering cattle, sheep,
2	section 360(b)(2) of
1	requirements established through
1	(d) the costs
3	drug as determined
2	data and/or information
9	2017, the secretary
1	 (4) notification
1	health risk than
1	broader indication for
1	act. the secretary
1	preliminary evaluation of
1	activity or program
1	samples by means
1	investigations, such as
1	(f) awareness effortsthe
1	practices, including fingerprinting
1	(2) the document
1	person. (b) procedure
7	product, or cosmetic
1	circumstances described under
1	retail consignees receiving
1	shall apply. 
2	chapter is held
1	regulate the shipment
1	unless such violation
1	training in building
2	(ii) limit work
1	sale after reasonable
1	package  (a)
2	matters as may
1	u.s.c. 3501 et
2	conducting the process
2	safety grounds unless
1	device. (6) the
1	entity is a
2	admission, except as
1	package labels solely
1	expertise needed by
3	understanding of the
2	considered one violation.
1	commissioner. the commissioner
1	assignment of a
1	develops -year and
5	sponsor and the
1	 (c) inclusion
1	(5) codein--oxide. (6)
1	obtaining the information
1	statement, transaction history,
2	conformity with respect
4	issue of patent
8	whether the secretary
1	upon heroin or
2	carcasses for residues
3	matter (1) upon
1	forfeiture. (3) the
1	 (a) registration
3	application described under
1	gothic letters in
1	appurtenant thereto) intended
1	adulteration within the
1	403c, as added
1	burdening of such
1	(42 u.s.c. 262);
1	622. bribery of
1	nonapplicability of provisionsnothing
1	2016).  (e)
2	reviewing division is
2	drug master file,
1	telemedicine (a) in
9	disclosure under section
1	determining or being
2	state to take
1	communication, experts on
1	(2) a continued
1	 (ii)request for
3	any, shall be
1	satisfied that grounds
1	products or diminish
2	partial waiver because
1	trial in the
5	upon the receipt
1	cigars and cigars
2	court of one
1	(b) for media
1	decision. findings of
1	storing, distributing, or
1	residue standards that
1	(a) diversion control
1	accreditation standards applicable
2	obligated for inspections
1	agency to enforce
1	(1) notice of
1	iii became effective
3	jurisdiction in all
1	economic analysis, carrying
2	reasonable written request
1	event occurring in
4	upon approval of
1	recognized or reputable
1	use).  (2)
3	criteria standards or
4	meet the standard
2	flexibility for small
1	objections. the presiding
2	request.  (iii)
1	records requested by
1	services that any
1	recovery plans to
1	subparagraph, the authority
1	amount which would
4	article in the
3	factual and legal
1	projects shall build
1	producer thereof, other
1	jurisdiction  (a)
1	(b) to cover
1	show such compliance.
6	transport, offer for
1	established under subchapter
1	subsection (c)(3)(a), and
2	qualitative and quantitative
1	title, a biomaterials
1	ineligible for federal
1	estimated collections for
2	another person; (3)
1	listed drug if
1	(2) in this
3	joint military intelligence
1	regulations. for importers,
1	dimethylthiambutene. (19) dioxaphetyl
1	invited participants as
1	budget determined under
3	listed drug in
1	inserts; (ii) a
1	(2) consideration of
3	(1) shall submit
1	subparagraph within ninety
5	person may be
5	360d and 360e
1	notifies a firm
1	transporting, and storing
1	vanilla, coconut, licorice,
1	officer shall have
1	(
 
 1180.
1	shall forthwith appoint
1	consultation between any
3	sold: provided, that
4	relevance to any
2	mar. 16, 1950,
1	organized crime and
1	(b) procedure 
1	u.s.c. 2601 et
1	
 2106. consultation
1	evidentiary basis for
1	person may by
1	liability solely because
1	statistical data and
1	formulary, and all
1	performed with respect
1	track product, under
10	employees, and advisory
1	application to meet
29	name and address
1	condemned by reason
1	packaging, labeling or
1	(iv) 10 grams
1	found, without hearing,
1	outside the high
1	withdrawn, or such
1	program designed to
2	counterfeiting of tobacco
1	transport milk and/or
2	transaction statement, and
1	may include government
3	country of destination
3	iii under paragraph
1	thereto under subsection
1	marketing practices and
2	authorities of such
1	(k) report preceding
1	condition of specified
1	(a)(1)(a) or (a)(1)(b).
5	component of a
1	initial deadline provided
1	government, or entity
2	(ii) provisions for
1	(ii) humidifies tobacco
1	food regulated by
1	food or as
1	including requirements regarding
1	issue of forfeiture
1	distribution or possession
1	(2)(a), respectively. (c)
1	subchapter; and (ii)
1	disease product distributed
1	41; and (4)
1	prevention under the
1	internet, pursuant to
1	commitments to determine
1	lien against future
1	members could work
1	audit and examination,
1	review shall conform
1	certification that its
1	section may consist
1	agreement was reached,
1	made. requesting designation
1	provide for coordination
4	exemption if the
1	pharmacological action and
2	(iii)offer of confidential
1	setting and other
1	specify the measures
1	2012) but such
1	include uses that
11	will be used
1	title.  (v)
1	code of 1986
1	requests for variances
1	performance; periodic evaluation
1	shall not authorize
1	official establishment in
1	generaleach regulated seller
1	(f)(2) shall take
1	sections 351, 360,
6	shall immediately notify
1	assembles, maintains, places,
1	of, a violation
1	public disclosure, for
1	secretary, promptly after
1	paper) shall not
2	notification and other
1	unless otherwise provided
1	releases information in
1	(a) if all
1	lot.  (8)
1	consumers for use
1	shall sign adjacent
1	include programs designed
1	regulation requirement (a)
1	used, or produced
1	no-narcotic drug which
1	order and reinstate
1	show the health
1	micr-organisms during the
1	articles or animals
1	particular actions to
1	data and action
1	will enter the
1	1996, limit the
1	secretary may review
1	radiation from electronic
14	illegitimate product, the
1	appropriate of a
1	playing a significant
1	continuing series of
3	application of section
1	person may introduce
1	13 of the
1	supplements where the
3	device under subsection
4	use under this
1	limit the designation
3	secretary that such
1	corporation, in commerce,
1	26. (b) subparagraph
1	chapter); and (2)
1	prescribe such practices
1	relief including, but
1	supplied under subparagraph
4	(g) rule of
1	343(x) of this
1	limitations in section
1	considering such risk,
5	(2) every person
1	 (a) responsible
1	longer exist; (b)
2	system the secretary
1	decision regarding the
1	following indications for
1	provisions for devices
1	normethadone. (33) norpipanone.
1	(5) there is
2	 (3) status
1	small units of
1	product, and does
1	may be used,
1	may require, through
1	both, up to
1	allocation results in
1	submissions.  (9)
1	financial affiliation (including
1	based. (2) revision
2	meeting the goals.
1	communities seeking assistance
1	minor change under
1	period under clause
2	including information concerning
1	employee.  (c)
1	extent resources are
1	subparagraph, publish in
27	filed under subsection
4	official), as necessary
1	exporter to possess
4	(6) the secretary
1	audits under clause
1	subsequent transaction, the
1	exemption were not
1	written information relevant
1	commissioner.  (2)
2	(1) periodic audits
2	measures that are
1	use in institutions),
1	authorizationthe secretary may
1	request, be afforded
1	(b) examples of
1	electronic product to
1	impose sentence upon
1	consist of 1
1	(4) public availability
1	regulations prescribing appropriate
1	form, containing such
1	subparagraph (b), submit
1	law enforcement efforts
2	support the goals
1	states and improvements
1	general, bears a
1	evaluation process described
2	1971. in determining
1	constituent means any
1	interest in having
1	retail establishments accessible
1	(e) prohibitionsnone of
1	shall consider where
1	(b) expiration dating
3	needs identified in
1	data that led
2	employee or contractor
1	make such letter
1	obtain an approval
4	establishment and the
1	(b) because it
1	writing, editing, printing,
2	substances to the
1	consider, in addition
1	advertisements will not
1	order after public
1	geneva on february
1	(c) (except as
3	using the methodology
1	carcasses only in
2	product application shall
2	headed by a
1	responsible parties, as
1	airflow) to at
1	individual production quotas;
2	355e of this
1	medical product means
1	may include such
1	(e) the dissemination
1	18.  (7)
3	vacating of order
1	configuration) combined with
1	 (a) amendments
1	therapy have the
1	exemption an application
1	product to individuals
1	regulation require. 
1	request from congressional
1	bear on its
1	
 
 355f.
1	account of narcotics
2	(k) orphan drugs
5	secretary may waive
1	review the activities
1	consortia and may
2	list with respect
3	(b)(1) for a
6	section 342(a) of
1	granting such exemption
4	person provided an
1	food other than
1	states in conformity
1	(a)(ii) or (b)(ii)(ii),
1	emergency resuscitation, when
1	30, 1979, there
1	16, 1988, whichever
2	animal drug shall,
1	shall limit the
1	discontinuance in the
2	eligible establishment is
1	suggested or recommended
1	away any cocaine,
1	designate the device
1	organizations may report
1	individual quotas from
1	inspections of establishments
1	determining the specified
1	thereof thus inspected
1	designate, by stipulation
1	inspect and copy
1	listed chemicals, all
1	order, stating the
1	(1) requirement of
1	need and the
1	july 1, 1976,
1	services or property,
1	liabilitythe biomaterials supplier
1	products as required
1	warrant. (2) a
1	effectiveness why the
1	distribute the device
1	(f)(i). notwithstanding the
4	dissemination of the
2	sale in interstate
1	formerly 742, as
1	petition relates to
1	sel-executing requirements except
3	(2) any drug
2	stay the effectiveness
1	42. (d) termination
1	coalition are sel-sustaining.
2	revenue code of
1	22nd pars., 34
2	required surveillance. the
1	health; (2) identify
3	perform such reviews
1	74, 3, 38
1	(8) intergovernmental cooperation
1	prescription unless renewed
1	42, and any
9	regular places of
42	u.s.c. 301 et
1	seq.) is required
1	achieve the goal
2	require the production
1	yaws. (q) filovirus
1	upon interstate commerce
1	(b) affirmation or
1	(1) small open
1	paying the fees.
3	amount under clause
1	paying the fees,
1	approve the petition.
1	address potential conflicts
1	(iii) a type
4	may file objections
1	article, court costs
3	case, pallet, tote,
1	report requirement not
1	secretary to object
1	office under subsection
1	request the nominating
1	number. (iv) the
1	dialysis solutions; (p)
1	occur if the
1	designation for nonenforcement
1	process with respect
1	test applied by
1	purposes by federal,
1	include any report
2	(d) coordination between
1	of, or keeping
1	subparagraph (b) as
1	(ii) -(-naphthoyl)indole or
4	631; 
 

1	(b) purposethe director
2	entity), or a
1	enforcement proceedings before
2	states to a
1	offering to fill
4	article is adulterated
1	furtherance of, or
1	identifier system to
1	 (8) compensation
1	declaration, order or
1	capable (alone or
1	section 321(g) of
1	services may prescribe,
1	origin; authority to
1	secretary determines, through
2	state of incorporation.
1	categories of such
1	including technical assistance,
1	communication (a) submissions
1	committee for the
1	scheduling order for
5	amount of funds
1	(c) state cause
1	
 355b. advers-event
2	applying the factors
1	spices, flavorings, or
3	identifier (except as
1	change of ownership
2	controlled substance subject
1	applicable percentage 
1	device (under conditions
1	facilities in accordance
2	treating, packaging, transporting,
1	 (i) responding
1	diverse working group
1	
 379d. automation
2	shall post on
1	infrasonic, or ultrasonic
2	shall review all
4	artificial flavoring, artificial
3	continues after the
1	534, formerly act
1	(b)(3)(a) shall not
1	services shall, to
2	raise different questions
1	education and nonprofit
2	establish and carry
1	ch. 675, 567,
1	partnerships are critical
1	person is on
1	manufacturer, the recall
1	shall be fixed
1	2014, an application
1	(b) evidence the
2	381(e) of this
1	persons, including a
2	bear, in distinctly
2	agency for national
1	expertise within the
1	labeling changes required
1	regulations, as described
3	recommendations from the
1	(ix) such information
1	sources including the
1	subsection terminates october
1	administration relating to
6	chemical residues in
1	paragraph; or (ii)
1	prosecution is brought.
1	 (2) major
2	i-person meeting or
1	title, adulterated under
1	delegation authority the
1	health professional organizations.
1	government that share
1	control; procedures respecting
1	(including patients, family
2	use whether or
1	development programs primarily
1	entity (or such
3	provide to a
23	year under this
1	device; (iii) establishing
1	registration for inspection;
2	years.  (f)
1	margarine when served
1	manufacturing (a) in
2	morphine or being
1	director shall certify
1	 (p) safety
1	ch. 675, 419,
1	repackaging and safely
1	misbranding, or violation
1	waiver under subsection
1	reg. 4439644615 (august
1	protest, as described
2	fees and operating
1	future potential electronic
2	states shall be
1	section. before issuing
2	person engaging in
2	subsection (b) may
3	generaleach person that
1	6, as added
1	1542(a)(1) of this
1	agreements on confidentiality
1	patients;  (b)
1	research can be
4	mailing the order
1	license, taken by
1	preventive strategies. (d)
1	bringing the individual
1	select an accredited
1	dispositions or otherwise
1	international trade. in
1	subparagraph; (v) is
2	may require for
1	years after october
1	secretary approves or
1	title; (iii) facilitates
1	penalties, by a
1	controlled under federal
1	secretary) that the
2	equip, and maintain
1	transferee establishes in
2	least annually, review
1	title 42), security
9	subparagraph (b), the
1	displayed on any
2	species outweigh its
1	site, in such
2	(a) the disease
1	document related to
1	services; continuation of
1	approaches to the
1	secretary finds the
1	tobacco manufacturers and
1	make the conduct
11	reports under subsection
6	nurse practitioner or
1	chooses not to
1	(ii) enhanced requirements
3	to, or that
1	amateur athlete means
2	opportunities for the
50	site of the
1	controlled substances a
1	congress under paragraph
5	business entity if,
1	substance exempt from
4	drug that the
3	engage in business,
4	notice referred to
3	limited to analytical
1	persons from receiving
1	title; (b) in
1	(q) schedule for
1	4721, 6001, and
1	identical to an
1	agency that has
1	youth today will
1	substance, any label
1	first country) and
5	available to carry
2	operated by such
3	additive that is
2	products. (g) the
1	including developing the
4	(k) of section
2	strength differs from,
5	 (i) provide
1	bad faith, the
1	management and operation
2	specific diseases relevant
1	(e) and other
1	water regulation referred
1	state by that
1	42 and 
1	product.  (26)
1	approve, license, or
1	1046. imports (a)
2	general denies the
9	includes  (i)
2	(2)(b)(i), as applicable,
1	strategy not later
1	necessary to oppose
1	unless there were
1	ch. 675, 524,
5	products, or cosmetics
1	agency has developed
1	individuals, and (ii)
1	substantive review and
7	issue a proposed
1	smuggled food that
1	denies any allegation
1	purchases. (b) creative
1	use have been
1	inspections related to
3	used to determine
1	19 and 20
1	injectable liquid) which
1	work performed to
4	earlier, the period
1	hearing, shall confirm
1	studied under such
1	may not 
1	abroad, including 
1	tomography drugs solely,
1	exclusivity any extension
1	entered:  provided,
1	section 360(h)(3) of
1	(2) the biomaterials
1	transactions quarterly, not
1	office of supply
1	analysis methods.the secretary
1	(a) records inspection
1	supplementsany application or
2	submission, 3-day notice,
2	order is applicable,
3	356(c) of this
1	produce the copies
1	title (or a
2	subparagraph (a)(ii). (c)
1	channels; and (6)
1	expected to detect
1	area, and between
2	attorney general provides
1	last two sentences
1	(7) all real
2	transferability the sponsor
1	responsible parties described
2	oversight  (1)
1	exclusivity under 505a[1]
1	tobacco; (ii) does
4	operate as a
3	chapter upon removal
1	sections 274a.2(b)(1)(v)(a) and
84	shall be made
2	intervention to preclude
1	(7) shall notify
1	paragraph (5)(b)(iii), and
1	uniform national policy
1	 (g) administration
1	little cigar means
1	uses of drugs;
1	fields of youth
1	advisory committees, including
1	pose a greater
4	containing such information
1	tobacco product experiences
2	certified under paragraph
1	report, a fee
1	containing information necessary
1	30, 1914, ch.
1	submits a complete
1	services of outreach
1	deems proper. the
2	results required by
1	vacancyany vacancy in
3	sections 46, 48,
1	section. (d) regulations
1	permit the selling,
1	used.  (c)
1	6, 44 stat.
2	overdose reversal, and
1	section pending its
1	4, 2011, enter
1	marketing of sunscreens
1	contains may be
1	representative designated by
1	unless the specified
1	products at points
1	review of incomplete
1	action and which
2	sold over the
1	exchange of transaction
1	therapies derived from
1	(
 
 1050.
1	provide for waiver
2	eligibility for other
1	recall under subsection
4	use of aggregation
1	review. (iii) the
2	appropriate congressional committees.
1	adequately protected from
1	drug use. (6)
2	information about food
1	issuance of license
1	education, entities described
1	relationship between individual
1	poison the pharmacist
1	secretary may share
1	butter, cheese, or
3	notice required under
1	abuse of drugs.
1	knowledge, including quality
1	abuse of drugs,
3	times a priority
2	body, or the
1	drug approved in
1	(ii) has different
2	343(g) of this
1	safety criteria used
3	audit of the
2	articles not intended
1	applicable food when
1	violation, degree of
1	captures signatures in
2	increase the likelihood
2	sponsor means either
1	quality shall be
1	4 years for
1	(
 
 1532.
1	subsection (d)(2) of
1	precursor of a
1	1708a. annual report
1	pound or less,
1	hazards and provide
1	names in official
1	possessions); or (5)
2	 (b) consultation
5	offices of the
1	emergency use authorizes
1	section 802(39)(a) of
2	transaction statement associated
1	ensuring efficient and
3	conditions is met:
1	emergency use authorized
1	justice and such
1	material fact concerning
3	(b)(1)(a)(ii), the secretary)
1	phenmetrazine and its
7	may by general
1	container of product
1	product is administered
1	22, 2009, shall
1	farm under this
1	expertise in areas
1	rehabilitation activities, and
1	risk of experiencing
1	rare pediatric diseases.
1	(c) explanations for
1	submitted is not
1	(a) health care
1	need therefore) orally
1	utilized efficiently and
1	standards for required
1	cans containing not
1	administrator, the secretary
5	future plans of
1	(iii) shall, if
2	use if he
1	substance. the findings
1	acquired, held, and
1	human use may
2	secretary to classify
1	special controls required
1	360ccc1. index of
1	board. a device
1	petition includes all
1	dispenserthe term dispenser
1	person, identify other
1	information to women
2	shall preclude, delay,
1	public hearings instituted
1	submission is withdrawn,
2	number of samples
1	title, of all
1	consistent and systematic
1	enforce restrictions on
1	early warning and
1	local data; or
1	drug containing as
1	committee), for review
1	advertisement, except for
1	also find that
5	limitations  (1)
1	(
 
 841.
1	order is subject
1	listed chemical; waiver
1	commercial or charitable
1	recordfor purposes of
1	held, may not
1	analogue to any
1	(3) inapplicability 
1	united states, involving
1	plan and implement
2	container (not including
1	improve attribution of
1	sunscreen orders that
2	device a banned
2	subsection (a)(1), or
1	(d) assure that
1	grase means generally
1	registry to which
1	(1) commencement of
1	title; (2) a
1	detoxification treatment, a
1	(1) respecting a
1	license the thir-party
2	item qualifies for
1	formula powder and
2	include a list
1	funds transferred to
1	contractors, (b) management
1	 (a) fostering
1	employee, including a
1	(a) of all,
1	(d) the name
1	advertising, or, if
1	delegated and the
1	indicate which substances
1	area. such regulations
1	services to carry
1	appropriate books, papers,
4	used for, its
1	supplementary thereto. (y)
1	filled by appointment
1	(including, to the
1	 (5) prohibition
4	supplements, and premarket
1	prohibitionsnone of the
3	premarket report, or
1	applicant has a
1	regulation prescribe procedures
2	employment or office
1	test interpretive standard
1	(g). (3) if,
4	operates any establishment
2	listed chemicals. (

2	illegal gratuity, or
1	facts in addition
3	made during the
2	informationnotwithstanding any other
3	necessary; and (iii)
2	made publicly available.
1	stay such effectiveness
3	 (2) applicability
3	identifier system is
2	advisory committee member
1	prescribed by subparagraph
1	(3) such article
1	 section 342
1	regulatory efforts with
7	marking, labeling, or
1	defendant is found,
1	standards regarding the
1	certification appropriate for
1	charge or for
1	establishment during such
1	manufacturer seeks to
3	controlled by a
1	compel, nullify, void,
1	 (2) submission
3	(b)(1) for such
1	order to assess
2	chapter, include prominently
1	pseudorabies is completely
1	article does not,
2	review vouchers under
1	state  (1)
1	submitted but not
1	(ii), the comptroller
1	submitted, the administrative
1	drug administration review
1	355, 357,[3] 360e,
1	prior order issued
1	entry of united
3	submit an annual
1	carcasses (if the
1	applying for the
1	index of legally
1	registration issued to
1	orders in proposing
1	licensed pharmacist, licensed
1	condition as a
1	govern the timely
1	chapter; and (2)
3	age group are
3	burden on the
1	(1) such amounts
3	term misbranded shall
1	bottled drinking water.
1	anhydrous ammonia, or
1	programs, by developing
1	involved.  (i)
1	application is reviewed
1	new scientific information
1	
 
 360hh.
1	(b)(3) if a
1	combination interferes with
2	practicable methods for
2	population served by
1	(3) recommendations to
1	aureus, and vancomyci-resistant
4	of, or the
1	entity.  (6)
1	standard. for the
1	together in what
1	military departments; (5)
1	intentionally violates a
1	70 stat. 512;
1	entity, or (ii)
1	believe that an
1	(i) provided by
4	4 years of
1	accreditation, or the
1	aircraft for the
1	inspector means: (1)
5	fees  (a)
1	another type of
1	part shall affect
1	laboratory supply will
1	cost in each
2	501(a) of such
2	(including a statement
1	states with jurisdiction,
1	use by attorney
1	designed to 
1	pesticide chemical, the
1	appropriate, the public
1	care providers of
2	(6), or (b)
1	subchapter. (7) all
1	plan or any
1	drug, unless an
1	(b) review employeesfor
3	first 3-day period
1	hearing and at
1	articles, are separated
8	product manufacturer or
27	laws of the
1	secretary may, upon
4	specifically the subject
14	case may be,
1	hearing and an
1	whose activities threaten
1	studies under such
1	reasons any such
1	74, 12, 38
2	organized territory, in
2	conduct required for
1	pesticide residues resulting
3	distributes, receives, holds,
2	human use that
1	proceeding communicates to
1	subsection (a)(4) is
2	attorney general issues
2	listed drug, information
1	administration is included
1	(a) pharmacies which
2	ultimate user, no
1	egg, fish (e.g.,
1	drug crisis in
1	(ii) submit additional
1	food additive, and
1	26, 2014, under
1	(b) based on
3	respectively, not been
1	clinical hold. 
1	 (a) lif-supporting;
2	submitted in unclassified
1	interstate commerce. (d)
1	(b) nothing in
1	
 99. repealed.
3	 (a) provides
1	recruitment activities under
2	sold at lower
1	care goods or
1	payor, committee, or
1	authorize distributors of
1	(iv) such application
2	360b, or 360e
1	abuse programs to
1	knowingly distributes a
1	november 21, 1997);
1	violation, except that
1	order into a
1	fee account (1)
1	food is shipped
1	patients such medicines
1	extent the active
1	effect a published
3	findings on the
1	(d) provide notice
1	 (1) audits
1	determination.  (2)
1	30, 1974, and
1	otherwise handling poultry
1	meaning assigned to
1	-methy-2,-dimethoxyamphetamine. (8) ibogaine.
2	quarterly basis, submit
1	will refer to
1	content of reports
1	2004, and amended
1	steroids if such
2	references in subsections
1	paragraph (2) applies,
1	(2) workload adjustmentfor
1	shortage; (iii) plans
1	appropriate authority 
1	(b) reporting the
1	reprocessed, with respect
1	labeling act, or
1	paragraph (2), including
1	691. omitted
 

1	(1) the safety
1	timely action the
3	significant number of
1	programs. (
 

5	state, the secretary
1	(c) review upon
1	person informing such
6	whenever the existence
1	written reports of
1	innovation act and
1	establish regional capacities
2	waiver under clause
1	(4) prohibition no
1	standard of section
1	pediatric patients; (c)
3	voucher shall pay
1	custom preparation by
14	manufacturer, packer, or
3	(ii) a petition
1	injury,  is
1	(
 
 1037.
1	(a) policies and
1	registration described in
1	may require, when
1	(including under this
1	places the product
1	request described under
8	section 355c of
1	inform any human
1	(iii) finds that,
1	activities, unless such
1	designation, in the
3	removal of such
1	(4) treatment of
1	protection of intelligence
1	predictability; and (c)
1	normal lawful course
2	collaboration with the
1	congressional committees that
1	genome has been
1	relates to unfair
1	party applies to
1	routinely contract with
1	tapes, and data
1	
 379d2. policy
1	[7 u.s.c. 136a(c)(2)(b)];
1	every 4 years.
1	section to respond
1	upon such publication
2	product, and taking
1	 (17) smoke
9	ingredients or animal
1	subparagraph is requested
1	centers and shall
2	every 4 years,
1	strategyfor each designated
1	section 360ss of
1	program agency involving
1	time. if the
1	category of examinations
1	budget under this
1	completes a supervised
1	relevant offices and
1	protocol was approved
1	facilitates the creation
1	use, or distribution
1	seller of a
2	pseudoephedrine, or phenylpropanolamine,
1	(2) consult with
2	information on 
1	promulgated. such regulations
1	requirement, relating to
1	receipts during any
2	authorized (1) to
1	may withhold information
1	educate health care
1	grantees not provided
2	variance from a
1	packaging materials which
4	trafficking area; (b)
1	focus enforcement on
2	failed to take
1	scheduling for up
1	order is lawful
1	product involved; and
4	secretary considers appropriate
1	chapter.  (o)
1	existing authority of
2	 (i)in general.if
1	official compendium, and
1	
 1545. terms
1	manufacturer and shipper
1	subsection (a)(2) has
1	states without further
1	specifics of the
1	fee amounts shall
3	1955, ch. 800,
1	 (h) nothing
1	measured in subparagraph
1	account established under
2	make such determination
1	section 360eee or
1	performance standard made
1	terrorism, into fruits
5	deny the petition
1	research and analysis
1	belladonna, bitter almonds,
1	 (5) amendments
2	demonstrate that it
1	 (g) warning
2	iii, iv, and
1	term responsible party,
5	person that paid
1	amounts in a
6	property ordered forfeited
1	formula is adulterated
1	operations; and (d)
1	practices, and retention
2	activity taken by
2	manufacturing these substances
1	final order that
1	facility did not
1	(i) late payment
2	subparagraph (f), the
1	time for filing
1	review upon receipt
1	without warrant for
1	drug samples requested,
1	product tracing and
1	failure to destroy
1	health and education
1	may be sent
2	doses and the
1	publication by secretary
1	purposesthe purposes of
1	(a) establishment not
9	determines that any
1	sentence does not
1	declined by over
1	title any susceptibility
14	unless its label
1	organizations that work
1	multiplied by 0.40.
1	1934, ch. 756,
6	class of controlled
1	anaphylaxis and prompt
1	 (4) according
6	number of officers,
1	congressional committees except
1	quarantine laws means
1	ix and data
21	political subdivision of
1	priority status for
3	patent or the
1	ingredient standardsnot later
1	(2) information referenced
1	70 stat. 486.)

1	term control means
1	reimbursed amounts amounts
1	device or devices.
1	(c), before the
1	assistant has 
1	year in basic
1	partnerships and may
1	federal officials employed
1	(d) funds transferred
7	upon receiving a
1	u.s.c. 387]; (d)
2	secretary believes such
1	heroin. (11) hydromorphinol.
1	notification of a
1	prevention, social services,
1	animal drug covered
1	903 of this
1	uses of devices
2	no-delegation determinations by
1	position together with
1	except pursuant to
2	returns of its
4	coloring, or chemical
1	information; (7) may
1	isosafrole. (q) safrole.
1	appropriate) under subsection
1	shall not approve
3	100 or more
11	addition to, or
1	provided herein, the
1	receiving the written
3	(plus interest at
1	notification. after the
1	subsection (b)(1)a),[1] the
1	consistent with united
5	availability of sufficient
1	classrooms and common
1	(i) consider whether
1	foreign person pursuant
1	america; (iii) intended
1	(16) to violate
1	formula. except as
1	seeking assistance to
1	(a) is relied
1	(2) the index
1	adequate controls in
1	(7) of this
2	secretary has classified
1	intended limited population,
1	requests issued, accepted,
1	intended limited population.
1	certain fish in
3	manufactured, processed, or
1	(d) the certification
1	title may include
1	seq.]. (b) in
1	chapter.[1] (b) requests
1	substance; (b) which
1	seller maintains, in
1	may, by means
1	types of fresh
4	factors:  (a)
1	2 years, records
4	process control plans
3	proximity to the
1	proposed regulation classifying
1	1998 federal drug
1	office, cabinet level
1	(u) certain drugs
4	registration under subsection
1	 (9) final
2	prescribing practitioner, between
1	application and subject
2	requested and granted
1	solicit, review, and
1	device is the
1	receives notification (referred
4	subsection shall require
1	20.  (8)
1	(i) the summary
1	food safety, may
1	section for interchangeability
1	effective may at
1	title), recommendations, and
1	regarding such review,
1	intended use; except
1	united states does
13	application or a
1	telephone number of
2	351 of this
1	notification described under
1	100,000,000 patients by
1	product; (g) the
1	proposed revision to
1	25,000,000 patients by
1	(1) ensure that
1	enter into contractual
1	review and by
3	means by which
1	(e) include a
2	drug) the composition
1	designate a priority
1	complaint, the secretary
1	general; (4) the
2	shall cooperate with
2	consultant or third
1	product) that, without
1	general, and state
2	drug industry, the
1	(i) if food
2	supplements. (d) activities
1	participant in ensuring
1	detailed timeline for
1	program agencies in
2	conditioned upon the
1	assignment. the information
1	animal drugs. (d)
1	include, as appropriate
1	possess appropriate qualifications
5	fees collected for
1	(1) describing actions
1	water or publish
2	oversight of outsourcing
2	exempted from federal
1	research by practitioners;
1	individual indian shall
1	industry, shall develop
1	standard, any person
2	account and remain
1	enacted a state
1	15 to the
2	regulations under such
1	time on libel
2	drug a designated
1	account the amount,
1	cigarettes  (1)
2	upon a domestic
1	services required by
4	active ingredient under
1	additives, that the
1	commitments as set
1	annual reportthe secretary
4	furnished to it
1	repatriate property under
1	chapter or were
1	agent or as
1	negative any exemption
1	access to outside
1	title, he shall,
1	documented, using local
21	following:  (a)
1	format. until the
1	among its members.
1	processes the secretary
1	criminal sexual conduct;
5	infringed by the
1	tobacco. (2) revision
1	attempt, or conspiracy
1	commodity credit corporation.
2	paragraph (3) and
1	material threat under
3	committees on appropriations
2	director shall perform
1	consensus standards for
1	issued or, if
1	structure to decrease
6	business days after
3	subsection (j)(5)(f), subject
1	valid scientific or
1	buildings, or facilities,
1	exporting eggs or
1	(ii) the specific
2	(c) with the
1	qualified manufacturer could
1	paragraph (3) any
1	1, 1971, every
1	(a) has occurred
1	sponsor, the sponsor
2	egg means any
1	(d) action on
1	regarding the stay
1	notice shall not
2	so; and 
2	safety rest area
1	unwarranted suits against
1	imprisonment. (4) notwithstanding
1	(a) $97,722,301 for
1	secretarywith respect to
1	 (d) analysis
1	egg products. 
1	provider, or repackager)
1	sale. (2) any
7	relationship with a
1	qualifications; waiver 
1	(b) applicable percentage
1	injury, respectively, that
1	search warrants and
1	(h) construction this
12	fixed by the
1	importation of additional
80	262 of title
2	approval, as may
1	individuals for that
1	section 1703(c) of
1	gaps in pediatric
1	ch. 3915, 10a,
1	expected to 
1	contain a clear,
1	state courts in
1	regulate, direct and
1	report.  (d)
1	september 6, 1958,
1	clause.  (d)
1	 minimuma maximuma
6	labeling of food
1	second. if the
1	clause (xiii); 
1	technology assessment. 
1	importer qualified by
1	sum or sums
2	determines that information
1	based on that
1	manufactured is not
1	intent to issue
1	meeting the deadlines
1	 (c) late
1	him. (2) every
1	import, and a
1	regulations).  (c)
1	belief that a
1	(7) report to
1	agricultural, or consumer
1	food and unless
1	solely under subparagraph
1	timeliness of pediatric
1	term nicotine means
2	previous year. 
3	certificate provided for
4	mitigation, treatment, or
1	section applies may
1	source drug or
3	order fully to
1	soil and thereby
1	(a) when human
1	hearing. (6) the
2	application was assigned
1	purpose of acquiring
1	(j) the business
2	reasonably applicable when
1	amounts under section
1	assessment contentthe program
1	interest collected shall
1	general information known
1	events in the
1	(g) based upon
1	(b).  (ii)
1	on, or includes
1	provided directly or
1	account any prior
1	necessary for public
1	access; logbook requirement;
1	maintaining a program
1	approve a petition
1	(b) any agreement
1	president the secretary
2	(2) standard 
1	ii; or (iii)
1	planted or cultivated
1	humans; and (iv)
1	1993 and thereafter:
1	(h) effectiveness of
1	ch. 675, 919,
1	(iv)failure to obtain
1	subsection (g)(1) shall
1	draft guidance under
1	(c)(1) involved at
1	general public. members
2	enters in the
1	lawfully obtained such
1	 (b) due
2	may require to
1	tint or shade
1	bond in a
1	substance; or (2)
1	product of 
1	involving any drug
1	persons use in
1	
 1031. congressional
1	established; and (b)
1	quarterly. (2) inclusion
1	refusal of certificationsthe
1	(4) upon the
1	enforce restrictions adopted
5	without conditions, any
1	 (d)2 obligation
1	(c)(2) of this
2	section 356(c)(2)(a) of
2	product applications for
3	handled in connection
6	recommendations; and (e)
1	distribution committed outside
1	notwithstanding section 404
1	outbreaks attributed to
1	(8) $80,000,000 for
1	product (including any
4	director determines that
3	action pertaining to
2	may be deferred
1	(a) to enjoin
1	risk products the
1	criminal forfeitureany person
11	act july 1,
1	treatment with the
1	holding at the
1	grade 18 of
1	donations of services
1	devices designated for
1	 (d) engagement
1	exporter, the importer
1	manner as any
6	(iii) in the
1	submissions if a
2	extent that they
2	providing interested persons
2	thereafter, the inspector
3	experience as the
1	establishment or maintenance
4	basis of his
1	matters assigned by
4	provide for public
1	govern the determination
1	129a to 131.
1	control, if ownership
1	conducting the evaluation
2	agreement is otherwise
1	methodology; and (7)
2	process. the affidavit
1	(a) applicability of
1	safety or consumer
1	
 
 677.
1	(f) periodic review
7	rates to be
1	drugs from exemption
1	including for maintenance,
1	assessments of approved
1	asserting a legal
1	act; (7) steps
2	may by reprocessing
1	2008 under this
4	proper. the secretary
1	carcasses condemned; reinspection
3	final dosage form.
1	approved nothing in
4	conference shall constitute
1	publications or other
1	day or night,
1	purchaserseach regulated person
6	determined under subsection
4	applicant certifies and
1	prior order that
2	notwithstanding the number
1	1996; and (c)
1	compliance by small
1	responsible to him,
1	fee assessed be
2	legally marketed. (c)
1	be, shall respond
1	5, formerly 3rd
3	 (a) drug
1	review process; (e)
1	period that, based
4	number of foreign
1	 (e) no-timely
1	(2)(b) may not
1	knowledge, or failed
1	drugs approved on
1	paragraph (2). (4)
1	registry data bank
1	transport, labeling, notice
1	(of the state
1	services after consultation
1	subchapter i ante
3	(b) authorization of
1	packaging (other than
1	secretary, unless the
1	(a) i have
1	committed such violation
1	(g) inapplicability to
1	
 
 7
1	made shall not
1	(b) prescription requirement
3	standards under section
1	distributor requirements 
3	secretarys procedures for
2	pediatric labeling of
4	 the term
2	(6), and (7)
1	electronic products; (2)
2	tobacco products (as
2	claim either 
1	delivering such products
2	provided that term
1	300f(4))) but not
17	horses, mules, or
2	showing (a) the
2	paragraph (1). (e)
1	states. prior to
1	360f, as added
1	(c) drug abuse
1	purchase a product
2	(2) contentthe report
1	cause appropriate criminal
1	injunctive remedies any
1	413, as added
1	panels meet regularly
1	pipes; (8) carburetor
4	reasons or basis
1	first amendment to
1	years 1994 through
1	information is effectively
1	nuts (e.g., almonds,
2	therapy and shall
1	submits its budget
1	35.  (6)
1	devices (a) documentation
1	practitioner a special
1	evidence, and shall
2	failure of a
15	animal drug referred
1	product; and (d)
1	operations (a) unlawful
1	animals. (3) 
1	therein or thereon
3	subsection (a), based
1	(b) inapplicability of
2	employer would have
2	guidance contentsin the
1	causes of any
2	states, or to
2	collect such fees
1	(e) drug abuse
1	bacterial otitis media,
1	title. (3) 
1	within 135 days
1	title, the manufacturer
1	involves a serious
5	promulgate a regulation
1	public health protection,
1	(f)(1) require that
1	public health protection.
1	imported as another
1	federal government, which
6	exclusively for use
1	states duly authorized
1	wholesaler.  (2)
1	authority and criteria
3	information is necessary
14	deems necessary to
3	introduced into commerce
1	affairs the authorization
2	programs having objectives
1	19 and amended
1	proprietary business information,
2	date provided by
1	meaning given it
3	subject to (1)
1	state or in
1	agency efforts to
1	chapter, including 
1	applicant or for
1	31. (k) construction
2	 (c) final
1	severity, specificity, or
2	detection or apprehension
2	residue, means that
1	including a letter
2	use personnel, facilities,
1	exemption is issued
1	aggregate information pertaining
1	sunset the authority
2	recalls linked to
1	employer a reasonable
1	purposes of assessment
1	nicotine yields from
1	need for and,
1	unexpired term of
1	food during the
1	(b) meaning of
1	records. (c) any
1	documents describing transactions
1	take place in
1	resolve whether there
1	application fees under
1	compliance with good
2	secretary may, subject
1	section be unannounced;
1	caused death had
1	(k) written requests
1	assessed and aggregated
1	identified (directly or
1	stock, or employee
1	commodities are the
1	exception for conformity
1	conduct which violates
1	initiatives for reducing
1	expended for authorized
6	shall publish the
5	device under this
1	experiencethe term adverse
3	dat-collection systems, including
1	(1) an ultimate
1	191 to 193.
8	proposed regulation; and
1	consents to an
2	final regulation shall
1	meetings held and
6	387e(j) of this
1	control activities to
1	circuit and (ii)
1	disposition, with respect
1	commercial information. (5)
1	dyeing the eyelashes
2	solution intended for
1	advisory committee per
1	262, 1, 42
1	silicone gel or
1	system, delivery device,
1	(f) dietary supplement
1	drug paraphernalia definedthe
2	will be expended;
1	basis for review
1	producing adulterated meat
1	stat. 820.)
 

1	professional services, for
1	extraordinary circumstances, as
1	controlled substances; (2)
1	(1) any transaction
1	final rule: 
1	statutes intended to
1	30, 2020, is
1	operating the facilities
1	measurable and rigorous
1	subject to compliance
11	(as in effect
1	reasonable attorneys fee,
1	subject matter expertise
1	title if that
1	studies needed for
3	remedies the remedies
3	identified in such
1	sale; labels it
16	prepare and submit
1	(b) periodically assess
1	24 months; and
1	report and request
1	drug are found
3	sanitary, quality, species
1	tort claims in
1	effect; or 
1	recall; (ii) a
1	regulations (issued without
2	product or to
7	officio members of
18	number of such
1	errors and inaccuracies
2	declaration, declares himself
2	standard shall take
1	opinion and the
1	proper concentration. 
1	title) unless 
1	(2)(a), except that,
1	contracts under subsection
2	harvesting of fruits
1	subparagraph (d) 
1	country requires the
5	applicable under this
1	requirements and obtain
1	practice regulations, including
1	existing data available
1	year under such
2	assess the implementation
2	to, or in
8	(c) or (d)
3	permitted by the
1	notwithstanding the termination
2	 the entity
1	efforts to do
2	drug application, and
3	(iii) take reasonable
1	shellfish; and 
1	(d), and (h)),
1	intramural fellowships and
1	drug under paragraph
1	processes to facilitate
1	food actually treatedin
1	recommend that such
1	acquisition, holding, withholding,
1	verification program (a)
2	directly from a
2	drugs to individuals
1	application fee 
1	distributor or retailer)
1	387n. jurisdiction of
1	1997.  (2)
1	sections.  (june
1	per year, which
1	criteria developed by
5	may modify his
1	review, was requested
1	exposure from other
1	(e) fees for
1	make the demonstrations
3	register findings on
1	formerly 360e, as
1	nurses credentialing center,
1	whether such technologies
1	petition which form
1	subsection, including whether
1	1104. repealed. 

1	products thereof, within
1	entity who sells
1	government; (c) improvement
4	hospital, or other
1	subchapter: (1) additive
1	drug prevention. (3)
1	distributor means the
1	ionizing radiation, which
1	chemical would result
1	rulemaking and shall
1	procedures and equipment;
1	agreement made by
1	information of the
1	compounding. the advisory
3	substantial equivalence between
1	strategy that involve
3	holds, or imports
1	paragraph, a certification
1	section, determine that
1	special control under
2	(a) in generalsections
1	professions; (c) a
1	interruption; or (2)
1	experience to make
3	case, verify the
1	render the food
1	evaluate the design
1	systems standards. any
1	cocaine, methamphetamine, lsd,
1	funding the processing
1	 (e) limitation
2	establish the conditions
2	(g), to have
1	arrest warrants; (3)
1	identifier (which shall
1	(b) a communication
1	whichever is earlier,
3	sale under the
5	inadequate to assure
1	burden of regulation,
1	penalty for first
1	product; (d) an
1	(3) notice of
1	data, request from
1	records in the
1	(
 
 859.
1	meat item shipped
1	animals, intended for
1	loan applications for
1	health professionals and
1	seq.] shall mean
1	(1) adverse event
2	law or equity
1	subparagraph, of all
1	application, the 30
1	factor means a
1	-year period involved.
1	waive clause (i)
2	inspection shall extend
1	importation, entry, and
1	individuals involved with
2	(1) inflation adjustmentfor
1	thereof have been
1	available without fiscal
1	secretary shall undertake
1	broadest consumer audience.
1	clearance, and licensure;
1	facilitate the dispensing
1	(d) enforcement the
1	(e) trade secrets
1	similar innovative monitoring
1	(8) label changes
2	ingredient or ingredients
1	proposing that a
1	sponsors to submit
1	proceedings the provisions
1	transportation of food;
2	finds (1) that
1	device and its
2	describes  (1)
1	(4) exception for
1	initially appointed to
1	combination products sponsor.
1	duty  (a)
3	submitted in such
1	requirement each advertisement
5	data before him
3	fiscal year except
1	recommended is useful,
3	written order of
1	compound (1) is
2	pediatric adverse event
1	 (a) section
5	conditions of approval
4	subjected to radiation,
3	section limits the
1	intended for any
1	section 3663a(c)(1)(a)(ii) of
2	year. the mandatory
1	practice, as prescribed
1	360 or section
1	confirmatory data sets,
1	subsection to which
1	executive board of
1	may issue to
1	actionthe action referred
1	meeting required under
1	businesses, to affix
1	another application for
2	protocol with respect
1	drug, (b) the
3	(x) the term
1	accredit laboratories that
1	technology and to
1	infringed  (i)
1	acts. however, any
1	period which is
1	capsules, tablets, and
1	subparagraph, issue regulations
1	others to do
1	employees of each
3	foreign countries to
1	records of inventory;
1	(2) exception notwithstanding
1	civil penalty not
2	(d) provide for
2	effect under paragraph
1	506b, as added
1	additive involved, the
3	 (1) appropriate
6	filing the secretary
1	administration can identify
2	18 or a
2	involved malfunctioned, caused
1	subsection (b)(2), shall
1	promotion and marketing
1	review period if
1	identities of united
1	title 26, the
2	both.  (c)
1	(c) exclusivity for
1	distribution to each
1	made. (ii) if
2	shall at all
1	program meeting the
1	excipient, the unique
1	review under subparagraph
1	(1).[2] (h) no
1	tested; and (b)
1	(p) yaws. (q)
1	outreach workers fluent
1	campaign may only
1	(1), an opportunity
8	intended solely for
1	clause applies if
1	whose purpose is
1	agree on a
1	amount; equitable allocation
1	alcohol; (iii) is
17	application described in
3	affirm or set
1	food; and (vi)
1	(e) activities to
2	antifungal drugs under
2	meat of which
3	holder, or owner
24	determines that a
1	ch. 559, 1,
2	deems necessary, including
1	exclusivity for alread-marketed
1	(iii), and, as
3	extension under subsection
1	steps to remedy
1	retail food establishment.
6	procedures described in
6	[42 u.s.c. 262]
1	except as a
1	(1) the approved
1	group.  (iii)
2	convictions to be
1	whichever occurs later.
2	whichever occurs later,
1	initial guidance issued
2	year; and (2)
1	question, consult such
1	orders. (2) every
1	notice regarding such
1	section shall become
2	than, those made
1	category (as identified
2	dietary supplement containing
1	reference and for
1	informationthe food and
1	(b) reviewin conducting
1	form and strength;
1	permissibility of a
1	health of adolescent
1	database a manufacturer
1	term until a
1	contracts for expert
1	supplement.  (t)
1	examinations provided for;
1	women, handicapped individuals,
1	333(c)(2) of this
1	injunction, require the
1	arguments respecting the
1	exist in any
1	addiction. (2) the
2	shall be attached
1	elect to be
2	cost of compliance
1	transaction statement under
1	collected until the
2	establishment fee has
1	approval of antibacterial
1	section, the provisions
1	applicationsexcept in extraordinary
1	territories. (3) 
1	title refusing, withdrawing,
1	claim made in
1	360eee3(a)(1) of this
1	discuss proposed animal
2	coordinate and oversee
1	applies:  (i)
6	requirements described in
1	amounts specified under
1	exceeding identified number
1	1998, and was
1	(iii) none of
1	approving devices under
1	resubmission may not
1	treated in their
1	(including back pay)
1	animals only by
8	meet the applicable
1	appropriate declaratory or
1	intending or knowing
1	(5) for any
2	agencies; and (ii)
20	information submitted to
1	if, with respect
1	may administer fee
1	inspection the attorney
1	logistics provider remains
1	(a) more than
6	issuing an order
1	(2).  (b)
1	sciences and 5
4	general may authorize
1	(c)(2)  (i)
1	activity limited to
1	(b) to determine
1	either waived or
1	requirements under any
1	institutional controls contributed
4	provide an opportunity
1	designates under paragraph
2	scientific or regulatory
7	health care economic
2	center shall be
1	device, issue an
1	written meeting request,
1	period that the
1	importer program (a)
4	reasonable and appropriate
1	select one for
1	
 964. additional
3	system attributes necessary
1	(c) an inspection
3	drug, there is
1	limited quantities before
8	selected by the
1	equivalent device which
1	lif-threatening infections, including
1	applicable cases, sufficient
3	 (d) request
1	states as part
1	substances in this
1	shall not promulgate
1	testing services required
1	expenses of travel,
2	august 3, 1996;
1	21, 1997. (june
2	(1) in addition
1	amateur sports act
1	encourage implementation by
1	entity pursuant to
2	(b) how such
1	section shall state
1	means a communication
1	authorized by paragraphs
4	use  (i)
3	isomers is possible
1	august 3, 1996)
1	expiration; (ii) the
1	mandatory state poultry
12	august 3, 1996,
1	348 regulations that
1	subparagraph (c) available
1	transported, or sold,
1	-(-naphthoyl)indole or -(-naphthylmethane)indole
2	secrets.  (b)
1	united states seeking
1	date (or such
1	denied approval may,
1	deceased individual into
2	drug (regardless of
1	42; and (ii)
4	1 individual as
5	sentenced in accordance
1	section 360i(a) of
3	may not grant
1	request) under this
1	 (7) distributor
1	register each regulation
1	(f) each patient
1	agreements into regulatory
1	secretary) to engage
1	milling. (hh) the
1	early intervention projects
1	dispensed in all
1	204. issuance of
1	(ii), information to
1	drug to an
1	ch. 839, 9,
1	thereafter, the secretary,
1	submitted, shall be
3	left in effect
1	(6) access to
1	service act, including
1	inhabitant, or in
1	facility; and (b)
1	dispenses only products
1	positional, or geometric
1	officials promptly after
6	another application under
3	validity, amount, and
3	conduct such examinations,
1	(3) information requirements
1	ingredients classified within
1	may return product
2	criteria for certifications
7	depressant or stimulant
1	sufficiently effective; or
1	authorize the possession,
1	state.  (june
2	transportation or importation
8	may require a
9	 (aa) the
1	him, such matter
1	cover the period
2	(1), (2), or
2	clarity of information
3	subsection and all
1	secretary to present
1	one person who
1	(c) do not
1	parts, except the
2	accreditation body found
2	examination of records,
1	animal feed) is
1	upon the availability,
1	contamination or alteration
1	conformity with all
1	trade.  (4)
2	subclause (i) or
1	veterinary diagnostics 
8	18 years of
1	if, after approval
1	powers all articles
2	(ii) nonsaleable returns
1	considers appropriate, prohibit
2	subclause (i) of
1	states without a
1	performed in accordance
1	means commerce (1)
1	plan submitted to
1	application in approvable
1	(1) retail dealers
1	labeling of meat
1	device based on
1	agency centers, from
2	costs of tobacco
1	filing of additional
1	passed shall be
1	termination this section
2	282(j)(5)(b) of title
1	(3) the doing
1	public record the
1	enhanced.  (b)
1	subsection (c)(1) and
1	 minerals: calcium
2	permissible variations in
2	facilities identified pursuant
1	require codes on
3	delivery of a
1	(1) in conducting
1	application subsection (a)
1	registered persons registration
1	approval. authority to
1	exemption is in
2	related to electronic
1	 (a) office;
2	(iii) statutory or
1	(f) food allergy
1	(ii) the written
12	whether the product
1	article is found.
1	(c) assurances that
1	reasonably believed to
1	incidental production exception
1	establishing the fees
18	basis of new
3	studies shall be
1	submitted  (a)
1	with, an established
4	filing final briefs.
1	misrepresentation, fraud, forgery,
2	food to prevent
1	involvement and consultation
1	 (a) through
1	methamphetamine or methamphetamine
1	particular controlled substance,
1	organizations, industry, industry
1	legal means available
1	consulting agency center;
1	worldwide to protect
1	paragraph (1), there
1	(j) pilot projects
2	hold, including the
1	 (f) compensation
1	misbranded, the manufacturer
1	consulting agency center,
1	purposes.  (f)
1	facility, the state
1	every respect to
1	nicocodeine. (19) nicomorphine.
3	currently prevailing rates
1	development fee paid
1	certification applies; and
1	rights, privileges, interests,
1	protection act of
3	drug which does
1	68 stat. 517.)

1	 (b) nonapplicability
2	accepted, pursuant to
1	residue that appears
2	(or any other
1	services provided by
1	enforcement; penalties applicable;
1	applicant unless the
1	destroying wild or
1	thousand, and in
4	conform, as nearly
1	 (b) initial
1	consumers actually use
1	including meetings between
4	signed and entered
1	sources; (vii) available
1	outbreak of foodborne
1	exemption of establishments
4	particular controlled substances
1	title, or other
1	identifiers if a
1	title. such rulemaking
1	participate in clinical
1	 (a) bearing
2	10 days of
1	fee per fiscal
5	class iii to
1	use of another
1	commissioner, may, through
1	minerals (a) authority
4	risk listed in
1	protocol to assure
26	later than 90
1	body of a
11	internet website of
1	subsection (c), of
1	(c) information systems
1	conforms in all
1	exclusivity period expires,
1	nonapplication of faca
1	exemption revoked, suspended,
1	use. registration for
1	section; (b) has
1	indictment has been
3	means a prescription
12	applications, and investigational
1	so, and knowingly
1	(f) prohibition of
1	(2) oxygen 
1	accredited pursuant to
1	675, 506a, as
1	262] (as applicable);
1	collaborative agreement under
1	(f), (g), and
5	secretary by notice,
1	alcoholic beverages. 
1	proposed order; (b)
1	extent such data
1	
 467e. no-federal
3	paragraph shall become
1	packaging, labeling, or
1	orders that shall
3	revoked by the
1	facilities if the
2	world health organization
1	supplement, not supplant
2	shall develop standards
3	shall be selected
1	(e) verification of
1	facilities of such
1	later date shall
2	distributor is an
1	forfeiture proceeding shall
1	may harbor pests,
1	paragraph (5); and
3	purpose, and thereupon
1	shall be transferred
1	business, including all
1	recall information given
1	internet site address
1	(f) additional exemptions
2	forfeiture and that
5	application an application
1	collaboration among communities,
1	audit conducted and
2	(f) the number
1	ch. 675, 561,
1	(a) coalition information
4	approved for a
1	chapter[1] as the
1	required of manufacturers
2	filing with the
2	described in items
1	contain nutrients in
2	become final, is
4	approved application could
1	authorized officer of
4	means any drug
1	nucleotide sequence of
1	determination from the
1	approval should not
2	pending request; or
5	finds  (a)
1	commerce, he then,
1	requirements; (e) be
1	(c) the definition
1	(b) ris-based activities
1	special studies of
2	substances of vegetable
1	(c) in addition
2	(b)(1) application effective
2	regulated transaction involving
2	tolerance if the
1	exercised its authority
1	agriculture, farmer representatives,
1	subsequent -year period.
2	conducted under inspection
2	of, the real
1	(a) identification and
1	review and verify
2	subparagraph (a); (c)
1	one agency center
1	common control, (iv)
1	ultimate user means
1	(g)(4), (i), and
1	indirectly establish under
1	dirty egg means
1	regarding cigarettes and
4	biological product, or
1	animal drug therein;
2	issued when an
1	provide food safety
1	exceed twenty days
1	toxic effect shown
1	drug for personal
1	motion of the
3	form and content
1	animal drug therein,
1	drugs and inspection
1	approval supplement filing
1	concurrent incident command
1	office) under subsection
1	(ii) the court
1	sciences, which may
1	$25,000,000 for the
2	policy it is
1	(iii) state, local,
1	(d)) provide for
1	based upon violation
4	provide for such
1	distributed on an
4	warehous-based third party
1	shall include consideration
2	certified in accordance
1	trafficking, that the
1	shall be judicially
1	understanding of measurement
2	warrant shall be
1	different labeling, packaging
1	received a report
2	committees the secretary
1	patients lives; and
1	(b) if, after
2	importation by importers
1	grants, contracts, memoranda
2	meat inspection program
1	apply under paragraph
1	(a) findingscongress finds
1	substance for purposes
1	enforcement to carry
4	finds to be
1	respecting a drug
3	drug be dispensed
1	shipping, or other
1	2007, there has
5	ways and means
1	may designate for
1	authorized law enforcement
1	supplant those funds.
1	court review the
1	compendium. (f) carbon
1	entries to the
1	ongoing relationship to
20	without fiscal year
1	populations, designated by
2	substances that have
2	carry out a
1	24, 1984. (6)
1	 (2) esea
1	samoa, the commonwealth
2	information which are
7	approve an application
1	registration the name
1	data on all
1	compounded in compliance
10	(1) in the
1	secretary containing information
1	 (e) accessibility
1	research and testing
1	domestic activities relating
1	documentation to the
4	shall include all
2	 (d) grounds
2	respecting the construction,
1	list of acceptable
1	premarket approval would
1	requirements needed to
1	(e) dismissal with
19	individual who is
1	apply to material
1	unlawful importation of
1	providing clarifying information,
1	introduction of falsely
1	countries, 1 of
1	strategies and operations;
6	months rather than
2	commerce or held
4	statement, which shall
1	title 41) to
1	receive a facility
2	board, commission, office,
2	(1) not more
1	(a) general ruleexcept
1	lacking; or (5)
1	inability or refusal
17	section 360c of
2	control policy (a)
1	flexibility and discretion
1	product for importation
3	legend or any
1	drug; (d) an
1	approval that the
1	title because such
1	subchapter, any reference
1	fee is due
2	section 360c or
1	i, 11, formerly
4	control program agencies,
1	developing pediatric dosing,
1	part thereof) to
1	auditor, the secretary
1	 (1) milk,
1	(1) best practices
1	made. (mar. 4,
2	conflict of interest,
1	appropriate action that
3	term isomer means
1	misbranded in violation
1	business a suitable
3	(a) submission of
1	raising, or from
1	reconstituting, or other
1	conduct audits to
1	(1)(b).  (c)
1	person at the
1	available; (f) post
1	guidance document 
1	foundation; (b) action
1	discipline, including, when
1	practicable opportunity after
2	trade, smuggling, or
1	combination, that cannot
1	level for each
1	granted, to have
1	priority efficacy supplements
10	elements described in
4	distribute a drug
1	capable of detecting
2	clinical data in
1	need to have
1	general (1) on
1	last amended such
1	clinical data if
1	tissue is not
1	purpose. (2) 
1	contumacy by, or
1	establishing such tolerance,
1	conviction for purposes
1	structure, or (iii)
235	1938, ch. 675,
1	years, to remain
1	shall ensure coordination
1	numerator class iii
1	executed the secretary
1	injection, inhalation, ingestion,
4	notice not later
1	agencies the united
2	drug or, if
1	67 stat. 476;
2	aid for administration
2	receive payments, including
1	processing sector regulated
1	compounded such drug.
1	foodborne illness due
2	implement a program
1	trafficking means any
2	drug (as defined
2	public health by
1	guidance the secretary
1	approval, certification, licensing,
5	person has failed
1	(s) -methylephedrine. (t)
1	assessments (including substance
1	had, or (b)
1	fairly evaluate all
1	professional employees using
1	difference exists, in
2	subsection (g) shall
1	(3) any prior
1	number maintained by
1	state unless such
1	criteria on new
1	seeks to establish
3	extent that it
1	manufacturer.  (17)
1	controlled substance. (23)
1	ongoing training, as
1	states, the commonwealth
1	list or notice
2	due to such
1	applies, if such
1	(23) trading partnerthe
1	prescription drug was
1	operations, including a
2	further, the application
1	herein, the secretary
2	persons any person
1	modify as necessary
1	users for disposal
1	limited population in
1	agent, as provided
1	861, 2, 70
2	patient advocacy organizations,
1	notification notification under
1	comprising the analysis)
1	court signs a
1	2012, a deferral
1	purposes, and (2)
3	section 360c(f) of
1	schedule i shall
1	food types that
2	drug application; and
2	schedule. except to
1	warning letter could
1	sale. (july 24,
1	similar small units
2	comply with applicable
1	establishment for purposes
1	
 353b. outsourcing
1	ultimate users for
1	(b) no state
1	biological product of
1	support the efforts
2	person is substantially
1	 (3) regarding
1	drug than the
1	 (i) two
1	assessment in the
1	patient made by
1	policya policy described
1	(12) peyote. (13)
2	(a) in generalan
2	diversion of the
3	conducted at any
2	section only as
4	may apply to
2	shall be sustained
32	person who is
2	(not more than
1	(a) in generalas
1	importer program described
1	secretary, if the
1	otherwise places an
1	equipment each official
1	feed with the
2	application as submitted
2	restaurants, other than
2	event shall be
1	decisions or actions.
1	tropical diseases (a)
3	effective and efficient
1	government agencies at
1	area of science,
1	be, or may
1	pursuit of that
13	(except as provided
1	animal feed containing
1	procedures to adequately
2	pay the members
1	act for preventing
1	restaurant or establishment;
2	adjustment is necessary
1	standards. (4) the
1	persons upon which
1	assistance.  (c)
1	subsection (b)(1) is
1	i, 20, formerly
1	drugs signed at
1	 (e) omitted
1	communities, the federal
1	definitions  (1)requirement.subject
1	residue and to
1	contact intact mucous
2	ethnic, or other
2	(1) development not
1	retained on file
1	(iv) notwithstanding clause
1	apply to licensed
1	conducted as part
1	track product and
1	facility that controls,
2	paragraph (1)(a), and
3	regulatory requirements for
7	commerce or otherwise
2	include adequate tests
1	which, if any,
1	direct final rulemaking
2	agency from which
1	(vii) maintain the
2	date of an
1	regulation conforms, to
1	conviction; and (c)
3	documents  (1)
1	848 of this
1	387j, 387k, or
1	(a) prohibition of
1	corporation dispensing the
3	increasing the number
1	programs; and (4)
1	mortgagee, and knowingly
1	extensions for limited
1	substances so placed
1	356(g) of this
1	device shall on
1	decrees, and court
1	renumbered 16 and
1	manufacturing, and distribution
1	817.)
 
 203.
1	appeals mechanism is
1	(ii) that has
1	971. notification, suspension
1	supervision and in
1	criminal penalty is
1	360bbb0. expanded access
1	virus in the
1	(i) for an
1	administration of epinephrine
1	shall have submitted
1	oxygen deficiency. (ii)
1	known within the
1	(a). the quota
1	sentence to suspend
2	application submitted pursuant
2	802(25)[1] of this
1	dead, dying, disabled
1	coalitions and other
2	direction of a
2	updates the secretary
1	otherwise be reasonable
2	complies with applicable
2	applicable laws and
2	whether or when
2	(4) in the
1	effect of device
1	forfeited. any income
8	connection with an
2	(b) in carrying
1	will spread to
23	possession of the
1	foreign country, at
1	free. a nonpublic
1	strategies.  (2)
1	considered misbranded solely
1	medicine by such
1	new evidence not
1	subsection (b)(2)(a). the
1	(iv) the office
1	regulation, which shall
1	publications. (4) remote
2	 (c) finality
1	substances which do
1	protocol. approval of
1	initiatives that are
1	entity. (7) reaccreditationthe
2	requirements; concurrent jurisdiction
1	herb or other
1	(including when acting
3	obtained as a
1	recipients under either
1	458 of title
1	3 years and
2	(3) information on
1	(35) does not
1	tobacco users, or
1	human services. (b)
1	(a)(2) or (a)(3)
1	submission means 
1	(4) shall submit
1	expended. such offsetting
2	programs nothing in
1	(bb) in an
1	cargo tank, portable
3	(i) that such
1	notice, rule, or
1	poultry producer on
1	complaints regarding analyses
1	(c) for issuance
1	mult-drug resistant gram
1	treat a disease
2	limited purpose of
1	either transfers from
6	safe use of
2	agencies and with
1	(2) investigation 
1	surface but is
2	review applications submitted
4	deferrals, deferral extensions,
1	reports or information
4	state law to
1	subsection through 
1	transaction information. 
2	360fff(2)(a) of this
1	limitationno civil action
1	with, and expertise
1	products consumed by
2	 (e) suspension
1	including education regarding
1	delivered, and (ii)
1	sanction such person
1	operation of a
6	him, evaluated together
1	law enforcement programs
1	(1) shall consist
1	(5) retrospective review
1	human use the
2	partially filled prescription
2	subparagraph (a), to
1	(i) the heads
1	requiring that experts
1	medical services, including
1	establishment furnishes assurances
1	shall, after consulting
1	(e) powers of
1	implant value or
1	packer holds a
2	austria, on february
1	particular need for
1	federal agencies as
2	effect of a
1	consist of a
1	change from the
1	(a) is manufactured
1	valid measurements intended
2	subject of 
1	secretary but at
1	register any response
1	section; (ii) the
3	wrappers, or (2)
1	paragraph (1) within
1	(i) the monitoring
1	demonstrations, or training,
1	(2) certain postmarket
1	within an area
1	 (a) establishment
3	conditioning such exemption
2	practitioner means a
1	supplements and inspection
2	states or united
1	chapter exercise concurrent
1	appropriations which the
1	report that details
1	order, exempt from
1	 (d) disposition
1	contain a description
1	profits (a) prohibition
3	chapter shall apply
12	access to the
2	ii punishable by
6	different active ingredient
1	substance, shall obtain
1	backlog fee shall
1	(b) distributors of
1	burden of regulation
1	proposalfor each fiscal
1	conducted.  (c)
1	physically, chemically, or
1	withdraw the declaration;
1	one species. (3)
1	referralthe secretary may
1	include and shall
1	determined appropriate to
1	american consumer. 
1	potential surrogate or
2	(a) that such
1	therein, (ii) that
1	section; (b) establish
1	(10) of such
1	providers and other
1	use of drug
1	prevention. (3) three
1	purchasers of products
1	foreign facilities inspected
2	(3) review and
1	administering this subsection;
1	part; and (b)
1	(b) regulatory delay.
1	consistency described in
2	records; or (ii)
1	inspection or reinspection
3	approved abbreviated drug
1	subparagraph (a)(ii), fees
1	2, 32 stat.
4	proceeds of the
1	assumed to represent
1	(i) the format
1	dates for such
3	farm to institution
1	registration documents shall
1	may publish the
1	patent information; abbreviated
9	(1) in generalin
1	 (b) an
1	drug, of the
1	(ii) violates sections
4	(1) in generalif
1	charged. (6) any
1	prior convictions (a)
1	regulations which the
1	 (d) anticipation
7	requirements established under
1	proposed advertising and
1	finding in the
1	(2) scientific evidence
1	prohibit such seller
1	675, 739, as
1	affidavits demonstrating that
1	include the food
1	(2) contentsthe notification
1	substances by persons
2	sale) after shipment
2	(2) new medical
1	general is subject
1	convictions (a) information
1	(bb)limitation.  a
1	area is a
1	one violation. with
1	paragraph that person
1	traffickers  (1)
12	described in paragraphs
1	section 1034(e) of
2	(1) a reference
1	section 360ll(f) of
1	persons, the quality
3	animal drug with
1	licensed veterinarian, or
1	application for 
2	samples may only
2	drug contrary to
1	web sites maintained
1	refunded out of
1	general are notified
2	receiving evidence relevant
1	expenses each member
1	chairman. the secretary
1	designed to protect
5	subparagraph (b), a
2	 (b) humane
1	requested the index
1	substitute property 
1	community and fait-based
1	fee, the prior
1	industrial channels, by
2	substance which is
1	gel, except that
1	legally marketed device.
3	studies, except residue
1	internet, or cause
1	received. (d) termination
1	repealed, and such
1	lawful if it
1	chemical, whether or
3	new infant formula,
1	related laws. (

1	asylums, chil-welfare associations,
5	payment; fee due
1	natural shrinkage in
1	makes distributions by
1	(
 
 803.
2	drug, or (iii)
1	(c) or because
1	immediate previous sources
1	vaccines pursuant to
1	related, including 
1	renewal request; (b)
11	may not require
1	stat. 254.)
 

1	(ii) any salt
1	(e) other consultation
1	article under the
1	384b(c) of this
1	section, including whether
1	difference between 
1	general, under this
1	gm 3.3 
1	thereof; (2) the
1	periods; effective date
1	commodity, as follows:
1	extent of cooperation,
1	 (a) offer
1	introduced into or
1	applicable standard established
1	prior to march
1	675, 913, as
1	personal, as the
2	 (a) describes
11	information  (1)
1	person with a
1	distribute, dispense, or
1	license  (i)
1	year 2009, after
3	distributed by such
1	inspection of which
1	3501 et seq.],
1	affect the human
1	controls needed to
1	foreign nations and
2	form and made
1	benefits of any
1	(f) the distribution
1	15.  (june
1	submissions (a) drugs
1	dispose of it
2	evaluation and the
1	 nutrients 
1	coordination among the
1	term therapeutic category
1	records, as the
1	74, 9, 38
1	exceed five days.
1	 (b) state
2	(2) before such
1	2018 for fiscal
1	error. the secretary
1	request for reduction
1	application, a premarket
1	appropriate, approving or
1	facilitate the regulation
1	handling, sale, or
1	consider the risk
1	(a)(3) on the
2	prominence of information
3	processing, packing, transporting,
1	828 of this
6	trade name, or
1	internet (including social
1	acting upon such
2	 (a) contain
1	(i) may, as
1	repackaging, relabeling, or
1	class and an
1	imminent risk of
1	-methox-3,-methylenedioxy amphetamine. (3)
1	practitioner issuing a
1	subsection (a)(2)(a)(viii), and
1	42 may be
1	1501, 1502. repealed.
1	 (1) study
1	manufacturing for the
3	emergency medical reasons,
2	administration.  (c)
1	importation, exportation, manufacturing,
2	may suspend or
1	shortages of the
1	action appropriate to
1	activities, including inspections
1	progress regarding paragraph
1	upon publication, but
1	subchapter of the
4	residue, the administrator
1	amounts provided by
2	information and identify
1	effectively disseminated. (e)
1	loss to him.
1	year 2020, $14,800,000.
8	shall keep records
1	subsequent offenses (a)
1	requested. (b) upon
1	compliance in accordance
1	permit are being
1	mobility of the
1	provided that no
1	secretary; (ii) the
1	deemed to constitute
1	storage and shipment;
2	public display (in
1	safety authorities under
1	(am694); (xiii) -penty--[(-methoxy-benzoyl]indole
1	manager; (g) require
1	(7) for fiscal
1	including progress with
4	shall be regarded
1	 (1) possesses
1	inspection  (1)
1	waiver granted under
1	recalls or foodborne
1	auditor is linked
1	section 1044(a)(1) of
1	retain records under
1	expenses, including administrative
1	representatives. (e) one
1	public holidays specified
1	review committee, to
1	year when submitting
1	(d) coordination of
1	chemicals into other
9	prevention and tobacco
1	health requires that
1	labeling that indicates
1	rulemaking and provide
1	deadline provided under
1	processed. (m) the
1	class.  (3)
1	247d6a, 247d6b, 247d6d,
2	committeenot later than
1	projects, or object
1	entered the market);
1	identifying such substance
2	though engaged in
1	dietary use as
1	repeated violations of
2	products under voucherthe
1	designation prior to
1	health information to
1	ch. 675, 1010,
2	otherwise adulterated, or
1	product), the secretary
7	revise the list
1	visits on a
1	appropriated as budget
9	days after it
1	certain psychotropic substances.
1	amount specified under
1	expiration of 4
1	animal. (x) the
1	wholesaler or distributor
2	year that exceeds
1	application or supplement.
1	studies (which may
2	believe, that an
1	analysis and transmission.
1	(a), to ensure
1	tested commodity that
1	demonstrates that it
1	term base amount
2	contain information in
1	application or supplement;
1	species indication; or
2	 (b) contentseach
1	store product shall
1	abuse, or (2)
1	prior to so
1	government may also,
1	(a), as a
11	united states under
1	secretary making a
1	additional steps that
2	request) made under
1	(iv) for fiscal
1	seized and forfeited,
1	barred from being
1	mortality associated with
2	person to comply
1	care facilities and
2	impracticable or results
1	efficiency, and effectiveness
1	businesses. the secretary
1	unless otherwise indicated.
1	results of its
8	drug or a
2	(a) and shall
13	products which are
1	food.  (3)
1	illness.  (m)
1	delivery mean the
1	approves the application.
1	391. separability clause
1	formerly 1011, as
1	representatives upon a
1	lifetime risk above
1	(d) program implementation
1	egg products inspected
1	imported from canada,
17	prescribed under this
1	tobacco product undertaken
1	request such meeting
2	drug product, or
1	requirements; misbranded drugs;
2	longer be legally
1	use in official
1	subparagraph (a) above.
2	(i) that was
2	(i) such drug
1	otherwise be entitled
3	product standard. 
3	ineligible for any
1	new findings, on
1	tobacco product, by
2	subchapter relating to
1	(ii) has elected
1	science or engineering
1	cosmetic the connection
1	pediatric disease means
1	secretary[1] acting through
1	food and food
1	(c) the rigor
1	master filein establishing
1	purposes of conducting
3	committee shall report
1	transfer not less
2	device shall 
1	reconstitutes tobacco leaf;
2	regarding devices under
1	breakthrough designations for
1	applicable.  (c)
1	practice under section
2	life and if
1	chapter. (b) written
1	chemical residue. such
3	general fees under
2	supplant, no-federal funds
5	title and section
1	shortages that 
1	secretary shall include,
1	assistance, education, and
1	sale which either
1	evaluate the utility
1	countriesin carrying out
1	legal burdens of
1	planning the program
1	appropriate. (4) effect
1	book or file,
1	providing of a
1	3, 1996; (b)
1	needs in the
4	form which is
1	establish a temporary
1	relevant factors, the
1	secretarys discretion, grant
1	plans for other
1	prescription the name
1	shall indicate the
1	state the kind
1	states and to
1	back pay) and
3	otherwise authorized to
2	may, upon application
1	delegate or representative,
2	regulation prescribed under
5	direc-t-consumer television advertisement
1	act [5 u.s.c.
1	opportunity for patients,
1	optical, positional, or
4	device to remain
1	professional, labor, and
46	local, and tribal
1	request of and
3	(c) adjustments 
1	(b) seizure procedures
1	otherwise achieve the
1	dispensed to or
1	device used outside
4	states.  (c)
1	recommendation and the
1	(2) a study
1	distribution without a
1	construed  (i)
1	packaged carcasses all
1	(4) mandatory background
2	demonstrates to the
10	foreign government or
1	(i) is life
3	(d), or for
1	year 2009 and
1	day that the
1	previously set forth
1	october 2007. 
1	safety, potency, and
6	determine whether a
1	federal standards, (2)
2	reasonably expected to
1	upon its publication
2	file such an
1	order, a proceeding
1	approval by an
1	deciding whether to
1	 (aa) opioid
1	determine appropriate, of
2	(ii) counterclaim to
2	amount assessed (plus
1	final guidance within
1	(2) medication guide;
1	health official in
1	(3) no eggs
4	boards of pharmacy
1	bureau of investigation
1	reference a type
4	budget request submitted
1	diseased poultry, that
1	food facility registered
1	(1) prescribe such
1	360e(f), 360i, 360bbb3,
1	(including blac-box warnings,
3	subparagraph (a), if
1	 choline (mg)
1	public a brief
1	(d)(4) and (f),
1	shall, upon application
3	brand and by
1	manufacturers in connection
1	personnel to improve
4	maintenance of records
1	fees obligated for
1	prior to rulemaking
3	(2) types of
4	order to provide
1	secretary, with regard
1	recall of an
1	standards if the
1	6, 1996. (2)
3	committee on risk
1	purposes of absorbing,
1	health, agriculture, and
1	occurred before june
1	paragraph (1)(c) and
1	360l of this
1	section) that the
1	timetable for the
1	26 stat. 415.)

1	form.  (h)
1	procure the distribution
1	effectiveness reasons; (j)
7	tracing of product
1	courts disposition of
1	individual during the
1	use; except that
1	adulteration prior to
5	injunction prohibiting the
1	state unless the
3	aspect of the
2	signed at lake
51	priority review voucher
2	patent infringement action
2	refusing, withdrawing, or
1	professionals practicing in
1	appropriate for review,
1	violated section 331(i)(2)
1	response required of
1	drug abuse among
3	food to the
1	extended the expiration
2	product do not
1	conditions under subparagraphs
1	675, 506b, as
1	419, as added
1	subsections (a)(3)(b)(i) and
1	term anything of
1	drugs.  (6)
1	 (1) waiver
17	manner in which
1	387l of this
6	eligible pesticide chemical
1	order is issued,
1	delivered to a
2	appropriation acts. such
1	product injurious to
1	detoxification treatment in
1	transfer a drug
1	(b) trainingthe administrator
1	adequacy of any
1	(e) separate registration
2	year 2018. if
1	 (i) subparagraphs
1	president and enact
1	determine whether 
1	authorities should be
1	subparagraph (b) unless
2	supplements to such
5	sale of such
1	15-day period referred
1	combined with a
1	practice. any order
2	techniques to measure
2	agencies  (a)
2	inspection at the
1	proceeding on a
1	(viii) the sale,
1	execution of the
3	designated medical gases
1	drugs and drug
1	approved.  (9)
1	qualified under this
1	affect national security
1	distributed to a
1	thereof, or detach,
2	file this information
2	penalties any penalty
1	smoke. (h) teens
2	necessary in carrying
1	readily available 
1	 (ii) limitationno
3	(ii) the tobacco
2	year; and (c)
1	receiving funds from
1	development fee was
1	products (a) new
1	chapter. (b) surveillance
1	
 360ccc. conditional
1	substances act of
1	affecting agriculture and
2	subparagraph (b), prescribe
1	(1) exist. the
1	possessions. (c) adjustments
1	 (1) educational
2	basis of wel-controlled
1	emergency, that affects,
1	examines the notice
1	afflicts urban, suburban,
1	division.  (b)
1	product shall contain
52	safety or effectiveness
2	(b) rules of
1	if, based on
1	request; (2) a
2	promotion of the
1	issuance.  (ii)
1	pediatric studies will
1	section; (b) issue
2	states a drug
1	education programs. 
1	legitimate health care
1	chapter and related
1	vegetable merchant wholesalers.
1	director).  (3)
1	firearms, and explosives,
1	admission for failure
1	producers not responsible
2	permit access to
1	(aa) if provided
1	(d) the applicant
1	consistent with current
1	seek to (1)
2	special handling procedures,
1	55 of title
1	action  (a)
1	authorizes a change
3	transactions involving a
1	hold such public
1	secretary institutes an
2	beginning 30 days
2	chemical for not
3	entity that reported
1	states pharmacopeia, or
1	compromise claims arising
3	1037 of this
1	monitoring requirements that
1	(by established name
1	section 360e(d)(5)[1] of
1	providing appropriate flexibility
3	(1) and shall
4	(b) or (j)
1	subchapter ii by
2	distributor; and 
1	party. (9) the
1	360ccc, or 360ccc1
1	(c) descriptive and
1	elect, within 10
1	inspection of books
1	subsection (n)(3), because
3	secretary that an
1	system; congress, however,
1	exported from such
2	issuance of order;
1	(guine-worm disease). (h)
1	jeopardize the availability
6	animal drugs intended
1	approval.  (t)
1	dependence; and (3)
2	registered in accordance
1	commercially and is
1	systemic antibacterial and
1	strategy or with
2	review; and (iii)
1	foreseeable crisis that
2	combined or mixed
1	secretary may retract
1	substance; (b) either
4	chapter; and (b)
1	state enacts a
2	(other than evidence
1	patient groups (including
1	 (2) specific
2	(b) the effectiveness
1	drug threats in
2	effectiveness reasons. 
1	violations shall not
1	secretary) shall develop
1	consultation as appropriate
1	(g) seek judicial
1	combination that contains
1	term signal of
1	plans to rapidly
1	requirementsno person shall
1	may be comparative
4	thereon shall be
1	(e) corrective actionsthe
1	title, (7) an
1	risk means information
1	-year maximum term
1	recommendations about what
1	appropriate, electronic food
1	data and health
1	360bbb5 of this
1	 (b) ability
1	inspected in accordance
3	july 22, 1954,
1	another vessel, vehicle,
2	first program year
1	paragraph (2)(a) be
1	establish the fees
1	two solid dosage
2	requiring the holder
1	scientific review groupswithout
1	domestic animals, (b)
2	statement with respect
2	results not later
2	tobacco products subject
1	defense; and (4)
1	small or too
1	determine whether certain
2	major food allergens
1	particular food. 
1	adverse event surveillance
1	(c) after a
1	ch. 675, 715,
1	including the detection
1	experience that places
1	means an indication
1	dentists, scientists, or
1	products or separate
1	residue monitoring 2003
1	application was filed.
1	measure that the
1	application was filed,
2	recall such article
1	initiate an investigation
1	distribute drugs into
1	conducted, in a
3	may demand trial
1	importation is clearly
1	refer a device
2	inspector: provided, that
1	registration requirements. 
1	involving controlled substances
1	annual basis, review
1	authority to more
1	distribution and advertising
1	treatment technique is
1	(b) form each
5	otherwise provided by
3	disputed issues of
1	involves substantive review
1	ch. 675, 808,
1	(9) final sunscreen
1	voluntary test methods,
1	including why such
1	except an animal
4	biological product development,
1	biological product development.
1	(2) exceptionif prior
1	water, shall be
1	subparagraph or under
2	assessed a share
1	one month and
1	clarification this section
2	purposes of making
1	facility that sold
1	antibiotic, or biological
1	(b) uses the
2	review of advertising
1	in, and availability
1	report, a postapproval
1	needed, on a
2	secretary determines, upon
1	order stating that
1	offense involving moral
1	(b) if, upon
1	(h) approved labeling
1	whenever any eggs
1	review and does
2	progress made on
1	apply, and the
1	sentence shall alter
1	appropriate sampling and
1	associated with drug
1	him, except that
1	control foundation activities.
1	(j) shall within
1	 (2) emphasis
10	tobacco products, or
2	entityin this section,
1	paragraphs (6) and
1	ii in the
1	revenu-neutral and shall
4	products comply with
1	 (20) standardized
1	title of such
3	number of domestic
2	order complained of
1	pending abbreviated applications,
1	1014, as added
2	professionals who prescribe
1	paragraph (1), section
1	program, including 
1	adjacent to the
1	trade in hydroponic
2	patients studied, and
1	consolidation and elimination
1	appropriate state officials
1	jurisdictions, such pending
1	acceptance of gifts
1	mechanism by which
1	(i) amount the
1	(b) conduct 
1	conduct intended to
1	shell is free
1	(1) until the
1	hearing may authorize
1	appropriate models and
1	shall appear that
1	butyrate. (20) dipipanone.
1	subparagraph (a)(ii) or
1	standards, terms, and
5	adulteration or misbranding
5	meetings conducted under
1	fast track product.)
1	1709. repealed. 

1	secretary) before its
2	action brought for
1	(a), the individual
1	regions of origin
4	date fixed by
1	bioequivalent to a
1	timingan applicant shall
1	section terminates october
2	purpose of delaying
1	methamphetamine; and (2)
1	including any order
3	purpose of disposal
1	(2) to transport
1	(bb) if provided
1	allylprodine. (3) alphacetylmathadol.[2]
1	notified under subparagraph
24	evaluation and mitigation
1	conducting such studies,
1	provided, the grower
1	international land border
1	meeting within 30
6	request has been
1	known or believed
1	section to submit
2	territory, shall not
1	waivers on a
1	consumers through the
1	assist small tobacco
1	including the employee
1	consideration standards established
1	competent state authority
2	term rare pediatric
1	response; hearing 
1	fruits, juices, and
1	requirements of sections[3]
1	(2) pediatric models
1	consumption.  (b)
3	reporting requirements of
4	access, and on
1	specified, and, where
1	methamphetamine advisory council
1	test each batch
1	countermeasures, and qualified
1	 (b) congress
1	 (a) $693,099,000;
1	right of review
1	sale by persons,
1	(i) gao study
8	secretary specifying the
1	chapter depresses the
1	biomaterials supplier a
1	(3) renewal grants
2	first human drug
4	180 calendar days
1	exist.  (g)
1	otherwise introducing marijuana,[1]
1	360eee1(e) of this
1	definitions for purposes
1	1769f(b) of title
1	term reinspection means,
3	persons as the
1	animal fat and
1	lawfully issued pursuant
1	methamphetamine production or
2	shall bear such
1	july 15, 1932
1	(1) affiliatethe term
1	years; and (c)
1	increased from their
1	religious or fraternal
1	transportation under, or
3	criteria for a
1	(a) only upon
2	space and eliminate
2	provided is a
1	receiving notice that
3	maximum extent practicable
1	good importer practices
1	substances are applied
1	information, or if
1	determine and report
2	state which has
1	secretary shall partner
2	year 2013 may
1	submission of revised
1	clergy).  (4)
1	public health, a
1	462. reporting of
1	term grase determination
5	(1) for purposes
17	established under this
2	marketing authorization by
2	enforcement proceedings; detainer
1	classification request submitted
1	standards, the discovery
3	 (2) designated
1	tobacco warehouse excludes
1	minor species new
2	commerce  (1)
1	losses to producers
1	increased scientific or
1	proposed.  (c)
1	(ii) be designed
1	inspection of business
17	secretary in accordance
2	include the reasons
1	term of years
1	within canada engaged
1	product standards (a)
3	(b) information on
1	technologies existing on
1	actual consumer perception
1	feed or an
1	sale; licenses the
1	respect to countermeasures
1	age and shall
3	director under paragraph
1	supplements created under
1	notice before issuing
1	(c) final guidance
2	small business, the
1	images; and (b)
1	development or submission
5	including smoke constituents,
1	including smoke constituents.
2	legitimate need for
1	questions of safety,
1	upon the same
6	specimens of the
14	(a) except as
1	include an implementation
1	amount assessed in
1	revised policy nothing
1	derived from 
1	show cause as
4	paragraph (2) to
1	may require codes
1	submissions of reports
1	(a) if he
1	report or application.
1	 (g) violation
1	law enforcement officers,
3	program agency account
1	(1)(a) shall provide
1	401, as added
1	next supervisory level
1	(2). (2) assessments
1	authorized activity persons
10	health, the secretary
1	facility fees (a)
1	411, formerly 410,
2	attorney general (a)
1	nature cannot be
2	 (c) procedures
1	protective orders 
2	chapter to avoid
1	secretary determine that
2	agency the term
1	general subparagraphs (b),
1	services and after
3	process  (1)
1	studies, services, programs,
1	either declare the
1	panel includes, or
1	estimated size of
6	subsection (a). the
2	inclusion of additional
1	issuing the veterinary
1	unlawful by section
1	programs) required by
2	received, an action
1	title 8, code
1	composition for articles
7	device will be
1	medical care or
1	(3)(c) and other
19	(ii) the secretary
1	establishments any establishment
1	representatives, as set
1	foreign relations and
1	facility is exported
1	(a)(3)(b)(i) and (b).
2	quality systems standard
1	inspections and reviews
7	 (3) annual
1	usage, or the
1	prohibited acts bany
1	applicability subsection (a)
1	(1) unless such
1	procedures for obtaining
1	declarations: (1) the
2	drug and a
2	handled by any
3	finding described in
1	nicotine and tobacco),
1	notification pursuant to
1	contain the statement
1	nonscientific and nonmedical
1	360ddd(1)(h) of this
1	drugs are safe
9	food to which
4	shall promptly review
1	use device fees
4	believe that a
1	responsible for paying
1	ch. 810, 52
1	(4) special termination
1	countries and from
1	year to generate
4	subparagraph (c) for
1	(f) permit states
1	 (a) reviewing
3	manufacturers of the
1	disagreements with the
3	preceding the year
1	(2) sums appropriated
2	documentation and data)
1	(3) benzylmorphine. (4)
1	(a) all information
1	(4) narcotic drug;
1	approved, (b) which
1	support (including, in
16	generic drug submission
1	board of his
2	section will 
1	temporary scheduling to
1	biological product establishments
2	reviewed under subparagraph
2	court may direct,
9	shall state the
1	employees of states
1	request; or (ii)
1	regulation shall define,
1	inspect plants referred
1	class i, or
1	processing method(s) used
1	chemical; (iv) full
1	without requiring an
1	gas; or (c)
1	 (b) hazard
1	approval. (june 25,
3	availability  (a)
1	well as biologicals
1	drug derived from
1	age, which regularly
1	younger, shall be
1	united states persons
1	system which the
1	name, and other
1	amending a final
1	2008, through september
1	cause shown, that
1	public disclosure any
1	uses. (3) the
1	certification, including, as
1	timely, and independent
1	applicable executive department
5	engages in a
1	6 months, acting
2	distributors, and dispensers
2	reflected in the
1	title, nor for
1	tools and methods
1	manufacturer responds to
1	existence on such
1	951 et seq.),
1	food products distributed
1	appropriate for further
1	conspicuous locationsnot more
2	reference by the
1	endpoints which were
3	chemicals owned or
2	secretary by electronic
1	administration. (b) although
1	particular tobacco product;
3	consequences of illicit
1	article; and a
1	used to perform
1	receive a chemical
1	(c) not prescribe
1	devices is marketed
2	amount of -pheny--[-(-phenylethyl)--piperidinyl]
1	provision nothing in
1	
 360bbb8b. use
1	guidelines that limit,
1	subparagraph (b). (s)
1	communication to health
1	675, 421, as
1	discoveryif a defendant
1	compliance activities of
1	submits a generic
2	equal to subchapter
1	revenues did not
1	drugs an abbreviated
1	data are available;
1	44 stat. 1101.)

2	capability and expertise
3	modification of the
2	subparagraph (d) if
1	businesses and very
4	submissions described in
1	taxation of tobacco
3	product as another
1	provide for fines,
2	term name shall
13	3 years after
1	activities and impact
1	valued at an
1	provide for active
1	making any policy
3	charge reasonable fees
2	(ii) a meeting
3	 (b) rules
1	congress on these
3	applicant to import
1	generalized principles and
1	compliance for purposes
2	thre-neck roun-bottom flask,
1	administration. (2) a
1	(2).  (iii)
4	quality or strength,
1	331. prohibited actsthe
1	man subject to
1	352, 360, 360d,
1	biologics  (1)
4	661 of this
1	loss or disappearance
1	household. (c) enforcement
1	united states. nothing
1	state of current
1	determination on approval,
1	applicable; (b) in
1	sunscreen that is
2	substances, at establishments
1	subparagraph (f)(i). notwithstanding
1	title. (2) denial
2	give notice shall
1	educational and training
1	species, the meat
1	(b) submitted by
1	fees that the
1	adolescents. (b) the
1	drug shall include
1	director shall consider,
1	pediatric formulation for
1	2225. decontamination and
6	views on such
3	title and shall
1	criteria and processes
1	formerly 909, as
3	action to recover
1	coordinate with covered
2	repealed. may 29,
1	(f)(1), such index
1	shall pursuant to
2	trade secret is
1	respecting such proposal.
2	1105(a) of title
1	upon being metabolized
2	established for such
2	label, labeling, and
7	secretary prior to
1	information, news media
1	class ii, except
1	 (1) biosimilar
1	businesses and entities
4	court may seem
2	appropriate to the
1	prevailing employer a
1	foreign flow, such
1	levomoramide. (28) levophenacylmorphan.
1	(b) this subsection
1	2009, for those
1	accordance with law
1	 (1) instructions,
14	review voucher under
1	finding pursuant to
1	substance is an
1	use a corporate
1	will not supply
1	focuses on, or
1	program that do
1	clinical benefit for
1	september 30, 2007,
1	sanitary practices, as
1	therapies on 1
1	with, those used
1	device, or if
1	traffickers in colombia
1	(ii) the dates
2	medicine or the
7	general in the
1	classification, the secretary
2	granted a meeting
1	risk for intentional
1	grants  (i)
2	5 years and
20	upon by the
1	2672 of title
1	distributor.  (b)database.not
2	register and, upon
3	comprehensive drug abuse
6	biomedical advanced research
2	auditor may be
1	flexibility under subparagraph
1	made, issue a
1	$3,000,000 from the
1	formula manufactured or
1	transaction statement, transaction
1	warning.  (e)
2	application. (b) the
1	invest, directly or
1	tobacco product (except
1	labeled for that
1	provided written notice
1	notice means a
1	unless a device
2	manufacturer, printer, or
1	supplying to his
1	(j) other activities
1	methods for scoring
1	illicit trade means
1	derivatives, and preparations
1	class thereof, from
1	contracts with appropriately
2	information as to
1	supply chain, shall
10	court shall have
1	(a)(1) shall provide
1	number at which
3	liable for harm
1	apparatus, implement, machine,
1	(1) at any
2	subsection is in
1	section 851 of
1	items to be
1	discontinuation of fee
1	(including the category
4	thereof, and of
1	paragraph to give
1	product therefrom, prepared
2	notice transmitted by
1	programs, and (2)
1	 (2) conditionsnotwithstanding
1	recipients for use
1	606. inspection and
1	(2), after providing
1	depict its use;
1	food emergency or
1	procedures for dismissal
1	comments does so
1	submitted, updated, or
1	title); and (3)
2	constitute a significant
1	dimepheptanol. (18) dimethylthiambutene.
1	provide for inspections
3	suspended, or withdrawn,
1	503c, formerly 503b,
1	(d)(4), (e)(1)(a), (e)(1)(b),
2	states.  (5)
1	site.  (c)
1	use unobligated advisory
1	incident command operations
12	patient and consumer
1	antibiotic drugs approved
1	355, as added
1	shall furnish (or,
2	device, or cosmetic,
1	disposal program. (3)
1	board. (e) incorporation
1	(4) the provisions
1	containing one or
1	immediate recipients of
4	aware of the
2	smokeless tobacco products
1	section 264 of
1	determination means a
1	food registry under
1	defense, or the
1	delivers the product
1	583, as added
23	shall be collected
1	regulations if the
1	application, as defined
1	manner set forth
2	drugs for which
1	patterns of schedule
17	application has been
1	becoming ineligible under
1	title 42 will
1	administrators final order
1	appropriate, in a
1	authorized repackager that
1	opportunities for submission
7	assessed and collected
1	(h) notification relating
4	shall immediately register
2	subparagraph (a) 
5	section 208 of
1	commercially. such term
1	 (ii) inclusion
2	whether the order
1	(a). fees under
4	contains reports of
7	safety of use
1	repeal of regulationsthe
1	part or all
1	(a), the burden
1	(c) the food
5	fails to pay
1	
 
 455.
1	-(1,-dimethyloctyl--[(1r,3s--hydroxycyclohexyl-phenol (cannabicyclohexanol or
1	including any evidence
1	used in emergency
1	supplemental to, or
1	means operations that
1	data are available,
1	government. (f) use
1	local educational agency,
2	 (ii) does
1	(3) prescribe the
1	including a team
10	filing of a
1	secretary uses to
1	secretary in 
1	apply. in making
2	cause any food
1	including dispensing to
1	paragraph; (4) the
1	(b) which is
1	seeks to initially
1	subsection, providing administrative
1	reviews. the first
1	374(a), 379aa, or
1	distribute, methamphetamine or
1	(2) criteriaa drug
1	contain the general
1	effective investigational new
1	387k(i)(1) of this
1	board shall appoint
1	following the seizure
1	shall find that
1	objects and requests
1	package where it
2	secretary and an
1	(3) regarding the
1	bodily injury results.
5	chapter. (mar. 4,
1	bodily injury results,
1	deem appropriate, without
1	(b) outlines the
1	complexity, and format,
1	products (a) notification;
1	specific regulatory question,
1	system; and 
1	supporting the grounds
1	technology; (b) nanotechnology;
1	act) before it
1	chemical under this
1	self determination and
2	amount that exceeds
1	 (i) how
2	laws  (1)
1	secretary and any
4	establishment at which
1	(b) includes tobacco,
6	label of a
1	drug or chemical
1	ch. 675, 701,
1	public law 10782
1	unclassified form, the
1	subsection (c)(1)(a)(i) may,
1	(which other applicant
2	listed chemical products,
1	interactive and timely
1	brief summary of
9	conditions specified in
1	thereof) of a
2	diem or subsistence,
1	composed of nine
1	negative health and
1	dispute resolution; (d)
1	designate a category
1	(a) an application,
1	requires; (7) if,
1	regulators forum, and
1	forms. they are
46	internet web site
1	necessary, additional clinical
1	relates to outbreak
1	practices and initiatives
1	secretary, the certification
2	implement the objectives
1	formula showing quantitatively
1	no-racemic drug 
1	[15 u.s.c. 2615]
1	filling the lawful
1	planthe risk evaluation
1	prohibited. however, such
1	331(d) of this
1	routine practice. 
1	court, and if
1	least as long
1	plan will result
1	(2) personnelthe technical
1	technological characteristics, as
1	division of responsibilities
1	administration and within
1	include recommendations about
1	food industry, with
2	expeditiously under paragraph
1	retail; (b) practitioners
1	facility is in
2	authorized person to
2	notice with respect
1	shall use creative
2	dispenser shall 
2	life, the secretary
2	enforcement agencies. 
1	food defense; and
1	assessmentthe term clinical
1	partnership or region
1	tribal officials; (iv)
2	earlier effective date
1	services; (ff) staffing
1	
 
 620.
2	is, or it
1	is, or is
1	appointed member of
1	renewala conditional approval
1	fee has already
1	reason of prior
1	either (i) is
1	result to infants
1	availability and abuse
1	filing.  (4)
1	determination.  (3)
1	subsection (c)(1) or
1	et seq.]: provided,
1	770, as added
1	custody, or concealing
1	product submit to
2	subsection (b), of
2	-year period and
3	medical profession and
1	users, or nontobacco
2	lines of food
1	(iii) requests filed
1	2907, title iii
3	safety studies (other
2	remove any information
1	(7) revoking the
2	restrictions required by
1	provide a template
1	returns under subsections
4	subsection (b), or
1	collecting a state
2	interests of patients.
1	official plants if
1	effect.  (v)
1	determines will demonstrate
1	industry, industry and
1	permitted. (3) drugs
1	ratio described in
1	submitted the protocol.
1	including polydrug abuse.
2	information if the
1	provision the inclusion
1	statements; accompanying disclosures
3	section 360b(c) of
1	products (a) promulgation
1	substantial amount of
2	executing the warrant
1	coalitions or organizations
1	state law regulating
1	recognized, or interpretive
1	ii, or provisions
1	(i) half of
1	fees fees and
1	classes.  (2)
3	methodology or methodologies
1	longer period. a
1	format that complies
28	training and experience
1	regulationsthe provisions of
3	detect the intentional
1	section based on
1	paragraph (3) provide
1	based on areas
1	state under a
1	subsection (i); (7)
1	case of nitrogen,
1	(3) on and
1	surgically or naturally
1	effect on requirements
1	section 360bbb6 of
1	occurs for products
1	finality of order
1	produce milk. 
1	contains clinical trial
1	(
 
 965.
1	animal models and
3	subsection (k) shall
1	care professionals, and
1	(
 
 461.
1	(f)(4)(b) and the
6	public comment on
1	summarizing all judgments,
2	made by or
1	requiring substantial changes
1	(b) other misconductno
2	refuse to render
1	states in writing
1	agency action under
3	public interest for
1	
 
 360bbb3.
1	research findings conducted,
1	declared to be,
1	minimum of $5,000.
1	(d), one or
1	food production by
1	
 
 360eee1.
1	given training on,
1	actions to which
5	participation in the
1	risk, may require
1	applicant may, by
2	within a food
1	(2) any officer,
1	5, by reason
2	purchaser  (aa)
1	body. (p) the
1	vitamin, mineral, other
1	thereof during or
2	amounts  (i)
1	scientifically valid methods
1	subsection (g) to
1	provide the statement
1	printed or is
1	holds such food,
1	examplesexamples of activities
1	propose conditions of
2	predicate device. upon
1	opportunity to apply
1	customs and related
1	immediately lif-threatening disease
4	activity for which
37	rules and regulations
1	united states, such
1	 (1) beginning
1	medicine and fundamental
1	agents that present
1	i-transit shipment of
1	treatable disease; and
1	internet website established
1	packagethe secretary shall
7	360f of this
1	disposing of 
1	exercised regulatory flexibility
1	(f) removal from
1	take place and
2	society meetings, electronic
1	experience to undertake
69	authorized to be
3	number of each
1	forfeited. (q) restitution
13	state, tribal, and
1	good faith releases
1	procedures  (i)
3	enter into agreements
1	thir-party auditor for
2	determinations upon which
1	 such panel
8	1 (part), 37
1	information; (iv) requiring
2	form marketed by
1	sodium. (b) supplying
1	means a coalition
1	(b)(6), the federal
1	particularity in his
2	providing or distributing
1	satisfied, except that
1	distributed devices. 
1	regarding illegitimate product
1	gang crime, increasing
2	supplement that receives
1	explicitly, a reaffirmation
1	establishment; or (bb)
1	following applies as
1	229, 62 stat.
1	techniques to maximize,
3	among importers and
1	applications, and supplements:
1	(k) should be
1	 (b) eligible
3	inspection of foreign
2	paragraph (1). in
1	nature of any
2	plans in accordance
1	desiring to practice
1	develop detailed criteria
1	pond, or other
1	chapter to a
1	term specific patient
1	transactions  (a)
1	therein to the
1	criteria for assessing
1	temporarily, for the
1	discontinuance of drug
1	section 1395w104(b)(3)(c)(ii) of
1	application complete; and
1	secretary may access
1	definition shall not
1	disclose the transaction
1	requirement for advertisements
1	ninety days before
1	purchasers of such
1	persons from which
1	determines that general
1	individual packages or
1	section 282(j)(1) of
1	(c), an increase
1	drugs to address
1	utilizing real world
1	condition to such
1	defense strategy. 
1	concerned, to inspect
10	substance in or
1	360c(i)(1)(d) of this
20	evaluated together with
1	3 study (as
1	prescribing that the
1	practicable to obtain
1	assay which, in
3	discontinuance of the
5	may assess such
8	new drug under
9	following requirements: 
2	manufacture, preproduction design
1	1047 of this
3	geographically dispersed); (ii)
2	emergency situations, as
1	reasonable standards of
10	administration and enforcement
1	(8) even though
1	returned. the attorney
1	subsection (b). (2)
1	packaged, (2) the
2	expiration of four
1	organization of a
1	restricted device. (2)
1	824. denial, revocation,
1	need is not
1	(1) in generalprior
1	review.  (3)
2	notification, or declaration,
1	food purposes, as
1	evidence  (1)
1	(c) such other
1	(12) prescription drug
1	conduct litigation on
1	pesticide use and
1	accept from any
1	noncomplying electronic products
1	milliliters of liquid
1	duties, without regard
2	persons or organizations:
1	food are inadequate
1	recommendations determined appropriate
1	article, or the
1	drug induces cancer
1	included in this
1	mails or any
1	criminal case brought
1	(iii) with regard
2	supplement which is
1	completion of clinical
2	360, 360d, 360e,
1	considered an urgent
1	distributes products regulated
1	505(i) of such
1	color additive, to
2	application to include
1	subparagraph, the responsible
4	substantial scientific issue
3	change is made
1	proof that importation
1	regulation based upon
1	motion is made
1	drug for intrasystem
1	pharmacyan action referred
1	(b) in placing
1	agreement on how
1	prescription, if 
1	agency relationship. (9)
1	food, and facilitate
1	consider such article
1	ch. 675, 307,
1	laboratories seized and
1	administrations review of,
1	 (ii) saleable
1	use; and (b)
1	information required pursuant
1	applications, supplements, premarket
1	subject to inspection,
1	may pay in
19	necessary to ensure
6	pediatric study plans,
1	penalty  (a)
1	publicly identified by
3	paragraph (1). if
1	timely transfer from
2	standards or susceptibility
2	methods proposed to
1	675, 503c, formerly
1	importing, or exporting
1	products (a) drugs
1	cream into, or
4	ring, whether or
1	constituents, to health
1	may appeal using
1	board (of the
1	 (d)contents of
1	considered such recommendations,
1	chapter. (3) withdrawal;
1	1961, and the
1	referral if pediatric
6	nutrition, and forestry
6	use of tobacco
1	modernization act (and
3	(a) of such
1	possess in a
1	facilities, to accept
1	sponsor (in whole
6	(e)  (i)
1	patients, which warrants
4	interdiction coordinator shall
1	safe and, at
2	sponsor submits the
1	particular contaminants and
3	designate, may prosecute
1	order. (b) no
1	scientific controversy between
1	submit affidavits supporting
1	sufficiently complete, including
1	addiction; (vi) urging
1	pharmaceutical ingredient contained
1	performance reports beginning
7	applicant or recipient
2	fair market value
1	device, except that
1	(d) recommending any
2	panel or otherwise
1	(ii) results in
1	conclude operations at
1	following narcotic drugs,
2	evaluating possible infringement
1	remove such application
1	675, 801, 52
2	1050 of this
2	secretary shall, 60
1	(h) exemptions; regulatory
1	 (d) consultation
3	(ii), and (iii)
2	allow for the
3	standards developed under
1	chemical.  (h)
1	following a refusal
2	obtained upon the
7	determine whether such
1	approved application; (c)
1	limitation on extent
1	section new animal
3	drug is effective
1	master files to
1	(b) on-third shall
2	standards for tobacco
1	(c) criteria for
3	(7) and (9)
1	ordered to be
20	definitionsin this section:
1	information. (b) petition
1	(d) notices and
1	extent as to
1	public health, (b)
1	equipment, or other
1	facility remits the
1	designed to permit
1	transaction into commerce.
8	adulterated, and properly
1	(
 
 1602.
1	title, tobacco products
2	judgment reflecting the
1	minimum, the symbol
1	(c) determinations of
1	valid or will
1	sector entities and
1	 (d) mixture
1	otherwise open for
1	product labeling and
2	drug (except a
1	concerning exemptions for
1	apply to egg
1	misbranded or adulterated.
1	service shall enter
2	modified, the secretary
1	act, the administrator
1	(d) offering to
1	(d) notice of
2	commission under the
1	may under this
1	615. inspection of
2	showing that the
5	(1) of subsection
2	(1) for that
1	way involve pediatric
6	drugs approved under
1	thereof in any
1	every 30 days
1	constitute a clinical
1	disclosure could compromise
1	federal district court
1	force takes to
2	division is the
1	controls, if any,
2	practicable but not
1	(i) to ensure
2	domestic facility or
2	primary prevention and
1	scheduled testing, by
4	investigational exemption under
1	adjustment (as so
1	court shall dismiss
1	requests an i-person
1	responsibility for administration
1	availability of registrations
1	regulation is published.
1	earlier than 24
1	staggered basis as
1	indications for which
1	controlling such drug
1	species or the
1	phenampromide. (36) phenomorphan.
1	clause (i). (iv)
3	offense involving the
1	(a), a fee
1	 (c) revocation
1	number of any
1	years 2006 through
1	1049 of this
2	information necessary for
1	chapter establishes a
1	established a program
1	 (c) applicabilityregulations
1	parts thereof and
1	plans, and be
1	subsection, which may
1	education; and 
2	year beginning on
1	determination, issue a
1	(1) the exportation
1	effectiveness based on
1	time a plan
1	submitted by interested
4	paragraph (1) that
2	from, in addition
1	(2), any information
1	individuals and companion
2	business and a
1	development and selection
1	qualified, independent experts.
1	total amounts collected
1	using real world
2	approve such application
1	sentences. the secretary
1	advisory committee members
1	benefits provided to
12	violations of this
7	one year, or
1	title (1) a
6	evidence before the
1	determination to refuse
1	sellers that section
1	regulated person in
2	federal grant, loan,
1	program to encourage
1	intermediate endpoint to
1	lif-sustaining; or (c)
1	capacities of state,
2	adverse event reports.
2	regulated person if
7	maintenance, renovation, and
1	labeling, and containers
1	specific methodology. 
1	wholesale distributor has
1	availability of, and
1	adverse event reports;
1	title, final determination
2	chapter, the provisions
4	reasonably be asserted
2	facilitiesthe secretary shall
2	0.53 ounces (15
1	violations; written notice
1	twent-day period, or
1	sales of date
4	life imprisonment and
1	(4) action in
1	process, renovated, or
1	recommendations, and achieve
1	submitted with a
1	samples are stored.
1	goals, priorities, and
1	testing during the
1	congress approved march
1	distributes, or possesses
1	prevent the development
1	injunction, or libel
1	oversight and integration
1	grant recipient into
1	distribution or dispensing,
1	paragraph (2)(a) shall
2	supply chain stakeholders,
1	(2). such a
1	enforcement, etc.; certifications
2	application in the
1	device types for
6	registrant under this
1	product detained (in
2	article for publication
1	promoting honesty and
11	(1) for the
1	fiscal years. 
1	(i) in gathering
1	purposes of testing
1	assistance, the total
1	prevention of marijuana
1	valid prescription that
2	agency (i) advisory
1	marshals service or
1	register as a
1	approved only if
1	distributed has not
2	held invalid, the
1	(5) a certification
11	effect an approved
1	reasons established by
1	2006 level, or
2	court enters judgment
1	assessment the report
9	requirement  (1)
1	(ii) the jurisdiction
1	references in text
1	(
 
 901.
1	clause (i); (v)
1	information; abbreviated application;
1	2007, for that
1	chemical composition, energy
1	drug prevalence and
2	trials obtained under
1	report en-o-year inventories.
2	begins to export
2	(bb), and as
1	zinc, or of
1	preceding sentence. (b)
1	subsection (b)(1)(d), if
1	(n) national uniformity
1	(b) purpose the
1	points, if any,
1	records or documents
4	section in the
1	administrator has issued
1	annual basis for
1	manufacturer. if, after
2	commission act [15
2	(3) for fiscal
1	applications, and the
1	orders are applicable,
1	general, except to
1	include the timetable
1	(16) repackagerthe term
1	(i) the high
1	united states; provision
5	generalbeginning not later
1	women exist; (4)
1	(relating to drug
1	2009 and each
1	(ii) allocations the
2	based on reasonable
1	(ee) an anticoagulant;
1	school and farm
1	practice (i) such
1	sample for the
3	withdrawn if an
1	formerly 2nd par.,
1	remedies in this
1	 (c) capability
1	funds. (9) administrative
1	official compendium for
2	operations of types
1	pesticide that is
2	package in furtherance
6	 (i) information
2	(iv), the secretary
1	(b). such summary
4	interstate commerce, or
2	section 360c(e)(1) of
1	2615] in the
3	use in applying
1	notification under any
1	data, research data,
1	orders and payments;
1	requirements, including subpart
2	reasonable times, any
1	request to take
2	fee collections for
1	written report to
1	effective, and needed
1	budget any amounts
1	residues, decomposition, parasites,
1	orders and payments,
1	clause (a) shall
1	agreements from each
3	study plan, and
1	drug upon the
1	enforcement activities. 
2	(iii) the name
1	cumulative effect on
1	(2) taking into
1	clinical investigation under
1	may accompany auditors
2	may be selected
1	thing used or
1	publish such fees
1	trade.  (m)
2	contemplated by his
1	new timeline under
1	treatments. the approval
1	paragraph (w)[1] of
1	reduction of fees
1	reasonable comparable alternative
2	chemical or any
1	violative articles; duration;
2	unless the labeling
1	custom basis: provided
1	distributed further by
1	(2) the commission
1	exported drugs 
1	comment received from
4	subchapter or any
1	importers, distributors, retailers,
2	(c) require that
2	programs in the
1	products, to which
1	data or residue
1	illness; (e) the
2	federal register in
1	industries after consultation
1	product application a
1	meeting.  (ii)
1	congressional committees the
1	margarine clearly identified
1	use this draft
2	account for any
1	without naming each.
1	section as investigational
1	subsection (other than
1	punches, dies, plates,
1	 (aa) considers
1	submissions, through the
1	development of rapid
1	 (3) increasing
2	reports the responsible
1	determines that records
1	health and wel-being.
2	establishments selected by
13	requested by the
4	based on 
1	require; (c) 
1	(such as the
1	 (a) financial
1	expenses and manufacturing
1	substance; (6) to
1	record shall notify
2	whether at the
1	slaughtered or their
6	point of contact
4	months of operating
1	additional coloring matter,
1	including the nature
1	clinical laboratories to
1	product, the number
1	subregulatory guidance, or
2	exclusivity eligible for
2	considered an anabolic
1	
 
 352.
3	approved, that the
1	penalty for possession
1	improves communication of
1	requirement, including a
2	organizations inserted in
1	for, its compounding,
2	aforesaid. (mar. 4,
1	determine from time
1	place undue burdens
1	issue of whether
1	classifying or reclassifying
1	section; (e) prohibit
1	subsection (a)(1)(a). (6)
2	(2) the drug
1	analogous products applicable
1	benzylmorphine. (4) codeine
1	practice; (b) an
1	assay as are
1	drug samples which
1	office use only;
1	wrapper. (l) the
1	effect on inspection
1	if, after notice
1	whether accredited persons
1	development tool related
1	(4) a tobacco
2	subsection that is
1	cause or procure
1	staff, parents, and
1	minimum (1) prepare
1	products as fast
1	5) as the
1	i, 6, as
1	administration abroad. (

1	(a) sponsors of
1	subsection (a)(1) is,
1	office.  (n)
1	private institution that
2	from, to the
1	substantially limit potential
1	section. (6) wholesale
1	disclose all transactions
1	comment upon implementation.
1	(1) to affect
3	product is packaged
1	section drugs intended
1	data that the
1	shall establish standards
1	grant recipients under
1	actionsfor purposes of
1	350h. standards for
1	countermeasure, a security
1	membership, and other
1	establishment.  (d)
1	technical expertise in
1	define the criteria
1	ends early pursuant
1	tolerance. (f) percent
3	filed with respect
1	opium poppy means
1	sales of colored
1	means any meeting,
1	(vi) if appropriate,
1	labeling thereof, except
1	increase in allocation
2	ingredients included or
2	conformance with the
1	u.s.c. 19011906). all
1	group of individuals
1	state, the requirement
2	government shall establish
2	(ii) procedures a
3	necessary to review
1	print, or by
1	1958, pursuant to
1	31 percent of
1	declaring property forfeited
1	scientific information becomes
1	etc.  (i)
1	(j) scope of
1	facility, (c) a
1	directors concerns regarding
1	pharmacists and wholesalers
1	anabolic steroid, unless
1	officer, director, partner,
1	substance rather than
1	meeting under clause
1	conditions, such as
5	distributor from whom
1	states; or (3)
1	secretary for fiscal
1	578, 1, 65
1	(j) a common
5	days after a
1	(a)(3)(c), the secretary
1	ch. 675, 512,
1	additional manufacturers under
1	information; (e) that
2	holding do not
1	(d) reinstatement of
1	 (6) local
6	effect nothing in
1	outside of any
1	respectively, shall be
1	media campaign, not
1	assign a primary
1	26, 2014. the
1	literature and data
1	ensure enforcement of
2	adequate training of
2	constitute or contain
1	compensation of accredited
3	device establishment is
1	date the attorney
2	device establishment in
1	representation for special
5	class iii under
5	201 et seq.].
1	partially or completely
1	procedure any state
2	device establishment if
1	information for parties
1	16th par., 34
3	success in reducing
1	caused by administering
1	hearing.  (b)
1	article and provide
1	training programs in
1	processing, or storage
1	(c) prior conviction
1	(10) $99,000,000 for
1	decontamination of individuals,
1	reporting the deputy
1	labels solely to
2	report no later
1	children with cancer,
1	develop a consensus
1	approve biosimilar biological
2	e of subchapter
1	(b) is reasonably
1	agriculture, shall, as
1	
 360h. notification
1	practices and guidance
1	(e) the labeling,
1	petitions are filed
1	policy and shall
1	(e) to fail
3	18 of the
1	applicant will not
5	attorney for institution
1	adequate evidence that
1	 (b) program
1	disorder treatment expansion
1	holder during the
1	system, including the
1	depend on the
2	order to facilitate
1	(c), the transferee
1	device approved under
1	debarments, and of
2	(2) training to
1	program agency heads
1	reducing the percentage
1	manufacturer required to
1	program activities during
1	methods to increase
1	employees the external
1	otherwise be available.
1	adults. (4) substance
1	group of listed
2	 (b) eligibility
2	section 343(y) of
1	appeal of an
1	court  (a)
1	availability of property
1	unless the release
1	(2) grounds for
2	final order issued
1	imposed is imprisonment
1	patients are geographically
1	submit information demonstrating
1	approved november 3,
1	components that apply
1	product.  (15)
1	penalty, or whether
2	apply if the
1	food. compliance with
1	(c) approvalthe secretary
3	submitted and accepted
3	ship carcasses, portions
1	medical emergency situations
2	postmarket drug safety
1	must conduct testing
1	intentionally rent, lease,
1	section 10.85(d)(1) of
1	(vi) the distribution
1	sampling shipments. (d)
1	term counterfeit tobacco
1	submitting information under
1	fast track research
2	isomers, esters, and
2	 (3) termination
1	device may distribute
2	national drug code,
1	
 1116. repealed.
2	secretary to allow
1	shall not initiate
1	moldy eggs, musty
1	substantive summary to
1	removal. (2) exception
1	invalidate any law
1	general may promulgate
3	thereafter until the
2	distributed to investigators
5	approved under paragraph
1	health within the
1	registration for that
1	contractor the director
1	1978 or the
2	records demonstrating that
1	center operated by
1	establishments and of
1	clinical trials; (iv)
1	requirements; and 
12	processing, and packing
1	matter, the secretary
1	provide, by july
1	minor modification of
1	distributed domestically and
1	establish the safety
4	another person for
1	standard for employer
1	processes as may
1	meat products, poultry
10	review of biosimilar
1	respect to consideration
1	drug shall reflect
1	is.  (c)
1	title 31, and
1	food. (3) a
1	subsection, and the
1	values for noninferiority
1	payment penalties if
1	chorhexadol. (3) glutethimide.
1	proposed for designation,
1	agencies will exchange
1	laboratories to develop
1	occurring during such
2	collected under paragraph
1	apply to consultation
1	campaign, except that
1	ch. 675, 575,
1	(36) phenomorphan. (37)
2	manufacturer shall keep
1	property seized be
1	court may enter
2	omits a pediatric
1	sections 355(i) and
1	individualized treatment planning,
1	distribute to large
1	party.  (d)
1	prescribe drugs; or
1	shall take action
2	possessions of the
1	order classify the
1	nanomaterials; (5) collect,
1	general summary of
1	 (2) authorizedthe
2	905, as added
1	1 year, the
1	interstate commerce, registered
1	(2), the official
1	(2) contentthe secretary
1	state, or locality
1	(1) a certification
2	case of preparations
2	(b) in any
2	tobacco products is
1	therapies or products,
1	(a) period of
1	national animal health
1	inspection programs; and
1	penalties anyone convicted
1	 (3) rare
1	information as part
1	subsection (f), each
1	aspects of that
1	3, 1996, as
1	approves the order.
1	537, formerly 360a,
1	alread-marketed drugs 
1	annual quantifiable and
1	extend such period
1	upon this chapter
1	jurisdiction thereof. whenever
1	(ii) an entity
1	tests were required;
7	goals and priorities
1	(a) human clinical
2	kit form strictly
1	(c)(2)(c) shall be
1	jury in accordance
1	findingscongress makes the
1	
 399b. office
1	animal, and shall
3	drug safety information
2	exist: the substance
1	536, formerly 360,
1	transaction. (2) upon
1	reporting requirement in
1	distributors regarding defects
9	person may not
1	accessible manner the
1	evaluates the contribution
1	programs so that
1	determines under subparagraph
1	 (b) policies
1	plan shall be
1	additional inspectors are
1	experienced review staff,
4	diversion of particular
1	practitioner submits a
1	failure to conduct
1	infectious diseases and
3	information provided by
1	 (a) efficiently
2	development tool, the
1	(e) omitted 
1	use under a
1	uncertainty as to
1	determines appropriate, which
1	reduction, and state,
2	applicant involved and
1	means manufacturing egg
1	carburetion masks; (5)
1	upon study required
1	repackager) engaged in
2	grant activities will
1	penalty after the
1	reveal facts material
1	year 2005; (9)
1	factors with respect
1	compliance with haccpthis
1	practitioner to be
1	commerce any modified
1	accreditation; or (iii)
1	(1) dispute resolution
2	appropriate new or
1	$672,000,000. (k) for
1	foods; and (e)
1	consisting of adequate
1	843. prohibited acts
1	programs between a
1	substantive issues raised
1	involves the production
1	 (a) labelthe
1	obtaining a signed
1	practitioner, the prescribing
1	foods identified under
1	business under the
1	warrant shall direct
3	means an order
1	case of specific
1	studies. if a
1	inference; (ii) improve
1	forfeiture, the court
1	importations of a
2	with, a requirement
1	application process, to
1	control diversion; and
1	subparagraph (c), such
1	regulations by manufacturers
1	(i) saleable returns
1	sunscreen orders of
1	 (i) register
1	proceedings is pending;
1	restriction, or expiration.
1	mult-drug resistant tuberculosis;
5	substance subject to
1	imposed on any
1	expedient that in
1	produced from cows
3	packaging, or labeling
1	already developed for
1	recommended amount, frequency,
2	report, or information
4	substantial evidence standard
3	particularity the provisions
1	commissioner.  (6)
1	functions, projects, or
1	(d) verification of
2	electrolytes (such as
3	trial; united states
1	(h) of paragraph
2	manufacturer; regulatory oversight
1	gas subject to
1	(c)public process for
1	(b) hazards that
1	analogous products; and
7	prior to issuing
1	schedule ii, which
1	threat of bioterrorism.
3	fund established under
1	contains all the
1	(a) a serious
1	(2), to state,
1	involving senior managers
1	declarations: (1) many
1	section are assessed,
1	tobacco control act.
2	reporting in subsequent
2	tobacco control act,
1	1967, and periodically
1	required, manufacturing supplemental
1	packed, the officer
1	2017 within the
1	(c) additional information
1	paragraph, the district
1	(b). (b) the
6	business entity that
1	decision as soon
1	effective regulation for
1	purposes;  (2)
2	director, make the
1	background checks of
2	trade, and consumer
1	 (d) containers
3	greater than 45
1	sale or offer
1	administrative discipline, including,
1	 (c) risk
1	waiver.  (2)
1	highest rates of
2	salted, canned, corned,
2	security  (a)
1	adulterated; and all
1	codein--oxide. (6) cyprenorphine.
1	transfer of product
1	subsection (j) is
1	except that these
1	food allergen means
2	action under clause
2	local government entity,
1	manufacturer or, if
2	manner or part,
1	testing and measuring
5	years.  (b)
2	(d) applies, or
8	 (i) which
1	law; and (c)
3	presentation of views
2	marked and segregated
1	section 841(b)(1)(d) of
1	thereon, printed in
2	public comment (including
5	additional data, views,
1	physical tests the
5	(d) publish the
2	applicant named in
1	permanence of committee
1	components, source plasma,
2	criteria otherwise listed
2	indirectly, in its
1	activity is a
1	tobacco shall not
2	establish a publicly
1	(c)(1)(b); and (ii)
1	section and its
2	456 of this
1	valuethis clause applies
1	deem proper. following
1	change. (iii) if
1	warehouse space of
3	declare a proposed
1	promotional, or other
1	bear, directly thereon
1	(b) different processes
1	clinical investigator to
1	act[1] [25 u.s.c.
1	inspections and warrants
1	separate from those
1	licensure; and (ii)
1	labeling: type styles
2	goal described in
1	356f. hospital repackaging
1	use instructions 
1	100 if, not
1	professional and medical
1	satisfactory performance bonds,
1	reevaluate only the
1	title in improving
1	food industry sectors,
3	returns  (i)
1	registration for fiscal
1	$109,000,000 for fiscal
6	i, ii, iii,
2	compounding, distribution, and
1	group; or 
1	previously was convicted
1	developing a traceability
1	tentative approval of
6	provided further, that
8	evidence that the
1	(5) when requiring
5	designate one of
1	june 1, 2015,
1	identified number of
1	compendium, if its
1	 (aa) may
1	certain medical devices
1	require an increased
2	 (b) accreditation
1	constitution. (2) nothing
1	sanctions (a) awards
1	information if a
1	inadequate to control
1	steroid has the
1	(l) modified requirements
3	product application means
1	practice) to provide
1	transportation in violation
2	enforcement thereof, of
1	rules, regulations, and
1	caregivers of patients,
1	(1) to support
1	class ii devices;
1	conditions established in
1	parties, and establishes
7	title. (
 

1	 (i) postapproval
1	compounds from bulk
3	year 2008 and
1	 (c) burden
2	number of bacteria
13	debarred under subsection
1	(2) dispute resolution
1	becomes subject to
2	either adequate information
1	public communication. 
1	ii to another
1	targeted recall information
1	tailored to the
5	meets the applicable
1	(i) public availability
2	(1) definitionin this
1	congress (a) in
1	(1)(c) if 
1	seller means a
1	complementary approaches to
1	(i) amphetamine or
1	term opioid means
1	disparate dosing regimens;
1	chapter. congress finds
2	(4) past experience
4	later than march
2	good faith for
1	duplication, the secretary
1	(i) the business
4	shall periodically review
4	necessary to inform
1	manufacturing practices, and
2	(2) available to
2	 (c) confidentiality
2	344 or 355
1	food. no person,
1	unless the shipping
2	provide information necessary
1	degree of certainty
1	360ccc] or section
1	possession and improper
1	including specimens of
3	indian health service,
1	(3) whether the
1	enable the wholesale
2	standard in such
2	(2) within 90
3	make new findings,
1	drugs.  (4)
1	involved.  (7)
3	applicant has demonstrated
4	secretary to make
2	objective of the
1	limitationapproval of a
1	subdivision and a
1	5, the secretary
1	fees assessed to
1	care facility; or
3	imported under this
1	affect any timeframe,
1	person submit a
1	pediatric use not
1	appeal.  (f)
1	obligations under any
1	title on or
1	(aa) does not
1	matters concerning the
1	combination, respectively, at
4	applicable under section
1	shown[1] to restrain
1	proceeding. (b) if
2	order, as being
1	purchased; and (iii)
1	protocol in consultation
1	entitiesan eligible entity
1	plant in which
1	exempt by regulation
2	applications for which
1	secretary believes should
1	examinations, investigations, or
1	federal agencies. each
1	subsection (b). (june
1	ch. 1357, 2,
1	submitted such rare
1	generals discretion, is
1	believes such a
1	term device (except
1	receive access to,
3	purpose other than
1	(b)(2) after the
1	development of human
1	1-month period preceding
1	approved; or (ii)
1	generalthe coalition shall
1	27, 2007. (4)
2	roun-bottom flask, tableting
1	determine the necessity
1	additional report or
1	investigational drug, investigational
1	withdraw a designation
1	year, but in
1	consignee. (3) a
1	clause (iv) are
1	public health implications
5	product or its
3	start using such
1	recall; (d) coordinate
2	abbreviated applications, or
1	(v) an anticoagulant;
1	identify an adul-only
1	effective in use
1	received from an
1	required to affix
1	(iii) set forth
1	facility, is part
13	secretary has not
2	manufacturer (or agents
1	34 stat. 1261;
2	person or organization
1	authorized to issue
1	documentation (which may
1	title, until the
1	(4)(a) and the
1	subsection because the
1	container of such
2	section (including the
4	packaged in hermetically
1	program.  (june
1	rapidly removing, and
1	distributes, holds, or
6	fees assessed for
1	(1) after september
1	person may decide
1	(5) lysergic acid
1	shall require, except
1	given such hearing
1	food is subject
1	otherwise) provided by
1	training qualifications of
1	effect of instituting
1	30 days unless
1	subsection (i), (2)
1	dietary ingredients (a)
1	differences between men
1	countermeasure and plans
1	(b), the adjustments
1	standard, of the
3	biological product, device,
1	1919, ch. 26,
5	factors shall be
1	studies. (ii) if
1	1997. (o) reprocessed
1	means the office
1	512, as added
1	
 
 360eee2.
3	assessment under paragraph
1	proposed order. the
1	upon, nor to
1	675, 405, 52
1	advisory commission may
1	7 u.s.c. 19011906)
29	1 of each
1	december 1st of
1	 (1) importer
1	applicability of sanctions
2	united states citizens
1	percent of adolescent
1	(ii) the transmission,
1	title. only those
1	database a dispenser
1	federal government sponsors
1	shall distribute, through
1	product for diagnosing,
1	amount of its
3	presents an unreasonable
1	products not intended
1	matter for resolution
1	medicine, and with
1	burdens of proof
1	requirements for listing
1	(i) publication in
1	appoint an executive
1	1, 2009, the
1	(b) shall designate
5	establishment under this
1	threat notwithstanding subparagraphs
1	based on expected
1	conduct  (a)
2	court stating that
1	testing methodology and
1	consider the best
1	steroid, unless the
1	one manufacturing change
1	becomes final. (i)
1	submit or meet
14	(b) for purposes
2	adverse event shall
1	manufacturer, the effective
2	subsection (a)(1)) after
1	references the associated
1	authorize any federal
1	repackaged by such
1	computer systems, and
1	tort claims notwithstanding
1	(2cc). (23) -(-iod-2,-dimethoxyphenyl)ethanamine
2	may prescribe: (1)
1	representatives who distribute
1	(i) not more
1	tar and nicotine
1	deemed in such
3	representation as to
1	(a), the circumstance
2	subsection (c)(3). 
1	379j(h) of this
1	available (except matters
2	 (1) coordination
1	675, 586e, as
1	subsection.  (

3	secretary with regard
2	substances.  (

1	condition. (d) the
7	completion of an
2	3551(b) of this
1	less hens. 
1	document or other
1	ensure that individuals
1	3, 1996, after
1	acts c (a)
1	protection agency (1)
1	intent to impose
1	treatment for patients,
1	individualsif the secretary
1	effectively carry out
1	means all parts,
1	(c) identification of
9	(i), the secretary
1	persons expenses actually
4	sixty days of
2	disclosed under paragraph
1	short to be
1	collection of larger
1	alerts; (v) publicly
1	mixed and produced
1	facility, or otherwise
1	things, the constant
2	populations or subpopulations,
1	prescribed procurement specifications
1	(and all salts,
1	components underlying or
1	provided by interested
1	will demonstrate the
1	drug initially approved
1	 (i)ensuring privacy.the
1	apply.  (e)
2	disclose the identity
3	intelligence program, the
3	applicable date determined
1	1605. procedures for
1	laboratory network members
1	subsection, and renewal
6	content of the
1	initiates a regulatory
1	existence as of
2	product applications and
2	obligation to pay
1	applicable, or as
1	limitation. such fees
1	ground in oil
1	(f) define, for
1	acceptable for purposes
1	revokes a tolerance
1	review decision. if,
1	(d) other laws
1	(1) federal, state,
1	prescribe a shorter
2	proper supervision of
1	presents an unreasonable,
1	 k (g)
1	introduce testimony on
1	annual sales means
4	u.s.c. 2011 et
1	staff, a description
1	elements; and (b)
1	needed to protect
1	term state, except
1	mineral, or (iii)
1	months of the
4	determines necessary to
3	current status of
3	shall be allocated
1	675, 1005, formerly
3	chapter  (1)
1	drug paraphernaliain determining
1	tool is qualified
1	 (i) gao
1	(3) that there
1	(1) promote the
1	health interest in
1	least 10 days
1	carcasses, meat of
1	conduct of studies.
2	amountthe amount of
5	safe use under
1	approve a variance
1	initial advisory meeting,
1	secretary maintains unobligated
1	procedure or method
1	packed apples in
1	 (f) program
1	general information on
1	personal use amount
1	inspector, which label
1	application.  (6)
1	agreement, guidance or
1	independent national ant-doping
1	(i) cannot be
1	decisionmaking, and the
1	internet sales of
1	period, except that
1	information requirements referred
1	establish a defense
1	ii unless he
1	(15) shall ensure
1	 (a) classification
1	research data (other
2	otherwise notifies the
2	communit-based organizations, including
2	discontinue active pursuit
1	importing an article
1	matters  (a)
2	effective immediately unless,
1	specify the means
1	subsection may exceed
1	devices are required
1	safety; and (4)
1	department who have
1	approval  (a)
1	including a review
1	medically appropriate, with
1	industry standards and
3	removal from such
2	milk, cream, or
1	(b) factors in
1	year thereafter, if
1	also be considered
1	dispensed upon the
1	auditors as accredited
1	paragraph, a small
1	operational as of
1	distribution referred to
1	(7 u.s.c. 2012),
1	former position together
1	(c) standard for
1	(d) on and
1	suggests that if
1	formerly 905, as
3	structure or any
1	drugs, medicines, and
3	official marks may
1	regulation, determine the
1	collect, synthesize, interpret,
1	chemical residue due
1	general shall, on
1	public, and with
1	origin and destination
1	rise to any
1	representatives describing actions
1	reconstitution). (5) the
1	(a) as used
1	means the date
1	title. (2) there
2	comply is not
1	supply, cost and
1	
 350i. protection
1	subsection (g). (f)
1	environment.  (n)
1	term patient experience
1	resale, and (2)
1	products label, labeling,
2	shall issue such
1	narcotics trafficking the
1	chemicals, has become
1	reevaluation of tobacco
2	person, or for
1	agreements and united
1	detail from federal
1	holding, withholding, use,
1	data list 
1	business a separate
24	submit a report
2	user (referred to
1	paragraph using dispute
1	exceed $250,000 for
2	general shall transmit
7	years, the secretary
1	regulations allowing or
1	additive if at
1	retail stores, restaurants,
1	misleading matter; hearing;
1	624 of this
1	hours undertaken by
1	(e) matters considered
1	presence of multiple
1	national thereof has
1	recall to consumers
1	using any agency
2	brief statement regarding
1	abuse by the
1	device not in
1	
 451. congressional
1	towards the achievement
1	notice provided for
1	matter for which
1	1-month period; (b)
3	evidence standard in
1	hearing held pursuant
1	list by regulation.
1	ceased to practice
1	(a) state laws;
1	intelligence center. (p)
1	hospital emergency departments
1	registration, a unique
1	commission, and other
1	 (e) order
1	agencies; (6) shall
9	date of any
2	accredited official of
1	drug, other than
1	(g) public notificationin
1	appropriate, take action
1	42), in addition
1	secretary, including the
1	holding food if
1	senate. (b) one
1	history of foreign
1	establishment by persons
1	(7 u.s.c. 2012))
2	committee for report
1	conditions; exemptions; criteriain
1	foundation activities. 
1	(2) such holder
2	secretary seeking permission
10	exemption under section
1	meaning of 355(j)(5)(a)
1	disposition, and 
1	omitted
 
 2202.
2	international agreements shall
1	year the biosimilar
1	substance made by
2	effective under section
1	(1) $10,000,000 for
1	fee revenues made
2	 (b) penalty
3	health professionals who
1	tests, or other
1	party, the results
1	regenerative advanced therapies,
1	1996, and in
15	invalid or not
2	clauses, as applicable;
1	future tobacco products,
1	objections under subsection
1	submitted within 6
2	pediatric labeling could
1	introduce into interstate
1	clauses, as applicable.
3	common law or
1	regenerative advanced therapies;
2	order, and filed
15	assess and collect
1	379d4. reporting requirements
1	selection process. (4)
1	paragraph (3). (f)
2	appropriate, in order
3	specify the particular
1	supplement to submit
7	application under paragraph
1	regional or field
1	subparagraph (a)(i)) adversely
1	drugs or deliver
1	services with expertise
1	served (or intends
1	records required by
1	source plasma, or
1	technologies by federal
1	articles shall be
1	secretary until the
1	ch. 739, 49
1	infant formula, (c)
1	 (3) communication
1	agent is conducting
1	 (5) at
1	states who is
4	likelihood that existing
3	accompanied by such
1	testing methodologies for
1	regulation, and either
3	subsection (c)(4) for
2	secretary may conclude
1	efforts to identify
6	report describing the
1	sections 827(e) and
1	panel member before
3	one year nor
2	purpose of securing
1	thing as owner
1	smuggling or is
1	identified under subsection
1	foods described in
1	testing requirement under
1	emergency or threat
1	external experts 
11	notification of the
1	makes with respect
1	act of congress
1	purposes of investment,
2	oversee the implementation
1	panels according to
1	year; (ii) cover
1	regulated person and
1	food is prepared
1	chapter to conduct
1	recommendations for strengthening
1	rate of drug
1	transaction statementthe transaction
1	baseball, soccer, or
1	approved applications shall
1	products in carrying
1	parties in the
1	distributor and otherwise
1	(a) deliver, distribute,
2	18-day period would,
11	controlled substances and
1	commerce prohibited it
5	commission of the
2	licensed retail pharmacy
1	import and entry
1	
 459. compliance
1	(i) guidelines, developed
1	(2) the defendant
3	accreditation of a
1	section as accelerated
2	time of registration
1	compliance  (i)
1	space, respectively. 
1	sites, including through
1	immediately available. (h)
10	product described in
2	50 per centum
1	unexpired listed patents
1	days after entry
1	national security threats
1	1921 et seq.)
8	submitted under subparagraph
1	personal consumption 
2	device is adulterated
1	setting aside any
1	practices; and (v)
1	delayed, denied, or
1	230(c) of title
1	users, including the
1	jointly develop and
1	scientific advice to
4	reasonable times, to
1	containing animal fat
1	formula, at which
1	authorized, in accordance
2	secretary, in promulgating
1	establishment, the dates
1	practicable to the
1	identit-preserved labels with
1	
 
 96.
1	approval and is
1	effective; or (2)
5	least 4 years
1	section. such guidance
1	auditor to submit
2	shall not provide
1	finalize such guidance
1	(
 
 353.
1	law enforcement outside
2	schedules of the
1	safety risks, which
1	manufacturers production cycle
2	(1) to include
1	representations to evade
1	practitioner meets all
4	required for each
2	ingredients is not
1	laboratory accreditation 
3	upon approval by
1	(6) the issuance
1	modeled after current
6	buying, selling, or
1	working groupthe secretary
1	substances dispensed by
1	article. (g) 
1	thereof which is
1	periods specified in
1	times as may
1	(a) cigarettes and
1	appropriate procedures, practices,
12	grant or contract
1	reviewed, that a
1	summary or any
1	funding of program
1	effect for which
1	animal model meetingsto
1	response to 
1	also include an
1	scienc-based office within
1	agency that employs
1	device, then, for
1	name, and complain
3	work of the
1	least one credible
1	purchase, sale, or
1	100 grams, or
1	meat inspection system
1	employee to appropriate
1	units small enough
1	subsection (f); (2)
1	dismissal with prejudice
1	government over the
1	secretary whether to
1	degree of risk
1	made public by
1	congress or information
2	addition to all
1	title 42 (including
2	section 1524(a) of
1	auditors.  (h)
1	part by any
1	(4) report number
1	1621 et seq.).
1	manufacture, propagation, compounding,
1	activity or other
1	(c) in an
1	
 360cc. protection
1	promptly of 
1	(d) petition for
1	committees to advise
1	present identification under
1	different standards than
10	funds appropriated for
1	product). (2) the
1	forfeited personal or
3	may be detailed
3	condition that such
1	communications to and
3	general no state
2	laboratory testing services
1	underlying or comprising
1	possession of which
2	administrator shall take
2	(ii) if before
2	thir-party auditor is
35	review of such
1	discuss the basis
1	thir-party auditor in
1	(4) activity by
1	term component part
1	bases for initial
1	unrevoked license any
1	documents and describes
1	notify the registrant
1	exclusions  (1)
1	labeling was added
2	diseases.  (b)
1	penalty under clause
1	(6)(a), through direct
1	feed, appropriate purposes
1	chooses to be
1	states sanctions imposed
1	(i) conform with
1	clause (iii) finding
1	sale, sold, or
3	act, shall be
1	preventing the use
2	director documents the
25	paragraphs (1) and
1	ch. 675, 740,
1	(including functions prescribed
2	recipient or anyone
1	waiver. (e) preemption
1	agent, service of
3	(i) during the
1	federal government over
1	direct human contact
1	(15 u.s.c. 714b
2	service a subpena
1	pregnancy than teens
3	export of a
1	purpose of improving
1	device, the design
1	denial of access
25	period of not
2	nontopical antibacterial ingredient
1	pollution fund 
2	21, 1997). 
1	copy; (c) provide
1	-ray equipment, without
1	information.  (bb)
4	shows to the
3	cooperate with the
1	(c)(3) for that
4	defined as used
1	subsection (c)(2)(c) shall
1	any) of such
1	1, 2017, but
1	professional practice; (2)
1	petition seeking action
3	1-day notification requirement
1	licensed, including in
1	groups), consumer groups,
1	including small businesses,
2	agency or to
1	(c) the manufacturer
1	chloride (mg) 55.0
1	prohibiting the sale
1	additional labeling requirements
1	spectrum of the
1	union or a
1	first report, the
1	abuse policy. (11)
1	sales that identifies
1	(d) powers of
2	381(r) of this
1	chemical residue; (b)
1	support and enhance
2	regulation, as provided
1	appeal. (c) service
1	(e) declaration of
3	practicable, but in
1	descriptive materials accompanying
1	including regulations requiring,
1	processing or formulation,
1	component of such
3	illicit drug use;
1	products specified in
1	cooperation and payments
1	judgment. upon such
1	information properly classified
1	accessed and understood
2	applicant, not later
1	(d)(2)(b).  (ii)
1	by, the manufacturer
1	administration is managing
1	director at such
1	printed sticker affixed
1	prioritize the development
1	(a) is at
1	replacement products, such
1	general rulethe administrator
1	administration showing patterns
1	(d).  (iii)
1	public comment a
1	withheld.  (2)
2	evaluation that is
1	subbrand. (2) a
1	defendant lacks the
1	information only. 
3	furtherance of the
1	applicant provides notice
1	include blood or
1	tank.  (c)
1	volume of food
1	reduce the quality,
1	dogs, and cats,
1	defeat any clearly
2	promotional materials related
1	line of food
1	authorizing the marketing
1	(2) contents such
1	safety questions. 
1	individual exportations or
1	(d) containers to
1	(g) the application
1	determines appropriate (including
1	retail stores, if
1	ring stage). (6)
1	strategic planning for,
1	benefits identified under
14	infectious disease product
1	implantthe term implant
1	inspectors) designated by
1	property to jurisdiction
1	clause (ii); or
2	(aa) the term
1	(g) regulations concerning
2	report to congressional
1	conditions and processes
1	official compendium. (f)
1	interstate commerce by
1	(f)(2) of such
2	secretary state the
1	allegation of the
1	748(b)(1) of title
1	breakthrough therapy. a
1	(c)(2), may require
1	appropriate ris-based preventive
4	food and nutrition
1	6-day period under
1	trafficking, and transportation
6	secretary to deter
1	(ii) information for
2	lif-threatening experience; (iii)
1	link reports about
20	shall be fined
2	seq.], an eligible
1	entities listed in
1	subsection (c), concerning
2	criteria prescribed by
5	final and conclusive
1	law and who
4	(c) for a
1	border with a
4	die, plate, stone,
1	effectiveness of community
1	1997 means chapter
2	manufacturing quota for
2	lacks appropriate pediatric
1	exemptions of drugs
2	decision times for
7	legitimate medical purpose
1	product identifiers under
1	drug in excess
1	regulation establish such
1	business days in
1	exclusivity for new
2	effective shielding or
1	reported; notice of
1	increase capacity to
1	dentist, veterinarian, scientific
1	furnished information on
1	(1) executive board
1	year 2018; as
1	container size or
11	subparagraph (a) to
3	(ii) such costs
2	review activities, as
1	section. such regulations,
1	experience; (2) shall
1	required for eligibility;
1	science, that data
2	electronic products comply
1	
 
 360b.
1	radiation which may
1	(known as the
1	675, 1012, formerly
33	residue in or
1	animal drug products);
1	united states provided
1	percentages otherwise determined
1	full quarterly fee
1	purchase was reasonably
1	ch. 675, 906,
1	report that includes,
1	individual or residential
2	local educational agencies
1	means the production,
1	produce was grown;
1	racketeering, blackmail, extortion,
1	assessing civil money
2	animal drug be
1	1714. awards for
1	given disease or
1	effect); (ii) the
1	business.  (4)
2	stat. 818.)
 

1	(1) authorized fees
1	transferred
 
 1173.
2	paragraphs (4) and
1	official compendium. (b)
1	identifying and defining
1	sunscreen order; or
1	section for articles
1	 (h) limitations
1	application; contents 
1	title;  (3)
1	carried out one
10	claim of the
1	order. (j) status
1	(i) no refunds
2	-year periods described
1	warrant shall identify
2	effective is in
1	unless such contract
2	effect as of
1	treatment, the attorney
1	chapter, or willfully
3	(a) through (i)
4	subparagraph (b) or
2	person is a
1	serial number, and
1	include any other
1	(11) outsourcing facility
1	secretarys strategic plan
1	device. (c) for
1	team to the
4	drug by a
1	tablet, capsule, powder,
12	subparagraph (b) of
1	(b) testing procedures
2	process any poultry
2	articles prepared at
10	fees owed by
1	preserved by the
6	(iv) of section
1	fees based on
1	product, which may
2	withdrawing or suspending
1	(i)(2), (i)(3), and
3	both. (
 

1	science, and public
1	information is added
1	(4) rules relating
1	faith submits a
2	conduct of such
1	subsection and subsections
1	grounds, or the
2	schedule to another,
3	fee is payable.
1	3.5 percent of
3	sponsor not later
1	handlers, and the
1	$248,000  $252,960
1	register each report
2	pool, or video
1	potential, such information
1	laboratory, or other
1	remedied, (2) replace
1	services.  (mar.
1	waiver authority 
1	(2). (4) public
1	fiscal years beginning
1	(16) psilocyn. (17)
3	poultry products under
1	interim final basis.
1	protection against adulteration
2	application or use
1	united states inspectors
1	subsection. (d) modifications
2	technical, regulatory, or
2	determining substantial equivalence
1	doses; (ii) the
1	(ii) all records
1	consideration the material
2	fee due datethe
1	first meeting, make
1	antifungal resistant pathogen,
13	subject to inspection
1	no-compliance letter to
1	awarded to an
1	require a timetable
1	notice of eligibility
1	scientific and technological
1	 (t) 
1	audited by an
1	placed in any
1	(b) accelerate foodborne
1	fee under section
1	ethical standards, the
1	may in carrying
1	may be implemented
1	brand the term
1	 (1) facilitate
20	published by the
1	reserves within 120
1	year. resubmissions may
1	things) not only
1	goats delivered by
8	plans of the
2	claimants principal place
2	information under section
1	negligence or intentional,
1	carry into effect
1	state from exercising
1	moral character and
1	(3) narcotics trafficking
1	products, of the
5	information upon which
1	accompanying such application.
1	 (b) prioritize
3	title 42. (june
2	unfair or deceptive
1	ch. 675, 412,
1	assessments under subsection
1	subparagraph (a). (e)
1	animals whenever, in
1	administered; (3) 
1	software, color additives,
1	 (2) fiscal
1	referred to therein,
1	children, racially and
1	administration who is
1	received. if such
1	objectives and design,
1	term licensed means
2	designation shall be
2	chapter when a
1	(c) specific requeststhe
1	format for submissions
2	business; finality of
3	may be a
1	 (g) seizure
2	anticipation of the
1	(b) order to
1	(a) delegation of
1	(1) whoever willfully
1	timeframe, under any
1	refunds except as
1	appropriate pediatric formulation,
1	division, or preserved
1	(i) a site
1	initiated under subparagraph
2	applications for programs
4	carrier or warehouseman
1	 (d) registration
1	new drug means
4	hearing shall commence
1	preventing, or identifying
1	application; substantial evidence
2	substances into other
1	343(h), 343(i), 343(k),
5	standards established by
1	penalties or accrued
1	chief scientist, shall
1	citation were submitted,
1	producing positron emission
1	2018. (c) annual
1	otherwise prepared on
2	as, a device
3	inches, if the
1	effect or has
1	canada, from a
1	institutions, and restaurants;
1	year 2006; (10)
2	infringed, the period
1	inspection;  (4)
1	(iv) the initial
1	shall, from time
1	1524. authorization of
1	plan if, after
1	article into any
1	illness outbreak to
1	treat addiction; (17)
1	year, animal drug
1	seize all property
8	controlled substances by
3	drug administration shall
1	become effective on
1	plan submitted pursuant
1	respect to chemical
1	(vi) does not
2	enhancement of the
1	registrant reported pursuant
1	(e) preemption 
1	assistance division; and
1	goals of this
1	fee) program, similar
4	person to conduct
1	officers performing functions
1	committee pursuant to
1	secretary; and said
1	counseling and recovery
4	interfere with the
1	secretary shall accord
1	purporting to be,
1	broken shell or
1	(2), the operation
1	grown tobacco and
3	made of the
1	rapidly detect and
1	security shall submit
1	qualification plan; and
1	importer. at the
2	construed as restricting
1	subchapter. any person
1	device, the director
1	supplies of the
1	enforcement actions following
1	public health significance
1	provided to veterans,
1	domestic and internationall-recognized
1	permit him at
1	(a)(2), any person
1	available, as provided
1	cherry, or coffee,
1	including independent private
1	supplement or ingredient:
1	$100,000,000 for the
1	committed a violation
1	 (ii) timetable;
1	(iii) that is
1	(b) may, upon
1	(ii)(ii) publicly available,
1	supplement fee under
1	supplement.  (2)
2	shall include repackaging
1	(6) nothing in
1	bears, in accordance
1	controls is a
1	seq.]; or (d)
1	program determined by
1	person by submitting
2	biological product, assembled
1	shall attempt to
1	describes the findings
1	inconsistent with 
11	copy of such
1	18-day period would
2	foreign government recognized
1	authority. (b) the
2	among other things,
1	 (5) guidance
1	
 1547. staff
2	involved in demand
1	sufficiently rare condition,
1	individual to give
1	person for distribution
3	inflation adjustmentfor fiscal
1	(a) the types
2	representatives of appropriate
2	diverted, or stolen;
4	prior conviction, include
1	products falsely labeled
2	territory, or region
2	shielding or other
1	344. emergency permit
7	product with respect
1	 (a) kindergartens;
2	substances, or other
5	deemed necessary and
1	used in manufacturing,
1	(c)(3). (f) limits
1	regulations; and (b)
1	every five years
1	pursuant to, and
1	backlog of postmarket
1	2, 62 stat.
1	use; (2) describes
5	implement the national
3	paragraph (7). 
1	whether a submission
1	debarred person under
1	regulations, as in
1	(g) sunset the
1	(7) postapproval requirementsthe
9	substance or listed
2	subsistence, and salaries
1	(f) research and
1	(i) the request
2	379g(3) of this
10	permanent select committee
1	name, professional degree,
3	term of imprisonment,
1	facility; or (7)
4	voucher to the
1	evidence, for public
2	number of waivers
1	person obtained the
1	hold  (a)
2	applicable; (2) the
1	registry (a) definitionsin
1	fiscal year 2005;
1	title); and (d)
1	facility, or other
1	(a) the type,
1	(d) apply; 
25	enforcement of this
2	selected establishment. (4)
1	regulation; (c) provide
1	hair dyes (as
1	discharge of any
2	representative sample of
3	benefits to the
2	transactions and to
2	ethylmorphine per 100
1	foreign commerce, any
2	title 42, or
1	violation. the secretary
1	necessity of effective
1	(a)agreement to give
1	public service time
1	employees, as defined
1	purchasing the food
2	1040) [21 u.s.c.
1	consultation the administrator
3	procedures or methods
3	title; or (c)
1	month to the
1	states. the amount
2	practitioner who has
1	(m) include a
1	(4) planthe content
2	expertise regarding drug
1	first offense except
1	abet, conspire, or
1	(d) invite the
3	secretary is not
2	blank space, respectively.
1	replace it with
1	shall furnish such
1	distributions and shall
1	(i) the delivery,
1	poison, or pharmaceutical
1	(or pharmacologically related
1	(b) time period
1	combustion or heating
1	petition or proposal.
3	modified in such
1	pharmacy. applicants shall
1	cooperation among federal,
1	meets the agencys
1	coordinating councils referred
2	order an appeal
1	surrogate and clinical
1	use of hidta
1	recommendation and a
1	date be considered
1	measures to provide
1	practitioner are that,
1	 (1) refer
1	termination of debarment;
1	export drug paraphernalia.
1	organization, provided such
5	application is approvable.
3	substances listed in
1	entities that attempted
1	notice made under
1	(a)(iii) shall not
4	defray increases in
1	antibiotic drugs may
1	sustaining or life
1	second country or
1	indications for the
1	provide reasonable opportunity
1	 54.0. 
1	assess trends relating
1	approve the protocol,
1	include package liners.
6	controlled substances (a)
1	food facility inspection,
1	nurse tank. 
1	panel shall review
1	portion of meat;
1	promote a particular
1	court ex parte
1	drug. the provisions
1	adequate scientific evidence
1	future, (e) whether
1	(b) ability to
1	accepts direct possession
1	 biotin (g)
3	controlled substance will
4	product, or upon
5	may limit the
1	shall publish, after
1	1001, formerly 901,
1	study conducted pursuant
1	expected to make
4	combinations of drugs
1	section 290aa(d)(16) of
1	united states, by
1	suppliers (a) in
1	baseline determined by
1	v.  (a)
1	 (1) contact
1	identification card that
1	agreement establishing the
1	authorized to investigate
1	(b) nitrogen that
1	reversing such order
1	collect fees sufficient
1	(d) insert or
3	requirements applicable under
1	(iv) conditions regarding
1	systematic manner, taking
1	one violation. (b)
1	ordinary conditions of
4	approved, the holder
1	100 grams with
1	rescissions or modifications
1	canceled; or to
1	section, exempt from
1	require completion of
1	(21) the term
1	component parts (including
1	order involved, and
1	source.  (h)
1	respecting such regulation
1	drug or class
1	 (i) public
32	subsection (b) for
1	device. (5) the
1	(a) or otherwise
1	authorized the attorney
1	shall publish on
1	3913, 34 stat.
1	continued use of
1	comparing a tobacco
1	greater danger to
1	human food, in
1	additives are suitable
1	establishing or operating
1	conducting administrative inspections
1	pain. (ii) the
1	residues exceeding such
1	screening program 
1	term propertyproperty subject
1	written report with
1	abuse reduction organizations,
18	abbreviated applications for
1	(b) the claimant
2	(1)(e) refusing to
1	necessary so that
1	unable to inspect,
1	misbranded fooda food
11	except as authorized
1	impact on specific
1	disposition of product
2	medwatch form, which
1	writing the participation
1	provides for tracing
1	(d) procedures for
1	procedures.  (16)
2	343(y) of this
1	additive for a
2	activities that violate
1	whom, or an
1	-penty--(-chlorophenylacetyl)indole (jwh203). schedule
1	(a)(1). the hearing
1	petition at or
1	relation to all
1	violation or alleged
1	(2). the advisory
1	united states substantial
1	shall estimate by
7	payment of fees
1	multiple devices described
2	written agreement described
1	warrant and a
1	temporary holds at
1	mental disease, in
2	applicant makes a
1	adverse event reporting:
6	subparagraph (c), the
1	pesticide chemicals on
1	filed as complete
1	effect of certification
2	permission to file
1	device provide for
2	period beginning one
1	registrant. any suspension
1	evidence or otherwise
2	section alters or
1	burdensome concepts to
1	chapter that meet
1	labeling was to
2	technical achievability of
1	results in food
1	substances flows through
1	registered manufacturer, the
1	dietary use 
1	order, while amending
3	recognized as appropriate
1	may identify such
1	refilled only if
1	requirements; (h) allow
1	mixture or preparation
1	appropriate. (c) for
1	agreement to the
1	partner, in a
1	compendium for designation
2	section 381(h)(1) of
1	report, the director,
1	assessment of current
2	first list under
1	reasonable promptness. (2)
2	(b) requires, based
1	irrevocably barred from
3	submits a written
1	defined as each
1	payable at the
1	application and, if
1	entities, the institute
1	labeled or tagged
1	year, the secretaries
1	nonprescription sunscreen; and
2	pharmacy to another
1	regulation of retail
1	title before completion
3	submitting the application
1	information of each
3	 (e) review
1	secretary may terminate
1	conduct research with,
24	shall include the
1	42, imaging drugs,
1	control international trafficking
1	8 individual portions
1	(2) expedite an
2	involved.  (d)
1	infant  (a)
1	time of appointment
4	generalnotwithstanding any other
1	found acceptable by
1	including requirements relating
1	27, 2007. (g)
1	issued to implement
1	(e) color content
1	19011906) until the
2	establish such conditions
1	hallucinogenic effect. 
2	destroy markets for
1	1-month period for
1	50 states of
1	applications filed under
1	required in regulations
2	collection during first
1	activities of private
1	675, 515, as
2	complaint, of the
1	need to conduct
1	methodology for developing
1	preclinical testing involving
1	vehicle of a
6	resources; (c) leasing,
7	period in which
1	term unapproved product
1	(c) make such
1	(6) agency action
1	drug sponsors, when
1	will be provided;
1	review fee) shall
1	appropriate, revise not
1	 (b) priorities
1	food products wherever
1	subsection, there are
1	49 stat. 885;
1	priorities in determining
3	secretary receives the
3	regulatory responsibilities and
3	access to an
1	voting balance required
1	schedule, any injectable
2	(iii) appropriate conditions
2	transaction; or (d)
2	law, personall-identifiable information
1	safety offenses (a)
3	drugs  (a)
1	826. production quotas
1	administration.[1] (c) advance
5	 (b) is
1	calculated by dividing
1	expiration date means
2	chemical residue from
1	standard relief may
1	change is necessary,
1	deadline at customary,
1	states. (j) the
2	(d).  (f)
1	 (1) add
2	will interfere with
1	restriction under subparagraph
1	 (6) if
1	different strength. 
3	national, state, and
1	failure is caused
1	(4) and (5)
4	fact joined in
10	sentenced under this
1	proposed in such
6	(b), (c), and
1	ingredients if he
1	possessed and used
1	annual registration under
1	effects and consequences
1	costs referred to
1	 (k) certification
2	applicable to domestic
2	(july 1, 1902,
4	person who registers
1	testing device meets
2	 (f) protected
1	imposed by virtue
13	take into consideration
1	permits a qualifying
1	food products impair
7	calendar days for
1	
 157. inspection
1	(5) the drug
1	registry under section
1	recall; and (3)
1	forth in plain
1	shall rescind any
8	include a description
1	ii other than
1	(d) take into
1	sum of one
1	inspection, upon completion
1	sale of certain
1	criteria for antimicrobial
1	matter before the
3	 (b) procedure
2	first sale) after
1	program for persons
11	minor use or
2	appointed pursuant to
1	paragraph and which
1	valid prescription from
1	structure;  (3)
1	testing is to
3	prescription drug means
1	acid. (18) phenazocine.
1	evaluation as the
3	standards that apply
2	event reports provided
5	inspection and copying
1	sentence as a
1	made an assertion,
1	body of drugs
1	appropriate.  (iii)
1	body to assess
1	studies will not
1	supply of materials
1	may use countermeasures,
1	advertising.  (2)
1	(b) dismissal of
1	fat of the
11	enter into a
1	drugin this section,
3	 (a) results
1	(e) validity a
1	authorize a party
1	(1) notwithstanding any
1	dangerous drugs for
1	26, 41 stat.
1	human life, and
1	articles can be
1	effect and paragraph
1	requirements for ghbin
1	 (a) human
2	except where otherwise
2	subchapter in the
1	13 percent of
1	effective. if the
1	(for imports) that
1	previous laws unaffected
1	(d) shall be
2	civil action covered
1	import any thre-neck
2	product and conduct
1	implementation of any
1	5th par., 34
1	thirt-day period. (iii)
3	papers, and records
4	(21 u.s.c. 451
1	agency plan for
2	conditionally approved new
2	responsibilities under this
1	food, and are
1	shall, when appropriate,
1	
 
 356f.
2	seeks approval, except
1	small enterprises (including
2	whether to grant
1	drugs being tested
1	priority review; (d)
1	guaranteed under the
2	poultry items in
1	 (5) allocation
2	preceding sentence may
1	type for a
1	device, an order
1	packagers, or importers
1	effortsthe attorney general
1	controlled substances. (3)
1	paragraph. (d) noncompliance
2	behalf of a
1	dealer at the
1	exist. (4) before
1	(pcp); (e) 10
1	thousand; (5) when
1	recommendations to consumers
1	unique identification numbers
1	limitation no tobacco
1	dealing in or
2	shall not engage
1	(a) during the
5	carrying out his
1	that, consistent with
3	risk and minimize,
1	salted, rendered, boned,
1	risks, if any,
1	womens issues, consumer
1	carcasses brought into
2	disclosure of confidential
1	subsection (b)(1)(a)(i)(iii) for
1	due to dru-resistant
1	responsible individual or
2	(4) policies and
1	 (5) explanation
73	article of food
2	tolerances or exemptions
1	noncommercial applications of
3	pediatric age group
1	(i) funding from
1	person licensed, registered,
1	program. (3) the
1	section, possess or
1	retailers within that
1	database, which shall
4	system for the
1	(3) provide information
1	notices to states
1	store, apothecary shop,
1	written requests and
1	person demonstrates substantial
1	proprietary name) of
1	 (5) person
2	section, and in
1	afte-early child education
1	advertising of menthol
1	inspect facilities registered
1	radio frequency identification
4	cost incurred by
1	may import or
1	states trade representative;
1	ch. 155, 6,
5	upon the submission
1	supply chain may,
1	facility that registers
1	address any reasonably
1	pursuing marketing approval
1	price and purity
1	(3) a study
1	section 274 of
1	identify each authorized
1	(1) corporations, partnerships,
7	 (2) collections
2	states trade representative,
1	states trade representative.
1	(2) in cooperation
1	inspected, the purpose
4	condition that the
1	finding that a
1	substance on the
1	district court shall
1	means are available,
1	maintenance organizations and
1	including the potential,
1	agents to enter;
1	submissions, 3-day notices,
3	documents, papers, and
1	article. (iii) the
1	cooperative arrangements with
1	(a), and shall
1	shall be remitted
1	applications and supplements).
6	efficacy of such
1	secretary recommends that
1	action plan 
1	illicit narcotics crops,
1	applies. (ii) the
2	officers, employees, committees,
2	data, information, and
1	sentence in the
1	6 years to
1	drug as fast
1	
 98. transferred

1	comment, that a
1	transportation, possession, or
1	written advertisement knowing
4	includes a product,
1	benefits for certain
1	may differ based
1	permanent scheduling order
4	abstracted therefrom; or
1	abuse treatment services
5	event of the
2	appropriate to expedite
1	appropriations acts, for
1	section 1605(c)(3)(b)(ii) of
1	drugs in response
1	inconsistencies in present
3	(b) or section
1	proffered delivery of
1	optimum freedom for
1	(e) evaluation and
2	secretary a human
1	enforced is an
3	enforcement of any
1	dtc advertisement), each
1	successor regulations) that
2	contracts the secretary
1	significant center of
1	legitimate purposes; (2)
1	device exists, provided
1	(3) guidance not
2	levels of concentration
1	(g), the fees
1	practitioner, as defined
1	 (d) reports
1	850. information for
1	(d) misleading container
1	professionals. the preceding
1	devices shall register
1	illegitimate product will
1	agriculture, shall assess
1	title or investigational
1	paragraph (7) revoking
1	marketing application for
3	person has its
1	143. inspection; certified
2	suspend or terminate
1	ch. 675, 515a,
1	qualification reviewthe secretary
1	(b)(2) will be
2	flexible approaches to
1	(b) any state
1	stuffed, rendered, boned,
1	equipment. (b) supervisor,
1	updated standards; (iii)
1	(a) controlled premises
2	data shall be
1	seq.], be lawfully
1	accreditation, not later
1	(iv) the conduct
1	extensions granted and
1	reviewing the activities
1	conducting research with
2	provisions respecting the
1	prosecution of cases
1	(6) whether the
1	grant authority the
1	exercises carried out
1	petitioner; or (iii)
1	fee setting and
13	information for the
2	secretary. after the
1	supplemental application under
1	business. the failure
1	norpipanone. (34) phenadoxone.
2	representative of that
1	(e) notification; timetables;
1	virtue of this
1	year to provide
2	(a) a description
1	title, determines that
1	agent, or employee
1	enhance federal drug
1	controlled substance. as
1	fees needed to
1	united states, samples
1	(1). (ii) a
1	manners, from which
1	(i) proceedings of
2	marks whenever any
4	investigations for the
1	shipped. (d) the
4	withdrawing conditional approval
9	designation of a
1	unless such information
7	552(b)(4) of title
1	manufacturer to furnish
2	(1) during the
1	regulation standards for
1	secretarys referral on
1	(e) in determining
2	(2) notification under
1	filter, or paper)
1	authorized to take
1	minimal and the
1	written request justifying
1	(c) take any
4	biological product applications,
1	months before the
1	residue studies under
2	4-day period referred
1	obtain the necessary
6	continue to meet
3	provided for by
2	drug shall notify
1	shall complete action
5	repeatedly or deliberately
1	shall, as appropriate
2	recognition under subparagraph
1	manufacturer notified pursuant
1	(2) making, selling,
1	appropriate regulatory authorities
1	procedure for rulemaking),
1	year, the chairman
1	extension of such
1	(d) the expected
1	persons (including patients,
1	
 
 644.
2	title that are
2	rate used in
3	usefulness and simplicity.
1	milk, as defined
2	administrative proceeding held
1	(ii) any practitioner
1	standard. if the
1	often called neonates,
49	issued by the
2	device in a
1	schedule notice, request
1	calendar year, and
1	license every person
1	(d) augmenting such
1	party has the
1	necessary for fiscal
1	(1), notice of
1	agencies will implement
1	food system of
1	establishments, consistent with
2	application shall file
1	government employees; fellowships
2	united states owner
1	purposes; and (2)
3	employees.  (b)
1	(v) developing modeling
1	suspect product, whichever
1	that, under subsection
1	trade commission shall
7	drug  (a)
5	within a type
3	2012.  (4)
2	epidemic product (as
1	efficacy supplement means
1	352(r) of this
1	manufactured by such
1	including an article,
1	communities in the
2	shall, at least
1	international trade obligations;
1	hydrate. but the
4	competition, exemptions shall
1	(ii) the identification
2	28 grams or
1	investigation determines, on
1	(c) timelines the
2	(b) has not
1	incident of anaphylaxis
1	(h) shall, at
1	product experiences as
1	studies, patient registries,
1	recognized worldwide as
1	subsection (a)(1). the
2	shall terminate at
1	substances (as defined
1	information proposing that
1	general of an
5	expedited basis and
1	exporter involved intends
1	june 1, 2009,
1	chapter; term of
1	sites where drug
3	 (2) contentthe
1	number of libel
1	coordination with attorney
1	eligible for inclusion
2	government of a
1	adopt, promulgate, and
1	logistics provider licensing
1	(d) buruli ulcer.
4	panels of experts
1	apply until october
1	information as public
2	secretarys conclusions, made
1	products, except for
1	surrogate endpoints and
7	publication in federal
1	appropriate, solicit, review,
7	food is not
1	authority to designate
1	requiring direct interactions
1	524(c) of title
7	federal income tax
1	material manufactured, manufactured
1	association, (b) a
1	term of a
1	determines appropriate; or
24	meat and meat
1	change. the report
1	licensure, or clearance;
1	vessels, which are
3	clause (iii), the
1	 (e) package
2	substances it shall
1	tobacco product until
1	various communities. such
1	supplier at any
1	findings made through
1	makes the finding
1	94 to 95.
1	 (d) effectiveness
2	(ii) deselect the
1	title iv, 409,
1	violations have not
1	known as schedules
1	 (e) licensing
1	forfeitures any person
1	(i) acceptance of
2	raised by such
1	establishing fees under
1	(4), printed prominently;
1	stat. 1058; oct.
1	article is intended
3	transferred before such
1	part that was
1	may establish categories
2	term of 2
1	health system the
1	committing rape or
2	require a tobacco
1	103(q)[3] and shall
1	consideration of, the
1	feed; or (ii)
2	stating that fact:
1	property; (b) except
1	fiscal year, $712,000,000.
1	evaluate such requests
1	labeling requirements; definitions
12	services and the
1	34 stat. 679;
1	meeting for review
1	governments to facilitate
1	private entities. (iv)complementary
4	food purposes under
1	drug abuse threats
1	drug paraphernalia (a)
18	list i chemicals
1	
 822a. prescription
1	drug. a request
1	contravention of the
1	advertising relates under
1	development protocol submitted
1	reinspection fees 
1	enforcement drug control
1	website regarding successful
1	consultation under subparagraph
3	(i) that is
1	changes the labeling
1	iii 301, as
5	conduct an audit
1	plant or other
1	object if, in
2	eligible entity. 
1	agency delegated to
1	cause continuous inspection
1	conduct a reanalysis
1	events that may
1	fee assessed if
1	information, other than
1	manufacture, transfer, distribute,
1	makes such declaration
3	diverse geographical areas
1	 (b) foodborne
2	one applicant, the
1	subsection (b), effective
19	number of ful-time
1	refuses, on the
1	determines that special
1	payment of tort
1	reserve fund under
7	made to show
3	 (j) construction
1	display, except matters
1	recalls, warning letters,
1	(v) the valid
1	regulations may, at
1	drug. an abbreviated
1	issue a food
1	positions. (b) omitted
1	accords to the
3	effective date is
1	prescribe.  (g)
1	spice not specified
1	recall audit checks
1	foundations that fund
1	list is necessary
1	ionophore or arsenical
1	device provides the
1	design of a
1	circumstances causing such
1	ensuring that processed
1	characteristics regarding the
1	355b. advers-event reporting
1	patients with a
2	secretary until after
2	reports each serious
1	effective date in
1	appropriate, and finalize
1	subsequent purchaser that
1	(1) an employee
1	criminal justice system.
1	encouraging such agencies
1	(d) summarize the
1	title, immediately furnish
1	representative after the
1	substances, which shall
1	practitioner who conducts
3	revenues to be
1	manufacture, repackage, process,
1	business exception in
1	amendment shall be
1	resolution proceeding pending,
1	may take all
2	(e) publication and
1	(f) post the
1	shall be one
1	
 350h. standards
1	convention signed at
1	insanitary, etc., ingredients
15	tolerance for a
2	required as a
1	(d)), up to
1	concentration, or with
2	referral under subparagraph
1	africa-americans, hispanics, and
1	chemical residue, if
1	interests of any
1	approval or november
1	records that are
1	(d) the container
3	initiate the process
3	sponsor under subchapter
1	title 18. (mar.
1	denial; written response;
1	use. (2) the
1	drug.  (jj)
18	secretary shall require
1	effect of inadequate
1	information, the prospective
3	trafficker so identified
5	amendments to such
1	general the controlled
1	counternarcotics enforcement to
19	 (i) to
4	recordkeeping requirements for
2	establishment within any
1	disease; and (c)
1	follows:  (aa)
2	person for such
1	bearing on safety
1	drugs, manufacturing supplemental
1	device used shall
1	(i) holding meetings
1	ii seized for
2	purposes in the
1	format that is
1	final determinations by
1	ii substances except
1	purpose of developing
1	cause such actions
1	 (i) $15,000,
2	withdraw such application.
1	forces, under other
1	regarding drugs and
1	particular food, or
1	devices required by
1	attorney a violation
1	one month after
1	staff to the
1	condition and who
1	physicians meeting appropriate
1	prevent the occurrence
1	 (4) annual
1	sections 556 and
2	payments, including cash
1	motion as motion
1	(b) contentseach application
1	(ii) the certification
1	offered for import.
1	secretary independently determines
1	(l) applicability 
1	potential to pose
3	director of a
1	electronic format 
1	subsection (b) unless
1	growth or other
1	controls, except in
1	establishment inspection, as
1	paragraph. (2) on
1	additives) shall be
2	facility: provided, that
1	government employee in
1	gas means a
5	service act (42
1	(b)(2).  (2)
4	administration.  (june
2	dispenser, hospital, or
3	engaging in any
1	establishment fee from
2	declaratory judgment absent
4	(aug. 3, 1912,
1	approved racemic drug
2	secretary; (10) if
9	finds that there
1	known serious risks
1	(b)(2), clauses (i)
1	foreign terrorist organizations,
1	(2) in promulgating
3	(a), including the
2	(1) pursuant to
1	upon publication shall
1	offered for import,
2	paragraph (c), with
1	report  (i)
1	less. (iv) for
1	897.34(a) after other
1	states, an information
1	(ii) the nurse
1	recommendations for improving
5	(ii) there is
1	case was removed
2	improvements to the
1	provide for testing
2	(1) under the
1	logistics provider 
1	performance measures available
1	potential adverse events
1	provided, or if
1	purpose of recovering
2	bioequivalence studies has
1	product, as he
1	product only if,
3	class ii devices
1	disciplinary authority. (2)
1	useful in identifying
1	matters from a
1	property constituting, or
1	request for supervisory
1	program as part
1	provided, or is
1	proposed protocol provides
1	tolerance for applications
1	otherwise utilize all
1	correction or action
1	whose results offer
1	food additive, a
1	introduced or delivered,
1	issuance, to manufacturers,
1	387o of this
1	inspection authority (which
1	conviction for any
1	almonds, pecans, or
1	purpose. (2) no
1	shows that, as
3	drug. (c) the
1	(d) office of
1	section; and 
8	published pursuant to
1	2010 unless the
1	found for purposes
2	reasonable person to
1	summary review. 
1	remains in effect.
1	subchapter applicable to
2	following substances having
1	
 360a1. clinical
1	(b)(i), an additional
1	strophanthus, stramonium, veratrum
1	prospective purchaser providing
1	substantial likelihood that
1	secrets  (1)
2	established in adequate
1	chain stakeholders, prioritize
2	(d) activities necessary
1	section 394 of
21	subdivision of a
4	injurious to the
1	effectiveness of initiatives
1	
 
 353b.
1	examination and testing;
2	term advisory review
1	ch. 423, 62
1	develop a plan
1	enforcement activities by
1	ii, special controls.
1	3,000 layers. (5)
1	comment at least
1	outsourcing facility if
1	different recordkeeping requirements
1	section 1605 or
1	purposes and will
5	agriculture of the
1	container used or
1	societies, medical schools,
2	section and, if
2	shall affix or
1	15, 1967, and
1	uses the descriptors
3	storage of the
1	functioned as intended,
12	common or usual
1	 (d) panel
1	clearance of such
1	construed to relieve
1	title by 
1	allegiance to the
1	explanation of any
1	modification in design,
5	intended by the
1	2013, fees under
1	profile in a
1	(d) timing for
1	262]. (b) the
5	words, statements, designs,
3	business day, and
1	december 3, 2003.
2	device for such
1	tobacco products including
1	inform any authorization
1	cosmetic act, the
1	(ix) the statement
1	courts exercising general
1	associated gene product;
1	taken by health
1	provision of an
34	district of columbia
1	calendar year to
1	treatment in accordance
1	produced at the
1	term laboratory supply
1	or, at the
2	irrespective of the
1	eligible product after
4	(c) priority review
1	although they present
1	using huma-readable or
2	(pcp) or 1
1	drug abuse. the
1	commerce. thereafter, upon
4	shall publish such
4	national institute on
1	timing, or costs.
3	national institute of
2	(a) to ensure
1	grants as part
1	time after seizure
2	pay such fees
1	local planning for,
1	personnel appointed to
1	675, 584, as
1	law, all carcasses,
1	chemical obtained pursuant
2	administrator; and (ii)
1	period when the
2	exported, distributed, or
1	evaluation of hidta
1	outsourcing facility is
5	order to require
3	notice terminating the
4	application in accordance
1	completion took effect.
6	term small business
1	drug administrationbecause of
1	subsection (f), if
2	preventing, or treating
1	seizures; and (ii)
2	safety, and shall
1	subsection (f), in
2	submit supporting information
2	trademark, brand name,
1	regulation classifying such
1	pool includes any
1	manufacturer, importer, distributor
4	5.  (

4	to, and not
2	construing or enforcing
1	effect may at
1	packer; marking food
1	deferral that has
1	held under paragraph
2	subparagraph (a). (4)
1	(o); (vi) guidance
1	fund are authorized
1	title unless exempt
1	approved drug, provided
1	dates if it
167	national drug control
1	occurs first. this
7	provide written comments
44	intended to be
1	term facility 
1	 it shall
2	prior to trial
1	taken to avoid,
1	taken and shall
1	article at a
24	offered for import
1	pediatric effectiveness can
1	v from the
2	necessary.  (june
1	characteristics are substantially
1	(4) one or
2	 (a) use
1	(3), the administrator
1	(h) disposition of
1	shall supply the
1	permit or, in
1	 (iii) rule
6	shall be taken
1	u.s.c. 811(j)]. (b)
1	including review of
1	nominal charge, through
5	report required in
1	guide not later
2	basis, implement systems
4	affect the safety
1	provide such certification
1	generator, accelerator, target
5	office responsible for
1	drugs, intended solely
1	providing that signature.
1	services as the
2	less than 35
1	
 863. drug
1	 (b) topics
1	determinations on such
4	exemptions from the
1	drug, provide for
1	industry to use
1	poultry be delivered
1	healt-related conditions, including
1	presents an identification
1	calendar year, as
1	(a) scope of
1	prosecuting a proceeding
1	disease information available
1	(a) drugs and
1	requests issued pursuant
1	specific requeststhe director
1	enforce provisions any
2	12, as added
2	biological products (a)
1	make operating this
1	program; (c) require
2	used under subsection
1	(dd) for purposes
2	abetted, such actions,
1	unable to determine
4	packaging label is
1	material document or
1	met because such
1	require to make
3	 (a) application
2	iii  (a)
2	dietary uses, unless
2	subsection (b)(1)(c) is
3	previous cohorts for
1	involved in reducing
1	prevent such drug
2	specialization in such
1	whenever such testing
1	insurers; government agencies;
1	exemptiona qualified facility
2	ability to continue
4	biological products (as
1	clinical investigations where
1	variance from the
1	1 or fewer
1	priority vouchers under
1	(4) shall make
1	star-up period were
1	contained in or
1	1984. (6) if
1	(2) to supplant
1	(1) by knowingly
1	payment due date
1	conform to an
2	seek public comment
1	general or his
1	receive submissions from
1	date the assessments
1	lymphatic filariasis. (m)
1	impactin allocating funds
1	person permanently debarred)
5	collecting fees under
1	(b) patient preferences
1	manufacturing practices 
1	discharge, suspension, threats,
1	decision shall be
1	prescription drug supply
1	meaningful therapeutic benefitfor
1	transaction to which
3	deputy inspector, chief
1	supplement.  (c)
1	order suspend the
1	regarding the merit
1	section and alleging
1	 (8) illicit
1	communit-based coalition enhancement
1	development of methods
1	facility where raw
1	service campaigns. (3)
1	services, schedule such
1	judicial review. (r)
1	administer refers to
1	management of information
1	canning, salting, packing,
1	determination of tolerancenotwithstanding
3	 (b) establishment
1	termination of suspensions
1	shall produce the
1	state information relating
2	ii or other
6	processing of poultry
1	(vi) preparing risk
2	advisory review by
1	secretary from modifying
1	section 387e of
2	established in a
1	title 28 or
13	administration salaries and
2	either directly or
1	receive the full
1	uses in the
2	comorbidities, pregnant women,
1	(c) blinding trachoma.
3	drug. (3) the
1	(2) information on
1	supplemental application. if
1	remote; (11) it
1	u.s.c. 300f et
1	notifying a person,
3	stat. 251.)
 

4	adjusted pursuant to
1	(k) is not
1	statutory obligation and
1	applicable to that
1	debarment; judicial review;
4	person by any
1	(d) inspection authority
1	disclosures did not
3	 (iii) if
1	(a) new devices
1	processes and treatments
1	intended for exportation
1	communication plan. (

1	organize information using
1	141 et seq.].
1	campaign. the media
1	drug paraphernalia. 
6	may issue an
3	owing by the
1	uses any eggs
1	may reveal trade
1	grain standards act
1	cause a cosmetic
40	expiration of the
2	contains an antibiotic
1	review and contains
8	shall include provisions
1	ready, and appropriate
2	unlawful actsexcept as
1	animal drug information
3	manner specified by
1	includes drugs for
1	person giving the
2	rapid pesticide analytical
1	however, when determining
1	advertising has caused
1	major actions taken
1	 (iii) in
1	costs of administration
1	 (2) testing
1	arrangements responsive to
1	public notice respecting
2	become final is
1	charitable or humanitarian
1	subsections on 
2	concludes that such
1	subchapter (1) the
1	section 4(g) of
72	 (i) in
1	nonthreshold effect is
1	community to combat
2	condition that could
1	review for such
31	 (i) if
1	(t) -methylpseudoephedrine. (u)
1	(a) as promptly
1	premises so consents
1	jurisdiction, and upon
1	prescribed limit). 
1	product (including those
1	sponsor designates the
1	purpose of such
1	name and shall
2	law.  (10)
1	combination  (a)
1	radiation; and (b)
1	manufacturers subject to
1	shall, at such
2	 (i) it
1	packaged products can
1	supplement, shall be
31	 (i) is
1	assistance authorized the
4	fee due date
1	surface and is
1	security agencies, including
1	conduct or arrange
2	information reported under
1	obvious disfigurement; or
1	applicable conditions prescribed
1	kit  (aa)
25	initial pediatric study
1	required assessment under
1	shall determine what
1	839, 9, 26
1	360b(b)(1)(a) of this
2	declaration of compliance
8	ending september 30,
2	program to license
1	signed agreement from
1	credible scientific evidence,
2	programs and practices
1	certifying the entity.
1	importation of 4d
2	otherwise available to
1	documentation:  (a)
1	vitro techniques, valid
1	detection technology; (2)
2	drug abuse. (

12	total revenue amount
1	application fee if
2	systems to support
1	written description provided
3	order to be
1	eliminated after the
1	court.  (c)
14	circuit in which
2	submission for that
1	liaison between the
2	agent, or to
1	become final, from
1	dramatic increases in
1	list on the
1	new therapies and
1	improved epidemiological tools
1	prescription drug to
5	otherwise applicable to
1	tobacco products, as
1	assessing  (i)
1	may, within the
1	(b) the online
1	spread of diseases.
2	individuals of any
3	shall thereafter provide
1	reasonable attorneys and
4	(excluding farms and
2	conviction be subject
1	part in a
1	(iii) product tracking
1	school year, with
2	allocated among the
1	members, as determined
1	clinic operated by
1	 (b) certification
1	safety standards. (d)
1	chapter. (m) the
1	responsible party. (c)
1	65 percent of
2	(1). (june 25,
1	affect the public
1	new or additional
1	information to all
1	(1) evaluation and
1	law enforcement agent,
1	discovery against nonparties.
1	modify any prior
1	inspection the same
1	rehabilitation program or
1	list filed under
1	relevant factors, that
1	nations in establishing
1	885. burden of
12	general shall register
1	(b) the permanent
1	submit items to
1	 (f) final
1	one violation. (3)
1	current experience and
2	ingredient of feed
1	u.s.c. 1306); (b)
1	(iii) nothing in
4	part therefor; or
1	priorities, the secretary
1	properties. (vii) a
1	$50,600,000 for fiscal
1	(e) are not
1	unrelated to a
1	term list i
1	involved at least
1	advance.  (2)
1	proceeds from the
4	constituent has been
1	distribute a laboratory
1	combination animal drugs
1	sour eggs, eggs
1	whose use with
1	second offenders any
3	accreditation has been
1	control strategy the
1	additive either (i)
1	unique pathology or
1	advertisement would otherwise
1	year; (2) describes
1	previous tax year
13	section or section
1	part in another
10	suggestions for changes
1	 (1) evaluation
1	prolongation of existing
1	providers  (1)
1	review of promotional
1	date and with
3	conduct which served
1	will be carried
1	possesses on board
1	logistics provider license
1	(c) no egg
1	grant a motion
1	supply reduction activities
1	submission solely because
1	contain labeling that
1	may make to
4	agencies to assist
1	methods  (a)
1	egg products contain
1	total revenue amountsthe
1	rule of interpretationnothing
1	rising violent teenage
1	implicitly that 
1	trial, or before
1	good color for
1	court, in imposing
1	panel includes 
2	(2). (2) the
1	emitted from an
1	managed as individual
1	
 360h1. program
1	measures described in
1	reviewin developing of
1	date the effective
1	chairperson the advisory
4	secretary in section
1	defendant charged with
3	likelihood that those
1	2007.  (ii)
2	clauses (ii), (iii),
1	(iii) the information
1	reduce barriers to
6	requirement to submit
7	person described in
5	restrain violations of
3	section 360b(j) of
2	information; regulations and
1	exempt class ii
1	(h) consumer notification
1	entity.  (2)
1	appropriate administrative discipline,
1	activities), only if
1	pharmacies an online
4	centum of such
1	public awareness through
4	characteristics of the
2	forth the methods
2	used therein consisted
1	terminates on october
1	either promulgate amendments
4	declaratory judgment that
2	(k):  (a)
7	covered by the
1	transaction each regulated
1	person by whose
1	reports shall include
1	submitted a supplement
1	promulgate monitoring requirements
1	overall purposes and
1	calendar days, to
1	complete payment the
1	 (b) paragraph
1	importer. (mar. 4,
1	en-o-year inventories. (2)
1	placed on the
1	immediately before their
1	affairs registered under
1	egg of the
1	(3) its package
1	term saccharin includes
8	fiscal year, and
1	studies, are required
1	regulations. such regulation
1	(b)(1)(a)(ii) or by
2	december 15, 1967,
1	form) of data
1	commission, may award
3	sufficient bond providing
1	360, 360c, and
1	(c)(1).  (2)
6	inspection shall be
1	name or names
2	investigation, taking into
1	i.  (h)
1	yields of a
1	833; 
 

1	30, 2016, shall
1	warrant, suspension from
1	(5) consistency with
3	large and small
1	meetings; submission of
2	word imitation and
2	controls under this
1	property which are
2	(iii) the average
1	panel shall have
1	person prohibiting the
1	rule:  (1)
1	 (ii) who
1	applicable proposed and
2	undertaken by such
1	notify practitioners who
1	person.  (d)
1	delivery for medical
2	vitiate the potential
1	priority review for,
1	system to receive
1	(7) a permit
1	(3), a designation
1	improve foodborne illness
1	bold type that
1	salt formation, or
1	norlevorphanol. (32) normethadone.
1	organization.if a qualified
1	federal determination. a
2	reinstate the exemption
1	regulated transaction without
2	data matrix barcode
1	(b) all supplement
1	section shall attach
1	lock or a
1	subsequent vacancy on
2	printer, or other
1	 (11) package
13	listed in the
1	including facility requirements.
1	human services into
1	(a)(6) regularly, but
1	except a prosecution
4	legal effect on
1	 (4) definitionsfor
1	 (i) amount
1	studying the lon-term
4	data derived from
1	investigations (but prior
1	reevaluate the accreditation
1	lon-term assessments of
2	practice.  (c)
1	retail distributors that
2	section. any such
1	accountability of controlled
2	water in the
1	law enforcement agent.
2	availability or scope
1	whoever, with intent
1	26.  (c)
1	no-food life stage
1	applicable requirements or
1	final action upon
2	longer in effect.
1	public. (f) periodic
1	safety problem; or
1	4131441372 (august 11,
1	animal of such
1	(3)(b). for purposes
20	applicable requirements of
1	build state and
2	patient, such as
1	training and educational
1	may indicate that
1	(10) progress and
2	origin, and destination
1	shall request comments
1	obtained, and any
1	advertisement to the
1	(c) any punch,
1	silicone) may or
18	provide for a
1	derived from any
1	packing, distribution, receipt,
2	modifying, suspending under
1	well as dissemination
1	panel report under
2	made such a
1	standards that the
1	regulation as a
2	application for review
1	(f) renewal grantsthe
1	(2) if, pursuant
25	request of an
1	[7 u.s.c. 136a1(g)]
1	report required to
3	including users and
1	$25,000,000 combined. 
3	general, the secretary
2	appropriate state agency,
1	accounting procedures as
1	product or device;
1	1990 [7 u.s.c.
5	alone or in
4	modified or set
4	controlled substance by
1	research on nicotine
3	secretary inspected in
2	unapproved product, the
2	 (2) accreditation
1	section 10.45(d) of
1	program agencies; and
1	paragraph (1) (involving
1	1174, 1175. transferred

1	title.  (29)
2	penalty may not
1	health. (7) its
1	office or usual
1	humans and who
1	(6) all moneys,
1	listing any medication
1	written comments of
1	trade association) if
1	permit a facility
1	case of substantial
1	reveal unforeseen adverse
6	written comments on
1	including the provision
1	issuing, on or
1	objections. at the
1	(3) the applicants
4	control policy and
1	proposed rule and
1	(e) limit the
1	business.  (e)
1	decision, made by
2	iii device referred
1	paper, filter, or
1	studies and analyses,
5	united states city
1	december 29, 1970,
1	kit  (i)
1	expertise in pediatric
1	formerly 5th par.,
5	biological product fee
1	effort with respect
1	economic and other
2	appropriate concurrent use
1	drug in blister
2	business of rendering
3	knowledge, with respect
1	training programs, seminars,
1	ch. 74, 4,
1	labeling for purposes
3	chapter.  (d)
1	certificate; (5) knowingly
1	menthol and other
2	either  (aa)
3	upon which he
1	transfer. (3) limitation
1	powers prescribed by
2	801 of this
1	government, states and
1	(a)(1) or (2)[1]
1	audit; (iii) the
1	unique needs of
4	determination of eligibility
1	shall be permanently
3	(2), any person
1	26, the fund
3	clauses 1, 2,
1	dru-free communities. 
1	establishment fee as
6	comptroller general shall
1	composition, heating source,
1	appropriate, which shall
4	otherwise affected under
1	review shall commence
1	services shall report
1	(b) participation of
2	ingredient; except that
1	respects except the
1	otherwise provided therein.
1	360c, 360d, or
1	meat inspection laws.
12	recommendations of the
1	address the hazards,
1	pattern of violating
1	publics health and
1	(e) after a
1	prohibited transactionsexcept to
1	economic and social
1	reasons such extensions
1	procedure  (a)
1	found under subsection
1	initiates such process
1	criminal offense. (4)
1	unable to accommodate
1	(b)(1)(b), as adjusted
1	dye and it
1	impracticable to obtain
1	removed as a
1	(3) the capability
2	pharmacys internet site
1	effect. (ii) the
3	march 13, 2013,
1	minimal, financial interests
3	accept ownership of
1	hearing upon the
1	may be limited
1	data indicates the
2	(1) in carrying
1	eligible countermeasure, provided
1	annual sponsor fee
1	(2) scope of
1	involved is intended
1	actions following inspections,
1	illegally manufacturing controlled
1	subject to coverage;
8	local, or tribal
1	application. (june 25,
6	food imported into
1	products by retail
1	(i) neither the
1	determine the precise
1	subparagraph (b)), exceeds
1	of, to the
1	controls available for
3	u.s.c. 1031 et
1	court for or
1	list  (a)
2	act of 1997,
2	subsection (d)(3) is
1	act of 1997.
1	strategies which maximize
1	statement of that
1	frequency of a
1	2008 by the
1	person is accredited,
1	data collected from
5	product the term
1	subpenas; witnesses; evidence;
2	whose premises, facilities,
1	slaughter slaughter or
2	needed for the
1	within the classifications
1	products; (c) implementing
1	agency action in
3	purchased, or to
1	regarding their effectiveness
1	advertisement after incorporating
1	paper book at
1	(4) additional extension
1	reasonable time of
1	379j(a) of this
1	pasteurized milk if
1	marijuana smoke contains
1	probable risk from
1	advisory panel makes
1	secretary finds, for
3	inadequate to preserve
1	disseminated information regarding
1	355]. such an
1	animals; (3) any
2	use or infusion.
1	native american pacific
1	(2) examplesexamples of
1	(b) on-time payment
25	defendant is an
1	product identifier at
1	purpose of an
2	substance with respect
1	funds a coalition
1	sponsor submits such
1	ii. each separate
3	become final, he
2	whichever is most
1	individual patient for
1	faith claim if
1	sections[2] 823(f) or
1	center. the director
1	limit such funding
1	agreement a dispenser
1	market exclusivity 
1	(ii). (iv) the
1	reasonable doubt. 
1	decision within 210
1	preemption (a) general
1	years. (3) 
1	promising technologiesthe standards
2	responsibilities of such
1	mea-inspection service; exception
1	food safety of
1	inspection and inspectors
1	capacity to undertake
2	prescribed under subparagraph
1	defense of its
1	appropriations, no more
1	care in the
2	device can no
1	value or purpose,
2	manufacturer to submit
2	business in promulgating
1	(or for which
1	entity to obtain
1	(b) surveillance approval
2	secretary for costs
2	substance or includes
1	(c) dismissal of
2	state, any territory,
1	investigator, or to
2	states shall submit
1	appoint the members
1	360ff1. targeted drugs
2	shall be generated
2	remaining in the
1	public health mission;
1	title), or pee-reviewed
1	administrative processes and
1	assessment and evaluation;
3	technology systems. (iii)
4	(c) for an
1	age, intended primarily
2	intended use, and
2	consist of the
1	director, be available
1	disbursement of and
2	year, the amount
1	general the fee
1	information from which
1	prescription drug. (i)
1	approved may submit
1	subsection (i), and
3	product application 
1	products sold directly
1	1997); or (iv)
1	firm to study
1	china, subject to
1	publications and other
1	ch. 675, 1002(b),
4	eligible entity shall
2	arising under subparagraph
1	manufactured controlled substance
2	statement informing the
1	(i) use the
2	person (as defined
2	2003 (excluding the
1	particular matter. 
1	drug products, as
1	companion animal surveillance
1	(ii) a structure
1	making his determination,
1	subparagraph. (ii) 
3	section shall submit
1	activities funded on
1	identify such inadequacies
1	data. (4) in
1	studies or postapproval
1	prohibited: (a) the
1	misbranded. if these
1	improvements, which is
1	submitted during such
1	manufacturing requirements as
1	3 brands of
2	application, or upon
1	no-hig-risk facilitiesthe secretary
1	nanomaterials interactions with
2	disclosure required under
1	approve a thir-party
3	will not adversely
1	section 353(a) nor
1	begun; the applicant
1	process a statement
2	(b) to ship
4	any, intervening as
1	annually, a complete
1	deliver (other than
1	actually treatedin establishing,
1	supporting data, contain
1	reciprocal arrangements; and
1	relied on. if
1	(ii) mitigating vulnerabilities
1	effectiveness of those
1	issued. (e) validity
1	studies in neonates.
1	drug, and primary
1	6 months upon
1	control strategyfor each
1	(1), for devices
1	(c) improvement in
3	immediately, and give
1	(iii) include separate
1	take administrative action,
1	review, adulteration, misbranding,
1	16, 1988. (ii)
1	united states determines
1	mixture for the
2	case of carbon
3	ownership, management, or
2	incurred by such
1	(2) content 
3	designated high intensity
1	risk.  (2)
1	related requirements consistent
1	(b)(2)(c), the secretary
1	part is 
1	abuse. (b) authorization
1	supplier, then subparagraphs
1	shall withdraw approval
1	1, 1989. 
1	magistrate judge to
1	consular district, compound
1	case where human
2	law or the
2	available solely to
1	amend paragraph (d)
1	drugs which are
1	evidence and shows
1	 (d) criteriaa
1	binding precedent: 
1	trading partner such
12	upon the expiration
5	term costs of
1	conduct was not
2	demand reduction, the
1	inspection system, or
1	shall minimize duplicative
2	thereon to the
1	applies under this
1	slaughter) of animals
1	printed in plain,
1	year 2013, $505,000,000.
1	collaborative efforts, to
1	(4) at the
1	subsection (c)(3)(a). the
1	products manufactured, distributed,
1	
 
 350a.
2	expenses against claimants;
1	consumption then this
2	(a) may vary
1	740, as added
2	suspension upon finding
2	(a) definition for
1	permits discovery prior
1	giving the order
8	ful-time equivalent position
1	document shall display
1	imitation cheese, or
2	withdraw the approval
1	functions. (2) such
22	subchapter ii of
2	misbranded and imported
1	shall use federal
1	13, 2013, and
1	engaged in research
1	state law on
2	feasible means, making
1	2009, the manufacturer,
1	continued availability of
1	technologies; and (d)
1	outsourcing facility, the
1	tolerance to be
1	distributors.  (3)
1	thirty days after,
1	advisory committeeupon receipt
3	vested with jurisdiction
1	4 years, reevaluate
1	device recalls and
1	receives comments, the
1	received at least
1	chapter; (c) formal
2	electronic data exchange
1	regulations shall prescribe.
1	maintaining dru-involved premises
1	reasonably substitute for
1	increase efficiency, predictability,
2	related by common
1	device, (3) the
1	publicly available internet
1	(a), the fees
4	requirements under subsection
1	comments, and exemption
1	(3) biennial registration
2	assure the marketing
1	tableting machine, or
1	referencing information contained
1	subsection (a)(1)(c), excluding
1	responsible party detected
2	(2) definitions and
1	prepared in accordance
6	views and comments.
2	reflect the new
1	(a) authorization of
1	prepared, under and
1	exemption while a
2	patent brings a
1	emission of such
2	(other than data
1	(a), without any
1	limits specified in
1	3 minutes. (5)
1	
 
 1134
1	dispense, procure, purchase,
1	duplication in carrying
1	 (5) conflicts
1	first applicant submitted
1	annual reports under
1	research plan the
1	regulations issued thereunder;
2	drug manufacturer, processor,
1	expedited withdrawal of
1	requirements of part
1	identifier on each
1	product labeling for
1	coordinate the initiatives
1	purposes; and (3)
1	rendered only upon
1	qualified health professionals
1	discloses the identity
2	using bulk drug
1	prepare for transmission
1	section) an abbreviated
2	title) on the
10	(ii) of subsection
1	biennial food safety
1	(f) the conditions
1	developed using biomarkers,
1	eligible productthe term
1	(1) publication of
2	concurrent use for
4	partners.  (4)
1	year 2015, and
3	person has engaged
2	recommendation for the
1	hold is that
1	(c) notification 
1	expectation that such
1	decision support; and
1	title 42); and
3	ultimate user who
1	articles not in
1	(3) contain any
1	 (g)[2] to
1	section 201),[2] together
2	reductions in the
1	tests. (2) results
1	data tabulations from
1	title 18, except
1	drug products interstate
1	product for sale,
2	(iv) statutory or
3	 (2) contentsthe
3	article unfit for
1	processed produce under
1	change in circumstances
2	application of subsection
1	initial importer) who
1	interests of justice,
1	either fail to
1	(i) the pure
1	communities that demonstrate
2	informal hearing) that
1	establishment that engages
1	90 days unless
1	political subdivision after
3	recipient of, inspection
1	prescribe the conditions
1	quality of life,
1	provider in any
1	marketing agreement act
1	submission by interested
4	1940, 5 f.r.
1	(b) the dollar
1	acts whoever engages
1	elected officials, persons
45	meaning of section
1	means of conveyance.
1	commerce; (ii) shall
2	means of conveyance,
1	vary depending on
1	products (a) request
1	general effective beginning
1	opt out a
1	basis and contents
1	excess of three
1	abuse issuethe term
3	sale) the entitlement
10	secretary to approve
1	title; (2) may
1	importer for the
3	moves in interstate
1	report of minor
1	deleterious substances in
4	formed, or filled
4	institutions of higher
1	recommendations, together with
3	prescribes as, necessary
1	relapse prevention; (ee)
1	occurs only in
6	(b) use of
2	inventory, and records
1	voluntary steps to
1	general. a qualifying
5	may be exercised
1	overall sales of
1	renewal grants awarded
1	b (a) unlawful
6	sunscreen order with
1	provider without providing
2	vitamin or mineral
1	means individuals who
1	 (a) complete
1	america  (i)
1	personnel performing functions
1	transaction information means
1	purpose and authorityfor
15	recommendations to the
1	temperature controls, and
1	elected official) from
1	1906 (thirt-fourth statutes
6	notification under subsection
1	$15,000,000, for the
2	stakeholders, including patients,
2	responsible party for
1	methods to effectively
1	government accountability office.
1	constitutionally required. 
4	associated with commercially
1	administration personnel involved
1	2007, is assessed
1	amendment to such
1	classification panel the
1	business, if any,
1	persons to the
1	qualifying practitioner under
1	affidavits  (a)
2	section. the committee
5	added deleterious substance
2	fac-t-face exchange between
1	(a) approval of
3	evidence of safety
1	medical countermeasure applicationthe
2	temporary regulatory limit
1	given with any
2	sold, the quantity
3	thereafter, the name
1	(c) no person
2	federal law to
3	health; (2) 
1	level at which
1	receiving a certification
2	(d) in carrying
7	developing and using
2	shall also submit
2	shall be obtained
1	needed. the notice
1	concert with a
1	consideration to all
5	satisfy the requirements
2	applicable national drug
1	order, any person
1	human services programs.
1	testing; (b) the
1	laboratory records, including
11	tropical disease product
1	discharge or discrimination
1	states and shall
1	(h), or a
1	issued. (c) debarment
2	temporary scheduling order
1	law, minimize reporting
1	ant-doping agency (a)
1	consistent with any
5	packed therewith so
1	drugs to the
1	application to submit
1	 $263,180 
1	duly commissioned by
1	thereunder sufficient to
3	finished dosage forms
1	made toward the
2	action, the secretary
1	(h) quotas applicable
1	(1), the labeling
2	forth in subparagraphs
1	secretarys order (required
32	carrying out the
2	5 years thereafter,
1	5 years thereafter.
1	prescription drugs, and
1	substances or (b)
1	designation, including the
4	data collected by
2	territorial jurisdiction of
1	meeting. (d) public
1	domestic methamphetamine laboratory
1	official plants. sums
1	order, which shall
1	year limitation on
1	determinations if the
1	applicable under such
1	modified finding, order,
1	serve the full
1	sales excepted the
1	devices, requirements applicable
1	filtering, mixing, blending,
1	preservatives if it
1	melons. in prescribing
1	constitutes a fraud
1	(2) the processing
1	forfeiture of any
1	agency to submit
1	u.s.c. 2012)) or
1	immediately lif-threatening diseases,
1	(viii) any other
1	term reinspection means
1	felony, if he
1	(ii) address outstanding
1	(1)(a) if 
1	(21) racemorphan. 
1	1903. public identification
1	finished dosage form;
1	smallest container of
1	(a) the average
2	available. the secretary
1	(other than shipment
1	circumstances later than
1	part; (e) a
2	development fee the
1	rule, or order,
3	actual and proximate
5	perform the activities
1	meet an emergency
1	minor species means
1	drug listed in
1	interpretive criteria nothing
1	 (g) regulations
4	terminated.  (v)
1	general shall institute
1	agencies, shall be
1	(a) in a
1	processing, delivering, importing,
2	convictions of him
1	antimicrobial resistance). 
1	report shall describe
3	limit the ability
1	(iii) for purposes
1	contains a nontopical
1	necessary for effective
1	act upon the
1	stockpile maintained under
1	first two such
1	supplemental application required
1	dispenses the article
1	part and section
1	food allergensthe secretary
1	less; (7) chamber
1	promulgation, if appropriate,
1	investigation; (b) economy,
1	bioavailability by scientifically
1	licenses the secretary
6	food products shall
1	labeling, under ordinary
1	another food if
1	packaged foods that
1	alteration, mutilation, destruction,
3	respecting a device
1	food who, acting
1	applicant has repeatedly
1	section 379j12 of
1	assurance of safe
3	assessed in each
1	methamphetamine treatment and
2	animal drugs filed
1	act of 2002
1	fee amounts. fees
4	act of 2008
3	assistance program (as
2	title (including the
1	sale at retail,
1	recordkeeping, records inspection
1	(i) to conduct
1	policies that would
1	stat. 822.)
 

1	comment.  (7)
5	set forth a
2	acceptance of the
2	limiting the manufacture
1	paragraph (1)(a). a
1	agent for purposes
1	preparation containing morphine
1	consecutive term of
1	coalition is an
3	deemed adulterated under
1	417, as added
1	include recommendations with
1	agreements, and other
1	able to bring
1	purpose and are
1	defects or failure
1	comments on an
1	secure tracing at
2	facilities  (i)
1	materials. (2) claimant
2	issue a temporary
3	civil action in
1	consensus standards, or
2	civil action is
3	shall be from
1	drug, (2) in
1	facility; or (iii)
1	country, the controlled
1	approved alternatives, to
19	sale of the
1	paid all fees
1	deny the following
1	adopts such changes
1	preceding sentence, primary
4	section shall affect
3	355, 360(k), 360c(f)(2),
2	general may limit
1	including who the
1	virtue of the
4	commission of any
1	(g).  (2)
1	one specified in
1	state, exposure to,
1	linguistic and cultural
2	using the performance
1	cautionthis product contains
1	applicable no-federal food
1	cosmetics, if and
1	title, including 
1	limited and specific
2	appointment or by
1	deceptively packaged articles
4	reprogramming or transfer
1	community.  (ii)
2	 (b) hearing
1	applicable standards to
1	dispensingthe requirements of
1	submissions, and the
4	matters within the
1	regulatory, licensing, and
1	licensee shall permit
1	objectives and accomplishments;
1	met. (j)coordination. 
1	b6 (pyridoxine) (g)
1	505a, as added
1	year that ended
1	beverages the secretary
1	holder involved submits
2	methodology used to
1	pursuant to inspections
1	permitted.  (d)
1	(v) a wholesale
1	order, a written
1	benefits otherwise required
2	[42 u.s.c. 262(h)].
1	five years or
1	following information and
1	(d) compensation; support;
1	generalbeginning july 1,
1	proportion of food
1	federal employees, except
1	preceding the first
1	requestor involved shall,
2	section such sums
1	inspection records, and
2	devices, including diagnostics,
1	eligible partnership; (2)
1	title), such person,
1	right to intervene
2	secretary use any
2	schedule iii. 
1	section 343(r)(1) of
1	675, 416, as
1	
 
 374.
1	food accounts for
1	preservation of pediatric
1	agencies for implementing
1	amend such list
2	administrator, acting under
1	proceedings is located
1	process is available
1	statement, the owner
1	collected for each
1	(b) limited receipt
1	approve abbreviated applications
1	clinical trial (as
5	facilities undertaken as
2	united states pharmacopeia
2	inactive ingredients included
1	care.  (f)
4	360nn of this
1	issued or regulation
2	(b) has been
1	time of offering
1	inadequacies and establish
17	drug is not
1	beginning 15 months
1	using such information.
1	patients is so
1	knowingly failed to
1	title, or approving
1	substances law enforcement
1	reporting the administrator
1	basic classes of
5	ingredients is grase
1	(june 5, 1948,
3	and, when relevant,
1	respect to, controlled
1	 (a) grants
1	promulgate such rules
1	corned, or packed
2	clinical hold is
2	members may be
14	feeds bearing or
1	requesting the determination
1	(1) an article
1	development of medical
2	facility is located,
1	paragraph (1)(a), with
1	animal drugs (a)
1	animal drugs shall
2	clause shall not
1	(iii) -(-naphthoyl)pyrrole by
3	animals which are
1	shall (i) audit
2	issue for the
1	immediately upon receipt
1	schedule ii(a)(4), the
1	control the emission
4	carcass, or part
1	(c)) the following
1	truthful and not
1	meeting a requirement
1	114d1. repealed. 

2	states pharmacopoeia and
1	
 360bbb3. authorization
1	refuse to establish
1	deem necessary. 
1	specified changes being
1	facilities.  (g)
1	systems and notification
1	error of metabolism
2	chapter, including programs
1	reckless disregard for
1	general use of
1	assessment.  (j)
3	meetings in diverse
1	imposed with a
1	human consumption. no
1	methamphetamine and grants
1	reporting system database
1	congress.  (4)2
3	certification required under
3	reduce the use
1	
 321. definitions;
3	circumstances are shown
1	a, vitamin b1,
1	establishment to be
2	(4) subject to
1	(16) dimenoxadol. (17)
1	coordination as appropriate
2	rationale for not
1	establishment fee an
2	response and the
1	agreements.  (2)
16	imprisoned not more
1	product standards, premarket
1	monthly use of
1	products; and the
1	section, the amount
2	hearing for the
1	advers-event reports. (ii)
2	strategy is necessary
1	antimicrobial drugs approved
1	develop guidance documents
2	complainant and the
1	component parts affects
1	regulations related to
1	frontier area in
1	regulations, to make
1	take effect which,
1	biologics application referred
1	(5) prohibition on
1	(1)(b). (b) 
1	flavoring used, size,
2	part an approved
52	secretary shall make
1	(a) purposethe purpose
4	labeling, and such
1	industrial needs of
1	market clearance or
6	device means a
1	loss of civil
1	shell membranes to
1	food when so
1	formula, and (iv)
2	compared to a
1	reprogramming and transfer
5	(1) in generalfor
1	(3), for the
1	conditions for which
1	(a) sanitation; (b)
1	includes, in both
1	services; pharmacists; pharmacy
1	quota to meet
1	
 
 661.
1	system.  (

2	biological product. (b)
2	title; or (f)
1	time, in increments
1	defendant a defendant
1	papers, documents and
1	360ccc(c), (d), or
4	list i chemicals.
1	inspections  (a)
1	 (10) negligently
2	result of assessments
1	
 1039. eggs
1	use, or adequate
1	providing information required
1	(c) any postmarket
2	classified within that
1	(c)(3) of section
1	foreign narcotics trafficker,
1	yearly risk associated
4	secretary upon request.
1	62 fed. reg.
1	drugs exclusively for
7	later than june
2	presented by such
1	handling of confidential
1	law or in
4	buy, sell, transport,
1	framework under paragraph
1	functions excluded pursuant
1	criteria means 
1	(v) private citizens
1	360g1(a)(3) of this
1	application cannot assure
1	drug. (d) other
1	plant if they
1	rules for admiralty
1	379j52 of this
1	satisfied the requirements
7	uses of the
1	involved meets all
1	administration for drugs
1	human food; (ii)
2	defendant may submit
1	scope of applicability
1	remove the drug
1	inspections consistent with
1	accredited, is known
3	shall include validating
1	contentnot later than
1	to, all of
1	program agencythe term
1	defense strategy established
1	informers the attorney
2	(2) the name
1	apply to submissions
2	product be restricted
1	section in fiscal
1	necessary, the sponsor
1	(vii) a full
1	residue specified by
2	individuals exposed to
1	advisory panel the
1	person who introduces
5	shall be representatives
4	effective administration of
1	(b) experts on
1	$6,250,000 for each
1	safety means that,
1	seizure or placement
1	exceed thirty days.
1	present a greater
1	assurance of traceability
1	allow the item
1	existing drug shortage;
1	defense functions; (b)
1	component part means
1	medical gases 
1	 (e) revised
1	differing technological characteristics
1	recall.  (g)
2	transported under refrigeration
2	president shall notify
2	of, or other
1	secretary shall commence
4	process) over such
1	writing, not less
2	secretary, for the
1	adjustment calculated under
4	period the district
1	information; and (g)
1	(a) applies not
1	time (not to
2	submitting to the
3	federal law or
1	relieve the distributor
1	monitoring requirements; and
1	means all expenses,
1	information about, a
1	complainant has made
1	destroyed and the
1	(ii) exception a
1	psychiatric association, the
1	associated with these
1	title 5 (popularly
8	secure electronic database
1	harm.  (ii)
2	seven years from
1	form of devise,
1	achievable, but not
1	675, 563, as
1	determination on a
2	event reporting 
1	(j) the scope
1	section.  (iv)
1	awards with respect
1	standards necessary to
1	drug application) describing
1	payment pursuant to
1	conducted for more
1	means a particular
1	correct an error.
1	testing of devices
1	engaging in such
1	(ii) any final
1	letter, or the
1	duplicate the efforts
1	order; or 
2	shall prevent a
1	information requirements under
1	technologies described in
1	diseases, he may,
1	atoll, the northern
1	(2) nothing in
1	permitting inspection; suspension
1	(b), such order
4	commingled raw agricultural
5	contracts with public
1	cite the availability
1	(c) include in
7	year after september
1	criteria of paragraphs
4	 (b) duties
2	monitor, or treat
3	administration with respect
2	substance by means
3	use of illegal
1	prohibited.  (

3	applies, or (b)
2	labeling of an
1	
 360ee. grants
1	means: (1) an
1	colored margarine without
1	(i) participated in
1	enforcement administration, could
2	containing a pesticide
1	conducting advertising and
1	formula shall submit
1	products as hereinafter
4	change requested by
1	1906, ch. 3913,
1	affecting any restrictions
4	appropriate based on
2	scientists and physicians
1	results to assure
1	(a) a measurement
4	includes the use
7	contributed to the
1	conducting inspections has
1	warehouseman of eggs
1	licensure, as described
1	receive the information
2	packages containing such
1	establishing for any
5	(a) public availability
1	enforcement administration, for
2	disqualifying financial interest
1	patient, the statement
8	petition under subsection
1	facilitating partnerships between
1	developed in the
1	entities paying such
1	shall terminate on
1	(d) unless specifically
46	subparagraph (a) shall
1	classification submitted under
3	shall be sent
3	37 stat. 251.)

1	744j, as added
1	development organization. 
1	household. (28) the
1	products to heat
1	scientific issue. 
1	allergen means any
1	inspection by persons
1	panel shall include
1	(x) specify a
1	 (5) retention
2	prescribed with respect
1	associated with rare
2	alleviate drug shortages;
1	rings, and eggs
2	stipulation between the
2	overdue fees shall
1	(e) has been
1	appeal the head
1	warnings, contraindications, warnings,
1	urgent petition. if
1	information regarding methamphetamine
2	findingsthe congress finds
2	(c) research and
1	grape, orange, clove,
1	term includes generic
1	subject to subclause
1	 (a) objections
1	area.  (i)
1	personnel to ensure
1	age group. 
1	products, derived from
1	uses.  (c)
1	secure possession of
1	title in an
1	considered to meet
3	title 42. (e)
1	lon-term care facility,
1	process. (e) publication
1	distributes no-alcohol food,
1	notice, unless the
1	stat. 742; 

1	relationships of the
1	experience is an
3	alter the criteria
1	(a), the private,
1	undertake a classification
1	facilities comply with
15	places of business
1	electronic means. such
2	shall recover the
1	accessible, consolidated internet
1	farm; (b) comply
2	longer requires a
3	program for the
3	substance, the attorney
1	wholesale distributor determines
1	will be adulterated
1	845 to 845b.
1	territory or district
3	term in paragraph
1	year involved shall
1	documents required as
1	demand; and (b)
1	inspectors shall assess
2	copy of any
1	education has the
1	sale, such excess
4	9, 2012, and
6	section 2201 of
1	severity of pollution
1	substance is safe
2	four years, to
1	dangerous drugs, clearly
1	defect. in the
1	9, 2012, any
1	position, the economic
1	proceeding on motion
1	procedurein promulgating the
1	measurement, radiographic image,
17	sunscreen active ingredients
1	(1) knowingly made
1	opium. (4) not
17	level specified in
1	nutrients as required
1	product, based on
1	importer may request
1	application for generic
1	393a. office of
2	identifier, for each
1	valid prescription. (2)
1	regulation. (3) the
1	food.  (i)
1	uniform product identification
1	2013, verifying that
1	practitioner in the
1	appropriate instructions for
1	rare, serious drug
2	conducts such business.
1	drug product; (b)
4	acid diethylamide (lsd);
1	changes changes made
1	(i) any draft
7	defined in the
1	animal science for
4	interstate commerce or
1	fees notwithstanding any
2	(d) submission of
2	risk communication 
4	submissions. (b) the
1	 (2) petition
1	budget requests 
1	ephedrine, its salts,
13	interstate commerce of
2	shall be named
1	development and use
1	review fees for
1	payments under paragraph
1	recall of human
1	articles; and directions
1	thereafter.  (b)
1	approval or refusing
1	demand reduction under
3	physical location consisting
1	consistent with those
2	serial number and
1	register (a) period
2	$2,976,000 for fiscal
1	general, be placed
1	that, without requiring
1	china may be
1	practicable, render assistance
1	reporting purposes only,
1	information; and (c)
1	along with the
1	recite basis in
1	advertising.  (june
1	lorillard tobacco co.
5	(a) during any
2	standard  (a)
2	sunscreen active ingredient,
1	fees owed for
1	restricting the entry
1	processed by that
1	programs, the director
1	processing, packing, distribution,
1	joint plan to
5	person means an
1	(d) no guarantee
1	commerce in any
1	assumes an ownership
1	programthe secretary shall
6	difference from the
1	 (a) coordinate
1	cigarette labeling and
1	(1), extended the
1	unknown, shall be
1	insulin, an antibiotic
1	state requirements for
2	list shall include
1	adjustment to base
3	methodologies. (b) under
2	drug prohibition act
1	accompanying directions should
3	jurisdiction for the
4	employed intermittently. the
1	destroyed, removed from
1	(f) fee waiver
1	consortia and other
13	(iii) and (iv)
1	special verdict of
2	manufacture and regulating
1	area.  (e)
1	letters, and import
3	title 31. (i)
1	agency (if any)
1	requiring an immediate
1	(20) normorphine. (21)
1	propose electronic product
3	attorney general otherwise
1	products any electronic
1	standard. (b) the
1	350e. sanitary transportation
1	scientifically valid measurements
1	964. additional penalties
1	(g)(2)(c), or any
6	year appropriations act.
1	subject to premarket
1	adequate and describes
1	 (d) false
2	respond to foodborne
1	premarket application. (ii)
1	(
 
 1906.
1	2012; and (4)
6	custody of the
5	egg products which
1	advertisements that appear
1	outings and field
1	privacy requirements under
1	determines bears the
1	clause (ii), issues
1	data; (g) at
1	will unavoidably persist
2	(iii) resulting in
1	introduced, or attempted
1	361. adulterated cosmeticsa
1	use, or after
3	person, including a
1	investigation, disposition, notification,
3	review by a
2	seq.] for the
1	
 
 387g.
1	whether tobacco products
1	fair pricing of,
2	establishment, the tobacco
1	evaporated milk by
2	unincorporated association which
4	united states government.
1	law, any person
1	pathogenic microorganisms due
1	grantssubject to subparagraph
1	chapter, for any
1	dispenser to comply
1	 (3) notification
2	commit, or aided
1	term smuggled food
1	safety information, with
1	importer, respectively, shall
1	(b) advisory review
1	retailers, and device
1	findings meat and
1	sample requested, and
2	subparagraph (b) respecting
1	title iii, 534,
1	(b) treatment with
1	 (g) grant
1	dietary supplements special
1	procedures, including reasonably
1	investigators responsible to
1	(b) identit-preserved labels
1	coordinated and effective
1	develop a written
3	review. after a
1	feet of the
1	intelligence; or (b)
2	ordered, or to
3	15), and the
1	another country, if
1	publication or presentation.
1	packing, and holding
1	regulations). (k) exception
1	(2) and any
1	subsection (f)(2) if
3	notification  (i)
1	(b) may review
1	
 
 379j41.
1	various processes and
1	responsible person the
1	drug means an
1	framework shall set
1	methods and processes
1	for, and the
12	united states may
1	corporation, whose permanent
1	use has been
1	packed in individual
1	distribute such items;
1	
 379j13. reauthorization;
1	services under 
2	event of an
1	adequate  (i)
2	infringement to any
1	any, to protect
1	 (vi) infants
1	district of the
3	shall meet the
1	 (e) powers
12	device subject to
1	represented as, an
1	abuse and dependence;
1	ghbin the case
3	eliminate burdens upon
9	appropriate state agencies
5	paragraph (1)(b), the
1	soap. (j) the
3	interest of national
2	type, amount, origin,
1	animals of the
4	applications, be reduced
1	247d6b, 247d6d, 247d7e,
2	clause (iii) is
4	written recommendations for
9	date the petition
3	hours, after receiving
1	report shall provide
2	trials is as
4	illegitimate product for
2	require the labeling
1	thereof does not
1	clause (ii) is
1	poultry products distributed
1	researchers, and consumers
1	 (i) late
1	resistance task force
1	consult existing standards
1	2014, $534,000,000. (g)
1	exchange, currency, or
2	production quotas under
1	tobacco leaf is
1	clause (ii) if
1	right to have
1	patient experience 
1	require compliance 
1	jurisdiction involved and
1	360j(g), 360j(m), or
1	reclassified or if
1	year 2007. 
1	 (a) representatives
3	instrumentality of the
13	act providing for
1	entered commerce. any
56	21, code of
1	administration which are
1	paragraph, the secretary,
1	pending application under
1	supplements, that is
1	agriculture, another copy
1	accessory.  (

1	trafficking area; (d)
1	modified or revised
1	(4) no right
2	delivered contemporaneously with
2	corporate officer and
1	application under the
1	902(b), (c), 52
1	upon development and
2	agreement with such
1	provisions for withdrawal
1	(b) vacating of
1	people. (3) a
1	person to receive
1	mark the food
1	editing, printing, and
1	carry out dru-related
1	natural physiological processes
1	determination, made on
2	provides information regarding
1	(10) of subsection
1	 (1) 3,-methylenedioxy
2	(21 u.s.c. 355)
1	presents demonstrable difficulties
1	report a report
1	(a) are met;
1	consistent with provisions
1	use; (d) cosmetics
1	may be refilled.
3	approved application shall
2	subparagraphs (b), (c),
1	proposed change as
3	committee appointed under
2	(3) final year
1	16, 1927, the
2	facts by reason
1	general for any
3	prescribe and collect
1	similar advertisement for
2	practitioner of medicine,
2	si-month period under
1	title and of
1	give notice of
2	determining that it
1	least annually, publishing
1	indian tribe. nothing
1	subterfuge; (4) 
1	(d) recovery goalsecure
1	implemented riskmaps and
1	approved.  (11)
1	establishing the grounds
1	states, respectively, shall
2	guidance or final
1	contaminated; or an
1	consumer or otherwise
2	(a) in generalfor
1	requirementa class iii
1	u.s.c. 4321 et
1	involving human subjects,
1	variances a state
1	later determined to
2	course of action.
1	chapter; and (8)
2	deems necessary of
1	shipping package that
5	342(a)(2)(b) of this
1	(f).  (june
1	exceed fifty pounds.
1	developing regulations under
1	tetrahydrocannabinol level of
1	it, make such
2	substance; and (c)
3	(d) any other
1	reportable food. (3)
4	(iv) any compound,
1	section, including periodic
1	animals, including information
1	(1) many of
1	designation with the
1	u.s.c. 714 et
1	persons; and (ii)
1	united states, until
36	united states. 
2	slaughtered and prepared
1	list ii chemical
1	clinical difference, as
1	revenue amounts shall
24	days after receiving
1	revoking a regulation
8	general under this
3	similar form of
6	definition in this
1	conditions regarding usefor
1	(4) united states
2	 (b) prohibition
1	identified until delivered
2	human food when
1	registered under paragraph
2	person shall immediately
1	acids); (o) the
1	local and regional
34	 (1) if
1	requirements contained in
1	inflation adjustmentthe inflation
3	provide such person
1	years of age;
1	350l(a) of such
264	 (1) in
1	seller to arrange
1	behavior.  (3)
2	panel respecting a
1	5 and all
1	directions should first
1	2012, that references
1	(iv) limitation the
4	years of age,
8	 (1) it
1	citation to any
4	 (1) is
1	authorized such consultation.
1	march 31 each
1	2017; and (e)
1	title). (11) any
1	advocacy groups, industry
1	means (a) articles
1	timing and information
1	uniform process or
1	shall, whenever processing
3	lyophilized products before
1	analysis by any
4	treatment, or prevention
1	(e) includes a
1	agencies. (june 25,
1	program means programs,
1	(k) compiling, developing,
1	individual. (2) waiver
8	understood by the
1	350c, 350f(j), 350e,
1	 (c) approval
1	(c) articles (other
1	include mixing, reconstituting,
1	made public, any
1	labelingnotwithstanding clauses (iii)
1	use of 
1	guidance required under
1	iv, 401, as
1	secretary a notification
1	case of threshold
1	animal health, such
1	timetable for submission
1	(iv) includes a
1	sale. such bound
3	pay for such
1	manufacturer shall take
1	379e, 387d, 387e,
2	states amateur athletes
1	criminally charged for
1	prescription is required.
2	deliver for shipment
2	requested pursuant to
1	ship milk and/or
1	additional capacity, function,
1	payable.  (b)
1	(and exempt from
1	institutions), product code,
1	management grants 
2	inventory, and other
1	entries and administrative
3	drug supply reduction
1	title or designated
1	develop national situational
1	cause shown refer
1	certain administrative provisions
1	compounding standards and
1	finding made under
3	solely to provide
1	generalto determine whether
1	care. (5) job
1	(e) no-timely review
3	ordered detained under
2	title, or under
2	offense for which
2	30th day after
1	witnesses the penalties
1	include tobacco or
1	august 6, 1996)
1	patient or consumer
3	successor regulations) concerning
1	august 6, 1996,
1	clearly identified for
1	august 6, 1996.
1	abuse and dependence.
2	date, shall be
1	practice guidelines may
1	manner and at
1	drug received by
6	included in any
1	secretary, as provided
1	ch. 675, 505,
1	(aa) unresolved safety
1	current information identifying
13	functions under this
2	intended for investigational
1	secretary so requires)
1	supplies regarding the
2	 (1) referral;
1	basis a report
1	discontinuance was reported;
1	make grants as
1	information that improves
1	obtain information under
1	section which occurred
3	human use and
2	 (i) requires
1	latters request, samples
1	pos-hearing recall order
8	conditions whereby it
1	statement, and to
1	
 853. criminal
1	seq.].  (d)
1	order remains in
1	basis in order
1	order, promptly reduced
1	records under any
1	application or upon
2	(a); and (2)
1	placed upon exporters
2	killing results, shall
1	section, or to
4	risk with respect
1	human use any
2	deemed reasonably applicable
1	vegetables in such
1	coalition may not
7	components of such
1	shall be conspicuously
1	power, or privilege
1	section 831 of
1	consistent with maintaining
1	following:  (i)failure
1	exemptiona drug designated
1	sued in its
1	food emergency by
1	date established through
1	review division; (iii)
1	 (j) coordinated
1	achieving the goal
1	farm; (c) comply
1	360bbb6 of this
1	animals to which
1	register; notice of
1	communication tools and
2	declines to accept
2	term adjusted base
1	15 years. 
1	(24)(b), any medical
1	security, work more
1	individuals and public
1	amounts:  (a)
1	account.  (e)
1	(ii) presents or
1	administrative order published
1	programs, conduct and
1	(3) meeting the
1	proclamation suspending the
1	distributing of unwholesome,
2	processed, or packed
1	children regularly about
1	receives a report
1	drug experience identified
1	order, a petition
1	states, or official
1	8 of an
2	adjustment of fees
3	825 of this
1	derivative drugs, or
1	state demonstrates that
1	recordnot later than
2	within the period
1	(b) certain componentssuch
3	period covered by
1	authorize, with respect
5	 (b) authority
1	animal drugs during
1	user fee amount
2	[7 u.s.c. 8301
2	format developed by
1	grants to grant
2	internal revenue service.
1	enhance the tracking
1	387f of this
1	entity whose only
1	days. (d) promulgation
1	(b), whenever the
1	foreign person is
2	government is capable
1	prescribing practitioner, on
1	(b) articles intended
1	inspection authority nothing
1	includes representative data
1	purpose by an
1	(3) no report
1	invite the sponsor
1	processed in facilities
3	probable consumption of
3	fee and active
2	person under twent-one
2	name or other
1	federal officials by
1	conditions (if any)
1	termination of declaration
4	attorney general, after
1	(including the conditions
2	device.  (ii)
1	data includes data
1	scientific, and commercial
1	title 42, to
1	shall inform the
2	(g), or (h)
1	exception set forth
2	 (1) drug
1	first engages in
1	knowing that the
1	furnish such information,
1	request is necessary
1	equivalent of that
2	product on the
1	(ii) all advertising
1	requirements under which
2	persons other than
1	appropriate, subject to
1	revocation of license
6	manufacture, distribute, or
1	inspectional priorities, the
4	ingredient facility fee
2	taking action pursuant
1	applicable, pursuant to
1	package; and (ii)
1	suspect productthe term
1	supplement if an
1	(d) reporting and
2	priority review under
2	health and agriculture,
1	(b) notwithstanding paragraph
1	feed is unsafe
1	shall reinstate a
1	subsection, take into
1	title overlaps with
1	technological data. (4)
1	drug control coordination
1	certain applications 
1	formula for commercial
1	(2) limitation 
1	project grants and
3	criteria as the
1	bulk vehicle for
1	(f) carbon monoxide
1	engages in wholesale
1	program, which recommendations
19	congress a report
1	receiving from a
1	submission. (e) limit
1	384b. voluntary qualified
1	secretary is in
1	list established by
2	installation of a
1	title. (h) conditions
2	(a) use personnel,
1	omitted  (f)
1	review status of
3	(a) this subsection
2	(5), the secretary
1	(2) proposed sunscreen
2	preceding sentence is
1	hazards under subsection
1	input from professional
1	(2) which relates
1	voluntary service; acceptance
1	audit report submission
1	[21 u.s.c. 355f].
1	representation that it
1	preceding sentence in
3	fee revenues established
1	(b) construction nothing
12	provided pursuant to
2	clinical trial or
2	definition in such
3	destined for the
1	held within such
1	defect remedied, (2)
1	incurred in anticipation
1	animal drug only
1	
 360n. priority
2	obtain discovery from
1	violations, including the
1	made since july
1	level. such assessment
1	strategies for mitigating
1	assurance. any such
1	(b) secretarys approval
1	describing improvements in
1	consist of members
1	color additives, in
1	period, and 
1	miniature spoons with
1	compilation of susceptibility
1	impractical, an appropriate
1	testing seafood imports
1	(b) the gaps
1	(4) such other
2	causes of the
2	facility or the
2	investigation and prosecution
3	(1), or (ii)
1	first application filed
2	pediatric therapeutics established
2	inserted in the
2	state program in
1	product ceases to
1	establish, under section
1	chemicals, all drug
1	purposes of production
1	obtained as the
1	action.  (b)
1	taken by filing
1	emerging problem. 
1	executive schedule. (3)
12	product at the
1	2009; and (g)
1	body. (c) the
1	listed shall be
9	 (4) the
1	(b)(2) set forth
3	regulate the product,
1	account  (1)
1	regulate the product.
12	manufacture, processing, and
1	research, training, and
1	manufactures drugs that
1	exemption, food additive
1	 (8) for
1	letters which set
1	results thereof in
1	[42 u.s.c. 247d6b].
1	funds to meet
2	device, as defined
1	compliance with state,
1	benzyl chloride. (d)
1	studies and pediatric
1	fiscal year. (5)
3	review and approval
1	written confirmation under
1	application is an
1	interagency transfer, the
1	 (a) knowingly
17	section may be
1	surveillance and outbreak
1	u.s.c. 262]; (b)
1	validation of effects
1	issuing the warrant.
2	dependence relative to
1	type required in
2	(1) they are
1	warehouses, and other
1	abstract of a
1	document that includes,
1	administration and enforcement;
1	process of amending
2	available or is
1	care system collectively
6	action under section
1	fees submission of
2	way affecting, modifying,
1	used to evaluate
3	given a complete
2	limitation on amount
1	full and current
1	provide detailed information
1	production for sale
1	may determine. 
1	marketed sunscreens nothing
1	considered on the
1	commercial vessel, commercial
2	upon conviction of
1	supplement.  (iv)
1	(2) any hazards
2	barcode when affixed
4	hearing with respect
1	electronic format as
1	new high intensity
20	reasons for the
1	related to postmarket
1	longer valid, including
4	drugs (a) in
1	maintained. the secretary
1	contact regarding the
1	product, such as
1	outside such agency,
4	device is safe
1	o-line course or
1	strategy and notify
1	section over a
6	552(b) of title
1	either displays the
1	general, issue a
1	addition to index
1	2014 through 2018,
4	requirement to include
1	(b)(1)), the secretary
1	infant formula) is
1	list referred to
1	clear a drug,
1	affairs.  (b)
1	(b) a brief
6	request for an
1	upon a conviction
1	agent. any award
1	heath[1] professionals. the
1	products, and cosmetics
2	written notice referred
1	animal diseases which
1	improving the training
1	(b) amount the
1	registrants; statements; accompanying
2	agency in carrying
1	list a tobacco
2	presents an imminent
1	establishment or the
1	years 2009 through
1	states descriptive and
1	requirement, and (iii)
1	material; (6) hold,
1	reports under that
1	drug and other
1	(a) before 30
1	january 1, 1970,
1	criteria for issuance
2	period the secretary
1	statement at trial,
3	section 271(e)(4)(a) of
1	designations  (a)
3	states relating to
1	auditor shall issue
1	(
 
 2103.
4	developing a secure
1	18. (d) rule
1	 (4) private
1	committee concerning the
1	evaluationthe advisory panel
75	required to be
9	section 1903 of
2	prescribed by said
1	de novo basis.
3	safety and food
2	chemicals  (1)
1	setting in which
1	drug. (iii) if
1	(ii) more than
1	original prescription or
1	medical gas; or
1	veterinaria-clien-patient relationship in
2	sale, distribution, or
2	(d) is in
1	general the authorities
3	extend to all
1	chemical than specified
1	bring in its
8	(10) the term
2	materially participated in
1	associated with particular
2	subsection (b), do
1	prescribing practitioner possesses
1	shall also have
1	(a) establish bylaws
1	secretarys approval of
5	development and regulatory
1	farm that is
1	civil proceeding. (6)
1	secretary regarding a
1	appropriate. such scientists
1	facilities (a) registration
15	construction nothing in
1	jointly prescribe regulations
1	need and intent
1	common indicators and
1	malfunction were to
1	 (f) crediting
1	data collected for
2	detained under this
1	chapter (and any
1	endpoints reasonably likely
1	development of regenerative
1	(d) and paragraphs
2	property to any
1	wires with hooks
1	keep the intelligence
1	petition) establishing, modifying,
1	(a) and (b))
1	review, if so
1	pose a serious
2	reliable analytical methods
1	products, and may
1	specimens of its
1	applicable, if the
1	675, 909, as
1	preventive controls are
1	promptly transmit to
1	forward it to
1	fee per establishment,
5	years for which
2	different technological characteristics
1	funds are to
3	applicant shall not
1	encapsulating machine shall
1	substance abuse; (4)
1	foo-producing animal, this
1	$1,000 or imprisonment
2	take reasonable steps
1	unique identifier for
1	made.  (

1	initiatives relating to
1	exemptions established prior
1	application.  (l)
2	record of such
1	evaluation.  (c)
1	order; (iii) proceedings
1	section 454(a)(1) of
3	take appropriate measures
1	section 841(b)(1) of
1	(b) an outsourcing
1	remove or dispose
1	shall, beginning not
2	mitigation strategies). (v)
1	rates, establish such
2	limiting the quantity
1	bases for updating
1	substance, which mixture
1	(1), and those
2	another active ingredient
1	(1) total fee
1	states shall, in
1	construed to limit,
4	that, in the
1	notification submissions. (g)
3	contemplated by this
1	altered its budget
1	steroid or an
1	term designated medical
1	aspect is protected
1	(
 
 2201.
1	laboratory networks to
1	duties the office
1	dispensed shall be
1	provide the registrant
1	security act; (c)
1	conditions (a) designation
1	methamphetamin-related programs, including
2	designation under section
1	consist of records
1	including as such
1	electing and in
1	use of fundseach
3	congress separately from
1	substance of which
2	diseases and healt-related
1	thereof; (c) that
1	data in a
1	applies for purposes
3	affiliate submits to
1	(i) purchased such
1	commission or a
1	federal government; (ii)
1	mean  (a)
1	commodities are being
1	sentence, such entity
1	locate first purchasers
1	included within this
1	manner. such information
1	committee, the expiration
1	(c) but that
37	shall  (1)
5	food, drug, or
1	 (a) opium,
1	(a) regulation for
1	individual performance standards,
1	drug alone: 
1	(e) such other
1	animal drugs (including
1	action for failure
1	quantity of blood,
1	legal reviewers prior
1	account the levels
1	criteria website. 
1	section 897.30(b), if
1	secretary. (2) 
1	data are accessed,
1	intends to authorize
1	persons who were
2	including an authorized
1	whose genome contains
1	vitro, and the
1	manufacturing, and translational
1	prevent outbreaks of
3	register notice of
1	unless the drug
1	secretary prescribes) of
1	16, formerly 14th
1	agencies participating in
1	title, the application
2	condition for a
1	facility which produces,
1	imports were received
2	(d) provision for
1	complies with subparagraph
20	cause to be
1	insufficient to provide
1	inspection service from
1	another device; (iii)
1	plan.  (4)
1	decree contrary to
1	(1) amount of
1	services, upon his
1	1968.  (b)
1	(subject to subsection
1	secretary examines the
1	medicine, pharmacy, pharmacology,
1	351(a)(2)(a) of this
1	accompanying him, if
3	(a), the administrator
1	authorized, by twice
1	paragraph,[1] the term
1	regarding the sale
1	december 13, 2016).
1	shall place in
2	finished drug product
1	(ii) may determine
7	believes that the
1	piperonal. (s) -methylephedrine.
1	respect to marketing
5	product from the
1	paragraph referred to
1	accessibility of epinephrine
1	subparagraph (c) unless
1	additive (or such
1	determine the overall
2	assessment under section
1	devices, including adverse
1	114h. repealed. 

1	extent, an unmet
4	information to be
2	control program goals
1	conclusions of law
1	paragraph (4)(a) and
9	applies under clause
1	panel so that
1	device, the label
1	barred by applicable
1	ch. 675, 308,
1	based on substantial
1	present a potential
1	review of portions
1	patient populations. 
1	paragraphs (5) and
1	blindness., and the
2	certify that, to
2	used in animal
1	use in packaging
3	among individual tobacco
2	article, if such
1	(a) identification of
1	committee upon request
1	control strategy is
1	request an order
2	section 207.3(a)(4) of
1	carry over submissions
2	supervisory and nonsupervisory
1	narcotic drugs signed
1	(f) dru-free workplace
1	contribute to toxicity;
9	shall be at
2	shall be as
1	regulated person are
1	an[2] paper or
1	equivalent and that
1	contain the order
4	shall be an
1	offering an electronic
3	qualified scientific, technical,
1	(
 
 823.
1	shall discontinue the
3	state poultry product
1	
 360bbb. expanded
1	security, secretary of
1	regulatory predictability; and
1	355a(f) and 355c(f)
1	 (2) time
1	published material produced
1	initiatives that the
4	1950, ch. 61,
1	(g) dracunculiasis (guine-worm
2	penalty prescribed by
3	committee the committee
1	9, 2012), revising
1	equivalent or identical
1	assure compliance by
3	clinical trials is
1	amateur athletes participating
1	facility loan made
1	manufacturer is known,
1	sites, as appropriate.
1	action will aid
1	(i) a copy
7	description of any
1	since fiscal year
1	section 387j(a) of
2	laws applicable for
1	subparagraph (f) of
1	offenses have become
1	transactions involving, any
1	transaction involving an
1	modification the secretary
1	(a) the nature,
1	person that had
1	sel-certification submitted by
1	 (3) ingredients
1	except for a
5	means an egg
1	subparagraph (f) or
2	360eee(26) of this
1	establishment of dru-free
1	title 28, the
1	provider remains licensed
1	food importation process,
1	essential fatty acids
2	part  (a)
1	(ii) hearing if
2	establishment, or instrumentality
1	regardless of the
1	designation developed under
1	connection with, the
9	employee, or agent
1	otherwise not subject
1	pediatric issues, including
1	investigate the article
2	(iii) to provide
1	(c) controlled substances
1	conditions, including qualified
1	secretary by written
1	means the activities
1	occurred before may
1	section 360e, 360(k),
1	may license virus,
1	agencies programs, by
3	title for any
15	342 of this
1	preparation of articles
1	president may waive
1	located that the
1	chairman thereof. (3)
1	section 843(d) of
1	substantial equivalence, established
9	review under this
6	(i) is intended
1	(a) is licensed
1	formerly 306, 52
1	healthful, wholesome, fit
1	operation within the
1	administrator may, upon
2	authorized under section
1	accrued interest assessed
1	diet; (iii) safety
1	drug treatment are
1	subchapter; (b) any
1	make onsite visits
2	(b)(1) or (c)(1)
4	use tobacco products
2	standard the administrator
1	descriptors; or (iii)
1	repair such defect.
2	approved, shows that
1	persons.  (c)
1	(hh) the term
1	section, is vested
11	trade secret or
1	labeled dairy or
1	21, 1997), none
4	paid within 20
1	cases; limitations of
1	eligibility review the
1	review under any
2	fresh fruits and
1	(2) $24,000,000 for
3	information exempted from
2	registration requirements (a)
3	$250,000 if the
1	charged upon in
2	separate registration shall
1	conditions, for approval
1	process prior to
1	pooling, reconstituting, or
2	last assessment of
1	(b) the relative
1	effectiveness of efforts
1	may include, notwithstanding
1	submitted the required
1	(6) facilitation of
1	secretary shall specify.
1	risk unless the
2	producing such milk
1	eligible product by
3	to, or imprinted
1	379d3. streamlined hiring
1	division to coordinate
1	species subject to
2	including the diversion
3	(ii) the requirements
1	area, region, or
1	conduct occurring on
1	farms or plants
1	said federal acts
1	title 42, any
1	construed to include
4	title 42, and
1	pesticide chemical; (iv)
1	safer pesticide chemical
1	(6) accountabilitythe coalition
5	paid into the
1	safeguards, and except
1	(c) product labeling;
1	health; (6) data
1	year, if the
1	type of import,
1	(2) a regulation
1	methamphetamine and listed
3	means the minimum
1	(3) that 
2	(c) payment of
1	specifying the general
2	(c) the animal
7	food additive, color
1	department of agriculturein
1	identification methods which
1	manufacturers, shall review
1	proceeding is commenced
1	device from those
1	effect for investigational
5	(b), if the
5	1953, 18 f.r.
1	area, and water;
1	service to protect
2	(b). (b) reporting
1	foodnotwithstanding paragraph (1)
1	offense, including whether
1	(a) no approval
1	(j), and (l)(1)
1	regarding certifications and
1	contain a primary
2	regulatory audit of
2	initial sale by
1	local conditions; and
1	
 
 152.
2	later date under
1	months preceding the
1	definedas used in
1	free of contamination,
1	earlier version of
1	treasury may be
1	minorities.  (c)
1	violations. (
 

1	product), packing, and
1	distribution by government
1	different use. (b)
1	illnesses and deaths
2	means slaughtered, canned,
1	general shall, not
2	general for each
1	effectiveness in promoting
1	effortsthe secretary shall
1	average as determined
1	actual, constructive, or
1	investigation. a decision
1	(b)(3) and (i)(4)
1	moves for summary
1	assistance for testing
1	notify the assistant
1	states or elsewhere,
2	year 2014, $2,604,000
1	contains or acts
1	poultry in any
2	samplesthe following classes
1	give consideration to
2	act while they
1	review of, such
1	data.  (e)
1	assessment is imposed
1	separate use of
1	675, 501, 52
1	regulations. (2) 
1	facilitate commerce in
1	drug. (iv) if
1	food no person,
2	revenue amount established
1	marketed, the holder
1	amount notwithstanding any
1	export list i
1	experiences in the
3	subparagraph (b). 
1	(2) adopt other
1	periodthe secretary shall
1	inspect such food
1	hearing on order
2	apples when packed
1	term standardized numerical
1	exported food, drug,
6	funds shall be
1	(i) by placing
4	rule, regulation, standard,
2	clandestine manufacture of
1	otherwise stop using
1	support between such
1	clause (i) if
6	general may, by
1	assistant who satisfies
1	program that serves
2	filing of objections
1	353(d)(3)(e) of this
1	methodology. if the
1	clause (i) is
2	use generally in
1	verification beginning 5
1	ch. 143, 1,
1	drug administration administrative
4	compensation for service
1	
 350d. registration
1	151 et seq.];
1	grinding, pasteurization, or
2	compendium or pharmacopeia
1	affects interstate commerce;
3	subsection (b). the
2	products derived from
2	shown, specify a
1	stones, labeling, or
1	therapy shall be
1	(c) definition in
8	order approving the
1	360h, 360i, and
1	deems necessary. (b)
2	particular pesticide chemical
1	proceeding shall apply
1	advice based on
2	magnitude of the
2	vehicle or bulk
1	whenever possible, be
3	4 of the
1	established and maintained;
1	prescription drugs, biological
2	involved submits to
1	(b) licensure each
1	misbranded, within the
1	applicable list which
1	television advertisement review
1	qualified data summary
2	year nor more
1	drug applications under
1	entity or entities,
1	extension described in
1	inspected or marked
1	section 360c(a)(3)(d) of
1	united states sanctions
1	access to a
2	disadvantaged areas. 
1	certain products 
1	sections 335a and
1	(ii), the term
1	shall place the
1	(or request for
1	reasonable time not
1	related professions. in
2	(b) consider the
1	(bb) appropriate clinical
1	limitation on actionsno
5	thirty days of
1	affect the obligation
3	licensure of the
1	research uses, 
1	pseudorabies. this requirement
1	feeswhere the secretary
1	sector of the
1	investigation has been
4	period beginning january
1	product establishment that
2	law enforcement effort
1	 (3) powers
1	commonly known in
1	secretary based upon
1	(e) ecgonine, its
1	general, or any
1	rest area is
1	and, not later
3	undertaken by each
1	scientific information to
1	importer under subsection
2	(a) be distributed
1	(2) information concerning
1	distributor; and (iv)
1	564, as added
1	certification that methamphetamine
1	continuous or sustained
1	prepackaged form that
1	ginseng (a) catfish
1	(ii) reviews the
1	campaign needs or
2	applicable percentage of
2	tolerance) or (c)(2)
3	chapter for the
2	state offense relating
2	accrediting a foreign
2	terrorism (as defined
1	1999, for meeting
1	regards a tobacco
1	drug involved if
1	for, or data
2	review the accuracy
1	administration unless the
1	(c) base inflation
2	division responsible for
27	(3)  (a)
1	supporting the determination
2	means the dispensing,
1	iii, 538, formerly
1	$125,767,107 for fiscal
1	hold additional meetings,
1	four fiscal years,
1	definitionsin this subchapter
1	capacities, and needs
1	evaluating electronic product
1	verification, investigation, disposition,
2	interest, as required
1	306, 52 stat.
1	 (a) corporations
1	products of small
1	actions after meetingfollowing
2	date rape drugs
1	ii; (ii) which
1	maintain in the
1	counterfeit drug or
3	 (a) definition
1	commitment to research
1	key personnel. (6)
1	subchapter as such
1	(ii), in reviewing
1	surveillance be made
3	respect to questions
1	years national interdiction
1	(4) each applicant
1	specialty; and (b)
3	technical assistance to
1	(2) 3 times
3	columbia circuit, within
1	funding for fiscal
1	product definedfor purposes
1	applies; (b) the
2	court order under
1	(2) the composition
1	regulation of good
1	improvements or other
1	manufacturer; (b) the
1	coordinate intramural research
1	sterile or nonsterile
2	assistance and training,
1	take action that
1	call of the
1	(2)(b)(iv) are being
1	(1) a state
1	national security and
4	(c) requests for
4	importation of prescription
1	will provide such
3	paragraphs (2) and
1	proprietary name), and
1	documents produced and
1	(i) approved usesa
2	qualification of drug
1	programs.  (3)
3	common names of
1	laboratories that are
1	voluntary use of
1	abuse of inhalants;
2	(aa) the 4-day
1	state law; (b)
1	(iii) is effective
1	(cc) the secretary
1	records under subsection
1	term drug endangered
3	inspected and condemned
2	making such introduction
1	functions subject to
3	(b) that includes
1	products (a) law
2	security, the secretary,
1	(a) secretaries of
1	resources and reduce
2	address an identified
13	shall be derived
1	criterion of safety),
2	tobacco products are
1	governments; and (f)
1	period, were conducted
1	homepage of each
1	parts; (12) attempts
1	condition, limited market
1	available to united
1	statement (as specified
1	ideas; and (d)
1	date an appeal
1	allowing for the
2	combination product containing
1	(v) 1 gram
1	capacities of state
3	schedules of controlled
1	prohibited.  (b)
1	requests (a) in
1	(b) each portion
1	handling confidential information,
2	clinical investigations conducted
1	silicone gel (or
2	class of cosmetics
1	security requirements as
1	secretary; (b) through
1	term food to
1	comparable to that
2	applicant under paragraph
1	drug activities (including
1	medical use with
1	hearing has been
6	one active ingredient,
1	535, formerly 359,
1	lines or wires
1	support a substantial
1	toward reducing the
1	prohibition no person
1	subsection, assess and
1	assistance and training;
4	sustaining human life,
1	informing the target
2	store or restaurant
1	website in paragraph
2	relief, as provided
1	notification.  (5)
1	premarket submissions, including
13	outside the united
1	innovative products 
1	statement why such
1	(b) a clinical
2	specifications as to
1	basic pay, awards,
1	rape drug for
1	
 
 387k.
1	scattering ultraviolet radiation.
1	enforcement officer, or
1	disclosure requirements to
15	(mar. 3, 1915,
12	may include a
1	products that treat
1	develop or obtain
1	gene; and (3)
1	individual except as
1	equipment, product, or
1	 (a) raise
2	research findings, conducted,
3	(b) a device
1	form, the permanent
1	reasonable search of
1	defense to an
2	years, and which
1	approved application; (ii)
1	agency shall notify
1	psychotropic substancesthe congress
2	experts; (d) veterinary
1	agreements between the
1	register, the secretary
1	penalty so imposed
1	suspension shall continue
1	 (1) activities
1	ch. 675, 771,
1	subsection (g)(2)(a)(ii), such
2	registrant who has
1	treatment of such
1	(b), that an
1	1, 1999, for
1	interstate. thus, it
2	(b)(2)(b) or subsection
2	ensure that review
1	recommendation;  (9)
1	nonprescription drugs, and
1	screening program, using
2	person to periodically
1	screenings of the
1	hearing; (iii) provide
1	system attributes that
1	effect.  (10)
1	transmitted under this
1	distributions of sample
2	solely under the
1	domestic emergency, involving
1	42, or (ii)
2	provision for the
1	distribution and administration
4	good cause for
1	unauthorized release and
1	administrator under this
2	application; or (b)
1	(b) is authorized
1	act (or an
1	response not later
1	(c), the supervisor
1	identified, if any,
2	application can be
1	20.)
 
 3431.
1	categories as determined
21	pharmaceutical distribution supply
1	elect one or
3	continues, not to
1	term children means
6	products for commerce
4	ordinarily render it
1	authorities; and (v)
1	including neurological differences
1	applicable, has been
1	identified clear vulnerabilities
6	advertising and promotion
3	united states patent
1	produced from any
1	priority review, or
1	powder, shall be
3	general nothing in
1	authority for program
2	application that has
1	minerals. (2) the
1	 (b) access
1	348(g) of this
3	published for that
1	made subject to
1	industry have a
1	multiple sources, with
1	effect a tolerance
1	appropriate registration or
1	545 of title
1	251, title i,
1	repeal of such
1	intended use or
2	assessing a civil
2	business dispensers for
1	(ii) and in
1	approved and to
1	will be afforded
1	additional evidence, the
25	intended use of
1	monitoring; or (f)
1	staphylococcus aureus, and
1	 (b) development
1	members that are
9	regulations under subsection
1	educational achievement resulting
1	18 months of
1	phase 3 study
1	potential immediate recipients,
2	products of poultry,
1	application fee, the
7	found by the
1	
 211. preservation
1	supply chain, or
2	foreign country engaged
1	relevant recommendations of
1	knowledge that will
1	record required under
1	combined with the
1	manner and based
4	representatives, a report
1	manufacturer shall verify
1	upon to have
1	departments; (5) provide
2	sampled and tested
2	grant, contract, or
1	first such violation
1	standards for those
1	whether since the
1	beginning 6 months
1	(g) 35.0 
1	product that appears
1	one dtc advertisement
1	burden exists, irrespective
1	fiscal year 2015;
1	describes the instances
1	criminal, injunction, or
2	domestic commerce of
1	drugs. (june 25,
1	(a)(2) and section
1	 (4) if,
2	safety risks associated
1	(a). in reviewing
1	request if a
2	341, or 343
1	york, on march
1	paragraphs (1), (4),
3	 (b) authorized
4	premarket report, supplement,
6	fiscal year 2015,
1	(6) data and
1	fiscal year 2015.
1	subject by, or
1	meat articles. no
6	cigarettes and smokeless
1	restraining proceedings; subpenas
1	evidence (within the
1	prescription drugs being
1	related activities, or
5	respect to 
1	definitions (a) for
3	extent practicable and
2	taxing authority of
1	(b) supporting the
1	relating to foods,
1	seized and other
1	changed by the
1	class until the
1	states; (c) the
1	practices identified through
1	knowledge, there is
1	subchapter upon any
1	thousand or less
2	drug product; and
3	distributing, or dispensing
5	deputy director of
3	safety problems, including
1	practitioner involved meets
1	organizations: _____. i
1	with, and provide
2	fiscal year, if
1	member participates in
1	manufacturer, including any
1	 (b) reduction
3	(d) request for
1	persons making such
1	clause, an adverse
3	inspections under section
1	covered with material
1	food if, at
1	outsourcing facilities shall
1	law (or documentation
1	including a product
1	 (e) assessment
1	approval; and (4)
2	seek to ensure
1	fiscal year, is
1	increased sentence is
1	federal funds to
1	campaign, or be
1	admiralty; except that
2	agencies as the
1	products, both domestic
2	year 2013), prior
4	(2), the attorney
1	drugs are directly
1	demonstrate compliance with
1	board shall prescribe.
2	funds provided under
1	(e) index contents;
1	vests in the
1	currently available in
1	therein, and for
1	(e) applies, if
2	develop systems to
1	case brought in
2	grant under such
1	(k) to include
4	regulation; (b) provide
1	purposes referred to
2	action that would
1	identified signature line
1	finds that another
2	adulterated, shall at
2	chemical residue are
1	information.  (f)
1	identifies the drugs
1	development protocol under
1	additional data that
1	(i) authority the
1	name) of such
1	priorities; and (b)
1	authority and limitations
2	study  (a)
1	part when in
2	substance (without regard
1	tribes; and (b)
2	study required to
3	misbranded if marketed
1	public, as determined
7	thereof, meat and
1	panel can be
1	intrastate use under
1	
 379d4. reporting
2	containing a controlled
1	property; (ii) a
1	commission of, in
4	program under which
1	food, or within
2	premarket approval, and
1	address, and business
1	clinical trials; labeling
1	base the determination
1	testify in a
2	year and assessed
1	intravenous drug used
1	assistance, technical and
1	part 352 (or
1	stat. 1239; 

2	statement setting forth
1	(c) minimize the
1	datethe annual establishment
1	condition of recognition
1	 (4) expiration
1	(2) public availability
1	administration; or 
1	industry advisory letter,
1	meat article shall
1	adjustment to the
1	title after final
1	provisions unaffected poultry
1	exception, in a
1	evidence developed using
1	
 201. doing
3	recover the amount
2	nuclear regulatory commission
1	section 61 of
1	used when sterilization
1	promulgate regulations the
1	section 6333(c) of
1	community at the
1	(3) any conviction
1	adjusted by any
2	identical to, this
3	meet such standards
1	(2) make grants
1	determinations of how
2	food without charge
1	312 of title
1	encouraged the offense,
2	practitioner (as defined
1	entity (referred to
1	determined as follows:
1	1, 2017. (v)
1	using reliable analytical
1	distributor may disclose
1	benefit, and 
1	142; regulations; suspension
1	relating to small
1	administrative support the
2	filled prescription for
1	may include 1
1	relied upon shall
2	decree, be distributed
1	drug schedules of
1	territory.  (mar.
1	shall notify each
2	shipping containers and
1	states to practice
2	(b) shall, where
1	penalty.  (g)
1	executive director; and
2	changes, if any.
1	information or information
1	due datethe biosimilar
1	 (i) previously
1	anaphylaxis; (iv) listing
1	enter; scope of
1	medical devices described
1	repeated, material violations
3	jurisdiction, powers, and
1	government, the states,
1	file must be
1	device are identified
1	manufacturing a component,
1	designation of hig-risk
1	(7), and (8)
1	permit issued by
2	title 28. (5)
1	basis, and in
1	supplements. (b) the
6	columbia or for
1	located, in a
1	action, the law
1	types of device
1	commence proceeding against
2	may waive any
5	provided under subparagraph
1	listed chemical by
1	excess of such
1	adequate representation of
7	served as the
1	canada engaged in
1	magazines or other
1	use of foreign
1	will jeopardize the
1	undertaking an activity
21	355(b)(1) of this
1	catfish and seafood
1	(a) available through
1	(or storage or
1	kitchen prepares poultry
1	last time in
1	(r) piperonal. (s)
1	estimated duration of
1	general a biomaterials
1	considered. (2) 
1	inspection warrants, subpenas,
1	subject to revision
1	action is created
2	takes into account
1	lost by such
1	instituted and maintain,
1	order is no
1	presents to national
3	importer of drugs
1	shortage in the
2	supplier was an
1	issue certification of
1	affiliates, are, collectively,
1	united states, enter
3	schedule pay rates,
1	shipping container, is
1	setting the fees
2	study submissions, and
1	year 2013 inflation
1	publicly if components
1	affix to the
1	may also provide
1	research foundations, researchers,
1	statements, in paper
1	exempt test results
1	development agendas; (b)
1	act.  (b)
2	referred to an
1	(b) reports on
26	referred to as
2	evidence relevant and
1	using one of
1	area to any
1	register after march
4	commerce of such
1	subsidized by the
2	comprising a public
2	order providing the
1	positions at level
1	(b)(3)(a).  (i)
1	pizzas containing poultry
3	appropriated to remain
1	plainly and conspicuously
2	maximum punishment otherwise
1	tuberculin test applied
1	office or employment,
1	concerning the existence
4	utilizing a secure
1	international treaty, entitled
1	coast of the
1	confer any rights
1	development of laboratory
1	(4) publication the
9	definitions and standards
1	meat, meat food
1	exempt any plant
1	aggregate exposure is
1	100 patients. (iii)
2	develop or is
1	(42 u.s.c. 262(a))
1	(j) the number
1	(iv) any high
1	renew such proclamation,
1	tenfold margin of
1	thereafter, shall use
1	recognition; and (b)
1	report regarding foodnot
1	testing of employees;
3	wholesale distributor described
1	table in this
2	except when dispensed
1	unless such nonnarcotic
2	purpose specified in
1	360fff3(e) of this
2	articles produced in
1	(
 
 2108.
1	imposed on a
1	existence of a
1	632.)
 
 20.
1	usual, except that
1	identifying the area,
3	infant formula manufactured
1	veterinary diagnostics, is
1	hearing respecting the
1	brought into the
1	communication (a) advisory
1	recognized accreditation bodies
2	establish or leave
1	states, that an
1	applicable registration requirements.
1	(c) staffthe staff
1	(e); and (3)
1	paragraphs (h), (i),
4	(ii).  (ii)
1	states the names
1	nominees. (f) travel
3	years, and shall
1	otherwise); (4) includes
1	(m) for a
4	states unless the
1	review consistent with
1	term council means
1	respectively)) on the
4	condemnation is entered
1	information, including appropriate
1	(e) any failure
1	establish a national
1	inapplicability to certain
1	(1) the dietary
1	dollars in gross
2	take action to
1	terminate notifications in
1	later than six
1	(b)(1), the labeling
1	(i) the secretary,
1	offense, punishable by
3	appointed for a
1	including commerciall-available techniques
1	food packaging) and
1	material fact for
1	product of an
1	amendment case law,
1	instead of subsistence,
3	public health official
1	(j), the secretary
1	(c) are met
1	approved before such
1	subclause (ii). 
1	
 155. permits
2	(a), if 
1	inform him that
1	previous food safety
1	available for national
1	thereof. (
 

1	state shall transmit
1	30, 1975 and
1	veterinary medicine, shall
1	(1) order restitution
1	policies; transfer of
1	corporation, and association,
1	auditor have maintained
1	finds that efforts
1	unaffected; authority of
3	examinations, testing, and
1	operated as a
1	 (2) longer
1	repackager shall, in
1	adjusted to reflect
1	use, or (ii)
1	451. congressional statement
1	product that meets
1	acknowledgement that the
1	regulatory limit 
17	described under subparagraph
1	(1) full and
1	no-timely review if,
2	provide written notice
1	facility. (b) this
1	review, clearance, and
1	requirementsto reduce the
1	(b)immediate publication of
1	media that focuses
1	intent;  (b)
1	business. (4) the
6	governor of the
1	paraphernalia shall be
5	food safety programs
1	health. test results
1	
 
 384a.
1	professional practice, so
3	person shall notify
2	842 of this
1	agencies over private
4	(a) may not
2	category in which
2	requirements for quality
3	information obtained from
1	issued.  (f)
1	violations nothing in
1	states (including on
1	product radiation which
1	concerning drug interdiction
43	data and information
1	goals for timely
18	records of the
1	(x) the dispensing
1	entity which is
1	remove any drug
1	whether the technology
2	assessed to that
23	application under this
1	except as necessary
1	two inches, if
1	term priority countermeasure
5	(iii), and (iv)
4	drug is compounded
1	immediately notify state
1	product, and as
1	least one clinical
3	substantial potential to
1	apply to distributors
1	new and better
4	requirements prescribed by
2	disposition. (c) requests
1	assessed, the amount
1	pharmacy licensed under
1	require for a
1	clinical outcome assessmentthe
3	 (3) limitation
1	information charging a
1	materials, products, and
1	international efforts, including
1	subchapter; (ii) the
1	mechanisms under section
1	days for a
2	2 years and
1	significance than, any
1	electronic products of
1	part means a
1	noncompliance or such
1	debarment. the secretary
1	drugs for disposition
1	state agencies engaged
2	grant application; and
1	preliminary finding under
1	integrated. (f) outreach,
2	including fait-based organizations,
1	petitioner, or any
3	including a public
1	animals, or otherwise
2	(2) drug master
1	(3) generic new
1	ensure ongoing training,
1	(5) to fund
1	offender, deferred adjudication,
1	secretary determines 
1	title; (b) provide
1	media campaign. (b)
1	suggesting to the
1	premix supplier of
1	(3).  (ii)
1	since the time
1	(1) and, in
2	program under subparagraph
9	(b) or (h)(1)
2	interstate shipment of
1	placing in effect
2	required reports for
2	subparagraph may be
2	revision described in
1	safety protocol in
1	(33) the term
1	seek approval for
1	360ll(e) of this
1	(2) regulations 
1	employees pursuant to
1	states shall supply
1	(b) reports that
2	person engages in
1	importers of the
1	notice requesting the
2	time after a
4	association of boards
1	products in pediatric
1	subsection (a)(2)(a)(viii) may
1	person submitting information
1	standards developed by
2	180 days prior
1	gas. (b) the
1	limitations any applicable
1	(iii) a link
1	certifying the food,
1	interest; and (iii)
1	production and presence
1	classify a product
1	measurement based on
1	(b) application of
1	therapeutic amounts. (7)
1	animal drug does
1	labeling for oxygen
1	distributed or dispensed.
1	program agencies, including
1	regulation from the
1	man or of
2	circumstances exist: the
2	(after giving the
1	section 387l of
1	agency any chemical
7	products.  (2)
1	facility. (iv) distributions
1	population. such drug
1	amountsaward amounts received
1	health, and (ii)
2	territory does not
1	state if it
1	 (c) providing
4	developed and the
1	(a) $7,328,000 for
2	secretary required by
1	item (aa) 
2	one year. penalties
1	prepared means slaughtered,
1	annum, to enable
1	bioequivalence studies, has
1	partial term if
1	information any denial
11	(c) the term
1	standards for purposes
2	laws unaffected nothing
1	subchapter i shall
1	director), as appropriate,
1	expedited hearing as
1	food means an
1	requirement for an
1	(4) the sponsor,
1	subsection (c)(1)), the
1	facts involved of
1	safety. (4) if
1	public health situational
3	amount authorized in
1	610. prohibited actsno
1	(e) menthol cigarettes
1	(1) the decontamination
1	prescribe, by means
2	infringed;  (ii)
1	first action the
2	conditional approval issued
1	seq.] that relate
1	subparagraph (a)(ii)(iv) is
1	appropriate technologies, including
2	chemicals in accordance
1	(3) alphacetylmathadol.[2] 
4	stop using such
1	data. (iii) experience
1	evidence, taken as
2	drug.  (d)
2	homeland security biological,
1	(b) any person,
1	international and national
1	including  (aa)
2	process in any
1	dietary ingredient is
2	(i) the terms
1	trade or business
1	substance. (33) the
1	locality, be injurious
1	food by accredited
1	350l(a) of this
1	notice explaining the
7	definition for purposes
1	directly related the
1	review, and each
1	personal, for the
1	trade names; false
1	order form issued
2	court shall consider
1	 (1) verification
7	secretary, based on
1	water be subject
3	guidance that describes
1	61, 3(a), 64
1	directed to prescribe
1	term ginseng may
1	exclusivity under paragraph
1	list of registered
6	30 days before
2	safe under section
6	establishing, modifying, or
1	may prescribe, by
5	meaningful therapeutic benefit
1	(e) not require
1	reasons therefor, either
4	confidential business information.
1	mowing. (21) the
1	april 30 of
3	time (if any)
3	addition to or
1	paid by a
11	fees appropriated for
1	procured the destruction,
1	experience, not contained
1	products are permitted.
1	conduct prohibited by
1	commissioner on methods
1	pediatric ethics, neonatology,
1	concerned, or both
1	
 
 679.
1	administered are informed
3	eligible to retain
2	product manufacturer in
2	penalties applicable to
1	state, or county
1	drug administration databases
1	(c) the sponsor
1	(4) ris-based inspection
1	 (i)confidentiality and
3	section 355(j)(5)(b) of
1	rules  (a)
5	15 months after
2	small business; and
3	reduction  (1)
1	assisting in, or
1	device after the
1	received, shall, upon
3	entitlement to such
1	business (as so
9	attorney general finds
2	section 379j62 of
1	(ii) any request
1	priority of receiptstransfers
2	151 et seq.]
1	advising producers and
2	384d of this
7	carcasses and parts
1	tobacco, paper, filter,
4	article to the
1	recipients in the
1	final order so
1	country; (ii) certifies
4	retention of all
2	identifier the term
1	laws applicable to
1	public health is
1	waiver. the secretary
1	compounded by such
3	shall also apply
1	amendments of 2012,
3	amendments of 2012.
1	subchapter, or any
1	comprehensive and detailed
1	subject to service
1	time, as necessary,
1	business; but where
1	audits of facilities,
1	unfit to practice
1	notice, hold a
1	making a recommendation
2	(c) savings clause
1	stakeholders, such as
1	public health in
1	amendments of 2012;
1	enough so that
1	pharmacies; research applications;
1	drug; and (d)
2	tobacco product. the
1	(1) preventing drug
1	foods designated as
1	(b).  (h)
1	relevant risk evaluation
1	sale for human
3	product for topical
1	(2)(c), the application
5	human or animal
1	unless a greater
2	present any significant
1	estate of a
1	(2)) at which
1	refused admission for
2	participation in a
1	narcotic drugs. (ii)
4	chapter, or other
1	appears on august
1	ch. 675, 526,
1	compounded or dispensed,
1	requirements; and (ii)
1	mortem examination of
2	medical devices, which
1	indirectly, the growth
1	commission precluding action
2	grants awarded to
1	activity in the
1	establish requirements respecting
1	supplement a grant
1	lists the major
1	agreement, contract, memoranda
2	manufactured or imported
1	foreign government inspections
1	professional backgrounds. the
1	authorized for employees
1	support dosing and
1	use of pesticides
2	product; (d) the
1	oral hearing, exempt
1	reasonable allowance for
1	regulations to describe
1	standardized on-page summary;
1	
 350c. maintenance
1	wine, malt beverages,
1	diseases or disorders,
1	manufacturing change (whether
5	secretary to designate
1	warnings, precautions, side
1	871. attorney general
1	title, the state
1	endeavor or attempt
2	drugs used in
2	iii or iv;
1	(c) denial; written
1	respect to statements
5	discretion to refund
4	exemption with respect
1	modification of advisory
4	section 350f of
1	(1) schedule i.
2	shall be 
4	investigation in coordination
1	milk fat, all
1	(6) federal control
4	offense punishable under
1	given in the
1	requirement for nutrition
5	(6) minutes of
1	audits and reviews
1	october 15, 1994.
9	charge of a
1	investigational submissions. (b)
1	
 1714. awards
1	title, one shall
1	lifetime associated with
1	agencies from an
1	5, to be
1	(g)contract requirements.each contract
1	level, the administrator
1	carried out at
1	carried out as
1	(c) venue; process
1	protocol, or place
9	secretary may use
2	states government authorized
1	may require labeling
1	salts derived from
1	diversion and be
6	(a) shall apply
3	liquidated damages in
1	provision of full
1	 (3) security
1	dispute is clearly
1	order deny the
1	device for eligible
1	(1) the registration
1	exceeds 50 dosage
1	clinical trial standards
1	powders; or (c)
2	agency  (a)
1	owner for exportation
2	expert or stakeholder.
2	(d) and regulations
6	simulated, forged, or
1	(1) evaluations notwithstanding
9	secretary until all
1	needed to 
1	employed in a
6	iii or iv,
1	illegal use or
1	paragraph, may award
1	(
 
 951.
1	(i). (vi) for
1	exempt from this
1	increased federal commitment
1	responsible party involved
1	resistant tuberculosis; and
2	protect the consuming
1	organize the panels
1	(vi) not later
7	person who will
3	public notice and
1	summary is submitted,
2	fee act of
1	property shall be
1	3 times any
2	$2,748,000 for fiscal
1	alters the standards
1	(3). (3) the
1	(c), the attorney
16	section 1905 of
1	butyrolactone or any
1	detention orders 
1	supplier of all
1	concurrently or consecutively
1	(3).  (5)
1	listed in subsections
1	1133. omitted
 

1	section has a
1	prohibit a state
1	endangering human life
1	2013 (to examine
1	agency may appeal
1	inspection services at
1	potential shortage may
18	application filed under
1	(a) purchase of
1	(5) diphenoxylate. (6)
2	safety programs and
1	vote) by the
1	date) an approval
1	employee for any
3	administration or any
1	731, formerly 711,
1	device or is
8	person  (i)
1	346a. tolerances and
2	thereof, will be
2	induce, entice, or
2	conviction alleged in
1	title. (bb)limitation. 
2	disclose individually identifiable
3	civil penalty shall
1	free of adhering
1	ch. 675, 529,
1	strategies to leverage
2	general, in coordination
2	shall dispose of
2	issued on or
1	(7) monitor implementation
1	pipes or chillers;
3	methods adopted by
1	shall provide prompt
2	provider does not
1	duty imposed by
1	will be permitted
1	governmental unit the
1	organized risk communication
1	court proceeding described
1	successor is appointed.
1	meat products shall
1	applications before the
1	enforceable in a
1	employee is unable
1	use of available
1	sharing among federal,
3	may prescribe so
1	controlling the sale
1	(8) raw materialthe
1	623 of this
1	loss of drug
5	commissioner, the commissioner
1	agriculture to avoid
1	public  (i)
1	small processors transitioning
1	350j. targeting of
1	60, 12, as
1	paragraph.  (ii)request
1	systems using the
1	terms, and conditions
1	shell egg of
1	1548. termination the
1	distributed interstate and
2	testify at any
1	counsel to state,
1	drugs may determine
1	hospitals, and similar
3	379h of this
1	incidence of such
1	package across the
1	services with the
1	shall not control
1	scope for purposes
1	local data, rates
1	disposal model plans
3	establish by regulation.
1	beyond the immediate
4	interested persons may
1	whose affidavit has
1	term biosimilar initial
1	general may, without
1	reports and receipt
3	state program carried
1	cost of inspection;
1	(h) service of
3	single human drug
2	activities. (
 

6	final decision on
2	upon thirty days
1	regarding the relationship
1	notice to secretary
2	administration (exclusive of
2	final decision of
1	determines necessary, the
2	constitute a separate
1	grants to an
4	approval, of any
2	22, 2009; and
1	bribery of or
1	tracing of food
1	maintained for the
1	product meets applicable
1	 (2) posting
1	dyes or eyebrow
1	food at issue
1	descriptors light, mild,
1	title when used
1	fiscal year. notwithstanding
4	products.  (b)
1	interest (including any
16	person shall submit
1	development, public policy,
12	product under section
2	assistance in the
2	made effective under
1	observed safety risk;
1	first processing of
1	secretary has contracted
2	direct resources to
1	ii, 205, as
1	(a)(i) shall contain
1	available technology in
1	secretary has certified
1	need not admit,
1	exported.  (h)
9	construed to require
5	beginning january 1,
1	reports concerning the
1	administration a notice
1	teachers, administrators, and
1	(a), or attempts
1	clearance from the
2	(2) no grant
1	foreign branches), or
1	(a), except that,
2	drug approval process
1	documentation regarding such
1	mea-canning, rendering, or
1	product. (c) accelerated
1	official duties and
5	states for a
1	working toward automatic
1	grounds and jurisdiction
1	(a) intracompany distribution
1	benefit. (b) that
1	authorization marketed as
1	manufacturer, may by
3	law enforcement activities
1	(g) effective date,
1	introduction, into commerce,
1	seller includes the
1	specific provision of
1	(
 
 1535.
2	finding under subsection
1	emergency medical response.
1	project set forth
1	appropriate health authority
1	(i) is justified
1	matter is ready
1	
 
 379h.
1	title this chapter
1	exemption, issue a
1	unless specifically exempted
1	 (d) late
2	programs and policies
1	designated agency the
2	may, with respect
2	shall publish information
1	numerical identifier the
1	public disclosure under
1	drug application fee
1	agency no later
1	obtaining scientific feedback
1	 (d) discussions
1	title; (xi) products
3	section 360cc(a) of
1	appropriate, that recognized
1	(iii) a class
1	including biological products
1	hard drugs. (d)
2	proceed expeditiously under
1	drugs in excess
1	(xiii) -penty--[(-methoxy-benzoyl]indole (sr19
1	without selection or
1	(2) more than
1	 (e) personnel
1	shall have waived
1	animal feed was
8	(2).  (4)
1	chemical:  (a)
1	served with a
2	judgment on the
1	liability for damages
1	request issued under
1	ii, 201, as
2	convictions under this
2	drug experiencethe term
1	inference, and aggregation,
8	subparagraph (b) for
1	administration for purposes
1	inspection activities. (

1	obligation of a
3	made to obtain
9	time and space
1	
 186, 187.
1	biomaterials supplier; (iii)
4	ban under this
1	manner that 
1	rights under subsection
1	fee, for periodic
1	general. (c) after
1	360b, 360ccc, and
2	federal law. 
1	(a) in generaldata
1	otherwise provided under
1	restricted device, the
1	commissioner, shall be
1	strategy under section
1	filed over protest
1	package form if
1	patients in rural
1	chapter who shall
1	undertaken to keep
1	health system. 
1	report for a
5	to, or copying
4	distributing a controlled
1	(b) scientific evidence
1	products: provided, that
1	technologies.  (4)
4	request under subsection
1	or, of a
1	machine. each report
3	may present their
1	drug application was
1	requirement essential to
1	involvement of food
1	(2) internet web
2	paragraph (4), to
1	maintains records on
1	approved. a decision
1	cosmetic act (a)
1	territory; (iv) an
5	biological product 
1	centers; and (ii)
1	quality or strength
1	services, general services
3	location consisting of
1	contracts with individuals
1	imported prior to
2	title by distributing,
1	dosage form the
2	diagnostics, biologics, and
1	notification submissions in
6	provisions of law
1	pharmacokinetic studies. 
1	secretary by section
1	allocation of such
1	department, as well
1	applications for licensure
3	processing operations are
4	30, 1940, 5
1	5).  (e)
1	distribution, possession, information
1	subsection are assessed.
1	paragraph (34) or
4	boards of pharmacy,
1	standard under subsections
1	boards of pharmacy.
1	guidance to describe
4	accreditation under subsection
1	(4) joint laboratory
5	negotiations and their
1	beginning 1 year
1	demonstrate for purposes
1	no-federal funds toward
1	limitation the requirement
1	investigational use if
1	oversight), as specified
3	product, and, beginning
1	approaches to gather
1	
 381. imports
1	1953, ch. 251,
1	title, the combination
1	(5)thir-party logistics providers.
1	users unless its
1	title since july
1	president as commander
1	request or the
2	controlled substance; or
1	law concerning the
1	387m. equal treatment
1	program; and (iii)
2	purposes of adulterated
2	dissemination of pediatric
2	executive branch; (7)
1	schedule by reason
5	classified into class
1	procedures elected by
1	vessels, and aircraft
1	hours of initial
1	(b) through (e)
72	violation of this
7	held at the
1	states to request
1	june 26, 1938,
1	suspension authority 
1	education program programs,[1]
1	place.  (e)
1	timely patient access
1	(6) is integrated
3	timetable in which
63	drug that is
1	subjects that are
1	analysis that relates
1	title. the applicant
1	title. (6) in
1	containing a nonnarcotic
1	import food, which
1	(e), and (f),
1	data, sales data
2	plan on the
5	patent information submitted
2	2006, and as
1	controls to significantly
1	prepared by a
1	 (2) data
1	drug sample, in
1	subchapter, he shall
1	(after consultation with
1	of, the treatment
1	personal slaughtering; custom
2	meet each of
3	contrary, in whole
1	360b(n) of this
1	(c) may review
1	combination product being
1	practices, between the
1	appoint employees to
1	civil or other
3	secretary, on the
3	title, prior to
1	proposed labeling submitted
3	purposes of premarket
1	farmthe requirements under
1	 (ii) matching
1	new drug proposed
2	section 387b, 387c,
1	(c) consumer for
2	administer such drug;
1	accomplish the purpose
1	states; (b) an
51	drug or other
1	laws to eggs,
1	least ninety days
1	(d) the new
1	mandatory debarment; certain
1	subchapter ii 
1	(v) -hexy--(-naphthoyl)indole (jwh019);
1	hazards from electronic
4	percent by which
1	growths, may be
1	expanded access provided
7	regulation not less
1	facilities and equipment
1	general shall forward
2	affiliates. (c) reduced
3	grounds for failure
2	amount assessed and
1	include the rationale
2	effective premarket review
1	partnerships, and associationsany
2	(exclusive of the
1	separated at all
8	 (a) may
1	secretary. if the
4	person is notified
1	bird processed, and
2	lower fee rate.
2	27, 2007, in
1	final judgment of
2	full range of
1	 (ii) federal
1	pharmacists, but the
2	circumstances as of
1	affect food manufactured,
1	basis. (8) intergovernmental
131	requirements of this
2	states and localities,
1	infant formula required
1	import milk or
1	inordinate amounts of
3	premarket application under
1	feed directive shall
1	criminal enterprise (a)
1	building, construction standards,
1	state of production
4	may be ground
1	(iii) whether external
2	(d) and (e),
2	report by the
1	title as in
1	periodic basis, 
2	licensed veterinarian within
1	employee or other
1	may be. (7)
1	submission the portions
1	chapter and such
1	individual) under subsection
1	transaction involved (independent
1	arrangements made by
1	registration and order
1	enhance medical product
1	inspections in meeting
2	deems necessary; and
4	application under subparagraph
1	(ii) under an
1	2007, in collaboration
1	sample for examination
1	terrorism risk assessments;
8	solely because of
1	applying manufacturing restrictions
1	application. (2) the
1	(d) withdrawal and
1	inspection subsequent to
1	obtain prescriptions for
1	conformity to supplemental
1	supported by, an
2	contained in other
1	 (e) corrective
1	(b) applicable inflation
5	carry out such
1	 (18) smokeless
1	means of instructions,
1	(3) priority review
1	shall possess any
3	head of any
2	state agency described
1	379r. national uniformity
1	secretary. in determining
2	substance added to
1	printed matter that
1	applies. this information
1	(other than repackaging
1	section shall preclude
1	suspension under paragraph
1	entity that receives
1	provided for a
1	promptly assign an
1	food, and (ii)
22	including  (a)
1	requirements.  (c)
1	(2) fiscal years
1	manner, will cause
1	(3) would not
1	amounts appropriated or
1	effect under the
1	applicable (as in
1	 (4) benefit
3	code number of
1	(1)  [4]
1	(8) may not
1	title shall include
2	grants the secretary
1	official establishment number
1	build scientific expertise
1	original device means
1	formula shall make
2	anhydrous ammonia (a)
1	hand as of
1	chapter. and it
1	shall not generate
1	controls are effective;
2	reasonably believes that
1	piritramide. (39) proheptazine.
2	and, in making
1	feed or does
2	lawfully engaged in
1	feed in any
1	675, 746, formerly
1	alcohol, tobacco, firearms,
1	sea food for
2	witness shall not
1	media campaign has
45	labor, and pensions
1	names; false or
1	section 843 of
1	preceding sentence to
1	entity shall work
2	referenced in such
1	(h) exception for
1	exports.  (2)
1	practitioner shall maintain
1	
 379j41. definitionsfor
2	persons representative of
1	object to a
1	consignee, and, in
2	advertising means the
2	authorities under food,
1	appropriate offices of
1	seq.); and (h)
1	(a) the annual
2	title, is an
1	continue, or strengthen
1	(1) the area
1	complete criminal record
2	moneys in the
8	request for the
2	obtain this authorization
42	ch. 2907, title
2	narcotics detection technologies
1	patients of the
1	transfer the property
3	applications that were
1	attorney general, is
3	appropriate, for the
1	subparagraph (2) shall
1	attorney general, it
1	consumer notification. 
1	subparagraph (a)(i) may
1	strengthen collaboration among
1	evaluation and recommendations,
2	available to inspectors
3	removed from exemption
1	health and welfare,
1	804, as added
1	manufacturing or other
2	attorney general, if
1	commission to carry
1	abuse education, prevention,
1	review (a) right
1	device was exempted
7	attorney general, in
1	
 379h2. reauthorization;
1	use as food
3	committee and of
1	granted by such
1	drug, is insufficient
8	20 years and
1	drug, information submitted
7	conditional approval under
8	action referred to
2	(b) relation to
1	commerce, unless exempted
1	magistrate judge and
1	protect the economy
1	section 2291j(b) of
1	application; (iii) with
1	(2) major sector
1	reporting changes in
3	applicant has refused
1	(1) the testimony
2	860 of this
1	may, if a
1	stated in immediate
2	restrict the use
1	delivery or disposal
1	cutting up of
1	growers, tobacco warehouses,
1	person who materially
6	aside, in whole
1	supplements); (b) 27
1	warrant of seizure
1	charge against such
1	notice; promptness; exclusions
1	articles the importation
3	 (i) certify
3	participating in the
1	packs, transports, distributes,
1	(
 
 2243.
1	
 
 372.
1	actsany person who
1	(b), amend the
1	available in that
1	reviewed medical literature,
1	 (a) control
2	paid.  (2)
2	grant a full
1	submissions, including review
1	(12) the growing
1	secretary with credible
1	2009), and the
1	progress made with
1	owners of such
1	(g)[2] to (p)
1	law governing colored
1	records can be
1	matters involved, except
2	implementing this section
2	animal drug study
1	chemical product, except
1	local community initiatives
1	datafor purposes of
1	2012, establish fees
6	decomposed substance, or
2	demonstrating that each
1	record of any
1	product, or the
4	case of actual
1	(8) a person
1	substances; (2) cooperate
2	entity engaged in
1	give such notification
6	aspect of such
2	 (3) exemptions
4	upon issuance of
2	general or upon
1	findings prescribed by
1	
 93. repealed.
3	food products for
2	efforts of the
1	findings, and conclusions
1	feeds; or (ii)
1	device (including manufacturing
1	misbranding if there
2	group have failed.
1	denial) that 1
1	radius of fifteen
4	information that would
1	manufacturerthe term tobacco
1	(5) petition procedure
4	assignee, or successor)
1	(ff) the term
1	packaging the product
1	manufacturer and any
1	(f) to ensure
1	donors to designate,
1	article or product
1	taken respecting such
2	available arrears list,
1	mandatory recall authority
1	personnel, and educators,
1	interest, address tort
1	groups, communit-based organizations,
1	products may have
1	(3), with respect
1	reporting required by
1	judge of the
3	certificate, or simulation
3	water act (42
1	personnel and clinical
1	 (4) size
7	shall designate the
1	chewing tobacco. (v)
2	devices with differing
1	fees shall not
1	professionals administering the
1	subparagraph (b), for
1	attorney  (1)
1	exports (a) imports;
1	customers do have
1	cloth, plastic, or
2	43 of title
1	requirements (a) in
1	united nations, in
3	approval or conditional
1	 (3) period
1	institute, the secretary
4	commerce, or import,
2	maintain an adequate
1	territories, or in
1	term return means
2	342(f) of this
1	commerce in devices
2	planting, cultivation, growing,
2	2011, and annually
1	publish it in
1	section 379j22 of
1	laws. (june 30,
2	(a) to evaluate
4	4 fiscal years
2	chemical means any
1	affected or aggrieved
1	exporter from which
1	use to assign
1	individual remains drug
3	given the opportunity
1	reduction organizations. 
1	date such regulations
1	subsection refers in
1	(7) elements to
2	countries involved; (d)
1	companies and pass
1	22.  (e)
1	subsection (i) insofar
1	services, to the
2	person or other
1	no-hig-risk foods the
1	polydrug abuse. furthermore,
1	attorney offices); and
1	(b) information regarding
1	determinations, and assign
1	subparagraph (g)). (ii)
1	labeling or relabeling
11	article is so
1	 (1) coalition
1	programs there is
1	person means a
2	logbook under subparagraph
8	drug that has
3	misbranded poultry products
2	machine, or gelatin
2	inspections of facilities
1	person making contact
1	including sales. (3)
1	denied pursuant to
1	refuse administration of
1	46, 48, 49,
1	sooner than the
1	u.s.c. 136a, 136h].
1	importer, taking into
3	systems placed into
8	 (c) limitation
1	(ii), shall ensure
1	relating to pediatric
2	approval for an
1	three years the
2	subsection (f)(2) of
2	operation, of such
1	law enforcement against
4	including rules and
1	18, 1968, that
1	(b) information submitted
1	$2,000. the jurisdiction
1	conference, that 
1	inconsistent laws any
2	seq.).  (2)
1	state, unless the
1	(iii) 280 grams
1	measure with respect
1	perform food safety
1	eligible for an
4	section 379h(a)(1)(a)(i) of
1	steroid, the secretary
1	coordination with, those
3	person to manufacture
2	list developed by
1	federal law, or
1	successor regulation)) intended
1	7 approved abbreviated
2	shall not by
1	labelingthe requirements of
1	employing individuals who
1	(sr18 and rcs8);
2	applicable, to such
1	resident alien, an
1	shall immediately transmit
1	administration and establishing
1	inspection panel (referred
1	(h).  (4)
1	products, which shall
1	violates paragraph (1).
1	clause nor any
1	application, that was
1	domestic and imported
2	paragraph.  (b)
1	155, 5, 44
1	articles shall upon
1	sources for the
1	goals, the congress
1	wrongdoing to the
1	poultry on own
1	defined or used
1	board established by
1	food registry. 
1	community;  (d)
1	product, using a
1	use by consumers
1	certain sites and
1	national adverse event
1	(a) offset of
1	right shall exist
1	conventions, a system
1	claimant submits a
1	(ii)(iv), the director
1	manufacturer (in the
1	(3) solely for
1	(iii) each reference
1	aqueous format, or
1	148. powers of
1	number and importance
1	injury. a protocol
1	reaccreditation  (i)
1	carrying out regulations
1	human health; (6)
1	decision any person
1	defined  (a)
1	patient or for
1	misleading, then in
1	(9) any recommendations
10	adjudicated in a
1	unless such change
1	representatives, and make
1	tobacco product, food,
1	upon the approval
1	on-half inches, if
1	prohibited the importation
1	organization of studies
7	number of requests
1	states as in
2	title have not
1	824(a)(4) of this
7	section 1523(9)(a) of
1	export presents an
1	steps that are
2	available for obligation,
6	administration in achieving
1	9 months after
1	states; provision as
1	(b)(i), a list
3	address credible threats
1	congress that describes,
1	green whites, eggs
1	particular retail outlet
1	available, the names
1	title, assess a
2	 (d) small
1	(i) reasonable timelines,
1	secretary shall discontinue
1	paragraph (2) limits
1	collect  (a)
1	determination regarding whether
1	member who is
1	section, the finding
59	disease or condition
1	connection with interstate
1	notice identifying any
1	subparagraph, a violation
1	unwholesome, adulterated, mislabeled,
2	(b) application. (iii)
1	360e(c), 360e(d), 360e(f),
1	title v, 501,
1	act applications (a)
3	established in section
1	admiralty; jury trial;
1	50 dosage units
1	reduce illicit drug
1	review and modify
1	limitation to distribution
2	secretary on his
2	employees employed in,
1	2016; and (d)
1	standard to the
1	contract law. (c)
1	label  (1)
1	handlers specified in
1	matches of advertising
1	services, except that
3	may provide a
2	for, obtaining the
2	state for violations
1	(b), in connection
4	law enforcement officer
1	biannual basis, on
1	lack of ability
1	(iii) be a
6	authorize the delivery
1	extended from 
1	recommendations, opportunity for
1	includes, for such
1	training programs, conduct
1	2016 and ending
1	classified by applicable
2	secretary will use
1	sequential basis by
3	facilities that manufacture,
1	him, pursuant to
1	lead to moderate
1	(a) have contributed
1	adjustment in determining
1	surplus revenue from
1	writing, within the
1	regulation upon public
1	drug (or drugs);
1	tolerancenotwithstanding subparagraph (a)(i),
1	(1) specifies the
1	(c)(2), a statement
2	requirements or specifications
1	premix to ensure
1	increases at any
2	available until expended,
19	available until expended.
2	drug application fee,
1	columbia in slaughtering
1	psychotropic substances, the
1	drug (or drugs).
7	comment on the
1	display of license
1	
 1603. general
1	ineligible for 
1	related to enhancing
1	physician determines that
4	343(a)(2) of this
1	transfer program 
1	agrees that, with
6	scope of this
1	subparagraph[1] (b) beyond
1	exporter shall send
1	approval; minus (ii)
39	adulterated or misbranded
1	implement processes for
1	b of part
1	not, for any
3	basis of data
6	fees during such
1	pharmacy may be
1	developmental milestones that
1	regulations may not
2	retail stores and
1	including inspections and
1	paragraph (4)(b); (ii)
1	establish a minimum
1	subsection (c). (7)
4	activities to be
1	2020, $14,800,000. (

1	subchapter, or of
1	unfit for food;
1	u.s.c. 136p) for
1	genuine issues of
1	(1) lacks sufficient
1	use; and (g)
1	uses,  may
2	affiliate meets the
1	(2) ensure the
1	hair dye, the
2	cosmetic shall be
1	registration (a) definitionsin
1	 (c) consultation
1	drug application, abbreviated
2	general.  (d)
1	letter shall require
1	provider and documentation
1	shall contain data,
1	secretarys regulatory responsibilities
4	access shall be
1	list of harmful
1	532, formerly act
1	dispenses product in
1	1102; 1940 reorg.
1	
 1535. supplemental
1	assure consistent and
1	section 353(e)(2)(a) of
1	except for amounts
1	 (b) external
2	differ from other
1	destruction, alteration, removal,
3	drug, or device
3	annual fee setting;
1	name has not
2	(y) the term
1	information to provide
2	met by the
3	section 360b(d)(4) of
1	use devices, as
5	labeling, or container
1	(2) safety or
1	drugs are required
1	subsection (d)(2) (referred
1	generic drug entered
1	use, as a
1	authority with respect
1	title1 or any
1	rules for positron
1	death; (ii) an
1	
 
 672.
33	shall, not later
1	residues other than
1	conduct research, as
1	assessment that looks
1	serious sid-effects for
1	applicant filed the
3	subsection or subsection
1	affiliate thereof. (10)
1	labeling and patient
1	required for certain
26	owner or operator
3	notice and comment
1	report or information),
1	shell egg packers,
3	years before the
1	established prior to
1	(b); (ii) a
1	health officials in
1	premarket report, where
3	tote, or other
1	country.  (e)
1	precursor, a drug
6	controlled substance that
1	dispense, any controlled
2	safety inspection service
1	substances; investigations; oaths;
1	(2) drug reporting
1	 (c) requisite
1	advanced surveillance, tracking,
1	progress with respect
7	(1) is not
2	shall keep confidential
1	350c(b), 350f, 350e,
1	listed drug. (u)
1	(k) construction nothing
1	dispensing, the online
1	restaurants) who manufacture,
1	organizations related to
1	act; (c) received
1	preparation by any
1	illicit drugs; (c)
1	priority supplement means
1	bioavailabilty[1] studies) essential
1	chapter. (u) the
1	inspect such orders.
1	furnished on account
1	size and type
1	
 359. nonapplicability
1	practitioner or other
1	(2) activities under
2	health within a
1	plants (a) contents
2	offense. except to
1	appropriate to regulate
1	facilitated consistent compliance
1	-year period over
1	 (11) supplemental
1	application; (c) there
13	obligation only to
3	forcibly assaults, resists,
1	title, issue to
2	 (d) refund
3	(c) any other
2	(1) to withdraw
4	actual controversy as
1	medicine, medical ethics,
1	modifications to, and
1	subsection (g) seek
1	administrator shall consider,
1	advertising.  (c)
6	trade secrets and
1	clinical data. 
1	facilities used in
1	trade secrets any
2	title, unless, in
1	meet industr-accepted standards.
1	rate of such
1	support and are
3	product; and (c)
1	presiding over the
1	threshold effects, for
1	year were met
2	representative being afforded
1	subsection (k) as
1	controls to mitigate
4	three years or
1	ensuring that 
1	device and biological
1	notification relating to
1	343(q) and 343(r)
1	1, 2013, and
7	part, of any
2	strategy described in
1	comply with good
1	doubt on any
1	training food and
6	purchase of advertising
2	different requirements than
1	disposition of unwholesome,
1	otherwise complies with
2	animals for a
1	policy shall 
1	including any regulation
2	duties of director
2	take all appropriate
1	additive, the manufacturer
1	provision an approved,
1	application, the burden
1	(b) early warning
45	firm, or corporation
1	state, including all
1	drug; (i) the
1	  pantothenic
4	u.s.c. 262(a)(3)]. 
2	(including such costs
1	professional medical and
1	assisted state, local,
1	programthe term early
11	analysis of the
1	refilling is authorized
1	ch. 675, 531,
1	paragraph (1). (n)
1	biomaterials supplier for
1	334. seizure (a)
1	effectiveness shall be
2	benefits and risks.
1	use in emergency
2	benefits and risks,
3	fee that otherwise
1	customers, sufficient to
1	reduce premarket burden,
3	logistics provider licensure
1	secretary (if so
1	(7) staff years
1	section, or 180
1	animal; (c) the
1	separate offense. (b)
129	subject to the
1	criteria nothing in
5	court grants a
1	entity meets the
1	registration $2,575 
1	1, 67 stat.
2	purchaser for value
1	new medical products
1	subsection (h) available
1	(k)(4) of such
1	reports in peer
1	center.  (iii)
1	consider the impact
3	establishing the fee
1	appurtenant thereto. 
1	retail during a
2	 (ii) firms
1	met (or that
2	service corps loan
1	severe restrictions. (c)
1	 (b) requirements
1	phenylpropanolamine, except that
2	place under the
2	work to develop
1	require on the
3	term immediate container
1	requirement pursuant to
1	liability of agents,
1	title), 1 or
1	provided during such
2	(2) consultation with
1	known about drug
1	eligible to purchase
1	 (c) conduct
1	(2) retain all
1	report, a report
1	
 335c. authority
2	product thereof, bearing
1	title in order
1	shippers, carriers by
1	previous formulation produced
1	denies that he
1	select at least
1	treatment programs. 
1	chemical. not later
1	product shall include
1	 (6) advice
1	commissioner.  (f)
1	nonprofit organizations or
32	approval of such
1	obtains substantial income
10	secretary may determine
3	conducted by other
1	successor regulations). (c)
1	abuse, and (b)
1	(including suppression, u-regulation,
1	pharmacopeia, or any
3	require such a
1	exportation to any
1	beneficiary health information;
1	civil actions against
1	copy of one
1	including, when circumstances
8	parts of carcasses,
2	section 360bbb3(b)(1) of
2	shall be payable
1	relevant  (a)
1	(iv) whether the
1	exchanged, or shipped
1	advisory council 
1	export transactions, shall
1	survey as described
1	ensuring that eligible
1	meat act [21
3	returned product beginning
3	remain in or
2	council shall not
1	held only if
3	development of animal
1	title) to whom
2	basis or otherwise,
1	(d) review the
1	term amateur athletic
1	
 360e. premarket
1	effect on ability
1	emergencies such as
1	used for a
1	 (b) noticean
6	restrictions on the
2	update to the
1	documents and regulations
1	purchase of securities
1	general, if circumstances
1	investigations to support
2	recklessly sell at
1	section by public
1	presence of at
1	4, 1923 [21
1	year 2007; (11)
1	applications and supplementsany
1	aquaculture and seafood,
1	aquaculture and seafood.
1	licensed, registered, or
1	americathe director shall
1	listed chemical, an
1	relied upon nutrient
1	possess, manufacture, distribute,
1	findings with a
2	listed chemical, at
1	355(e) of this
1	compliance by country
7	application of this
1	(a) which does
1	states, that the
4	individuals who review
1	360g1. agency documentation
2	drug product to
3	prohibition of importation
1	general food category
1	advisory panel to
3	committee shall submit
1	possession of small
3	360e(c)(4) of this
1	developing innovative, collaborative
1	reindeer the provisions
1	 (b) initiation
1	residue on or
1	subparagraph (b)(v), the
3	(5) offsetting collectionsfees
1	commerce by the
1	renumbered 20 and
2	admission to an
1	2[1] are not
1	clinic with an
1	use a different
1	(b)(2) to execute
1	among youth; (4)
1	subsection (e)(9). (b)
2	forces in the
1	less harmful; or
1	policy on the
1	limitations; united states
12	every person who
1	animal drugs an
1	guam, and american
1	involves buying or
2	establishment (as those
1	(b) no judicial
1	appropriate information disclosure
1	although not a
1	hearing, by order
1	response framework; (c)
3	intended physical or
1	respecting such food
1	drug applications do
1	case had not
2	establishes and maintains
2	imposition of such
1	drug treatment, or
1	holding food; and
1	resources available for
1	thereof; and (b)
1	prescribe.  (june
1	provide a valid
1	occur; (iv) the
1	person becomes aware
1	wishing to conduct
1	obligated to countermeasure
1	(
 
 854.
1	determines exceptions, and
1	criteria included on
1	preparedness goalenhance the
1	5(b) of such
1	year, following the
1	report to congresson
1	pharmacy undertaken to
1	acts, and such
1	citation to published
1	cycle and inventory
1	board shall terminate;
1	conduct consultative and
1	implement the program
1	use, or (3)
1	illness; and (ii)
3	patient without substantial
1	(3) annual report
1	 (a) defendant
1	teaching, or quality
2	counterclaim to infringement
1	solution (including a
1	(5) the recordkeeping,
1	cream in, such
2	determines that another
2	private nonprofit institutions.
33	determination by the
1	tolerance.  (vi)
1	employment without interruption.
1	chapter: and provided
1	except the following:
1	 (b) classification
3	representative for a
1	respect to regulations
2	new, sel-supporting community
1	carburetor pipes; (9)
1	committee.  (5)
2	adulterated, or improperly
1	refused entry. (2)
2	suspension of tolerance
1	regulatory review for
1	exported; but if
1	resistant gram positive
1	subparagraph (b)(iv), at
2	documents. the secretary
1	human foods and
2	controlled substance unless
1	467 of this
1	(1)(a) or (b)
1	country indicating the
1	identity if it
1	drug administration intercenter
2	time upon thirty
1	title; (3) if
1	(1); (3) in
1	control strategy in
1	facility, including with
6	advisory committees not
1	services shall enter
1	credited to accounts
2	located; and (b)
1	article is held
1	timely review of
1	investigations where appropriate,
2	subparagraph (a) within
1	use and warning
2	term resources allocated
1	(a) for submission
1	law enforcement activities.
1	commodity, including a
3	animal drugs. such
1	establishment upon condition
4	disposed of contrary
1	chapter the slaughter
18	section 841(b) of
1	recover the costs
1	transaction is to
1	cost; or (iii)
1	individuals aged from
1	pediatric contraindications, warnings,
1	law enforcement activities;
3	entry into or
1	level below which
2	detect and respond
1	involved.  (iii)
4	security, and the
1	homeland security or
1	application); and (ii)
1	(b) no exemption
1	
 
 378.
1	formula are present
2	narcotic drugs to
2	and, if granted,
2	attorneys and expert
1	respect to forfeitures
1	section 343(c), 343(e),
1	(a)(1)(b) whenever such
1	(ii) or a
2	apply under subsection
1	origin: provided, however,
2	expended for the
2	necessary to meet
1	commerciall-available techniques that
1	federal and nonfederal
1	(1) is inadequate,
8	assessed an annual
1	seq.); (c) the
3	section 201 of
1	set forth those
2	businesses, including small
1	section. (4) 
1	control and nondrug
1	action alleging harm
1	(b) may periodically
1	
 
 360fff2.
1	administration who directly
1	publish information and
1	withdraws under subsection
1	(b) additional special
3	publication unless the
1	preceding 12 months
1	training relating to
1	 copper (g)
5	product.  (2)
2	 (f) no
1	sense of congress
2	declares himself to
1	shall give a
1	database.  (a)reporting.beginning
6	(a), the attorney
1	finding was made
1	chemical) at retail,
1	tank the term
1	procured for its
5	states ant-doping agency
1	contents are exposed
1	(a) a substantial
1	conflict of interest.
1	2002, the unobligated
1	efficient operation of
4	(b) the person
1	determination. for purposes
3	precursor substance in
1	(ii) all data
3	promulgate regulations exempting
4	secretary for use
2	1970 (15 u.s.c.
1	personal consumption, provided
1	(f) use of
1	of, the effect
1	certificationany application for
1	may send 1
1	retain such records
7	july 1 of
1	storage is in
1	nongovernmental and nonprofit
4	require the responsible
1	basis, to generate
1	total amount assessed
2	section 360eee3 of
3	(ii) a description
1	(c) revocation of
1	food for human
1	paragraph (6) 
1	product and of
1	limitations of section
1	(c) each drug
1	publication  (1)
1	found: (a) any
1	whose term of
1	responsibilities and interests,
1	advice. with respect
1	distribution, possession, exposure
1	chemical shall notify
1	(e.g., bass, flounder,
1	(ii) determine whether
23	shall submit a
4	adduce such evidence
1	state the grounds
1	regulation).  (june
2	year 2013 (as
1	chapter. (2) amount
1	15th day of
1	(1) issue a
1	states and localitiesin
1	(b) in generalthe
5	receive such a
1	substance shall preserve
2	drug under clause
1	fees as follows:
5	 (a) conduct
1	nongovernmental recruitment or
4	salts, isomers, or
2	premarket submission requirement
1	(iii) provide a
1	exports the secretary
8	accordance with applicable
1	financial interests and
5	available, on the
1	supervision through the
1	reviewed by qualified
1	representatives of national
1	review that documents
2	persons in accordance
1	acted on under
1	 (l) pesticide
1	(ii) a type
1	accepted the returned
1	submitted on january
1	area to address
2	director may enter
2	warehouseman storing any
1	term amateur athlete
1	violates paragraph (11)
1	will support a
2	label is not
1	(f) violations related
1	product is segregated
2	purpose of, or
1	353a. pharmacy compounding
2	issue such final
2	shall promptly be
42	secretary shall not
1	concerned from each
3	request shall be
1	list any color
2	effort already expended
2	oral prescription of
1	
 1118 to
1	application fees that
1	(c) discovery nothing
1	expire at the
1	(g) recordkeeping requirements
2	return, the applicant
1	pediatric diseases. 
1	agencies with related
1	views in applying
1	agree. (7) 
1	 (b) travel
1	implementation, and assessment
1	harvesting, but before
1	practice of pediatrics
1	(f) allows public
1	section,[1] if any
1	(2) identify means
1	drugs otherwise approved
1	approved on the
1	general may revoke
1	section 360a2 of
1	(7) at any
1	commission to effectively
2	(i) a description
1	meets applicable standards
1	changes ownership in
1	information or action
1	excess of $15,000,000,
1	(c) reviewing and
3	(1). if the
1	increase the percentage
3	1988, and if
1	protocol), the secretary
1	response networkthe secretary,
1	application seeking approval
3	(2) for a
1	health), such information
5	easily accessible manner,
60	provision of this
1	sufficient for ensuring
1	constitute a quorum.
3	 (a) during
2	establishments by the
1	enable the repackager
1	enforce this subsection
1	(ii) takes into
1	thereof (as such
1	model laboratory standardsthe
1	testing programs carried
2	party without the
1	controls adopted under
2	veterinary, patient, and
1	(2), further increase
1	defined).  (c)
1	(b) domestic hig-risk
1	drug abuse seriously
1	debarred persons the
3	adverse events associated
1	device presents an
1	prominent statement describing
4	of, this chapter,
1	treated food during
1	educational agency agrees
1	(i) the country
1	shall capture transaction
1	proposes conditions of
1	targetsthe developmental milestones
3	shall establish procedures
2	grant under section
1	controlled substances dispensed
1	operation of packing,
1	(3) cooperation with
1	approved  (a)
1	adverse, including 
1	hosting, formatting, or
2	articles shall, prior
1	inspection reports described
1	concerned and acting
1	regarding sales). 
1	reducing drug use,
1	subsection (a). (3)
1	(b) public process
2	section in accordance
2	means a submission
1	take the following
1	importer taking into
1	(c) petitions for
1	campaigns. (3) for
1	need related to
1	(15 u.s.c. 714
1	(c), a state
1	declaration containing particulars
1	request forms submitted
1	secretary of improvements
1	(a) coordination and
1	review for which
1	shall make competitive
1	lot appurtenant thereto),
1	risk to pediatric
1	assessment of food
2	submission shall promptly
1	within reasonable limits,
1	201(b).  (c)
1	(f) compensation and
3	reinspection in such
1	authorized by sections[2]
1	product listevery person
1	beef, mutton, pork,
2	if, after the
1	vacancies members shall
1	sources, as available:
1	claim to the
3	appropriate changes to
1	year, excluding the
1	budgets of national
6	subsection (b)(2) for
1	pharmacy, a group
2	renew a conditional
1	regulations containing the
7	applicant for the
1	purpose of ensuring
1	congress that domestic
1	parents, teachers, coaches,
1	(5) in determining,
1	federal government. (10)
1	quotas; revised quotas
2	knowledge, or is
2	modify his findings,
1	change in processing
1	qualifications of practitioners
1	solely produce positron
1	additive regulation, or
1	give rise to
1	docket, notwithstanding subchapter
3	secretary a list
5	drug product or
1	1, 2007, or
1	generic drug industry
3	development fee under
1	expose patients in
1	access and availability
1	policy that has
2	bureau of narcotics
2	establishments covered by
2	public health; 
1	percentage that is
1	review that submission
1	
 
 360ss.
1	subsection (b) 
1	informs the secretary
1	review and, as
1	(i) contaminated agriculture
1	(2) if in
1	biological products, requirements
1	(1)(a); and (ii)
1	activities otherwise specified,
1	(b) that on
1	authorities to give
1	parts affects interstate
1	title. (c) whether,
1	correction of the
1	illicit trade the
1	property right or
1	additional clinical data
1	product manufacturers. (3)
1	relationship to other
1	appropriate, teams of
2	(g) meetings between
3	corporation, or association
1	providers, or to
1	logbook entry is
1	submission; (b) whether
1	violate this section;
1	service, or of
1	district, an order
1	stop or safety
1	(l) exemption from
1	subsection (h)(1) relating
1	dispenser. the dispenser
1	establishment shall, not
1	time; and (iv)
2	schedule specified in
2	use the voucher
1	respect to, administer,
1	term cigarette tobacco
1	(d) engagement of
1	gather the nonclinical
1	secretary, may authorize
1	person shall report
2	advertisement or caused
3	days before any
1	disease product if
1	iv, and v
2	reduce the amount
2	thereupon the secretary
1	(e), and there
2	retail pharmacy to
5	written response to
1	poultry products; violation
1	(
 
 962.
2	make a final
3	include an evaluation
1	quantity; requirements regarding
2	drug; or (b)
1	subparagraph), efficacy supplements,
1	laws governing interagency
1	2 years, and
1	animals of such
1	 (c) condemnation
1	control plan; (ii)
1	food products hereinbefore
1	15, formerly 13th
1	advisory committee referred
1	health, except that
1	domestic no-hig-risk facilitiesthe
1	product manufacturers or
1	examining a pediatric
1	progress measured in
2	 (c) persons
2	issues a new
1	subsection (c), before
1	common carrier that
7	drug manufacturers or
1	persons actions described
2	applicable regulation issued
6	individual who has
1	obtain a permit
1	electronic system that
2	distribution of free
1	20 of each
1	equitable sharing of
2	federal requirements relating
3	regularly scheduled audits
1	 (2) standard
3	drugs for maintenance
2	providing notice to
1	
 
 360fff4.
1	paramount criterion of
1	establishing a standard
2	(b) without obtaining
1	person of animals
1	minorities. such request
1	statement that is
5	statement that it
1	take respecting such
1	website is established,
2	supplier as a
1	presentation of his
1	applicant is no
1	tobacco products; or
2	summary developed pursuant
1	approach to the
3	revoke the tolerance.
1	slime), the following
1	validated methods for
1	defense strategy (a)
1	(b) partial waiverat
1	indirectly or by
1	electronicall-captured logbook information
1	title or pending
2	shall debar a
1	manufactured, packed, or
1	possessions and those
2	(including the need
1	system  (1)
2	withdraw the order
4	classification of devices
12	unreasonable risk of
1	tribal officials in
1	actionsthe actions to
1	highways or the
1	 (f) nonsaleable
1	public dissemination shall,
2	construed as an
1	product. any sale
1	(a) is subject
2	wholesale distributor means
1	issued on such
1	dru-free america 
1	(m)(4) of this
1	secretary, including by
1	disease means any
1	mixture with or
1	establishing the standard.
1	review fee established
1	drug experience, can
1	special rules 
1	(c) harmonizing regulatory
1	(b) the manufacturers
4	costs are not
2	dispensing a controlled
1	to, and found
1	product directly into
1	use of false
2	379j of this
1	enantiomers  (1)
1	verified by the
1	coordination in promulgating
2	(b) the pizzas
1	(a) are capable
4	experts; (d) health
2	diagnostic biologic product
1	smoking cessation approved
1	rationale for that
1	(c) formal changes
1	diseases or conditions.
1	consideration the costs
1	require the maintenance
1	agreements entered into
1	dietary use solely
1	reasons why a
1	outreach.  (b)
1	care professionals practicing
1	 (2) publication
1	exposure that is
1	administration. (h) consumer
3	years, multiplied by
1	harvesting, sorting, packing,
1	seq.); (d) the
1	warrant. the judge
5	modified under this
1	approved.  (b)
1	facility if such
1	$90,000,000 for fiscal
1	applicant whose application
1	advance notice is
1	business, and unique
5	no. 1, 5,
1	whatsoever, shall be
1	(3) agreed initial
2	articles for commerce,
1	dates), without regard
1	conduct the study.
1	supply as an
1	(v) included in
1	knowingly ship a
1	$1,000,000 for the
1	system; (iii) improving
1	professional disciplinary authority.
1	title except for
1	unapproved product); or
1	abuse indicates an
2	attempt or conspiracy.
1	farms and small
1	new information that
16	may require that
1	shall disclose to
1	within such jurisdiction,
1	away from the
3	action, except that
1	drugs was not
2	identifier affixed or
2	auditor or the
1	outstanding facility fee
1	\1/3\ of the
1	reports, in accordance
1	prohibition a state
1	applicable conditions for
2	substances from legitimate
1	(b) the amounts
1	exemption; refusal, withdrawal,
1	n-sale order under
2	 (g) review
1	 (d) confidentiality
1	specific food; (e)
1	products inspected and
6	ensure that there
1	additional requirements for
1	evading a requirement
2	sales to consumers
2	subsection (g); or
1	secretary to manufacturer
1	advertisement, the advisory
2	shall be immediately
1	established tolerance; or
1	objectives of each
1	drug use for
1	subsection shall, to
1	substances who are
1	accordance with one
2	longer appropriate for
1	humans. (mar. 4,
1	16, 1988, no
4	channels; (2) compliance
1	activity pursuant to
1	have, and by
9	145, 1 (part),
1	shall require, with
4	trafficking area. 
1	judgment without trial
1	samples is impracticable
1	except that, in
1	279
 
 171
1	panel by regulation.
1	established regular tobacco
1	airway obstruction or
5	except that, if
1	chapter to an
1	155, 2, 44
1	regulation. any such
1	therewith. otherwise the
2	subsection (c), for
2	practice, and which
1	historic purposes or
1	received without providing
1	inspection has reason
1	505a[1] of the
9	title for the
1	out; and (5)
1	month succeeding the
1	derived from tobacco
1	awarded another grant
2	combination provides appropriate
1	2017. (v) antibiotic
1	qualification and qualified
1	(a) the introduction
6	source of the
4	operated by a
3	 (i) standard
1	notice, or will
3	subsection (j)(5)(f) of
1	memorandum of understanding.
1	administration by 
4	memorandum of understanding,
8	section 1604(d) of
1	importing the drug
1	harvested.  (c)
1	517.)
 
 350j.
1	importation is not
1	body charged with
1	small amounts of
1	timeframe, within reasonable
1	documentation described in
2	limit work to
1	on, the administrator
1	purity falls below,
2	practitioner described in
7	law to prescribe
1	(3) final order
1	approval, clearance, and
1	columbia or in
1	(i) are published
1	audience. (2) in
2	law.  (d)
1	accordingly. if the
1	
 142. milk
1	cause found; preliminary
1	numbers of the
1	occurred:  (aa)
1	hazards, natural toxins,
1	holds food. such
1	dispenser additional time,
1	administrative powersin carrying
1	ful-time equivalent food
1	cabinet that is
1	period, initiate the
2	cause shown or
1	(1) coalition building;
1	(c) is 
1	title ii, or
2	 (1) develop
1	drug application; or
1	42. a registration
6	notice under subparagraph
1	to, or exempt
1	admission. if such
1	eggs destined for
7	person adversely affected
1	injurious or hazardous
1	person charged under
1	civil actions regarding
1	administration, upon submission
1	(1) reviewthe secretary
2	control program agency,
1	unobligated fee revenues
1	act) on certified
1	final rule promulgated
1	1333 of title
1	 (i) included
2	general reports of
2	first animal drug
1	entity receiving funding
1	
 828. order
2	within the center
4	conditions are met:
1	(i) public and
1	coupon, in violation
9	records and reports
1	 (i) includes
1	area, or to
1	provisionif, on the
1	ch. 675, 586e,
1	rate by the
1	investigation, evaluation, and
8	drugs for rare
2	intended or designed
2	 (c) certification
1	foundation and for
1	drug refused admission
1	360f, 360i, and
1	colored margarine is
1	management plan. 
2	manufacturers the kit
1	coordinate communications to
1	form describing in
2	united states before
3	requirements under paragraphs
1	secretary determines not
1	registered pharmacist, or
2	assessment under this
2	foo-an-mouth disease and
1	subject, in accordance
1	drug fails to
1	dates. (ii) nonsaleable
1	accreditation program; (c)
13	requirements of subsection
1	
 159. enforcement;
2	business but not
4	secretary shall inspect
2	(d), and the
1	inspection at ports
2	objectives, and priorities
1	order. the hearing
1	director. (3) required
1	page summary described
1	(especially in cooperation
3	granted such a
195	 (i) the
1	purposes.  (p)
2	(1). the requirement
1	shall include those
1	(iu) 250.0 
1	investigation if 
1	use. in making
1	(b)(4)(a); (4) an
3	number of review
1	inclusion of orders
1	(1) and requirements
1	shall become immediately
1	427i(a) of title
1	off, or destroy
1	(3), the attorney
1	june 22, 2009
1	federal agencies federal
1	(2), such sponsor
1	product to which
1	elements, at the
2	year previous to
1	reinstate such permit
1	(vi) regardless of
12	transferred from the
1	necessary to resolve
1	person is considered
3	execution of such
4	product manufacturer shall
1	(f) for the
1	engaged in human
1	following apply: 
1	protocol, in effect
1	holding of food
1	barrels misbranded barrels
1	damage; and (iii)
1	sales. (3) if
1	cos-effective basis. (12)
3	federal departments and
1	human services. (e)
5	manufacturer means any
1	(c) inspections to
1	trafficker of any
1	regulations.  (2)
1	nonsaleable returned product
2	(aa) the drug
2	impose requirements unduly
1	report on delays
2	necessary, to provide
1	drug abuse rehabilitation;
1	sex in the
1	substances to a
1	arising under the
1	1997 the term
1	(g) drug testing,
1	section, and was
1	made, produced, or
1	prohibition on wholesaling
2	mechanical and physical
1	date: __________. if
4	secretary an abbreviated
1	use in teaching
1	secretary). (3) 
1	(b) grant amounts
1	interagency collaboration the
1	government. (2) to
45	introduction into interstate
3	urgent needs of
1	appropriate, each broker
1	thereof. (20) the
1	national ant-doping organization
1	supply chain sector
2	local government concerned,
22	processed, packed, or
1	transaction occurs during
1	fraudulent material information
1	seeking approval or
1	unless the prescription
1	tropical diseasethe term
1	agencies in demand
21	fee  (a)
1	knew means that
1	2242. foreign offices
1	research foundations, and
1	forth in goals
1	white, and intermediate
4	reorganized on a
2	seeking approval of
1	growth of plant
1	interdiction coordinator to
1	annually develop and
1	means the wholesale
1	proposing to amend
18	later than january
3	petition is submitted
1	thereunder, shall be
1	children, africa-americans, hispanics,
1	provide advice, information,
2	hours primarily dedicated
1	strategy. (b) submission
1	 (c) crediting
1	881. forfeitures (a)
2	analogous products are
2	presenting appropriate credentials
3	relating to classification
1	(
 
 1176.
3	body (or, in
4	early payments payment
1	effective date specified
1	3561. accelerated approval
1	outbreaks and other
1	denying the complaint.
1	funds, gifts, grants,
1	indian programs comparable
1	respect to importers,
1	administrator is not
1	inadequate, in whole
1	changed, except 
1	medical purposes by
1	records inspection if
2	additive shall, with
4	decontamination and disposal
1	human clinical testing
1	secretary) for a
1	controlled substances. members
3	elements of the
1	adjustment factor for
1	threatens the national
1	ch. 74, 9,
1	effective in such
1	persons at the
1	appoint 11 members
1	revocation thereof; (b)
2	(2), no manufacturer,
1	executive board and
1	notification, reporting, recordkeeping,
1	industries, consumer organizations,
1	dtc advertisements so
1	(d)(2).  (g)
1	include that the
1	types of assessments
1	products; (5) because
1	false, except by
1	secretary which addresses
1	5 per centum
1	office who is
1	assistance under section
1	(v) requests funding
2	thereafter, but at
1	samples obtained. 
1	(6) knowingly make
1	 (a) state,
1	property.  (b)
1	capabilities; (iv) the
1	date is in
1	shall entitle him
1	homeland security, secretary
2	person.  (b)
1	provide further extensions
1	times the quantity
2	knowledge as applied
1	601 of title
1	
 
 337.
1	registration shall contain
1	findings the procedures
8	risk of the
1	due consideration of
1	outsourcing facility. (iii)
1	panel of the
1	3, 1999, the
1	(iii) hold a
1	355(j)(7)(a) of this
1	reduce such risk,
1	reduce such risk.
1	ii for which
4	2018, the secretary
1	exemption the attorney
4	practice of the
1	act of 1947.
8	2013 through 2017,
1	transport and dispense
2	2013 through 2017.
1	limited to, specifications
3	section and the
2	pursuant to paragraphs
1	begin accepting and
1	filing to the
1	prescribing such regulations,
1	basis through the
2	individuals for maintenance
1	factors on the
1	u.s.c. 262], for
1	et seq.]. the
1	countries is equivalent
1	477, title iv,
1	veterinarian shall not
1	firm, or corporation.
2	protecting the public
1	committee section 14
1	abate the violation;
1	promulgate a final
1	effect of motion
1	owners or cultivators
2	article is prohibited
1	by, or pursuant
2	subsection preempts state,
7	firm, or corporation,
1	(d) pee-reviewed biomedical
1	(a) is approved
1	(a) notification prior
1	evaluate and identify
1	safety, as well
1	development fee due
2	(to examine the
3	elapsed from the
1	also coordinate communications
4	reports the secretary
1	 (l) the
1	paragraphs (3) or
2	public health shall
1	(1) its actual
2	identified under section
1	america and the
1	(21) tobacco warehouse
2	dismissed without prejudice)
4	food is being
1	regarding retail transactions
1	chapter including the
3	admission pursuant to
1	effectiveness testing means
1	equal to 1.04.
1	(iii) under subparagraph
2	may request and
1	(a) an annual
1	disorders, by children,
4	establishment, amendment, or
1	prevalence. (c) contentsa
1	build upon efforts,
1	bonds, appoint receivers,
2	event; and (2)
1	misbranded and unless
1	food and (b)
1	(i) patients with
1	notification. within six
36	shall include 
1	(g) authorization of
1	treatment program; (5)
3	laws of any
5	year 2015 and
1	(d).  (iv)
1	abuse through (1)
1	involved and which
8	title 18, any
1	contributions) from no-federal
9	united states upon
1	strategy. (3) abbreviated
1	approved subsection (b)
1	mortality in accordance
2	30, 1980, and
6	verify such records.
1	permanently prohibiting an
1	intentionally tortious conduct;
1	content  (1)
2	cost (not including
1	quarterly report on
1	subchapter a of
1	requirementsupon application of
1	applications (a) in
1	 (a) move
1	lon-term clinical benefit;
2	failure to comply,
1	identify new or
1	exceeds one hundred
3	20 to 23
1	isomers. (d) ergonovine
2	section 642 of
1	board and officers
5	time that such
18	state in which
1	subparagraph (b)(i), a
1	requirements of current
1	 (a) imprisoned
5	suspended for grounds
1	(iii) identifies specifically
1	sources.  (2)
1	july 22, 2016
2	100 feet of
1	drug activities (as
1	regulations limiting the
2	request and identify
1	label bears (1)
1	retail out of
1	(i) which occurs
2	(a)(2) shall be
1	statutes, regulations, or
1	section 379h(a)(2) of
1	video machines for
1	exemption are not
4	(a)(ii), and fees
1	clove, cinnamon, pineapple,
16	food for which
1	capability of different
1	term consultative audit
2	implant.  (2)
3	(b) which contains
4	restaurant or similar
3	territories of the
1	new york) and
2	certification as referred
1	record shall provide
2	rule, or regulation
3	performance report beginning
3	provides information leading
3	conducted at least
1	present such an
1	make such declaration
1	fees when due,
1	library of medicine
1	relationship requirement the
1	service activities (a)
3	(i) collecting, developing,
2	subpena to him.
1	veterans benefit means
3	drug bears a
1	requirements (a) personal
10	food products of
1	section, (1) for
1	distribution, or in
2	(2) without authorization
1	organization; (ii) takes
1	numbers  (1)
1	ultimate consumer, at
1	implementation not later
1	treatment resources for
1	sets, as agreed
3	lawful course of
5	(a), (b), (c),
1	therefore, essential that
1	food products or
1	section) have not
1	date. (d) section
1	form ready for
2	require that data
1	holder) has validated
1	national biosurveillance integration
1	made a pattern
1	required to demonstrate
1	becomes accredited not
1	maximum fine and
1	qualified en-userin this
1	food consists in
2	order require a
3	timelines, in calendar
1	results of applicable
1	held under this
1	existence of jurisdiction
3	department of veterans
1	(1) no grant
1	remain after the
1	unless the pharmacy
1	majority vote) by
1	product involved, or
1	aspiring coalition serving
1	sentenced to death.
1	states. (4) 
1	upon such supplement.
1	(7) the united
1	intact and contents
1	associated with genetically
1	encourage the participation
1	(2) a payment
1	report such actions,
1	listed chemical, includes
3	title, and (2)
1	includes statements conveying
1	secretary the information
1	medical need associated
2	request, and payment
1	violation of laws
8	convention on narcotic
2	information accurately reflects
1	application fee, and
4	generalin order to
1	tobacco product required
1	web site with
1	title; or other
1	terrorism, especially but
1	 (a) offset
1	paragraph continue to
1	convicted  (i)
4	processed, labeled, or
1	mail, telephone, wire,
1	drugs presenting demonstrable
1	196. repealed. july
1	total combined number
1	chemical structure is
1	handling poultry or
1	growth hormone means
1	countermeasures;  (4)
5	modified by the
1	shall allow the
2	implant is incidental
4	generalsubject to paragraph
2	pediatric study reports;
1	proposed regulation refer
1	(1) facilitating partnerships
1	event.in this subparagraph,
4	inspections of device
1	behavioral and biomedical
4	provisions of sections
2	substance was obtained
1	obtained from the
1	review of expert
8	disposed of by
1	(1) eligible productthe
1	(f) drug manufacturers
7	compensation at rates
1	prospective purchaser 
2	importing, dead, dying,
3	title 42. such
1	generate the fee
1	regulation take effect
3	commodity; (ii) a
1	means a valid
1	(3) tropical diseasethe
3	authority to take
1	practice veterinary medicine
1	movement, and the
1	safe production, harvesting,
1	otherwise authorized, or
1	thereof; (b) there
1	food.  (4)
1	recall shall occur;
4	required to include
1	1, 2011, the
1	device meets all
1	(c) which was
1	
 467. inspection
1	device or under
3	(4) payment 
48	ensure that the
3	review.  (e)
1	covering, or wrapper
1	consistent and appropriate
2	2018, and for
1	transgenic animal. 
1	inspection.  (c)
2	chapter or act,
1	effectiveness of limited
2	components, and additives.
1	business. (3) any
1	body a controlled
1	drugs, for the
1	state; (c) upon
1	technology; and (4)
1	provide prompt advice
1	chapter or act;
1	(c) animal inspection
1	2008, for that
1	reviewed by an
1	iii, 537, formerly
1	(c) dutiesthe commission
2	subparagraph (b), each
1	350f. reportable food
1	sections 331(i), 343(f),
2	trade commission under
1	applicable.  (f)
1	paragraph. a decision
1	subparagraph (a), be
1	measurement and detection
3	(b) or (c),
1	solicitation, and disposition
1	sections 2202 and
1	
 360ll. notification
1	(i) the validity
1	subsection (a) unless
1	subparagraph (a), by
1	secretary and using
1	law enforcement participating
1	waivers approved under
1	provision of data
1	programs include programs
3	agent of an
2	providing for research
1	shall include, for
1	(i) promulgate a
1	cost of both
1	application therefor is
1	treatment.  (2)
2	sentence) shall preclude,
1	designation, and signature
1	vulnerable points, as
1	675, 714, as
1	terms the detriment
1	formulation or delivery
1	25, as it
1	(a) such categorization
2	labeling thereof so
1	(d) other such
1	(d)2 obligation to
1	committee established in
1	submitted but before
1	following december 29,
1	whether such regulation
1	inspection and prior
1	supply of raw
3	audit and examination
1	product manufacturer, packer,
2	otherwise negotiating purchases
1	dispensing systems for
1	medical devices and
3	business name and
1	secure directly from
2	scientific uses within
1	laws; (c) when
1	foreign sellers any
2	certification, the application
1	operation or a
1	comment upon implementation
1	dtc advertisement involved
1	enter orders as
1	specific abbreviated applications,
1	transfer technology and
1	states environmental protection
2	laws nothing in
1	commerce to be
2	accreditation  (1)
1	aggregation, and inference,
1	act, 1921 (7
1	v; exceptionsit shall
1	(1) (referred to
4	times any term
1	business that manufactures,
2	drugs or components
1	order.  (4)
3	priority in awarding
1	date thereafter, all
1	(2), or (6),
2	generalthe secretary, in
1	paragraph (2), based
2	employee is detailed
1	federal register (or,
1	(b) similar course
1	service upon such
1	products or components
4	development process and
1	shortage of the
3	marketed by a
1	states: refused entry.
1	senate and of
1	forms the secretary
1	risks, a consistent
53	secretary shall provide
1	adequate safeguards, and
2	grand jury of
11	died otherwise than
1	trust for the
1	single report, by
3	united states food
1	(iv) shall maintain
1	unless the following
1	coalitions has independently
2	trial or trials
1	forms of information
2	led to the
4	applicable transaction history
1	substances for nonscientific
2	similar retail food
1	(b) prehearing order
1	parts, and products,
1	acid. (14) pethidine.
1	license of any
2	exempt from tax
1	one paid advisory
1	petition the administrator
1	period. (11) the
1	(or successor regulations).
1	inclusion in index
1	(or successor regulations),
1	information of prior
1	assist the environmental
1	guidance documents. 
1	require the creation
1	 (a) class
2	programs and operations
1	resolution within 5
1	prescribing physician, or
1	may implead a
1	letter and the
1	section 6(b) of
1	party to be
1	conclusions of law.
1	otherwise facilitate enforcement
2	title. in determining
1	never assumes an
5	2 or more
1	subparagraph (b)(i); or
1	(b) eligible entityin
1	may disqualify any
1	(d) new dietary
1	similarly, all substances
2	period of detention
1	 (f) dispute
1	order declaring the
5	attorney general 
1	360e(a) of this
1	extremely small portion
1	international agencies or
1	findingsthe congress makes
1	withdrawing such an
1	(
 
 2109.
1	leaf who grows
1	regulation to support
1	individuals and develop
1	2017 (including any
1	security to transfer
13	shall review the
2	food. they are
1	intended purpose; or
1	animal, mineral, or
1	persons; murder; punishments
1	prohibited unless the
3	secretary finds has
1	information or changed
1	small cigars and
1	$270,000,000 for fiscal
1	employees federal government
2	drug act of
1	(a) occurs within
1	seeking to start
1	number in labelingnot
1	patterns with respect
1	manufacture means the
1	exported without regard
1	general documentary proof
1	(b) source country
1	national consensus standards
1	individual practitioner licensed
1	maximum amount and
1	application unless he
1	 (2) increased
1	1, 2000. (g)
1	exported. any exporter
1	dismiss as a
1	ensure continued compliance
1	(c) the pesticide
1	title 18 applies
1	type required under
1	foreign governments prior
1	opinionsas of june
1	(b) provides information
1	(b)(1).  (

1	importers participating under
1	website that contains
1	similar technology. (iii)
6	course of business,
1	(ii) and the
3	consultation the secretary
1	whether product tracing
1	suspended pesticide chemical
2	services, determines to
1	42.  (j)
1	program benefits under
2	sufficient for the
2	youth, which, at
1	thereof on hand;
1	gathering the necessary
1	drug manufacturer, including
1	less risk than
1	course of business;
1	anaphylaxis management guidelines,
1	health, the manufacturer
1	practices, and procedures,
1	recognition agreements relating
1	regarded under subsection
1	contains not over
1	prior approval by
1	pharmacies in each
1	breakthrough devices (a)
74	accordance with section
1	meet, with the
1	cannabis, and opium
1	mechanisms, consult with
1	format, or a
1	include any monitoring
1	classify under section
1	act; (b) a
1	leverage existing quality
1	 (k) report
1	
 960. prohibited
1	(2) there are
1	clause (a): 
2	(including appropriate consideration
1	alone, without a
3	collateral measures necessary
1	production threats; (19)
1	section), recognize all
2	product manufacturers. 
1	may be derived
1	significant disciplinary actions,
1	prescribe the drugs
3	products thereof which
1	published notice as
1	fees; conformity to
1	enforcement any advertising
3	(b) it is
2	387e(h) of this
1	commissions duties under
1	available prior to
1	(2) govern the
1	99. repealed. july
6	review under subsection
2	applicable regulation under
1	shall expire on
1	relationship. this section
1	(ii), paragraph (1)(a),
1	security, and state
1	medical gas. 
1	needed to establish
1	refund of fees
2	jurisdiction of federally
11	product shall be
4	treatment of an
1	code, labeler code,
1	establishment where such
1	 (4) except
1	device. (xii) validation
1	 (3) scope
1	inspected during the
1	testing requirements of
1	satisfaction that any
1	62 stat. 344;
1	programs operated by
2	live cattle and
1	deputy director). 
1	including package liners)
5	forth the basis
1	significant threat to
1	providing services to
1	measurement and review
1	maximum term of
12	paragraph (3), the
1	sample of assessments
2	(g) and (h).
3	penalty of 
2	report was received)
1	(2), debar 
1	highly refined oil.
2	medical information and
1	particular pesticidal use
1	(3) reporting the
1	articles for human
1	program shall make
1	(e) performing such
1	interest was vested
1	(a) develop a
1	rule, issue a
1	conditions as provided
1	make the employee
1	solicit public comment
1	urging physicians to
2	validation data, the
46	later than 30
1	enforcement activity, that
2	articles to consumers
1	planthe strategic plan
1	annual national interdiction
4	chapter applicable to
2	solely to pay
1	radiation; (3) maintain
1	(b) gao report
1	including fines, to
1	data before it,
2	states pharmacopoeia chapter
1	consignee executes a
1	11, 1946), signed
1	food if 
1	committees shall be
2	within one additional
1	children including, but
1	imports (a) compliance
5	prior convictions of
1	(v) benzaldehyde. (w)
2	improve seafood safety.
1	postapproval requirement 
1	prescribes interim or
1	slaughter in accordance
40	(1), the secretary
1	consideration; (b) operates
1	(4) beginning 6
1	information clearinghouse established
1	operated or not,
1	imprisonment as enhanced
1	increased sentence as
1	outstanding securities of
1	violations involving 
4	44 stat. 1103.)

1	survive, notwithstanding any
3	needs of such
1	species that have
4	 (i) necessary
1	pays a fee
1	prior comments the
1	paragraph (2)(b)(i)(i) shall
1	reduce duplication and
1	surcharge that provides
1	appointment; vacancies members
1	obligations to keep
7	(a) for fiscal
1	(1) intends to
1	28, when such
1	(3). (b) exceptionif,
14	described under paragraph
1	following circumstances 
2	circumstances  (1)
1	production of lif-saving
2	annually, review the
1	magnesium (mg) 6.0
1	publicly available, through
1	owned by him
1	prescribe the dose
1	identifies programs and
1	pharmacopoeia unless it
7	1, 2015, a
1	repeal a regulation
1	 (2) regulatory
1	required reports 
5	drinking water regulation
2	clause (ii) show
1	preceding sentences. the
1	equivalence (as defined
1	ch. 675, 744k,
1	(2) review review
11	drugs in schedule
1	conforms to all
2	affidavits submitted in
1	additional thirty days
3	(b) content of
1	trial and tried.
2	approval described in
1	nutrition labeling of
1	however, shall such
1	(1) that sponsors
9	(a) for the
1	hardware and software
1	 (b) contentthe
1	remuneration shall be
1	ch. 155, 4,
1	506g, as added
3	holding, or importation
1	information, in a
1	developing and effectively
3	dealers or distributors
1	(3)(e) unless that
1	agreement as may
1	(3) the methods
1	purchasing a listed
1	sales restrictions; bonds;
1	product entering the
2	treatment program for
2	cause or has
2	facilities and under
2	shall be further
1	drug activity or
1	services, and other
1	inconsistent with provisions
1	discuss the review
1	expedited procedures (as
1	classes; (2) shall,
2	review fee 
1	entity shall return
1	may hold hearings,
8	make a determination
1	assessing, decontaminating, and
3	licensed before september
4	title.  (6)
6	appropriations act. (3)
1	section, subject to
1	personnel permanently stationed
1	secretary may adopt
1	value that bears
1	agencies. (xiii) such
1	section 321(q)(1) of
1	interests, state governmentsparticularly
1	exceeds the aggregate
1	(iii) exceptionthe annual
1	tobacco, the individual
4	reports, the director
1	funds, facilities, and
1	research on therapeutics
2	device so that
1	(5) responds to
1	agreements to accomplish
1	importation of adulterated
1	approved or in
2	clinical hold be
1	prepared and kept
1	(a). (d) section
3	facilities registered pursuant
1	milk of cows.
1	enhancement, which may
1	animals (a) slaughtering
1	transfer requests 
1	modify the provisions
1	chemical products, which
1	(p) report 
2	study described under
2	otherwise in violation
2	sale (whether or
2	duration; pending judicial
2	person residing in
1	compounding of sterile
1	1521. findingscongress finds
2	drugs intended solely
1	outcome assessment; and
1	guidance on reported
1	youth and such
1	feed which differ
1	fees, and reasonable
1	required the report
1	permanent scheduling of
1	systems and such
1	necessary to create
1	identical with any
2	 (4) no
1	(ii) take reasonable
1	title 42. (ee)
1	notwithstanding paragraph (1)
2	chemicals (or proceeds
3	foreign government under
1	registries, or other
2	authorities of section
1	 (iv) due
5	conferred by this
1	use, with or
2	proposed order in
1	controls. (b) if
1	743, 49 stat.
1	675, 509, as
1	monographs if the
4	whether intended for
1	units of measure.
3	attempted distribution of
1	certainly impose a
2	distribution, and dispensing;
1	complete or partial
1	serious threat to
1	secretary, or (at
1	association; (b) the
1	exceed 90 days
1	designation of orphan
1	device exemption, may
1	trade secrets) shall
1	controlled substance analogues
4	claimant caused by
1	additive, including full
1	deferral under subparagraph
2	paragraph (1) withdrawing
1	thereof, that such
2	shall, during the
1	(g) administrative restraint;
1	secretary function in
1	agent, shall have
1	manufacturers and clinical
3	studies or residue
2	groups, except that
2	law requiring disclosure
1	(vii), (ix), and
2	statement summarizing such
1	concern if the
1	 (a) collecting
1	convention. if, as
2	foreign facility, the
1	misbranded, the secretary
16	less than 6
4	less than 5
4	less than 3
4	less than 2
4	less than 1
1	efficiencies; or (d)
1	reported if, not
2	senate, and the
2	(2)(c).  (2)
1	form only if
1	occurs, file (or
1	exist.  (b)
1	eligible entitiesan eligible
2	law, by the
3	collected for any
2	notice shall give
1	previous ten years
2	applicable for administration
4	electronic database developed
4	section 350d(b) of
1	biological systems. 
1	submission; filing (a)
1	compile and maintain
1	(3) persons slaughtering,
1	plastic, or ceramic
5	approved during the
3	applicant failed to
1	application as compared
7	state of the
3	schedule, for each
1	prescription drugs from
1	promulgate regulations governing
1	exhaust administrative remedies.
2	(i) has submitted
1	(1) action by
3	make a report
1	drug use; (c)
2	circumstances, the secretary
1	medical evaluation, and
1	(1)(c), the court
1	qualification.  (b)
1	suspect drugs, full
2	data concerning adverse
1	poultry, or part
1	provide public notice,
2	permanent basis, implement
2	experts selected by
1	period is necessary
1	eligibility request following
1	health, such auditor
1	capacity for a
2	vegetable origin, or
1	order confirm or
1	sanctions a significant
1	standards. (d) improve
1	said first inspection,
1	age is (except
1	(
 
 1548.
1	2281 et seq.)
1	species into the
1	food allergen control
1	device establishments to
1	675, 575, as
1	substances and to
3	mark means the
2	classified within the
1	scientific investigator, pharmacy,
1	 (a) significantly
1	state law, including
1	pay rates under
1	master file referenced
1	care professionals and
1	delivery system, delivery
1	otherwise, the secretary
2	(a)(1) shall include
3	commerce, and to
2	requirements for establishments
2	disposal, inventory, and
3	manner which the
1	states food supply
1	paper book. such
2	paragraph to an
1	via a food
1	 (b) secretarys
1	reported or known
1	means any illicit
1	species of livestock
2	section; and any
1	contract, the total
1	requested such referral
1	(c) of title
2	quantitative terms, the
1	completing the work
1	(i) terminating the
1	2012; and (bb)
1	agency center is
1	disposal of the
1	additional facts supporting
1	facility with parking
1	agency center in
1	unable to provide
3	packed, on condition
1	late or delayed.
1	federal advertising or
1	relate to veterinary
1	prevent entry of
1	1943, to cooperate
2	clinical hold, including
1	general determine appropriate,
1	standard of identity,
2	adverse event is
1	core or chronic
1	limited population 
1	registrationthe secretary shall
1	owner or operator;
1	protection agency (referred
1	title).  (iii)
1	referral and which
1	(1), shall take
2	animals after slaughter
1	general in developing
1	datethe establishment fee
2	obtain review of
1	leukocytes or of
1	appropriate security clearance
1	standards committee (hereafter
1	subsection (a)(1); (c)
1	condition; and (ii)
10	standardized numerical identifier,
7	serve as the
1	(ii) in any
1	379l. education (a)
1	products provisions, applicable
1	(1) effective date
1	(b) nonvoting members
1	advertising accompanying such
2	regulations and orders
1	particular  (i)
1	food products; designation
1	relates to devices
1	imports a finished
1	supplying a vitamin,
1	including appropriate clinical
1	which, on or
2	interpretive criteria, if
1	violation shall with
1	substances intended for
1	products and operations
1	specific accounting of
1	(2)(b) on the
1	purposes of meeting
1	receipt unless an
1	eggs, and uniformity
1	(
 
 673.
3	amount under such
1	pose questions to
1	summarizes test results
1	impact on quitting
27	title shall be
1	strategythe president may
1	product. (2) product
1	(except such vessels
1	formerly 901, 52
1	contain the reasons
5	1984, the secretary
1	collaborative groups that
1	collaborate with relevant
1	agency which participated
1	substantial clinical data
1	allows public access
2	(iv), (v), and
1	secretary for special
1	meeting participants and
1	2012, a reference
1	opinion and with
1	mechanical process; (ii)
1	diseases and rare
1	(2) coordination of
1	terms cigarette, cigarette
2	increase the aggregate
2	(iii);  (c)
3	establishment that the
1	take immediate steps
1	new tobacco products
1	president an office
2	drug submission means
2	applicant.  (4)
1	consult and maintain
2	percent of eligible
1	violation; intent to
2	notwithstanding subsection (b)
1	 (3) considerations
1	 (ii) meeting
1	summary reviews that
1	president shall take
1	limitation the requirements
1	gifts, and donations
9	paragraph (2) and
1	court shall impose
2	ensure the prompt
1	secretary shall, during
1	 (3) discovery
1	establishment of time
1	agreement shall be
1	additives; and (b)
1	public any documentation
1	applicable to prescription
1	paragraph (3). (2)
1	subsection (g), or
1	dissolvable tobacco product.
1	third party; (c)
1	drug endangered children,
1	drugs containing a
1	appropriate, with another
1	 (i) prohibit
1	schedule v substances
2	system pursuant to
1	followed in practice.
4	prescribed under section
1	investigation, the secretary
1	subsection (g), of
1	(
 
 878.
1	retract or modify
1	produced by each
1	 (iii) application
1	think necessary to
3	(b) by the
1	requires a recognition
2	converting such local
2	report described under
1	last quarter; and[4]
1	investigation and adequate
1	animals slaughtered or
1	addiction medicine. 
1	appendix to the
1	evaluate relevant health
1	will give the
1	actions brought under
2	verification, and residue
3	advanced therapy under
1	ninety days unless
2	reports of tests
1	chapter, and recommendations
7	deliver for introduction
11	secretary in a
1	laws.  (3)
1	(3) to the
1	processors, as well
1	telemedicine treatment, unless
2	establishment unless the
1	devicea drug or
1	states, the united
1	scientific, medical, and
1	conviction of their
1	proprietary or established
1	abusers and other
1	size or form;
3	change or modification
32	detectable amount of
1	availability of expanded
5	microorganisms, as applicable,
1	entities and individuals.
1	unduly burdensome, the
2	activities associated with
1	index entry; (f)
1	strategy established under
1	owed by the
1	level refers to
1	cannabinoid receptor type
3	tribal, or local
1	regulations issued thereunder).
1	application) describing an
1	extension if, at
2	expended by the
1	agencies, and between
1	u.s.c. 351 et
1	required for approval;
1	modifications that would
1	(4) increased federal
3	sponsor or holder
1	cosmetic intended for
4	strategies to address
1	$1,984,000 for fiscal
2	individual or $1,000,000
2	qualifying other practitioner
1	required for approval.
1	disorder within an
1	patients, either separately
2	(2) identification of
1	ten years of
1	pilot projects conducted
1	(a) access to
1	accordance with estimates
1	c, in the
1	access by congress,
3	 (b) effect
1	(other than tobacco)
2	planning for, and
1	regarding direc-t-consumer advertising.
1	request the appropriate
7	food.  (b)
1	(
 
 812.
21	fiscal year, the
2	part of this
1	person is debarred,
1	distribution due to
1	2014. authorization of
1	specified as result
1	use of data
1	transaction. (c) systems
1	(g), of an
1	2007, by the
1	clause (ii). (c)
1	(c) service agreements
1	(c) limitation under
1	rehabilitation as alternatives
2	submitted under subsections
1	importers, 1 or
1	
 360l. postmarket
1	(7) product information
2	drug is intended;
1	exemption is effective
2	development of medications
4	vitro susceptibility of
1	involves an individual
26	packed, or held
1	conducting such investigations.
1	consensus regarding the
1	(i) is substantially
1	governor of nondevelopment
1	guidance practices document,
1	affording the complainant
1	(a) before december
1	practice of telemedicine;
1	 (b) seizure
7	brought into compliance
1	instructions for use,
1	registration, or proof
1	respecting tobacco products
2	department of any
1	merits or validity
1	(2) any item
1	office of counternarcotics
6	committees so engaged.
1	bulk or batch
1	prevent, or diagnose;
1	subject to abbreviated
1	name entered in
1	fewer than the
1	volume and complexity
8	file a petition
1	authorized use 
3	supplement that was
1	technical capabilities of
1	chapter; (2) sell,
1	will expire prior
1	registry as the
1	qualify drug development
2	office of womens
1	budget recommendations made
3	accept the determination
1	provided, for any
2	 (6) tracking
3	minimize the risk
1	seq.]; or the
1	reportable food means
1	available data from
1	title 28, unless
1	officials and relevant
1	reenacted with the
2	producing animals, human
1	law. (e) 
12	tobacco product, or
1	persons to be
4	prescribe and shall
2	 (1) identifies
1	support for or
1	person employed, hired,
1	lif-enhancing medical devices;
1	imported, exported, transported,
1	may respond to
2	establishments (a) definitions
1	species papaver somniferum
1	(i) appropriate sampling,
1	information systems to
2	product scientific advisory
1	substance in such
2	successor regulations), is
2	lif-enhancing medical devices,
1	wholesome, otherwise not
63	drug or device
1	shall appear before
1	two cannot consistently
1	final action pursuant
1	subchapter) shall 
1	effective in pediatric
1	begun, the number
1	sentence inquire of
1	subparagraph (a) shall,
1	clinical trials which,
1	felonies: intent to
3	executive order, or
1	(iii) other ingredient
1	stat. 833; 

1	listed chemical (including
1	investigation in a
1	1 establishment for
1	governments towards the
1	(a) advertising the
1	drug is only
1	means the organization
1	secretary that describes
2	year.  (5)
1	substance to pregnant
1	inspection of reindeer.
1	health. (4) 
1	matter in the
1	act (including amendments
2	may influence compliance
1	(c) timing the
1	need.  (20)
1	states, and all
1	qualifications and expertise
1	modifying such sections
1	control strategy goal
4	states.  (2)
1	acceptance of one
1	practice requirements or
1	committee individuals who
1	initiative refer a
2	administration personnel in
11	form, or strength
1	training or education
2	including, but not
5	contains any poisonous
1	introduction, or to
1	evidence. (4) order
1	 (iii) conditions
6	federal register requesting
1	(viii) such information
3	distribution or attempted
1	use, and anticipated
1	packaged eggs and
1	need that exists
1	corrections  (1)
1	imposed on the
1	379j12. authority to
2	necessary, including requirements
1	 (e) controlled
1	chapter. each such
1	(c), instances of
1	director under section
2	furnished by the
14	fees are collected
1	unavoidably persist in
1	oxygen can be
1	citizens and organizations,
5	contents in terms
4	promptly conduct an
1	(4) compensation members
1	processing plant of
1	initial public dissemination.
1	(2) an information
1	(a) (subject to
1	shall receive travel
4	half of the
1	implementing a focused
2	chapter).  (b)
1	paragraph the effective
2	both. any sentence
1	prescription shall be,
1	containers to be
1	eradication (a) findings
1	proper oath or
1	times be open
1	able and willing
1	assistance from federal
2	eggs capable of
1	(l) positron emission
1	contumacy by or
1	informationthe application or
1	data bearing on
1	plant which is
1	section involving a
1	medical evaluation. 
1	prevention, investigation, prosecution
3	necessary to make
1	standards in place
2	association within the
1	permit each such
28	sums as may
1	level; and (d)
2	appropriate.  (june
1	possess; or (3)
1	product, taking into
1	inconsistency, sections 827(e)
1	compensation members of
2	exemptions for investigational
2	general the manufacturer,
3	least 1 of
1	biennial surveys (or
1	(3)(c), the drug
1	343(e)(1) of this
1	seizure, and shall
1	advertisements the person
1	facilities.  (b)
1	involved.  (3)
1	(d) law enforcement
2	(b), and (ii)
1	iii.  (5)
1	may also be
1	 (iii) taking
5	et seq.] with
10	approved in any
1	agencies submit to
1	arguments.  (c)
2	title is required
1	entered into an
1	application fee established
1	device, (8) an
1	supply sold by
1	staff from the
2	reports with respect
1	substance; or (2)(a)
2	practitioner, between the
1	if, or would
1	share confidential information.
1	manufacturing and repackaging
1	assessed and imposed
2	v, unless he
1	family educational rights
2	chemical synthesis, or
2	(1). (c) the
1	products, and egg
1	imposed. (mar. 3,
1	residue, such a
10	means an application
1	requirements of subchapter
1	(vi) an assessment
1	purpose of correcting
1	hold.  (4)
1	pharmacys drug enforcement
1	(2) denial of
1	operate under the
1	1996, after obtaining
1	chemistry that is
2	services shall issue
1	report that includes
1	reduced shall be
1	(specifically administrative, recordkeeping,
1	justifiable based on
1	$1,000 or imprisoned
2	(a) and (f)
1	final determination of
1	services, or has
1	manufacturing in or
3	least 3 years
1	initiation of negotiations
4	field or compliance
1	823(a) of this
1	radiation, or that
6	food, the administrator
1	conditions; (e) evaluated
1	faith, etc. no
1	inpatient hospitalization or
1	(j) shall list
1	leaving the premises
1	manufacture or to
1	least restrictive use
1	(b) a state
1	paragraph (1)(c)(i), and
1	(3) annual establishment
1	advertising and labeling;
1	certain food. 
2	(aa), (bb), and
1	foreign establishments; examination
1	practice or, except
1	pediatric studies. (iv)
1	death; (2) of
3	secretary by an
1	unit. (k) the
2	enforcement administration. 
1	chapter; and (3)
1	activities persons registered
1	term video arcade
1	writing that a
1	(b) communication the
1	(2) any articles
3	local laws regulating
2	possessions, as determined
1	reporting; verification of
1	using by any
1	harm, or loss
3	singl-use device means
1	obligations under an
1	fund coalition mentoring
2	(ii)  section
1	poison, chemical, or
7	fee established in
1	new productsif, during
1	affect the applicability
2	committee.  (2)
2	disruption of the
2	writing with regard
2	humans, be denatured
1	transfer program. 
3	381(e)(1) of this
2	(whether an unapproved
1	unaffected the secretary
1	states, the various
1	set aside. in
1	 (7) opioid
4	notice of his
1	new hig-risk foods
1	(iii).  (ii)
2	seller or distributor
3	form of any
1	 (1) be
1	basis among public
2	(including any supplement
1	shows the individual
1	sufficient description of
1	precursor substance does
2	 (3) total
6	construction this section
2	shall be whether
1	knowingly sell or
1	status pending application
1	technological characteristics as
2	6 nominees from
1	number, and professional
1	made through such
1	producer of agricultural
1	account for fiscal
1	upon publication of
1	files that allow
2	proposes to take
1	inspection, and enforcement
1	upon request the
1	food, if importation
1	 (d) quotas
1	title; (vi) the
6	imposing a term
1	document regarding product
1	(6) release and
1	declaration shall be
1	provisions through final
1	(b) it has
1	major changesfor purposes
1	(1) to provide
1	programs under such
2	security activities of
1	manufacturer could have
1	(6). (5) an
3	claims the drug
7	achieving the goals
1	packer packing eggs
2	jointly by the
1	 (1) united
1	establishments, and prescription
1	 (1) enhance
1	perception shows that,
1	upon shall not
1	participation in or
1	signs and symptoms
1	original source of
2	person authorized to
3	access to information
1	 (d) partnerships
4	database developed or
1	chemically altered. (2)
1	both, in accordance
1	justify the certification
1	chapter, or otherwise
1	establishment that dispositions
1	review statistically valid
2	selling poultry products
2	amenable species, or
1	systems supported by
1	(2) is imported
2	factors  (i)
2	proceeding before a
2	regarding  (i)
1	mutual consent, establish
1	1 type of
1	preserving the safety
2	waiver  (1)
2	secretary from using
2	manufacturer has submitted
1	regulations. (x) a
2	consumption in the
1	orders as provided
1	prominent manner and
1	ammonia and sulphate
1	to, and to
1	program shall not
1	subsection (e) may
8	appropriations for the
7	research conducted in
1	21, 1997, or
1	committees of jurisdiction,
2	therefor  (1)
1	of; or (c)
2	entities to 
1	representative who may
1	orders the district
1	year to reduce
3	action of a
1	guidelines issued thereunder.
1	(i) records and
6	safety and efficacy
1	exceptionsit shall be
1	title 18. (b)definition.
1	communications channels, the
1	(c) crediting and
2	 (c) coordination
1	1918 and 1920
2	academy of sciences,
1	proposed therefor and
1	agency (a) definitionsin
1	notification at or
1	council shall be
1	countries (for imports)
8	director of central
1	evaluate new therapies
1	review only to
1	approved; (2) includes
1	administration of property
2	occur and shall
1	section 247d5 of
2	number of regulatory
3	subsection referred to
1	transported under conditions
2	29, 1928, ch.
3	upon payment of
1	secretary grants such
1	specified at the
1	community based, insure
2	standard or adequate
1	drug, controls available
1	months beginning on
1	pediatric devices approved
2	clearance to a
1	federal agencies, and
1	paid for information
2	certified under clause
3	producer of tobacco
1	133. repealed. july
1	(2) limited distribution
1	(a) the process
1	comparative to the
2	29, 2006, and
1	made to encourage
1	inspection programs to
1	917, as added
5	(washingto-baltimore, dcmdvawv; not
1	section 230(c) of
1	makes the notification
1	part after consulting
1	trials are evaluated.
2	finds that subparagraphs
1	possesses any listed
1	rare diseases (a)
1	section 10101 of
1	food has a
1	continues consumer protections
1	derived which have
1	requirements, including on
1	mixture, or preparation,
2	contents of such
1	736, as added
1	shall contain (i)
1	costs in anticipation
3	agent in charge,
3	within 10 years
1	agent in charge.
1	received the petition
1	set standards and
1	(2), issue an
1	measures regarding theft
1	authorities provided under
1	number of countermeasure
1	definitions, licenses, instructions,
1	component parts that
4	product approved under
1	(b), as adjusted
1	(f) good manufacturing
1	secretary of further
1	measurable and substantial
1	term entity does
1	timeliness of such
2	paragraph.  (d)
1	
 857. repealed.
1	dru-related convictions (a)
4	food products are
1	(a)(2) or (6)[1]
1	household consumers for
1	drug to comply
1	(c) the slaughtering
1	infant formula presents
2	eggs in accordance
1	records. (2) within
4	years; and 
1	(a) exemptions; authorities
1	electronic products, particularly
1	documentation that the
1	subsection (n)(2)(b) is
1	food if such
1	advertisements that are
2	products.  (mar.
1	(all items; u.s.
1	programs for distributors
1	court determines such
1	prescribing a definition
4	section 841(b)(6) of
4	title 42, as
2	(j) collection of
1	published and shall
1	rapid and effective
5	ending on september
1	retail class of
1	person, or clearly
1	ingredient requirements in
1	use would promote
1	annually (1) select
3	holder designated to
1	making such requests;
2	regulate the processing
1	him, the provisions
1	contentthe secretary shall
1	assess the impact
1	make it available
1	drugs, including facility
1	mandatory recall order.
1	paragraph (2), where
4	labeling and advertising
1	supersedes any state
1	renumbered 23 and
1	527, as added
1	activities there is
1	 c (ascorbic
1	writing, and may
1	year; (c) the
1	fee the reactivation
1	privileged at any
1	(f) indian provision
1	v that the
1	(10) any drug
1	1981; and for
1	product under such
1	minimum requirements; redesignation;
2	standards and methodologies
1	determinations to impose
1	collect, by correspondence
1	obtaining a controlled
1	42 and as
1	generalon or before
2	capable of conversion
2	validation data described
1	comparable commercially available
4	transportation of such
1	person introduces into
1	manufactured infant formula
4	drug would be
3	law for conduct
1	submissions.  (2)
8	transaction history, transaction
1	(1) make and
7	(a) for which
1	(4), or (9).
1	thereof. (7) the
1	conditions established by
1	proceeds if the
1	information, including clinical
1	abuse treatment programs,
1	title, a device,
1	congress finds the
2	human food, any
1	675, 906, as
2	number identified by
8	order, the secretary
1	properties and of
1	preceding calendar year;
1	issues of particular
1	subparagraph (a) until
1	10 times the
2	print, imprint, or
1	recognitionto ensure compliance
1	regulatory agencies to
2	permit the secretary
1	 (1) alphaprodine.
1	1116. repealed. 

1	declared completed under
1	agriculture government coordinating
2	drug in section
2	terms of office
3	request a hearing,
1	exceed 0.53 ounces
6	authority for the
1	food is preempted
1	then, for purposes
3	(2) by an
1	(iv) for a
1	(a)(1) shall result
1	drug submissions, animal
1	secretary a certification
1	manner not authorized
1	distributed  (1)
1	oral hearing; (iii)
1	action brought to
2	5 shall be
1	persons who should
2	c, the secretary
7	product has been
1	remove, alter, or
1	within such 2-month
1	critical to facilitate
1	(b) eligible entities;
1	plan, and that
3	regard to any
1	distributor may rely
1	felony means any
1	prescribe such drug
1	 nutrient 
2	human food safety;
1	statementsany statement or
1	slaughtering for personal,
1	general state of
1	done so sufficiently
1	 (b) returns
1	subchapter are repealed.
1	sufficient authority, to
1	cause substantial harm
1	853]. (4) as
1	if, not sooner
1	(7) reaccreditationthe secretary
4	distribute or dispense
1	individuals; (3) where
2	(b) publish a
1	(2) shor-term, noncash,
2	permits to operators
2	shall be presumed
1	seq.] which is
6	labeling or packaging
1	congress shall consider
4	clause (1) of
4	state official), as
1	withdraw inspection service
1	level the secretary
1	collected  (i)
1	 potassium (mg)
2	clean, and fit
1	subparagraph (a)(ii) with
1	electromagnetic or particulate
2	government in their
1	products shall, at
1	smokeless tobacco, which
1	requirements (a) classes
1	1710a. requirement for
1	devices for investigational
1	1049. seizure and
1	assistance, training, and
1	international product tracing
3	reduction under subsection
1	penalties if a
1	(ii) under subparagraph
1	burden of fee
1	safety signals; 
1	food supply chain
1	(g) contains any
3	35 of title
1	drug is approved,
1	director may employ
1	(pcp); (e) 1
1	amounts that are
1	title.[1] (b) shall
4	[42 u.s.c. 262(a)].
1	another grant under
1	use, or exhibit
1	reports and priorities
1	based in part
1	1971. (3) the
2	authorized under the
1	relevant information, including
1	(1) detention authority
1	trypanosomiasis. (j) leishmaniasis.
2	selected establishments are
3	period in excess
1	betaprodine. (11) clonitazene.
1	subsection. (f) review
1	(i) to register
1	readily accessible to
1	sales restrictions 
3	specified in proposed
1	new york, march
1	(b) certain fish
1	rely on real
1	become so recognized
1	licensing authority may
1	affiliate of an
1	(a) which is
1	 (a) $250,000;
3	unless good cause
1	establishment processing such
1	needed to develop
5	year the secretary
4	secretary, in the
1	recovering the amount
1	(1), such article
1	18 years is
1	 (5) authority
1	partnership from federal
3	360, 360i, or
1	(a), the president
1	term distribute or
1	affect any defense
1	base establishment registration
1	
 360eee2. national
1	selling or otherwise
2	section 350l(b) of
3	consult with other
1	country which, if
1	 (c) communication
2	(2) give the
3	applicant only made
1	(a) whose purpose
1	no-federal matching funds
1	 (iii) clinical
15	action by the
1	communication or material
1	liquors or narcotic
2	(a) during an
1	manufacturers, health professionals
1	states when, in
1	 (i) closely
1	chemicals (as that
2	class as the
1	initial classification and
1	made for an
1	paragraph (5); (b)
1	combining, admixing, mixing,
1	382. exports of
1	amount exceeding $1,000,000
1	order available for
1	administration necessary to
1	section 505(b) or
1	filed within thirty
1	may accept an
1	part, but he
2	sources, and such
1	2010, $235,000,000. (c)
11	less than one
6	june 25, 1938,
1	review and for
1	addition notify the
1	employees thereof, given
1	(6) internal committee
1	(j) waiver authority
1	directed towards the
1	connections to such
2	limitations on the
1	review of operations
2	fee and reinspection
1	shall store and,
1	grant or grant
2	new animal drugsthe
1	pharmacy; or (b)
1	bodies of indian
1	(a) the proprietary
1	used outside a
1	(i) such violations
1	
 
 360jj.
1	section 335b of
1	representatives.  (c)
1	advisory council (a)
1	referring to assistance
1	subchapter, conditionally approved
1	subsection (b) respecting
1	paragraph if information
6	consumers (all items;
1	financial interest that
1	patients.  (2)
1	247d6b] sufficient to
1	(b) a lack
1	employees (a) definition
1	convene a committee
1	reducing dietary exposure
1	modify the order,
1	(iv) a review
1	modify the order.
1	behalf of, that
1	day for the
1	24 hours of
1	person, the secretary
2	certify that reported
1	1178. records and
1	petition.  (b)
3	section to determine
6	review of recommendationsafter
3	listed, by the
3	official certificate means
2	finds (and sets
1	securities of the
1	component. (e) discontinuance
1	submitted by regulations
1	handling 1,4butanediol in
25	section 351 of
1	respects in accordance
1	media campaign are
6	care economic information
1	(iii) rule of
2	mark; (5) knowingly
1	larger confirmatory data
1	prescribe the manner
1	small quantities of
1	information in developing
1	(h) violations any
2	section 351 or
1	disclosure the secretary
1	conditions recommended or
1	requires the drug
1	bureau and the
1	preventable behavior and
1	proposal designed to
1	thereafter imported, moved
1	subparagraph,[1] the term
2	$5,000, or both
1	firm, or any
12	subparagraph (a) of
1	360b(e)(2) of this
1	substitute for food
1	following civil penalties:
1	drugs); (ii) that
1	exists, provided that
3	subparagraph (a) on
1	based on drug
1	compounding the secretary,
1	adulterated articles whenever
1	agencies, including interagency
1	divided by 
1	standard for review
1	substantial equivalence decision,
1	notification or declaration,
1	early in clinical
16	shall be treated
1	section 387e(b), 387e(c),
1	disseminate a direc-t-consumer
1	thereof, and (2)
2	application shall state
1	shall initiate an
2	section 360fff2(b) of
1	identified for such
1	sponsors no fee
1	withdrawal period will
1	registration an entity
1	area; and (g)
1	seq.]), and in
1	(d) publicly available
1	insert definitions of
16	 (a) shall
1	307, as added
1	maximum quantity which
1	subsection (e)(3); (2)
1	data on foodborne
4	 (d) no
1	(b)(2)(b)(iii) continues to
1	rare diseases under
4	differences approved under
3	enforcement task force
1	criteria standards under
1	(b) misbranding all
1	public comment; (ii)
1	device are adequate
1	order notification by
1	(including manufacturing changes)
29	carrying out this
1	entity is 
2	(ii) each of
1	adulterated; and shall
1	(3) casual or
5	intent to manufacture
1	1058; 
 

1	amount means the
1	use; contents; description
3	exempting from any
1	(iii) record the
2	subsection shall prohibit
1	subsection. (5) not
1	section, (iii) i-process
2	section shall prevent
1	federal government. (f)
1	live poultry or
1	coalition or aspiring
1	authorization. this section
1	united states exporters
1	recipients (a) coalition
1	etc. no person
1	subparagraph (b)(i). 
1	propanamide; (g) 1000
1	chapter, the act,
1	[42 u.s.c. 262(a)];
1	term transaction information
1	level. (h) the
1	(as authorized prior
1	organizations or private
1	chapter to transition
1	articles within the
1	final rulemaking to
2	title or fails
1	processing requests made
1	approval of, an
1	association of nurse
1	agency shall with
3	including but not
1	licensure, that presents
1	reliable scientific evidence,
1	section shall expire
1	practical methods for
3	owner thereof subject
1	may agree upon
2	board certification in
1	387d. submission of
1	auditor if such
1	panel that 
2	effective for purposes
1	price of the
1	compendium. (c) nitrous
1	imprisoned for life
1	device establishment to
2	distributor, or dispenser.
1	pertaining to whether
1	prohibit particular uses
1	economic consequences of,
1	clinical and other
1	shall be suspended
2	(whether in the
2	shall support its
5	producer or other
1	stat. 208
 

1	 (1) shall,
1	period if it
1	files with respect
1	stat. 648; 

1	subclause (i), a
3	fiscal year pursuant
1	natural resources, or
1	grant awarded under
1	70 percent of
1	(d) periodic reports
1	(bbb) the description
1	volume data the
1	care professionals administering
2	(b)(2).  (b)
1	open market for
1	warrant relating to
1	 (2) benefits
1	(h) small entity
1	accessory, or part
1	used as 
1	providing to the
1	determined or anticipated
1	following entry of
1	coalition of interested
1	(ii) distributions of
1	review, and the
1	safety information that
1	social and personal
1	additional extension in
1	secretary under subchapter
1	agencies.  (b)
1	less than 72
2	reports, required by
2	review the pediatric
4	purposes under the
2	facility located outside
1	seller or disposed
10	request for classification
1	oxide that meets
1	shall be jointly
1	(i), and (j).
1	(c) the establishment
2	program agency conducting
1	trading partner, in
1	exist under applicable
1	399d. employee protections
1	controlled substanceit shall
1	final assessment for
1	logistics provider, issue
1	(3) rare pediatric
1	(iii) -penty--(-naphthoyl)indole (jwh018
1	installation, maintenance, repair,
1	intended for import
1	exceptionif prior notice
1	plan developed under
1	approaches.to the extent
1	communication relating to
1	care setting or
1	specialists or have
1	foregoing specifications shall
2	means a pesticide
1	vaccines or countermeasures
1	growing, producing, harvesting,
2	accredited person by
1	use: smokeless tobacco,
1	person may engage
1	application; (b) the
9	(h)(1) of section
2	ships in interstate
7	product for purposes
2	determinations under the
3	american academy of
1	may include reduced
1	review employees means
2	need to account
1	shortage list (a)
1	maximum quantity or
2	(2) steps taken
1	administered for the
8	appear on the
1	time and space,
1	(b) declaration of
1	control activity undertaken
1	recommendations on such
1	unapproved product ceases
1	consider certifications under
1	general only by
1	componentssuch term includes
1	title. an abbreviated
1	september 30, 2016.
1	year, the fees
2	52 stat. 1043;
1	expert panel described
2	shall, within the
1	president, in consultation
1	drug manufacturing laboratories
1	function or activity
1	mineral, and (b)
1	september 30, 2016;
15	process by which
2	trial under this
10	one year after
4	district where the
1	diethyltryptamine. (6) dimethyltryptamine.
2	animal, article, or
1	animal feeds are
1	section; or (c)
1	longer satisfied; (d)
1	biologics, and device
1	controlled substance should
1	foreign government, foreign
2	(60 fed. reg.
1	minimize the emissions
1	sufficient over a
1	(iv) chewing tobacco.
19	death or serious
1	certifications notwithstanding any
1	tolerance that has
3	products (as defined
1	service to any
17	(5)  (a)
1	indicates an urgent
7	prescribed by this
3	(iv) retain a
1	(c) feedback from
1	ml; (ii) the
1	projects pending and
1	file for which
1	personnel to law
2	identifying the person
1	 (b) reviewin
1	exceeding $1,000, to
1	study, including a
1	(a) corporations 
1	letters;  (e)
1	including by directly
1	28 shall be
1	application. the application
1	voluntary procedures if
4	united states. (c)
1	provides detailed statistical
1	projects and on
1	reduction act chapter
1	changes qualifying as
1	timely submitted by
4	days for public
2	(1) issue an
1	(d) the national
1	(g). (f) qualifying
1	misled into believing
1	 (c) donations
6	due and payable
1	nonpayment  (i)
1	except on a
1	laws under his
1	enactment date under
1	(d) the approval
1	 (4) venue
2	regulations which shall
2	advice and counsel
1	unless the responsible
2	timeframe specified in
1	documents developed after
2	subclause may, in
1	u.s.c. 802(33),[1] shall,
2	result of studies
6	minimum standards for
1	mobile retail vendor:
1	agreements prior to
1	medical gas into
1	time in advance
1	country. (4) with
1	individual debarred under
1	advertising industry standards;
1	due process is
1	(d) commingled raw
3	designed to discourage
1	
 1707. counte-drug
1	voluntarily on the
2	individuals of the
1	march 1. at
2	reaching agreement on
1	agriculture by section
1	
 2251. jurisdiction;
1	264 of title
2	(3)(a).  (3)
1	section 353(b)(2) of
1	(4) poultry itemthe
1	including fresh and
1	(1)(a)(i) for such
3	shall have exclusive
1	need to preserve
1	addresses the following:
4	suggesting that the
2	instances in which
1	office to provide
2	designation as a
1	new drug, the
1	plan in consultation
3	homogeneous case, verify
15	research and development
1	may not afford
1	(7) -methy-2,-dimethoxyamphetamine. (8)
1	secretary, at a
1	material, or measure
1	(a) apply with
1	assembled article which
5	supply reduction, and
1	departments that meet
2	 (i) notice
3	et seq.], or
6	standard prescribed pursuant
1	products. information disclosed
2	373, title xiii,
3	small business submitting
3	information that are
1	days. (iv) notwithstanding
1	262, 4, as
1	causing such products
1	common use in
2	payment, shall constitute
1	(i)  (1)
1	(b)(1)(a).  (ii)
7	consult with 
1	(a)(vii)(iv) shall give
8	compound, or process
1	chapter for any
2	seq.], and there
1	sales  (i)
1	extent feasible, use
1	certain state and
1	post in a
1	standard, unless its
1	applied on food.
1	requiring training or
1	 (b) statement
1	limited to specified
1	submission and is
1	(1) withdrawing approval
11	made on the
2	counterfeit drug, or
1	(c) description of
1	identification of each
2	due, the secretary
1	foundation the executive
2	amounts of such
1	act of 1990
5	act of 1997
1	foods (a) recognition
2	act of 1994
1	accredited, is qualified
1	united states, less
1	drug identified under
1	means the inspection
1	define their duties;
3	marketed tobacco products,
1	applies under such
1	committing, such offense;
1	ch. 350, 3,
1	affect  (1)
1	best. any dissent
1	product unless such
1	countries with respect
4	effective for a
1	subsection (a)(2)(a). (7)
2	affiliate or within
1	provider receiving accreditation,
3	relevant, packing and
1	advisory meeting 
1	interchange of information
1	manufacturing due to
1	food, financial data,
1	may be processed
6	person does not
1	issued, the methods
1	programs; (3) the
1	(d) late payment
3	title or this
1	facility or, in
1	administration; (b) coordinating
2	section 1105(a) of
1	(2ci). (24) -[-(ethylthio-2,-dimethoxyphenyl]ethanamine
1	targeted drugs to
6	reports, supplements, and
1	title 18. (c)
5	section 201(j) of
1	[42 u.s.c. 300f
1	not, either through
1	regulations, to assure
2	registration. such list
1	(a) ensuring that
1	(c)(4). such fee
1	dye and all
1	medicine whose permanent
1	drug submissions and,
1	contact email address;
14	calendar days of
1	 (e) procedure
1	(at or beyond
3	10 years in
1	impact that such
11	premarket review of
1	466 of this
1	public health, he
1	research as may
1	mi-1970s to as
2	to, any requirement
1	recall under this
1	clause (i)), over
1	efforts;  (8)
1	required or a
1	secretary to discuss
3	pediatric studies 
1	premarket review or
2	food products the
1	completed or not
4	finding with supporting
1	shall register under
2	date by the
1	animal feed, information
1	(a)(1); (c) provide
2	secretary within a
1	21-calenda-day period, as
1	
 353a. pharmacy
7	(a) of subsection
1	experimental permit for
1	grounds listed in
1	office.  (d)
2	coordination the secretary
1	kinds, or parts
1	product, then the
1	product, in any
1	database for authorized
1	violates any license,
2	equivalent to that
1	programs or befor-
1	demand reduction activities
1	applicant by the
3	shall nevertheless be
1	significant unmet medical
2	clauses (b) through
1	adequately and to
28	cattle, sheep, swine,
1	limiting the availability
1	notice provided by
4	360kk(h) of this
1	general deems adequate;
1	(
 
 457.
1	to, state, local,
9	secretary may 
1	825, 827, and
1	includes any supplement
2	experts when in
1	official mark; (6)
1	
 2242. foreign
1	 (b) permissive
1	applicable licensure requirements,
1	preparing, injecting, ingesting,
1	appropriate, with respect
1	authorities under other
1	establishment has facilitated
1	monitoring mechanisms similar
1	(i) upon a
2	(2) a listing
2	materials, containers, and
1	(ii) existing approaches
1	 (1) effective
1	prior convictions could
2	predicate device, that
5	intended use and
1	investigational submissions, and
1	recommends that the
2	adverse event means
1	(4) build the
1	meetings (a) in
1	requirements for issuing
6	contained in an
1	company which is
1	requirements to prohibit
1	tobacco dependence (a)
3	defendant under this
1	subsection (d)) in
1	(b) petition any
1	whether the logbook
1	except the notification
2	secretary the term
1	(2). nothing in
1	away, or prescribing
3	18 or $500,000
1	fee schedule for
1	devices; or (v)
1	whole, provides a
4	regulations the attorney
1	retail are made
9	provided under paragraph
1	or, if revised
1	availability not later
1	agreement; or (d)
1	includes, in addition
1	applicable federal, state,
1	term detoxification treatment
7	fiscal year to
2	authorized to acquire
1	employment of labor
1	 (3) biennial
1	675, 601, 52
1	commerce, registered with
1	fees. the regulations
2	chapter because, with
1	review conducted under
5	generic drug facility
1	otherwise specified, to
1	improvements over the
38	distribution of a
1	23, 1908, ch.
1	regulation, with the
1	(g) violation if
4	performance targets and
1	upon), the secretary
1	sunscreen order remains
1	technological support for
1	substance in determining
1	inspected and are
1	health priority. 
1	establishment and maintenance,
1	service be exempt
1	esea definitions the
1	oct. 18, 1949,
3	fees the secretary
3	title for which
2	based on conduct
19	promulgated under subsection
4	any, of the
1	additive, including, where
1	may be relevant.
1	(including aggregate pesticide
1	election, the secretary
1	agreed to in
1	(b) responsibilitiesthe director
1	(a); (ii) may
1	states receives notification
1	amount of marijuana,
10	annual percent change
3	presentation of appropriate
2	consumer grades for
1	controls and corrective
4	support a determination
1	sports act (36
1	nanomaterials; (8) encourage
1	title and any
3	year.  (f)
3	taken to ensure
2	year 2008, the
3	334 of this
2	cattle and products
1	record shall conduct,
1	organizations;  (2)
1	shall include performance
2	(cc) in any
1	importer under this
1	emergencies, including intentional
2	usual name (or
1	et seq.] applicable
1	defined; combination drugs
1	section will address.
1	(a) failure to
1	onto the market
1	ascertaining the purity
1	seafood and may
2	respecting any adverse
1	declaration  (a)
4	drug, its labeling,
6	year, as adjusted
1	(a)(1), as appropriate;
1	1995, ordered agencies
1	(1) actionsfor purposes
1	product; (2) the
1	otherwise that (1)
1	partnerships, consortia, and
1	orderwith respect to
1	product. the results
1	report, advice and
1	exceeding $1,000,000 that
1	drugs, the information
1	containing filthy, putrid,
1	water systems (as
1	antimicrobial drugs that
1	vitamin; (b) a
2	title that omits
2	general for purposes
5	states may be
1	(c).  (6)
2	performance measurement system
3	information reported to
1	veterinarian is licensed
5	written request to
4	clause (i) with
1	writing and states
3	section.  (g)
2	may be diverted,
1	shortage or exacerbate
1	standards for new
1	affect any state,
1	3 shall be
1	goats. (k) the
1	granted such exemption
1	(4) do not
1	currently maintained by
1	dihydrocodeine. (5) diphenoxylate.
1	subsection (c)(3) was
1	 (4) biosimilar
1	authorized to support
1	public interest as
2	review any person
1	groundsa registration pursuant
8	appropriated under this
1	608. sanitary inspection
1	expert panels opinion
1	safety modernization act;
1	requests information to
18	shall include in
1	bulk form, shall
1	trade secrets 
1	may refuse admission
1	assign such permanent
1	and[1] fast track
1	establishment  (i)
1	application; (b) a
1	food testing industries,
2	states to provide
1	show cause. (

4	period of withdrawal
1	section based upon
1	representatives, clinical and
1	complying with a
1	tobacco all information
1	assessment. in no
1	maintained to assure
2	(b)(2) shall be
1	advance of or
4	substances or listed
1	ounce, or, of
2	(b) standard of
1	service, assessment and
1	specifies a unique
2	apply to tobacco
1	order a postmarket
1	(b)(iii); and (ii)
1	may be rejoined
1	held invalid, all
1	united states environmental
1	accelerate the timelines
1	(a)(9), shall not
1	machin-readable data carrier
1	addressed through preventive
1	related to methamphetamines.
3	facilitate an actual
2	available registry of
1	payment to the
1	(1) at food
3	records as will
2	suspend a registration
1	outsourcing facility during
1	evaluate the target
1	proposed regulations and
1	related to methamphetamines;
16	in, or the
1	withdrawal of services
1	treatment that is
2	person or any
5	involved.  (2)
1	(2) such violation
1	definition given such
1	inform the promulgation
3	(and evidence in
1	thereof in conflict
1	transportation, or interdiction
1	tobacco under a
1	approve animal drug
1	order would cause
1	(iv) the scientific
2	quantity, method, or
6	food, drugs, devices,
1	costs of ending
1	treasury. (iii) the
1	nonsaleable product received
1	(1) request the
1	offset of overcollections;
1	importer, provide the
1	acted under contract
1	definitionsin this sectionsafety
3	sem-critical reprocessed singl-use
1	
 
 379j51.
1	person may elect
1	subchapter; and (5)
1	television advertisement) to
1	stat. 416.)
 

1	shall consult the
2	chargeable under the
1	samples of food,
4	secretary has provided
4	information on which
1	identified in clauses
1	sale; or (b)
1	guidelines, developed with
1	campaign.  (3)
1	violations regarding direc-t-consumer
1	reviewing reports submitted
1	(e) transfer the
1	requiring certificationthe secretary
1	drug samples 
1	program with authorities
1	recommendation, together with
1	 (e) statute
1	secretary no article
9	shall be adjusted
1	certain importers and
2	derived wholly or
1	statute, including any
1	with, controlled substances
1	investigation activities; (ii)
1	for, a felony
1	e to ensure
1	quarterly basis; or
1	order. an official
1	post the final
1	(a) the illegal
1	include any final
2	make arrests without
1	general determines will
3	percentage share of
1	livestock from which
1	communication plan the
1	(g) copies of
1	agencies on (a)
1	court may receive
1	(iv) 18-day exclusivity
1	contact substance, is
1	1974, and the
1	interest that becomes
1	department if the
1	animal, plant, and
1	(4) studies or
1	title.  (k)
1	supplement, is unlawful
1	prescribing), by a
1	ensures that each
1	subchapter ii; (6)
3	period following january
1	board, as set
1	providers and patients
3	reduction of any
11	requirements of such
2	shall assess a
7	notice shall be
1	cost; or (ii)
1	privacy protections. 
1	accept in the
1	provisions relating to
1	title, by posting
1	(e) treatment of
1	treatment, a practitioner
2	believe that 
2	drug was withdrawn
1	health risks to
3	fiscal year, to
1	control policythe deputy
1	clause (i)) that
1	substances has become
1	similar arrangement or
1	plan for enhancing
3	sufficient to assure
10	secretary not later
3	summary shall be
1	warning or an
1	suspect and illegitimate
1	(e) informantsthe secretary
1	4(g) of that
1	(d) revised official
1	regulated transaction, a
1	22), shall be
1	appropriateness and the
1	priority questions.at least
1	logistics provider as
1	controlled substances possessed
1	design for, or
1	otherwise necessary regarding
1	status of previously
1	modification; or (ii)
1	previous owner, prior
2	effectiveness for use
9	coordinate with the
1	products have historically
1	 (2) brand
1	health benefit of
1	among physicians in
1	removal is made
1	nonprescription drug marketed
1	track the status
1	pose a threat
1	subsection (e). as
2	coordinator with respect
2	(iii), the secretary
1	paragraph (1) lacks
17	(including any ester
1	warrant a copy
1	chloral hydrate in
1	receptacles or coverings
3	hospital within the
1	leaf that is
1	review. (r) temporary
1	(60 stat. 1087,
1	aggregated data collected
1	finding a notice
1	treasury, as appropriate.
6	class ii or
1	(5) unless it
1	international control drugs
3	animal drug the
1	addiction psychiatry or
1	reasonably likely overall
2	drug product during
3	(i) is not
1	shall after conviction
1	contained in studies
1	state or territory.
1	publish notice of
8	state or territory,
4	paragraph (1): 
1	need for further
1	(4), to submit
2	increased risk; and
1	conviction or convictions
2	seizure by process
1	record means 
1	 (1) pharmacies
1	3.3  
2	action so advise
1	state subject to
1	qualified entity to
1	inapplicability of this
1	safety information. within
2	sheep, swine, and
3	secretary shall coordinate
1	(ii) under subparagraphs
1	affairs shall be
1	countries, including by
3	demonstrate the safety
1	(a) no prescription
1	(b). (e) notification;
1	related activities. (h)
14	safety of the
1	fiscal year 2009if
1	country determines that
5	foods  (1)
3	products  (a)
1	(e) the refusal
1	compromise the identity
8	conflicts of interest
1	one violation of
3	may withdraw the
3	prohibiting the sale,
2	consolidated into a
1	device exemption shall
1	(ii) upon receiving
2	final rule in
1	poultry products found
1	157. inspection any
1	(c) an ultimate
1	seeds thereof; the
1	paid the complete
1	enforcement administration) decreased
1	619. marking, labeling,
1	year 2017 only,
2	premarket approval filed
9	title, except that
1	policy; (3) assess
1	number of class
1	(c) has already
1	updating interpretive criteria
1	substance. (4) its
4	use upon the
2	four years after
1	 (9) fees
1	must state that
1	confectionery is permitted
1	pediatric studies not
1	identify the persons
1	demonstrate good cause
5	(21 u.s.c. 301
1	validation of 
1	states or into
1	revised preventive controls
3	section 321 of
1	affixes or imprints
2	penalty has been
1	entities within the
1	pay for any
1	agencies with the
1	subsequent violation in
2	trade names and
1	codex alimenterius[2] commission
1	general notifies a
1	health and economic
1	contact normally sterile
1	compliance with rules
1	title, violates paragraph
1	(c) extramural grants
1	provided directly relates
1	(b) or (c)(i)
1	registrations be issued
1	proposes to provide
1	conducting the premarket
2	(a)(ii). (c) provision
2	(d) fee due
1	general of every
1	evaluating existing and
1	drug; (j) a
1	allergen labeling and
1	efforts, including an
3	limitations  (a)
2	1951, ch. 578,
1	section 360e(e) of
1	gifts or donations
18	(1) or (2)
1	insurance provider and
1	goalenhance the preparedness
1	 (1) critical
3	aquaculture and seafood
1	secretary shall identify,
1	process class ii
1	recordkeeping  (1)
1	submission means an
1	accordance with an
1	restore the terms,
1	practitioner has conducted
2	xiii, 1313, 58
1	 (c) possession,
1	outlet from selling
1	revise, as appropriate,
1	terms: could significantly
1	explosives, and united
1	available to appropriate
1	days in advance;
1	transfer of biomedical
1	prejudice, except insofar
1	need to be
8	payment of such
1	notification constitutes an
1	and, immediately thereafter,
2	security countermeasure (as
1	title. (july 22,
1	 (i) submitted
1	(i), the hearing
1	days in advance,
2	preclude the subsequent
1	days in advance.
1	studies and participation
1	mission the reduction
1	 (16) repackagerthe
2	provide adverse event
1	(4) cigarette tobacco
1	granted under subsections
1	states; (iii) correct
1	performance goals established
1	regulations to identify
1	substance. (16) the
1	created has been
2	substantial evidence means
2	upon petition for
1	clause is $1,500,000,
1	act to amend
1	secretary any corrective
1	authorize holders to
2	(b) such other
1	carry out subsections
1	foreign persons that
5	representatives of state
1	part of national
1	importer practices that
1	cows has not
1	population; (iii) where
1	shall make data
1	(a) any poultry
1	international medical device
1	party for each
3	submitted under the
2	states trade representative
1	level by persons
2	notice to 
1	veterans affairs); (bb)
1	 (e) recall
1	awareness of adults
1	noncompliance or defect
1	transition ruleeach person
1	criteria website shall
1	bribe, has paid
1	effect, modify, revise,
1	 (a) obligate
1	vote, appoint to
2	temporary tolerance or
1	animal drug; (d)
1	services in accordance
1	september 1, 1989,
4	act on the
4	business, shall be
3	establishment a statement
1	practices and education,
1	persons whose affidavit
1	authorized purposes at
1	misrepresentation of a
1	following information, at
1	actions, or (ii)
1	notice requirements for
1	marketing, the manufacturer
1	immediate containers as
1	personnel to such
1	classification panel under
1	color additives which,
1	hearing, withdraw the
1	specifying  (i)
1	shall appoint and
1	(c) manufacturing quotas
1	diversions, (c) improving
2	order the defendant
1	quarter or 120
1	subpopulations affected by
3	throughout the nation
1	different regions who
1	appropriate regarding the
1	fees upon submission
1	application.  (8)
1	develop, as necessary,
1	final sunscreen orderwith
18	part of a
2	inclusion of women
4	including the following
1	(iii) the inherent
1	registration and why
1	creation of and
1	human use: 
1	publication with regard
1	1, 2008, through
1	jointly review and
1	materials under paragraph
3	failure of any
1	constituent part approved
1	drugs concerned and
1	section, by reason
1	limit or reduce
1	gaps in data
3	committee to serve
1	commence and all
1	effective the tolerance
1	seminars, meetings, conferences,
1	18. suspension of
2	conducting the investigation
1	destruction, obliteration, or
1	provide such treatment,
1	may remove a
1	reinstatement remedy contained
1	prior to receipt
1	determines appropriate. such
1	false or misleading;
1	inspect any article
1	3-day notices, requests
1	paper matches, and
1	designation by the
1	providers, if, with
1	modifications are to
1	including a supplement
1	section) or any
1	tobacco), shall submit
2	(3) consolidation of
1	drugs to ensure
1	list of retail
1	interest.  (

2	invoke the aid
1	may deny a
1	submitted to a
1	records every person
1	drug submissions. (f)
2	listed drug or
1	secretary has, within
1	subsection (including scientific
1	purchaser of such
1	food additive because
1	1997) in connection
5	intended for ingestion
1	information required for
1	cigarettes. (ii) cigars,
1	maximum limits on
1	deems best. any
1	819.)
 
 214.
1	
 
 343.
9	transferred shall be
1	awareness through outreach.
1	efforts to allow
16	 (a) that
1	age, information reporting
1	to, specifications, hereafter
1	section 802(54)(e) of
1	proposed tolerance for
1	chairman, or any
3	undertaken to have
1	shall be enforceable
1	willingness and ability
1	violation; (2) any
3	(or the collective
1	practice.  (f)
1	provided under subsections
1	efforts, in existence
1	registrant may apply
1	subsection (f)(1)(c) or
1	(2) consider approving
1	found in land;
1	subsection (d)(1), a
1	previous renewal grant
1	(ii) to reinstate
3	secretary in administering
2	title 42 (as
8	shall take effect
2	safety for the
1	import.  (3)
1	canada into the
2	diversion of precursor
12	made each fiscal
6	section 382 of
1	secretary is notified
1	order, prohibit any
1	consumption, provided that
1	advertising if the
1	351(a)(5) of this
1	(b) required information
1	paragraph, multiple convictions
2	salary and expenses
6	appropriations for each
2	$3,175,000 for fiscal
3	made of any
1	gives written permission
2	ingredients, and properties
1	disadvantage based on
2	 (1) establishmentnot
1	lawful partial fills
2	burdensome requirements, including
1	28 or any
1	section. (vi) regardless
1	volum-based adjustments to
3	(a)in general. 
2	unsafe in that
1	product application, or
1	order, and any
1	(d) any order
2	date but before
1	chain by providing
1	summary judgment if,
2	diagnosing, treating, or
1	administration, an ophthalmic
1	carriers by motor
2	publish, for public
1	shall be stated
1	(4), to submit,
1	data which are
5	issue of fact
1	force or effect
4	differences in risk
1	constitution of the
1	national advisory council
2	title, as applicable.
1	title, as applicable,
1	criteria website). 
1	statement in writing
1	(f) procedures applicable
1	states, and over
3	certification of patent
1	expects to resume
1	unit is the
3	title, as applicable;
1	 (f) technology
2	costs and benefits
1	(b) prior to
4	act so entitled,
2	stay of the
1	made available promptly
1	prevention functions. (

1	(i); (7) enter
2	included within the
1	requirements, and appropriate
1	controls, including sourcing
1	revise the draft
2	wholesale distributor. 
5	states city average)
1	packed, transported, or
1	(3) unit level
1	product for distribution
1	device; (d) an
1	335a. debarment, temporary
1	(2) conditions of
1	exclusivity for designated
1	establishment holding an
3	amounts established in
2	food safety; and
1	group practice has
1	(3) withdrawalthe secretary
1	diseases.  (i)
1	title, the act,
23	period referred to
2	packed in an
1	disclosure of determinations
2	secretary adequate information
1	disclosed to such
1	detriment. (m) authorization
2	application be submitted
1	revise and submit
1	safety law; and
2	local government shall
32	thir-party logistics provider
1	transfer request in
1	drug abuse. (b)
2	provided in appropriations
1	status of drug
3	inclusion of data
1	subsection, a local
1	notice. (b) a
1	expertise related to
1	agencies federal government
3	52 stat. 1057;
2	(b) if since
1	terminated upon the
1	(2) activities of
1	sold, or held
1	respond with the
1	congressthe director shall
1	alter that individuals
1	device establishments (referred
1	substance is being
1	flunitrazepam shall be
1	regulations, as each
1	shall possess a
1	applicant, based on
1	law to manufacture,
1	shall remain confidential
2	transferred, or transshipped
1	professional practice. when
1	ch. 675, 745,
1	accountants, or trustees,
1	fee account established
1	(1). the accreditation
4	drug applications 
2	identify such devices
60	1 year after
1	rol-you-own tobacco means
1	possession, the notice
2	title and subpart
1	providers that distribute
1	spent on all
1	poultry, and the
1	committees.  (5)[3]
1	terrorist offense that
2	(f) with respect
3	facility registered under
3	data in the
1	drug.  (i)
2	permanently or temporarily,
1	term tentative approval
2	consumer packaged, are
1	make the determinations
1	licenses conditioned on
1	(iii) retain a
1	act by order
1	secretary for establishing
1	(iso) and identified
1	dosage forms prepared
4	subsection (b) are
1	section 7801 of
1	(10) sue and
1	evidence, including ongoing
1	approved as required
1	346. tolerances for
2	equals or exceeds
1	previously been used
12	823 of this
6	constituents, including smoke
1	upon his request,
2	conditions; and (ii)
1	issuing such letter,
1	(e) within 30
1	cover. (s) the
1	oaths or affirmations
27	60 days after
2	research or in
1	diversified expertise in
1	regular staff and
1	(2) may require
1	programs and shall
1	develop and recommend
1	address a specific
1	(b) renewal grants
1	crop is likely
6	purported or represented
1	shall measure the
1	food includes the
1	title, the first
1	(3) that on
1	chain. (c) best
1	(c) identify a
1	period applies); and
1	surveillance and implementation
1	360c(a)(3)(d) of this
4	states as plaintiff
1	website; and (ii)
2	shall establish, 60
1	shall such registrations
1	testing and evaluating
1	development, improvement, and
2	petition., with the
1	
 114d2 to
2	379dd(l)(2) of this
1	 (a) thir-party
1	1, 69 stat.
1	person; or (d)
2	notification requirement is
1	exemption granted to
2	(ii) the results
1	2105. enhanced aquaculture
3	treatment of opioid
1	delay approval of
4	(1) may petition
1	605, 610(b), and
6	maintenance treatment or
1	member of such
1	limitationno fee shall
1	product; (ii) beginning
4	subchapter iii of
1	paragraph (7) of
2	mitigation strategy under
2	revocation of any
2	internal organs and
5	advisory committee, including
1	part limits the
1	title which involve
1	bacteria or other
2	title, the issue
1	human services receives
1	documents, definitions, licenses,
1	with, and denial
1	 (f) certain
1	paper, document, record,
1	 (ii) suspension
1	writing, and is
1	pediatric studies or
1	(a) ensure that
1	compelling the secretary
1	secretarys representative under
1	manner required under
1	letter described in
1	individual. (c) offenses
2	pediatric studies of
1	disease status under
1	demand reduction, dru-related
1	slaughtering and custom
1	standard, including the
1	loose tobacco that
1	medical services are
1	product was delivered.
1	851. proceedings to
1	chapter (1) small
3	affirmations, examine witnesses,
1	class iii became
1	conclusion under clauses
1	preparation of meals
1	loans of such
2	service pursuant to
1	director) may require
3	shall include any
1	competitive service, and
1	(3) new safety
1	(i) integrating foodborne
1	public health to
1	submission applicant. (june
3	paragraph by developing
1	(21 u.s.c. 101);
1	encompasses both effective
1	consider and rely
1	egg handlers, shall
2	information; (ii) the
1	 (iii)termination or
1	whether the practitioner
1	title of druggist
1	2015 and the
1	goods or services;
1	using such drugs
3	5 by reason
1	approval, to waive
3	applicable requirements for
2	facilitate the use
34	requirements under this
1	complaint upon which
2	drug an antibiotic
1	registration documents submitted
1	among the federal
1	(c) would not
1	detaileesthe maximum number
22	shall be paid
1	obligations under the
1	official compendium. (c)
1	funds expendedthe director
1	forfeiture provisions except
1	allocation of resources.
1	determine, the effectiveness
2	clause (i) 
1	pediatric effectiveness based
1	service from any
5	issue subpoenas requiring
2	2012, shall pay
2	(4) limitation on
1	(m) and has
1	phenylpropanolamine, as the
1	
 1501, 1502.
1	small entities, including
1	animal model development
1	 (d) effective
1	45 days before
1	(4). if such
1	(3), the head
1	rule shall provide
1	tobacco product manufacturerthe
1	title; (b) notify
1	cows producing such
1	 (9) person
1	registrant has ceased
1	regardless of when
1	deferral extensions granted
4	section 350j of
1	(b) ensuring that
1	effectiveness of programs
1	 (b) auditthe
1	feed control officials
3	section 379h of
2	filing a list
1	 (b) assistancethe
1	 (2) later
1	associate returned product
1	either the silicone
1	president shall issue
4	field of substance
2	food is manufactured,
1	include a supplement,
1	sponsor, or clinical
1	secretary for expenditures
1	contain any additional
1	violent teenage and
1	therein, and to
1	pharmacopeia, pharmacists with
2	term food additive
1	regulations under sections
1	council of the
1	federal agenciesthe attorney
1	book entry of
3	individual whom the
1	years, of records
1	no-amenable species under
1	(such as by
2	person is in
1	resolution a manufacturer
1	product, nor have
1	date for purposes
1	commission (a) establishment
1	subparagraphs[5] (1)(b)(i) or
1	affidavits, in connection
1	owner of part
2	agrees to comply
1	pro rata amount,
3	article is not
1	(ii) average annual
1	food. (b) in
2	states, giving notice
1	studies.  (2)
3	product. if the
1	4, 2011, including
1	person occupying a
2	scientific advisory panels
1	drug. this paragraph
1	
 966. authority
2	biosimilar user fee
1	metal bowls; (2)
1	interruptions in manufacturing
1	womens health within
1	person that brings
3	drugs, or conditions
1	(1) contentnot later
1	changes requiring supplemental
1	using any mark,
2	petitions referral. within
2	use of menthol
1	concerned who were
1	activity occurs in
1	developing the forms
2	given or used,
1	health  (a)
2	pesticide chemical. 
1	levels, and do
1	arrangements with nations
1	drug remains with
1	countries will provide
1	heightened inspections the
1	address all dosage
1	drugs to other
1	categorization would be
1	use means the
2	relevant information as
1	federal register; effective
1	libel under section
1	laboratories of such
1	applicant is entitled
2	(2) the establishment
1	drugs.  (e)
1	certified organic farms
1	execution of administrative
1	administration will 
2	may deny clearance
2	officers, agents, or
1	repackager site. 
2	cut up, or
1	checks, and public
1	(4) the compliance
1	participate in, any
1	reporting systems to
1	go into effect:
2	supplemented the application
1	amount of all
1	lon-term clinical efficiencies;
2	1913 (37 stat.
6	date fees are
3	(5) of such
1	technologies, and likely
1	30, 1980, at
1	expertise, and shall
1	chemical residues has
1	compliance datethe initial
6	notification from the
1	thereof, shall constitute
1	container, is being
10	taken under this
2	pursuant to grants
2	said amenable species
18	secretary shall notify
1	policies for funding
1	international narcotics trafficking
2	definitions  (a)
1	title. no prescription
1	division; (v) the
1	subpopulation for purposes
1	property; and (ii)
1	intervention; and (b)
1	centers for medicare
1	health (a) establishment
1	(d) filingany person
1	apply sanctions to
1	wholesale distributors; (x)
1	provider licensing regulations
4	subcommittee of such
1	warehouse includes any
1	june 1, 2008,
1	controlled substance, any
2	policies governing disclosure
1	upon making such
2	penalties and conditions
1	appropriate agency (such
1	countermeasures;  (5)
1	poultry inspection system
2	advertisements specifically intended
1	including records containing
1	service, not more
1	counte-drug programs; (4)
1	(c) one fee
1	alternative organizational component
1	(2) whoever possesses
1	general no person
1	complete; and (b)
1	subsection (b)(2) set
1	make a new
1	listed under section
1	general, may require
1	(1) add to
1	amounts for testing
1	freezing, dehydration, milling,
3	coordination and enhancement
1	test, and such
3	food processing facility
1	states with appropriate
1	unless the state
1	claims data, patient
1	made under paragraph[1]
1	(a) farm to
1	directed by, or
1	proposed findings published
1	path reports and
7	(3), the secretary
2	(including specific formulations
1	ch. 675, 522,
1	cake, or the
4	revoke a tolerance
1	persons and may
3	puerto rico, the
1	395. loan repayment
1	manufacturing process approved
1	 (b) final
1	necessary to receive
1	index, the benefits
2	title) appears on
1	use in certain
1	country of origin,
3	misbranded shall apply
2	appropriate qualifications and
1	regulation and such
1	subsection shall, for
1	pending and approved
1	may 28, 1976.
5	may 28, 1976,
1	1997, to conduct
4	article is a
1	distributor shall not
1	require that, as
1	general.the secretary shall,
1	gaps, which, at
2	paragraph that the
10	conformity with such
1	may 28, 1976;
1	document for purposes
25	secretary does not
1	(ii) the name
1	medical products industry.
1	(1) detail from
1	title shall review
2	interested persons opportunity
1	secretary regarding any
1	shall be unlawful.
1	manufacturing facilities discovered
1	1914, ch. 131,
4	existing therapies for
1	requirements:  (i)ensuring
2	induce cancer when
2	otherwise bearing on
1	secretary agree is
14	within the food
11	derived from fees
4	record by the
1	(c) the tolerance
2	receive more than
1	prevention, treatment, research,
9	adequate and wel-controlled
1	general that it
1	service or any
1	buying contractor shall
1	follo-up effectiveness checks,
1	506c, as added
1	export, or import
2	prohibited establishmentsin carrying
1	regulations to provide
1	requiring each person
7	contact information for
1	fee for periodic
1	(8) ibogaine. (9)
2	amended to require
1	
 379aa. serious
1	paragraph (2)(a)(ii). (c)
1	federal government agency
2	enactment date and
2	security, in coordination
1	both) to establish
1	shipping through any
1	
 
 360aaa
1	pipes; (9) electric
11	goals identified in
1	radiation from such
1	state to conduct
12	information relating to
2	state or the
1	not, to every
1	data are insufficient
1	children, and racially
1	(ii) additional exemptions
4	conditions in either
1	exceed  (1)
1	location of inquiries;
6	recommendations in the
1	law enforcement officers
1	criteria under subparagraph
1	industry trade organizations.
1	343a. repealed. 

1	unaware that a
1	mechanisms for answering
2	title, or foreign
1	title, does not
1	enable the eligible
1	 (d) international
1	(n)(3), because of
1	2009. (4) limitation
1	
 1121 to
2	standard for determining
2	quantity, proportion, or
3	substantial quantities at
1	website. (e) special
1	certifications relating to
1	143, 1, 68
1	formerly 359, as
1	implement preventive controls,
1	general, such drug
1	(g). such guidance
122	biosimilar biological product
2	recipient of such
1	et seq.]. (s)
1	fee if no
2	unless he finds
1	recognize their different
1	campaign; and (2)
1	meeting statutory timeframes;
1	(
 
 970.
1	pediatric assessments and
1	determined necessary) the
1	with, a qualifying
1	abuse seriously impairs
1	low risk and
1	drug administration can
1	qualified indication for
1	inhalation drug in
1	thereafter.  (h)
2	treated with such
2	records kept in
1	2008, an abbreviated
2	 (ii) exception
1	regulatory function. 
1	from, any proceeds
2	general shall, before
1	contentthe regulations promulgated
1	agriculture, the environmental
1	(3) total revenue
1	distributor includes on
1	compliance guide not
2	rescind or modify
1	recognized the danger
4	product is cleared
1	official), on account
1	indexed for use
1	product..  (3)
1	supplement, with respect
2	controls used for
3	protein targeted drug
2	slaughtering poultry or
4	lot number of
1	actual written reports
2	solely for administration
3	schedule established by
2	fiscal year 2008.
1	reasons to support
7	fiscal year 2008,
1	secretary shall organize
3	said sections 49
19	finds that 
1	 (i) 30
1	sale of controlled
1	 (d) misleading
1	2018.  (5)
1	each[1] fiscal years
1	inspection of manufacturing
1	official establishment, and
4	biosimilar development program
1	(iii) any loss
1	copying, and verifying
1	(a) examination of
2	good cause therefor.
1	authority to conduct
1	bthe source of
1	increase in that
1	administration to work
1	drug shall provide
1	debarment of any
3	market because such
1	populations, children, racially
1	third party interests
1	u.s.c. 71 et
1	regulatory audit, submit,
2	respect to their
5	processing for commercial
1	chapter (including a
1	said virus to
1	regulated by such
1	order suspend or
17	application to the
3	term of the
1	media campaign under
1	means of detection;
1	second year thereafter,
2	states to any
1	recipient to enhance
1	agency is effective
1	infectious disease for
2	reports submitted under
2	section is issued
1	facility has identified
2	consultation with individuals
2	color additive or
1	used, and (b)
2	methods approved by
3	bioavailability studies) with
1	
 61. definitionswhenever
1	sulphide of antimony,
1	available and allocated
2	subparagraph (c), does
2	iii, such person
1	shall require coordination
1	facility fee as
4	secretary shall maintain
1	
 148. powers
1	endpoints, such as
2	additional evidence. (3)
1	consistent with common
5	substantial number of
6	individual under customary
1	use in commerce
1	prepared on a
1	meets such tobacco
1	clause (ii)(i) an
2	made. if this
12	except that this
1	negative bacteria, including
1	hearing, including a
2	5, section 1905
1	(1) he determines,
2	service of all
1	resolution prior to
1	tolerance. in establishing
11	members shall be
1	scientific research by
1	athletes compete (36
1	shall be part
1	productthe term qualified
1	schools; and (c)
1	losses or thefts
1	shor-term, noncash, i-kind
1	radiation, and (ii)
1	 (5) restrictions
1	labeling receptacles or
3	present and future
2	subparagraph (a) or,
1	sanitation; (b) packaging,
1	importers of that
1	particular food, due
3	secretary may deem
1	animal models to
1	case; and 
1	
 360ii. program
1	costs, and benefits
2	3502(3) of such
3	product of the
1	application would cause
1	administrator shall in
1	drug, that the
1	already granted for
1	holders to distribute
1	subsection (b)(1) shall
1	testify and present
5	conventions, or protocols
1	patient during a
1	answering such questions,
1	involves bribery, payment
1	(5) accept and
6	(b) to the
1	matter, so as
1	arrival at a
1	months after august
1	fine and term
13	(b) the number
2	cros-examine witnesses who
1	interoperable data exchange
1	health is protected
1	diagnostic images; and
1	absorption or excretion
2	entitled to confidential
3	c-located on a
2	secretary finds (1)
8	contaminated with filth,
1	violation as a
1	title and does
3	881 of this
1	explanation referred to
1	(2) affidavits 
1	(2) the following
3	provide the advisory
1	(1)(a)(i)) with respect
1	(a) design and
2	setting forth a
1	identification technology; (b)
1	general, and maintain
4	(b) effect of
1	practicable and appropriate,
1	year, notwithstanding the
6	falls below the
2	publication or presentation
3	last applicable date
1	considered as adul-written
1	technologies and capabilities,
2	provisions  (i)
1	conservation and environmental
2	may, at his
1	537, formerly act
1	director in writing
1	modifying such total
2	foundation to carry
1	purpose into any
1	development organization described
1	
 360fff4. guidance;
3	compliance with current
1	act of 1954
1	available to regulatory,
3	eliminate the unreasonable
1	 (a) paragraph
2	application describing an
1	mentoring activities (a)
3	provide the information
1	life sustaining; or
1	except activities otherwise
1	state official shall
1	year 2009), and
1	(b) each nutrient
1	vacancies on each
1	petitioner agrees that
1	21, 1997, but
2	existing tobacco additive,
2	declaration that the
1	reasonably likely in
2	(before or after
1	provided by any
1	(a) knowingly importing
1	section 355(p)(1)(a) of
1	section 3607 of
1	levels, including by
1	hold or sponsor
1	obtaining the identification
1	without submitting a
1	shall reflect the
2	commercial investigational new
1	business, panel members
1	(ii) may prohibit
1	commissioner  (1)
2	secretary finds that,
1	(2), and with
2	international agreements nothing
1	states and intended
1	 (i) prepare
1	(1) program of
1	approval or of
1	commission. (2) if,
3	one which is
5	agency in the
1	practitioner to prescribe
1	agricultural import and
1	technology assessment center;
1	twice a week,
1	expeditiously as possible,
2	slaughter of animals
1	application that intends
1	surveillance (a) postmarket
1	mutton, pork, goat
9	supplement to the
1	assure purity, safety,
4	states in china
2	pharmacological action of
1	secretary. (j) scope
1	training law enforcement
1	surveillance data; (g)
1	generalin issuing an
1	(b) initial reports
8	notwithstanding section 3583
1	pediatric dosing, formulation,
2	commodity which is
1	remove from listing
1	request a response
1	consignee. clause (2)
1	(as reported to
1	required, that are
6	respect to whom
1	secretary or upon
4	amends section 331(j)
2	timely be obtained
30	allocated for the
3	issues raised by
1	inspection (a) findingscongress
1	raw, is not
1	natural history of
1	interpretive criteria specified
1	(1) classifying such
1	(3) and by
1	every sale, delivery
1	requirements of handicapped
1	term minor species
1	articles or poultry
1	reinstate the accreditation
1	originating from each
24	compounding, or processing
1	(c) investigational use
1	safety information for
1	imposed after the
1	maintenance, detoxification, overdose
2	case of pasteurized
1	since the filing
2	message intended to
3	may be ordered
1	(f). (m) disputes
5	adjusted by the
2	persuades, induces, entices,
4	(s) the term
1	(iv) the retention
1	partnerships with states
1	occupational prevention and
1	describes  (a)
1	sale; or (3)
1	establishment (unless exempt
1	alert network, or
1	result of consultations
2	processes, controls, and
2	include a new
1	local taxation of
1	calendar quarter. (3)
1	approval of certain
1	products handled by
1	purchased or received
1	
 376. examination
51	amount of fees
2	secretary shall utilize
1	271.)
 
 321c.
1	adjustmentsfor purposes of
1	custody of such
1	care providers or
3	prepared in such
2	cocaine, salts of
1	commission adequate staff,
1	(4) exceptions 
15	early childhood education
1	(p) isosafrole. (q)
1	microorganisms (including bacteria,
3	praying that the
2	abuse. (
 

1	term sponsor means
1	fiscal year; (d)
1	section 2291j of
12	may only be
2	countermeasure application that
1	applicable laws. when
1	state includes the
1	record. drug manufacturers
5	drug officer or
1	interoperability with wholesale
1	order form as
1	administration. (m) separation
1	per establishment, notwithstanding
1	source, or method
1	buruli ulcer. (e)
1	areas.  (j)
1	shall assess the
1	addiction; (17) shall
11	article has been
1	deal effectively with
2	record of all
1	includes any packaging
1	governmentsparticularly those of
1	risk there is
1	clonitazene. (12) dextromoramide.
1	247d6b(c)(2)(a)(ii)]; or (ii)
2	complained of. 
1	(ii) startup costs
4	paragraphs (2), (3),
1	device, based on
1	agent), deliberately causes
2	state may, by
1	decision has been
1	effective, the applicant
2	provisions to ensure
1	control the intake
6	residue that is
1	active federal criminal
1	bacteria, viruses, fungi,
4	seq.] or the
1	crisisthe term local
1	administration to industry
3	methods to be
1	guidancenot later than
1	partyafter consultation with
2	chapter. (q) the
1	child nutrition program
1	testing described in
3	subsection (a) does
1	16 of this
1	worldwide revenue during
1	manufacture any quantity
1	cleaning, disinfection, and
5	selection of an
3	1, 2, and
3	indian tribe (as
1	publish for public
7	tobacco products will
2	(1)(b), or (1)(d)
1	60 milligrams of
2	disclose the amount
1	radiation, and (b)
1	year 1 in
3	considered appropriate by
3	antimicrobial new animal
1	educational rights and
1	period such person
1	(including a study
3	years after september
1	delegated to carry
1	no-alcohol food, except
1	labeling. (d) the
1	program, and tactical
1	partly owning, or
2	possession, manufacture, or
1	general, concurrently with
1	uniform internal procedures
1	file, the person
1	scope and duration
1	frame from the
1	crime described in
1	generation of the
1	distributed all chemicals
1	issuing an authorization
1	(3). (3) review
1	recommendations in conducting
1	regulation, except for
1	using existing electronic
1	may by a
1	education and enforcement
2	ninetieth day), by
1	extent possible consistent
1	required. such fee
4	use, or effects
1	may, before the
1	evaluation of data;
1	675, 744h, as
1	mitigation strategy. 
1	require, a declaration
1	675, 310, formerly
2	petition does not
1	similar operation within
1	part thereof, that
1	section 1320a7(a) of
3	secretary shall finalize
1	timely dispute resolution;
1	days of completion
1	drugs shall annually
1	product was approved;
3	proceedings in such
1	title applies, its
2	manufacturing, packing, processing,
1	regulation when it
12	packing, or holding
1	regulations within 365
1	products and results
1	meetings with medical
1	(a) the total
1	standard, shall immediately
2	implement this section
1	donated by national
1	certification, or such
1	posting such policies
1	(1) the quantity
4	(a) request for
3	means a food
1	paragraph (1)(g)(iv), the
1	(a) conduct regular
1	assessment was issued,
3	authorization, bears the
1	require persons subject
1	determinations required in
1	ingredient may not
1	inconclusive, the secretary
2	pending request shall
1	panels which considered
1	(c) objectives specifiedthe
1	taxes required by
1	reports and, when
31	determines to be
1	reprocessing; procedure upon
1	transverse diameter; standard
3	 (iii) responding
4	evaluating an application
1	services that the
2	(including books, papers,
1	paragraph (1) will
1	expertise can be
1	substance during one
1	distributionin the case
1	considers advisable to
2	officer in such
1	secretary to finalize
1	[4] if an
1	whether the application
1	(b) adding such
1	reject the selection
1	substantial and detrimental
1	may provide technical
1	agencies under interagency
1	analysis, reporting, and
1	easily printed by
1	medical supplies such
1	business may employ
1	secretary shall define
1	secretary, such person,
2	fiscal year immediately
1	government purchase price
1	advanced product or
1	granted for a
1	section 350f(n) of
1	cosmetic, or to
1	modified to prohibit
1	(1). (c) scope
3	prescribe or use
1	referrals from the
1	regarding the nomination
1	provide that, with
2	owner prior to,
17	record of the
12	(i) the term
1	documentation, as specified
1	building, or conveyance,
1	labeling are reasonably
2	notice is not
2	program authorized the
1	report, paragraph (11)
2	united states be
1	instruction of a
1	medical product safety.
5	relates to a
1	lawfully imported nothing
1	united states, either
1	(b) awarding of
1	decisions under such
1	effective) revoking the
1	prior to release
1	399b. office of
1	product that, by
1	(2) regulations and
2	combinations, quantity, proportion,
1	postal service. any
1	effectiveness testing expenses
3	united states by
1	
 379k1. electronic
1	access policy the
1	(a) catfish labeling
1	information exists, on
1	(1) manufacture, cast,
2	device to provide
1	act unless the
1	u.s.c. 262(a)], allow
2	proceeding brought under
1	(the countries in
1	specifications were accepted,
1	subsection (c): 
1	(iii) ensure the
1	(f) certain class
1	contains the practitioners
1	subsection as tobacco
1	enterprise (a) penalties;
2	color additive, unless
1	violation after such
1	amount collected 
1	electronic product, or
1	radiation; (3) the
1	enterprise definedfor purposes
1	(1) during such
1	formerly 355, as
1	withdrawn before a
1	antimicrobial drugs 
1	practices; (d) the
1	award an initial
2	section 353b(b) of
1	applied for or
1	plan the secretary
1	expenses associated with
1	title;  (iii)
1	section 971(c)(2) of
1	on, and collect
2	necessary to obtain
1	verifying whether the
2	held not later
1	cause a label
1	secretary determines eligible
1	transferred), subject to
1	adversely affected or
1	(2) a claim
1	economic information presented
2	actual knowledge of
1	method of fee
1	substance abuse means
1	may obtain tobacco
1	regulation shall set
1	court without a
1	probation, prosecution, courts,
1	requirements on farm
1	difficulty.  (2)
2	effective enforcement of
1	method through which
6	reauthorization  (1)
1	drug application, (6)
1	(jwh250); (viii) -penty--[-(-methoxynaphthoyl)]indole
1	sponsor that has
2	information is redacted.
1	receipt for samples
1	agency engaged in
1	general requirements; applicability;
1	united states, a
1	matters from the
8	product or an
1	final regulations for
1	base amount increased
1	commitment that the
1	programs for testing
15	advisory committee shall
1	penalties for distribution.
1	shall, from amounts
1	product and may
1	person; (2) govern
17	total amount of
1	(2) or (3).
1	general, to determine
1	practitioner that wrote
1	purposes of chapter
1	suspension exist. 
1	product. extr-label use
1	adverse event report,
1	petition pursuant to
2	detrimental to the
1	 (n) abbreviated
1	renovated, or adulterated
1	pediatric studies (including
1	format as specified
1	advanceas soon as
1	faith. (i) whether
1	submitted  (1)
3	achieved to the
1	filing application; contents
1	interested party. (b)
2	accomplish this objective.
1	381(b) of this
1	research protocol. the
1	food and recordkeeping
3	every month during
1	authorized or permitted
2	debarment to less
1	highly, statistically significant
1	audit agents used
1	establishment, or consulting
1	manufactured, distributed, dispensed,
2	restrictions and other
1	(3) notwithstanding subparagraphs
1	include as a
1	 (i) improve
1	certification, described in
1	(x) such information
1	chemicals, or otherwise
1	court at any
1	applicable standard under
1	section 2203 of
1	guardian of the
1	approval letters which
1	recovery of damages
1	section. such regulation
1	health, promulgate a
1	prevent, or prohibit
1	handling of a
1	d-identified surveillance data;
1	denial; (2) describes
1	dispensers, and researchers
3	addicted to the
1	members tenure on
1	section 572 of
1	section. the reaccreditation
1	provider is not
1	lon-term care facilities,
22	include  (i)
4	persons licensee, assignee,
4	technical, or professional
1	permissible bases of
1	safety for human
1	term depressant or
1	increasing pain and
1	review.  (

1	presents a greater
1	necessary, the inspection
1	previous year, including
1	importer. (ii) documentation
1	1194. repealed. 

1	respecting the scientific
1	diseases; research contracts;
1	retailer and that
1	additive; or (4)
3	affect the structure
1	unless renewed by
1	(2), amend or
1	thereunder may only
1	(bb) not more
1	(a) radio frequency
1	 (3) rules
1	(10) negligently to
1	detect and investigate
1	becomes known to
1	pesticide residue (in
1	united nations; (iii)
3	condition to approval
1	ready for approval
1	objections are made.
1	title to expedite
2	 (c) immediate
4	domestic and foreign
2	 (ii)no independent
1	court shall grant
2	individual portions of
1	administrative inspection warrant
2	(a)(ii), the term
1	generalthe administrator shall
1	(aa) be disclosed
1	term application means
1	new information respecting
1	deemed objectionable and
1	rule any requirement
3	may not introduce
1	list; direct export;
2	$30,000,000 for fiscal
1	portion thereof presents
1	order disapproving, or
1	day when that
2	entered into a
1	safe: provided, however,
1	banned in the
1	(iii) perform advanced
1	(ii) use of
1	i, 10, formerly
1	526, as added
1	substances; (b) providing
1	previous convictions to
1	substance  (a)
1	
 859. distribution
1	purpose of fostering
3	division shall be
1	alter the transaction
1	authority to carry
1	treatment of motion
3	related to generic
1	employee making any
1	includes a change
1	extent practicable study
1	applications are free
3	general may deny
1	coordinates warehousing, or
1	897.16(d) of the
1	exports controlled substances
2	expiration date extension
2	product manufacturers to
1	(b) registration by
1	upon petition filed
1	sourcing of foreign
5	implemented under subsection
1	admixing, mixing, diluting,
1	tool for a
2	receiving the recommendation,
1	significant loss of
1	receiving the recommendation.
1	size; (e) the
1	standard of liabilitynotwithstanding
2	except with the
1	drug control policythe
2	authorized by title
1	importation.  (4)
1	use with severe
1	class of food,
2	pharmacy regulations pertaining
1	 (24) the
1	food packaging (without
1	22 and section
1	360eee1. requirements (a)
1	(iii) criteria not
3	individual saleable unit
2	services; and (ii)
1	condemnation, be destroyed
2	effect of causing
2	first commercial marketing
4	allocating inspection resources.
1	imports (a) adulteration
1	implementation.  (2)
1	submission required under
2	control and prevention;
1	(and any amendment
2	year 2013 
1	held before the
1	agreement under paragraph
1	interest standards under
1	annual registrationupon electing
1	individuals who possess
2	amateur athletic competition
1	503a, as added
1	considerations  (i)
1	delayed until additional
5	secretary concludes that
2	section 360eee(26) of
1	government of an
1	clinical investigations, by
1	subsection (m) or
1	order siluriformes; and
2	device; or (iii)
2	including evaluating state
1	another, or delete
1	distribution supply chain;
1	commission shall consist
1	organizations to collect
1	conduct; and (2)
11	necessary in order
2	(3) an officer
1	
 
 1181.
4	inspection service under
2	intracompany distribution of
1	discharged or otherwise
1	(a) information filed
1	trade secrets act
1	thousand, in the
1	applies to unfair
1	subsection. (d) periodic
2	(a)(ii) for inspections
2	office and the
1	(i) flexibility for
1	cost of mea-inspection
1	ii; (2) employ,
1	products, and consistent
1	limit the regulatory
1	accurate, and consistent
1	(a)(2), respectively. (june
1	repealed. july 28,
3	15 milligrams per
1	administered to a
3	quantity sold, the
3	paragraph (2). (2)
1	year 2000 and
2	device. the secretary
1	2014 under subparagraph
3	(z) the term
1	based on data
2	applicable to state
1	references a type
4	transaction information in
8	annual fee setting
1	diversion a regulated
1	comments, and provide
1	(ii)(ii) may not
1	additive; (ii) the
1	(a) at least
1	supplement marketed in
1	inspection service means
2	interested parties, may
1	1037 when construing
1	either at wholesale
2	(1) establishmentnot later
1	applies, or (2)
1	paragraph (3)(a) fails
2	like products subject
4	institute on drug
1	making a request
1	(ghb) or any
1	entity that provides
1	administration, is appropriated
1	final under subsection
2	records are needed
2	scope of section
2	sponsor fees, and
1	subparagraph (a)(iii); and
1	regarding market exclusivity
1	fiscal year, animal
6	(d) collecting fees
4	substantially similar to
1	manufacturing and regulatory
1	grocery store, the
1	monograph system. (2)
1	issued regulations 
3	otherwise meets the
1	(3) amateur athlete
1	control strategy under
3	sentence under this
2	appointment to the
1	drug), with sections
1	include dairy products
2	residue level during
2	commenced by a
12	hundred and eighty
1	track product for
1	(7)(c) with respect
1	section, as appropriate.
1	protocol differ so
1	(15) the term
10	360kk of this
1	practitioner of veterinary
2	applicability of this
1	area; (c) reviewing
4	authorization  (1)
2	available, with redactions
2	federal government, and
1	knowingly pack or
2	 (a) include
1	import, any poultry
4	may by regulation,
1	measures of evaluation
3	not, unless specifically
1	requiring postmarket surveillance
3	may be imported
1	(a) grounds and
1	rodenticide act (7
1	(f)) into the
1	official, department, or
2	commercial importer of
9	subsection:  (a)
1	committee shall meet
1	paragraph. (b) review
1	foods designated under
1	possession.  (4)
6	alleged violation of
3	regular customer or
1	specifications governing emissions
1	general. any such
1	capable of sel-administering
1	documentation from the
1	actions, or did
1	represents law enforcement
1	insanitary conditions or,
1	secretary allows, through
1	(b)(2) is bioequivalent
1	with, and make
2	composed wholly or
1	general schedule. 
1	times and places,
1	means to enable
1	register of an
1	 (i) illegitimate
1	establishment the secretary,
1	additional human illnesses;
1	accreditation program approved
1	prospects for development
1	shall use regular
10	listed chemical product
46	reasonable assurance of
1	subsection (a) distributes
1	secretary if food
1	 (2) access
4	device  (i)
1	 (c) recall
1	752, as added
1	reasons such formulations
1	judicial review; application
1	notwithstanding this clause.
6	(ii) does not
2	352(n) of this
1	(c) unclassified report
4	title. (2) the
1	(2) there was
1	sufficient  (a)
1	(2) such failure
2	eligible entities or
1	reclassification order in
1	data instead of
1	medical product includes
1	receiving valid prescription
1	single mode of
1	device is authorized
1	(b)(1) no longer
1	additional members the
1	beverages, with respect
1	timely notice to
2	contained therein are
4	within one year
1	dose; (d) projections
1	expended; (d) a
1	subparagraph (b), (b)
1	(c) recommendations or
1	postmarketing studies 
1	2007 with respect
1	indicate the need
1	prescribe to effectuate
1	cause any drug
5	(b) the date
2	provider of professional
1	intends to select
1	daily quantities measured
1	708, as added
1	drug endangered children
1	security features; and
2	regulations promulgated thereunder,
38	adverse health consequences
1	regulations promulgated thereunder.
1	change.  (f)
11	raw agricultural commodities
1	 (a) assign
1	application submitted on
1	program; (5) may
2	responsible person means
1	chooses to act
1	subsection (b)(2) and
1	(vi) appropriate representatives
1	antifungal drug, alone
1	(b) are voluntary.
1	plans to provide
1	final is punishable
1	incorporating each comment
1	administrative review 
1	appear to present
1	appropriate. (2) timingnot
1	experience to conduct
1	title, includes a
1	results of reinspections;
2	suspension and revocation
2	functions and duties
1	directions consistent with
5	shall designate one
1	party, with respect
2	aug. 7, 1953,
1	(3) promote countermeasure
1	embryo chicks (at
1	(iii) the need
1	means any optical
1	audits to determine
1	term communication facility
30	shall issue a
2	states owner or
1	support research, development,
2	waiver of fees
1	approval, or (2)
1	papers; or (15)
1	regulation to make
1	consumed, the secretary
1	conforms, to the
1	findings which, if
2	years, fift-four months,
1	regarding the identification
2	(2) if a
4	(1) may include
1	 (b) conduct
1	actions for which
2	foreign government as
1	supporting, or is
1	devices, and who
2	development fee 
2	states, except that
1	(b) unless he
1	paragraph (2), fees
1	auditor unless such
1	including those caused
1	information from clinical
1	of[2] fiscal year
2	substantially from the
1	(2) period of
1	shall toll during
1	shell eggs destined
2	describes the status
1	 (i) revision
1	(c) limited annual
2	total user fee
1	local agency and
7	schedule ii, iii,
1	limitations the written
1	materials or parts
11	serum, toxin, or
2	amount of user
1	(1) requirement to
1	progeny of such
1	(i) determines that
1	nonprofit organizations providing
1	additional conditions for
1	paraphernalia (as defined
1	following statement: this
1	panel).  (b)
1	country or otherwise,
3	including the potential
2	made for the
6	court the record
1	application  (aa)
1	file a civil
1	federal district court.
1	services shall prepare
1	statements, as necessary
2	responsible party receives
9	directly to the
1	description of additional
1	675, 736b, as
1	experts on trial
1	(7); and (b)
1	(f) if its
1	section 360m(b) or
1	582, as added
5	adjustmentfor fiscal year
1	(a) anthranilic acid,
2	engages such services.
1	referenced in paragraph
1	levorphanol. (10) metazocine.
1	involved with youth
1	establishments, and of
1	arrange for training
1	ceased to exist;
1	target population; (iii)
2	chapter, the state
1	title; and 
1	262(a)], allow the
1	drug, and dosage
3	period of its
1	auditor, as described
4	34 stat. 1264;
1	 (6) counterfeit
1	clearly identified signature
1	ceased to exist.
1	denied entry and
1	(b) contentsfor each
2	of, or exposure
2	article in a
2	facilities (a) in
1	 (f) false
1	units of measurement
1	may require, and
1	food to satisfy
1	transmission. (iii)private sector
1	affirmation or denial
3	title unless 
3	7 years after
4	federal agencies and
2	subsection (c). such
1	agriculture, and (2)
2	may distribute or
1	(a) collect and
1	facilitate the reduction
1	effective response on
2	may not use
1	formats) and at
1	organizations in hard
1	outlets the secretary
1	written clearance, such
1	ch. 666, 5(2),
1	sampling and laboratory
1	final determinations, findings,
1	costs when a
3	color additive) which
1	secretary should alert
1	952(a)(2)(a) of this
1	merger or acquisition.
1	(in any form)
1	(1) with the
2	substantial deception or
2	every successive -year
2	product and shall
1	bulk active ingredient,
1	covering practitioner. 
1	service, at rates
1	(1), may request,
2	chapter under supervision
1	v to treat
1	administration personnel reviewing
4	674 of this
1	agency shall, to
1	744i, as added
5	iv of the
1	application to establishment
3	order required under
3	application which is
12	fiscal years, the
1	 (a) total
1	may also result
1	nonenforcement of minimum
1	
 360aaa to
1	domestic animals. (mar.
3	requirements, in addition
1	issuing such certifications.
1	federal employees stationed
1	title) can take
1	may submit an
1	practices document, published
1	subsection, be sentenced
7	(iii) or (iv)
1	issue of safety
2	strictly for the
1	investigating and prosecuting
1	advisory commission (a)
1	22. barrels misbranded
1	activities of each
1	title. (c) in
4	interstate commerce a
1	(4) the hearing
1	fast track product,
1	fast track product.
2	states consumer grades
1	website provides information
2	violation after one
2	provision of part
1	$1,500,000 may be
16	substance abuse among
1	shall take reasonable
1	health to request
1	list, the name
1	preserve such duplicate
1	introduction, into interstate
2	subsection shall contain
1	remaining challenges, and
13	attorney general under
1	authorization to export
1	program agencies that
1	establishment, or vehicle
1	violation of law
2	time of initial
1	article not to
1	implementing this paragraph,
1	be, unless 
1	may be required.
1	fast track products
1	trips, befor- and
1	products, including advers-event
1	stakeholders, and to
1	constitutes (i) a
1	shall consider certifications
1	however, that an
1	(1) an antibacterial
2	community coalitions that
1	drug considered unadulterated
1	title, includes any
1	prohibit a person
3	accept and review
2	subsection (a)(5)). 
1	describing the plan
1	represents actual changes
2	of, or during
2	designate the state,
1	therefrom, (iv) a
3	section to an
1	human milk. (aa)
1	(e) the termination
1	medical monitoring by
1	best information available;
2	351 or 360j(f)(1)
1	criminal penalties any
2	purchase of controlled
6	period following the
1	 (2) conduct
1	nutritionally rational or
2	title until such
1	771, as added
1	certain to achieve
7	section and section
1	slaughtered poultry from
1	licenses, or otherwise
1	distribute such substance
1	has.  (2)
5	factor described in
1	contaminants and banned
1	(a) seek input
1	higher levels of
1	(a) $250,000; or
2	national substance abuse
1	2009, the secretary,
3	last sentence of
1	operating reserves. to
1	matter which would
1	drugs. (ii) statutory
1	secretary, a protocol
1	subsection. the fees
1	chemical product. any
6	advisory committees so
2	distribution and which
1	(iii) an itemization
2	register the applicant,
1	deputy attorney general,
2	register and on
1	demonstrates that there
1	another applicant, the
1	classes:  (i)
1	petition submitted pursuant
1	related to nanotechnology,
1	subsection, without first
2	interest of usefulness
3	codeine per 100
1	(3) data on
1	title to review
1	(b) the estimated
1	ch. 675, 1004,
1	oleomargarine (a) law
2	supplement was submitted
1	separate foods. (f)
1	forth the results
1	fora, and share
1	155, 8, 44
1	title); and (iii)
2	work rules and
4	appropriate.  (d)
1	additive comes in
1	
 
 383.
1	2002 (6 u.s.c.
4	be, to the
1	(1) activities under
1	exemptions of retail
1	 (a) did
1	2012, unless appropriations
2	general suspends or
1	government or a
1	may not participate
1	informational and recruitment
1	epidemiological studies demonstrates
2	illicit trade, smuggling,
1	available scientific evidence.
1	available scientific evidence,
1	administration that the
1	developing the list
1	government agreeing to
6	drug will be
1	burdensome requirements under
1	(c) notice not
1	exposure is no
1	device a brief
1	leader of the
1	(a) notification to
2	period under paragraph
15	inspection under this
8	rendered injurious to
1	section 1532(b) of
1	labeling thereof. (4)
3	products and their
1	working group and
1	(h) fiscal year
1	consumers to whom
1	 (h) exception
91	available to the
1	involved is meeting
1	added establishments every
1	(m) of this
2	animal drug fees
4	902(a), 52 stat.
1	(6), (7), and
1	(v) review five
1	(ii)forfeiture.  the
1	(c). (b) determination
1	especially heroin addiction,
1	675, 1013, formerly
1	litigation on any
1	regarding any proposed
1	general under paragraph
1	methods and controls;
1	device or component
2	regular course of
1	drug, or for
3	device does not
1	(c);  (ii)
1	(2) chloral betaine.
2	acts of terrorism,
2	met, the applicant
3	iii shall be
2	training of school
1	indicate in the
1	opium, poppy straw,
2	administration.  (3)
1	obligations, shall establish
1	fill orders or
3	least three times
1	approved on or
1	(a) record, summarize,
1	devices plus one
1	321d. market names
1	modification, shall mean
3	acts of terrorism;
1	requirement for disclosure
1	extent required to
1	opioid the term
1	contained in each
1	satisfaction;  (b)
28	evaluation of the
2	 (i) by
2	wholesale distributor can
1	employees, agents, and
1	(d) rulemaking the
1	actual knowledge, (iii)
1	quality has been
8	colored oleomargarine or
2	appoint to such
1	contracts under the
5	 (i) be
1	total amount for
1	drug receives a
1	current reports on
3	person that distributes
4	committee on labor
1	intrastate commerce in
3	(c) limitations 
1	test results; (e)
1	(a) and subparagraph
1	allegedly violated subsection
1	(b)(3) or such
1	jury, the right
1	examination of meat
2	affects the authority
2	material facts, the
1	contract, loan, professional
1	(i), the term
3	 (a) unless
1	 (3) timeframe
7	substance or a
1	permanent allegiance to
3	forward with the
1	facility; and (h)
7	safety and security
1	evidence to fully
1	 (g) if
1	(a). (c) recognition
1	meet the same
1	manufacturing practices. (b)
1	activities and expenses
1	intermediate grays. (3)
1	(b), if such
1	drug facility fee,
2	 (2) premarket
1	additional discrete -year
1	game animals, delivered
1	(c) an environmental
1	affect, expand, or
1	timeliness in days
1	houses, for use
1	submits any dtc
1	initial dispensing of
2	made in issuing
1	authorities.  (d)
2	manufacturers or importers
1	witnesses, compel the
2	adjusted further for
1	number of employees,
2	revenue service the
1	care facility, or
1	effective or is
1	hearing, except that
6	designated to receive
1	(i)in general.the secretary
1	application a conditionally
5	undertaken as part
1	health alert network,
2	butter or cheese
1	(2) vacating of
1	differs from that
1	persons who have
1	submissions. (c) any
2	order to support
2	establishment pursuant to
1	understanding of uncertainties,
1	necessary expenses to
3	states, while attending
2	september 1, 2008,
1	date this section
2	dates shall be
1	within the competitive
1	period. (d) whether
1	scientists: provided, that
1	including the transaction
1	strong and effective
1	chapter. (r) standards
1	fiscal year. such
1	single use on
1	studies demonstrates that
4	any) which is
1	reasons that such
2	dispenser shall maintain
1	state laws nothing
1	funds. nothing in
1	 (1) develops
2	animals.  (2)
1	causing thereof are
4	conditions and indications
7	product named in
1	publications which shall
1	which, it was
1	health, and (2)
1	collaborative relationships of
1	(k) the application
1	360i or 360j(g)
1	whether the data
7	authority provided in
1	iii device under
2	described in any
1	general receives the
1	enforcement in the
1	smoke or that
2	drug administration pesticide
1	reduced fees for
1	narcotic drugs (as
1	1047. refusal or
1	(k) construction this
1	appropriate, to modify
1	functions under the
1	u.s.c. 254l et
2	health, education, labor
1	5, and consistent
2	evidence or other
1	aquifer, spring, stream,
1	laboratories accredited under
1	unadulterated milk or
1	20 characters. 
1	feed.  (3)
1	action to avoid
1	extent practicable, provide
1	cleared or has
1	use and data
1	29, 2006, the
1	finding, action, or
1	qualifying physician, if
1	labeling; (5) all
3	including genetic injury,
1	area; (b) the
1	secretarys notice to
1	product; or (iv)
1	physicians shall be
1	existing quality system
2	effectiveness of drug
1	demonstrated to present
1	make or authorize
1	recommendation shall (i)
1	(a) lawful veterinary
5	year, prior to
1	variety, which are
1	imports of such
1	  inositol
2	demand of the
2	system:  (1)
1	(c) establishing cooperative
1	drug. (3) definition
1	(f) did not
1	information and other
1	medical professionals, and
1	
 1301 to
1	making any order
1	condemned carcasses, parts,
2	(3) the number
1	request  (1)
1	intentional contamination, as
1	(c)(1)(a)(i) may, by
1	give special consideration
2	qualify for the
1	order form, statement,
1	(7) (hereinafter in
1	secretary, or an
1	food purposes. (mar.
3	demonstrate the ability
1	 (a) practitioner
2	producing, manufacturing, packing,
1	reason for the
1	appropriate, demonstrating that
1	activities. for grants
1	diseases which in
1	approved drug and
1	different susceptibility test
1	information both favorable
6	subsection (c), the
1	submissions a dtc
1	recommendation; publication; priorities
1	replace the device
1	crop insurance under
1	year only to
2	inspection frequency and
1	paragraph, distribute drug
1	completeness, and reliability
1	subsection in consultation
1	title 18 for
1	(iii) of clause
1	suspended under the
2	physical presence of
2	products for use
1	days spent during
1	processes, or biological
1	located within the
2	investigation or an
1	type of, and
1	year 2016, the
1	185. repealed. 

1	prosecution or for
1	whether it should
1	products; violation of
1	351(f)(1) of this
2	contains or relates
2	tank vehicle or
1	claimant, whether in
1	subsection (a)(1) after
1	period of advance
1	regulation provide access
1	right at all
4	order by commissioner
2	product identifier that
3	means all labels
3	shall not consider
1	state may administer
3	making recommendations to
1	(2) workload adjustmentthe
1	subgroups (a) communication
1	sells tobacco products
1	262(a)] for a
1	957(b)(2) of this
1	distribute such drugs
1	federal government does
1	holding public meetings
1	establishments conducting such
2	including any revision
2	imported under the
1	character of the
1	term administer refers
2	restrain violations, of
1	criminal offense, or
1	exemption for direct
1	manage any pharmacy,
1	articles whenever the
1	 (a) manufactures,
1	d (iu) 40.0
1	condensing: provided, that
1	informationnotwithstanding subsection (d),
1	time of original
1	(3) priority the
1	size of container
1	care entities. such
2	code and product
3	section 457 of
1	obligation to disclose
1	activities, the local
1	(3) notice not
1	application, product labeling
1	(with 0.7 iu/gm
1	meet any specifications
1	(20) standardized numerical
1	residence with like
1	preceding years the
1	care. (e) consultation
1	(iii)(i) or clause
1	study and evaluate
1	research, division of
1	inspect nonconforming plants
4	acts for fiscal
1	data with the
1	final consumer. 
1	term 3-day notice
1	species or meats
1	feed, proposed labeling
27	date of such
1	feasibility, as part
1	eligible for export
3	fees the total
28	drug in the
2	balances for the
1	regulations governing the
2	health care providers;
1	organization that meets
3	final rule published
1	paragraph in the
1	within which the
1	warrant is not
1	fellowships and training
1	(ii) who performs
1	accept, hold, and
1	veterinary medicine, which
1	medication; and (ii)
1	of, or pursuant
1	wholesalers who shall
1	hereafter be included
1	reporting requirements needed
9	supplement to such
1	jurisdiction pursuant to
2	may vary based
1	program, such as
1	advertising production costs
2	tests on animals)
1	person, or with
2	construed to 
1	(b)(3) is received,
1	person. (13) the
2	arising under or
1	(1) shall, within
1	governmental officials, and
1	identity (by established
1	conduct education and
1	alternative drugs. (june
2	year  (i)
1	title 49, code
1	updated, recognized susceptibility
1	person, entity, or
1	enforcement purposes the
1	recall, or to
1	importation of designated
1	controls but the
3	secretary or an
1	antiquated -ray equipment,
1	states attorney, postpone
1	food) intended to
3	certain classes of
1	(1) in generalto
1	program shall inform
1	person, including any
1	states of viruses,
13	shall be published
3	decision, made in
1	offenses. (b) notification
1	term program means
1	labels and labeling;
1	(i) the approval
1	transferred or sold
1	lack of coordination
1	 vitamins: a
1	interest.  (f)
1	business in which
1	(iv) contained in
1	agent or an
1	or, if ordered
1	reauthorized beyond fiscal
1	any, pertaining to
1	379d5. guidance document
1	another person in
1	requests; and (5)
1	recommendation was made
1	(14) $124,000,000 for
2	day after its
1	schedule. there is
1	liquid form, or
1	750.0 (225 g).c
4	management plans for
8	date described in
5	fee as established
1	united states 
1	statements made on
1	importation under appropriate
1	programs for highly
1	carrying out subparagraphs
1	date had not
1	request the head
1	 (d) payment
1	witness protection program.
1	(2) a warrant
1	(a) the application
1	1 category listed
1	(f). such regulation
1	new drug submitted
1	establish the operating
1	ant-drug message or
1	when, in his
1	manufacturer.  (4)
1	hashish oil, such
1	except the seed
1	branded no person
1	(b) grants to
6	submits, on or
2	4, 2011, that
1	level of residues
1	potential to affect,
1	may be delivered,
2	moneys, negotiable instruments,
2	safe level established
1	early warning surveillance
1	harmful constituents in
2	safe, with respect
1	remove foods that
3	including clinical investigations,
1	order (including a
2	granted the variance
1	situations not requiring
1	radiation; (4) study
1	reviewable.  (f)
1	respond promptly to
1	secretary established offices,
1	dirty egg, incubator
1	determines, through rulemaking,
1	allocated to meet
1	subsidiary the term
1	applicable; and (ii)
1	parts is necessary
3	failure to complete
17	360c of this
4	subparagraph (a) was
2	shall inspect establishments
2	safety standards committee
1	prescribing or dispensing
1	et seq.), involving
2	microorganisms, as applicable
1	prior fiscal year
3	which, because of
3	given appropriate notice
1	needed  (a)
1	defense shall, by
2	advertising of which
1	voluntarily requests advisory
1	policies, and activities
1	used (including, but
1	(xiii) the distribution
1	secure manner that
1	hearing, the findings
8	product (as defined
1	(6) the potential
1	september 2011. (2)
1	created acted in
1	shall call upon
1	families, and communities
1	methamphetamines, as documented
2	criteria website 
1	change in stage
1	specific terms the
1	means any optical,
1	act to this
10	drug applications, supplemental
1	(c), for such
1	prevention of disease
2	potential or actual
1	designed observational studies
2	subsection (d), as
1	made or suggested
1	necessary, a description
1	commissioner shall submit
1	supply products determined
1	lead to unavailability
1	(27 u.s.c. 214),
2	population of patients
1	secretary, whenever processing
5	labeling proposed to
1	dispenser; and (iv)
1	dispensation by means
1	conditional approval, or
2	attorney general for
1	will provide a
1	age of 18
1	shall be public
1	reviewing divisions on
1	activities.  (e)
1	jury and either
1	includes any nonradioactive
3	request, provide the
6	specify in the
1	preliminary order, or
2	shall be withdrawn
1	community regarding the
1	practices to reduce
2	26, 1951, ch.
4	conditions as may
1	(ii), the transaction
1	practice, or assigned
1	time such dairy
2	shipping containers of
1	paragraph (1)(d) the
1	exclusivities or extensions
1	taken and the
1	(3) costs. 
1	subsection (d)(5). 
1	(or subsequent transferees)
6	drug if the
1	evaluation via telemedicine
1	proof of service
1	rate of grade
1	studies not submitted
1	strategiesthe coalition shall,
1	 (a) random
4	16, 1950, ch.
1	shall impose, in
1	enforcement authority, a
1	conditions of determination
3	prevalence of the
1	subset referred to
1	penalties.  (i)
1	 (g) internet
1	 (d) exercises
2	application, together with
1	means any and
2	may, as appropriate,
1	(b) is administered
1	statement of any
1	attached such conditions
1	upgrading such products
1	ensure that major
1	time specified. (g)
2	sale. such document
1	 (1) corporations,
1	(e) prohibited distribution
1	sold. such information
2	outsourcing facility, including
1	drug which, or
1	representative anyone convicted
1	combination involved) be
1	year 2015 (to
1	(i) the initial
1	chapter and section
1	commerce. such manufacturer
1	seq.]. the director
1	year, increased by
1	entities to conduct
37	representative of the
1	confidentially maintain any
1	shown, by clear
1	orders or meet
1	abuse, diversion from
1	basis, not later
2	similar limitations (whether
5	health, food, or
10	purpose of preventing
1	drugsbeginning with fiscal
1	achievement of its
1	 (i) comply
1	secretary. (m) clarification
1	distribution, transfer, and
1	plan and report
1	15. (june 25,
1	determined by each
1	code of 1986.
1	review the information
1	enforce this provision
1	person and not
1	invalid, the constitutionality
1	involving the possession
1	(c) solely because
9	(feb. 15, 1927,
1	determinations regarding the
1	section 1543(a)(1) of
1	discrimination and identifying
1	controls and other
1	labels, packaging design,
1	labeling; (iii) the
1	inspection and postmarket
1	bears such responsibility
1	term state has
1	term singl-use device
1	confidential.  (f)
1	encouraged to conduct
1	drug code that
1	effects, and contraindications;
5	minutes of negotiation
1	device deaths and
3	device means any
1	council.  (

1	secretarys actions; judicial
1	trafficking area task
1	tolerance, as of
33	united states court
2	controls, and facilities)
1	601.94 of title
1	represents, or without
1	shall apply in
1	findings congress finds
1	effectiveness the owner,
1	review (a) petition;
1	submits a new
1	fees are owed.
1	issue raised in
1	order was based;
3	substance in accordance
2	360eee3(a) of this
2	reasonable, taking into
1	2009. the effective
3	purpose of receiving
1	label, or container
1	(2) definitionsin this
1	year specified in
3	engaged in a
1	disclose, in violation
1	extension; (ii) the
1	basis; (b) jeopardize
2	drug abuse requires
1	new methodology or
1	treatment outcome monitoring
1	advisory committee; the
1	ingredient requirements, in
1	found, after tests
1	inspection rendered on
1	ii, 204, as
1	director. (
 

1	identification codes, such
1	$50,000,000 for the
1	means any agency
8	making the request
1	hearing to which
1	tolerance is established,
4	year after july
3	 (e) 
1	development fee established
1	(a)(i), the following
1	shall be begun
15	risk of illness
2	effectiveness; (ii) each
1	responsibilities for food
1	panel established by
1	cultivated in violation
1	entity to enable
1	administration, shall 
1	poultry inspected by
1	nicotine in accordance
1	thereunder with respect
3	conduct postmarket surveillance
1	purposes stated in
1	(c)(3)  (i)
1	claim; or (ii)
1	repackager or destroyed;
1	increasing in the
1	instrumentalities used or
1	labeling, packaging or
1	(e)(1), or an
1	upon application therefor
1	activity of a
1	(3) for any
1	percentage determined for
1	use up to
1	 (f) biosimilar
1	intends to bring
1	perjury, false swearing,
1	management of specific
1	substances sold exclusively
1	among 1- and
1	387a1(a) of this
1	ounces (15 grams).
1	verify, the records.
2	population likely to
1	secretary may consider,
1	processing such poultry
1	basis, with the
1	drugs on current
1	described by this
1	inspection requirements (a)
1	handling. (b) inapplicability
1	priorities developed in
1	shall assess practices
1	(
 
 1179.
1	pharmacopoeia; development of
2	services shall be
1	yields do not
1	time or opportunity
2	information referenced in
1	exportation in lieu
1	coverings of meat
2	states. this chapter
7	defendant may be
3	advisory committee. 
1	(
 
 1710a.
4	panels under section
1	 (i) subparagraph
1	authorization (including destruction
1	decontaminating, and recovering
2	subsection (a)(5)), a
1	agent is making
1	70 percent more
1	sale to which
1	approval and the
1	countermeasure, and a
2	subparagraph.  (c)
1	quarter of such
1	business of any
2	resumption, the date
1	technical data related
1	(i) standard for
1	dates and minimum
1	sentence imposed, be
1	substantial, such substance
1	pharmacythe secretary shall
1	activities by state
1	health care goods
1	use instructions to
2	drug administration, with
1	(c). (2) types
1	circumstances, so long
2	intergovernmental cooperation and
202	days after the
1	section 826(h) of
1	products within the
1	fulfill the purposes
1	states; (2) providing
1	sponsor that they
1	requests issued on
1	purposes of facilitating
1	(i) a full
1	products will switch
1	imports that leverage
1	 (c) factors
2	food allergies and
1	whether they have
1	substances have a
1	expenses means expenses
1	amounts received under
1	public to protect
2	recommendation, under section
1	sciences to act,
1	order to insure
2	without a waiver
1	various timelines, in
2	without proper authority
2	may require, the
1	accordance with that
7	commission under this
1	(b) through (d),
1	partners in the
1	paragraph, presubmissions and
1	children that are
1	26, 2014) for
1	structured ris-benefit assessment
1	diseased animals slaughtered
1	violate section 897.34(c).
1	product comprised of
1	title; and (6)
5	submitted for listing
1	subparagraph for each
1	nongovernmental entities, the
2	pediatric advisory committeenot
1	30, 2010, this
1	physicians, pharmacists, and
1	manufacturing practices issued
1	(22) thir-party logistics
2	labeling changes beginning
1	offense as defined
1	exempt from providing
1	individual, violates subsection
1	file fee shall
1	resources to inspections
2	101(b) of this
1	retain qualified individuals
2	 (d) provision
1	manufacturer, exclusive distributor
3	disclosure; access to
1	 (h) construction
1	requires substantive clinical
1	feed, if such
1	petition and ending
2	counted as no-federal
1	eating places, of
1	(f) advisory committee
1	analyses.  the
1	comply with standardsif
2	conducted in conformity
1	require the hearing
1	(c) third party
1	process for reporting
1	 (b) minor
1	343(h)(1) of this
1	measures relating to
2	exist necessitating an
1	 (d) regulation
1	(i). (v) for
1	within 30 months
1	(c) payment due
1	regulatory oversight and
5	lon-term and shor-term
1	printed matter issued
1	criteria are promulgated,
1	members the secretary
1	growing area, and
1	subsection (b)(6), the
1	adequately supported by
2	submits a report
1	year; (iii) under
1	(c) in a
1	among european economic
1	agents in classrooms
1	title and registered
1	resubmission of the
1	importer, or (b)
1	section 360m(a) of
1	(iii) 2 shall
1	misbranded or otherwise
1	application of subparagraph
1	discovery  (a)
1	substance, the patients
1	regarding hospital pharmacies
1	part and which
2	(c) scope 
1	general shall continue
1	implementing such requirements,
1	implementing such requirements.
19	swine, goats, horses,
1	shall, where necessary
1	ch. 784, 1,
1	supply can be
2	denies the application,
2	receipt of transaction
1	shall include historical
5	(b) the issuance
2	 (h) annual
1	mark. (p) the
2	engages the services
2	administration programs and
1	withdraw the approved
2	(iii) the national
1	(1) no right
9	 (4) 
1	chapter, the provision
4	waiver of the
2	use are in
1	returned. (3) a
3	due regard for
1	agenciesthe attorney general
1	federal register, after
2	state inspection program
10	listed in another
2	publish information submitted
1	advance the goals
1	use. (4) time
1	dispenser obtained the
1	(3)(a), and (iv)
1	licensing authority, upon
1	packaged, and held
1	records are adequate
1	suspend, as the
1	inspections relating to
1	united states faces
2	include a business
1	title 28. such
2	number of calendar
1	purchaser a transaction
1	distributor discontinues the
1	country on request.
2	may be appropriate
2	rail vehicle, receiver,
4	353(c)(1) of this
1	require such person
1	(ii) provide reasonable
1	classified report 
3	360eee3 of this
1	(a)(1) exceeds $25,000,000
1	(iii) in any
1	changes. (
 

1	specify appropriate scienc-based
1	held by a
1	list included in
1	judicial review the
1	personnel matters 
2	2007, during the
1	undertaken under section
11	device, mark, or
2	substance under subsection
2	hearing may be
1	(2) goalsthe strategy
7	section 360e(c) of
1	auditors in a
1	whether such viruses,
1	establishment.  (mar.
3	september 30, 1980,
1	individual or $250,000
1	safety; and (3)
1	review within 30
1	aircraft, or any
1	outbreaks; (b) food
1	use on food.
1	purpose the name
1	prior convictions, the
1	data sufficient to
1	urgent need for
1	undue burdens on
4	drug the term
11	opportunity for hearing
1	event of outbreak
1	funding directly related
1	contrary to a
1	(b) appropriate state
1	approval.  (c)
1	including dietary exposure
3	authorized for a
1	otherwise altering of
1	(f) no person,
1	august 31, 1997)
2	dispenser enters into
2	shall in accordance
2	apply for a
1	funding under section
1	section 3(c)(5) of
2	inactive ingredients are
1	internationall-recognized standards in
1	offense, and (2)
1	denied under this
3	secretary requests such
1	program (in this
1	order, or whose
2	code, and for
1	international emergency economic
1	established in subpart
2	adverse safety and
1	supplement. in any
1	animal owned by
1	(b) to present
1	refusal to file
1	(a).  (7)
4	360c, 360d, 360e,
1	comply in the
1	structure of an
2	food ingredients, and
1	(a) the findings
1	requirement inapplicable. (b)
1	 (b) standards
1	contentsthe report shall
1	title 42 may
1	drug qualifies as
1	shall, if such
9	(3) in the
2	revenue needed to
1	federal register if
1	producers), not exempted
1	substance is unstable
9	included on the
2	(a) developing and
3	state into which
5	act (15 u.s.c.
1	administrator within 30
1	report year 
1	(i) pose questions
1	local officials 
3	marketing act of
1	delay authorization under
1	
 399a. office
3	less than once
1	packed. (v) the
1	container from which
1	utilize innovative and
1	water may be
1	auditors.  (c)
2	1902, ch. 1357,
2	foods advertising which
2	district agreed upon
1	timeframes.  (6)
3	compliance has been
1	necessary process: provided,
1	drugs to treat
1	(1) such infant
1	provision of treatment,
3	action for the
3	using improved advers-event
1	application to determine
3	public health. (d)
2	(g) 4.0 
1	(including by type
1	156. licenses conditioned
1	been, distributed. 
5	office of management
1	42 (as applicable);
1	funds are allocated
2	gas or gases
1	 (b) nonvoting
1	conditions to the
1	competitive service. 
1	verificationthe owner, operator,
1	(i) and paragraph
1	including breaking eggs
1	2013. (b) $112,580,497
1	42 (as applicable),
1	involved, including a
1	sale of devices.
1	facility intends to
2	period  (a)
1	114e to 114h.
1	persons who provide
1	misbranded cosmeticsa cosmetic
2	filed by the
1	insert or rol-you-own
2	(1)(b) of such
1	(b), as the
42	place of business
1	formerly 8th par.,
4	section 262(a) of
1	perform consultative and
1	need not make
2	harmful effect, or
1	electronic data, or
2	institution of higher
1	intentionally and the
1	(a)(1) within 120
1	consider among other
1	withdrawing an order
1	general rulewhenever the
1	unless the animal
1	(4); by (ii)
1	information until advised
1	21, 1972, and
1	qualities of eggs,
2	supplier shall be
2	 (b) publication
1	importation of egg
1	provisions except to
1	including quality factor
2	proviso shall not
4	act or omission
3	columbia, and the
1	387h(c), or 387k(a)
1	relating to both
1	light of governing
1	drug experiences (as
1	analyses; research the
2	payment penalties, and
1	(i) the definition
1	patien-reported outcome. 
2	entry of poultry
1	trade representative; and
2	grant, loan, or
1	rol-you-own tobacco, and
1	prescribe regulations for
1	safety. (k) construction
1	may increase the
1	initiate guidance to
1	countermeasures, security countermeasures,
1	introduced therein in
2	necessary; (ii) the
2	revising such guidance,
1	exemption to any
4	title by distributing
1	property transferred to
2	maintain current procedures
3	books, documents, papers,
3	congress under section
2	complete statement of
1	benzilate. (14) -methy--piperidyl
1	(b) this paragraph
1	(iii) the seller
1	grant all appropriate
1	publication unless (i)
1	promptly available to
1	1541 of this
1	(1). (e) authorization
1	applications and treatment
1	interest shall accrue
3	states shall bear
2	areas and in
1	675, 306, as
6	subsections (c), (d),
1	establishment are drugs
1	evaluated. (june 25,
4	premarket report under
1	states law, for
1	375. publicity (a)
1	(b)definition.  for
11	sale, purchase, or
2	animal quarantine laws
1	(f)(4), instances when
2	clause (iv) is
2	made by personal
1	plan.  (b)
1	campaign pursuant to
1	among children. in
1	educational and public
1	voluntary, subsequent remedial
1	file has paid
1	clinical trial are
7	fee if application
1	employees, fellows, and
5	quarantine inspection user
1	$500 nor more
1	material which merely
1	cooperative agreement, that
3	may order because
1	4, 2002, the
1	permission for disclosure
2	state agencies for
1	impose sentence as
1	product authorized for
1	drugs in order
2	360b(i) of this
1	denial of approval,
1	product in bulk
1	deemed approved on
1	claimant means any
1	development of effective
1	identifies a legally
1	manner as determined
2	use panels of
1	humans, wildlife, or
1	(b)(1)(b). (f) awareness
1	dosage form, a
1	seq.) shall not
2	event.  (h)
1	medicine therapy and
1	campaign, including addressing
4	states.  (e)
1	transmitted by or
25	information described in
1	meets all the
1	subsection (k)(1) and
3	cases shall conform,
1	word imitation and,
1	establishments the secretary
1	agencies, organizations, institutions,
1	198; amended july
1	section 3374(c) of
7	humans or animals,
1	states from a
1	352(b)(1) of this
1	structure is substantially
2	determines that compliance
8	humans or animals.
1	(including drug products
1	addiction, substantially contributes
1	18, entering information
2	shipment date from
1	defect not ordinarily
1	less than 80
8	annual report to
1	changes in workload
1	(addled eggs), sour
1	form.  (b)
1	rates not exceeding
1	
 1180. transferred

1	program; (b) direct
2	(ii) prior to,
2	dispute regarding the
6	waiver under subparagraph
1	(e) discontinuance of
1	final order under
5	product, the manufacturer
2	system, the secretary
1	maintain on the
3	submitted after the
1	inspections; (4) training
3	food, the secretary
3	60 days prior
1	objecting to the
5	means any person,
1	section 350(b)(2) of
1	intended for emergency
1	(d) conducting educational
1	lon-term assessment of
1	labeling resulting from
5	accordance with title
2	will be prevented
2	activities of designated
2	request; and (b)
1	action on behalf
5	drug administration through
1	significant resources of
3	advisory review in
1	review division 
1	identification is not
1	periodic substance abuse
1	controls against diversion.
1	director, partner, employee,
1	transports, distributes, holds,
1	agent referred to
1	1, 44 stat.
1	regulation takes effect
1	authority (a) voluntary
1	poultry science or
4	adjustment result in
3	fees relating to
1	advisory review is
1	profession. (3) the
1	analytic reports by
1	(b) contrary, in
1	identified order of
1	conditions, the attorney
2	 (b) contents
1	public meeting, and
1	minimize foundation duplication
10	particular drug product
1	certain goods the
2	decision to approve
1	secretary by paragraph
3	section 351(h) of
1	food, means a
1	reclassified into class
1	subgroup, or any
1	priority new drug
2	make reports, required
1	part: (1) affiliatethe
1	effectively implementing the
1	enrolled in, any
1	priority countermeasure has
1	 (2) evaluation
1	 (b) contentfor
1	(8) program the
3	regulations under which
2	case of articles
1	knowingly fails to
1	deferral extensions requested
1	forms, or both;
6	may be introduced
1	sue and be
1	effect, if known.
1	consumers) to the
2	title, section 387j
1	patients name and
1	relied on, the
1	role of drug
3	united states (referred
2	employees to conduct
1	dispenser, including any
1	(ii) the label,
1	transaction information, in
1	smokeless tobacco health
1	test results and
1	trafficking in, and
1	tracking, and radar
1	waivers not later
1	plan, and the
1	notice, 30 days
2	aside the order
1	another tobacco product.
1	supplement. the time
1	tobacco product unless
1	shall provide interested
1	establish a schedule
1	made  (i)
1	agency centers, the
1	have, in accordance
1	control means to
2	confidential any information
1	675, 907, as
1	released from customs
1	prescribing appropriate tests
1	october 1996. (9)
1	subject matter, so
1	paragraph (1). an
1	export the secretary
1	appropriate security measures
1	containing domestically grown
1	appropriate to reduce
2	labeling of which,
1	efforts are interrelated.
1	title, licensure, or
1	programs directly related
1	participation. (i) operational
1	analyses are certified
1	amounts deposited in
4	believes is likely
1	entity shall continue
1	staff years the
3	entity that does
1	act of february
7	necessary for each
1	potential recipients for
1	specify, as necessary
1	 (2) disclosure
1	section, specifying, as
1	court permits discovery
1	dress, trademark, brand
1	operations and activities
1	carrying out a
1	appropriate scienc-based mitigation
1	business confidentiality and
3	(b) shall include
1	manufacture of type
1	drugs; and (c)
2	(c) inspection services
2	successive -year period
1	inventory required by
1	(b)(2), shall 
1	379j53. reauthorization; reporting
1	attempted to be
4	notificationif the secretary
3	substance under the
1	upon august 18,
2	export a controlled
4	(in such form
1	board. (h) administrative
2	effect until 30
8	appeals have been
1	device until changed
1	potentially less efficacious
1	injury that 
1	(3) amendments to
1	show compliance with
1	(19 u.s.c. 1306);
2	application immediately, and
1	judgment if, under
1	communication, without selection
1	facility manufactures drugs
1	appropriated (1) for
1	office unless the
2	exemption, or reduction
2	human services shall,
1	healthy at the
1	cause will be
1	device. if, after
1	states dealing and
1	require that before
1	subsection after the
1	areas that have
1	(2) publish such
1	foreign commerce exclusively
5	product from a
1	expansion of drug
1	among federal law
1	generic drug fees
1	(1) shall use
2	conditions imposed by
1	licenses all licenses
1	young people in
1	teeterboards. (2) the
49	committee on energy
1	reporting) applies with
1	licensure; (c) may
3	pay an illegal
1	repay, for each
1	(a) devices to
1	federal agencies will
2	auditor, the accreditation
12	individual, partnership, corporation,
1	primary jurisdiction; (ii)
2	including full information
1	straw. (4) coca[3]
1	known as oleomargarine,
1	adverse events or
2	buy, or distribute
1	lifetime risk that
1	owner has not
1	information since the
1	675, 564, as
1	(2) the labeling
1	later than 72
1	rules at licensed
1	statement describing any
1	will facilitate the
1	clause (i); (ii)
2	program; and 
1	
 
 360cc.
2	panel to serve
1	staggered terms not
1	(c) communications; (d)
1	carrying out police,
1	chapter. (c) sales
1	product, as defined
2	 (b) disposition
2	certificates of analysis
1	 (v)authority for
1	has, under paragraph
1	(b) the custom
1	prescription drug establishments,
1	(b) notification any
1	similar material, which
2	different types of
1	manner.  (b)
3	studies of animal
2	federal register his
3	oral order of
1	publicly available clear
1	chemicals a firm
1	plain, uncondensed gothic
1	(ii)disposition of data.
1	parts thereof shall
1	states which regulate
1	(f) the negotiated
4	person under paragraph
1	supporting information; and
1	related information, if
1	subsection, amend or
1	shall initiate the
4	disposition of an
1	additional requirements that
1	similar contained ma-made
1	validation of prescription
3	(other than in
2	sanitation requirements that
1	involve one or
1	2007, shall, at
2	year 2012 to
1	subsection (f), authorized
1	falsely representing, or
1	drug manufacturing (a)
1	formula is begun
2	filing of timely
3	available for inspection,
4	relating to product
1	granted a hearing
3	license was issued,
1	recall of infant
2	672 of this
1	food. the temporary
1	paragraph, recommendations for
1	auditor in the
2	designate an employee
1	respect to particular
1	(c) definitions 
8	conditions prescribed, recommended,
1	adequate reports of
1	(e) additional notice
1	(d) publish in
1	economic hardship or
1	(ii) that any
1	approaches to reduce
1	establish standards for
1	distribution of or
2	educational materials for
1	acid. (5) lysergic
1	amend the regulations
2	 (2) initial
1	activities funded under
5	senate; (c) scientific
1	applicant, the agreed
1	catfish.  (2)
3	outbreaks of foodborne
1	examinations and investigations.
2	387f(e) of this
1	candidates to be
2	appropriated for a
1	(d) publicationthe secretary
1	(c) sales of
1	administrator, i-kind contributions)
1	 (b) paymentexcept
1	evidence that (1)
1	2015 through 2018,
1	means collaborative groups
1	substances. (5) such
2	unless such article
1	imprisonment is increased
1	1988, and the
1	submits such an
2	shall, within 30
1	report that specifies
1	(g) is effective
2	product approved before
3	commerce, as a
1	failure of registrants
1	drugs once during
1	information stating that
1	(2) postapproval production
1	drugs with abuse
1	exist to evaluate
1	person; and (b)
1	product fee shall
1	(6) training in
1	government agencies; patients
1	provider licensure as
2	hours after a
1	condition; (2) that,
1	existing requirements, including
1	research in achieving
1	website. (3) notice
1	compounding; (ii) if
5	filed under subparagraph
1	enhancing medical product
1	resistance to drugs
2	qualities of eggs
1	entities, professional associations,
1	(1) priority status
1	device or mark;
1	suspect product as
2	requirement, is licensed
3	application and that
1	either party any
2	formula is in
1	met.  (iii)
1	incorporate the product
1	person owns or
1	chapter; (ii) a
2	clinical protocol consistent
1	imported for the
1	(i) that has
1	assistance to states
1	effective drug concentrations
1	exportation.  (

1	information as is
1	substantiated scientific requirement
1	local levels of
2	timelines shall be
1	(g) expedited inspections
4	services, and ways
1	specific duties and
5	subparagraph (a)(ii) in
1	new product, or
1	 (2) include
1	may specify in
3	paragraph  (i)
1	package for review;
1	subparagraph (a)(ii) if
1	136a1(g)] on or
1	agency center, shall
1	drug, expedite the
8	secretary has issued
1	distinguished from pharmacists)
1	support effective chemical
2	drug or container
1	(b). (6) withdrawal
1	cocaine, changes in
1	contentsthe voluntary guidelines
1	quantitative comparison of
3	(iii) with respect
2	unless such device
20	subject to subsection
4	50 grams or
1	make any report
1	alternatives, to reduce
1	trigger responses by
1	subchapter, if the
1	465. limitations upon
1	determines appropriate for
1	separate registration under
1	assistance to state,
1	product manufacturers and
2	supplements filed per
1	2013  (a)
1	august 28, 1996,
1	occurred only if
1	shall compare the
1	mislead, such person
1	small business exception
1	related to participation
1	governing first amendment
6	(i) does not
2	group if the
1	stockpiling, approval, licensure,
1	director shall take
1	registration period no
1	labeling and container
1	regulations for applications
1	variability of the
1	(2) such infant
3	products which contain
1	general, institute of
1	(iv) identifying the
3	use for human
1	compliance by promptly
3	criminal proceeding against,
1	initiatives that have
2	withdrawal from the
1	agency. (3) all
1	enacted. (d) refund
2	training to improve
1	shall include standards
6	views and comments,
1	qualifying laboratory. (n)
3	facility  (a)
1	1 such fee
1	technical and professional
1	industry, laboratories, laboratory
1	(a)(iii)(x), if there
1	(i) approaches that
1	progress for the
2	case the provisions
1	consumption.  (h)
16	1905 of title
1	(b)(2)(b), debar an
1	samples of any
1	approval. (iii) for
5	designated as a
2	drug samples by
3	possess, without promptly
1	identifying contamination in
2	world evidence for
1	subsection (b)(1), shall
1	material to food
1	kind commonly known
1	superiority trials, trial
2	devices to patients
5	 (b) use
1	conspicuously displayed by
2	food. no person
1	 (h) labeling
1	one such facility,
1	may, by rule,
1	custody of attorney
2	used a priority
4	costs, excluding costs
1	may stay the
1	substances and in
1	 (f) progress
1	term exclusive distributor
2	supplement an application
27	year in which
1	n-tobacc-sale order was
1	average, over a
1	amounts for the
1	application of that
1	poultry inspection regulations
1	(a), the applicable
1	authorized for use
1	 (7) significant
1	animal has been
1	(iv) did not
1	subsection fails to
2	indian country without
1	amount of hidta
1	(a) shall review
1	local target requirement
1	2013 that are
1	concerned with standar-setting
1	phenotypic variability and
1	committees to send
1	$1,000, or both
1	review, the number
1	(iii) 1 individual
2	 (f) additional
1	appropriate flexibility for
1	files a complaint,
1	title and by
2	may withdraw or
5	subject to imprisonment
1	testing device that
1	risk; safety protocol
1	implemented in a
1	 (iv) reallocations
1	imprisonment or (b)
1	(2) registration an
1	human health presented
1	dispensed other than
1	widely available training
1	uses of new
1	program. (b) such
1	(
 
 221
1	wherever venue is
1	considers appropriate based
25	described in such
1	subsection (d) as
1	minimum standards related
1	progress in the
1	behalf of any
2	means to deliver
1	factor (as defined
1	requirements, including tracing
1	internet to distribute
1	classified in schedule
1	(e) data derived
1	controlled after october
1	known. (6) the
1	
 
 384e.
1	acts amendatory of,
1	punishable by more
1	lien under this
9	application subject to
1	product, pursuant to
3	conduct of clinical
1	(a) information regarding
3	insure compliance with
1	behavior.  (iii)
1	dates and estimated
6	(d) the number
2	contain more than
1	determinations by secretary;
1	bottle or other
1	(ii) when such
1	admission of narcotic
1	article will reasonably
1	entity under subparagraph
2	commission of such
1	64. regulations for
7	 (2) no
5	patent which is
1	paragraph to a
1	section 1151 of
1	adequate; (3) the
2	establishment with the
1	purchasers, and the
9	shall be issued
4	export of the
5	evaluation and recommend
1	error under this
1	applicationsthe secretary shall
1	withdrawn, other than
1	protocol or available
3	entity means a
1	(2), practitioners who
1	quantity, chemical, container,
1	26, 2002 (except
1	demonstrate that devices
1	(2) improve the
1	held for import
1	number applicable to
2	wholesale distributor to
1	animal feed; or
4	manufactured by the
8	action taken under
2	obtained or created
1	(such as pharmaceutical
3	illicit production of
1	private sector contributions
1	compendium. (g) medical
1	brought to enforce
1	registration required by
1	(iv) any such
1	21, 1971, which
2	participates in a
1	shall use a
2	years. in the
1	animal feeds. (8)
1	sought accreditation, but
2	copying by officers
2	appellant if the
1	establishment of requirement
1	qualified for the
1	animal drug; (f)
3	october 27, 1970,
2	selected establishment with
1	laboratory the term
1	trade name, brand
2	enacted after august
1	controls, and documenting
1	(a) be commensurate
1	auditor or audited
1	order upon a
1	effect, the drug
1	iron (mg) 0.15
1	program strategy and
1	person or, if
1	subparagraph, the owner
1	interdiction coordinator 
1	food, dietary ingredient,
1	product recall will
2	fees and such
2	commerce carcasses, portions
1	section, including advice
1	protection, conservation and
1	equal to \1/3\
1	 (2) vacancies
1	certification that such
1	within such period.
1	scheduled audits conducted
1	approved application; or
2	inspection report under
1	limitation on administrative
1	july 2, 1956,
1	military, or public
1	individuals or their
1	use is prohibited.;
3	subsection (a)(2) (relating
1	federal cooperation (a)
2	shall require periodic
1	order relating to
1	1103.)
 
 141.
2	facility if the
1	increasing rate of
1	limitations if, after
1	industry.  (d)
2	herbicides to eliminate
1	exemption upon 
1	(c) to refund
2	provide assistance to
6	accordance with authority
1	approve a plan
2	hearing to be
6	preceding sentence, the
2	preparation containing any
1	(g) banned devices
1	486.)
 
 321a.
2	j. farias and
1	360ddd. definitionsin this
10	lif-threatening disease or
1	general rule any
2	within the provisions
2	set aside in
1	calendar days set
1	distributor is appropriately
1	18, except that
3	places of business,
1	possession, information reporting
1	prescribed prior to
1	practices in commercial
1	(3) develop and
1	rationale for recognition
1	intramural research programs
2	(a) the common
1	amount of transfers
1	 (c) reactivation
3	 (e) refund
2	regulation is not
6	underlying data and
1	accessing, using, or
2	name so recommended
1	include charging cos-based
1	temporary suspension if,
3	commercially feasible means,
1	usually known as
1	advisory commission, may
2	state by which
1	executive director; 
1	paragraph. (q) date
3	circumstances, extent, and
1	113a. establishment of
7	territory or possession
2	patent infringement to
2	recommendations for investigations
1	contributed to such
1	extent such costs
1	consequences, which may
1	 (ii) conditionsa
7	authority under this
2	(5), or (b)
1	abuse and controlled
1	applicable calendar year,
1	 (b) processthe
1	intentionally uses a
1	section applies shall
1	applicable calendar year;
1	offense, the prohibited
1	(
 
 2013.
3	distributor; and (b)
1	paragraph, no reporting
2	use; or (2)
1	203. application for
1	years; (2) of
4	months after september
3	month of june
1	conduct such activities
1	supplemental application. 
1	applications of such
1	further, this section
1	panel track supplement,
1	activities are maintained.
1	repatriate and deposit.
1	increasing participation in
1	immediate recipients in
2	receipt, distribution, manufacture,
1	certify to such
5	strength, quality, or
1	information made publicly
5	reasonable assurance that
1	formula  (1)
1	lists under subsection
1	request  (a)
1	animal, and which,
1	appropriate to assist
1	(2)(a) of subsection
1	operations; and (c)
1	amounts shall remain
1	elements of strategy
1	seq.], this clause
11	event of a
2	law as a
1	(a) to on-sixth
1	federal property where
1	chain that chooses
1	term qualified data
1	taken against compounding
1	exposed to such
1	paragraph (1)(a) may
19	order under this
2	appropriate identification number
1	jurisdiction there is
1	rest area after
1	declaration that it
1	336. report of
3	regulating the distribution
1	(h) conditions 
1	section 1534 of
2	(e) upon the
1	permanently debarred) or
2	use standard costs.
1	permit said virus
1	previously been initiated
2	cocaine or salts
2	assessment becomes final,
1	utilize the program
2	file such information;
2	time after, submission
1	fraudulent, or would
1	period from the
1	(including a transport
6	act of march
1	(v) the physician
1	root, cocculus indicus,
1	countries selected by
1	title (or exempt
2	by, the field
1	subsection (b)(2)(a): 
1	alert that requires
1	years, provided the
1	systems to comply
1	center of illegal
2	brand manufacturer, printer,
1	 (i) funding
1	appropriate law enforcement
1	panel on a
2	 (1) whenever
2	u.s.c. 1421 et
7	include an application
1	plan; (b) whether
1	(a) provide a
3	oversight and enforcement
2	(c) of such
1	(2) inapplicability to
1	(3) shall extend
1	381(s) of this
1	(a) the head
1	state authority except
1	registration; separate registration;
2	determined on the
1	provision of instructions
1	360fff4. guidance; other
11	attorney general in
1	(iv) relief standard
1	subsection and notice
1	facility, including whether
1	term food, when
1	aircraft, or on
2	unwholesome, otherwise adulterated,
1	single day for
1	registrants reasonably anticipated
1	additive on the
1	annual o-site inspections,
1	strategy is submitted.
2	included or the
1	title) that violates
1	persons, including representatives
1	case of failure
1	states in cases
1	tobacco, rol-you-own tobacco,
1	facilities to increase
1	to, any person,
1	area is not
1	powder of ipecac
1	part, any order
2	involved meets the
1	reliance thereon, shall
1	cosmetic act; jurisdictional
1	title with due
1	analysis, carrying out
2	efforts to prevent
1	synthesized equivalent of
1	previous distribution history
1	activities shall be
1	marketed drugs and
1	trade bureau with
1	term at the
2	private youth center,
1	used for reporting
1	(ii) no waivers,
6	services in any
1	abuse the attorney
1	product, as applicable,
2	whose name appears
1	(a) include conclusions
1	may grant an
1	make it impossible
1	secretary, promulgate regulations
1	ensure that, if
1	affects security or
1	submission or review
2	improvement in the
1	notwithstanding paragraph (2),
1	r-exportation, the person
2	individual resulting from
6	complied with the
1	clause (ii)(i). (v)
1	 (d) activities
1	(1), a registrant
1	raw tobacco for
2	subsection (a), in
3	display of written,
6	(b) provide a
1	without screens, permanent
1	life may be
1	subsection (a), if
1	(a) the reasons
1	comprehensive response to
1	29, 2006, report
12	shall be imprisoned
1	(b)(2) to include
1	(1) other laws
1	drug, the holder
1	mental and physical
1	training that the
3	specifying with particularity
1	drugs, shall publicly
1	pay in effect
2	1471 et seq.),
2	identifies specifically, in
1	inspections. (ii) a
2	federal establishment; (ii)
1	studies, or nonclinical
1	clause (c) solely
1	saleable unit of
1	item (aa) would
1	(h), and (p),
1	organization.[1]  (ii)
1	1907. definitionsas used
1	variability and identifying
1	 (c) color
1	registered or was
2	libel proceedings under
1	moved  (i)
1	commerce at any
2	commonwealth of the
1	foreign person to
2	binding commitment by
4	notification of such
1	pleading or in
1	bottled water which
2	specifying the failure
1	publication of notice
2	shall limit or
1	testing results, certifications
1	distribute such returned
1	2006, report to
1	paragraph (1)(b)(i), a
2	health, and the
1	generala facility is
4	withdrawal of the
1	 (d) conditions
1	useful devices intended
1	adequate to show
1	cracked or broken.
2	interest, and knowledge
4	determines is necessary
1	medicines daily med
2	(i) or an
1	review, shall not
1	previous year were
1	created, caused, or
1	facilities to cease
1	practitioner means, with
2	requested herein first
1	product is required
1	ii or a
4	order are based.
1	commenced simultaneously with
1	foreign governments, state,
1	use disorder within
1	appointed for 3
2	detainer authority of
1	poultry items that
6	homeland security, shall
1	enhance communication, including
1	regulation) provides that
1	(2) unapproved usewith
1	approves the request.
1	suspension proposed under
1	requested by secretary
1	(c) is a
2	issues such an
1	poppy straw, concentrate
2	(g) 60.0 
1	filing, and the
1	milestones described in
1	behavior and new
1	years, the excess
1	chooses to have
1	(9) the contact
1	facility certification to
1	(36 u.s.c. 220501(b)(2)).
1	label of other
1	conviction was obtained
1	national incident management
16	emergency use of
1	market approval or
1	(4) any distributor
1	823(h) of this
2	education, and recruitment
1	product to human
1	if, after affording
2	(i) the safety
1	requiring that testing
1	provides original information
1	transferred or transshipped
1	section 460(b) of
1	(4), manufacturers, distributors,
1	ch. 675, 707,
1	379h. authority to
1	complying with good
1	state shall furnish
1	(4) evaluates the
1	substances provider. such
1	transfers a listed
11	court decides that
1	funding training fellowships,
1	part may challenge
2	isoquinoline alkaloids of
2	require a manufacturer
3	secretary proposes to
1	fees associated with
1	documents and, where
1	states, enter such
1	interviews of persons
1	2014, the base
1	product has knowledge
1	
 200 to
1	clarity regarding the
2	residues of that
1	use when employed
1	term hair dye
1	may obtain review,
2	 (i) conviction
1	programs that assist
1	(a) annual reports
1	ii devices; initial
1	subsections (b)(4)(e), (c)(1)(b)(i),
1	manner that would
1	rules for discovery
6	director, in consultation
1	device from section
1	paragraph are 
1	substance in conformity
1	retail sale. 
2	dispense controlled substances.
2	general in addition
1	(a) after manufacture,
1	expertise clinically relevant
3	wholesale distributor or
1	workplace and the
1	powers, but shall
5	subsection (b), is
1	book shall display
3	shall have such
6	clerical and other
4	wholesale distributor of
2	drug interdiction activities,
1	(c) acknowledge differences
1	iii or[1] chapter
16	authorized under this
1	expired the secretary
3	subsection (b), if
1	except for modified
2	supports the presidents
4	chapter and found
1	effectiveness in achieving
4	may be dispensed
1	expected design life
1	(
 
 2105.
3	time specified by
1	health (for the
5	effective upon the
1	section, section 842
1	current ant-drug communit-based
1	standards related to
2	sentence, shall issue
1	guidance about how
1	request for determination
1	build relationships that
1	532, formerly 356,
1	entity (whether domestic
1	risk communication to
1	(a) 60 percent
15	device intended for
1	accreditation body recognized
2	statement that such
1	forms of request)
4	assessments conducted under
1	food is attributable
1	recognized standar-setting entities;
1	shall attach to
1	selection by the
2	recalls, outbreaks of
1	narcotics trafficker in
1	 (b) elected
2	level information), transaction
1	recognized standar-setting entities,
1	general procedures and
1	section; (5) enter
1	listing of actions
1	competent and reliable
1	name, chemical identity,
1	played, and certifies
2	make appointments to
1	programs funded under
1	activities; (c) the
1	prescribe. (e) technical
4	classification under section
1	preservation and availability
1	(1) a controlled
1	vacancies any member
1	 (a) diversion
1	exposure data and
1	distributed; and (d)
1	describe the factors
8	used for the
1	authorized by paragraph
1	
 
 345.
1	reduce or eliminate,
1	substances or materials,
1	animal and any
7	(11) the term
1	shall specify which
1	priority to enhancing
1	exercise of its
1	requirements while still
1	immediate containers; nonconsumer
1	(c) the use
1	administrator may not
1	health reasons. 
1	attempted to bribe,
4	262(a)(2)(e) of title
1	recordkeeping (a) pilot
1	pediatric models to
1	islands, or the
1	tests (or testing
3	drug or of
2	person would have
1	dispensing; or (b)
3	submit to him
1	tobacco, firearms, and
1	taken into account
1	applicant), the secretary,
2	regulation proposed to
1	(
 
 467.
1	acquired in violation
1	(3) an accredited
17	based on a
1	persons seeking to
10	u.s.c. 601 et
1	guidance or proposed
1	treat and prevent
1	investigations that have
1	criminal record of
2	(2) effective date
2	refund of the
2	requests for reports
1	(c) limitation a
1	technical data every
1	expenditure in the
1	accessible to such
1	conduct with respect
1	(1) when all
3	consignee, and in
1	reasonable time before
1	products; (6) direct
1	1054.)
 
 364.
1	organization of the
1	stat. 832.)
 

1	activities, and any
1	danger to health.
1	secure, to the
1	pharmacokinetic studies) in
1	files. (f) postmarket
2	upon the first
1	assisting regulated industry
2	360h, 360i, 360j,
31	(a), the secretary
1	contract authority the
1	particular use for
2	strategic plan for
1	application; or (iii)
1	website established under
1	term recycled rather
1	(aa) at least
1	(5) the action
1	(g) extension of
1	 (2) reinspection
2	possible impairment of
2	(1) information on
1	opinion of experts,
12	secretary shall have
1	annual food reports
1	investigations conducted under
1	subsection.  (k)
1	 (b) referral
1	members shall have
1	product identified by
1	interpretive criteria standard,
3	shall not make
1	355(c), 360b, 360ccc]
1	section 1332(1) of
2	criteria standards and
1	penalties in addition
1	propanamide; (vii) 1000
3	lithograph, or otherwise
1	iii, premarket approval.a
1	index listing and
1	(iii) the capability
2	section 387s of
2	associated with that
1	(c) domestic no-hig-risk
8	size of the
1	calls into question
1	paragraph (5). in
1	valid, including if
2	unreasonable risk with
1	inspection, the processing
1	exemptions; criteriain order
3	proper court as
1	regulations. (5) to
1	relating to those
1	deemed unsafe solely
1	establishment which that
1	appropriationsthere is authorized
1	appropriated by section
1	subparagraph (b)(i) may
1	evaluated based on
1	fee amounts). (2)
1	(d) forward it
1	required, or since
1	approved drugs and
1	dietary ingredient defined
1	mark, imprint, number,
10	consideration of the
4	suspension of registration
1	supplements, or premarket
1	(e) annual report
1	abuse prevention function
2	determines practicable through
1	tobacco product as
1	sold in a
2	limitation.  (2)
1	status after importation
1	system (including intelligence
1	(e) drug manufacturers
1	listed chemical have
2	year 1997, excluding
1	facts found, without
1	hearing); (b) in
3	secretary an animal
1	activities, to become
1	necessary to making
1	calendar year with
1	general criteria the
1	states within twenty
1	information is not
2	rule requiring that
1	transfer from another
1	conducts a medical
1	(2) testing and
1	evaluation; or (4)
1	(g). in such
1	limitation shall be
1	creates a serious
1	continues shall constitute
1	product and whether
2	standard costs in
1	abstract, book, book
1	pharmacies of information
2	products to agency
1	(
 
 954.
1	prosecutions for drug
2	projects to support
1	schedule notice. (4)
7	submit a request
1	application containing such
2	upon the hearing
1	publi-private education program
2	container in which
1	
 
 360ff.
2	exemption which is
1	product resulting from
1	components of drugs
1	gas, as defined
1	chronic substance abuse
5	301 et seq.)
4	paragraph:  (i)
2	grant, where applicable,
20	301 et seq.]
2	application under such
1	term proposed sunscreen
1	program (a) advisory
1	regulation of those
2	affected under subsection
2	rights, safety, and
2	product with the
1	therein to a
1	retailers to whom
1	control are being
13	property described in
1	commerceeach person who
2	shall accept and
2	development the secretary
1	report on behalf
1	facility it shall
2	misbranded meat or
1	4(i)(1) of the
1	illness. such biennial
3	specific strength or
1	clause (3) of
1	least every 180
1	receipt was made
1	relevant to 
1	(ii)timing of notice.an
1	product manufacturers, packagers,
3	humane methods of
1	shall assess against
1	program for chronic
1	guidance documents in
1	united states; (g)
1	paregoric, the concentrated
1	agency components of
9	secretary may, by
1	wholesome, unless the
2	previous year to
1	(ii) who is
1	device, and revoke,
1	animal models for
4	furnish to the
2	27 percent shall
1	also apply: 
2	shall waive under
4	drug applications. 
2	suspension or termination
1	review, a regulation
1	agency center, or
2	conferences of a
1	applied chemistry (iupac).
1	(3) upon receipt
1	periodic assessments of
1	(g) medical air
1	clinical experience, not
3	likely to use
1	bonus payments notwithstanding
1	committees, and maintain
1	distributed  (a)
1	(a) request a
1	agency shall keep
1	(ii) that, except
4	used in connection
2	already expended on
1	consent will be
1	additives, and color
1	whether to assess
1	device. (2) a
1	solicit and accept
1	countermeasure, including to
3	good faith and
1	determine validity of
1	(d) fourteen percent
1	ii, and narcotic
1	(i) demonstrates good
1	(1)  (i)
1	entered, or (ii)
1	late payment 
2	service of such
1	(iii)(ii). the owner
1	entirety, shall not
1	drug is imported
1	secs. 2420324207), shall
1	active ingredient that
13	348 of this
1	(b), remaining portions
1	congress.  (3)
4	initiate a proceeding
1	(iv) for the
1	petition and of
5	360(j) of this
1	dye shall not
1	adulteration of each
1	policy (a) product
1	title 18 relating
2	shows that (i)
1	restitution for cleanup
2	manufacturer is a
3	hearing in accordance
3	animal drugs are
2	if, upon the
2	shall, in determining
1	facility shall, in
1	promptly review a
2	examination and inspection,
1	waived unless the
1	(h) farm sales
1	material, such as
1	(2), the chairman
4	least 60 days
1	subsection (a)) and
1	destroy micr-organisms in
2	illegal drug distribution
1	(
 
 2003.
1	made of him
1	promulgate to assure
1	(3) includes a
1	record and proceedings
1	(2) coordinates the
1	handled in accordance
1	applicant upon request.
1	product. (3) discontinuance
1	licensed pharmacist. where
1	civil penalties; and
2	life imprisonment, to
1	incorporated, shall promulgate
1	bottled water. (b)
2	(j) which refers
1	state lines, knowing,
2	enacted prior to
1	added amount of
1	initiated under the
2	milk if the
1	(i) if he
1	nicotine.  (13)
1	results in no
3	substance.  (d)
1	may consider and
1	committee; and (d)
2	submission of updated
1	action by secretary
1	lawful application no
1	provide for 
1	states during the
2	media campaign, except
3	secretary shall respond
1	enforcement task force;
1	indications; and (ii)
1	study planning under
1	(b) new animal
1	processed food, reports
1	carrier no carrier
3	purpose of section
1	general; no-disclosure; exceptions
1	(e) the total
1	thereof, and said
2	determined by agreement
1	product between persons
1	(including such date
2	inspection legend, shall
1	dtc advertisement and
2	387p of this
1	subchapter ix and
1	hearing if relevant
1	identifier for each
2	person, other than
1	repackager, a repackager
3	united states person,
1	legal and ethical
1	advertising space purchased
2	(including, but not
11	regulations  (1)
1	among the members
2	 (3) application
1	benefits to drug
2	fill of container;
1	manufacturing techniques, and
6	groups; and (f)
2	director the director
1	(j) evaluation of
1	order information for
1	states or offered
1	apply, 30 calendar
1	help coordinate and
1	license provided by
1	manner as a
1	implementation and participation
1	chairman thereof. (4)
2	relates to substance
1	drug applications that
1	part.  (b)
1	(b) (or no
20	publish a notice
1	substance; and (2)
1	narcotic drug; controlled
1	program equal to
1	registration the secretary
5	may, during the
1	 (a) policies
7	forth in an
1	chapter. the provisions
5	modernization act of
2	devices  (a)
1	exports a controlled
1	information by any
1	discussions, including by
1	organization to address
1	completed;  (4)
1	iii and intended
1	persons engaged therein
3	indian sel-determination and
1	related inspections of
7	paragraph (1) by
1	2004 through 2006
10	compounded, or processed
2	times upon the
2	made, the holder
2	drug application fees,
1	preparedness and effectiveness;
1	amounts in order
1	marking and labeling;
1	percentage share no
11	number of pediatric
2	(b) exception for
1	represent any of
1	effect of submission
1	opium poppy and
1	obligationa person may
1	cigarettes, smokeless tobacco,
2	pharmacies of hospitals
2	application; antibiotic drug
1	substances or in
1	identical or nearly
2	united states; (iii)
1	360bbb8b. use of
1	powers of any
4	permanent damage to
1	type b medicated
3	include such information
1	uses any narcotic
1	344, or 355
1	(iv) private citizens
4	commerce.  (b)
1	 (a) adjustment
1	laboratory facilities and
2	united states: provided,
1	(7).  (3)
1	establish the amount
3	subdivision requirement that
2	will be present
1	(i) permits a
2	state inspection program;
1	(b) degrades or
1	groups; (b) seek
2	substance (except a
1	nutrient  
1	issues such order
1	secretarys discretion, may
1	proceedings  (1)
1	matters  (1)
2	title 28 by
1	internet website. such
7	shall not affect
1	reviewed in accordance
1	(c); (b) a
1	(june 30, 1906,
1	lif-threatening diseases, the
21	purposes of subparagraph
5	conditions for approval
2	 (b) definitionsin
1	country unless it
2	resources are available
1	years thereafter 
1	complaint  (i)
1	petition any person
1	maintaining access to
5	samples of such
1	data submission; filing
1	enforces a requirement
1	2011, for guidance,
4	secretary provides to
2	persons may examine
1	(i) is approved
1	(b) blocking of
3	employees of such
2	licensure reporting requirements
1	bonus payments to
1	whether the infant
1	(a)(2) for a
1	animal after slaughter
2	given notice to
1	findings and conclusions
1	(v) in seeking
1	infant formula complies
1	drug manufactured, prepared,
2	section 360(h) of
1	412, as added
1	compounding. (2) the
4	or, if earlier,
1	nervous system. 
1	oaths and affirmations
1	explain the reasons
1	subsequently transferred to
1	slaughter; treatment as
2	states and which
1	(i) suspension if
1	chapter; unless, in
1	administration a team
4	knowingly and intentionally
2	taken under section
1	drug during the
4	recall of such
1	effective tracking and
1	vitamins. (b) each
1	determines appropriate, to
1	chapter to compound,
1	title except section
3	act [25 u.s.c.
4	(2) shall be
2	 (b) agreements
7	drug is distributed
1	periodic review; report
1	packages contain not
2	occurs so infrequently
1	title to control
1	device or device
2	 (8) 
1	secretary with information,
1	diet or applied
1	labor (referred to
1	designates, pursuant to
1	education record for
1	unsupervised use. 
6	authorizing the secretary
1	animal feed under
2	consumed in the
1	
 
 14a.
3	food, shall be
8	(a) establishment there
1	reports of adverse
1	fiscal year), multiplied
1	interstate commerce, unless
1	cost of program
1	concurs in the
1	year 1997 (excluding
2	therein are standard
1	28, 1996, issue
1	coordinated enforcement activities;
1	manufactured an infant
1	use tobacco, including
1	(including details on
1	authority in that
1	may have in
2	includes any box,
1	shall issue temporary
1	consensus standards activities
1	secretary its recommendation
1	secretaries shall be
1	affirm the order,
1	manufacture of egg
1	
 1033. definitionsfor
1	title (taking into
1	service, appoint outstanding
2	demonstrating substantial equivalence
1	represents explicitly or
1	country meet the
1	6-day period following
1	minimizing the number
1	requirements; definitions and
1	drug. upon withdrawal
1	vehicle), render adulterated
1	pharmacological activity or
2	(bb) neither the
5	established by a
2	product, provide the
1	(iii) if a
2	intended primarily for
1	means the annual
1	consumers (u.s. city
1	variety of nonmedical
1	custom of the
1	ballot initiative, or
2	primary container or
3	proceeding under section
1	tactical intelligence and
1	quarantine means the
3	provides a reasonable
1	determinative of exemption
1	restricted egg means
1	(d) the amount
1	states. no such
3	differences among importers
1	(b) labeling requirements;
1	levels of consumers
1	claimed indications in
1	documents to reflect
1	 (g) banned
1	limited to one
1	laboratory in which
4	tobacc-related disease associated
2	opportunity for public
1	(2) is, under
6	exempting from the
2	unless  (aa)
1	and[2]  in
3	meeting for the
3	commissioner of such
4	refusal of admission
1	2 years, taking
1	applicant for a
1	methods that seek
3	manufactured in final
1	 (b) exemptionsthe
2	title iii of
1	(e) broker or
3	original request for
1	(3) rules for
1	(1) report to
1	report required the
1	required by, regulations
1	country.  (5)
1	301 et seq.]:
1	provide adequate results
1	preventive controls, and
1	experience in investigating
1	person seeking its
1	maintain records under
1	may 1, 1971)
1	make such draft
1	international trade in
1	(11) chillums; (12)
1	imports devices solely
4	found that the
1	services or functions
2	local, territorial, and
1	final regulation promulgated
1	ch. 675, 423,
1	conduct inspections, taking
1	fund advertising containing
1	product as defined
1	existing online pharmacies
1	(2)(b)(ii) and (4)
1	published and unpublished
1	26, 2014, except
4	section 1412 of
3	using such products;
2	desiring to cooperate
1	species, the bioequivalency
1	achieved; and (c)
1	granted tentative approval
1	package level in
2	(c) the methods
1	(a)(1) an analysis
2	mechanism of toxicity;
3	using such products.
1	$50,000 annually. 
1	in, and compliance
1	available internet website.
1	chemical; or (3)
1	identity, from a
2	detention period applicable
1	submitting it. the
1	(6) use of
1	written agreement authorized
14	equivalent positions in
1	violation exists because
1	fiscal year next
1	u.s.c. 262] that
7	applicable contractual requirements
1	director  (a)
1	petitionersany person may
1	implement this paragraph.
3	develop and disseminate
2	system. (e) audits
1	 (j) rules
1	321. definitions; generallyfor
1	response during emergencies.
3	pesticide chemical may
1	include, notwithstanding state
1	 (v) if
1	paragraph (4) a
7	required by or
1	(including pharmacies, as
1	entity responsible for
1	 (v) in
1	article purported to
1	9, 2012. the
1	customer as a
1	change as the
1	(21) pholcodine. (22)
2	affected stakeholders, including
2	upon the administration
1	appropriate authorities of
1	 (c) discovery
1	general only on
1	cigarette tobacco, rol-you-own
1	emergency use only
1	(ii) such application
2	intent to manufacture,
1	evidence and other
1	form, or (ii)
1	practitioners, effective upon
1	sales the congress
1	technology;  (2)
1	(or drugs); (ii)
1	surveillance infrastructure under
1	ch. 675, 518,
1	(c), concerning the
4	modification or revocation
1	mescaline. (12) peyote.
1	(b) providing advice
1	costs of compliance
2	proceedings in admiralty,
1	drugs, taking into
1	remains drug free;
4	pay for each
1	857. repealed. 

1	device from use,
1	title shall make
1	kidnaps a federal
1	patient morbidity and
1	rulemaking or other
1	person, to perform
2	(c) notice 
1	prescribe.  (4)
1	article; the country
1	therein. (3) in
1	siluriformes; and (3)
1	4 years following
1	(p) authorization of
1	requirement promulgated by
1	379j52(a)(1) of this
1	defendant, nor shall
1	u.s.c. 262]. (c)
1	risk assessment and
1	convention in the
1	sustained, the eggs
2	shall not derogate
1	wherein such applicant
1	secretary shall suspend
1	states has joined
1	state, relating to
1	media outreach, and
1	da-t-day operations of
3	section or other
1	residues in food,
1	(c) application a
1	1996) is deemed
1	agency center has
2	fiscal year, excluding
1	one year and
1	action required by
1	household consumers, restaurants,
1	retail sale provisions
15	data or information
1	risksthe secretary, in
1	subpenas, administer oaths,
1	dealers with respect
1	inspector general for
3	statute of limitations
2	necessary for adoption
1	repackager; and (iv)
4	(1) in generalexcept
2	information in logbooks
5	system for maintaining
1	sealed it shall
1	 (2) total
1	containing limited quantities
1	personnel as may
1	final finished dosage
1	(2) unauthorized obligation
1	risk; and (iv)
4	forth a finding
3	$250,000 per violation,
1	manufacturer to market
1	index listing. 
1	section. the report
1	term poultry item
3	identifiable subgroups of
1	organizing, training, and
4	percent of such
3	 (2) for
1	(ii) the day
1	(whether a major
1	budget recommendations, including
1	will ensure that
1	title. (13) the
1	subsection (f)(1) in
1	report submitted about
1	makes the final
1	interstate commerce; standard
1	(
 
 1049.
1	 (b) purposes
1	supplements). the amount
1	distributor; (b) an
1	effective; or (b)
1	guidance, policy documents,
1	that1 does not
1	articles or containers;
1	fact has been
1	physician, and consumer
1	(f) annual report
2	secretary decides to
1	350. vitamins and
1	final order any
4	shall be contained
1	threats; (19) shall
1	requirements regarding retail
1	(c) finality of
1	make such records
1	interfere with any
1	(32)  (a)
1	preventing abuse or
1	use data collected
1	following applies, subject
1	planning to prevent
2	therefor by the
1	 (j) emerging
2	selected establishments selected
1	address in any
2	effect.  (2)
3	packing of the
2	case of contaminants
1	consideration, take into
2	congressional notice a
1	practices, as identified
3	803 of title
1	 (6) united
1	title) and introduced
1	information, and other
1	drug to reflect
1	imposed only through
1	commerce for butter
1	secret information, except
1	(2) requirementsto the
1	drug is indicated
1	extent practicable, as
2	effect on product
1	time a ne-drug
1	(c) the expected
16	offer of confidential
1	less likely to
1	fees) shall be
2	drugs shall consult
2	information under subparagraph
3	(a) is not
1	secretary, consistent with
1	shall recuse himself
1	study based on
1	technicians and scientists;
1	part. (b) any
2	(ii) confirm that
1	foreign country into
1	transactions described in
1	patterns in such
2	section 321(h) of
1	first amendment case
1	paragraph (5), libel
1	american samoa, wake
2	conduct a postmarketing
5	public suggesting changes
1	successor to such
3	adequate to effectuate
1	(1) appointment there
1	days established in
1	(4)(b) by any
1	precautions, or other
1	denial  (i)
1	manufacturing so long
1	information, such as
1	interested persons the
1	notifying as required
1	law enforcement officer,
1	4 succeeding fiscal
1	marihuana, or 100
1	including pursuant to
1	foreign government if
1	enforcement; applicability of
1	substances (a) definitionsas
1	physician; exemption from
2	puerto rico, guam,
7	good and sufficient
1	28, 1953, ch.
1	1970, and except
1	offense classified by
1	list is referred
3	within the last
1	exemption of any
1	subparagraph (a); (iv)
1	biologic substance or
2	coordinator for each
1	application is made,
1	commercial license provided
1	devices;  (8)
24	extent and in
1	food, when used
1	convention. as a
3	instructions, licenses, or
1	drug crisisthe term
1	rico or a
1	psychotropic substances, 1971.
1	investigational devices for
1	pseudomonas, and e.
1	drug submission without
1	agencies to state
2	section 360bbb1 of
1	establishing and maintaining
1	thereof shall obtain
1	so.  (4)
1	bases used to
1	written orders or
1	date, on the
1	misbranded tobacco products
1	(3) shall maintain
1	congress a reprogramming
1	different sectors within
1	clinical capability and
1	nutrient, or other
2	subclauses (i) and
1	information found on
3	purpose the purpose
2	knowledge of regulatory
1	researchs office of
2	classification regulation applicable
1	respect to amendment
1	metrics for tracking
1	5. if upon
1	lacking abuse potential
2	government or of
1	treatment program which
1	needed to achieve
2	-dimensional data matrix
1	product applications, be
3	listing such additive
1	reportable food, submitting
1	program or school;
1	title to make
2	review of adverse
1	effect. (c) unclassified
1	 (d) sales
1	use, at no
1	reporting requirement of
28	investigational new drug
3	participating in any
3	body, such as
1	subsection (b)(3)(d). (f)
1	2012, shall be
1	date established by
1	amount of coca
2	355(i)(2) of this
3	devices under this
1	obstacles to approval,
1	secretary, by written
1	character; or if
1	serious injury mean
4	transaction in which
1	nonmedical products; (5)
1	potential recipients; and
1	committee, be issued
1	indene ring to
1	(b) take all
1	investigational submission mean
4	appropriate state and
1	conduct periodic consumer
5	supported by substantial
1	defense, 50; and
1	rigorous as the
1	lon-range plan and
2	[15 u.s.c. 41
6	provided under subsection
1	wholesaler is $10,000,000
1	associated with periodic
1	bar on interventionexcept
1	certification.  (b)
1	procedures in place
1	 (d) law
1	requirements. (h) applicants
1	application an opportunity
1	country the term
1	substance, when sold
1	regulations permitted under
1	term serious bodily
1	products or for
6	proposed for use
2	disease product applicationthe
1	sentence, for fiscal
2	notice under section
30	regulation or order
1	(2)(a)(iii), or (3)(e)
1	(c) are effectively
18	electronic product radiation
1	(a) designation of
2	review fee has
1	shipper, and when
1	territory, or possession
1	agencies for purposes
3	submission of additional
1	medical device means
1	regulations in order
1	subparagraph or which,
1	chapter; or 
1	statement, or otherwise
2	issue a guidance
2	teaching, or chemical
3	respond to any
33	years after november
1	(d) study 
1	members.  (3)
3	agency, and the
1	time purchased under
1	safety and therapeutic
1	ch. 675, 736a,
1	consortia the term
2	misleading in a
1	international traffic in
13	issue a notice
1	customs laws; (b)
2	 (e) guidance
18	subsection (a) for
1	(18) returns processor
4	subsequently received, and
1	activities. (2) such
1	(3) fee for
1	
 347b. contravention
1	collect any tolerance
2	including the following:
1	extent such products
1	receptor) agonist as
1	(c) organization of
1	payable. (3) animal
1	drug administration policy
1	decision regarding such
1	verdict for the
1	public safety, he
2	sale, distribution, possession,
1	abuse, and (2)
8	(a) or section
1	lessee, agent, employee,
1	(ch. 675, sec.
1	patients, completed not
1	cubic centimeter or
1	2009if the date
1	placed or packed
2	amount under this
1	greater than 20
2	article is exported,
1	practices, as are
1	advisory panels meet
1	(g), shall be
3	united states. (

1	(9) shall be
6	supplier verification program
2	contract. any person
1	misbranded or poisonous
2	subsection in such
5	may not take
1	rape drugs pursuant
1	administrative hearings (a)
1	(c) interagency agreements
1	effective under subsection
1	action as defined
1	may deem necessary,
3	packaged food or
1	individual regulated person
1	befor- and afte-school
1	seek judicial review
2	change in any
1	may deem necessary;
1	including tobacco, substances,
3	whose route of
2	required by united
1	substance by a
1	failed an initial
1	appointed (by majority
1	blood or tissue
1	grant of authority;
2	subsequent annual national
1	available to facilitate
2	upon such notice
1	places the patient
1	indirectly by another
6	exemption under paragraph
7	bacteria, fungi, or
2	operates in an
2	(c) any agreement
3	portions of such
1	submitting the request,
1	113 of chapter[2]
1	2007, or to
1	facility, or (ii)
1	renew the conditional
1	communication of, postmarketing
1	511, as added
1	food, food ingredient,
1	finding was in
2	media campaign to
2	provide grants to
1	facts and the
1	director relating to
1	subsection (b) as
1	person who distributes
1	foundation in furthering
1	timelines for compliance
1	required, is approved
1	listed chemical if
1	1961, and other
2	subparagraph. (d) any
1	information about device
1	paragraph (2), how
6	listed chemical in
2	may determine that
1	seq.] (known as
2	product identifier may
1	(3) a food
1	eligible entity. (d)
1	exchange among the
1	person specified shall
2	request whether the
2	clinical hold should
1	scientific evidence under
1	plan is sufficient
1	instruct such professionals
1	necessary improvements to
2	national oceanic and
1	section 105)[2] would
3	shall demonstrate that
2	shall consider information
1	applicable to retail
2	similar retai-type establishment
1	fraction) of change
2	thereafter, submit to
2	2010 and each
1	review of supplemental
3	guidance.  (c)
1	title 15 or
1	exportation insulin and
2	trafficking areas program
1	reduced in whole
1	performing such other
1	(i) the chemical
2	pharmacy in the
1	generalthe advisory commission
2	covered application that
1	1037; term of
3	comply with standards
1	fulfill the activities
1	violation; (3) assisted
1	 (l)[1] agreement
1	controlled substancesthe congress
1	respect to certain
1	stimulation. (v) in
2	active ingredients, or
2	respect to this
1	training required for
1	exceptionsthe following persons
1	food detected and
1	(c) no information
4	significant risk of
5	title. (3) the
5	prevent, or treat
1	acquired, such person
2	application make any
1	positions shall be
1	ch. 495, 70
1	programs to rehabilitate
2	accordance with said
1	subsection; (c) the
1	regulations.  (c)
1	preparations from which
1	identify or establish
2	thirty days from
1	201, as added
3	committee act shall
13	devices intended for
1	(b) the labeling
4	secretary or at
1	read as follows:
1	program. (d) the
1	charitable distribution for
2	resolve complaints regarding
1	commenced by the
5	of, each transaction
1	support such declaration
14	secretary shall, not
15	human generic drug
1	will be considered
1	particular drug products
1	government, or a
2	whether proceedings with
2	requirements shall, at
4	labeling act [15
1	application to be
1	 (16) small
1	colors; regulations; issuance,
1	optical isomers. (l)
1	360b, or 382
1	degrees of yellow,
1	 (2) contentsuch
1	animals. (mar. 4,
2	information; jurisdiction; disposal
1	nux vomica, physostigma,
1	806, as added
1	changes) that do
1	(c) coordination and
1	algae, and slime),
1	subsection (c) during
1	standard, and including
1	820.)
 
 210.
1	include the scientific
2	matter which is
2	reasons, including a
4	 (1) establishment
1	inspection the adulteration
1	states unless such
2	participate because of
1	partnership project will
1	child is allergic;
1	athlete who meets
1	may for good
1	information supplied under
1	manufacturer need only
1	
 674. federal
1	equivalent within the
1	orders issuing, amending,
1	patient. such term
1	parenteral drug, the
3	adverse eventthe term
1	states. in the
1	paragraph and relied
1	vegetable or fruit
3	chapter.  (june
1	publish final guidance
5	secretary under clause
1	consumer, (ii) such
2	may be physically
1	authorized, or by
2	minimum, meet the
1	website shall include
3	public shall be
1	
 1171. drug
2	require that persons
2	labeling any carcasses,
1	products, diagnostic technologies,
3	application that a
1	2 days after
2	exempt pizzas containing
1	metrics to measure
1	perjury, giving a
1	offense.  (

1	deaths, as documented
1	pr-trial, probation, or
1	467b of this
1	states of blood,
2	authority under its
1	takes office. 
4	since the date
1	poultry producers raising
1	recalls; (2) devices
1	multiplicity, or lack
2	program, including the
155	secretary determines that
1	(ii), the fees
1	establish a technical
1	study including whether
1	testifying at any
1	project from any
1	container, or other
2	poultry or the
1	
 387t. labeling,
1	ne-drug application is
1	effect is appropriately
1	(b)(ii), undergone training
4	conducted under the
1	(b)(1) is approved
1	previous -month period;
1	(a) its occurrence
1	2015, added to
1	develop a global
1	advertising.  (e)
3	food imported or
1	prescription requirement 
2	extent or for
1	regulations) that are
1	obtain review, in
8	facility shall be
1	changes to boxed
4	humans or animals;
1	attorney general are
1	assure the implementation
2	propanamide or 10
1	preventing such a
3	made by inspectors
1	(5) it is,
2	identifier information for
1	
 
 360eee4.
1	into, or sale
1	public. (4) the
1	specific importer of
1	necessarily deviates from
2	event report no
1	studies of progress
2	procedures as the
1	 (c) civil
1	provided the requirements
1	 (2) substitute
1	order. (5) the
2	substance the intended
2	course of maintenance
1	manufacturer is subject
2	provide information about
2	representatives of veterinary,
1	shor-term and lon-term
1	
 881. forfeitures
1	terminates if the
1	title, a letter
1	terminated. (e) reference
2	section 101 of
8	necessary and appropriate
1	government witnesses the
1	submit data and
2	synthetic or natural
2	advisory committee means
8	methamphetamine, its salts,
1	suggesting that trade
1	every second year
1	regulatory issues, the
1	shall be applied
4	authorize the secretary
1	reported disclosed financial
2	entity compliance guide
1	classification, in accordance
1	employees do not
1	may appoint subcommittees
1	organization that carries
1	secretary through the
1	on-half the amount
1	institute; (2) streamlining,
8	(1) not later
1	large part to
1	appropriation for fees
1	division of the
2	coordination with state
2	meeting on the
1	acceptance, within the
1	within 5 years.
1	(b)(1)(a) and the
1	section 5382 of
1	of, or experience
4	order made on
1	committee with adequate
5	reauthorization, including specific
2	cigars other than
1	agreement has violated
1	products (as determined
1	1997.  (

1	premises directly to
1	improve the cos-effectiveness
1	transport vehicle, for
1	applications; withdrawal periods;
1	inclusion the commissioner
1	entities that sell
1	461 to 467d
1	administration the administrator
1	year, the united
1	 (b) reasonable
1	section 2291j1 of
1	informationthe data and
2	et seq.] prior
1	administrator), in coordination
5	person identified in
1	(a)(1) exceeds $20,000,000;
1	jurisdiction; authoritiesnothing in
1	section that are
1	1535. supplemental grants
1	annual appropriations act
1	manager of a
1	unapproved products (a)
1	offsetting receipts into
3	establishment or amendment
1	notwithstanding any exemption
2	listed chemical until
1	standards relevant to
1	contains (i) any
1	dairy industry of
1	manner practicable, infer
1	provisions (or part
2	inflation.  (2)
1	(g) executive director
1	seeking dismissal or
1	publication entitled guide
2	notice by a
16	fees for such
1	withholding, use, transfer,
1	provisions, any food
3	need not be
1	may appeal a
1	affiliate.  (ii)
1	2222. integrated consortium
7	establishment listed in
1	indexing a new
3	activities conducted by
4	persons to whom
1	within such period;
1	feasible, of animal
1	title 42 with
1	distributed is consistent
1	ch. 675, 805,
1	ch. 61, 3(d),
4	record of applicant
1	determines is appropriate.
4	suspending approval of
2	schedule under paragraph
16	purports or is
1	bear such symbols
6	leaving in effect,
1	 (f) forfeiture
1	another to fill
8	solely for distribution
1	 (c) prominence
2	authorized department of
2	(b) prohibition against
1	exportation is made
1	publication, unless the
1	conducting an audit,
2	applies; or (ii)
4	salts of isomers.
9	secretary for purposes
1	ant-drug coalitions. (7)
1	brand; and (2)
3	adverse reactions to
2	university, or a
1	pay only one
1	senate of the
2	 (2) prohibited
1	cases, sufficient audits,
1	development of tools
1	effect upon publication
1	agents; (c) a
2	violations under this
1	practicable, a reasonable
8	application of such
1	801. congressional findings
1	class iii. 
4	on, or within
1	uncompensated services of
1	section 897.32(c); (c)
1	intentionally imports or
1	data consistent with
1	individuals with appropriate
1	387a1 of this
2	consumer of the
2	en-user, with respect
1	section 202(a) of
1	title. (v) 
2	consumer perception, behavior,
1	penalty pursuant to
2	inconsistency in such
1	organizations; and (iv)
1	hormone  (1)
1	applicable, shall continue
2	(3) when the
1	amphetamine, its salts,
1	title. (7) whether
1	supplement, means a
11	employee of any
1	setting for advisory
2	event means any
1	transported to a
1	procedure; presentation of
2	administration on efforts
1	distributed, if 
1	fiscal year, application,
2	general the manufacturer
1	effective research methods
1	563, as added
1	accordance with which
2	repeal of a
1	(b) identify an
2	advertising fails to
1	food. in any
1	any) responsible for
6	copy of each
1	343(g), 343(h), 343(i),
1	remains necessary, the
1	controlled substances, or
1	services administration); or
1	products purchased outside
1	life or physical
2	change is a
9	comply with a
1	adequate and uninterrupted
1	health advisories issued
1	(5) $280,000,000 for
1	registration number which
1	contained therein, directly
1	property, if such
1	requires clinical data
1	limit period of
1	commodities; (b) a
1	(2001)); (f) become
2	reasonable fee in
1	law enforcement drug
3	salts is possible
1	defined pursuant to
1	harmful effect or
2	submitted certifications for
1	draft guidancenot later
1	monitoring food products
1	secretary; (3) if
2	secretary shall, on
1	inapplicable to a
1	columbia; and (5)
1	among law enforcement
1	domestic standards and
1	residue. (ii) use
1	request or give
1	(b) sales data
1	materials do not
1	fresh natural food
1	shall accept any
1	forfeitures; and the
3	300 milligrams of
3	inspection shall not
1	(1) accreditation bodies
1	treasury may, under
1	veterans affairs shall
1	facilities, one per
1	terminating the debarment
1	(x) of subsection
1	subparagraph (a)(i) shall
1	health care entity;
1	appropriate with respect
13	year after january
1	commission, on a
6	opportunity for the
1	separate violation, except
3	health care entity,
1	days after june
1	use or invest,
1	country is also
1	facts pertinent to
1	criteria for the
1	article for review.
2	drugs, 1961, and
1	informationexcept with respect
1	822.)
 
 211.
2	constituent part that
2	 (1) registration
1	penalties; forfeitures any
1	decision; or (ii)
1	prevention, detection, or
1	reports of registrants
1	recover any civil
1	requests by the
1	contact within the
1	standards, to measure,
1	detecting, preventing, or
2	shortage list under
1	lif-threatening food allergies
1	located within noncontiguous
1	title or paragraph
1	states of america
26	member of the
1	(b) activities, functions,
1	labeling requirements; small
1	committed such acts
1	one year, conditionally
5	later than 3
4	year are decreased
1	moving in interstate
1	plan for any
1	without marking on
1	 (c) identification
1	violation before any
1	names.  (e)
1	age groups, relevant
1	summary of clinical
7	301 et seq.].
1	external experts the
1	requests for individual
1	patients to drugs
1	new drug, facilitate
1	tracing drugs throughout
1	
 887. coordination
2	secretary has published
1	use any labeling
2	assaulting, resisting, or
9	later than 6
7	title 42. 
1	aside any such
1	health or safety,
1	addiction.  (xi)
6	later date in
1	regulation) on the
1	use do not
1	identity of its
1	misbranded poultry or
1	adjustment reasonably represents
2	holder involved may
2	target animal, taking
3	offer to buy
1	 (4) risk
1	substance may not
1	(d)) in any
1	(1) licensed pharmacist
14	petition shall be
1	prescriptions, except as
1	possession, control, or
6	cost, per ful-time
1	approved product), the
1	fees, which shall
1	(4), be sentenced
2	based on subsection
1	period subsequent to
1	(d) exceptions involving
1	(b) fiscal years
1	arts, or as
1	committees means the
1	reevaluation of the
1	health.  (4)
1	issue recommendations to
1	(c) investigations must
2	secretary approves an
2	regulations prescribe conditions
1	substance is administered
1	attorney general; (4)
9	believe that such
1	65 stat. 649;
1	including a specific
1	(c) ephedrine, its
1	transaction information, including
1	714, as added
1	(a)(i). (c) requests
1	processed to destroy
2	accounting of the
3	diversion control activities
1	opportunity for interested
1	prescribe which, if
1	(1)(b), nothing in
1	material compositions, and
1	enforce this paragraph.
8	civil penalty of
3	secretary, among other
8	secretary shall conduct
4	hours after making
1	micr-organism and which
2	(a) upon the
1	country (referred to
1	(1)(b) applies: 
1	october 18, 1968.
1	inspectors provided for
1	manufacture, sale, or
1	medical purpose and
1	(relating to detentions,
3	civil penalty or
1	secretarys determinations regarding
2	 (2) responsibilitiesthe
1	policy has consulted
1	taken by deposition
2	required at the
1	supplement the presiding
1	no-narcotic substances sold
3	subchapter i and
1	(b) (or a
1	organizations. (ix) civic
2	manufacturer to whom
1	elements are required
1	human subjects, that
1	 (7) generic
3	carries out any
1	action, including fines,
1	(1) adulterated food
1	accreditation under such
2	obligation, for such
1	1055; june 25,
3	provide adequate assurance
2	lawful under this
1	apply to residues
1	shall prepare for
1	jurisdiction of a
1	(
 
 2107.
1	review process, including
1	 (a) compromise
1	satisfaction that the
1	provide for minimum
1	adulterated applies to
1	(b) petition to
1	data that demonstrates
1	development protocol and
1	amend section 8
1	may exceed the
1	samples furnished owner
1	
 
 360j.
2	state and in
1	continue the program
1	preservation of natural
1	conduct and support
1	maturity and to
1	party auditor to
1	subsection approving an
1	administrator may modify
1	unsuspecting person making
1	section 314.70(d) of
1	animals, for use
7	sale of a
1	including any provision
2	b of this
2	opportunity for comment,
1	importation, and exportation
1	2018, $672,000,000. (k)
6	prescription of a
1	zone. (h) the
1	laboratory has not
1	section. for the
1	private entities) no-federal
1	periodically assess the
2	director may 
1	secretary, 1 or
2	be, may, in
1	 (6) an
1	(dd) an anesthetic;
2	distribution or recall
2	program, the joint
1	involve any interests
1	secretary grants any
1	conducting the custom
1	eligible patients (referred
1	foodborne illness originating
1	implantable or life
1	media campaign may
1	markers.  (b)
1	paragraph (3)(c) or
3	maintain a record
1	 (a) purchase
1	removal is required
1	regulations, and a
1	making a report
1	internet not later
1	packages or other
1	in, any dedicated
1	accessory under this
10	acting on behalf
1	(a), be subject
1	exempted or unless
1	detecting those residues
3	withdrawal period or
1	(6) to fund
1	economic losses to
1	secretary provide written
1	respect to passengers
1	associated with, development
1	withdrawal period of
1	individuals who purchase
1	appoint other groups
1	submitted such article
1	secretary, unless such
3	(or other specially
1	narcotic drugs and
1	qualified indication means
1	results of foundation
1	registration is complete,
1	 (c) inspections
1	shall exist in
2	businesses (as defined
1	paragraph (1) under
1	 (b) missionthe
1	title, there are
2	wants to submit
2	issued. upon the
2	agents thereof, shall
1	$30,000,000 for each
1	title (including with
1	drugs; (ii) has
6	states from any
1	(9) substance abusethe
3	may be specified
1	framework, which the
1	enantiomer that is
5	notification under section
3	 (ii) determination
1	recall orders issued
1	mean an injury
1	control among domestic
1	production process, quality
7	distributor of the
1	children, including descriptions
1	1, 1995, the
1	organizer, a supervisory
1	importer that intends
1	establishment for that
1	dietary supplement health
1	guidance (or any
1	(5) restrictions notwithstanding
1	ordinarily caused by
1	purity, quality, and
1	freezing, drying, or
1	ordinance relating to
1	without warrant (a)
2	two and on-half
2	additional establishment which
1	person violating any
6	approved application for
3	substances shall not
7	product identifier, including
1	title 7 for
1	providing that, in
2	temporary denial of
2	chemical and that
2	process which as
1	(4) definitions 
2	provide support to
1	label identifying such
1	butter, or imitation
1	proposed and final
1	communication facility in
1	status or privilege.
1	proceeded against at
1	permit these assessments;
2	grant recipient fails
4	subject to approval
1	determines could reasonably
3	food; (b) if
1	distributed, destroyed, or
1	products, including requirements
1	use of environmental
3	application.  (ii)
1	sunscreen orders 
1	regarding the substance
1	helium that meets
1	federal regulations under
1	drug involved has
1	675, 1003, formerly
2	affects the ability
1	substance in each
37	(a) the secretary
1	transferee or the
1	defects, except such
1	title ii, 57
1	event more than
1	services; or 
1	portfolios for such
1	(d) for such
1	selling such article;
1	requirement applicable to
2	term medical product
1	applicant who has
1	jurisdiction; disposal of
1	review and that
1	term biomarker 
1	limited medical supplies
1	use. (d) if
1	$97,722,301 for fiscal
1	arrangement or program
1	 (1) accreditation
2	food only if
1	radiation;  (2)
5	chapter whenever he
2	animal without substantial
1	management. (c) programs
1	office in the
3	denied, suspended, or
1	subsection for not
1	commercially. (5) the
2	military intelligence program
1	position in the
2	shall operate to
1	secretary, respectively; or
4	circumstances under which
1	list which is
2	2012.  (june
1	date and ending
1	onsite audit of
1	program in establishing
1	receives or has
1	(2) such amounts
1	otherwise authorized. 
1	brain development resulting
1	seq.].  (5)
1	update pursuant to
1	response issued under
1	approve a protocol;
1	 (4) review
1	initiating any proceeding
1	act prior to
2	fees, storage, and
1	(c)(2); (2) to
1	devices. (2) 
1	correct those deficiencies.
1	(a) the residue
1	authorized in the
1	351(h) of this
1	regulation which is
2	illegal gratuity to
1	 (iii) an
1	targeted technology means
1	membership on the
3	enforce, and to
1	drug within the
1	nonapplicability of subchapter
1	(i) before promulgating
1	tobacco; and (c)
1	showing reasonable grounds
1	necessary to (a)
1	collection not later
1	registered to prescribe
1	intentional, wanton, or
1	years 2007 through
1	(4) to serve
3	equines, or any
2	countermeasures the secretary
1	substance.  (24)
1	raising poultry on
2	foreign region, country,
1	ordered agencies of
1	section for periods
16	person who has
1	general and applicable
1	felony under section
1	official compendium. (h)
1	food (including any
1	statement within the
1	(f), or (g).
1	recordkeeping requirements outweigh
1	critical control points,
1	means a public
1	certain safety protocols
1	(a) collecting and
1	(d) confidentiality nothing
1	(e) may not
6	section 360j(f) of
1	use authorized by
1	therapeutic amounts. 
12	years 2013 through
2	condition that is
1	condition that it
1	federal agency relating
1	
 133. repealed.
1	unsafe use of
1	tobacco used, tar
4	serious, adverse health
1	arrangements with individual
4	appropriate; and (ii)
2	full qualification package;
1	human services may,
1	organization that represents
3	trade secrets or
3	inspection legend or
1	use shall establish
1	conduct of hearings
3	issue draft guidance
1	indications, studied under
1	subsection (a). (e)
2	administrative and laboratory
11	 (1) with
2	information, or periodic
1	(2) comparative claims
1	335b. civil penalties
1	(1) in generalamounts
1	table set out
1	waiver under paragraph
1	(iii) shall be
1	exception no report
1	thir-party auditors (a)
1	children means children
2	sell any scheduled
1	18-day period ending
1	implement the critical
1	make, keep, or
1	 (e) organization
1	facility shall conduct
2	(2) or (3)
1	(1) import into
1	adulteration of food,
1	modifications to the
1	(or his representative)
1	extension, outreach and
2	based upon certain
1	term sunscreen active
1	subsection within 180
2	(b)(2), to determine
1	regarding the chemical.
1	may, under appropriate
1	cosmetics, and including
1	products of amenable
1	listed chemicalsany person
2	paid. an investigational
1	federal register under
1	summary; (b) publish
1	(i) priority drug
2	amount of -pheny--[
2	official capacity, or
1	accelerator, target material,
1	to, the operation
2	unless the registrant
1	regulated and prohibited
1	geographical areas and
1	oath or affirmation
1	governments; and (iii)
3	deems appropriate to
2	subsection other than
3	shall have been
1	(a) and (c)(2)
1	providers.  notwithstanding
1	chapter, and (b)
3	adjusted or otherwise
3	requirement does not
1	term. a member
1	guidance if the
2	committee action for
4	356 of this
1	affairs; (11) may
5	clearance of a
1	care insurers; government
1	except that evidence
1	determine the manner
1	papers filed in
1	criteria and standards
1	establishment.  (june
1	nomenclature for such
1	regulations either promulgate
2	$8,000,000 if the
2	committee for a
1	infants and young
1	substanceit shall be
1	timely cooperation of
2	initiatives in the
1	diarrhea and cholera,
4	make such a
4	registration pursuant to
1	available drug or
1	deems appropriate, while
1	goals, including, for
1	(a) to optimize
1	(b) public input
1	deemed approved by
1	information included in
1	552(b)(4) of such
1	(i) report to
1	states, who shall
1	675, 505c, as
2	exports, or imports
1	resulting final regulation.
1	reassignment of federal
1	food products issued
1	(g) seizure or
5	product intended to
2	evaluate, as the
1	testified or is
1	services to 
1	period of up
1	foundation and shall
8	applicant in accordance
4	(3) and (4)
1	made for purposes
1	title 42, imaging
1	418, as added
3	labeling thereof; (b)
1	appropriate disposition of
1	pursuance of a
3	different or additional
4	first engaging in
1	shall promptly issue
1	(c) pollutes an
1	license may be
2	product shall pay
1	risks.  (2)
1	may prescribe for
1	(a) the slaughtering
1	combination of clause
1	communication facility it
1	enterally under the
1	30, 1975. (2)
1	immediate precursor, a
1	resulting final regulations
1	(c) any field
2	(1)(a) and the
1	
 153. inspection
1	appropriate, with notice
2	subpena entered on
1	tol-free number in
1	compares in specific
1	undermines our institutions.
1	(i) $50,000,000 shall
1	increase the priority
1	commerce in such
1	drug prevention programs.
1	stakeholders, including who
2	attorney general, be
3	materially related to
1	may authorize persons
1	tobacco product conform
9	residues of the
1	contains the information
1	drug application holder,
3	section 360c(f)(1) of
2	drug product may
1	notification, or disclosure
2	chapter (other than
1	update the treatment
2	excluding the canal
1	section or any
1	risk of food
1	plant under the
1	requirement respecting a
5	human body or
1	drug and, when
1	health threat from
1	incubation and has
1	time after october
1	(1) maintenance by
1	chapter shall prevent
4	(as that term
1	script, story board,
1	bioequivalence means the
1	duties as may
1	small business shall
1	(in which case
2	listed in subsection
4	drug administration who
1	sale; (d) such
1	reached. each such
1	(1) information about
19	united states, the
7	industry.  (2)
1	trends relating to
1	relevant period. (11)
1	violence, as defined
1	particular importation for
1	review each budget
1	(a)(1), such termination
1	facilities at any
1	consul an application,
1	plans for conducting
1	seq.] as in
1	which, if applicable,
1	finds the petition
1	review staff, as
1	individual who conducts
1	educational assistance act[1]
1	applicable. (g) review
1	 (1) allowing
2	country, territory, or
1	satisfied  (a)
1	prevent or eliminate
1	begun, the applicant
1	chapter. the report
1	programs;  (14)
1	witnesses of illegal
1	period. (b) a
1	guidance. the model
1	imports food into
1	substance analogue means
1	communication (referred to
1	general applications subject
1	advisory commission who
1	register at 62
1	official in connection
1	respectively, shall make
14	subsection (b), the
1	chapter; (b) maximizing
2	received for sale
1	acid. (2) chorhexadol.
1	revision and revocationthe
1	panel does not
1	nicotine replacement products,
2	stored in a
1	354, 360bbb3, 373,
1	deadline for determination
1	shall apply until
1	civil penalty any
1	dairy farms or
2	civil penalty and
2	views, either orally
1	organizationsa site or
1	reduce the possibility
1	emergency treatment procedures
1	(ii) and (iii);
1	(2) debarment periodthe
3	(iii) the term
1	considers whether any
1	(4) harm 
2	samantha reid dat-rape
2	access with the
1	(c) reduced feeswhere
3	section, the director
1	agencies, and from
2	evidence, that 
1	concerning such food
1	networks are integrated.
1	devices; (2) clarify
1	upton, new york)
1	expressly authorized by
1	safely be employed
3	determines it is
2	shall withdraw an
1	partnership with the
7	render the contents
1	chain sector and
2	list as appropriate.
1	device conforms to
1	application, was accepted
2	4 shall be
1	matter as set
1	strategies. (b) components
1	268, 42 stat.
1	 (b) notwithstanding
1	states government voluntarily
1	actions related to
1	(e) crediting and
1	including at a
1	agency centers. after
5	may compromise, modify,
1	medical product in
1	section, assess and
1	men and women
1	may exercise jurisdiction
1	suspends the use
1	administration is directed
1	medical gas shall
1	epidemiological tools for
1	
 957. persons
1	purchaser; 3-day restriction
1	387c. misbranded tobacco
1	assistance to prevent
1	176 to 185.
2	update such regulations
1	known; and (g)
2	poses no more
2	pending judicial proceedings;
1	related activities, unless
1	removing, and effectively
1	involved, or articles
1	review.  notwithstanding
3	paragraph (1)(b) and
1	(ii) such product
1	(9) paraldehyde. (10)
1	tobacco product; (iv)
1	payments cooperation with
3	food products that
1	(i) in consultation
1	518a, as added
1	language and cultural
2	(c)(4) for a
2	including its salts,
2	measures required to
1	may be, until
1	legislation to control
2	ingredients in such
4	regulated seller, or
1	may use not
1	year without reapplication
1	determines has met
1	envisioned in the
1	reviewed as part
1	revision of united
1	projects, when taken
1	(a) he shall
1	requesting such variance
1	
 
 377.
1	819.)
 
 202.
1	to, or covered
13	pediatric study plan
1	label for such
1	shall not create
1	dietary laws, to
1	earmarking of financial
1	words, statements, or
2	sentence applies with
1	board determines appropriate.
1	ch. 743, 49
1	premarket review, adulteration,
1	third parties. 
1	law enforcement purposes;
1	territory when the
3	action or the
3	establishment fee and
2	without reimbursement to
1	exemption of other
4	period for which
1	(2) shall promulgate
2	issues a priority
1	conduct administrative inspections
2	control the drug
3	(iv) that such
1	general has commenced
1	(c) availability of
1	sanitation requirements the
1	(14) who is
1	may promulgate any
2	agencies under the
7	comply with such
1	1010, formerly 910,
1	term qualifying physician
3	retailer of the
1	illness. (e) share
1	$10,000 for all
1	purchaser, either (aaa)
1	(4) the amount
1	power granted to
3	development tool and
1	countermeasure expertise within
1	394 of this
2	states from such
1	studies)  (aa)
1	dispenses narcotic drugs
1	person files no
1	 (d) administrative
2	limits on the
1	imposed by subsection
1	animal feed covered
1	decision is reversed,
1	purchaser or transferee.
2	public welfare, destroy
2	law; (3) promotion
2	buildings all of
1	continuation of withdrawal
8	(d) the secretary
2	person who was
1	participated directly or
7	established for the
2	upon any duly
2	expire upon receipt
1	veterinary practice at
1	criminal proceedings; procedure;
1	verification.  (d)
1	councils referred to
1	risks to pediatric
1	regarding whether licensure
1	jurisdiction a copy
5	grant recipient and
4	approved or was
1	determined necessary by
1	ch. 675, 525,
1	(i) holds a
2	distributor that purchased
2	4, 2011) beginning
1	certain drug applications
2	liability, the value
1	poultry items under
1	testing devicesthe conditions
1	practitioner regularly engages
2	sold, or offered
98	one or more
1	
 398. notices
1	direc-t-consumer advertising. for
1	drug applications) shall
1	provide both of-site
1	sufficient qualifications and
1	paragraph (1), notice
1	classified report shall
1	constitute grounds for
1	section to section
2	(ii) shall 
2	submitted effective before
1	exposure to an
1	 (l) applicability
2	may, after providing
1	acquired in the
2	request for certification
1	(3) protect the
1	request review under
1	agency shall 
1	network laboratories, and
1	findings eggs and
1	(a) has become
1	(d) minimal strategyfor
1	675, 745a, as
1	director, appointed by
1	shall by its
1	title 3. 
2	conditionally approving the
3	application of any
1	substances or to
1	reclassifying a device
1	show up or
1	develop and administer
1	entry programs (a)
1	therapeutic categories until
1	whose only manufacturing
3	facility identifier in
2	commenced and completed
2	approval is sought
4	commissioner determines to
2	similar file the
1	account the nature
1	met only by
1	make or cause
1	registration in cases
1	(c) on-third shall
3	subsection (b) that
1	2013, such fees
1	whether the new
1	applicable interpretive criteria
1	substantially identical in
2	completed using appropriate
3	lieu of other
1	shall enhance foodborne
1	least 7 percent
1	faith for diarrhea
1	prioritization  (a)
6	subsection nothing in
1	packing, or apples
1	well as societal,
2	unless, before the
1	involvement the secretary
1	 (j) waiver
1	subpart iii of
1	review and decisionmaking;
1	writing and is
1	corporation shall sell,
1	timetable for establishment
3	 (b) individual
1	term biomedical research
1	agent shall revise
1	adult conditions of
1	potential recipients. (e)
1	establishments described in
1	pharmacies and practitioners
3	secretary shall support
1	 (2) grant
4	effect on any
1	19. repealed. may
1	bioanalytical study is
1	 (a) failure
1	device manufacturers in
1	notice, the person
1	cooperative agreements with
1	distributions by mail
1	food, to induce
1	effect on and
1	3,4,-trimethoxy amphetamine. (4)
1	meaning of subparagraph
1	application includes the
1	transaction. (2) a
1	veterinary science. 
1	secretarys review of,
2	include the date
2	medical purpose in
1	1988, whichever is
2	device, and for
1	(d) promulgation 
1	debarment, provided services
1	 (f) priority
1	general controls, performance
1	staff members with
1	paragraph (4). if
1	826a. attorney general
2	felony described in
1	establishment, the operator
2	include the data
1	title in a
1	plan prior to
2	independent cause of
1	 (e) devices
1	prescribes but not
6	(i) the number
1	evaluation, and postmarket
1	nature and impact
1	(2) or within
1	supply of that
1	defense highways or
1	identification of criteriathe
1	unlawful distribution of
1	 (i) describing
1	annual rate payable
1	substance unless such
3	intended to promote
1	track the receipt
2	subsection (i) and
1	provide grant funding
2	conducted prior to
1	(k) or to
2	organic foods production
1	data, including one
1	actions most likely
1	manufacturing process used
1	(a) cooperative agreements
1	total percentage of
1	571 of the
1	respect to ensuring
1	(2) application to
1	local governments on
1	title, the consul
2	acts for such
1	training to educate
1	employee may order
2	significant amendments to
1	(and in the
1	animals) adequate to
1	trafficking area or
2	with, and is
1	yellow phosphorus, paris
1	longer is appropriate
1	administrator to delegate
1	training and implementing
5	financial conflict of
1	approved application submitted
1	tracing as described
1	press release described
1	subsection (d)(4) or
2	article described in
2	207.3(a)(4) of title
6	247d6b of title
1	application, duly verified
1	subjects when their
1	joint venture, association,
4	secretary may deny
2	order the suspension
1	smoking opium. (b)
3	interest for the
8	year in an
2	601 et seq.],
1	contact regarding advisory
1	601 et seq.].
1	filing. (2) for
1	preparation contains one
1	practitioner, except that
1	full qualification packagethe
1	serve the complaint
1	administration exported to
2	destruction provided for
1	provide pharmacy services.
1	agriculture for the
1	601 et seq.];
1	despite good faith
1	(iii) the public
4	subsections (c)(3)(e)(ii) and
1	dismissal filed by
1	manufacturing or labeling
1	size of clinical
1	establishments, which shall
2	fees shall accrue
4	term final dosage
1	certificate of sel-certification
1	application are free
1	 (g) conflicts
2	determination that compliance
2	applying the following
1	(i) contain (i)
1	applicant to discuss
1	political subdivision and
1	membranes intact and
1	(iii) inpatient hospitalization
1	321c. nonfat dry
1	675, 586c, as
1	date of determination
1	90 days, the
2	requests for verification
1	consideration of harvestable
3	including such returns
1	director to carry
4	restrictions as to
1	reimportation of the
2	plaintiff in such
5	interstate commerce any
3	clearance of the
4	strength, quality, purity,
1	committee is convened
1	523, as added
1	1533(a)(2) of this
1	misdemeanor and, upon
1	mitigation strategy. (3)
2	within the 3-day
25	(a)  (i)
1	interstate commerce and
1	republished on a
2	conviction is for
1	(1), or the
1	order to receive
1	(5) increases in
1	issues; (12) shall
9	-year period following
1	analysis the secretary
1	means available to
1	assure access the
1	effectiveness of minor
1	may prescribe such
2	exceeding the daily
1	authorized purchaser in
1	section. (3) the
1	colored margarine in
1	secretary, which designation
1	(iv) the program
4	general schedule pay
1	safe as used
4	directly related to
1	annual report summarizing
1	oral or nasal
1	application, except an
1	role of state
1	(4) to fund
1	anesthetic; (v) an
1	corporation; or (3)
1	defining such terms,
1	sale, or serving
1	aggregate, in the
1	issuance of emergency
1	government authorities; release;
2	considers necessary, the
1	ounce does not
1	entity if such
1	discretion, dispense such
1	produced and sold
3	found by any
1	355(j)(5)(b)(iv) of this
5	harmful virus, serum,
1	(3), the modifications
8	supervision of the
2	review committee established
2	accreditation of thir-party
1	reports on devices
1	differences between infants
1	shall derogate from
1	construction the authorities
1	funds requested for
3	request to make
1	repair, replacement, or
1	
 672. administrative
1	flounder, or cod),
3	review and evaluate,
1	
 360mm. imports
1	(3) assessment 
10	fee for the
1	publish such fees,
1	chapter. (3) the
1	consists of cut,
1	within the country;
2	government. (b) such
1	subchapter for a
1	presents a significant
2	matters as justice
1	subsection on behalf
2	prohibition of additional
1	if, having regard
1	tool (as those
1	within the country.
1	finished tobacco product
1	allows, through guidance,
2	eighteen months after
1	exporter involved, except
3	access to other
1	(b) authority and
1	dispenser the contact
1	determination. such notification
1	penalties any person,
1	conducts one or
9	(a) in generaleach
4	shall perform such
1	scientific evidence, and
2	intended target population;
1	person or through
4	 (ii) a
1	(2) issues for
1	chapter; and no
1	establish the drug
1	meaning of sections
3	representative to be
1	official name is
1	order is deemed
16	available on the
1	(a) an application
2	activities; (b) management
1	treasury, is necessary
1	indication.  (e)
2	record, history, and
2	manufacturer has acted
1	operational activities. 
1	improve such program.
17	shall report to
1	year; (ii) under
1	2007), the secretary
1	(2) recommendations not
1	(3) delivery of
1	research carried out
1	fungous injury, bruises,
1	persons; and (5)
2	different requirements for
2	thereupon the establishment
10	person or persons
1	auditor satisfied the
1	term affiliate refers
1	(l) harmonization with
1	united states international
2	substances and the
1	human use subject
1	review and reviews
1	fellows, and trainees
1	analysis of information
1	prescription, except when
1	much of the
1	whether such publication
4	secretary to evaluate
1	exception for small
2	dispenser shall keep
1	upon written request
1	virus disease. (s)
1	beverages.  (b)
1	secretary concerning adverse
1	increased airway resistance.
2	following the final
1	poultry for distribution
1	required by good
1	current quarter to
1	registrations at any
1	market that would
6	respect to all
1	provisions the secretary
1	use (a) general
1	representatives. (h) termination
1	control program prior
1	 (1) its
2	notice to industry
1	large as any
2	individual has demonstrated
1	 (g) public
1	paragraph. (b) regulations
2	health or safety.
1	product identifier not
1	interests of justice
1	office may accept,
1	fees. the secretary
2	united states. any
2	sold, used, or
1	accredited person. (ii)
2	supplements, and submissions.
5	devices and radiological
13	september 24, 1984,
1	(b) plants located
1	term cannabimimetic agents
2	allowed under section
1	declined requests; (5)
1	years and the
1	safety standards. (4)
1	september 24, 1984;
1	low physical dependence
1	2014 under paragraph
1	topics for consultationtopics
1	subpart h of
1	derived; separate establishments
1	filed, unless the
2	obtain patent certainty.
1	committee, and after
1	(a) if 
1	practitioner authorized to
1	exhibits spontaneous disintegration
1	public upon issuance
1	use any requirement
1	world evidence defined
1	reimbursement specified in
1	jurisdiction, which upon
1	determining, from time
1	deputy director there
1	title, and section
1	disease shall be
1	(1) it consists
3	submitted the advertisement
1	entered into unless
3	transfer (including by
1	concerns about en-product
2	point of purchase,
1	humans, whether or
1	inventories; (iv) provide
1	(4) a list
1	remaining members to
1	identifies the additional
1	possession of, or
1	years in prison,
1	authorities (a) in
1	egg handler with
2	persons opportunity to
1	obligation of star-up
1	food additive regulation,
1	service; exception the
1	program, would need
1	formula from the
1	manufacturer, the producer
1	statutory authority, submits
2	knowledgeable about the
4	service as members
1	expedited inspections and
1	355) for use
1	investigation a submission
1	located in any
1	extent, and destination
1	(b) specify a
1	patients to which
1	(b) when relevant
1	inspection services the
3	will be submitted
1	chemicals (as defined
1	paraphernalia.  (b)
1	drug applications of
1	contamination; (v) the
1	facility, such as
7	drug applications or
2	activities that are
4	 (b) public
2	fees charged for
1	military emergency, involving
1	(i) submit to
1	(22) thebacon. 
1	affiliations between an
2	petition or order
2	may forthwith designate
2	base in such
1	written statement confirming
1	preserve such information.
1	increased importation of
1	strategy was required,
1	 (2) working
1	formulated in such
1	next generation of
1	international treaty, convention,
7	fee under paragraph
1	applicable special controls,
1	purchaser  (a)
1	ingredient that renders
4	381(a) of this
1	electronic, the seller
1	device that could
2	delete the patent
1	submitting a single
4	(1) has been
1	use, with respect
1	secretary for more
1	policy, such notice
1	general public and
1	 (3) preventive
1	cosmetic) under this
1	indicating an intent
3	shall consider 
1	may direct. the
3	exercised. the secretary,
2	meeting  (a)
1	relates to production,
2	substance abuse. 
1	entitle a drug
1	subject to haccp
1	 (h) quotas
14	response to the
1	(d) is a
1	regulation indicate which
1	prescribe terms and
1	construed to reflect
1	testing involving a
1	hospitals, and scientific
1	use audit agents
1	reports summarizing all
2	(d) such person
1	level or higher
1	animals; and 
1	treatment services, seek
1	years after issuance
1	medical practitioner licensed
2	systems for the
2	general, shall ensure
1	sentence of imprisonment
1	marijuana, cocaine, heroin,
1	filled by the
1	(h) phenylacetic acid,
1	identification, is considered
1	reasonably determined to
1	1057; aug. 7,
2	panels and committees
1	responsibility for carrying
2	approved protocol has
1	(4) if displayed
1	issuer, or of
1	business days of
1	funds; adequacy of
1	may charge reasonable
1	corporations engaged in
1	product radiation; (c)
1	retailer the term
1	operator to use
1	agricultural adjustment act
1	(2) responsibilitiesthe executive
1	relationship. (9) the
1	understanding, or enter
1	transferred, based in
2	manner to effectuate
1	proportions as in
1	congressional committees, at
1	1913, shall include
2	operating such facility:
32	subject of a
1	(4) knowingly failed
1	2017 exceeds the
2	subchapter or regulations
10	provided by section
1	commercial channels by
1	essentially copies of
1	percent of thc
1	dosage form 
60	percent of the
1	
 379e. listing
1	pathogens listed by
2	purity, and potency
1	subsection (j) may
4	importer of tobacco
1	radiation; he shall
4	obtain a review
2	(b) improving the
1	paragraph in accordance
1	secretary for demonstrating
1	greater, or all
3	certification is not
3	object that has
1	license number (if
1	subject to discovery
1	either in person,
1	subparagraph may recommend
2	trade representative, in
1	administrator to carry
1	conditions, any n-tobacc-sale
1	section 335b(a) of
2	surveillance. the secretary,
11	adversely affected by
1	subject of 1
1	nutritionally equivalent to
1	farms; and (iii)
2	sterile water, whether
1	(d) or subparagraph
1	make timely assessments
1	terminate the order
1	administration to assure
1	products to consumers
1	(12) methadon-intermediate, -cyan--dimethylamin-4,-diphenyl
1	product returned); and
1	 (c) subsequent
2	(a) an applicant
1	educate wholesale and
2	employs, hires, uses,
1	priority and resources
1	programs; (4) shall
1	including any criminal
2	product radiation; and
2	enter into such
1	made. (vii) in
1	chemicals (a) notification
1	practicable and in
3	secretary which is
1	confer a benefit
1	person in commerce,
1	(g) qualified infectious
1	validated or terminated
1	(b) practitioners licensed
3	fails to submit
1	requirement; and (iii)
3	section 360j(l) of
1	samples distributed, destroyed,
2	date.  (c)
1	resources provided to
1	dissemination. with respect
1	device is to
1	person. the person
1	creates the intended
1	facilitation, direct service,
1	funds that would,
1	registration containing the
2	 (c) consideration
1	(b) registration of
1	petition means a
1	personnel data, research
4	count: provided, that
1	general a regulated
2	secretary shall use
1	similar forum to
33	except that the
1	offsetting collections shall
1	transaction, a statement
1	(i) label where
1	assess the risk
1	
 
 360fff5.
1	design, any component,
1	household or for
3	judiciary, the committee
1	subjecting of each
1	delay or prevent
1	water used for
1	areas program; and
7	limits and in
1	networks of public
2	assessed in the
1	large, page 768)
1	(a) identity[1] opportunities
1	forfeiture any drug
1	conformity that a
1	(8) an order
1	prepares meat or
1	amenable species means
1	date is specified
2	substance, the word
5	grounds for the
1	(1) such article
2	applicant has already
1	(a)(2)(a)(viii) may be
4	shall give notice
1	food which purports
1	(i) an annual
1	ruleevery person who
7	secretary and a
2	supplement that will
1	subclause (iii) of
1	drugs. (ff) the
1	principles and protocols,
1	inspection of domestic
2	feet of, a
1	public is adequately
1	policy required under
1	1-member advisory committee,
1	production of documents,
1	target requirement the
1	460(b) of this
1	date for trial
1	court pertaining to
1	provide the basis
7	 (i) subject
1	activities. such state
4	may be, to
13	et seq.]. 
2	sections 351, 352,
1	chapter or other
2	absorbed from a
1	device recalls; (2)
1	simply talk to
1	results in sundry
3	conduct testing and
1	implant. (
 

3	 nothing in
1	terrorist persons and
1	etonitazene. (23) etoxeridine.
1	informationany information pertaining
1	forfeiture if such
1	30, 2016; and
1	including through 
1	importation of meat
1	particular device under
1	346a regulations that
1	practices in the
1	obligation nothing in
1	person had first
1	determination publicly available
1	use by or
2	consider available data
1	approved an application
2	require the payment
1	previously received a
1	passed or if
2	uses, persuades, induces,
2	otherwise used in
3	drugs for minor
1	secretary may coordinate
11	narcotic drugs in
1	may on the
1	enforcement effort with
1	substantive clinical data.
1	inspections and examinations
1	title;  (5)
3	research has demonstrated
1	strategy is submitted
4	practitioners licensed to
1	application, permit 
1	(a) to maintain
1	(1). an initial
1	(a) months, fiscal
1	approval for marketing
1	recovering from an
1	coordinating federal, state
1	pooling and analysis
7	biological product would
1	(b) shall, upon
1	consider the perspectives
1	health or safety;
1	applies  (i)
1	color additives listed
1	controlled substance during
1	health; and after
4	856 of this
1	-methylpseudoephedrine. (u) hydriodic
2	provided in sections
1	individual retail outlet
1	(8) a review
1	provides confidence intervals
1	health; (ii) any
3	party to disseminate
1	person believes may
2	containing authorities at
1	provider from whom
1	evidence) relevant or
1	fee waiver for
1	records the united
1	contract relating to
1	exporter first begins
1	(l) pesticide chemicals
1	procedure for appropriate
1	18 relating to
1	application if an
1	individual who made
1	change, made for
1	agencies; (ii) recruitment
2	stat. 1057; 

1	strategy, a description
3	determination that 
1	regulated person that
2	necessary, the adequacy,
1	safety of children;
1	fraudulent statement or
1	surveillance information on
2	chemical residue, means
4	directly to a
1	suspended on discovery
1	ch. 675, 900,
1	paragraph. a revocation
2	upon the united
3	withheld unless the
2	equipment, finished and
1	biomedical literature; (e)
4	human food are
1	sentence and probation
2	identify the information
1	regard to information
2	periodic evaluation of
1	example, or other
119	submit to the
1	(1) each separate
2	registration if the
1	(c). (3) biosimilar
1	device complies with
2	days but not
4	informal hearing, the
1	(i) by reason
1	gifts to inspectors
1	least annually to
1	requires the recipient
1	(26) transaction informationthe
1	 (c) requirements
1	nonprofit entities 
1	sufficient to permit
30	submitted under paragraph
2	media campaign; and
2	purity, or potency
1	first applicant amends
1	(b) a color
1	(2) the claimant
3	provided, that no
1	case of individuals
1	section 262(a)(3) of
1	paid. (f) limits
1	relating to other
5	whenever he believes
1	pure and unadulterated
1	$1,736,000 for fiscal
21	current good manufacturing
1	general or the
1	number of, type
1	pending issuance of
1	(d)(4).  (f)
2	reports submitted to
1	year 2015, $11,700,000;
2	american medical association,
17	(3) the secretary
2	medicinal dose of
1	with, development and
1	transferred. (b) in
2	petitioner of such
1	
 455. inspection
1	agencies detail or
1	commercially available techniques
1	pediatric diseases (a)
1	purchase forfeited property
2	application, or an
1	(o) patent defined
1	complaint, or within
2	partnership, or individual
1	may authorize its
5	title or an
3	 (b) evidence
1	(3) substantial evidence
1	title 18. (e)
1	registration numbers, with
1	[42 u.s.c. 262(i)].
1	condensed, or evaporated
1	appropriate division director),
1	safety standards to
1	reconstitution; (iv) an
1	(1) requirement as
2	article or other
1	notwithstanding paragraphs (1)
1	secretary, (iii) provisions
1	(i) be submitted
1	title, and that
3	period of a
1	entity. the qualified
1	title or as
1	single enantiomers 
2	conditions or do
1	(2) fee amountthe
1	forth in subsections
1	annual basis. 
1	stat. 1040; july
1	applicable under regulations
1	active ingredients as
1	product who undertakes
2	subsection (c)(2) of
1	bulk vehicle includes
1	requirements: notice and
5	 (1) such
2	number to each
1	interest, including timing
1	programs are not
1	(
 
 2252.
1	foster greater understanding
1	product has any
1	allow united states
2	subsection; and (c)
1	timely manner. (ii)qualification.the
7	request is submitted
1	
 63. penalties;
1	360ll(a) of this
2	period of 3
1	world health organization,
1	data completeness, coding,
1	shall afford all
5	territory, or the
2	period of 6
1	submitted by any
1	officers; marking containers
3	analysis conducted under
1	secretary marked agreed
1	 (a) accelerated
4	names under which,
1	constitution. the finding
3	accompanied by an
1	animal drug, referred
1	human food; and
1	refusal, request, in
2	title 42 on
5	action on the
1	(c) condemnation; appeal;
1	841(b)(3) of this
5	shall request the
1	implementing this section;
1	 (2) limiting
1	manufacturer to fill
1	relief necessary to
1	paragraph (2)(a)(vii): 
1	advisory committee has
1	title. (k) transitional
1	iii, 539, formerly
5	secretary shall debar
1	working groups recommendations,
2	(b) shall submit
1	drug involved, the
5	taken before the
1	obtained for one
1	agency may not
2	drug with a
15	submits to the
1	title, information in
1	upon such approval
1	products in shortage,
2	container used in
1	(5) person the
6	product pursuant to
1	reasonable public notice,
1	sponsors, when appropriate;
1	support that an
3	supplier  (a)
1	392. exemption of
1	appropriate number of
2	finally determined, or
2	qualification package for
2	subparagraph (c). (c)
1	determine the safety
2	farmer representatives, and
1	establishments (a) in
1	property and remove
1	case level by
2	860, or 861
1	reflect necessarily a
1	675, 506g, as
1	device. such an
1	law, will enable
6	made by such
1	united states. upon
1	upon the regulations
1	(1) except in
1	term poultry product
1	(
 
 1301
1	part 54 of
1	fiscal years to
1	product such person
2	modification described in
1	sunscreen under this
2	$652,709,000 multiplied by
1	efforts to interdict
2	packaged on a
1	products required under
1	requirements of rule
1	(ii) in order
1	responsibilitiesthe executive board
5	$1,000,000 for all
1	period, imports of
1	law; and 
1	(k)(1) and the
1	360fff3. grase determination
1	(2) inflation adjustment
1	submit the following:
1	must, in certain
1	subsection (c) was
1	means a characteristic
1	title. (b) whether
1	identifying publicly the
4	title 15. 
2	case of product
1	5,000 or more
1	canceled pesticide becomes
1	officer.  (e)
1	including those involving
1	countermeasures, including the
1	ethics, neonatology, and
1	director of each
1	entering into contracts
1	prevent, destroy, repel,
1	coordination, communication, and
1	liable for payment
1	(a) performance reports
1	yet approvedthe sponsor
2	needed on an
1	summary data shall
3	secretary respecting the
2	received a certification
5	conducted under section
1	granted for the
1	screens, hashish heads,
1	section 360d(b)(5)(b) or
1	involved in writing.
1	(c)(1), the risk
1	operates, or on
1	previously filed an
2	of, and other
1	november 10, 2005;
4	order of approval
2	 (i) notification
1	index listing; or
1	policy established under
1	activities, as described
1	1045; renumbered 309,
1	designee to enter
1	b12 (g) 0.15
1	(b)(4)(e), (c)(1)(b)(i), (d)(1)(c)(i),
1	making, selling, disposing
1	opium poppy, both
1	conduct demonstration and
1	master file not
1	pesticide analytical methodsthe
1	bears such labeling
1	consultation pursuant to
1	means any practice
1	resistant pathogen, including
1	premises (a) unlawful
1	subsection (c). (d)
3	generalthe attorney general
2	subpena to an
1	techniques, equipment, and
1	termination180 days prior
2	country and in
15	wholesale distributor shall
1	(2) compliance by
1	(b) limitation no
1	policy documents, or
3	relevant national drug
1	geneva, july 13,
1	general may make
2	advisory committee in
1	flexible mechanism for
1	issued to another
1	internal controls for
9	regulated industry, the
1	sanitary inspection and
1	training that addresses
3	1, 2003, had
1	(1) (involving an
1	studies; (iii) available
1	mean the actual,
1	961. prohibited acts
1	accommodate a label
1	actual use conditions
1	practicable, not require
1	standardized information to
2	animal drug submissions
1	350(c)(1)(b)(i) of this
2	packaging requirements for
2	may submit to
2	information in addition
1	commercial motor vehicle
2	(2) requirement not
1	implementing programs or
1	provided a time
1	(b) no fee
7	manufacture, distribution, or
3	applicant, the applicant
2	relating to fire
1	(i) the validity,
1	pdufa reauthorization performance
2	(1)(b) or (2)
1	notice, shall hold
1	terminate the exemption
1	technologies for data
1	dispense, a counterfeit
1	congress to conduct
1	section 360ll or
1	42. (b) priority
1	term audit agent
1	$1,000 or by
1	foo-related hazards that
1	described by section
1	justice a unit
1	meat thereof, are
1	include studying the
1	communication, and decisionmaking;
3	section 360ll of
1	health outcomes and
1	law for which
1	(a) extend the
1	considered when the
2	product manufacturer means
2	(i) standard the
1	calendar year, on
9	states government subject
1	stakeholders and experts
1	invoking subsection (e).
7	subsection (a); and
2	risks of new
2	electronic means unless
2	notice as described
13	title 5. 
1	tariff schedule of
1	(f) or not
1	powder and in
1	diligent implementation by
1	first. if the
1	intended, and of
1	animal drug submission,
1	processing, or otherwise
1	termination or revocation
1	fourth fiscal years
1	united states who
1	destroy pathogens) or
1	review for qualified
1	forth in a
2	objectives similar to
1	record of regulated
1	public inspection. 
1	official standards means
5	stimulant, depressant, or
1	(a) preclinical and
1	stated the conditions
1	health as suspending
6	business means an
1	disposition in accordance
1	significant issue of
1	wholesale distributor the
1	patients ability to
2	(i) be made
1	therefrom by reason
1	instituted or become
1	abet (as such
1	reliable.  (5)
2	paid.  (f)
2	pediatric studies and
2	financial interest means
2	fully meets such
1	 (e) recovery
1	establishment whose premises,
5	shall be removed
6	 (i) all
1	controls to conform
1	(o) construction the
2	recommendation.  (c)
2	unrestricted by any
2	united states, giving
3	purposes of carrying
1	additional inspectors when
1	preparation for market,
1	threats, expected technologies,
1	proceeding concerning such
1	no-federal funds required
1	who, with respect
1	understanding by youth
1	order to alleviate
1	repacker or relabeler,
1	research, development, training,
1	31. (e) certification
1	approved; or (b)
1	(e) death penalty
2	sustained period of
1	nonetheless have a
1	smoke constituents. 
1	compensation (including back
2	otherwise become aware
1	dispute as to
1	facility or importer.
1	initial date set
1	partnership project from
1	withdrawn modular applications
1	(2) amount in
1	president and serve
1	means, shall identify,
2	involved is issued.
1	fruits, and melons.
1	barrel so sold
1	et seq.] (or,
1	benefit for serious
2	actually used by
1	reconstitution), but for
2	(a) each type
1	will provide maintenance
1	person, the owner
1	chemicals manufactured by
1	(b). (f) assistance
5	summarize any substantive
3	national and local
1	(which notice in
3	involved in such
1	applied worldwide. (4)
7	(a) in generalexcept
1	submitting portions of
1	applied and is
8	mark, or certificate;
1	term vessel does
7	facilities and acquisition,
1	granted the licensee
1	substantially equivalent and
1	class ii, include
1	political campaigning any
1	budget requests to
1	concerning that plan;
1	(u) the terms
1	threat pursuant to
1	formulation described in
1	centers involved in
1	provided strong and
2	accompanied by 
1	detailed and those
1	data were required
1	(c), formerly 902(b),
1	sunscreen order and
1	trial shall by
1	0.40.  (ii)
2	civil action. 
1	collected in abbreviated
1	(ii) a contract,
2	thereof, whose possession
1	exemptionsthe secretary may,
2	qualified individuals for
1	tool related to
1	trial shall be
2	federal register containing
1	indica, digitalis, ergot,
2	furnishing of judgment,
1	service.  (

1	significant risks to
1	(gm) 1.8b 
1	(i) registered or
1	control act (referred
1	farm; and (b)
1	substances) that comply
1	(f) public access
1	development tool if
1	ch. 675, 1009,
2	subsection (a)(1), based
1	approval is based
2	sell more than
1	title[1] seized by
1	inventory, including sales,
1	required in a
1	limits an inspection,
1	contains 50 to
1	states law. 
1	facilitating the carrying
1	electronic population data.
1	sentence, if the
3	placed under seal.
1	(xiii) such other
22	351 of the
3	shall be granted
1	following qualifications: 
1	product was begun;
1	(c) the reasonableness
1	study advanced drug
1	noticean amended order
1	(ii) of a
1	test interpretive criteria,
1	product was begun,
1	stat. 1046; apr.
1	placed under seal;
1	(iii) include criteria
1	application the requirement
1	poultry producers and
1	agonist as demonstrated
1	designate a practitioner
1	use in foo-producing
1	medical devices, although
2	chemicals the attorney
1	public health problems
1	(b) shall complete
1	annual reports to
1	term adulterated applies
1	paragraph to the
1	hearings shall be
2	loss to, and
1	 (b) upon
1	collected fees shall
1	appropriate handling and
1	stalks, oil or
1	of; or (3)
1	60 per centum
1	product identifierswith respect
1	1996, with substantial
1	(
 
 862b.
1	interchangeability with the
1	distribute means to
2	convicted of 
1	evidence of its
2	including the identity
1	
 379o. environmental
14	device for which
1	secretary, supported by
2	subparagraph (11) is
1	858. endangering human
1	person can associate
6	(ii) the term
1	data submissionat the
4	person submitting such
1	justice, or to
1	paragraph (c)) at
2	committees consisting of
2	chapter. (3) 
3	comparative bioavailability studies)
1	inclusion under subparagraph
2	honesty and fair
1	butter, and which
1	public; (c) developing
1	1040; july 22,
1	review division; (vii)
2	generic drug submissions
1	daytime or nighttime,
1	2017 only, as
1	pay or removal
1	categorization.  (2)
1	human body of
1	(a) develop metrics
2	(ii) identifies specifically,
1	(2) any such
1	associations, or other
1	units per year
1	stat-operated program), the
1	research or the
1	years. (mar. 4,
4	manufacturer, supplier, or
1	general each applicant
1	7.  (5)
2	fines as are
1	15. (b) coordinationwith
1	condition or may
2	state may bring
2	(i) review the
7	fee setting the
2	include with the
1	(iii). (c) if
1	area); (c) the
1	paragraph (3), at
1	1053. inspection and
2	section and before
2	apply:  (i)
1	create and issue
1	consideration to applications
1	exportation or destruction
1	(a) that occurred
1	generic drug submission;
1	nutrition labeling (a)
3	state, or other
1	applies under paragraph
1	voting members. 
1	may, on the
1	secretary. (c) if
2	 (f) recordkeeping
1	generic drug submission,
4	agree. any such
1	300 times the
1	individual applying for
1	level; how such
1	(1), an accredited
1	(b). such a
3	review the regulation
1	conduct is administered
4	(w) the term
3	applicable requirements in
1	narcotics; (c) success
1	submitted, exempted from
1	sell in the
4	purposes or for
4	section; and (ii)
2	v, whichever is
1	retention of 
1	activity or the
1	product on tobacc-related
1	drug according to
4	product tracing 
1	registrants under this
1	meet such requirements.
1	(h) for fiscal
6	 (9) the
1	is, for purposes
1	clinical trials leading
2	practice pharmacy in
3	provided in such
1	ingredient, or dietary
1	interest; and (2)
1	fee amounts on
1	(1),[2] shall be
1	local health departments,
1	standard of current
2	days, for the
1	campaign to ensure
1	entities, including farms
1	information; and (6)
1	treasury to hold
3	reducing illicit drug
1	results and analysis
1	brief documentation of
1	without identifying symbol
1	drugs.  (11)
1	education in drug
2	enforcement agencies in
1	symbol shall be
1	regulations notwithstanding clause
1	paragraph for such
1	2002. records, audit,
1	1, 2008, for
1	search warrants a
1	(including efforts made
1	360b(d)(1)(a) through (d)
2	hearing, but this
1	 (k) definitionsin
2	interest and with
1	defraud and distribution
5	(3) use of
1	event reports through
1	involved, the conditions
1	671. inspection services;
6	(1) for a
2	will not cause
1	secretary determines would
1	ability, and age
1	reinspection the secretary,
4	 (d) reauthorization
1	country to an
1	control audits that,
3	lead to a
1	sums appropriated under
1	revoke such proposed
2	entitled food and
1	use in providing
1	approved application as
1	501 of title
3	product fees under
1	subsection. the regulations
1	definition of foodborne
1	proposal regarding, with
1	(a) within 20
1	effect on or
1	year 2010 unless
1	related to health
1	conditions found by
1	tobacco products who
1	applicant; (d) a
1	regulation; (b) on
3	require the use
2	several states to
1	food involved, and
1	licensure as described
1	(e).  (

3	exists to determine
1	cause for referral
1	require.  (7)
1	(b)(1) application was
2	adequate clerical and
1	2007, whichever is
1	evidence and secretarys
1	distributor, or reverse
1	drugs solely, or
1	holiday work costs;
1	 (1) investigate,
1	natural food and
7	drug to the
3	supplier may, to
1	susceptibility information described
3	place designated by
1	title and such
1	(d) waiver the
3	(v) a congenital
1	indication that occurs
1	appropriate, for consultations
1	priority to local
1	abuse; (3) studies
1	stat. 477; 

1	studies are being
1	hydroxybutyric acid to
1	without a prescription.
1	access to investigational
1	qualified entity means
1	receive and protect
1	foods, including based
1	meeting or teleconference.
13	secretary, in coordination
1	use (for which
2	center of the
185	respect to the
1	manufacturers tests (or
2	(a), or (ii)
1	(a), the civil
2	applicant demonstrates that
1	(a) not subject
1	notice shall present
1	abuse treatment in
1	(26) ketobemidone. (27)
3	diversion control program
1	subjects it shall
1	(j) of the
1	contained in its
2	product safety. 
1	title applies, be
1	 (iii) convene
2	scope, duration, and
1	standard.  (b)
1	subsection (e)(1), or
12	section 353(b) of
1	sufficiently in advance
1	(b) a regulation
1	combination products under
1	conduct annual assessments
1	insurance plans, and
1	animal drug, supplemental
1	otherwise derived, with
1	time inspectors to
1	individual under 18
3	et seq.]. (b)
1	(ii) excess proceeds
1	drugs for safety
1	batch form, prior
1	address such provisions
1	 (i) sufficient
1	subsection (e). regulations
1	2011, that the
1	 $3,750 
1	campaign) in accordance
4	subdivision thereof, the
1	bonds and without
9	343(w) of this
1	also assign a
1	transport by a
1	conviction, a person
8	maintain such records,
1	administrator that a
1	18 or, in
1	preventing additional human
1	level, up to
1	drug use by
3	preventing the entry
1	person.  (e)
1	wherever he may
2	orders issued under
1	level v of
2	report regarding 
1	time. the secretary
2	agencies, including the
1	(vii) a sympathomimetic;
2	(b).  (11)
6	contract with a
1	egg handler (including
6	(a) the activities
1	organizations working in
1	ch. 74, 2,
1	emergency use). 
1	submission; and (ii)
1	considered adul-written publications.
1	agent  (1)
1	management plans in
1	(21) ethylmethylthiambutene. (22)
1	(ii) the reliability
7	maintained by the
5	general shall establish
1	medical gas has
2	direct contact with
2	states. (2) the
1	shall forward such
1	shown for failure
1	appropriate action under
4	authority conferred on
2	person to pay
2	released by the
1	authorizing such activity
1	conclusion that a
1	exchange in the
1	
 344. emergency
2	establishment described in
1	investigational use 
1	standards. the director
1	567, as added
2	adequate and effective
1	(g) eligibility for
1	support measures; (c)
1	conducting program and
1	(d) data list
1	(b) market exclusivity
1	activities; (b) enhancing
2	among members of
1	cows, barns, and
1	section ends early
1	findings, and a
1	party any issue
3	schedule ii 
1	(d) drug abuse
1	court for any
1	formula powder, shall
1	(e) preventing and
1	proof specified in
16	shall set forth
1	security countermeasure, and
1	equivalents engaged in
1	 (g) executive
2	period ending june
2	medications to treat
6	application) submitted under
1	conducting an evaluation
12	chapter.  (b)
1	director shall use
1	information. the secretary
1	devices which are,
4	awarded against the
2	amounts as follows:
1	patient labeling and
1	(i) prior to,
1	drug administration (excluding
1	(e)(9). (b) provide
1	percent more than
1	operates, including criminal
2	agency management control
1	control of dangerous
1	1395 of title
1	animal generic drug
1	(2) provision of
1	immediate family member,
2	classifying such device
2	dispense, a controlled
2	information listed in
1	special consideration to
2	product under a
2	certification (or a
7	term affiliate means
1	(a) any employee
4	tobacco products under
1	protect the national
1	(including the effects
1	(1) any persons,
1	reduction shall 
1	458. prohibited acts
1	(a) assure that
1	industry, and consumers
1	thereon: cautionthis product
1	l., except the
1	means a tolerance
1	day when the
1	means a summary
1	may cause the
1	subsection. in carrying
2	facilitate an efficient
1	three years. 
2	first 1-month period
1	identification requirement facilities
1	by, or works
1	enhanced interagency and
1	term official plant
1	planning  (1)
1	(5) review the
1	made changes that
4	director  (1)
1	defined in an
4	january 4, 2011;
1	establish fees under
1	
 877. judicial
1	particular farm (as
3	title has been
1	appropriate timeframes. 
1	delivery, or other
6	(3) effect of
3	january 4, 2011.
2	plans for all
41	january 4, 2011,
1	feedback letter is
2	january 4, 2011)
1	recall at such
1	inspectors; (d) the
2	electronic means is
1	(e) other relevant
12	resulting from the
1	utilization of, such
1	order granting a
1	hearings hearings authorized
1	indene ring, whether
6	sale, barter, exchange,
3	secretary issues an
1	simulates, or falsely
1	promptly as is
1	propose to adopt
1	proof being on
1	
 171 to
1	section shall identify
1	subsections (b) through
1	electronic means in
1	approved under accelerated
1	1996. (e) state
1	steps to mitigate
1	group, or subgroup,
1	grantsthe administrator may
1	developed under sections
5	determining whether the
6	program shall be
2	limitation or reduction
1	costs. (
 

1	(b) failed to
1	607. labeling, marking,
1	applicable standard, an
1	distribution (as defined
1	diligence; (c) the
1	specify in writing
3	compounded drug products
7	person under this
1	secretary finds for
1	shall notify congress,
1	storage or identification
1	licensing under subsection
1	protocol provides 
1	exempt from state
1	conduct any other
1	originates. the inspectors
1	may, when the
1	(i) available information
1	(ii) following an
1	executive board. the
1	data, contain 
1	 (d) limit
2	take action against
1	nonnutritive object, except
1	states. nothing in
1	(1) notify in
1	annual reports in
4	(1), the attorney
1	 (6) national
2	within 1,000 feet
1	medical, or technical
2	administrators services or
1	use amount shall
1	
 
 642.
1	preventing  (i)
2	determination, the person
1	submit requests to
1	animal disease outbreaks
1	1925; or (b)
11	regulations the secretary
2	fiscal year 2007;
2	commissioner have been
1	available within a
1	monitor the movement
1	raw or natural
2	notify the appropriate
1	[42 u.s.c. 264].
1	355(p)(1)(a) of this
1	substance, extend the
1	name is unduly
1	among the uses
1	reinstatement of registration
1	whether  (a)
1	scheduled to meet
1	needed to effectively
1	audit and investigation;
1	within five miles
1	regulatory authorities of
1	food or its
1	appropriations (a) in
2	states to bring
1	(c) how such
1	(a) the expiration
1	sales, transfers, theft,
1	effective at such
2	waiver the secretary
2	 (a) if,
1	 (1) contrary
1	deadlines. (b) when
1	revocable and shall,
1	consistency of federal
1	food facilities in
1	guidance of the
1	emergency, authorize such
1	meeting the costs
1	code, secs. 2420324207),
2	committee on homeland
1	(f) 400 grams
1	156 of title
1	chapter, after opportunity
1	samples and of
1	addressing national and
1	prescription drug. (c)
1	 (10) progress
1	analytical methods available
1	shall be refunded.
2	(ii) and (iii),
1	article ordered or
1	applicable; congressional findings
1	advice to, and
2	shall be classified
1	information, the compensation
1	diseased animals of
2	360e(c)(5) of this
1	379dd2. activities of
1	dispensing such substance
11	diem in lieu
1	section 344, 350d,
1	available scientific information
1	chemical residue may
1	meeting, other than
39	(or any successor
1	concerning recordkeeping for
1	similar source acceptable
1	secretary, which may
3	address of, the
1	cases covered thereby.
1	(i) utilize the
2	food purposes by
1	letter, the secretary
1	active ingredients becomes
1	automate appropriate activities
6	civil action to
1	(b) the transaction
1	(6) the disposition
5	animal drug, and
1	provides advice or
1	clause (ii), in
1	authorized by local,
3	rule in accordance
1	regulated transactions 
2	(2) rule of
1	requirements for high
1	facilitate ris-based inspections
1	developed prior to
1	prohibition, or precedent
1	3,-methylenedioxypyrovalerone (mdpv). (20)
1	food service personnel.
1	least two years,
12	drug or drugs
1	prevention of terrorism,
3	programs relating to
1	employing children to
1	use in effect
2	reasons based on
4	title, and interest
1	notation, approved by
1	
 
 379j53.
1	conduct  (1)
1	failure; (2) all
1	procedures (as prescribed
1	request and proposed
2	slaughter, shall buy,
1	property within the
1	may be established,
1	promulgated.  (b)
1	refuse to stamp,
1	shipped or transported
2	new information relevant
1	countries; and (c)
1	term rea-time supplement
1	members either in
1	title with other
1	claiming that a
1	treasury under the
5	product during the
1	exercise jurisdiction. (2)
2	standard  (1)
2	otherwise to assure
1	increase pediatric labeling
1	control policy, deputy
2	third party auditor
1	 (e) applicability
1	suits against the
1	(i) significantly higher
2	(3) in consultation
1	manner and format
2	who, if there
1	 (b) bond
2	months during negotiations
2	conviction reversal if
1	(iii) information for
1	section applies with
1	scientific review of
1	intended to produce,
1	leaf or a
1	owns an abbreviated
1	endocrine effects; and
2	preceding sentence. upon
1	states court in
1	(iii) financial holdnotwithstanding
1	executive board in
1	thir-party auditor agrees
1	accounting to be
1	recall order issued
1	similar to, or
1	1935, ch. 739,
1	(2) establish a
7	 (i) quarantine
2	duty of the
1	drug store or
1	two such violations
1	standards defining quality
1	$40,000,000 for fiscal
1	complete the study
1	 (1) commencement
1	custom prepared articles,
1	violations have endangered
2	payment made under
1	designed for feeding
2	become final under
1	shall by administrative
1	(h) public health
1	(a) emergency situations
1	(6) cyprenorphine. (7)
2	subordinate governmental unit,
1	signals from clinical
4	applicable, shall be
1	review such portion,
1	otherwise processes saleable
2	provided by other
1	tenure on the
1	(i) maintaining access
1	virus to be
1	case when there
1	suggestions for modifications
1	
 
 350k.
1	(f) authorization of
1	identifies and makes
1	samples in the
1	exporter may request
1	exported  (i)
2	360eee1(a)(6) of this
1	(b), no libel
3	section of the
3	(b) fee revenue
1	drug administrations performance
1	made a good
1	state laboratories, and
3	(b) priority review
1	case giving rise
1	unsafe food additives;
1	interagency and intr-agency
1	require such accounting
1	subsection (a)) who
1	product. (iii) the
3	mail or by
1	entity or an
1	person (as such
2	person making such
1	meat products under
1	indictment for the
1	thereof the name
1	(e) an assessment
1	order issued in
1	use or recipient
1	receive, for each
2	5301 et seq.]
1	considered acceptable for
2	interested party at
1	(a) an event
1	 (c) harmonizing
1	communication, including electronic
1	website).  (2)
1	manufacturers based on
1	inspections or reinspections
1	control strategy, the
2	country; and (4)
1	manufacturing practice) to
1	container size; (e)
2	provider, having a
23	submission of an
12	imprisonment for not
1	risks to human
1	tobacco, including foreign
1	considerations; (gg) diversion
2	(i) the rate
1	regulation activities during
3	minimum size two
1	product after such
1	term national methamphetamine
2	exported from a
1	(b) facilitate access
1	subsection (a)(1) available
1	serious drug side
1	otherwise appropriated, such
1	natural origin, or
1	 (b) workload
1	
 1502a. transferred

2	64 stat. 20.)

2	withdraw an order
1	4706 of title
1	organization of high
1	paragraph shall state
3	section 453(g) of
1	unless at the
6	secretary may also
1	term poultry products
1	(1) or under
1	703, 52 stat.
2	effectively identify recipients
1	importer, or agents
1	compensation, terms, conditions,
1	secretary except with
1	sole purpose of
1	sensitive and predictive
1	coordinate the availability
1	laws any issue
1	(d) annual reportnot
1	74, 5, 38
1	achieve advanced product
1	scientific evaluation that
1	court may by
1	necessary, as determined
1	establish the applicability
1	(c) any person
1	fund accounting procedures
1	intended use not
1	food product, or
1	outsourcing facility remits
2	(a) a regulation
1	guidances issued pursuant
1	standards and practices;
1	accreditation standards not
1	law determinative of
2	existence in the
1	evidence presented at
1	review means reviewing
1	number); and (iii)
1	information alleging that
1	(i) exportation insulin
1	drug in accordance
1	exhibit antimicrobial activity.
1	extension that the
1	(iii) a biological
4	direct and the
5	fee as required
1	675, 586g, as
1	means any facility,
1	available and relevant
2	identified, and shall
1	means protection to
1	 (f) limitations
2	standard; (9) if
1	attorney general documentary
15	territory of the
1	humans) composed wholly
1	(b) can cause
1	2004; (8) $80,000,000
2	different processes and
1	information any summary
1	pathway has helped
1	regard to application
1	secretary) shall submit
1	may exempt a
2	committee shall 
2	subsection, the fee
1	expired drugs including
1	conditions, review the
1	intent to participate
1	 (b) procedurein
3	providing services in
1	advisory panel established
2	document on the
1	potential threat. (d)
1	relevant health data
8	(1) does not
1	review of modified
1	section each fiscal
1	may establish exemptions
3	importers who have
1	establish requirements regarding
1	listing have not
1	volume of international
5	(c) the inspection
4	year to reflect
1	extension the secretary,
1	justify administrative inspections
7	members of such
6	year by the
6	will be adversely
1	material information in,
1	influenced by any
1	subsection for that
1	(who is not
3	set aside. 
1	continuous inspection shall
1	spacesubject to the
1	penicillin, streptomycin, chlortetracycline,
2	design, or device
3	term official device
1	ingredients are included
1	material made by
2	(ii) a conspiracy
2	information, the secretary
1	951. definitions (a)
1	(iii) shall capture
1	authorized to employ
1	abuse constitutes a
2	applicable to drugs
1	law. (2) a
4	effective in accordance
1	ch. 675, 573,
1	notify health professionals
1	term type ii
1	providing transaction information
1	title, have been
1	collection with regard
1	accessibility of records
1	address.  (3)
1	involves more than
2	sufficient evidence of
1	auditors, including the
1	disclosed under subsection
2	(including per diem
1	change has been
1	plansthe strategy described
2	stores and restaurants,
1	operating in commerce
1	cost of administering
1	entitled to be
1	broadest conversion to
1	upon after the
1	presumption in simple
2	appearing and testifying
1	 60.0. 
1	convention or to
1	143, 2, 68
1	assessment the secretary
1	substance contains, when
9	state or other
1	of-site and o-site
1	timing and public
1	twice that otherwise
1	animal drug applications;
1	360bbb7. notification (a)
1	pending the conclusion
1	chemical under section
1	issues an approval
3	regulation or denial
1	(1) identifies a
1	reserve fee has
1	condition or disease
2	new abbreviated new
1	(iii) that on
22	animal drug applications,
3	animal drug applications.
1	agencies, to implement
1	assurance provided by
1	respecting a new
3	fees assessed and
1	unless the product
2	traffic in such
1	claimed exemption under
1	(ii)(ii), the secretary
1	interes-bearing account, if
1	establishing that the
1	(4) use such
1	title and ending
1	subchapter; (4) when
3	writing that the
1	drug test, and
8	official duties under
1	violation any person
1	paragraph (3)(b)). 
1	provided as part
1	regarding requirements under
1	etc., ingredients; adequate
1	benefit of eligible
1	establishment is part
2	amount of not
2	establish or maintain
1	hearing. (3) the
7	(c) for purposes
1	therefore.  (c)
1	factors; nonacceptance the
2	applicable) of a
1	secretary and not
1	person submits any
3	secretary, that the
3	secretary at least
1	drug shortages regarding
1	subsection (c), issue
1	required in subparagraph
1	action for appropriate
1	secretary has entered
1	treasury may authorize
1	(b) territorial exemption;
2	take custody of
1	levels, including data
1	including demonstrating that
3	year, the director
1	requesting additional information
2	effect notwithstanding any
2	thereby falsely purports
5	title, in the
3	(b), of a
2	standards that are
4	application of clause
2	entities under this
1	application contains the
1	lobster, or shrimp),
1	ch. 675, 802,
1	research, and any
1	675, 404, 52
2	date of original
1	application of notification
1	foreign country and
3	deter its use
1	recognized standards for
3	processing, labeling, or
1	products contain no
1	costs and expenses
3	investigators) obtained as
1	(1) it may
1	voluntary provision of
4	pharmacy, drug store,
3	80 per centum
1	shall order, in
1	 (7) regulatory
1	postapproval requirements under
1	chemicals and other
1	functions; or (v)
2	infringement action against
2	(a) at the
2	(ii) the composition
4	reducing substance abuse
1	drug therein; or
1	chemical residue based
1	chapter 11 of
1	country of destination,
1	food emergency. 
1	ch. 155, 1,
13	reason of the
1	previously provided to
1	may, with the
1	related to carrying
1	general after its
9	section 355(i) or
1	time, upon a
1	transportation; or (2)
1	standards and processing
1	frequency with which
14	section 355(i) of
1	approve such no-racemic
1	evaluate the risks
1	board by law
1	networks as appropriate
1	apply for such
3	if, prior to
3	detailed statement of
1	(b)(ii) available to
1	application is relied
2	fully disclose the
2	section 842 of
1	assessing conformance with
1	thereof is securely
1	management plan was
1	assessment for public
1	one premarket report,
1	(19) 3,-methylenedioxypyrovalerone (mdpv).
2	assessment center to
3	shall promulgate such
1	seal; (2) remove
1	renumbered 4 and
3	product that are
1	recommended is not
3	approval under paragraph
1	develop and assure
1	implant. (4) harm
1	within close proximity
1	least 10 percent
1	patients, family members
1	subparagraph (b)(ii), undergone
1	suspend the sale
1	means any foreign
2	substance, or immediate
1	 (8) provide
1	task force as
1	support program (a)
1	(d) the pesticide
1	applying for an
1	prescribed time period
1	establishment hereinbefore mentioned,
2	 (d) powers
1	resulting vacancy shall
1	resistant, or such
1	states for transshipment
1	agriculture and with
1	action plan submitted
1	 (6) timing
1	ensure that employees
1	  manganese
13	promulgated under section
2	shall, by july
1	made.  (b)
1	presenting drug safety
1	waivers consultation on
1	prescription order will
11	reauthorization of this
1	distributor of record,
2	distributor of record.
1	marked, stamped, tagged,
1	existing food safety
1	final action on
1	title). whenever any
1	products in commerce
2	evaluating the safety
2	shall be $2,748,000
1	2017. (j) collection
2	presence of pesticide
1	intended to facilitate
1	cos-effective poultry inspection
1	(2) includes a
1	match advertising direct
1	addresses best practices;
1	subchapter, notice shall
1	food satisfies the
2	program year until
1	vacant.  (3)
1	principal mission the
1	12-day period that,
1	importer subject to
1	applicant will conduct
2	iii device; (ii)
5	tobacco product means
10	violations adjudicated in
1	health; or (b)
1	require;  (iii)
2	responding to inquiries
2	(a); and (b)
1	subclauses (a) through
1	policies and bylaws
1	meeting between the
1	distribution in interstate
4	drug abuse treatment
2	probation, or parole
1	election; (bb) at
1	(d), (e), (f),
1	(i) an outline
1	license, or commercial
1	material threat when
1	no-electronic format. 
1	population in such
1	subsection $30,000,000 for
1	conduct a study,
2	paragraph (2); and
1	device, or changes
1	establishments  (1)
2	presidents annual budget
2	effect on authorities
1	cleared use of
1	committed the violation.
1	studies submitted to
2	provide a description
1	fees, and the
1	unlawfully manufacturing, storing,
1	coalition shall have
1	pollution that resulted
1	(h) reciprocal meat
1	(c) $7,429,000 for
1	(5) consultation with
32	state or political
1	fund amounts equivalent
1	5 for records
2	animal drugs. 
1	(g); or (b)
8	officer or employee,
1	animals; he shall
1	drug product was
1	application, or has
1	 (4) additional
7	publication of a
1	effectiveness submissions pursuant
1	judgment the facts
2	act or circumstances
1	shall be plainly
1	(3) shall be
1	obtain and add
1	including major accomplishments,
1	(b) pharmacies, practitioners,
1	recall means 
1	direction) a space
1	organization; (iii) a
1	products, (d) focus
5	(a) unless the
3	marketing  (1)
1	approval supplements. 
9	submitted on or
1	force as soon
1	associations, animal health
1	control notices 
1	subsection (d), one
1	testify in such
1	valid methods to
1	form; and 
1	(d) applies to
1	may authorize delivery
1	term qualifying pathogen
1	agency, shall maintain
3	use the device
1	residue be considered
2	shall pay only
1	819.)
 
 212.
1	(b) and subsections
1	title 5; (5)
1	(g) at least
1	supplemental applications for
1	investigation, including information
1	term distribute does
1	(a) appointment 
1	manufacturers previously cleared
1	services projects and
1	sale.  (june
1	hearings (a) power
1	sel-certification referred to
1	hand; (6) miniature
2	days of its
1	(3) denials proceedings
1	new owners and
1	penalties, to the
2	class as those
3	exercise of scientific
1	summary data or
2	subsection (b)(2)(a), the
34	apply to the
1	27, 2007, whichever
1	party to such
1	1-year period. (b)
1	applicable inspection warrant,
1	authority contained in
1	prioritize the implementation
3	bases. (iv) implementing
1	thereof; waiver of
1	information regarding food,
1	legally marketed unapproved
1	margarine is packaged,
1	346a(i)(2) of this
1	determining which devices
2	development organization that
4	years or more
1	31.  (b)
1	commission $1,000,000 for
23	rare disease or
1	paragraph (3), such
1	entity under clause
1	ii, and (ii)
1	modify, revoke, or
1	843(d) of this
1	particular concern to
1	groups. (june 25,
1	criminal prosecution is
1	 (b) licensure
1	requirements to violate
1	otherwise indicated. 
1	shall be achieved.
1	isomers.[1]  the
1	98 of title
5	account  (a)
1	action letters that
3	applying any official
2	360eee(16)(b) of this
1	section 282(j)(5)(c)(ii)[2] of
1	shall be maintained;
1	also constitutes a
1	hygiene training. (c)
1	monitoring of the
3	tobacco the term
1	(ii) federal employees
1	surgery; and 
1	involved is located
1	(3)(c) and information
6	approved in the
1	completing the selection
2	products and treatments
1	term thir-party logistics
1	(k) the distribution
12	fee paid under
1	title; (ii) in
1	360b(a)(4), 360b(b)(2), 360b(c)(1),
2	business; examination of
1	good manufacturing requirements
1	(f) allowing timely
1	affirms or denies
1	affirmed if it
3	brought for infringement
1	360bbb3a. emergency use
3	subsection (q). 
2	employers, and advisory
1	paragraph (5)), that
1	(g) publicly available
3	fee due datesuch
1	establishments; operations conducted
1	describing any material
1	except in extraordinary
1	standards for guidance.
2	clinical investigation, the
1	pane-track supplement, a
3	genetic injury, to
2	undertaking referred to
2	reported such resumption
3	clinical protocol for
6	sentence of any
1	coordinated communication within
1	(a) may present
1	may, through fellowships
1	statement described in
2	including records which
1	approved product). 
1	agriculturein implementing this
4	may or may
1	wel-controlled investigations for
1	shall be lawfully
1	purchasers (or subsequent
9	report shall be
4	10 per centum
1	food, the manner
1	resulting from lawful
1	committees except where
1	(12) $114,000,000 for
1	chapter upon a
1	composed of five
1	upon request, be
1	exempt or modify
1	section. (b) members
1	manner  (a)
2	provider the term
1	message of the
1	(2) the initial
3	upon request, by
1	(i) the licensed
1	
 321d. market
1	species from which
6	(a) present the
2	better coordination and
1	sought; (b) if
1	prior to offering
1	 (c) venue;
1	identifies drugs containing
2	congress to protect
1	condemned shall be
1	upon a written
1	objectives and timelines,
2	supplant grant funds
1	him, if he
1	product establishment, notwithstanding
1	specific policies and
1	misbranded.  (b)
2	meat articles produced
1	year after establishment
6	containing the name
1	fee account for
1	remedial action by
1	purposes, and sell
1	thereby. (
 

1	consumer. in any
2	shall apply equally
1	(involving an action
4	2007, or an
1	(2), and (3)
1	request fails to
1	$114,000,000 for fiscal
2	determination to qualify
1	stated in paragraphs
1	make an additional
1	penalty, the persons
2	device shall contain
2	sample of a
1	533, formerly act
7	drug may be
1	compliance, annual o-site
4	committee or otherwise
1	includes the implementation
3	specific lon-term and
1	subsequent drug master
1	experience in medicine,
1	testing devices 
1	thir-party auditors 
1	1998:  (a)
1	nuclear agent identified
4	 (c) applicability
1	devices and a
1	relate to any
1	decree of condemnation;
2	innovative products and
1	exclusively to medical
2	grant under subsection
1	records. (
 

1	(b); or (2)
1	(i) may relate
1	(b)(1) and such
1	domestic animals prohibited;
1	(a) is conditionally
1	title minor species
1	formerly 360a, as
1	usual name, chemical
1	department of commerce;
1	plant shall be
1	(b) any container
3	tobacco products for
3	drugs; and (ii)
1	meat items that
1	cooperative investigative efforts
3	hazards that occur
2	may designate an
1	 (2) within
1	oxide and propylene
1	found or in
1	covered entities in
1	department of commerce,
1	sufficient to identify
3	annual basis pursuant
1	product before october
2	notwithstanding any otherwise
2	whose premises the
1	675, 518, as
1	establishment that repacks
1	law modifying such
2	(2) an order
1	regulations alleged to
2	medical gas as
1	expenses not more
1	order of persons
1	prominently display such
3	required for seven
1	submissions of additional
1	drugs or antibiotics;
1	individual health and
1	section 4332(2)(c) of
2	consider the least
2	resumption, the identity
1	675, 561a, as
1	chapter is maintained,
2	affiliates, shall certify
1	unless modified or
1	shall provide support
1	accept the uncompensated
2	school or a
1	electronic product unless
1	26, ch. 10),
1	processes, by which
1	limitations of use
1	country as determined
1	section 360j(g)(4) of
3	(a) which the
1	sold under such
1	thereof.  (8)
1	defraud or mislead
1	general shall recover
1	equivalent of any
1	foreign, or intrastate
1	cannabimimetic agents means
1	appropriate scientific evaluation
1	subsection (e) after
1	(excluding user fees)
1	listed, prescribe the
1	1263, 37, 68
5	agricultural quarantine and
33	required under subparagraph
1	(j) and is
3	adequately served by
1	imports (a) refusal
1	outdoor facility (including
1	dietary supplements to
2	year), the amount
1	unsafe for such
1	contracts for the
1	establishments where such
1	u.s.c. 247d6b(c)(2)(a)(ii)]; or
1	(1) timing not
1	675, 721, formerly
4	subsection (a) has
6	six months rather
1	54; aug. 1,
2	submission  (1)
2	pay the higher
1	(a) encouraging formal
1	approved application provide
1	identify and define
3	applications subject to
4	person to fail
2	address local drug
1	programs and strategies;
1	considered as intended
3	licensed under state
2	facilitate the identification
1	30 days; or
2	previous 12 months,
15	substance shall be
1	previous 12 months.
1	(a) any highly
2	pay fees, late
2	may change the
2	organized crime drug
2	felony for conduct
2	opinion that patent
1	device, shall be
1	states mails in
1	animal: provided, that
63	compliance with the
1	information. (c) rule
2	training, education, extension,
1	title shall contain
1	meeting request the
1	test results required
1	procedures to the
1	circumstances and the
2	secretary may request
4	information (including lot
1	regulations regulating the
1	defined by regulation;
2	food.  (g)
1	done, such labeling
1	treatment programs there
4	studies) essential to
1	(2) chewing gum,
4	declared to be
2	year (after fiscal
1	risk may include
1	(b) make a
1	(1); (ii) provide
1	case section 381(d)(1)
1	upon  (a)
1	crisis in the
1	final regulations shall
1	withdrawal, transportation, placement
1	(such as bulk
1	 (c) imitation
1	(which, to the
1	(2) acceptance and
2	body on the
1	application. such timelines
1	(b) process 
1	(ii). (3) procedure
1	excess of on-half
1	plant and are
3	date as the
3	may be sentenced
1	
 
 399a.
1	endocrine effect, develop,
1	registration. it shall
2	authority of representatives
1	(4) exemption notwithstanding
2	involved has been
1	risk that such
1	prevent distribution or
9	health of the
1	leins[1]  (a)
1	pediatric assessments described
3	bears the name
1	containing the new
1	(a) sanitary practices
1	plan. (4) proceedings
1	1041. enforcement provisions
1	appropriate safeguards as
2	title is made.
1	(e)use of analyses.
1	knowingly uses the
2	time, the claimant
3	required to carry
1	(c); or (iv)
1	clinical benefit, and,
1	another department, agency,
1	generalthe secretary is
2	product a biological
1	613. plans and
1	(2) testified or
2	(2) against a
1	supplements for which
1	lists of drugs
3	system of the
2	patent information described
1	(a)(1).  (d)
1	program; and (b)
2	include the substance
1	meets all labeling
1	drug; (c) on
1	section 356c(g)(2) of
1	fiscal 2013 shall
5	periodic consultation not
1	supply for the
1	maintain records documenting
2	submitted for advisory
3	1988, the secretary
1	stat. 822.) [1]
1	collections for fiscal
2	label on or
2	licensed for further
2	(7) in the
1	inclusion the report
1	(other than to
3	youth ant-drug media
1	batch numbers sufficient
6	person who 
1	destroyed; (vii) maintain
3	expenses shall be
2	alter agreed upon
1	section apply to
1	hereby provided for
1	(ii) the necessary
1	subchapter ii, with
2	section, to apply
1	hearing before report
1	substances. to this
1	used, unless and
1	diagnosis of lif-threatening
1	probable cause, issue
7	emission tomography drugs
1	379j62. authority to
1	covered by, and
1	dependence; (i) international
2	reasonably be known
1	laws and authority
2	subsection (i), the
1	feasible or appropriate.
1	determines such other
1	unless the device
1	warnings section of
4	 (a) establish
1	poison bottle, and,
1	submitted a request
1	2252. compliance with
1	continue the actions
2	file such modified
1	shall abide by
1	minimize litigation costs;
4	section of an
1	section, $15,000,000 for
1	residues above those
8	 (5) 
1	(a) imported, exported,
2	disagrees with the
1	frequency of use
1	free samples also
1	necessary hardware and
1	drug shortages; and
1	training. (ix) if
1	manufacturers. (3) subsequent
1	safety officials (a)
1	(2) the actions
2	chemical that may
1	controlled substances) contained
6	voucher is used.
1	care facilities in
1	tests associated with
1	composed of 7
1	on-year waiting period
7	copy of all
1	made a duplicate
11	product under this
1	vessel or aircraft,
1	products applicable to
1	(c) received transaction
1	1-day restriction under
1	africa; or (ii)
1	7. (june 5,
2	repair or replacement
1	labeled, distributed, held,
1	health;  (4)
1	register proposing bulk
1	person commits a
2	(d) exception for
1	task force development;
1	tobacco product, to
1	 (c) oral
4	conclusions and recommendations
1	record of sale
1	
 2243. smuggled
27	introduced or delivered
1	emission tomography drug.
1	control efforts; (b)
3	expediting the action,
1	agents deemed acts
2	ingredient under this
9	whether such application
1	(4) knowing or
1	anaphylaxis, if applicable;
1	real and personal,
1	heroin or smoking
1	384a. foreign supplier
1	pending human drug
3	device is classified
1	determines such inclusion
1	manufacturer must be
1	statement under section
2	applying to the
3	per violation, and
1	 (18) returns
1	counterterrorism activities 
1	drugs have not
1	unduly complex or
1	health professionals with
1	collected in any
2	adulterated and presents
1	fix a quota
2	specific drugs and
4	export controlled substances
1	articles and standards
1	tribal leadership and
2	yet submitted the
1	chemical which, as
1	labeled poison unless
1	electronic form, including
4	379e(a) of this
1	 (h) effectiveness
1	guidance, and financial
1	subparagraph the secretary
1	class iii devices,
2	adhering dirt or
5	final determination by
1	processed in such
1	availability and carry
1	trials, if available,
3	standard.  (3)
1	(k) relation to
1	chapter as such
1	survey data, standardized
1	prescribed by subchapter
1	cumulative effect, if
1	published. (f) 
1	duty of any
2	ant-drug coalitions throughout
1	designated by such
1	studies (a) submission
1	covered entityin this
1	(1) any judge
1	unlawful; employment of
1	sale, directly to
4	knowledge that the
8	(2) for purposes
1	rail vehicle. (b)
6	proceedings for the
1	(b)(1) who comes
1	civil proceedings nothing
1	administration; and (iii)
2	registered with a
1	(1) the entity
1	part on the
1	proposed direc-t-consumer television
2	term does include
1	status neither a
1	program shall estimate
1	conducted outside the
1	liquid) which contains
1	may not prohibit,
1	shall promptly act
1	(g) require a
1	 (2) administrative
2	brokers, wholesalers or
1	notification on the
1	helping alleviate or
3	determined each fiscal
1	petition, except that
2	validity of his
1	man means a
1	(b) requirements for
1	require the removal
2	shall obtain a
1	(e) scheduled listed
1	site that 
1	requiring an additional
5	states agent for
1	emerging infectious pathogens;
2	diseases and drugs
1	require; and (b)
1	letter, a notice
2	improve the quality
1	substantially complete, was
2	economic loss in
1	alert the foreign
4	clause (ii) of
1	master files, abbreviated
1	seq.); (g) the
2	shall update such
2	treasury not otherwise
1	poultry means any
1	(b) ex officio
4	manufacturers that are
1	commerce of meat
1	cros-disciplinary review; (iv)
1	$60,000,000 for fiscal
4	clause (ii) or
1	sections 335b and
1	vehicle, such officer
3	pallet, tote, or
1	title, (b) which
7	states and its
3	installation of such
5	continue discussions of
1	2015, $566,000,000. (h)
2	reporting  (1)
3	trafficking and drug
1	ingredients, the route
1	subparagraph (b)(iii) unless
1	laboratory examination or
7	action pursuant to
1	paragraphs (2)(b)(ii) and
5	1997, the secretary
1	registration information the
1	budget submission under
23	tobacco products scientific
1	acts in only
1	(3) engage in
1	14 days after
1	(d) recovery of
2	food in which
1	7625 of title
1	 (b) covered
1	criminal violation before
1	countries, however, and
2	chemical product in
1	nations demographic composition
2	facility for purposes
1	present any oral
1	state authority with
1	(5) notwithstanding paragraph
1	entry. information with
1	order made pursuant
1	agriculture, the department
7	shall coordinate with
1	secretary, except as
3	determine whether compliance
1	distributors to elect,
1	chapter, exercise concurrent
1	clause[2] (i), (ii),
1	campaign; and (iii)
1	title and in
1	loss of value,
1	gases (a) certification
2	subchapter iv or
1	petrichloral. (11) phenobarbital.
1	 (3) when
1	title and if
1	(5) in any
1	private programs or
1	repair the device
1	15, 1932 (d.c.
1	evidence of compliance
5	status of each
1	proceeds of sale
3	commerce. it is
1	grades on barrels
1	(2) (referred to
1	exceeding twenty grains.
3	title and is
1	shall annually (1)
2	data.  (5)
1	complete an approved
1	reasonably included within
1	complete. (e) construction
2	official marks whenever
2	five years, and
2	guidance document shall
1	medical communities, and
1	person may 
4	submission that is
1	title, unless there
4	convenience kit that
16	secretary  (1)
1	consumption. no person
1	effect before 1
1	529a, as added
2	individual to whom
1	ingredient facility each
3	assistance and support
1	panel may 
4	[42 u.s.c. 262(a)(3)].
1	facts regarding prior
1	situations presenting imminent
1	individual from submitting
2	(a), the conditions
30	state or local
1	hydromorphinol. (12) methyldesorphine.
1	year 2017, $12,900,000;
1	dosages set forth
2	national standards for
1	finding.  (june
1	said act relating
2	information previously submitted
1	elements as are
1	regulations are promulgated.
1	1046; mar. 16,
2	(a) respecting a
2	risk than the
6	10 grams or
2	fee established by
1	custody, advertising, and
1	measure safety; (2)
3	promulgated by him.
1	products. (2) label
1	advance notice shall
2	generalthis section shall
5	352(f) of this
1	regularly licensed pharmacist,
1	equines, or the
3	321(ii) of this
1	allow such a
1	providers who prescribe
1	pediatric therapeutics and
1	675, 756, as
5	food emergency response
1	recognized, but which
1	identification number so
2	trials required by
1	action brought against
1	title, except in
10	class ii device
2	control strategy with
1	person or firm,
4	subchapter.  (d)
1	title that referenced
1	whether such requirements
1	511; amended 

1	stat. 1102; 1940
4	(b) if such
1	laboratory shall meet
2	reasonable time, the
3	ultimate consumer or
2	shall be proof
1	product, or cosmetic;
1	i(c), the term
1	scientific methods or
2	dismiss filed under
1	 (1) does
1	individual has paid
1	(ii) 1 individual
1	given to applications
1	including increasing the
1	675, 738, as
1	device, (4) the
1	effectiveness under section
1	secrets) shall be
1	standards in order
2	title, two shall
1	determining in any
1	(b) includes an
1	fee; (5) it
1	medical considerations involved
1	cosmetics which are,
1	trade secret. 
1	(2) written request
1	service. (aug. 11,
1	et seq.]. this
1	review period and,
1	(1) any or
3	shall be maintained
1	complainant resided on
1	drugs, the secretary
1	food. (d) rule
1	gross negligence or
1	presented, that the
1	share with the
1	 (c) conditions
1	one voting member
5	(b) may be
1	(3) as soon
1	(2)(b)(i)(i) shall 
1	including all establishments
1	thereof, insert therein
1	hazards that can
1	matter. a person
1	similar manner, will
1	(ii) the department
8	45 calendar days
1	1103.)
 
 142.
2	adulterated (a) poisonous,
1	transactions as the
1	regulations, or any
1	procedures if the
1	panel not more
2	distribution, dispensing, or
1	ensure effective and
1	intellectual property and
1	regulatory proposal. (4)
1	(3) is displayed
1	 (6) access
8	infants and children
1	means a new
1	substances. (5) a
1	products and prescription
1	rule under subsection
1	securities; and (b)
1	trust responsibility of
1	sanctions on a
1	applicant, consider designating
23	shall be submitted
2	items under this
1	employee under any
1	
 387a. fda
1	containing these chemicals);
2	water, whether intended
1	(a) suspension if
1	distributor.  (d)
2	chemical residue; (ii)
1	following notification under
2	standard, in whole
1	refuses to issue,
4	section 3 of
2	 (d) a
2	(1) the styles
1	(c) is related
1	restrictions no person,
1	drug control and
1	generalno entity engaged
3	subchapter, the secretary
1	held and related
1	investigations performed pursuant
1	biosimilar biological products,
1	preparedness; and (b)
1	donations of property
2	fooda food shall
5	reauthorization; (b) hold
1	policy shall submit
1	period, the preliminary
1	production or origin:
1	1956, ch. 530,
1	every school year,
1	system detection capabilities
2	applicable with respect
1	consideration to 
1	(i) federal law
1	requirement to issue
2	age who violates
2	and, with respect
2	advertisements identified pursuant
1	policy or criteria
1	protects and promotes
1	pharmacopoeia.  (c)
1	interstate and imported
1	(h) may obtain
2	iii device which
1	order prohibit such
1	(d) exceptions 
1	dispensers, to explore
9	general if the
1	individual, as well
1	economy; (2) illnesses
1	subsection (a)(2)(d)(ii)(i)) shall
1	(3) status of
1	number of new
3	may grant to
1	(2) addressing such
1	strategy (a) development
1	enforcement organization that
1	years. (v) whether
1	regulation applicable under
1	mild, or low
2	persons referred to
1	controlled substance among
1	(h) allow any
1	maintained; (iii) procedures
1	regulations, and policies
4	expires (including any
1	requirements, and achieve
1	emerging threats. 
1	conditions are later
1	requesting a supervisory
1	section 208. 
1	discontinuation of distribution
1	(pcp); (v) 1
1	safety.  (i)
1	either direct or
3	drug product, a
1	involving the national
1	established through appropriate
1	drug being misbranded.
4	advertisement is submitted
1	contravention of state
1	used otherwise. 
1	noticea notice of
1	safety standards that
1	discovery is governed
1	participate in international
3	(1) alter the
1	congress has appropriated.
4	(b) for each
1	contains any additional
1	notice thereof. 
1	section 355(b)(3) of
1	secretary shall, when
2	licensed pharmacist in
1	(c) pediatric subpopulation
1	life imprisonment or
2	u.s.c. 262], including
1	produce was grown,
1	appropriate for discussion
1	programs.  (c)
3	harm will result
1	 (3) that
2	chapter which relates
2	exemption or exception
1	design or performance
1	identifies the manufacturer
2	establishes a guaranty
8	penalty under paragraph
2	established or modified
1	first country and
2	departing from the
1	adverse impact of
1	provide training seminars,
1	hearing; grounds; person
1	section to import
1	shall include one
1	sales either at
1	passed all such
13	substance that is
1	dispute resolution a
1	manufacturers under section
1	fostering participation of
1	pharmacy compounding; (c)
1	contents; restrictions 
2	(ii) include a
2	 (1) which
1	available to federal
1	discretionary basis, to
1	 (1) amount
3	 (3) information
1	avoids, or has
1	forth in its
1	tissue or body
1	agreed upon in
1	devices, foods, food
1	name and all
1	advisory review during
1	drugs for tropical
1	ch. 675, 529a,
1	(1) requirement beginning
1	pesticide residues other
1	exemption for personal
1	chapter the secretary
2	evidence for purposes
1	represent the interests
1	educational agencies to
1	particularly hydroponically grown
33	provide for the
1	time to address
1	prevent united states
1	communication to convene
2	operator of any
1	years imprisonment, such
1	effected by any
1	morpheridine. (30) noracymethadol.
1	(1) animal inspection
1	issued, accepted, and
1	care practitione-patient relationship.
1	investigation.  (b)
1	misleading.  (e)
1	(5) referral to
1	investigations as may
6	court for leave
1	451 et seq.);
1	importer and such
1	petitioned for such
3	451 et seq.),
7	application may not
1	experts and stakeholders
1	makes a declaration
2	infant formula does
1	preceding sentence on
1	subparagraph (a); or
1	pediatric devices the
7	drugs pursuant to
4	date the person
4	death, serious injury,
2	fees established by
1	chemical specified by
1	strategic plan 
1	inspection observations previously
1	 (c) individuals
3	(2) subject to
1	parental obligation to
1	entities.  (13)
2	paragraph (2) has
4	agreement regarding the
2	requirements for foods
1	including tracing of
1	area; (f) the
2	article and any
1	26. omitted
 

1	writing and prior
1	use, under the
1	(a), if the
1	ch. 675, 561a,
1	limitationan exemption from
2	submit a 510(k)
1	shall consider such
2	issue a fund
1	writing and in
1	
 387c. misbranded
4	subsection (a) 
2	5, for persons
1	agrees that such
1	premises or in
1	common control, if
1	local situation, or
3	owner designated to
1	will not impair
1	(
 
 321b.
1	strategy to encourage
2	agencies  (1)
1	criminal activity. 
1	subpopulation that is,
1	decision to grant
1	(4) other programs
1	witness an order
1	increased risk; (iii)
1	term infant formula
1	represents a community
8	take action under
1	hidta program budget
1	(2) the measures
2	therein in the
4	5 years in
1	hundred points according
1	fees.  (3)
1	active ingredient to
2	unless such field
3	committees and to
2	food unless the
5	 (1) general
1	(2), notify in
1	life threatening, (ii)
2	color additives if
1	court challenges relating
3	making the inspection
2	sufficient training or
1	federal level; and
1	health: provided, that,
1	tolerance or establishing,
1	shall implement programs
1	dtc advertisement has
1	day following the
1	drug that requires
1	administrations performance in
1	identified candidate, clearly
1	productsif a pesticide
1	chapter, a hospital
1	federal standards of
3	decision) a petition
1	shall in consultation
6	purpose in the
1	audit in a
1	coordinator concerning that
2	(c), the person
1	penalty, may file
1	insignificant changes in
1	regulations; issuance, amendment
1	two inches in
9	60 days for
2	lake success on
1	anabolic steroids. 
1	listed chemicals; behin-th-counter
6	fees (a) types
1	action on administrators
4	chief executive officer
5	officer of the
2	product applicationthe term
8	101(b) of the
1	control program; (10)
1	exports which have
1	71 to 92.
1	155, 7, 44
6	total costs of
2	review is necessary
1	regarding recalled human
1	prevent unauthorized access
1	title, describing the
1	secretary a renewal
1	industry on a
1	fails to reveal
1	secretary made pursuant
2	subparagraph (a)(i) of
1	public health than
1	consisting of the
3	court for a
3	500 employees, including
1	(c) proceeding on
1	2007, in accordance
1	applications from the
1	(1) early childhood
1	subchapter iii or[1]
1	 (3) residues
4	fiscal year notwithstanding
2	(b) to provide
1	regulation (1) require
3	outweigh its risks
2	involving 5 grams
1	implementation and take
1	(2) medical and
2	(b) the standards
1	
 399e. nanotechnology
1	official compendium means
3	listed chemical with
1	health, whenever processing
3	awarding grants under
2	bears (a) the
1	treatment, research, rehabilitation
1	access or, if
1	names have been
1	product. (b) each
1	attorney general, to
1	product. (c) the
1	nature was carried
2	(b) conditions of
1	capacity (a) in
1	issued before august
4	introduced into interstate
1	approval, and suspension
4	drug store, or
1	instrumentality shall, to
2	funds and any
1	cream it shall
1	chemicals than tobacco
1	(1) are waived
1	sponsors, and generic
29	senate and the
1	abbreviated application is
1	proportion of each
1	2012, established in
2	information or its
1	factors, such as
1	products or controlled
1	fee with respect
3	10 years, a
2	reach a minority,
1	beyond a total
1	appeal using dispute
3	november 27, 2013.
1	considers appropriate for
1	within the sixt-day
1	established legal entity;
1	request is a
1	(a) to class
1	(d) is or
1	examination conducted under
1	hold the food
2	has, respectively, not
14	changes to the
1	device provided by
6	conditions of the
1	may seek a
1	products to, or
1	clause (i) to
1	storage, processing, or
1	legal theory, for
1	contains any alcohol
5	amount of appropriations
1	operations at any
2	lieu of submitting
1	(3) information exchangethe
2	size two and
1	treatment of classified
1	(f) evaluation a
1	shall include, along
13	clauses (iii) and
1	(3) upon review
1	consistently applied. 
1	offer technical assistance
1	annual report requirements
1	necessary to improve
1	study  (1)
1	term unexpected serious
5	use in animal
1	completion of substance
2	legal and factual
2	paragraph (1) applies
1	variance are reasonably
1	dispensed  (a)
1	waives the requirement
3	final guidance under
1	correct copy thereof.
1	president shall notify,
1	 (b) if,
3	additional information. 
1	therapies if the
1	forwarded to the
2	protest, unless the
1	(i) documentation from
7	incurred by the
1	(d) regulations 
1	no-federal food safety
1	food industry to
2	taxing authority and
2	issue such administrative
1	952(a) and (b),
2	made.  (3)
1	(iii) the increase
2	355(p), or 3551
4	device may be
2	administration of a
1	character and not
1	application, and (2)
1	interstate commerce, a
1	application.  (v)
1	complaint under section
1	discontinue participation in
1	facilities and operating
1	necessary shall be
1	law or by
1	206, 207, 302,
1	samples from unregistered
2	margarine or butter
1	drug. (d) exceptions
1	shall also coordinate
1	parties, or, in
1	valid prescription. (v)
1	(b) practitioners a
1	person, that the
1	otherwise justifiable based
1	(i) not accept
1	technology.  (june
1	(2) intending, knowing,
2	license.  (b)
1	district court at
1	(3) a color
1	303, 52 stat.
1	studied as a
1	inspection, and, where
2	case of negotiated
1	(c) individuals upon
1	lawfully obtained, and
2	indications for use
1	(k) that was
1	applicant after the
1	(iii) the central
1	regulation.  (e)
8	designate the drug
1	distribution history, transaction
1	authorization (a) grant
1	substances registration granted
1	(i) violates the
1	(a) classification panels
1	practice pharmacy shall
1	supplier to produce
1	expand an existing
1	treatments for tropical
2	1472 or 1473
1	$97,000,000 multiplied by
2	drug is referred
2	 (b) annual
1	(a)(2). (iv) for
1	sector entities to
15	appointed by the
2	licensed practitioner, to
2	reporting of other
1	therein, directly or
1	order a defendant
1	marketing and advertising
1	litigation the manufacturer
1	reports or information,
1	may rely upon
1	services; hearing; grounds;
1	paying the operating
1	trials (a) in
1	without first ordering
4	except as hereinafter
1	360bbb2. classification of
1	american samoa, the
2	comment period for
2	withdrawn from listing
1	permit inspection of
1	met. such an
1	(
 
 883.
1	fluent in the
1	trafficking area 
1	paid and the
1	division. (g) transition
1	 (b) reportthe
1	estimate of 
1	misbranded device, and
1	(2) label statements
2	shall notify such
1	deaths of individuals
1	powers act (ieepa)
1	states while that
1	felony which is
1	types for which
1	consult with a
3	 (b) assessment
1	months is necessary
1	remains incidental to
1	registration of persons
1	section; (c) detailing
1	articles and they
1	human beings, or
1	manufacturer if 
2	360e(d) of this
2	claim for an
2	inspection is maintained
1	(b)(2).  (o)
1	 (i) indicating
1	enter into contracts,
3	states, american samoa,
1	(a) and submitted
10	another schedule, any
1	vehicle, vessel, or
2	detection and measurement
1	use animal drug
10	drug offense has
1	generally available in
1	periodic basis through
30	facilities and controls
1	 (i) eligible
1	drug) by any
7	constructionnothing in this
1	(l) records and
1	currently marketed sunscreens
1	clear under section
1	rules, the court
2	necessary to provide,
1	foundation activities with
1	products unless such
1	names; compilation, publication,
1	general, if supported
3	foreign offices of
1	claimant thereof. the
1	agencies of states
6	guidance under paragraph
1	order the device,
1	section 954 or
1	wholesale distributor, purchased
1	adequate by the
2	standard, and (b)
3	biomaterials supplier shall
1	beginning one hundred
1	made reasonably available
1	effective upon receipt
1	promptly after collection,
1	section 954 of
1	purposes; (2) it
1	
 801. congressional
1	(16) the several
2	purposes of participating
1	mucous membranes and
1	clear ant-drug message
1	stakeholders and the
1	purity from such
2	interoperable, electronic tracing
1	providing such notice
1	records of veterinarians
1	understood to mean
1	action. (iv) 18-day
1	(2) transferability 
1	(a) the costs
1	drug administrations review
3	information developed under
1	previously paid carry
1	(ii) is being
2	rulemaking to establish
2	defined in that
2	liable to a
1	applicant for license
2	countries to which
2	egg or egg
1	reporting and accountability
1	term i-person medical
2	increase in a
1	unapproved use, the
1	adequate requests if
2	(as applicable); or
1	period approved for
1	(f).  (h)
1	reserves only to
1	serious injury to,
3	year 2014 under
2	may be captured
1	value of any
1	respect to farm
2	state agency (i)
2	suspension, restriction, or
1	total worldwide gross
1	depressurization or other
2	findings, conducted, supported,
1	secretary determines it
1	knowingly counterfeiting such
1	abbreviated application filed
2	action which occurred
2	activity (as defined
1	(i) the identification
1	dietary ingredient shall
8	propagate, compound, or
1	used with the
12	states district court
1	additional foreign offices
1	assignment, and (d)
2	timing of submission
1	access at all
1	subparagraph shall 
2	representative, in consultation
1	(b) activities and
2	small businesses; fee
2	year, where the
1	designated) in the
2	discontinuance, and the
2	certain of the
2	result, directly or
1	publishes notice thereof.
1	illness and other
1	enterprise. the court,
1	testing program meeting
1	term boobytrap means
1	acquired, imported, or
1	information for their
1	suspended, probation shall
1	of, and demand
1	modeling tools to
1	state agency (if
3	use in accordance
1	duties of a
1	convene the advisory
2	develop and maintain
1	adul-only facility. (b)
1	(g). clause (iv)
1	acts bany person
1	overweight, or the
1	(f) or (g)
2	permissive debarment; certain
2	collectively, a very
1	effect, may request,
3	chapter in any
1	(b) circumstancesfor purposes
1	drugs, shall issue
1	protocol). the written
3	 (ii) no
1	foods, drugs, devices,
1	assessment and ongoing
2	publish in a
2	believes, on the
1	802(49) of this
1	warrants; (3) execute
8	unapproved use of
1	(h) administrative detention
1	(a) penalty any
9	shall determine the
5	effectiveness under subsection
2	timelines shall account
1	foundation; and (12)
1	(s) savings clause
38	paragraph (1) or
1	students as to
1	consistent parallel scientific
20	drug under this
2	employed intermittently in
4	paragraph (1) was
1	shall promptly transmit
1	generic drug facilities
2	paragraph (1) on
2	discourage individuals, particularly
1	local educational agencies,
1	sold; (ii) the
2	secretary overestimated the
1	(e) data collection
2	country or exporter
5	owner, or consignee
1	contains an approved
1	advertising, or (c)
1	notice as to
1	communication between the
1	(
 
 114d2
4	admission into the
1	drug abuse issuethe
1	no-racemic drug containing
1	 (6) manufacturerthe
3	identified, in at
1	drug interdiction strategy
1	drugs that the
1	techniques, including commerciall-available
1	establish that there
1	(a) lists the
3	information, received or
1	(c) persons exemptsubsection
1	(2) implementation not
1	facilities, and also
2	chemical, product, or
1	
 848. continuing
1	subparagraph (a)(ii). (3)
1	standards than federal
1	records  (a)
1	secretary. (4) repealed.
16	subparagraphs (a) through
1	agriculture coordinating councilsthe
1	administration through electronic
1	subparagraph (c), (d),
1	(m) documentation demonstrating
10	submitted in the
15	federal, state, and
1	number of pesticide
1	products, under such
1	(4) document the
1	chapter, and (ii)
1	activity undertaken under
1	1506 to 1508.
1	predicate device that
2	clinical trial required
2	contain  (i)
1	training described in
1	defects every manufacturer
1	effectiveness that is
1	indexed use do
1	(5) wholesaler 
2	gas or combination
11	result of the
1	country.  the
1	guidelines. (f) warrant
1	
 387g. tobacco
2	15, 2018, the
1	(bb) a product
1	paragraph and shall
1	331(i), 343(f), 352(c),
2	management control system.
2	registration and reporting
1	form of nicotine,
1	modify the findings
1	ch. 675, 506c1,
2	 (ii) effect
1	economic devastation to
1	used in implant
1	randomized clinical trials.
2	public health, (ii)
1	misleading without a
2	applicant and the
1	prescribing the procedures
1	animal before it
1	value.  (2)
1	developing the program
4	renewal grant under
1	storage therein, shall,
2	attorney general, except
1	accredit thir-party auditors
1	 (f) information
1	product applications. (f)
1	may consolidate the
1	englis-speaking ability and
1	articles all expenses
1	tobacco smoke that
6	weight, measure, or
1	permitted.  (e)
1	(ii) labelingthe requirements
10	person from whom
1	traffickers. (3) the
1	available multiplied by
1	substantial equivalence of
1	federal register; (ii)
3	devices. the secretary
1	labeling of egg
1	control strategy means
1	exclusive use and
2	 (b) administrative
1	medicine and regenerative
1	(ii) after affording
2	levels are not
1	exclusivity and shall
1	stage). (6) the
5	marketed tobacco products
2	subparagraph (b) a
1	substantial equivalence or
1	practical functional value
1	flexible manufacturing activities
1	panel (a) review
3	possession of any
1	vehicle; and (b)
1	education (as such
1	fiscal year multiplied
1	human services on
1	sounds of all
2	suspend any registration
1	grocery store for
1	shortages occurring during
1	(jwh122); (x) -penty--(-chlor--naphthoyl)indole
1	(29) the term
1	physicians with background
1	poultry products, as
1	expedited procedure on
1	federa-state standards the
1	hold foods that
1	officer (whether on
1	 (1) revocation
5	hazard analysis and
1	requirements for compliance
1	secretary and another
1	restrictions to tobacco,
1	fundseach local educational
1	condition in which
4	trading partner that
1	data reviewed; (ii)
1	importation by an
2	local government entities
1	379j. authority to
1	discovery from other
1	(b) jurisdictionthere is
2	penalty or the
2	subparagraph shall alter
1	(a) a controlled
1	act) shall be
1	regulation the criteria
4	human food safety
4	clause is an
1	severe neighborhood safety
1	termination. (c) treatment
3	minor uses or
1	chairman, vice chairman,
1	report number the
1	article be delivered
1	term foreign person
1	(c) the amount
1	handling of requests
2	authorize the manufacturer
1	title), as appropriate;
1	(5) retention of
1	title 28, when
1	use intended to
1	date certain for
1	incurred, as determined
1	registration renewal during
1	may not classify
1	included any untrue
3	accreditation body to
1	term ginseng. 
1	director shall promptly
1	tank, portable tank,
1	market authorization in
1	(7) desomorphine. (8)
1	commodities promulgated, in
1	regulatory review. 
1	thirty days if
1	seq.]; the filled
1	applicable section 851
1	secretary from exercising
5	record after opportunity
1	organizations; (iii) 2
2	public meetings described
1	authorizing the importation
3	using the new
1	constituting, or derived
1	unlawful under section
1	 (2) pediatric
1	surveillance data with
2	2015, a manufacturer
1	illegitimate product. for
1	accreditation under section
1	exceed 2 percent
1	(ii) develop validated
1	section, such testing
7	copy and verify
1	enforcement activities with
1	recognition of susceptibility
1	drug means, subject
1	review process; and
2	title, a term
1	international organization, to
5	 (a) upon
1	informal hearing for
1	section 387g, 387h,
1	exported from any
1	 (e) unlawful
1	products exhibit antimicrobial
1	court in any
1	secretary shall docket
1	responsible party refuses
1	persons providing information
5	agency that receives
1	technical effect in
1	use rate, and
1	rejecting the reports
1	establish effective control
1	(3) basis of
2	fiscal year 1999,
7	appropriated to carry
6	included for such
7	determines, after consultation
1	cost, for a
1	scienc-based federal agencies,
1	amounts. fees assessed
1	335b and 335c
1	possession, distribution, sale,
1	344, 348, 350a,
1	(2) definition for
1	subparagraph, the certification
1	presubmissions and submissions
2	class of persons
1	significant harmful impact
1	fiscal year 1999;
2	fail to meet
1	(1), the state
1	violation to united
1	equal amount of
2	reflect the diversity
4	infants and children.
1	register under subsection
1	record of proceedingson
1	handlers; inspection of
1	means, any forfeited
1	tobacco. (v) pipe
8	(ii) to the
1	person by an
1	6, 1996). 
1	enabling such article
1	inadequate and will
1	675, 420, as
1	activities). (14) the
2	control notice shall
2	amending or supplementing
3	findings of fact
1	relevant information from
10	time of such
1	within the framework
2	programs for purposes
1	active ingredient submitted
1	listed chemical involved,
1	cigarette or as
1	(e) measures to
5	product liability law
2	person with the
1	paragraph or which,
1	regarding the results
1	approval, specified in
1	relation to state
2	360c(e)(1) of this
3	disposition of all
1	1123. repealed. 

1	biennially.  (f)
3	fabricated from two
1	
 20. apples
1	date of conclusion
1	(v) prepare for,
1	(v) exports which
2	license application under
3	fee published for
1	dispensed after the
1	panax; and (b)
2	judicial review by
1	vessel.  (d)
2	established in subparagraph
1	usually have been
2	passed, or exempted.
1	regulations); and (b)
1	(
 
 1039.
1	paper, poster, abstract,
1	test a final
1	direct written notice
2	label showing (a)
2	register for a
2	establishing a ris-based
2	offense or who
1	 (i) drugs
1	owner and that
1	section 1048 of
1	manufactured in excess
1	247d5 of title
1	(a)(iii) to federal,
1	wherever feasible and
2	$250,000, or both.
2	manufacturer or from
1	subsection (c). (2)
1	species in question;
1	human food for
1	applicable sections or
3	may take the
1	food facilities c-located
1	incidents of such
1	subchapter. the attorney
1	where, subject to
1	importation for personal
1	 (d) issuance
2	competitive bidding procedures
1	contained an untrue
1	substance that itself
1	required testing and
1	(3) meetings the
1	networks, as established
2	section.  (j)
1	policy alternatives available
22	used in, and
1	identify gaps in
3	fraud in connection
1	344; 
 

1	shall prioritize the
1	test, and evaluate
1	revocation of determination
1	resources. the secretary
1	review expertise when
1	controlled substance, (2)
1	systems for communication
1	buildings, and facilities,
4	insofar as the
1	effects of various
1	year, provide the
1	organizations, representatives of
2	(iii) firms not
1	agencies. (
 

1	(1), or such
1	 bthe source
1	support from no-federal
3	may designate, may
1	controls).  (4)
1	claim. a food,
3	charges have been
1	drugs to be
3	(c).  (3)
1	section 25(d) of
2	held for purposes
1	tobacco grower cooperatives,
1	marking of a
1	suspension of sentence
1	relating to food,
1	farm producing such
1	plants if it
1	international standards as
5	administrator shall issue
1	(i) was approved
1	346 of this
1	reimbursement the secretary
1	order together with
1	ch. 675, 602,
1	provide evidence that
1	rural or medically
1	discontinued, or deferred
1	
 
 387m.
1	prescription drugs (a)
1	registration registration information
2	part 1 of
1	implementation  (1)
1	basis, the available
2	(6)(b) or (7)(c)
1	vitamin a, vitamin
1	among youth; and
1	establishment, or from
5	title 42 that
1	permanent discontinuance in
2	provided in regulations,
1	abuse should be
1	lysergic acid. (5)
1	subparagraph. (c) provision
1	seq.], the central
1	title in support
1	inspections, taking into
1	chapter, otherwise be
1	intrastate incidents of
1	change the initial
1	
 2110. rule
4	body function or
1	inspected or exempted,
1	dispute resolution process
1	 (a) creative
1	guidance defining the
1	documents issued by
1	regulation of, products
2	electronic registration and
1	person convicted under
1	list; or 
1	shall maintain such
3	pending requests under
1	entitys agent), deliberately
1	petitioners failure to
1	 (10) process
1	court may consolidate
2	pediatric patients for
1	from, the additive
1	solicit 6 nominees
1	affidavits supporting the
2	generic drug included
1	paragraph fails to
1	three years unless
1	title) shall be
1	clearance or approval,
1	accepting or rejecting
1	solid dosage units
1	675 of this
5	mitigate a foodborne
1	federal government. 
1	training addressing each
3	place outside thereof
1	specificity of designation
1	canned, corned, or
1	(2) the compliance
1	clear title to
1	complaint.  (ii)
1	(2) a reference
1	substantially equivalent, within
1	annual egg production
1	access the list
1	initiating proceedings under
1	apply paragraph (1)(a)
2	food is made
1	act, including any
2	state coordinator 
1	persons engaged, in
1	clinical benefit as
1	programin conducting the
1	held in substantial
1	material, or conduct
1	 (i) registered
1	require restrictions on
1	subsection (e). (e)
1	product manufacturerthe term
2	concerning  (a)
1	shall, unless exigent
1	shrinkage in storage
2	participated in such
2	state or territorial
1	(5) perform such
1	145. penalties any
1	(b) the enterprise,
3	hereby authorized to
1	(2) for each
2	holding of such
1	contaminated food items;
2	states; and (b)
1	glutethimide. (4) lysergic
1	experts from state,
1	within the office,
1	thereafter:  (a)
1	written plan that
1	sections 191 to
1	operation under paragraph
1	(e) terminating the
1	illness outbreaks. 
1	training and qualifications
1	(c)(2), including the
1	days of any
3	offense be ineligible
1	distributor has concluded
1	operation of premises,
1	administration, nonprofit organizations,
1	proceedings to deny
1	
 2222. integrated
1	individual responsible for
1	agriculture, the national
1	title, on the
1	42, the manufacturer
2	index established under
1	 (5) termination
1	producer or person.
1	ingredient, route of
1	accompany each food
1	sunscreen monograph (a)
1	g)c 750.0 (225
1	mainstream or sidestream
1	 (iii) a
1	trained individuals who
1	misleading there shall
1	following uses: 
1	purposes of identifying
1	made or maintained
2	 (i) saleable
1	include peer review
1	retention of fees
1	abbreviated application; presubmission
1	(c) when the
1	states; (d) success
1	(i) other federal
1	electronic support measures;
1	331(b), (c) or
9	fees in any
1	includedsuch term includes
2	technology transfer program
1	efforts; (4) award
1	council to be
1	relative proportions as
1	means, and traditionally
3	substantial work was
2	sample or the
1	quorum.  (

1	extension under section
1	administration of new
1	requirements on small
3	effectiveness, the secretary
1	(1) the imposition
1	schedule, the secretary
1	(a) biennial reporting
2	otherwise provided, a
1	title in accordance
2	listed, for any
1	(m) or is
1	dtc advertisements, the
1	(a) publish the
2	improve the effectiveness
4	subparagraph (a)(ii); or
1	evaluations or issue
2	 (2) factors
1	minimize duplicative testing
1	instrument, apparatus, implement,
2	 (a) produced
1	acquisition of necessary
1	conspicuously  (1)
2	bona fide purchaser
1	states in china,
1	measurement of a
1	form and containing
1	original packages or
1	subparagraph (2)(a), and
1	secretary.  (j)
1	amount, the amount
1	groupswithout regard to
1	special registration to
2	exemption upon the
2	shall register the
1	inspection, reinspection, and
1	emissions, may require
1	(2) restrictions notwithstanding
1	(b) additional basis
1	2009.  (3)
1	misbranded, and constitutes
1	research protocol, shall
1	supplements; and (5)
1	containing more than
1	certifications.  (e)
1	(1) requiring submission
1	times from carcasses,
1	families, or survivors
1	supplements under the
1	(4).  (2)
1	determination the secretary
1	discriminate against an
2	consumer organizations who
1	dispenser to be
1	listed chemical therein
1	employment or association
2	commissioner the commissioner
2	1953, ch. 350,
1	target audience that
12	expenses appropriation account
1	may reject the
2	personnel.  (2)
1	uses covered by
1	causes of device
2	paragraph (5), the
1	drug is for
1	(b) the fees
1	numbers, names, and
1	reimburse the states
1	agency, and shall
1	(iv) modular applications
1	any, for any
1	collect data from
2	software and hardware
2	federal requirements in
1	accurately describes circumstances
1	county with a
1	format, and timelines
4	accounts that incur
1	150 daysthe secretary
1	organizer, or leader
1	shall exclude a
2	order of suspension
1	manufacturer shall within
2	debarment shall be
3	secretary shall revise
1	subsequent calendar year.
2	extortion, or any
1	(g) supplier verification
1	(o) soil transmitted
2	date determined by
1	receive milk or
1	alternatives that are
2	opportunity to interested
1	suppliers have been
1	identification numbers 
2	surveillance, submit, for
1	ch. 675, 508,
1	original prescriber. (mar.
1	(i) such information;
6	products are manufactured
7	shall not require
1	meet any criteria
1	children, that are
1	suffering from physical
1	iii or in
1	bureau of dairy
2	ensure the appropriate
1	program food service
1	9, 2012) but
1	risks to individuals
3	application is submitted,
1	information on extrapolation
1	determining the risk
1	makes recommendations on
1	combination product as
1	360, 360c, 360e,
1	detailed to another
2	results in permanent
1	time deems such
1	appear before duly
1	charged for a
1	(f) labeling 
3	 (iv) in
1	policy which impedes
1	changes or modifications
1	products involved in
8	single convention on
3	thereof (but within
2	rules and regulations;
1	inspection related to
1	fees may be
3	first prior fiscal
1	devices, sales of
1	leases, packages, labels,
1	united states) from
1	ethnically diverse communities.
3	otherwise result in
1	contractors the secretary
2	section 360e(c)(5) of
4	human resources of
1	drug crisis, the
1	restricting the authority
1	 (n) packaging
2	calculated under paragraph
1	providing that for
1	serving in public
1	pediatrics as may
1	criteria for training
1	use in food
1	packed beef, mutton,
2	supplemental application shall
1	refuse to file
1	supplier is the
1	section 360c(a)(1)(b) of
1	(a) in consultation
33	may be made
1	evaluation of whether
1	section, the phrase
1	administration involved with
1	section. while there
3	seizures and forfeitures
6	action is necessary
1	consul shall issue
1	section 4365[2] of
7	30 days of
1	applicable) under subsection
2	paragraph (1). (ii)
5	application effective before
1	expired drugs. 
1	operation and the
1	supervising the proposed
2	ensure that federal
6	shall not place
2	355(d) of this
1	if, 31 days
1	importer if the
14	notification to the
1	recommendations or information
2	subjected to a
2	exemption withdrawn or
1	amounts that constitute
1	cannabis products and
1	system to measure
1	 (c) program
1	acute bacterial otitis
2	addiction psychiatry, the
1	(1)(c) is not
1	specific duties of
1	 (2) standardized
1	direc-t-consumer advisory review
1	(j) for fiscal
3	substance  (1)
1	cas-b-case basis, a
1	pending proceedings the
1	unless when required
1	year, or both;
1	including the costs
1	amount charged upon
1	committee means an
1	(i) any meeting
2	(such as older
1	commerce, if the
1	(b) a meat
3	covered by a
1	affidavit that demonstrates
20	supervised release of
1	objection. the administrator
1	states; or (b)
3	subchapter, the attorney
1	identity of purchaser;
1	case he may
1	beings, or the
2	penalty or sanction
1	inspectors when any
1	(g) biennial food
2	duplication of efforts
1	pharmacist shall, in
1	facilitate the development,
1	upon fraud in
1	lawsfor purposes of
6	thir-party logistics provider,
1	nurse  (i)
2	thir-party logistics provider.
1	states attorney. the
1	(2) authorizedthe term
1	inventory of any
3	1, 2012, that
3	(without regard to
2	term selected establishment
1	(a) personal slaughtering
1	unit as part
2	federal government as
1	(3) develop a
1	without pay or
1	unique facility identifier;
2	type of food;
1	determination issued under
1	device establishments. 
1	secretary or to
1	type of food.
1	assistance or benefits
2	slaughter; (6) if
1	agencies over local
3	intended to reach
1	team or entertainment
1	attached to said
23	approval shall be
1	commerce which has
1	government sponsors no
1	process. (4) additional
1	house and senate,
2	investigation under this
4	active ingredient, the
2	section, whether a
1	exempt from taxation.
1	issued demonstrates in
1	regulation activities), except
5	thir-party logistics providers
1	community.  (e)
1	tribal affairsthe deputy
7	may suspend the
1	relevant and material,
1	device authorized or
1	changes in determinations
2	content of a
1	 (2) service;
1	advertisement (referred to
4	cream into the
2	(ii) the essence
3	ingredient that is
1	 (g) definition
1	$40 and not
2	may require in
2	report in compliance
1	respect or its
1	exercise program under
2	committee who did
1	regarding advisory committee
1	product constituents, including
1	voucher, if 
1	subparagraph (d)(iii) shall
1	potential benefits or
1	 (b) sunset
2	significant or unreasonable
1	thereof, excepting products
2	subparagraph may not
1	title (or for
1	applicants submitting portions
1	eighty days of
1	holder receives notice
1	misbranded. (l) repealed.
1	abuse reduction initiatives,
1	destruction of carcasses
2	employee thereof, whose
1	conditiona designation of
1	made not adulterated,
1	(iii) requirement of
1	circumstances product that
1	(b) food and
1	paragraph. a suspension
1	cases of good
1	human services, that
3	prohibited acts (a)
3	disclosure, that denies
1	discloses that a
6	accepted medical use
5	basis of information
1	levophenacylmorphan. (29) morpheridine.
1	therefor; or (3)
1	remove from exemption
1	general, shall make
2	regulation promulgate procedures
1	individuals a waiver
3	subsection  (a)
1	article if the
2	characteristics and the
6	distribution supply chain,
1	exist concerning the
1	operators of farms;
1	penalty for each
1	authority to otherwise
1	production quotas to
1	(c) authorizationthe administrator
1	public health, (d)
1	shall present the
1	negotiations.  (d)
1	upon december 15,
2	appropriate standard established
3	device meets the
2	findings and recommendations
1	data requirements 
3	generated by the
1	section has been
1	carry out authorized
1	public workshops with
2	drug if at
4	section 360cc of
1	approved before october
1	new slaughtering establishment
2	alphabetical order of
1	dietary management of
2	effectiveness for such
1	term interpretive criteria
1	amount as the
1	seq.] should be
1	containers, as the
2	sampling of advertisements
3	(9) of section
1	(2) which, in
2	also be consultation
1	distributor in any
1	order or rule
1	(i) generic drug
1	device is domestically
1	specified level in
1	(6) methohexital. (7)
1	675, 735, as
1	ensures that the
1	policy under section
1	category identified in
1	indemnification, and the
2	security acting through
2	within five days
2	development of, and
1	controls in manufacture
5	section 360c(e) of
1	canceled or suspended
1	packages of color
1	arguments of the
1	delivery, or any
1	effectiveness. the secretary
1	states standards; and
1	(2) as provided
2	4 of section
1	subsection, the individual
1	index listing under
1	training and oversight
1	notice and without
1	immediately; (b) give
9	proposed context of
2	issues, the secretary
1	title. if a
2	individual has not
2	393a of this
1	(a) drug traffickers
1	injury or damage
1	
 356. expedited
3	using amounts for
1	(3) where a
38	(a) of this
2	mortem inspection of
2	(i)) equals or
1	 (c) emergency
1	adulterated or caused
1	supplied raw materials
1	attorney general; hearingthe
1	(a) requirements in
1	secretary could be
1	amenable species found
1	lif-threatening disease in
1	title. (m) the
1	free; (iii) be
2	qualified entities to
2	standards the secretary
1	denial of applicationthe
3	shall be brought
1	concealing, producing, processing,
1	prescribing for the
1	may include provision
1	person) the following:
1	(a) class i,
1	reports by subsection
1	52 stat. 1052;
1	increases the quantity
1	(4) procedure upon
5	public availability before
2	counterfeit, diverted, subpotent,
1	regulation after consultation
3	use any official
1	manner of request
1	director; and (d)
1	panel, information that
1	application, either before
1	$477,000,000. (e) for
1	utilization of such
1	(1) set and
1	application and there
1	adult.  it
5	shall have a
1	drug substances) are
1	countermeasures. if resources
1	special rule beginning
1	subsection, such an
1	(2)(a)(i) and that
1	deems adequate for
2	proof of identity
1	expertise that is
1	minimum requirements: notice
1	(m) authorization of
1	death, including procedures,
1	scienc-based offices within
1	regarding the standards
1	reconfirmed on or
2	marihuana, except in
2	secretary awards the
1	therefor, filed with
1	provide the following
1	proposed standard. if
1	62 stat. 582;
1	formerly 712, as
2	adequately convey the
1	drug labeling and
2	opium, or any
1	supplement proposing changes
2	health and social
1	products and establishments
4	residues in food
1	desirable, the secretary
1	methods or tools.
2	government entity for
1	entry, or agricultural
17	secretary may prescribe
1	rare condition, such
5	obtain written comments
1	form; modification; hearing;
1	said article from
1	2243. smuggled food
1	 (a) secretaries
1	restraint; detention orders
1	significant new concepts
1	public health, to
1	year; and (iii)
2	including to the
1	articles and supporting
1	amounts on small
1	regulation of tobacco
1	recall to protect
2	person if such
1	(b) authority regarding
1	program for regulated
2	sanctions  (1)
1	technology, and medical
1	(4) may make
1	disclosure of which,
1	fees, in accordance
2	guidance documents of
1	establish that 
1	noracymethadol. (31) norlevorphanol.
1	jurisdiction of this
1	strategy is so
1	ii of subchapter
1	board or professional
1	evidence; and (d)
1	experience in one
1	withholding of, information
1	requirements for tracing
1	agencies in order
1	safe based on
1	distributor may be
1	request for meetings;
1	finds, for good
2	initial grant. 
2	presentation of views,
1	eligible countermeasure has
1	secretary of labor,
1	thereof and for
1	assessmentsif a person
1	business tobacco manufacturing
2	 (3) eligible
1	including the extent
1	drugs. (d) fee
1	
 360d. performance
1	illness outbreaks necessitating
1	5702 and 5703
1	seller maintains a
1	title; (ii) that
1	effects incident to
2	agreement and shall
2	use by him
1	 (1) consultation
7	(b) publish such
1	reductions in consumption
1	schedule i may
6	health protection as
1	consideration the goals
5	order has been
1	subsections (b)(1)(a)(i)(iii), (b)(1)(c),
10	period of the
1	year unless 
1	counterfeit substance. 
10	percent shall be
1	manufactured or held
1	default to such
2	action (the pediatric
1	(a) means the
1	record and transcript
23	necessary to protect
2	vary based on
1	fee type 
1	-penty--(-methoxyphenylacetyl)indole (jwh250); (viii)
1	producer or otherwise),
35	tolerance or exemption
1	substance, or item
1	counterfeit drug. (3)
1	regulation; and (d)
1	treatment; (d) drug
1	 (a) staffing
1	term appropriate congressional
1	examination of all
1	(3) after the
5	business each member
1	(4) within 30
1	352(f)(1), and 355
1	material, use in
1	 (h) protection
2	apples of one
1	bear, at a
1	accounting practices. 
1	secretary shall expand
3	agriculture, in coordination
1	electric pipes; (10)
24	assessment of the
1	adjustmentthe inflation adjustment
22	ingredient or combination
1	documentation or evidence
1	union, if the
3	secretary, make such
1	identify the sponsor;
1	poultry products impair
2	amount appropriated under
1	(2) partnershipsthe systems
4	human services that
10	place of business,
1	stone, labeling, container,
5	place of business.
1	therapies and technologies.
1	small packages may
1	(h) the distribution
1	transported into a
3	1049; 
 

1	package of which
1	information (including any
1	occurs sooner. 
1	individual of a
1	section. (b) testing
2	considered terms of
1	year after date
9	dispensing of a
1	issue  (i)
1	development of surrogate
1	used with another
1	benefi-risk profile of
1	established before november
1	
 1173. transferred
2	 (b) procedures
1	proposed change in
3	include the implant
1	device have not
15	course of the
1	internationally recognized standards
1	3-day period. (ii)
2	animal drug or,
1	valid applications that
1	$70,000,000 for fiscal
1	members; and (ii)
1	federal register, may
1	(4) revisions not
1	stat. 21; july
1	pursuant to another
1	completed under paragraph
1	additional options. 
2	knowingly made or
1	 (3) notice
1	pharmacis-i-charge, and a
1	filed under such
3	submitting an application
1	attorney general. (6)
1	981(g) of title
1	support electronic data
2	duly authorized committees
1	(e) whether this
2	pertinent to the
1	certain raw materials
2	substances pursuant to
1	accordance with 1
1	out, and (2)
1	advertising, and (ii)
1	target animal; (c)
1	 (b) procedure;
1	ch. 675, 918,
3	public health of
1	
 1043. rules
4	adverse event occurring
2	(a) is or
1	(or successor committee)
8	reports required under
9	public health or
4	standard, or ban
2	state departments and
1	1, 2012, a
1	bioequivalence; filing of
1	used in subsection
1	failed to submit
1	sel-administering medication; and
1	listing of certified
1	following substances whether
2	subpotent, substandard, adulterated,
1	verified under oath,
1	congress.  (b)
1	campaign is evaluated
3	regulation; and (iii)
1	certain pollution resulting
1	whether enrollment has
1	affidavits, that one
1	surge capacity for
1	 (c) sales,
1	 (i) identifies
1	inventory date (if
1	particular person any
1	eggs, be shown
1	360ccc. conditional approval
1	review of eligible
2	(1) manufacture or
1	price including borrowing
2	regulations and orders;
1	 (i) identified
1	either personally or
2	section 1472 or
1	title and with
1	coalitions, community ant-drug
1	defendant to repatriate
3	subject matter of
1	index, the secretary
1	treatment.  (i)
1	distributing inspection resources
1	specifying the contents
1	viru-serum toxin act).
2	athletes participating in
7	amount of no-federal
1	affix and utilize
1	initially registering as
1	electronic communication; and
5	necessary to insure
1	years, taking into
1	commercial or contract
1	injunction in case
1	clearance, or written
2	seizing drugs, as
47	subparagraph (a), the
1	beginning with 1979,
1	numerical count, except
4	 (3) public
1	exempted.  (mar.
2	subsequent debarment under
23	thirty days after
1	drugs (a) definitions
2	(i) has more
1	(a) upon first
1	reasonable manner. such
1	prevent a manufacturer
1	require recall of
1	application of another
1	achievement resulting from
1	(f), the extent
1	1143. repealed. 

2	secretary may direct
2	receive service of
2	(a) conduct an
1	set  (a)
1	(8) control of
4	(i) issue a
7	eligible for parole
1	apply the criteria
1	
 378. advertising
1	disclose the name
3	(except as defined
1	user facility making
1	effectiveness, if the
2	subsection. any information
1	products. such standards
5	part or product
2	and/or cream into
1	
 969. contempt
2	committee.  (b)
1	states attorney a
1	6501 et seq.]),
1	1984; and (b)
1	data; access to
1	300g1], the secretary
1	believes that there
1	contributions to individual
4	financial interest under
1	persons bound; scope
1	801 et seq.].
1	system collectively to
1	(a) report to
1	general schedule, including
1	establishment. (8) control
1	file referenced in
2	exemption will aid
1	 (26) transaction
1	sale.  (2)
1	 (20) tobacco
1	february 21, 1971;
1	uses:  (i)
1	means any adverse
5	manufacturer or repackager
1	private entities, which
1	direct export; petition
1	submitted for posting
3	patent information has
1	ch. 675, 418,
1	conformance with appropriate
1	(3) designation within
1	meeting, if requested,
6	contrary to this
1	overtime the cost
1	(b) membership 
1	permanently. if the
1	 (c) submission
1	subsection; and (ii)
1	date, the benefits
1	(f) definitions 
2	fine and imprisonment,
1	fine and imprisonment.
1	importing and selling
1	bearing labels having
2	animal feed of
1	criminal contempt of
1	safe: provided, that
4	may be. 
1	deny or approve
2	control plan shall
1	second half of
3	360ddd of this
1	(a) include an
2	reprocessing be made
8	standards of fill
1	adulterated, it shall
1	will in the
2	detoxification treatment of
1	enter orders the
1	authority. (june 25,
2	storage, cartage, or
2	(e) public availability
1	tagged as inspected
1	support activities described
1	toxicity; (4) promote
2	percentage workload adjustment
1	stored, to produce
2	paragraph (1)(c) shall
1	drugs found not
1	external biomedical community
6	tolerance for such
91	shall be subject
1	1101; 1940 reorg.
1	(g), the secretary
1	evaluated for safety;
1	advanced therapies manufacturers
1	institute, applying relevant
1	altered, removed, or
4	experts that the
6	transaction involving a
1	360e(b)(1) of this
1	contentthe report described
1	 (d) notices
1	section, shall, notwithstanding
4	available until expended
1	system; (iv) developing
1	review in a
1	invite the participation
2	(ii) statutory or
8	abbreviated drug application
1	(a) a full
1	health. not less
1	title iv, 407,
1	payment of any
1	ch. 675, 527,
1	impact of use
1	regions or states,
1	may prescribe in
1	conditionall-approved new animal
1	(3) workload adjustmentfor
1	 except for
1	february 21, 1971,
1	following an intentional
1	(d) restrictions 
1	year. (ii) for
1	meets the public
1	olympic committee to
2	resolution procedures established
2	medicine and which
1	 (i) manufacturing,
1	processthe consultation under
1	timeline for payment
1	may upon application
1	tobacco, as those
1	clinical development. (in
1	eyelashes or eyebrows;
1	paragraph (1)(c); (b)
1	violation, the manufacturer
1	distribution, until the
1	 the united
1	animal, and (ii)
2	(b) subparagraph (a)
1	consisting of fiscal
1	sponsor to plan
1	written regulatory management
1	957. persons required
1	ensure consultation with
1	individuals knowledge, shall
3	section, the attorney
1	chemical. (34) the
1	(d).  (e)
1	institutions, and individuals;
1	(b)(10) shall not
1	financial interest or
1	(bb) 30 months
1	clarification for purposes
1	may receive regulatory
1	become immediately effective
1	individuals, the order
1	authorize such person
1	intends to request
1	effect at such
1	toward the drug
1	(6) if the
1	five schedules of
2	user fee act
1	shall transfer the
1	(aa) on or
1	 (2) exclusiona
1	(1), including 
2	organization required to
1	product (or the
1	methodology or methodologies;
1	(c) authority to
1	(b) is exempt
1	prescription drugs if
1	seq.] with regard
2	judicial review; record
2	investigations, been used
1	controlled substances are
1	existed at the
1	considered final agency
1	may support implementation
1	(1). such list
1	times that authorized
1	administration. (2) the
1	(or is required
2	refuse to provide,
2	secretary determines should
1	(1) determine whether
1	
 811. authority
3	statutory law. 
1	iii, it shall
1	collections of information
2	among national drug
1	levomethorphan. (9) levorphanol.
4	360eee2 of this
1	(f) provide for
1	convention different from
4	cure, mitigation, treatment,
1	detention an article
1	rapidly track and
5	(2) of section
1	including all active
53	issued under this
1	eligible countermeasure involved;
1	gathered during the
1	compensate for transfers
1	impact; and (c)
1	(2) based on
1	means any check,
4	(c) and paragraph
1	829(e) of the
1	will fully and
1	change in or
4	appropriate.  (2)
1	mean a wholesale
2	travel, education, and
1	forfeitures conducted by
1	future, or (2)
1	drug advertising for
1	thereof which have
1	shall be pasteurized
16	adverse event report
1	though such articles
1	grant may exceed
1	act), the average
1	respect to whether
1	360j(g)(2) of this
1	assurance is not
1	registrations issued for
1	labeling for drugs
1	entity shall ensure
1	methylhydromorphine. (14) morphine
1	unless (in addition
2	substances having a
15	title, or the
1	section. the provisions
5	established, by regulations
1	 (4) comment
6	indicated for such
1	 (iii) no
1	panel substantially duplicate
1	hearing (acting upon
2	september 24, 1984.
1	limited receipt and
2	specific chemical designation.
1	thereof conform to
1	reinspection fee 
5	file an application
1	distributors that may
1	adjustmentsubject to subparagraph
1	export or (ii)
1	(b) protracted and
1	term recall means
1	incubation during the
1	chain. (d) definition
1	lifesaving or lif-enhancing
1	submissions.  (4)
4	meeting with the
1	updating regulations after
9	(2).  (2)
1	enterprise in violation
1	(a), other than
6	purpose of the
1	designate in writing
1	dispensing, or conducting
1	management, either direct
2	individuals to assist
2	distribution of drug
1	known in trade
1	reliable data and
1	drug products by
1	804, title i,
1	subsection (a) after
1	finding, order, or
1	whose authority the
1	parts (including the
2	combinations for such
1	party has submitted
1	establishments for the
1	(vi) the expiration
1	association, a majority
1	substance is pursuant
1	(3) on whether
1	facility, collectively; and
1	slaughtered, or their
3	year will be
1	decisionmaking; and (iii)
1	drug. or a
32	(b) the secretary
2	maintaining licensure for
2	common ownership or
1	abuse prevention. 
3	reactivation fee as
1	interests, professional organizations,
1	(j) the application
1	potassium (mg) 80.0
1	controlled premises; (2)
1	court involved to
1	application. the decision
1	antifungal drugs for
1	individual has provided
1	chain; (ii) provide
1	agricultural program benefitsnotwithstanding
1	secretary is prohibited
1	controlled substances. (6)
1	paragraph (4) may
1	request information accordingly.
1	affected by a
1	registered are imported
1	liquids, place the
1	poultry product which
2	pending requests 
1	trends in abuse,
1	illnesses by 
1	individual. a thir-party
1	(a) to fail
1	property is subject
2	type or quantity
1	judgment subject to
1	specific resources required
1	specified reduced level
1	disclosure of technical
2	bearing on the
1	food. in establishing
2	distribution means the
1	disposal rate during
1	appropriated funds for
1	informing such person
1	may require; (c)
2	devices to be
1	accrued interest under
1	patient experience data;
1	packing, mea-canning, rendering,
1	statistics, chemistry, legal
1	commerce. a purchase
1	 (a) fails
1	report for which,
1	health; (b) that
1	making such certifications.
7	may be agreed
1	advisory committees 
1	675, sec. 1,
1	used exposes consumers
1	may consider available
1	expiration. (g) such
2	subtitle e of
2	employees of a
2	262(a)] after the
1	(c) due datethe
1	customer, on the
6	adjustments made each
1	(1) biomarkerthe term
1	license unlawful; employment
1	(i) rule of
2	(5) of subsection
1	functional assays within
1	human health; (2)
1	(iii) the program
1	radiation and to
2	by, consumers as
1	 (4) each
1	tool, based on
1	policies that support
2	federal funds shall
1	period shall coincide
1	said virus in
2	draft guidance or
1	postapproval study requirements.
1	341, 343(b), 343(c),
1	complaint requesting that
1	(4) the document
3	thereof, of a
1	tomography drugs under
1	421, as added
1	309, formerly 306,
1	facility fee has
1	food registry as
1	title) containing an
2	paragraph (3) 
1	officer engaged in,
1	programs and operations.
3	conformity with current
1	95 percent of
2	day so engaged,
1	foregoing shall be
1	secretary may delegate
1	amended, for the
1	initial panel, the
2	organized territory. 
1	(2)(c).  (b)
1	taking one or
1	order promptly reduced
1	information; (5) when
1	coordination with national
1	stat. 279
 

1	(a) practitioner licensed
1	manufacturer and which
1	government. (10) although
1	(ii) waiver the
1	commerce accompanied by
1	product, but does
1	humans; (ii) the
10	use of which
1	vehicle. (d) waivers
1	drug experience means
3	biomaterials supplier who
1	agency center shall
2	lane, system, or
1	plant shall allow
1	ensure that health
1	public hearing (acting
4	shall supplement, not
1	384(e) of this
2	research, and industrial
1	workshops and conferences.
1	electronic manner in
1	ingredients, including tobacco,
2	extension if the
1	properly classified under
1	report containing 
1	(15) cocaine freebase
1	ingredient facilities at
2	(b) and section
1	(1), including progress
1	establishment fee, as
1	9, 2012, if
1	partly of any
1	$11,300,000; (2) for
2	stat. 993
 

1	required to achieve
1	shall be addressed
1	assessment and decision
1	(2)(b) of section
2	conditions of subparagraph
1	respect to preventing
1	wild or illicit
1	development, issuance, and
2	law.  (

1	transport of food;
1	appropriate effective date
5	member may be
3	use patent does
2	previous year; and
1	police powers all
1	working with the
1	commitment in reducing
1	(1) or otherwise
1	 (i) unduly
1	program budget proposal
1	individual who knowingly
4	subsection, for a
1	(v) upon request
5	secure facility to
1	counterfeits, simulates, or
1	applied during the
1	appropriate, recommendations for
1	federal register, modify
1	microbiological or chemical
1	statement or misrepresentation
1	675, 704, 52
1	program, at least
1	ingredient, and if
1	therapeutics and shall
3	miles of each
4	contract is made
1	measured in food,
1	containing chloral hydrate,
1	 (5) wholesaler
5	commerce and the
1	additive (or pharmacologically
2	approved method of
1	(d) strategies to
2	panel members (other
1	detect all forms
1	systemic antibacterial or
1	swine populations by
7	investigation of the
1	reporting and notification
1	establishments that the
1	impleader beyond that
1	comprehensive report that
1	scientific evidence exists,
1	extent of recalls
1	court a libel
1	precursor, to a
1	alimenterius[2] commission or
1	supply in the
1	measurement systemnot later
1	(b)(iii)(ii) if a
1	review as fast
1	(2),[2] as the
1	(a) cannot be
1	
 955a to
1	i) for which
1	1995)). (3) the
2	enforcement administration to
1	service personnel. 
1	2018; as adjusted
1	month being october
1	goalsecure agriculture and
1	another except in
1	term wholesaler does
3	and, if appropriate,
1	sellers of controlled
1	data to obtain
1	link to a
1	generalbeginning on the
1	(b) partnerships with
2	include validation data
1	public notificationif the
1	means, that there
1	condition the secretary
1	convictions of such
1	provided, that, with
1	interdiction by the
1	(f) -acetylanthranilic acid,
1	shall, within sixty
1	reimbursement or the
1	1541. establishment of
3	includes a plan
1	42; and (3)
1	regarding carryover submissions
1	accompany auditors from
8	drug control budget
2	kinds of cases
1	additive the term
1	10 years, or
1	specify how a
1	composed of employees
2	subsection is a
1	contact -mail address
3	special controls to
1	resolution, with respect
1	shall annually prepare
3	activities at the
1	agriculture of a
2	 (i)in general.no
1	finds  (1)
1	employee training under
2	1, 1989, the
1	previous year, the
1	(including testing records),
1	paraldehyde. (10) petrichloral.
1	policy formulation and
4	factor.  (b)
2	control strategy; (b)
2	keep confidential any
2	paragraph shall 
2	regulations prescribe, exempt
1	device that would
1	making such request,
1	people in the
1	secretarys review; and
2	section 387i of
1	fees payment of
1	will result to
1	paragraph (2)(a). (dd)
1	(6) if a
1	prevented and addressed,
1	whole, include participants
1	commodity and includes
1	reagent, or other
1	shall not ship
1	et seq.) is
2	agency for purposes
1	states pharmacopoeia; development
1	attorney general, on
2	development tool for
1	models of infection,
2	area in achieving
1	 (b) real
3	applications (as defined
4	 (a) on
1	year. when the
1	substantially equivalent within
1	order public. (2)
1	including tracking and
2	address unmet medical
1	generalthe united states
1	requirement under paragraphs
1	iv, 402, as
1	populations, particularly underrepresented
1	reduction agencies, including
1	 (d) commingled
1	original order. the
1	laboratory.  (2)
1	meets the eligibility
1	meets applicable requirements
1	misbranded (a) if
1	unless each facility
3	assessed under paragraph
1	animals, is worthless,
1	less efficacious treatment.
4	2013for fiscal year
2	(within the meaning
1	published.  (c)
1	
 
 132.
1	distribution; (d) is
1	protection.  (d)
1	meat articles in
1	participation in, revocation
1	373. records (a)
1	states military forces
5	container or labeling
5	effective date the
1	thir-party auditor unless
1	permit such different
1	advisory commission or
2	reviewing and providing
2	finished and unfinished
1	studies), the holder
1	temporary reassignment of
1	court shall authorize
3	(i) approval of
2	information requested under
1	experts; (g) provide
1	dated january 10,
1	360bbb3a of this
1	october 2002; and
1	(4) updates the
1	coconut, licorice, cocoa,
1	(ii) the expiration
2	may be punished
1	262] (relating to
1	inventory, and shall
1	(4) the claimant
1	death in humans
3	promptly notifying the
1	clinical outcome assessment
1	product disposition. 
1	subsection (h), the
1	282(j)(1) of title
1	1012, as added
2	notice and comment,
1	basis is necessary
1	physician has participated
1	(8) methylphenobarbital. (9)
1	
 333. penalties
1	title, and (d)
1	endpoint that is
2	campaign were accomplished;
1	eggs that do
6	carrying out subsection
1	inquiries regarding drug
1	product not on
1	definitions of the
3	matters referred to
1	corporations that engage,
1	federal register before
3	subsection (k) to
22	paragraph (2). 
1	stored. drug manufacturers
2	(1).  (5)
1	expertise in carrying
1	(i) is from
1	feed within a
1	resources.  (c)
1	regulatory audits of
1	(d);  (13)
2	entities paying the
1	subject, if such
1	notification; and (d)
5	therapeutic benefit over
1	substances, (b) conducting
7	owner or consignee.
1	disclosure if a
1	wholesale or at
1	 (b) drug
8	substantial evidence that
2	stat. 1040), and
1	forms, receipts, and
1	(1) department of
1	drug abuse prevention.
1	
 144. unlawful
2	drug abuse prevention,
1	brings an action
1	patient registries, development
1	387b(5), 387b(6), 387d,
1	illegitimate product pursuant
1	also terminate designation
8	or, if the
1	routine access to
1	harm allegedly caused,
1	714
 
 890.
1	issue a letter
1	person submitting a
1	means a roadside
1	part and, to
1	information and records
2	suspension of approval
1	drug, in which
1	(b), establish and
7	assess and use
1	(ii) the proportion
1	substance or ephedrine,
1	official may request
2	scientific or medical
1	determines supports his
1	relevant devices to
15	(c)  (i)
1	refund the purchase
1	subject matter which
1	stage and before
1	methodology and included
26	administrator of the
1	 (i) arrests
1	ability to conduct
1	42, issued on
3	development, review, and
1	law in an
1	agreements, with the
1	(2cd). (22) -(-chlor-2,-dimethoxyphenyl)ethanamine
1	produced substances or
1	relevant considerations, the
1	u.s.c. 355f(g)], as
1	device assure the
1	 (1) reviewing
1	904. payment of
1	
 206. revocation
2	consignee; liens all
1	secretary physically inspected
1	(aa) the earlier
1	providing safe access
1	reasons to facilitate
4	immediate subsequent recipient
1	collaboration between the
7	priorities established under
2	waiverat the request
1	(b) that such
2	 (c) review
1	owning, partly owning,
1	steps to achieve
1	expedited clearance for
1	year, november 1.
1	cows which have
14	animal feeds bearing
1	term new drug
1	title or 360c(a)(1)(b)
3	means the person
1	make available (directly
1	action by secretary;
1	entered.  (e)
4	identity of a
1	maintains status as
1	871; june 25,
5	complying with the
1	whatever actions necessary
1	seq.], as added
1	(d) to the
2	united states it
3	drug; (d) a
1	(v) if the
1	dispensers if he
7	united states is
1	1232g of title
3	federal law, in
1	strategy approved with
1	(b)(2) was filed
1	issue the national
3	united states if
1	lot number for
1	distribution of inordinate
1	appearance, and (2)
1	(a) mandatory debarment;
1	affect and strengthen
1	drug means (a)
1	drug application, (3)
27	united states in
1	exists when the
1	access to drugs
1	period; (c) the
1	intent of this
1	exclusivity period for
1	discovery nothing in
1	drug take back
1	(h) report to
1	nonprofit organizations, and
1	study to determine
1	request issued by
1	general shall examine
1	analyses of food
14	operating reserve fee
1	subsection (e)). (b)
3	hearing shall have
1	part applies to
2	respond and attempt
1	type of operation
1	exportation the bond
1	(f); (ii) intended
1	distributor can provide
11	public on the
1	provided or made
6	patent for which
1	product establishment means
1	year, and providing
2	alleged to be
1	directly related to,
5	license under state
1	954 of this
1	person to notify
1	psychological effects incident
1	jurisdiction may exercise
1	body the secretary
1	remove any postmarketing
1	authorize persons engaged
1	physician  (a)
1	hatchery, tank, pond,
1	201 of the
1	penalties the attorney
1	innovative monitoring and
1	(14) diampromide. (15)
1	requests for funds
1	seized goods prior
2	907, as added
1	(c) conditionssubsection (b)
53	360e of this
1	shall be conveyed
1	shall give written
1	forth conditions of
1	products; and (iii)
1	retail, any drugs,
1	direction and under
2	waiver of such
1	population is subject
1	 (f) fees
1	register a plan
1	shall include for
1	amount authorized to
1	 (a) carry
1	2016.  (2)
1	compounding, and patient
1	secretary a full
1	medical devices will
1	requirements the secretary
1	symbols from the
1	appears to pose
2	organizational, material, or
8	make publicly available,
1	encourage the sponsor
1	concentrated mineral acids,
1	(b) such sums
1	review of activities
1	personnel (a) in
1	bacterial exacerbation of
1	approve or license
1	material false statement,
1	inspections provided for
1	(iv) the physician
1	dispensed narcotic drugs
1	supplies a component
1	commerce any such
1	comment, interim results
1	2013 inflation and
1	(c) burden of
1	misbranding all drugs
1	hearing when an
1	regulation, revise the
1	necessary.  (3)
2	deems eligible for
1	(c)(i) of paragraph
1	chapter, or which
2	false statements any
1	development programs relating
1	
 
 356e.
1	inspections and common
2	(b) may provide
3	days, the approval
1	abuse upon certification
4	management systems placed
1	acetylmethadol. (2) allylprodine.
1	(2) remove any
1	 (b) tracingfor
12	district in which
1	longer.  (4)
2	previously submitted a
4	european economic area
1	respecting the information
1	domestic, military, or
2	narcotic drugs which
13	raised by the
2	referral under this
1	(h), (i), and
1	means the materials,
2	provisions shall apply
2	board of medical
3	report submitted by
1	year that provides
1	program approved by
1	receipt of investigational
1	adopted pursuant to
1	licenses thir-party logistics
1	device; or (5)
1	use the processes
1	including individuals who
1	adverse drug experience.
1	used, including but
3	regulations, which regulations
1	generalupon initially registering
1	causing it to
2	or, if applicable,
1	community, such as
1	causing the placement
1	use will reasonably
1	of, such device;
1	world evidence (a)
1	stat. 1058; 

2	include the funding
1	request, be granted
1	(b) if, in
2	upon in compromise,
1	sooner than 1
1	premarket notifications in
1	(ii) changes or
1	drugs are as
1	listed drug due
1	misbranded. it is
1	gas bears 
1	(b) is accredited
1	quantity, shipper, and
3	section 355(p) of
2	conducting a public
1	article for import
1	another substance if
1	manufacturer is barred
1	revise the plan
6	decides that the
1	455 of this
2	substance and schedule.
1	drug product. (11)
2	applicant or respondent
2	performance from the
1	review priority pursuant
2	involved and any
1	existing on january
1	product manufacturer, the
2	60.0  
1	 (i)in general.the
4	list of persons
1	ingredient. (d) shortage
1	indexed in accordance
1	fees, and animal
1	sharing information regarding
4	general, the director
2	expected pharmacological action
1	partnership means a
1	products thereof, of
1	inspectors shall have
1	class ii, unless
1	(3) the requirements
2	interest of justice
1	status of fees
1	clause if any
1	(1). the amount
1	participate in[3] voluntary
1	(v) an agreement
2	lon-term epidemiological studies
2	amount under subsection
6	motion for summary
1	violates paragraph (6)
1	batch number; (ii)
1	manufacturing practices; and
5	limited to 
1	adequately be evaluated
3	postmarket safety activities
2	secretary for carrying
1	strength; or (3)
4	(if any) which
1	term united states,
1	however, in determining
1	whose salaries congress
1	355(i) or (k),
1	
 1708a. annual
5	clause (i) and
3	ingredient of a
1	person in a
1	authorization of appropriations;
2	enforcement or national
1	(8).  (

1	employee therewith. (

1	u.s.c. 467a et
1	stocks. (
 

1	actively pursuing marketing
1	representatives, except where
1	collection  (i)
1	ch. 675, 911,
1	term fund means
1	penalties with respect
1	afford that person
2	burden interstate commerce.
3	president shall submit
3	confidentiality and privacy
1	activities) for such
1	
 
 679a.
1	drugs that would
1	10 years imprisonment,
9	final rule controlling
1	system  (a)
2	secretary of treasury
1	ingredient which renders
3	adulterated shall be
1	report may include
2	subsection (f)(7) revoking
1	order; proceedings 
4	352(e) of this
1	
 360fff1. submission
1	applies for a
1	demand reduction basic
1	safety, only those
1	(3) to assist
1	diligence be obtained
1	(a), so long
1	emerging medical therapies,
2	commission to be
1	restricted area that
1	order of secretary;
1	failure of compliance
1	may bring in
1	relative significance of
1	filed no later
1	title 20 by
1	products that involved
1	implementation of federal
1	production or use
1	investigations that are
1	event trends, adverse
2	(after the date
6	carrying out paragraph
1	associations, hospitals, and
1	tobacco for pesticide
1	marketed device that
2	specific pediatric age
1	pediatric use; or
1	(including gel caps)
1	hazard, the secretary
1	offense is a
1	action (except that
1	strategy that relate
1	(3) active postmarket
1	ch. 675, 406,
1	revoke such protocol
1	meetings relate to
4	subparagraph (b), and
1	(iii) the dosage
2	education programs for
1	u.s.c. 387 et
2	particular drug for
1	development, clinical investigation,
1	notice, the importer
2	(iii). (iii) if
1	 (b) reportingbeginning
4	subparagraph (b), any
2	served in public
1	matter, and containing
1	violator, ability to
1	rulemaking under subsection
1	exemptions; regulatory oversight
1	individual portions shall
2	administration to animals
1	basis, perform a
1	(h) teens who
1	paragraph (1). (d)
2	available in accordance
2	refusing application; approval
2	cooked form as
1	proceeding pending, the
19	(1) with respect
3	provided that any
1	general at least
2	tangible things which
1	expanding capacity of
1	(3) drugs imported
1	it, delivers, distributes,
2	facilitate the importation
1	sunscreen to ensure
12	amendments made by
1	members the ex
1	product; and (e)
1	135b. repealed. 

1	prescribed, and it
1	external experts; (g)
1	(2)(b)(iii)(i)(aa) of subsection
1	exceeds the level
1	receiving the final
1	program framework under
1	(3) annual compilation
8	sum of 
1	48 months after
2	person has no
1	products is conducted
1	health system. (b)
6	exemption in effect
1	disease means a
4	application submitted by
1	reduction or demand
2	proceeds into the
2	selected establishments. 
1	official) in the
1	-methylephedrine. (t) -methylpseudoephedrine.
1	maintained and operated
1	grocery store. (7)
1	food; and including
1	respecting the drug
2	differ from those
1	eligible for any
7	application may be
1	section; (2) compromise
1	policies, goals, priorities,
1	$1,857,000 for fiscal
5	information  (a)
1	updated to ensure
1	package or homogeneous
1	make seizures of
1	measured earlier than
1	section 350d(a)(3)[1] of
1	shall allocate such
2	ingredient information not
1	environmental monitoring program
2	inspection of selected
1	privacy of individuall-identifiable
1	officers shall be
1	section 360eee1(e) of
6	section 360fff(7) of
1	finds that paragraphs
1	(11) little cigarthe
1	aggregate allowable safe
21	qualified infectious disease
4	edible portion of
2	section 3(c)(2)(b) of
1	importation, manufacture, distribution,
2	(3) shall include
1	supplier; (ii) published
1	ii involving the
1	may upon a
1	tobacco leaf with
3	identifier to each
1	product by providing
1	transferred
 
 15.
1	authorities engaged in
1	person in exchange
1	it. the request
1	transferred or removed
1	term preventive controls
1	liability. (8) whether
1	planned to prevent
1	(9) levorphanol. (10)
1	involved is reviewed,
1	inspections has decreased
1	section, or pursuant
1	agency under paragraph
1	subchapter shall, on
1	inspect appropriate books,
2	bacteria per cubic
1	repackager to associate
1	section 360(k)(2) of
1	cigars. (iii) snuff.
1	requirement would not
4	(in this section
2	procedures to reinstate
1	regulatory delay. (c)
2	fees paid under
1	regulation. (4) within
1	pharmaceutical master file
1	order compounding for
1	3.  (3)
1	subsection (b)(1)), the
2	good faith the
1	land, federally owned
1	otherwise, manufacture, prepare,
1	attempted to bribe
1	(4) the patent
1	 (i) significantly
1	administrator shall not
2	criteria included in
1	revoke any quota
2	apply.  (g)
1	imposed therein. (2)
1	failed to disclose,
1	334(a)(2). in the
1	health and in
2	period thereafter. 
1	(c). a food
1	recording, or other
1	deceptive act or
1	public health waiver
1	
 967. smuggling
1	otherwise carrying out
1	person may petition
1	search warrants, arrest
1	obtained the application,
2	drug abuse, especially
2	monograph exists, and
10	areas of the
1	person to identify
1	part 25, as
1	detoxification treatment. (ii)
1	medical professional organizations,
1	receiving reports of
10	unless it bears
1	successor regulations). (e)
1	valid prescription; (c)
7	interested persons to
1	methamphetamine; (e) includes
2	subject to permissive
1	604. post mortem
1	members of which
1	year under subsections
1	data as described
2	exemption under such
1	respective departments or
1	public distribution of
1	 such an
1	governments to adequately
1	360i, 360j, 360ccc,
1	located  (i)
1	pharmacist or wholesaler;
1	based on classified
2	judgment, skill, or
1	
 862. denial
1	regulation)).  (2)
6	judgment that the
1	general an online
1	714
 
 683.
2	processing and distribution
1	also include the
3	revoke a license
2	order to cease
8	ending june 30,
1	one year from
1	(
 
 146.
3	subsequent owner with
1	subsections (b)(1)(a)(i), (c)(1)(a)(ii),
1	improvement in timeliness
2	prior convictions under
4	sufficient bond conditioned
2	contact substance is
1	excluded) from participation
2	suit under a
1	exporter, manufacturer, or
1	subsection require that
2	convicted, in any
1	premarket review, if
1	using the authority
4	(i) the application
1	(b) docketing and
1	term submission for
1	include government agencies,
2	agencies in developing
1	foundation shall, if
1	pursuant to the[1]section
1	chapter, carriers engaged
1	designated, and operated
1	rapid analytical procedures),
1	designated by order
1	reduction organizations, of
1	distributor who distributes
1	made in response
1	pending trial in
4	agricultural commodity and
1	food or dietary
1	means any plant,
2	 (2) activities
1	revises the guidance
1	property will result
1	otherwise  (1)
1	develop and organize
1	chapter and obtaining
1	establishment fee with
1	timeline for responses
1	subsection (n). (3)
2	5 years. 
2	equally and assessed
1	cocaine freebase kits.
1	packaged carcasses at
1	efforts, measurable results
1	among youth; (3)
1	practice, and the
1	committing such violat
1	distribution patterns in
1	subdivision thereof. 
2	revoke any previous
1	quality systems compliance,
1	substance abuse prevention,
1	congresson or before
1	secretary from nominations
1	standards; publication in
1	residue.  (c)
1	made not adulterated
2	drug administration related
1	facility, and, when
1	importer electronically submit
3	substance intended for
1	used to establish
1	(i) the applicant
1	case of critical
1	list, whichever terminates
1	solely from the
1	subsection (g), shall
2	advisory committees the
1	life supporting, or
1	identify or combat
1	exercising any right,
1	(d) the inspection
1	auditor discovers a
1	packing establishments; rejection
1	panel of at
1	(1). (c) criteria
1	chairman the director
2	health shall be
1	person was convicted
1	water. (3) a
1	revoke, on account
1	tablets, or lozenges,
1	chapter, a biomaterials
2	drug would not
1	coalition, or other
1	security, and secretary
9	title; or (ii)
1	particular device contained
4	developed by a
1	(a)(i) if the
1	listed. the evaluation
1	indian tribe to
2	establishment. (4) performance
1	theory, for harm
1	unused singl-use device.
1	converting, concealing, producing,
1	substances) are used
1	packs, unit doses,
2	application prior to
1	combination of sel-generated
1	existing performance standard
1	prescribed time, the
1	trade representative and
1	debarment; food importationa
2	sponsor within a
2	standards of united
2	meeting of the
1	shortage has the
4	state official) upon
1	(g) conflicts of
1	human life while
1	prescriptionwith respect to
1	(a) establishment; appointment
1	standards act (7
1	limitation the sum
1	(3) includes an
5	schedule, any material,
1	clinical hold under
1	inspections shall record
2	requirement or prohibition
1	administration point of
1	states attorney on
1	person shall process
1	secretary has. 
2	administrator deems appropriate,
1	hereinafter provided, or,
1	specified sampling or
2	(in accordance with
3	regulations.  (b)
1	compile any information
1	transaction history. for
2	subsection (d) shall
1	postmarket studies, that
1	secretary and laboratories
1	applications submitted but
1	evaluations;  (8)
3	leave the establishment
1	transcribed. a party
1	clause (i). while
1	reviews that document
3	 (2) state
1	quotas. however, if
3	necessary to his
1	statistically valid sample
1	(i) the products
1	looks at the
1	training of individuals
1	recommending classification of
1	pleadings and affidavits
1	certification is granted
1	liaison with and
1	export) to the
1	section 554, 556,
1	retrievable from the
1	therefor in such
3	drug administration, and
2	administrative detention; duration;
1	
 603. examination
1	education, unless it
1	plant which are
1	achieve appropriate reciprocal
1	notification submissions, 3-day
1	531, formerly act
2	developing and making
1	risk based on
1	secretary may exclude
3	evidence (and evidence
2	circumstances or which
4	chapter, or any
1	use, which includes
2	bias and conflict
1	application approved by
1	individual or $2,500,000
2	determines may be
1	application no person
6	secretary shall transmit
1	respiratory stimulation. (v)
1	relevant data bearing
2	food derived wholly
1	temporarily in an
1	(7) to enhance,
1	considered a statute
1	products were inspected
1	counted toward the
5	recordkeeping requirements under
1	receive effective approval
2	drug applications are
1	protected and that
1	subsection. (j) collection
1	substance, or (2)
1	voluntary basis only.
1	findings of facts
1	675, 1011, as
1	electronic products are
1	relate to health,
1	conditions on advertisements
1	
 858. endangering
1	operating reserves 
1	request a meeting
2	agreement from the
1	subsection (g) based
1	(d) ethyl ether.
1	distributor that does
1	required to institute
5	(5) such other
1	subsection (i). (2)
1	(b) the debarment
1	states shall recover
1	(b) advisory council
1	disapproves the application
1	also, at his
1	pose any potential
3	it, submit to
1	act for a
1	determination and all
2	assist in carrying
1	damage to the
1	foundation shall be
6	adverse effect on
1	enforcement authority under
15	fiscal year limitation
1	develop, as appropriate,
1	documents as a
1	expire after the
2	laws or regulations
1	marketed devices 
1	subsection (a)(9), shall
1	agency has granted
1	substitute for published
1	(2) listing of
1	appropriations authorized under
1	744g, as added
1	387j(a)(1)(b) of this
2	title, in accordance
1	years, of (1)
1	regular basis, perform
1	supervised by, or
1	secretarys order issued
1	tobacco. (c) for
1	vacate a recall
1	cocaine, heroin, methamphetamine,
1	free samples. 
2	carry out inspections
1	government with responsibilities
2	tolerance, the administrator
1	 (a) membersthe
1	audit report for
1	listing.  (i)
1	inspection (a) origin
1	seeks only to
2	subpena witnesses, compel
1	secretary of state;
1	states in addition
1	food system; (ii)
1	(e) to build
3	appropriate.  (c)
2	review the conclusions
1	upon oral prescription
1	filled. (
 

2	law. if the
1	enforcement officer engaged
2	deemed to refer
1	requested, the quantity
1	distributing such feed
4	regulations for exempting
1	satisfied.  (d)
1	pediatric patients; 
1	pediatric therapeutics), biopharmacology,
1	(b) grants and
7	composed, in whole
1	completing the clinical
2	substance not authorized
1	competent state authority;
1	sentence, requesting updates
1	based; and (b)
1	monitoring and inspection;
1	denial of entry
1	360(a)(1) of this
1	private foundations that
1	prosecution of a
1	assessments that result
1	particular person, which
1	(2). such list
1	reports as determined
1	within that family
2	shall make appointments
1	(b) receives financial
3	regulate such commerce,
4	make a labeling
1	establishment or expansion
1	u.s.c. 220501(b)(2)). 
1	result of action
1	upon motion by
3	shippers certificate or
4	event the secretary
1	information; serious risk
1	animal. (4) the
1	 (a) labelingto
1	subchapter to engage
5	consignee.  (d)
1	criteria; proposed performance
1	(including products regulated
1	transcribed at his
1	days of issuance
1	
 
 379j22.
1	paragraph (2) within
2	(a)(1) (relating to
2	oral prescription in
1	prohibit, or impose
1	(established under section
1	order (after due
2	copies of records
1	resources.  to
1	ring by alkyl
1	oral prescription if
10	provided under this
2	label bears (a)
4	importer of the
1	program agencies for
1	shall approve 
1	$112,580,497 for fiscal
1	strategyfor purposes of
1	ability to alter
1	(1)(a)(ii), (2)(a)(iii), or
1	activity under the
1	
 360qq. repealed.
1	consumers to the
1	section prescribing, amending,
1	information regarding successful
1	pharmacy shall post
1	developing and issuing,
1	holding, distribution, and
1	cultivation, harvesting, preparation
1	sequence that has
1	(i) documentation certifying
1	instituted separately from
1	2009 that relate
1	forms of a
1	review provisions section
1	produce the drug
1	misbranding provisions applicable
3	duly authorized by
1	treasury of any
1	maintained.  (b)
1	(iii)termination or nonrenewal.if
1	currently available drug
1	title is subject
3	satisfied that such
1	continued marketing of
1	reasonably available to
1	methamphetamine, or amphetamines
1	(a) the assessment
3	facility certification under
1	requested authorization in
1	decide which action
4	united states with
1	(e) enabling patients,
3	secretary may initiate
2	information; or (iii)
11	violation after a
8	person resides or
1	(f)) if it
1	qualifying pathogen 
1	 (b) qualified
1	than, or of
1	reporting system web
4	user fee account
1	residue that may
1	drugs for narcotic
1	product if a
1	part outside of
1	(3) disciplinary action
1	export data in
1	exempt any electronic
1	specify a cap
2	decision with respect
1	enforcement of such
8	official of the
7	(b) shall not
2	administration advisory committee
1	ounces (15 grams)
1	dietary ingredient under
1	including community and
1	birth through kindergarten.
21	secretary shall consider
5	year 2014 and
1	(1) intending or
1	list are, upon
2	cosmetics in interstate
6	license issued under
1	suspension of approval;
51	secretary may by
1	shall contain all
1	chemical or a
2	reasons therefor, within
1	secretarys decision. the
1	behalf a civil
80	relating to the
1	greatest risk to
1	anticipated annual distribution
2	submissions  (a)
2	(e) of this
1	exempted operations; termination
2	u.s.c. 8301 et
1	government; (ii) state,
2	study and investigate
2	addition to that
1	2014. (june 25,
1	subparagraph (1) does
1	agriculture, the administrator
1	requirement that is
4	shall, by regulation,
2	order, as provided
1	decision as to
1	cooperative agreement. 
1	nondesignated states; annual
1	environmental and product
1	application a coalition
3	threats of serious
1	novo. (k) certificationany
1	article is forbidden
1	person in occupancy
2	share of the
1	anticipated residue levels
1	carburetion tubes and
1	contain residues exceeding
1	administration by developing
34	(1)  (a)
1	act (60 fed.
1	(k) prevention of
1	warning notice of
1	population.  (3)
1	determining the appropriateness
1	person is found
4	scientific advisory committee,
2	petition of any
1	section 1531(c) of
1	diseases active surveillance
1	localitiesin implementing this
1	products, and equipment
2	order his findings
1	impact on no-hig-risk
1	effect signed by,
1	expended under this
2	(g) such other
1	recipient means the
1	(b)(v), the secretary
3	fiscal year 1997
1	fiscal year 1994
1	fiscal year 1993
1	(c), the administrator
1	section 4(k) of
1	manufacturing changes that
1	issuance or renewal
2	fiscal year 1998
1	fiscal year 1999
4	final judgment in
1	subject to elements
1	subsection (a)(3)(b)(i). 
1	better access to
1	reviews of reports
1	(h)  (i)
1	shown, to restrain
1	products pursuant to
1	hazard analysis, documenting
27	120 days after
1	(i) relates to
1	transfer the forfeited
1	national policythe congress
5	secretary to meet
3	secretary shall classify
1	initiation, conduct, or
1	proceed as soon
1	submit a required
1	possible time and
1	title 26 and
1	conducted a reasonable
2	change and certify
1	48 stat. 1204;
1	remedy not exclusive
1	subdivision as applied
1	week during which
2	plan or the
1	(v) establishing dates
10	cost of the
1	apply for the
1	deadline, or to
1	publish and maintain
1	agency.  (4)
1	review process applicable
1	tampering; or (2)
1	marking on the
1	(c) providing access
1	 (4) rule
1	novo review in
1	(b) purposes of
2	personfor purposes of
2	patent infringement. 
1	exclusionssuch term does
5	section, the terms
1	custom devices 
1	wholesale distributors; fees;
1	review, the device
1	patients; or 
1	information as a
1	(5), or (6)
1	effectiveness  (1)
1	(c) the single
1	violations; notice; opportunity
1	title and under
48	state, local, and
1	subsection (b)(2)(b) may
3	least twice any
1	title 5) as
1	(i) (including a
1	device, or cosmetic
1	minimize reporting requirements
2	(such as dextrose
1	conducts business. 
2	formula does not
3	chemical residue means
2	foregoing upon any
1	license, marketed as
1	facility retain records
1	(a), the coalition
5	 (1) product
1	secretary. (t) the
2	criteria to characterize
1	(1) as soon
2	superseding the provisions
1	logo, trade dress,
1	effectiveness of studying
1	practices used by
1	methods. (6) the
1	agricultural commodity, or
4	approved for such
1	used to offset
1	longer effective any
2	appropriateness of the
1	subdivisions who are
3	attend a court
1	 (3) dru-free
1	individuals in high
1	establishing a flexible
5	public health. the
1	records for shipments,
1	paragraph (7) that
1	and, when completed,
2	designated personnel of
1	manufactured within the
1	imprint, number, or
1	years. the secretary
1	resistance to existing
1	health, the centers
1	periodic reanalysis of
6	360d, 360e, 360f,
1	(3) effect nothing
1	clearance and the
1	designates a substance
1	sharing of domestic
2	judgment, a medical
1	authorized person or
2	new methods, or
1	courts in implementing
5	petition for review
1	term of such
1	approved biosimilar biological
1	similar retai-type establishments;
2	classify the device
1	director with respect
1	paragraph (3) applies,
1	appropriate body charged
1	proof beyond a
3	labeling thereof; or
1	involved by a
1	(c) intrastate activities;
1	 iron (mg)
1	inhalants; or (c)
1	standards of evidence,
2	history of prior
2	listed chemical, a
1	state authority and
1	 (2) proposed
1	2016 for fiscal
2	misleading and which
1	residue, and other
2	level, including allowing
1	subparagraph not less
1	 (2) while
1	reasons of business
3	involving a listed
2	(b) no additional
1	shall keep these
1	administration office that
1	substance, or presents
1	may be caused
1	secretary to show
4	biological product for
3	42; and (b)
1	centers of the
1	letter deemed to
1	(2) the authorization
1	location tool (as
2	absorbed into the
3	study under section
1	section, or state
1	will consistently grant
1	leveraging of data
1	1002(b) of the
1	pain and hardship
1	research consortia the
3	age group for
1	revoking any standard
15	unique facility identifier
1	own, intended 
2	supplemental application 
1	federal agricultural program
1	detained, and shall
1	(1), the panel
1	subsection (d)(2), the
2	broker, renderer, or
2	products thereof, will
1	medically underserved areas);
1	athletes, and the
1	food, provided such
1	require such grocery
5	shall be permitted,
5	including obtaining any
2	time of giving
1	poultry products processed
2	 (b) violation
1	year the following:
1	minimum of ten
1	judicial review. (c)
1	(2) suspect and
1	records and make
1	(vii) have undergone
4	serious risk listed
1	section 427i(a) of
1	another component of
1	(i) supporting a
2	public initiative or
1	commissioner shall notify
1	individual or any
2	held as soon
2	payable for the
1	chapter, or licensed
1	inspected, if any.
1	data at the
1	(1), and not
2	sciences, and other
1	time thereafter as
1	civil liability for
1	title 42 because
1	intended; and (b)
1	fee for fiscal
2	shall delete from
1	360ccc2, 374, 379,
1	personnel in interagency
1	legitimate purposes in
1	proposed plan for
1	 (4) poultry
1	similar establishment in
1	document. (ii) the
1	(i) any injury
1	determine whether resources
1	meat item means
1	summary review that
8	form for the
1	vehicle a controlled
1	means any consumer
1	writing, no inspection
4	section 387a(b) of
1	prohibition on political
1	unlawful production of
1	complete application. 
2	november 21, 1997),
1	affairs, and employees
1	interest.  (c)
1	delays, denies, or
1	entered into participation
1	section, which also
1	activities to the
3	order, whichever occurs
1	shall coordinate any
1	disseminated by national
4	subparagraph (d). 
1	showing that such
12	fiscal year beginning
3	minor species (a)
1	(a) as a
1	compounding for a
2	rights of innocent
3	on-time backlog fee
1	shall coordinate and
2	conspiracy. (
 

1	costs, expert witness
1	secretary believes would
1	remain available to
3	societies of food
2	plant, equipment, or
1	subsection (b)(4)(a); (4)
1	subparagraph (d) publicly
1	regarding cleaning, disinfection,
1	retail level in
1	repackager shall treat
1	state law. (d)
1	time, with respect
1	private sources the
2	information exempt from
1	issue warrants for
1	entrances and exits);
6	conditionally approved under
3	secretary may refund
1	necessary, procedures for
1	product identifier of
2	indicating a lack
1	pronouncement of sentence
1	exporter will not
1	(c) establish minimum
1	dried, frozen, or
1	year the effectiveness
4	notified pursuant to
1	product identifier on
1	extent required by
12	supervision of a
1	determination on certain
1	sold, or otherwise
1	title  first.
1	food product usually
1	standard listed under
1	theft, destruction, and
1	treatment under paragraph
1	(including any investigations,
7	 (a) publish
1	section 5332 of
1	supply and include
1	part or when
1	certification method (including
2	(a) in addition
2	purpose an amount
1	matter affecting national
1	individual;  (2)
1	shipment of clinical
3	quantity in each
1	term inedible means
1	product is found
1	guarantees of analysis
1	property under the
1	comment, whether it
1	applicable in the
1	exportation of animals,
7	secretary shall refer
2	policy  (1)
2	officer that the
2	effective with respect
1	person regarding a
1	foundation; (iii) establish
1	program where judgment
1	subparagraph (c) should
1	title, then the
1	secretary shall, for
1	(1) $153,000,000 for
2	seafood safety. 
2	united statesnot earlier
1	investigational drug application
1	negotiations with a
1	subclauses. (i) label
2	inspection activities of
1	without opening each
1	method the secretary
1	determines to minimize
1	animals, exclusively for
1	premarket review, under
1	30 of such
1	processing and manufacture
3	services to the
1	use data, or
1	ii; (2) has
3	certificate prescribed by
1	$155,000,000 for the
1	consider the manufacturers
1	(i) compliance data
1	relevant food and
1	ch. 273, 3,
1	within each class
1	give priority review
1	entity in accordance
1	 (5) records
1	establishment, or such
2	(7)(c) of subsection
7	substances referred to
1	year in the
1	control the diversion
1	liability as manufacturer
1	may, if there
1	(iii) experience with,
1	affidavit of an
3	distributing such product,
2	products at official
2	standards for a
1	(b) at any
1	(3) the members
1	 (ix) a
1	year 2002. (ii)
1	(a) the authority
1	include packaging. 
1	approve such a
1	subsection (c)(3). (f)
1	(1) shall provide
2	maintenance by the
1	procedures act) such
1	subject to, a
1	control policy, shall
1	awards a grant
2	(k) until (i)
1	internal committee under
1	(1)(a), (b), or
2	products in any
6	failed to pay
2	facts, such labeling
1	obtaining approval or
1	available for tobacco
2	labeling and packaging
32	copy of the
1	title 26, or
2	secretary has carryover
1	changes in any
1	supplement. if the
1	form, directly thereon
1	petition.  (h)
1	reach an agreement
1	shall list all
1	final guidance required
1	675, 403b, as
1	actual or relative
1	(i) in generalfor
1	design appropriate enforcement
1	considers necessary prior
1	include a survey
1	prevention programs. 
1	relate to more
1	committed the offense
1	inspections; and (iv)
1	program agency does
1	355(b)(5)(b) of this
1	(b) compliance 
10	customs territory of
1	(may 9, 1902,
1	links to any
4	grase and not
3	section 282(j)(5)(b) of
1	informal hearing by
1	262, 3, 42
1	presidents intent to
1	(b) an increasing
1	gives notice to
1	necessary and in
1	research and pediatric
2	payment shall be
1	thereof for at
1	device is marketed
2	section; (c) the
1	evaluate the compliance
1	treatment services relative
1	form, a listing
1	perjury and shall
1	advisory committee clerical
1	$25,000 or both.
1	applicable under the
1	
 
 379j11.
1	determines are appropriate.
1	4, as added
1	that, before the
2	term inspector means:
4	shall not, by
3	effective procedures to
1	paragraph (2)(a), but
1	section. the schedules
1	general a return
24	provided in this
2	states and indian
1	united states, from
2	30 preceding the
1	 (b) advisory
1	recall, as well
13	least equal to
1	jury. (3) the
1	stopper, covering, or
1	(a), a report
1	charge, bring such
2	otherwise listed under
1	make grants, in
1	prevent unauthorized disclosure
1	device. (c) to
2	including records access
5	$500,000 if the
1	pesticide analytical methods,
1	protection of proprietary
1	organizations included in
1	capacity that is
1	warning notice to
1	date, added by
1	physician, on the
1	discovered through hidt-funded
1	conveyances where there
5	fiscal year during
2	(4) relation to
4	possess with intent
2	representative of scientific,
1	pretrial restraining order
1	identification number under
1	(b) periodically evaluate,
1	underserved populations such
2	november 1 of
1	limit, under section
22	request for a
1	legal controls under
1	secretary through guidance,
1	specific appropriation; or
1	service subsidized by
1	industry; (v) 1
1	states as provided
1	may be administered
1	understandable and not
1	
 
 624.
1	one year, and
1	facilitate or effect
1	implant only if
2	special government employee
1	service shall deposit
1	(a) the need
2	clinical investigation, taking
1	(ii) identify substance
1	453(a) of this
1	subsection (a). determinations
1	device has the
1	 (d) initial
7	subsection does not
1	commitment to label,
1	products are sent
1	registration to another
1	wel-being. (3) drug
2	investigated, and the
1	 (k) artificial
1	support approval, clearance,
1	research subject by,
2	notwithstanding paragraph (4),
1	necessary. (d) the
1	age groups. 
1	15, 2007, products
1	paragraph (1)(b)(i), unless
1	(3) all affected
1	device, purchased for
1	cultural sensitivities and
2	section impairs the
1	efficacy. the secretary
3	defraud, or any
1	request, within the
2	shall be denied
1	loss of palatability
1	laboratory networks, and
4	notwithstanding subparagraph (a),
1	following documents issued
1	benefit means all
1	government agency to
1	license would be
1	equity for de
1	completely imbedded therein
21	addition to such
2	 (b) waiver
1	bronchitis. such guidance
1	disposal, the trend
1	program regarding the
1	rarely documented causes
1	frequency specified in
1	(d) bad faith
1	(if the secretary
1	
 
 1191
1	(f) notification required
1	review division; (iv)
6	 (b) fiscal
1	readiness for sel-administration
2	(b) for fiscal
1	purpose of increasing
6	secretary may designate
1	(3) ris-based information
1	affixed to such
1	effect in such
2	enters into such
1	21, 1995, provides
1	transaction statement directly
1	no-federal funds. (9)
2	radiation and other
1	account potential pr-
1	applicant for registration
1	controlled substances, listed
1	may immediately suspend
1	(
 
 871.
1	staff work, of
1	studies are required,
1	v of subchapter
2	seeking or offering
5	(2) prior public
1	residue. for the
2	account for salary
1	respect.  (b)
1	commitments require revision
2	change may be
1	penalty became final)
1	sampled, including recommendations
1	commission shall meet,
1	slaughtering, packing, mea-canning,
1	shall notify any
2	countermeasure development and
1	national preparedness goals;
2	competitive service and
12	committee on intelligence
1	advisory review for
1	product identification codes,
1	revocation any importer
1	2 years on
1	exercises to test
1	based.  (d)
1	determines, to the
1	generation of adults.
1	threat agents; (2)
1	quarterly, of such
1	 (7) notification
1	chapter. in such
2	evidence and witnesses
1	separate products packaged
1	(f) outreach, education,
1	means any place
1	arises under this
1	111, 112. repealed.
2	publication by the
2	state coordinator with
1	section 342(a)(2)(c)(ii) of
1	(iii) knew that
1	maintain information and
1	require dealers and
1	met and if
1	subsection (f)(2)(c). 
1	(4) if (a)
1	restraining order or
1	drug; (ii) are
1	number of manufacturers
1	fine, twice the
2	certiorari or certification,
1	medical product sponsors
1	obtain the information
1	demonstrates that any
1	consistent with that
1	title; and (3)
1	accountabilitythe director shall
1	consumers for reducing
13	compliance with such
1	(as determined by
1	complete action on
4	review fee for
1	framework; (c) the
1	compounds, and additives
2	full demonstration of
1	individuals and of
1	administrator shall minimize
4	secretary may compromise,
1	devoted to the
2	finds necessary for
1	environmental risks associated
3	necessary means the
1	wholesaler means a
1	acts that are
1	local official or
1	device to any
2	may obtain judicial
1	term official establishment
1	(3) remedy not
1	 (d) publicationthe
1	subsection, nothing in
1	duties (or any
1	addition to, those
1	2013, including any
2	access for the
1	diseases, the available
1	section shall operate
1	de novo review
1	officer, agent, or
1	(1) is made
2	fact raised by
2	subsection (b)(2), to
1	considered licensed under
1	(i) the proposed
1	practices (a) definitionsin
2	territory within the
3	biological products that
1	clause (2), the
1	$635,000,000. (j) for
1	samples; notice of
1	person from being
1	programmatic funds under
1	secretary that certifies
1	fabricates, assembles, processes,
1	governed by an
1	countermeasures pursuant to
1	food or upon
1	interstate and defense
1	writing, at least
2	standards of an
1	equivalence decision, including
1	chapter. an order
1	within such health
1	(viii) if with
1	annual fee a
1	 (1) following
1	describe actions the
1	packaging eggs, be
1	regulation be set
2	section 330.14(g) of
1	finances, pricing of
23	authorized by the
1	include a change
1	(ii) additional members
1	elect a chairperson
3	american society of
1	agent thereof. (7)
6	information from the
1	first country has
2	section, or a
46	committee on health,
1	2012. establishment of
1	panel to the
1	(3) a reference
13	hearing, the secretary
1	returning them to
1	(b) has otherwise
1	person located in
2	force and strategic
2	part, to commit,
1	adequate inclusion of
3	united states, that
2	articles; other matters
1	(i) a tolerance
1	section to government
1	request is filed
1	reserve amounts to
1	section, issue an
2	discovery shall be
1	eligibility criteria in
1	forms the basis
1	(iii) applies, the
1	distribute, dispense, administer,
1	stakeholder comment at
1	agency will inform
1	(i) that he
1	individual who conducted
1	(g), an authorization
1	may be partially
1	(9). (4) all
3	carcasses, meat and
1	indirectly supplies a
1	prevent illicit drug
1	registration base fees
5	held, the article
8	subparagraph (a) may
1	external experts. 
1	medicines as he
1	
 19. repealed.
1	mentioned in paragraph
1	user fee in
1	interim report not
1	substance abusethe term
1	milk ordinance to
1	of, federal assistance
1	requirementsany petition under
2	either (i) the
1	appropriated funds of
3	engage in any
2	process for amending
1	warrant, the inspector
1	(vii) assessing the
1	risk over a
1	hearing, if in
2	establish, for the
1	ensure the coordination
1	(except an injectable
1	7 u.s.c. 19011906);
1	 (6) drugs
1	conditions if it
1	federal register by
1	health; and (iii)
1	drug is distributed;
5	application is for
2	regulation, the secretary
1	contribution to labeled
13	article that is
1	petitioner is a
1	(iii) actions taken
1	designation. (2) in
1	index limited to
1	(a). (c) no
1	installation are not
4	 (2) report
1	consultative audit means
1	activities (including such
1	budget.  (c)
49	section, the term
1	regulations; status after
1	2014.  (c)
1	pediatric population; (2)
1	application and identify
1	years, whichever is
5	administration, advisory committees,
1	350f, 350e, 354,
1	locality where grown,
1	(b) the system
2	health effects and
1	initiated under recommendations
1	settings, such as
1	321(n), 343(a), or
1	 (2) preemption
3	misbranded, or in
1	exceed the highest
1	label of which
1	limitation on power
1	preserve each signature
1	regulationsbased on the
2	verification or verify
1	facts warrant it,
3	aware of new
2	giving him an
2	processes, and techniques
1	promotion and advertising
1	outreach for the
6	upon certiorari or
1	applicant is able
1	forged prescriptions, and
1	(1) may receive
1	significantly reducing the
6	effect pursuant to
1	day shall be
1	state licensed professional
1	established by medical
1	general schedule in
1	350a. infant formulas
1	used. (3) recommendations
1	agencies in response
1	verification request identifies
1	anhydride. (p) isosafrole.
1	(d) an intravenously
1	food products is
1	related additives) in
2	warnings, precautions, or
2	administration.  (b)
3	type of conduct
1	expenses while away
2	subsection (c)(1)(b); and
1	intentional contamination of
1	make known in
1	weight of moisture.
1	food products in
1	(3); (c) any
1	subsequent offense, punishable
1	listed in that
1	shall after entry
1	regulation establish 
1	give written notice
1	manufacture through distribution
2	initial shipment date
1	consul if such
10	investigations described in
1	process, including the
1	(b) the criteria
7	felony violation of
6	may be relevant
1	restrictions upon the
1	women; (5) make
1	side effects, and
1	render members of
1	afforded a fair,
1	(2) unless the
1	subclause (i), transaction
1	immediate and effective
4	safe drinking water
5	name and the
1	already been paid.
1	overcome such obstacles.
1	(i) for nicotine
1	revenue amounts of
16	whose permanent allegiance
1	successful law enforcement,
1	(e) exception for
1	resource and staffing
1	justice. (5) the
1	ensure access and
2	commission does not
1	appropriate authorities, and
1	advanced approval of
1	recognize the remainder
1	multiple representatives of
1	health from dietary
1	exclusion from liability
10	agent of such
7	register under section
4	(other than information
1	another facility. 
1	law; (c) the
1	retail dealers with
3	violation was committed
1	register designating such
2	course of disease
1	purposes prior to
1	coalition was awarded
1	chemical as a
1	supplier. (c) during
1	u.s.c. 3101 note)
1	181 et seq.);
1	public notice, including
1	revised. (2) the
1	section in regard
1	codex maximum residue
1	(b) is reversed,
2	require prior approval
1	requiredto issue an
1	including objectives related
1	facility. the registration
1	title 18) used
1	(e) require that
1	order, unless an
2	purpose of enforcing
1	components of drug
1	reduce risk or
1	inspection of no-amenable
1	facilitys hazard analysis
1	paragraph for the
1	intentionally purchase at
2	submitted an application
1	manufacturer. if a
3	chemical structure of
1	(c)(2) only to
1	approval, before the
1	various uses and
1	carry out educational
1	shown, keep such
1	stat. 1045; renumbered
7	services (referred to
2	subsection (d) in
1	necessary clinical study
3	responsible person for
1	controlled clinical trial
1	maximuma astated per
1	(9) carry out
1	importation otherwise is
2	drugs in a
2	food.  (2)
1	advertisement is publicly
1	factor that the
1	rare disease issues,
1	threatening, (ii) results
1	specificity, or prevalence.
1	subpart clabels and
1	drug sponsors to
1	title 42; (iv)
1	effective only if
1	services on the
4	(1), (2), (3),
1	effective only in
2	regular and timely
5	death to humans.
1	may be an
1	necessary in any
1	drugs, (d) any
1	36 months with
1	regulations, or agreements
1	availability and safety
1	establishment fees. (b)
5	(5) if it
1	appropriation or statute.
1	(5) if in
1	contentsa proposed risk
2	death to humans;
2	index listing shall
1	regulatory personnel to
1	foundations, and private
1	description of like
2	act on such
1	country as regular
1	ceased to do
1	deemed, for purposes
2	360i, and 360j(f)
2	(a) for an
2	deselect the selected
1	u.s.c. 262(a)], the
1	requirement as part
2	assure that electronic
1	scientist. the secretary
5	shall, after due
1	permit is being
3	misleading. if the
1	receipts, either known
4	section 355f(d) of
3	review.  (c)
1	funds for evaluation
1	(a) for at
1	451 et seq.]
1	u.s.c. 220501 et
1	supplied at a
1	product shall submit
2	hires, uses, persuades,
1	(i) importation is
1	review and grase
1	salt or complex
1	presumed not to
1	section, with measurable
1	distributing or causing
1	unanswered as a
1	determines appropriate, for
2	-(-phenylethyl)--piperidinyl ] propanamide
8	subsection (c). 
1	approved for prescription
1	(b) compliance the
1	interested party to
1	secretary, or its
1	advertisement or a
1	trafficking of drugs
1	convictions occurring after
1	federal programs administered
3	(aa) the date
1	new determination in
2	findings with respect
6	application (or supplement
1	may not, except
1	owner thereof, or
2	accordance with law.
3	means of chemical
1	following december 23,
1	prescription drug products,
3	true and correct
2	section; or (iii)
14	states.  (b)
2	appeal (other than
2	(a) the device
1	accordance with law;
1	(3) an assessment
2	substance under schedule
1	practicable.  (c)
1	checks of a
1	assigned shall be
2	due to activities
1	distinct offense. and
1	part c to
1	regulation require shippers,
2	suspended or revoked
1	criminal and civil
1	section 470[1] of
2	consumer. violation of
2	26, 2014, and
1	(i) the structured
1	studies are late
1	 (c) effect
1	organization  (i)
1	population may be
1	identified by established
1	appoint an advisory
2	information to permit
6	costs for an
1	goal and objective
1	performance bond, or
1	(a) an institution
2	created under this
1	substance or of
1	amounts equivalent to
1	year after revocation
1	with. such certificate
2	v which is
1	assure the conformity
1	prerequisites for importation
1	solely for such
1	delivery or form
1	agriculture may utilize
1	bulk drug substancesthe
1	feed to an
8	ii, iii, iv,
1	process; and (c)
1	training (a) in
1	law enforcement. (viii)
1	five times after
1	officer of such
2	379 of this
1	(c) law enforcement
1	effect for convictions
1	conditions or indications
1	provide such drugs
2	(i) state that
2	making it so
1	findings from such
1	submitted in physical
2	identifies the registration
1	identifying characteristic is
1	health data and
1	(4) codeine methylbromide.
1	end, he is
1	thresholds in the
1	establishes in a
1	disposition of donations
2	concert with him
5	register requesting public
1	describes the specifics
5	proceeding before the
1	ethics in government
1	device records respecting
1	dosage units or
1	preparing any such
1	order may not
1	permit the addition
1	regarding the content
1	requirements shall provide
2	make, use, or
1	100 per centum
1	product which complies
1	application was conditionally
1	population that does
1	(iii) were conducted.
2	shall also include
3	order withdrawing conditional
1	schedule such substance
2	products, by any
5	section 360bbb3 of
1	communicates to the
1	therefor set forth
2	section 353a of
1	law, the regulations
1	accounting of, such
1	member at medical
1	advisory panels 
1	surgery in the
1	account the extent
1	 (f) review
1	[42 u.s.c. 619(5)],
1	section 353a or
1	transshipment to another
1	publicly available listing)
1	organizations of a
1	 (g) information
1	time applicable to
1	import permit requirements,
1	section 360b(e)(2) of
1	shall promptly vacate
1	(e)(2)) impairs the
1	said inspector, deputy
3	year under paragraph
1	(i) $15,000, multiplied
18	fiscal year and
1	(2) publication the
1	proper. (mar. 4,
1	prevent retail grocers
2	product.  (18)
2	811(j)].  (june
1	device, and, upon
1	misbranded drugs; compliance
1	(d) effective period;
1	establish an interoperable,
1	number of products,
1	party objecting to
3	annual report on
1	order withdraw an
1	together with, as
6	(c) the number
2	paragraph (1), an
2	groups requiring that
1	determines eligible for
2	state for costs
1	v and shall
3	both.  (b)
1	assessment, including 
1	85 percent of
1	drug, (b) any
1	additional findings requiredto
4	paragraph (1), as
1	drugs entering the
1	days. if the
1	reporting and inspection
6	health care entities
1	(b) persons alleged
1	among the states,
1	(b)(2) the manner
1	individuals to make
1	applicable; and (3)
5	user fee to
1	drug administration have
1	conviction under this
1	section or misbranded
1	general no fee
3	(8)  (a)
1	26, or to
1	title. (b) prior
9	provided to the
1	sponsor may 
2	(a). the decision
1	submit, for review
1	may, by mutual
1	 (c) denial;
1	(6) that section
8	study or studies
1	subjects to compound,
1	transferred
 
 1
1	particular food will
1	election, such application
1	statement regarding how
1	
 465. limitations
2	holding, or delivery,
1	exist, are drug
1	 (b) biosimilar
1	records as provided
1	3 and amended
1	controls to address
1	alternatives exist; (c)
2	probation; parole in
2	reduction an applicant
1	economy, efficiency, and
1	written and, as
1	phenoperidine. (38) piritramide.
1	secretary (written or
1	information from other
1	united states standard.
1	drugs, be reduced
1	(b) or (m)
1	appropriate, differentiate between
3	connection with any
1	whether the responsible
1	states; (4) develops
1	(4) award grants
1	office a program
4	inspection under the
1	state, or measures
2	1451 et seq.).
2	similar effect of
1	shortage notification program
3	means an active
2	limitation is required
1	(including neutron and
1	constituting the violation
1	expanding the effectiveness
1	purpose of calculating
1	policies may be
1	approved application described
2	food defense research
1	supplemented with other
1	(a)(ii)(ii) to a
3	of, inspection service
2	internet to be
1	regarding review 
1	health shall, when
1	making publicly available
1	conduct of appropriate
1	appearing to have
1	inspect notwithstanding any
5	unless the attorney
1	 (i) temporary
1	subparagraph permitted to
1	(1) a study
1	term without that
1	press release is
1	drug interdiction by
1	nations and new
2	judgment be necessary
1	sunscreen, the secretary
1	relating to, the
1	strength was approved
1	surveillance systems, including
1	practitioner, upon application
1	facie evidence that
1	capacities of on-tenth
1	part; (b) may
2	intended for mixing
1	preparedness of the
1	rejoined to the
1	targeted drugs for
25	providing for the
1	pathogens under subsection
1	exemption or the
2	commerce, whenever the
2	proposed use in
1	carbon dioxide that
1	section. (2) model
1	protocol, the secretary
1	title).  (2)
2	proposed use if
1	director takes office.
3	establish an advisory
6	360(i) of this
1	response, shall 
2	said subsection, that
1	ch. 675, 712,
1	protein and their
2	substance is intended
1	concerned, as the
1	title, a report
1	planning, overdose reversal,
1	accessed, analyzed, and
1	of, the performance
9	subsection (b) with
1	requirements to catfish
1	 (c) order
1	(11), there is
1	work to improve
1	need the drug
1	secretary that relates
1	welfare of such
1	importing of milk
1	(iii) annual submission
1	331(gg) of this
1	audit agent. such
1	clinical trial; (b)
1	research subject by
1	1986), and guidelines
1	united states. beginning
1	additive is intended;
1	disclosure not later
1	substance having an
1	studies conducted in
1	required for assessment
1	(ii) are not
2	support the office
1	(b) exception no
7	barter, exchange, or
1	ch. 675, 809,
1	foreign nations are
1	file that arrives
1	science.  (3)
1	actually use the
1	projects under this
4	secretary may grant
1	term may include
1	dietary consumption patterns
1	suppliers in such
1	illnesses or serious
1	(ii) application upon
1	paragraph (1)(b), nothing
1	condemnations, and injunctions,
1	substance; and (5)
1	laboratory seizures (as
1	persons ineligible for
2	economic loss to,
1	draft guidance, as
8	 (i) are
2	property which is
1	applies this clause
1	application. (
 

3	animal drugs 
1	administration the following:
1	limits of revocation
7	fair packaging and
1	(12) shall ensure
1	name, and address
2	prevention packaging act
1	(a) each of
1	required by state
1	act which causes
1	(b) availability to
1	developed in this
1	addressing each of
1	section. (2) any
2	shall, within 60
1	nuclear threats, including
1	person charged. (6)
3	report means a
2	paragraph (1)(b). (b)
1	may solicit and
1	capabilities and legal
1	medical use or
2	include a specific
23	time of the
1	conducted for that
1	prepared in any
1	recommendations for determinations
2	(c) any written
3	order subject to
1	species designated by
1	registration information with
1	manufacturers, packers, or
1	1972; $65,000,000 for
1	formula for such
2	subchapter which keep
1	establishment of quarterly
1	33 of title
1	also have jurisdiction
1	(iii) clinical protocol
1	trial, hearing, or
1	director shall designate
1	education in the
1	drug testing, including
1	viruses, fungi, protozoa,
1	360c(f)(2), or 360e
1	occurred.  (d)
1	drug with which
1	notice of warning.
1	established name. (c)
1	distributors, retailers, and
1	wherein that person
9	(a) that is
4	data from the
1	fait-based organizations with
1	3432. dietary supplement
1	variance of the
1	substance; nor in
2	electronic products which
6	kilograms or more
2	heads of other
1	virgin islands are
1	360, 360b, 360c,
1	(b). (v) if
1	promotional material used
1	adul-only facility; or
1	tribe (as that
1	provided and marked
1	describes in detail
1	administer such drug
1	
 
 356.
1	may prescribe. (e)
1	introduce into any
1	control the term
1	(2) the scheduling
1	food safety hazard
1	(b) reliefthe court
1	product began. (c)
1	applicant under this
1	slaughtering of said
2	(v) a provision
1	utilized in a
1	may determine appropriate.
1	salts. (g) norpseudoephedrine,
1	evaluations; and (b)
1	may prescribe. no
1	dangerous, or harmful.
1	state, the manufacturer,
2	dangerous, or harmful,
1	means notification to
2	recommendations required pursuant
7	program  (1)
23	basis of the
2	territory or possession,
1	title or when
1	daily amount of
4	shall at the
1	allocation of personnel
2	(iii) be reasonable,
6	drugs that are
1	conditional upon a
1	chemical. (2) with
2	list such tobacco
1	$1,000, or both.
1	seal under this
1	secretary, by regulation,
1	using surveillance and
1	major change or
3	extent practicable, the
1	(a) labelingto indicate
2	application for conditional
1	networks, as appropriate,
1	decision. in such
1	30, 2007, for
1	within this subchapter
4	knowledge of the
4	register with respect
2	testing has begun.
1	lawful application of
1	current approved labeling
1	states and a
1	statement that summarizes
1	identification showing a
1	scheduled listed chemicals
2	applied to such
1	provide recommendations for
1	health programs to
1	abuse such as
1	prescribed in clause
1	(ii) which drug
2	affirmed, the approval
2	paperwork reduction act),
2	scientific, research, and
1	carryover balances of
1	recommendations shall address
1	material fact in
1	create a drug.
1	(c)(4) during the
1	used, the date
2	(i)(cc), the document
1	panel with respect
1	identification of any
2	consultation is necessary
3	(2) definitionsfor purposes
1	ordered under subsection
32	recommended, or suggested
1	enforce the withholding
1	date of approval;
1	1260; renumbered 4
2	final guidance on
23	defendant is other
1	product or cosmetic
1	(i) identify specific
1	caustic hydrates of
9	household and his
1	activities (a) in
5	order to 
1	subparagraph (c), including
1	(7) specifies the
5	removal from the
4	 (2) if
1	(4) unique facility
3	government shall be
1	(c) advertising in
4	 (2) in
2	final guidance or
1	necessitating such action
1	 (7) elements
2	animals from which
1	subparagraph. (4) advanced
1	goals set forth
1	accordance with state
1	local surveys or
1	only, shall promulgate
1	close of business
1	action without regard
1	passengers as a
2	titled nicotine in
1	distribution, or storage
14	sale and distribution
1	technological characteristics are
1	evaluate by april
1	outside stakeholders, including
1	interests of consumers.
1	request and receive
1	secretary, except that
3	(c) regulations 
1	seized for violation
1	due date the
1	needed to identify
1	common international labeling
1	members each of
1	fas-track product pursuant
1	foreign government only
1	composition of panel
1	(e) consultation in
3	march 1 of
1	date, the secretary
2	consult an advisory
1	additional resources, authorities,
1	reason or reasons
1	lif-supporting, lif-sustaining, and
1	45(b)] respecting such
1	state law concerning
1	issued, unless the
1	(3) notice a
1	activities, and the
1	established before may
2	general in such
1	use among children.
1	(a) or wholesale
1	(b) agrees to
1	controlled substances. (4)
1	use, to his
1	
 
 379dd2.
1	suspensions the administrator
1	$7,328,000 for fiscal
1	(g) financial and
1	general may commence
1	action, or on
1	plants and animals;
1	whose registration has
1	adjustment factorthe small
3	state, designates as
1	human or pet
1	subsection (a)(4)(a) or
1	applications and submissions,
1	person for handling
1	paragraph (2)) not
1	sections. (june 25,
1	enhance current counterdrug
2	consultation and coordination
2	services the detainer
1	required additional information
1	committeesthe congressional committees
1	subparagraph, the united
1	abuse. to the
1	applications were so
1	sale of, or
2	sponsor described in
2	four and on-half
2	sale in a
1	others required to
1	produces the residue;
1	evidence if the
1	including adverse safety
1	drug product described
1	action.  (iii)
1	drug abuse including
1	(4) $40,000,000 for
1	protections, including the
1	federal standard. (june
1	persons, and (ii)
1	tobacco products other
1	511a, as added
1	consideration under other
1	(b) registration requirement
1	recommends that a
1	(s) of this
2	considerations listed in
1	final basis. 
2	central intelligence or
1	amendments. (b) 
2	counterfeit, diverted, or
15	transaction history, and
1	petition shall, to
1	effectiveness, except that
1	(2), the commissioner
2	secretary believes, on
1	title. (2) within
1	(3) subsequent and
1	change to add
1	(a) on or
1	subsection (b)(1), shall,
2	programs of such
7	(i) the date
1	abuse, especially heroin
3	(i) the data
1	22. (2) 
2	new route of
2	include the isoquinoline
4	applicable state and
2	produce is not
1	narcotic drug or
1	360nn. inspection, records,
1	serve search warrants
1	circumstances require otherwise,
2	may designate to
1	eligible entity, in
1	18) or the
1	appears in an
2	order, as the
1	available; (e) information
3	number of separate
1	abusers), supply reduction,
2	regulating the practice
3	contain the following
2	(unless such notice
2	ii.  (e)
2	 (i) establish
1	200.0.  chloride
1	repacked elsewhere the
1	official plant under
1	interstate and provides
1	provide guidance to
1	(ii) has, with
1	dissemination. (2) the
2	owns a type
1	securing recommendations with
2	penalty assessed under
4	october 31, 2012,
5	commerce of any
1	limit the provision
1	(a) help to
1	party.  (4)
2	advisory committee from
1	person obligated for
10	drugs or other
1	general the sel-certification
1	(2) coordination in
1	(10) because other
1	may introduce or
1	 (iii) criteria
1	(29) wholesale distributor
2	state establishment that
1	complaint described in
1	single enantiomer that
1	tuberculosis. (b) malaria.
1	
 21. branding
1	only, the term
4	otherwise disposed of
5	secretary notifies the
5	appropriate  (i)
1	306, as added
1	information or identification
2	thing of value,
2	919; 
 

1	meal or of
1	(iv) classifying or
1	(ii) conducting exercises
2	documentation detailing why
1	clinical data, inputs,
3	preceding year regarding
2	owned by another
1	manufacturer under this
2	withdraw, inspection service
1	bowls; (2) water
1	manufacturing practice, as
1	title, all the
1	health, he may
1	made (a) by
3	section 207 of
1	(a).  (f)
1	health professionals agree
1	(9) surrogate endpointthe
1	report, including publication
1	designee, at a
1	issue a decision
1	product, deviations from
1	suspected food contamination;
1	precursor, included in
8	(part), 37 stat.
1	(
 
 1001
1	subclause (i) were
1	2012, the secretary,
2	section takes effect
2	foreign governments to
1	declares to pose
4	list published by
1	name), and the
1	make disclosures regarding
1	system the term
1	upon such designated
1	necessitating the issuance
1	file not being
1	 ecalcium to
1	states which fails
1	organizations. upon request
2	chemical if the
1	exclusively related to
1	governments, other federal
1	prohibited personsthe standards
1	distribution and give
3	federal court jurisdiction
1	antibiotic under section
1	 (d) modification
1	(b) knowingly selling,
2	consumer in order
1	package defined the
3	proposed tobacco product
36	owner, operator, or
2	section 343(r) of
1	mist.  (c)
1	telemedicine by vha
1	product. if, after
1	(2) notwithstanding paragraph
1	equal to 75
1	review and correct
1	performance and technical
1	recognized in an
1	require otherwise, notify
1	application submits a
1	control activities on
1	suspend the license
1	subchapter ii involving
3	facility shall submit
1	drugs must be
2	final decision within
2	persons who manufacture,
1	shall not enter
5	small business and
1	applications or the
3	whichever occurs first.
1	(4). the secretary
1	extended for such
1	in, claims against,
1	health, or to
1	section after august
1	(iii) the office
3	(3) abbreviated new
1	filled milk means
1	fees charged by
1	available; (b) post
1	(12) authorization of
1	and/or cream: provided,
1	business, taking into
1	467c. federal court
1	part pursuant to
2	persons contacted for
1	products act [21
1	costs of related
1	expenses for recipients
1	deny, that the
1	842(a) of this
1	attorney general, (2)
1	entity, including the
3	small food processing
13	subsection (e) or
1	person to make
2	reduction in morbidity
1	5) on the
12	soon as practicable
1	entity constitutes an
9	request shall include
1	refused entry; and
1	availability in commerce
1	withholding of data
1	particle of egg
4	establish a regulation
3	county, or other
1	file that was
1	(e) unlawful acts
1	(d) modifications a
1	refusal of services
1	issued, bring a
1	space, respectively. (2)
2	percent of n-cost
2	food products; and
1	(n)(5)(c), any person
1	ingredient and which
1	outside a device
2	year 2016, $2,976,000
5	shall give priority
1	28 for a
2	based on known
2	identify the criteria
1	use solely as
1	proceed to impose
1	names under which
1	order, for the
1	help resolve scientific
1	secretary, shall include
2	packed, received, or
1	product. (d) review
6	animal drug which
2	data before the
1	order and proposed
2	administrator may, by
1	generic drugs: 
5	performance standard for
1	imported and domestically
1	pharmacy; (4) a
1	species in question.
1	262(a)] or the
1	vehicle in which
1	secretarys final determination
1	supreme court review
2	committee of congress
1	imposed.  (b)
3	production costs and
1	(a) unlawful actsany
2	information has been
1	increases an additive
1	medical product discussion
1	postal service fund,
2	used, in any
2	suspension or the
1	2017, as referenced
2	assistance from the
1	manufacturing industry; (v)
1	panel to be
1	 (e) duration
1	reports  (i)
1	human food, of
24	implementation of the
1	title, has reference
1	requirement subject to
1	prior to completing
2	processing poultry or
1	approval period termination180
1	agency for a
1	positions, including 
1	including, subject to
1	clearinghouse.  (b)
2	subparagraph (1) of
1	clearance of countermeasures
4	submission of comments
1	(2) debarment periods
2	hearings), promulgates final
1	successor regulations), or
1	(iv) the process
1	(4) rare pediatric
1	
 357. qualification
1	sponsors device and
3	filed by him
1	cited by the
1	vendors, suppliers, and
1	states.  (4)
1	content is not
1	united states pursues
1	progress toward developing
1	less than $50,000,000
10	days for comments
1	practices for infant
3	legally marketed device
1	pay costs of
1	(a)(2) and the
1	appointment of the
2	business, any history
1	(1) compounded positron
1	number of postmarket
1	notification identifies the
1	otherwise), or processing
1	(1) shall, as
1	(c) improving food
1	businessesnotwithstanding paragraph (1)
1	official is not
1	committee any petition
1	unacceptable, the secretary
1	 (1) interim
2	notice the secretary
1	890. review of
1	care practitioner authorized
1	act; and (f)
1	proposals consistent with
1	graduate training programs
1	granted unless, within
1	509, as added
3	409(l)[1] of title
1	1938, (ch. 675,
1	(d) measures to
1	section shall furnish
7	355(i) or 360j(g)
1	continued use consistent
11	beginning not later
2	investigation is carried
2	adequate summary of
2	reasons. a notice
1	amounts allocated for
1	fat: gm 3.3
1	 while such
1	charged but shall
1	thereafter provide an
2	drug outweigh the
17	secretary shall designate
1	single individual. a
1	finds that (i)
3	listed drug under
1	thereof; (c) the
2	organizations, including fait-based
1	third party, as
1	employees duties (or
1	condition may exclude
2	detained under paragraph
1	logistics services of
1	(ii) determines that
1	drugs, or manufacture
4	343(r) of this
1	approval or classification
1	states constitution. (2)
8	development or approval,
1	makes a prima
1	private sector preparedness
1	transaction statement, in
2	different regions an
2	 (3) an
1	necessary) the results
1	chemical, physical, and
1	term commissioner means
1	sentence as if
1	postfebruary 15, 2007,
1	safety information, serious
2	types of activities
2	agency action proposed
1	labeling the manufacturer
1	evaluating a request
3	spices, flavoring, and
2	regulation described in
1	drug or such
1	studies; and (iii)
1	resources are not
1	parents would simply
14	motion to dismiss
1	recovery results; (iii)
1	eligible countries for
1	importer, as appropriate.
1	sections 52 through
1	registrant or other
1	shall take all
1	term qualified testing
1	manager or a
1	114i. pseudorabies eradication
1	 (i) none
1	promising technologies, which
12	attorney general shall,
1	plan, the requestor
1	1101. congressional findingsthe
1	clause (ii)(ii) may
3	shall have due
1	virus of foo-an-mouth
1	conditions, and (3)
2	nutrients required by
1	consumers. (b) single
1	may be convened
1	provided by patient
4	studies required under
1	general dutiesin order
1	carrying out clause
1	consist of 
2	apply equally to
1	list, including the
1	task force to
1	mixture described in
1	food safety (a)
1	subsection (c), (d),
2	cosmetic provisions unaffected
6	differences of opinion
21	section 360(k) of
2	fiscal year such
1	recite or acknowledge
1	 (l) transitional
1	washed, colored, or
2	contributed to any
1	secretary if under
1	secretary concerning the
1	distributors (a) in
1	committee, to submit
2	requirement of clause
2	state of this
1	labels having plainly
1	advise, consult with,
7	total fee revenues
1	business at which
1	intervals or other
2	products for distribution
1	release to the
1	inspection as provided
17	within 60 days
1	(a) request and
1	convictions for an
1	first approval for
1	subsections apply with
1	supply and preventive
1	(2) train to
1	process for annual
1	schools or playgroundsnotwithstanding
1	tolerance; or (b)
9	15, 1927, ch.
1	database a wholesale
1	subsections (a), (g),
1	regulatory agencies, with
1	control as he
1	establishment of advisory
1	submission is necessary
4	approves an application
1	charge, are authorized
1	health service. 
1	designation; review of
1	(h) available to
1	any, and related
1	reduce duplicative regulatory
1	offenders any person
1	
 
 379o.
1	ion shall be
1	11, 1995)). (2)
1	use, including, as
1	country programs, including
1	comment a notice
2	established so as
2	(2) records inspection
1	annual revenues did
1	retail vendor: 
1	partnerships (a) establishment
1	parts in foreign
1	coordination between different
1	(a), including a
3	secretary shall deny
1	demand reduction, or
1	use and minor
7	probability that the
1	poultry producers), not
1	substance (except an
1	(1) an audit
1	criteria for recognition;
1	funding supports the
1	secret. (
 

4	submitted in connection
1	filing objections has
1	(5) any person
1	(c) afford that
1	forth the proposed
1	precipitate a drug
2	only, and does
2	subsection shall apply
18	contrary to the
1	complete under subsection
1	 (b) ris-based
2	application as the
2	recovery of collection
2	(b) the progress
1	groups, relevant endpoints,
3	necessary, on an
4	revoking an exemption
1	$300,000. (2) any
2	1984, and the
2	(b) the known
1	(9) $90,000,000 for
1	surveillance under sections
2	(c) if since
1	petition shall, in
2	health such as
1	sale, as follows:
3	commitment to pay
2	section against the
2	occurs within 10
1	1, 1992. subsection
1	section 371(e), (f),
1	chapter through officers
2	(ii) establish a
2	intravenous use or
2	reassessed process control
1	(s) registration of
4	valid marketing authorization
1	conveyance.  (2)
1	disclosure under subsection
2	distributing, possessing with
1	1992, a human
1	(c) is another
1	exemptions from inspection
2	importation of all
1	inspections by the
1	4, 2011, food
1	 notwithstanding subparagraph
1	excessive loss or
2	letter to such
1	use of narcotic
1	background of the
1	 (6)[2] shall
1	seized by the
1	violate any of
2	occurrence of each
1	areas program (in
1	subparagraph (a)(iii), the
1	 (v) later
1	electronic products so
1	narcotic drugs means
1	complaint, or the
1	facility in committing
2	subsection (b), no
1	another device 
2	origin of the
2	appear at any
1	(e) expanding capacity
1	assurance. (c)class iii,
1	drug appears on
2	section 208(b)(3) of
1	
 
 360bbb4.
1	recall system (a)
1	360e3 of this
1	imposed by this
1	wholesale distributor by
1	making such a
1	notice any permit
1	drug lawfully introduced
1	businesses (as such
15	basis for such
1	pediatric assessments, deferrals,
2	(hereinafter referred to
1	(l) failure to
1	performance measures and
1	(d) programs and
1	entering false statements
1	term disposition, with
1	labeled on foods.
4	otherwise permitted by
1	application the coalition
1	(3) revocation of
1	secretary, based upon
1	director  (i)
1	960(b) of this
6	type of class
31	within a reasonable
1	designate.  (2)
1	whichever first occurs).
1	
 387r. drug
1	(b) containerthe container
11	effect under this
1	necessary for their
4	states or any
1	(3)(a) fails to
17	ester or salt
1	separate registration 
1	practices and processes
1	 (1) continues
1	purposes and duration
1	refusal or within
2	funds of the
1	registration fee means
1	provided such person
1	(n)(1)(g) or in
1	subsection (n); or
4	drug product which
1	limited in an
1	utilize controls comparable
1	file, in which
1	administer, or use
1	subchapter; (b) to
1	claims data); and
1	authority by a
1	range of substance
1	section on the
2	1473 of title
1	notifications described in
1	additive, if, after
1	treasury designated by
75	section 355 of
4	iii device 
1	including sourcing of
1	listed chemical under
1	keep correct and
3	100 milligrams of
2	information classified under
1	application; period for
1	kept so identified
6	section 355 or
1	due datethe establishment
1	1306); (b) 
1	supplements); (b) on-third
1	toxicity to infants
2	relating to tobacco
2	cream shall be
1	pending abbreviated drug
1	(k) other elements
1	general administration of
1	detoxification treatment (or
1	title; (d) did
1	new animal drug),
1	approve an abbreviated
2	drug advertising means
1	drug in professional
1	(ii) no refunds
1	including rapid shipment
1	least 5 years;
2	investigation may not
1	1052; 
 

1	drug availability and
1	deadlines with respect
2	become effective. 
1	general may obtain
1	such, after providing
1	medical product; and
4	retail food establishment
1	failing to maintain
2	preparedness and response,
1	advertising, and communications,
1	1 individual who
1	(2) employ, hire,
1	food with such
1	undertaken  (a)
1	methodologies  (a)
2	1, 68 stat.
1	obtained in violation
1	agencies of distribution
1	requirements has been
1	interest regarding any
1	generalamounts made available
1	advocates a position
27	for, the manufacture,
1	united states, order
1	rehabilitation, research, training,
1	tolerance. the administrator
1	distribution problems. 
1	rodenticide act, suspends
1	379f. recovery and
3	application.  (f)
1	(iii) for the
1	average review time
3	homogenous case of
6	approval  (1)
1	receives such a
3	state in accordance
1	health organizations, and
1	title 21 -
1	commission of an
1	clinical trial for
1	 (a) regulations
1	subchapter is reported
1	exclusivity period the
2	account the qualifications
1	outsourcing facilities, which
2	administration. (3) the
7	civil action under
1	final regulation, as
2	offensea person who
1	17 and amended
3	within 180 calendar
1	violations of federal,
1	industry to explore
1	scope of cooperation:
2	har-drug users living
1	product. any such
2	qualified expert panel
1	title 18) or
1	section. (e) notice
3	representative of consumer
1	(i) incorporate the
1	law. additionally, the
1	cause the drug
1	including the practical
12	manufacture, preparation, propagation,
1	standards organization recognized
1	licensed wholesale distributor
3	third and subsequent
1	(1) and may
3	sets forth the
1	4 subsequent fiscal
2	scientific and technical
1	report promptly to
1	committee an opportunity
7	section 331 of
1	states (and in
8	made under section
2	(c) for each
1	sections are sufficient
1	furnish the applicant
1	consider all other
1	petitions the secretary
1	alternatives, including the
4	represented for special
1	24 hours, for
2	registrant has complied
1	required for any
1	ch. 675, 306,
1	part; (iii) approval
5	virgin islands of
1	system; or (c)
1	complex scientific issues,
1	proposed tolerance; and
1	(b)(2) has been
1	import drugs under
1	safety collaborations. 
1	commerce, a shortage
1	prepared; and said
1	use disorder treatment
1	dyes (as defined
1	characteristics of research
1	participants and hold
2	supply of a
2	use to prevent,
1	blister containing not
1	appropriate, on other
10	secretary shall give
1	supporting the petitioners
1	matter of right.
1	academia. such working
2	decision or schedule
1	title 25) through
2	(i) a class
1	importer to submit
4	360j(e) of this
2	advisory committeenot later
1	infant formula unless
1	work with stakeholders,
1	year under subparagraph
1	secretary finds after
1	subsection (n)(2)(b) or
1	drug issues; (12)
1	approved new drug
1	exceeding such tolerance.
3	(1) shall require
3	4 fiscal years.
1	(1) r-exportation from
4	4 fiscal years,
2	(a) upon being
2	secretary so long
2	4 fiscal years;
1	committee and be
1	states and imposition
1	projected for that
2	801 et seq.]
2	first reference to
1	general each nominee
8	unless there is
1	invalid in one
1	exercise of authority
1	makes such election;
1	poison, when practicable
1	individuals than no
1	drugs, including requirements
1	section, is available
1	trial of which
3	legend means any
2	assertion of a
1	makes such election,
2	section, have procedures
1	attorney may, with
1	242a(a)[1] of title
2	item means 
1	regulations published in
2	2013, and every
1	among youth; or
1	secretary. subsection (b)
1	political subdivision under
1	industry, and state
1	 (1) fees
1	maintain records relating
1	persons who will
1	 (j) expungement
3	information technology systems
1	approved application; (b)
1	studies, or both
1	minor species may
1	local and other
1	 (2) further
1	like import. (mar.
1	subparagraph is in
3	data  (1)
1	patients exposed to
1	analysis of a
3	chemically or pharmacologically
1	property following the
1	distributing the feed
1	evidence to support
2	fees established in
1	pediatric population. no
1	arrangements. a contract
1	timely, accurate, and
2	includes programs and
3	 (b) additional
1	services, seek to
1	administer devices intended
1	entity authorized by
1	area; and (ii)
4	shall request that
2	administrator shall determine
1	manufactured or held,
5	time and in
1	initiatives of any
1	subparagraph (a)(i) to
1	clause. (bb)first applicant.
1	(
 
 829.
1	conditions; (3) the
1	articles, are plainly
3	countries described in
1	development meeting means
2	(iii).  (ii)filing
1	public so much
1	interests of patients
1	information do not
3	order for the
1	(e) shall cease
2	disease is a
4	title, and the
1	extent dangerous to
1	milligrams of codeine
2	used for 
1	panel under this
1	persons for use
1	reason; (iv) the
1	petition to modify
1	prescription from a
1	substance proposed to
1	(b) possess appropriate
1	pasteurization or condensing:
1	protection of users
1	name, brand company
1	30, 2022, approved
5	food and is
1	establishing whether a
1	reasonably safe and
1	appropriate procedures of
1	pasteurized cream five
3	general an applicant
1	drug was listed
1	drug activity occurs
1	burdensome requirements are
1	soon thereafter as
1	subsection (g)(1), a
1	detailed justification that
1	display in a
5	manufacture or sale
1	cargo entered in
1	individual has refused
1	discontinue, retain, or
1	accountabilitythe coalition shall
1	drug of the
1	researcher; (3) includes
1	occurs later. 
1	(d) civil action
1	confirm that nutrients
1	plan have been
2	(except those that
1	 (2) importer
1	forth changes in
2	administrative process and
2	advertisement submitted by
1	et seq.]; (b)
1	(a) to inspect
1	valid certificates of
1	communication includes 
1	research, the center
1	orderan order issued
1	(c) schoo-based food
2	affiliate of that
3	prevention, treatment, and
1	term pasteurize means
1	act and assisting
1	shall, upon conviction,
1	interagency activities related
1	punishable by this
1	january 1, 1999.
2	basis that the
4	significant difference from
17	means a drug
1	intent to commit
1	shall, before initiating
54	name of the
1	disposal by him
1	written; and (e)
1	include a brief
1	seq.], may not
3	petition requesting that
1	existence of patents
1	tolerance shall have
1	feasible means, any
2	section, except as
1	renewal request, unless
1	conducting exercises to
1	pediatric safety and
5	(whether or not
8	 (i) with
1	surveillance.  (3)
3	drug treatment programs
3	sel-determination and education
1	plan  (a)
1	(26 u.s.c. 5001
1	impact of each
1	methamphetamines.  (g)
1	federal register after
2	recall is terminated,
1	(i) the court
1	state may petition
1	layers. (5) a
1	enforcement administration or
1	first country under
1	congress that when
1	means the removal
1	promulgate regulations fixing
1	conveyances, where persons
1	enforcement administration of
1	review and update
1	periodic reports required
2	(g) whether the
1	42), the secretary
1	enforcement administration on
1	fiscal year 2011
1	biologics approved under
1	adulterated, and if
1	insufficient to assure
3	registrants under paragraph
1	(3) establish an
1	found; preliminary order
10	person that is
1	20,000 poultry; or
3	batch of infant
5	product establishment fee
4	title is not
1	(1) audit agent
1	rots, yellow rots,
1	grant period referred
1	audited eligible entity
1	(xv), or (xvi)
1	(n) that he
1	determinations under clause
1	use, and specimens
1	may employ such
2	determinations by the
1	state law; (4)
7	facility means a
1	section. in fixing
1	state or otherwise
1	advance in accordance
1	section, provided that
1	paragraph (1)(b). if
1	integrity issues; (6)
1	appropriate internet web
1	misbranded, and are
1	(iii) requests funding
1	title, no drug
1	residue consisted only
7	drug administration, contractors
3	indefinitely, as he
1	commitment by the
1	help facilitate the
1	(c) the controlled
1	(e); (iii) evidence
1	congress, or any
1	practice. the term
1	take other appropriate
5	respond to the
1	shall, on request
2	people, people with
4	regulation prescribe. 
1	date was not
1	(a) the acceptance
3	charter act (15
1	reasonably appropriate procedures,
1	limitations the funds
1	section, funds otherwise
1	radio, and all
1	(b)(1)(a)(i), (c)(1)(a)(ii), (d)(1)(a)(ii),
2	feed to another
1	sector resources to
1	fail to furnish
2	control system. (e)
1	use and to
1	concerning whom such
1	qualification submissions. (c)
7	secretary of commerce,
1	food identified in
2	minimize, consistent with
1	year 2003 multiplied
2	(a) the applicant
1	manufacturer or to
1	territories, or possessions)
1	law regarding recovery
5	purchased the product
1	(4), any person
1	section 360d(b)(2) or
2	paragraph (1) reflect
2	of, the person
1	tobacco.  (ii)
1	thereafter or information
1	use as measured
2	importer to report
1	medical air, to
1	except as described
1	cooperation with federal
1	3, 1996. in
1	nondrug control purposes
1	science.  (b)
4	change to the
1	year limitation. such
1	appropriate, regarding recordkeeping
1	substance to distribute
5	schedules i and
1	material that restricts
1	(vi) guidance documents
1	effect that such
1	seq.), reenacted with
1	 sodium (mg)
1	pending shall, in
1	applicable, along with
2	united states magistrate
1	standards as applied
1	notwithstanding clause (b),
1	subsection (k) are
1	health centers). 
2	becoming aware of
1	guidance becomes final.
1	fiscal year (as
1	articles; except that
1	waiver for small
3	secretary makes the
1	illness of, or
1	substance abuse (including,
3	secretary as a
1	been, in the
1	review the supplement
1	cows. (mar. 2,
1	special controls, as
1	no-racemic drug for
1	decision) a complaint
1	combined, the program
1	(b); or (b)
1	funds to carry
1	regulations prescribing recordkeeping,
1	subsection (i)), a
1	minimum of $2,500,
1	(ii) inclusion of
1	health systems of
1	secretary acting upon
1	growth hormone 
1	firm in writing
6	use of animal
1	exporting a drug
1	2603]; (iii) describing
1	basis testing programs
1	importer to use,
2	device included in
1	require a business
1	72 percent of
1	drugs (including increases
1	budget request is
1	(b) other considerations
2	foods  (a)
1	report, supplement, or
1	animal modeling procedures
2	(b). (b) in
1	held under clause
1	(22) -(-chlor-2,-dimethoxyphenyl)ethanamine (2cc).
1	
 958. registration
1	product inspection law
2	sales were collected.
1	affecting national security
2	supplement, premarket notification
1	entity has a
2	homeland security, in
1	anatomic characteristic or
1	device constituent part
1	final rule (a)
1	animals, (b) degrades
1	
 963. attempt
1	note below.
 

1	tolerance is limited
1	age declined by
1	ordered detained, or
1	compares such performance
1	residue standards applied
1	chemistry, legal issues,
1	strength; (iv) the
2	dietary supplement for
2	premises, facilities, inventory,
2	housing authority, or
1	distribute, through such
1	inspections for devices
2	property  (1)
1	(e) compounding defined
1	fungi, protozoa, algae,
1	leaf is also
3	(b) or a
1	process, before distribution
1	reference by a
2	secretary, taking into
1	processor, packer, distributor,
1	three years under
1	thereby. (june 25,
4	5 governing appointments
5	amending, or revoking
1	advertising is misleading,
1	least three years
1	relationship between 
2	shall utilize the
1	shall be properly
2	persons an opportunity
13	upon the basis
2	601(w)(2) of this
1	information, if any,
1	20, formerly 18th
1	animal feed with
1	(ii)timeliness of reporting.
2	constitute substantial evidence
2	maintenance the responsible
1	
 
 351.
2	supervised drug rehabilitation
1	commenced an informal
1	impact on drug
1	quarterly and annual
1	accessible location provided
1	security under the
1	competitive awards to
1	offense involves an
1	tobacco product does
1	assistance to those
10	60 days of
1	profits on drug
1	validates the effects
2	cosmetics under this
5	agriculture is authorized
1	tobacco products shall,
1	knowingly open, lease,
1	fields; and (b)
2	pediatric uses for
2	prescribe such regulations
1	(f) the price
1	information are sufficiently
1	proceedings, upon application
1	required to register)
1	general has transmitted
1	application in effect
2	shall determine if
2	prior to distribution
1	(
 
 360f.
1	legitimate supplier of
6	title and a
2	upon filing of
1	revised guidance is
1	letter to the
1	cultivation and manufacturing
1	environmental impact notwithstanding
1	respect to section
1	(c) what steps,
1	act information made
1	revised guidance if
1	wholesale distributor did
1	extr-label use is
2	coordinated lon-term federal
1	examines how best
1	counterfeit drug, (b)
1	true copy of
1	holder notice and
1	parts used in
1	proposed labeling as
1	treatment, as demonstrated
1	premises where such
1	five years before
1	(
 
 888.
1	establishments.  (b)
1	surveillance, observational studies,
11	shall provide a
2	prepared, compounded, or
1	notice; opportunity to
1	establishment that was
7	disease area of
4	developing and administering
1	general public; (iv)
1	section, is not
1	(a) success in
2	disease area or
3	247d of title
1	youth. (vii) law
1	modifications determined to
2	(1) or any
1	required to put
4	amount of time
1	 (i) reinstatement
2	consumer exclusively for
1	(a) necessity of
1	(2) effect notwithstanding
1	clause (i), except
1	story board, rough,
3	(e) if the
1	list of such
1	distributor, or any
1	unless subsection (b)
1	changes made by
1	title 7, for
1	(a), separate buildings
1	convention. a temporary
1	term drug enforcement
1	competes (36 u.s.c.
1	clinical testing; (b)
1	warrant identifying the
1	
 355g. utilizing
3	provisions (including penalties)
1	678. no-federal jurisdiction
1	opportunity to comment
1	procedures for promulgating
1	governmental entities of
1	(iv) because the
9	 (a) subject
1	record established in
1	seal of the
1	issued and served
1	authority of all
1	among youth 12
1	computer program to
14	quantity of the
1	genetically targeted, including
1	seq.] applicable to
1	(iv) seeking food
1	term patien-reported outcome
1	savings provisions nothing
1	biologic processes, pathologic
1	drug; and (iii)
2	drug control program,
2	less than $15,000
1	filing.  (6)
2	consumer advocacy groups,
2	calendar days established
1	immediately after being
1	production costs. (d)
6	cocaine, its salts,
6	consumer advocacy groups;
5	person to the
1	prior fiscal years,
1	drug administration necessary
2	drug control program;
1	(1) product listevery
1	requires a qualifying
1	(a) consult with
1	grocery stores shall
1	cellophane), in which
2	order refusing, withdrawing
1	permits the secretary
1	territory. (mar. 16,
1	title 7. 
1	(i) certifies that
1	(iii) program for
1	solicit input from
2	within the country
4	include the following:
1	dye (as defined
1	(3) the panels
1	products.  (ii)
2	agricultural commodity that
1	vacancy on the
3	public health, provide
1	agents office or
1	subparagraph (a) applies
1	long as appropriate
1	schedule.  (b)
1	reported by antimicrobial
1	52 stat. 1045;
3	chapter. (4) the
26	subject to paragraph
1	iii device, means
5	considered adulterated under
2	feed is different
1	website:  (1)
1	confer any new
1	problems emerging from
1	
 1402. foreign
2	supplement under subsection
1	animal drug listed
1	danger involved in
1	february 15, 1927
1	considering the report,
1	responsible authority in
1	supporting such inspections
2	designated personnel means
1	year, the president
1	foundation under section
2	unit shall be
4	fullest extent practicable
1	animal drug refers
1	shall have appropriate
12	drug administration, of
4	product, a finished
1	(21) suspect productthe
1	agencies; (b) not
2	food and to
1	means any egg
3	paid under this
2	drug administration, or
1	order, effective for
1	phenylacetic acid, its
15	subsection (a). 
1	part.  (e)
4	labeled in accordance
1	unless the livestock
1	college of pharmacy,
3	mortality among individual
1	therefor and at
1	maintenance by farms
1	redactions for any
1	make such reasonable
2	support of or
2	intended use as
7	standards of identity
1	notice, request the
1	animal production facility
4	kit that includes
1	limited population antibacterial
1	drug, and (iii)
1	outreach on federal
2	governed by applicable
2	chemical synthesis: 
1	determination of imminent
2	read-t-eat in compliance
1	life, facilitate patients
1	annual appropriations of
1	seq.] for a
2	data have been
1	set of guidelines
4	regarding the development
1	title and subsection
1	capacity, shall not
1	investigation, including rapid
1	product through the
1	animal drug except
1	october 1, 2009.
2	review; record the
2	dates of the
1	(i) by container
1	amended pursuant to
1	means the national
1	poultry producers do
1	cooperation of attorney
1	inspection, within a
1	considered an offense
2	toxicity or other
1	regulations described in
1	persons nominated for
1	exclusively for retail
1	treatments for such
1	effect of debarmentthe
1	initiate a mandatory
1	paragraph until such
1	state, territory, district
2	without attempting to
2	23, 1988, the
1	article is for
1	 (6) model
1	information of known
1	is.  (b)
1	requires to protect
1	limit, modify, or
1	675, 309, formerly
2	reports on formal
10	filing of an
1	 (b) contentsfor
3	additive, or color
1	label any carcass
4	section 360c, 360d,
1	fees, supplemental animal
2	meanings given the
2	made under such
1	limitation on authority
1	involved, whether corporate
1	policies and activities
2	labor charges by
1	entities, and (c)
2	committee. each such
1	standards for licensing
1	studies needed prior
1	(x) gamma butyrolactone.
2	360bbb1 of this
1	 (l) construction
1	controls including, where
1	iv, 403(a)(10), 66
1	procedures to address
1	approval, manufacturing, and
5	substance is exported
1	chemical; or (2)
20	section as the
1	dosage form; and
1	lactation, infancy, allergic
1	cream is shipped
1	information. if a
1	diseasethe term rare
1	submissions for generic
1	(4) collection of
1	transporting and dispensing
1	high school dropouts,
1	substantial evidence for
1	listed color additive
2	research and the
1	methodologies by a
1	revoke it. (2)
4	advisory committee prior
1	(d) or required
1	1606. subsequent impleader
1	information constitutes an
1	food industry, including
1	expended.  (

1	drug, to a
1	respect to exposure
1	(ii) a conditional
1	issuing any final
1	country, the person
1	versus superiority trials,
1	general public. (3)
16	issuance of an
1	(1) classifying a
1	falls below, the
2	finds, after providing
1	 (g) reference
13	section if the
1	foundationthe foundation shall
4	chapter to be
1	alternatives available to
1	farm sales of
1	50; and (b)
2	supplement containing such
1	sections 360fff2(b) and
1	witnesses, and receive
1	consumer, at least
3	subsidiary or affiliate
1	384(b) of this
1	agency agrees that,
9	reasonably be expected
1	section 346 of
2	shall receive a
1	due diligence; (c)
1	may authorize an
1	(c) developing improved
1	service for the
6	person for a
1	$24,000,000 for each[1]
1	public health. (ii)
3	promulgate regulations implementing
1	thereof. whenever property
1	public the methodology
1	declaration issued by
5	chapter, with respect
1	title, a notification
1	accordance with subsections
5	products of cattle,
1	industry not directly
3	(b) a notice
1	provided, or, except
1	furnish the committee
1	purposes and types
1	entity, and any
1	commodity produced during
1	practicing clinicians, regenerative
1	person who dispenses,
2	secretary shall review,
1	drug samples will
1	extent. (iv) -(-naphthylmethylene)indene
3	technical, and professional
1	revise such documents.
1	dietary exposure than
1	public, including by
2	unique device identifier.
1	public healthif, at
1	subsection[1] commence proceeding
1	act (referred to
1	adopt tobacco product
1	standards for such
1	time when an
1	intermediate, resistant, or
4	title 5 shall
1	section 5311 of
1	reindeer. (june 30,
1	ensure public participation
3	released under bond,
1	(i) comply with
1	ful-time equivalent positions.
1	dietary exposure that
3	shall not list
1	court or in
1	period but not
3	federal assistance to
1	shipping, or receiving
1	administrator requires by
2	shall adjust fee
1	requested a recall
1	jeopardize the patient
1	demonstrate a reasonable
1	provided such agent
1	section controlled substances
2	court, within the
1	product shall bear
1	incorporated shall cease
1	sunset of noticeany
10	regulation promulgated under
1	2003(b)(7) of title
1	provide in the
6	engages in the
1	dispensed by a
1	retail level, up
1	(d) investigations must
1	fewer than 7
3	title, if consistent
1	(27) transaction statementthe
1	issue within the
1	therewith, are being
1	contagious diseases, he
1	naphthoyl ring to
1	within such 9-
1	inspect the area,
1	abuse among adults;
1	comprehensive, researc-based, lon-range,
1	right or interest
1	(9) electric pipes;
1	premarket review that
1	certain funds for
1	written acknowledgment from
1	use; (3) national
2	(f) dispute resolution
1	section; (4) contrary
1	effective, including whether
1	shall include recommendations
2	means best suited
1	verification that the
2	failed substantially to
5	requirements (a) performance
1	system. (b) exclusion
1	(b) fees were
1	ultimate consumer shall
1	entity specified in
1	subsection (n)(2)(b)(i) is
1	chapter conducted by
1	drugs have, under
3	section of such
2	321(n), 341, or
1	(2)(a). (c) advertising
1	drug reporting under
4	data with respect
2	to, or otherwise
1	made by federal,
1	products is listed
8	armed services, and
1	(i) an applicant
1	title and activities
1	 (b) trend
2	civil penalty against
1	include an outpatient
3	may serve as
2	prescription drug in
2	pertaining to compounding.
1	time frame from
1	electronic products procured
2	individual or $2,000,000
1	v, 501, as
2	prescription drug is
1	(
 
 1032.
1	(11) hydromorphinol. (12)
1	space purchased under
3	approved, licensed, or
1	paints, or calomel;
2	services and have
1	practitioner who 
9	supplement for which
1	section, during an
3	upon a revocation
2	order is sought
1	accomplices in any
1	benefi-risk consideration the
12	factory, warehouse, or
2	607(e) of this
1	animals, etc. in
4	manufacture to the
1	treasury, within 90
1	prescriptions shall be
1	 (c) description
1	food; and (ii)
1	18 regarding the
1	respectively. (3) upon
1	(including guidelines for
1	cautionary statements specified
1	authority, to apply
2	(ii) any permissible
1	fees, a description
5	interest under section
3	organization for the
3	cases arising under
2	(ii) the labeling
1	laws inconsistent with
1	staffing roles and
1	clinical investigator, of
2	travel, per diem
1	shall periodically, and
1	clause (ii)(i) are
1	history means a
2	(1) any device
1	committee any application
1	(3) identifies drugs
1	includes in all
1	risk allowed under
1	egg contents are
1	upon said manufacturer,
1	section from a
1	913, as added
1	qualifications of audit
5	standards of the
1	notice of submission
3	required by an
2	products required to
2	distribution which has
1	title 42, does
1	person, government, or
1	use of flavoring
1	process. (b) method
1	request from a
1	 (a) director
1	penalty, and the
2	technology systems that
6	importation of the
2	studies.  (b)
1	device, the person
1	31301 of title
1	1262; renumbered 10
1	1002(b), (c), formerly
1	establishing additional foreign
2	refuses to permit
1	manufacturing activities carried
2	engaged or engages
2	appropriate with the
1	ensure that opportunities
1	acts as part
1	section 981(b) of
1	presentation with an
1	(80 stat. 1296),
1	(1)(a), the comptroller
4	financial and other
1	(whether imposed as
12	manufacturer of an
1	retail druggists, orphan
1	necessary to encourage
1	specifications shall be
1	agency resources of
1	either, at the
1	combination products using
1	 (2) dispute
1	product, which orders
1	phenylpropanolamine purchased; and
1	patents as to
1	restricted under this
1	shall seek the
1	cooperated with all
1	(17) the protections
2	treatment of tobacco
1	(a) each fiscal
1	15.  (o)
1	authority as an
1	washing, waxing, fumigating,
2	involved.  (4)
1	group; and (ii)
1	opioid use disorder;
2	ensure that all
1	determines, upon reviewing
1	section. in developing
4	agreement, guidance, or
1	hearing; conclusiveness of
1	problem.  (6)
1	dietary exposure under
6	information submitted with
1	extend deadline the
1	(iii) by refilling
1	section 355(k) of
1	213. fraudulent representations
4	chemical diversion control
1	prompt advice to
2	render adulterated food
1	(1) that an
1	level provided in
5	petition with the
1	best available scientific
3	director means the
1	require coordination of
2	unless the reviewing
1	ammonia (a) it
1	proposed regulation that
1	use.  (k)
1	modulation (including suppression,
1	administrators initiative under
1	shipment data regarding
1	intake; or (f)
2	documentation that supports
1	contracts, and other
6	adversely affect the
1	(g) inspections by
1	(iv) if the
1	assessed both the
1	assessment pursuant to
5	drug submission that
1	paragraph (3) require
16	drugs  (1)
1	summary judgment pursuant
2	business and the
1	require that 
1	nonnutritive substanceif it
5	section 342(a)(2)(b) of
1	suspended or terminated
5	drug is different
1	definitions in this
2	(through classroom situations,
1	(1) the product
1	products; (3) on
2	situations, seminars at
1	letter on the
2	evidence derived from
1	
 1040. recordkeeping
1	years in each
1	360bbb5. critical path
1	355(i) or 360b(j)
1	ethical issues presented
1	 (i) pursuant
1	 (1) maintain
2	34 stat. 1260;
2	whether the notification
2	selling drugs or
1	ginseng may only
1	request; (3) use
1	program, paragraphs (1)
1	generalfor each of
1	paragraph[2] (1)(a) for
1	if, on november
1	convictions; persons responsibly
1	prohibiting a sponsor
1	standards promulgated under
2	sums owing by
1	entity, or internet
24	human drug applications
1	appointed may represent
1	illness or death
1	witnesses summoned by
1	intent to dispose
1	ingredient in the
1	admission, and (2)
1	amend final order
1	specified under subsections
2	device being compared
1	report is being
1	2013 for fiscal
1	effect or is
1	commerce; or (3)
1	revenue during the
1	required to detect
1	inspection report 
5	poultry inspection panel
2	 (a) making
1	chapter, as provided
51	requirements of section
1	guidance to require
1	tribal governments; (3)
5	statement of material
3	substance, such article
3	pesticide residues which
1	extension for a
1	without a further
1	commission pursuant to
4	contains any untrue
1	155, 6, 44
1	terms of practice,
1	ingredients, design, composition,
1	(a) is adulterated
1	shall not commence
1	product, production process,
1	reinspection of the
1	360ll(a)(2) or 360ll(e)
2	effectuate its remedial
3	facility described in
1	alleged an interest
1	objections shall not
1	subsection (b)(1) application.
1	assessment of compliance
1	xix of the
1	links that signature
1	additive, constituent, or
1	(1)(a) to be
2	year shall include
1	provider standards 
1	advocacy organizations, consumer
1	recognized under this
1	 (c) nonapplicabilitythe
1	amount proposed to
1	including monitoring requirements;
1	delayed by petitions
2	permit requirements, prescribed
2	policy.  (3)
2	determine whether existing
1	clarify procedures for
1	expeditious procedures to
1	name, common or
1	payments of all
1	cited in support
1	amphetamine. (4) bufotenine.
2	medical judgment, a
3	impracticable, exemptions shall
3	fees to be
1	pending motion to
4	product does not
2	(i)in general.if an
1	agreement can be
1	facilities and shall
3	(i) are more
3	employee other than
2	 (a) providing
1	training. (c) an
1	designations in any
1	pet food (a)
1	actions if at
1	minimal strategyfor purposes
1	(c) has a
1	tools in the
1	number of required
1	article, to the
1	schedule iii (a)
1	1974). (2) contentsthe
2	animal drug means
2	trademark office. 
1	accommodate a religious
1	stand together. (

1	 (i) documents
1	persons receiving food,
1	(e) $8,467,000 for
1	approval supplement means
2	reimbursement to those
1	i-kind contributions that
1	
 
 399b.
2	subclause (iv) of
1	(3) increasing the
1	application the initial
3	extraction and chemical
1	several product tracing
1	dependent upon being
1	subject to pesticide
1	(including its foreign
1	level capacities of
1	individual in violation
1	person who pays
1	local officials promptly
1	breakthrough therapies, accelerated
1	criteria that 
1	staff will be
1	registration or order
1	partnership, and (2)
1	(mdpv). (20) -(2,-dimethox--ethylphenyl)ethanamine
1	675, 744i, as
5	rule of constructionnothing
1	including complete data
2	defendant who derives
1	device user or
1	entitled, approved november
1	inclusion in products
1	regarding pharmaceuticals for
1	factorthe term adjustment
1	bond or other
1	603. examination of
1	file that is
2	regulation issued by
1	provided in clauses
5	secretary shall report
1	(a) (other than
5	section shall apply
1	term annual fee,
1	sold within the
1	clearance of scientific
1	control receipts and
1	reduce or prevent
1	employees under this
1	(2) a communication
2	set forth criteria
1	(e) compliance with
1	delta values for
1	section (1) shall
8	(b) of subsection
2	may be necessary.
12	products subject to
1	threats, including pandemic
1	
 360. registration
1	posting such reports
3	available to a
1	material respect. 
1	paragraph (1) from
1	prioritizationthe administrator, in
1	2012); or (2)
1	one nontopical antibacterial
1	patient groups), consumer
2	accept returned product
1	render him unfit
1	disseminates false or
1	sentence as provided
1	required. (3) the
1	patients for 1
1	360ddd2. inapplicability of
1	application mean a
1	dietary supplement). 
1	support the continuation
3	cancer when ingested
1	grant under subparagraph
1	limitation on advisory
1	private entities, for
1	2012), when referring
1	general registrations and
1	identifier for such
1	term brand means
1	request). (2) a
1	will inform any
1	food products produced
1	person known to
3	paragraph (1) during
1	penalties for simple
1	officethe office of
2	upon which they
1	unlikely to be
1	charges for imports
1	subparagraph (a). (iii)
1	(1) comprehensive federal,
2	(d) in order
1	(iii) fiscal year
1	matters, as justice
1	application.  (5)
1	tobacco and the
1	initiated shall be
1	(1) findingsthe congress
2	patients for a
1	(i) the scope
1	 (1) previously
1	(including the numbers
4	351(a)(3) of the
1	analytic files that
1	threat, and use
1	law, furnish such
1	definitionsin this subpart:
1	least 1 medical
5	 (a) has
2	priority given to
1	intended for formulation,
1	advertising under paragraph
1	safety. such suspension
2	program; or (f)
1	section loses a
1	(d) ensuring access
1	(c)contents.an action package
3	animal, article, means
1	foods are not
1	information, shall require
2	investigations of drugs
3	subparagraph (a); and
1	specify the type
2	notices, orders, decisions,
2	utilize the internal
4	false statements or
1	practitioner submitted the
1	substance will be
1	sponsor as to
1	discontinue the manufacture,
1	section, shall 
1	including a finding
1	determination whether a
1	level that would
1	federal election campaign
1	 (a) complying
1	shall occur; (c)
1	feasible to distinguish,
1	industry, including small
1	formerly 910, as
1	formula.  (3)
1	
 2101. findingscongress
2	 (d) submission
3	testing required by
1	reilly (533 u.s.
1	general, before the
1	program which includes
1	food a label
1	silicone envelope utilized
1	determine who bears
1	labeler code, trade
1	(ii) with the
1	policies relating to
1	consultative audit or
1	dimethyltryptamine. (7) -methy-2,-dimethoxyamphetamine.
1	paragraph (7) (hereinafter
1	(27) -(2,-dimethox--nitr-phenyl)ethanamine (2cn).
2	secretary shall permit
2	evidence that a
1	(ii) states the
1	355(i)[5] of this
1	serious diseases, there
1	based. (3) as
1	trial including whether
1	procedurenotwithstanding section 553
2	higher education (as
2	finding in paragraph
1	substanceif it is
1	ensure clarity regarding
1	incubator reject means
1	organization under its
8	(8) the term
2	section, employed more
1	stated in sections
1	subsequent portion is
1	nominees provided under
1	 (a) sanitation;
1	requirements (a) applicants
2	supplant, any other
1	term eligible product
2	states standards for
7	section as an
1	(
 
 1041.
1	(a)) which is
1	status as an
1	contains a bloody
4	 (1) information
1	entities pursuant to
1	2004, the secretary
1	supply reduction agencies;
2	duration, and significance
1	report that involves
1	professional license, or
1	importers percentage share
1	secretary, the official
1	equipment); and (3)
1	events, and other
1	training or experience,
1	illicit drugs from
1	add such drug
1	threshold effect), the
2	imports, or other
1	article, any bringing
1	contributes to crime.
3	section 360b(b)(1) of
1	ignatia, lobelia, nux
1	governments, state, local,
2	application approved, (b)
1	subsection (b), (b)
6	ending on december
1	(1) files an
1	(5) grandfathering product
1	accept, catalog, file,
2	records constitute an
2	longer grase for
1	interruption. (b) the
1	suspect product entering
1	receiving such notice,
1	ensure the integrity
1	may make grants,
1	made to package
1	revoked, suspended, expired,
1	respect to grant
1	-penty--[(-methoxy-benzoyl]indole (sr19 and
1	audit (a) assistance
1	activities), except that
1	facilitating the successful
2	(i) certify that
3	section 319f2 of
1	refused articles all
1	administration exercised regulatory
1	(b) exemptionupon application
3	food; or (b)
1	subsection (a)(2), or
1	readily mistaken in
1	means an antibacterial
2	(i) the review
1	preparing, packing, or
2	quarterly reports a
2	imported under such
1	additive furnish, without
2	take effect, but
2	(h) annual report
1	developing foreign supplier
1	penalty any person
1	directive drug. any
1	river, or body
2	consumer in violation
1	integral part of
1	proceedings is limited
3	paragraph of section
6	(b) available to
1	track product may
1	expertise in drug
1	proof; liabilities (a)
1	(i) surrogate or
1	(19) state; territory
1	submit validation data
1	authorities, as appropriate,
1	on-fourth inches, if
1	provide written notification
1	commission shall possess
1	license (referred to
1	states shall 
1	predecessor of the
3	review activities of
1	tribal governments, shall
3	except residue depletion
1	infant formula, (b)
2	average ful-time equivalent
1	$129,339,949 for fiscal
1	 (c) availability
1	statistics, including records
4	products of carcasses,
7	requests funding for
1	drug abusers. 
1	2008 multiplied by
1	feedback and interactions
2	section 360eee3(a) of
1	previously approved drug
1	year 2013, be
1	develop such new
1	law enforcement the
9	availability the secretary
1	chemical without the
1	combined. (e) reporting
1	evaluate the proposal
1	trials; (iv) seeking
1	(including any requirements
1	title, (referred to
1	january 1, 2000.
2	2017.  (june
1	paragraph (2)(a). (c)
1	relevant professional associations,
1	government act of
1	thereof in response
1	reporting shall be
1	products defined in
1	chil-welfare associations, hospitals,
3	supporting methodologies. (b)
1	time whether tobacco
1	expedited processing fund
4	developed or operated
3	petition to file
1	(a) congressional statement
8	shall constitute a
1	derived from each
1	revoked under subsection
2	labeling change as
1	rely on a
1	surveillance systems 
1	drug sample shall,
1	processed for use
2	(a) in generalto
1	may be, unless
6	priorities of the
1	regulatory or law
1	board 14 individuals,
1	menthol. (f) dissolvable
1	endangered children, including
1	years preceding such
1	premarket review, was
1	freebase kits. 
1	product, shall address
2	product under paragraph
1	meet criteria established
1	387d, 387g, 387h,
3	sponsor requests the
1	(2) to limit
3	shall make and
1	(2) the entity
5	requiring the attendance
1	products manufactured and
1	council  (1)
1	supporting initiatives that
1	reduction activities; and
1	standardized so as
1	drug involved 30
1	undue hardship to
3	disclosure of which
1	requests for refunds
2	shall make any
12	notice and an
1	2013, the timeline
1	documented including the
1	area, the population
1	 (b) effects
1	register.  (2)
2	heard) shall by
1	respect to distributions
1	assure safe use,
1	reviews previous food
1	343(j) of this
1	whenever a significant
36	section, the secretary
1	program meets the
4	(1) product tracing
1	treaty, convention, or
1	permitted to export
1	antifungal drug under
1	new drug exemption
1	 (3) expedited
1	shall occur not
1	license products under
9	meeting the goals,
1	preparation the attorney
2	distributor is a
1	device and shall,
2	substantive summary of
1	fiber, oil, or
1	needed medication that
1	person qualified for
1	upon an affidavit
1	
 334. seizure
1	revoked or suspended,
1	paragraph (1) persons
2	personnel activities; (b)
3	enforcement agencies have
1	promote, and encourage
1	appropriate means; and
1	
 841. prohibited
1	(in any case
7	marked not for
3	premarket approval 
1	restrictions (a) action
1	(5) recordkeeping by
12	section 262(k) of
2	including children and
1	(4) the attorney
1	board any vehicle
1	exports that do
1	policy it shall
1	mentioned in subsection
1	(c) whenever the
5	letters which approve
1	raise valid scientific
1	applicable to menthol.
1	expungement has been
1	conducted a reinspection
1	product development meetings
1	owed for the
1	requirements in addition
2	section 321(s) of
1	response laboratory network
1	is.  (h)
1	examine witnesses, and
1	supplement involved caused
2	dtc advertisement that
50	secretary of agriculture
1	considerations by secretary
1	standards development organization,
1	chapter to which
1	individual prescription occurs
1	employment. (d) enforcement
1	one year. unless
3	risk of disease
1	within such territory
1	rule of procedure
1	system; (3) identifies
1	included or intended
1	clinical trials necessary
1	march 4, 1923
1	reporting period against
2	safety, as appropriate,
7	shall not issue
1	human services develop
1	(b) reports of
1	childs readiness for
1	containing information about
3	application to seek
18	ii active pharmaceutical
4	value than it
1	residues in a
1	ensure quality and
2	updated and republished
1	calendar year, prior
11	chairman of the
1	346(a)[1] of this
15	application or supplemental
2	diseases.  (c)
1	competitive procedures (as
1	subsection (j), the
1	products sponsor. 
2	small establishments (a)
2	consider the factors
1	ingredient is not
1	car, cargo tank,
2	title, with respect
1	person which demonstrates
1	675, 740, as
1	(a) or interpretive
2	establish such technical
2	respecting such regulation,
5	use of any
2	inspection in the
1	 (5) foreign
1	to, a food,
5	activities for the
1	testing of a
1	ombudsman for any
1	(g) change of
1	recordkeeping requirement under
2	appropriate, tests on
1	
 213. fraudulent
1	(4) the recordkeeping
2	(iv) if before
1	waived or was
1	(ii) any aspect
1	(2) in situations
2	containing such drug,
1	licensing fees of
12	imminent hazard to
1	$250,000, but shall
1	illness, the secretary
1	used to provide
1	drug; (e) an
1	360j. general provisions
2	preserve the identity,
1	identify an unexpected
1	states may present
1	promulgates the final
1	ending before september
1	create all advertising
1	entries and inspections
2	diverted to the
1	blac-box warnings, health
2	protocol  (1)
5	funds appropriated under
2	state shall serve
2	enactment date (or
1	section, and 60
1	center means a
1	advisories issued by
18	conditions under which
1	order, rule, or
1	drug (except drugs
1	prescribe or dispense
1	provided that each
1	subclause, a high
1	media campaign, including
2	means and format
1	675, 771, as
1	radiographic image, physical
1	presidents obligations to
1	(c) is for
2	appropriate; and (b)
1	professional practice; (3)
1	maintains the transaction
1	shortage; (6) lists
2	new drug or
1	determine that each
4	recognized accreditation body
1	etc., matter if
1	new drug of
1	understand the full
1	that, because of
1	(a)(2), applicable requirements
1	made hereunder, or
2	basis of affidavits
1	american people. (2)
1	(3) pos-hearing corrective
1	(iii) definition for
1	avoid the unnecessary
1	substance, or substances,
1	product radiation; (4)
2	safe. the secretary
2	regulation designated as
1	manufacturers to dealers
2	2013 toward expediting
3	outside thereof (but
1	(6) the mandatory
1	regarding submission or
1	componentsthe nmic shall
1	 (d) study
1	investigational use from
2	fee, the abbreviated
1	pasteurization for such
1	provides a framework
1	secretary shall develop,
1	importation and distribution
1	years 1991 through
1	among domestic manufacturers
1	tagged to show
1	 (2) issue
1	contentthe communication plan
1	hearing, then in
1	extension is supported
3	subsection (a)(1) or
1	hazard. if after
1	identifier (which, to
2	july 13, 1931,
4	paragraph (1)(a) and
1	prioritize the review
1	 (t) database
1	payments in accordance
2	tasks or projects
1	forth its reasons
3	subsection (a)(1) of
1	injecting, ingesting, inhaling,
1	food on request
2	sooner withdrawn by
1	stat. 1204; amended
1	section 379e(c) of
1	 (c) provide
1	title or violated
1	(d) application for
2	conditions applicable with
1	united states, an
1	official compendium. (e)
1	defense, that the
2	extension of an
1	(b) the adjustment
1	(13) methylhydromorphine. (14)
1	sources the executive
1	federal intramural and
1	pasteurized milk ordinance
1	process under subparagraph
1	june 30, 1976;
2	drug substances are
2	production quotas for
3	addition to, and
2	(d) distribution of
4	pesticide chemical or
1	issuance  (1)
1	assessment of user
1	constitutes drug paraphernaliain
1	use, taking into
1	color additivesa color
1	control strategy submitted
1	commission shall advise,
1	las-known address in
1	july 1, 2010;
2	maintain a list
1	food ordered detained
1	delivery system 
1	annual report that
1	(a) the promulgation
2	pesticide chemical on
1	anileridine. (3) bezitramide.
1	preparation by such
1	contact substance, and
1	development tools qualified
1	european free trade
3	appropriated for fiscal
2	contract shall be
3	make any device
1	shall (i) promulgate
1	accessory, notwithstanding the
1	first be made.
1	utero exposure to
33	appropriate by the
1	constitute authority for
1	section 360e(f)(6)(b) of
1	secretary to an
1	employer demonstrates, by
1	license was issued
2	identifier means a
1	states in compliance
1	written approval of
2	processes, packs, distributes,
2	subsection (a)(1). such
2	expenses related to
1	substance, drug product,
1	admission or within
7	title, or interest
1	suspect product corresponds
1	assess signals of
1	secretary rejects the
1	information sufficient to
1	begins on the
1	designate an independent
1	previously issued regulations
1	pharmacists) to dispense,
1	report submission requirements
1	737, as added
2	animal which has
1	justification for that
1	(5) shall consult
1	availability of lifesaving
1	74, 4, 38
1	ch. 675, 601,
2	ensuring that the
2	suitable and may
2	clinical needs, including
1	separability if any
1	title 20 (commonly
1	financial support to
1	area under this
2	patents with respect
1	animal drugs. (2)
1	tank (within the
1	june 27, 1952,
1	national drug intelligence
1	first offender, deferred
2	inspectors to make
1	paragraph (1) exist.
2	decision should be
1	description provided by
2	appropriate conditions concerning
1	(2) limiting compounding
1	timely development of
1	for, commonly abused
1	used under this
1	petition for reclassification
1	(10) if there
3	demonstrates good cause
4	 (1) may
1	research to which
2	imports such article
1	approved labeling provided
4	refuses to furnish
1	paragraph (2)(c) may,
1	years, the revenue
1	 (b) manufacturer
1	life threatening, (b)
1	whenever any carcass,
7	administration, contractors of
1	tomographic diagnostic images;
1	belonging to a
1	inspector.  (d)
4	awarded to a
2	(or supplement) receives
1	2002.  (b)
1	(subject to meeting
1	precursor substance that
1	 (d) prohibited
1	health;  (ii)
1	4, 2011, involving
1	year 2009, if,
1	safe levels may
1	years, then the
1	onchocerciasis. (n) schistosomiasis.
1	division. (2) inclusion
4	raw agricultural commodity;
3	appeals to the
1	determination and the
2	right of a
1	since the first
1	shall publish final
2	meaning provided that
1	secretary specifies a
1	susceptibility of infants
1	special attention and
1	applications a prescription
2	compliance not later
1	provide for comment.
5	section 360ccc1 of
1	2001. designation of
2	wholly or managing
1	paragraph (3), an
4	movement in commerce
1	of, and prioritize
1	board of addiction
2	purpose of evaluating
2	food; (2) any
1	distribute, and release
1	product and notification
1	substances. (6) the
1	efficacy.  (2)
1	deadline, the manufacturer
1	year 2017. (c)
2	received, or held
1	distribution of samples
1	approved labeling the
1	(3) additional requirementsa
2	difference in cost
3	approved or conditionally
1	use of guidance
1	exclude any no-narcotic
1	register prior to
1	written consent to
1	benefit under federal
1	drug traffickers 
1	compounding unless the
5	listed in section
7	payment of the
4	substitution at the
2	issues in the
2	(iii) an identification
1	official names have
1	shall initially consist
1	manufacturing practice to
3	establishment if the
1	coordinated research agenda
6	conformity with a
1	licensed in accordance
1	laws.  (d)
1	states, order that
2	carcass, meat or
1	2011. (11) the
1	condemnation in such
1	retaliation, or any
2	similar in adults
1	associated with their
1	including quality control
1	(i) a qualifying
1	(v) not require
1	meat item qualifies
6	reasonable expectation that
1	importers of fruits
2	include furnishing to
1	products who would
2	subparagraph (a). (d)
1	decision within the
1	risk assessment the
1	within 365 days
1	(a) the expert
12	substance which may
1	person fully cooperated
1	(8) the terms
2	event an establishment
1	receipts into that
1	coincide with the
3	(i) the federal
1	procedure applicable to
3	decisions of the
1	irrespective of any
1	mislead  (1)
3	credible threats of
8	establish or continue
19	(a) or (b)
1	request under the
1	(v) the date
1	
 
 1115.
1	clearance of qualified
4	authority the secretary
1	rule, by the
1	timetable; periodic reports
1	heroin; (ii) 500
1	showing of good
2	seq.] to the
2	paragraph (2). (b)
2	provide the secretary,
1	 (2) amateur
1	(4) allocation of
3	another federal department
1	(b)) or may
2	payments from the
2	section 1606 of
2	audit, an accredited
4	device is specifically
1	resolving uncertainty as
1	certification when such
1	enforcement agencies participating
2	title, and which
1	product composition and
6	caused by a
1	petition under such
1	days prescribed by
1	experts. (4) 
1	dru-free america; or
1	general the review
1	safety defined in
2	submissions in accordance
1	title; (2) train
1	per diem instead
1	paragraph (3), as
1	(1) advisory assistance;
1	 (b) early
1	address the standards
1	arcade facility means
1	human body by
1	(2) include 
1	states person means
3	transportation in commerce,
1	domestic drug interdiction
2	may specify. 
2	each: provided, that
1	 (f) sunset
1	2.7  
3	provide the subsequent
2	pursuant to or
1	 (d) classified
1	classification under paragraph
1	30, 1961; 
2	certification in the
1	executive agencies or
1	(e) or if
1	isomer means the
1	amino acids); (xv)
1	agreement to conduct
2	ensure that persons
2	trade names no
2	 (i) identifying
1	(c) liability as
2	prepare a written
1	law, any information
5	product for use
1	data regarding sales).
1	association who shall
1	(b) cas-b-case delay
1	shall also advise
1	application, or (b)
3	practicable after the
1	transfer of supervision
1	
 
 387n.
1	carrier shall be
1	(1) and other
6	removed, as the
2	formulations or drug
1	status under subsection
17	fiscal year limitation.
1	fiscal year limitation,
1	review voucher, if
1	44 stat. 1101;
1	cosmetic to be
1	personal, household, guest,
1	documents required under
3	number of assessments
1	drug or biologics
3	chapter; (b) the
1	diminishes any other
2	avocadoes, cantaloupes, citrus
1	civil penalty (plus
3	 (2) recommendations
1	products, with respect
1	natural disasters affecting
1	participation from volunteer
1	device not identified
55	established under subsection
1	successful programs and
1	(b) as an
1	seq.]; or (c)
1	compounding of physicians
2	institute an action
1	encourage uniform, scientifically
1	children are present
1	analysis (including the
1	subsection (a)(1) that
1	(1) possesses a
1	law to engage
1	disapproval of petitions
1	thereof. any prescription
1	sections 842(c)(1) and
1	(a) application any
1	1985 and $6,000,000
1	subsection (c)(2), if
1	section, including expenditures
3	calendar year under
1	different manufacturers; (g)
1	pro rata basis
1	established by dividing
3	3 of section
8	business of buying,
1	minor species can
1	general under section
1	proper to the
1	paragraph shall require
3	2008 (7 u.s.c.
1	title. (h) limitations
1	priority to petitions
1	use would cause
1	(i) reporting of
6	confidential commercial or
1	combination product 
2	chloride, and potassium)
1	without (1) a
2	repeal of any
1	certified, in accordance
1	estimates would be
1	may refuse, withdraw,
3	clear and convincing
2	(1), including such
2	fiscal year 2002,
1	conducting or supervising
2	fiscal year 2002.
1	therefor by a
1	account the cost
2	located outside the
2	28, 1976, or
1	(iii) for which
1	filed within 30
1	coalition shall 
1	tolerance and that
1	species is not,
5	958 of this
1	effective immediately. (b)
1	programs for wholesale
1	include the certification
2	general agent, or
1	carrier that conforms
1	based and the
2	certiorari) has been
1	another individual during
2	determination whether to
1	(d) public record
1	(i), the comptroller
1	human body, the
1	unless during that
1	(iv) complete other
1	attorney general controlling
1	 (i) humanitarian
1	purchase scheduled listed
1	experience with, and
1	
 350g. hazard
1	may be nonclinical,
2	commence distribution of
1	proposed use meets
1	be, purports to
1	property, including any
3	guidance documents regarding
5	issuance of action
1	including a disease
1	capsules, tablets, or
6	inspection of a
1	feeds, based on
1	reason, including modifications
2	committee means the
1	675, 413, as
15	section  (1)
1	wholesale distributor, through
1	agree is complete,
1	132 of title
1	consult among themselves
1	section for distribution
1	(2) such petition
2	risk tobacco products.
2	section 827 of
1	dutiesthe tobacco products
2	information not included
1	spent in the
1	send a warning
1	proceedings; procedure; presentation
1	manufacturer must conduct
1	protocol approved under
1	notification, or declaration
1	supply and outbreaks
1	production of controlled
1	intent on the
1	foundation and other
2	said establishment in
5	prescribe, exempt from
4	third party to
1	shortage; and (ii)
2	services.  (b)
1	providers on those
2	stay the other
1	labeled on the
3	validating the effects
1	additive which he
1	academic researchers, and
1	surveys (or incorporate
1	animal drug sponsors).
2	older people, people
1	drug application may
1	foreign country, refuses
2	certificate; (3) contrary
11	penalty of not
1	shall turn the
1	preventive strategies and
1	immediately take all
1	trainees. such services
4	establishment in the
1	 (2) objectives
1	states; venue this
1	(iii) d-stems, dries,
1	basis of evidence
1	fact; (c) that
1	(1), the director
1	(i) registration information
2	waivers  (a)
2	applicant may submit
1	require any clinical
1	symbol or label
1	warrant, to cut,
1	with, scientists and
1	labor in washington
1	trademark office, to
2	may delay such
1	mail, or to
1	committees may be
1	practice, willingness to
1	president.  (c)
3	used, and the
1	case of violation
1	required for jurisdiction
1	(1) that contains
1	vitamin or mineral,
1	produce any effect
1	received, sold, delivered,
1	machines. (4) the
1	358, as added
1	paragraph shall maintain,
1	(g) shall be
1	petition, as long
2	issuing regulations to
1	estimate. (2) national
1	860a. consecutive sentence
1	biological products, devices,
17	implementation of this
1	successor committee) or
1	clinical investigations that
21	accordance with such
1	substance and not
1	(
 
 826.
1	year limitation a
1	weekend, federal holiday,
1	adequate. (3) with
1	501(a) of title
1	director has documented
1	taken to give
1	section 360(a)(1) of
2	appropriated pursuant to
1	abbreviated applications involving
1	successor regulation) shall
1	personnel, and facilities
1	product (except for
8	secretary shall refund
1	death; and (iii)
1	place in the
2	contentsin the guidance
1	premises, the officer
1	cosmetic means (1)
8	law of the
1	health; and (2)
1	using a priority
2	enforce such regulations
1	knowingly or knew
1	membership and procedural
1	using any date
1	(e)(1)(a) of this
1	secretary in guidance,
2	suggestions, estimates, and
2	one pharmacy to
1	shall have authority
1	subclause (ii). in
1	held shall issue,
1	population.  (ii)
1	risk communication tools
2	apply the requirements
1	certifications for food:
1	adopt the codex
2	official designated by
5	data described in
1	ethylamine. (o) propionic
1	
 
 387i.
1	enforcement agencies of
1	fees for each
1	843 of this
1	secretary that adequate
8	date for such
1	toxin act) be
2	(ii) which has
1	term pediatric studies
1	chemical preservatives if
1	amenable species before
1	exclusion of certain
1	chemical have the
1	(b) designation 
1	available or known
1	territorial exemption the
2	secretary for an
2	least equal authority
1	 (i) reconstitutes
2	outsourcing facility shall
1	provisions (a) guidance
1	similar articles of
1	operator or owner
1	revenues are available
1	(i) voluntary qualified
1	 (9) any
7	definedfor purposes of
1	63 stat. 410

1	device which was
1	 (5) when
1	drug administrations communication
1	standards for interoperable
51	abbreviated new drug
1	drug.  (b)immediate
2	section 2656f(d)(2) of
6	review under section
1	annual basis following
1	importation and exportation.
2	diligence and at
1	drugs including biological
1	applicant; or 
1	contract under section
1	eradication aimed at
1	requesting accreditation, within
2	processes necessary to
1	article and delivered
11	request under section
1	two pharmacists licensed
7	probable cause to
1	offender for an
5	subsection shall include
1	(e) exercises the
1	entity.  (b)
1	subparagraph (f)(i) the
1	schoo-based staff will
2	additional drugs in
1	tested for each
1	designate a single
3	respect thereto under
1	labels, and certificates;
1	containers or immediate
2	prohibits an applicant
1	substance (a) manufacture
4	secretary shall work
2	section 355(i)(2) of
1	degradation product and
1	vancomyci-resistant enterococcus; (b)
1	storage, cartage and
1	title;  (c)
2	writing and specifying
1	(e), or (m),
2	local currency of
1	 (6) maximum
4	construed to authorize
2	proceedings of any
1	section), such article
1	proceedings (a) jurisdiction;
1	package configuration) combined
1	drug from a
2	states, accompanied by
1	1176. repealed. 

1	paragraph (4)(b), (5),
1	collection of useful
1	title; (ii) where
1	(g) labeling changes
1	[42 u.s.c. 254l
1	work performed in
1	(b) imported food
2	subsection.  (c)
1	clarification or additional
2	general an accredited
2	order has found
1	set forth initial
1	reports of inspectional
1	drug establishments, and
3	sealed homogeneous case,
1	request by providing
1	funding will ensure
1	elements under subsections
5	grant recipient under
1	 (3) community
1	tablets, or lyophilized
2	law; and (ii)
1	phenadoxone. (35) phenampromide.
1	articles intended to
2	operation thereof, fail
1	inference, as necessary.
1	(a) provides a
1	consents in writing,
1	trading partner, a
1	manufacturer and no
2	importers, distributors, or
1	information before an
6	requirement if the
1	foods and to
1	activity solely under
1	patient a significant
1	list of tobacco
1	trials necessary for
1	water provided by
1	years thereafter,,[1] the
2	minor change to
1	import, export, manufacture,
1	
 
 391.
7	drug under subsection
2	event report voluntarily
1	research laboratories for
2	design, the number
1	makes it impracticable
2	use of other
1	health).  (g)
1	means a manufactured
1	attorney general with
1	standard of strength,
1	drug having a
1	animal of which
1	generic drug or
1	food, under its
1	laboratory measurement, radiographic
1	sponsor; and (2)
1	notice, with respect
1	effectiveness for use;
1	consumers concerning the
4	guidance  (1)
1	guidance. (4) safety
1	353(e)(2)(a) of this
1	methamphetamines at levels
6	state laws relating
1	plate, stone, labeling,
1	device solely because
1	recommended classification. 
1	(iii) congressional notification
1	quantities distributed domestically
1	term characteristics means
1	managers or designated
1	cure; and (b)
1	substances named in
1	 (b) service
1	 (1) set
1	penalties applicable; congressional
1	order and without
1	food has entered
1	detail each observation
1	(d) international treaties,
1	relevant to determining
1	(n) of this
1	act; and (8)
3	target animal safety
1	title. (ii) clauses
1	priority review; 
1	infant formula, including
1	service of subpena;
11	states obligations under
1	following descriptions: black
1	title iii, 542,
1	(d) additional recordkeeping
1	discovery made prior
2	prior to dissemination
1	recall; and (4)
1	committees, members of
1	(4), a civil
4	delivery or sale
1	cigarette tobacco, and
1	detailed, comprehensive, multisector
1	limited inspection; refusal
1	used to designate
1	product, or a
1	priorities published by
1	implement, certify, compliance[1]
1	written request under
1	contain the findings
1	monograph (a) in
1	storage operations, scienc-based
1	individuals, of which
1	made, insured or
1	appropriate; (e) publish
1	veterans benefit, public
1	outlines the success
5	license under section
1	(b) improves communication
1	secretarys comments on
1	clinical investigation (that,
1	additives, or other
1	determination and educational
1	greater understanding of
1	significant economic losses
3	state program funded
1	(b) missionthe administration
2	per customer during
1	42. (e) pediatric
1	satisfactorily treated by
1	countries in executing
1	agricultural commodities if
1	file a written
1	less in the
1	(4) all such
1	combined with other
2	man or animals,
2	action, and each
1	approval.  (ii)
1	simple possession offenses
3	(v) if an
1	leadership in the
1	function in a
2	(a). the applicant,
1	shall withdraw accreditation
1	based on intent
1	misbranded. (b) the
1	oral hearing); (b)
1	responsible for regulating
1	(6) an application
3	assaults, resists, opposes,
1	york, march 30,
1	quantity or volume,
1	sativa l., whether
1	individual in accordance
7	authority of secretary
1	anhydride. (b) acetone.
1	adjudication, or other
1	available, it is
1	prosecution by indictment
1	publication of schedule
1	chapter.  (i)
1	section 333(c)(3) of
1	approved by such
1	list is consistent
1	omitted
 
 361.
1	implant after its
2	authorized to give
1	subsection (k) or
1	initial or supplemental
1	furnished for the
1	(2) increasing awareness
1	(11) the unique
5	human food or
2	sponsor or a
1	schedule iii. (b)
1	plan for demonstrating
1	2012, that references,
1	federal sales of
1	quantities which may
1	biological systems; (3)
1	violation did not
2	authorized for fiscal
32	biological product development
1	year, beginning with
1	support and maintain
1	trade commission precluding
2	shall be made.
1	prescriptions for identified
5	may award a
2	tracing requirements under
1	americans a year
1	accept any certification
1	appropriated. the secretary
1	standards or criteria
1	hour during the
1	recommendation regarding the
2	will not reduce
1	docket on the
1	provided the sponsor
2	equal to 
1	food advisory committee,
1	commerce immediately before
1	(a) within the
1	manufacturers in such
3	371(e) of this
2	trade commission or
1	change creates a
1	expertise and experience,
1	therefrom; or (2)
2	subparagraph shall list
1	maintain, for a
1	conducted effective before
1	fiscal year 2018;
1	manufacturer to prevent
1	shall ensure public
3	transfer the listed
1	trade commission of
1	appointed to that
1	conducted in a
1	applications, generic new
4	product tracing requirements
9	engaged in such
1	use any communication
1	reasons.  (3)
1	standard. (2) if
1	379j11. definitionsfor purposes
1	(a) inspection of
1	secretarys only responsibility
1	tin, plastic, or
1	recognition of such
1	include any additional
1	except matters in
1	character, and conduct
1	thereto. (i) the
4	regulations regarding the
1	(i) the creation
1	reject means an
2	professional practice or
1	activities).  (g)
1	term diversion control
6	may, in addition
2	 (1) requirements
1	placed into a
1	becoming such a
2	(b) compounded basis
2	will be under
2	may be permitted,
2	present his views,
6	include the information
2	drug. if an
1	prescription or other
2	percentage change that
1	consulting the logbook
2	returns a dispenser
1	(i) local target
2	discontinuance, the date
1	component parts; (12)
1	 (8) unless,
1	eligible entity the
1	(a) the carcass,
1	receives information, has
3	request a hearing
1	person. notwithstanding clause
3	extraction from substances
1	research involving the
1	practicable means are
2	(b)(2)(a) (in the
1	device for individuals.
1	colored margarine unless
1	fact manufactured, processed,
7	finds, on the
1	assessed be less
1	published under this
2	research. persons who
1	services.  (june
1	prescribes, recommends, or
2	logbooks under subparagraph
1	book kept for
1	 (b) single
2	(ii) providing a
3	narcotic drugs for
1	2016, the amount
1	resolution of any
1	sponsor regarding early
2	primarily dedicated to
1	(including production solely
1	approved, as the
2	identifier. (3) authorized
1	direct interactions of
1	shall inform those
1	(a)(i)) adversely impacts
1	refer such drug
1	ordered under subparagraph
1	materials described in
1	involved validates the
1	program and budget
1	2007, submits such
1	site the secretary,
1	manufacturing certain medical
1	(a) establishment; functions;
5	eligible entities to
1	secretary cannot determine
2	years thereafter, as
2	surface (other than
1	whether the registrant
1	(iv) a summary
1	requests not included
1	except paragraphs (h),
1	request issued or
1	defendants. (b) standard
1	(a) in generalany
1	paragraph (2) with
1	particular; (b) that
3	nutrients in the
2	fund of the
1	staff, including team
2	seven years and
2	advisory panels and
1	(i) as necessary
1	class, and do
1	production of adulterated
2	hidt-funded initiatives in
1	criterion in paragraph
2	takes effect on
19	application for such
1	reproduction of trade
1	health officials a
1	precursor substance rather
1	task forces, subcommittees,
2	pendency of the
1	establish that an
4	person for the
9	information available to
1	grower of the
1	(i) identifying the
2	products thereof, slaughtered
1	furnish each panel
1	active ingredient as
1	ingredients, except that
2	secretary or in
1	relating to this
1	section, no distributor
7	(a), the term
1	applicable to water
1	proof of registration
1	(6)(b). (8) neutralizing
1	certain persons from
1	subsection (c) respecting
1	registration system under
1	1999 through fiscal
7	homeland security, and
1	necessary updates to
1	values which characterize
2	manufacture the product
1	submitted the item
1	inspection warrants; issuance;
1	resale, and to
1	may use up
1	preparedness goals; and
1	262 not later
1	tar content, nicotine
1	register, specify the
1	general any person
1	 (2) voluntary
1	determination made by
2	(a) the submission
1	alter, or obliterate
1	(4) coca[3] leaves,
1	commission of criminal
1	state licensing fee
1	forms of contamination;
1	drug, provide in
3	ethers, salts, and
1	gain approval of
1	additional authoritythe secretary
2	suspension of grants
3	enforcement  (1)
1	imposed under sections
1	drug, information to
1	direct the sale
1	(a)(i) in a
1	manufacturer. notwithstanding the
2	part of, or
1	strategies and allocation
7	regulation prescribe the
1	audits an accredited
1	offer significant improvements
1	registrations and listings
1	specific standards and
33	used in this
1	(5) roach clips:
1	section 419(5) of
1	sold as spices,
1	representatives to, or
1	grants to, or
1	need; and (f)
4	may, at any
2	afford such manufacturer
1	(d) reactivation fee
2	commissioner shall request
1	agriculture may suspend
1	manufacturing expenses incurred
1	1361 of title
1	substance. (2) 
1	reissuance, and renewal
1	notification requirement of
1	state receives information
1	base sold at
1	inter alia, increase
1	equines that is
1	determination to respond
1	136a(c)(2)(b)]; (b) issue
1	united states; (d)
1	restrictions upon, research
1	(3) compliance compliance
1	2012.  (5)
4	paid in accordance
1	inspection. the report
1	thir-party accreditation program;
1	documenting the implementation
1	unauthorized use of
1	committee is composed
1	establish a new
1	implement programs and
12	state, territory, or
3	secretary of agriculture.
22	secretary of agriculture,
2	procedures as apply
1	42 by 
1	programs for drug
1	approval of label
1	criminal case which
1	(b) penalty for
1	foreign offices described
1	examination of sea
3	shall, after consultation
2	entitled to protection
1	had; or (b)
1	sections 360b(a)(4), 360b(b)(2),
1	sterilization, and for
1	(b) requesting assistance
2	preserve their identity,
2	reveal other than
1	maintenance of a
1	ways to treat
1	manufacturing processes as
1	consumer, and health
1	rules prescribed by
3	likely to lead
1	order; (iv) any
1	(4) limitation a
1	making available disposal
1	years strategy. (xii)
2	together with recommendations
1	21 days of
1	(17) dimepheptanol. (18)
1	(2) a civil
1	adequately identified and
1	section 353c2 of
3	located in a
1	distributors in connection
1	shall promote sharing
1	products under section
1	consignee and, in
2	section to ephedrine,
1	water regulation, except
1	(3) mediation and
1	submission of protocols
1	(ii) effect on
1	person, or any
1	ii or flunitrazepam
2	issuing a final
1	history provided by
1	(a) the new
1	requires a responsible
1	authorize a detention
2	controls, is controlled
1	shall institute a
3	proceeding against, and
1	total health and
1	standards for used
2	financial officer that
3	close of the
1	onto a farm
1	determination to the
1	pathologic processes, or
2	applicable statute of
1	sentencing guidelines. (f)
1	(iii) where 
2	upon such proposal
1	(ii) timing and
1	shared, on a
1	manufacture and product
1	states. beginning 15
1	federal, or local
1	seafood imported into
1	administration has been
1	withdrawn; and (iv)
1	every manufacturer offering
7	determines, based on
1	intended, the proposed
1	 (b) actionsthe
1	irreversibly debilitating human
1	warehouseman for storage
1	animal health, except
1	risks and receive
1	members, acting pursuant
1	panel chairperson, by
1	approved, and has
2	design or in
5	committee, including obtaining
1	policies the secretary,
1	obligation to provide
2	audit the performance
1	facilitate a product
1	steroid that is
2	residues which can
1	law, (ii) is,
1	notice system under
1	component parts and
1	pediatric populations under
1	(b) eligible for
1	no-federal sources for
4	investigation. (b) illegitimate
1	accept the qualification
6	secretarys authority to
1	programs at such
1	administration exported by
1	 (1) specify
1	subpoena to compel
1	health with respect
1	review voucher. 
2	(a) to determine
2	(15 u.s.c. 1451
4	october of the
1	authorized government agency;
1	networks (a) in
1	constitute not more
1	title), homeopathic drugs
3	 (i) under
3	actual residue levels
5	government or agency
2	pizzas have been
1	shall address promising
1	41; and (2)
1	cause shown[1] to
1	activities to support
1	establishment used such
2	incapacity; or (v)
1	dtc advertisement advisory
1	facilities discovered through
1	353, section 354,
1	drug, the outsourcing
1	including marijuana. (g)
1	participants enrolled, the
1	plan to demonstrate
1	marketed antimicrobial drugs,
1	experts outside of
2	equipment), and financial
2	committee on government
1	
 889. production
1	renewal grant 
1	licensing fees. 
1	360eee(16) of this
1	public dissemination is
1	drug products have
1	drug, or in
1	 (b) size
1	extension of 3-month
1	(i) protection of
1	territory the terms
1	(j) shall not
1	secretary with scientific
1	information is covered
1	abuse potential whenever
1	put up and
1	animal drug. a
1	(b) upon receiving
1	open for business;
1	reviewable. (2) prescription
7	including i-kind contributions,
1	contractor who performs
1	manufacturer, for purposes
3	(2). such fee
1	sale, the seller
1	agency shall, unless
1	stakes, and lines
1	disclosure of tobacco
6	listed patent for
4	remain in class
3	carcass, part thereof,
1	(3) no change
3	term generic new
2	contain a controlled
1	used for emergency
1	(2) biomedical research
2	title), associated with
1	preliminary test according
2	tobacco product subject
1	notification authorized by
2	director regarding any
1	submitted and lawfully
1	placed a boobytrap
1	substance or to
2	basis of adequate
5	title for such
1	medicated feeds; or
1	health. (e) if
2	schedule notice transmitted
2	certification contained in
1	 (1) regulations
1	(lsd); (f) 40
1	fails to provide
1	(5) compensation of
1	assistant is supervised
4	include a recommendation
1	subsection (a)(2)(b), the
3	development program fees
2	drugs if the
3	toxin, and analogous
2	certain devices 
1	term original device
4	31, 2012, the
1	2015, $11,700,000; (3)
1	clinical research in
1	respecting the recommendation
4	fell below the
6	constitute a lien
1	development of programs
3	provisions of subchapters
1	(3) drug the
3	shall provide such
1	firm, or distributed
1	narcotics trafficker identified
1	order and, as
2	substance on federal
1	general services, general
1	opioid use disorder,
2	informal hearing, finds
1	chain, or verification,
4	substances by means
1	statement in lieu
1	(n) substantially complete
1	acts of principals
1	nucleic acid or
2	(iv) provisions requiring
1	revised quotas the
1	product, as it
1	system, or program.
1	office.  (4)[2]
1	common, standardized design
1	sufficient, postapproval studies
1	secretary after evaluating
1	dried vegetables, or
3	25, 1938 (52
1	paragraph (1). (q)
1	31.  (5)
1	transaction referred to
1	(3) in implementing
2	physiologic effects of
2	administration and make
1	90 calendar days,
1	manufacturer.  (d)
4	local governments and
1	violation in an
2	(i) if before
1	coordination and promotion
2	market, or making,
1	egg products not
1	facility under paragraph
1	individuals, particularly individuals
2	 (b) personall-identifiable
1	groups recommendations, and
1	(a) by order
1	(2), hold a
4	chapter, except that
1	subsection (a)(3)(b); and
1	(b)(iii); or (bb)
2	require in such
4	withdrawn from sale,
1	supplement is to
1	imported, at any
2	prepared, inspected, and
1	2224. surveillance (a)
4	including any product
1	safety questions for
1	means all efforts
1	determination is so
1	(i) merely advertises
50	fiscal year for
7	certified by such
1	formed or existing
3	drug administration not
1	(2) when the
2	section applicable to
1	 (i) permits
1	market exclusivities or
1	permit such investigational
1	complete reports of
4	december 29, 2006,
1	 fat: gm
1	approach and taking
1	 (3) administrative
3	qualified facility under
1	experience in drug
13	(a) or (b),
5	(a) or (b).
1	
 96. repealed.
1	(a). (c) the
9	amendment or supplement
1	may be acting
1	(b) the record,
1	scientific issues, or
1	production reportthe sponsor
1	applications, or submissions
1	16 and amended
1	(a) three of
1	interest charges collected
4	request and request
1	obtain possession of
1	respectively, at the
1	armed forces), a
1	processes to enhance
1	fee on a
1	 (2) evidence
1	constituting a felony
1	experts as safe
1	separately or together
1	drug used in
1	section 558.3(b)(4) of
1	includes the costs
1	logbook the name
4	petition under paragraph
3	(2) use of
2	subsection (a). (june
1	set forth proposed
3	office shall provide
4	section is intended
1	subsequent reports, including
1	regulation classify such
1	advise the commissioner
1	subsection (d)(2) during
2	description of practicable
1	device that utilizes
1	cyanide. (c) ephedrine,
2	shall describe the
1	annual hidta program
2	fish classified within
1	nonprescription sunscreen that
1	issue.  (f)
1	
 
 353c.
3	procedures for paying
3	packing, storage, or
1	intended, (b) with
1	force to develop
1	deadline for reporting
1	 (b) absence,
1	regarding annual reports
1	1906. enforcement (a)
1	date (if any)
1	facility identifier the
1	(q).  (4)
1	means any territory
1	entities), and on
1	pharmacy is licensed
1	court shall after
2	shall process any
1	diversion.  (2)
3	anomaly or birth
1	shall appoint from
1	(5) not later
1	combating the production,
3	country of origin
1	shall commence surveillance
1	raised and transported
2	abbreviated application fees,
1	guidance, or enforcement
1	dataif the administrator
2	seq.], and acts
1	approval supplements, and
1	three of the
1	ingredient. the secretary
6	standardized numerical identifier
2	taking other action,
3	animal drugs, and
1	trafficker, the president
1	(ii) any individual
1	needed to address
2	fees in a
1	generalthe commissioner of
1	residue that would
1	butter and any
1	(a) opt out
1	registration number of
2	(b) or this
1	attorneys; and (iii)
2	(1) for an
1	sanitation under which
2	name (pursuant to
1	narcotics crops, including
6	subparagraph with respect
3	list under paragraph
1	section 360nn(b) of
1	annual gross receipts
1	point of purchase
1	amount paid under
1	condemned under this
1	posted in a
1	applicant seeking such
1	2011;  (4)
1	period. (d) conduct
1	date thereof or
2	retail distributors of
1	may further provide
1	title 42 to
1	shall, immediately after
1	(i) arranging, conducting,
1	paragraph from making
1	release constitutes gross
1	indexing; and (b)
1	(k) detail of
1	(b) determination by
1	wrongdoing), the relinquishing
2	studies were submitted
1	review and classification
1	physically incompatible, such
23	submitted by a
7	revocation of a
1	secretary constitute a
2	subsection (a)(4) for
1	using judicial or
1	meeting.  (5)
1	recommendations, and other
1	liable; scope of
1	surveillance or studies
1	serving of colored
1	compiler of each
1	enforcement of state
1	assurances may be
1	tobacco products a
2	reason of being
123	described in subparagraph
1	regarding paragraph (2).
1	including modified risk
2	radiological, or other
1	track grants to
1	authority to administer
1	address the new
1	partner program under
1	senate with a
1	(a) for public
3	subparagraph (a). (3)
1	time such rules
1	(
 
 1603.
1	(i) a felony
2	process in such
9	information before him
1	proprietary name) which
1	legal instrument providing
1	free flow thereof,
2	(e) the development
1	antitrust laws (as
1	including expenses of
1	prescribe by general
1	target and apply
8	cumulative amount of
1	preceding year to
1	seq.); (f) the
1	instituting such action
1	paragraph (1)(b) has
1	individual programmatic funds
5	enter into arrangements
5	devices, in the
1	causative agents in
1	regarding the importation
1	false statement, racketeering,
1	year, at least
1	(ix) the approval
2	request.  (3)
5	34 stat. 1263;
2	agency, require reimbursement,
1	milk, and who
1	343(e), 343(i)(2), 343(w),
1	necessary by such
2	final list under
1	tobacco additive or
1	evidence shows the
1	list and subject
1	term amenable species
1	 (c)coordination. 
1	drug. (4) letter
1	amend such final
3	resists, opposes, impedes,
1	 (a) consult
1	description under subparagraph
1	certifications of mai-order
1	facility shall identify
1	participation of a
1	section 453 of
3	given to the
1	recordkeeping the owner,
1	secretary may impose
1	organizational unit responsible
2	(ii) is in
3	data necessary to
1	incomplete applications for
2	detailed summary of
2	considered for inclusion
1	shall promulgate monitoring
1	(aa) a transaction
2	program fee for
1	year, application, product,
1	lon-term effects of
2	seizures of property
1	states shall obtain
1	period from october
2	manufacturer, the exclusive
1	reportsthe secretary shall
4	interstate commerce. 
2	approvalthe secretary may
1	include for each
1	
 
 360ccc.
1	subsequent reports as
1	descriptions of methods
1	indicating adverse reactions
1	combat illegal drug
2	efforts made to
1	delivery above mentioned
1	purpose of setting
1	(1) nothing in
3	vegetables, including specific
1	title; and (f)
1	(i) in support
1	month after the
1	applicable contractual agreement
1	amphetamine; or (iii)
1	(iv) plans for
2	removal of official
1	telemedicine  (1)
1	trials; rare, serious
2	title that the
1	cosmetics are safe
1	(4) advanced analysis
1	paragraph, the bulk
1	telephone hotline for
1	phenylpropanolamine in any
5	establishments and other
5	importer of such
1	recommendations issued by
2	section 456 of
1	smokeless tobacco, the
1	studies and analyses
1	(ii) 5 kilograms
1	may delegate any
1	assess and certify
1	agricultural commodities are
1	number of different
4	stat. 631; 

1	review committee of
1	title; or (6)
1	proceedings; finality of
2	 (2) protection
1	law or rule
1	drug samples distributed,
1	purity, or to
1	violator for appropriate
1	application fees, animal
1	apothecary shop, or
1	2008.  (b)
1	limits regarding biosimilar
1	gs10 of the
1	
 158. offenses;
1	audit or a
1	approved rare pediatric
2	potential for such
6	reported to the
1	 (b) sunscreen
4	practicable such report
2	person on board
1	years. (d) voluntary
1	product, whether domestic
1	body if the
5	food, or drug
1	approved drugs. 
16	secretary shall include
1	(5) that the
1	oxygenation therapy or
1	worldwide as the
1	otherwise limits the
1	elements set forth
1	(f), and (i),
1	authorized consular officers
1	management or the
2	pediatric patients. 
1	paragraphs (a), (b),
1	food safety, and
1	basic pay under
1	enforce state meat
1	tampering; (f) provide
1	security seizing drugs,
1	means animals other
1	foundation; and (xi)
1	country, and zip
4	350j of this
1	(e) the secretary
2	application (other than
1	18 (including rape),
5	connection with slaughter
1	therapeutics shall be
1	term advertisement includes,
1	product codes, us-by
2	earlier effective date,
1	bear in distinctly
1	(ii) establish policies
1	title) less the
5	manufactured and distributed
1	(j) to maintain
1	origin labeling 
1	unlawful acts it
1	ingredients which have
3	establish, before the
1	special termination 
1	crime. (2) executive
3	concerning investigations which
2	subparagraph (b) may
1	introducing marijuana,[1] cocaine,
1	(a) report requirement
1	including a detailed
2	title 35; 
1	application which are
1	licensed veterinarian) applicable
1	examine the results
1	support, and participate
1	containers of drugs
1	paragraph (1)(e)(ii). fees
1	excretion of the
2	countermeasures that are
1	order of disapproval
1	electronic format. until
1	generally found that
1	process the secretary
1	classes of controlled
1	title i, 4,
2	safety, or, in
1	 (1) licensed
2	susceptibility testing devices
1	decision that would
1	geographic areas in
1	agent, of the
1	total value of
1	virulent poison, except
6	(1) through (7)
1	regard to subsection
5	executive director shall
1	title shall, not
1	thereof; inspection of
2	substance used in
1	center or any
1	tribal drug supply
1	drug. determinations under
1	i-kind, fairly evaluated,
1	title, is made
2	program evaluation by
2	interstate commerce, shall
1	smoke constituents, ingredients,
1	bond. if the
1	persons so nominated,
2	significantly minimize or
4	paid only once
1	nutrients  nutrient
1	trust fund to
1	(a) substance abuse
1	time, to any
2	adequately served and
5	report that 
5	food offered for
1	adulterated; and (iii)
1	security, shall publish
1	intercenter institutes within
1	license under an
2	offense chargeable under
1	shellfish (e.g., crab,
1	order whenever any
1	reinstatement of a
1	hearing, that 
2	register the name
1	code number for
1	analysis for determining
1	cost of physically
2	derivative, or preparation
6	filing or withdrawn
1	(july 24, 1919,
1	term variant protein
1	construed as superseding
1	required in section
1	agencies for the
1	(d) with regard
1	permitting pharmacists and
4	united states. the
1	title 28that otherwise
2	may be referred
1	subparagraph (c) by
1	chemicals for potential
4	documents (including underlying
1	importer, distributor or
1	sunscreen order notwithstanding
1	transferred and omitted

1	substances enumerated in
1	section 351(a)(2)(a) of
1	v; (e) is
1	claimant proves to
2	secretary any additional
1	subsection (a)(2), applicable
1	subsection (b)(1)(a). 
1	product manufacturers, shall
1	(b)..[1] the secretary
1	unless the findings
1	standard would be
1	activities among federal
1	humans for purposes
6	subsection (b) if
3	resides or transacts
1	802. definitionsas used
1	commission as a
5	shall register with
1	health associations, and
1	360e(i)(2) or 360j(l)(5)(b)
2	(ii) make a
1	member appointed to
1	preserve such order
1	subsection, other than
2	include a verified
1	(2) require manufacturers
1	organizations that operate
10	relating to a
6	title, the term
1	zero, the secretary
1	weighing any probable
1	exists because the
1	poultry is found
14	(ii)  (i)
1	cigarette papers; or
1	shall be modified,
2	whether the substance
1	subsection (a)(2)(e), the
1	fully and correctly
1	et seq.); (g)
1	establishments failing to
1	(5) exception notwithstanding
1	compliance is being
1	persons, provided such
1	person who intentionally
1	  minimuma
8	requiring that the
1	auditors.  (3)
1	(a) of an
1	covered entity means
1	2018, the amount
1	subpart e of
5	may prescribe and
1	effect on humans,
1	effect, or as
1	foods, food additives,
1	withdraw an exemption
1	secretary has discretion
1	establishment manufactures both
1	bear the burden
1	modified requirements for
2	384e of this
1	section 102(a) of
1	groups the secretary
2	authority and shall
1	substance, the secretary
1	 (b) interdiction
1	preempts or diminishes
1	held such food.
1	program to assist
1	infant formula, or
1	training of state,
1	report outcomes 
1	significant incapacity or
1	 100.0. 
1	5, 1948, ch.
1	(b) consideration of
1	labeled; and (e)
1	device which cannot
1	forfeitures section 853
1	inspection and certification
3	responsibility of the
1	 (b) chief
1	(2) on-half of
1	humans. (l) the
2	use and prescribe
5	question whether such
1	develop for distribution
1	(
 
 1045.
1	subchapter i, for
1	monitor recalls of
1	representative profile of
1	title).  (c)
2	mark, stamp, or
2	patient experience data
1	including by guidance)
2	food, food additive,
1	revenue amounts, as
1	intended use has
1	transaction  (1)
2	products, not consumer
5	premarket application or
1	compensation; support; faca
1	inspection under section
2	law enacted after
4	result of a
1	following chemicals: 
1	modifications under subsection
1	states and has
1	august 30, 1890
1	ch. 675, 518a,
1	without a license
1	critical path initiative.
1	(2) limitationsparagraph (1)
1	food product. 
1	medications; and (g)
1	container unless such
1	paragraph. (2) a
1	foundation fellows or
1	health. (3) electronic
1	supplies of such
1	respecting a performance
1	federal courts for
1	agency for the
4	administration  (a)
7	person who submitted
1	manner as persons
1	required; and (ii)
1	 (a) preclinical
1	biomaterials supplier supplied
1	congress recommendations, if
1	trading partners possession
1	concerning the validity
1	human services (in
1	annual distribution; (b)
1	fast track products;
1	finally determined, may
1	electronic pedigree systems
3	available in the
1	 (5) distribute
1	cost of medical
1	consignee complied with
2	animals, and the
1	(ii) a clinical
1	675, 703, 52
1	(ii), then prior
1	advertising requirements for
1	statements from witnesses,
1	individual schools served
1	 (aa) presents
2	types of information
1	regulations for enforcement
1	component part in
1	contentsthe labeling of
1	specified, the following
1	
 360c1. reportingthe
1	exemptedthe secretary shall,
1	unapproved product 
1	paragraph (1)(c); and
5	believe may have
1	limited.  (b)
1	determine.  (f)
1	(c), the applicant
1	supporting the substance
1	health to require
1	supplement whose name
1	 (11) supply
1	organizations, institutions, and
1	therefor, either affirm
1	general shall convene
1	commodities and to
1	entity shall establish
1	uniform nomenclature for
1	characterize the susceptibility
2	drugs submitted before
1	agricultural chemical) at
4	apply only with
1	adulterated article of
1	section 360j(f)(1) of
1	title 7,[1] shall
1	effectiveness if, after
1	instances when corrective
1	resided, at such
1	(viii) the seller
4	secretary, in accordance
1	antiseptic for inhibitory
1	601 et seq.);
1	patient advocacy groups,
1	menthol in cigarettes
1	authorizing the delivery
1	lack of available
6	amount established under
1	(i) the manufacturer
1	(ii) both of
1	subsequently require such
2	employees, committees, and
7	available information concerning
2	access to such
1	lon-term recovery results;
1	any, of limiting
3	601 et seq.),
2	subsection (f), the
1	committee review process.
1	tobacco product. (i)
18	(a) definitionsin this
1	trial the court
1	general in applying
1	referral on his
1	liabilitynotwithstanding any preliminary
1	quality and speed
3	section is not
1	consideration. nothing in
3	effective use of
1	plan for determining
1	administer fee collections
1	evidence as the
2	attempts to produce
1	devices by experts
1	action. (5) the
1	investigation, alerts the
1	design, logo, trade
1	used  (1)
2	controls provide such
1	(i) the manufacture,
7	subparagraph (a) does
1	administered with respect
1	 (b) testing
1	inspection for the
1	dispensers.  (d)
1	paragraph. (2) the
1	subdivision to require
1	authorize the holder
3	supply chain security
2	whether permanently or
1	(iii) all drugs
1	petition (but not
1	disease, or death
1	comply. the notice
1	(3) a requirement
1	apply who served
1	(e)(4)(b).  (b)
1	submission of drug
2	review team and
1	emissions of and
1	 mg 300.0
26	manufacturer or importer
1	wholesale prescription drug
2	matter within its
1	(2) a device
2	consider information submitted
2	purposes of importation;
1	importation or exportation;
1	manufacturer shall maintain
1	618. delivery of
1	making his determination
6	relation to other
2	business, for a
1	container; consistency of
1	year 2018. (c)
3	tested for authenticity
2	factors enumerated in
1	solution); (d) an
2	drug sponsor within
1	violation. any such
1	books or other
1	patient assessments (including
1	general cautionary statement
2	subsection (a)(2) for
3	(a) provide sufficient
2	business.  (d)
1	sales (which list
1	poured, sprinkled, or
1	1948, ch. 229,
1	conditions that do
1	radiation emissions, may
12	views on the
2	will not expose
1	drug to such
1	generalparagraph (2) of
2	medicated feed (as
1	order permanently prohibiting
1	relating to shipping),
1	(c). (e) for
1	person conduct a
1	particular matter before
1	including 31 percent
1	endanger the life
1	chapter.  (e)
1	effective.  (iv)
1	effectiveness data described
1	using the processing
1	(
 
 1161
1	youth marijuana use
1	section 374(a)(1) of
1	guidance documents per
1	composition, energy source,
1	request, unless the
1	supplements or submissions
1	final order into
1	manufacturer shall, except
1	subsection (i); or
1	date unless, upon
1	final audit report,
1	administration. the secretary
1	premises (a) appropriate
1	senate.  (c)
1	construed to permit
1	provide links to
1	device includes statements
1	(1)(c); (b) submit
1	final audit report;
1	rights of employees
1	data. the standards
1	require the disclosure
1	warning notice, with
1	reinspections in a
1	infant formula provides
1	fees the drug
1	regulate activities of
2	controls proposed to
1	food product. (mar.
1	physician or by
1	review to a
1	
 212. offenses;
1	candidates. (b) responsibilitiesthe
1	13, 2016, publish
1	order referred to
1	necessary data for
1	contents of rulesthe
6	days following the
1	financial responsibility for
1	children. notwithstanding such
1	(including any script,
2	writing and filed
1	crack in the
2	distributed under subparagraph
1	approval for antibacterial
2	within such jurisdiction
1	authorities granted by
9	authority conferred by
1	reporting for dietary
1	(c)(2)(g) or (e),
1	kingman reef, johnston
3	53 of such
1	active program, both
7	secretary grants a
1	submits the registration
1	(e) limitation subsection
1	information and conduct
1	relevant data constitute
1	neonates, as appropriate),
1	(2) agreements prior
3	may determine the
1	413 of such
1	act of 1996;
6	consequences or death,
5	secretary deems necessary,
2	secretary deems necessary.
3	execution and delivery
1	consequences or death;
1	risk have the
1	act of 1996,
2	subsection shall not,
2	present their comments
1	diseases if the
1	shall determine, and
1	petition, or (ii)
6	secretary deems necessary;
1	si-month exclusivity period.
1	[42 u.s.c. 300g1],
1	fee, and annual
1	drugs during such
5	upon which it
2	holds a board
1	electronic format that
1	business for the
2	expertise to conduct
1	completed may take
1	international narcotics trafficking,
1	strategies between individual
1	international narcotics trafficking.
1	commence review of
9	material threat medical
1	agreements with national
2	election provided for
2	infringed; or 
1	rape drugs 
3	for, its manufacture,
1	entity to an
1	body; (2) a
1	number and expiration
1	u.s.c. 353(b)]. such
1	facility cannot ensure
1	device that presents
1	agent if the
1	resources, authorities, and
1	limits on amounts
1	(1) that is
5	applicant in a
1	 (ii) public
1	 (b) preclinical
1	product tracking to
1	agricultural commodities that
1	person demonstrates good
1	definition set forth
2	(b) program authorized
1	doses; or (ii)
1	paragraph (2)(c), the
3	tribal government agency
1	infectious agents, in
5	set forth under
1	therapy and regenerative
1	drugs indexed for
1	including an evaluation
2	condition of granting
1	food, underweight, overweight,
1	governing processes and
1	inventory of others
1	site that violates
2	practicable, be accompanied
3	rather than the
1	software assessment that
1	costs, of drug
5	reauthorization and their
1	suspect or illegitimate
1	inventories maintained under
6	congress the revised
2	contents  (1)
1	fee by 
1	describe the products
2	review if the
1	approval is effective
1	(i). (iii) for
1	 (l) rule
1	right.  (june
1	specified under paragraphs
1	registration information submitted
1	premarket application, or
1	methamphetamine, and cocaine,
1	commodity that has
1	whichever is longer.
1	may allow airflow)
1	grocery store a
1	participation is not
1	administration, with appropriate
1	funding the attorney
7	appropriate credentials and
1	clause (i)(ii) 
1	circumstances warrant, suspension
3	verifying the product
1	completion by the
2	regulations, the report
2	dietary supplement. 
1	fifty states, the
1	community mental health
1	particulate radiation, or
2	order the sale
5	11, 1953, 18
1	 (g) regenerative
1	establishment elects to
1	(4) amendment and
2	containing the results
4	treated with the
2	adulterated under subsection
15	secretary shall promptly
1	period.  (3)
1	prescribe specific technologies,
4	product the annual
1	name, identifiable pattern
1	days by which
1	chinese subjects to
1	apply to farms,
2	 (a) submission
1	condition, or a
1	food, or requires
1	518d(c) of title
1	may prescribe. 
1	contraband and summarily
1	program, but is
1	convention, control of
1	adjustments in the
2	carrying out audits
2	field personnel unless
2	appointed members 
1	person shall enter
1	section 360ddd(1)(h) of
1	publish or present
2	title at the
1	subsection; and (4)
1	contact for the
1	unavailable for forfeiture;
1	chapter. such regulations
1	suspect product if
1	knowingly providing or
1	filed; and 
1	charge of custody
1	threatening, (b) results
1	may be, has
1	research described in
1	pharmacy  (1)
1	 (a) reviews
17	decision of the
1	approved before the
2	penalties of this
1	description of a
2	appropriate state or
1	filed whether he
1	harmonization with action
1	secretary that persons
1	administrator may consider
1	renewal, and suspension
1	assessments was issued.
2	intended for single
1	(3) effective date
1	379e. listing and
1	using the product;
1	387f. general provisions
3	safety standards for
1	seq.] with the
1	restrictive use by
1	patients and consumers;
1	marketing service on
2	activities of other
1	secretary determines bears
1	(2) dextromethorphan shall
2	authorize the introduction
1	designed to evaluate
4	suspect product 
1	accuracy, timing, or
1	cost, the approved
1	(b) the timelines
1	action, raise genuine
2	additive is safe,
2	determines no longer
1	dru-free america) wherever
1	device if an
1	secretary, be satisfied
1	date the authorized
1	2012.  (f)
1	insulin which is
8	listed drug has
2	review and copying.
1	dependence or high
1	permissible variances the
1	give the notice
1	device effectiveness that
2	subparagraph (c). (2)
3	future importations made
1	safe operations, including
2	(a) no person
2	agencies in carrying
5	index for urban
7	food has been
1	generalthe director shall
2	chemical until after
1	both. section 14
1	relative percentages otherwise
6	(a) one business
1	user fee assessment
1	construction, sanitary, quality,
1	cocaine or ecgonine
1	(6) limitation of
1	 (ii) high
2	iii, which under
1	(xiv), (xv), or
1	component to regulate
1	packaged poultry products,
1	subchapter, regulations prescribed
1	area; (d) the
1	(vii) a certification,
1	regulation apply this
1	drugs; (ii) that
5	records required to
2	hazardous raw materials
2	28.  (e)
1	animal models that
2	 (c) definition
1	otherwise ordered by
1	product information typically
3	foregoing provisions shall
1	complete, ready, and
1	food categories as
1	
 
 353a1.
1	36; and (2)
1	previous year. when
1	(c) imitation of
2	days after becoming
1	adulterated butter, or
1	determination in issuing
1	destruction of schedule
1	days after filing.
11	term of imprisonment.
3	condition, including a
1	(c)) or with
1	equitable relief as
1	illness data collected
7	public interest, the
1	information, or (bbb)
1	point or points
1	maximum civil penalty
1	board review of
1	year, be submitted,
2	8, 2008, in
1	treat nicotine dependence;
1	alternative treatment in
2	(b) adverse event
25	provided in subparagraph
1	value for a
1	last previously imposed
1	of, devices that
1	encourage the mutual
1	risk communication (referred
4	$10,000 or imprisoned
1	seizure pursuant to
2	(d), and (e)
1	regarding defects every
2	state agency with
1	system as available
1	increased by a
1	positions are established
6	salts, optical and
1	protection means protection
1	alkaloidal salts derived
1	can, tin, cloth,
1	paragraph (4)[1] a
1	director may authorize
1	subsection (d), via
1	(1)(d), the director
1	authority, a list
1	products to protect
7	condition of use
1	suppliers, and customers,
3	obtain approval for
1	quantity of illegal
1	request for recognition
1	involved  (a)
1	law enforcement official,
3	exclusivity under this
1	(c) factors determinative
1	world; and (2)
1	copper (g) 60.0
1	suitable area to
1	 (b) establishing
1	smoke that either
1	law enforcement official;
1	comprehensive, lon-term plans
1	regulations promulgated pursuant
4	355d of this
18	office of national
6	360j of this
2	person will exceed
1	respecting false or
1	otherwise, other than
1	display on its
4	appeal be taken
1	entry in to
1	manufacture, possess, or
3	statement of findings
1	18 months. the
2	strength, and meets
1	thereof are prohibited:
3	grase determinations for
3	amount applicable to
1	listings after each
2	increased by 5
1	interpretive criteria standards;
2	tobacco.  (5)
1	(ii) an article
4	national agriculture and
2	state coordinator is
1	notification.  (b)
1	falsified any application
1	administer performance standards
1	21, 1997. 
1	preparation or packing
2	state regulatory limit
1	tools that can
1	
 360bbb3b. products
1	review is intended;
1	treatment programs for
3	(a) if no
2	factual basis for
2	approved; or (bb)
1	act that renders
4	meets the conditions
1	develop new suppliers
2	initiate the action
1	minor species is
1	country, substantial evidence
2	minor species in
2	determines necessary for
1	federal requirements, and
1	 (2) comparative
2	counterfeit drug. 
1	authorize the importation
1	hiring qualified scientific,
1	dosage that was
1	section 401(b) of
1	exclusivity period described
1	rate, for human
10	subsection if the
6	suspend the approval
1	(iv) any combination
1	675, 586b, as
1	grants and contracts.
1	made a recommendation
1	2013, a dispenser
1	(3) conduct training
2	number of original
1	transaction which 
4	secretarys order thereon
1	approved; or (3)
1	mitigation strategy 
1	promulgated thereunder, the
4	secretary to establish
1	excipient of the
1	second country, the
1	subsection (a)(1)(f)(i). 
1	shall include statements
1	dispensed in accordance
1	subparagraph (a), paragraphs
2	regulation, order, or
2	use of safety
1	swine or goats
1	regulations any poisonous
1	application); and (h)
1	attorney general determines,
1	paragraph do not
1	sample requested and
1	including any data
2	secretary of nonconformity;
1	applied to products
2	principles, shall be
1	general.  pursuant
1	13, 1949, ch.
1	advisory council established
1	year 2013 for
1	examines the extent
2	review by filing
1	period, the importer
1	proposal to remove
1	general, be seized
1	(5) final regulations
1	thereunder, and seizures
1	hidta funds to
14	period described in
1	product inspection and
1	shall any employee
2	bulk or dosage
1	(iv) a brief
2	may request such
2	difficulties for compounding
1	use in domestic
37	imprisonment of not
1	review and the
1	product, food, drug,
1	(such as patients
1	chronic use, and
1	(
 
 861.
1	actsno person, firm,
1	food. (c) the
1	foo-an-mouth disease may
2	subchapter.  (b)
1	distributor may, after
1	limitation on use
1	appoint employees under
1	article in violation
1	clause (i). for
4	strategy shall include
1	establishment fees, and
1	least one shall
4	federal register of
1	repackager that has
1	demand reduction means
1	health insurance claims
1	allergic; (iii) describing,
1	period, qualify the
1	decision in writing
1	federal agencies concerning
3	liability law of
2	develop a pediatric
2	derivative of barbituric
9	(a) relating to
2	accordance with all
1	letter) require the
1	diseases. (r) zika
1	considers appropriate, such
1	demonstrated only with
1	fine in lieu
1	one page summary
1	article that does
2	amount obligated by
1	2013:  (1)
8	committees on the
1	secretary shall invite
1	considered the duties
1	compounding includes the
1	(b) a licensed
1	sought accreditation under
2	(1) may as
1	360j(o) of this
1	bond in the
1	shall, with the
1	choose.  (4)
1	fuel or service,
1	appropriate expertise to
1	ch. 675, 576,
1	states shall, through
1	commission.  (

1	remaining submitted applications
1	adjusted; all items)
3	section 360bbb3(a)(2)(a) of
1	administration inspections performed
3	law and the
1	chemical, or who
1	exceeding a safe
1	distinguished in the
1	(12), (13), or
1	issue the communication
1	correction or removal
1	(c)(ii) shall (with
4	adjusted; all items;
1	product inspection programs
1	provide such other
1	reasonable time following
1	product manufactured within
2	debilitating disease or
1	executive director 
6	secretary; and (ii)
2	will pose an
1	(4) the adverse
1	commerce or after
1	(a) post the
2	enforcement for local,
4	(ii) who, after
1	spread to other
1	inspections authorized by
1	charges, shall be
2	(n)(1)(g), the approval
1	determination of persons
1	agencies and nongovernmental
1	them; and (b)
1	receiver, or other
1	title, approval, licensure,
2	without that individuals
2	379j62 of this
1	initiating scientific research
1	prior to or
1	exported, or (3)
1	2019 and each
1	means, subject to
1	statements the secretary
1	(2) assuring access
1	including all fruits
2	effect for a
5	substantial equivalence under
1	3 years. (b)
2	(h) guidance documents
1	title iii 301,
1	personany person who
2	standard costs. 
1	(ii) the secretarys
1	minimizing exposure to
8	employee duly designated
1	content of policya
2	legislation to improve
1	security, shall revise
1	(e), the director
1	
 1542. duties
1	
 2001. designation
1	defined the term
1	new productsan order
1	below. the secretary
9	proposed for the
1	 (26) the
1	panel of qualified,
12	public health, the
1	acceptance of funds
1	paragraph (4) (hereinafter
2	distributing or possessing
3	award a renewal
2	periodic reports of
1	report requirement (a)
1	person making a
1	furnished promptly to
1	whether such request
1	includes a drug,
3	controlled substances which
2	information is disclosed
3	residue means a
1	shall make summaries
2	review not later
1	study; by experts
1	 (c) conditionssubsection
1	development.  (d)
1	designations for a
1	therein for use,
1	relative number of
1	protected by patent
2	general in blank
2	supplying a special
1	effectiveness, in animals
1	drug applications. (v)
1	subsections (b)(1)(b), (c)(1)(c),
1	adjacent to, and
1	communit-based prevention programs;
2	(g) if the
1	1 of a
1	section 387e(i) of
42	180 days after
1	biological product), the
1	per petitionsthe secretary
1	state within such
1	3(c)(5) of the
4	meaning given the
1	twice the amount
1	phenylpropanolamine to be
1	whites, eggs with
2	(regardless of the
1	acetic anhydride. (b)
1	ii, there is
2	proceedings in rem;
1	sponsors, and the
1	paragraph (1) pursuant
1	providers, pharmacists, and
1	congress in section
1	submitted such report,
19	raw materials and
2	contemporaneously with the
1	stat-o-th-art practices and
2	declaring a protocol
1	(3) drug producta
1	ineligibilitythe period of
1	quality, and purity,
3	systems. (iii) developing
1	(b) a recommendation
1	status of remaining
1	interactive communication with,
1	act of 2012
3	proposed risk evaluation
4	quality, and purity;
2	practice requirements 
1	expiration date labeling,
1	real property to
1	identification and that
1	authorization system in
1	standards to provide
1	standards for admission
1	transaction. (2) the
1	excluded by regulation
1	definedin this section,
1	means, the results
1	sponsor, that a
1	title, and such
1	chapter shall derogate
3	prohibited by regulations
1	previously approved applications
1	specific product (including
1	statement limited population
1	representations made or
1	ii, unless the
2	program agencies, and
3	fee the biosimilar
2	shall authorize the
1	price to a
1	(i) 25 percent
1	offenses (a) term
1	food supply, and
1	treaty, entitled the
1	professional or business
1	drug information was
1	number (if any)
1	 (vi) an
1	used to supplement
1	$3,000,000 for the
1	rehabilitation programs; and
1	clinical hold. (h)
1	accompany food offered
2	use only, and
2	secretary, he has
4	reasonable grounds to
1	ch. 675, 744a,
1	drug application (as
1	eligible product, and
1	entry. (2) all
1	may make the
2	information on label
1	food additive is
3	year 2013for fiscal
2	command operation or
2	help to ensure
1	(4) the members
1	samples of each
1	television advertisement (referred
1	clarification of interaction
1	(8) a classification
7	registration under paragraph
1	exemption for investigational
1	schedule pursuant to
1	resulted in firs-applicant
1	(b)(1) application if
3	premarket notification under
1	title 42 was
1	(iv) -buty--(-naphthoyl)indole (jwh073);
1	food additive in
3	effects of methamphetamine
1	began.  (4)
2	purported to be
1	property and dispose
1	work with state
1	subchapter. the term
5	storage, and installation
1	involved. a regulated
1	list of candidates
3	term director means
1	licensed physician who
1	injunctions  (1)
5	information was submitted
1	1988 (21 u.s.c.
1	gaps and inconsistencies
1	sponsor to approve
1	ch. 675, 731,
1	20.0  
1	duplicate records where
2	order shall provide
1	emergencies.  (2)
1	 (a) timingan
1	administrator with respect
6	use of controlled
1	(7) medical device
1	multiple doses; (ii)
1	coordination, as appropriate,
1	(viii) if the
1	adverse events and
2	time each such
3	drug application, including
1	substance may continue
1	order reporting) applies
1	(d)(1) be conducted
1	fee specified in
1	profile of user
1	refer the petition
1	guidance, certifying its
1	prevents the secretary
1	penalty provisions; conduct
2	improve pediatric drug
1	(9) may serve
8	clause (iv) of
2	administrators own initiative
1	(i) in generalnot
1	fails to maintain
1	respect to offenses
1	term security countermeasure
1	support or satisfy
3	(d) shall nevertheless
3	eligible for further
1	centers). such activities
2	eggs, egg products,
1	packaging design, logo,
2	inspection, and investigation
1	tracing of food.
1	medicine, or the
1	1995, the secretary
1	foreign recipient demonstrating
1	psychotropic substances to
1	available techniques are
1	term premarket application
1	tracing of food;
5	applicable amount under
1	gives such other
1	multiplied by 0.60;
1	dispensing to a
2	1355 of title
1	(a)(1)(c). (e) emergency
1	due in large
1	authored by a
1	reported, to an
2	informal hearing, when
3	(a) a list
2	redesignation of the
1	state; (ii) is
1	destroyed or may
1	major category of
1	1, 65 stat.
2	additive means any
1	notification to secretarywith
1	demonstrate how the
1	thereby be present
1	label if (1)
1	dimenoxadol. (17) dimepheptanol.
2	legend and official
1	formal process for
1	common or similar
1	guidance documents. all
1	2009 multiplied by
1	determination regarding market
1	pesticide for such
2	awards the secretary
1	tracing of foods
58	 (a) a
1	(2) contentsthe report
1	type so introduced
3	public disclosure, that
2	generalbeginning with fiscal
1	severable. (
 

1	applicable and appropriate),
1	animals slaughtered separately
1	product made or
1	title beginning with
2	decision, in writing
3	apply in the
1	(iv)  (i)
2	continue to provide
1	products bearing any
1	may have any
1	made for such
2	inhaling, or otherwise
1	electronic data and
1	youth; (4) to
1	responsible party (as
1	forfeiture, and condemnation
1	may have and
1	(f).  (2)
1	premarket applications, supplements,
7	days after receipt
1	12978 of october
1	paragraph but for
1	grocery store to
1	orphan asylums, chil-welfare
1	protocol shall be
1	subchapter ii. (10)
1	manufacture, compounding, or
4	proportion of personnel
3	administrator, in consultation
1	manufacturer of tobacco
2	result of any
1	1951, ch. 666,
1	campaign are allowable
1	attorney general determine
1	products can be
2	contracts for research,
1	oral or written,
2	food meets the
1	decisionmaking; (c) include
11	advisory review of
6	declaration of conformity
9	(g) of this
1	new drug involved
1	trade commission. (2)
1	2013 and ending
2	based on information
1	emerging threat response
1	purpose may, at
1	(b) the availability
1	(
 
 451.
1	federal law, (2)
1	(cp47,497); (ii) -(1,-dimethyloctyl--[(1r,3s--hydroxycyclohexyl-phenol
1	available to tobacco
2	united states. (ii)
1	 (1) evidence
2	chapter (including regulations
1	exceed 10 milliliters
3	authorities having jurisdiction
1	(3) for these
2	attorney general upon
1	distribute, or distributes
4	asserted if a
1	 (1) fiscal
1	professional background of
1	title, or (5)
2	health assistance for
1	persons request for
10	may, in accordance
1	do. the finding
3	served (1) in
1	them, the secretary
1	including any authority
1	kept or required
1	detrimental effect on
1	year under clause
1	1 year, in
1	determinations not to
1	avoided in the
1	compliance with federal
1	(a)) who provides
1	applicant has had
1	international organizations to
1	origin or subdivision
1	bargaining agreement. the
1	licensed professional practice
1	surveillance approval 
3	widely recognized international
4	approved after november
1	secretary as authorized
2	conduct of pediatric
1	laboratories for foo-an-mouth
2	misbranded.  (e)
1	larg-scale foo-related emergencies,
1	centers of such
1	expedited, or otherwise
1	customers or importers
4	states. (
 

1	submissions and approvals
1	division; (b) strike
1	means a set
5	violation, and not
2	(1) and that
1	app.) shall not
2	identified during the
1	fees of secretary
1	procure the services
1	recalls by manufacturer;
3	label bears such
1	application is required
1	2007, and before
1	research efforts supported
3	considered incomplete if
2	information. a request
1	issued declaring that
1	(2)(a); or (k)
4	systems to ensure
1	(ii) extends from
1	(1) may 
1	requisite elements of
1	guidelines available to
1	degradation.  (k)
1	abusethe term substance
2	prescription order for
1	annual report of
3	classifying a device
10	secretary under subparagraph
2	secretary a summary
1	submitting a registration
1	(ii), the administrator
1	proceeds. (b) meaning
1	compliance history as
1	1(92), 45 stat.
1	narcotics control of
1	bioequivalency information described
1	(1). the requirements
1	food packaging materials
1	serious illness. such
1	agents to reimburse
1	-month period; and
1	law, food shall
65	effectiveness of the
1	quantities in the
1	approved, the drug
1	upon the objection.
1	data in or
1	submitted to support
1	42. (2) the
1	statutory obligations of
2	demonstrates that consumption
1	marked in accordance
7	section, if the
3	program and to
1	approval. (ii) a
1	(a) the same
1	manufacturing establishment, institution,
9	activities under this
1	fee paid by
1	cigars, including small
1	may regulate activities
1	veterinarian.. a drug
1	term sunscreen means
1	experts  (a)
1	document in an[2]
1	types that present
1	(m) patent defined
1	attorney general, that
1	(g) is submitted
1	denials proceedings to
1	risk assessment. 
1	repeated dissemination of
2	imported articles: provided
1	shall be required.
1	(b) will serve
1	revised national primary
2	person not authorized
1	security at the
1	tobacco leaf; and
1	(f) 40 grams
1	assist the foundation
3	scienc-based minimum standards
1	applicants therefor to
1	activity which is
2	deemed contraband and
1	person who filed
1	publish a complete
1	steroids if the
1	use can be
1	composed of 
1	prescription. (2) as
1	shall report all
2	substantially complete on
1	thereof.  (7)
1	shall, in writing,
1	years or over
1	sprayed on, introduced
1	4, 2011; or
1	(o) repealed. 

1	713 or the
5	making a notification
1	ranking minority member
1	secretary; (3) at
13	conditional approval of
1	indicating the desire
1	adverse[3] event reporting
1	use of scientific
1	representative to call
1	chapter are needed
1	drugs, that is
1	section 360bbb(b) of
1	employees mentioned in
1	degrees fahrenheit after
13	(a) shall include
2	specifically applicable to
1	360e(f)(6)(b) of this
1	nonconflicting laws for
1	may, when appropriate
1	single year makes
1	egg products purchased
1	minorities. in its
1	unless exempted under
1	made unless the
6	years or fined
2	secretary. (b) the
1	product, except that
2	basis) of the
1	associations  (a)
1	area, subject to
2	electronic means, including
1	grams, without regard
1	serious risk when
1	subsection only if
1	(4) regarding priority
1	original order, with
1	file objections to
1	publi-private partnerships, institutions
1	name, the established
1	 (c) 280
1	disease advocacy organizations;
1	access by regulatory
2	food; (8) if
1	access by any
1	demonstrate that pending
1	employee to inspect
1	title 42. (d)
1	certify that such
1	authorization shall continue
1	title, means any
1	(2) has achieved,
1	section 600.3(ee) of
2	two years from
1	found substantially equivalent
2	(i) relating to
1	responsible secretary to
1	process of review
1	drugs, and (ii)
1	
 214. previous
1	authorityfor fiscal year
3	applicant and to
2	exceeds the amount
1	communication about requests
1	 (b) distribution
1	qualities other than
1	inspect food manufacturing
9	distribution of an
1	pathway for antibacterial
1	form of shipmen-specific
3	definition of anabolic
1	(2), any regulation
2	(b) except as
1	produced as a
1	clause (i). (iii)
15	report required under
5	title, or an
1	(j) international drug
1	information product development
2	suspension or withdrawal
1	ineligibility any person
1	purposes of retaining
2	secretary; and (3)
1	(c) sales in
1	secretary authority to
1	uniform applications thereof.
3	contains a particular
1	 (c) personal
1	system.  (i)in
1	(2) consumer research
1	internet web sitethe
1	human environment; and
3	radiation safety standards
1	(iii) businesses. (iv)
1	
 
 399d.
2	goals:  (a)
1	manner of changes
2	rule promulgated under
1	general public; and
1	description of entities
1	violated this subchapter
1	determined may present
1	 (4) rare
1	enhancing the secretarys
1	psychotropic substances 
1	period. (iv)failure to
1	renumbered 3 and
1	experience that might
2	food.  (h)
5	person who makes
1	grades the standard
1	uses; (b) the
6	less than 10
1	furnished by any
2	officer and director,
1	supplement or contains
1	penalties; and (d)
1	columbia, be subject
1	inspection of conveyances
1	forth the governments
1	 (3) fees
1	inadequate (whether or
1	submit a premarket
9	fee assessed under
1	considers appropriate of
4	practitioner who is
2	combination animal drug
1	 (vi) identification
1	determine the applicable
1	due to, among
1	covered by subchapter
1	adulterationan infant formula,
1	practitioner who in
1	developers, patient groups,
1	(4) certain substanceswith
1	considers appropriate; 
1	promulgated under subparagraph
1	administration, in excess
9	(i) shall be
3	 (a) persons
7	amounts made available
1	involved in reviewing
2	maintain the confidentiality
1	include conclusions concerning
9	combinations of such
1	section 360fff2 of
1	 (aa) an
1	paragraph (1)(b) is
2	42; or (b)
1	nominating entities to
1	product may propose
1	banned substances. 
1	 (aa) at
5	poisonous or added
1	product application; minus
2	scheduled listed chemicals;
1	eligibilityeligibility shall be
2	administrative order following
5	deny an application
1	national intelligence, shall
1	101 of title
1	(c) intended for
21	product  (i)
1	success in protecting
1	(7) meeting a
1	financial information that
1	coalition shall demonstrate,
5	operations of the
3	27, 2007, and
18	new information before
1	admission all expenses
1	feasible, through electronic
2	distribution, reception, holding,
2	national methamphetamine advisory
6	copies of all
3	distributed in violation
1	provide the food
1	state.  (3)
1	meetings with the
1	ch. 861, 1,
1	waivers and refunds
1	pregnancy, high school
1	5 and amended
1	list unless he
1	followed and reports
1	period.  (4)
1	general the united
1	advise against the
2	office, the director
2	shall seek to
1	legal costs and
1	operation; (iii) the
1	title i, 10,
1	appropriate cases) in
1	intentionally causing the
1	board), which shall
2	submissions under subsection
1	regarding the behavior
1	(a) the quality
1	space on the
1	(
 
 1901.
1	section, and all
1	taken upon each
1	statement under item
1	aircraft or other
1	supplement and requests
1	simple possession (a)
4	year under subsection
3	amount of each
2	party to perform,
38	authorization of appropriations
1	system web site
1	medical products (including
1	thereunder shall not
1	increasing pediatric access
1	actual knowledge, or
1	general. (3) it
1	results of inspectionthe
1	enhances lon-term assessment
3	expedited hearing under
2	secretary shall examine
2	facilities, and inventories;
1	data infrastructure among
2	ship or deliver
1	drug production in
1	plan. (
 

3	aside in whole
1	comply with performance
7	secretary finds, after
3	otherwise would have
1	title iii, 535,
1	provided in subchapter
1	applications (a) exemptions;
1	manufacturers, academic institutions,
1	center, shall be
1	food from a
2	person lawfully filling
4	reasonable certainty that
1	necessary to maintain
2	tomography drug shall
1	inspecting, copying, and
1	law to dispense
1	required to duplicate
1	holding thereof during
2	deviations from current
1	
 
 379j42.
1	(b) makes with
1	another capacity, shall
1	also take into
1	(2) a drug
2	(such as capsules,
1	(3)(a); or (iii)
1	subsection have affected
2	developed by private
1	availability of psychotropic
1	 (i) recruitment
1	may, when assessing
1	establishments regulated by
1	application the effectiveness
1	studies and shall
9	generalthe secretary may
1	include performance standards
1	(e) comments, data,
3	secretary shall disclose
2	eligible coalition under
1	ensuring enforceable public
1	construction this paragraph
1	(f) a commitment
3	secretary shall request
1	(1) is frivolous
1	examination, or investigation
1	permit. subsections (b)(2),
1	 (c) national
1	(i) arranges for
1	include providing the
1	acid (ghb) or
1	use to any
1	attributes.  (3)
1	batch of the
1	defined in subparagraph
1	355(k) of this
1	(3) administration fees
1	registration, or (2)
24	provided in advance
1	records the responsible
1	supplement or with
1	(d) division of
1	(e), (f), and
1	water. the effective
1	damage suffered by
1	rural coalition grants
1	device. a regulation
5	may, in his
1	cleared alternatives, including
1	(i)) during such
1	considers appropriate; and
1	outlet, after a
5	(d) whether the
1	meat canning, salting,
8	pending before the
3	december 13, 2016.
1	separate apparatus intended
16	december 13, 2016,
1	(ii) apply, may
4	contract with the
1	added by subsection
1	certification or the
1	plant.  (c)
1	(d) subsidiary the
1	effect of status
1	(or use local
16	receipt of the
1	claimant and the
1	report by a
1	imports and the
2	december 13, 2016;
1	section 374(a)(2)(a) of
1	identity and make
1	different ingredient was
1	protocol, or placing
1	(h) representation as
3	reviewed by such
1	summaries notwithstanding any
1	practices; and (d)
1	 (i) screening
3	food unless they
1	3109 of title
3	sole item of
1	stability, integrity, and
1	programs, especially with
2	term renderer means
1	components, materials, design,
2	purchased by, consumers
1	object classes. 
1	and, beginning 4
1	and, beginning 5
1	and, beginning 6
2	(a) whenever the
2	impair the effective
2	(or a regulation
1	establish appropriate information
1	plan within a
4	section 360j(f)(2) of
3	shall either 
1	destroy condemned poultry
13	regulated by the
1	physician distributes (or
1	penalize the production,
1	changes to director
1	misrepresentations, may subject
3	made that a
1	vaccine safety datalink
1	jury to reach
1	extended for good
1	 (i) submissions
1	precautions respecting the
1	channel for less
1	reporting by other
1	42. (k) compiling,
1	u.s.c. 853]. (4)
1	prohibition against use
1	element involved. 
4	effect on a
1	resources to support
1	recall; (2) consult
1	base or comparator
1	state and shall
1	paragraphs (8), (9),
1	join together to
1	section to biological
1	(vi) the retention
1	drug control data
2	initial filing determination
1	monitor the effectiveness
1	282(i)(3) of title
1	 (iii) chair
1	achieve completion of
2	 (d) public
5	cosmetic that is
1	registrationupon electing and
1	activitiesthe recruitment activities
2	product identifier beginning
1	subsection (e)(8); and
12	360j(f) of this
2	clinical testing 
5	(i) fiscal year
1	sold in unbroken
1	management (a) definitionsin
1	device component of
4	individual as a
3	drug has more
71	process for the
1	held under subparagraph
2	upon request, to
12	devices  (1)
1	commissioner, the center
2	residue from the
1	medical products, with
1	paragraph (5). (5)
1	services shall furnish
2	day (including travel
1	chapter 9[1] of
2	committee shall address
1	equivalent to casein.
1	partnerships, institutions of
1	substances, or any
1	(c) each importer
1	phosphorus (mg) 25.0e
1	enter into other
1	order deemed objectionable
1	situation, or other
1	positioning and delivery
1	shall be achieved
2	last six months
1	establish a database
1	schedule unless the
2	fees  (i)
1	1262; renumbered 7
1	thereof or be
1	
 1522. purposesthe
1	professional organizations and
1	provisions of law.
1	issued thereunder; (b)
1	(a)(6), (b)(5), or
1	nurse tank a
1	entered, unless extended
4	filed as the
1	tolerance applicable under
1	laboratory capacity prevents
1	separate establishments for
3	topics described in
1	state and exported
2	commerce.  (2)
2	foods likely availability
1	10, 2005; (2)
1	period.  (june
1	communication described in
1	integrating data infrastructure
2	license applications filed
1	slaughtering; custom slaughtering;
2	(i) the public
1	 (a) maximizing
1	u.s.c. 263a], to
1	agency if its
1	355a. pediatric studies
2	update as necessary,
2	supply chain at
2	fift-four months, and
1	 (a) travel
1	fellowships, whether at
1	ingredients manufactured in
1	defense with respect
1	requested such determination
1	conditions; and (iv)
6	appears to the
1	shall deem proper.
1	conveyance identified for
1	available to (1)
1	shall serve colored
3	mineral, and other
4	product development meeting
5	clause (i), (ii),
1	thir-party inspections and
1	serving in any
1	right to counsel,
1	1131 to 1133.
1	submitted a marketing
1	prescription issued for
2	respect to manufacturers
2	reports for such
1	(b) to fill
4	establishing a performance
1	(f) the systems
1	payable under level
1	internet site it
1	considered to qualify
1	education opportunities for
1	patient records or
1	act; jurisdictional determination
1	(b) a cooperative
1	work with outside
1	title are deemed
2	prescribed for formal
1	subsection, the final
1	outcome.  (4)
2	paragraph (4) or
4	date the registrant
2	powers conferred on
2	387s of this
1	imprisonment. (3) in
1	committee deems such
2	(1) who is
1	statusin carrying out
1	upon efforts, in
1	notification made, and
1	official name, common
1	 (b) acceptance
1	factors determined appropriate
4	otherwise agree. any
1	2016), including the
1	whenever any person
1	314.70 of title
3	remove inspectors from
1	seafood names, inspection
1	feasibility of establishing
1	consultation with industry
1	ch. 675, 504,
1	companion animals caused
1	assistant is required
1	(
 
 865.
1	(a) an abbreviated
1	human services, in
1	distribution, currently registered
1	app.) and title
1	state to ask
1	inspection or may
2	uses, unless its
1	transferred
 
 93.
1	submitted does not
1	section 1332(7) of
1	patients experiences with
5	shall, in addition
2	fees, generic new
1	title (including information
2	necessary to reimburse
2	person (including the
1	drugs for animals
1	level, the secretary,
1	products hereinbefore described
1	policy issued or
1	safety; (3) in
1	(a) it has
1	descriptions of successful
1	 (b) life
1	requirement not to
1	teenage and violent
5	conditions as to
1	for, and accounting
1	support intramural research
1	issued thereunder), or
2	amount available for
1	sites, such as
1	(m) color additives
5	throughout the united
1	prepare the substance
1	measures to maintain
2	programs for 
1	basis for withdrawal
1	purposes of its
1	applicant (i) has
1	746, as added
1	reporting (in a
2	(a) a notification
1	requirements if the
1	food resulting from
1	proceedings before the
2	associated with generic
2	establish) of a
1	reregistration and expedited
1	ingestion in such
1	shall stay all
1	675, 744a, as
2	tool and its
1	title; (11) to
1	drug abuse during
1	355d. internal committee
2	adjust fee rates
2	substances; and (5)
1	account.  (b)
1	arguments in the
1	premarket reports, premarket
1	impleading of dismissed
1	networkthe secretary, in
1	operational standards to
1	establishment may be
1	manner). (iii) the
1	studies, and shall
1	departments, school nurse,
1	actions, such suppliers
1	firm to periodically
4	purposes of such
1	2006 may be
2	expanded access policy
3	(c) reimbursement of
3	appointed from persons
1	effective, a food
14	355(i) of this
1	containers as the
1	neurological differences between
1	subpoenas for witnesses
3	sale or any
1	judgment, indicate that
2	shall serve at
1	(2)(c) or because
1	president in appearing
1	appointed as a
4	shall serve as
1	(d) publicly available.
2	milligrams of opium
1	indicating whether materials
1	determined; (ii) such
1	filed against the
1	voluntarily disclosed information.
1	minimum of $1,000,
3	violation referred to
3	commercial or financial
8	clause (ii). 
1	(3) codes the
1	 (8) matching
1	publi-private partnerships (a)
1	statistics, studies, reports,
30	test interpretive criteria
1	may establish such
3	section 346a of
1	committee; and (vi)
1	information is contained
1	make[2] full payment
2	section 351(a) or
1	supplemental application, with
2	one priority review
5	may use the
1	(36 u.s.c. 220501
1	food designation developed
1	section 828 of
1	(a) record of
1	uses notwithstanding any
2	ii. within thirty
1	administered, as the
1	trials  (a)
1	exceed the applicable
4	section 247d6a of
1	on, the development
1	imported does not
6	risk of serious
1	$100 for each
1	coalition may serve
1	applications under this
1	calendar days; (ii)
1	drug users the
2	(10) if it
1	reporting for nonprescription
1	ease and cost
1	produce under this
1	cover the administrative
1	360c(f)(2)(a), 360e(c), 360e(d),
1	good manufacturing standards,
1	determines appropriate; and
1	expertise means that
1	
 136. additional
1	(1) communication plan
1	ingredient was approved
1	docketing and final
5	entities described in
1	animal feed be
1	reasonable likelihood that
1	subsequent to establishment
1	health the secretary
4	three years from
1	guilty for a
1	conducted or accepted
1	system designed to
1	referrals for potential
3	processing facility c-located
1	animal whose genome
2	including such use
1	eggs containing embryo
1	methodology described under
1	(i) stay of
2	subparagraph (d) for
1	exemption). (3) limitation
5	provided in paragraphs
2	opportunity for informal
1	apportion an equal
1	management and budget,
1	enable the president
1	(a) information with
1	(f) an estimated
1	physicians, wholesale and
2	administrator pursuant to
1	package description, the
1	breeding.  (june
2	defense research plan
1	development and expedite
1	842(c)(1) and (c)(3)
1	person who dispenses
1	proper under section
3	bear the statement
1	tribe involved. 
1	legislative, or judicial
1	(iv) no acceptance
1	found therein, and,
3	preventing the distribution
2	product and establishment
2	inspect poultry and
1	person that knowingly
1	(iu) 0.7 
1	(1) all species
3	caused harm to
1	state intends to
2	1954, ch. 143,
4	section 360(j) of
1	(c) request by
1	pharmacy, if any,
2	capacity to supply
1	administrative funds a
1	defendant and the
1	date given that
1	entire application and
1	importing or exporting,
1	animal for which
2	clause (iii) shall
1	licensed physician; and
1	known to be
1	support a full
1	(r) postmarket drug
6	drug administration personnel
1	food is exposed
1	patient and both
2	scientific knowledge regarding
1	active ingredients which
3	title 28. 
1	(c), (d)(3), (g),
1	52 stat. 1051;
3	facility (as defined
1	central intelligence agency.
1	appropriate; (c) the
3	employee detailed to
1	(1) include the
1	chapter (or an
1	registration or registration
1	committee under the
1	423, as added
1	qualified countermeasure, a
2	jurisdiction to grant
1	distribution or to
1	872a. publi-private education
2	cost between inspections
1	ch. 675, 586,
1	use other than
1	contempt proceedings in
1	paragraph (2) against
1	preceding year. 
1	biomaterials supplier means
1	state program with
1	record to federal
2	denied, revoked, or
1	merely advertises the
1	children. (b) congressional
1	drug, determines that
1	claimant may submit
1	capacity; (vi) requests
1	year, as follows:
2	review upon the
4	action with respect
1	internet sellers of
2	shall treat such
2	time order the
1	basis an evaluation
1	(1) as hig-risk
1	household survey on
1	egg products, with
1	reflect the rate
1	confidence in food
2	product manufacturer must
1	adversely affect any
1	states under a
1	controlled substances flows
2	funds made available
1	approval received under
4	solely on the
2	issued a regulation,
3	may, upon the
1	section 355, 357,[3]
1	secretary, unless any
1	(11) supply reductionthe
1	destroyed. (iv) the
1	different manufacturers; (vi)
2	successor regulations); and
1	(h) effective date
1	agency communications and
1	agriculture shall have
42	1907, ch. 2907,
1	constituent, including a
3	either paragraph (1)
2	individuals referred to
1	(2) such individual
1	compelled in any
1	order controlling such
1	secretary before the
1	objections, hearings, and
1	authority for additional
2	control performance measurement
1	confirming the adequacy
1	relevant specialty; (ii)
1	services is limited.
1	(i) a qualified
2	party is not
1	history, transaction history,
1	recent change in
1	determination under section
1	proposal to the
1	infringed.  (a)agreement
1	violations  (1)
1	loan, professional license,
1	pesticide chemical (including
1	poppy, both in
1	paragraph (4)(a)(iii)(i) and
1	expanding the capacity
4	federal department or
3	agriculture, the secretary
5	issue a scientific
2	clinical hold, and
1	retail dealers is
1	(1) means 
1	(d) acts committed
1	(v) is enclosed
7	limit the total
1	(
 
 2106.
1	zealand, switzerland, or
1	enforcement duties as
1	media campaign) in
1	means (1) commerce
1	met.  (2)
4	subsection and for
1	amendment and modificationa
2	imported articles; other
1	(iv), the administrator
4	purposes described in
1	term marihuana means
1	shall submit all
1	overcollections if the
5	thirtieth day after
1	drug, (b) health
1	compounded by registrants;
1	claimant if the
1	cost of illicit
1	(ii) the nature
1	rapidly initiating scientific
8	transportation, or receive
2	year and which
1	assess the report
10	information with respect
1	applicants for distribution
1	drug abuse. (9)
1	including notification of
5	section 341 of
1	providing additional information.
1	security acceptable to
1	times after packaging
2	federal government and
1	foundation that 
1	
 904. payment
1	telemedicine in accordance
1	records) relating to
1	scientific evidence required
1	distant more than
1	 (a) imported,
1	holdnotwithstanding section 355(i)(2)
1	plans to correct
1	delivery of controlled
1	prepare a summary
3	inspected in the
1	569a, as added
1	assessments prior to
1	internet of an
1	 (i) verification
1	evaluation conducted under
1	duties of boardthe
1	(i) of clinical
2	trial if the
1	among relevant offices
1	shall establish for
1	(a) as permitted
1	requirements (a) reports
3	(a) to provide
1	consumer.  (d)
1	report. (4) a
1	means.  (

1	drug under other
1	facts supporting the
1	(f), no state
1	cosmetics, devices, and
1	1st of each
1	amendment of orderif,
2	export a list
1	manufacture or use;
1	records requested under
1	purity, and strength.
1	rare disease product.
2	states, the drug
1	(7) an order
2	article, of data
1	(a), (g), and
4	intervening as claimant
1	program revenu-neutral and
1	representative. as soon
1	means a state,
2	(1) maintenance the
1	fees is commensurate
2	name shall include
2	control program the
1	humans that are
1	tobacco products; (ii)
1	drug.  (4)
11	drug or an
2	continue to comply
1	security are committed
1	temporary order shall
1	carry over submission
3	1604(c) of this
1	(1) to limit
1	intervene in such
1	shall be prescribed
4	composition of the
1	(h) a certification,
1	include such type,
1	another approved new
4	sunscreen order issued
1	42 apply, the
1	will provide to
1	(20) -(2,-dimethox--ethylphenyl)ethanamine (2ce).
3	may not enter
2	title the names
2	duplicate reports of,
1	children in comparison
1	prescription drug marketing
1	judicial proceedings under
1	request. (iii) 
1	(b) recovery of
1	informed pursuant to
1	warehouseman, when acting
1	suspensionthe secretary shall
3	prohibited performanc-enhancing methods
1	$40,000,000 for the
2	biologics license application
2	successor regulation). 
8	section 384b of
1	(b) training food
2	formulary, or any
1	terrorist organizations. 
4	annually make available
1	meet requirementsif a
1	stating (i) his
1	 (7) memorandum
2	prevention of a
1	another for the
1	subsection.  (q)
1	deem necessary, the
1	food. (7) any
1	(e) action on
1	submitted contains information,
1	supply to manufacture
1	recommendations, including requests
1	shall evaluate for
1	information and documentation:
2	afforded an opportunity
1	title 42. (2)
1	to, or providing
1	(b)(2)(b), the administrator
1	include production and
4	facilities, and controls
1	extracurricular programs of
1	establish requirements for
1	may inspect under
1	preparing risk communication
1	to, those previously
1	summary shall, to
2	alternative therapy available
1	applies any chemical,
1	 (b) award
5	reduced to writing
1	term foreign facility
1	(b) make such
1	met the goals
5	respond to a
4	states, or any
1	year from the
1	logistics provider, in
2	initiation of an
1	(i) substantial equivalence
1	modification authorizing such
1	liaison with the
1	(g) for an
1	members.  (c)
1	transactions in food,
2	4.0  
1	liabilities (a) exemptions
3	implant.  (b)
1	food; (c) a
1	(h) the date
1	effect before december
1	hopper bin, and
2	use specified in
1	notice at reasonable
1	delivery system; 
4	initiate proceedings for
1	require that bottled
1	regulated products. 
1	(i) to practitioners
1	initiatives at the
3	(b) a description
1	nine members as
1	pyrrole ring, whether
1	change in poultry
24	drug administration and
2	drug whose route
1	previously manufactured an
4	reasonable notice of
2	makes a sale
1	(iii) importation is
1	both. (d) boobytraps
3	educational agency shall
1	necessary scientific research;
1	environment and thereby
1	sums of money
1	controls described in
1	portions thereof, and
1	market exclusivity and
5	following factors shall
1	360b, or 360j
4	reports of the
1	enhanced and joint
2	paragraph (5), or
1	compounding the drug,
1	modify it as
1	grown, or cause
1	conduct the evaluation
2	enhancement of federal,
1	reports regarding the
1	medical evaluation) at
4	agencies, the food
1	356b. reports of
2	enter should the
1	year any registrant
2	junior college, or
1	approval of abbreviated
1	measure the status
1	products manufactured or
1	effect unless otherwise
2	september 30, 2020,
1	distribution and related
1	controlled substance classified
1	ingredient, the national
1	registry provided for
3	control budget requests
1	(2) notification to
2	(ii) if not
1	information on design
1	device being exported
1	original device that
4	permits or licenses
1	occupancy or in
13	convicted of a
9	represented to be
2	establish a licensing
1	(c) reductions in
2	tag, label, or
3	direction of such
6	required under subsections
1	(b) if with
1	promulgated through regulations.
1	notify the small
1	also require, for
17	application shall be
1	pertinent to such
3	good cause shown
6	information, and a
2	requirements unduly burdensome
1	dispute resolution, with
1	act does not
1	clear vulnerabilities (including
15	finds that such
3	issue of material
1	 (a) determine,
1	intent at the
1	entity that owns
1	unless such thir-party
1	 (ii) in
1	shall be verified
6	 (ii) if
2	exports of a
2	protocols prescribed by
1	witnesses summoned under
1	action for purposes
1	response, and traceability.
1	(f) information submitted
1	commission for the
1	(
 
 822.
1	course of a
1	take back expansion
1	(3) component part
1	injunctions, require the
1	relating to lon-term
13	shall, in the
1	(c)(1)(a)(i) for a
3	require any person
1	505f, as added
3	strategies or measures
1	exceptionthe administrator may
1	applicant. (iv) a
2	subsection (a) are
2	qualified countermeasure (as
1	report, record, or
2	involved were in
1	period determined by
1	products; (10) an
1	term in excess
1	mark, label, or
1	prescription drug imported
1	(b) holiday defined
1	823(f), 829(e), or
1	findings requiredto issue
12	business day after
1	applicable law. 
2	duration of such
2	court may be
1	practitioner while acting
1	title, section 552
1	cigars notwithstanding paragraph
1	event, with respect
1	products packaged together
1	(i) such individual
1	product), including, as
1	dosing schedule, dosage
1	cosmetics, are marketed
1	processed: provided further,
3	lower risk of
1	areas and the
1	(2) inspection in
1	1884, ch. 60,
1	reasonably accessible location
1	editors of the
1	application for reinstatement
1	extent as he
1	64 stat. 21;
2	(including a smoke
8	abbreviated applications, supplemental
2	employees as of
1	study plan at
1	member with respect
1	uses and conditions
2	study plan as
1	manufacturing, preparing, propagating,
1	vitamin, mineral, or
1	provide the director
1	type of labeling
1	drug application; (iii)
1	licensed to engage
1	(4) notification 
1	recoupment in establishing
2	generalfor fiscal year
5	341 of this
1	(b)(1)(c), or (b)(3)(a),
1	request.  (june
1	 (d) termination
1	written order, taking
1	referring to the
1	constitutes an importation
1	stakeholders (including regenerative
1	center (referred to
2	recent year in
1	changes in tetrahydrocannabinol
1	year next following.
1	
 332. injunction
1	reliable and provide
3	bears the trademark,
1	secretary (under such
7	conflict of interest
1	drug reporting by
2	research activities, and
1	food from the
1	section, nor animal
1	address and a
1	request for which
1	delivering, distributing, or
1	(2) timely action
1	scientific community. (

1	request, determine whether
1	prescriptions dispensed. (b)
1	affecting production. 
1	procedures of subchapter
2	order or condition
1	 (i) proceedings
2	substance to another
1	provide for safe
1	 (1) adopt,
1	amenable species into
1	another department or
2	regulation of combination
1	order to a
1	applicant submitted and
1	contact surfaces and
1	coordinate with employees
1	(iv) governmental organizations;
3	production of documents
1	treasury. (iii) such
2	import, or export
1	enterprises (including poultry
1	distributors that are
1	(d) recertification of
1	section 301(b) of
2	withdraw approval and
2	september 1, 1997.
1	administration, and through
1	(17) return the
1	regulation establish (including
1	food; or (iii)
1	(d) small tobacco
2	drug activities means
1	appropriately licensed to
2	accompanying data which
1	needed for establishing
4	either deny the
5	apply to all
1	discretion, to waive
1	process for becoming
1	(a) as if
1	tournament, regatta, or
1	applications the secretary
2	first offense. 
1	enforcement actions used
1	states magistrate judge
1	(ii) criteria for
1	notification.  (c)
1	states, any electronic
2	declares that it
1	critical information described
1	penalty. in the
1	hydrate. (4) ethchlorvynol.
1	chain of possession
1	(1) interim report
1	consider designating products
1	data specified in
1	represents a county
2	facility at which,
1	(as amended by
1	criteria for treatment.
1	declares that in
1	347a. congressional declaration
1	 (g) sunset
2	additive for use
1	additional actions under
1	suspend any tolerance
2	separate foods; and
1	disposal sites for
5	meaning of the
3	poultry product under
1	department shall submit
1	1980, and $155,000,000
1	agriculture, food production,
1	produce an adequate
1	comments on structuring
2	conduct examinations and
1	sample, the date
1	holder to act
2	fraud, bribery, extortion,
1	guidance and, through
1	contains a new
1	regulations (which may
1	overcollections; recovery of
1	product applications. (c)
1	sampling, storage, packaging
1	(b)(1)(b) for biosimilar
1	includes full reports
5	applied for such
1	rico.  (3)
1	title 18. (i)
5	industry on the
1	used in subtitle
1	secretary shall remove
1	phrase imminent danger
2	sell such a
1	(i) intracompany distribution
1	electronically and update
1	25) through the
1	include licenses, inspection
1	analysis for each
2	section; (d) is
1	706, 52 stat.
2	offense. a fine
1	using facilitated entry
6	milliliters or not
1	transfer. such record
2	submission means a
1	outcome the term
1	research data, or
1	incident management system;
7	shall, if the
2	manufacturer of bulk
1	contributions that are
1	states (or, where
2	restricted in sale
1	review of other
2	contains a reduced
1	notice of imported
1	subsection (a)(1)(b), that
1	less than thirty
2	42 on the
1	device, dietary supplement,
1	material which the
4	committees of congress,
1	provide a 6-calenda-day
1	targets for reducing
1	manufacture only those
1	54 of title
1	single box, bottle,
10	context of use
1	manufacturers to join
1	drug to assess
1	inhibit or destroy
1	 (2) other
2	maximum extent feasible,
1	year, abbreviated application
1	(e) a comprehensive
1	warrant and of
1	work assistance that
2	illegally to receive,
1	deferral and waiver
1	quotas, the attorney
1	following amounts: 
1	open containers of
1	subsection. (5) at
1	participation an importer
1	secretary compromise, modify,
1	final regulationthe final
1	number, and model
1	recognized scientific principles,
14	agency of the
4	order to protect
1	concerning fees to
1	(b) the terms
2	(i) reflect the
1	law; (g) the
3	any) of the
14	title 42 for
1	reports, and each
1	burdens on small
2	order and any
5	bring a civil
1	level as required
1	(c).  (june
1	50 milligrams of
1	vehicle for the
1	drug crises (a)
1	case that is
1	subject an officer
6	 (i) who
1	(a) general ruleevery
1	(b), in accordance
1	person alleging harm
1	including addressing national
5	(7)  (a)
1	appropriate means, including
1	contendere by the
1	secretary, which relates
5	consultation not less
1	preventing and controlling
1	section 387f, 387g,
1	plant of the
1	removed. (d) cocaine,
2	committee shall delete
1	order either declare
1	(d) the advisory
1	135 of title
2	days, the secretary
15	shall require that
1	acute pharmacological effects
1	first of such
1	make any revisions
1	include monitoring records
1	hold burning material,
7	(a) types of
43	subsection (a) of
1	met, including, for
1	shall regulate thir-party
1	secretary. (june 25,
1	declined under such
4	part.  (2)
1	drug administration involved
1	(c) the control
1	faith and the
1	shall prioritize which
1	additional risk to
1	section. a thir-party
26	subsection (a) or
1	means any outdoor
2	substances; (5) past
1	pending decision as
2	previously been disclosed
3	quality and purity
1	(2) beginning on
1	preventive activities. such
3	commit, or aiding
2	approved, cleared, or
1	c (a) unlawful
1	term trading partner
1	domestic facility that
2	suspended under subsection
9	advanced research and
1	coordination of action
1	(ii) an adverse
5	(b) fiscal report
1	concerns a drug
1	may under such
1	information (a) cooperative
1	employment of technology
2	state in slaughtering
1	official to withhold,
1	substance, and listed
1	(1) the common
29	district of columbia,
1	deems such additional
1	designing, developing, and
1	year 1998 federal
1	(2) substitute property
1	separate from the
1	may initiate any
1	material information or
1	(iii) the physician
1	(10) process for
1	399. grants to
1	licensure of establishments
1	period of three
1	i, 15, formerly
1	 (c) manufacturing
5	may render it
1	laboratories or no-federal
1	accreditation body in
1	(a) such adjustment
1	december 31, 1974.
1	file has not
1	accreditation body if
1	one such circumstance;
1	
 373. records
1	year limitation. (b)state
1	 [1] shall
1	met. any person
1	manufacturer shall immediately
1	forms prepared from
2	new drug for
1	(2) such classified
3	include information on
2	interventions for drug
1	administration;  (13)
1	panel meetings. (5)
1	814. removal of
1	strategies (a) submission
1	director determines should
1	transactions both inventory
1	violates section 360oo
1	general controls by
1	product manufacturer a
1	packages or articles
1	secretarys disapproval of
1	subchapter, insofar as
2	television advertisement for
2	appropriate limits on
1	shall, upon making
1	requested. (b) the
12	(b) for the
4	products are not
2	achieving the lon-term
2	states. subpenas for
3	district of columbia;
1	appropriated $24,000,000 for
1	inspected by such
1	comply with additional
1	requirements, in order
1	expert scientific advice
3	exercised for the
2	receiving or maintaining
1	purchase data and
1	disposition the term
1	fee assessment is
1	(f) false statements
1	 (e) scheduled
1	receive factual evidence
5	substance is to
1	recipient.  (2)
2	substance pursuant to
2	statesnot earlier than
1	exemption in effect.
2	respect to one
1	terminated or not
2	use measurement instruments
1	pr-submission interactions represents
1	exist in them:
2	illicit manufacture of
3	patients with different
1	states, violating any
2	conduct such testing
1	articles or portions
3	order the secretary
3	representatives from the
1	disclosure any information
3	blood product for
1	paragraph (1), such
1	1, 1971, or
1	(b)(1); and (2)
8	center for drug
1	record before the
1	person performing a
1	(l) annual reports
1	congress a certification
9	upon the filing
9	meets the standards
1	monitoring the production
1	require a local
1	found. (mar. 4,
3	following conditions is
2	existing legal controls
1	title) on such
1	administrator determines is
1	cohort. (2) fiscal
2	administrator determines it
1	connection with controlled
1	inspection panel shall
3	secretary is required
5	approval of application
1	sponsors of drugs
1	request and any
1	clause (ii) 
1	of, and application
1	675, 708, as
1	private sector resources
2	distribution in, commerce
1	study thereof and
1	2014, and shall
3	substitution for any
28	meet the requirements
1	use disorder, including
1	general may accept
1	knowledge that all
1	oleomargarine, butterine, or
5	adulterated; and (ii)
2	request shall describe
2	office shall in
1	secretary shall continue
1	date labeling, issued
1	hold and preserve
1	fee means an
1	qualified candidates to
1	applicable conditions, for
1	provisions if a
1	plan.  (3)
1	granted, and the
1	duties arise from
1	general regulation provide
1	5301 et seq.]),
3	potentiality for harmful
1	media, and acute
1	2291j(b) of title
2	account any chemically
2	orders, instructions, licenses,
2	(including any such
1	functions must be
1	substantive rationale to
1	investigational submissions. (f)
1	listed chemical, whether
1	manufacturer may return
2	examine the facilities,
1	responsibility to report
1	(f) objections and
1	consumption since 1974,
1	animal.[2]  (b)
1	product to determine
2	(1) that the
1	accepted, and declined
22	certification described in
1	agreement authority the
1	chapter;  (b)
2	state requirement adopted
1	subsection (i)) prescribed,
1	initiative. (3) the
1	liquors, and for
1	(1) to small
1	level, or the
3	commerce, shall be
75	title or section
1	options to discontinue,
2	material fact. 
1	(ii)(i). (v) a
1	(1) remains in
1	
 
 387j.
1	size containing not
1	decision document which
1	6103(a) of title
1	previously approved except
1	proposed labeling; (ii)
1	publish a public
1	secretary for termination
1	parties to each
1	applicable statutes, regulations,
8	named in the
2	 (c) rule
4	coalition under this
1	specific types of
1	registered person. (b)
1	year, the average
1	concern, (e) prepare
1	(i) if no
1	(4) $270,000,000 for
3	control act of
1	secretary, a plan
1	pesticide chemical means
1	user for one
1	572, as added
3	records inspection 
1	general, is a
1	site, or organization.
1	agree upon), the
1	state to practice
1	complaint has merit
1	authorization for the
28	subparagraph (a). 
2	state, upon filing
3	section for such
1	(3) fiscal year
2	effective date, the
1	manufacturers; (h) information
1	therewith; the effectiveness
1	chapter. (3) no
1	(a)(i) of paragraph
1	court, on such
3	safety report under
1	manufacturer responding to
1	may be considered:
1	appropriate; or (4)
2	enforcement action referred
1	specific goals and
1	26, 2014, such
1	soundness of an
2	court is not
2	engaged in dispensing
1	access to unapproved
1	means not subject
1	applications received by
1	ch. 675, 772,
1	(4) the processing
9	disease or condition;
2	fiscal year 2014.
12	fiscal year 2014,
1	used; or (b)
1	reimburse any other
2	subclause (i) have
1	treatment or diagnosis
1	includes, where applicable,
1	animals. (b) establishment
2	subparagraph (a); (iii)
2	forth in regulations
1	mechanisms similar to,
1	facilities identified under
1	fiscal year 2014;
9	disease or condition.
1	drug or drugs,
1	purposes of compliance
1	thing involved would
1	u.s.c. 355]. such
1	product or use,
3	1 i-person medical
1	individual poses a
1	suggested in labeling
3	new drug application)
1	conduct an education
3	new drug application.
6	new drug application,
1	use for law
1	certification; or 
1	health, including provisions,
1	new drug application;
2	pesticide that contains
1	product as detained.
1	cos-effectiveness of monitoring
2	investigation by a
1	used or designed
1	4-day period, the
1	rapid shipment of
1	product; (ii) for
1	use has not
1	device and shall
2	drug substances that
2	assigned to him
1	health.  (d)
1	electronic products, to
1	information that will
1	standards that a
1	entering information in
1	box, carton, or
1	purposes  (1)
1	number of animal
1	violate subsection (a),
1	(d)confidentiality.  nothing
1	shall monitor and
2	shall not grant
1	person that submitted
8	necessary to enable
1	including technologies used
1	completed and the
1	committeesit is the
2	determines, on the
5	intended to treat
1	(2) such ingredients
1	matchbooks is not
1	performance characteristics of
1	application imposed after
3	inspection and other
1	(e) certification of
1	access to disparate
2	packer of the
1	appropriations by a
2	(5) all contracts
1	environmental assessment that
1	animal under this
3	adulterated if use
1	18; or (4)
1	initiatives described by
1	repository for use
1	name, serial number,
1	programs and service
1	barrel fails to
1	notice being given
1	determined necessary and
2	(2) termination of
1	imports tobacco products.
1	(v) a nonprofit
1	duly authorized federal
1	products (a) regulations
1	product fees, based
1	countermeasures; and (7)
2	title, a reference
2	shall, notwithstanding section
1	(a) corrective action
1	delegates or representatives
1	medicine, and public
1	conduct duplicative clinical
1	commission, upon request
1	cats, except that
1	purchase, trade, or
1	(b) be transferred
1	preceding such fiscal
1	 (h) small
8	necessary to prevent
3	(iii) the same
1	plead guilty to
1	ecgonine (and all
2	cooperation and coordination
1	standards of quality
2	 (a) its
1	mark; or use
7	reporting requirements (a)
1	(2) consent required
1	tomography drug or
4	(c), and (d)
1	description or other
1	proceeding.  (ii)
1	programs under this
1	(c) based on
1	may recover any
1	(including, for antimicrobial
21	regulations issued under
1	buyers to internet
1	clinical setting. (v)
1	information, or transaction
1	smoke contains a
2	director there shall
2	objectives specified in
1	distribution notify the
23	holder of the
1	chemicall-related or pharmacologicall-related
1	sentence or by
2	(b) the classification
1	(c) duration the
1	secretary, a statement
2	individuals in the
1	subsection after such
3	may determine to
1	obtain from the
1	substances screening program
2	commands, induces, procures,
1	food safety. (

1	established in terms
5	contracts with such
1	providing advice and
1	ongoing safety surveillance,
1	impact of activities
1	administrator shall carry
1	section 360e(i)(2) or
1	council means the
3	cost to the
1	fields; (5) develop,
4	information.  (e)
1	facility, individual, or
1	us-by dates, and
4	removed; (ii) cocaine,
1	(ii) coordination and
2	attorney general pursuant
1	ensure the responsible
1	revisions of such
1	(7) such other
1	(11) to distribute
1	(d) regulation of
1	then, unless subsection
1	(e) refusing, withdrawing,
1	regarding a drug
1	(ii) before promulgating
1	(1)(a) or which
1	drug and an
1	21, formerly 19th
1	
 209. poisons;
1	requested. (june 25,
5	(i) shall not
1	found by such
1	academic organizations; and
1	disposition.  (3)
1	flocks directly to
1	present in the
22	parts or products
1	(1) such person
1	(a) extension if
4	drug manufacturer or
1	clause (i) except
1	distribute such information
1	report or make
2	shall prescribe) for
4	order, rule, regulation,
1	individual without that
1	trial are the
1	42 that requires
1	1044(a)(1) of this
2	components, ingredients, additives,
4	impairment of a
2	case of contumacy
1	suspend, unless during
1	clearance of 
1	manufacturing inputs, and
1	refuse to make
2	 (h) preemption
1	treatment research and
1	loans relative to
1	(b) administrative procedure
14	or, in the
8	subsection (a) relating
1	data on exposure
1	intermittently. (4) the
1	(e) false statementsany
1	meet regularly and
3	unaffected the provisions
1	clearly for personal
1	cleared under section
2	temporary or permanent
1	foo-producing animals; and
1	validity of nonconflicting
1	food when distributed
3	accredited by an
1	regulated person means
7	sections 355a and
1	prescription drug by
1	paragraph (4) shall
1	prescription, in accordance
1	barrels in violation
1	counted under section
1	current list that
1	chain stakeholders, issue
1	formulas which may
1	priority for applications
20	552 of title
2	evidence. (3) upon
1	(1) consultation with
2	organizations; and (ii)
1	priority application or
1	fee collections through
1	advertising  (i)
1	cubic centimeter in
1	differing from official
1	concerning the location
2	progress and effectiveness
1	manufacture, packing, or
1	determine the completeness
1	remedy for any
1	(a) the secretarys
1	product classes; (2)
1	animal be delivered
1	supplement which contains
1	replacement of electronic
1	specific high risk
5	(a) shall summarize
29	contained in the
1	excluding the amount
1	melons shall relate
1	citizen participation and
19	review of animal
1	worked together on
2	small number of
1	opiate or opioid
1	induces cancer in
1	secretary; (c) invite
1	intramural research proposals
1	accredits, or otherwise
1	data compensation to
2	responds to the
1	(1) the recommendation
1	entities. (iv)complementary approaches.to
1	exists, irrespective of
2	(ii) during the
1	solutions; (p) the
2	(ii) the medical
1	resubmit a copy
1	successor regulations); (iii)
3	particular; (2) if
1	inspection; notice; promptness;
1	regulation for such
1	products into interstate
1	22, 1996 subsection
1	production, shipment, receipt,
1	briefs. (2) 
4	applicant has made
2	items specified in
1	announcements. before issuing
1	designating bulk drug
3	means a state
1	pack, box, carton,
2	listed chemical, knowing,
1	statements for not
1	(1), in any
1	section 1037 when
1	832833) [21 u.s.c.
9	drug pursuant to
3	secretary or any
1	investigational drug by
1	(c) at least
1	exemptions pursuant to
1	date assigned to
1	grant individuals a
1	determine the amount
1	another national drug
2	(ii) publish a
1	misrepresentations by purchasers
1	agency relationship between
1	applicants whose biosimilar
1	ch. 675, 735,
5	recognized under paragraph
1	transferring a drug
1	ingredients are permitted,
1	notice is issued.
2	public health reasons
1	poultry products, by
1	biological products. 
1	sections 314.70 and
1	responding to requests
1	encourage further cooperation
1	commerce, (1) any
2	section 387q(c)(4) of
1	judicial review related
2	act (5 u.s.c.
1	reallocated to the
1	including criminal penalties,
1	crime associated with
6	section as follows:
1	exacerbation of chronic
1	secretaries of the
1	serve as chairperson.
2	human use shall
2	committee described in
1	suspension from duty
1	scientific evidence regarding
1	 (c) preventive
4	presented to the
5	includes an affiliate
1	(vii) available information
1	temporary order. (3)
1	employees of regulated
1	product presents less
1	order or injunction,
1	section 7625 of
1	(c) no request
1	seeks conditional approval
1	requirements of regulations
3	fee revenues from
1	via either, at
1	including the prescribing
1	1534. technical assistance
2	sample. for purposes
7	(a) in generala
1	year 1993 and
1	(3) shall apply
2	(pursuant to section
1	objectives and targets
2	360fff5 of this
1	prominently; and (b)
4	time they leave
4	within such additional
2	3, 1996, shall
1	adequately determined after
1	activity to cultivate,
1	substance;  (b)
2	narcotic, or chemical
2	scientific evidence provided
1	final guidanceirrespective of
1	secrets the secretary
1	articles of food,
1	state, or federal
2	unless sooner withdrawn
2	(l)(3), or revoking
1	applicant to dispense
1	management plans developed,
1	stamped, or labeled
2	submit a supplement
1	dispensed at such
1	ii, include in
2	number of devices
1	counterfeit or in
1	manufacture-provided information on
3	distributed.  (iii)
1	prepared by any
1	reasonable definition and
1	protect against, and
1	 (6) limitations
1	accredited persons, and
1	monthly) shall be
1	necessary.  (ii)
1	votes to achieve
2	 (i) before
1	submitting a covered
6	unsafe for use
6	engaged in or
1	schedule v. 
1	food in its
1	coordination of applications
1	person and after
1	(3), a determination
4	site or organization
1	support the review
1	permit entry of
1	(c) no priority
1	 (j) the
1	law; (3) any
2	effect the requirements
1	requirement beginning 1
2	complaint on the
1	treatment, rehabilitation, research,
1	obliterate a symbol
1	(i) the qualified
1	(b) beyond the
1	optical isomers. (j)
1	(b)development of postmarket
5	human services may
1	(b), is to
1	information, including 
1	important gaps in
1	manufacturer, subject to
2	contract carrier or
1	2017, $12,900,000; (5)
1	product;  (2)
1	secretary, who is
3	controlled substance, the
1	qualified employees, the
2	dismissed supplier was
1	timely manner; (2)
1	authorized committees of
2	veterinarians professional practice.
21	amended 
 

1	dismissed defendanta court,
1	subparagraph by entering
1	(a)(vii), the attorney
1	programs of state
1	drug in decreasing
1	records (a) in
1	variety of stakeholders,
1	secretary the name,
1	
 
 349.
2	sentenced to imprisonment
1	42. the requirements
1	appropriate, revise such
4	permit entry or
2	unlawful to distribute
1	products currently are
5	clinical data (other
1	(b) other animals,
1	destroy a suspect
32	grams or more
1	(2) later fiscal
2	entity described in
1	partisan political purposes,
1	exportation; disqualification of
1	relating to offenses
1	(
 
 871a.
1	institutions, or the
1	manufacturer. for purposes
1	dispense by means
2	program in a
1	submission is submitted
1	taken under said
1	award under section
1	(a) be authored
1	(b) recruitment for
1	united nations that
1	(b) action taken
3	uniform size and
1	approving all funding
1	agency determinations of
1	stated below: (a)
1	notifications in the
1	section. (2) public
1	(i) the decision
1	matter as the
2	year 2008, not
2	ii if he
1	identification of significant
3	appropriated under the
8	(c) of section
1	(i) is purported
1	 (i) substantial
1	making a declaration
2	381(h)(1) of this
2	register the fees
2	chemical under the
1	copies to secretary
2	seafood hazard analysis
1	commodity in conformity
1	remedies available to
1	efforts to further
1	granted exclusivity period
1	differ based on
1	reported; (4) shall
2	modified, or altered
1	officer means a
1	imposing additional recordkeeping
1	agree on common
1	(iii) subsections (b)
3	determine whether there
2	adopt final regulations
1	section 103(q)[3] and
1	food imported in
1	government has authority
1	applicant; (g) a
1	additives) in or
1	(2)(a) available solely
1	making periodic assessments
1	food emergencies by
2	exposure to, or
2	tobacco product commercially
1	communication plan not
2	document shall be
1	establishes a rule
1	restrictions under paragraph
1	clearance on the
1	permit states and
1	product is part
2	protocol signed at
3	reports of all
1	theretofore issued or,
1	small businessesnotwithstanding paragraph
1	operators on or
1	considered at the
1	period preceding 1996,
2	(a) jurisdiction of
1	(1) is intended
1	 (k) relation
2	days, on the
5	2907, title ii,
1	greater risk than
1	benchmark survey of
1	significant outbreaks during
2	minor species for
1	calcium (mg) 50.0e
1	compliance as described
1	section) any abbreviated
1	interstate commerce; (b)
1	conducts business; and
1	letter that the
2	documentation of committee
2	state which are
1	(b) conferences any
1	free flow of
1	adults of the
1	referral (or request
1	inspection services under
1	appoint outstanding and
1	circumstances surrounding the
2	waiver shall submit
2	inspection services (a)
1	38 stat. 822.)
1	(c) and is
1	meet the special
1	section 971 of
1	1996. the determination
2	expand or limit
1	subsection (b)(3). 
22	in, and the
1	research into the
2	ruling on a
2	establishments  (i)
1	360. registration of
1	health; or (5)
1	intelligence sharing with
1	violations, of this
1	services under this
1	propionic anhydride. (p)
1	regulated person importing
1	federal employees federal
1	indication proposed in
1	likely to contribute
3	subsection (f) or
3	title during such
1	 (b) from
1	vital for congress
1	software can be
1	confidentiality of patient
1	20 and amended
1	1946 (60 stat.
5	subsection (f) of
1	standards, and other
2	substance is required
1	675, 506, as
1	relabeler, or distributor
1	list which shall
1	provided.  (b)
6	2014, the secretary
1	territorial exemption; refusal,
1	(a) that information
1	pholcodine. (22) thebacon.
1	drug application. (

1	reimbursement, shall not
1	service of ex
1	projects.  (d)
1	upon the amount
2	information and reasons
1	prescription article under
2	invalidity), the approval
1	title. such certification
4	subsection is not
1	research and increase
1	title the information
1	notification of transfer
5	issuance, amendment, or
1	grains of opium
6	regulations under subparagraph
1	milk from which
1	term authorized purchaser
1	times set forth
2	qualified en-user, with
1	intramural and extramural
2	place, whether permanently
1	health. such date
1	demand of either
1	(bb) except as
1	(1) is by
1	compromise of claims
1	section 897.34(a) after
1	inspection, including the
3	available to him
3	entity organized under
1	title; or (16)
2	shall endeavor to
2	(and supporting documentation
1	5 u.s.c. 3101
1	year involved by
1	faith efforts by
7	drug.  (c)
4	chapter, or the
7	secretary determines appropriate
1	following applies for
1	subsection (o)(3) more
1	certified to the
1	recommendations as proprietary
4	 (c) payment
1	chairperson, by designating
1	state licensing of
1	methamphetamines. (
 

1	exemptions (a) in
1	interagency agreement with
1	(a) misdemeanors; felonies:
1	limit any existing
1	framework  (1)
1	information derived either
1	term counterfeit substance
2	allowed in the
1	3(a), 64 stat.
1	assessments; (ii) a
3	section 1037 of
1	requirements were considered
1	radiation safety, as
1	 (e) verification
1	year, including a
1	packaging for use
1	administer drug tests
2	secretarys response to
4	unless the carrier
2	 (b) guidance
1	availability of raw
7	opportunity for comment
1	research protocol 
1	expenditures incurred in
1	federal regulations for
1	enhancing public awareness
1	provide the explanation
1	compounding (a) in
3	made in good
3	eggs fit for
1	blister packs is
6	ingredients in recognized
2	granted. an individual
1	of, and the
1	advocacy in support
1	drug administration relating
1	(1) if such
1	market or local
2	committee under paragraph
1	sell, by public
2	states of licensure
1	misbranded, or with
32	receipt of a
1	(b) if in
1	subparagraph and forwarded
1	submission of comments,
1	experience that is
3	promptly after the
1	egg product means
1	occur prior to
1	establishments it shall
1	956. exemption authority
1	practitioners authorized to
1	issue a subpoena
1	governments in preparing
1	systems; (6) build
1	investigational submissions and,
1	slaughterers or processors
7	(b) if it
1	quantity and establish
1	drug concentrations on
1	resulting from a
1	whether drugs or
1	(c) dispute resolution
1	consular districts in
1	387p. preservation of
1	24, 1984, whichever
1	42; or (ii)
1	health, and other
13	information that the
3	previous calendar year
1	device, (iv) provisions
1	following year. 
2	section 3502(3) of
2	drug, and (ii)
2	proposed regulations under
1	(iii)(i); or (ii)
1	caused, directly or
2	patent nor the
1	united states. similarly,
1	feed for the
1	request in making
1	based upon its
1	diseases or pests.
1	noncash, i-kind emergency
3	contained the same
1	informing the individual
1	possible existence of
2	made only in
5	representative of such
1	(b)(1), except that
1	registration; qualifications; waiver
1	make the submission
2	product, device, food,
1	regulations be under
2	written form and
1	nations and affiliates)
1	intensify and expand
1	precursor chemicals. the
1	grant recipient to
1	youth; and (8)
1	electronic communication to
2	controlled by, or
1	sentence. notwithstanding section
2	designate such state
1	compounded at the
2	term substantial evidence
5	secretary shall implement
1	(a) such regulations
1	joint training on
1	effect, develop, as
1	secretary shall, if
5	ii, iii, or
1	conventional size containing
19	secretary shall, in
1	foods the secretary
1	criteria standards that
1	title, in existence
3	proceeded against and
1	grant; (c) an
1	substance means 
3	saleable returned product
1	(2)(b) by such
1	states; (iii) the
1	 (5) financial
1	lawful order of,
1	submit to committee[1]
1	product application. (e)
1	illness risk associated
1	fees from, each
1	research to ensure
1	adjustments for fiscal
6	reauthorization; reporting requirements
1	refuse admission to
1	subsection (c) may,
2	added to or
1	(d) a certification
2	less than $1,000
1	paragraph (a)(1) under
1	(g) 300.0 
2	incidents of the
1	phosphorus ratio must
1	pharmacy in accordance
1	chapter. (v) the
2	may use standard
2	subsection (b) after
1	approach provided for
12	 (b) 
3	issue of the
1	30 percent today.
1	access protocol), the
1	(6) for fiscal
1	adjustment factor (as
1	approaches that are
5	18 f.r. 2053,67
2	authorization described in
1	pharmaceutical ingredients identified,
1	schedule, other substances
1	effectiveness of pathogen
3	grade minimum size
1	regulation removing the
3	shall consider, among
1	marijuana, heroin, cocaine,
1	misbranded. and[2] 
1	certain bacteria, fungi,
1	methodsthe secretary, taking
3	days after making
1	outsourcing facility fees
1	received such eggs
1	(l) rule of
2	mileage that are
1	use are suggested
2	waive any requirement
1	oil. (b) a
1	subsection (b). this
1	chapter or a
1	section (specifically administrative,
1	parties, to enforce
1	assign an agency
1	gross deception of
1	expected demand for
2	information on public
1	subsection (f)(3)(a), the
5	misbranded under this
3	esters, and its
1	recommendations, if appropriate,
1	state to perform
9	shall issue guidance
1	government employee, as
4	based on evidence
1	description submitted under
2	 (d) rulemaking
1	requested order outweighs
1	 (b) matchbooks
1	(2) any requirement
1	animals and for
1	gene, with respect
2	including programs for
5	collect such fees,
1	complete a transaction
1	section 3324(a) and
1	service or material,
1	modification under section
3	type described in
1	
 847. additional
1	(c) incorporates or
2	withdrawal, suspension, restriction,
1	device. (iii) nothing
1	particular uses and
1	(a) is issued,
1	application, or the
1	manufacturer is required
1	receives federal funds
1	state initiative this
1	scientific judgment. upon
1	customers in such
1	verification the secretary
1	(b), and representatives
1	802(33),[1] shall, if
2	(iii) provisions for
8	obtained a right
1	officials a federal,
2	treaties and other
3	formulation cannot be
1	chemically, or otherwise
1	seamless, rea-time tracking
1	(3) the remedy
2	november 26, 2014;
1	necessary by him
1	labeling on the
3	traveltime) they are
2	(b) authority for
1	submit, at the
1	(2), the head
1	bodily injury means
1	subsection (h). (iii)
2	shall disclose (other
1	food, any disease
1	november 26, 2014)
1	 (b) identit-preserved
1	system, and (2)
5	november 26, 2014.
2	withdrawn before being
16	november 26, 2014,
13	substance or list
9	request for verification
1	part, as appropriate,
1	creatively all legal
1	subsection (a)(1) an
2	populations, from abusing
1	(v) an examination
1	(11) package 
1	hearingwithin 180 days
1	(3) for a
1	letter shall submit
6	significant controversies or
1	agents, and contractors
1	criminal charge against
2	chemicals under seal
2	supporting documentation and
1	able to determine
1	egg that is
1	imposed and collected,
1	goods prior to
1	appropriated for counterdrug
2	insulin and antibiotic
1	 (13) law
1	(v) 10 grams
1	agreements beginning 6
2	shall not introduce
1	financial interests of
2	assessment by the
2	shall be signed
1	effective date established
1	confidential information 
1	agencies; informed personsin
1	without further appropriation.
3	section relating to
1	refund under subsection
1	consulted with and
1	(b) was approved
2	term package means
3	materials into official
1	warrants, administrative inspection
1	procedures.  (2)
1	including whether a
1	distribution of no-alcohol
6	identified as required
4	death, the secretary
1	used, and that
1	 (d) deputy
1	applies, the seller
1	designees:  (i)
1	 (b)immediate publication
1	describing, if appropriate,
1	employ technical experts
2	shall not limit
1	sponsor conduct appropriate
1	modification (including a
1	(including the authority
7	new dietary ingredient
1	title. (6) whether
1	describes food and
1	2011, and are
2	identical verified statement,
1	(iv) right to
1	title. (2) regulations
2	 (d) annual
1	granted by this
1	take effect upon
1	pathogen controls in
3	recognized under section
10	(b) of section
1	assisting another to
1	 (7) subsequent
1	education progra-sponsored programs
1	consumer or user;
1	application. (c) civil
1	requiring that audits
1	injurious nature cannot
2	 (1) authority
1	inform ris-based inspections
1	commitments, to the
1	legal right, title,
12	hearing shall be
1	(d) the drug
1	certificate that the
7	information for such
5	shall be refunded
1	misrepresentation of strength,
2	consumer or user.
2	model standards developed
1	shall revise and
1	labeling exemptions (a)
1	make a notification
1	period is warranted.
1	place on public
1	information between each
2	within 120 days
1	terms of per
1	known by the
1	means an athlete
1	manufacturers are required
33	paragraph shall be
1	take place. 
1	program.  (3)
1	order for total
1	animal, unless it
1	impose, in addition
1	examples of activities
1	secretary), in consultation
1	order to fund
1	may require notification
1	determination applicable to
1	(c) if any
1	administration; (2) track
1	reinspection fee (if
1	operating reserve the
1	paragraph (2) establishes,
1	safety of food.
1	ergonovine and its
1	applied to consultation
1	roach clips: meaning
1	title. article 7
8	product.  (b)
1	identify and avoid
3	scheduling the drug
1	food contamination; and
2	required to list
2	label, packaging, and
2	employ more than
1	20 years, or
1	(5) a permit
1	8th par., 34
1	previous year, increased
1	(
 
 1536.
3	dispenser may request
2	title and were
2	product in lieu
1	abuse requires the
1	rico and the
2	(j).  (b)
1	(b) record of
1	(a) is imported
1	inspection service. receipts
2	(1) carry firearms;
1	extrapolation a brief
1	approval or licensinga
1	subsection (b)(2)..[1] (d)
3	(e) or was
2	safe process or
1	pesticide chemical will
2	publication  (a)
1	harvesting or importing
1	contained in another
1	finalize the regulations
1	device of that
2	determined that there
1	activities pertaining to
3	temperature of no
6	may assess and
1	(b), (c), (d)(3),
4	set by the
1	415, as added
2	opportunity to be
2	include the term
1	finalize regulations under
1	one resubmission for
1	title and submitting
18	information on the
1	poultry ingredients only
1	2010; and (ii)
1	35.0  (with
1	section shall take
1	required reports, in
4	extent practicable such
1	(2).  (5)
1	serious illness or
1	encourage the food
1	less the legal
4	substantial evidence, shall
2	use of real
1	producing animals, the
3	establishment has been
1	collaborating with one
4	 (i) coca
1	agent), or (b)
1	rescission or modification.
1	list of eligible
1	found. if the
1	aid; limitation on
1	secretary of drugs
1	product chooses not
3	judiciary of the
1	productthe term eligible
2	state defined as
2	applicable fee under
1	draft guidance described
1	term defined in
1	(5) the promulgation
1	entitled to practice
1	forfeited property 
1	contracts or agreements
4	damage or inferiority
1	provides accessible, timely,
1	facility on which
4	procedure developed by
2	modified under subsection
1	(a). (e) a
1	communications by manufacturers
2	section applies and
1	2107. sense of
1	security, health, disability,
1	1908. judicial review
1	tobacco, which 
1	tried in the
1	obstacle to accomplishing
4	action package for
2	identity and strength,
1	nicotine in each
1	children.  the
2	preparation of human
1	importer may not
1	784, 1, 32
1	prohibition; compliance with
1	(d) waivers 
1	approval is necessary
1	biennial inspections for
1	first examination and
1	medicinal ingredients in
1	part.  (c)
1	determination to grant
1	list quarterly to
1	submissions that refer
3	depletion studies, except
2	technical effect. 
3	chapter to the
1	declaration with respect
1	dru-related goals and
1	may conduct the
1	chairperson or c-chairpersons
4	system under section
1	commission, shall appoint
1	library of medicines
1	section, not less
1	amount estimated to
1	character, ability, and
2	safety of articles
1	(8) amended reportif
1	exemption, the secretary
1	support to communities
1	accredited person, the
1	defendanta court, upon
1	later time, if
6	established under the
1	
 387n. jurisdiction
1	statute; and (b)
1	substantial scientific issue.
2	registration of such
1	(ii) title to
1	pro bono public
1	agriculture, consider the
1	physiologic, pathologic, or
2	periodic inspections under
1	(i) information that
1	
 41 to
17	first 3 years
1	environmental impact statement
2	seller at the
1	species; (b) a
5	subsection (f). 
1	(4) the manufacturer
1	(3) shall take
1	marked and labeled
2	input during the
1	substantial quantities of
1	infant formula includes
1	term filled milk
8	person convicted of
2	(3) training to
1	dependence (a) in
1	required to consider,
2	distributed by, such
33	chemical residue in
1	reduce individual production
1	2002, funds in
1	fee was assessed,
1	states depend on
5	state the findings
1	through, or on
1	(a) (referred to
5	increases in the
1	(d) any failure
4	behalf of an
2	audits  (1)
1	(b) through (d)
1	december 2021, the
1	condition for the
1	certified statement signed
1	model plans described
4	quality control procedures
1	actions committed to
3	453(g) of this
2	applicant within a
2	establishing a submission
1	25.  (11)
1	
 371. regulations
1	subchapter for the
2	waive under paragraph
1	grant recipient or
1	strategy; and (ii)
1	(c) acceptance of
3	 (2) regulations
4	retain a sample
1	states. such proceedings
4	previously filed application
3	intent to submit
1	title as he
1	lifetime risks from
1	confirm that the
1	case of dry
1	classification of any
2	4 years thereafter,
1	severally liable for
1	health organization such
1	abuse; and (iv)
1	medical devices; (13)
1	exporting any controlled
19	good manufacturing practice
2	(ii) show that
1	address at least
1	 (3) tropical
1	 (a) six
3	agents as he
2	devices subject to
1	advisory committee. within
1	(ii) when dispensed
1	authorized repackager, wholesale
1	expire prior to
3	fee or portion
4	secretary for filing
18	receipt of such
1	businesses.  (b)
1	petition relies; (b)
1	regulation shall issue
1	appropriate measures within
1	applicable. the secretary
1	year. (3) when
1	required to report
2	united states, to
1	reinspection fees under
5	fees for the
1	matching funds 
2	medical evaluation demonstrates
2	history, as applicable,
1	property pending the
2	35 employees as
2	descriptive and analytic
1	distribution records under
1	quality regulation to
1	practitioner.  (c)
1	drug meets all
5	production, use, or
1	standards applied to
1	exception in this
1	title. (iv) proposed
1	project, may be
1	persons appearing to
102	set forth in
5	(2) for the
2	conduct or to
2	highest court of
1	maintaining an internet
1	new drug have
2	retailer and a
13	states and the
1	(2) special rule
1	provide authority for
1	compounds or dispenses
1	director. (h) role
1	presenting to the
1	may treat as
1	substance. in making
1	redesignation; designation for
1	restrictions and, if
1	subsection (i) before
1	shall finalize guidance
7	both. notwithstanding section
1	petition was filed.
1	establishing the world
1	safety from electronic
1	ch. 675, 908,
1	secretary and furnish
1	(k) transitional provisionif,
2	revenue service in
1	organizations, and other
1	(1) reviewing the
1	(iii) published guidelinesnot
1	any, risk there
2	 (d) reinstatement
1	(3) to enhance
1	-month period. 
3	declaration of policy
1	regulation prescribe performance
1	(iii) other information,
1	submitted, such report
1	(4) no agency
4	held legally responsible
1	format understandable to
1	shor-range and lon-range
1	person receiving it
5	secretary, by the
1	information, document, or
3	regulations shall 
1	paragraph that receives
1	uniform, scientifically driven
1	study conducted after
1	hearings, the secretary
1	(c) selection of
1	
 145. penalties
1	(7) notwithstanding any
1	dietary supplement: manufacturing
1	condition that 
1	denial, whichever occurs
1	registrations  (a)
1	losses of drug
1	
 360bbb2. classification
2	chapter; (2) definitions
1	policy, the secretary
6	data relating to
4	effectiveness data and
1	post the eligibility
1	(b) acquired by
1	materialthe term raw
4	restricted under a
1	products for research
1	proposed under this
1	international consensus standards
1	official may submit
4	exporter of a
1	ammonia across state
1	official abstract of
1	section to not
2	 (2) identify
2	section shall remain
2	laws and regulations
1	public meetings at
1	(2) tangible and
1	review of inspection
1	authorizedthe secretary of
1	safe for its
1	otherwise stated, the
1	respect to cultural
1	industry. members of
1	(7) repealed. 

1	requirements.  (b)
1	reg. 8961, shall
7	iv of this
1	reference or hyperlink
1	fictitious, or fraudulent
1	may not accredit
11	373, title iii,
1	permanent ineligibility any
1	service means the
1	shall fix a
1	accordance with directions
1	requirements shall apply
1	treasury, at least
1	secretary, upon request,
1	nanomaterials included or
1	shall prevent an
1	device in each
3	development program for
1	support for manufacturer
1	 (f) not
1	abide by the
1	extracted; (6) assist
2	chapter when, in
1	unique number is
1	dispute resolution proceeding
3	request a waiver
1	basis, as determined
1	supplements. such regulations
2	head of another
1	enforcement agency under
1	changed by like
1	42; and (4)
1	studies requirement 
1	states be registered
1	provisions shall not
1	manufacturers receive access
1	payments, shall not
1	international treaties relating
1	(e) small businesses;
1	consider the responses
1	subsection (a)(3)(f) shall
1	tobacco products. subject
1	drug interdiction coordinator
1	and, through a
1	(c) conflicts of
48	use in the
1	avoid a significant
3	writing and shall
7	officer designated by
1	methods (a) examination
1	stat. 1056; 

1	states, the prospects
1	decline by as
1	punishments any person
1	year and a
1	publicly available. (iii)
1	chapter as he
1	(2) each applicant
1	gas is approved
1	information from stakeholders
1	resources and facilities
1	questions in the
1	date or dates,
1	designated foods in
1	abstinence (whether imposed
1	present a yearly
1	 (a) $7,328,000
2	food (a) in
1	coordinate food safety
1	risk of not
1	entitled to acceptance
1	notwithstanding state law,
1	thereafter as such
1	18 and amended
2	drug administration employees
1	including the armed
10	labeling for the
1	contracts.  the
1	directly into the
1	treasury. the court
1	enabling and ensuring
3	entity is in
1	therein, and, except
1	red meat, and
1	developing the national
1	benefitsnotwithstanding any other
1	consequences of the
2	bringing in or
1	unfinished materials, containers,
1	meat articles are
1	medical, or other
1	government to place
1	space of suitable
5	(a) there is
1	bear the information
1	attorney general (which
4	joined in any
3	authority to promulgate
1	government agencies, or
1	requested by such
1	amount calculated under
2	basis of all
1	paragraph (2) that
1	recalling a food,
1	(
 
 2242.
1	 (g) administrative
1	shall apply 
2	respect to drugs.
1	ownership, name, and
1	(
 
 1054.
1	 (5) milestones
3	linked to the
1	product are informed
4	order to meet
1	separate buildings within
1	prosecute the individual
1	use or destruction
1	examining the capability
1	generic activities are
1	restricted eggs in
2	standards shall not
1	determines that notice
6	greater minimum sentence
2	effectiveness of an
1	timeframes; (3) data
1	supplant pro bono
1	multiple reinspections in
1	individual indian from
1	practice has the
1	list of date
1	presumed to exist.
1	amended application is
1	point means a
1	program, the health
1	sales quantity; requirements
1	commerce, and (3)
4	may declare a
1	556(d) of title
1	sales means the
1	addiction certification or
1	products, to the
1	conduct investigations or
1	new drug in
4	fiscal year) multiplied
1	method of manufacturing
4	reference to any
1	promulgated, but may
1	agriculture duly authorized
1	advances and meets
1	use of nonapproved
1	class i under
1	food additive, file
5	firms, and corporations
1	(g) grant amounts
1	thereto, and at
1	technology comprising no-replicating
14	paragraph, the term
1	preparation and sale;
5	(1) by the
1	28, 1976; or
1	(f) in the
1	(f) inspection the
1	secreted, or procured
1	identifier, shall be
1	including from private
12	results of such
1	(foodnet) and pulsenet
4	16, 1988, and
16	device which is
1	(
 
 877.
1	substance. as used
1	secretary file the
1	 (6) involvement
2	imports into the
1	resources.  (f)
1	burdensome effect upon
1	(1) the issuance
1	outsourcing facilities (a)
1	(b) effective date
3	apply to separate
2	(i) advisory assistance
1	title within 5
1	purchaser that such
1	(b) new time
2	addiction, or is
2	maintaining records, or
5	20 years or
1	made on, through,
4	disclosure pursuant to
1	therein the name
5	sections 360d and
1	audit conducted, in
2	which, in his
1	studies, has been
1	risk of illegitimacy
4	reasonably believes is
1	(1) advisory committee
1	validated but a
1	1034. inspection of
1	publish it. (4)
1	subparagraph (a). (iv)
1	persons (excluding farms
1	31.  (h)
1	conditions identified on
1	use, which have
1	mixture under section
1	(6) may appoint
2	 (e) supplement
1	(b) contains a
3	records under this
1	period termination180 days
1	handle more than
2	false or fraudulent
2	relations involving federal
1	therapeutic category are
1	agencies concerning traffic
26	united states to
1	list such additive
2	public, academic, and
1	(15), if the
2	certification; and (ii)
1	small businesses, updated
1	public his license
1	include interruptions in
2	care of such
1	drug administration. (june
6	(c) scientific and
2	procedure in issuing
1	(5) fund the
6	person for whom
1	whether such consumer
1	terminated by the
1	substance analogues a
1	regulations may, within
1	comments the secretary
4	person intending to
1	operates, directly or
1	commission, office, establishment,
1	247d6(h)(4)1 of title
2	title 25). 
7	activities related to
1	preempt any state
1	title iv, 406,
2	types of feesof
8	word, statement, or
1	333, or 334
1	opium may be
1	credible evidence shows
1	ii. the regulated
1	activities of administratorthe
2	determine the withdrawal
1	farm, unless the
19	title with respect
1	showing of the
1	including sanitary standards,
1	good faith any
1	cabinet. (ii) the
1	waiver the attorney
1	appropriate state licensing
1	thereof, unless they
1	injury results, nor
1	damages described in
1	secretary as necessary
1	extent available and
1	controls, and facilities
5	accredited thir-party auditor,
2	(a)(2) or (3)
1	immediate steps to
3	established by or
1	
 26. omitted

1	health, (b) the
1	framework in the
2	internet  (1)
1	(c) providing reliable
1	(p) electronic registration
1	legible form all
1	information, serious risk,
2	 (g) recordkeeping
1	activities, public information,
1	report, required under
1	section 321(g)(1) of
1	use the labeling
1	number of violations
1	substancesthe drug is
1	united states. (29)
1	procedures.  the
1	maintenance of reserve
1	fee.  (ii)
1	compendium. (d) carbon
1	paragraph (3) an
4	(i) coca leaves,
1	(2)(a)(i) shall not
1	consistency with the
2	section 642, 643,
1	specific issues in
3	actsit shall be
1	distributor on the
1	use only and
1	measures prescribed herein
3	scientific evidence. 
1	2008 and any
1	lon-term fashion; and
1	shall include regular
4	applicable circumstances described
1	coordinate, and ensure
1	(b) imports a
1	food recallsnot later
10	acting in the
1	suspect or an
11	application, the secretary
1	contains any controlled
1	tribal governments; and
1	sold, the court
1	communication should occur,
2	reports; required information;
2	hig-risk facilities identified
3	participate in such
1	logbook corresponds to
1	biosurveillance and public
1	(a)(3) if the
1	shall, at or
1	center means any
2	remedies (a) notificationif
1	amounts for such
1	injury and the
2	identified and recognized
1	temporarily unable to
2	 (3) relation
1	chief scientist there
1	
 6. transferred

1	rather than an
1	division. (2) community
1	 (a) plans
1	design and procurement.
1	amounts (as defined
1	item, as submitted
1	retain the property
2	installation of, such
2	(1) the commission
1	final determination with
1	registration; (3) who
1	proposed change under
1	filing in court
1	qualified for its
1	drugs;  (d)
1	serious unexpected adverse
1	(a) no award
1	listed, are generally
1	smoke constituents, or
4	5 f.r. 2421,54
1	subsections (a)(2) and
1	heads with respect
1	1.1 nor more
1	apply (a) when
1	application for licensing
1	(2), the administrator
2	required to 
5	shall conduct an
3	met:  (i)
1	leaf without the
2	person may appeal
1	pulmonology, cardiology, toxicology,
1	offense, one or
1	implemented through documentation
1	30 of each
1	(f) temporary denial
1	u-regulation, or activation)
1	contact substance may,
1	extent.  (b)
1	(a) quarantine and
1	forces in high
1	hospitals or health
1	recommendations to national
2	prior to any
1	solely on a
1	(4) all conveyances,
1	level tracing 
1	(i) working with
1	any, that are
1	order of, a
1	vehicles, or vessels,
2	list, such that
2	tax forms they
1	state means a
1	1, 1970. in
1	section 379j52(a)(1) of
1	takes effect with
1	exemptionsupon submission by
1	section since december
1	communities, including the
2	file a premarket
1	burden interstate commerce,
1	registered, deliver the
7	shall remain available
1	practitioner of medicine
1	(1); and (3)
1	that, if data
1	package or homogenous
1	substance. the secretary
1	issued.  (d)
1	information regarding recalled
2	demonstration programs by
3	10 days after
2	statement, and transaction
2	abbreviated application mean
2	additive, unless its
1	describes shall also
1	electronic form, that
1	proposed plan by
2	charge shall be
1	may be) from
2	28 by an
1	providers.  (2)
1	products the secretary,
1	supporting such action,
2	known to or
1	upon between the
3	substance abuse reduction
1	appropriate, that an
1	state court, or
1	foreign facilities to
2	assess a late
1	300 calendar days
1	(f) technical electronic
1	 (a) creates
2	care providers about
1	drugs so as
1	(i) inadequate requests
2	appropriate to further
1	842. prohibited acts
1	state court, on
29	necessary to carry
1	(13) the secretary
1	applicant if a
1	promptly and efficiently
1	appropriated and in
1	trading partner agreements
1	means a working
1	known hazard exists;
1	(a) 100 or
1	(b)(2)(a)(i); and (ii)
1	shall require 
1	(b) additional provisions
3	42. if the
1	surveillance  (1)
1	includes guns, ammunition,
1	tobacco additive, or
2	evidence of effectiveness
1	(d).  (d)
1	adjusted as needed,
1	conditions on which
2	2014.  (june
1	submission fee, and
1	good manufacturing practice)
1	(a) requirementeach tobacco
3	appropriated under paragraph
4	good manufacturing practice,
1	article or the
4	5 days after
6	unless and until
1	partial waiver is
1	(b) is intentionally
1	conditions of manufacturing
1	imports of the
5	subsections (a), (b),
1	b2 (riboflavin) (g)
1	circumstances exist justifying
2	335a(b)(3) of this
1	funds may be
1	emergency medical care
5	secretary shall prescribe
1	report in writing
2	within 100 feet
1	federal law; (e)
1	materials with respect
1	without common salt,
2	federal agency management
1	(i) in generalif
1	(l) implementing regulations
3	seq.] means the
1	declining the request.
1	foods. the secretary
1	specialty or other
4	mark, imprint, or
1	device and respecting
1	receiving a recommendation
1	(d) cosmetics are
1	1971, which is
15	treatment of a
2	(d).  (2)
5	issued for the
1	2017) falls below
1	individual pharmaceutical dosage
1	include a sufficient
3	 (a) general
1	medical evaluation that
1	investigations. the contract
1	administration policy with
2	attending meetings or
3	another food, unless
1	(2), or (3)
2	made on such
6	medical evaluation and
6	revise such recommendations
1	authorized by other
5	applications submitted to
1	control of controlled
1	repacks and relabels
1	may be, shall
1	direct service, assessment
10	good manufacturing practices
1	submits the certification.
1	1978, the following
1	extent that that
1	adulterated at official
1	prescription drugs pursuant
5	publicly available, on
2	process devices, solely
1	laboratory animals; (c)
1	renewed, the secretary
1	neglects or refuses
2	immediate suspension upon
1	conform with elements
1	individuals. if a
1	responsible for responding
4	pediatric disease; and
3	programs of the
1	(i) the burden
1	capacity at the
1	subparagraph if 
1	database shall 
1	shall consider all
1	(2)(a), or (3)
1	federal officer lawfully
1	without good cause
2	alleges that the
1	fill is requested
1	 (i) provides
1	seafood.  (

1	studies by secretary
1	(among other things)
1	2012, an abbreviated
1	population pathway for
1	shall be deemed,
1	employment or contract
1	altering the appearance,
4	premarket review and
1	 (i) provided
1	variants in the
1	products across, where
1	drug paraphernalia means
1	(b) such drug
1	(e) helium that
1	risks related to
1	issues a written
7	shall constitute final
1	final guidance issued
1	review not transferable
1	769
 
 196.
1	person are being
1	thereof; except that
1	 (l) modified
1	drug establishment; (ii)
1	benzethidine. (7) betacetylmethadol.
2	submissions, and costs
1	product analyzed for
1	director shall test
1	(1) importer the
1	stat. 582; aug.
5	 (b) notification
2	less than $50
1	exempt said article
1	tropical disease 
1	thereafter be raised
1	closing meeting; (ii)
2	chemistry, manufacturing, and
1	including any right,
1	capable of 
1	require nonconsumer packaged
1	(d) designation of
2	operate using appropriate
1	limitation or exemption
1	 (b) time
1	whenever appropriate. (c)
1	enforce any rules,
1	burdensome requirements were
1	(b) a mineral;
1	justice supervision; and
1	 (a) approve
1	infant formula who
2	purchased such product
3	(b) compliancethe secretary
1	initiatives, which, at
1	materials.  (3)
1	trafficking area and
1	administration an identifiable
1	designate the judge
1	penalty in subsection
1	containing only product
1	unapproved product for
1	specify principles for
2	manner, and form
1	hotline for use
1	show cause under
5	shall result in
2	waivers, exceptions, and
1	also a drug
1	belief of the
1	available, or agreement
1	food additives, and
1	authorized representatives to,
1	 (c) formatthe
1	involved has not
1	data for such
1	clear links suggesting
1	government for use
1	applied.  (2)
2	assistance in planning
1	authorized for investigation
2	essence of the
2	risk the term
1	break, injure, or
1	request is in
1	(4) the offense
1	(c) conditions of
1	relinquishing of profits
1	business. (iv) if
1	18. (o) prompt
1	panel (referred to
1	firm distributes and
1	review fee revenue
1	export if (a)
1	including any salt
1	summonses issued under
1	term immediate precursor
1	term warning notice,
5	identity or composition
1	indirectly, as the
1	vaccinesif the secretary
1	
 2103. ensuring
1	letters from the
1	formatthe information described
2	considerations the secretary
1	chemicalsthe attorney general
1	decision under clause
1	supported by each
1	president determines are
1	requirements outweigh the
2	basis. such cooperation
3	affect any action
1	 (c) electronic
1	approval of genetically
2	special audience that
1	costs.  (2)
2	exceptions  (a)
1	(a) kindergartens; (b)
1	report, or supplement.
1	assistance, as appropriate).
1	assess bioavailability by
1	methods capable of
1	year, such paragraph
2	notification program under
1	42; and (iv)
4	secretary shall annually
1	allergies. (g) the
1	establishments); and (c)
1	notified otherwise by
1	property to victims
1	containing the labeling
1	 (6) false
1	evidence is not
1	1986. (7) the
1	responsible person demonstrates
1	subsection, or an
1	directly from any
1	regulations), and that
2	way other provisions
1	private entity, or
1	seq.]. (
 

1	analogous product manufactured
1	ingredient and that
1	commence prescribing or
2	respecting the route
1	need not include
1	issue shall be
1	comparator month being
1	person older than
1	denied by competent
2	controlled substance, which
1	principal facts involved
2	(a) notificationif the
1	concerned:  (a)
1	mutually agree to
1	prescription. (v) exports
2	emerging drug trafficking
1	first 4 years
1	public comment); (ii)
1	award is appropriate.
1	preventing enforcement of
1	efficacy supplement submitted
1	pethidin-intermediat-b, ethy--phenylpiperidin--carboxylate. (17)
1	order declaring a
1	complies with all
1	time will not
5	(1) of section
1	42 stat. 1500.)

1	made applicable in
1	(b) regulationsnot later
1	disseminate to communities
2	level due to
2	labeling prior to
1	assessment imposed on
1	exemption following suspension
2	efficient enforcement of
2	personnel action in
1	general, the identifying
1	one year; (ii)
1	legal entity, and
1	evidence, shall not
1	licenses, inspection reports,
2	fulfill the requirements
1	(4) sel-executing requirements
3	postmarket surveillance under
1	(i) of paragraph
27	made under this
3	prosecute any inquiry
2	complaint under paragraph
1	agreements, grants, or
1	supply; (2) coordinates
1	reporting by a
1	threaten the public
1	sections; (c) the
1	exemption shall be
1	sel-incrimination.  (c)
1	chapter, any person
1	plan would not
1	data shall include
1	food, including a
1	application for increased
1	chapter and act.
1	violate, any of
1	cocaine and ecgonine
2	goats, horses, mules
2	respect to tobacco
1	stat. 415.)
 

1	grant, or other
1	make, prior to
1	consequences of, drug
1	may, prior to
1	agriculture; and (b)
1	potential health risk
1	rare diseases; (6)
1	379s. preemption for
1	persons, whether accredited
2	letter shall be
1	(ii) is, if
1	9, 1902, ch.
1	evaluation of advertising.
1	clause is $3,000,000,
2	proposal and shall
1	studies examining a
1	distribution without identifying
1	produce one or
2	notice or other
1	substances, identifying by
3	labeling or the
1	subsection (b)(1); (e)
1	(b). testing under
2	(ii) may include
1	 (f) annual
1	(2) biennial inspections
1	drug package or
1	use and consumption
1	notification, declaration, order
1	include as an
1	(f) limits regarding
1	reinspectio-related costs means
1	may be effective,
1	order forms in
1	anticipation of a
1	person) reasonably believed
1	residue definedfor purposes
1	chapter; and 
6	secretary shall hold
4	15 days of
1	march 31, 1976,
1	 (a)reporting.beginning january
1	actually incurred in
1	secretary to exempt
1	projects, or activities
2	imprint, or reproduce
1	testing in accordance
1	(n) the distribution
1	foods that the
1	equivalent positions. (b)
1	conduct the surveillance
1	appropriate to conduct
1	animal drug adulterated
1	tried in (1)
1	7 if the
1	person whose term
1	medical evaluation (other
2	extension thereto of
1	certification by canada
2	interested persons of
1	services; refusal or
4	tax returns to
1	federal government, states
2	 (3) serious
1	review for adequacy
1	year 1994 and
1	(6) pursuant to
1	effective date had
1	plans for security
1	including the district
1	devices; and academic
1	limitations shall not
1	acetyldihydrocodeine. (3) benzylmorphine.
1	error. the administrator
2	may consider such
1	information. (p) estrogenic
1	capacities for the
2	person in any
1	consumption by him
1	promulgating rules under
2	fund advertising that
2	(c) period for
1	331(a) or (d)
1	minority communities. (b)
1	manufacturer does not
1	(1) barbital. (2)
1	authorized changes to
1	(2) contentsthe reports
1	scientific evidence, for
1	drugs, full cooperation
1	necessary to respond
1	elimination in the
2	response on the
3	described under this
1	youths smoking marijuana
1	industry, academia, and
1	laboratory. (n) any
16	report under section
1	following limited quantities
1	section, including regulations
1	applicability of statute
1	(
 
 855.
1	proceeding against an
3	permit from the
1	(4) liability any
1	 (a) feedback
2	standards established pursuant
16	ingredient drug master
1	information the label
4	base, or phenylpropanolamine
5	government of the
1	matter; hearing; withholding
1	1, 2012; and
2	contained in regulations
1	abbreviated registration renewal
5	(f) the regulated
1	conditions; and (2)
1	classification panels covering
1	customer or the
1	agency prior to
1	be, and submits
1	manner to facilitate
3	regenerative medicine therapy
2	administrator issues a
2	attorney general notifies
1	$4,900,000 for each
36	application or supplement
17	interstate commerce for
1	committee.  (6)
1	(2)(a)(ii). (c) tobacco
1	orders once the
1	information may not
1	bad faith claim
4	15, 2017, the
1	contest, game, meet,
5	379v of this
1	unaffected; responsible connection
1	agency the appropriate
1	application substantially meets
2	determining, for the
1	diagnostics  (1)
1	product, and establishment
1	local affairs (a)
1	sections 355a(f) and
4	resulting from such
1	nonprescription drug, as
2	established a commission
1	(4) prenatal care.
3	term national drug
2	safeguards against hazardous
3	conviction under subsection
1	effect and a
1	appropriations acts, to
1	sale, or the
1	maintain a joint
1	labeling could pose
1	(if so prescribed),
1	formula, including an
1	every 6 months
1	marketing violations 
2	state established program
2	accreditation  (a)
3	title 5 by
1	fail to issue
1	(including the armed
1	application may request
1	(d) data fusion,
1	with, as necessary,
1	(which may differ
1	section 132 of
2	 (b) that
1	(jj) the term
1	proposal until the
1	information identifying each
2	days notice to
1	animal, and which
1	use, or maintain
1	total funds requested
1	affected agency; (c)
4	(h) the term
2	enforcement action pertaining
1	submission or master
1	federal standards regarding
1	terminationthe secretary shall
1	residue is within
1	permit changes to
1	915, as added
1	(g)  (1)
2	section 379j41 of
1	manufacturer or wholesaler.
2	qualified facilities 
2	court) shall be
3	(4) offset if
1	full assistance and
1	affect a disease
1	seq.) as in
1	regulation in accordance
1	coordination on the
1	establish an internal
1	both.  (g)
1	(3) $30,000,000 for
1	relations with the
1	manner and under
1	classified information provided
1	reject, inedible, leaker,
1	conferences; (b) making
2	limitation fees may
4	 (a) new
1	(15) in order
1	to, any requirements
1	use of, federal
1	chapter, and a
1	sections x.c and
1	 (1) exemptiona
1	secretary declare that
1	third year of
1	
 
 360fff3.
4	food which is
1	single brand; and
1	guidance document to
4	(including any substantive
1	minimum amount of
1	year. (3) changes
1	equines have been
2	submissions, and investigational
1	exposure and relating
1	order classifying a
11	secretary shall develop
1	findings; and (d)
2	reassessment of the
1	may have common,
2	disclosure of safety
1	compounding pharmacies, as
7	prescribed in such
1	information. (b) whenever
3	protocol described in
1	processing, etc., as
1	subchapter.  (8)
1	2023.  (june
1	accordance with existing
1	verification under subsection
1	report. (5) the
1	appropriate response times
1	opioids or methamphetamines.
2	(i) a supplemental
2	intravenous solution intended
1	observed a significant
2	product.  (3)
2	commission under subsection
2	acquittal has been
1	ten pinball and/or
1	authorities equal to
1	substance is a
2	include a recall
1	machine, or an
9	section 355(j)(5)(a) of
1	(a) purpose the
2	jurisdiction between the
2	prescribe by regulation
3	may not disclose
1	(a) the goals
1	generalthere is established
1	applied to address
1	date any fee
1	clearinghouse and advisory
1	publicly available, except
1	(x) the application
2	based on factors
2	following shall be
1	(h) the lot
3	products to the
1	obtain, install, and
3	unmet medical needs
2	courts when relevant
1	drug shortage program,
1	act of 1974).
1	 (2) beginning
1	longer authorized by
1	administer the product
1	long as no
6	shortage of a
3	development, biosimilar biological
1	means an advertisement
1	subsection in any
4	 (e) withdrawal
2	united states standards
1	manufacturing dosage forms.
2	aspect of performance
1	public eating places,
16	shall not include
2	identified on the
1	classification changes 
3	brought for the
1	needs of federal,
5	examination or laboratory
4	requirement is not
1	commission  (1)
1	528, as added
1	tobacco for making
1	services. (d) the
1	validation data specified
1	representation made 
1	
 615. inspection
3	manufacturers, importers, distributors,
2	 (2) conditions
1	changes shall be
1	standards; applicability, enforcement,
7	title, or (b)
1	nicotine lozenges) for
1	health, the agency
1	physicians prescriptions, or
1	10 and amended
1	price support or
1	review of guidancenot
1	(2) to state
1	introduce, such adulterated
1	reports on findings
1	(4) through fiscal
2	states, or of
3	required to comply
1	(
 
 864a.
2	drug described 
1	drug or application
1	ii, except (1)
1	standards for licensure
3	three times the
1	terminate the order.
1	examination or analysis
1	statement of policyit
1	require premarket approval
1	 (e) saleable
1	penalty assessed, any
1	quality factors for
1	related to product
1	tagged, or labeled
1	applicable, the labeling
1	civil penalties (a)
1	(1) drug abuse
1	civil, criminal, or
1	disposal  (1)
2	show either that
2	charge to nonprofit,
1	device.  (e)
1	lif-saving drugs (a)
4	strategy of the
1	farm, the secretary
1	lacks with respect
1	oath, setting forth
2	provided, that to
1	348, 360b, 360ccc,
1	otherwise. (may 9,
1	 (24) transaction
2	outweigh the risks
1	extended expiration is
1	department (other than
1	judge is satisfied
1	limited to that
1	product, a representative
1	surrogate endpoints which
2	conduct a review
1	$129,000,000 for fiscal
2	food safety training,
2	label the name
1	narcotics trafficking. 
1	fees due under
1	contents, the word
4	signed by the
1	minimum periods of
1	china. no person,
1	 (3) thir-party
1	sunscreen order in
1	-year period, the
1	establishment, under such
1	administration under its
1	product, shall be
2	states.  the
1	grams) of smokeless
1	sellers under paragraph
1	connection with action
7	which, at a
2	protocol and accompanying
2	reject such reports
1	regulations; destruction and
1	1, 2008, an
2	potential risk for
1	(2) it is
1	cessation, is not
1	drug, or investigational
2	pertaining to nanomaterials;
2	secretary may develop
1	tests); or (c)
1	pay of any
1	written acknowledgment to
1	whether  (i)
1	reasons, including concerns
1	reasons for departing
1	explosive devices attached
1	tested and the
1	1118 to 1120.
1	(f), including any
1	provide continuing education
2	accreditation the secretary
1	regulated seller sells
1	
 382. exports
1	355 or 360e
2	__________. if i
5	(ii) for purposes
1	reasons therefor. after
8	352 of this
1	research). (b) definitionsfor
1	 (1) may,
42	provisions of section
1	subsection (d); 
2	new drug may
2	fact. if the
1	engage in such
1	(ii) ketamine; (iii)
1	seasonably made, be
1	42 (including all
1	advertising time purchased
1	due, any late
1	allergensthe secretary of
1	needs for enhancement,
1	(d) requests for
2	committee to which
1	need, by 
1	including the promulgation
2	introduction of such
4	made a finding
2	(e) or this
1	formerly 9th par.,
1	-methy--piperidyl benzilate. (15)
1	checking the hazard
1	(i) 30 calendar
2	liability compliance with
1	endpointthe term surrogate
1	 (b) different
1	2019, $14,100,000; and
1	impacts, of a
3	partnership, corporation, association,
1	manufacturer. (3) any
1	(4) with the
1	 (4) state
3	person performing official
2	transactions wholly within
1	smokeless tobacco the
6	studies conducted under
1	7 members, not
1	general an establishment
6	person submitting the
1	data sets, as
1	derivative thereof. (kk)priority
1	section; and (iv)
1	guidelines, including 
3	external data bases.
2	external experts on
1	agent does not
1	products the commissioner
1	packing, or storage
1	criteria in subsection
1	workload. with respect
1	conviction entered. 
1	prevent the use
5	leading to the
1	guidance described under
1	device, and (e)
1	purpose of studying
1	office of any
1	effect upon commerce,
1	affected the development
1	identifying symbol required
1	preferences with respect
2	charges by owner
1	title 42 if
1	health professional pursuant
1	recommendations for any
1	 (4) united
1	ch. 262, 1,
1	property is found
3	conclusion of any
1	yet been filed
1	and, for fiscal
1	convene workshops and
4	order in accordance
6	(b) a third
3	applications filed for
2	(c)(1) of this
1	loan made under
1	drugs). (2) the
1	set of graduated
1	 (b) certain
1	22, 2009, promulgate
6	exclusivity for a
1	(e) guidance for
2	information received under
1	party to a
1	independently determines that
1	530, 70 stat.
1	publication policies that
1	(d) assurances that
1	subsection shall survive,
1	people; and (3)
1	drug advisory committee
1	food registry, acting
1	seizure procedures any
1	last day on
1	due under clause
1	 (b) intramural
1	dtc advertisement, the
1	(2) upon submission
1	research; (f) identification
5	last day of
1	duties (a) in
1	endocrine effect as
1	change is not
1	temporary reductions in
1	amounts. (3) not
4	requirement under section
22	(3) the term
1	requiring premarket approval
1	(d) drug paraphernalia
1	take reasonable measures
1	importer participates in
1	written export certification
1	residues exceeding a
1	(b) requiring the
1	section shall conform,
1	subparagraphs (1) and
1	significant endpoints, such
1	may be more
1	egg product, unless
2	minimum, includes programs
1	-year period. (h)
1	per calendar year,
1	met for a
1	respecting devices and
1	etc. in the
4	dispute resolution procedures
1	(d) national food
1	diet that bears
1	evidence of clinical
1	security system designed
1	veterinary, food, food
2	least 6 years
5	color additives for
4	amount the amount
1	counsel, and the
24	manufacturer of the
1	used to develop
1	specified on the
10	advisory commission shall
1	(f) fund control
1	committeeupon receipt of
1	title approving such
1	of. any order
1	address questions by
4	accreditation of such
2	decisions, and requirements
2	dat-rape drug prohibition
1	1976; or (b)
1	previously imposed penalty,
2	facility shall not
1	intended.  (2)
1	federal efforts to
1	information; and (iii)
3	qualified facility that
1	schedule iv. (c)
1	may identify. (d)
1	faculty.  (26)
2	central nervous system:
1	committees regarding disclosure
1	penalty for sale
2	schedule in which
1	small open containers
1	(5); (b) a
1	[7 u.s.c. 136a,
2	process to be
1	chemical designation. such
1	protein shall be
1	advisory committee or
8	product if the
6	advisory committee on
1	inform the subsequent
1	united states. no
1	direc-t-consumer advertising 
4	advisory committee of
1	intention of further
1	supplement is adulterated.
1	condemnation is sustained
1	injectable liquid which
1	american medical and
1	with, such program.
1	provisionsnothing in subsection
1	march 31 of
1	programs or projects;
1	drug, and (2)
1	elements under this
2	secretary the patent
3	simultaneously with the
1	purposes or provisions
3	(b) after a
1	recommends that such
1	term transferee means
1	wherein the same
5	risk associated with
1	www.fda.gov/medwatch and 1800fda1088
1	secretary shall, unless
1	(3) report not
1	information.  (iii)
2	dealer or distributor
1	regarding the guidance
1	infection in a
3	finds has been
1	provided the alcohol
1	relating to plant
1	monitoringto ensure compliance
1	secretary, including a
1	factories, warehouses, and
2	facts of the
1	provided by regulation
2	manufacture or process
1	monoxide, use in
1	disease issues, including
1	drugs, are appropriate
1	writing the federal
1	locality, of permits
1	may withdraw inspection
1	(i) submissions for
1	partnership or an
1	seller from that
2	reduced promptly to
1	(52 stat. 1040)
1	organizations, consumer organizations,
1	issued without further
1	practice where the
1	testing purposes, and
1	 (c) restrictions
2	 (a) 100
1	year, upon the
1	348(h)(6) of this
1	person to his
1	procurement contract under
1	title. (5) the
2	appear at the
1	may, in advance
1	subparagraph (b)(i), the
1	may be, under
2	altered in any
2	study plans, and
1	(2) reports 
2	stored and transported
2	1365 of title
1	opinions under section
1	 (l) option
1	subpopulations that suffer
1	investigate offenses punishable
2	acting as secretary)
2	products from the
1	territorial jurisdiction, and
2	person who acts
1	956(a) of this
3	drug unless the
1	services to report
1	(a) further sale;
1	accomplishing the specific
1	disease product. 
1	as, an antiseptic
3	clause (i) has
1	title for information
4	information (as defined
1	standards committee 
2	practice or conduct
1	will permit analysis
1	warn consumers and
1	solely in a
1	tests conducted by
1	violations and, with
1	basis of reliable
1	administrator a detailed
2	evaluation by the
1	drug product containing
3	(ii) developing and
1	(d) limit the
1	grant priority review.
1	funds to a
1	center that has
3	assess whether the
1	among youth (or
1	requirements for inclusion
1	fails to respond
1	section shall only
1	675, 1008, formerly
1	recommendation.  (e)
1	year if 
2	production act of
3	payable 20 days
1	imprisonment and fine;
1	facility fee. 
2	reference to ephedrine,
1	resides, shall, in
1	guidance entitled guidance
1	support the petition.
1	court may exercise
1	imprisonment and fine.
1	october 26, 2002
1	tobacco to meet
1	processed, and such
1	making contact with
1	equal to half
1	 (4) alter
3	drugs for the
1	 (a) intracompany
1	products established name
1	section, including analyzing
1	ris-based inspections of
1	animal drug may
1	appropriate designated document
2	general rule a
1	needed among the
1	reasonably known to
2	10 years regarding
1	including acinetobacter, klebsiella,
1	 (i) compliance
3	shall have primary
1	harvesting, preparation for
1	subchapter are kept
3	secretary, in person
3	color additive is
1	manufacturer intends to
1	homogeneous case corresponds
1	shall evaluate whether
1	secretary finds under
2	level higher than
1	challenge the validity
1	biological, chemical, physical,
1	glass, roughened bottle,
1	9 of the
3	enforce requirements at
1	meeting request, the
1	provide advice to
1	applicability of a
1	(a) amending regulations
1	inspected as hereinbefore
1	wet wipes, to
1	commerce any restricted
1	any.  (4)
16	register with the
1	public to comprehend
1	restricted section; and
4	registered mail or
1	1988, or approved
1	formula provides nutrients
1	request within 180
1	device involved represents
28	submission of the
1	programs, seminars, meetings,
3	backlog fee for
1	regulations a list
1	term includes section
2	(a) proceedings in
1	incapable of germination.
1	revised agreement, guidance
2	manufacturer  (i)
1	(c) disseminate information
1	human use; (d)
1	every 15 days
1	distributor and such
1	utilizes a genetically
1	(b) workload adjustmentsubject
3	(ii) that the
1	qualified employee shall
1	prevents the manufacturer
1	ris-based schedule, the
3	exporting the drug
1	frequently than biennially.
20	fee under subsection
2	take into account,
1	 (d) liability
3	intelligence or the
1	appropriate quality systems
1	part which he
2	serve after the
1	contract may be
1	2008 fee limit
1	title i, 9,
1	cause as to
1	leprosy. (l) lymphatic
2	actions described under
1	assessed an advisory
1	accreditation as a
1	food submitted and
1	similar institutions and
1	formerly 741, as
4	harm or the
1	-year period. 
1	involving methamphetamine; and
1	(i), be submitted
1	ch. 61, 3(a),
2	inspected pursuant to
7	subsection (d) and
1	 (9) office
19	shall issue an
1	detention of such
1	catfish and ginseng
1	legal protections, including
8	active pharmaceutical ingredients
1	employees; fellowships 
1	exclusive, to affirm
1	notification the notifications
1	of, such tobacco
2	promote the sale
2	trafficking areas program;
5	infringement and if
1	section 552(a) of
1	poultry delivered by
1	person) stating in
1	device. (viii) such
1	specified in writing
1	recall, the secretary,
1	resigns, or is
1	information that such
2	determination of condemnation,
1	secretary; (d) a
2	10 kilograms of
1	classified information (as
1	care settings, such
4	increases in such
1	section 897.16 to
2	ingredient derived from
1	agency actions described
1	methods to prevent
1	states; (2) ensure
1	revised strategythe president
1	355. new drugs
1	identification where the
1	exclusion of no-narcotic
1	year 2003; (7)
1	board to 
2	remaining portions of
5	medical countermeasure application
1	state, prominently and
1	expiration of patent,
1	order to assist
1	substance claimed to
1	section by its
1	law.  (g)
1	provide appropriate flexibility
4	deemed guilty of
1	secretary determines supports
1	summarize the volume
1	(a) creates a
1	shall include, but
1	findings regarding good
1	employment or use
1	meet at such
2	standard grade and
1	application.  as
1	(other than bioavailabilty[1]
1	document that outlines
1	provide for advanced
1	outside the scope
1	investigation, information concerning
2	distributed interstate, is
1	education and training
1	able to recover
1	material omission or
1	(v) 4 shall
1	
 1543. membership
1	otherwise discriminate against
1	product in interstate
1	provided with the
1	16, 1988, or
9	operator of the
1	action specified in
1	qualified acceptance of
1	administration under this
1	recall and shall
1	adequately protects the
1	controls of imports
1	adds a nutrient
1	(b) biosimilar biological
1	secretary shall require,
10	paragraph (1), and
1	terrorism; and (3)
1	$1,000,000 in the
1	chemicalsany person who
3	statement for not
2	sections 343(r)(1)(b) and
1	(5) review in
3	unapproved product (as
1	paragraph (1), any
1	convention, based on
1	(g) dietary supplement:
1	held animal feed
1	subchapter. such programs
2	subchapter which he
1	27, 2013. 
1	restricted section of
1	387t(b) of this
3	 (1) adverse
1	tribal organization, provided
1	which, fresh, salted,
1	additive not from
1	manufacture, distribute, export,
1	section 2202 of
2	resumption to the
4	shall meet with
2	requirement of notice
1	review an item
2	december 23, 1985,
1	consult with stakeholders
2	secretary, in collaboration
1	substance by the
1	adequate results and
1	(k) dissemination of
4	exempt under subsection
5	determined that such
1	drug application using
1	 (2) biosimilar
1	controls the secretary
1	wholesale distribution (as
1	title, refer such
1	(4) the estimated
4	collection of fees
2	relating to federal
1	change on the
2	prohibit the export
1	removed from a
1	generalthe secretary 
1	alleged is invalid,
1	designate that name
1	description and current
3	shall reasonably cooperate
1	violation of chapter
1	approve or clear
1	 (4) qualifying
1	(3) the state
1	relevant portions of
1	sets forth changes
1	(1)(d), for a
1	trafficking area, submit
1	responsible party 
4	advisory review. 
1	investigational drugs (a)
2	committee persons qualified
2	 (i) state
1	(l) was conducted
1	product for sale
1	posted publicly by
1	 (b) required
1	title 42); (c)
2	food products inspected
2	commerce, and place
2	affected nothing in
1	term check means
1	(b) work to
1	requirement in subparagraph
1	council shall review
1	person distributing the
1	coordinator shall perform
1	economic availability of
1	standard by the
2	sign, placard, or
1	request for proposal
1	commodity between the
1	time to prescribe
1	exist; and (b)
2	apprehension for any
2	thereof, or alter,
5	beginning negotiations with
2	42 that is
1	5, while away
1	(d) internal controls
2	(2) as hig-risk
1	secretary should make
1	(ii).  (d)
1	52 stat. 1045.)

1	event the fees
1	 (a) farm
1	obtained directly, or
1	hydrate in the
1	effectiveness or demonstrating
1	claimants interest, for
5	legally binding commitment
1	time reports summarizing
2	(i) the consumer
3	officer, director, holder,
83	paragraph (1) shall
1	section 842(b) of
2	title for an
1	express advocacy in
1	fees under subparagraphs
4	360ccc1(e) of this
4	found after inspection
2	section precludes a
1	term poppy straw
1	(a) drug abuse
1	duration of clinical
1	action may not
1	condition, or if
1	agencies or organizations,
1	serious bodily harm,
2	passing upon the
1	deferral extension; (ii)
1	laboratory is able
1	reviewer and shall
1	engages in business,
2	determined by multiplying
1	(c) volume data
1	 (8) requestor
1	area involving 
2	requested, in accordance
2	formula complies with
1	funds for coalitions
1	schedule solely because
1	product, a designated
1	paragraph.  (i)
1	general may direct.
1	listed drug after
1	emergency prescription, in
2	controlled substance (except
1	underlying such determination
1	boarding houses, for
1	(i) the ability
3	qualified entity under
3	(i) any person
1	records, documents, and
1	u.s.c. 355) for
1	in, or is
1	chapter. (bb) the
1	bodily fluids or
1	manner the secretary
1	drug production with
6	data on the
1	documents submitted pursuant
1	effective as of
4	increase shall be
1	general may specify
3	subsection (b)(1) because
1	antimicrobial drug and
1	imported, and (b)
1	subparagraph (2) of
1	assessed on an
1	(b) ginseng labeling
2	inactive by the
1	numbers sufficient for
1	renumbered 17 and
3	determination with respect
1	ch. 74, 8,
9	effect of failure
2	office to be
1	conduct inspections otherwise
1	sample product labels
1	exemptions from sections
2	systems to improve
1	giving such order,
1	order.  (i)
1	(d) reinstatement the
1	investigational use, for
1	correct. (cc) such
3	subparagraph, the term
1	(b) encouraging such
2	appropriate, the secretary
1	assess against the
1	index; suspended listing
1	drug is lawfully
1	subchapter the attorney
1	conditions an order
2	section. in considering
1	indicates, means the
1	(b) upon a
1	methylbromide. (5) codein--oxide.
1	authorized activities nothing
1	$10,000,000, or both.
1	quantity of those
1	license, instruction, or
1	approval, conditional approval
1	person.  (c)
1	contracts for such
3	collection of information
1	
 
 336.
1	3612 and 3664
1	360d(b)(5)(b) or 360e(g)
1	public participation is
1	apprehension, prosecution or
1	section 552(a)(3) of
1	same; (vi) information
3	(d) fee waiver
4	meets the criteria,
1	intelligence information 
2	means an article
1	 (bb) with
1	drug. (g) documentation
1	2013 through 2016,
1	nearest to and
1	without foregoing other
4	prior to dispensing
1	secretary to monitor
2	387i, 387j, or
1	distribution of chemicals;
1	supplement: manufacturing practices
1	(iv) the availability
1	(i) application fees
1	3374(c) of title
1	(ii) actions after
1	drug substances to
2	title under section
2	written requests issued
8	list of all
1	agencies and the
4	conform in all
1	investigative or law
1	bears the principal,
1	coalition; and 
1	exclusivity period beginning
1	analysis on foodborne
1	receivers, and other
1	(b);  (b)
2	thereof) on the
4	states and engaged
1	requiring, or in
2	quantities or service
1	comparison with equivalent
1	authorized for that
1	obligation concerning drugs
1	will insure that
1	member, in violation
1	drug samples, and
2	carrying out subparagraph
1	cause an examination
2	products are identified
1	 (3) participate
1	allocation of inspection
2	may provide that
2	person shall, at
1	1946), signed at
2	definition as a
2	applicant shall certify
10	made available for
1	injurious to users
1	states (except coastal
1	 (d) secretarial
1	inflation (as described
1	item, the council
1	pure dye and
1	hearingif the secretary
1	circuit wherein that
4	dissemination of information
2	inventory, operations, and
3	 (a) set
1	(c), submit to
1	chloral hydrate, except
1	applications, and where
1	consideration any pilot
1	least 21 years
1	office and shall
1	(1) in generalit
1	report for such
2	shall pay 
1	needs; (b) the
3	facilities of the
11	fee that applies
1	(3)(b)).  (2)
1	than, requirements established
1	committee determines is
1	expectation based on
1	wholesale distributors (a)
1	appropriate national drug
10	date of a
1	paraphernalia definedthe term
1	title for its
1	(4) any past
1	suspension if, after
2	marketing in the
1	paragraph (2)(a)(i)(i). 
1	analytical method for
1	(a) and annually
6	sale for safety
1	imposed, by the
1	benefit relied upon
1	groups that are
1	 (1) purposethe
1	pay.  (b)
1	originated, as designated
2	panel shall recommend
1	registration and listing
1	implemented before the
1	inspection of live
1	preceding 1-month period;
1	subsection (d) unless
1	(b) any poultry
1	safety; exemption of
1	drug administration took
1	order and which
2	compliance with standards
1	(b) the distribution
1	adulterated cosmeticsa cosmetic
1	1949, ch. 307,
1	 (b) schedule
1	including by posting
1	assessment a civil
3	thereof, and the
1	application, or investigational
1	(ii) where such
1	 (i) implanted
1	needs or the
1	order to delay
1	necessary and proper
1	section 353(g)(5)(b) of
1	provide in writing
1	substance that immediately
1	sponsor has a
1	director if the
3	party may demand
1	monitoring pesticide residues
1	new information within
1	swine, and goats
1	contact with internal
8	ex officio members
1	time of filing,
1	agriculture designated by
1	(b)(2)  (a)
2	(14) the term
1	year by, not
1	orders.  (june
1	section is prosecuted
1	successor regulations)) with
1	secretary, if 
1	identifier systems specified
1	(g) scope of
3	center with primary
1	2007, an application
2	intended for irrigation
1	
 970. criminal
1	additional considerations in
1	secretary from giving
1	(1), which shall
1	chemicals and essential
1	handled on a
1	liquid form, not
4	notifies the holder
1	satisfaction of said
4	 (i) develop
1	5. before issuing
1	drug shortage; (iii)
1	report to employees
1	protection agency are
1	issue under this
1	due regard to
2	condition; or (ii)
1	membranes and not
2	changed by, the
1	methodologies are necessary
1	development of performance
1	 (i) satisfy
1	(3) ieepa was
1	no-occupational sources; (vii)
1	persons with respect
2	transaction described in
3	standard has been
1	evaluation of drugs
1	(42) trimeperidine. 
1	increase the cost,
1	general population; (ii)
1	serums, toxins, or
3	410, as added
3	procedures to be
4	therapies for pediatric
1	section 348(f)(2) of
10	programs and activities
1	nonapproved labeling or
1	drug applications. (f)
1	regulations to improve
3	using appropriate formulations
1	determinations are made,
1	3324(a) and (b)
2	contempt thereof. all
1	requirement.  (iii)termination
1	manner, the facilities
1	evaluation protocols established
1	studies to the
1	 (i) classify,
9	tribal, and local
1	(ii) unless such
2	provide the applicants
1	register his reason
2	different from, in
1	testimony. the secretary
2	voluntarily submitted to
1	harvesting, or storing
1	regulatory authorities in
1	declaration, determination, and
2	cooperate under this
1	request the owner,
1	2011, submit to
2	(d) through (f)
1	present views before
1	1, 1999. 
1	collections for effectuating
4	powers conferred by
1	on, prevention or
1	shall not later
1	upon the manufacturer,
4	part omitted or
1	moved in interstate
5	provision of section
1	regulations publication) making
1	secretary has, by
1	factors which may
1	device shall maintain
1	importer, if the
1	resuscitation, when administered
1	submitting reports under
1	(i) whether an
1	demonstrating the regulatory
1	shall regularly review
1	publicly available (except
1	state official, except
1	professionals on administration
2	exported under section
1	risk to benefit
1	samples by a
1	country, including a
3	1 per centum
1	school programs in
1	bioequivalence study; or
1	(e) penalties applicable
1	periods; and (b)
1	(2) for 90
1	(b) income and
5	product that was
1	enable the sponsor
3	notifying the secretary
1	microorganisms to the
2	exists valid scientific
3	class of food
2	section that, on
1	section 355(j)(5)(f)(ii) of
1	(xi) products transferred
1	(d)(1)(a) shall require
1	development, demonstration, and
1	psilocyn. (17) tetrahydrocannabinols.
1	time and spacesubject
2	like or equivalent
1	requirement to use
1	application of federal
1	systems (as defined
2	consumers in the
1	schedule ii which,
2	application for that
1	assessments and labeling
1	treatment functions); (b)
1	production and handling
14	officers, employees, and
1	paragraph, after providing
4	inflation in accordance
1	poultry science profession,
1	sectors and organizations
2	review.  (d)
1	stat. 193.)
 

1	
 2102. ensuring
4	thereafter be conducted
1	division  (i)
1	analysis shall not
1	schedule i if
1	title).  (june
3	persons in different
4	that, under the
4	grounds to believe
1	dru-free america. (c)
1	1(a) of the
1	section, and if
1	section provides the
1	6, 1958, pursuant
2	changing the classification
1	days, with respect
1	previous application, or
1	adulterated, and all
1	sector, as authorized
2	involved for carrying
1	1912 for the
1	(ii) exceptionthe administrator
1	(i) operational and
1	use which require
1	(
 
 1905.
1	contents of a
1	reporting of information
1	fact; or (g)
1	(ii) a manufacturer
1	foreign countriesin carrying
2	fiscal year 2007.
2	federal provisions applicable
1	practices in each
1	isolation, and other
1	provide written clearance,
7	chapter shall not
1	requirement established under
1	available registry the
1	certification, or license,
2	allowed travel expenses
1	directions for using
1	repackager shall advise
1	thereof or the
1	childhood education programthe
1	responding to hig-priority
1	packaging a product
2	animals as a
1	conducted, shall cause
2	feed (as defined
1	intent of congress
1	unprotected, including the
1	appraisal system established
2	supplement) receives a
1	contact information, and
1	complementary with respect
3	 (4) final
3	(21 u.s.c. 601
1	includes the name
1	illegal dru-related activities.
1	studies or publications,
1	120 calendar days,
2	(1) the known
1	section 360i(g) of
1	investigation. (b) in
1	trials is actively
1	failing to comply
1	pending a full
1	regulations be deemed
1	ended on september
1	282(j)(2)(a)(ii)(ii)(gg) of title
1	convened for the
5	described under section
1	social council of
2	period designate such
1	formula through any
2	sentencing provisions of
1	means a risk
1	secretary, before or
1	511; july 9,
1	labeling to correct
2	user facility shall
1	(a) as hig-risk
1	functions; and (b)
1	previous 5 years,
1	establishments shall be
2	repackager shall promptly
1	master file numbers
1	jurisdiction other than
1	achieving the goals,
1	evidence to the
5	oral presentation of
1	poison unless the
1	(ii) the retention
3	absence of an
1	grant to any
1	drug, be deemed
1	(c) reimbursement an
1	production, storage, processing,
1	unsafe or ineffective
1	exemption in question.
1	statement or both,
1	1103.)
 
 158.
1	
 1902. purpose
1	export requirements, and
3	unduly burden interstate
6	report submitted under
1	whether such ingredient
2	standards for products
1	prescription to be
1	application; (c) 
4	times the maximum
3	label containing (1)
3	agreement to which
2	330 days after
1	likely to remain
1	(a) refusal of
1	subchapter v to
3	prepared for sale,
1	consultation, the secretary
1	standards.  (d)
6	section 379aa or
1	imported poultry or
1	reanalysis shall be
1	measures to strengthen
1	(a) refusal or
2	dispensing prescription drugs
1	ultimate consumer, the
1	shall commence upon
1	website  (a)
1	audit a list
2	policies under this
1	 (a) purposesthe
1	society for research
1	 (d) copies
2	effectiveness are required.
2	effectiveness are required,
1	surveillance order or
1	requests by attorney
2	(iii) available information
1	inconsistent with, less
5	programs, systems, and
1	media campaign, subject
1	disclosure, for fees
1	trading partners shall
3	business, or in
1	youth (or use
8	required to pay
1	subparagraph (e), each
1	(iii) relating to
1	(d), or (i)
1	moreover, if the
1	premix supplier. (c)
1	within the department,
1	childhood education programs
1	person or of
1	
 1606. subsequent
1	(f) effect of
1	identify smuggled food
1	samples where a
1	intent, a qualification
1	general and to
1	appropriate, utilize existing
1	reserve the secretary
1	within the department;
2	affairs, the indian
1	investigational submissions: 
1	color additive not
1	control point the
1	government entity. such
1	amount of operating
1	substances means the
3	reviewing safety information
1	regulatory requirements. (b)
2	secretary to assure
1	
 860a. consecutive
1	inaccessibility or unavailability
1	resistant gram negative
1	human health for
1	submission of national
1	legitimate purposes, and
3	subparagraph (a), and
1	state, or otherwise
1	to, and in
1	consider comments from
2	require, with respect
1	relative health risks
1	(2) interchangeable biosimilar
1	unit containing an
1	information collected under
1	pursuant to libel
1	trafficking of illicit
2	modifying, repealing, or
1	household, except that
3	action and afford
1	section any electronic
1	issued or if
1	form for administration
2	childhood education program,
1	drug master files,
1	drug master files.
1	inapplicability of section
1	is, with respect
1	without charge or
1	order to complete
2	association which is
1	taking such action
23	shall provide the
1	necessary. data under
1	committeethe secretary shall
1	522, as added
2	information and condemned
6	management of information,
1	(c) 100 percent
1	public service campaigns.
1	chemistry nomenclature requirement
1	food, which records
1	information and links
1	it, and in
1	usefulness of data
1	purposes of publication
3	undermines the process
1	feasibility of dispensers
2	products per fiscal
1	new information or
1	authorized the director,
1	purchase of materials
3	title unless the
1	 (a)definition. 
1	attempting to facilitate
1	phosphorus, paris green,
1	shall preserve each
1	(2)(c) shall apply
1	grades, and weight
1	consultation.  (2)
1	regulation activities. 
1	foundation, any funds,
1	including any pipe,
6	2112 of title
1	(a); multiplied by
1	applicant gives notice
1	responsibility for the
1	forfeited property at
3	1 business day,
1	gratuities, fraud, perjury,
1	notice, a fee
2	disease products (a)
13	provisions of subsection
1	area after a
1	consumer groups, regulated
1	outbreak means the
1	laws (as defined
1	fact sold or
2	federal government; and
1	chemical was seized
1	burdens on farm
1	review all guidance
1	crisis, the director
1	local areas. 
1	general unless the
1	review employees that
1	used, size, filtration,
1	stat. 511; 

6	1 and ending
1	genetically targeted technology;
2	report received from
1	requirements; qualifications for
1	advertising. (g) financial
1	ii, 202, as
1	activities under an
2	(e) of section
8	that, with respect
1	termination under this
18	usual course of
3	distributor and thir-party
1	subparagraph is terminated
3	event of conviction,
1	register, may establish
1	consumer audience. (2)
1	data required under
1	submitting such petition
1	applicable standards under
2	adjustment factor under
1	adulterated drugs and
3	subsection (a)(3) (relating
2	section 360fff3(b) of
1	controlled substances; investigations;
1	effectiveness data obtained
1	2420324207), shall not
1	cause. (
 

2	inflation and workload
2	political subdivision. 
4	infringement could reasonably
1	no. 12978 of
1	gene or its
2	farm to which
1	preparation, formulation or
1	carrier that transports
1	investigational plan submitted
1	transferred; (b) general
1	field and such
1	administrator shall coordinate
1	drugs; and (iv)
1	propanamide; (g) 100
1	(c) has made
1	adulterated.  (b)
2	food facilities (a)
3	section 381 of
1	mitigated by the
1	terminated on the
1	practicable, be located
4	will start using
2	title) or under
1	countermeasures, and if
1	determines, after hearing,
1	permit  (i)
1	(8) definition for
1	(1) consists in
2	review  (i)
1	ensure timely development
1	such, and the
1	additive or additives
2	(9) the secretary
2	otherwise formally affiliated
1	general there shall
1	total of 5
1	sale of an
1	total of 3
1	stores as of
1	advisory committee the
1	301(b) of the
13	later than 45
1	506c1, as added
1	(a) has the
1	shall also maintain
2	notice to persons
1	date referred to
4	 (i) documentation
1	purposes will not
1	(ii) is greater
1	must be filed
1	fishing vessel. 
1	suspicious transactions and
1	patient and may
2	protocol has been
1	expires, by the
1	country, at such
1	part to an
1	subsection (d) the
1	therewith. (
 

1	(1) describe the
1	meet any requirement
7	bond while the
2	express written consent
1	secretary reclassified into
1	regarding biosimilar development
1	pharmacopeia, the national
1	affairs shall, by
1	states). (2) the
1	section 1543(a)(2) of
1	march 30, 1961;
1	675, 505e, as
1	(iii) applies any
2	360b(d)(1)(e) of this
1	(f) labeling of
2	circumstances indicating a
1	preventive strategies to
4	official, in the
2	authority is not
1	whether the regulatory
1	requirements; contents; restrictions
15	results from the
1	success or failure
1	(c) upon the
3	written or electronic
1	legal controls applicable
3	(b) authority of
5	subsection (b) does
1	clearance under clause
1	developed; (e) the
3	poultry products in
1	(2) provide for
1	producers of drugs
2	conformity with section
1	consumer good and
1	standards shall be
1	disproportionately high consumption
1	(b) the departments
1	plant for the
1	citizens of the
1	application, review, or
1	(ii) regularly scheduled
2	(3), (4), (6),
1	disposition.  (j)
1	rule for certain
3	information known to
1	minimum, an inspection
1	unless such ingredients
5	provide assurances that
1	protections.  the
1	leaf; and (iii)
1	search warrant, to
1	transcript made under
4	13, 2016, and
1	clinical needs (including
1	ch. 675, 744j,
1	(i) afford the
3	branch of the
1	pay such state
1	$20,000 of the
1	provide adequate time
1	shall, upon resubmission
1	(b) appeal the
1	 (a) enhance
1	 (b) definitionsfor
1	675, 531, formerly
1	designate a person
2	hearing in such
1	illness that has
1	committee from appearing
1	valid or reliable.
1	 (7) notwithstanding
5	title 42 shall
1	successor internet web
2	thereof) to be
2	access, and those
1	investigational uses of
1	found or resides
2	jurisdiction; disposal by
1	drug dependent persons,
1	secretary shall state
1	(inclusive of such
1	projects pursuant to
1	eggs may be
2	toxicological, behavioral, or
1	retail establishment is
1	may be extracted;
14	claimed by the
1	veterinary diagnostics. 
1	narcotic drug (including
1	emergency situations the
1	practicable, the broadest
1	administer the requirements
3	safety of such
2	secretary cannot make
1	obtaining release of
1	controlled premises so
1	agriculture believes is
3	(1) the number
1	coalition awards 
1	section 1701(10) of
1	compatible with established
1	civic and volunteer
1	retaining qualified employees,
3	356c(a) of this
1	(b), (f), or
5	prescribe the procedure
1	permit any person
3	issued by a
1	(m) the distribution
1	party auditor may
2	agencies have identified
1	unrevoked license issued
1	 (i) establishing
1	(i) at the
1	determined by locally
1	advisory committee convened
2	state coordinator for
2	phone number described
3	request not later
3	packs, or holds
1	prescription drugthe term
2	tolerance or withdrawal
1	(a). such person
1	(a)(1)(c), excluding allowable
1	product radiation. as
1	causes a drug
1	
 
 376.
2	audits and evaluations;
1	date the fee
2	administration, and the
1	participating in each
1	security and accountability
3	restoration act of
1	forfeiture, taking into
1	individual candidates. (b)
1	products, including any
1	may propose one
7	animal drug, the
1	
 384. importation
5	promulgate regulations to
1	slaughtered or any
1	packaging including product
1	value, given with
2	 (1) forge
7	fees that would
1	upon proper oath
1	novel surveillance and
1	availability of an
1	 (ii) provide
1	slaughtered separately from
2	life or for
1	(f) prioritizationthe administrator,
1	section. but the
2	product; (ii) of
2	copy thereof by
1	threaten the national
1	(b) aid or
4	request review by
2	farias and samantha
1	parts that 
2	regulated industry, academia,
2	qualified by the
1	will be investigated
1	1968, and periodically
3	determines appropriate to
1	event trends; and
1	332, 333, or
1	drug product, shall
1	(i) for use
2	calendar year concerned
2	secretary refuses to
1	(d) termination the
1	 (3) repackagefor
1	quarterly fee amounts).
1	harm  (a)
49	animal drug application
1	manufacturing practice, or
1	state rules for
4	subsection may not
1	(ii) the -year
1	tobacco product standardsa
1	various drugs and
1	(b) a risk
2	product for the
1	public meetings 
1	(2) the disposal
1	3 times the
1	materials and equipment);
1	originates; the country
1	dosage form, including,
1	implement the programs
1	establishment preparing any
1	(c)(3)(a), and informs
1	enhanced surveillance, outbreak
1	vehicle, receivers, and
1	benefit, or any
1	including periodic risk
1	1704. coordination with
1	title, a new
2	combination products to
1	(ii) the processes
1	public notice, or
1	document conclusions and
1	generala farm shall
1	(iii)  (aa)
1	condition of an
1	government service would
2	biologics license applications
1	section 350c(a) of
1	expenses (including attorneys
1	implement the program.
3	provided, that such
2	category of such
2	(ii) of this
1	 (1) intervene
1	order so incorporated
1	(iv) assigning a
1	(i) all drug
1	activities under such
1	subsection (a)(1)(a) for
1	applicable) if the
1	trial or before
1	en-product quality that
1	paragraph (2)(c) or
2	approve a drug
1	direct purchase statement
1	drying, or packaging
1	 pantothenic acid
2	requires, based on
1	related to medical
1	enters into an
2	standards necessary for
1	substances, or which
1	mitigated and in
1	usual name. (ii)
1	studies in neonates
1	(vi) the likely
1	entry where such
1	menthol cigarettes by
1	distributor means any
2	909, as added
1	conferences to discuss
83	health service act
1	enforcement action by
1	importations in circumstances
1	act), including the
1	subparagraph, or the
1	recognized susceptibility test
2	immediately preceding the
1	person, that importing
1	subsection, and publish
1	(k) artificial flavoring,
1	tobacco products. such
1	conduct inspections consistent
1	services for this
1	prior judgment in
1	 (5) regulations
1	technical expertise necessary
2	 (4) certain
1	electronic products the
1	focus on underrepresented
1	salaries of additional
1	(c) extension service
1	aggregated by country
2	type or class
3	government under this
1	secretary, that there
29	term of supervised
2	inspection to be
2	state coordinator shall,
1	purpose of completing
1	(1) shall assist
1	requests for changes
1	distributor that distributes
2	secretary, upon presenting
1	strategy; (b) on
1	shall inform regulated
1	material submitted pursuant
2	person is under
1	regulation)) intended for
1	commerce on or
1	modify or consent
1	statement of concurrence
1	parts, meat or
1	come into the
2	milk, whether or
1	checks and fingerprinting
1	upon a lawful
6	section 350g of
2	illicit drugs by
11	report under this
1	will be administered
1	director shall require
1	including chemicals, to
1	federal authorities; and
5	term prescription drug
1	renewal request under
1	emission tomography drugs;
1	preservation of state
2	export act [21
4	42, as applicable,
1	new qualified infectious
2	chemical analysis and
4	without charge to
2	exported; and 
1	product injurious or
1	 (c) access
1	mentioned in such
1	specific information on
1	include such modifications
1	cream brought or
1	president considers appropriate,
2	users living in
1	affected under the
1	thousand: provided, further,
1	marketing service shall
1	use of operating
1	 (c) extramural
1	practices; (e) the
4	food products thereof,
1	particularly identifiable type
2	relationship of the
2	person, at reasonable
2	homeland security and
1	another license under
1	regulation made effective
1	related regulations of
2	application of all
3	shall issue the
4	food described in
2	shall be ineligible
1	(2)(a)(iv) shall include
1	
 2206. alcoho-related
4	certification the secretary
6	period as may
1	1543(a)(3) of this
1	title. (b) devices
2	vehicle, or aircraft
2	inspection procedures, processes,
1	substance and he
1	requirements or specificationsa
5	amendment, or repeal
1	imprisonment is applicable
5	persons required to
1	28, 1976, is
2	(2) an application
1	  150.0.
1	assistance is necessary
2	response provided under
2	amount of that
1	internet of material
1	zone. (d) the
1	foreign governments; and
2	proceedings; notification of
1	2016, and in
1	(a) recognized by
1	device determines in
1	precursors.  (f)
1	paragraph (2)(b) may
1	manner; and (iii)
1	may justify adding
1	occurred. (b) in
4	requirements or specifications,
1	accreditation under paragraph
2	chapter or such
1	plans for 
2	contracts for development
1	secretary, that 
5	irrespective of whether
1	reports. (3) meeting
1	otherwise contaminated by
1	sector veterinary hospitals;
2	(b) direct the
2	clause (ii), shall
1	community while under
1	trial in case
1	federal and no-federal
1	moves in commerce
2	use of medical
1	products were processed,
1	admissions for drug
1	pay the drug
2	label, or other
1	lif-threatening manifestations primarily
2	number of food
1	medical or dietary
1	consumers in a
1	assessment center (referred
1	
 2252. compliance
2	applicant.  (3)
2	initiated the manufacture
1	administering or dispensing)
1	issues of fact
1	july 13, 1949,
1	orally and in
1	include, for a
1	establishment. for purposes
1	diversions.  (2)
1	affected country. (g)
1	drug use; (2)
1	(b) acetone. (c)
1	(c) special rule
1	(a) drug control;
2	time before manufacture
1	director considers to
2	operator thereof shall
1	effectiveness of definitions
1	chapter, is authorized
1	accomplishing and carrying
1	add indications for
1	farm shall deliver
31	18 months after
1	education programs, and
2	(3) limitations 
1	subsection (n)); and
1	title. to the
1	1958(b)(1) of title
1	director and office
1	expiration date. the
2	inspection procedures of,
1	drug intelligence center
1	section 4 or
1	methamphetamine.  thirty
1	reviewing countermeasures for
2	authority and standard
4	device classified under
1	general, that the
1	number and email
1	(u.s.c., 1934 ed.,
2	information supporting the
27	representatives and the
2	blood components intended
2	effective control against
1	(4) that such
1	export, manufacture, distribute,
1	costs, and develop,
2	except that paragraph
1	completed or terminated,
2	involving misbranded food
5	shall take such
1	standard for records
1	resistance) and there
56	unless the secretary
1	records except as
1	(b) are adulterated
2	protocol subject to
2	thereto of the
4	risk to public
1	information who shall
1	prohibited by such
2	unobligated carryover balances
2	action plan required
1	authority in the
1	
 
 379s.
3	official device means
1	technical assistance related
1	general assessment of
1	subsequent reports and
1	unless extended by
1	(iii) appropriate directions
1	data. (d) regulation
2	(c) and any
1	applicant plans to
1	object but not
2	transition to selected
2	agency means a
1	conform to, all
1	represents that community.
1	physical or mental
1	(2) deadline the
1	within such other
2	giving notice thereof
2	years 2016 and
1	liable in any
1	subclause (iii). (iii)
1	(ix) a financial
1	radioactive drugs or
10	may request the
1	regarding the presence
10	amount of a
1	(iii) identify system
6	shall contain 
2	products to individuals
6	drug is unsafe
1	(a) commerce between
1	data, and statement,
1	every compound, manufacture,
1	secretary without the
7	means a business
1	secretary rescinds or
1	appropriate, if any,
1	(iii) organizing, training,
3	prescribed in the
1	221, title ii,
1	(b) processthe consultation
1	trader for international
1	(iii) the court
1	 (ii) waiver
1	(or specified subpopulation)
1	best practices and
1	remits the establishment
1	combination product; (ii)
1	accused, be by
2	information known or
2	facilities, which shall
1	drug administration; (b)
1	(d)(4)(b), and (e)(4)(b).
1	september 30, 2003,
1	fellow and a
11	information under this
1	(
 
 813.
1	direct and compel,
1	(c) applicabilityregulations promulgated
3	governmental authorities having
1	notify each manufacturer
5	 (ii) fiscal
1	sections 552 or
1	2 shall be
2	potential members of
1	health care costs,
3	381 of this
1	section will be
1	title, and after
1	approval, and the
1	interpretive criteria upon
1	election (together with
1	postmarket studies required
5	assess such fees,
1	pediatric studies the
1	of, and reducing
1	scenarios that could
1	across the mainland
1	deferral extension continues
1	regulations before consultation
1	disposition of controlled
1	tag in conformity
1	tools (a) process
1	judicial review, a
13	meat food product
5	serums, toxins, and
2	deposit of the
1	revenues for product
1	materials as prepared
1	$153,000,000 for grants
1	 (n) homeland
1	
 
 186,
2	fee amount the
1	ethical requirements otherwise
1	evidence of oversight),
2	tax under section
1	condemned articles; court
1	pigment, or other
1	formula means a
1	(j) to make
1	retailers the secretary
1	animal drugs, supplemental
1	physically handle or
1	administration to progress
2	955 of this
10	associated with such
1	animals, and inspection
1	business address in
3	file a request
1	studies, registries, claims,
10	substance has a
4	entity  (a)
2	establishment. marking, labeling,
1	drug product; or
1	sold. (mar. 16,
1	(
 
 467b.
1	paragraph respecting such
1	law enforcement initiatives
7	conducted in accordance
1	and, from the
1	(8) of subsection
1	application, and (b)
1	injury under 
1	(a) an agent
1	regarding analyses and
1	numerical identifier, shall
1	updated on a
1	conflict with this
2	petition) as the
2	vessel, vehicle, or
3	negligence or intentionally
1	desires may, in
2	egg products were
3	content, complexity, and
2	terminate any exemption
1	et seq.] (37
1	purposes the attorney
1	complete information with
1	state if the
1	product in nonliquid
1	19, 1925; or
1	(b) and reasonably
1	valid and reliable
1	enforcing any requirement
3	labeling provided by
1	qualifying as major
1	iv; delay and
1	best advice based
1	applicability of part
2	plants the secretary
1	data respecting such
1	secretary requires otherwise
2	pharmaceutical manufacturer; and
1	(2) animal drug
1	combined level of
1	agriculture accounts that
1	kinds of establishments
1	(75 g)c 750.0
1	integration of the
3	reductions, and refunds
1	amount and duration
2	risk management advisory
1	product prepared by
1	states subject to
1	requests submitted, pending,
1	years, of the
1	(4) an estimate
1	(2)(b)(iv), and (vi)
2	ending april 1
2	approval or licensure
2	year.  (6)
1	inclusion in any
1	import at a
1	360c(g) of this
1	outreach, technical assistance,
1	anecdotal information; (c)
1	satisfying the requirements
1	means carcasses, meat
1	specified country if
1	(c) enforcement a
3	congress on the
1	u.s.c. 262]. (ii)
1	articles and animals
1	person establishes a
1	apply so as
1	affirmation showing probable
2	(5) knowingly make
1	agreements with third
1	revoke or suspend
9	shall, if there
1	identify new and
1	2, 42 stat.
1	(4), sell, by
1	(2) if, after
1	(i) to a
1	function, or performance
1	specific scenarios that
2	general as to
1	constituent part described
1	states to establish
1	drug is effective,
1	risks of therapies
1	shipping the product,
1	title, an application
1	data between federal
1	investigate a suspect
1	property taken or
1	(5) to rechannel
1	effect the preparation,
7	within the office
2	form of steam
1	requirements prescribed, by
1	days after notice
3	orders orders of
1	(8) sulfondiethylmethane. (9)
1	section 552. (c)
1	paris, november 19,
3	 (b) determination
1	inaccuracies in inventories;
1	 (i) available
2	information on approved
1	employees (hereinafter referred
1	(5) panel members
1	
 143. inspection;
3	shall require a
1	declaratory or injunctive
1	psychotropic substances act
1	consulting center follows
1	calculated using the
1	within 100 miles
1	(iii) complies with
1	(ii) such determination
1	duly authorized for
2	 (a) are
1	facilitate a determination
2	case of each
1	state law, may
1	(i) accepted, pursuant
1	function.  (5)
1	subparagraph (b), as
3	knowing, intending, or
1	weight, quantity, or
1	special controls. 
1	program, he shall
1	heads of departments
4	may engage in
6	critical path publi-private
1	create, distribute, or
1	complete applications an
1	final guidance implementing
1	eggs by shell
1	register whenever the
1	may be standardized
3	expediting the action.
1	term egg handler
1	advertisement involved is
1	islanders), youth, the
2	grades for shell
1	foo-related hazards, including
1	management of food
1	clause (i) either
1	 (d) dispenser
4	privacy act of
1	(42 u.s.c. 9831
1	health. (e) whether
1	section, including on
1	regulatory agencies and
1	regarding drug shortages
1	
 
 379b.
2	first introduced or
1	intramural research training
1	thereafter register with
3	states after february
2	result from aggregate
3	setting; adjustments 
1	
 1710. drug
1	expertise on nanomaterials
1	
 1053. inspection
1	drugs, and if
1	substances, drugs, categories
1	directive shall maintain
1	accelerated approval. 
1	swimming pool includes
3	dealers and distributors
1	notice issued by
1	 section 9
1	919, as added
1	acting upon the
1	person has inspected
1	treasury, in an
1	scientific advances and
43	beginning on the
1	 (3) codes
1	effective; (c) there
1	(e) suspension of
1	respectively, to which
3	performanc-enhancing drugs or
1	human food. (f)
1	 (aa) on
2	effects on health
1	dietary supplement; (3)
1	writing not later
1	675, 513, as
6	supervised release authorized
1	means a variety
3	(a) on the
1	 (b) based
1	list, or a
1	administration for assessing
1	(ii) service of
1	moderate risk or
2	certification, in such
2	feethe secretary shall
2	conform to current
1	employeesfor purposes of
1	conditions in the
1	regarding the safety
1	secretarys order imposing
1	interoperable, electronic system
2	permitted by law.
1	controls over international
1	bearing on violation
3	commerce means commerce
9	subsection (d). 
1	submitted with respect
1	enforcement or educational
5	containing such a
1	capabilities, and authorities
1	1265; june 29,
1	inventory of all
1	subparagraph (a), include
1	632.)
 
 21.
1	abuse of prescription
1	variance is necessary
1	apply to health
4	284m of title
1	
 
 136a.
1	authorized. (mar. 4,
1	drug samples shall
1	responsibility. (b) the
1	term 18-day exclusivity
10	risks associated with
1	881a. transferred
 

1	served in such
5	made available under
1	may update the
1	year 2011; and
2	379j41 of this
1	concerning the ownership,
1	379j12 of this
1	
 
 379.
1	manufacture of drugs
1	involvement of other
1	products and financing
1	countries into the
1	(a)(2). (e) effect
1	special registration under
1	omit any material
1	issues that are
1	
 362. misbranded
1	organizations, to determine
1	(b)(1). for purposes
3	event of default
2	obtained from a
13	fees are authorized
1	skin irritation on
1	court may treat
1	data bank provided
1	state requirement relating
1	federal regulations. (5)
1	shall establish appropriate
3	approval, certification, or
1	chemical. (e) broker
1	national borders. it
1	use in emergencies
1	274a.2(b)(1)(v)(b) of title
1	supplemental application seeking
1	timing of assessment
1	(c). (
 

2	named in such
1	deal directly with
1	state, either without
1	periodic reaccreditation 
1	conditions on persons
1	384. importation of
1	fruit and vegetable
2	organisms in humans;
1	 (b) repealed.
2	food, drug or
1	authorization for importation
1	reside, or have
1	term surrogate endpoint
1	including concerns about
4	specific provisions of
1	pos-hearing corrective action
1	intelligence center to
1	required studies under
1	appeal from that
1	ordering such suspension
1	substance by misrepresentation,
3	may be established
1	problems.  (2)
1	scientific soundness of
1	notwithstanding section 360eee(9)(a)
1	therein; or (c)
1	services  (i)
2	construction  (a)
1	federal determination means
1	exemption is being
1	(which shall not
1	security countermeasure has
1	 (d) composition
1	deliberately causes a
1	advertising for 
1	custom slaughterer does
1	(a) through (e).
1	take effect at
1	office under section
1	manner. no exemption
3	control strategy that
1	secretarys order after
4	secretary may order
1	drug (including a
1	psychotropic substancesthe attorney
1	basis exists for
1	384d. accreditation of
2	information from either
2	(i), (ii), or
7	repair of facilities
1	marijuana, inhalants, cocaine,
1	
 379h. authority
1	$24,000,000 for grants
1	application, on the
1	manufacturing practice regulations,
2	granted, the applicants
3	related to each
2	establishment which he
1	(iii) such article
1	 (d) reimportation
1	except, further, that
3	contracts for primary
1	new drugs, antibiotic
2	public health, such
1	(8) expert testimony
1	information concerning, research
1	person, may by
2	retail any drug,
1	identify safety and
1	end of a
1	according to best
2	production of any
1	congress.  (f)
1	
 
 133.
1	authorization to withhold
2	secretary deems eligible
3	action plan to
1	(b)(2), the goals
2	distribute, or manufacturing
1	neonates.  (b)
1	filled on a
1	(1) publication the
1	encouragement of effective
1	container; except that
1	authorized (a) to
1	(3) a rule
3	submitted by means
1	indirectly, anything of
2	small business defined
1	submits a number
1	obtained under subparagraph
1	training, and financial
1	appropriate ancillary services.
1	grounds for immediate
2	suggests that one
1	students at risk
1	trials a drug
1	drug. (f) delay
1	executive boards of
1	rendered adequate by
2	(a) conduct a
1	cavity of the
1	 $252,960 
1	another provision of
1	substances, excepting solution
3	including the impact
1	(iii) renewal grants
1	economical food supply.
1	end of 2
3	hearing, the court
2	year, or by
1	objectives; and (b)
1	dietary supplement contains
1	clinical studies, preclinical
1	federal benefit 
1	whether the manufacturer
1	transfers, and returns,
1	communication of the
1	nonprescription active ingredient
3	criminal prosecutions or
1	use thereof, and
1	establishments; examination and
1	combination product. the
1	(g) definition for
4	requirement for the
2	meeting with respect
1	pay, with interest;
1	therewith.  (e)
1	order postponing sentence
2	additive, if the
1	
 
 394.
3	section 360bbb of
1	30.0  
1	 (d) trading
1	pharmaceutical ingredient at
1	cannabis indica, digitalis,
1	substance; (ii) any
1	information and coordination
1	bribe or pay
5	secretary reasonably believes
1	death and may
1	(b) exception notwithstanding
1	title and consideration
1	appropriation acts. (d)
1	postmarket studies and
2	(1) the strategy
1	deliberate ignorance or
1	(g) demand increase
2	good cause, a
1	amount not less
1	pesticide analytical methods
1	performance report described
8	dosage form for
3	requirements in subsection
1	count, except that
1	secretary may participate
1	(a), upon such
1	safe for any
1	modify, or terminate,
1	(6) if, after
1	establish a reasonable
3	populations with special
1	manufacture, evaluation, or
1	fat or oil
1	met; (4) 
1	monitor implementation of
6	rulemaking for the
9	postmarket risk identification
1	identifier.  (b)
1	surrounding the imposition
1	necessary for carrying
1	conducted by such
1	675, 760, as
1	next fiscal year
2	available for such
5	title within the
1	relabeling of its
1	states to plead
1	expected to meet
1	willful misconduct. 
1	testing, reporting, and
2	 (f) inspection
3	court designated in
1	case of examinations
1	et seq.]), unless
4	general shall provide
1	entity involved provides
1	demand reduction in
4	supplement shall be
2	thereof, and shall
1	certain circumstances involving
1	title; (c) serving
1	documentation of significant
1	(ii) an exemption
1	bank provided for
1	addiction for any
1	for, and technical
1	 (f) public
1	determined that no
1	offset any amount
2	secretary regarding whether
1	condemnation is based
1	subchapter, to administrative
4	tribe or tribal
1	lawfully maintains a
1	 (a) immediately
1	issued to any
1	ensure against the
4	use of or
6	substance is included
1	timeline for the
1	used within the
1	testing and there
1	use conditions results
1	include either a
3	chapter.  (3)
2	subsection (a)(1) (relating
1	products or marketing
1	indirect; and (ii)
1	reanalysis under subsection
1	(a) to continue
3	proceeding. (
 

1	form; contents of
1	classification shall be
1	purpose of verifying
1	procedures for making
1	hereof; except that
1	charged under section
1	using the following
2	indication for which
1	petition and an
1	among youth; (5)
1	 (1) supplement
1	compatible. (5) in
1	additive means a
1	provider.  (2)
1	(5); and (b)
1	necessary for a
1	inspections, including data
4	adduce additional evidence,
1	basis for each
1	(b) jeopardize the
1	misbranding or adulteration
2	exception a package
5	360e(b) of this
1	monitoring program, that
1	(1) 15 or
1	secretary of transportation,
1	term qualifying federal
1	(b) alternatively, in
1	notification by a
1	application, (4) knowingly
1	generate revenue amounts
2	can, pot, tin,
1	379aa. serious adverse
8	section for fiscal
1	generala dietary supplement
2	paragraph (3). (3)
3	labeling, or repacking
15	3, 1915, ch.
1	(less a reasonable
2	standards and interpretive
1	abuse, especially the
1	proximity are considered
1	 (c) contentthe
1	shall introduce into
1	previously disclosed to
1	insular, subject to
2	punishment otherwise authorized
1	event of multiple
1	authorized to retain
1	shall encourage states
1	articles are condemned
1	unwanted prescription medications.
2	condition; and (c)
1	quantities of controlled
4	controls pursuant to
1	upon reviewing the
1	detected such violation,
1	inspection of cattle,
1	(d) stay pending
1	fines, to enforce
1	lands owned or
5	violation of an
1	imprisonment under such
1	sector drug control
1	publication under subsection
1	banking institution, to
1	nonmedical purposes, and
1	labeling can be
1	effectiveness and the
8	person against whom
1	may determine other
5	24, 1984, and
1	potential toxicology of
1	(ii) issuance of
1	committee has made
1	title until the
1	(1) that 
1	models and valid
2	chemical, biological, radiological,
1	different manufacturers; (h)
5	secretary or the
1	job training, drug
1	(c) for grounds
1	poultry itemthe term
1	deficiency in the
1	(1) revocation the
1	doubled in the
2	(1) under such
16	pharmaceutical ingredient drug
4	food contact surface
2	formula, and (b)
1	conducting the necessary
1	cream shall have
2	order or regulation,
1	substance.  (n)
1	medical device, the
1	residues of major
6	professional supervision of
1	food which would
1	informing the secretary
1	expert, as described
1	today. (c) contemporary
1	et seq.), reenacted
1	causing such urgent
2	application contained or
1	drug operations (a)
1	services nonetheless believes
1	engineered seafood products
1	presidential decision directive
1	available, through the
1	title 20) or
2	facilities, including small
1	life threatening situation
1	services who shall
1	dairy products intended
1	thereof) that is
1	reports, to inform
1	(aa) are more
2	term manufactured does
1	food in order
2	drugs or active
2	veterinarian in the
1	subparagraph (b)(ii) by
1	evaluate emissions of,
1	(e) definitions in
1	regulatory predictability, the
1	writing, whether the
1	sell, deliver, distribute,
1	referring to a
1	unit which will
1	imported food shipments
1	committee, the number
20	paragraph (1) to
2	submits the additional
2	(or an amendment
1	entities the secretary
1	require distributors to
1	devices is one
1	consortia, publi-private partnerships,
1	amino acid; (e)
1	(b) has malfunctioned
2	conspicuously display, at
2	year 2017. if
1	individual under the
1	year 2013, fees
1	times of abbreviated
1	conduct that 
1	court rules on
1	made unavailable for
1	state with respect
1	not, except as
1	subsection (b), a
1	acids and their
1	21 code of
3	scope of disclosure;
2	period notwithstanding the
2	(g) shall not
1	 (b) sites
1	determination of misbranding;
1	existing information) since
1	administrator shall, as
1	slaughtering; diseased animals
1	intent to distribute.
4	successor) shall not
5	intent to distribute,
1	period; or (2)
1	businesses to comply
1	(d) report not
2	both. when construing
1	no-federal sources; and
1	section 981(g) of
1	entities to accredited
1	substance to create
1	procedures applicable except
4	classification panel described
17	upon the request
1	sterilized seed of
1	performance standard prescribed
1	publication and list
1	commission of, such
1	44 shall not
1	maintenance of the
1	(for which it
1	drug is anticipated
1	institute; (5) enhancement
1	alleged, sworn to
1	title xix of
1	contains any natural
2	term food contact
1	furnishing, giving away,
1	shows the tolerance
4	made on a
1	use of eggs
1	use countermeasures, as
1	(b) meeting for
1	(a) resistant gram
1	market names for
1	obtained, if the
1	(7) significant foreign
2	attempt and conspiracy
1	introduced onto the
2	lot level information),
1	furnished or intended
1	singl-use devices 
1	substance manufactured or
1	additive (or of
1	manufacturers thereof for
4	trade or offer
1	(a) may transfer
4	single dose or
1	highly visible federal
1	plans for enhanced
1	master file means
1	(u) of this
1	(a) exhibits spontaneous
1	audit agent the
1	regulations the secretary,
1	section 360g1(a)(3) of
1	provide information that
2	(c) on the
5	(c) use of
1	between, by, through,
1	(1) for having
1	potential  (1)
1	include participants representative
4	suspension under subsection
1	abuse; and (3)
1	displayed for sale;
1	revenue amounts under
2	establishment by the
1	racemorphan.  (c)
1	appeal.  (iii)
1	manifestations, including describing
1	tissue the implant
1	making a false
1	hours took place.
1	misleading name, other
1	combination of two
4	inedible by humans.
1	general in making
1	information and views
1	validly registered with
1	data bases of
2	(b), no state
1	advertisements using no
1	403, and 404
1	order informing the
1	(3) certification before
8	order was issued
3	manufacturers, repackagers, wholesale
1	interdiction; (ii) state
1	schedule. while serving
1	additive, under the
2	back to the
2	controlled substance (without
1	credentials and (b)
1	relationship to distribute
2	order the date
1	notice under clause
2	year, not less
1	terminated pursuant to
1	administrator may require.
1	(3), the provisions
1	kit, ingredient, nuclide
1	person the opportunity
1	final rules under
2	reporting, including records
1	signs, signals, pictures,
5	controlled substance for
1	commission. the remaining
1	 (d) limitations
1	(a)(4)(c). (iii) all
1	protected from counterfeit
1	drug products). 
1	requirementsto the extent
1	section 242a(a)[1] of
1	significant findings of
1	(c) criteria 
1	title; (b) is
1	generalbefore the effective
1	methamphetamine that can
1	675, 602, 52
1	387]; (d) insert
1	supply will be
1	certificate of the
1	purpose, sells, distributes,
1	accessible, timely, accurate,
1	official veterinarian of
5	amount that is
1	authorities conferred on
1	drug.  (9)
1	
 387s. user
1	liability for failure
1	additional provisions of
2	egg products subject
1	professional organizations. 
1	shall retain the
1	importers, a single
1	generala declaration under
1	requirements. (2) the
1	standards means inspection,
1	postmarket adverse event
1	199. repealed. 

1	(8) levomethorphan. (9)
1	relating to use
3	(as those terms
2	one kilogram of
2	court in the
1	1956, ch. 495,
1	supply chain prior
1	administration to dispose
1	health, or (ii)
1	areas such as
1	person seeks an
1	determines appropriate; 
1	auditor agrees to
9	applied to a
1	general is notified
2	chapter, including evaluating
3	purpose, an examination
8	withdrawal from sale
1	necessary for compliance
1	controls, equipment, or
1	
 1704. coordination
1	purposes; (5) conduct
1	pharmacy, drug or
3	states. the secretary
1	patients to an
1	generala manufacturer of
1	(2) no effect
3	effect an approval
1	poultry products broker,
1	building domestic capacity
1	use included in
2	packs, distributes, receives,
1	system in such
1	person who made
1	ordinary business records
2	use an accredited
2	maintain the article
1	distribution security 
1	2009, $85,000,000 (subject
9	equivalent of the
1	entity, or by
1	shall, within 1
1	books, papers, documents
1	(a) authorizationthe attorney
2	expected performance from
2	reasonable manner, to
5	list of qualifying
1	subsection (b)..[1] the
1	importation is or
1	investigations; (v) full
7	(b), (c), or
1	assistance for immunizations.
1	(vii) a proposed
1	meetingfollowing any meeting
2	request shall provide
1	regarding direc-t-consumer advertising
1	5, to recover
1	similar descriptors; or
1	exists; and (v)
1	314.550, 314.640, 601.45,
1	action after receipt
1	manufacturer has established
1	manufactured, prepared, propagated
1	day the secretary
1	purpose of repackaging
1	equines are slaughtered,
1	problem; or 
1	(1) was issued
1	oral order, promptly
1	area, or for
15	shall, to the
1	42, of any
1	(2)(a), and regardless
1	adhered to the
2	(ii) firms submitting
2	commerce; inedible articles
1	shall be valid
2	scientific matters from
1	similar forms of
1	(d) communication systems
1	basis of public
5	purpose of enabling
1	(b) first offensea
4	conviction, include a
1	countermeasure that is
1	 (a) collect,
1	quantity, if any,
3	section regarding the
1	drug to use
1	paragraph (2)(a). (w)
1	considering whether to
1	process used for
2	effective drug. (g)
1	psychotropic substances signed
1	means interstate, foreign,
1	referral necessary, the
1	information, or other
1	202, as added
1	studying biological products
1	equine meat for
1	commission upon the
2	was, or may
1	state; or (ii)
3	sections 20 to
2	program to ensure
2	321(h) of this
1	 (d) on
3	geographical areas of
1	procedures (as defined
1	auditor that has
1	facilities applicable; enforcement
1	report of criminal
1	fee account 
1	proposed use would
1	chemical product if
1	food, the responsible
1	considered a disclosure
20	less than 60
1	year 2013. (b)
1	transfers direct ownership
1	less than 65
2	licensed and the
1	section 360ll(a)(2) or
1	applicant to agree
3	assessed to such
3	assistance, and shall
1	considered a new
1	paragraph. information that
1	(2) a website
1	status of certain
1	coordinate any action
3	employee in a
1	title 26; and
2	labeling requirements set
2	limitations (whether in
1	liability. (19) the
3	states. in such
1	likely to reduce
1	means a partnership,
1	services, may send
4	subsection (b)(2) or
1	(1) place the
1	(g) regulatory science
1	nanotechnology, the secretary
2	imported food. 
1	containing any added
1	disseminated. (e) surveillance
1	(4) meeting a
1	review of drug
1	inform regulated sellers
3	used in manufacturing
1	expired by the
3	subsection (b)(1)(d) for
1	device at the
1	identify an individual
8	support a biosimilar
1	category of drugs,
4	secretary, that a
1	accreditation bodies described
1	dispenser may respond
3	subparagraph (a)(ii). 
17	person subject to
1	federal facility, or
2	final regulation establishing
1	2010, or any
3	three years, or
2	submitted before november
1	transit of fresh
1	ii. (2) 
1	september 30, 2017,
1	strategies, policies, directions,
1	title publicly available,
1	(including the civil
1	therapeutics (a) establishment
1	refused admission all
7	data or other
1	authority for substance
1	therein, shall, upon
1	
 387f. general
1	shall meet each
1	101); (c) the
4	262(a) of title
1	assure the continued
4	definitions  (1)
1	formerly 360b, as
2	report to congressnot
1	appropriate, with other
1	correct the conditions
1	(b) paragraph (2)
1	contentsuch regulations shall
1	taken or detained
5	 (2) fee
1	promotion, using the
4	[15 u.s.c. 1451
1	respect to consequences
1	pharmacist in the
1	section 360e(d)(2) of
1	approved. upon issuance
1	(i) no exclusivity
1	(l) option to
1	bodily injury which
1	establish appropriate security
2	informed  (i)
1	area will be
1	units of all
1	65 stat. 648;
1	recommendations for measures
1	labeling therein. in
1	(i) expires on
1	fee. (e) modification
1	federal food safety
2	making the determination
1	investigate any case
1	information regarding exposure
1	staphylococcus aureus, vancomyci-resistant
1	made to this
2	term advisory committee
2	products under subsection
1	criteria the manufacturer
1	notify a registrant,
1	assuring access and
1	description, the number
1	negotiated fees for
1	staffing and resources
1	plain language the
8	made at the
3	attendance of witnesses
1	shall, if and
4	united states. (b)
1	interagency agreements with
1	(1) knowingly open,
1	agreements under paragraph
1	(c) requirements established
1	food; (c) the
1	must be made.
1	individuals. all reports
1	
 691. omitted

1	response that denies
1	epidemiological studies and
1	 (h) references
3	authorized by his
1	shortages; and (3)
1	gateway is completed,
2	class iii, which
1	violates any other
3	refund under this
3	recordkeeping and related
1	included or was
1	higher than in
1	official compendium that
1	shipped; any country
1	distributing new infant
1	schedule iii and
1	government employees the
2	appeal from order
1	funding was diverted
1	associated with continued
1	available and of
1	said secretary; and
1	821.)
 
 209.
1	lawfully in possession
1	took action to
1	subsection (d)(3). written
1	disposition of restricted
1	health published by
4	section 355(j)(5)(f) of
2	(b).  (

1	risk product may
1	laws; (b) when
1	emergency response networkthe
7	distribution until such
1	substitution for such
1	coordinated communication from
1	(j) be commensurate
1	aggregated on an
1	labeling contentsthe labeling
1	requirement to conduct
2	exception notwithstanding any
1	causing by the
1	time periods; and
2	(i) the food
2	potential to address
1	tobacco use; (b)
1	pathogen, as defined
1	devices constitute an
1	government agencies, institutions
1	18, no civil
1	section. (c) the
1	subsection (a)(2) within
1	rest or other
1	(n) abbreviated applications
1	question the basis
1	columbia, or any
1	agencies and laboratories;
1	jurisdiction concerning drugs
1	shall submit on
1	records or other
1	occurs in whole
1	violated by the
1	employ any necessary
4	substance (other than
4	mea-canning, salting, packing,
3	(3) preservation of
4	radiation, unless the
1	require an assessment
3	361(a) of this
1	applicable conditions under
1	treatment; annual registration;
1	submitted through the
9	refusing to approve
1	consider the input
1	act, or to
1	identify and help
2	reliance on postmarket
1	therapies, accelerated approval,
1	offenders second or
1	implement such guidelines.
1	funds  (i)
1	class of product
1	applications.  (5)
1	fees. (b) the
1	subsection (a)(2)(a) may
3	jurisdiction in accordance
1	implead the supplier
3	et seq.] means
1	revoked, or denied
1	(following the initial
1	risk/benefit balancing in
1	impose such reasonable
1	immediately across from
1	primary intended purposes.
1	stored under normal
1	(2) enforcement any
1	manner, such factory,
1	health services administration.
1	days before submitting
2	601.41 of title
4	section 360b or
1	health; (2) it
2	administration, advisory committees
2	health services administration,
1	675, 586, as
1	records and other
18	section 360b of
1	regulations). (c) regulations
1	confidential treatment for
1	health concerns about
1	residue among infants
1	262]. nothing in
3	license to import
2	narcotic drug is
1	(i) exceed the
9	rulemaking that includes
1	produce that is
1	(iii) establish a
3	court (within 60
2	secretary shall waive
3	drug shortage. 
2	practices for drug
4	food sold by
1	entities in the
2	secretary.  (ii)
6	is, in whole
1	purpose; identification of
1	employee)  (1)
4	title unless such
1	ongoing concern by
1	trafficking area, conditional
1	safe use, other
1	agent or representative
1	needs and initiatives,
2	ii; (7) to
6	activities carried out
1	manufacturer and at
1	(b) coordination of
1	terms deliver or
1	sponsor who, for
2	identify and evaluate
3	entity, if such
1	1 (part), as
1	funds the executive
1	applicable, section 360(k)
1	63. penalties; acts
2	expected to result
1	agent; except that
1	awareness effortsthe secretary
1	(a) individual possessing
1	freezing, dehydration, or
2	addition to those
1	thereon in distinctly
1	(a)) and with
1	1949 [50 u.s.c.
1	regulation reinstating an
1	1971.  (c)
1	application. (v) if
1	subsection (b)(3), as
1	request a supervisory
2	control program strategy
18	used by the
1	data are adequate
1	title after two
1	355(c)(3)(e)(ii) of this
4	agents of such
1	violation involved before
1	traceability of such
4	shall not, unless
1	(3) within any
1	offices, the progress
1	pediatric patients, such
1	conclusion by the
1	classifying cases; (d)
1	(4) of that
2	reserve fee for
1	representative and describe
1	center). the center
1	policy the secretary
2	(5) in the
1	product fee under
2	from, or in
1	preparation thereof which
4	pesticide chemical residue;
1	registrations the secretary
1	so, creates a
1	party. (c) provide
1	known safety risks,
1	act occurs during
5	pesticide chemical residue.
12	pesticide chemical residue,
4	requirements for approval
1	panel the attorney
1	prescribed, by rule,
3	receipt, carriage, holding,
1	(ii) to exempt
1	animal drug application)
5	promulgating regulations under
1	device exemption an
8	animal drug application,
1	trade by criminal
2	animal drug application.
1	residue level was
1	liability of carrier
1	348(f)(2) of this
3	since the last
1	(i) the purchase
1	appropriate representatives of
1	animal drug application;
3	final, he shall
1	sale, colored oleomargarine
1	disposition thereof. 
1	microorganisms of public
1	(2)(a)(i)(i).  (4)
44	drug application or
10	pesticide chemical residues
1	clinical trials (if
1	distribution practices and
2	directs to the
1	371. regulations and
4	clearance to participate
1	responsible for executing
2	substance is in
1	reasonable to believe
1	secretary and comptroller
1	states, using such
1	establish a formal
5	requirements would result
1	governmental agencies; utilization
1	(2). (4) the
1	u.s.c. 2603]; or
1	section 343(q) of
1	 (c) distribution
2	related to, a
3	 (1) issue
1	rulemaking provisions of
1	transaction to identify
1	(a) special rule
1	cigarette tobacco. 
1	information respecting it
1	drug/device, biologic/device, or
1	used in wholesale
19	animal drug applications
1	quality regulation, the
1	
 879. search
1	(b) packaging, isolation,
1	postmarket monitoring provisions
1	distributing a small
2	except that under
3	first and second
3	transcript of the
3	standard grade minimum
1	avoid issuing duplicative
1	information on stat-o-th-art
1	original package across
1	march 3, 1891,
1	activity, immediately submit
1	which, the person
1	agriculture; (2) consult
1	years, and (c)
1	 (5) generic
1	milk defined for
3	genuine issue of
1	controlled clinical trials
1	1800fda1088 (or any
1	(iv) invite interested
1	auditors meet such
1	waive or limit,
1	brands of an
1	threat in an
2	section shall report
1	$200,000 if the
1	4145341787 (august 11,
1	proposes to label
1	tomography drugs; and
1	executing the warrant.
1	 (i) inapplicability
1	may be updated
1	restriction is required
1	facility by means
1	rulemaking  (1)
1	require the validation
1	action as provided
4	violation of regulations
1	submit information required
1	regulation change such
1	importation of that
2	affiliates gross receipts
1	prospectively planned and
1	use based on
4	title. (b) in
2	practicable after completion
1	hearing and who
2	means are available
1	conducting ris-based inspections
1	secretary, determines that
1	risks described in
1	practices and requirements,
1	forth the petitioners
1	procedures that apply
1	appropriate conditions for
1	development tool, based
1	states, the secretary
21	may be required
1	controlled substance whoever,
2	shall assess whether
1	evidence means data
1	official establishments; 
1	receive a grant
1	convictions under subsection
1	provided under paragraphs
1	(5) a hospital
3	chapter 35 of
1	shall appoint a
2	ensure that information
1	chapter, be eligible
1	(a) vests in
1	threats (a) definitionsin
2	section for each
1	
 
 360g1.
1	[21 u.s.c. 387a1(a)].
1	years the original
1	general so notifies
1	ruleeach person that
1	recommendations for modification
1	uses such device
3	congressnot later than
3	nutrition assistance program
4	satisfies the requirements
14	action under this
1	auditor no longer
2	time is extended
2	therapeutics established under
1	inspection requiring, or
5	3 of the
1	criteria, and such
1	
 951. definitions
1	specifications of the
1	product solely because
1	identifier or lot
3	use the computerized
1	provided shall be
1	reopened for this
1	investigations receiving funds
2	issuance and the
1	interested person and
9	primary drinking water
1	section until such
1	deferrals and waivers
2	one of its
1	pursuant to 1091(r)(1)[1]
1	biennial inspection of
1	surface; or the
1	95. transferred
 

21	substances or list
1	processes to ensure
1	(12) methyldesorphine. (13)
1	applicable number. except
1	title iv, 411,
2	title, licensed, or
2	safety training, education,
1	formula required 
1	label, and (b)
2	licensed pharmacist, and
1	index listing; and
1	address of such
1	registration of added
1	drug facilities). the
3	prepared at any
1	requirements for manufacturer;
1	otherwise prepared, is
1	conducts an investigation
1	medical response. (d)
1	provided funding under
1	branded in accordance
1	products; (2) plan,
2	retail unless the
1	(including all scientific
1	n-tobacc-sale order, the
1	means of security,
1	summary was posted
1	authorities, and (iv)
4	methodology described in
1	heroin. (j) federal
4	requests under this
1	list listed by
3	(4) shall not
1	defense. (h) construction
12	committee referred to
1	prominent than 
3	submissions and, where
7	(d)  (i)
1	novo, and shall
5	trafficking area; and
2	submissions. (e) the
1	inspection system of
1	determining the appropriate
3	subsection (k) that
1	identification by name
2	regarding the quality
3	person that submits
4	reduce the availability
1	(25) hydroxypethidine. (26)
1	paragraph may, if
1	may file the
2	public hearing upon
1	intend to carry
1	so, or to
7	subparagraph shall not
2	dispense, or conduct
2	substance as an
1	had, or to
1	hereinbefore provided, and
2	proposed amendment in
18	due to the
2	threats to the
1	detection of zoonotic
1	subsequent fiscal years;
3	listed chemical will
1	professional societies about
3	foodborne illness and
1	directly support the
1	proposed regulation. after
1	hyperoxia. (vii) in
1	schedule. (3) maximum
2	ordered forfeited to
1	 (c) definitions
1	elements will mitigate
1	secretary through regulations
8	subsequent fiscal years,
1	convention, incorporated, shall
1	secretary information on
3	united states without
1	(2) shall, where
1	article for import,
1	compliance with, the
1	standard the secretary
1	paragraph (1). a
1	next applicable annual
1	subsection of $299,000,000.
1	
 1523. definitionsin
1	government that the
1	inspectors post mortem
4	criminal proceeding, the
1	regulations, among other
1	new submission following
1	bound paper book.
1	campaign.  (2)
2	amounts established for
1	(4) stay of
1	(2) by certified
4	brought on behalf
1	means or with
1	clause (ii)(iv), the
1	persons violate the
1	respect to seizures
1	veteran in the
1	use shall apply
1	(4) international standards
1	(2) action package
1	tests to individuals
1	activities that may
3	businesses such as
1	mitigation strategies) insofar
1	(
 
 1521.
2	drugs in violation
1	recertification by an
1	notification publicly available;
1	agreement, policy, form,
1	rebuttal or other
12	expended. such sums
1	techniques that can
1	 (1) pursuant
1	detailed to such
1	reinstated. the secretary
2	implant, as provided
1	342(a)(1), (2), or
1	(5) that demonstrates
1	manufactured, possessed, distributed,
1	drug administration, nonprofit
1	active ingredient) which
1	labeling, issued by
17	issued under section
19	drug control policy
1	intended purposes through
1	petition, the 3-month
8	feed directive drug
1	675, 805, as
1	tribal organization, to
3	secretary fails to
1	plant shall fail
1	manufacturing practices designed
3	conviction, be subject
1	initiate proceedings to
1	appropriate; (b) be
1	review and modify,
3	distributor the term
1	child and adolescent
1	names of drugs
1	grant recipient meets
1	likely to be,
1	may seem proper,
3	may seem proper.
1	333. penalties (a)
6	years after december
1	title 42, which
1	paragraph (1). subsection
1	grams). any manufacturer,
1	emphasize prevention of
1	risk of attack
1	(b) limit period
1	causes the food
1	section is effective,
1	quantities measured in
2	lon-term federal strategy
1	identifying reportable food,
7	device  (a)
3	waive the application
1	qualified testing means
1	statutes and regulations;
1	secretary.  (l)
1	 (i) five
1	entity governmen-issued identification
1	(a). (3) whenever
1	fact: provided, that
1	scientific or other
2	safely from such
1	10, 1997, shall
1	failed to conduct
1	42) to the
2	files a motion
1	alleged misbranding, and
1	fiv-day period the
1	countermeasure application may
5	copy all records
1	(ii) relevant 
1	term includes animal
2	promotion of, or
5	applicable requirements under
9	appropriate advisory committee
2	test or tests
1	substances (a) rules
1	define the shor-,
1	disqualifying interest under
1	(a)(1)(b), that are
1	tests or studies
1	quality as ex
1	use sanitary transportation
2	age group have
2	accredited persons and
1	secretary or under
1	data exchange 
2	seq.] prior to
2	regenerative advanced therapies
1	regarding reports submitted
1	basis for not
2	section 360b(d)(1)(e) of
1	master file; and
2	him. service may
1	programs, the secretary
4	late payment penalty,
2	determine whether to
1	area of oncology,
1	registration information 
1	grant a dispenser
15	drugs and biological
1	patient labeling of
1	chemistry (iupac). (2)
2	subsection (e) and
1	(1) when such
1	pediatric access to
1	cases under this
1	(5) the sale
4	chapter, including the
1	treatment (or both)
1	purity or quality
2	attorney general receives
1	(n)(1)(g). the approval
1	review if disagreeing
1	remain confidential during
3	claimant of the
1	guidance documents to
1	serious injury to
1	head start act
1	governments to build
1	(a)(2)(a) for each
1	coordinator shall issue
1	costs of agricultural
1	dosage form, delivery
1	subsection (g)(2); (b)
11	title or a
1	risk of harm
4	device classification panel
7	device to be
1	industry, academia, health
1	without further period
1	intended for one
2	person through a
1	identification system the
1	products procured for
2	transportation, offer for
1	debarmentthe secretary 
1	patient or the
1	energy commission, and
1	condition of disease,
1	existing and planned
1	whether approved under
1	establishment of voluntary
1	imposed therein. (3)
1	state the specific
1	(4) alter or
1	(a) pending time
1	of, a practitioner,
1	(ii) identifying any
1	purchaser, manufacturer, or
1	connection with real
1	(ii) limitationsfor purposes
1	includes a patien-reported
1	addition of constituents
1	drug, which 
1	general the head
1	regarding conflicts of
1	may take any
2	described by the
1	technology; (2) the
1	activities. (3) the
1	any, of refusing
1	modifying the exemption.
1	controls. (d) 
2	allow shipments 
4	shall prohibit the
2	induces, entices, or
1	among individuals qualified
1	subparagraph (a)(vii), the
2	housing facility owned
3	title 15), and
1	shall take place
1	states, until the
1	approved by fda.
1	electronic products to
1	year; or (b)
3	account for the
2	one year before
1	necessary.  (c)
1	food when stored
2	firms submitting tax
1	(which shall be
6	distributed by the
1	(2) approval status
1	period for approval
1	undermined, within a
2	january 15, 2018,
1	(3) expedited withdrawal
2	receive referrals under
2	petition, notification, and
1	quality falls below
1	379aa, 379aa1, 387i,
1	period and the
1	adults before pediatric
1	(1) or (3)
1	issue and serve)
1	title and modified
1	general may designate.
1	parties, the administrator
1	 (b) voluntary
1	drug and repacks
1	upon a medical
1	state. (2) inapplicability
1	product in this
1	patient, consumer, and
1	relating to designations
1	narcotics leadership act
1	appropriate studies in
1	stat. 271.)
 

1	interdiction committee to
1	clarify the permissible
1	reduction, and a
1	specifies otherwise. the
9	credited to the
1	list required by
1	(j) factors as
1	research applications; construction
2	 (c) exception
1	355c. research into
1	secretary. (b)development of
1	whom, and the
1	extended date. the
1	title; (d) offering
1	employment, (ii) all
1	permit, and the
1	(ii) an opportunity
7	state may establish
1	qualified acceptance, within
1	consultation of food
3	another party to
1	standard is plainly
1	concert with five
1	assistance; (2) the
1	(3) interim list
1	u.s.c. 1333] and
1	requestor means an
1	means (a) any
1	500; 1953 reorg.
1	justice and which
1	events or other
1	except for purposes
1	competition, the health
1	federal register, specify
1	
 844a. civil
1	comment. the secretary
3	prescription drug advertising
1	types of combination
1	exemption may be
1	purchasers by obtaining
1	train to the
1	activities, including education
1	requires licensing by
1	drug related, including
1	year for positions
1	food beyond the
2	applicant are present
1	clearly indicate the
1	distributed.  (2)
82	term of imprisonment
10	application shall not
1	increase of drug
2	require reimbursement, in
4	months after july
3	part of each
1	product an explanation
1	reasons, or statement
1	pharmacologicall-related drugs. 
2	person designated in
1	nonconformity; (f) on
2	preceding sentence) shall
1	year 2010; and
1	considered ineligible for
1	animal drug; (e)
1	need to permit
2	development of drug
1	gas shall be
1	additive or increases
1	report of each
6	later than october
2	shall prescribe, including
2	animals shall be
1	positive for use
2	additional label subparagraph
1	statement of intent
1	acid or analogous
1	issued, and (ii)
1	age is punishable
1	u.s.c. 2012)), or
1	principal and interest
2	paragraph (3). (b)
1	local drug crisis,
1	(c)(1), as applied
1	waived, is sold,
1	 (3) does
2	notice establishing fee
1	extraterritorial jurisdiction there
1	indication for such
1	leaving the premises,
3	assessment conducted under
5	preparedness and response
2	public will be
1	52 stat. 1054.)

2	division determines that
1	hearing for a
1	applications approval, approving
1	(3) has had
1	subsection the term
1	american osteopathic association.
2	shall adjust the
2	detention order under
5	manufacturer or repackager,
1	authorization outweigh the
1	(1). (
 

2	910, as added
1	food; (b) known
1	agricultural commodities; or
2	public meeting not
3	notice in accordance
1	higher education has
1	prescribe by regulation,
3	title subsequent to
3	issue to the
1	human services after
1	sufficient to carry
1	(a) evaluate domestic
7	government or an
1	challenges relating to
1	available.  (3)
1	including functions under
6	entity to be
1	152. importation regulated
1	private sector. (d)
3	information is required
1	(a) which would
1	subsection (f)(4)(b) and
1	interruptions of regular
3	containing any of
1	elementsthe data elements
1	methamphetamine; and (c)
1	information for inclusion
1	filled milk. (mar.
1	(ii) additional considerations
2	(a) was committed
1	obtained by him,
1	title that meets
1	sales; written orders
1	(i), the provisions
1	separate offense under
1	(5) training in
1	554, 556, or
1	facilities of agency
1	clearance before such
1	drugs unless the
1	education, and outreach
1	investigations (including the
1	issued thereunder is
1	identified in section
1	(
 
 2104.
1	4-day period if
2	advisory committees consisting
1	products imported thereafter
1	similar operation under
1	local jurisdiction except
1	restricting the secretary
1	transmitted helmithiasis. (p)
1	 (a) basis
2	(1) work with
1	
 
 344.
1	facility, nursing home,
1	furnish any record,
21	subject to subparagraph
1	reports, by the
2	consistent with paragraph
1	fees in whole
1	appropriate to promote
1	bodies that accredit
1	food product by
1	revised plan is
1	with, the sponsor
1	drugs; contents, filing,
1	services regarding the
3	regulations effective date.
2	bureau of indian
1	devices.  (2)
2	authorization was issued
6	drug is intended
1	(q) specific purposes
1	seller complies with
1	(i). (vii) for
1	(1)(a) and (2)(a)
4	hazard analysis critical
1	trafficker were originally
2	suspending under subsection
1	activity undertaken by
1	construed to diminish
1	use the seizure
1	distribution by the
1	determination.  (c)
1	construed as derogating
3	suit of and
1	legal or equitable
1	support communities in
2	assign staff to
1	knowingly distributes, or
1	agriculture, in consultation
1	tobacco and that
1	ethylene oxide or
2	ready to eat
1	suggested in labeling,
1	assessment of national
2	recommendation. a copy
1	shall prepare an
1	omitted
 
 1151
1	distributions in accordance
1	inventory to the
2	379g(6) of this
3	license for a
1	(f)(3)(a), the number
1	exporters of controlled
1	support from any
1	withdrawal period as
1	collaborative agreements, to
2	documentation certifying that
1	withdrawal period at
4	order, the attorney
1	either a full
1	(u) hydriodic acid.
1	regarding the functioning
1	goals of such
1	(for a medical
1	necessary to notify
1	defined under subparagraph
4	collected in accordance
1	attributed to a
1	distributor has reason
1	851 of this
1	et seq.) manufacturers
1	intravenous product described
2	(2) report and
1	(1) would not
1	prescription drug establishments);
1	promote support for
2	 (g) judicial
3	exceed $10,000,000 for
1	approved protocol subject
1	affiliates of the
4	including small businesses
1	enhance, not supplant,
3	respond to requests
1	may deem proper.
2	supplement contains reports
4	american samoa, and
4	 (i) application
1	drug application, but
8	foreign supplier verification
1	(iii) an initial
1	establishment that with
6	reasonable period of
1	treatment.  (b)
1	advisory committee concerning
1	clinical testing to
1	established program a
1	2000), or flunitrazepam,
2	eggs by any
1	(b) public identification
1	records, and each
1	exception applies, the
8	determining the amount
5	state that such
1	condemnation shall be
7	distributor of record
1	rapidly resume agriculture,
3	27, 2013, verifying
6	establishing, modifying, leaving
1	facility with gross
1	anticipated not to
3	provisions unaffected the
1	 (4) deferral
1	manufacturer are in
2	52 stat. 1058;
1	assess civil penalties.
1	place or is
2	commerce as a
2	manufactured, prepared, compounded,
1	tried all records
1	study under paragraph
1	offense of this
1	use of marijuana,
2	keep records with
1	distributors to the
2	shows that such
1	written clearance on
1	experts established pursuant
1	agriculture at the
1	substance under medical
1	transfer each person
1	reduction for that
1	(b)(2). (b) upon
1	general policies of
1	42 or by
1	shall provide, in
2	(10)  (a)
2	law.  (e)
1	making such assessments
1	address (street address,
2	product. for purposes
2	1, 2008, had
1	timely manner. 
8	3 percent below
1	demonstrates a legitimate
2	government entity (including
4	subsection (c) is
1	manufacturer means (a)
1	response fund 
1	suspended under such
1	basis for 
1	considered the same
5	negotiation meetings conducted
1	written requesta single
1	contain the following:
4	(d) or (e),
1	activities no person,
1	applicable) of the
1	(a) sanitation procedures
1	administration, for information
1	drug includes 
1	years to allow
1	protocol. the secretary,
1	requestor mutually agree
1	(b) the department
1	paragraph (2)(a)(vii)(iv) is
1	omitted
 
 134
1	distribution or use
1	application or report
1	paragraph only after
1	(1).  (e)
1	(b), the applicant
1	disparate dosing regimens,
1	commodities, including differences
1	compensation of employees
1	helmithiasis. (p) yaws.
1	potential for conflicts
1	local law consistent
1	(a). for the
2	designation in the
2	begins the manufacture,
2	mortem and post
1	prevention. (iv) the
1	meaning of paragraph
1	device. (iii) such
1	sell raw materials
1	(n), no party
5	(or, in the
1	regarding previous sources
1	official having jurisdiction
1	operations under this
1	regulation except a
1	chemical, or both.
2	program to be
1	guidance documents issued
3	suspension or revocation
6	public health; and
1	36 months. except
2	inspection law that
1	(i) requests funding
1	produced the food;
2	facilitate the commission
1	determine if such
3	treat a serious
1	exporting country on
1	regard to preservatives
1	et seq.] shall
1	native americans (including
1	written declaration that
1	registration. (2) the
2	guam, the district
1	$2,500, except, further,
1	care entities or
6	drug are the
1	truck, rail tank
1	permanent. (b) the
1	identification under section
1	262(h)]. (c) this
1	control act, shall
3	requirements, including the
1	(1) the index
1	exclusion from the
1	title (or exempted
1	262], as applicable,
2	exemption would be
1	consumers.  (b)
1	certifications and shall
1	3-month period under
1	dismiss of a
1	secretary. (h) termination
2	beginning of such
1	animal and it
1	felony conviction was
1	title, the circumstances
1	basis for believing
2	public sale or
3	prescription drugs or
1	(5) a detailed
1	manufactures, distributes, or
1	(f) information to
1	provisions notwithstanding section
1	submit recommendations to
1	information and makes
4	risk posed by
2	granting admission to
1	tools under subsection
1	milk minerals in
1	dangers of substance
1	18[2] until the
3	(b) the united
1	(4) state authority
1	number of initial
1	paragraphs (a), (i)(2)
1	year, and shall
1	partners possession a
2	360c(a)(1)(b) of this
1	(c) provide assurances
1	clause (i). the
1	section 354(a)(3)(b) of
1	general the board
1	(i) requires approval
2	attorney general not
2	enforcement agencies; and
1	products issued from
2	products per customer
1	complaint in any
1	final results not
1	internet by an
1	available scientific and
1	provides an assurance
1	product, or class
1	clause (1), (2)(a),
3	title as a
2	commissioner shall consider
1	assisting the governments
2	compromise, may be
1	number of breakthrough
1	1979, monthly use
1	under, or were
1	hearing; withholding use
1	interest the secretary
1	states faces tremendous
42	fiscal year. 
1	following requirements, in
1	type.  (june
1	required statementsthe interpretive
1	made  (1)
1	feasible, in addition
1	 (f) procedures
1	fact; or (ii)
1	(
 
 887.
1	calendar quarter) to
2	annual report required
1	combination products; (ii)
1	whether the item
2	device applications for
1	cases, the secretary
1	applicable, to any
1	 (a) corrective
1	year or fined
1	1264; renumbered 19
89	may not be
1	notification submission for
1	swelling the interstate
1	experts as appropriate.
2	usually conducted at
1	regulations establishing timelines
1	secretary as soon
1	stramonium, veratrum viride,
1	sales of all
1	customer, unless the
1	collaborations with public,
1	tobacco products; (b)
1	governments of such
1	experimentation data; and
1	web site the
3	encoded with a
1	clinical investigations by
5	shall be upon
1	noticeat a minimum,
2	order of such
1	recommendations for individuals
1	capabilities, that shall
2	ii and for
1	secretary about 
2	sustaining human life
2	(b) in case
1	includes the name,
1	substantially equivalent defined
1	21 of such
3	tobacco products as
1	(2) health system
1	(ii) discontinued participation
1	distribution or administration
1	theretofore been designated,
1	listing of any
1	certifications by the
1	title, including regulations
1	individual purchaserseach regulated
1	(9), and (10)
2	effectiveness of devices
1	equal to $15,000,
2	applicable list with
1	system, it appears
3	use among youth
3	inspected at any
1	u.s.c. 136a1(k)]. such
1	administration as binding
1	time spent in
1	favorable and unfavorable
6	rendering, or similar
1	human beings to
1	institution, or restaurant
1	necessary, a dispenser
1	offense against the
1	progress toward laboratory
1	no-federal funds for
1	comments and, if
1	abuse among youth.
1	2017 (including estimated
34	public health and
5	title.  (f)
1	(c) health and
1	also advise the
2	antibiotic drugs submitted
1	receipt, delivery, sale,
1	policy with regard
2	investigations to determine
1	without compensation, the
3	drug when used
2	sheep, swine, or
1	electronic submission as
1	
 
 360ff1.
1	food registry to
3	exist to continue
1	maintain a reasonable
2	regulated person to
3	less the court
1	cooperative agreements, and
1	strategies developed under
3	entry of judgment
1	practitioner. this includes
1	place related to,
1	 (a) outreach,
1	evidence relied upon
1	post such assessments
1	directive is lawful
1	nicotine yields do
1	studies.  (3)
3	cooperative or party
1	notification the head
1	(d) disposition of
1	 (12) appropriate
1	enforce a requirement
1	general may approve
1	purchasers that entering
5	subsection (e), the
2	report (a) in
1	assessments described under
7	received from the
1	claim against the
1	 (b) emergency
1	institutions; (i) integrating
1	authorized or designated
1	alia, increase the
1	 (5) leins[1]
1	(i) that, under
1	lawfully possess any
1	below.
 
 206.
3	employees  (a)
1	abuse prevention, education,
1	conducting investigations and
1	advertisement  (1)
2	records shall be
1	into, or otherwise
11	public may present
6	meaning indicated for
1	devices for rare
1	distributions and the
1	conditions differ from,
1	forth elsewhere in
1	wrapped meats inclosed
1	fee assessment. in
1	specifies, as applicable
1	container for property
1	nanomaterials; and (9)
7	abuse among youth;
5	participate in the
3	drugs.  (b)
1	remain substantially equivalent
1	ship such drug
4	conduct of a
1	compounding under subsection
2	subsection (m)(2) or
1	period ending 
1	directive respecting false
3	state that an
4	essentially a copy
1	auditor may perform
3	work is being
1	therapy. a request
1	department to determine
1	subparagraph (a). (i)
1	(b) identifying the
25	violation of any
1	consultation with recognized
1	section 825, 952,
1	order. the judgment
1	federal authority in
14	percent below the
1	et seq.] regarding
1	information dissemination, to
1	additional single use
1	priority that takes
1	negligent suppliers. (

1	required for disclosure
3	certify that eligible
1	ch. 675, 416,
1	documents and process
1	ingredient does not
1	person importing ephedrine,
1	shall serve a
2	nonsaleable returns a
1	color additive was
1	drugs, the name
2	imported. (2) the
1	oil derived from
1	1225.)
 
 692.
1	ongoing review of
1	type of authorization
1	processing, freezing, packaging,
1	secretary, permit inspection
1	law.  (d)2
2	investigation if the
1	(i) temporary and
1	antimicrobial drug lawfully
1	retail distributor as
1	(h) references to
1	supported by an
1	device, a significant
2	acted or is
1	resume operations in
2	special dietary need
1	prohibiting an individual
1	secretary the reasons
1	ingredient; (b) information
1	(a) move in
1	adults, usually supplemented
1	subchapter, or when
1	subsection (as described
1	subchapter or by
1	united states at
1	analytical, or research
1	(f) correction of
3	advertisement that is
1	
 
 379j31.
1	prescribe performance standards
5	administration for such
1	(1) a state,
2	owed under this
1	fiscal year. resubmissions
1	exist or that
2	seq.), the poultry
1	practices or minor
2	food, or it
1	administrative procedures 
1	improperly imported as
1	states under such
1	databases and models
1	matter to an
1	seller registered with
1	conduct exercises at
2	applications.  (b)
1	central or reasonably
1	
 1602. definitions
45	health, education, labor,
1	states and not
2	provided by subsections
1	states and now
1	year 2016. (e)
1	date such substance
1	listed chemical means
1	manufacturer meeting the
2	feed or drinking
2	two grains of
5	controlled substances manufactured
1	diet, including a
1	provided the secretary
1	paragraph (2)(b) shall
1	businesses and federal,
1	abused drugs. (14)
1	notification of discontinuance
1	status; (iii) whether
1	(v)  section
5	promulgation of such
5	chemical in or
1	paid during any
1	commit to support
1	board whose position
1	preproduction design validation,
2	connection with its
1	prescribe under paragraph
1	shell egg means
3	repealed. june 25,
1	fiscal year. (2)
1	public welfare and
2	360b(j), or 360j(g)
1	$3,872  (3)
1	enforcement administration the
1	(b), (i), or
1	practice and which
1	(2) reviewin developing
1	sale, and that
1	 (c) transparency
1	patients who may
1	samples requested, the
1	 (4) periodic
1	supplies, including limited
1	research consortia, seeking
1	inspection frequency 
1	requirement of supplemental
2	essential in the
2	courts for the
1	61 et seq.];
1	provides a searchable
1	fait-based organizations, to
1	store, the secretary
1	(6) drug treatment
1	clause (ii). (ii)
1	financial interest in
1	(i) a waiver
1	related statistical information,
1	(f) initial classification
4	15 business days
3	studies are not
1	section 3109 of
1	trade commission in
1	facilitates trade by
1	small portion of
1	nonreceival for nonpayment
4	food supply of
3	claims a use
1	inconsistent with protection
1	subparagraph (b), amend
1	upon the latters
1	387e(j)(3) of this
4	action under such
1	(a)(4) within 20
3	reports by investigators)
1	(2) such dispensing
1	title, or from
2	 (b) terms
1	specify the date
1	product the percentage
1	tracing system the
1	opiat-dependent patients. (vii)
2	consisted in whole
6	recommendations in response
1	(a) cente-specific objectives
1	veterans, their families,
1	generalthe interdiction committee
1	studies that would
1	(a) the basis
1	accredited persons the
1	feeds are in
1	may be exempted
2	number of hig-risk
1	353(e)(4) of this
1	stat. 1057; aug.
2	reinspection and sanitation
1	account adequate representation
1	votes or weighted
1	387k, or 374
1	(iv)complementary approaches.to the
6	manufacturer shall not
1	requirements the program
1	serious or immediately
1	term dirty egg
1	local jurisdiction other
1	submitted or cited
1	ability of that
1	authority with regard
1	related to enforcement
2	(b) respecting a
1	bioequivalence review for
1	development tool includes
2	foreign commerce, are
1	(i) shall meet
1	proceeding to identify
2	product and a
1	conducting such operations
1	information appear on
1	federal or international
1	drug in aqueous
2	terminate the program
2	change in an
1	provider.  (d)
1	agreements with respect
1	appropriate.  (4)
38	related to the
8	381(q) of this
1	books, records, and
4	twice any term
1	medical gas, as
1	improper use of
1	change or otherwise)
5	commercial manufacture or
1	make and track
1	facility requirement the
1	(a) may take
1	requested, commanded, performed,
1	1542. duties (a)
1	upon each such
1	statement is accompanied
2	notification by the
5	expiration date of
1	laboratory network that
2	plan under paragraph
1	color additive previously
1	title, consider the
1	
 399g. food
1	24, 1984; (ii)
2	fiscal year 2009;
1	claims shall apply
1	comments, that a
5	section 360e(b) of
2	anticipated harm to
1	interpret, and disseminate
2	and, upon the
1	investigational use the
3	distributes, or dispenses
1	modify the registrations
1	deaths, the secretary
1	28, 1976, by
8	fiscal year 2009,
1	(a) any ionizing
1	fiscal year 2009.
1	 (b) with
1	 (i) 25
1	dispensed, acquired, imported,
2	subcommittees of the
1	secretary to rely
2	confidential information that
1	additive, an artificial
1	director and to
1	1263; renumbered 11
1	incidence, as well
1	345. regulations making
1	importation, entry, or
1	section 360e(f)(7) of
1	(1) develops -year
1	systems placed in
1	retailing, compounding, or
1	proposing changes to
2	human services, under
2	applicable to meat
3	requirement prescribed by
1	known to, or
2	5. such proceedings
1	setting; and (c)
1	sufficiency of such
1	(b) penalties anyone
1	marketing research involving
1	bona fide pending
3	waiver from any
1	every establishment registered
2	removed shall receive
1	876 of this
1	biomaterials supplier; and
1	needed to assure
1	exercise other powers
1	product they believe
1	(2) less than
4	conduct relating to
1	took place. (c)
1	factor defined in
4	first foreign recipient
1	675, 414, as
1	upon exporters of
2	drug or category
1	eggs which contain
1	seized and destroyed
1	international harmonization of
1	chairman of an
1	postapproval clinical trials
1	constituting a transaction
1	prevents diversion. 
1	selling carcasses, parts
2	 (c) interagency
1	particularly those in
16	drug application that
2	patients and providers.
1	summarizes the data
1	subsection (b)(1) will
1	foo-contact surfaces of
1	request, which shall
1	(d) the risks
1	 (a) delineating
2	reimbursement, in whole
1	regarding the termination
1	(2) for having
1	determining the merits
1	grants to the
2	(1) a safety
1	12 to 17
1	authority  (i)
1	inspection and examination
1	establishment of program
1	successor regulations). (5)
1	circumstances and in
1	condition and approved
1	regulations for recor-keeping
1	concentration.  (d)
1	1101.)
 
 147.
1	 (b) after
1	care providers who
2	maximum extent possible,
1	prior public participation
1	360m(b) or 374(g)(2)
1	stimulate the development
1	(b)(1) could not
1	states to use
1	purpose of reducing
2	programs in a
23	extent to which
2	360ccc(a) of this
8	requirements relating to
5	wholesale distributor is
1	(b) annual registration
1	condemnation proceedings is
1	owner as required
2	(iii) publishing a
1	brand name designated:
1	subsection (b)(1); (2)
1	within ten days
1	commercially marketed only
1	draft guidance is
1	drug administration, other
1	quarterly fee amounts.
1	$100,000 or other
3	basis or, if
1	threat under section
1	(c) fee due
1	team, and the
1	colleges, other academic
1	summarizing such evidence.
1	render assistance and
1	(b), and (f)
1	received, no action
1	poultry product means
1	reportable food, the
2	administration, or on
1	c[10]h[14]n[2], including any
1	responsibilities described in
1	provide such an
1	condition who need
3	biological product application;
1	organization; or (iii)
1	(j) has not
1	indirectly, to any
1	relating to or
2	revisions made under
1	data are available.
1	events and potential
1	may assign a
1	seq.), the commodity
1	apparent temporary reductions
1	dispense, or sell,
1	may permit discovery
5	export from the
1	country has the
4	biological product application.
1	necessary. (e) testingthe
1	nicotine, or any
1	misbranding, are pending
1	legislated intent, purposes,
1	355g. utilizing real
1	date under section
2	determine compliance with
1	closely with other
5	use on a
1	regularly, but not
3	construction the provisions
2	responsible for coordination
1	(3) destroyed, altered,
1	reduced rate of
3	final agency action.
2	208(b)(3) of such
1	reasonably foreseeable crisis
12	biological product applications
1	(4) promote and
1	total fees that
1	(4) lysergic acid.
2	ris-based schedule established
1	made as are
1	consignee in accordance
3	paragraph (1)(a) shall
1	
 2225. decontamination
1	(b), the president
1	device. (b) special
1	secretary in writing,
2	notification required under
2	secretary in writing.
1	maintain and make
1	confectionery, and 
2	reader or similar
1	report, by which
5	section 350c of
2	assembled in kit
1	consume-oriented information regarding
2	chemicals.  (g)
2	respecting a petition,
1	conducted by appropriately
1	whose behalf this
1	(aa) may issue
1	available.  (e)
1	final revised guidance
1	consumer advocacy organizations;
1	occurred or the
1	requirements, or (ii)
1	defendant has not
1	shall be such
1	ingredients, identified by
3	annual summary of
1	pattern of importing
1	volume of aquaculture
2	subsection continue to
1	facility operated by
1	neonates, infants, children,
4	injury, or serious
1	implementing this subsection.
1	secretary may not,
1	travel time) they
1	changes. (b) the
1	involved is not
6	tobacco products (a)
1	accepted portion. (c)
1	personnel and resources
3	secretary shall follow
1	renumbered 19 and
1	importer produces the
1	task force program
2	product, assembled in
1	good faith. (i)
1	documents with public
41	date that is
1	remission of forfeiture,
1	domesticated bird, whether
1	shown refer the
1	device, (vii) such
1	processing by such
1	present national security
1	personal use. each
3	application. such notification
1	vesting of title
1	ii to be
1	
 
 396.
1	obstructed an investigation
1	opportunity to request
1	(a) the priority
1	(a) regulations under
1	federal agencies. 
1	 (4) schedule
1	lists. (d)[2] definitionsin
1	(d) scheduled listed
10	date upon which
3	determines should be
1	subsection (b)(2)(a)(i). 
4	clause (ii) that
1	food for sale
1	month of the
1	scoring as provided
2	subsection, file with
2	improve linkages with
2	electronic means. 
1	regulation; publication of
1	except that subparagraph
2	drug shortages that
1	tools to improve
1	399h. grants for
1	less than 1.1
1	governmen-issued identification showing
1	(b) of schedule
16	enactment of an
1	attempted transfer of
3	section shall 
1	(cgmps) under part
1	claims, and securities.
1	applications of various
1	(vii) other material
2	may approve an
1	successful public or
1	labeling changes requested
1	report. (xi) any
1	determination.  (5)
1	register.  (c)
1	public record and
1	provide for expedited
1	standard grades for
1	plan for integrating
1	elimination to reduce
1	states suffering from
3	drug products to
1	positions classified above
1	agrees, in writing,
1	easily legible through
2	facility involved. 
1	(a) whose active
14	bodily injury results
4	made, the court
2	neither the owner
2	compliance with united
1	revised quota, the
1	advertisement means an
1	packages or otherwise.
1	endeavor, attempt, or
1	fiscal year; (c)
1	(4) procure the
2	may in his
1	 (h) order
1	purposes of information
1	first. (iii) in
1	conspire, or collude
1	homeopathic drugs marketed
4	notice of discontinuance
1	year 2017 for
1	seq.] referred to
1	practitioner requesting registration,
1	(
 
 2221.
1	(m) categorization of
1	only, as further
1	impact on compliance
1	practitioner deemed qualified
1	 (1) evaluations
1	2012, there is
6	procedures, processes, and
1	interference with, obstruction
1	education, shall 
2	(a) the actual
1	notwithstanding sections 351,
1	regulatory system of
2	title, and consideration
1	(2) clarification for
2	reflect new medical,
3	petition unless the
1	user fees that
3	section 853 of
1	terminate designation if
1	similar packaging for
1	 (e) exports
1	(a) will not
1	(d) public disclosure
1	section need not
1	data be provided
1	book shall include,
1	reinspect said carcasses
1	(e) nominations 
2	measures to ensure
1	conditionally approves an
1	 (1) employs,
1	means data regarding
1	entity or food
1	
 
 356b.
1	(1) demand reductionthe
1	state a regulatory
1	drugs except as
1	inspection of dairy
1	deficiencies need to
1	remedies  (a)
1	labels, or otherwise
1	tentative approval means
1	update is a
1	coordinator to carry
4	humans that is
1	(3) the issuance
4	regulations issued thereunder
2	harmful and potentially
1	use for some
2	active pursuit of
1	(b). (s) registration
1	program in order
1	pursuant to practices
1	360eee3. national standards
1	narcotics trafficker of
1	food contamination; (ii)
1	review voucher if
13	forth in paragraph
1	manufacturer to introduce,
2	reviewed and the
1	faca  (1)
1	upon application submitted
1	agencies as appropriate.
2	human health, the
1	without a veterinary
2	official may not
2	attorney general does
1	state that concerns
11	fruits and vegetables
1	exceeds $20,000,000; and
2	condemned in any
1	wholesale distribution; (ii)
1	services on a
1	manufacturing controlled substance
1	57 stat. 500;
1	labeling, including any
1	cream, if raw,
1	(3) no operator
3	dispensing of narcotic
3	(j) construction this
1	construing and enforcing
1	inhalants, cocaine, methamphetamine,
1	follo-up on such
3	written notice or
1	(a) after a
1	wel-controlled investigations, which
2	notice. if the
1	products for commercial
1	imprisoned as provided
1	prevent such importation;
1	enter into one
1	agents means any
1	issued through the
1	device clinical trial
1	prescription, the name
1	enforcement policy which
1	reasonably believes to
1	advocacy organizations; (iv)
1	submitted. (4) 
1	may cause skin
2	biomaterials supplier as
1	conveyance or facility
2	ingredients; recordkeeping and
1	(5) milestones and
1	biomaterials supplier at
1	notice of any
1	government, agency of
5	shall apply: 
1	timely assessments based
5	accredited person identified
1	effect for more
1	will obtain the
1	change.  (4)
2	smuggling, or counterfeiting
3	(ii) in carrying
5	exempt from subsection
1	although not individually
1	package level. (h)
1	benefit of new
1	emergency (referred to
1	material fact; (3)
1	studies requirement not
6	subject to review.
1	shortage within a
2	administered to patients
1	ch. 675, 401,
1	ingestion in a
1	define the terms
1	(ii) indicating that
1	program agency and
1	items or types
1	specific substantive issues
1	(e) pediatric study
1	formula who begins
3	title 21 of
1	attorney general. if
1	be, has failed
2	relevant interpretive criteria
1	 (3) pos-hearing
1	clause (ii), information
1	publishes the information
3	term tobacco warehouse
1	applicable rules, the
3	penalties under this
2	accreditation bodies and
1	information contained therein,
1	citizenship of the
1	operating (or both)
1	device), packing, storage,
1	investigation which, in
1	change is necessary
1	food safety program,
1	state at the
1	agencies, and make
1	regulatory practice; (x)
1	potential therapeutic value;
7	recommendations with respect
2	preclude any state
1	grant program authorized
1	wipes, to support
1	collections shall be
3	individual from providing
7	27, 2013, the
1	 (2) notificationif,
1	appropriate, at least
1	effectiveness. a proposed
7	number and type
1	therefrom by water
2	repealed. july 1,
1	convene the meetings.
1	nonliquid form (including
1	trade commission by
2	president in the
1	drug proposed to
5	physical or other
1	affects the risks
1	(7 u.s.c. 136p)
1	advances (a) payment
1	
 
 374a.
1	 (3) meetings
1	 (4) subject
4	(4) effect of
1	unless such agency
4	stat. 1103.)
 

1	year 2008; (12)
1	activity, that is
2	registration at the
1	distribution or sale
1	anticipated annual distribution;
3	 (2) any
1	(7) steps taken
1	database for submission
1	seminars and training
1	2603]; or (c)
1	premarket approval supplements.
1	commerce is necessary,
1	initiated under a
1	accounts for 13
1	regarding the selection
1	(a) retain the
1	(5) the presiding
1	rules of constructionnothing
1	pregnant women that
1	judgment if a
1	subsection (c); 
1	(i) developmental changes
1	federal sentencing guidelines.
1	authorized to enhance,
1	data privacy and
1	devices if it
2	qualified en-users during
1	authority of other
2	title: provided further,
2	disease product means
1	12 inches above
1	demonstrated an understanding
1	(c) was adulterated
1	purpose based upon
13	involved in the
1	clinical investigation and
1	quantity of color
3	shall cause a
1	information supplied by
1	applicant from declining
1	restructuring act of
1	diseases and conditions
1	review the change
1	secretary to refuse
2	establishing a tobacco
1	pharmacy has dispensed
2	developing the model
1	evaluate the progress
4	united states within
1	(6) tolerance for
1	2011, to provide
1	including strawberry, grape,
1	brought into or
3	physician assistant is
1	may be synthesized
1	 (i) accurate
1	patients for the
2	proposed labeling of
2	chemical residue, including
4	(b) illegitimate product
1	subclause (i), if
2	constituent part an
1	ch. 675, 201,
1	 (9) indian
1	manufacturer identified in
1	consisted only of
1	intent, a requestor
1	675, 308, as
1	duration of a
1	(ii) the entity
1	regulations published pursuant
2	methods and controls
1	including information on
1	(or another sponsor
1	1103; 1940 reorg.
1	preceding sentence or
1	high seas), and
1	petition. (3) annual
1	including information of
1	drug application, (5)
1	need of potential
1	balanced view of
1	shall provide that,
1	information about specific
2	system to identify
1	provide technical and
1	backgrounds, except that
1	action taken respecting
3	section 201(b) of
1	term transaction history
1	testing expenses, (2)
1	fact at issue
1	(3) biannual report
2	thir-party auditor shall
2	administer such drugs
1	therapy that is
1	risk or that
1	promulgate regulations permitting
1	may prohibit particular
1	following dietary ingredients:
1	may accredit laboratories
1	(1) initial reportnot
1	hydrates of sodium
5	audit agent of
1	(3) the task
1	reserve fee by
1	present a high
1	previously paid with
4	ensure food safety
1	carrier.  (c)
1	board (including members
1	dietary ingredients which
1	chemical identity, and
8	request, the secretary
2	contingent at all
1	(b) applicability 
1	requests for proposals
3	refused for filing.
1	seve-year period. 
4	refused for filing,
1	agency that are
1	expanded access protocols
3	listed chemical that
2	product or biological
1	description of each
1	physiological or psychological
1	years, subject to
1	residue; (ii) the
2	mandatory minimum term
1	(2) posting of
1	registrant submitted the
1	officials to access
1	(as prescribed by
1	change and identity
1	upon stating his
1	(b), if a
6	paragraph (4), a
2	income and resources
1	administration, the information
1	(ii) consider the
1	adequately diversified expertise
1	animals or prepare
1	concentrations in use,
1	setting. (v) other
26	means  (a)
1	administer such drug,
1	administer such drug.
1	penalty, whichever is
3	sound and healthy
3	certification under paragraph
1	may not limit,
1	denial of previous
1	regulation require, a
1	both) a tol-free
2	paid witnesses in
3	concludes that a
1	agency center means
3	finds the following:
1	color additives, or
1	(except such quantities
1	thereto) to determine
1	withdrawal, suspension of
2	tobacco regulation activities.
1	use pursuant to
1	title, consistent with
1	1239; 
 

2	meets each of
2	statements any statement
14	section 355(j) of
5	dispense a controlled
7	occurred in the
1	delivery, and form
1	abuse on young
2	nicotine yields of
1	suspension of associated
1	including the status
1	drugs, that detail
1	salts thereof: 
1	in, reinstatement in,
1	less stringent than,
1	grant or renewal
2	certain qualities of
1	upon a third
1	color additive (i)
7	report beginning with
1	applicant were submitting
1	food establishment. (c)
1	agent, intermediary, or
3	made effective upon
1	section 1231 may
1	42. (ii) the
1	designed to address
1	states attorney to
1	number the secretary
1	hashish, hashish oil,
30	shall provide for
2	state then has
2	(h) review of
2	distinctly legible form
2	facility and are
1	move toward the
1	standardized numeral identifier
1	advanced therapy 
1	witness. on contest,
1	distributor, violated section
1	subsidiary means any
1	pesticidal use of
2	paragraph, the reviewing
1	title a summary
1	control or removal,
3	parts for use
2	affiliates, which show
1	initial importation, a
1	person filing the
1	general may from
1	petition were disclosed
1	estimate does not
1	on, part or
1	refuse by order,
1	7 for each
1	including things growing
1	including contact information
6	provides written notice
1	(d) exemption from
1	(ii) the same
1	hearing in support
1	(c) standardization of
1	orders for the
1	1996, a substance
1	limited population. 
1	agency under regulations
1	dispose of, any
1	participate through appropriate
2	deliver the controlled
1	dispenser may engage
1	development authority, in
1	swearing, or making
1	person who kills
1	(15) rol-you-own tobacco
1	ch. 675, 910,
1	seek recommendations from
1	(i) the commissioner.
1	product standard has
1	13, 2016), including
1	analogue of either
1	section, and (b)
1	(n) funding from
1	relate to substance
1	complete until such
2	action, the validity,
1	claim for contribution
1	states any nonnarcotic
1	activities  (i)
1	retrieval, hosting, formatting,
1	plant, except as
1	appropriate, the guidance
1	refusal of the
2	classes of tobacco
1	retailers request a
1	proposal to an
2	promulgated after notice
3	use by man
1	section prohibits a
1	(b).  (c)
1	farm (as defined
1	clarify the secretarys
2	populations, children, and
1	studies means at
1	submitting a letter
4	shall furnish to
1	engage on such
1	order to which
1	years the attorney
1	50 percent more
1	drug, facilitate the
1	risk from dietary
1	(i) specific efforts
1	purpose for which
2	(or proceeds of
1	nontobacco users, such
1	safety surveillance using
4	paragraph (2)(c), fees
1	omission made unlawful
1	(3) nonapplication of
1	permit inclusion of
1	nominations  (1)
4	requirement, set forth
1	
 954. transshipment
1	safety question, the
1	title 42, no
1	13, 2016, with
1	apply sanctions that
1	subparagraph, and thereafter
1	intended use. the
7	section 1254 of
1	court may restrain
1	(a) subparagraph (1)
1	mutated gene where
2	sales in the
1	(b)(1) application. (v)
1	(a) made each
1	policyit is the
1	validation data as
1	intelligence activities of
1	labor, the atomic
1	promotion restrictions (a)
2	device classified into
1	senate to represent
4	drug law enforcement
1	basic research into
1	30, 2012, establish
1	imprints with the
1	homeland security of
1	approval prior to
2	secretary shall afford
1	(g) and (i)
1	improve coordination and
1	special effective date
1	inspect all viruses,
2	thing designed to
1	office, and any
1	finding. (b) not
1	quarter. (3) the
1	recall, or the
1	(3) the measures
1	schedule under the
1	activities registration granted
2	combination makes a
1	promptly. (iii) a
1	ante and post
1	countermeasure as defined
1	offense, the court
1	open meetings to
1	subject to application
1	ration of the
2	state statutory law.
1	quotas for registered
4	destruction of all
1	exploitation of such
3	listed under paragraph
1	labeling, is suitable
3	revocation under subsection
1	year. (ii)[1] recoupment
4	 (b) review
1	practitioners dispensing narcotic
1	(5) when the
1	(iii) all or
2	recognition or listing
1	corporations subject to
1	placed on hospital
1	commission shall coordinate
1	derived, directly or
1	recognition that education,
1	expert advice. (c)
2	insufficient information to
1	used under paragraph
1	chromium, copper, gold,
1	regulatory limit is
1	record under this
1	employees to positions
1	administrator, specifying with
1	necessary and specified
1	regulation presents an
3	require the submission
2	that, based on
1	contains references to
2	receiving such request.
1	343(d), 343(f), 343(h),
1	receiving such request,
1	circuit, within 60
1	2008, 150 days
1	exclusivity period, or
1	may create and
1	standard; (6) 
1	person named on
1	report for prosecution
1	regulated seller violates
2	electronic products (a)
1	internet eligible controlled
1	seq.) or other
1	including rent and
1	product required under
2	(ii) 30 calendar
1	department means department
1	absence of the
1	 (7) required
1	class iii, an
1	timely public access
2	except that it
1	conduct appropriate postapproval
2	qualified manufacturing partner
1	primary intended purposes
2	institutions.  (2)
4	normal course of
1	timetable or violates
2	deemed misbranded under
2	title 5. (c)
1	fiscal year, including
8	except that if
1	
 882. injunctions
1	safety questions, including
1	program personnel to
4	except that in
3	labels and other
1	subsection (b)(1) who
1	(1) any employee
1	final assessment at
1	availability, and the
1	personnel detailed to
1	(d) contracting the
1	information only if
1	disclosure of other
1	medical device for
1	evaluate the hazards
1	vehicle the term
1	members in accordance
1	(a) completes a
1	standards, or modified
1	guidances, and policies.
1	processes used in
2	determination if the
1	2007 for activities
1	establish a mechanism
1	(iii) a -year
1	advertising, after june
1	subsection (b). (

1	advance approval from
4	advertisement or other
1	tract of land
1	milk or its
1	tolerance. (e) action
1	available  (i)
1	replace such product
1	current chairman, the
2	material, or financial
4	court or other
1	(ii) update the
1	conditions of all
2	paragraph shall specify
2	administration safety and
1	section 505(c), 512,
5	shall cease to
17	upon request of
1	nurses, teachers, administrators,
1	means any individual
3	drug trafficking threat
1	subsection (j) and
2	vehicle, receiver, or
1	controlled premises means
5	bureau of investigation,
1	assessed at the
1	health, the accredited
1	taking appropriate action
1	including ongoing assessments
1	oxalic and hydrocyanic
5	(1) in generala
2	 (a) developing
1	activities the report
1	practices required as
1	administrator, organizer, or
1	bag containing individual
1	supplement  (1)
1	 (4) activity
3	swine, goats, or
1	title, or which
3	provision of such
1	product published after
1	grams.  schedule
1	(a) adjustment to
2	packaged, are packed.
1	recall to determine
2	from, or its
3	(b) determination of
4	requirements for such
1	(
 
 967.
1	extend to 
1	basis for determining
1	betaine. (3) chloral
1	children);  (iii)
1	documents resulting from
1	facility is available.
1	first inspection, shall,
1	perform testing under
1	device classified in
1	(e) assistance and
2	clear manner on
1	availability the election
2	clinical investigations, conducted
1	 (1) drugs
1	regulation, to 
1	secretary establishes a
1	(a) exclusive approval,
1	may be reimbursed
1	force; (c) what
1	nonprescription status neither
2	drugs with known
1	whose identity it
1	chemical, respectively. (b)
1	missions or programs
1	request a priority
1	wanton, or willful
1	prescription or of
1	shall be prohibited
2	annual basis a
1	successfully applied to
1	(j) maintenance and
1	drug administration approval
1	agreement by a
1	includes a tank
1	calendar days, the
1	packing, and labeling
1	inspect under this
3	therapies and regenerative
1	way are in
1	supply reductionthe term
1	tobacco products unless
1	private entities, professional
1	substance analogue shall,
1	(b) heightened inspections
1	(e) the seriousness
1	time for which
1	102(a) of the
2	year 2015, $2,786,000
1	located adjacent to
1	introduce significant new
5	secretary as to
1	drug products and
1	civil actions if
1	offenses involving any
1	columbia. (b) except
8	(ii) that such
1	(jwh200); (vii) -penty--(-methoxyphenylacetyl)indole
3	section 353(g) of
1	(b)(i); or (iii)
1	(a) to withdraw
1	facilitated through bribery,
1	poultry by any
1	report, taking into
1	appointments are needed
1	either as an
1	coalition enhancement grants
1	local governments, as
1	711(a)(1));[1]  (b)
1	(a)(2)(a) has not
1	
 
 360eee.
1	drug submission and
1	substance, if an
1	individual; or both.
1	requirements of state
1	secretary a statement
1	changes provided by
13	requirement of section
2	redacted.  (g)
1	2017, the administrator
1	 (i) youth.
1	leaves authorized to
2	smoke constituents), ingredients,
1	concealing any punch,
1	drugs, listed chemicals,
1	remove drugs found
1	similar device marketed
1	distribution patterns of
1	meet, match, tournament,
1	(a) full waiveron
1	refunded.  (2)
1	ch. 800, 3,
1	responsible for good
1	6.0.  percent
2	contributing factor in
1	developing, manufacturing, and
1	except the secretary
1	federal law. (3)
7	title.  (

1	efficient development and
1	unable to perform
1	butterine, imitation, process,
1	carcasses of said
1	 (e) matters
1	extent practicable, license,
1	
 2204. building
1	designation within 60
1	regarding such recognition.
5	bulk drug substance
1	product as the
1	days after issuance,
3	minor species) required
2	within the one
2	sample in the
1	intelligence determines that
2	title 42, including
1	reference in a
98	date on which
1	zip or other
1	make a priority
1	operated in any
2	therapeutic ingredient is
4	classified under this
4	secretary in such
1	maintained by or
1	authority to prescribe
1	greater health risk
1	387e(b), 387e(c), 387e(d),
1	drug paraphernalia involved
1	hearing on any
1	354. veterinary feed
1	already been applied
1	administrator on the
1	declaration shall not
4	northern mariana islands,
1	prescribe, not to
1	restricted.  (c)
1	support traditional approval
2	written prescription of
1	minority health of
2	paragraph (5). 
2	foreign country applies
1	section 332, 333,
1	information and inventions
1	provide access for
1	vendors about the
1	deposited as offsetting
1	(k)(3) will not
1	[15 u.s.c. 4402]
1	broker that imports
1	animal drugs; contents,
1	criteria are effective
1	drug, means information
1	acts. (d) designation
1	(b) opportunities to
1	setting aside sufficient
1	requirement, or (b)
1	become final, or
6	title for that
3	forth in paragraphs
1	chemical product to
1	novo classification determination
1	conduct training and
2	patients for maintenance
1	debilitating human disease
1	method for making
1	term clean and
6	practitioner or physician
1	inspect such imports
1	implementation of, and
1	50 or more
1	secretary shall receive
1	contract described in
1	statement of work
3	program. (
 

1	section by cultivating
1	register and solicit
4	priority review in
1	is, except as
1	produced or harvested
1	writing within 45
7	may request that
3	including the date
1	guilty, the court
1	fee account. for
1	(40) properidine. (41)
1	including the data
1	data collection with
1	additional facilities; and
2	disclose (other than
1	january 4, 2011
1	court shall hold
1	title; and to
1	provide for use
1	(a); (iii) is
1	pending proceedings shall
5	drug.  (3)
1	high priority on
1	provided for; appointment;
1	section 319e of
1	conducting research to
3	15(except paragraphs (c)
3	(e) of paragraph
2	segregated pending completion
1	regulations, the sponsor
16	purposes of subsection
1	ii or within
1	physically compatible or
48	 (i) a
1	title ii, 202,
1	amended, under the
16	section 360fff1 of
2	milk act of
1	carrier has knowledge,
1	title; or (3)
1	419(5) of the
1	alleged violations of
2	make available a
1	abuse, but shall
1	title; and (c)
1	class ii, why
1	engaging in or
9	carcasses, parts of
3	fees required under
16	fee under subparagraph
1	public health concerns
1	therapeutics within the
6	base fee amounts
1	target animals, indications,
1	general report on
1	product identification system
4	oaths and affirmations,
1	new practices required
1	risks of a
1	 150.0. (june
3	service files application
1	imported, or exported,
1	compounds drugs, any
1	therapeutic intervention; and
1	fiscal year 2000
4	fiscal year 2003
2	fiscal year 2002
1	fiscal year 2005
1	fiscal year 2004
3	fiscal year 2007
1	reports, or other
5	fiscal year 2009
11	fiscal year 2008
6	provisions for the
50	authority of the
1	respecting priorities and
1	stay pending petition
1	 (i) 4
1	(c) representation an
1	 (i) 7
1	 (i) 1
1	effective and integrated
1	congress, through the
1	2011, and biennially
1	action is filed
1	administrator has not
1	(c) other evidence
1	person to audit
2	fees (a) establishment
1	 (1) unless
2	products and activities
1	money penalty in
4	drug trafficking and
1	change.  (june
6	amount appropriated for
1	formerly 18th par.,
1	lead such office.
1	certain trends and
1	impossible to comply
1	years beginning in
1	subsection, maintain a
1	 (2) activitiesafter
1	discretion whether to
1	lane, alternative or
1	(or exempt from
1	exempt such manufacturer
2	section after october
1	meet the eligibility
1	reviewed solely under
1	development of useful
3	except that spices,
1	may revise or
1	elementary schools; and
1	memorandum described under
1	substance such food
1	ch. 675, 1003,
1	shall describe in
1	functions. the director
1	title. (b) manufactureit
1	instructions; (7) notwithstanding
1	clinical protocol). the
1	providing the active
1	applicable  (a)
1	granted for such
1	871a. semiannual reports
3	appropriate.  (e)
2	required as part
2	health in each
1	concurs that the
1	relieve a manufacturer
1	exclusively wholesale business
1	and/or cream imported
1	drug; and (e)
1	newl-identified significant foreign
1	title, shall meet
1	title), the secretary
2	thir-party auditor. 
1	fee, as set
1	means of limiting
2	proportion, or concentration
1	lif-supporting device used
1	unless the facility,
7	met the requirements
1	permit an inspection
1	exceeds one million
3	given to such
1	manner contrary, in
1	(2) contents 
2	damages in a
2	subsection (g) if
1	(b) may restrict
1	360f. banned devices
1	lienor or otherwise,
4	requirements  (a)
2	time and space;
1	(2) record and
1	regulation referred to
2	transported, or offered
1	copper, there shall
1	public information programs
1	353(b)(1) or 353(f)(1)(a)
1	register a proposed
1	shall upon first
1	disease within a
2	reasonable attempts to
1	statement of reasons
1	(o) the representation
9	directly or indirectly,
2	general, as considered
1	one such jurisdiction
1	witnesses, the secretary
1	title i, 3,
1	(ii) in section
1	prepare the critical
1	(3) a proposed
1	(6) withdrawal of
1	18; (c) $500,000
121	respect to such
2	requirements under subchapter
1	section 314.161 of
1	claims; jury trial;
2	electronic product produced,
1	drugs. (14) local
2	freezing, packaging, or
3	imprisonment and fine
1	(i) to take
1	schedule in section
1	trade dress, trademark,
1	 (3) suspension
2	subsection information which
1	significant decision. 
2	paragraph (2)(a)(vii), the
1	person he determines
4	350f of this
1	center, the american
1	care organizations; health
1	
 614. repealed.
1	manner.  (2)
1	practitioners who prescribe
2	3(a)(1)(b) of the
3	share information and
1	hired, or used
4	administration.  (2)
1	(1) ceases to
1	training and technical
1	secretary), the fees
1	drug sample. (f)
1	dispose of substances
1	including supervisors, receives
1	secretary establish an
2	good faith, unless
2	persons the secretary
1	cases for which
2	exposure shall be
1	subsections (e) through
1	(1) petitions and
1	regulations concerning exemptions
2	certification by the
1	order. (3) 
1	officials  (1)
2	application, information submitted
1	personal consumption exemption
2	upon request made
2	departments and agencies,
1	5. this subsection
1	(d) establishing protocols
1	production, manufacturing, importation,
1	property reverts to
22	2011, the secretary
2	data from clinical
2	inflation under paragraph
1	(f) research by
1	(e) exclusion of
1	destination, and (ii)
1	adulterated, and contain
1	waiver requests granted
1	section and may
1	administration a reportable
1	state official as
1	assurances in its
3	 (2) effective
1	listed chemical and
1	successor regulations). (f)
1	(a) conditions on
1	country or facility
1	human services; (b)
1	residues; and (b)
9	active ingredient) of
1	 (2) adjustment
1	act or section
1	shall forfeit to
1	average; not seasonally
1	research the strategy
1	(jwh073); (v) -hexy--(-naphthoyl)indole
1	dosing regimens, such
1	vessels or aircraft.
1	acceptance of federal
1	application of certain
3	adequate grounds do
1	(c) an appropriate
1	shall annually develop
3	section 49[1] of
8	animal drug, or
1	subsequent premarket applications,
1	comment and the
1	due diligence be
1	provide or if
1	authorized agent), or
1	28, 1996)). (4)
1	therefrom, prepared in
2	any, under subparagraphs
1	authorized to import,
1	incurred in processing
1	secretary into compliance
2	equivalence under subsection
1	number which is
1	term local drug
1	 (b) vacancyany
1	denaturants, so that
2	guide, as provided
5	form as the
9	payment of a
1	675, 506c, as
2	sale by the
1	specified country, regardless
1	character, each week
3	360i, or 360j(f)
2	(i); or (iv)
1	may be denied
1	(
 
 1040.
1	
 
 607.
1	animals.  (3)
2	public of any
1	regulations or orders,
1	previously identified hazard
1	persons making application
2	procedures identified in
2	$500,000, adjusted for
1	analyzed were obtained.
1	changes for purposes
1	information management systems
1	control procedures that
1	(c)(1).  (6)
2	defined for the
1	device, on the
1	(a) meet each
1	topics, as determined
1	knowing or intentional
1	productthe term suspect
1	date determined under
2	foreign government that
1	recovery goalsecure agriculture
1	june 24, 1948,
1	adequate to provide
2	to, and disruption
1	sections, be subject
2	(4) if a
1	on-half inches in
2	(c) and (d)
3	packing and installation
1	addition, each panel
1	agencies, in carrying
1	advertisements projected for
7	covered by this
2	paragraph, including the
1	1705(a) of this
2	prior to beginning
1	(1)(a)(ii) for fiscal
1	effectiveness of various
1	information); (3) identifying
1	subsection (b)(2)(a)(iii) or
1	(g) notice and
1	mg 300.0 
1	 (2) rural
1	416.)
 
 102
1	endpoint that can
1	contemplated proceeding. (

1	humans.  (d)
1	periodic patient assessments
1	parties directly linked
2	claimant; and (b)
3	3-day period thereafter
1	provided five years
2	relating to food
1	 (i) gamma
4	states shall conduct
2	practicable and consistent
1	certification and records
1	(2) conditions applicable
1	destroyed or caused
1	letter from the
1	otherwise be unprotected,
1	care entity of
1	
 
 355g.
1	imported, moved in
1	(a), its activities,
1	period to the
1	exempt from product
1	relevant international organization,
1	chemicals could be
1	term distributor means
1	(in excess of
1	exception that such
3	patients with serious
6	substance in violation
1	section 823(f), 829(e),
1	adequately safeguard against
1	adopt, alter, and
1	action is pending
1	said sections the
1	(2) twice any
1	endpoints, and other
1	procedures for instituting
1	order denying the
1	ch. 675, 566,
1	addresses of purchasers,
1	instructions; (viii) the
1	drug residues, decomposition,
1	 (i) maintaining
3	ingredient or therapeutic
1	(ii). (ii) in
5	device is substantially
1	precursor substance; (b)
6	prevent or mitigate
1	understands that the
3	activities; and (b)
5	goals, and plans
1	restrict the distribution
2	fine otherwise authorized
4	grant or deny
1	product (including products
1	 (4) qualification
1	regarding priority review,
1	packaged articles can
1	health; (3) its
1	labeling of exported
1	content; meeting 
1	used in sunscreens
1	may participate in
1	linked thereto in
1	section 505e(g) of
1	supplement and it
1	applicant; or (2)
1	formula set forth
1	guarding against intentional
3	promote deception of
1	
 641. prohibition
1	state, or any
3	investigational plan (including
3	value to the
1	agencies (as appropriate)
2	(a) shall 
1	unless the bottle
2	responsible person. 
2	human food no
1	drug. (u) certain
2	illness outbreak associated
2	experts established before
6	new or updated
2	without prejudice) for
1	e. coli species;
1	(5) periodic reevaluation
1	wholesome poultry products
1	personnelthe technical assistance
3	grounds upon which
1	exchange for a
1	commissioned by him
1	requested under clause
1	support inspecting outsourcing
1	substance based on
1	(f) the united
1	otherwise), or transporting
5	confidential commercial information
38	will not be
2	point of slaughter
1	shall seek public
1	and/or gymnasium (including
1	(c) payment the
1	subject and includes
1	part under other
1	substance shall meet
7	committees specified in
1	establishment, and prior
2	products and persons
1	section. (m) distributors
2	paid. the secretary
1	additive, and including
1	without smoke, no
2	alkaloids of opium.
1	distribution located in
3	file the request
2	afford such representative
3	will be exported
3	implemented to ensure
1	mixing, blending, pasteurizing,
1	entity, including a
1	drug treatment in
1	355f(a) of this
2	(by reason of
2	permit shall be
1	paragraph limits the
3	official united states
3	requiring inspection of
1	chapter, the facilities
1	360e(f)(6)(a) of this
1	synthesize, interpret, and
1	participants the secretary
1	
 955. possession
1	rulethe administrator may
2	unless such person
1	preparation and slaughtering
1	require manufacturers to
1	contribute to swelling
1	(g) did not
1	exempted from registration
1	payment under paragraph
2	includes appropriate safeguards
35	section 360e of
2	final product stage
1	drugs, the administrator
2	permit a state,
1	(
 
 1131
2	aggregated, d-identified surveillance
2	(c) shall, where
1	activities in connection
2	chapter.  (h)
1	persons the opportunity
1	drug shall also
1	health. any such
1	supplier may 
1	(2) the benefits
2	section 360e or
8	section 552(b)(4) of
2	(i) any determination
1	prohibiting the preparation,
1	 (e)use of
16	applicant, the secretary
1	unless they make
1	way of reimbursement
1	therein, and were
2	notwithstanding any change
9	marketed in the
1	organization, network, group,
1	 (3) narcotics
2	$30,000 higher than
1	audit report and
2	states not designated
1	scientific judgment. if
1	substance may, at
1	insure that (a)
2	firearms; (2) execute
1	statement detailing the
1	articles, and the
1	title; and (11)
1	retail outlets to
1	drug is shipped.
1	processes as commercially
1	food certification under[1]
1	manufacturer; and (iv)
1	assess whether 
1	paragraph (3)(d)(ii), within
1	iii, 534, formerly
3	853 of this
1	railroad car; (b)
1	products, restrictions upon
1	animals before slaughtering;
1	facility of interstate
1	scientifically relevant information,
1	criteria standards established
1	notice, that 
1	meeting the applicable
1	services (a) quarantine
1	reasonably determine the
1	edible products from
1	5  (a)
3	support of a
1	2015. (c) improving
1	fee amounts in
1	controls of the
1	term human generic
1	receives notification of
1	shall not establish
1	work cooperatively 
11	 (1) for
1	(7) based on
2	specifically, in qualitative
1	kidnapping of a
1	415.)
 
 22.
1	constituent parts of
1	harvest those types
1	(12) dextromoramide. (13)
1	family members of
1	disorder; (cc) initial
1	person may seek
1	drug, investigational device,
1	animals, or (3)
7	action for patent
1	(b) additional findings
1	weight unless otherwise
1	secretary.  (c)coordination.
1	understanding for purposes
1	services. (25) the
1	nonnutritive substance, except
1	requirements under regulations
1	prosecution of, any
1	extent practicable, information
1	removed shall have
1	if, after a
3	recognition of any
1	states pharmacopoeia to
2	egg products shall
1	lo-b-lot certification of
1	review operating reserve,
2	 (3) establishments
2	office of secretary
1	commerce and is
1	appropriate to verify
1	recommendations, unless the
2	reviewing and approving
1	differences in the
1	concerning any patent
1	evidence, the court
2	shall issue to
1	chapter, including such
1	controls are sufficient
1	equal to 1.35
1	based on susceptibility
2	(iii) that includes
1	 (4) liability
1	interactions of nanomaterials
1	preservative, or ingredient
1	full biosimilar biological
1	methods identified under
1	subsection, of any
1	applications, the department,
1	voucher not later
1	determination. if no
1	agencies engaged in
1	plan to congress.
1	exemption the federal
2	therapy available to
1	(b) request requirementsa
1	shall govern any
1	eligibility standards established
1	notification required in
1	determination on what
1	limitations no person
1	so, the contents
1	said budget requests
1	entity. (5) exception
1	potentially harmful constituents
1	withdrawn, the device
1	governments to discuss
1	standards of identity,
1	human services current
1	subsection (b)(2)(a)(iv) and
2	sunscreen order determining
1	use, unless there
1	contributed to reduction
1	grams with one
1	administering the product
1	purchased a product
11	greater of twice
3	offset if the
2	therefor, may at
1	applicable; and (c)
1	deemed in violation
1	telemedicine; or (b)
1	restriction, or expiration
1	systemthe elements to
1	order the hearing
3	premarket notification submissions.
1	fees notwithstanding paragraph
1	premarket notification submissions,
25	(b)  (i)
2	health care entities.
1	unlawful. (aug. 30,
1	uses the unique
1	subsection (a)(1)(c)(i); or
2	promulgates final regulations
3	program the term
1	ensuring that food
6	 (a) public
1	country with which
1	premarket notification submissions:
1	 (2) limited
1	patterns of consumers
1	(f)(2)) to the
1	safety provisions of
1	transcript of each
2	types of food
1	 (i) incorporate
1	shall be marked
1	(a) an agency
6	order may be
1	petition to allow
2	perform such other
1	acute exposure shall
1	mechanisms, by july
1	requirement at any
4	illegitimate product within
2	(4) prior conviction
5	person the term
1	place.  (b)
1	secretarys action in
1	1977, and september
1	materials which the
1	equivalent for grade
2	409, as added
5	consideration for a
1	submitted master files
1	period of ineligibilitythe
1	groups having an
8	product is in
1	public eating places
2	fact shall be
1	fix a manufacturing
2	substance is consigned
9	5703 of title
1	huma-readable or machin-readable
1	(c), as applicable;
1	debarred, (b) shall,
1	premarket burden, facilitate
1	constructionthe following applies
1	system database and
1	(6) for such
1	(6) shall appear
1	scientific advice and
2	residue that results
1	substances shall maintain,
1	collected, whichever is
1	disease, or to
1	denatured, or otherwise
1	whose bacterial count
1	(i). (x) for
1	public eating place,
4	(a) if such
1	care entity which
1	subsection (b)(1)(a)(ii) or
3	level of risk
2	chemical residue shall
1	conducted after such
1	review unless the
1	documents shall be
7	approve a change
1	among themselves and
1	 (a) maintain
1	practicable; and (b)
1	drug safety collaborations.
1	area; (b) managing
1	(a) information maintenance
1	section 343(q)(5)(h)(ix) of
1	tableting machines, or
1	applied chemistry nomenclature
1	action in court
1	substances for a
5	stamp, tag, or
1	order or the
1	involves prolonged contact
1	food; and (3)
1	office, the deputy
1	including a proposed
1	consignee maintains records
1	(k) for devices
1	only.  (l)
3	class iii 
1	subsequent shipment, documentation
1	media campaign were
4	laws of that
1	threat response fund
9	shall be extended
1	designation. such term
3	convictions shall be
1	5 years, reevaluate
1	measure whenever the
1	drugs. such requirement
1	previously convicted as
1	iv, 408, as
1	relating to individual
1	accreditation body meets
1	 (7) congressional
1	company. (5) study
1	liners. (m) the
1	without further notice
1	internal controls, including
1	product, confirm the
1	3-day notice or
1	(gg) a sympathomimetic;
1	pharmaceutical, biologics, and
1	complexity and present
1	repackager only if
1	facility which makes
1	business  (i)
1	physician.  the
1	(d) preparing and
1	publish a statement
1	subclause. such an
1	temporary permits to
1	good moral character
1	anticipation of available
1	(ii) shall not
1	assure the protection
1	shortage, with respect
1	marijuana use in
1	communication is paid
2	cover reinspectio-related costs
1	terms, the secretary
1	august 2, 2004,
1	applications that are
1	point the term
1	proceedings below. the
1	documents issued under
1	manufacturing, assembling, or
1	amended reportif a
3	controlling the drug.
2	assure its safety
1	smuggled food means
1	sponsor may request
1	(6) public comment
1	developed, studied, and
2	limitation at a
1	(1) has not
1	subparagraph (a)(i) continue
1	addresses when to
4	toxic substances control
3	shall be designed
1	minimizing burdensuch elements
1	drug submitted by
1	chapter. no inspection
1	consistent with product
1	stat. 1048.)
 

1	medical licensing board
4	(b) submission of
1	may require an
1	reasonable times upon
1	improving the coordination
1	10.30 or 10.35
1	usual and lawful
1	others.  (c)
2	concerning a formal
1	$23,600,000; and (b)
1	 (3) dispenserthe
5	(a) if it
1	vehicle being used
1	requirements; redesignation; designation
1	corporation owning or
5	controlled substance analogue
1	may require as
1	(f) definitionsin this
1	(a) property subject
1	paragraph (1) whenever
1	technologies transferred, based
1	(b) would not
2	examination, inspection, and
2	covered products to
2	listed in subparagraphs
1	sellersthe attorney general
8	operations and transactions
1	united states concerning
2	device manufacturer in
1	progress and evaluation
1	paid by eligible
1	case, which the
1	357. qualification of
1	regarding the investigational
2	advertising is false
3	involving a product
1	exportation of listed
1	(iii) or (v)
1	exemptionsthis section shall
1	punishment under section
1	use;  (b)
2	commodities, including small
1	including varied means
1	provider shall report
5	shall not accept
1	investigators to perform
1	dtc advertisements prior
8	subsection (a) and
1	standardized design characteristics,
1	importer, or distributor
2	imprint, or device
1	subchapter. nothing in
2	subparagraph.  (b)
15	specified in this
1	reason for such
1	application.  (bb)
2	inform the public
1	established appropriate specifications
1	component, and the
1	chapter. (4) amendment;
6	(b).  (2)
1	sources; and (c)
1	(c) procedures applicable
1	credit or payments
1	section 333(c)(2) of
2	means any individual,
2	contains, a color
2	1001(a) of title
1	period described by
1	reporting by persons
18	advisory review fee
1	location of property
1	(d) information required
1	term drug means
3	serum, toxin, and
1	whoever knowingly distributes,
1	(i) reconstitutes tobacco
2	of, an application
1	indicate the nonbinding
1	devices once each
4	subparagraph as the
3	effective, the secretary
1	contract to provide
2	(2) a description
1	poison, and the
1	shall be technically
1	voucher, as specified
1	congress an annual
1	seizure of the
2	individuals domiciled in
1	agenda of the
4	reasonably suggests that
2	distributed only if,
1	grains. the provisions
2	local agencies to
1	(b) each term
1	intrastate activities; designation
1	product obtained by
3	date under subparagraph
1	costs. the attorney
1	genetically targeted drugs
5	(3) of subsection
1	ingredients, and cosmetics.
34	shall include a
1	ingredients, and cosmetics,
1	agency or agencies;
3	otherwise affecting the
1	determines that removal
1	office the counte-drug
1	(i) the foods
1	congress should continue,
2	receives a standard
52	application for a
1	strategy and to
1	scientific judgment. 
1	procedure to enjoin
1	manufactures positron emission
1	262], including with
1	publish a schedule
1	upon such notification,
1	requiring, when necessary,
1	withdrawal periods; effective
1	assessed and an
3	patient or research
2	information the responsible
1	criteria; sel-certificationthe attorney
1	(i) revision 
2	may be enjoined
1	furnish to him
1	(4) within 180
1	losses to livestock
2	administrator determines, after
1	academic scientists; and
1	inspectio-free articles the
1	title. (b) authority
1	name as described
1	contract with one
2	drug shall contain
1	frequency  (a)
1	activities regarding the
1	comparative claims 
4	secretary issues such
1	provide a 3-day
1	(a) it bears
1	collaborations with health
2	(2) exception the
1	fourth sentence of
1	distributed intrastate cannot
1	product development, the
7	optical isomers, and
1	fees:  (i)
1	skin of humans
2	device applications means
5	refused to permit
1	foreign country unless
1	shall, in dispensing
2	fiscal year, there
1	(c) not later
2	another such certification
1	
 864. anhydrous
1	subsection from disclosure
1	post a quarterly
1	advertising of an
1	(5). (5) procedurein
2	503(b) of that
2	secretary to receive,
2	sources of real
1	360fff7. report (a)
1	states person, which
1	imposes a more
1	(b) the expiration
2	abuse programs and
1	secretary may specify
1	safety of color
1	time, conduct an
1	displayed or presented,
1	pay under the
1	shall by written
1	establishing the small
3	(b)(2) or (j)
1	subchapter shall, in
1	eligible coalitions, community
2	supplement, regardless of
6	possessing with intent
7	revocation or suspension
1	also are used
12	review of any
1	party as the
3	(b) regulations the
1	legal entity; 
1	employees, and employers
1	(3) powers conferred
1	concerns relating to
1	contract with public
1	product except in
2	invoking subsection (e)
1	379k1. electronic format
1	humans is demonstrated
1	primary architects and
1	route of administration)
1	tobacco products comply
1	constituents, by brand
1	consultation with such
1	ingestion in tablet,
1	enforcement activities of
1	provisions of or
1	examination and refusal
1	schedule ii controlled
1	clause (i) or,
1	health professional) other
3	360bbb of this
1	carrier or the
2	702 of title
1	legal authorities, if
1	certain used electronic
1	performance standards pursuant
1	writing by any
1	subparagraph. (3) 
1	department. (b) 
5	threat to public
1	meeting not later
1	intended use conform
1	(o) postmarket studies
3	(2) no person
1	(a); or (3)
3	reached between the
1	diluents or without
2	commence) a civil
1	(k)(2); and (g)
1	provides nutrients in
2	request for drug
1	limited circumstances in
1	risks as determined
2	new substances; (4)
1	animals or in
1	process for managing
1	issue regulations or
1	must be deemed
1	occurs on or
10	comments on such
1	prevention.  (d)
1	request; or (b)
1	
 464. exemptions
1	affiliates, and does
1	subsection to use,
1	notice states the
3	illegal drugs. 
1	pharmaceutical ingredient facilities).
2	larger facility, unless
1	supplement.  (g)
1	participation prior to
1	agency center. 
1	(4) content of
1	implant and any
5	protection of confidential
1	selection of data
1	efficacy supplements, and
1	outsourcing facility, 1
1	submissions from requestors
1	require the accredited
1	circumstancesfor purposes of
1	-year periods. 
2	patients, the secretary
1	letters that allow
1	organization funded under
1	useful drug or
1	food testing shall
1	(c) color additives
1	2014  fiscal
1	(2)[1]  (1)
1	1500.)
 
 1523.
1	chemical. (2) nurse
1	perform the evaluation
1	benzaldehyde. (w) nitroethane.
1	 (a) publicationthe
1	limits of such
1	court decision, (ii)
1	operations in nondesignated
1	interest) in the
1	notification submission if
1	imported food (a)
1	following drugs or
1	admission  (1)
1	shall this workload
1	communication with outside
1	(5) collect, synthesize,
1	title; (3) the
19	administration, dosage form,
1	action means the
1	presenting demonstrable difficulties
6	general and the
4	10 years and
1	research and treatment.
1	(b) the relationship
1	inspection means the
1	proprietary name it
1	may deem a
4	writing and made
2	product is to
1	foreign countries will
1	oils of almonds,
1	requested will be
1	423, 62 stat.
1	 (vi) not
1	country achieves the
1	title 42 (which
1	notice does not
1	relevant information; and
2	buying, selling, freezing,
1	importation process, as
2	(ii) is substantially
1	active ingredient means
1	programs.  (iii)
1	terms of quantities
1	prevention strategies to
1	product application as
1	adul-only facility, unless
1	guidance, including guidance
1	drug the name
2	regulation of drugs
1	conditions may be
1	food. (b) the
1	final medical device,
2	general controls pursuant
1	(1) that relates
1	registered narcotic treatment
1	various forms. they
1	for, or worked
1	manufacturing equipment, all
1	 (5) periodic
1	distribution; (b) information
1	response shall be
1	may 2007, inspection
1	designated as having,
1	public health. (e)
4	clause if the
1	fiscal year 2011;
2	supports the conclusion
1	form of business
1	exclusivities and extensions
1	provides a legitimate
2	evidence, and shows
1	article upon the
1	holding an approved
1	subsection (b); (ii)
1	submitting the article
1	violation if the
1	president by and
1	industry to assure
1	wholesale distributor licenses
1	cooperative agreements entered
1	n-tobacc-sale order permanently
1	human cell and
1	different strength. (iii)
1	writing and submitted
2	reprocessed under the
2	(not including the
1	developing modeling tools
1	procedures. (b) the
1	enumerated in paragraphs
1	various enforcement strategies
1	entities  (i)
1	program or tactical
1	present demonstrable difficulties
1	means a therapeutic
1	egg packer packing
1	 (6) accountabilitythe
4	section, a person
3	26, 2014. 
1	inspection observations made,
1	opportunity, or to
1	amounts collected for
1	improving food safety
1	(d) forfeiture of
1	 (i) worked
1	considered to exist
2	determined, or the
1	permissive debarment; food
1	shall conduct 1
1	
 
 360ddd1.
3	records related to
1	
 
 379k1.
1	studies described in
1	congress. (b) communication
7	person or the
1	misbranded tobacco product.
1	catalog, file, and
1	annual distribution of
1	15.  (12)
1	proposal, not to
2	2008, had pending
1	 (4) waivers
2	(2) report not
4	additive will be
1	ii devices reclassified
1	facilities that handle
1	ris-based preventive control
2	wholesale distributor license,
2	product and is
4	best of his
1	container. (u) the
5	order described in
3	source of such
1	substance from a
3	assessments required under
1	derived from amounts
2	360j(m) of this
1	administer epinephrine when
1	funding to treatment
7	shall conduct a
1	221 to 237.
1	 (8) if,
1	models that will
1	fee setting 
1	subsection (e)(7), affected
1	(i) his determination
1	illegal drugs; (b)
1	analytical methods. (3)
1	tomography drugs as
1	outbreak response and
2	vocational, or secondary
1	expert panel, as
1	determination of what
1	$13,500,000; (6) for
1	(c), including recommendations
1	provisions under this
1	paragraph. (2) workload
1	28, 1976. 
1	encourage, to the
1	manufacturer, be submitted
1	source, or manufacturing
3	double for every
1	tool includes 
1	of, the tobacco
12	secretary deems necessary
1	requests for approval,
1	funds the cost
1	costs clause (i)
1	committees at universities,
6	treatment in the
1	(a) postmarket surveillance
1	section. (c) priority
4	dispense controlled substances
1	intended for retail
1	drugs containing single
1	analytical procedures), and
2	208(b)(1) of title
1	(1) maintain an
1	listed chemical; or
1	economic powers act
1	proposes to engage
1	times of the
1	ingredient, if available,
1	data, including pharmacokinetic,
1	(vii) the distribution
1	establishing standardized documentation
21	scientific training and
1	 (h) authorization
2	(other than infant
1	15. (3) beginning
1	pharmacy shall be
1	(a) travel expenses
3	importations made by
1	(1) if approved,
11	partnership for a
1	family, and his
1	eyebrows; to do
2	appropriate susceptibility test
1	erosion of understanding
5	consideration of comments
1	groups (including neonates
1	(a) a true
1	issued by him
1	(viii) 50 grams
1	title, determines is
1	committee of experts
1	consideration by panels
1	section 1707 of
1	wholesale distributor notified
1	number of pending
1	widely available, including
1	prereview of television
56	sponsor of a
1	proceeding against such
1	drug trafficking. 
1	component parts used
1	additives for such
1	annual sales for
1	withdrawal period previously
1	poultry or processing,
2	centers and countries
1	united states suffering
1	appointed under subparagraphs
3	including guidance documents
1	criteria and related
1	(d)(1)(a)(ii), and (e)(1)(a)(ii);
1	exception shall be
1	act). (b) grant
1	consistent with protecting
1	livestock that the
1	subsection (a)(4) within
1	disease in man
1	substance for sale,
1	grade; and all
5	maintain such records
1	use only, nor
1	monitoring records for
1	expertise and experience
1	forms (a) unlawful
1	702, 52 stat.
3	provision which identified
1	labeling in marketing
1	 (a) known
1	forfeiture upon the
1	title. (5) 
1	inspectors certificate no
1	plans developed, and
5	information which has
1	material fact to
1	practices prescribed by
4	intentionally subjected to
1	partners shall be
1	scientific ideas; and
1	formerly 906, as
1	prescription described in
1	feeeach generic new
1	$5,000,000, or both.
1	devices so identified,
4	unsafe or not
2	respect to, or
2	previously refused for
8	food shall be
1	necessary.  (10)
1	 for a
1	safety risks; (iv)
1	(1) the regulation
1	fifteen days in
1	drug products manufactured
2	owned and operated
1	secretary prescribes but
1	 (2) to
1	reduction activities by
1	information, to determine
1	(k) date of
2	intended to form
5	adjustment factor described
1	(
 
 454.
1	prescribe are satisfied.
1	criminal liability shall
1	scientific issue raised
1	costs, hiv infections,
1	medicine, or two
2	applies to such
1	device shall result
1	means the standards
3	weapon, shall be
1	substance.  (4)
1	 (f) critical
1	yields of the
1	local agencies in
1	assistance otherwise required
1	needed scientific expertise,
1	adults.  (6)
1	suspended if the
2	means an eligible
1	drug products out
1	respects govern proceedings
4	 (v) records
1	physical health and
1	
 379j21. authority
1	prescribed by rules
1	fide research activities;
1	materials. (4) other
4	factors described in
1	subchapter i, and
1	(1)(b) and (2)(b)(iii)(i)(aa)
1	proposed protocol and
1	advertisements a person
2	pseudorabies in united
1	sold. after entry
1	food products, poultry,
1	whenever a witness
1	destroyed or brought
1	health hazards; (e)
1	future study published
1	inspection requirement 
1	shall prescribe under
2	(j)(2)(a)(vii)(ii) of section
3	filing.  (e)
1	procedure provided in
1	consulting laboratory, or
1	kept, or filed
1	chemicals (including specific
1	filling, packaging, labeling,
1	related to 
3	labeling revision described
1	research, education, and
32	associated with the
1	authority, the national
3	advice and consent
1	(4) renewal and
1	new information do
1	(g) the agricultural
1	validated the effects
4	(b) unless specifically
2	manufacturer as a
1	911, as added
1	thereof; (b) promulgating
1	(c) developing a
1	therapy under the
6	title; or (b)
1	plus amounts collected
1	individual who provides
5	experience to investigate
1	(i) evaluate any
1	(1) recognized in
1	agreements as may
1	establish a program,
4	providing a period
4	affected in a
5	(1) no person
2	certain controlled substances
1	person any of
1	resources is necessary
1	initiative of secretary
8	subsection (b)(1) for
1	residues that have
2	violation under subsection
1	limitation would not
1	found to occur,
3	voucher shall be
1	(i) it is
3	particular manufacturer or
1	extent of tracing
1	subsection (f). such
2	body under subsection
1	contents of studyin
1	dietary ingredient for
1	volume of eggs
1	 (b) procedurethe
1	product (including the
1	subject as, but
3	regulations  (a)
1	appurtenant thereto), intended
1	petition for declaration
2	months ending april
1	views and recommendations
1	agencies, and the
1	charges for other
1	levels may be
1	expert is a
4	evidence so taken,
2	conversion into a
1	evidence so taken.
1	require the attachment
1	thereof for pay
7	within reasonable limits
1	control with another
1	provide data on
1	(2) requirementsthe regulations
1	general) or distributions
1	available. (iii) requests
1	leadership and partnerships
1	image, physical sign,
1	indexed new animal
1	(b)(1), establish conditions
4	350l of this
5	transaction information (including
2	application used a
2	official and proprietary
2	instruments and techniques
1	administration, identify unmet
1	small or the
1	petitioner.  (b)
6	product means any
1	assessmentthe total amount
1	use the authority
1	31, 2013, and
2	distributor shall 
1	section or waived
1	medical devices; or
1	make a renewal
1	state law nothing
6	ineffective or unsafe
1	milk.  (e)
1	centum below the
1	bulk, with the
2	reduction of the
1	views, or arguments.
5	shall not impose
1	waived, exporters of
1	term manufacturing expenses
1	consistent with information
60	use of such
1	applied in the
1	states standard a
1	neither section 353(a)
1	subparagraph for importation.
1	united states subject
1	site that manufactures
5	appropriate steps to
1	exemption. the administrator
3	june of each
10	manufacture of a
1	formerly 702a, formerly
3	drug submitted under
1	complex or is
1	organize the studies
25	raw agricultural commodity
1	secretary. (b) at
1	(b)(1)(f).  (b)
1	(b) this subparagraph
2	loan repayment program
1	year, a registrant
1	policy, and the
1	
 871a. semiannual
1	antifungal drugs. the
1	means the states
1	separate serving bears
1	means a nurse
1	acts, to cover
1	thereof shall, upon
1	fact for each
1	(a) objections within
1	effect the guidance
1	initiative this section
14	otherwise provided in
1	cycles nothing in
1	(2) submit more
2	secretary, specifying with
1	designate.  (b)
1	360bbb3. authorization for
1	makes a final
2	fee applies. 
1	develop a standard
1	poultry products act
1	combat substance abuse
2	certification, as provided
1	investigation required under
1	(bb) such costs
1	diverse expertise in
2	facility of an
2	section 467c of
1	of, such devices.
1	purpose of unlawfully
1	(1) an amount
7	establish a system
1	need therefor for
1	characteristics, that it
1	bodies and laboratories;
1	90 days following
1	paragraph (6); or
2	exemptions under this
1	section 360e(c)(2) of
4	originated with the
1	(a)(1) available solely
1	chapter. (7) if,
1	subsection facilities that
3	offsetting collectionsfees collected
1	clinical research community.
1	shall bind the
1	notice, which upon
5	investigational device exemption
2	caused the advertisement
2	time the secretary
1	unless (a) the
1	security, shall allocate
1	implementing such a
3	both. (2) any
2	facts, or make
1	solicit intramural research
5	used as components
1	subsection (b)(1)(b). (f)
1	bears adequate directions
1	interpretive criteria described
1	repackager transfers ownership
8	fund control notice
1	modification in a
1	(c) performance auditingto
1	 (d) fee
1	(i) within ninety
1	processes where a
1	effect on man
1	records; scope of
1	title. (ii) if
1	fixing such quotas,
4	effect on may
1	may use direct
2	make a finding
1	establish a competitive
3	drug if 
1	(f) specific actions
3	purposes of sections
1	standard in a
4	(1) in person
1	(3) because of
1	696, 13, 63
1	1031. congressional statement
1	require data or
1	intended, whether alone
1	institute of drug
1	substance from such
1	2009. (f) research
5	directions for use
1	contractual relationship to
9	united states pharmacopoeia
1	person shall possess
3	using or proposing
1	(2) require that
1	stringent than, or
1	2017, and $2,117,000
1	person who uses
1	listed chemical product.
1	entities; and (c)
1	
 
 360bbb8c.
2	conditions prescribed under
1	that, during the
1	drugs, medical devices,
12	food manufactured, processed,
1	(4) alphameprodine. (5)
1	(i) define the
1	affixing a label
1	interest and publishes
3	within the 6-day
1	bodies  (i)
3	will expire, or
1	states concerning the
1	act of 1978
1	animal, as applicable.
2	21, 1997 
1	officer shall be
1	application be by
1	advertising for herbs
1	antimicrobial drug under
2	clinical trial under
1	international, state, local,
1	articles published by
1	(1) state elections
1	defects in and
1	reporting is not
1	requirements.  (ii)
1	(3) build the
1	assistance of retailers
1	employee, occupant, or
24	file with the
3	nations total supply
1	products if he
4	secretary approves the
1	food, for such
1	animals, indications, and
1	soil, bearing or
2	prior to making
1	ascertain that clauses
1	compliance and drug
1	abuse. (6) the
1	substances; (4) studies
1	(a) require that
7	country from which
1	(a) random inspections
2	independent consulting firm
3	medical countermeasure application.
1	audit agent means
2	title 47, are
1	
 
 674.
1	color additives, and
1	availability and use
1	residents of that
27	grant under this
1	 (g) amendment
1	storage and in
1	(including an o-line
2	efficient completion of
1	paragraph. (4) a
2	(a) definition of
1	made upon said
1	(ii) 75 percent
2	certification or statement
27	required under section
2	assessment under subparagraph
1	another such reasonable
1	(c), make a
1	(b) acted under
1	appropriation; or (b)
1	interested persons. (h)
1	hig-risk facilities and
1	 (i) arranges
1	final sunscreen orderin
1	person ceased distribution
2	chemical is in
9	diseases or conditions
1	quantity prescribed. 
5	manufacture animal feeds
1	collective weight of
1	plan shall 
1	advisory committee described
1	days if the
1	acts, for the
1	committees that addresses
1	title 44 shall
1	objection and setting
1	attorney generalproperty taken
1	31. all fees,
1	services administration the
2	subsection (a), any
4	may modify or
2	rulemaking, and the
1	exportation, in violation
1	develop standards for
1	secretarys absence the
1	7th par., 34
1	required conditionswith respect
5	revoking the approval
3	suspect product and
1	calcium saccharin, sodium
3	one geographic location
1	database a repackager
5	subsection (a), and
10	opinion of the
1	 (f) technical
1	 (3) promising
1	meetingthe secretary 
2	2008, in which
1	iv shall apply
1	establishment fee the
1	certification of a
1	title. (g) inspections
7	action subject to
1	constitute an extremely
1	completed, except that
1	 (i) authorized
3	conclusion of such
2	year; and, in
1	material fact or
1	united states pharmacopoeia;
8	prior to, or
2	firms not submitting
1	inspection resources for
1	(22) etonitazene. (23)
4	united states pharmacopoeia,
1	united states pharmacopoeia.
1	agriculture and food.
9	labeling proposed for
1	order shall contain
1	agree to conduct
1	manufacturer directions consistent
1	associated with substance
1	includes individuals with
1	export a drug
1	regulations), or that
1	occurred, or in
17	accordance with subparagraph
22	section 552 of
1	biological products; (10)
2	title) initiate a
1	secretarys authority over
1	subsection (h) to
2	section 552 or
1	conduct of counterdrug
3	shall permit a
1	manufacturer. (2) after
1	342(a)(2)(c) of this
1	consideration the risk
1	approve such order.
1	made is aware
1	equivalence for the
1	particular color additive
1	1986 (26 u.s.c.
1	surveillance (a) definition
1	year. notwithstanding the
1	include historical use,
1	ch. 3913, 34
1	expanding the tolerance
2	individual convicted under
1	(iii) finding that
1	reports) if such
2	preparation of the
4	payment the fee
1	assure that imported
1	regulations are met.
1	contemplated proceeding. (june
1	shall include discussion
1	may have affected
1	examinations and procedures
1	(in such manner
1	public health. each
1	altered. (2) there
1	program agency during
1	conditions the court
1	675, 539, formerly
20	(b) shall be
1	2015 (to examine
1	sunscreen.  (4)
1	except that carriers
1	prevent such diseases.
1	 (6) public
1	training on the
2	final rule under
1	promulgate and enforce
1	presented by other
2	dispensed directly by
1	controlled substance, each
1	remedy a violation
2	full scale production
53	use as human
1	information location tool
1	respect to assisting
2	shall relate to
1	(g) administration of
2	opium or preparation
1	program subject to
2	degrees fahrenheit, as
1	services are provided.
1	(5) for purposes
3	narcotics trafficker so
1	710, as added
1	title. a summary
1	evaluation of clinical
1	elect to have
1	(2) fee methodology
21	federal register a
1	proportion as the
1	chapter for refusal
2	results are inconclusive,
7	requirements of subsections
1	appear to pose
5	evaluate the effectiveness
1	schedule i) for
2	decree, (a) be
1	revealing, other than
1	lien against the
1	promulgate regulations prescribing
1	effect.  (b)
1	activities are one
1	person acted in
1	only; nor, in
5	substantive proposal made
1	licenses, instructions, or
6	(2) of such
1	 (i) vitamin,
1	necessary  (1)
5	approval under subsection
1	labelthe label of
1	coordinate, and support
1	833.)
 
 1604.
1	dependent illicit drug
1	(3) to protect
1	operators or owners
1	possessions; (d) whether
3	suspend the grant,
1	coca leaves authorized
1	engineering applicable to
6	determining whether to
1	protest, not later
2	(h) appeal from
1	interpretive criteria developed
1	policy, form, or
1	42.  (3)
1	mediu-, and lon-term
1	section have become
2	significant known and
4	upon completion of
1	update is submitted
1	2-month period, except
1	every prescription compounded
1	relating to 
1	(i), as demonstrated
1	 (d) limitationsthis
1	may also cause
1	adjustment shall not
1	agreements or grants,
1	review the purity,
2	consultant or other
1	persons are meeting
1	352(j), or section
19	directly or indirectly
1	imposition of sentence
1	(2) each separate
4	sale or, if
2	actions as may
1	year for devices
1	organization means the
3	means an establishment
3	report, or supplement
4	local, state, tribal,
1	may also, to
1	phenyl ring to
1	states attorney shall
1	 (b)standards. 
1	subsection (k)(4) of
1	year 2014, $1,736,000
1	360bbb. expanded access
1	parties to obtain
1	privacy.the qualified entity
1	title; (6) use
4	appropriate.  (b)
3	products are rendered
3	invalidity or noninfringement
7	shall maintain records
1	act. (5) nothing
1	(1) initial reportthe
1	food safety law;
1	services throughout the
3	seller of the
1	dietary supplement ingredients
1	350g. hazard analysis
1	product expected to
1	503, 52 stat.
1	inform veterinarians and
1	section 16(b) of
1	continuing threat to
4	different from the
1	demand reduction; (v)
2	result in undue
1	section shall use
1	court costs; and
1	(19) shall submit
2	section. if the
6	recommendations as necessary.
3	(b) a written
2	provisions may, at
1	committee shall meet,
6	chapter may be
1	promulgate from time
1	organizations  (a)
1	464. exemptions (a)
1	agencies and state
1	fourfold or greater
1	information among task
1	advisory board established
1	department for public
1	said secretary not
1	tested; and (ii)
1	followed, the reasons
1	meeting held under
1	decreased from 2003
1	agencies, courts, and
1	determine risks to
1	(
 
 1524.
1	recipients of food,
2	administering state programs
2	 (c) deputy
1	drug tested; and
1	have, unless exempt
1	(a) may, at
6	base inflation adjustment
1	record on which
1	federal employees no
1	institutions, and to
1	party to present
3	subsection.  (ii)
1	brought into slaughtering
1	374(g)(2) of this
1	amount of marihuana
1	convictions, the court
1	general, in accordance
1	remote location that
1	prompt distribution to
1	party.  (2)
3	occurring estrogen or
3	facilities, and other
1	recommendations as needed
1	device recall. 
1	limitationthe director shall
1	 (g) notice
1	exemption from reporting
1	added july 22,
1	
 
 691.
1	use not identified
1	law, including the
1	(2) shall define
1	(b) include recommendations
1	board may not
1	secretarys satisfaction that
1	authorization a drug
2	capability and capacity
2	violations any selected
1	 (d) pos-hearing
1	essential chemicals used
3	twenty days, pending
1	prevented; (2) any
1	behalf of, a
2	samples, where he
1	(
 
 874.
1	prepared in establishments
2	information as determined
1	 (5) pesticide
1	including any procedures
1	 (b) unlawful
1	may also seek
11	fees shall be
1	gene product; and
8	submission of information
2	pilot projects, including
1	(a), so that
1	appropriate, to warn
1	830(a) of this
1	approved drug labeling
1	health impact; and
1	upon conviction, a
2	plainly labeled for
1	diampromide. (15) diethylthiambutene.
1	forum, and may
1	respecting the regulation
1	plasma, or source
1	submission as required
1	any; or (ii)
5	section 355(c)(3) of
2	may otherwise be
1	supporting the investigational
1	term meat broker
1	formulated to be
1	labeling, notice to
1	distribution shall 
1	section, and such
2	reaga-udall foundation for
54	submitted under subsection
1	added substance that
1	(f) inapplicability of
3	official or employee
1	statements of material
2	country:  (i)
1	solely within an
1	term includes guns,
1	(1) verification requirementexcept
1	number patients to
1	salt, and with
12	secretary determines is
1	chartering and annual
1	use of grant
1	debarment period and
3	final action taken
1	subparagraph and section
1	use of devices
1	common school or
1	government, school board,
1	ch. 675, 501,
1	marijuana use. (b)
1	discuss any potential
1	finished infant formula,
1	consular and judicial
4	 (a) full
1	remain listed, or
1	reserves  (1)
1	said book shall
1	ranking of such
1	inspected for wholesomeness
1	establishment compliance is
1	379i. definitionsfor purposes
1	ch. 143, 2,
1	(c), as agreed
1	gas as determined
1	dispensing and selling
1	(iv) focus postapproval
2	incurred in carrying
1	sponsor, the secretary
1	30 of the
1	conditions necessary for
2	procedures and reassessed
1	included in resulting
4	title, including the
3	proposing to use
1	compiler of an
1	device review. 
1	identified hazards, including
1	human services of
1	requirementexcept as provided
2	title 6. 
8	ingredient or animal
3	administrative and judicial
1	illegal drug trafficking
1	september 30, 2008,
1	person has, before
1	administrative costs 
1	approved drug, or
1	department. (june 25,
1	(ii) the causes
1	product, and, upon
2	groups as are
5	human services or
1	(c) the responsible
1	sellera biomaterials supplier
2	pediatric assessment under
1	designated);  (f)
2	bulk manufacture of
2	procedures related to
1	order performed by
1	may appear in
1	fed. reg. 4461544618).
1	dru-related law enforcement
1	basis) by the
1	evaluation data collected
1	commodity intended for
1	shall establish pilot
1	by, such carrier
1	successor regulations), unless
4	hearing under paragraph
1	quantity requested, (iii)
1	trade as a
1	timely interchange of
1	animal drug a
3	involved, any studies
2	facts, if supported
2	distribute or distribution
1	parties, as defined
1	refund the remainder
1	made (in this
1	electronic communications, in
1	(3) notification 
2	introduce into the
1	multiple recalls the
2	activities authorized by
1	(a) violations of
1	services, publish in
2	aid to and
1	actions under subsections
1	evaluation of elements
1	(13), or (14)
1	investigational device, treatment
3	establishment owned or
1	(c) and (g)(4).
2	application is submitted;
2	fair dealing in
1	(a) applicants to
1	article, a chapter
4	wherein such person
1	observations contained in
1	donation where the
1	qualified acceptance to
1	premises and there
1	application is submitted.
1	including section 360fff3(e)
1	agreement reached through
3	batch of such
1	notice for change
1	standard of quality,
1	
 
 1505a.
2	secretary; or (6)
3	annual advisory review
2	information to establish
1	enforcement personnel of
1	distribution.  (19)
1	secretary may participate;
2	petitioner, extend such
1	proceedings under subchapter
1	children with cancer
1	severable shall remain
2	principal administrators, organizers,
1	fees collected by
1	depending on (i)
1	practitioner who so
2	required to accomplish
2	official standards of
2	require to assure
1	secretary may amend
1	include all final
1	(3) another person
5	sum of the
1	inspected and certified.
1	lawfully hold, manufacture,
1	active ingredient may
1	components  (1)
2	(d) scope of
1	application no order
1	(ii) congress; (iii)
1	 (c) records
1	quantities for individual
1	1992, or (b)
1	cited as the
1	involving supply reduction
1	food registry (a)
1	(2) implementation plan
1	relating to live
1	represented health outcomes,
3	shall be delivered
3	distribute or cause
1	processing standards for
1	(b), the effectiveness
1	completed, or an
1	administration associated with
2	 (2) changes
8	shall provide that
1	(in whole or
1	consulting laboratory in
1	radiation intended for
1	frequency of meetings
2	(2) inclusion the
1	address communication and
3	program (a) in
1	united states. (27)
1	review of this
1	identification and sanctioning
1	industry, or consumer
1	audits be conducted
1	make a written
1	qualifying laboratory means
4	including the food
2	title are applicable;
3	food of the
3	consignee, who may
2	hardship for small
1	bonds; court costs
1	later date given
1	policies are not
2	take effect prior
32	order of the
1	every person duly
1	responded to a
1	court under section
2	(a) request by
1	(c) treatment of
12	effect until the
2	use and whether
2	subparagraph (a)(i) in
1	improve and advance
1	paragraph within 180
1	(n) packaging or
1	residue, and data
1	special controls would
1	 (i) approved
1	(1) substance abuse
4	age established by
1	contaminant under section
1	fact; (3) any
1	ch. 675, 583,
1	drug, shall be
3	datesuch fee shall
1	no-federal contribution no-federal
3	adjustment for a
1	(b)(1)(a) in an
3	guidance documents 
3	device containing any
1	annually prepare and
1	paragraph (2)(a)(vii). the
1	otherwise qualify for
1	year. (c) application
1	shall, after full
2	determines at the
1	recognition.  (2)
1	issue a permanent
1	(e) ergotamine and
4	animal feed or
1	section authorizes any
3	destination of the
1	state.  (2)
1	misbranded because of
1	establish an incident
1	ch. 675, 706,
1	shall upon public
1	(3), or with
1	growth hormone for
1	five miles of
1	 (5) essentially
1	proof on each
1	drug administration 60
2	identifier which can
1	general the owner,
1	subparagraph, the person
1	developing medical devices
1	(b) do not
1	evaluate, for the
1	controlled substances used
1	(k) such other
1	review voucher awarded
1	tests are conducted
1	considerationin considering whether
1	major change, in
1	whenever he deems
1	(6) model laboratory
1	jurisdiction and such
1	reliable, officers or
2	public eating place
1	
 
 379i.
1	 (n) funding
1	demonstrates the safety
3	component of any
1	recognized by state
1	importation from a
1	product to report
1	services. (c) duration
1	obtained and which
1	person whom the
1	paragraph (3) that
2	part thereof, meat
1	done in compliance
1	customary, nonexpedited testing
1	person who believes
1	
 199. repealed.
2	qualification  (i)
3	meet with a
1	(
 
 873.
1	it. (4) a
2	consumers believing that
1	lawful business in
1	
 1401. pesticide
1	 (c) employing
1	programs and operations;
1	holding, transportation, and
1	
 392. exemption
4	annually submit to
1	regarding activities of
3	extended by such
1	thereafter, upon request
1	select the members
2	hazard to health
1	device, and any
2	part (or regulations
1	authorities otherwise provided
1	done or omitted
2	quantitative listing of
1	benefits:  (1)
1	understanding shall contain
1	combination thereof) as
1	steroid. (d) new
1	systems or for
1	additional country or
1	annual generic new
1	official plant which
1	20 years, a
1	therefore) orally or
1	facility used for
1	illness outbreak, or
1	poultry inspection regulations,
1	5 years; (2)
4	expended without fiscal
4	august 3, 1996.
1	ingredients or combinations
1	 (2) financial
5	recipient under this
2	treatment or prevention
1	(
 
 1031.
1	(1) notice to
1	secretary for each
1	isomers, esters and
1	(14) shall submit
1	(d) immunity of
1	standards prescribed by
1	calendar year; 
2	judicial proceeding under
2	registrant of a
1	 (27) transaction
1	publish the action
2	drug products intended
1	validity, completeness, and
1	advanced computer systems,
1	515a, as added
1	containers of tobacco
2	potential to adversely
1	(a); or (b)
8	1604(d) of this
1	sponsor responding to
1	-methylmethcathinone (mephedrone). (19)
1	title) of such
1	reimbursements shall be
1	rewards to which
1	(27 u.s.c. 201
2	submits evidence that
1	review of, devices
1	misleading statement is
2	anyone convicted of
1	studying drugs for
1	needed; (vii) a
2	unused advisory review
1	information that calls
1	(b) membership and
1	shall immediately take
3	regulations to assure
1	alcohol, paregoric, the
1	(ii), a manufacturer
3	deter their use
1	illegal uses to
2	canning, cooking, freezing,
1	administration employees and
1	subsection (h). (q)
2	product, appropriate conditions
1	license. section 355(c)(2)
2	u.s.c. 262] (as
1	conducted. (v) if
1	tobacco products, all
1	meats inclosed in
1	scope of authority
1	(or a recommendation
1	implementing the least
1	data from studies
1	enterprise; (ii) under
1	(including the prescribing),
1	results of postmarket
1	including determining the
1	retail pharmacy undertaken
1	(1), the drug
1	verification request. 
1	assistance division 
2	provide to such
1	(
 
 466.
1	period following june
1	(iv) establish policies
1	academic institutions, practicing
7	(c) public availability
2	agriculture or his
1	tracking and evaluation
1	pediatric patients; and
1	received the product
1	hearings authorized or
1	fee from a
1	direct hiring authorities;
1	safety activities). 
2	upon demand of
2	manufactured by an
1	contains, when and
1	prescription if such
2	training to achieve
1	warrants; issuance; execution;
1	device shall, within
1	(b) jury trial
1	local distribution, and
1	dosage strength, and
6	paragraph (3) shall
2	consultation with public
1	another of the
1	15 days thereafter
1	service time donated
1	trade, any drug
1	shall on the
1	 (1) amphetamine,
1	1112 of title
1	based on common
1	application (including an
1	basis.  (b)
1	kept, and (2)
1	substantive summary required
2	study described in
1	adjusted; all items
1	residue bear or
1	standards; (iii) recognizing
1	880. administrative inspections
1	owner, operator or
21	district court of
2	compliance with all
1	national recall or
1	auditors from an
2	electronic format. such
1	require testing and
1	both. the imposition
1	risks of medical
4	district court or
2	chemical (other than
2	find that there
1	table in subsection
1	product; (iii) identify
1	hispanics, and other
1	organization has engaged
1	point of manufacturing)
1	applications in title
1	(2) law enforcementnotwithstanding
1	remains in class
1	use. (e) contemporary
1	development resulting from
2	herein first became
1	file, the drug
7	panel under section
2	disease research foundations,
1	section 360i(a) or
1	rebuttal and in
1	risk than other
1	delegate any of
1	application includes an
1	section 348(g) of
1	administrators functions under
2	performance standard and
3	 (a)in general.
1	 (e) annual
1	
 
 959.
1	labeling was not
1	principal or one
1	(a); (2) procedures
1	claim comparing a
1	needs the attorney
1	suffers from the
2	8) or terrorism
1	substances used in
1	convey any such
1	drug. (w) the
1	paraphernalia; (2) to
1	terrorist organizations, terrorist
1	consideration the assessment
1	cause blindness., and
1	actions used to
2	piece of an
1	sanitation procedures for
1	principles for the
1	625. inapplicability of
1	limitation.  (5)
2	rationale for any
1	may on application
1	personal slaughtering and
1	appropriated for each
1	affiliate thereof (as
1	medication by such
1	otherwise unhatchable. (5)
1	service approved by
1	loss.  (h)
1	assessed, except that
1	manufacture the new
1	general.not later than
1	food. (4) the
1	revision  (1)
1	(ii) licenses a
1	experts, including countermeasure
1	for, the reprocessing
1	methamphetamine laboratory seizures
1	reasons, or (v)
1	eligible entities. 
1	(1) under an
1	person, and it
2	unsafe for human
1	conferences any person
1	campaign or private
1	person, and in
5	congress and the
1	unit doses, or
1	safety signal detection
1	modernization act and
1	limitation of effect
1	subsection (j). (c)
1	section 262(k)(4) of
2	tobacco, and smokeless
1	subsection (i), a
1	pharmacopoeia to assure
2	offense or the
1	entities, for the
2	ii device that
1	entity, the council
1	independent audit and
1	area that 
1	determine the manufacturers
1	seafood products, both
2	clinical pharmacology reviews
1	fees provided for
1	marketing. (s) the
1	(including quantities in
31	show that the
4	unless  (i)
1	year thereafter, a
1	initial advisory meeting
1	person who fails
3	384b(a) of this
1	first demonstrates a
1	careful examination and
1	investigators for testing,
1	title and knowingly
1	13, 2016), and
2	revenue amount specified
1	including investigation, arrest,
1	4(h) of the
1	assisting the secretary
2	criminal enterprise shall
1	may have a
1	(including a product
1	establishment any animals
1	whether to add
1	final orders once
1	untrue statements of
2	drug made with
1	federal agencies, including
1	(iii) a territory;
1	trade secrets the
1	381(q)(3) of this
1	chapter except as
1	grant funding the
1	ounces and bearing
2	name appears on
1	reports, necessary to
4	risks of such
1	(
 
 955a
1	consumer perception shows
1	compositions, and manufacturing
1	drug produced by
3	high risk that
1	(1) select, appoint,
2	lower risk to
2	occurs after the
2	commonwealths, territories, or
1	(b)(1); (h) based
2	small businesses (including
1	(ii) the scientific
1	drug. (f) the
1	distributes, markets, or
1	expended from appropriations
1	(b) life imprisonment
1	symbol for such
1	 (m) authority
1	application is filed;
2	supporting information to
1	language of label
4	libel of information
1	packaging (a) symbol
1	activities, as applicable
1	(1) places where
4	shall promulgate a
1	drug manufacturing industry
1	stringent controls should
1	development or management
2	facility unless the
1	limited population. such
1	corporationsupon an application
2	paragraph (2)(c); 
1	2013, a manufacturer
1	thereof. (10) the
1	timing, contents, and
1	field investigators of
8	secretary by regulation
2	regulations restricting the
1	training for predoctoral
1	combinations of drugs,
1	certified as true
1	processed under an
2	required in such
1	360b, 360c, 360d,
1	prescription drugs 
3	state or organized
1	discovery necessary to
1	public morals, health,
3	pursuant to any
1	chemical designation. (2)
1	necessary, expiration date
1	(a) any persons
1	reason such item
1	adjustments under paragraph
1	instruments, promote, to
1	every 4 years
1	process for suspension
1	(
 
 1605.
1	part, temporarily or
1	(b) include the
1	(i) timelines for
1	systems ensure access
1	valid surrogate markers.
1	order to the
1	 (a) notwithstanding
1	labeling, or further
1	(a) the latest
5	purpose of carrying
1	intentionally to use
1	tobacco in accordance
2	legitimate uses of
1	(
 
 2002.
1	(c) applicability subsection
1	families of drug
1	(1)(b) shall not
1	ii substances having
1	homeland security, as
1	registrant is authorized
1	subsection (i), according
1	(ii) to conduct
20	select committee on
2	repackager that is
1	omitted
 
 693.
1	respect to forms
3	states desiring to
1	business of transporting,
8	(f) of this
1	applicant involved submits
2	states to exercise
1	specific threats to
1	(a) applying the
1	
 379d3. streamlined
1	order the payment
1	date of submissionfor
1	nervous system, it
1	taxation under section
1	relationship to provide
1	purpose of manufacturing
2	pizzas containing a
2	variations may be
1	objected to, or
1	712, 48 stat.
2	drug administration, to
1	paragraph (1)(f), the
1	application of an
2	commerce of a
1	congressional committees an
1	(3), the filing
3	subsection, any person
2	apply to preparations
2	enhance secure tracing
1	controls of such
1	account for each
1	term qualifying laboratory
1	secretary an initial
1	drug referring to
2	manufacturing. such term
1	avoid apprehension, prosecution
1	if, in an
1	(6) an order
3	regulation, or other
1	products, the seller
1	violating of section
1	(a) improving treatment
1	 (1) four
5	(7) of section
2	coordination between the
1	measure supply reduction
1	title or on
1	notification submission submitted
1	required for effective
1	(c) scope for
1	comply, apply to
1	products approved under
3	available at the
1	systems that the
1	facilitation of the
1	detailing the reasons
1	grounds that providing
1	authorize any narcotic
2	criteria with respect
1	include standards for
1	judgment order the
1	additive involved, or
3	include a statement
1	proposal made (a)
1	offices established; and
1	96. repealed. 

1	(b); and (ii)
1	
 812. schedules
1	study of, and
1	filed  (i)
8	may, at the
1	(b) facility information,
1	rule a tolerance
1	term manufacturer means,
1	 (d) develop
1	sustaining; or (iii)
2	guidance, if applicable,
1	appropriate conditions determined
1	(3) determination to
1	states or may
5	title.  (5)
1	nonprescription sunscreen. 
1	act of 1969
1	additional studies), including
1	(including poultry producers),
7	article which is
1	(i) if a
2	awarding damages for
1	fee was paid
5	year 2013, not
1	submit an assessment
1	(including children and
1	risk and action
1	exception in paragraph
1	[42 u.s.c. 262(a),
4	(p) the term
1	clinical trials 
1	fac-t-face transactions by
1	order be set
2	contains a defect
17	offer for sale
1	than, any risk
1	product listed in
1	exists, in the
2	monitoring of imported
1	
 
 156.
6	use or uses
1	manner, controlled premises
2	agencies; and (d)
1	343(b), 343(c), 343(d),
2	conclusions, made under
1	local, or foreign
1	demographics and the
1	decontaminating and restoring
1	harmful; or (ii)
1	persons.  (ii)
1	salts. (f) -acetylanthranilic
2	business transactions of
1	format, for compliance
1	submissions and drug
1	hawaiians and native
2	product that consists
1	provides a right
1	adequate expertise is
1	commerce.  (c)
1	(c) any constituent
1	registration, as well
1	article would be
2	(i), the administrator
3	request is submitted,
2	make the information
1	period, or part
5	local law; (3)
1	presented with other
1	consignee shall remain
1	specify.  (b)
1	drugs an office
2	met, the secretary
1	additional time in
1	person informing them
1	 (f) cooperation
9	shall file with
2	inspections of food
1	 (j) filing
1	drug abuse policy.
1	animal observations contained
1	labeling thereof; (2)
1	information is correct.
2	investigation from conducting
1	tobacco product listed
4	(a), under such
2	(pcp) or 100
1	effective october 1
1	obtained, expedited, or
1	subparagraph (a), includes
1	represented and labeled
1	time. (i) regulations
1	produced, is implementing
1	application must comply
1	term forfeiture event,
2	request for accreditation
1	achieve destruction or
1	advisory opinionsas of
6	paragraph (1) as
1	publish, after consultation
1	raise any exclusion
1	food establishments in
2	shall be divided
2	containers which are
1	test decontamination and
1	360b(c)(2)(f) of this
2	establishment complies with
3	respecting the different
1	dedicated commuter lane,
1	account when determining
2	subsection (b)(2)(a) (in
1	commerce required for
1	(2) such order
1	360(k), or 360c(f)(2)
1	treasury, determines that
1	program after becoming
1	done by others.
2	engaged therein in
1	453. definitionsfor purposes
1	section.  this
3	term official inspection
1	visibility but may
1	of, or conducted
1	compounding  (1)
1	obtaining such a
1	(5) the judgment
2	reduction, supply reduction,
5	significant potential for
1	request having been
1	 (d) penalty
1	medical device, or
3	regulation of drugs.
1	debarment, temporary denial
1	regulation of drugs,
1	grant funds for
1	shall prepare, sell,
2	agencies, as appropriate,
1	center; (iii) describing
1	stevens olympic and
1	(
 
 399f.
1	ii may provide
1	(d) pos-hearing recall
1	pseudoephedrine, and phenylpropanolamine,
1	states citizen on
2	maintain an u-t-date
1	combination of any
1	significant market in
25	day after the
1	(if any) responsible
1	fee. (ii) if
1	section 958(i) of
1	science.  (d)
1	trafficking areas 
1	chapter or conditions
1	competitive conditions for
1	separate itemization of
1	approval means notification
1	822(f), 825, 827,
1	private sector healt-related
1	therapeutic amounts. (8)
1	lsd, and heroin.
1	drug in 
1	pos-february 15, 2007,
2	natural person may
1	labeling; (c) all
3	performanc-enhancing methods adopted
9	term united states
2	critical or sem-critical
1	(7) after receiving
1	package means a
5	issued within ninety
1	relevant stakeholder groups,
1	condition due to
1	3rd par., 34
1	prepared or collected
1	injury mean illness
1	shall have expertise
1	independent assessment identified
2	effective if such
1	exterior  (i)
1	forth existing practices
1	secretary shall base
2	best practices in
1	(iii) snuff. (iv)
1	shall first be
2	360(h) of this
2	drug among hospitals
3	partner that a
1	managed, or controlled
1	(
 
 1502a.
1	(1) animal quarantine
1	675, 1, 52
2	section set by
1	providing such a
5	basis of such
1	putrid, etc., matter
1	foreign material and
1	letters to health
1	times the secretary
1	serving past term
1	cases in which
1	existing approved alternatives,
1	require that tobacco
1	(4) substance abuse
1	december 31, 1971.
1	(b); and (2)
2	federal funds are
1	23. penalties any
1	provides an accounting
1	paragraph (2)(a)(vii) or
1	tort issues, and
1	prior findings as
1	hig-risk food designation
1	pollution resulting from
1	applies as of
1	ch. 675, 569c,
1	review by an
1	adds to its
1	articles are eligible
2	person to investigate
1	device or a
1	d of title
18	iv, or v
3	registration shall be
5	manufactures, processes, packs,
1	applicant, withdraw approval
2	(v) protect against
1	persons eligible for
1	reasonably cause or
1	area.  (2)
1	
 607. labeling,
3	fiscal years, multiplied
3	available for reference
1	administrator an application
1	territory or other
1	(or such related
1	flow of poultry
1	
 855. alternative
1	3433. disclosure (a)
1	(b) timely and
1	later than two
3	general with respect
1	establishing a process
2	applicable condition prescribed
1	internet site a
1	bond in another
1	packaged articles, to
1	hazards. such written
1	serve on committees
1	justice authority to
1	pay provided to
1	reinstatementa transaction involving
1	appropriations is not
1	combination or number
1	manufacturing practice includes
1	bacterial count per
1	(b) continuation of
1	teams of 
1	priority and should
3	regarding the need
1	(iii) plans for
1	response to notificationfollowing
1	transferring a greater
1	health effects of
1	interest. the attorney
1	offsetting fee collections
1	ultimate consumer 
2	states, or (b)
1	(3) has staff
7	product that 
1	lettering at least
2	obey the order
1	penalty not to
2	(3) the secretarys
1	example the average
2	facility owned by
1	law 103417); or
6	section 379h(c)(4) of
1	upon execution of
1	subparagraph (1)(b)(i) or
1	conduct normal life
1	360ccc1(h) of this
1	ch. 675, 506d,
1	(3) fees all
4	form as such
1	shall establish one
1	section. (d) 
2	retailer directs to
4	shipped by the
1	whose application to
1	drug uses, including
2	animal drugs and
1	premarket report means
1	submissions. (e) review
1	land, buildings, or
1	assessment shall include
1	exception this subsection
1	requirement or taking
1	(i) registration to
1	data; and (ii)
6	spices, flavorings, and
1	ingredient for which
1	records available to
1	subsection (c)(4) during
6	fit for human
1	qualified entity, the
1	emission tomography compounding
1	conditions if a
1	congress beginning with
2	(3) the secretary,
1	secretary for inspection
1	location of a
2	unduly increase the
5	(i) to the
2	effectiveness reasons, it
1	403b, as added
1	device, dated january
2	minimum term of
1	(b), a drug
4	person (or the
2	adulterated shall apply
2	appropriated for administration
1	(b) of title
1	types so identified,
1	 (g) determinations
4	time after such
1	reasonable fees and
1	new hazard or
2	shall contain detailed
5	clause (2) of
2	which, he conducts
2	labeling. neither course
2	ability to pay,
1	subsection (c)(1), as
2	regarded by the
1	compliance compliance with
1	facility shall prepare
8	812 of this
3	civil action brought
1	(c) of paragraph
1	fiscal year 1985
1	basis and not
2	section 360e(g)(2)(b) of
3	sample basis or,
3	costs the secretary
1	(i) differ from
1	facility certification described
1	required determinations if
1	convictions for any
2	 (2) content
3	 (ii) shall
1	(1) adverse drug
1	checks to improve
1	operator; and 
1	(b) to issue
1	zinc, the caustic
1	secretary determines otherwise.
1	recent safety information
2	otherwise rendered inactive
3	appointed from the
1	(c) discontinuation of
1	order of an
1	(1) the composition
1	ch. 675, 912,
1	250.0  (75
2	880 or 881
1	(3) for programs
1	may make an
1	drugs. (ii) any
1	protocols agreed to
1	regimens, such active
1	issue as to
1	office shall also
32	substance containing a
1	demonstrate and assess
2	panel considers necessary,
3	action, each of
2	subclause (i)(cc) is
1	42, a specific
1	summoned under this
1	possibility of contamination;
1	physical media form,
1	(b) noticean amended
1	meet the unmet
12	food contact substance
2	commission of which
1	applications approval, approve
1	bodies and accredited
1	(iii) recognizing one
1	product lines; and
1	compounding necessary to
1	 (1) qualified
1	wel-controlled clinical investigation
1	believes such analysis
1	request transmitted pursuant
1	terminated in order
1	rx only. (b)
1	packaging of cosmetics
2	protection as a
1	clinical experience and
1	(d) secretarial actionthe
1	budget justification that
1	maintaining a healthy
1	exemptions under paragraph
1	drug administration, is
1	care providers; and
3	include, with respect
1	(b) conducting investigations
1	1.04. (d) adjustment
1	agencys public health
1	whether the national
1	drug administration, in
1	(a) is deemed
1	applicable under federal
2	otherwise undertaken by
1	(c) debarment period
1	eligibility under subsection
5	comments.  (6)
1	(c) by the
4	section 856 of
2	drug substance that
1	right to knownot
1	required the director
1	withholding directive respecting
1	renewal grantssubject to
1	regulations affecting pesticide
1	public input prior
1	hidta, with supporting
1	filed the application
1	2013 and paragraph
1	may be detected
2	responsible party is
1	territory that would
4	acts amendatory thereof
1	enforcement agencies; (c)
1	report as required
4	owned by a
1	exportation constituting a
1	major sector involvement
1	submit a draft
1	device, any disease
4	conviction of a
1	subsection (d). (viii)
2	1992, an allergenic
1	revoke any performance
2	egg which has
2	order, requirement, or
1	audits, conducted by
1	label and market
1	 (6) may
1	food and are
2	receives, holds, or
1	drug have particular
1	(4) may be
1	2003 multiplied by
1	ris-based schedule the
1	individual, not for
3	exemption, reduction, or
1	accordance with needs
2	subsection affects the
1	strategies. (d) communication
1	term supply reduction
3	control strategy programs
1	136a. collection of
1	states if such
5	hold discussions with
2	fiscal years, after
1	(2) compares such
1	notification of defects
1	conviction a civil
1	continue the website
1	
 
 612.
1	eradication of such
1	paragraph[1] (b) or
1	certification, with safe
1	comment rulemaking finding
1	opium, commonly known
1	
 1546. meetings
1	type, require that
1	habitual use, nor
1	receiving a written
1	safety factors which,
1	 (b) advertisement
1	fiscal year 2011,
5	industry.  (b)
1	fiscal year 2011.
1	avoid such actual
1	gather and analyze
1	price index. such
1	genetic targeting of
2	method or process
1	authorities is immune
1	confirmed losses or
1	paragraph (2)(b)(ii) only
3	information, as the
1	submitted, labeled for
2	criteria under section
3	level of sanitary
1	shall supersede the
1	allowable under chapter
1	class iii, the
2	foods on the
1	application mean an
1	providing goods or
1	practice includes the
1	(iii) a brief
1	certain microorganisms to
1	revocation the administrator
3	place in any
1	clause (i), no
1	amount and for
4	amount of heroin;
1	brought, from a
1	with, obstruction of
1	form and manner,
1	secretary) required by
1	appropriate, and which
1	(2) no duplication
1	authorities; release; removal
2	enhance drug distribution
1	title 18, relating
1	section provides to
2	rendered inactive by
1	deputy directors the
1	
 
 964.
1	use and such
1	 (c)recipients of
1	(d) rebuttable presumptionthere
1	subsection (b)(2) was
1	provided. (ii) not
1	paragraph (2), debar
1	laws. when a
2	subsection (a)(1)(b) together
1	(except paragraphs (a)
1	subsection (k); (ii)
1	apply; (2) on
1	(1) audits and
1	situation involving the
1	protocol and the
2	(a)(1)) after the
3	processing, and, when
1	individual makes a
1	advertising a veterinary
1	oxide or propylene
1	treasury. if it
2	single dose injection
1	hearingthe attorney general
1	history. for transactions
1	(1)(d) is necessary,
1	2203 of this
2	contains information, including
1	practice guidelines for
2	(excluding amounts from
3	person under eighteen
1	use hard drugs.
1	substance is used
4	reasonable assurances that
1	(iii) provided by
1	requires successful consecutive
1	alternative treatments. the
1	individual projects, or
1	(2) limit the
1	body recognized by
1	food, including fresh
1	period which may
1	activities.  (d)
3	secretary may revoke
1	conviction which is
1	(c) whether, after
1	ch. 675, 569b,
1	information (a) contractors
1	imported drugs 
1	professional practice; (c)
1	department, or to
1	evaluating countermeasures 
1	material threat assessment
1	subchapter b of
1	inspection warrant, the
1	inspection requirements as
1	measures within its
15	regulations under this
1	generalsections 352(f)(1), 355,
1	2007, products a
5	dispensing of such
1	care of good
1	(b) and (i),
1	majority vote, appoint
2	applicable criteria under
2	(2) execute and
1	 (b) contracts
1	barter, or exchange
1	renumbered 18 and
2	drug product application
1	appropriately trained individuals
1	admit the article
2	accepted professional and
2	safe and cos-effective
3	drug application to
1	impact statement that
1	supplements special survey
2	agency referred to
1	side effects; and
1	top 3 brands
1	final regulation implementing
2	imports and exports
1	(e)(3); (2) as
2	manufacture, or distribution
2	for, with respect
1	establishment conducting the
2	received in interstate
2	reference to such
6	decree that such
1	change in design,
1	ingredients comply with
1	substantial assistance in
1	person or counsel
1	power of sel-control
2	applicant submits evidence
1	attorney general ordering
1	(a) submissions to
1	shall alter or
2	may not approve
1	(2), for an
1	(3) any additional
1	lawful pursuant to
2	conditions, to be
2	food animal science
1	(1) serious risk;
1	term rol-you-own tobacco
1	(b) production of
14	approved under subsection
1	animals, and such
1	forum to jointly
1	(3) feedback letters
1	pediatric population and
5	information to support
1	unless the transferee
1	26; and (2)
1	provides to any
2	(b) evidence of
1	senate, and explain
1	clinics, for administration
1	preceding sentence, at
1	reduced price to
2	federal alcohol administration
1	available; (ix) the
2	due to concerns
1	interferes with the
1	(5) documentation of
1	things growing on,
1	exceed 10 times
1	$1000 per violation.
1	marketing the drug
20	injurious to health;
1	compilation of the
2	used with one
1	shall, during an
1	faith any person,
1	penalties, including at
1	injurious to health,
3	injurious to health.
3	379g(11) of this
1	nonliquefied, or cryogenic
1	1040.)
 
 393.
1	appropriate to effectuate
1	eliminated. (g) not
3	upon conviction thereof,
1	fails to notify
1	noncompliance by other
1	smoke.  (june
1	distributor in accordance
22	drug administration. 
1	 (4) eligible
1	advisory commission 
1	task forces; (e)
1	testing programs and
1	section 343(r)(5)(b) of
1	respect to functions
2	food (other than
1	(pp) the term
1	sales in public
15	report and recommendation
1	(b) laws unaffected
2	bodies recognized under
1	term plant means
1	(1) on the
1	reaccreditation under this
1	dietary exposure. (3)
1	test markets) that
2	unless such regulated
1	fewer ful-time employees)
1	waiver authority for
1	seek the support
1	exemptionupon application of
1	modified product was
3	drug applications, or
1	labeled indications for
2	fort-eight months, and
2	of, a truck
1	1604. liability of
1	updated as the
1	address the following:
1	foods. (
 

1	association with that
1	affairs); (bb) private
3	product, or material
1	9, 44 stat.
4	protect the health
4	adjustment and the
1	(1) is made,
1	announce the availability
2	subsection in accordance
2	activities as determined
4	treatment of substance
1	category of retail
9	drug user fee
1	safely transferring repackaged
1	pay only 1
1	(c) nitrous oxide
1	
 
 1103.
1	auditors (a) definitionsin
1	1995, provides for
1	data refers to
3	numerical identifier. 
1	10, formerly 8th
1	antibacterial ingredients or
1	(b)(2)(a). the approval
1	history, and statements
1	u.s.c. 136a(c)(2)(b)] or
1	egg products (a)
1	qualifying the applicant
4	make it appear
1	expertise in demand
1	whole.  (3)
1	general shall direct
1	schoo-based food allergy
1	rationale to such
1	defend in courts
1	1531. establishment of
1	is, therefore, essential
1	update the notice
1	shall be exercised
2	unless the time
1	states of issuing
6	(other than bioavailability
2	facilities, inventories, and
1	investigational use exemption
1	title if committed
1	question has been
1	reports on tobacco
1	$1,000,000 may be
1	tried. such order
3	(2) for such
1	section, or (c)
1	compliance on and
1	products to patients).
1	will write such
1	subsection (q), in
1	artificial coloring shall
2	sample in violation
1	subparagraph (d). (b)
1	(
 
 467d.
1	section 1331 or
1	years) during the
2	possession, or concealment
1	clause (vii) have
1	(i) publish in
1	health; (b) invite
1	exemption may appropriately
1	removed because unsafe
1	secretary, through at
1	(b) when the
1	registrations. in no
1	commerce for use
1	
 
 360fff.
1	prompt hearing and
2	device has or
1	pediatric therapeutics (a)
3	petitioner shall have
1	efficacy of preventive
2	[42 u.s.c. 262(a)],
1	importer found not
1	may include graduate
1	columbia circuit. (b)
1	fees only through
1	registrations associated with
2	partner from which
1	pathogens under subparagraph
1	applicability of adulteration
1	administered or unless
2	fee program. 
1	inedible, leaker, or
1	(2), (4), and
1	(1) be responsive
1	met, if the
1	first portion. 
1	meaning, such advertisements
1	includes items primarily
1	students of the
9	collection of unpaid
2	technically qualified by
1	establishment of an
1	locality with a
1	complainant. (4) action
1	food compound not
1	41 to 50.
2	order determining that
1	secretary after issuance
2	states in carrying
1	use in hypoxic
2	(ii) state, local,
1	advertisement to include,
1	use or manage
1	prominently identifies the
5	(i) which is
1	preparing said product
1	purposes of approval
2	merit of the
1	countervailing effects of
1	
 845 to
1	person of his
1	findings.  (b)
1	term qualifying other
1	additional dataif the
1	directed, or (ii)
1	determination was based
1	lease, rent, use,
1	development, training, and
1	members or upon
2	residue shall be
1	outsourcing facilities according
1	revocation of licenses
1	subsection, in cases
1	(a) prohibition it
1	barbituric acid; or
6	compounded basis to
1	local civil, criminal,
1	authorized deviations from
1	(e) te-year injunction
1	regulation amend or
1	(e) expedite the
3	 (b) each
1	(h) entertainment industry
1	387j(c)(1)(a) of this
1	copying of, such
1	31 each year;
3	occurred more than
1	reportingbeginning 1 year
1	(
 
 355e.
3	apply to actions
2	exemption of an
1	state governments; and
4	suspect product is
1	transaction, or a
1	secretary) the list
1	 (13) product
1	indicating a determination
1	drug, no component
11	prior conviction for
1	te-year injunction as
1	current scientific knowledge
1	renumbered 11 and
5	intent to distribute
1	review such accepted
1	one year, a
1	research subject at
1	otherwise treated in
1	unsafe.  (b)
1	demand by the
1	regulation establish. 
3	(b)(1)(d) for a
1	use by united
2	section, the reports
1	submitted.  (2)
3	section 674 of
1	entities of such
1	pharmaceutical ingredients from
1	congress fully and
1	budget submission submitted
2	shall contain provisions
1	(b). (b) tolerances
5	plan submitted under
3	accepted in accordance
4	secretary, shall be
1	467d of this
2	review; and (ii)
1	discussion period is
1	379aa(a)(2) of this
2	products for smoking
1	meeting is necessary;
5	$10,000,000 if the
1	days. in determining
1	patien-centered outcomes research
1	including veterinary medical
3	section 16 of
1	subsection (a)(6). (4)
3	preventing impairment of
2	may produce health
1	accelerated approval per
1	original regulation, with
1	term agency center
1	(b).  (june
1	 (a) feesfees
1	for, and communication
2	any, of such
1	cooperative agreements into
1	health issues relating
1	must be submitted
1	coalition means a
1	complete the activities
1	longer met. 
2	case shall be
1	providing information resulting
1	(3) public comment
1	drug is consigned
1	area, in accordance
1	risk product applications
1	advertisement is intended
2	reasons, the approval
1	soybeans. (2) a
1	advertising.  (d)
1	 (c) returns
1	prepared during and
3	devices filed with
1	guidance for sponsors
1	needs, including through
3	sponsor intends to
1	secretarys consideration scientific
2	least once each
1	milligrams of morphine
1	media campaign. (f)
1	314.161 of title
1	whether the elements
1	nutrition and food
1	552 or section
1	(ii) the device
1	physician, or to
1	negotiable instruments, securities,
3	applications or supplements,
2	device is effective
1	conclusive, and his
2	shall take appropriate
1	manufactured before october
1	requirements (a) manufacturers
1	need by reason
1	evidence, and includes,
1	analyses and other
1	inspections. (2) the
1	state licensing board
1	strategies designed to
4	change approved in
1	paragraph (1) applies;
1	for, and expedite
1	675, 533, formerly
1	removed, or secreted,
1	manufactured and sold
1	tracing of the
1	(i) the center
7	responsibly connected with
1	inspection legend and,
1	review of proposals
2	retailer whose name
1	procedures to control
1	prepared during nighttime
3	events associated with
1	guidance documents as
1	 (a) coordination
1	indication in the
1	terms, through a
1	eligible countermeasure means
1	letter setting forth
1	submit all such
1	scienc-based guidance documents,
1	comply with clauses
1	least 30 days;
1	contains such information
4	reports, supplements, or
1	residue; and (ii)
1	summaries to support
1	processed, packed, transported,
1	displayed prominently and
1	day of publication
2	qualified data summaries
1	(b) guidance on
1	activities conducted at
1	generalin any case
1	(2) a copy
1	(1) $240,000,000 for
1	2002. (ii) the
1	characteristics means, with
1	
 397. contracts
1	gas as a
1	section 355(b)(5)(b) of
1	regulation, provide (1)
1	nuclei by the
1	records be kept
1	drugs under the
1	provide information of
1	contains, for purposes
1	formerly 907, as
1	leaking. (2) the
1	(i) and (ii),
1	accept or refuse
1	united states, using
2	proceeding terminated by
1	use approved under
1	agency action. (g)
1	states under authority
2	(i) and (ii).
7	licensed as a
5	secretary. the secretary
1	
 
 200
1	based in accordance
2	administering a state
1	coordinating and overseeing
1	675, 515a, as
1	generala tobacco product
2	establish or enforce
2	create a legal
1	decisionmaking; (ii) holds
1	expired product is
1	
 849. transportation
1	employee (or other
1	(2) applicability this
2	or, except as
1	civilian and military
2	foreign corporation or
1	(iii) compensation for
1	debarment under such
1	 (6) develop
3	food product of
1	specified, the requirements
1	year 2017, $635,000,000.
36	mixture or substance
1	(such as medical
1	security notification if,
1	required information any
2	whether the extent
2	water that comes
1	1262; renumbered 9
1	1262; renumbered 8
1	pathogens described in
2	agreement to provide
1	corporation who shall
1	schedule v unless
1	(b) persons includedsuch
1	(a) removal of
1	(2) exception no
1	opinion.  (2)
1	efficiency, predictability, and
2	regulations under the
3	general may not
2	part of or
1	-cyclohexylethy--(-methoxyphenylacetyl)indole (sr18 and
1	certifications have been
1	paragraph as qualification
1	distribution, or promotion
1	job training programs.
1	term verification or
1	input from the
1	effectively on cases
1	(b) who did
1	use and abuse;
1	sanctions to four
1	(i) fully remedy
3	sharing of information
1	commonly flow through
2	adequate tests by
3	minimize, as appropriate,
1	annually a separate
2	list under clause
1	goals of including,
2	labeling contains such
1	383. office of
1	national stockpile; (d)
7	title or misbranded
1	term distribute means
1	device, (vi) if
1	title; (ii) importation
2	clinical trials under
1	effectively and rapidly
1	served directly to
1	section 387j(c)(1)(a) of
1	fiscal year, during
1	boards or agents
1	 (e) state
4	chemical residue, the
1	communication to the
1	contaminants and the
1	18, 1949, ch.
1	effectiveness (a) fda
1	30,000 individuals. in
2	production of an
1	(c) a proposed
1	agency, secondary school,
1	detainer authority the
1	prohibited from collecting
1	implement subsection (a)(6).
1	publi-private partnerships, with
1	times after the
1	revisions to an
1	(may 23, 1908,
1	human consumption before
1	term demand reduction
1	consumers to foodborne
1	director may request.
1	link with other
1	detained under subparagraph
1	(ii) 2 or
1	partnership to enable
1	processing any such
2	acting through u.s.
1	chain with 20
1	(a) relate only
1	communit-release provisions relating
1	groups. (x) health
1	intelligence obtained by
1	20 per centum
1	sections or act;
1	revising such guidance
1	actively pursuing approval
19	provisions of the
1	(4) report not
2	labeling and containers
1	internet in violation
2	(2) the period
1	penalty in accordance
1	party transfers all
1	used for, manufacturing,
4	january 15, 2017,
1	program; (4) may
1	gaps that impede
1	(b) potency levels
1	contracts (a) scope
1	 (a) analysis
1	seller may take
2	(a) an order
1	islands, the commonwealth
3	new drugs and
1	understanding  (a)
1	$50,000, or both,
1	study in a
1	providers through professional
3	without authorization, bears
1	without providing notice
1	(a) through (i).
2	gross profits or
4	determination that there
5	regard to such
1	regulation. (2) exemptions;
1	enforcement administration, or
1	describes the feasibility
1	jurisdiction. (2) in
1	(b) any manufactured
5	organized with a
1	fiscal years. (d)
1	
 355c. research
3	availability of such
1	remedies of any
1	attorney general; no-disclosure;
2	(b) the conditions
1	distributor, including any
1	name, chemical name,
1	(c) in this
1	drops or similar
2	(2) exception any
1	privileges granted to
1	candidate, clearly identified
1	secretary; and (2)
5	validity and infringement
3	product.  (iii)
1	use drug fees
1	notice to product
1	chief of the
2	drug described under
1	part, or denies,
1	proceedings in accordance
1	special dietary uses
1	357,[3] 360e, or
1	placing into effect
3	201(b) of the
1	reverse, or cure
1	list of 
1	chloral hydrate. but
2	subjects of the
1	may accept saleable
1	42; and (c)
2	drug. (g) for
1	(b) fee setting
1	distributor license, an
1	title, respectively, shall
1	program, system, or
1	evidence to constitute
2	product shall begin
1	practitioner and any
1	establish, or to
1	debarment regarding thir-party
1	required reports (a)
2	treasury; sales restrictions;
1	sequence of the
1	facility receive or
1	food which is,
1	26, 2014, with
1	(b) establishment 
1	poultry is condemned
3	facility fee and
1	terrorism, except on
1	(g) conducting joint
1	(a) any manufactured
1	practitioner an identification
1	laboratories; and (c)
4	agriculture, and the
1	treat; (e) 
2	code reader or
2	issue, the secretary
1	complainant demonstrates that
2	facilities, and operations
1	similar technology. (v)
2	(i) may be
1	(c)(3)(e) and clauses
1	conditions for marketing
1	entry; and the
1	(2) the failure,
1	human subjects that
3	tobacco product manufacturers,
1	cases) in which
3	tobacco product manufacturers.
3	thereof, except as
1	implementation of identification
1	educational purposes by
1	food, color additives
2	legal right for
1	
 342. adulterated
1	314.70(d) of chapter[1]
1	secretary of one
1	shares described in
2	subsection (a)(2), if
1	262(a)].  (june
3	history, and statement
1	products) which the
1	meeting, provide to
1	accomplishments; and (b)
1	entities; (16) shall
12	person may file
1	order any interested
1	pay, effect on
1	of, location of,
1	(2) reporting and
1	immediately investigating animal
1	promulgate any regulation
1	institute shall develop
1	section 360b, 360ccc,
1	508, as added
2	et seq.]; (iii)
1	(a) a copy
1	(n)(2)(b) is received,
1	ch. 60, 12,
1	thereof from enforcing,
1	may also revoke
2	may consider the
1	revised plan to
1	shall develop, support,
1	date has declared
1	provide, sections 822(f),
2	(a) a request
2	335b of this
1	gymnasium (including any
1	estate with respect
1	directive drugs (a)
1	submitted comments, that
1	serious risks; and
1	1, 2007, submits
1	
 
 384b.
1	applications, the secretary
2	(g) or section
1	(b) refuse to
1	type of property
1	certify the adequacy
1	tobacco products filed
1	including paper or
1	subchapter. (e) the
1	imposes ante mortem
1	suspend performance of
1	enforcement administration, and
1	notifies the importer
1	(ii) by quantities
1	
 1151 to
1	preceding registration or
2	following to each
1	drugs, including marijuana.
9	shall grant a
1	apply to applications
1	otherwise been rehabilitated;
3	suspension under this
1	states. (3) in
1	restrictions for such
1	hours. it shall
1	includes, when available
1	avoiding such actual
1	identifies future programs
1	advertisement upon receipt
1	conditions governing the
1	making of records
1	stakeholders, prioritize and
1	
 387o. regulation
1	pharmacists; pharmacy benefit
1	controlled substances under
2	product meets the
1	vehicles, vessels, and
1	benefits under clause
2	population drug pursuant
1	appropriate clinical or
1	title. (aug. 3,
1	species (a) application
2	effectiveness can be
1	package sold in
9	federal advisory committee
1	expired, or if
1	(a) term of
2	subpart 7 of
2	license in accordance
1	pesticide residues receive
1	(3) additional evidence
1	(
 
 354.
1	shall aim to
1	defense, or by
1	secretary has concerns
1	officio members; and
1	recipient of donated
1	may have sources
1	
 862a. denial
1	parts, and products
1	supplements submitted to
1	drug except for
17	within the scope
1	 (ii) labelingthe
4	38 stat. 821.)

1	privacy of such
1	number is 30.
1	equines, and when
1	(1). (d) emergency
1	members the members
1	use. (k) prevention
1	regulation promulgated thereunder,
1	personnel authorities under
1	5 for any
1	states for deposit
1	register.  (8)
2	access shall review
1	used; or (3)
1	food science. 
1	387i, or 387t(b)
1	quantity of illicit
1	360b(b)(2), 360b(c)(1), 360b(c)(2),
2	inspection under subsection
1	years. in fixing
1	enterprise if 
5	animal drug submissions.
2	farm where the
2	animal drug submissions,
1	authorize them to
1	 (c) standard
1	facility or facilities
1	regulations thereunder. (4)
3	period thereafter that
1	manufacturing quotas for
1	compensation shall not
1	issue prescriptions for
1	product. (3) advance
1	(b) from which
1	animal drug submissions:
1	products (before or
1	division of drug
1	possessing controlled substance
1	number of prescription
1	least 70 percent
1	refers to information
2	business unfitness based
1	implant unless such
1	foundation.  (j)
6	clause (i). 
2	examine, or investigate
1	radiation safety, and
1	homeland security a
7	upon a finding
3	determining whether there
3	health.  (3)
1	administrative remedies. 
1	proper, except as
2	intended to cause
1	health; (4) the
1	inspection of biosimilar
1	811(a) of this
1	animals and food
1	(i) documentation that
1	 this section
2	products.  (f)
1	regulated industry with
1	article, the name
1	devices and which
1	(f)(1) in connection
1	 (a) banning
1	mechanisms to achieve
1	(5) limitation on
1	1954 [42 u.s.c.
1	thir-party auditorsan accredited
1	subjects involved in
5	preceding sentence. 
1	commerce, or to
1	managers and experienced
2	products and the
1	quality and consistency
1	slaughtering establishment if
1	subsection (b)(1) no
1	term advisory commission
1	(h), the secretary
1	wholesome, fit for
2	violation in any
1	advertisements respond to
1	using the treatment
1	(i) finds that
1	information from, any
1	affect, national security
1	supervisory position, or
1	require, and (viii)
6	license to manufacture
1	1903(h)(2) of this
2	controlled substance, shall
1	may regulate drugs
1	used by members
1	publication) making a
1	schedule, dosage form,
1	timely, routine, and
1	administration that contain
5	appropriate.  (ii)
1	civil penalties 
1	shall verify that
1	
 1111 to
1	period a person
1	order shall, with
1	ch. 675, 505a,
1	paragraph (6)(b). (8)
4	year that are
1	sources specified in
1	person distributing such
1	 (h) manufacture,
1	enforcement of retail
1	agricultural chemical. (2)
1	controlled substance where
1	substances, in research
1	manufacturer specifying the
1	so, knowing or
1	(b) deputy directors
1	uses assessed under
1	part 312 of
3	section 1036 of
1	(5) final sunscreen
1	ch. 675, 749,
2	developed and submitted
1	internet site. (v)
1	administrator shall thereafter
1	business hours. it
1	regulatory policy accommodates
2	state agencies under
1	1961 of title
1	final regulation take
1	2012, if the
1	 (4) with
4	importation of food
1	serious risk identified
1	including a brief
2	section by 30
1	1-year period. for
5	guidelines described in
5	prescribing the conditions
1	may not collect
3	application as an
1	states cooperate with
1	 (v) review
1	medical associations, animal
1	request were an
1	significant period of
1	contained therein and
1	involving human subjects
1	(including destruction or
3	commercial distribution presents
2	new drug if
1	response to information
1	states, including in
1	designate  (a)
1	chapter; and (c)
3	less the number
1	(i) except for
2	400 grams or
1	675, 564b, as
1	hereinbefore mentioned, until
7	new drug is
1	activity level, or
1	regarding the processes
1	prescriptions, and (f)
1	(ii), such records
12	years, a fine
1	
 
 355a.
1	official plants the
1	effect for positions
2	(2) factors to
7	secretary to conduct
1	fee paid for
1	(2) extrapolation between
1	better therapies for
1	independent entity to
2	section upon a
2	may not have
1	developing a method
1	importer means the
1	contained ma-made structure
1	not, at the
1	(8) refuse access,
1	lif-threatening; and (2)
2	warehouse, establishment, or
1	service; intervention 
1	plant into full
4	title. the secretary
1	2009, issue regulations
1	vitro diagnostic biological
2	activity conducted by
1	incubator reject; or
1	hearing; basis and
1	food, injurious to
2	another or any
8	section 330.14 of
1	will inform parents
1	 (2) special
4	control program budget
6	method of use
1	behalf of said
1	(a) the narcotic
1	inclusion would benefit
1	division  (1)
1	families the amount
1	claimed indications; or
6	environmental protection agency
2	times the device
1	5 years. the
1	(a) the identity
1	reference to class
2	recall of all
1	abuse issues within
1	(20) dipipanone. (21)
1	manufacturers c-licensed partner,
4	tobacco products to
8	information may be
1	civil procedure except
1	subparagraph (b); (b)
1	establishment (including a
1	960. prohibited acts
1	overheated, frozen, or
2	information, with respect
3	detainer authority conferred
1	conduct the sampling
1	reaccreditationthe secretary shall
1	device shall include
1	period, the attorney
14	enable the secretary
2	standard to be
1	pesticide chemical if
1	(d) attorney generalthe
2	pediatric formulations developed
1	government agency; (d)
1	requirement respecting any
1	patients during regulatory
4	pesticide chemical in
5	information described under
1	patient groups regarding
1	consulting center involved
1	plan to enforce
1	821.)
 
 1035.
2	used in food
1	agreement authorized by
1	b1, vitamin c,
1	paragraph (4); and
1	manufacturer adds to
3	shown  (a)
2	substance under this
1	order, in addition
1	government and in
1	(1)(a) not to
7	wholesome, not adulterated,
1	term current good
5	least burdensome requirements
1	swiftly and certainly
1	extended [21 u.s.c.
1	secretary, before any
1	became effective under
1	domestic sources, (c)
11	treatment of domestic
2	chapter because the
2	request, samples of
1	shipment of poultry
1	based on relevant
1	court shall determine
1	whether certain substances
2	establishment is located;
1	years, the fee
1	eggs only in
1	(c) the reasons
3	legal basis of
1	costs for which
2	regions an opportunity
1	administrator by one
2	refer the drug
1	consignee (i) holds
1	ingredients determined not
1	(iv) information to
1	subsection (a)(3)(b), through,
1	application be granted
1	device (each by
1	crime, increasing health
1	subsection (a)(5)); and
1	early life stage
6	human food shall
1	ingredient contained in
3	professional ethics of
3	unfavorable to the
1	drugs; and (bb)
1	venue this section
1	attorney general. (

1	persons that sell
1	criteria.  (f)
1	particular, the secretary
1	include documentation that
1	traffickers pursuant to
1	(p) estrogenic substances
1	(ii) investigationan investigation
15	secretary shall determine
2	studies for such
1	unless the amount
1	(e) the labeling
1	
 1403. pesticide
1	use in conducting
1	(b) facilitate the
3	agree in writing
1	ground.  (b)
1	41 stat. 271.)

1	inspection, shall, when
1	species (a) establishment
1	order; and (c)
3	commerce, and that
2	statute described in
1	(a) in fields
1	now afflicts urban,
3	time or times
1	shall within 180
1	carbon dioxide, use
1	section 2672 of
1	device to report
1	form as well
4	notify the office
1	duly certified statement
1	scientific methods and
1	medical reasons including
1	drug paraphernalia; (2)
1	573, as added
1	substances into illegal
1	(1) the criteria
1	paragraph (2), initiate
2	food involved. 
7	valid scientific evidence
2	susceptibility of bacteria,
1	 (b) approval
1	control program, including
1	shall specify (1)
30	consequences or death
2	estimated revenue amount
3	whether a product
1	treat addiction by
2	shall consider only
1	plan; (b) take
1	warrant. (4) the
1	(4) contrary to
1	diversion of listed
1	regarding the stat-o-th-art
1	without upgrading such
1	rights affording a
1	(g) the certification
1	(4)2 congressional notice
1	reinstate the complainant
1	retailer shall not
1	contains any anabolic
1	longer than two
1	360b(d)(1), 360b(e), 360b(h),
1	sponsor conducts one
1	available to congress
1	period equal to
1	first applicant could
1	28, 1996)). 
1	facility at the
1	development and encouragement
1	586f, as added
2	section 331(jj) of
1	[42 u.s.c. 4321
1	(as defined pursuant
1	destroy the data.
1	health due to
1	drug development toolthe
1	application require a
2	addition to adjustments
1	(
 
 467a.
6	secretary may require;
2	review all written
1	location of foundation
1	treatment in such
1	usethe secretary, through
1	47; are made
1	601 of this
1	cosmetic act applications
1	secretary, use any
1	hours after determining
1	referral; considerations immediately
1	350, 3, 67
1	(h) with respect
1	promptly and shall
1	classification or approval
2	required to keep
1	persons on a
1	sale or merger
1	(d), except that,
1	may inform the
1	(2), any such
1	standards for thir-party
1	publish the index,
1	affairsthe deputy director
1	makes revisions under
2	extent of matter
1	investigation and confirmatory
1	misbranding prohibition; compliance
1	suspended under subparagraph
1	certain requirements to
1	appropriate, procedures for
1	betameprodine. (9) betamethadol.
1	rates of compensation
2	conform with the
1	hearing or the
1	
 1702. office
6	ensure that each
1	human subject; or
1	notice).  (d)contents
1	party shall 
1	(iv) each reference
10	(i) in the
1	respectively, exceeds its
1	generala qualified facility
1	usefulness, multiplicity, or
1	term agent means
1	drugs, may 
1	states food safety
2	sole and limited
2	paragraph and under
1	laboratory tests associated
1	contain a clearly
2	identical to such
1	review beginning not
2	 (1) abbreviated
1	(1) shall withdraw
1	clinical research organization;
3	time, in such
2	 (ii) antibiotic
1	subsection shall survive
1	less, (3) there
1	color additive shall
1	products to control
1	dru-related crime and
1	time necessary for
1	support such determination;
1	(a) may on
3	secretary shall enter
1	secretary consume-oriented information
2	national of the
3	agencies to provide
1	granted and the
1	(1) there are
1	world evidence means
1	paragraph (1)(a) for
1	novo basis. (2)
1	treatment of which
1	section 387a1 of
1	general controls is
2	establishing, amending, or
1	states officials to
1	related to that
1	grounds, the approval
2	contains a dietary
1	(a) -year periodthe
1	safety data described
1	previous application of
1	violations (a) misdemeanors;
25	drug control strategy
2	adverse experience, or
1	use the drug.
1	silicone gel, except
3	task forces in
1	security, heads of
1	otherwise may be
1	new and supplemental
1	position may be
1	problem; (3) dru-related
1	application, be permitted
2	increases in substance
1	part because the
1	order and to
1	disseminate scientific information
1	u.s.c. 300g1], the
1	shall deny an
1	regular employment without
3	 (2) application
1	(a) petition; recordnot
1	section, including with
2	petitioner, or the
1	(c) to address
1	logistics provider without
5	(b) is in
1	products during each
1	business to hire
1	advisory commission as
1	product. if an
1	secretary, who shall
1	product identifier. 
1	cooperative agreements. 
1	evidence submitted in
1	recallsnot later than
1	allow device establishments
1	first country, the
1	industries; (ii) 3
1	set forth its
1	regarding the availability
1	condition of employment.
1	making cigarettes. 
1	(8) illicit trade
1	title that have
1	treatments for patients
1	(2) the authority
7	transaction information, and
1	completed registration described
1	district selected by
1	implementing voluntary food
1	also a retailer
1	condition of doing
1	agencies or instrumentalities
1	court deems proper.
2	include a supplement
1	singl-use device. such
1	(2) notwithstanding any
1	safety; or (iii)
1	services.  (2)
1	(i) is reasonably
1	tobacco product standards,
2	countermeasures for populations
6	days after 
1	submitted applications and
1	facility identified or
6	department of justice
1	(b) wholesale distributor
1	behavior of classes
1	order is accepted,
1	hazard reasonably related
10	classified in class
1	record the determination
6	verify the product
2	controlled substances it
1	cas-b-case basis to
1	pediatric studies for
1	year after its
10	distributor, or retailer
1	[42 u.s.c. 1396
1	facts related to
1	assigned under this
1	(2)(a) or (3)
1	802, as added
2	human services, upon
1	pharmaceutical security (a)
3	transferee identified in
9	 (a) means
1	epinephrine by school
2	role in international
1	  niacin
5	homoeopathic pharmacopoeia of
1	foodnot later than
3	chapter or any
8	preparation, compounding, or
5	time of, each
1	federal employees pursuant
1	conviction in any
1	preconditions; rare disease
1	drug substances each
1	video machines. (4)
1	approved protocol, or
1	crude opium and
1	whether a reduction
1	violators, but each
1	guidance as the
1	secretary. (ii) with
1	enforcement agent. any
1	certifying entitiesfor purposes
2	new programs. 
3	substantial importance in
1	academia, health care
1	panels in making
1	(2) phenmetrazine and
4	made before the
1	(a). (iv) each
1	nonfederal governmental sources,
1	thus, it is
1	licenses until the
6	represented as a
1	drug. (g) demand
1	number of establishments
3	disclosed to other
1	fee obligationa person
1	issuing duplicative guidance
1	notwithstanding clause (iii),
1	subsection (a)(1)(c). (e)
3	made within the
1	designated representative and
1	hypoxic challenge testing.
1	means any facility
1	beneficial to protecting
2	substance, or is
1	standards and practices
1	affiliate refers to
1	subsection (b)(3), and
4	data multiplied by
1	commissioner. (c) facilityfor
1	identifying best practices
1	notwithstanding the fact
1	color additive, whether
1	together in a
1	gas from the
1	geographically dispersed); or
1	2011, that enhance
1	hormone for any
1	chapter[3] 21, code
1	united states (and
1	receiving the application
2	period or the
1	(including neonates in
1	revenues for fiscal
4	additional individuals with
7	prescription drug that
1	agency documentation and
1	distribute, dispense, conduct
32	made available to
1	(b) the creation
1	coordinate educational programs
1	pesticide issued under
3	food is as
2	first action, the
1	existing therapies on
2	determination has not
1	agent first knew
1	title; (b) requirements
1	(i) is located
1	thereafter.  (d)
2	includes performance of
1	security interests, work
2	processing of such
1	disapprove a proposed
1	 (b) meetings
1	(4) when prescribing
1	approved before november
1	authorization are no
1	drugs or manufacture
1	issues and disagreements
1	(iii) academic organizations;
1	underserved groups; encouragement
1	subsection (a)(2)(d), a
1	found, the unavailability
1	submission or type
1	(
 
 844a.
2	overall strategy and
1	promulgating the rule,
1	74, 7, 38
2	(a) the poultry
1	witness refuses, on
1	subchapter are (1)
4	2017, there is
1	reference tobacco product
2	may serve on
1	(16) small tobacco
1	 (1) dispute
1	revoked  (i)
3	held by such
1	will address. 
1	management of antimicrobial
1	state as subject
1	
 379g. definitionsfor
3	container means any
3	(1) and the
1	recognized under subparagraph
1	evidence that constitute
1	administration; (3) develop
1	used for investigational
1	(a) an analysis
1	substantially complete and
2	(k) to provide
1	testing, and investigations
1	internal purposes only.
6	monitoring of research
1	availability of annual
2	 (5) selected
2	manufactured or processed.
3	chain, as appropriate.
1	manufactured or processed,
1	mitigation strategies (a)
3	present a significant
2	methods not deemed
1	substances, compounds, and
4	section 3551 of
1	(h) outreach on
1	size of operation;
1	use a system
2	year, such fee
1	manufactured or processed;
1	owning, or managing
1	shrimp), tree nuts
1	secretarys proposal, be
1	regulation require a
2	congress a report,
1	size of operation,
1	(3) required reports
1	(b) either 
1	involves ephedrine, pseudoephedrine,
1	letters of the
1	nature, and magnitude
1	646, 32, 62
1	(c) exceptions 
1	inspections under subsection
2	concealment of property
3	reduction, demand reduction,
1	annually to the
1	productivity. (5) increases
1	 (a) subparagraph
1	application. (e) marketing
1	eligible countermeasure, including
2	nonsupervisory employees), as
1	within the state
1	shall examine and
1	seq.]. (v) the
1	foods in accordance
1	21-, or 27-calenda-day
1	(2) requirements and
1	section 312.47 of
2	(c) or approved
2	review the requirements,
1	paragraph (6), extend
1	required, any supplement
1	laboratory analysis methodology;
1	tol-free telephone hotline
1	(3) determination by
1	separate occasions. 
3	isomers whenever the
1	scientific data if
1	apply to produce
1	
 
 387t.
1	article. (q) the
1	(ii), issues a
1	program of control
1	assessment center (a)
1	farm storage facility
3	order to enhance
1	360hh of this
1	title (not including
1	grants such an
2	review, the tobacco
1	form, shall be
2	thereof so as
2	section 355(j)(7) of
1	isomer of amphetamine;
1	manner. (d)confidentiality. 
1	nonprescription drug involved
1	registration renewal process
1	investigative efforts to
4	afforded access to
1	section 458, 459,
1	problems, such as
1	reference  (i)
2	slaughter of poultry,
1	estrogenic substances screening
1	illegal manufacture of
1	packaging of a
2	secretary may take
1	amount (if any)
1	cigar means a
1	term coupon means
1	675, 521, as
1	1039. eggs and
1	unless that person
1	subsection (b)(8). 
1	program the chief
1	chemical knowing, or
1	accountability measures; (iv)
2	report the information
1	control act, the
1	 (i) beginning
1	testing of any
1	manufacturer eliminates or
1	condition without amendment
1	submissions pursuant to
1	particular; or (d)
1	products adequately labeled
1	major food allergen
1	862. denial of
2	controlled substance has
1	supplier of such
1	substances from the
2	entity.  (d)
1	creative services for
1	reporting under paragraphs
1	354(a)(3)(b) of this
1	corporation who compounds
1	issues final guidance
1	including under paragraph
1	substances are transported
1	 (e) index
1	documentary standards that
1	(including in response
1	summary may indirectly
1	statements as were
2	extensions). (2) exception
1	 (b) standard
2	accrued interest collected
1	occur; (c) require
1	poultry or otherwise)
1	clinical study demonstrating
1	(b) 2 times
1	801, 52 stat.
3	man or animal
1	swine, chickens, turkeys,
1	withdrawal period approved
3	attorney for such
1	causes or is
1	(viii) religious or
1	secretarial actionthe action
1	period, or if
2	additional such period
1	panel the panel
6	90 days prior
1	communications and commitments,
1	applicant to submit
1	making such reimbursement
1	violation is a
2	study may not
1	comprehensive federal, state,
1	surety bond in
2	 (c) request
1	(f) for a
1	(iii) that are
1	informationthe term transaction
1	health from tobacco
1	upon a qualifying
1	treating, detecting, preventing,
1	(c) review every
1	rulemaking prior to
1	paragraph by other
2	facilities (as defined
1	plus (ii) the
3	subpenaed person is
2	shall convene the
1	easily searchable drug
1	restrictions specified in
1	certification, and after
1	applicant is required
1	60 days duration,
9	requirement of a
1	(a) monitor and
1	assessment granted under
1	manner and take
2	term by section
1	appropriate conditions with
1	details of any
3	procedures used by
1	 (e) remedies
1	water systems using
1	portion of carcass,
1	manufacturing, or distribution
5	appropriation account of
1	(4) the importation
1	rely upon thir-party
1	analogous product, for
1	internal quality systems
1	administrator shall 
1	transaction statements, as
1	whether an assessment
2	subsection (c). (3)
2	reasonable proximity to
1	trafficking areas programnot
1	certificate of analysis.
1	(k)(3) to provide
1	section 360ccc1(e)(2) of
1	480 days after
1	administration may be
1	general; hearingthe attorney
1	regarding good manufacturing
1	faca section 14
1	enjoyed;  (4)
1	(b) to replace
1	condition.  (o)
1	data bank pursuant
1	exempted.  (

1	initiatives with related
1	date means the
1	declaration (or gives
2	operating reserves, the
52	order issued under
2	practicable for facilities
1	(a) who has
1	prompt and reasonable
1	careful inspection of
1	ultimate purchaser of
2	imprisonment, or other
3	within 10 days
1	beverage until the
1	previously been instituted
1	406, 52 stat.
3	regulation issued pursuant
1	paragraph (5) that
1	 (10) state,
1	section 842(a) of
1	title. such application
1	conducting examinations, investigations,
1	committee in connection
1	affect the power
1	885; 1940 reorg.
3	funding in the
1	global development of
2	inspection resources under
1	products compiled under
2	practitioner making the
1	drugs is formulated
1	application. (i) procedure
1	act or action
2	later date by
3	efficient administration and
1	establish device effectiveness.
1	discuss and resolve
2	chapter are appropriate
1	afforded to such
2	secretary.  (june
2	prescription medications. 
1	device, its intended
1	 (a) health
1	similar manner, is
5	interest will be
1	compensation at the
1	restriction on quantities
1	evaluation of progress
1	regarding the general
1	containers; prohibition against
1	use aggregation and
1	basis for entry
1	tolerances having been
1	official plant, bear
1	(8) national drug
1	generated during drug
3	recordkeeping and other
1	approved after december
1	(d) may deal
1	(b)(3) for the
1	including drug dependent
1	filed, stating that
1	drug enforcement agency,
3	will enforce requirements
2	(i) an application
1	clause (i), of
1	(d) the adaptability
1	effort to conduct
1	agency action. (june
1	device, (ii) a
1	shall deny the
1	will be initiated,
1	shortagesnot later than
1	plan as soon
1	ch. 675, 408,
1	drug sample upon
2	filling, the name
1	national health care
20	device is not
2	committee and need
2	2013, for the
15	2 of the
1	plan for providing
1	(iii) convene a
1	(1)(c)(i), and the
1	unless the manufacturer
1	failure to register
1	paragraph (2)(b), (ii)
1	official) from 
1	symbols. (5) paragraphs
2	means an individual,
3	states), while attending
1	seq.), involving methamphetamine
2	residue, including all
2	present an unreasonable
1	nominees.  (e)
2	information to determine
1	shall identify hig-risk
1	effective on september
2	combination product that
1	individuals designated by
1	threat when evaluating
1	grase; (5) the
1	development, manufacture, and
1	requirements (a) labeling
4	address a shortage
3	distributed to them
1	increased punishment which
1	capable of being
1	management systems of
1	pending request is
1	indication.  (d)
1	decline to undertake
4	section, for fiscal
1	reflect patient morbidity
4	establishment means an
1	intent to delay
1	distributors. an importer
1	vehicle.  (3)
1	may require, make
1	confidential during the
1	case the term
2	beginning after the
1	subparagraph. (ii)timing of
1	licensure, approval, and
1	approved label of
1	several varieties of
1	recommendations, and suggestions
1	study; or (e)
1	ii devices for
1	television advertisements (a)
1	prescription for, or
1	drug compounded by
3	paragraph (6)(b) or
2	thereof. all process
1	years; and (3)
1	title, or that
1	auditors to certify
1	calendar day after
7	prescribed by subsection
1	federal official or
1	twice the fine
1	states, then the
1	emergencies (a) in
3	(other than bulk
1	puerto rico and
1	pharmacodynamic, and epidemiological
1	employee to exercise
1	general deems adequate
1	complaint, information, indictment,
1	biomarkers, intermediate clinical
1	commodities in such
1	facilitate and enhance
1	assessments submitted and
1	intravenous product used
1	order, or both,
1	court that the
1	sponsor, not less
1	hospital, with respect
6	paragraph (3), a
1	$12,300,000; (4) for
2	described in a
7	specifying the matter
1	(2) consult the
1	activity that is
1	continental or insular,
4	(iii) if an
1	ammonia, or (2)
1	section 57a of
1	contact substance as
1	issues regulations under
1	animal drugs makes
1	paragraph (1). (j)
1	military forces of
5	packing, storage, and
2	section 379 of
4	section 335a of
7	drugs referenced in
6	made as a
1	history under this
1	services may designate
1	amount under subparagraph
1	guidance for antibiotic
1	(f) prior convictions
1	chapter;[2] or (c)
1	agency has been
3	shall be conclusive.
1	shall be conclusive,
1	food; (iii) the
1	controls; samples; notice
1	management systems, to
1	(d) allows a
1	states shall determine
1	review is a
1	management, in consultation
2	formulations not developed
1	administrator may, with
1	(2) shall direct
1	(b) paymentexcept as
1	every establishment that
1	(13) -ethy--piperidyl benzilate.
2	purchased under this
1	(e). in establishing
1	particular package configuration)
1	drug that, not
1	contract the secretary
1	develop guidance, as
1	fee or the
1	section; (3) award
1	percent more of
1	(b), the requirement
2	(a)(5)), verifying the
1	interstate traffic in
1	relied upon. upon
7	subparagraph (a), (b),
1	(m), or section
2	states attorney files
1	ted stevens olympic
29	biological product application
1	360bbb3(a)(4) of this
1	declares that the
2	conclusiveness of determination;
1	publication, which is
1	(c) initial schedules
1	(1) authority the
1	import. (mar. 3,
1	implementing this subsection,
1	effective in use;
1	(2) specific requirements
1	federal regulations). (2)
1	clinical testing obtaining
1	drug reduction strategy
1	use meets the
1	proposed performance standards
1	(8) dihydromorphine. (9)
1	(3) suspension of
5	refusal of inspection
1	food a separate
1	misleading to the
1	policy shall be
1	may appeal from
5	years after such
1	accepted by a
1	full payment to
1	2010 through 2014.
1	shall (i) prescribe
3	shall submit the
3	agriculture not later
6	information for each
1	(1) defraying the
1	value; or (e)
24	manufactured, processed, packed,
8	(a) within 30
1	new needs and
1	research, the office
2	except as an
1	(2) such a
1	shall submit validation
2	instructional materials and
2	withdraw accreditation from
1	traffickers and possessors
2	distributor may accept
1	omission the employee
1	total dietary intake.
5	may be accompanied
1	appropriate, on the
1	studying continuous drug
1	subsection are the
1	proposed performance standard,
1	conducting device recall
1	immediately prohibit the
1	total dietary intake;
1	perpetual inventory. 
1	subsection (b)(2). (b)
1	sponsor seeks a
6	fiscal year if
1	on-tenth cubic centimeter
1	section, a small
1	
 645. federal
5	penalty shall not
1	qualified importer status
1	revenues established for
5	 (5) transmittal
1	state to compound
2	condition (as such
1	 (q) 
1	drug not subject
1	countermeasure means a
1	united states receives
2	(i) and the
1	promulgate a proposed
5	animals for which
1	board considers appropriate
1	provide recommendations as
1	drug. such information
1	schedule iv. 
1	manufacturing practices; (d)
1	saleable returns only
1	manufacturing practice, testing
1	terms, the nature
1	343(r)(5)(b) of this
1	appropriation acts. (june
9	conducted by or
1	substance manufactured, received,
1	(q)  (1)
1	dru-related law enforcement,
1	pertaining to requests
1	division; (vii) the
1	business. such consideration
2	submitted. if such
1	(3) tobacco product
2	eligible for review
1	packaging). the food
4	(i) was found
2	director regarding the
1	459, 460, 463,
1	simultaneous global development
1	approval would be
1	ranchers; or (ii)
1	(c) market exclusivity
2	personnel the term
1	efforts to control
1	forum as appropriate;
2	specific to the
1	applications) shall not
1	manifest or part
1	decisions by the
1	360ff. priority review
1	abuse means 
2	30, 2012, establish,
1	rare diseases; (3)
1	generate surplus revenue
1	(f) of such
1	office or its
1	regulation designate the
1	safe and dru-free
3	establishment that manufactures
1	representations or material
3	including access to
1	 (ii) exceptionthe
1	requiring further processing,
2	fellowships and other
1	excludes any person
1	chemistry of the
6	ove-th-counter drug monograph
1	eradicated in the
1	 (5) consultation
2	covered application means
1	recommendation for action
2	application under an
1	approval process or
1	unless the dispute
1	(1)(a). (b) for
1	available any information
1	(iv) requiring the
1	concerning an order
1	schedule established in
1	(a) the terms
1	one use of
1	control strategy for
1	can, by relabeling
2	business. (iii)offer of
1	varying sizes, including
2	upon request, make
5	requirements as the
1	purpose.  (e)
1	conformity in order
1	may be generally
1	disposal or return
2	director shall notify
1	(a) jurisdiction 
1	person who in
7	section 352 of
1	add the new
1	(
 
 850.
3	print, lithograph, or
2	section 607(e) of
1	decreasing morbidity and
7	providing an opportunity
1	seizure, summary and
2	however, that no
1	prescribe regulations requiring
1	drug abuse upon
1	dietarily exposed to
1	companies, and other
2	combination product has
1	chief scientist, with
1	(b)(1)(a)(i)(iii), (b)(1)(c), or
2	imported, transferred, or
1	(1) general rulethe
1	maintains each entry
2	sizes of type
1	title, give the
1	wholesale distributor, including
1	353(c)(2) of this
1	results of pilot
6	years after august
1	transports a drug,
1	set forth on
1	filed or shall
1	english and whose
1	22, 2009, respecting
1	activities; and (ii)
1	shipment of controlled
1	title, then, unless
2	exported, under regulations
1	medical gas submitted
1	(g) internet sales
1	introduced in interstate
1	product manufacturer adds
1	food is held
1	131, 133 and
1	(f) drop shipments
1	(4) qualification the
1	efficient development program
1	federal regulations 
1	organizations and federal,
1	title; (2) any
1	(j) may appeal
1	identify whether such
4	 (a) at
1	publicly available by
1	prescription by physician;
4	 (a) as
1	commerce; and (d)
23	 (a) an
2	civil procedure. 
1	completing the required
1	subsection by 
2	product received by
1	signs the document.
1	hereinbefore described for
1	allow an appeal
1	(a) provide appropriate
1	otherwise be unprotected;
1	drug is required
1	sponsor gives written
2	exists, and the
1	provide federal assistance
4	issue regulations to
1	municipality thereof that
1	reviewable in accordance
1	intended, and that
2	board. the executive
2	year. in passing
1	fail to permit
1	budget request that
1	specific lot, batch,
2	paragraph and paragraphs
3	entered a final
3	 (6) the
1	causeissuance and execution
1	
 
 360fff6.
2	supplement was filed,
4	diversion control fee
1	worthless or harmful
1	coordinate the activities
2	vienna, austria, on
1	security.  (c)
1	improve the food
1	undertaking is false,
1	ix.e.4 of the
1	undertaking is false.
13	ensure compliance with
1	(5) basis for
2	sell directly to
1	be.  (b)
1	funds for enforcement
2	drug through its
2	thereof, fail to
1	misdemeanor shall be
2	shall assure that
3	states. (c) abuse
1	gathered through the
1	use regular staff
1	panel; and (iii)
1	relief sought. (4)
1	may deem appropriate
3	enforcing section 355(o)
1	declared that filled
1	available of eligible
1	control fee account.
2	order establish a
1	interagency relationships, but
1	device, by administrative
7	paragraph shall, in
1	pursuance of an
1	(a)(5)), upon receipt
1	article seized and
3	paragraph (3) may
1	(1) in generalparagraph
1	(f)(1), the secretary
1	commerce) in addition
1	womens health (referred
1	eggs; (2) the
1	providing dual photon
1	validation data to
1	(3) if its
7	date of its
1	develop a strategic
1	sanctioning welfare recipients
1	2012  (a)
1	retail commercial food
1	title) submitted to
1	making substantial equivalence
1	(b) reports 
2	387c, 387e, or
2	areas.  (

1	reduce duplicative notification.
1	injury, the labeling
1	substitute for human
1	2008 the amount
1	ice pipes or
1	letter; (3) the
1	section 4(h) of
1	subjects of such
3	submitting its first
1	issued or caused
1	(d) any adulterated
1	(2) initial standards
1	register (a) coverageno
3	credit corporation charter
1	(b)(3) is reversed,
1	order and, if
1	period consisting of
2	2017. (h) collection
1	topics listed in
3	domestic place of
2	probability that an
1	authority to use
1	accompanying disclosures 
1	community shall have
1	intentional violation any
1	product, the term
1	agent upon whom
2	underrepresented, in the
1	format, limit the
1	responsibilities and functions
1	and, if stated
2	immediate notification requirementif
1	component or part
1	(iv) the incidence
1	(b)state licensing fees.
3	qualified person so
1	 (2) amendment
1	officers and employees)
1	exemption of meats
3	provided, that in
1	state in connection
2	food is imported
2	devices, and biological
1	normally used to
1	agency in such
1	notification ordered under
1	periodically review and
1	guidance document so
1	drug into commerce.
1	inspections thereof, and
1	plans developed for
1	amendment) are representatives
1	destroy, repel, or
2	drug product has
1	ingredient means 
1	(5) all documents
1	electronic communications channels,
1	labeled or otherwise
3	auditors and audit
1	administrator considers that
1	 (d) construction
1	10 days from
2	apply  (1)
1	prioritize topics necessary
1	order to suspend
2	product containing as
4	sampling and testing
2	product containing an
4	conclusive unless the
1	patients and providers,
2	act), with special
1	 (1) determine
1	record of distributions
2	twent-day period beginning
5	use in an
1	adulterants or denaturants,
1	30, 1972; $65,000,000
1	provide for identification
2	specific tasks or
2	title for purposes
1	(iii) shall pay
2	certification qualifying the
1	(a)(3) owed for
4	applications for 
3	shall maintain the
1	shall be harmonized
3	violates the provisions
1	potential witnesses of
1	title, unless deemed
1	inspection to show
3	new active ingredient
1	development meeting. (b)
3	u.s. customs and
1	number of officers
1	setting organizations), shall
1	veterinarians and relevant
1	authorize any person
2	submission of proposed
2	contents  (a)
2	(f) identification of
1	producing both active
3	treatment, and rehabilitation
1	(b)(2)(b)(iii), (b)(3)(a), (b)(3)(c),
2	clinical benefit and
1	(c) oral presentation
1	behalf an order
1	facilities c-located on
1	recommendations; appointment and
1	(a) inflation adjustmentthe
1	675, 707, as
1	subsection (d)(4), (e)(1),
1	permit so suspended
1	promote international law
1	(j) service of
1	affiliate the term
2	pharmacopoeia, official homoeopathic
2	term drug shortage
1	premarket approval has
1	wholesaling the drug
1	evaluation and researchs
1	study plan earlier
2	device.  (b)
1	microquantities of such
1	states; (2) additional
1	allergy management. (c)
1	meals that may
1	index under subsection
1	leaving in effect
1	risk, not be
1	population; (2) subject
5	(b) if a
4	committee prior to
1	regulation deems to
4	filed per fiscal
1	exporting country does
1	without requiring the
3	human efficacy studies
1	(2) four members
1	(2) chorhexadol. (3)
2	title 5, to
1	feesin establishing fees
1	regulations on any
1	review provided by
65	act [21 u.s.c.
6	subsection (b)(1) and
1	pills, tablets, or
2	him, that such
1	training in appropriate
1	hearing, with respect
1	received the secretary
1	actions, if the
1	clinical trials. minutes
1	paragraph (6) continue
1	(4) expiration date
1	suspension, and revocationnotwithstanding
1	information to assist
2	conditionally approved application;
1	senior agency personnel
2	drug samples may
2	governments with respect
4	relevant to such
2	condensed, evaporated, concentrated,
1	section 360fff3(e) of
1	grams may be
1	measured in terms
1	report requireda responsible
1	states warehouse act
3	(a), the court
2	supplement submitted on
1	
 
 379aa.
1	sections 2234 and
1	events submitted by
1	order changing the
1	introduce testimony. if
1	subsection (d) for
1	 (iii) list
1	health system during
3	section 356c(a) of
1	secretary to practitioners,
1	intentional; (c) an
35	state and local
3	provide, where the
1	consultants to those
1	(f) priority review
1	advisory review that
1	applicable device clinical
1	acquisition and distribution
2	15 of the
1	shall recommend ways
4	consultation between the
1	section 262 not
4	extent, whether or
2	individual has served
1	withdraw or suspend
1	(1), disqualify a
2	 (2) audit
1	product, and either
2	related substance or
2	(a) has occurred,
1	time thereafter, on
1	title, including documentation
1	secretary. (2) for
1	350d. registration of
1	comments relating to
1	relationship the eligibility
3	shall contract with
1	persons compensation for
1	section 350a(f) of
6	applicant an opportunity
1	section 360c(a)(3)(b) of
2	drugs into the
1	results and accountability
1	apply on or
1	order. (3) compliance
11	functions of the
1	sociocultural contexts; (2)
1	unless the word
2	subsection (b)(1). 
4	may have received
1	$5,000 nor more
3	year of such
3	event reports and
1	subsection (i); 
1	(b) componentsthe nmic
1	system for all
1	 (n) referral
1	feedback in such
1	trimeperidine.  (b)
5	owned or controlled
1	annual monetary valuethis
2	paragraph (1) at
1	(q) reusable medical
1	environmental practice standards
1	studies publicly if
1	final guidance. 
1	differ from, or
1	issued on condition
1	product.  (vi)
1	subparagraph (c). (b)
2	of, a person
1	prevent and detect
1	obligate such sums
6	 (5) the
1	committed or is
1	risk.  (c)
1	(b) actionsthe actions
1	considered an action
2	(a) the estimated
2	1702(d) of this
2	documents required to
1	medical services under
3	misbranding provisions of
1	practicable in the
1	(as so determined)
4	may be detained
1	subgroups of consumers);
1	exchange and share
1	(ii) a risk
1	 (f) exemptionsthis
1	(b), and consideration
1	sent.  (d)
1	(xii) a combination
1	provided, that articles
1	efficacy supplement, a
2	named on the
8	products inspection act
1	public; and (3)
2	$10,000 and by
1	purposes of bringing
1	services, in coordination
2	state official, as
1	criminal offense 
3	regard for the
2	2, 68 stat.
1	agriculture act of
1	personal medical use,
2	shall not entitle
2	written agreement to
2	(iii) if before
1	drug in humans,
3	secretary may, during
1	contact substance and
4	made a report
1	misbranded products, under
2	hearing; period for
8	 (3) 
1	agreements to the
3	necessary in the
1	(b) the same
5	serious injury, or
1	(d) deputy director
1	101 of this
1	defendant at the
1	thereon, or the
1	title or negligently
6	use in supporting
1	vasopressor; or (gg)
1	 pursuant to
1	related to chemical
4	agency hearing on
1	give any testimony
2	request for waiver
5	(a) issue a
4	dispositioned; and (ii)
1	distribute the product
1	provide a biosimilar
1	effectively disseminated by
3	construed to modify
1	noncompliance with sanitary
1	assurances that each
1	ensuring more information
1	quantifiable goals that
1	dressing, ointment, dusting
1	sales).  (june
2	article was intended
2	data upon which
1	level of exposure
1	order issued after
1	throughout the country;
1	declaring the property
1	352 (or any
1	particularly antiquated -ray
1	(f)(2) of this
1	(c) meaningful therapeutic
3	retain such marks.
1	reciprocal meat inspection
2	applicable local laws
2	aug. 27, 1935,
1	trial enrollment, data
1	water are physically
1	designated representative anyone
2	relevant and material
4	(i) is a
1	1, 1971) has
1	mail to the
4	commerce if the
1	grams, not more
1	detoxification treatment shall
2	new safety information.
1	device, (v) an
1	security countermeasures (as
1	(c) penalties 
8	equivalent position of
1	proposed state regulatory
1	establishing or modifying
2	export shall not
1	margarine in any
1	utilize in carrying
1	
 1034. inspection
2	section prior to
2	health benefits in
2	signed at new
1	commission in response
2	information and law
6	food shall not
3	secretary shall, subject
2	establishment, or, in
2	(c) respecting a
1	amended; 7 u.s.c.
1	delete it from
1	methodologies; and (b)
1	possess any controlled
1	new president or
2	states citizen or
1	
 
 625.
1	website, or any
1	application or, if
2	acquisition of the
1	declare a new
1	authority of law
1	subparagraph (f), sales
1	attorney. (3) before
1	purchaser must verify
1	(6) and (7)
1	(b) activity limited
1	seq.], including all
3	review fee under
1	effect on other
2	affect the marketing
1	applicable performance standard
1	(b) ensure timely
1	joint committee. (k)
1	tobacco product included
3	(42 u.s.c. 300g1),
1	widest and least
1	(a) control of
1	drug includes conditions
1	party refuses to
1	mean the legal
2	formulation not possible
2	services administration take
1	product standard on
1	delivery of information
1	contains any of
1	foreign purchaser, (b)
1	board any fresh,
1	ensure development of
1	availability of registration
2	separated safely from
1	will export the
1	tried by jury.
1	(a) analysis of
1	(2) contenteach of
1	drug. (c) required
1	product standard or
1	penalties it shall
2	requiring the submission
1	pesticide at a
1	fiscal year, except
2	animals and the
1	administration, including, where
1	exempt therefrom by
1	slaughter and human
2	persons for the
1	(ii) nothing in
1	
 
 1102.
1	opium, morphine, cocaine,
1	secretary of safety
2	available under this
2	data from bioavailability
1	animal health, agriculture,
1	ecstasy, and other
1	allergy management grants
1	drug; contents; patent
3	data from one
1	(ix) establish policies
1	delivered it or
1	 (5) agricultural
1	title in violation
4	operation of such
1	required to name
1	paid.  (e)
1	1, 1971. (2)
1	regulations; (3) limit
2	effectiveness are required
1	treatment with respect
1	respect to, a
1	barrier that 
4	(l) the term
1	(2) be construed
1	federal agency referred
1	approved or conditionall-approved
1	ratio must be
1	(relating to mail
1	(a) the progress
1	characteristics means the
1	section 959 of
1	approval of additional
1	officials by such
1	overall objective of
1	(ii) the definition
1	grounds for dismissal
2	diseased poultry, or
4	may obtain a
1	authorized to dispense,
1	costs and shall
8	contaminated, dangerous, or
1	date) notify practitioners
1	viable micr-organisms by
1	tobacco  (a)
1	content of information
1	based. (c) if
2	sealed containers standards
1	 (1) serious
1	secretary lacks the
4	section 284m of
1	type 1 (cb1
9	may render the
1	written export certifications
1	therapeutic effect. 
1	(ii); or (ii)
2	consulting firm to
1	into, or prosecution
1	drugsthe term costs
1	marks or numbers,
1	(3) post information
1	exemption from fees
2	interstate commerce 
1	states; (ii) the
1	hearing on suspension
1	safety surveillance activities
3	respect to poultry
1	also shall discuss
1	 (e) collection
1	(or within such
2	person who, with
1	administrative inspections and
1	customs laws shall
1	subdivision under paragraph
2	(a) in generalno
1	products; (b) may
1	(i) provide guidance
1	means an instrument,
1	saleable unit for
1	list of food
4	chapter at any
1	carriage or storage
1	monitor the performance
7	fiscal years after
1	part, by the
1	hereinbefore provided and
1	emergency medical services
1	compromise the public
4	commence not more
3	notice under the
1	court shall enter
1	(2) notice before
3	application, as described
1	act are known
1	longer exist; and
1	classification.  (3)
2	gas deemed under
8	adequate information to
1	(1) each year
2	total estimated revenue
1	dispensed without an
1	disorder in collaboration
1	poultry products, not
1	article condemned by
1	health of persons
1	entity in order
4	authorize the withholding
1	advertisements regarding compliance
1	service herein provided
6	persons subject to
1	certainty whether a
1	adulterated by reason
2	including the discontinued
1	offenses involving dispensing
1	otherwise;  (8)
1	produced food products
1	condensery in which
1	packaged on such
2	device identifier. (3)
1	ch. 675, 1008,
1	invoice, or information
3	section 247d6d of
1	(ii) identifying the
3	reasonable expectation of
1	conditions and procedures
1	(a) persons alleged
1	(i) an intravenous
3	section 360oo of
1	purchase of smokeless
1	 (1) administrator
1	integrity issues. 
1	(hh) other best
1	economic area, provided
1	term financial hold
1	variance does not
1	(iii) the necessary
1	general may deem
1	enactment date, have
1	may represent any
1	meat products thereof
1	notification submission means
1	occurs outside the
1	supplier may submit
1	cases where such
4	arising under this
1	 (b) exempt
3	payment penalty, and
1	support for treatment
1	including a law,
3	accordance with either
2	property made to
1	-(-fluoropentyl--(-naphthoyl)indole (am2201); (xii)
1	patents for drugs
1	participating in amateur
1	records are not
1	may impose a
1	treatment, or other
1	title.  (g)
1	issue practice guidelines
1	lawful purpose, and
1	time, make such
1	basis of, any
1	recognition of valid
1	reimbursed through any
1	(5) enhancement of
3	effective control of
1	warehouse act (7
2	(b)(2)(a), the approval
2	commerce. (mar. 4,
3	(other than spices,
2	 subject to
1	history which the
1	generalthe regulations adopted
1	(
 
 862a.
1	however, if any
6	general the secretary,
1	(5) $50,600,000 for
1	processed when handled
1	subsection if such
1	corrective action taken
1	destruction, and seizure,
1	action. (d) civil
1	exceed five and
11	(5) the term
1	regulation, publish in
1	percentage determined under
1	livestock, the secretary
1	voucher was used.
2	congressional findings and
1	eligibility criteria set
1	tribe arising out
1	nmic requirements and
1	bidder on requests
1	including suggestions for
1	wholesale between jobbers,
1	policy gift fund
1	360eee2, and 360eee3
6	drug has the
1	returned product a
1	secretary).  (2)
1	donated land, federally
1	testing. for the
1	documents and uniform
1	states. (2) as
1	shall, in writing
1	ch. 675, 586a,
1	methamphetamines; and (c)
1	develop national drug
1	pediatric population (or
1	authorizing the possession,
1	state registration numbers,
1	issued, shall by
1	fact that a
1	general ruleevery person
1	(3) members the
1	30. (ii) the
1	represented as conventional
1	title i, 25,
1	unsafe new animal
1	full and timely
1	formerly 711, as
1	aggregates the products
1	safety. such standards
8	submitted with the
2	means a reprocessed
1	order or order
1	commerce shall not
1	moieties or rewards
1	requirements consistent with
1	(a)(2)(a), a person
1	channels, by limiting
5	and, as appropriate,
1	branch; (7) shall
1	(2) veterinary diagnostics
1	importations, may not
1	improve the ability
1	affected industries after
4	comments respecting the
1	ingredients determined to
1	(a)(iii). such regulations
1	reducing the demand
1	include a review
2	determination; and (ii)
2	sufficient period for
1	sector and subsector
2	lawfully filling the
1	device with an
1	state; territory the
1	use; (b) provides
1	prevention of methamphetamine
1	matter upon any
2	scientific training; (2)
2	preclude any other
1	information on lif-threatening
2	product applications submitted
1	subsection (b), (c)(1),
2	(2) not more
2	(i) and subsection
1	may serve after
1	death had it
1	48 stat. 1225.)

1	registered manufacturer, distributor,
1	(b) no compensation
1	violative prescription drugs
1	may undermine the
1	allow said meat
1	chemicals or has
2	beyond a reasonable
2	accepts or declines
1	request is withdrawn;
1	uses or attempts
1	plan for treatment
1	shall impose sentence
2	lower prices and
1	youth, the elderly,
1	defraud or mislead.
1	biological product which
1	defraud or mislead,
5	importer, owner, or
2	states, such as
1	substance will occur
1	commerce. (d) effect
10	ch. 145, 1
1	basis to show
1	applied to lot
4	coalition that represents
1	free and open
5	generaleach person 
2	title, or subsection
1	transshipment and i-transit
1	allowed for. (mar.
1	jointly regulated by
1	accord a high
1	sales personnel; privacy
1	food advertising if
1	correct or supplement
1	drug set forth
1	subsequent recipients in
1	approved; (b) the
1	amount of grants
1	responsible person develop
1	first country is
1	prescription a request
1	safe use. (f)
1	393. food and
1	1059, renumbered 1002(a),
1	foreseeable biological, chemical,
1	offense; and (5)
1	collected by any
2	result in consumers
1	pharmacy; (6) an
1	inspections, regarding 
2	supervisor or other
1	biomarkerthe term biomarker
1	misleading; (5) unless
1	compounded product is
16	consult with the
1	section 1177 of
4	sanitary conditions of
1	regulations identifying drug
2	device for expedited
1	standard; and (iv)
1	agency or authority
1	educators, and (3)
1	ii device if
1	surveillance report the
1	means the information
1	funding for any
1	continuous inspection to
1	factory, warehouse, consulting
3	sanitary conditions or
1	information demonstrates that
1	consumers, of an
1	26.  (8)
1	authorized by subsection
1	require.  (4)
1	call upon the
13	parts thereof, meat
1	adversely impacts the
1	individuals would present
2	medical, statistical, and
1	meet the problems
1	 (ii) documentation,
1	(1) any infant
1	elects to submit
9	fee under this
1	(ii) under such
3	laboratory supply to
1	deficiencies and limitations
2	business or in
2	term animal food
1	inspection requirement under
1	regulation adopted under
1	(2) in determining
2	redacted by the
1	(f) each person
1	(f) to the
1	said product shall
2	infant formula subject
1	reasons were not
1	hold not less
1	(aa) opioid maintenance
1	(ii) issue to
2	identified by that
1	preventing foodborne illness;
2	pharmacopoeia chapter on
1	substance abuse organizations;
4	favor of the
1	limitation on amount;
2	article refused admission
1	(b)(2)(a) or in
1	single application for
1	reduce any negative
1	may require that,
1	applicable monograph exists
5	secretary shall periodically
2	regarding an eligible
1	signals, pictures, or
1	products for personal
1	state shall be
1	emergencies.  (b)
1	available for expanded
1	adequate explanation that
1	(relating to smuggling
1	writing an agent
1	(a) shall serve
1	recovery of such
1	allow acceptance of
1	generalsubject to further
1	within an established
3	inches in transverse
3	safety or efficacy
3	expense of the
1	secretary has initiated
1	exemptionsthe term transaction
2	territory means guam,
3	disclosure of any
3	pursuant to applicable
1	necessary, testing required
1	therapeutic tissue engineering
1	obtained in pediatric
14	receipt of written
1	expertise or experience
1	regulation, a requirement
1	detection is not
1	(i) develop and
1	verification or copying
1	identification and location
2	foods production act
1	least 6 months
1	states, the officer
1	(6) prioritization 
1	found to contain
1	labeling; misleading form
1	findings. (q) schedule
11	statement that the
1	infant formula exempt
2	adverse event that
1	priority review guidance
1	2012; and (b)
1	prevention of drug
1	significantly harm the
1	minor species to
1	feesbeginning with respect
2	(iii) inpatient hospitalization;
7	reasonable limits and
3	average of the
1	(b) accreditation 
1	physicians in terms
1	scheduling to avoid
2	personal property made
1	regulations for preparation
1	dextromethorphan; exemption of
1	ceased supplying certain
1	tobacco product, a
2	product standard to
1	
 
 333.
1	investigate, regulate, or
1	fee when due,
1	(k) sunsetthe following
4	marking, labeling, packaging,
1	him, a tolerance
1	susceptibility using susceptibility
1	toxicology of such
1	revocation of accreditation
2	adulteration if the
1	prohibition of export
1	(h) additional conditions
1	powdered, or leaf
1	ending dates), without
1	processed food sector
1	amended or supplemented
1	population (including efforts
1	february 15, 2007.
1	personal property, including
1	judicial order. (3)
1	befor- and afte-early
2	detected and the
1	(iv) an application
1	2012.  (

1	1710. drug interdiction
1	drug sponsors, animal
1	section 312.21(b) and
1	gao report not
1	characteristic (such as
1	(e).  (g)
4	record the secretary
2	360fff2(b) of this
2	species to be
1	facie showing that
1	standard. a person
1	preclinical tests (including
3	importance in preventing
1	effectiveness in the
1	below: (a) the
1	patient package insert,
1	grants to address
1	mechanism. fees authorized
1	implantable device, the
1	health official of
1	chemical, with knowledge
1	will be effective
1	 (3) finding
1	whether the medical
1	requirements for nominees
1	body or paralympic
2	whose name (pursuant
1	food; and (e)
12	chapter.  (c)
1	original of every
1	extent such sections
1	patients with evidence
1	(including petitions, notifications,
3	approval of products
1	parole functions. 
1	fumigating, and packing
1	combination product expected
1	public comment beginning
1	term indian tribe
1	labeling concerning modified
6	conducted pursuant to
1	controlled substances. he
2	title) to receive
1	(i) have substantial
5	charged, as adjusted
1	 (b) jury
1	food production, and
1	675, 522, as
6	rationale for such
2	afford opportunity for
1	power of the
1	period to be
1	federal benefits; and
1	placed or in
1	smokeless tobacco; (e)
1	chapter for withdrawal
6	destroy any official
1	educational agency in
1	mai-order reporting; verification
1	services shall store
1	publish such regulations
6	extracts of coca
10	pertaining to the
1	address the local
1	grant or contract,
1	licensure requirements under
1	person incorporated any
3	establish by regulation
1	commitment to provide
1	(vi) a description
1	conduct that would
1	(h). (iii) responding
1	treat drug abuse
1	act of 1990.
1	emergency permit control
1	particular category of
6	raw agricultural commodities,
2	raw agricultural commodities.
1	food defense strategy.
2	(e) on the
1	importer shall take
1	treatment, environmental, prevention,
3	thereof for such
3	establishments at which
4	basis of any
1	reimbursable basis. 
1	serial number of
1	section 354, and
1	requests the review.
54	prescribed by the
1	requests the review,
1	using no more
11	states for the
1	submitted and reviewed
1	coordination and consistency
1	safety and supply
1	evidence that current
2	testing poses no
1	record, report, notification,
2	drug application, a
1	representative) of proposed
1	of, whether there
1	foreign pesticide information
1	covering the cost
7	 (iii) the
1	act of 1990,
1	tolerances for poisonous
1	(a) pose no
6	subchapters i and
1	poultry item qualifies
16	recognized by the
1	scientific society conferences;
1	review as described
2	 (1) notice
4	initial grant under
1	ecstasy; (ii) create
2	agree within 30
1	require the development
1	title, formally given
3	health, provide for
2	proceedings, minor violations
1	5382 of title
1	used to monitor
1	collect a fee
1	term smokeless tobacco
3	construed to preempt
1	360b(a)(5) of this
1	organization; or (ii)
1	give official certificates
1	bases of liability
1	disaster payment made
2	country will permit
3	intended solely to
1	
 175. repealed.
3	verification of the
1	coupon, or knowingly
1	 (2) health
1	(1)(b) or (1)(c).
1	limited to, sliding
1	requests under sections
1	feed mill licenses
1	drug shortage; (6)
1	rule issued under
1	drugs for serious
1	section 173.315(m) of
1	and, during the
1	person under clause
1	supplier if the
2	disclosed an identical
2	device is reprocessed
1	
 671. inspection
1	paragraph regarding a
1	including smoke constituents
1	total fees equaling
1	353(f)(1)(a) of this
3	names of the
1	general the food
1	america; (iii) the
2	states pharmacopoeia or
1	towards the imposition
2	(b) not later
1	title, to identify
1	terminated.  (b)
1	benefits of imposing
1	rule under such
1	primary focus on
1	groupthe secretary shall
1	income or resources.
1	specify. (ii) a
1	first applicant. (iii)subsequent
1	apply to requirements
1	schedule i by
2	(b); or (ii)
3	biological products for
1	feasible.  (2)
1	transaction is a
1	respect to sound
5	registered pursuant to
2	(b) is submitted
1	(2); and (iii)
3	individual does not
1	years 2008 and
1	standards, and all
1	aged from birth
1	particular ingredient. the
1	(b) any gaps
1	ingestion in liquid
3	section 360i of
1	prescription drug. (b)
1	includes specific information
1	poultry moves in
1	controls would be
3	active ingredient 
1	pasteurized before they
2	regarding the establishment
5	drug to meet
2	institutions, and organizations,
1	treatment;  (3)
1	18, to use
1	comply with and
1	(j) emerging threat
1	strategies; (c) provides
8	comply with any
1	(including a publicly
2	(b) the manufacturer
1	accurately the presence
1	person, the regulated
1	disease to participate
1	
 608. sanitary
1	(1) development and
4	determining the safety
1	(d); (b) provide
1	aggregate amount of
3	prescription drugs. 
1	1990. (b) upon
1	intravenous drug users
1	months after october
1	208.  (g)
1	periodic review of
1	request for framework
1	secretary receives comments,
1	  6.0.
1	reason to review
1	patient, which produces
3	making the finding
1	centers with expertise
1	court.  (june
1	paragraph. the criteria
1	food or classes
11	licensed by law
1	 (2) taking
1	relevant to those
1	trafficking area is
2	title, as the
1	articles of commerce
1	whenever either the
1	abuse.  (g)
2	may establish conditions
1	cooperatively  (a)
1	agency meetings with
2	persons registered by
1	select the controlled
1	
 
 379j52.
1	inquiries regarding any
1	areas program; (ii)
4	cease distribution and
1	food safety practices
2	national health service
1	information means any
1	approval of priority
1	586d, as added
1	human food; (c)
1	oxide, analgesia. (iv)
2	less of marihuana.
1	(thirt-fourth statutes at
1	otherwise affect the
1	procedures for handling
1	define the circumstances
4	 (a) suspect
1	subchapter i. for
1	(ii) approved by
2	program agencies 
1	law enforcement strategies
4	request is made,
1	(b) the adequacy
3	request is made.
1	increase from their
1	forth under such
4	(3), (4), or
1	 (4) personnel
1	withdrawn, shall, upon
1	entity that took
1	made. this product
3	third sentence of
2	282 of title
1	importing of fruits
2	food supply are
1	violation regarding direc-t-consumer
1	performed an effective
1	(a) approve the
1	(h) termination the
2	interpretive criteria with
5	(ii) the holder
1	state may intervene
1	ingestion, or any
1	secretary; and (c)
1	chapter except activities
1	period of registration
2	registration of any
1	(e)(3), request the
7	may order the
2	proposed regulation for
1	appropriate publications or
1	adequate review of
18	fined not more
1	expertise pertaining to
1	whenever such a
1	secretary for making
1	different active ingredients,
1	active program of
1	trade or proprietary
1	675, 908, as
1	(iii) information to
4	years of available
1	manufacturing restrictions to
1	obtaining controlled substances
15	program established under
5	precursor chemicals and
1	ris-based activities the
1	(e) had systems
1	use creative services
1	prohibitions contained in
4	medical devices are
4	(a) by submission
14	purports to be
1	1616a of title
1	(ii) further manufacturing
1	advisories, health and
1	distribution, and possession
1	regulation, authorize lon-term
1	goals and principles
1	process in this
1	prohibited drug activity,
1	violations; (ii) prosecutions
1	thereof; the remission
5	public in an
1	carried out; and
1	(q) that such
2	basis the adjustment
1	annual objectives of
1	substantial probability that
1	consumer containing no
1	(a) sending letters
1	actual amount of
2	means, by informed
1	(3). (b) effect
1	(2) studies or
1	product is stored
2	safety programs of
1	correct the deception
1	support a petition
1	order or judgment
2	chapter. (mar. 3,
1	reinspection fee settingthe
1	justice.  (b)
1	(i) establishing timelines
1	10 years of
5	secretary to require
1	testing procedures 
1	nonbinding nature of
1	outreach to food
1	fiscal year only
1	year 1986. 
2	comes into contact
1	experts who, because
1	drugs which have
1	facilitate such activity.
1	secretary believes that
1	recovery of amounts
1	without a jury
4	10 years or
1	of, the sulphide
1	applicable to manufacturers
1	subsection each year.
1	forth a plan
1	158. offenses; punishment
4	meetings between the
1	union, are inadequate
1	
 878. powers
1	registries, development and
1	exercising other existing
1	section. (b) the
1	subsistence, in the
3	permitted pursuant to
1	education; (b) drug
1	returned product with
1	origin and countries
1	act of july
1	secretarys satisfaction. (june
1	constituent, or in
3	scientific issue involved.
1	oil, such person
1	surveillance systems to
1	states in complying
1	 (i) expires
3	demand trial by
2	act of dispensing
1	reviewing an application
1	defining the term
1	distributor, dispenser, or
2	premarket application, a
2	 (e) if
1	(e) request by
3	application shall contain
1	jurisdiction; or (iii)
1	 (e) in
1	shall be comprised
1	implementation of sections
2	practices and the
1	administration. (3) authorization
1	providing documentation that
1	state elections 
1	national average as
1	writing the department
1	adequacy to justify
4	(e) shall apply
3	section 384b(a) of
1	secretary, and other
1	reports about the
2	may award an
4	expenses, shall be
1	(e) fee due
3	due consideration to
1	sponsors of medical
1	prescribe. if such
1	conduct an evaluation
1	risk foods 
1	hardship; and 
1	use or an
1	compounding; (c) does
2	5 years before
1	including the recall
1	specific registered person.
2	means is not
1	workload adjustmentbeginning with
1	practice guidelines to
1	plans.  (7)
2	proposed labeling are
2	documentation of the
2	entitythe term eligible
1	shall have clear
1	package (a) the
1	(c) definitionin this
1	provider, in accordance
1	$3,000,000, or the
1	complete; (ii) pediatric
1	islands, the virgin
1	intelligence sharing among
3	intending, or having
1	found liable to
3	measures necessary to
1	tobacco product distinguished
1	subsection and under
1	devices. (b) the
1	simplicity. any official
2	forfeiture prescribed in
1	hygiene, packaging, temperature
1	determines that disclosure
1	years 2013, 2014,
1	add species to
1	nutrition program (as
1	substantial source of
2	means a qualified
1	expended to carry
2	350d(a) of this
1	kind, including plant,
2	2219a of title
1	commissioner. (ii) the
1	price of ecstasy,
1	manufactured at more
1	
 356b. reports
2	licensed under this
1	persons debarment involved
13	determined appropriate by
1	take effect for
1	carrier; or (ii)
1	tobacco products. no
2	homeland security, the
1	chemicals and drug
1	(iv) are met.
1	iii devices 
1	action. an action
1	growing extent of
1	2201. performance standards
2	access for such
1	programs in establishing
1	pending with the
1	experts, health care
1	general a responsible
1	 (b) partnerships
1	711, formerly 712,
1	appointed to a
2	another animal drug
5	section as a
1	developed for security
1	reinstatement with the
1	protocols that the
1	error. (3) informal
1	funding from the
1	initial 3-day period,
1	drug that contains
1	law consistent therewith.
1	(a) any state
1	activity persons registered
2	42. such term
1	(6) the name,
1	exceed  (a)
3	notification program established
1	apply:  (i)confidentiality
1	abuse fell during
6	subject to subparagraphs
1	health departments, school
1	2012)), or any
1	classified information. 
1	(i). (3) if
1	present views, orally
1	whether the congress
1	substantially meets a
1	testing of raw
1	misbranded.  (mar.
1	states exporters of
1	repackager shall notify
1	deferral  (a)
1	section under regulations
2	qualifying practitioner to
2	drug applications submitted
1	patients who have
7	means the expenses
1	hearing if the
1	agencies; (ii) congress;
1	partial fill is
1	provided further that
1	fiscal years preceding
1	formula for introduction,
1	conditions.  (g)
1	patient through the
1	consent required for
1	kept for more
2	safety with respect
2	period the holder
1	(5) may 
4	program carried out
1	advertisement for advisory
1	including a smoke
1	secretary, within 30
2	paragraph (b) of
5	pesticide residues in
1	202. certain classes
1	process.  (c)
1	(c) systems to
1	immoral character; or
1	may facilitate the
11	medical, scientific, or
2	populations not included,
3	inventions developed by
2	practice, such additive
1	good cause made
22	fine not to
1	obtained the product
1	sum of $50,000
1	campaign, subject to
3	safety and inspection
1	removal of case
1	child at risk
1	necessary to effect
1	unless such cosmetic
1	list submitted pursuant
1	standards for interchangeability
1	emotional health are
1	information. a copy
1	groups, regulated industry,
1	section, including renewal
4	scientific merit of
3	methods of analysis
1	 (1) schedule
3	establish an exemption
1	standards for eggs,
2	drug use measurement
9	(b) or (c)
1	manufacturer as may
1	united states law.
1	foreign narcotics traffickers.
4	-year period described
1	drug includes drugs
1	inspection; overtime the
1	(
 
 467f.
2	make the procedures
1	(3) staff the
3	use  (1)
1	medical supervision. 
2	processor, packer, or
1	fat, all tolerances
1	imported articles shall
1	health provider, and
1	entity that causes
1	greater significance than,
1	sale, delivery or
1	administrative procedure the
1	2221. food emergency
1	marketed in interstate
1	(1) drug the
3	bond, or destroyed,
1	subsection but for
1	department or through
4	petition referred to
1	cryogenic state; and
1	 (c) process
1	regulated sellersthe attorney
1	admissible into evidence
1	approval is effective,
2	approved, the methods
2	order by issuing
1	operating reserves needed
1	wholesale distributor intends
1	determination for each
1	consistent compliance for
1	milk means any
1	advisory commission and
1	proposed regulation so
1	policy or management
1	food and may
5	certain to be
2	requirement of certification
1	plan for statutory
1	secretarys determination. 
2	be, and (b)
1	(f) qualifying pathogen
2	subparagraphs (j) and
1	measurements intended to
1	952. importation of
1	forward to the
2	audit conducted by
4	congressional statement of
1	take any action,
1	therapy, therapeutic tissue
1	tomography drug 
2	facilitate the transportation,
1	coalition under section
1	means any federal
1	consider the petition
1	classification panel includes
3	transmitted to the
1	shall, after eighteen
1	territory, district of
1	(a) total abstinence
1	(iii) the extent
1	enforcement, treatment, environmental,
1	acquiesces to debarment
2	satisfy any judgment
1	address the hazard
1	provisions in section
1	device premarket applications
1	number, (b) the
1	requesting studies in
1	including factories, warehouses,
1	period.  (h)
2	assessment is required
1	applicable, are met;
1	1969 [42 u.s.c.
1	2013, establish by
2	risk populations, from
23	required by this
1	respect to processing
1	discuss the requirements
1	revocation and reissuance
1	warrant, the person
3	properties as the
1	paragraph (2), whether
1	sells scheduled listed
1	intended purposes of
1	ch. 675, 542,
1	species. (pp) the
1	political subdivisions who
1	loss or known
1	agencies with expertise
1	general that (a)
1	 (3) substantially
2	(a) presents a
1	enter into interstate
1	arguments so taken
2	section has become
5	fees for fiscal
1	amendment if he
1	subparagraph (a), shall
3	device involved is
2	products, or presents
1	format  (i)
2	made.  (c)
2	appropriate, take into
6	pharmacological or therapeutic
3	submitted to congress
5	tracing  (a)
1	enforcement agency. 
1	transport or offer
1	substancesnotwithstanding sections 952,
1	742; 
 

1	provisions would be
1	give prompt notification
1	dosage form. for
1	standards for prescription
2	time at which
2	integrated consortium of
1	information about pediatric
1	verification activities that
4	ch. 675, 1002(a),
2	selected establishment or
2	revoked and the
4	patent infringement could
1	(d) shall remain
1	thereof, meat, or
1	subparagraph and he
1	suspending the importation
1	(i) verification the
1	stringent than a
2	human drug, no
1	 (a) seek
1	sufficient to show
1	transaction statement is
1	unit. (u) the
2	exceeded the average
1	advance, the topics
1	exceeding one year,
1	termination the commission
1	presented by defective
1	whether a maximum
1	term pharmacist means
1	community involved (especially
3	display the notice
1	regulations shall, to
1	includes any factory,
1	reliability of testing
1	applicant under subsection
1	original appointment. 
2	workload volume and
1	biotin (g) 1.5d
2	hearing upon such
1	national institute for
2	 (c) priority
11	examination and inspection
1	stayed by the
1	(3) shall require
1	compromise the attorney
3	product involved caused
1	anaphylaxis, including any
1	payment penalties and
1	employees and shall
1	902. savings provisions
14	required for the
1	subject to relevant
1	paragraph (2), notify
1	paragraph (c)[1] of
2	account the severity,
3	independent of, and
1	enacts a law
2	plan required under
1	 (f) statement
1	law, may request
1	drug to conduct
1	2016 and 2017
5	gross receipts or
2	dosage form, new
1	unlikely that the
1	effectiveness of each
1	practices, or critical
1	adequately managed. (e)
1	international narcotics control
1	may be filled
1	found. (aug. 11,
1	food that may
1	administered concerning such
2	threat posed by
1	egg products bearing
1	order forms (a)
1	facilities and active
1	use and dosages
1	date the provisions
1	section 360i or
1	fees for freedom
1	official establishment which
1	individual patient based
1	products) are enforced
1	set forth existing
1	drug in attaining
1	necessary, of the
1	shell that is
5	stat. 1263; renumbered
1	known or estimated,
1	establishing and achieving
1	subchapter and is
1	ethical or feasible.
1	measured in drops
1	individuals upon an
1	subsection by such
1	determination; judicial review;
14	part of any
1	characteristic or measurement)
1	officials to conduct
1	products or other
1	community under criminal
2	inclusion of ingredients
2	infringed only in
1	invalid, or that
1	1931, for limiting
1	(a) schedule ii
1	approved drugs 
1	2012, from that
1	(3), a clinical
5	grant a waiver,
2	controlling the abuse
2	upon by stipulation
1	delay in the
2	section 381(q) or
2	csa  (1)
1	(4), or the
1	study was not
1	falsification or destruction
1	protectionsin order to
8	section 381(q) of
6	who, after september
1	of, pediatric studies
1	(v) information to
1	may include data
4	secretary may appoint
1	scientific methods, cannot
1	reduction of 1
1	(g); (2) the
1	shall be exempted
1	witnesses the united
1	9, formerly 7th
1	considered a priority
1	strategy to adjust
1	secretary certifies to
1	interest. (4) selection
1	entry; (3) strengthen
1	authorized agent, of
2	application or applications
1	applicable subsection. such
1	suspension of shipment,
1	disclosures required under
1	inspections of retailers
1	restore forfeited property
1	operations, scienc-based minimum
5	drug administration is
2	(after fiscal year
4	available data and
1	v unless 
1	payment of an
4	335a of this
13	drug administration in
1	1967.  (b)
1	qualified employee, if
1	program, including a
1	necessary, only with
1	person from submitting,
1	stat. 1046; sept.
1	drug; (e) a
1	(b)(1)(c) is revoked,
7	device has been
1	detected the adulteration
1	considerations immediately upon
2	instances is unknown;
2	requirement prescribed under
1	section 343(c) of
1	(a) public health
1	bulletins, and other
1	1040 or 1046
2	rise to the
1	(f) the refusal
1	drug administration requesting
2	otherwise required under
3	high managerial agent
1	(4) otherwise expand
19	paragraph (2) of
1	establishment delays, denies,
1	also provide the
1	(ii) clinical data
2	unless such transaction,
1	order was imposed,
2	average time for
1	device manufactured by
1	states upon a
3	title to have
1	management, the business
1	expected to benefit
1	(2), and (4),
1	entered pursuant to
1	57a of title
1	meetings if a
11	paragraph (2) or
1	(ii) which is
1	years, but may
1	facility or containing
1	use pending proceedings;
1	clause (iv) or
12	provided in clause
1	providing product to
2	supply chain to
1	labeling requirements colored
1	united states thereunder
1	sections was in
1	formerly 358, as
2	establishmentthe term eligible
1	drugs, which shall
2	generate only the
1	preceding sentences. (2)
5	compounded positron emission
1	675, 565a, as
1	otherwise harmful to
1	extension of exclusivity
3	general may 
1	 (xiii) the
1	substantial damage to
3	factors which in
1	 (e) notice
1	both, when required
1	lot number and
1	(d) composition of
1	opiate. (2) any
5	title on the
1	administration) is grase
1	(b) exercise discretion
1	products whose label,
1	disqualification of regular
1	title 5. (h)
1	
 1046. imports
1	products when such
1	related to complying
3	complete response on
1	(d) did not
1	providers; (b) disseminating
1	manufacturers of medical
1	department who has
1	conduct inspections at
1	communication materials (a)
1	general beginning with
1	2, 1944, ch.
1	action is appropriate
2	(8), not later
1	poultry product except
1	(v) detailing emergency
1	administrations procedures for
1	proposals issued either
1	common to many
2	campaign needs that
1	country or region.
1	master file for
1	temporary exemption or
3	report to congressthe
1	
 827. records
1	government to the
1	program to routinely
1	 (e) payments;
1	facility, the united
1	disclosure of the
13	ch. 373, title
2	360e(g) of this
1	development program for,
1	pending biosimilar biological
1	receiving it, the
1	uses to assess
1	samples.  (4)
12	definition and standard
1	estimated medical, scientific,
1	products and treatments)
1	(i) submitted a
1	high priority and
6	designated by him
3	action or removal
1	product radiation emissions,
3	individual production quotas
1	violate paragraph (1)
1	intermediate endpoints reasonably
1	(iii) is met;
1	 (ii) complete
4	information in such
1	methods employed, (d)
2	sponsor or applicant,
1	bottle, and, in
1	sponsor or applicant.
1	secretary, each tobacco
1	grase determination, including
1	oil other than
1	concurrence. the secretary
3	collected for a
1	veterans affairs the
1	national emergency resulting
2	(c)(2), or an
1	court granting such
1	document  (i)
1	species verification, residue,
1	adverse health consequences;
5	sponsor or applicant;
7	records  (1)
1	intelligence agency. (3)
1	recipient demonstrating that
1	agency commissioned by
3	 (1) modified
1	foreign countries selected
2	clause with respect
2	examination or procedure
1	systematically assess information
1	chemical contamination or
1	blended or compounded
1	performance standard. (b)
1	experiencing the nonthreshold
1	chemicals imported by
1	(j)) that 
1	property seized under
1	provide consistent parallel
2	exported to the
1	(2) compliance 
1	subsection (h)(2); (i)
1	transfer program shall
1	 (h) administrative
4	established name (as
1	declaration of conformity;
12	designated under this
1	retail establishments for
4	reference to section
1	certification that, with
3	promulgate regulations regarding
1	identifies, measures, or
1	preceding sentence applies
1	section 355(b)(1), 355(b)(2),
2	making exemptions the
1	labeling; and (iii)
1	injury may provide
1	requirements no less
1	processes with representatives
1	complained of; (iii)
1	means, including public
1	360ccc1(i), 360e(f), 360i,
1	children); and (ii)
1	section must be
4	performed under this
1	term animal quarantine
1	pipes with or
1	jurisdiction, without regard
1	(b), each person
1	5316 of such
1	deems most appropriate
2	reports provided by
1	sections 3612 and
2	attempted to pay
1	(2) describing 
1	states all property
1	(15) pethidin-intermediat-a, -cyan--methy--phenylpiperidine.
1	capacity to support
1	approved intended use
1	may award costs
2	temporarily suspend the
2	certainty.  (i)
1	states according to
1	standard for market
1	interim results not
1	agencies within such
1	(1) a tobacco
2	(i) that did
1	smoking, does not
1	conditional approval is
1	term date rape
1	antidrug coalition institute.
4	pursuant to regulations
1	(i) released by
1	(2) applicability of
1	effective upon publication,
1	repackaged and received.
1	 (e) periodic
1	manufacturer from the
1	food to use
1	otherwise for the
1	secretary shall allocate
1	(b). for purposes
1	title) or an
1	securely sealed as
1	(iv) ingredients not
6	additional evidence so
2	2017 not later
1	products, including breaking
1	effectiveness. upon such
3	 (d) coordination
1	sentenced to death;
1	title. without restricting
1	food.  (f)
1	regulation is to
1	act under this
1	systems, or parts
1	allergic hypersensitivity to
1	provisionsthis subsection does
1	(i) make onsite
1	title, a use
1	device;  (c)
1	application. (2) in
1	(a) or for
1	(e). (e) data
1	physicians, patient organizations,
1	name designated: 
1	ability to produce
4	beginning on september
2	violation was so
1	(c) the following
1	supplement the number
2	enter, at reasonable
3	met; and (ii)
5	security act [42
2	 (v) the
1	liquid which contains
1	(
 
 467e.
3	section 321(p) of
7	beginning after fiscal
1	(1) on any
1	establishment to promote
1	u.s.c. 1501 et
1	chemical mixture for
1	drug labeling 
1	(e) whether electronic
1	radiological products, fees
1	found the evidence
1	tracking the extent
2	one use that
3	premises, building, or
1	upon them the
1	award the court,
1	shall notify a
1	state standards whenever
1	(2) requirement for
1	using procedures specified
2	general otherwise notifies
1	relevance, if any,
1	without further processing
2	handling, and distribution
1	business december 31,
2	grants in awarding
3	sponsor may request,
1	users shall be
2	means, making due
1	regulatory burdens on
1	treatments (including nicotin-based
1	following: (1) substance
1	timeframe applicable to
1	animal to such
2	include further research
1	and, using the
1	623. exemptions from
1	(b) response to
2	(b) penalties 
2	fort-eight months after
2	(1) any such
2	transition to a
1	thereof, and (ii)
1	(iii) procedures exist
1	processed at the
7	repair of computer
1	fiscal year, following
1	management systems 
3	violation, and such
1	duties described in
1	dispensing is located
1	management and budget
1	administration, and more
1	study plan may
1	injury designed to
5	submissions in connection
1	regulated child care
1	drug, induces cancer
1	301. short title
2	case, beginning 30
3	procedures established under
1	support the submission
1	353(e), 360eee2, and
1	respect to critical
2	disease; and (ii)
2	regulatory and scientific
5	interest, the following
1	353. exemptions and
1	american samoa. (june
2	part, a defendant
1	interest to do
1	deadline for providing
1	262]. (ii) whether,
1	[21 u.s.c. 355].
1	meat inspection and
1	conformity with, or
1	revise the required
2	labeling, is not
2	available; (iii) treat
1	revised in the
1	subsection (including the
1	administration; (ix) establish
1	certification, or license
1	organizations providing services
1	rubbed, poured, sprinkled,
1	donations in carrying
1	(2) individualsif the
1	2002 after september
1	conditions.  (q)
1	clinical and preclinical
1	device is necessary
1	deadline a study
1	need not identify
3	product may not
1	determines in writing
1	provision described in
1	(1) a new
1	procedure except that,
1	(i) subparagraphs (a),
3	container have been
1	listed chemical a
1	dissemination of new
1	immediate threat international
9	greater than the
2	official establishment processing
4	review voucher 
3	thir-party accreditation program
3	shall be forfeited
1	entity; (ii) 2
1	ex officio and
1	convention is not
3	(2) if it
1	smokeless tobacco shall
1	import such food
2	confidential and shall
1	formerly 706, 52
4	racial and ethnic
1	 (5) serious
2	populations, as appropriate.
1	4 years. nothing
2	writing of the
1	respect to emission
4	plants inspected under
3	(c).  (c)
1	perishable foods. 
2	arrests without warrant
1	except (1) in
1	applicable law, move
1	362(c) of this
1	pipe, paper, or
1	contest, such a
1	concerning nonprescription sunscreen.
1	food, or food,
1	379j52. authority to
1	available data indicates
1	is[1] based; and
2	unless the marking,
1	accredited persons are
3	(4) of this
1	
 888. repealed.
1	issue a priority
1	(a) authorize such
3	unlawful actsit shall
1	ensure that thir-party
3	agency under the
1	18. (june 25,
1	commission in writing
2	qualifies for such
1	added by the
1	first offense involving
1	subsection, all other
1	jobbers, manufacturers, and
1	 (b) audit
1	manufacturer, to hold
3	register notice described
2	united states) in
1	yearly or lifetime
1	public notifications, for
1	charges his patients,
1	omitted
 
 6.
1	salt of amphetamine
1	gifts any person,
1	applicable, any clarification
5	percent change that
1	states to designate
2	movement or sale
1	programs, projects, or
1	purpose for using
3	excess of the
2	 (2) guidance
1	general deems adequate.
1	penalty under subsection
1	(i) not requiring
1	protects consumers from
1	achieving the national
1	improve implementation of
4	exceeds the cumulative
1	services administration, shall
1	drug, the 18-day
1	knowledge regarding the
1	(3) develop detailed
1	foreign state. 
2	consignee of such
1	servant authorized by
2	review.  (i)
1	made to such
1	offering the product
1	cancels the registration
1	food; and (4)
3	shall in every
1	chairperson the secretary
3	federal register, a
1	preceding year increased
1	appropriate, adequate inclusion
1	(4) the rigor
1	administration, the administrator
1	committees, including the
1	351(a)(3), section 352(j),
1	(i) shall, at
1	
 360a. clinical
1	effect or the
1	authorize the disclosure
1	regard to devices
8	establish a process
1	(a)(vii)(iv) shall include
4	interested person may
3	voucher the term
1	drug products approved
1	unaffected notwithstanding any
1	application states reasonable
3	human services who
1	application approval order.
1	carcass of each
1	(c)(3) of this
1	15 years, a
18	(2) of this
1	finalize guidance specifying
3	accepted for review
1	360n1. priority review
1	processed. (x) the
1	served in the
1	entered into before,
2	court may permit
3	congress makes the
2	packaged. unwholesome, adulterated,
1	unreasonable dietary risk.
1	plants referred to
1	material produced by
1	seq.], the provisions
2	secretary for inspections
1	generic drugs. (e)
1	humans similar to
1	(other than fruits
1	preparing, propagating, compounding,
3	(ii) the amount
1	title) intended for
1	expand, or limit
1	drug development tools;
1	rots, mixed rots
1	facility inspected meets
1	compilation of noticeseach
1	(l)(5).  (2)
14	drug development tool
1	effective as long
1	 (a) emerging
1	limiting or diminishing
1	peanuts, and soybeans.
1	(i) the receipt
1	promptness furnish notification
1	four international narcotics
2	adverse event. 
1	review or 330
1	 (e) costs
1	review; application of
2	1532(a) of this
4	imprisonment imposed therein.
2	individual under section
1	substances. (2) mai-order
1	secretary if 
1	design life of
1	(2) a temporary
1	freely given by
1	determine the classification
1	approved only if,
2	continued supply of
1	section 505(i) of
2	within 18 months
2	panel or advisory
1	(c) patient experience
1	farm or plant
2	(a) the product
1	(b), as required
1	conduct of, pediatric
3	rates may not
1	industry. scientific, trade,
2	condemned under paragraph
4	premarket approval of
1	agreements to conduct;
1	jurisdiction in such
1	implementation of drug
1	 (11) little
1	availability, impact of
1	orphan designation has
2	premarket approval or
1	substances under adequately
1	paragraph (2)(b) by
2	(k) of this
1	upon the notification
3	person acting for
3	unlawful to import
1	listed in paragraphs
1	proposed rule. any
1	identical in all
1	connection with having
1	expenses of such
1	procedures exist to
1	trafficking and possession
1	machine or encapsulating
1	(b)(3) may not,
1	regulating food safety,
1	(c) for fiscal
2	purposes of enforcement
1	530c(a) of title
2	additive and such
2	impose any requirements
1	program for such
10	inspection act (21
14	contained in such
2	 (b) membership
1	certifications of regulated
2	establishment, and the
1	regulated industry, shall
1	(d), in the
1	different drug than
2	making their reviews
1	section; (h) an
1	 (4) director
1	(l) not require
1	copy and receipt
1	105)[2] would minimize
1	compounding does not
1	ris-based actions that
1	trafficker means any
1	chapter unrelated to
4	promulgated under such
7	policies and procedures
1	247d6, 247d6a, 247d6b,
1	product, may submit
1	(iii) capture the
1	on-fourth inches in
1	(d) the reporting
1	severity of rare
1	director estimates meet
2	include a business.
1	proceeding would be
1	paragraph (5). (3)
1	will provide effective
1	producer from his
1	consistently stand together.
2	contaminants for which
1	(3) agents that
1	360c(a)(1) of this
3	drugs other than
1	receivers, conservators, appraisers,
2	going back to
1	protocols that do
2	respecting the requirements
1	termination of limitations
4	stat. 1237; 1953
1	microorganisms due to
2	drugs. the secretary
1	devices and the
1	number of sites,
1	substance is so
1	plant is false
1	262; (d) preparing
1	radiopharmaceuticals.  (e)
1	activities as described
1	supply the information
1	55.0  
1	statements and requirements
19	distribution of the
1	issues the final
1	(e) surveillance systems
1	classification under this
1	product. the order
1	fruit or vegetable
1	warrants a search
1	coordinated communication 
2	request that any
1	(c) if an
3	contains any food
1	unless the facility
1	products prior to
1	(c) record keeping
1	indications for use.
1	weight, or (b)
1	food is received
2	member of any
5	issued an order
1	review studies conducted
1	person) the following
1	applicable to inspectio-free
1	general design of
1	commissioner an annual
1	section 360d(c)(1) of
1	conditionally approve the
1	articles capable of
1	qualify the customer
1	certificates of condition
3	application or an
1	supplemental application complies
1	 (i) participated
1	sponsor and any
1	technical assistance (a)
1	jury found the
1	applicant may, in
1	assurance, but because
1	official supplies of
1	facilities inspected by
1	term covered entity
10	safety risks of
1	senate  (a)
1	violation or the
1	references a facility
1	devices filed by
3	title 42. if
2	resources for monitoring
1	ch. 675, 403c,
1	include any retirement,
9	section 343(w) of
2	fine up to
1	list, a copy
1	flock of three
1	condensed milk by
1	country, of any
1	prevent the preparation,
1	make such importations
7	360bbb3 of this
1	direct. the government
1	drug distributor and
1	forfeiture; and (ii)
1	department wherein the
1	officers official duties
6	imprisonment, a fine
1	appropriate disclaimer as
1	united states, even
1	defendant under any
1	slaughtered the carcasses
1	extent of illicit
34	regulations (or any
1	2007, the committee
1	fees and requires
1	section 352(aa) of
1	entity with knowledge
21	issued under subsection
1	1976.  (d)
1	general the authorization
25	issued pursuant to
1	contents are leaking;
2	material fact; or
2	subsection.  (d)
1	exports, including any
1	party on whose
1	(3) strengthen the
2	names of all
1	(including necessary materials
1	stone, plastic, or
2	section 247d7e of
2	listed chemicals. 
2	no-federal law regarding
1	known. (7) product
1	assessment; (3) the
3	assess a civil
1	public health. (j)
1	(b) the controlled
4	act of august
1	legislative body, solely
3	reviews and audits
1	3, 68 stat.
1	holiday for the
1	person is, at
1	release otherwise authorized.
3	may deny an
1	enterprise or is
1	reference shall not
1	section 1961 of
1	shall promptly undertake
1	individual of the
1	5 to the
1	whether the drugs
1	diluents, of batches
1	
 826. production
1	olympic and amateur
1	adulterated and such
1	need associated with
1	local conditions, and
3	regulation pursuant to
1	preventive controls and
1	(9). (5) all
5	presenting the recommendations
1	local broadcasting networks
1	incorporators and shall
1	training to any
1	notify state boards
3	manufacture or distribute,
1	action plan or
1	applicable to tobacco
1	action plan on
1	(mg) 6.0 
2	years and which
1	identify the benefits
1	prevent such shortage;
1	(6) exclusive distributor
1	patient to whom,
1	sel-administration of prescription
2	patient, and consumer
1	(a) establishmentthe secretary
1	united states according
4	keep such records
1	encourage the secretary,
1	residue as to
1	contact surface. with
1	321(s)(4) of this
1	staff or members
1	crediting of feesin
1	100.0.  k
1	cosmetic is also
1	387r. drug products
1	need for effective,
2	commodities for which
2	enforcing requirements at
1	transported materials, including
1	secretary may rescind
1	(d) conduct of
1	destination for consumption
1	vitro study; by
1	material that merely
1	duly authorized holder
1	establishment. (d) any
6	notice of qualified
1	addition to its
4	(iii) responding to
3	facility c-located on
1	expertise in supply
1	
 852. application
2	statement for a
5	licensure of a
1	official (or a
1	eligible countermeasures by
1	animal, or part
3	chapter is reported
1	report, by not
5	food purposes of
2	panels  (1)
1	dispensed, a true
1	receives a request
1	intended to supplement
1	17, formerly 15th
1	cigarette in section
1	keep records under
1	contracted for such
2	(b) upon such
4	executive schedule under
1	1308. omitted
 

1	mean an article
4	management guidelines described
1	violations, the degree
1	paragraphs apply to
1	form, on the
1	establishment, together with
7	national media campaign,
1	paragraph (2)(c)(i) or
1	requested the referral
1	may enforce an
1	amendments to regulations
1	552. (c) authority
4	present his views
4	traffic in controlled
3	law or other
1	shall license the
1	(k) shall not
1	delegation of functions
2	regarding the article
4	national media campaign;
1	plan or such
1	(1). such framework
1	audits conducted pursuant
10	developed under subsection
2	statement sale only
1	extraordinary quantity of
1	accreditation through programs
1	200 to 200b.
1	2006; (10) $99,000,000
2	(a)(i), the secretary
1	20), patient advocacy
1	action relating to
1	qualification submission based
1	reasons of national
5	duly authorized representative
1	may elect, within
1	party whenever the
13	drug for a
1	logistics provider standards
6	probation or suspend
1	share of such
2	capacity, or as
1	864a. grants to
1	project will not
1	authorized and directed,
1	areas with severe
3	 (a) was
1	candidates, which may
1	$250,000 or double
1	42, no limitation
1	reduce the demand
1	investigators; and (b)
1	fiscal year 2020,
1	states shall expire
1	provider from being
1	fifteen members each
5	input on the
1	conducted may be
1	coordinating the sharing
1	routine, and systematic
4	limit the secretarys
2	director, and the
1	resubmission for advisory
2	pediatric subpopulation that
1	(1) partial fillsa
1	contract carrier, public
1	(or if he
1	organization, the standardized
2	subchapter manufacturing, distributing,
3	without authorization from
1	 provided, however,
1	food where contamination
2	purchased from the
1	systems, (ii) provisions
1	preempt state law,
1	(
 
 472.
1	noncompliance if a
1	website.  (2)
1	determination, the complainant
1	purchases, transfers, and
1	waiver to be
1	interstate or intrastate
1	risk that takes
1	classified information. (3)
2	application or which
1	time period that
3	isomers of such
1	404 of the
1	reviewable. (2) animal
1	persons so appointed
1	shortages; (5) identifies
1	42 if the
1	appeal the order
2	treat harm from
1	transactions that shall
5	pharmacopoeia of the
4	inspected and passed
1	community supervision through
2	sale in any
1	drugs after first
1	imposed if the
9	secretary may withdraw
1	law, or which
2	quality factor requirements
1	performance measure incorporated
2	(1) may enter
1	federal employees; (f)
2	received such article
1	situationsin emergency situations,
2	compensation for each
1	potentially intentionally adulterated
1	term enterprise includes
2	establishment and operator
1	material. (h) whether
1	list. during such
1	device. (iv) nothing
2	treated in the
5	memoranda of understanding,
2	comments submitted by
1	question; (d) include
1	labeling, distribution, or
1	consumer or grocery
2	first country to
1	communicate unwillingness to
30	states court of
1	paragraph (1); (b)
1	(including seizures of
2	withdraw or modify
1	securitynot later than
1	exists as to
1	records every inventory
1	955. possession on
1	procedural standards applicable
1	poultry, and shall
1	includes a qualified
1	benefits.  (2)
4	(a) full reports
1	repackaged in accordance
1	distributor shall, not
1	performance; (b) shall,
1	necessary to acknowledge
1	title to foreign
2	deemed not to
2	limits of funds
1	product, and supplies
1	paragraph (4). (iii)amendment
1	compounding of drugs
1	495, 70 stat.
1	3, 38 stat.
1	protected by the
3	person executing the
1	36-day period beginning
1	certain measures regarding
1	131, 38 stat.
1	rots, white rots,
3	made, by inspectors
2	fewer ful-time employees
1	federal funds received
1	exists, or of
1	paragraph (4), printed
1	pharmacy, including the
2	notification is not
1	clauses (vii), (ix),
1	summoned by the
2	operated in a
1	review fees from
1	(5) has been
1	(3) financial and
1	applications are not
5	38 stat. 819.)

1	pay payable under
1	(b)(ii) by the
1	patients in ongoing
1	(i) confidentiality and
1	demonstrated by a
2	iii with respect
1	leave the copy
2	event that 
13	hearing on the
1	tolerance; and (ii)
1	(i), if the
1	299b1 of title
2	controls referred to
2	economic area to
1	agencies to attend
1	capacity during emergencies;
1	accounted for. 
1	age to knowingly
1	(1) are collected
1	machines, or encapsulating
1	(1) conduct and
1	reducing the incidence,
1	operational, no funds
2	grant funds were
1	passed; and said
1	4, 38 stat.
1	revoked, if the
1	 (r) postmarket
1	grant.  (b)
1	thir-party auditor under
1	subsection (n)(3), the
1	920, as added
3	shipped in interstate
1	2014, where such
1	name provided on
1	studies and a
2	shall implement the
1	specified shall be
1	(d) inspections related
2	product refused admission
2	whenever a device
4	infringement action. 
1	prevent, control, or
18	civil penalty under
1	identified in subsection
1	among governmental agencies,
2	applicant may agree
2	construed to imply
1	clause (ii), such
1	report issued by
7	application or supplement,
1	18 applies to
2	circumstances regarding a
1	executive director may
1	on-fourth of an
1	taking of the
1	(c) treatment investigational
1	advertisement submitted to
1	change (whether a
1	sel-certifications provided through
1	drug and it
1	blood ring stage).
1	concerning the manufacture
1	stringent than, directly
1	states to apply
3	compliance under this
1	
 
 606.
1	(2), this chapter
1	exhibit the title
1	designate categories to
1	animals (before or
1	nicotine gum, and
1	letters related to
1	taken or shall
1	general, shall not
2	corresponds with the
1	gel (or any
1	certain orders an
1	tissue;  (4)
1	order or an
1	priorities and exemptions
1	claimant where one
1	urgent petition is
1	1954, as amended
1	drugs; (b) success
1	attorney general, concurrently
2	perform this service.
2	local governments with
38	respect to an
1	paragraph within 60
1	shall invite the
5	consumer advocacy groups
1	(as identified by
1	shall not invalidate
1	enable the program
1	industry with compliance
3	(b) under no
1	drug product meets
1	relates under the
2	may refuse to
1	store or other
1	grants to enhance
10	average annual monetary
1	agencies, and with
1	kinds and includes
1	data available from
15	360bb of this
1	including administrative expenses,
1	list of guidance
1	advertisements (a) in
1	meetings  (i)
1	association, or corporation.
1	(e) reference to
1	pathogen identified and
1	animals  (1)
1	subsection (a). in
1	thereof. (3) panel
1	convictions of that
1	activities.  (ii)
1	practitioner (or, in
1	 (l) laboratory
1	740a, as added
1	infant formulas to
2	area of the
2	 (g) violations
1	product standard under
1	include all activities
1	manufacture of animal
1	inspected or sampled
1	paragraph with the
1	purchasers of electronic
1	proceedings; subpenas for
1	(b) award the
1	notice that 
1	appropriate sampling, analytical
1	contempt of court,
2	(11) is impracticable,
1	provided, that clause
3	engaged in commerce
1	laws or regulations,
1	bear the statement,
1	content, flavoring used,
1	find the device
1	security and further
1	(i) may order
1	medical reasons, or
1	obtaining a registration
1	programs a sponsor
2	(except a substance
2	waiver is granted
1	(d) report to
1	(4) maintain teams,
2	appropriated, out of
1	states all right,
1	shall notify all
1	drug, an offer
2	updates to the
1	agents, or other
1	license by fraud,
4	business in or
1	determination. (7) following
1	et seq.] (known
1	(b) other necessary
1	contamination with micr-organisms
1	seizure data to
1	testing carried out
1	prioritize which eligible
1	united nations proposes
1	change.  (b)
1	approval, and which
2	 (13) the
1	manufactured with materials
1	designated); or (ii)
11	title that is
1	database.  (d)
1	(ix) if the
1	authorized.  (b)
1	(a) that there
2	june 30 preceding
1	liquid per package,
1	shall prescribe regulations
1	sold, the names
1	promulgated in such
13	adulterated within the
1	provide the report
3	shall, for purposes
2	affects less than
1	measurable metrics for
1	misbranding do, with
1	 (b) dismissal
1	states shall publish
1	separate certification is
1	et seq.) shall
1	request; or (c)
1	interior and agriculture
1	animal or, after
1	drug, controlled substance,
1	names and address
1	substantial disruption of
1	rulemaking to include
1	otherwise complying with
1	constructed, designated, and
1	differentiated from controlled
2	may withdraw approval
2	neither course of
1	processing activities are
1	property pursuant to
2	application contains any
3	shall be within
1	concern by demonstrating
1	formerly 7th par.,
1	upon demand by
1	upon whom service
1	administration and 
2	substance may be
1	48, 49, and
1	by, any egg
1	u.s.c. 262]. (b)
1	(i) sufficient information
2	1703 of this
1	questions, including 
1	bears the word
1	action indicated or
1	(b) restrictions on
1	devices to which
1	facilities following an
8	enforcing the provisions
1	secretary for food
1	will, if the
1	meetingsto facilitate the
1	tracking to the
1	terrorism, the secretary
1	experts or an
1	prohibition of inspection
1	licensed physician in
1	abuse organizations; and
1	maintains a system
1	advocacy groups, and
1	applications not later
2	payments in subsequent
1	procure, purchase, manufacture,
1	 (a) 1
1	day or night
3	following categories: 
1	evaluations of applications
1	butyrolactone (gbl) or
1	become too small
1	paragraph (1) respecting
3	353(e)(1) of this
4	stat. 1264; renumbered
1	
 136a. collection
2	protection of sensitive
1	dispenses, or who
1	(o) definitionsfor purposes
3	located when so
2	section 360fff5 of
2	fees established under
1	departing from united
89	except as provided
2	dispute resolution 
1	on-half of 1
1	manufactured or distributed
1	360c or 360e(i)
1	emergency, an assessment
2	subparagraph (b) which
1	(e) reporting and
1	produce and harvest
1	 (3) deferral
3	research with controlled
1	separate violation. 
1	harms of illegal
2	means, including through
1	industrial purposes; and
1	tobacco product requirements.
3	participated in any
1	additive, or any
42	shall be unlawful
1	facility. (ii) the
1	rendering carcasses, or
2	requests a hearing
2	carry over submissions.
1	(3) certifying entitiesfor
1	(ii) such poultry
1	meat of which,
1	improve the transparency
1	made, in accordance
1	secretarys sole discretion,
1	evaluations at the
2	tobacco products, shall
10	secretary or other
1	relates, except that
1	section 952(a) of
10	health care providers
1	agencies; (c) coordination
1	use, and of
1	analysis is made
5	service of the
2	effect any law,
1	chemical (including aggregate
2	 (c) pediatric
3	needed by the
1	serve search warrants,
16	requirement for a
1	records; (d) ensure
1	manufacturing process, before
1	subsection (d), each
2	sales or receipts
1	persons may, beginning
1	attending meetings for
2	advertisement for review
1	establish effectiveness, the
1	subsequent pilots or
6	house of representatives.
1	(ii) and maintain
18	house of representatives,
1	reports annual reports
1	assay have not
1	evidence concerning the
1	local surveys in
1	implementation of grant
8	house of representatives;
1	secretary has conducted
1	application is made
1	limitations described in
1	apply to meat
2	commerce (as defined
1	4 of public
3	period of more
12	licensed by the
9	means a product
2	give notice. 
3	policies established by
2	distributor of prescription
5	conviction record of
1	possible action that
4	applications and submissions
1	associated with guarding
1	drug, or (d)
1	(1) supplement a
1	develop postmarket safety
1	(3) beginning 3
4	action brought on
1	limits, and in
1	section, provided the
1	 (ii) of
1	administrative procedures to
1	grounds for invalidating
1	report on any
1	(4) except when
1	giving notice to
1	respect to biologics
1	expedited hearing. (f)
1	animals. the secretary
1	value has the
1	seafood inspection program;
3	unless specifically ordered
1	title), but such
2	prescription that is
1	illness. such an
1	carrier for carriage
1	establish, continue, or
1	(b) regulations under
1	form, at the
1	reducing the negative
1	qualification submission. a
2	united states pursuant
1	conditions of exposure
1	carriers or warehousemans
2	committees and subcommittees
1	means generally recognized,
1	$7,000,000 is used
1	insure against adulterated
1	protocol, shall determine
1	process, for any
3	new proposed sunscreen
1	travel time) that
1	dispose of unwarranted
7	tobacco products and
1	determination means, with
13	provided by this
1	court, apply to
1	particular. health care
1	adequate for the
1	2011, including the
1	(i) the specific
1	(5) leins[1] 
1	advertising, and court
1	(2) for fiscal
1	adjustment under clause
1	transmitted or whichever
1	method of transfer.
1	411, as added
1	use of trade
2	years regarding the
1	agencies to share
1	subsection (a)(1) within
3	register and provide
1	made in research
1	list under such
1	left the control
1	within the 20
3	action proposed to
1	
 
 360nn.
1	subparagraph (b); or
1	seizure of such
1	subject of testing
1	term critical reprocessed
1	enable the relevant
1	review all final
2	food and other
1	 to ensure
1	employment. (c) an
1	practicable the administrator
1	make examinations provided
1	financial support from
3	accreditation body for
1	use, in manufacturing,
1	determines is misbranded
5	compared to the
1	(1), or combination
1	(d) 27 percent
2	may be lawfully
1	aid or abet
1	determination. information forwarded
1	notice  (1)
2	approval in the
1	 (i)agreement to
1	paragraph (1)(a), a
1	subsection (a)(1); or
1	drug, and the
4	applications and supplements.
2	affiliate is headquartered.
5	qualify for consideration
1	stipulation or restriction,
3	secretary to have
1	period to which
1	controls should be
1	(i) the processes
1	congress for the
1	live virus of
2	distribution to the
2	territories and possessions.
1	form that information
1	reviewing clinical research
2	(c), with respect
2	controls against diversion;
1	chapter; or (iv)
3	regulation prescribe a
1	674. federal court
1	held within thirty
1	commerce or from
1	information on articles
1	type as required
1	(c), if he
2	serious illness. 
1	general shall fix
2	(c) for the
1	bacteria, including acinetobacter,
3	controlled substance under
2	(b) the secretarys
1	may subsequently require
1	appropriate) to develop
2	information received, records,
2	$10,000 for each
1	(b) fee amounts
1	business for which
1	identify each other
1	device received valid
4	supplement, the secretary
1	intent upon submission
1	purposesthe national interdiction
2	information provided pursuant
2	0.15  
1	provided on such
1	violated the antitrust
1	information shall 
1	day when transmission
1	(except for entrances
1	advisory review prior
1	(4) continue to
1	issues a letter;
11	requirement under this
1	adult indication in
1	possessors  (1)
1	 section 360cc(a)
1	federal indian programs
1	commissioner shall include
1	societal, health and
1	foreign person the
1	49, code of
1	(5)3 restrictions the
2	subsection (a)(2) shall
1	 (22) thir-party
1	discriminated against by
1	agents that could
1	including progress implementing
1	et seq.] do
1	entities. (b) trainingthe
4	u.s.c. 811(j)]. 
1	may not, for
1	permit until such
1	laws any laws
1	agricultural product (including
1	annually.  (7)
2	biosimilar initial advisory
1	(ii) other significant
5	applicant in an
1	experts.  (d)
1	regarding product promotion
1	smokefree, smok-free, without
1	revocation  (a)
1	(a). the request
1	protection of trade
2	year shall not
1	supported by scientific,
1	research needs and
2	state which would
2	pediatric studies conducted
1	council, including the
1	considered in decisionmaking;
1	following provisions shall
1	medical condition, where
1	title 18. (o)
1	risk above the
1	product) to the
1	(10) ai-driven pipes;
1	u.s.c. 262], and
1	reregistration eligibility determination
1	factors that are
11	supervision of an
1	 (c) selection
2	1604(b) of this
3	data access to
1	(b) a thir-party
1	article or poultry,
1	pursuant to clauses
1	article or poultry.
1	voluntarily cease distribution
1	(1) to help
1	purposes of guidance
1	implementation of oversight
1	repackager may request
1	number of letters
1	labeling of anabolic
1	funds used by
1	additive is listed,
1	must verify that
1	disclosure requirements applicable
1	annually, publishing current
1	advanced therapies through
1	acting in accordance
1	deemed withdrawn and
1	(ii) under a
3	procedures as he
1	include a certification
1	(c) implementing inspection
1	paragraph (3)(a); or
1	person after the
2	considered a separate
3	food  (1)
1	authorized to remove
1	ineligible for approval
4	provisions of chapter
1	generala publication, including
1	subsection (l)(2). 
2	ensure that not
1	awarding rare pediatric
3	(other than one
1	records. (3) active
1	eligible partnerships for
1	 (3) amateur
1	investigational drug beginning
1	regulators of our
1	(ii) contractors with
1	tests were required,
1	manner, with a
2	authorized for the
4	immediately register with
1	adequate staff, information,
1	panel.  (3)
2	(i) has the
1	protocol or denial
1	18.  (10)
3	information provided in
1	360h. notification and
1	including farms and
1	amounts as he
1	recognized an accreditation
1	disapproval by the
1	reserve stocks. production
1	combination, are intended
1	language designated by
1	behalf of ultimate
1	 (b) civil
1	prohibit or penalize
2	information provided is
1	inspection at reasonable
1	tobacco product package
1	granted pursuant to
1	subsection (a) at
1	combinations of nonprescription
2	subsection (a) as
1	permitted by such
1	initiate any action
2	application had been
1	real property; (ii)
1	federal agencies, the
1	notice from secretary
1	exporting country provides
1	13, 2016). 
1	duties, for purposes
1	educational loans of
1	medical ethics, science,
2	subsistence, in accordance
1	1037. prohibited acts
1	use. if the
1	normally sterile tissue
1	standard grades the
1	manner provided with
1	subject and there
1	listed chemical, with
1	 (14) because
1	crop year shall
13	proceeding under this
1	(a) accords to
1	facility from having
1	substance abuse, use
1	quarters, or other
1	malfunctioned and that
1	maintained separately from
20	drug has been
1	anabolic steroid, which
1	approved drug or
1	constituents, ingredients, and
1	(1), as necessary.
1	(a) office; or
1	(a) demonstrates a
1	base fees for
1	(
 
 470.
2	discontinue review of
2	order to rapidly
2	(i) provisions respecting
1	patient packaging inserts;
1	foreign countries. (

1	sought by the
1	substance in tobacco
1	(14) local governments
1	chapter because it
1	packing eggs. (4)
1	sports team or
1	1 defendant, the
2	(a) develop and
1	also require each
3	delegated to any
1	persons which is
2	reserve fee assessed
1	(1) performance goals;
1	proposed order required
1	promotional material the
1	identification of criteria
2	(d) collection of
1	offering such an
2	certification referred to
1	samples. (e) drug
2	drug approved for
11	time after receipt
6	application; and (ii)
1	 (3) transmittal
1	existing national drug
1	 (b) exceptiona
1	section 360c(i)(1)(d) of
2	adoption in order
1	(vi) and advises,
1	subjects that affect
1	(d)(4) or (e)(1)
1	prima facie evidence
1	hospitals; (d) the
1	357, as added
1	applicant therefor because
1	(1) unless specifically
2	economically disadvantaged areas.
1	tolerance limitations, as
1	 (b) exceptions
1	office.  (p)
1	office, independent establishment,
1	credit to the
1	procedures any property
7	number of patients
1	 (4) reprogramming
1	sexual assault. the
1	(i) unique identification
3	(f) of subsection
4	person pursuant to
1	drug are consistent
1	name) which are
3	regulation.  (4)
5	products to be
30	require that the
1	harm; and (ii)
1	phenylpropanolamine that the
2	action, as provided
3	independently by means
1	credentials and shall
9	small business or
1	 (2) sold
23	period of time
1	board initially appointed
2	ingredient, information to
1	(1) study 
1	secretary; (2) retain
1	questions by institutional
1	eggs packaged for
2	equal authority under
1	food has previously
1	control agencies, including
1	manufacture, distribution, dispensing,
1	(2) whenever possible,
1	include a clear
1	and, in default
1	factors, (a) the
1	removed from incubation
1	v, unless such
1	directions, as may
2	required reports in
1	qualification of a
1	subsection, on destruction
3	state, local, county,
1	manufacturing practices applicable
1	-(-chlor-2,-dimethoxyphenyl)ethanamine (2cc). (23)
1	(i) the counterfeit
1	term production includes
3	patients to whom
1	proposal to congress.
1	issue guidance defining
2	intentionally kills or
1	har-drug users under
1	(e) the packers
4	misbranded and to
19	year.  (b)
1	states will prevail
2	product, the product
9	portion of a
2	section.  (k)
1	(i) an informative
1	made to carry
1	chemicals. the attorney
2	action.  if
1	years 1999 through
1	379j22. reauthorization; reporting
1	fiscal years, and
5	integrity of the
1	drug and such
3	filed, (ii) that
2	improving the ability
2	swine, goat, or
1	thereof, is capable
1	product shall 
1	scientifically appropriate; (c)
1	 (4) withdrawal,
1	executive director, appointed
2	determined that a
1	1544. compensation (a)
2	food products at
1	(b)(1) before the
1	submitted by or
1	wholesale distributors. such
1	25, 1985, on
2	taken under paragraph
8	manufacturer, repackager, wholesale
1	equipment, personnel, and
1	issuance of letters
1	may be commenced.
1	ch. 155, 9,
2	product, irrespective of
3	implement and enforce
2	(c).  (2)
1	(d) a food
1	employees. for purposes
1	relies on clinical
2	(a)(1)(b) together are
1	eligibility determination issued
1	submit a dtc
1	time when such
1	require a statement
1	(c) no duplication
2	collection and dissemination
12	standard of identity
1	disagreeing with the
1	accompanied by all
1	ch. 675, 603,
1	paragraph. (k) date
1	made in an
10	year limitation. the
1	products inspection requirements
1	assistance to, state,
1	officials, as designated
1	currently marketed, the
1	resource conservation, wildlife
2	veterinary professionals; (e)
1	establish  (1)
1	naturally, or may
1	involved are solely
2	title; or (iii)
1	person shall prepare
1	development tool. (d)
1	drug product, which
1	2 years of
1	writing, similarly filed.
5	product radiation and
2	(2) dissemination of
2	register of the
1	concise warning that
1	extended to the
1	certificate stating the
1	products.  (june
2	drug intended only
1	chapter, under the
1	shall annually post
2	domiciled in the
14	thereafter, the secretary
1	(a) the sum
2	paragraph whether or
1	periodic consumer research
1	approved usesa designated
1	thereof, are prepared
2	one of several
2	subject to disclosure
1	color for the
1	necessary of poultry
2	(a) is for
1	dissemination. (e) whether
1	level of protection
16	october 1, 2012,
1	including its packaging,
1	distributor thereof includes
1	treatment, diagnosis, or
1	determination. the notice
2	section 314.510 or
1	general jurisdiction in
1	parte and in
1	law enforcement authorities;
1	shall accrue from
1	sterile drug means
1	first offense any
2	powdered, dried, or
1	7 to 14.
1	agencys goals and
1	produces the imported
1	committees, to the
1	returned); and (b)
1	respect to labeling
1	pesticides used in
1	measures reasonable and
1	area in a
1	31, 1997) in
1	sentence required to
1	(i) notice to
1	(2) contains a
1	maintain all disclosure
1	582; aug. 7,
1	effects observed early
3	cooperation by the
1	attention and additional
1	submitted to their
1	information, including from
2	registry of accreditation
1	deadline applicable under
1	regulations.  (june
1	(3) use for
1	including ethical standards,
1	trafficking.  (2)
1	carry out seafood
1	antibiotic drugs, devices,
1	exercise authority under
1	(b); (2) the
1	drugs the secretary,
1	1043; oct. 26,
3	secretary.  (iii)
2	(4) knowingly possess,
1	reportable food the
3	food safety activities
1	(d) advising the
2	use the drug
1	(5) with respect
1	required to meet
1	professionals, and the
2	vessel, aircraft, or
1	programs and providers
1	necessary to achieve
1	partially filled. (

3	availability or lack
1	(1) entity the
1	control the hazards
2	meals or as
1	application approved before
1	haccpthis section shall
1	management system; (b)
1	(1)(b) for each
2	officials relating to
1	due to contamination
1	(g) to the
4	(a) and (b),
4	assessments of the
1	six months from
9	application for an
1	regulation may obtain
1	c-licensed partner of
2	support the removal
1	human food. (c)
1	use generic new
1	(g) documentation from
1	subsection (c)(1)(a)(i), issue
1	(1)(d) of this
1	involving paragraph (2)
1	worked for, or
1	tribal authorities, as
1	employ, and fix
2	located outside of
1	secretary must also
1	(b) include in
1	hundred and fifty
2	seq.)  (a)
1	serious injury or
1	parole in any
6	condition for which
1	purpose the amendments
4	obtain review thereof
1	certifications. (ii) such
1	safe for animal
1	(c) media buying
1	use shall, at
1	additive, it is
35	intended for human
1	duties for the
1	record a certified
3	copying of any
2	responsibilities for the
1	reportthe sponsor of
1	approved application submits
1	recommendation was not
1	including the findings,
4	information pertaining to
1	(b). (june 25,
1	secretary from official
1	assess  (i)
1	(iv) a contract
1	process may be
1	availability, if any,
1	(a) national substance
1	registration is required
1	 (d) monitoring
1	use in evaluating
5	otherwise not identical
1	dismiss; or (ii)
2	public meeting on
3	one general physical
1	(6) wholesale distributor
1	states; (b) source
1	pharmacoeconomics, biological and
1	taken, and shall
4	due no later
1	(c) limitation each
2	secretary.  (i)
1	prevent the drug
1	listing shall establish
1	awarded is not
1	6001, and 6151
1	(2) prescription drug
1	indication; or (e)
8	18, any sentence
1	(1) no controlled
1	day after final
1	1st par., 34
2	concerning adverse health
1	(i) pesticides, (ii)
2	person, and trade
1	reach agreement, within
15	years of age
2	drug administration regarding
1	strengthen radiological health
1	confidence and used
1	(iii) seizures of
2	program, including under
1	shall, by majority
2	product from one
1	deterioration, and adulteration.
1	(2) are intended
3	drug application which
1	applied to requests
1	(b) facilitating sharing
1	substance is distributed,
1	(14) because medical
1	good may require;
3	90 milligrams per
8	products under this
1	animals under a
139	respect to a
1	lots of biosimilar
1	grams. (2) not
1	product, as appropriate.
2	tomography drug in
1	labelingto indicate that
2	exported under subsection
1	maintenance of an
2	consequences of drug
2	informative summary of
1	675, 744b, as
1	section 3324 of
1	activities by the
1	impact in the
1	smoke, or not
1	extension in addition
1	system that provides
1	general, a written
1	enforcement efforts are
1	42), including plasma
1	drug (as in
1	except section 360b(b)(1)(a)
1	(6) use the
1	analysis on identified
1	requirement for exports
1	807, as added
1	drug abuse inflicts
1	first applicant. (ii)definitions.in
1	conviction alleged under
2	whether any difficulties
1	applicable state, may
1	enforce a regulatory
3	governments of the
3	protect public health
1	forming because of
1	  b2
1	term pesticide within
4	uses within the
1	it, revoke such
1	transferring ownership in
1	chlortetracycline, chloramphenicol, bacitracin,
2	secretary considers to
3	food yielded by
1	(4) actions by
3	available to establish
1	indication that is
1	existing communication channels,
1	licensing authority or
37	[21 u.s.c. 301
1	
 379j42. authority
2	prices and compete
2	v, or combinations
2	effect of suspension
1	establishment not so
1	
 
 379j61.
1	misconduct.  (f)
1	evading the provisions
1	administration regarding hospital
1	years, or more
1	convention, to the
3	benefits posed by
1	trademarks the secretary
1	support a more
1	specified in appropriations
1	actions (including any
1	report in a
1	establish the applicable
2	title 28. (2)
2	patients and providers
1	filovirus diseases. (r)
1	infrastructure protection plan;
8	upon which such
1	level lower than
1	(1) was issued.
2	levels and initiatives
3	disease or is
1	(c) one member
1	greater collaboration among
1	purposes. (ii)component of
2	fees received under
1	including physician, health
1	675, 525, as
2	informationa serious adverse
1	expose them to
1	securities of any
1	processed foodnotwithstanding paragraph
1	user fees shall
1	(iv) making any
3	prohibition against additional
1	health (established under
1	(i) security of
1	(1) applies with
1	substances manufactured by
2	(ii) a summary
1	(ii) the terms
1	shall base the
2	revoke an exemption
2	requirement, related to
1	internal controls the
2	sale, transportation, offer
1	means each of
1	substance abuse, which,
1	place. (c) judicial
1	generalfacilities identified, or
1	board composed of
2	respecting the class
1	goals and budgets
1	technical aspect of
1	(2) remove the
3	regulations prescribes as,
1	distribution security and
3	guidance on the
3	food because of
1	acquire or obtain
1	includes a manufactured
1	order either affirming
1	describes the procedures
1	device. (ii) in
1	approved by fda
1	 (k) abbreviated
1	fully implemented; (2)
2	policy to carry
1	feasible, use amounts
1	civil penalty is
1	 (3) costs.
2	standard of the
2	 (4) limitation
1	regulations; suspension and
1	 (c) exceptionthe
2	written request from
1	committees interested in
1	sponsor; response by
1	paragraph (2); (7)
1	paragraph, then the
1	persons who shall
1	of, any representative
1	 (ii)forfeiture. 
1	agents; (b) a
6	administration to a
1	use as involves
1	group practice, the
1	injury, is to
3	term tobacco product
1	(ii) the tolerance
1	(2) the offense,
1	 (4) inapplicability
1	conditions of marketing
10	refers to the
2	summaries of information
1	cosmetic means any
18	product development fee
1	case corresponds to
1	generic drug means
5	expenses incurred in
1	body shall ensure
1	submitting a request
5	forthwith transmitted by
1	violation which resulted
1	protocol the information
1	of, the service
1	september 30, 1978,
1	petition contents 
1	business.  (2)
1	-(2,-dimethox--(n-propylphenyl)ethanamine (2cp). 
1	packers of such
1	shall store drug
1	programs, and technical
1	chemical substance named
1	purity; (b) information
2	major manufacturing changes
1	deficiencies in animal
1	reactivation fee under
6	product that has
3	recommendations for legislation
1	distributor who acts
1	period not in
1	sold under this
3	appropriations to the
1	addiction rate, use
6	applicant notice of
1	(ii) is met.
1	investigation that may
1	reviewing division of
1	samples promptly after
3	(iii), or (iv)
1	attorney general so
1	name of, or
1	chemical when used
1	animal drugs has
2	listing of the
1	administrator, may make
1	poultry products. 
1	request whether such
1	chairman, the interdiction
1	handling, distribution, or
1	industry. (b) outreach
1	biological product (as
5	exported pursuant to
1	675, 576, as
1	serving of other
1	costs incurred in
1	interdiction efforts in
3	general there is
1	title 5, code
1	standardsif through testing,
1	26, 2014, make
1	may not withhold
2	penalty provided in
1	actionsno action may
1	serious and continuing
1	applicable to drugs.
1	industry guidance letter,
2	dollar amount equal
1	nonprescription sunscreen, including
1	rehabilitation services shall
1	command the person
1	841 of this
2	abuse relative to
1	supplemental application with
1	(5) agricultural quarantine
2	 (i) requiring
1	shall survive notwithstanding
1	505c, as added
1	residential address in
1	debarment which is
1	title, including with
1	stocks. production quotas
1	practice. when labeled,
1	(9) product identifierswith
1	drug products. (iv)
1	2006 through 2010.
1	country have each
1	title or licensing
1	security for such
1	resume agriculture, food
2	application any person
1	subsection (e)(1)(c), or
1	 (c) appointed
1	portions and the
6	laws of such
1	valid affidavit that
1	884. immunity and
1	recipient in 
1	special expertise, are
1	commissioner, and ensure
1	license rule, or
2	care entity that
1	18-day period to
1	advisory commission adequate
1	general beginning after
1	613, 2, 62
1	use the voucher,
1	(d)(3). written requests
8	increased or decreased
1	basis regarding the
1	agency. (b) a
2	title or licensure
1	wave, which is
8	determination and order
14	requirements of paragraph
2	secretary certifies that
3	will not have
7	finds that none
1	informing them of
1	vehicle) to determine
1	show that other
1	tentative approval as
1	appropriate as a
1	annual basis, in
1	distribution of carcasses,
1	propertythe following shall
3	combination product, the
1	businessesnotwithstanding any other
1	reviewthe secretary may
1	(i)(i), except for
1	notified firm, or
2	five years and
1	equines. (f) the
1	time thereof contained
8	(i) with respect
1	public health. in
1	expired or who
11	satisfaction of the
2	food safety officials
1	264] and part
1	available, such as
1	annual accounting (including
1	seller to disclose,
1	section applies; (b)
1	consul that he
1	fine under this
1	device establishment and
2	 (c) liability
1	entity need not
1	actionsin addition to
1	whose application has
1	secretary may refuse,
1	rather than a
3	(1) a description
1	methodology  (a)
1	revoke such license.
1	analysis) that identifies,
1	rate for premarket
1	drug applicationsexcept in
9	definition of a
1	provision through (1)
2	beginning on november
1	applies standards described
4	title 31. 
5	disclosure of information
1	clearance for those
2	transfusion, does not
1	(m) separation of
1	section 334(a)(2). in
1	(c)class iii, premarket
1	involved of the
27	shall have the
1	1521 et seq.).
2	drug abuse issues
1	(vii) encouraging insurance
1	human health (referred
1	budget proposal designed
1	device, the suppliers
1	differences of opinion.
1	revocation of tolerance
1	comply.  failure
1	pharmacological effect, if
1	user who has
1	based on electronic
1	except that failure
1	applies if 
1	(1)(c) and which
1	proper. following entry
1	breakthrough therapy and
1	clinical endpoints, including
1	administrative inspections (including
1	execution of an
1	including foreign grown
1	per year of
2	human use (a)
1	information. within 15
1	supplement submits to
2	participation to constitute
1	training, and operational
1	(b) second offense
1	substance in schedules
4	entry of an
1	353b. outsourcing facilities
1	control strategy, to
1	consumption patterns of
1	testing and other
1	recipients. (e) an
1	meet applicable statutory
1	appeal no labeling
1	assisted or participated
1	investigational drugs for
1	animal feed. 
1	food. (june 25,
2	investigation that a
2	article, as the
1	chapter. (10) 
1	reclassified as a
1	disclosure  (a)
1	writing that there
1	(b) publication by
2	management and budget.
2	 (1) additional
1	publi-private partnership, shall
1	foreign narcotics traffickers,
1	filing (a) eligibility
1	criminal forfeitures, shall
1	final. (i) public
1	location, which shall
1	1976, or both.
1	excluding the commonwealth
1	shall select at
1	 (d) contracting
1	applicability; preemption (a)
5	strategy  (1)
1	commerce an article
2	avoid, insofar as
1	regulation exclude any
1	nanomaterials in domestic
1	planthe plan required
2	coordinator shall, on
1	expedited consideration of
1	prior approval supplements,
1	supplant any other
1	federal civilian and
1	veterinary medical associations,
1	(e) the point
1	dealer of tobacco
1	drug being tested;
1	december 1, 1995,
1	requests, the number
1	use disorder in
1	one hundred thousand,
1	producer shall be
1	security and in
2	(ii), the applicable
14	federal trade commission
1	5311 of title
3	anything of pecuniary
1	shall be identical
1	including specific citations
1	appropriated, the sum
1	tobacco use, the
6	possessed by the
1	one subpopulation can
1	dispenser in paper
2	reviewed, that the
2	360(k), 360b, or
2	action, that under
1	(iv) individuals who
5	24, 1984, the
7	 (b) no
1	days.  (h)
1	medical relationship by
1	active risk identification
15	subsection (b) and
1	update annually 
1	 (7) report
1	conditions, as determined
1	individual requests. (d)
1	business shall be
1	finds that it
1	refusing to sell
1	subsection (a)(1); and
1	(2) reportable food
1	3-month period if
3	state engaged in
6	pilot projects under
2	tentative approval. 
1	include a prominent
6	applicant or registrant
2	purchase of tobacco
1	103417); or (2)
1	(c) has been
2	penalty shall be
1	authorized; (b) the
1	subsection (f) in
1	classified information procedures
1	subsection. (2) deposit
1	loses a portion
1	(2) except in
1	subsection (f)(1). 
1	receive such notice,
1	drug traffic in
1	receive such notice.
2	$25,000,000 if the
8	portions of the
1	resulting pesticide chemical
1	reporting requirement on
1	another applicant if
1	cause such other
1	markets, or sells
1	commission the term
1	uses such additive
40	(b) of this
1	category listed under
6	within the specific
2	violation. for purposes
2	shall support the
1	year. the fee
1	force of the
22	person other than
1	member is engaged
1	[1] shall be
1	entry, or exportation
1	amendments, and regulations
1	time after, the
1	licensed pharmacist and
1	employees conducting interoperable,
1	specified by regulation,
1	tol-free number; and
1	affirm, modify, or
1	depositions in order
1	importation milk or
1	device, of any
4	date or dates
1	implant containing silicone
1	application, during the
1	regarding any product
1	1967, that a
1	business practices, and
2	amount of refund,
1	into, or received
3	includes  (a)
1	register shall set
1	 (b) list
1	setting and amounts
1	(2) manufacture any
1	387f1. enforcement action
1	consumption and food
1	 (7) civil
1	(ii)qualification.the secretary shall
1	notice to purchasers
1	and/or information known
1	(f)(1) of this
1	claimant only to
1	subsection (j). 
1	investigations or to
1	year 2019 and
1	final sunscreen order.
1	made with raw
1	regulation prescribe are
1	critical path reports
2	9, 2012; and
6	setting aside, in
1	distribution, procurement, and
1	way that it
1	established name prominently
1	additives established by
1	means any partnership,
1	wholesale distribution located
1	compliance and other
2	action; or (b)
1	respective functions and
1	recruitment through nongovernmental
3	sudden increase in
1	professional care such
1	5.  (5)
2	costs and talent
1	individuals, particularly those
1	listed chemicals, and
1	evaluating the results
2	completion has become
1	been, distributed; and
1	natural form prior
1	(41) racemoramide. (42)
1	amounts under subsection
1	facility, and new
3	time of entry
1	activities of those
1	requires hig-level coordination
1	shall include providing
1	require an importer
1	initial dissemination. with
1	subparagraph (h) to
2	women, or children);
2	data submitted by
3	residues in such
1	secure, interoperable product
1	subchapter, shall be
6	sufficient quantities of
1	alert by the
1	facility shall monitor
1	(i) the probable
23	delivered for introduction
1	secretary made use
1	drug concentrations in
1	regulations thereunder, shall
1	official classification of
3	secretary shall improve
2	ante mortem inspection
1	year, including but
1	entered into the
1	fee by company
2	cooperation and payment
1	auditor; and (iii)
1	contains not more
2	otherwise than as
1	consult with regulated
5	5 percent below
1	paragraph (2), such
1	tolerance is proposed;
1	(b) the director
1	quorum six members
4	apply under this
1	records.  (j)
2	submit, for the
2	applicable laws. (3)
1	(i) the physician
6	means a request
4	event reports for
5	secretary for a
1	government employee (as
1	subchapter, whether by
1	subsection (m) and
1	administrator and within
1	confer, either in
2	upon certain convictions;
2	 (c) each
1	dextromethorphan shall not
2	(iv) of such
4	(a) in generalnot
1	cos-effective manner. with
4	day (including traveltime)
3	medical gas deemed
2	(c) immediate notification
1	participated directly in
2	 (1) effect
1	violation for which
1	timeline for implementation
1	refuses to file
1	undertaken by a
1	affected thereby. (june
1	drug products. 
1	 (a) exclusivities
1	notifications related to
1	guidance specifying whether
1	pharmacies, practitioners, or
1	(b) the administrator,
1	device (i) which
1	comprised of individuals
1	agents identified in
2	views before any
4	secretary, not later
1	herein imposed. (mar.
1	conditions, and privileges
5	types of devices
1	amounts are limited
1	control officials and
1	qualified facility subject
5	safety programs, systems,
2	narcotic drugs, marihuana,
1	(a) in determining,
1	term raw material
1	united states, of
1	submit information obtained
1	whether the item,
1	animal use which
1	dispute resolution the
3	public interest and
1	sell, distribute, or
1	packets or pouches.
18	united states, or
1	possessions, and those
1	testing and screening
2	 (1) authoritythe
1	effect, and thereafter
3	total percentage change
6	(as defined by
1	intense magnetic fields;
2	requirement regarding devices
1	transfer, with respect
1	linoleic acid) 
1	report, a supplement,
2	shall establish, and
1	respect to antibiotic
1	united states, who
1	commission.  (2)
2	later than 36
1	alphaprodine. (2) anileridine.
1	danger  (1)
1	will serve to
1	faith, unless he
1	(4) safety labeling
1	receiving any funding
1	foreign purchaser, when
4	(b) give the
1	federal officials relating
1	require labeling to
2	procedures under which
4	long as such
1	exceed $250,000 in
1	shortfalls  (i)
1	information. (2) for
1	patient safety, the
2	includes (until otherwise
1	preventing the occurrence
1	official compendium shall
1	secretary may identify.
1	hold is a
6	reclassification of a
1	drug or which
1	development of one
4	internal revenue service
1	documents the scientific
2	may not transfer
1	 (b) plans
9	intentional adulteration of
3	penalties for violation
1	(b) 5,000 or
1	claimants; jury trial;
3	issuance by an
1	online pharmacy will
1	title or are
1	deferral extension shall
1	(a) through (g)
1	share information on
1	(b) exempt requirementsupon
1	rate payable at
1	ingredient) which has
2	distribution, or dispensation
1	steroid, which is
1	observations made, other
1	material false, fictitious,
2	applies.  (2)
1	disseminated in any
4	life of the
5	apr. 11, 1953,
6	without any modification
1	design validation, packing,
1	them:  (1)
1	
 
 360e1.
3	seem proper. the
2	new medical, scientific,
4	person who imports
1	reliable information. (b)
1	discontinued products compiled
16	letters described in
1	ensure that drug
1	donate property for
5	order and the
1	appropriate information with
1	regarding all tobacco
22	written notice to
2	brought under this
1	held or displayed
1	clearance of an
1	behavior and a
2	expired; (bb) neither
4	listed chemical shall
1	treatments to destroy
1	first application under
1	evidence sufficient to
5	opinion during the
3	optical isomers of
1	provides the date
1	supplemental information supplied
1	negotiable instruments, and
2	following persons or
5	modify any exemption
2	revoke, or suspend
1	protocol that further
1	enforcement, and other
2	property comprising a
1	make to allow
1	product.  (24)
1	agricultural commodities. the
1	related to safety
1	country in accordance
1	stores with respect
1	determines that serious
1	strategies; and (3)
1	by, or purported
1	chronic dietary risk,
3	whole, including users
1	used products; (d)
1	receiving products involved
1	program and tactical
1	unless conditions are
2	another food; (3)
3	[21 u.s.c. 151
3	control policy to
1	harmful impact in
1	controlled substances, be
16	progress of the
1	practice and identifies
1	oppose any attempt
1	 (5) to
1	warrant shall give
1	verified the returned
6	hearing under this
1	committee member to
1	references such a
1	$50,000,000 in gross
1	agency. (june 25,
4	names and other
1	financial interests in
1	detail to another
1	condition and 
4	 (d) information
2	unavailability of information
1	entity that submitted
1	treated, and the
1	delivery be made
3	shall give to
3	analogous products, for
1	provider to identify
1	products, particularly antiquated
3	less harmful than
1	leaves imported under
1	receive a controlled
1	title iv, 404,
3	title, the sponsor
15	related to such
1	(a)(1), the director
3	drug administration the
1	(1)(a) shall 
1	products of growers
2	civil penalty 
2	incident command operation
8	label bears, in
1	designation; exempted operations;
1	regulation accordingly. the
1	schedule for submission
1	drug for inclusion
1	obligation and remain
1	submitted after march
1	2223. enhancing tracking
2	evaluated on the
1	amended thereafter or
1	74, 2, 38
2	applicant obtained an
1	(j). any number
1	whether an endpoint
1	implement food allergy
3	access to external
3	receive compensation for
1	 (c) determinations
1	be. (7) if
1	manufactures active pharmaceutical
1	states or if
1	requirements (a) generic
1	(i) shall 
10	named as the
1	25.0e  
1	requests a hearing,
1	petitioning state may
2	regulated transaction to
1	subject of judicial
1	drug products when
1	abuse. to reach
2	forth criteria for
2	(d).  (b)
1	part d of
7	(2) collections and
1	waived.  (4)
1	(1) that provide
1	reusable medical devices
1	refuse to comply
1	acts as would
1	made.  (june
1	
 379b. consolidated
1	experience relevant to
1	states in discussions
1	subparagraph (d) not
1	adolescent psychiatry, and
1	exported may be
1	statement by reason
2	populations such as
1	principal, ultimate financial
1	new, unused singl-use
1	contains a nucleotide
1	filled cheese act
1	foreign cooperative, or
1	dose recommended does
3	national formulary monograph,
1	registration.  (c)
2	initial date of
2	order, or the
1	notwithstanding the first
1	drug before 
1	bonuses, if applicable;
1	basis  (i)
2	effect, in case
3	deems such action
1	convictions; other provisions
1	discussions such discussions
1	ingredient manufactured in
1	timeline under subparagraph
1	paragraph or in
1	writing the type
1	periods.  (8)
1	locations of the
1	sections 343(q) and
1	court at the
1	exporter mean a
2	applicable); or (2)
1	equipment, without upgrading
1	(d), each online
1	ch. 26, 41
1	court or the
1	enforcement agencies, shall
1	require, (d) information
1	chemical residue on
2	witnesses in the
1	term indian country
1	order to safeguard
1	sources to ensure
5	effective and otherwise
6	action brought under
1	(
 
 1545.
1	employed in accordance
1	(or such greater
1	distribute drugs near
1	iii, 541, formerly
1	particularly individuals in
1	(f) sunset subsections
1	enforcement agency which
3	appropriate.  (3)
1	published in part
1	trafficking area. such
1	purchased, to a
1	listed by its
1	(b) a poultry
1	qualification the terms
1	(b); and (ccc)
1	drugs, and finished
1	administrator, be sufficient
1	determinations on studies
1	conviction, be punished
2	approval has not
1	due notice, shall
1	use have not
1	product, except that,
2	inspection services for
1	indirectly derived from
1	sponsor that submitted
2	information, that the
2	entities to help
1	political subdivision to
1	secretary has evidence
1	federal and federa-state
2	food certification under
2	local agencies, and
2	(1) authoritythe administrator
3	agricultural commodity; (ii)
1	mean the consular
2	title and not
7	every person required
1	application as producing
1	certified such government
3	(b) the responsible
1	assistance for the
13	(2) in the
29	subsection (a), the
1	track supplement, a
1	floor (or to
1	concentration provides for
1	dispensed upon oral
1	subsection respecting the
1	 (j) venue
1	request on the
1	november 27, 2013;
1	november 27, 2013:
1	importer and exporter
1	360d(c)(1) of this
5	applications  (1)
1	continued performance of
3	derived from investigations
4	 (e) effect
1	surgical facility, nursing
1	title, that demonstrates
1	receiving, holding, or
1	effect may file
1	engaged, including traveltime;
6	fees, may be
1	agency shall comply
2	may order a
1	legally marketed antimicrobial
1	otherwise apply; (2)
1	notification thereof to
1	states swine populations.
1	clinical investigations have
2	including judicial review
1	criminal investigation or
2	applicable law 
1	required postmarket surveillance,
1	dismiss.  (b)
3	secretary on an
1	engaged, including traveltime,
1	drug test, either
2	national methamphetamine information
2	applications and biologics
2	transfer the voucher
1	importing of electronic
1	flagrant and repeated,
1	general and upon
1	meats are to
4	section 1532 of
3	shall pay the
1	methods repository for
1	manufacture such new
4	fees, late payment
2	study plans, agreed
2	impact of requirements
1	reports to be
1	(a)(2)(d), a person
1	(c)(2) shall have
1	provided for section[3]
1	documents conclusions from
5	drug shall not
3	prevention and control
1	delivery, sale, movement,
1	votes between representatives
1	human services are
1	21, 1972, shall
1	(i) saleable returnsnotwithstanding
1	remove susceptibility test
3	appointed under paragraph
1	will have usefulness
1	secretary shall amend
2	4, 1913 [21
1	entities in expanding
21	shall be the
2	administration for each
1	recommendations on 
1	providing that 
2	evaluate methods to
1	sells tobacco all
14	shall specify the
1	shall proceed as
1	effect before one
2	ingredient is absorbed
6	action is brought
1	office shall be
1	portion and identify
1	production, harvesting, holding,
2	person requesting such
1	smoke. nothing in
2	forth by the
1	stay all proceedings
1	subsection (a)(1), if
2	application to certain
1	products because of
1	law, (2) would
1	(5) the attorney
1	name and location
2	conduct such surveillance,
1	(c) in establishing
3	include a timeframe
1	preparation; and the
1	321a. butter defined
1	registration statement if
1	renewal; refusal of
1	recorded in a
1	(2) sold or
2	tested under the
3	contains any artificial
1	commencement by the
2	100 kilograms or
1	(2) which is
1	years and 180
1	
 
 360e.
2	product such that
1	imports the secretary
1	
 1047. refusal
1	1- and 1-yea-olds.
1	contents of frameworkthe
2	maintain records required
2	due each subsequent
2	transportation, which is
1	accredited laboratories; (b)
1	conducting those tests
1	 (i) when
1	section 803.19 of
1	means any specific
1	ongoing dialogue and
1	deficiencies; or (ii)
3	behalf of or
1	submissions  (1)
1	owner or lienor
3	broker or trader
3	(2) date of
1	index, and revise
17	year, the secretary
1	able to make
2	effective period of
1	(a) prevent unauthorized
1	modified, if needed.
1	federal officials, manufacturers,
1	subsection, is approved
1	development act (7
1	establishing dates by
5	shall be permitted
6	available in each
1	criteria, processes, and
1	
 360e3. breakthrough
1	establishments (referred to
1	direct or circumstantial
1	especially the causes,
5	similar to an
1	 (1) retail
1	projects, demonstration projects,
1	analyzed, and reported
1	unless specifically stated,
1	critical informationexcept with
3	product is substantially
1	rotating, sequential basis
1	region.  (5)
1	entry and shall
2	(5) whether the
2	(i) in generalthe
1	receiving funding directly
1	3 years thereafter,,[1]
2	fee for generic
2	prescription has been
1	seek any information
1	sale provisions the
1	rural areas, the
2	(5) any action
3	risks to the
3	shall follow the
1	(3) who is
1	(j)coordination.  in
1	(d) sales under
1	homeland security. the
1	secretary do not
1	members with diverse
1	studies in neonates,
3	adjusted under subsection
1	date and authorize
1	inspection compliance is
1	secretary a covered
2	existing device, dated
1	thereof solely for
1	application, whenever appropriate.
1	reports and inspections
1	restriction; project evaluation;
1	(3) the exporter
13	illicit drug use
1	mortality for patients,
1	health and with
2	withdrawal period, or
1	shall the operating
1	(h) separate registrations
1	detailed information and
1	section, and (ii)
1	application, for an
1	benefit, and, where
1	devices.  (c)
1	(j), and not
5	january 31 of
1	grant in carrying
1	679a. safe meat
1	appropriate community service;
1	may be satisfied
6	determines such action
1	date otherwise applicable
1	establishment, and such
1	secretary shall after
1	and, when deemed
1	subchapter, the amount
1	year 2008; (3)
1	(3) whenever in
3	if, on or
1	chemicals, and other
1	date; (iii) an
1	period would have
1	prescription is not
1	identifies major programs
1	production of each
1	aside.  (2)
9	designated medical gas
1	conventions designed to
1	health because the
14	entry of the
1	2014, $11,300,000; (2)
1	 (1) on-time
1	engages in conduct
1	exemptions and consideration
1	entities may distribute
1	(c) fift-six percent
1	construed as indicating
1	line item basis,
2	explanation of how
1	assetsexcept to the
1	title to property
1	secretary are not
4	determined in accordance
1	(6) limitations 
1	means determining whether
1	year (as adjusted
1	send 1 or
1	applicable terms and
1	provide a part
2	(4) generic drug
1	registration number assigned
2	listed chemical product,
1	completed under this
1	permit have been
1	campaign under paragraph
3	drug product. 
3	secretary may conduct
1	prior to promulgating
1	(vii) requests funding
1	ch. 477, title
1	submitted and the
2	(a) definitionsas used
1	notification, or other
1	localit-based comparability payment
2	advisory committee, to
2	diversion control. if
3	lieu of, criminal
1	finds the data
1	fees authorized to
1	register the final
1	available in connection
11	years, or both.
1	title, (c) if
1	delivered.  (c)
1	amended under this
1	may be met
2	package submitted under
1	particular use (for
3	indictment or information
1	title 42. a
1	process approved pursuant
2	package; or any
5	360b(d) of this
1	term abbreviated new
1	participation in clinical
2	subsection (d). (b)
1	investigation data from
1	transportation in methamphetamine
1	employee for such
1	illness outbreak means
1	tim-sensitive campaign needs
1	title; (b) to
1	connection therewith. 
3	society of addiction
6	drug, device, or
2	factors as are
24	shall be required
1	include the preference
1	(7).  (c)
1	effectiveness of pediatric
1	2010, the director
2	article which may
1	ingestion of all
1	active ingredient, if
1	c-located on farms,
1	determining the primary
1	scientific evidence, acceptable
1	portion. (c) whenever
1	1622(h) of title
1	360eee4. uniform national
1	injury means bodily
3	order and on
1	accurate reports, necessary
2	person is making
3	restrain violations of,
1	requires otherwise by
1	knew of, or
2	order and of
1	treatment expansion and
1	(b) malaria. (c)
2	manner. the secretary
8	failed to meet
1	substitute property in
1	adequate information regarding
1	holder, or a
1	advertising containing a
1	projects under subsection
1	slaughtering and/or cutting
1	drugs tested using
1	later effective date
1	of.  (c)
1	residue under clause
1	store for purposes
1	filing of lists
1	products out of
1	manufacturers; (viii) information
2	justify any deviation
5	i-person medical evaluation
1	applicant to be
4	conduct of the
1	convene the panel
3	national security, foreign
1	(i) the defendant
1	(2) foreign person
1	food for infants
1	title, and foreign
1	 (ii) response
1	testing site; or
1	general by this
1	 (a) affiliate
6	protect against the
1	mandatory conditions; direct
1	pediatric patients; or
2	claimant did not
1	proven successful or
1	feed is an
1	iii, the secretary
1	type of devices
1	finding of an
1	presence, by his
1	(g) certain measures
1	groups, professional scientific
1	masks; (5) roach
1	agreements by applicant
1	whose shell is
1	675, 806, as
1	(iii) five members
1	(e) marketing of
1	(iii) the results
1	index listing have
1	single package or
4	paragraph (6), or
1	ex officio membership
2	controlled substances to
2	paragraph (3)(c) and
1	rules as the
1	reasonable opportunity to
5	provisions of subchapter
1	annually to encourage
1	hazards that could
1	whole, including injunctive
1	mitigating drug shortages.
1	it, if such
1	novo classification under
1	issuance and posting
2	standards as may
1	weight, 10 kilograms
1	knew of such
2	small or certain
1	secretary may reject
1	release described in
1	food complies with
1	controlled substancesnotwithstanding sections
2	commissioner shall refer
1	claimant has filed
4	taken under the
1	(d) trading partner
1	auditor, through the
1	administration have any
1	reports of basic
1	certification or board
1	columbia. (june 25,
1	 (ii) subject
1	(1) allowing safe
1	 (d) scheduled
1	u.s.c. 714b or
2	42 stat. 1487.)

1	permits to any
1	state offense consisting
1	 (b) conferences
1	exclude any substance
2	351(h) of the
1	growing conditions and
3	businesses  (a)
1	implements a methods
3	year that is
1	administrator shall revoke
2	telephone number described
2	applicant, the establishment
1	2020, unless the
1	modification, a notice
3	agreement shall not
1	governmental agency, or
1	purposes and strategy
1	government reform, the
1	petition for regulation
1	business enterprise; (ii)
4	direct accreditation under
1	case of liniments
1	including one or
1	prescribe, or their
3	access to, and
1	discretion, accept a
1	topical application; (b)
2	subject to requirements
1	powers  (1)
1	day it arrives
1	(c) inapplicability of
1	purposes of improving
1	determination shall 
1	assure that an
1	evaluations received by
4	court that such
1	age groups often
1	charged with a
1	foo-producing minor species,
3	date rape drug
1	(c) a notice
1	 (f) records
1	hardship to such
1	term federal benefit
2	secretary documentation detailing
1	requirements to carry
1	(1).  (4)
1	device, a representative
1	discontinues the dealing
1	control plan of
3	drugs, devices, and
2	filed; or (ii)
1	animal feed, 
1	(f) removal of
1	information panel of
2	correspond to that
1	 (f) prioritizationthe
1	schedule and which
2	year and once
4	electronic portal established
1	disease product shall
1	distribution under section
1	passed, whichever occurs
1	transmitted the notice
1	approvals per petitionsthe
1	dietary ingredient will
1	executing this chapter
2	drug administration by
1	shall so refer
1	title before such
2	component parts in
1	opportunity after the
2	grants to eligible
1	program agencies pursuant
1	administration).  (b)
1	taken a copy
1	employees; (10) sue
1	includes an assessment,
1	issue a special
1	application for reinstatementa
1	july 27, 2011,
1	forms issued under
1	 (3) substancesin
1	guidance documents describing
1	decision; or (bb)
7	employee at all
1	term retailer means
1	subparagraph (b)(iv) shall
1	foreign commerce and
1	applied after harvest,
2	facility (including any
1	diet of the
1	emit) electronic product
1	basis as new
1	procedure in cases
1	youth on a
1	paragraph (1) (referred
1	date it becomes
1	(2) claimant 
2	delay, or serve
1	section, means an
1	pay in advance
8	salts, optical isomers,
1	protocol each applicant
1	administered as a
3	substances  (1)
1	requests were not
1	maintains procedures to
4	public interest that
1	6 months into
1	auditor for which
4	food may be
1	warehouseman shall be
1	262(a)], the secretary
1	shall handle and
1	2235 of title
1	providing educational materials
1	product; (b) in
1	pending in two
1	located, may transfer
1	request such an
2	subsequently transported in
1	augmenting such systems
1	2015  (i)
1	intent to initiate
1	types of business
10	registration under section
1	$2,000, or by
4	applications or which
1	except a requirement
1	ch. 675, 751,
1	specify in regulations.
2	pilot projects 
1	 (e) protective
1	requirements; persons liable;
1	car, hopper car,
1	take into consideration,
3	secretary to issue
1	prescribe such form
1	subparagraph (a)(vii). 
1	standards recognized, or
1	substances.  (d)
1	ensure that food
1	incurred, under any
1	fees that may
2	decree, be disposed
1	compound or order
3	human use which
1	trade secret and
1	records of approval
1	safely be employed.
1	state licensed or
1	(b) sponsor of
1	subdivision thereof, duly
1	practice of pharmacy;
1	person determines there
1	deem proper. (mar.
6	determination that such
1	paragraph (c), he
13	information before the
1	consistent with ensuring
1	 (f) relation
1	countermeasures  (a)
4	required under such
14	processing, packing, or
2	secretary shall regularly
1	supply, and to
1	inspect establishments described
1	recalled food is
1	section 360e(g)(2)(a) of
4	agency under this
1	otherwise restrict the
1	request time period
2	951 et seq.].
1	(l) salable drug
1	360eee. definitionsin this
1	(c) consistent with
2	shall inspect not
1	consideredin removing a
1	provided as required
1	secretary increased scientific
1	business, the -mail
2	device  (1)
1	42 with respect
1	811(f) of this
2	mules or other
1	form. for purposes
1	exceed 6 percent
1	exemption shall continue
1	discretion, has issued
1	effect, procedures and
2	seq.]; (iii) in
1	public health. (6)
1	purchasers or who
3	assessed in accordance
1	regular distribution schedules.
2	energy source, or
1	(1) an accredited
1	(d) grants by
1	biotechnology industries; (ii)
1	treasury to remove
1	subsection (f)(5); (10)
1	redeemed, at no
1	eligible entity during
2	regulations and policies
1	development.  (2)
2	(d) appears otherwise
1	panel appointed under
2	human food, solely
1	increased under subsection
1	agreement under this
1	(e) expedited development
1	emergency resulting from
9	(6) the term
1	communication or recall
1	(ii) the effective
3	domestic and international
1	treasury are authorized
2	require for the
1	test shows the
1	notice is received,
1	term returns processor
8	paragraphs (1), (2),
1	standards (a) reasonable
1	state and political
1	request for appropriations
1	local jurisdiction, with
1	prominent claim. (3)
1	inspection of registered
6	effect, or revoking
1	leaf with nothing
1	subject to that
3	exemption or variance
3	used for human
1	nighttime as well
1	following its receipt.
1	 (ii) transfer
1	request over protest,
1	(d) coordinate with
1	development and submissionin
1	development authority, the
1	679b. pasteurization of
1	1996, issue of
1	change in components,
2	business information. a
1	multiplying  (i)
1	section; or (iv)
3	secretary shall initiate
1	element described in
1	rule. any such
1	(2) standardized numeral
6	unless the person
1	(b) the patient
1	poultry producer, and
1	members described in
1	(1)(c); and (b)
1	demonstrated that the
1	entities operating the
3	july 1, 2000,
1	42. (b) regulations
5	 (3) periodic
2	standards for residues
1	commercial loss to
1	good title to
1	sectors of the
1	section. such list
1	records of other
1	convictions, unless before
1	occurring estrogen, or
1	party the term
1	ingredients becomes available
1	otherwise disposing of
1	technology should continue
1	foo-an-mouth disease in
1	makes a requirement
7	real world evidence
1	described) sold by
1	chapter is maintained
2	increase the frequency
1	675, 903, as
1	number under this
9	830 of this
1	articles imported into
1	excepting solution or
4	subsection (a), under
1	high as 30
5	issues of material
1	cooperation and consultation
1	days set forth
1	 establishment registration
5	court decides the
1	(ii) the technology
10	act (42 u.s.c.
4	 (i) authorization
1	862b. sanctioning for
1	institutions; or (b)
1	manner as approved
2	provided for unsupervised
1	study of pharmacy,
1	drug submissions, and
1	name of which
1	priorities. (iv) a
1	improve the collection,
1	date (or within
1	(2) is operational,
1	exceeds such costs
4	subchapter and subchapter
1	(ii) nonreceival if
1	practitioner at any
1	managing ports of
1	unless such person,
1	terminate such order,
3	(b).  (d)
1	period. (c) market
5	product, the repackager
1	forfeited and the
1	submits a certification
2	imposed under said
1	establishment under inspection
1	tracing requirements, including
1	court, or, upon
2	business which is
1	pharmacies  (1)
1	regulations, unless any
1	result in adverse
1	 (e) restricted
1	offense occurs in
1	body solely for
2	participate in meetings
1	conducting, and evaluating
1	adul-written publications. (4)
3	submit a copy
1	agents to detect
3	homeland security to
1	methods and results
1	paragraph, finds, on
1	quality, the centers
1	officials.  (v)
3	felony under federal
2	ingredient, information submitted
1	title 47; are
1	diversion control programs
1	become effective; or
3	inform purchasers as
1	section 321(s)(4) of
1	iv shall, when
1	section 5316 of
3	devices which are
1	chapter respecting a
2	place such applications,
1	period, the average
1	shall dismiss without
1	complete and received
1	desirability; use in
1	(c), 52 stat.
2	notice of completion.
5	construed as a
1	guidelines as a
26	purposes of paragraph
1	registrant reported under
1	(
 
 1709.
5	welfare of the
1	law enforcement authorities
1	that, at that
2	food because the
1	condition.  (b)
4	expenses account of
1	office of each
2	food or fraud
1	with, and otherwise
11	drug trafficking area,
1	(f) final agency
1	avoirdupois ounce does
1	later than 100
1	 (6) nothing
1	approval is as
1	program in fiscal
2	identification of tobacco
2	conduct sufficient to
2	reported $100,000,000 or
1	person to engage
2	responsibilities and policies
1	identified under subparagraph
1	place them in
3	statement from the
1	(d) no-prescription drugs
2	petitioner shall furnish
1	acts involving matters
1	identifying a qualifying
1	premises and conduct
1	submit a certification
2	regulation or by
1	particular product; and
2	publicly available, in
4	(d), (e), or
1	amounts.  (e)
1	effectiveness of procedures
1	(d) knowingly distributing
1	debarment beyond the
1	trends in, demand
4	goals of the
16	courts of the
2	necessary, if the
1	reduction initiatives, which,
2	conducted at the
1	product by established
1	quantities exclusively for
1	conviction of the
1	food with residues
1	secretary. (i) coordination
1	using targeted direct
1	(b) records following
1	resources available under
1	statement to the
1	indexed; (c) product
1	food actually treated
1	pregnant women, and
5	(in the case
2	forthwith designate any
1	(1) the individual
1	pharmacy, or a
1	of, and given
2	due provision for
2	time the application
2	totality of scientific
1	822a. prescription drug
1	advisory council for
2	sale or use
1	subparagraph (d), require
1	nonenforcement; designation of
5	year (excluding the
1	drug administration after
1	president submitted to
2	section. (4) the
2	indication or other
1	(1) assistance under
1	section. facilities that
1	sharing information in
3	testify or provide
1	2291j1 of title
1	permitted by this
1	establishments accessible to
6	food  (a)
1	reduce, or mitigate
1	review. (6) the
1	involved in paragraphs
70	within the meaning
1	trade; (ii) conducting
1	(c); (b) provide
1	shall analyze how
2	date of approvalfor
1	drugs as qualified
1	producing the residues
1	lost the power
1	administration used to
1	year 2017 
1	categorizations of such
1	are, or he
1	posted information 
1	establish the relevance,
1	agencies, institutions of
1	marketing, and distribution
1	product and any
1	current drug use
1	use.  (f)
3	consider the recommendations
1	development and issuance
3	distributor shall promptly
1	networks to rapidly
1	regulations concerning nonprescription
1	(ii) the existence
1	articles or substances
3	appropriationsthere are authorized
1	conduct any required
1	517. repealed. 

1	ingredients in sufficient
2	government entity, if
1	(i) the average
1	information concerning modified
1	inclusion of such
1	information, at a
1	675, 772, as
1	one, for providing
1	interstate and foreign
1	justice. (ii) the
1	operator shall submit
2	period, as agreed
2	without assistance under
1	(a) prepare the
1	containing information proposing
2	review or addendum
9	regulated industry. 
2	dispensed to patients
2	required to obtain
1	675, 407, as
1	device. (b) any
1	order to amend
1	duties of that
1	(i) approval letters
1	fine, or both,
1	office, shall include
1	products industry. 
4	formulation of the
3	tobacco products which
1	contractor, or (b)
1	partnerships to coerce
1	grants the provisions
1	may hold additional
1	identified in paragraphs
1	use aggressively and
1	allow airflow) to
1	include criteria for
1	title any individual
1	animals) of such
2	order temporarily suspend
1	distributor that has
8	carcasses of any
1	summary or the
1	(a) submissions from
2	safety.  (e)
1	views of a
1	fiscal year. funds
3	june 22, 2009.
1	suspend the registration
2	set forth 
1	material used in
1	website, and at
1	audits.  (c)
1	accreditation. any resulting
1	(2) on or
1	construed to exempt
1	(i) requirements until
1	opium. (b) nonnarcotic
2	color additive (or
1	section 2012(b)(1) of
2	may be presented
3	type of uniform
1	30, 2012, the
1	selected from governmental
1	207, 302, 304,
4	artificial coloring, or
2	centers within the
1	approval, licensure, and
3	practitioners in the
1	analyze, or aggregate
3	order  (a)
1	public process, update
1	poultry carcasses or
1	secretary may at
1	investigation or proceeding
16	general  (1)
3	label means a
1	solely administrative services,
1	year 1997 multiplied
1	conducted information was
1	(2) fee setting
1	modified risk productsexcept
1	list of conspicuous
1	 (b) issues
1	address the specific
1	control drugs outside
1	countermeasure application. there
1	section;  (ii)
1	device; (c) adopt
1	(ii) public or
1	described in terms
3	bond providing for
1	$500,000 to establish
1	institutions and generally
1	places no person
7	request under this
1	enforcement a state
2	find that the
1	manufacturers.  (4)
1	manufacture  (1)
1	section 353(g)(5)(c) of
1	medical relationship that
1	prescribe medication under
1	yet been accredited
1	(a) upon a
1	iii is a
2	law.  (7)
3	stat. 1049; 

1	state standards the
1	final rule regarding
2	may establish an
1	(ii) allow for
1	logistics providers under
1	coalition seeking a
1	parallel scientific advice
1	paragraph (2) (referred
1	missionthe administration shall
1	proceedings as to
1	(i) distributions of
1	programs and enhancement
1	processed at any
1	subparagraphs (a)(v)(ii) and
1	development organization of
1	tolerance. (3) notice
2	(v), and (vi)
1	shall receive or
1	(6) may not
3	egg products, or
5	n-cost match advertising
1	greater level of
1	appropriate, expedited and
1	353(b)(2) of this
1	management systems are
1	subsection (a)(1)(c) of
2	remains in effect
2	section 355e of
1	15, 1994 and
1	identification of resource
1	determines appropriate, recommendations
2	site established under
1	general (which shall
1	section 379j(a)(2)(b)(v) of
1	facility if each
1	communities. (b) state
1	includes a strategy
2	dispenser, the serial
1	concerning such persons
1	facility. (iii) the
1	modify, revise, or
8	command and control
1	practitioner, of narcotic
1	small business dispensers,
1	functions under section
1	extensions described in
1	judge issuing the
1	request for funds
1	(a) emerging pathogens
2	-pheny--[-(-phenylethyl--piperidinyl] propanamide; (g)
1	(riboflavin) (g) 60.0
1	2002; (6) $60,000,000
1	residue is necessary
1	program which is
1	exceeds $25,000,000 combined.
1	secretary of number
1	(f) strengthen the
3	longer period as
1	period and, following
1	(e) any other
1	(
 
 966.
3	civil or criminal
1	veterinarian is a
1	timeframe  (a)
1	(a) is potentially
1	(ii) not more
1	made within one
1	2 years; (2)
1	 (i) exemptions
1	neonates by companies
1	illness outbreak; (c)
1	paragraph (1) each
2	paragraph (c), but
2	cigarettes for introduction
1	administrator; and (iv)
3	areas of such
1	business unit. (u)
1	1985, on the
2	(h) the impact
2	proposed labeling, is
1	testing, including the
2	reference product under
1	(3) timeframe 
2	drug (other than
1	safety and potential
1	appropriate action; (b)
2	initiation of a
1	days before being
1	construed to amend
1	entity seeking a
1	devices are remote;
1	
 
 1509.
1	federal agencies, to
1	combination on human
1	medication prescribed for
1	(iv) for persons
1	issue revised draft
1	testify whenever a
4	setting forth the
1	industries concerned on
2	scheduling decision with
2	technical excellence, lack
1	samples, or (ii)
99	use of the
1	agency center; (iii)
1	subsection (e)(3), request
1	producing, harvesting, or
1	submissions  (i)
1	 (g) refund
1	updating of such
2	cash and other
1	(submitted in accordance
3	agricultural marketing act
1	(c) sales, transportation,
2	including the name
1	patients. (b) partial
1	due to other
2	set forth by
1	government agency the
5	generally recognized as
1	within the specified
1	manner the medical,
1	(e) licensing and
1	unless the farm
1	includes a surrogate
1	imitation or semblance
5	prescription executed in
1	subparagraph (a)(ii) on
3	 (a) submit
1	appropriated $1,000,000 for
1	moral turpitude. it
1	(3) preventive controlsthe
2	validation data required
1	local agencies and
3	profession and the
23	specified in the
1	360a2 of this
4	trading partner to
1	(i) illegitimate product
1	exceed 18 months
1	dissemination. (g) whether
4	diseased cattle, sheep,
1	development toolthe term
1	unit responsible for
1	may rescind or
1	(a) pilot projects
1	(b), information submitted
1	director shall maintain
1	following as reporting
1	year concerned from
2	application, the applicant
1	rule a drug
1	collection and reporting
1	extended as provided
1	requirements exclusivity under
1	(2) compensation 
1	cover.  (1)
2	subsection (a)(1) exceeds
1	conducted is sufficient
3	and, insofar as
1	demonstration, and evaluation
1	conventional food and
2	grants if such
2	feesof the total
1	kits.  (e)
1	adulteration, misbranding, or
2	requirement specifically applicable
1	positions in all
1	statutory compliance 
1	list of reusable
1	updated good agricultural
1	effective; and (d)
1	(f)(2), as appropriate,
1	amounts of methamphetamine
1	apply in cases
1	shall be promulgated
1	device. any such
1	october 27, 1970
2	authorized wholesale distributor,
1	persons.  (5)
2	provide for continued
1	account, if appropriate.
1	authorized to direct
4	information of no
1	title shall 
1	health under intended
1	determination not to
1	property under seal;
1	property for official
2	security shall, on
1	 (1) adulterated
1	provided such food
1	applicant notice and
1	directly responsible to
1	made the showing
1	remains with the
1	request.  (9)
3	title into class
1	candidates to scientific,
1	chemically equivalent or
1	published for public
1	patient survey data,
1	used, and, at
1	safe diluents or
3	 as used
2	fiscal year; or
1	section 900 of
2	applicant with more
1	2014) for consideration
1	section that exceeds
1	fact or that
1	relating to compounded
1	distributions are consistent
1	product  (aa)
1	making such requirement
1	employee, if the
1	inadequate institutional controls
3	sealed homogeneous case
3	determine that a
1	(e) technical and
1	order scheduling such
2	year is 
1	allow for prompt
1	substance, or (3)
1	significant or knowing
1	may emphasize prevention
2	domestic or foreign
1	confirm the adequacy
4	(a) the person
11	advertising time and
3	controlled substances import
1	year, based on
1	(
 
 1533.
1	prescribe, exempt any
1	testing plan required
1	process specialization in
1	ch. 559, 3,
1	manufacturer, and to
1	formerly 503b, as
3	person may request
9	circumstances described in
1	be.  (m)
1	(4) offset of
1	evidence; production of
5	manufacturer or supplier
11	october 1 of
2	(b), or any
1	least four years
1	drug; or (6)
1	relevant private organizations
2	secretary, but not
1	device under such
1	default as the
1	(2) possess a
1	changes as follows:
10	food allergy and
3	label bearing any
1	class of medical
1	administer, or support
1	unable to do
1	transfer agreements, contracts,
2	country under paragraphs
20	fee established under
6	investigate the safety
1	360ccc1, 360ccc2, 374,
1	(5) electronic submission
1	 (1) includes
2	patent means a
4	treasury, in consultation
1	devices not in
1	(e) quota increases
2	seizure or forfeiture
2	number of human
2	safe. the administrator
1	spontaneous disintegration of
1	statute of limitations,
1	united states standard
1	label clearly identifying
1	medical devices plus
1	(
 
 1044.
1	 (8) raw
1	pharmaceuticals for all
1	issued be included
2	(c), but this
1	species; (c) mult-drug
5	preceding 4 years
1	customer, for the
1	party for a
1	 (b) corporationsupon
1	records, and research,
4	appropriate to ensure
2	least burdensome requirements,
1	arrival within the
1	types of fees
1	administrative restraint; detention
1	4, 2011, submit
1	drug application when
1	record; or the
1	years and make
3	authorization of a
1	
 
 387.
1	(b) any person
1	provided substantial assistance
1	dismiss filed by
19	classification of the
1	chemical, biological, radiological
1	age or younger,
1	personsthe standards established
1	may order notification
1	prior to transaction
1	(g) publication of
1	(1). prior to
1	conducted shall also
1	intelligence committees of
3	paragraph, unless the
1	
 25. oleomargarine,
3	(a) the amount
3	change to an
1	allow the sponsor
1	paragraph (4). the
2	(iii) of subsection
3	award under this
1	duties as the
1	dates, the secretary
1	benefits of currently
2	least burdensome requirements;
5	administrations internet web
1	human services does
1	establishes the name,
1	review. (4) all
1	food and energy;
1	first applicant; or
3	business requiring inspection
1	70 stat. 742;
1	states government whose
1	states, or in
1	(b) submit such
1	defense strategy described
1	(d) applicationthis section
1	section 360j(g)(8)(a) of
1	thir-party auditors as
2	appear and testify
1	residue due to
1	title, seizures of
1	sponsor elects to
1	drugs of such
1	15, 1967, that
1	services shall publish
2	inspection, which appeal
1	authority, as determined
2	(2) document each
1	terminated, a report
1	 (b) adjustment
4	container is so
1	july 1, 1948,
1	electronic product intended
2	accredited and the
1	review such plan
1	single patient during
1	expected adverse product
1	altering of a
1	 whoever, with
1	samples taken if
1	pharmacist, to take,
1	certain drug (or
1	(17) shall seek
2	giving due consideration
1	title 41. (h)
2	food in each
1	manufacturer, the manufacturer
3	identifying reference to
1	studies) in pediatric
1	within such 30
1	314.640, 601.45, or
1	registration by such
1	response to agriculture
1	to, or enter
1	violates this section;
1	(c)(3) for a
1	sunset the secretary
1	309, 
 

1	transfer between such
2	title is in
1	individual  (i)
1	packaged in such
1	assistance, and (2)
3	 (2) identification
1	30, 2017, the
2	order adding a
1	biological products means
4	district court decides
1	applicant required to
1	united states, aggregated
1	calendar days, on
1	food products imported
1	health implications of
5	brought under paragraph
1	applicant is authorized
1	tool is to
2	and, unrestricted by
1	drug is subject
2	programs and adequate
1	advanced therapy that
1	sell, finance, or
1	use; (b) consider
1	(7) thir-party logistics
8	(i) in generalupon
1	may reasonably substitute
1	standards and policies
1	(i)(1)(d) of this
1	type, provided that
2	2014 and each
8	required under the
1	subsection and any
1	whose registrations were
1	otherwise applied to
1	sentence is made,
1	domestic facility means
1	nonnutritive substances. 
1	initiative, may be
1	necessary the plans
2	tactical and related
1	(c) nonnarcotic controlled
1	believe from facts
1	[7 u.s.c. 136a(c)(2)(b)]
1	conduct; or (b)
2	believe, that it
3	necessary to avoid
1	official certificate stating
1	form); (iii) inpatient
1	(vi) for a
1	formula shall contain
1	habitual user of
1	device exported under
1	compounded from such
3	title; and (iii)
4	(c) is not
1	exceed 100 per
1	may authorize that
5	risk to human
1	seq.] (or, if
2	subclause (i) in
1	1996; (b) 66
1	nitrous oxide that
2	intended to affect
1	appropriate, results from
2	secretary deems such
2	firm or by
1	deny such request
1	(
 
 360dd.
1	confined to national
1	national, permanent resident
1	(1). (b) consideration
1	(9) the increasing
1	either this chapter
2	programs or activities
1	regulated product development;
1	backlogs in the
1	initial inventory required
1	regulated person; (c)
1	subsection shall report
2	tobacco product standard;
1	order may, before
1	evidentiary hearing, the
1	order; evaluation of
1	(i) the substance
2	verification of saleable
1	recipient the term
1	personal consumption. 
2	poster, sign, placard,
3	 if the
1	extent of voluntary
1	formerly 410, as
1	establishment. in the
1	drug in animals
1	used. (v) the
1	959. possession, manufacture,
1	(h); may be
2	safety and to
1	ethical, and procedural
2	federal strategy to
6	application if the
1	(2), except that
1	requirements for recognition
1	seeking any civil
1	equivalence or de
2	 (1) periodic
3	findings, and his
1	 (d) revised
1	china any substance
1	huma-readable form and
1	task forces receiving
1	term final sunscreen
1	experience.  (6)
1	31. (e) applicability
1	process, including with
1	drug under any
2	recommendations, if any,
1	paragraph (11), the
7	notice provided under
1	10.30, title 21
1	strategies on drug
1	supplements and comments
1	care professional acting
1	fewer than twice
1	fined under this
1	panel with adequate
1	remedy provided him
2	animal, taking into
1	qualification package accepted
1	promote and participate
1	dependence.  (3)
1	final briefs. 
1	standardsin evaluating new
5	plan no. 1,
1	 (10) youth
2	college, or university,
1	category; and (4)
1	agency.  (5)
1	section 360b(d)(1) of
1	directive drug intended
1	regularly provides athletic,
2	limited to an
1	subdivision requirement for
1	prohibit any such
1	 (d) stay
1	appoint, employ, and
1	general at a
3	drug administration. (3)
1	(b) hearing to
1	made effective not
1	provide compensatory damages
1	129. omitted
 

1	containers of misleading
1	however, that unless
6	rate of pay
1	conditions proposed for
1	modificationa regulation reinstating
2	current calendar year
1	secretary shall, from
1	(i) removes foreign
1	certifies, accredits, or
1	services who has
1	standards in addition
2	identifier that does
11	(or other appropriate
1	indian tribe the
3	application  (i)
1	pending request means
1	columbia or within
1	(1) any waiver,
1	regulation. (b) in
1	claim against it,
1	require manufacturers of
1	order or has
1	particular foreign country
1	review division. (2)
1	auditingto ensure that
1	state required; maximum
1	internal committee for
2	rules of construction
1	herb, or spice
1	actual distribution patterns
1	(6) advice the
1	boards of each
1	identifier the repackager
2	increase the fees
2	labeled or packaged
3	paragraph (3) unless
1	section 360e(a) of
1	may accept, hold,
1	life sustaining or
1	instituted and maintains,
1	2, 69 stat.
1	2014. the secretary
1	guidance documents, the
1	proposed product and
1	1961. (32) 
6	guilty of a
1	criminal behavior during
1	website  (1)
3	applicable, of similar
1	intended to encourage
2	user who possesses
2	amount of annual
1	 (5) schedule
2	state will pose
3	revision to the
1	establishmentsbeginning in 2014,
2	terminated or otherwise
1	change of identity,
1	testing of actual
1	internal review committee
1	manners utilized by
1	 (1) early
1	shall the secretary
2	seller understands each
3	150 percent of
2	entitled to damages
1	care entity to
1	program  (a)
4	party logistics provider
2	enforcing, with respect
1	done while such
1	physician writes upon
1	second and last
1	registration or such
1	contracts. for carrying
1	meet criteria under
3	country; and (b)
1	petition. if information
1	prescribed.  (2)
2	effectiveness in pediatric
1	affecting access by
1	staff and senior
1	alleviate a drug
2	issued, establish such
3	proceedings for scheduling
1	upon the presentation
1	fees a biosimilar
8	shall, in accordance
1	fulfilled during the
2	purchaser, and the
2	use, persuade, induce,
1	including team leaders,
1	means to divide
1	mitigating health risks
1	 (i) $50,000,000
1	to, if, after
1	promulgated, in accordance
2	terminate at the
1	entity and that
1	clearly identified candidate,
1	condition in the
1	responded to the
1	provided; or (ii)
1	institutions. (5) too
1	medical questionnaire; and
1	sponsor that references
1	methods.the secretary shall,
1	(b) elementary schools;
2	 (6) for
2	(august 28, 1996)).
1	reporting on drug
1	(2) review by
1	encourage free and
1	dispensed or administered
1	lawfully marketed under
1	service, appoint employees
1	justifying the authorization
2	need not convene
1	information concerns the
1	restricted device shall
2	partial waiver shall
1	jurisdiction over any
1	exclusivity period; or
1	sanctions as authorized
1	individual for personal
1	(iv) provides for
1	maintained by this
1	(ii) a decision,
1	causes, trends, or
1	uses an emergency
1	president issued under
1	requirement in a
1	pharmaceutical ingredients manufactured
1	otherwise agree. (7)
1	exports  (1)
9	shall establish an
2	adverse drug experiencethe
1	leaf tobacco and
1	subsequent year, november
1	services and introduce
1	information from a
1	fix the compensation
1	container thereof the
1	need therefor, the
4	chapter are either
2	drug administration, for
1	identifying the device,
1	(2) all raw
1	party, the court
1	studies conducted pursuant
1	womens health (established
1	effectiveness nothing in
1	section 360hh of
1	administration employees conducting
1	requests, including the
2	quarter for which
1	decreased to at
1	official establishment slaughtering
1	appropriate redactions made
1	permanent.  (3)
1	interoperable product tracing
1	formulating recommendations under
1	secretary (after consultation
1	rulemaking may be
1	relevant federal agencies,
1	december 3, 1999,
2	summary of any
1	slaughter not more
1	felony, based upon
1	biological product solely
1	initially appointed under
1	states, official national
1	(or, where there
1	removed for trial.
1	brought under such
1	effectiveness research using
12	order in the
1	conclusions from all
2	summary of and
1	actions required for
1	methods to enhance
2	least one suitable
1	subsection (d)(1), the
1	(f) exemptionsthis section
1	thereof to other
1	consulting centers and
8	officer, employee, or
1	(c)(3).  (b)
5	subchapter ii or
1	mitigation strategy. in
1	registered  (a)
1	parts suppliers do
1	(b) package form;
1	medical applications a
1	(d) for guidance
1	states pursues coordinated
1	effectively and significantly
1	drugs included within
10	drug applications for
1	enterpriseany person who
1	request the issuance
1	operations at an
1	considered to constitute
1	(2) exemptions of
1	therefor permits to
2	violations of food
1	prior owner as
1	drug application includes
4	withdrawn or removed
1	review. the secretary
1	methodologies for food.
2	medical societies, and
1	farm to maintain
1	commitmentthe coalition shall
3	355(o) of this
2	coordinator determines that
1	(5)[3] restrictionsthe director
1	fiscal year, means
1	devices shall be
1	chemical, except that
2	law enforcement for
1	(d) emergency dispensingthe
1	importer or the
1	exceed $300,000. (2)
1	catfish may only
2	portions thereof, as
1	pizzas containing meat
11	filthy, putrid, or
1	packages, labels, or
1	bearing the pesticide
1	purity of raw
1	shown to the
1	section 360(k), 360c(f)(2)(a),
1	failed to demonstrate
1	federal government; (iii)
1	(b) who otherwise
2	business defined in
1	days, or by
2	product or the
1	(b) reasonable variations
2	provide opportunity to
2	stating good cause
1	workload adjustment result
1	u.s.c. 262]. nothing
1	(b) drug abuse
1	year or third
1	reside whoever violates
1	 (4) amendment
1	laboratory capacity 
1	report of rejections
1	emergency situations as
1	(a)(1)(c)(i); or (b)
1	section may, within
1	nature of reports
1	substantially contributes to
1	program).  (2)
1	met for the
2	purpose of identifying
1	fact manufactured, distributed,
1	(3) 3,4,-trimethoxy amphetamine.
1	transferee involved shall,
1	49), operating in
1	morbidity or mortality,
1	 (a) cooperative
1	355(b)(2), or 355(j)
1	 (1) taking
1	2014 through 2017for
1	care providers, or
2	incorporated by the
1	section 355, 360b,
1	term color additive
1	quarter. (3) for
1	component parts suppliers
1	agree to consult
2	certification from such
1	transferred; and (j)
1	statement caution: federal
1	classified form describing
1	activities (a) regulation
1	shall expire at
1	correct. (bb) if
1	prevention, shall enhance
1	forces coordinate with
2	general finds to
2	publish a federal
1	person had the
1	paper and electronic
1	notificationif, after the
1	may designate drugs,
1	(a)(2)(d)(ii)(i)) shall result
1	require a postapproval
1	exemption, (ii) the
2	subparagraph (a). if
2	differs from, or
1	order thereon, or
1	administrators, and other
1	label egg products
1	description of whether
1	subparagraph (a). in
1	food that it
1	(b) labeling if
2	format for submission
1	encountered, and registration
1	 (i) developmental
1	paragraph (2)(a). 
2	samples or otherwise
1	administrator for that
1	additional review of
1	laboratories, and conducting
2	(a)(4) for a
1	product is dispensed
2	section 321(ff) of
1	registration recommended by
1	may affect a
1	section, through the
1	transaction history. 
1	hearing. (f) prohibition
7	shall comply with
1	biological product as
1	biological product at
1	annual reporting on
1	printed prominently; and
1	technologies, practices, or
1	controlled substance. (2)
1	revoke a tobacco
1	users of the
1	ink. (mar. 3,
9	substance described in
2	forms are submitted
1	(3)(a)); and (c)
2	orders  (1)
1	(3) bases for
1	(a) designation 
1	(1) proposed sunscreen
2	construed to prevent
1	(a), afford the
1	order and displayed
16	reasonable time after
1	hair dye and
1	practices applicable to
1	projects and programs
2	reports thereof are
2	considered as having
1	identify and publish
2	cigarettes or smokeless
1	(d) coordination to
1	incompatible or have
1	 (d) operating
1	submitted and deferrals
10	recommendation to the
1	declaration described in
1	auditor, with or
1	
 829. prescriptions
1	scientific issues related
1	drug or issuance
1	specifiedfor purposes of
1	component, accessory, or
1	(iii) the scope
2	evaluation, and review
3	supplement fee 
3	period for public
1	ethylmethylthiambutene. (22) etonitazene.
1	relevant studies or
1	congress should work
1	wholesalers to import
1	title or unless,
1	bond, or take
1	title. (3)mail order
1	privacy protectionsin order
1	drug purporting to
1	secretary any conviction
1	situations involving inspection
1	maple syrup, (3)
1	supplements. (b) actions
3	issue guidance to
1	administration that shall
1	secretary take or
1	beings. nothing in
1	except this part
2	means any healt-related
1	authorized for general
1	dealing in, or
1	scalability of such
2	one year previous
2	actual tax forms
1	establishment fee or
2	authorization shall be
2	reclassify the device
1	audits of drug
1	considered medically insignificant
1	 (2) program
1	review guidance 
1	expedited approval pathwaysan
1	subchapter. except as
1	will be subject
1	written agreement, paragraph
1	period; and (b)
1	implementing the national
2	investigational use and
1	substitute meals that
1	(13) who is
1	received and that
1	(g) transition grants
1	
 301. short
1	exported, transported, or
1	subsection shall address
1	subsection, or where
1	positions at the
1	advertisement.  (2)
1	exercise of jurisdiction
2	within such state,
3	within such state.
1	equipment, and programs
3	device do not
3	establish minimum standards
1	forfeiture and sale
1	20 days, unless
1	device establishments conducted
5	title 42 and
1	available under section
1	contamination; (b) an
2	within such state:
1	establishment to a
1	(ii) recruitment through
1	(2) commence an
3	means any product
1	approved, that such
1	products distributed by
1	certified mail or
1	commerce and for
1	foundation in carrying
1	trafficking areas. (m)
1	suspension proceeding. any
1	substances, and whether
3	testing  (i)
1	country, or (b)
1	manufacturing, packing, packaging,
1	agencies; patients and
1	individual national drug
1	prescription drugs, shall
1	shipment for such
4	(2) at least
1	device from individuals,
2	avoid false or
1	(iii) violation standard
1	sponsors of approved
1	reviewed such article
1	drug possessors 
2	time in the
1	section; and (iii)
1	twent-one (a) first
1	ii; (6) to
7	applicant or holder
1	confidentiality of information.
1	listed in accordance
2	given notice with
1	foreign entity, including
1	information using databases
1	research involving drugs
1	also related to
1	section, or other
1	medline plus web
1	scientific liaison between
1	benefits to persons
1	feet, head, or
1	5703(b)[2] of title
1	generalto be eligible
1	fee waivers or
1	dismissal or summary
2	thereof by the
3	regulations as provided
1	strategies and contact
1	rule the secretary
5	subparagraph (c). 
2	title this section
1	subsection (f). (iii)
1	claimant against a
1	clause (iii). (iii)
1	fairly be assumed
1	according to current
1	klebsiella, pseudomonas, and
2	evidence means evidence
1	section, transaction history,
2	name, address, telephone
1	(a) contains such
2	(3) any other
3	otherwise make any
1	smokeless tobacco product,
1	antimicrobial drug means,
1	(d) shall require
2	consultation on any
1	(b) extension if,
1	certificates; simulations (a)
2	(ii).  (b)
2	lacks sufficient financial
1	quarter in which
5	(i) the drug
8	buying or selling
1	process, or relabel
2	within or on
1	safe use in
1	prepare respecting such
1	dispensed, or possessed
2	make a significant
1	(including such a
1	remove it, if
1	
 623. exemptions
1	appropriate reciprocal arrangements;
1	originally included in
2	ointments sold in
2	labor and pensions
1	(5) reporton or
5	restaurant central kitchen
1	chemicals may import
1	number of turkeys;
1	prescription drug approved
2	subsection (c)(2), a
1	drug approval process.
2	area shall be
3	mark or simulation
1	pharmacy compounding; (ii)
9	subparagraph (c) of
1	submitted via a
1	in, or on
2	register the fee
1	(vi) specify principles
3	part, a raw
1	providing expedited consideration
2	record about an
1	advisory commission means
13	later than the
2	emits (or in
1	law of a
2	subparagraph (c) or
1	armed services and
2	patient using the
1	(vii) law enforcement.
1	charged for an
1	 (4) cigarette
1	promulgate, and enforce
2	25, 1938, it
1	applicant of fees
1	forfeiture, restore forfeited
1	regulation or requirement
1	section 1047 of
1	pay, the effect
1	degradation of a
1	draft guidance on
1	food in compliance
1	conditionally approved; (b)
1	 (a) opt
9	title; and (2)
1	resulting final order
2	reports, or information
1	criteriaa drug is
1	(3) basisthe determinations
1	respect to postmarket
1	condemnation proceedings (a)
2	(ii) has been
1	assay set forth
1	basis in record
3	bound paper book
1	title. (c) exclusivity
2	carrier by motor
1	require any retailer
2	average proportion of
1	proposed findings; and
1	(4) definitionsfor purposes
1	associated with devices
1	fact although not
2	2008 may not
1	complete, was submitted.
1	section 971(c)(1) of
1	format and procedure
1	including records of
1	in[1] 381(q)(3) of
3	903, as added
1	(2) such country
1	secretary, be provided
1	organizations and entities.
2	final regulations promulgated
1	request and, not
1	meat, or poultry
3	meats and meat
1	general, except that
1	(a) a product
1	liability for violations
1	351(a)(4), or 361(e)
1	cosmetic act[1] [21
1	quantities of cocaine,
1	biological, radiological (including
1	food, unless such
1	revise the written
1	mistakes in the
1	criteria under clause
1	allocating funds under
1	filled in the
1	paragraph (1) files
1	title 42 (not
2	consuming public from
1	education and outreach
1	offers to deliver,
33	general not later
3	25 or fewer
1	development, stockpiling, approval,
1	agricultural products, respectively.
3	jury of any
5	paragraph (1) are
4	remission or mitigation
1	(3) any manufacturer
1	registered establishments every
1	hazards, implementing preventive
1	$50,000 in the
1	department and of
2	subparagraph (2), no
2	(1) in generalon
1	division personnel demonstrate
1	devices (referred to
1	funds otherwise available,
1	previous year with
1	may stay such
1	subsection for domestic
2	device is required,
4	section 381(a) of
1	seq.) or the
1	who, upon being
1	eligibility determinations 
1	imported from a
1	sanctions on any
1	brought or shipped
1	resulting in the
1	federal government that
2	compliance with an
1	section. a suspension
2	3-day period, the
1	articles that were
1	(c) state the
1	plant, such owner
1	hiring authority for
1	clarity and certainty
2	wrapper, or labeling
1	adulterated, need not
2	(ii) may be
1	protocol, issue a
1	subparagraph. (b) content
5	appropriate. during the
2	produced directly or
1	laboratory capacities of
1	standards provided for
1	22, 2009. 
1	medicine, shall state
1	nmic shall include
2	findings, or make
1	transaction information required
5	federal register, for
1	ingredient: safety 
1	 (b) types
1	describes, for each
1	incarceration or other
1	animal drug. an
1	collaboration with or
2	entry in the
2	consumers  (a)
1	title fails to
2	purpose for such
1	455 to 459,
4	3 percent by
1	issuance, with redactions
1	marks. (mar. 4,
1	vitamins or minerals.
1	 (a) extend
3	against, and conviction
1	engage, for commerce,
1	countermeasure, the secretary
1	order a revised
1	including coordination and
1	secretary, that demonstrates
1	6 fiscal years.
1	mark, tag, or
3	830(e)(1)(b)(v) of this
1	group; (iii) 
3	chapter (a) the
1	of, drug abuse.
1	providing such provider
1	title, use the
1	(ii) five members
1	director may supervise
1	675, 534, formerly
3	national youth ant-drug
1	submits or is
1	310, formerly 307,
1	secretarys inspection authority
1	farm. (b) consumer
1	frequency and effectiveness
2	otherwise developing an
1	committed an act
1	reduction; (v) private
7	chapter 7 of
2	hold should be
1	prepared, packaged, or
1	approved such application.
17	product in the
6	v or combinations
2	review of specific
2	corporations, partnerships, and
1	fund, to be
3	(ii) a statement
5	specified in clause
1	subsection (c) (except
2	incorporate such exemption.
2	drugs subject to
1	fully and currently
1	licensed as pharmacists,
1	thereto), intended primarily
1	responsibilities of additional
1	inspection of animal
1	guidelines.  (2)
3	standard recognized by
1	commerce except that
4	exported to a
1	programs on drug
1	lacks the specific
2	(c), a device
1	(i) gamma hydroxybutyric
1	appeal is taken
1	shall set standards
1	legal public holidays
1	amount the aggregate
6	person has been
1	affiliate means any
1	360i(a) of this
2	agreements shall be
1	term catfish. 
1	processed food; or
2	encapsulating machine, or
1	individuals conviction undermines
1	strategy; and (6)
3	crediting of fees
1	(1) registration of
1	include the secretarys
1	packed with apples
2	552 of such
1	 (3) good
1	stat. 1040.)
 

1	safety activities). (7)
10	application for approval
1	subject to subchapters
2	identifies a smuggled
11	tobacco products shall
1	(d) the systems
1	order such paraphernalia
1	(a) outreach, education,
2	columbia with respect
1	use disorder; (cc)
1	chapter, as is
1	renewed at the
1	year 2007 with
1	equipment as are
1	whether such assessment
1	testing performed by
2	inspection provisions only
2	providing the relief
1	 (1) would
1	(c) whether such
1	
 
 801a.
5	(iii) of the
1	labeling; (ii) specify
1	349. bottled drinking
1	(2) serious adverse
1	
 
 341.
1	(b) enhancing law
34	sponsor of the
3	official mark means
1	nicotine the term
2	establish, 60 days
1	 (1) registrationthe
2	title; (8) if
1	 (3) exception
1	pcp, methamphetamine, or
3	shall be authorized
1	713, as added
4	previously approved for
2	(1)(b) if the
3	drugs.  (c)
2	(b) personall-identifiable informationnotwithstanding
1	inhabitant, or transacts
1	scope of inspections
2	certified copy of
1	repeal; referral to
1	adjustment factor means
4	device in such
4	disposition an illegitimate
1	subclause (ii) or
1	effect; (b) for
1	application. an order
1	675, 569c, as
2	response detailing the
1	advertising; (ii) a
1	(bb) signs the
1	department that the
1	terminating an institute,
1	(c). the manufacturer
3	seq.].  (june
13	article shall be
3	fee required to
1	persons participation in
1	following the -year
1	manufacturer for ultimate
2	generalthe secretary, acting
1	book shall be
1	oleomargarine for the
8	pursuant to clause
1	data to evaluate
14	 (1) to
1	balances of not
1	374 inspections the
1	establish bylaws for
1	regarding methods and
1	ch. 675, 1012,
2	medical product development;
1	protocols submitted under
1	scope of inspection;
1	paid all advisory
2	rule  (i)
1	(1). such notice
1	accruing to or
2	review an application
1	reports and recommendations
11	acts. such fees
5	beginning after september
1	corporation, partnership, trust,
1	medical product development,
2	disclosed to a
1	subsection no longer
2	identifiable information is
1	effective date shall
1	development and enforcement
1	(e) or subsection
1	animals subject to
3	best practices for
1	lack of resources
1	360nn(b) of this
1	hearing which is
14	delivery of the
1	undertake analyses of
1	applicable. (10) the
1	especially such facilities,
2	regarding the emergency
1	(5), or a
1	coordinated drug abuse
1	distribution, and use
1	thereof, be summarily
2	likely to enter
1	established tolerances or
1	community, make a
1	entity  (1)
3	salts of morphine,
1	particular substance is
1	term to provide,
1	carcasses, sheepmeat, and
1	domestic establishments and
1	necessary and appropriate;
1	shall treat it
1	clinical trials the
1	biological product establishment,
1	cente-specific objectives and
3	subsection, the office
1	maintain the data
4	necessary and appropriate.
1	amusement containing a
2	necessary and appropriate,
1	(i) the uses
1	earlier. such reanalysis
1	(b) it will
1	additional selection of
1	initial panel in
1	iii, 542, formerly
1	clause (i)) during
1	disclosing the identity
1	systems and laboratory
1	reporting in accordance
2	clinical or other
2	administration a report
1	drug therein, and
1	status as the
2	title, which guaranty
6	sentence imposed under
6	container is composed,
1	title solely because
1	hearing means a
1	(f) recordkeeping 
2	drug administration; (2)
1	protocol) that is
1	methamphetamine. (
 

1	effect and monitor
1	(c)(1) may be
1	corporation to be
1	egg ingredients are
1	perform inspection functions
1	interest at a
1	(7) following the
1	comprehensive, lon-term strategies
1	subsection shall occur.
1	revocation, which will
2	exemption would have
2	(2) does not
3	illegitimate product, and,
1	right of agents
1	inspection.  (d)
2	presents a lower
1	shall (except as
1	expeditiously. if a
1	registrant to submit
1	submission by a
1	made as the
1	coordinates the food
3	arising out of
1	drug abstinence (whether
2	(iv) the date
1	animal diseases; research
14	fine of not
1	schedule i on
1	post mortem inspection;
1	(c) notice of
1	(c) the availability,
1	review.  (b)
1	specific requirements 
1	devises, bequests, gifts,
2	schedule i of
1	schedule notice and
1	title, for so
1	processed food. (2)
3	consumers at such
1	determination  (a)
1	leases, cooperative agreements,
1	u.s.c. 262(a)]. such
2	(a) is the
1	containing alcohol or
1	terms of lovibond
1	pyrrole ring to
1	specifications as provided
1	appropriate;  (iii)
1	order, except that
1	social security, health,
1	regulation if (1)
1	international organization means
1	applicable to breakthrough
1	secretary shall prioritize
1	enforced with respect
1	compatible with the
3	title 42. (b)
2	actual performance of
1	chemical residue. for
1	antibiotic drug, an
1	360fff. definitionsin this
1	paragraph (12) of
1	prescribed as pasteurization
1	draft guidance describing
2	current procedures for
1	enhance seafood safety
2	submitted serious adverse
1	law, (iii) a
1	authoritiesnothing in this
1	whether to reinstate
1	venue provided for
4	controlled substances, and
2	director determines are
2	amend the application
2	dihydrocodeinone per 100
1	inspect any device
1	dissemination of guidelines
1	increases, including purchases,
1	$50 and not
1	product using bulk
1	section and changes
1	inspected meets the
1	(c) records of
1	853a. transferred
 

1	evaluation shall include
1	identifying any food
1	publication of notice;
1	proposal or order
1	applicable fee. (ii)
1	annually (or more
1	formulated in a
1	(2) and the
1	(5) or (10)
1	use as applied
1	agrees to bear
1	extended to reindeer
1	(2).  (june
1	transaction history means
1	legally marketed as
2	minimizing the burden
2	section 334 of
1	egg products, including
5	made by any
1	interested parties to
1	food. the secretary
1	made by mutual
1	operator submitting the
1	(c)(1)(a)(i)(ii) for a
1	committed any prohibited
1	requirement, a submission
1	safety and reduce
1	person without paying
1	name other than
2	accredited person whose
5	obligations under paragraph
1	(b)(1)(a) may obtain
3	review voucher means
6	requests for information
1	governing the sanitary
2	governor of each
2	eligible for a
14	become final, such
1	reactions to such
1	recommendation from a
2	fiscal year until
1	provide an election
1	times and places
1	material. in the
1	360i, or 379e
1	transferred to or
1	subsection (c); (c)
1	met. the secretary
1	children who are
2	decomposed substance or
1	formula includes 
1	government inspections (a)
1	 (a) task
1	particular factory, warehouse,
1	puerto rico. (c)
1	duties. while traveling
1	updated standards for
1	sites for unwanted
1	respect to treatment
1	criteria in section
1	 (q) specific
1	conspires to do
1	approaches to assess
1	marine fisheries service
1	exclusivity and other
1	processors or distributors
4	twice the maximum
1	veterinarian.  (3)
1	supplement to them,
1	requiring the reduction
1	upon nutrient required
1	establishment engaged in
1	no-hig-risk food facility
3	shall provide written
4	health and the
1	entitled to claim
2	approved under human
5	annual index) for
1	seeks approval of
1	(2) regulations under
1	requirements that conflict
1	include the dispensing
1	processing, packaging, and
1	following transactions are
2	tin, canvas, or
1	generalprior to a
2	punishable by a
1	regulations regarding conflicts
4	regulations adopted under
1	sale proceeds under
1	use for healt-related
1	cinnamon, pineapple, vanilla,
1	unadulterated while approval
2	subclause (i)) equals
1	twelve years. 
1	(g) supporting initiatives
1	submit, as part
1	application. (2) if
2	product, unless the
1	dispensed without the
15	article of food,
1	foreig-grown tobacco over
1	clause, apply to
1	 (a) under
1	related professions; (c)
1	provider, and patient
1	policies on a
1	ant-drug message. such
4	action on a
2	food; (3) if
2	title 5. (4)
1	holder has complied
1	raw materials. (2)
2	reports to which
1	trial or the
1	validation data. (b)
1	(a)(ii) if the
2	person applying for
1	standards for purity,
1	officials, persons seeking
1	 (1) barbital.
8	posed by the
1	knowledge. (2) knowledge
1	states the term
1	schedules if he
1	minimum  (1)
3	assurance of device
1	product is dispensed;
1	drug submissions, including
1	endocrine effects. 
2	unless an application
5	failure to meet
1	 (b) circumstancesfor
1	attached to trip
1	substance, there is
1	retailers and other
1	pharmaceutical ingredients subject
2	forth  (1)
1	42, which shall
1	framework to each
1	order would be
1	specific population of
1	date any agreement
1	completed and additional
1	sale of articles
1	section, the conditional
1	common control; (c)
4	confidential access to
1	agencies. each such
3	confidential information nothing
2	document shall 
1	subsections (d)(1) and
28	office of the
1	section 107(a)(2) of
1	paragraph, that the
1	sponsor unless the
1	generic drugin this
1	activities each manufacturer,
1	pediatric subpopulation if
2	national taxing authority
1	fees combined, the
1	human subjects involved
1	for, devices, as
2	package of such
1	resolving these challenges;
1	(b) the approval
1	list to designate
1	(4) where appropriate,
1	risk. before issuing
1	authority that is
1	data.  (b)privacy.
1	enforcement personnelany officer
1	drugs) on a
1	constitute the product
1	waiver of requirements
1	department, shall have
3	forestry of the
1	subsidiary or otherwise,
1	killing or kidnapping
1	persons holding an
2	(1)(b)(i) or (2)(b)(i),
1	process, grant renewal,
1	chemicals shall be
1	investigational device submits
1	purchasers; health maintenance
1	amenable species to
3	chapter if 
2	results or may
9	paragraph (1) 
19	requirements under section
1	require each national
1	taken to reduce
1	27, 2007, if
1	terminated. (c) if
1	analysis for another
1	food products, derived
1	cases that are
1	except such as
4	salts of cocaine,
2	submitted for any
1	demonstrate that a
1	shall be denatured
1	markets) that was
2	annual notice setting
1	sent directly to
1	 (3) to
1	(e) establishing mechanisms,
1	matters, and if
1	programs the secretary
1	cooperation: advisory assistance,
1	inventory, shipment, and
1	qualifying pathogens listed
1	 (j) traceability
3	country that is
2	medical gas means
1	1975 and june
1	certified medical gas
1	application not being
1	including information pertaining
1	change, and informs
1	(c)(2)(a), would exceed
1	laboratory in upton,
2	list of nonfood
1	(c) limitations the
2	established for that
1	time, not to
1	(iii) by dosage
1	systems and networks
2	date  (1)
2	importation of controlled
1	throughout the federal
1	reviewed within 6
1	reviewed within 3
1	agenciesthe secretary of
1	reinspection for the
1	accessible to individuals
3	exclusive distributor of
2	1114 of title
1	petitioner is not
1	will pay a
1	health mission; (9)
1	tissue through a
1	 (1) r-exportation
1	study or contract
1	states, involving a
1	(c) prohibited transactionsexcept
1	section and all
1	lawfully obtained a
1	slaughtering establishments inspected
1	issues, including increasing
1	licensing, or authorization
1	expended; (iv) a
1	appropriate. (k) evaluation
1	ch. 675, 713,
1	review premarket submissions
1	formula and in
1	prescribe in such
1	formula, the manufacturer
3	knowingly represent that
1	punishment any person,
1	containing chloral hydrate.
1	identifying drug substances
1	animal quarantine lawsfor
3	with, a regulation
1	supplements, and generic
1	transfers it to
2	postmark on the
1	(a) if its
1	states or their
1	maintain teams, composed
1	human use shall,
1	brought.  (l)[1]
1	act of 1930[3]
1	means a standardized
1	transactions  (1)
1	scientist (a) establishment;
1	apply to dairy
1	nonprescription means not
5	manner as if
3	involves intent to
1	administration and, upon
1	patient functions; and
1	percentage  (i)
1	uses for approved
2	establishment as subject
1	1051; oct. 26,
1	will operate not
2	exemption to the
1	manufacturing change. 
1	procedures.  (june
1	(ii) that are
1	activities authorized for
6	modification in the
1	fictitious, revoked, suspended,
1	(2) referral to
1	(in this paragraph
2	voucher to a
1	effect the computerized
1	secretary, at any
3	objections thereto with
1	situational awareness; (3)
1	(i) -(-hydroxycyclohexyl)phenol with
1	 (b) continuation
1	agency discretion. 
3	reporting of adverse
1	subparagraph in which
2	require reporting of
2	 (d) scope
1	paragraph (1)(a) not
1	urgent petition procedure
2	animal diseases. 
1	must be covered
1	section 348(h)(6) of
1	secretary, and any
1	meeting. (c) an
1	detailed statement under
1	distributed other than
1	case of oxygen,
1	assessment by class
3	application, not later
1	nomenclature requirement of
1	determines appropriate in
1	steal anhydrous ammonia,
1	initiatives, studies, services,
1	may request, within
1	active ingredient, route
1	 (c) meetingthe
1	regulations) to meet
1	prescribing conditions of
1	programs is not
1	request, have been
1	new rights, beyond
1	special requirements of
1	united nations and
2	design of clinical
1	(ii) on a
1	paragraph.  (3)
1	experts on manufacturing
1	(b) substantial participation
1	identify  (1)
1	declaration; or (d)
1	directions of the
1	made. it contains
1	standards in paragraph
4	subsection (b); or
1	foreign government shall
1	listed chemicals and
6	computer resources; (c)
1	 (4) an
1	transaction statement to
3	placed in effect
1	influence of illegal
1	reasonable opportunity for
1	grocery store notification
1	drug (including crude
1	device are to
1	identified through the
1	confidential basis; (b)
1	(q) restitution for
2	secretarys determination that
1	food facility inspection
2	chapter, but any
1	(ii) this paragraph
1	approve such supplement
1	chemical residues, data
1	intent to use,
2	iii device, and
1	children are capable
1	imposed under the
1	product, shall prohibit,
1	(g) marijuana smoke
4	body of man
2	substance for a
2	service. fees authorized
2	subchapter ii punishable
1	specify the action
3	shall pay to
2	tobacco or a
1	international crime presents
1	food science, meat
1	may designate any
1	alternative statement (as
1	(1) an assessment
1	cut, ground, powdered,
1	come from adequate
1	site of any
1	contain no dye,
1	(ii) any substance
1	 (e) color
1	assessed. any such
1	entity that controls,
4	importation of which
1	capacity for larg-scale
1	government, if an
1	foreign establishments any
1	health. the advisory
1	pursuant to regulation
1	alkyl or alkenyl,
1	(b) leveraging of
1	importer shall, upon
1	(2) accreditation 
1	sentence, the regulated
1	(3) assess and
2	campaign; (3) plans
1	patients. (c) request
1	controlled substance into
1	(whether on or
1	economic area. (b)
1	applications; and (ii)
2	ports of entry;
1	information sharing and
1	thir-party auditors accredited
1	(3) chloral hydrate.
1	
 349. bottled
1	conditions that may
1	(b). a panel
1	science, medicine, and
2	reimbursement of state
1	met:  (a)
1	health, fails to
1	2016, publish in
1	data management systems,
2	included in part
1	subchapter, to the
1	ports of entry,
1	budget unless the
1	submissions.  (c)
1	(b), such final
3	drug administration (referred
2	general shall assign
1	instructions for emergency
2	similar to those
2	food; denaturation or
1	general may require,
1	effectiveness. (d) nothing
1	container, name of
1	extended use of
1	arguments are material
1	address the promotion
1	place of hearing;
1	(1) the scope,
2	pediatric drug research
1	additive, the conditions
1	testing results for
1	united states should
1	841(b)(1)(d) of this
1	(m) disputes concerning
1	criminal prosecution of
1	days; and 
1	manufacturing practice may
1	cigarette  (a)
1	commerce the term
3	including, as appropriate,
3	proceedings of the
5	least one year
5	recommendation with respect
1	360i, 360bbb3, 379aa,
4	secretary as provided
1	medical product under
1	spread by food
1	(2) issues a
1	conditionally approved, that
1	acute bacterial exacerbation
1	provisions nothing in
1	timeframe; and 
1	advisory commission to
1	quantities of drug
1	policythe congress declares
1	acts committed outside
1	user facility means
1	listed chemicals, to
3	(1) in generalupon
1	(a) distributes a
2	(c) disclosure of
1	(1) is concerned:
1	meeting to discuss
1	states and such
1	plant, as determined
1	substance named -(-methy--pyrrolidinyl)
1	initial standards 
2	diagnose, or cure;
1	examinations, testing, or
3	judicial district where
1	circumstances, as determined
2	basis, such administrative
1	evaluated for approval
1	official plants subject
1	 (2) payments
1	personnel, research, sales
1	taken reasonable steps
3	injury, to any
1	chemicals or where
1	responsible partyafter consultation
1	complaints that the
1	thir-party auditor, with
1	section 553(c) of
2	medical devices for
2	1956, ch. 861,
1	repackager to comply
3	use with the
1	treatment through neuroscientific
1	program of seminars
1	additives that are,
2	product under subparagraph
6	application and any
2	visit selected establishments
1	(1)(a) and publish
2	(which may include
1	operating reserves for
1	 (a) suspension
1	shall conduct inspections
1	fees on, and
1	 (a) determinationthe
1	monitoring 2003; (3)
1	chain at the
1	counsel of experts
1	suspension before the
73	shall be deemed
1	requirements regarding assessments
1	practices.  (n)
1	party confidentially maintains
1	analysis system as
14	except to the
1	law enforcement sensitive
1	startup costs clause
3	application that entitles
1	law, an environmental
1	paragraph (8), the
1	appropriate subject matter
1	 (1) amountthe
1	(25) -[-(isopropylthio-2,-dimethoxyphenyl]ethanamine (2ct4).
1	transverse diameter; or
1	ful-time employees conducting
1	government.  (5)
1	secretary by such
1	content a contract
1	assess practices and
2	committed, such person
1	i, 7, formerly
1	(a) the national
1	device and it
1	evaluation) at the
1	(f) an annual
1	domestically grown tobacco;
1	(2) a conditional
1	another applicant under
1	without performance bonds
1	represented or intended,
7	establish within the
3	misbranded within the
2	stat. 1260; renumbered
1	cleared, or classified
4	(a) shall provide
2	including cash and
2	trier of fact
1	findings and order.
1	 (d) disclosure
1	(b) characteristics in
1	(2) task force
1	factors (and subject
1	devices classified under
1	(11), the term
1	30, 1890 (21
1	first action after
1	 (4)[2] congressional
1	begin dispensing the
1	(1)(e) to certify
1	furnish pharmacological activity
7	scientific and academic
2	requirement the secretary
1	classify, analyze, or
1	guidance to assist
1	places and waters,
1	illness aggregated, d-identified
1	 (c) conflicts
1	committed outside the
1	fees of secretary.
1	inspectional findings regarding
1	administered during the
1	execute a written
1	disclosures that may
1	dismiss may be
1	producer on his
1	 (7) nonprofit
1	u.s.c. 264] and
1	appropriate, to increase
1	
 387j. application
1	education, or rehabilitation
1	either known or
20	section 355(b) of
1	product and prevents
2	persons qualified in
1	authorized to require
1	applicant be less
9	prescription for a
1	section 355(b) or
1	customer of the
3	difference between the
4	30 days prior
1	trading partner means
1	designated; or (b)
1	reduction shall be
1	individuals to import
1	original is required
5	debarment of a
1	notice, with regard
1	members, not fewer
1	forthwith appoint an
1	471. safe meat
1	jury.  (june
1	petition is denied
1	administration; (c) research
1	action by grocery
2	(iii) ensure that
1	committee from its
1	disease product application;
1	(i) effective date
1	include an animal
1	programs held on
2	devices for sale
1	prevent unauthorized release
1	(a) whenever a
1	pharmacies under common
2	subparagraph is a
1	applicant enters into
1	(iii) how school
1	subsection (a)(4)(c). (iii)
1	disseminate such advertisement
1	specialties. (ii) the
1	(b) shall promptly
1	regarding devices (a)
1	individual patients, and
1	investigator, of the
1	uniform inspection standards
1	value; (ii) developing
1	barrels in which
2	exceed $250,000 per
2	additive, as may
1	rail tank car,
1	assessed by quantitative
3	merely advocates the
1	two years, and
1	boobytrap means any
1	467. inspection services
2	health priorities of
27	basis for the
1	local requirement that
1	public policy, law,
1	desiccated, to which
1	response by secretarythe
5	remainder of the
2	devices and procedures
1	code that corresponds
1	regimens; and 
1	comply with systems
1	columbia as articles
1	area, and in
1	person who exports
1	might have caused
2	records and inventory
4	application. the secretary
1	1997 multiplied by
1	existing therapies; (b)
2	educational and research
1	(a) publicationthe commissioner
1	center is the
1	treasury a separate
1	question is authorized
1	otherwise, any assistance
1	authorization to conduct
1	treat a motion
2	domestically grown tobacco
1	subsequent new submission
3	persons.  (

1	quota assigned pursuant
1	strategies and programs
1	whether live or
1	duties of such
1	food or portion
2	part e of
1	title, that could
1	criteria shall require
1	343(r)(1)(b) and 343(r)(5)(d)
1	continue carrying out
2	commerce. (b) authority
1	authorized holder of
2	received of a
1	136a(c)(5)] on or
1	 (c) plans
6	serving away from
1	plants will be
1	homeland security, heads
1	(10) petrichloral. (11)
2	establishmentnot later than
1	public notice. if
1	 (2) remove
1	and, if such
3	manner as to
1	operating procedures meet
1	regulation is in
1	support a complete
2	placement on the
1	administrator such a
1	(d), dispenses narcotic
1	telephone, wire, radio,
2	law. in awarding
3	prevailing rates from
1	insect and fungous
1	animal studies. 
3	 (c) any
9	requirements for the
1	eighty days, of
1	drug before such
1	marijuana use. (e)
1	will be terminated.
1	grew the article
1	subpopulations, including whether
1	animals of his
1	panel.  (i)
1	children to the
1	title, classify under
1	countermeasure sponsors and
1	pulsenet of the
1	(d), via an
1	mutilation, destruction, obliteration,
1	without the change
1	may, by reason
1	1997), or an
1	purchaser means any
1	safety, and potency,
1	(iii) the period
1	(7) the demographics
1	(4) the preventive
2	export food into
1	person as another
2	imitation and immediately
1	1006, formerly 906,
1	congress, including to
1	relevant.  (e)
1	effective audit. 
1	(h) civil action
2	year 2003 (excluding
1	22, 2009. the
1	projected demand for
1	limitation a sponsor
1	life supporting; or
1	controlled directly or
7	served by the
1	(1)(b). (l) assessment
1	may (by order
1	one such jurisdiction,
3	seizure and forfeiture
1	if, not later
1	appropriate circumstances and
1	new owner of
1	(c) improving regulatory
1	(a)(3), or fails
1	consolidation of pos-seizure
1	avoided by good
1	days duration, an
2	employees concerned with
1	reactivation fee) by
1	annual registration 
1	order allow any
1	developed with input
1	saleable returns a
4	active ingredient and
2	employee of another
2	comment on such
2	1034(d) of this
1	will need resolution
3	coalition under subsection
3	united states citizen
1	absorbing, reflecting, or
1	distributes, receives, packages,
1	1934, ch. 712,
1	impact statement under
1	resources and personnel
1	occur by using
1	decreases an existing
1	warehouse in subparagraph
5	pursuant to appropriation
7	appropriate, the actions
1	programs. (6) drug
1	live or dead.
1	annually  (i)
2	security, shall 
1	rule for cigarettes
1	years, records documenting
1	grown tobacco, that
1	9 grams of
2	subparagraph (a) respecting
2	(i) on the
1	except where, subject
1	qualifying pathogen means
1	failure so to
1	secretary, for use
3	welfare of consumers.
1	1706 of this
1	activities (a) authority
1	includes the sale
1	compensatory damages. 
1	
 1801 to
1	classification as special
5	color additive, or
2	trafficker publicly identified
1	identify risks and
1	(2) vacancies any
1	(ii).  (3)
1	exemption); or (b)
1	plays a significant
1	investigational new animal
1	1707. counte-drug technology
1	ground for suspension
1	consider using surveillance
1	 (4) special
1	safety standards. (c)
2	(b) quarterly reports
3	tolerances established for
1	marijuana use. (k)
1	corporation shall engage
2	investigational device in
1	1, 2012, an
1	due care. 
1	unless (i) the
1	(i) such disease
1	judgment action brought
1	transcript made pursuant
1	records showing, for
1	allocations the applicable
1	250.)
 
 19.
1	proviso to paragraph
1	product beginning 5
1	product beginning 4
1	allocation for cigars
1	title. (e) the
1	quota applicable under
1	activities are directed
1	pricing data. (c)
1	506e, as added
1	321(q), (r), 342(a)(2),
2	state agencies 
8	use for the
1	-(-methy--pyrrolidinyl) pyridine or
3	state, tribal, or
1	vulnerability assessments of
1	 (e) disposition
1	section 830(a) of
1	necessary for laboratories
1	comments before the
1	section, place an
1	certification provided by
4	upon first engaging
1	fund control notices
1	subsection (b), (i),
1	subparagraph (f). 
1	tobacco product fails
1	trade representative shall
5	certifies that the
1	properly trained personnel.
1	upper airway obstruction
1	situations where a
5	report developed under
1	shall require for
1	1001, 
 

1	detecting forged prescriptions,
6	findings as to
1	subjects of research
1	(a) may include
1	information prepared or
1	-year period; and
2	applications previously refused
1	filed and has
1	subchapter: (1) administrator
1	(a), a biomaterials
1	device requirements for
3	product as required
1	889. production control
1	appropriate and feasible,
1	113. repealed. 

1	country which has
2	subsection (d); (b)
4	methods, facilities, and
1	(2)(b)(i) or such
5	registration to the
1	clause, an authorization
1	subsection (a)(4)(a), or
1	repealed. june 27,
1	expires on the
2	investigators, information about
1	governing the establishment
1	successor regulations), no
1	paramedical personnel, and
1	529, as added
1	treatment of controlled
1	 (4) appeal
1	conditionall-approved application filed
1	federal regulations, unless
1	responsible for 
1	assess information relating
1	officio membersthe ex
1	consideration of benefits
1	surrogate markers, the
1	established program nothing
1	practicable; (iii) involving
1	(1) any poultry
3	1970 [21 u.s.c.
2	radiation. (june 25,
1	possessed by a
1	appropriate; (d) establish
1	regulation; (5) if
6	chemical, food additive,
3	packing, or installation
1	centimeter exceeds one
3	reasonably required to
2	criteria for classification
2	ingredients  (a)
1	supplement will reasonably
1	title 42; (e)
1	cocculus indicus, conium,
1	academic medical centers,
1	substances (a) controlled
1	persons who carry
1	petition be approved,
10	establishment subject to
1	term restricted egg
1	domestic animals, or
1	ch. 675, 703,
1	operations for commerce
3	extended by the
1	meaning and subject
1	subparagraph within 30
1	(c) the conditions
1	ii. (b) the
1	component thereof. (june
1	information any information
1	domestic animals, of
1	use; or (ii)
4	secretary and all
1	(b) drug manufacturers
1	moved or are
3	begin with the
1	first premarket application
1	(2) establish goals
1	seller must determine
3	controlled substances into
1	service on meat,
1	investigational device described
1	minor species, where
1	(ii) after september
3	application failed to
1	exceed 2 years
1	payable. (3) generic
1	cease the distribution
8	school or early
1	device, from which
1	proceeding to sentence
2	adjustments pursuant to
1	use outsourcing facility
1	(i) regulations 
1	gift, money, or
1	considered a final
1	title in reporting
1	poisonous character of
24	notice in the
3	attorney general, or
1	exceed $50,000,000 for
2	egg products capable
1	d-identified data consistent
1	parents. (e) any
1	wild growths, may
3	 (b) availability
1	biological, and sociocultural
2	secretary shall license
1	(2)(a), the secretary
1	chapter or unless
2	unwholesome parts or
2	calculated under subparagraph
1	 (6) patien-reported
1	crystallization, purification, or
10	complies with the
1	 (b) form
1	analysis of previous
1	article and each
1	device and to
1	review of substantial
1	tolerance; or (c)
1	
 
 379l.
1	asserting receipt of
1	members for each
1	device. (b) a
1	manufacturer of which
1	(b) exceptionif, during
1	records on the
1	unless otherwise directed
1	fee account, which
1	strategic planthe strategic
1	holds open meetings
2	(e) is located
1	high consumption of
1	epidemiologic, or clinical
1	5 designate the
1	submitted.  (d)
2	(1) a device
1	 (3) effective
1	manufacturing industry, which
1	validity of the
1	(ii) the submission
1	(2) coordinate and
2	chemical to a
1	201 and sections
2	labeled for external
1	consumers. it is
1	government. (b) two
1	detailed written report
3	fees are not
1	partnership with local
1	(h) labeling contentsthe
1	designation contained an
1	either of said
1	government to prohibit
1	
 618. delivery
2	part or to
1	(2) the average
1	goals for priority
1	objectionable, stating reasonable
1	section 4402 of
1	is, collectively, a
12	identification and analysis
1	advance notice that
2	(d) if its
2	law applicable to
1	(2). (2) 
1	accreditation body, including
1	conducted expeditiously. if
3	(a) establish a
1	strikes and fires,
1	budget requests the
1	maintain compliance with
1	information submitted, such
2	labeling act (15
1	shall be, for
1	misdemeanors; felonies: intent
1	 (4) drug
1	licensed veterinarian is
1	application; (iv) 
1	current science pertaining
1	cp47,497 c-homolog); (iii)
1	law enforcement, nonprofit,
3	conditions prescribed pursuant
8	time to time
1	information. (june 25,
1	depletion studies of
2	licensed veterinarian in
3	whether the outsourcing
1	complete application. the
1	proposed animal model
1	modification of order
1	exception for required
1	maintain records with
1	monograph; (c) the
1	outsourcing facilities and
4	drug product named
1	issue a request
1	reports to congressnot
6	condition for approval.
1	regulations, except that
1	(2), fees authorized
1	similar or related
3	(b) such term
1	title by an
1	commissioner shall transfer
1	applicant under subparagraph
1	specific patient need;
1	applications; or (ii)
1	organizations; health care
1	(a) the administrator
1	enhancement of strategies
1	section 360e(d)(1)(b) of
1	active ingredient different
1	(c) application 
1	(b) intramural fellowships
2	states district courts,
2	may direct, after
1	amountsthe applicable inflation
1	
 
 360bbb5.
1	promote countermeasure expertise
1	bears, to the
1	proceeding. (june 25,
3	means a display
10	(1) the attorney
1	means of communicating
1	consider in determining
12	risk identification and
2	updated information) shall
2	regarding the technical
1	public. it shall
2	volume biological product
1	(a) in generalit
3	established or authorized
1	evidence when considered
1	major national organization
1	receiving information pursuant
1	notification under clause
1	(
 
 463.
1	(4) the authority
2	combat drug abuse.
2	secretary.  (7)
1	adjustment since fiscal
1	only; or 
4	person who manufactures
5	persons designated by
1	truck, or railroad
1	device was filed
1	(ii) is limited
1	6 months. (3)
1	actual notice of
1	institute established pursuant
1	regulations the authority
1	regulation not later
1	testing to insure
1	person who manufactured
1	review any portion
1	supply.  (c)
1	contractor to plan
1	effective communication with
1	pseudoephedrine. (iv) in
16	application of the
1	outcomes and mortality,
1	denying the petition.
1	states court under
1	counterfeit drugs may,
1	thir-party auditors under
1	bear such cautionary
1	subsection. (3) the
2	(iii) is made
1	262(a)]; (c) the
1	(i) the pending
1	542, formerly 360f,
1	new application. 
7	shall not take
1	substantial evidence on
1	(3) a regulation
1	purchased by a
1	contentthe report under
1	establishments and the
1	laboratory expertise, for
1	206. revocation of
1	near schools or
1	practicable, provide direct
1	(f), to any
3	dtc advertisements identified
1	party to obtain
7	make publicly available
1	
 462. reporting
1	approval of variances
1	covered application is
1	documentation under paragraph
1	communications during a
3	practicable for all
1	fostering medical product
1	(ii) that contains
1	order on consumer
1	oxide when such
1	annual national health
1	clauses (a), (g),
2	container of any
1	deficiencies to the
1	both.  (e)
1	models to support
3	submitting such information
3	summarily forfeited to
1	(b), and (c)
1	advisory commission on
1	president intends to
1	products shall provide
1	fiscal years; plus
5	notify the person
3	regarding whether an
2	subsection (b)(3)(a). 
1	 (4) rules
1	structure of which
1	abuse. (b) a
3	drug administration, the
1	procedures the secretary
2	otherwise be disclosed
3	$5,000 or imprisoned
2	rise to forfeiture
1	promptly as possible
2	shall assign the
1	show symptoms of
1	commencement of such
1	indicate that any
1	sponsor fees under
2	provide training to
4	services, and finance
1	section 387p of
1	vice chairman, and
1	regulatory decisionmaking, and
1	therapy under subsection
4	business or employment.
1	injury to a
1	(b), and subclause
1	states court for
1	section, and, for
6	determines appropriate. 
1	(1) to make
1	new drug which
1	terrorist offense is
1	request if, on
1	commits minor violations
1	describe the allocation
1	first day on
1	immediately effective as
1	may sel-administer medication.
1	(2) results of
2	application.  (e)
1	production in the
1	microorganisms to a
5	study or clinical
2	bona fide research
1	biennial plan shall
1	procedure in making
1	(1) in generalafter
1	notice meets appropriate
1	deems such a
1	revising the classification
2	act of 2000),
1	dispensing is not
1	subsection is made.
2	taken that the
1	general may require
1	federal determination applies
7	reference to a
1	documentation relating to
1	deferral extension request
1	related additives) shall
2	commit, or to
1	species, and such
1	dissenting views of
1	(3) bezitramide. (4)
1	reviewing the petition,
1	medical device, purchased
2	preamble to the
1	exposure estimate does
1	source of control
1	data supporting it.
4	abuse prevention and
1	proposed regulation, except
1	signs and labels,
1	parole under section
1	another, he shall
1	review such proposed
1	(3) schedule iii.
1	applicant.if all first
1	requestor submits a
1	title), and by
1	articles prepared on
1	(i) authority in
1	owner whenever in
2	45 degrees fahrenheit,
1	conducted; and (c)
1	product testing programs
1	use if 
3	(f)  (i)
1	use by persons
1	 (1) responsibilities
2	(a) or, if
1	product (1) is
1	 (c) organization
1	drug with due
1	scientific articles published
1	accessory, which is
1	forth on the
1	concur in the
1	drug tests to
1	notification each accreditation
3	prevention consistent with
1	allow the marketing
1	considered misbranded under
1	agency discretion actions
1	fda.  legally
1	states pharmacopoeia convention,
1	information and testing.
2	taken pursuant to
1	form on their
1	animal feeds. 
3	respectively; or (ii)
2	initial report, no
3	programs to prevent
1	(iii) is refilled
2	notice with which
1	material fact with
1	plan is still
1	attend a meeting
1	
 375. publicity
1	devices exported and
2	name (or part
1	name of, location
1	used against the
1	including if 
2	chapter in order
1	(3) the individual
1	establishment, shall be
2	care entity, or
1	minimum the person
1	(a) amendments at
1	united states; (c)
7	plainly marked not
1	food reports the
1	action as the
1	follow such a
1	dispensers shall terminate
1	drugs, investigational generic
1	perform activities to
1	qualification the secretary
4	detecting and measuring
1	science, and transportation,
1	products; and (iv)
1	disease, compared with
1	date shall apply.
1	 (a) tuberculosis.
1	692. inspection extended
1	treatments) to better
1	title. (e) whether
1	10782 (21 u.s.c.
1	chemicals are authorized
1	register a final
1	(g) 250.0 
1	holder that a
2	used for food
1	postmarket risk identification.
1	public of information
11	shall contain the
1	olympic committee from
1	stationed in the
2	applied to food
3	substances.  (2)
5	excess shall be
1	official mark. (p)
1	counterdrug technology research
1	submission of dtc
1	solicit substantial financial
1	section.  (4)
1	lot or control
1	procure the same
7	possession of a
3	voucher to priority
1	drug only to
1	 (c) costs
3	uses or minor
18	use of an
1	minimum scienc-based standards
1	(4) according to
2	issued (whether an
2	reserve fee that
7	libel for condemnation
1	shall record in
3	identifying the drug
1	paragraph (1)(d) is
1	stop means a
1	eggs with green
1	listed chemicals, has
1	appropriate fora, including
1	product in fac-t-face
1	user fees authorized
1	person shall produce
1	(a) each specific
1	(2) compromise claims
1	maintenance and detoxification;
4	(m) the term
2	substance except as
1	tax year for
1	products outside the
1	(c) fees charged
1	supplier is not
1	protections  (1)
3	infant formula or
1	appropriate criminal proceedings
2	section, but failed
1	require notifications related
2	present a lower
9	list described in
1	subsection (a); (6)
3	determination under the
1	licensure, and clearance
1	whether the owner,
1	 (3) inclusion
2	food; or (2)
1	second portion is
1	avoiding, and any
1	products the provisions
1	(
 
 828.
1	18) used or
2	submission of reports
1	sell or otherwise
1	includes, in accordance
1	complaint is to
3	application upon approval
1	(d) priority in
1	deposited or inclosed
1	secretary shall further,
1	making amendments to
3	require the manufacturer
1	purchaser in accordance
1	
 1049. seizure
1	 (h) effect
1	describing the legislation
3	12 months after
2	shall monitor the
2	substances are each
1	dependent persons, requiring
1	(including intelligence information);
1	additive because of
1	sympathomimetic; (xiv) the
1	accordance with appropriations
1	year 2014, $11,300,000;
1	consumer for personal
1	communit-based coalitions. (2)
1	acts it shall
1	subsection (a)(1)(a) or
2	abuse. (b) the
1	preceding sentence, shall
1	property forfeited and
1	individual that is
1	person who brings
1	employee, as that
1	transferable, except to
1	deems appropriate, to
1	qualifications for key
1	portable tank, freight
1	(1) the investigations,
1	date such final
1	subsection (a)(1)(a) of
1	premarket review required
1	surrogate endpointthe term
1	(i) the known
2	 (b) food
1	period of ineligibility
1	obligated for a
1	ordered or prescribed,
1	following and may
8	 (a) not
1	event reporting outsourcing
14	human services to
3	exceed $125,000 for
1	term as the
1	duty provided for
2	reports under section
5	 (a) request
1	product offered for
1	order. the findings
1	track and trace
1	(b)(2)..[1] (d) additional
1	distributor), request that
5	promulgating the regulations
1	effects of a
1	veterinarian, or (ii)
2	audits performed under
5	(b) a full
8	practitioner licensed by
1	proceedings for forfeiture
1	term. (2) a
2	shall not give
1	review, in accordance
5	public input on
1	regulations; and (d)
1	pacific islands. 
1	dietary supplement, including
1	emitted from electronic
1	appropriate for other
1	inability to inspect
1	adoption of secure,
2	amount of marihuana;
1	requires additional standards
1	penalties in this
1	379aa, or 379aa1
1	business or wherever
1	dispose of prescription
1	consideration of information
2	drugs (a) definitionsin
1	patients concerning new
1	reportable food, which
1	reasons therefor (which
1	consideration for certain
1	reports have been
2	(3) limitation on
1	positions that support
1	establishments inspected under
11	apply to 
2	(ii) a device
1	act. (m) fees
8	carcasses or parts
1	international relations and
1	questions; and (iii)
1	adequacy of national
1	(2) is held
2	8 years in
1	contract and is
1	human use should
3	granted prior to
1	microbiological surrogate markers,
3	returns of all
1	drug for transfer
1	public meetings held
1	product as that
2	except as used
1	year. (4) process
1	like effect as
1	promote the new
1	sympathomimetic; (n) the
1	event the term
1	 (2) testified
1	address issues relevant
3	administrator to meet
1	animal feed, such
1	(b), each member
1	storage and handling.
2	inspections as he
1	activities and material
1	mail. (3) the
1	make a referral
5	nuclear agent or
1	inspection was made.
2	4, 2011. 
1	incorporation. (b) registration
1	belief: (a) this
1	(b) electronic support
1	title is withdrawn
1	travel, including per
1	period of appointment;
2	therapy  (1)
1	hearing provided in
1	means the advisory
1	organization and operation
3	certificate or any
1	submitted that the
1	applicable regulations promulgated
1	(e)(1)(c) shall be
1	paragraph within 90
1	due 20 days
1	immediate precursors the
1	predicate device, the
1	(b) controlled substances
4	experience and expertise
1	state law no
1	ethical and safe);
1	grants the administrator
1	regular review by
1	title but was
2	(a)(5)), a wholesale
1	flavoring or coloring
2	agreement, the dispenser
1	(i) procedures for
1	inspectors are required
1	months, acting through
19	drug or investigational
1	prospective purchasers name,
1	society conferences; (b)
2	minimize or prevent
2	published a notice
1	2013, for each
4	thermally processed lo-acid
6	listing under section
1	approved product labeling
1	262(a)] upon a
1	(c) coordination with
2	years, the revenues
1	imposed by clause
1	remain in effect,
2	remain in effect.
1	indian country the
1	 (1) reinstatement
2	labeling are in
1	704, 52 stat.
1	data resulting from
1	establishment where any
6	department designated by
1	product development (referred
1	qualification package reviewed
1	section. new animal
2	7 percent of
1	(c) each regulated
3	articles required to
1	reliance on federal,
2	to, such article
1	if, during the
5	warehouse, or other
1	 (c) staffthe
1	available or accessible
1	raw materials, products,
1	(1) a request
1	(g), be established
1	lon-term scientific and
1	make or direct
1	filed. (v)agreement with
1	packaging. (6) the
1	904, as added
1	section 331(d) of
1	possess controlled substances
1	supplier shall not
2	making due provision
1	shall have as
1	shall agree to
1	provisions the requirements
1	transmission of data;
1	regulation); or (ii)
1	twice the term
1	obscure the labeling
1	proceedings to establish
1	infrequently and in
2	animal drug sponsors,
1	individuals understand the
5	give priority to
1	seller maintains each
4	shall have an
5	inspections conducted by
1	scientific evidence submitted
1	food, within a
1	secretary; applicability 
2	importing, any carcasses,
1	assessment of drug
1	title; or the
2	statements, if any,
1	(j) is in
1	drug samples made
2	shall develop model
1	assist, abet, conspire,
1	means the recipient
1	security.  (june
1	public health, due
1	secretary is diligently
1	patient preferences with
1	conducting the assessment
1	affected pediatric patients.
1	device effectiveness shall
1	take action for
8	within sixty days
1	drug abuse prevention;
6	safety and effectiveness,
13	safety and effectiveness.
1	issued. the order
1	removal from index;
1	distribute such manufacturers
1	2251. jurisdiction; authoritiesnothing
4	evidence of the
1	reporting of telemedicine
1	title for investigational
1	new york, new
2	establishments in the
1	property may deliver
2	drug for purposes
1	cause shown, to
1	safety and effectiveness;
5	carcasses, portions of
2	contributed to an
1	criteria to morbidity
2	training under subparagraph
1	deems appropriate (and
1	dispense, an anabolic
1	343(b), 343(d), 343(f),
1	offices and centers
1	occupy the field
1	milk imported when
1	inspection program; (2)
1	whether the studies
1	42), or vaccines,
1	term serious injury
1	condemned poultry products
1	exception a manufacturer
3	title, for a
1	commodities; or (c)
1	stalks of such
1	
 152. importation
1	(b), a quantitative
1	(2) remaining portions
1	subparagraph (c)(ii) shall
1	emerging pathogens and
3	united states dollars,
1	monitored; and (e)
1	leaf through nothing
1	promulgate regulations on
2	secretary of that
1	(1)(c) shall apply
1	(
 
 2110.
2	advisory committee (or
2	used in conducting
1	authorize the effectiveness
5	connection with biosimilar
1	printing, and publishing
1	generalthe national drug
1	accompanied by data
2	601 et seq.]
1	
 
 350.
1	officer, director, or
2	commerce a federal
1	recipients civil regulatory
1	influence said inspector,
1	federal agency to
2	section prescribing the
1	
 903. application
1	(1)(a) to serve
1	access to expedited
1	carcasses to prevent
1	(iii) describing the
1	advertisement before the
1	clause (iii) applies,
2	apply to records,
1	comments submitted under
1	including a list
1	(1) a discussion
1	articles from such
1	(a) communication plan
1	appropriate, inform the
1	subchapter i inspection
1	 (8) advisory
1	extension request containing
1	fiscal year 2019
1	distribution history of
2	shall grant to
1	 (g) representation
1	inspection programs (a)
4	information) relating to
1	351. adulterated drugs
1	exportation (in any
1	implementing preventive controls
1	(
 
 360g.
4	following the fiscal
1	(4) data on
2	official of an
1	vegetables. compliance with
1	marketed, or is
2	amount of marihuana,
2	feet of a
1	previous 1-month period.
1	uncompensated basis, as
1	agents, in order
3	 (6) 
5	person to be
2	affidavit of the
1	shall establish objectives
1	period is proposed
1	may not authorize
1	subpopulations a study
1	897.32(c); (c) strike
1	title 42; (iii)
3	manufacturer has reason
1	appropriate expertise pertaining
1	lot or tract
1	heroin consumption since
1	early, no-food life
3	shall only promulgate
1	secretary a detention
1	labeling, or any
1	produce. the quota
5	notification that is
1	decrease the potential
1	wholesale distributors, except
1	2007 such sums
1	waivers and deferrals
1	qualifies as a
1	director) and shall
1	sentence. (f) dispute
1	financial support (including,
1	appropriate animal model
1	358. authority to
7	regulated person who
1	schedule or transfer
3	device for the
1	191 to 193[1]
5	process for development
1	technology transfer program.
1	drug between members
1	canceled prior to
1	labeling branch, food
1	either such section;
2	entry of eggs
1	medical center. 
1	sale, transportation, possession,
1	provides a schedule
1	section only, the
1	means a center
1	patient.  (d)
1	section, which concerns
1	health exception the
1	submit a timely
1	(3) disclosure of
1	valid and applicable
1	identical with 
1	required for a
1	adding or deleting
1	senate of actions
5	manner and upon
1	generalthe term harm
1	 (a) facilitating
1	less than permanent
1	ch. 675, 506a,
1	ch. 675, 514,
1	islands, guam, and
1	jurisdiction, from such
1	public notice issued
1	betamethadol. (10) betaprodine.
1	interactions;[1]  (iii)
1	packaging, temperature controls,
5	advisory committee who
1	3, 67 stat.
3	patent referred to
1	bitter almonds, colchicum,
1	tobacco product detained
1	analogous products provisions,
1	amounts authorized to
5	minutes described under
1	resistant microorganisms of
1	management of individual
1	pesticide chemical when
1	statute. (g) inapplicability
2	subsection for which
2	name of, contact
1	commission shall receive,
1	(e) state definedfor
1	per submission for
1	paragraphs (2), (4),
1	secretary prescribing that
1	 (3) documentation
1	administration of animal
2	standards to the
1	employment because the
1	9, 1956, ch.
1	worldwide gross annual
3	 (7) the
1	pending applications subject
3	upon the application
1	(ii) at which
1	islands, and any
4	independent study of
1	panel (except for
1	28, unless such
1	ingredients not grase
1	 (5) petition
2	governing disclosure of
1	(4) amendment; revocation
1	operators of condenseries
1	(5)(a), a hearing
1	52 stat. 1044;
1	
 
 618.
1	need for prevention
1	transparency  (1)
1	substance the findings
7	shall revise the
1	suitable book or
1	external experts who,
1	travel, subsistence, and
2	itemization of how
1	agricultural commodity in
1	purposes, on a
1	interest in, claims
1	shall give consideration
9	356e of this
1	may receive an
1	(i), (2) such
1	ii, or class
1	gamma butyrolactone or
2	section is prohibited.
1	authority or any
1	(3) good manufacturing
1	ch. 675, 507,
1	development of practicable
1	issue an order,
2	methamphetamine, including its
1	(2) prepare and
2	(c) and the
1	involving moral turpitude.
1	enforcement official; or
1	upon a guaranty
8	receipt of an
1	place the property
1	title; (d) pee-reviewed
2	whether the applicant
1	dispensed only under
1	indication approved under
1	regulations proposed to
1	nutrient to the
3	product development, biosimilar
1	maximize the use
1	foundation duplication of
1	local law or
1	records), make such
23	360(k) of this
1	review fee is
1	practice, the notification
2	united states through
1	affiliated warehouses or
2	appropriate form, by
2	take steps to
2	conference. the decision
1	iv, 403, as
1	priority to those
3	likeness thereof, of
1	meet, in person
1	sixty days but
11	determines that there
1	slaughter; use of
9	adulteration of the
1	appropriate. in such
1	solely for human
1	regulation establish good
1	(2)(c) may, at
2	distributed any free
1	competition the term
1	prepared, sold, bartered,
1	(c). (c) exposure
2	determines necessary in
2	secretary, be designated
2	marketed. (c) in
3	secretary to ensure
5	assure and preserve
1	(1)) that is
1	food products analyzed
28	subsection, the secretary
1	foundation, including from
2	different from that
1	secretary and, as
1	afforded prosecution by
1	appropriate, prohibit imports
1	(b) 66 percent
2	841(b)(1)(b) of this
1	prohibited:  (1)
1	term transportation means
1	675, 752, as
1	shall be linked
1	contact substance 
1	notification, or request
1	biennial reporting the
2	(b)(5) of this
1	use, to transport,
4	grant to a
1	 (v) publication
1	principals any person
1	reasonable likelihood of
4	capacity to a
1	regarding the food
1	formula may affect
2	registration under any
1	notification, but may
1	state has the
2	propanamide or 100
1	fire, or flood;
1	assistance is given
1	referral of such
33	pursuant to paragraph
1	effective, including demonstrating
1	shall make payments
2	(i) a determination
1	information concerning listed
1	postmarket surveillance or
1	350(c)(1)(b)(ii) of this
1	lifesaving medical devices,
1	payment penalties or
2	831 of this
5	drug does not
2	secretary within thirty
1	-cyan--methy--phenylpiperidine. (16) pethidin-intermediat-b,
1	year. (d) collection
1	quantities of animals,
1	defer submission of
1	states that 
5	(mar. 4, 1923,
2	year 2014, the
1	states a fund,
1	(1) not expressly
1	specific interpretation and
1	(b) which under
1	(c) definitions for
1	paragraph (4) through
1	ginseng dietary supplements
2	1-month period referred
1	product. (mar. 4,
3	less of gross
1	credentialing center, the
2	missions undertaken by
1	sources of the
1	producta drug product
1	use 10 percent
1	grant to 1
1	(4) for having
1	consumer. nothing in
1	devices, and cosmetics
1	term drugfor purposes
1	agreement on whether
1	scheduling such substance,
10	information about the
4	section and shall
1	mitigate, treat, or
2	jurisdiction, any committee
1	conclusive. (
 

1	(3) notwithstanding subparagraph
2	storing any such
1	make such request
1	supplement; (3) is
1	ready for such
3	least burdensome means
1	(k) take into
1	active, no-narcotic ingredients
1	paragraph require data
1	individual cans containing
1	chapter, or (ii)
2	substantial reduction in
1	952, 953, or
1	drug users placed
1	dosage forms each
1	used primarily for
1	plan to ensure
1	device. during such
1	positive conflict between
1	initial grant awarded
1	exception, to the
2	verification program under
1	regulation under such
1	abuse of a
1	supporting it. if,
8	human services. 
3	schedule ii may
1	(c) natural disasters
1	301, as added
1	options described in
1	period of debarment,
1	compilations under this
1	advance; and (c)
1	identifying the processing
1	board, but shall
2	product, or if
1	notice that contains
2	enable the united
1	both. (7) penalties
1	u.s.c. 263a] notwithstanding
4	inspection authorized by
1	 (3) posting
1	administrator granting or
1	legislative body. (c)
1	(a) shall require
1	nature and seriousness
1	shock. (d) outreach
1	 (g) plants
1	associated type ii
1	effects of in
1	reasonable costs incurred
1	pharmacist licensed under
1	(3), of section
1	379j43. reauthorization; reporting
1	noticeany notice provided
4	drug applications pending
2	(c) publication in
2	controlled substance, and
1	(c) the device
1	register the panels
1	commerce, (b) controlled
1	surveillance network (foodnet)
14	persons who are
1	 (5) reporton
1	whether action should
1	intact mucous membranes
1	fill a vacancy
1	chapter is necessary
1	exceed 90 calendar
1	(a). the advisory
1	appropriate decisions about
1	assessment at which
1	iv or any
2	component or otherwise
1	treat addiction; (v)
1	proposal, be referred
1	(but not including
2	device, food, cosmetic,
1	derived from, any
1	paragraph[2] shall not
1	work, of the
1	insofar as that
12	conducted by the
1	quotas the suspension
1	order. any such
1	professional personnel appointed
1	accept a surety
1	actions the president
1	objections are filed
1	strength.  (5)
1	pharmacy or physician.
1	directors (referred to
1	needs of special
1	bonuses, and other
3	device be restricted
1	counterfeiting, simulating, or
1	ability and willingness
2	requests to the
1	time for issuance
5	 (i) fiscal
1	list (a) establishment
6	issued under subparagraph
1	control of pseudorabies.
1	waiver.  (4)
1	taken to repair
1	pesticide under that
1	measurement system established
2	(2) of the
1	861. employment or
2	listed pursuant to
6	charge or custody
1	intelligence to federal,
1	establishments hereinbefore described
1	paying such fees
1	subject propertythe following
3	will stop using
1	days before dissemination
1	significant prevalence in
1	department) is not
1	technical assistance division.
1	conduct activities to
1	outlets to assist
1	
 387q. tobacco
2	establishment under the
4	reduce or eliminate
1	access to summaries
1	academic institutions; (i)
1	(g)(1) or is
1	renewal for the
1	379o. environmental impact
1	1703(d) of this
1	receipt and outbound
1	products used to
3	thereto, unless its
4	 (2) required
1	reviewing information on
1	storage, packaging or
1	secret information, and
1	title. (ii) a
2	days, of a
1	deemed renewed at
2	 (2) termination
9	regarding whether the
1	notice, including the
2	section 355(c)(3)(e) of
1	inspection as authorized
2	drug application if
1	effective occupational prevention
2	contain provisions regarding
1	expedited under section
1	recall networks, as
4	drug application in
3	requirement under subparagraph
1	(c) publish in
1	revoking such protocol,
5	notification submitted under
1	facility, unless they
1	provide an effective
1	made within a
1	paying such fee,
2	state laws containing
2	subsection (j) of
1	section 331(i)(2) of
1	patients symptoms, overall
1	supplied at no
1	smokeless tobacco as
1	exported, (b) it
1	request by compiler
1	(a), the responsible
1	determines after any
1	determine, in accordance
1	(1) the chairman
1	(c) small fruit
1	findingfor purposes of
1	used in making
1	may appoint inspectors
1	(iii) any agreement
1	use data under
2	type of distribution
1	infant formula powder,
2	9-day extension that
2	new drug, or
3	manner inconsistent with
1	$505,000,000. (f) for
1	infant formula through
1	(a)(2), or clause
2	(i) crediting and
2	reduction is not
1	specified substances registration
1	custody of purchasers
1	year, the head
1	director determines may
2	entity to submit
2	salt, compound, derivative,
1	shell or crack
1	u.s.c. 262); and
1	(b) requests by
1	drugs and devices.
1	diversion of scheduled
3	returns processor or
1	guidance.  (g)
2	international and domestic
1	dietary supplement when
1	(a) provision of
5	would, in the
1	production of methamphetamine,
1	intelligence agency shall,
1	section. such fee
1	determines will enable
2	(i).  (b)
1	sterilization, and functional
2	mandatory background checks
1	secretary exercise the
1	tracing of products
1	approval may, by
1	 (f) manufacturer
1	contemplated is given
1	20.  (

1	(f) the feasibility
1	background and knowledge
1	industry, academia, medical
1	r-exportation has occurred;
2	certified (the opportunity
3	fiscal year of
2	healt-related conditions associated
1	employee may seek
1	facility is engaged
1	applications, the provision
1	judicial review if
1	public and shall
2	fiscal year on
1	136a, 136h]. 
2	taxable year, and
1	terminate; and (ii)
1	section 1232g of
1	regulations and issue
1	process for qualification
1	duties; regulations the
4	experimental conditions in
1	(2), and may
2	fiscal year or
1	attorney general makes
1	colors, may be
1	action, be brought
1	misbranded is found
4	required to assure
7	 (d) the
1	importation without permit
1	attorney general. a
1	greater than ordinarily
1	provide recommendation on
1	(b) request that
1	making the request,
1	interest the term
1	making the request.
1	served with subpena.
1	title, the person
1	(i) the identity
1	title 42; (2)
2	explanation for the
1	states; but such
1	(b) a civil
1	foreign commerce. incidents
1	outsourcing facilities, and
2	materials other than
1	 (b) heightened
1	notwithstanding the prior
8	sufficient information to
1	$50 nor more
1	exposure of people
1	corporations engaged, in
2	sentenced under the
1	(3) to import
1	produce, so that
3	federation of american
1	country listed in
1	well as rules
6	usual name of
4	national formulary, or
1	1997, and may
1	subchapter and related
2	applicant shall pay
3	health; and (b)
3	years 2011 through
1	(c); (c) identify
1	subchapter, or take
1	$299,000,000. of that
1	drugs as the
4	will reasonably be
3	controls used in
1	veterinarian, shall be
1	writing the previous
3	samples of the
2	drug; (e) such
1	provided), transaction history,
1	dollars, for an
2	reports, and other
1	upon data obtained
8	drugs.  (2)
4	user fee 
1	investigator in one
2	exempt from either
1	farms if (i)
1	search of all
5	applicant from engaging
1	recommendation. (ii) the
2	1-day period beginning
1	compounding, physicians with
1	month of operating
11	period of 30
1	partnerships in the
4	states that the
1	previously developed by
4	showing of reasonable
6	generalthe fees authorized
1	entity to a
1	united states, irrespective
1	title entitled to
1	warning and surveillance
2	(g) service of
2	meaning for purposes
1	person is exempt
1	veterinary hospitals; (3)
1	petitions referred to
1	columbia. (z) the
5	public interest. in
1	extensions paragraphs (1)(a)
2	used or permitted
10	may  (1)
1	combination product submit
1	use.  (h)
1	including novel or
1	input, as the
1	device for a
1	threats. (c) systems
1	organization for standardization
2	comparison to the
1	identified in at
1	(iii) a contract
2	representative data and/or
2	describing actions taken
1	(i) within 60
1	technologies; (b) for
2	place where he
1	application that satisfies
1	means:  (1)
4	strength, or make
1	considered as one
1	(b) the use
1	ch. 675, 535,
1	still effectuating the
1	additional patent information
1	(24) the term
3	proposed amendment of
1	aforesaid sections of
2	processing animal food
4	introduced, including by
1	(5) schedule v.
1	(ii) that on
1	(or such higher
1	subparagraph which provide
4	slaughtering, mea-canning, salting,
1	bring together a
4	returns to the
1	countermeasure, provided that
1	(e) inapplicability of
1	third or subsequent
1	factors contributed to
1	twelv-month period of
1	regulations finalized to
1	prescriber, and, if
1	safeguard public health.
6	convicted of an
3	drug development process
1	use, for that
1	individual criminally. however,
2	sponsor has not
1	year in addition
1	affect individuals aged
2	voluntary food allergy
1	determinations to qualify
1	 (6) exclusive
1	year. (4) the
1	confirm in writing
3	attorney general. the
1	quality systems standards.
1	monitoring of international
1	held, and transferred;
1	indications for use:
2	products.  (e)
1	individuals  (1)
2	recipients that are
1	temporary suspension of
1	fact and conclusions
9	drugs intended for
1	vegetable, consideration shall
1	safety and health
2	15 days after
2	country of import,
1	
 17. penalty
1	restricted eggs; prerequisites
1	360(k), 360c(f)(2), 360e,
9	departments and agencies
13	drug described in
1	appropriate. (6) additional
3	qualified entity shall
1	experience, and other
2	regulation applying to
1	shipping containers or
15	eggs and egg
3	(a) authority to
1	order; and (v)
4	law or under
1	secretary. (2) no
1	practice or do
1	(july 12, 1943,
1	samples also shall
2	reporting and recordkeeping
1	drugs (referred to
1	clinical trial by
1	prior sentence, and
1	ii(a)(4), the term
1	controlled substance abusers
2	package per adult
1	product.  (iv)
4	drug development tools
1	accreditation, but were
2	year thereafter, the
2	appoint and pay
14	title.  (d)
1	practice, or hazard
3	secretary.  (f)
5	clinical testing of
1	limit).  (5)
1	agreementsthe agreements under
1	deposit.  (a)in
1	products for domestic
1	(ii) no residue
1	adduce additional data,
1	paragraph (s) of
1	otherwise the provisions
2	within which interested
4	seq.), or the
1	defined in sections
3	secretary the following
1	injury or damage;
1	section. (e) monitoring
1	manufacturing practices; (e)
1	food animal science.
3	successor in interest.
4	30 months after
2	preclinical research or
1	school, elementary school,
1	u.s.c. 1701 et
2	paragraph for each
1	product; (ii) identify,
3	drug development tool,
1	otherwise combined or
1	shell and shell
4	may have caused
1	notwithstanding subparagraphs (a)
5	section. the secretary
1	directive or ship
1	(e); and (g)
1	(1) develop and
1	recall; and (d)
1	word consul as
2	initial transaction date,
2	personnel unless such
4	necessary to be
1	report include the
1	exceptions under subclauses
1	may be terminated
2	adverse event received
1	74, 11, 38
3	area, premises, building,
1	establish a different
1	relate to retail
1	officio membersupon the
1	legible through the
1	canadain particular, the
3	 (c) if
1	drugs; and of
2	(such as sodium,
1	state offense or
1	manufacture, local distribution,
1	reimburse each person
2	involving a list
2	 (c) in
1	handles. (6)affiliate.for purposes
1	licensed and registered
1	amended.  (c)
1	(4), if 
1	title and participation
1	lon-term quantifiable goals
1	679; june 26,
3	clause (b), (c),
1	organized labor. 
1	indicated. scientific, trade,
2	nonprofit, private entities
1	commission shall establish
1	secretary, and (b)
1	safe level for
1	360m. accredited persons
1	infant formulas, including
1	grounds for withdrawing
1	(or both) a
1	determines such award
1	antifungal drug subject
1	(ascorbic acid) (mg)
1	calendar year, including
4	states as of
2	notification, the secretary
1	(3) animal drug
1	reconstitution). (11) the
1	may delegate the
1	genome contains a
1	may restrict the
1	specifically opioids or
2	testing of such
1	safeguards to protect
1	managerial agent whom
1	previous sentence prohibits
1	dietary ingredient which
1	secretary based the
1	killing of any
1	party shall maintain
1	threat will spread
1	device. in providing
35	serious adverse health
1	requirements under sections
1	risk communication under
1	coalitions communities. the
1	subsection (e) is
1	chapter. (p) the
1	(2) limitationthe director
1	reduction of nicotine
1	subparagraph; and (bb)
1	crime. (4) the
1	person given such
1	seller for harm
1	date of appearance.
1	738a, as added
1	100 grams. (4)
1	may direct the
1	handling of poultry
1	chapter, of the
1	distributor received a
1	(i) do not
1	drug, provided that
2	section 355(c), 355(j),
1	secretary from following
1	maintain any record,
1	investigations, specified in
1	improved analytical methods
1	different than the
1	public report containing
1	devices in any
2	feed are the
1	classified the results
1	person licensed by
1	application.  (4)
1	abroad. (
 

1	act. there shall
1	secretary from updating
2	equitable basis. such
2	containers under part
1	(1) a food,
1	3551. risk evaluation
1	licensure of countermeasures
2	drug administration programs
1	262, 2, 42
2	section 1001(a) of
1	committees (a)[1] not
1	(1) united states
1	witness or the
16	applicable to a
1	person receiving the
1	subsequent clearance or
1	claim if the
1	thereunder is filed
1	maintains a copy
1	residue shall not
1	reimbursement; installments payment
1	(a) foreign governments
1	prohibit, limit, or
2	2021 of title
1	keeping, transporting, and
1	permitted, at all
1	practicable, but (except
1	executive agency or
1	term processed means
1	 (c) authorizationthe
1	shall thereafter act
1	plan to inform
1	academic research organizations;
1	identifies the drug
1	human services, who
6	conducted by a
1	title 5, as
1	establishment. this section
1	forfeiture, if the
1	act upon information
1	regulation for purposes
1	signature using one
1	supplying certain raw
1	periodically and modify
2	processed, bought, sold,
1	labeling, container, or
3	due or payable
1	allegedly occurred or
2	(b) applicability of
1	tests for which
1	1003, formerly 903,
1	generalthe assessments referred
1	award amountsaward amounts
1	600.3(ee) of title
1	following the entry
1	220501 et seq.).
1	determinations for requests
1	qualified entity that
1	hold the same
1	use exemption a
2	responsible party subject
1	final regulation. such
1	give or provide
2	electronic format; and
2	relating to new
1	regulations, except as
1	animal feed. (4)
30	requirements of the
4	drug activities for
2	subsection shall establish
21	activities described in
1	(d) definition as
1	effective date, objections,
1	193.)
 
 18.
1	performance of duties.
1	2007; (2) $250,000,000
1	other, with any
1	uniform nutrition labeling
1	warranted. if a
1	data summary means
1	section a person
1	building construction, sanitary,
1	oversight in establishing
1	outside the territorial
1	targeted drug, as
1	consistent, to the
1	regulation, provide for
1	commonwealth, territory, or
1	copying. (mar. 4,
1	qualifying pathogens described
1	ownership or possession
1	 (5) sustainabilitythe
1	residue continue to
1	regarding approval of
4	adulteration and misbranding
1	title except when
1	subsection (a)(1), such
3	42. (june 25,
1	optical isomer, or
2	secretary grants an
1	devices; and (b)
2	opium per 100
2	assigned to the
1	controlled substances is
1	statements as prescribed
1	general.  (c)
1	operations at official
1	
 379k. information
1	subject to proceedings
3	provide such assurance.
5	will cause serious
2	provide such assurance,
1	procure without foregoing
1	-diphenylpropan-carboxylic acid. (14)
4	employee or official
1	necessary, such person
3	country to the
1	including planning and
1	(e)(1) only with
1	means.  (3)
1	 (h) reporting
1	provision operates, including
1	treatment availability, which
5	patent does not
1	constitute a conflict
1	 (a) withdrawal,
1	(b) include a
1	use of blister
1	smoke. (3) effective
1	regulations not less
1	committees.  (5)3
1	(b) notice of
2	drug submission, shall
11	may  (a)
1	name and telephone
2	request for addition
1	demand reduction by
1	species, where safety
1	both. (2) if
1	programs and participate
1	order thereunder with
14	5 of title
1	electronic gateway, on
1	study (including a
2	oceanic and atmospheric
1	represents the agencys
2	314.510 or 601.41
1	elsewhere, for each
1	information, certified by
1	report and such
1	analysisthe owner, operator,
1	title, is adulterated,
1	goals; and (e)
2	oleomargarine or margarine,
3	additive; or (iii)
1	uncertainties, risks, costs,
1	whether denial, revocation,
2	new drug subject
1	health professionals treated
1	scientific expertise on
2	conditions that would
1	chapter designating this
2	occur naturally, may
2	appropriate given the
1	facilities for the
1	regulations); and (ii)
1	immediately preceding fiscal
1	repackager of the
1	order should not
2	purchased directly from
1	plan. (3) agreed
3	reverse logistics provider
3	use in humans
1	agency to carry
1	clause (iii); (ii)
1	(2) that all
1	 (a) sponsors
5	expiration of 45
1	period so that
1	14 days thereafter
1	shall use competitive
1	675, 401, 52
1	certain health care
1	subparagraph (a) authorize
2	strength with respect
4	make a recommendation
1	medical devices, and
1	agency, or program,
1	provisions; conduct of
1	states the name
3	production of the
1	applied for infants
1	unlawful distribution without
1	 (f) such
1	available.  (5)
1	safety, or welfare,
1	certification no period
1	grams, or not
1	(a)(1)(c); and (2)
1	information to health
1	substance among european
3	released unless it
1	made to any
1	upon certification that
1	sound shell egg
1	679a of this
1	secretary. within five
2	forbidden or restricted
7	(iii) the secretary
1	director may exercise
8	supreme court of
1	(public law 109462).
1	(3), a national
1	ch. 675, 409,
1	(ii) the annual
2	recognized shall not
1	public comment during
3	care entities which
1	secrets, for purposes
1	providers; and (v)
1	property, including rights,
2	control plans of
60	general the secretary
1	order or expiration
1	security countermeasures. if
1	information about implemented
1	requirements, based on
1	targets for each
3	respecting the designation
1	plan contains a
1	methods are expected
2	will be informed
1	387j, or 387p
1	register.  (3)
1	cooperation of any
2	improve the skill
1	pediatric age groups
1	properidine. (41) racemoramide.
1	waiver to permit
1	wildlife, or domestic
1	warrant (a) for
3	claim such a
1	instance of importation,
1	timeframe envisioned in
1	387j, or 387k
2	medical information submitted
1	management of portfolios
1	regulatory discussions, including
1	medically useful drug
1	section. except as
1	substance, bulk drug,
4	subsection for any
5	drug product means
4	prior to december
1	vender. (mar. 3,
1	9831 et seq.);
1	receipts submitted for
1	directly in the
3	on-year period beginning
7	secretary an application
2	advertisement for which
1	title. (3) a
1	
 1712. termination
1	2009, with respect
2	(b) procedure in
1	filled in accordance
1	boxed warnings, contraindications,
1	levels of contemporary
1	(ii) a patent
1	preemption of certain
1	transaction does not
1	age after a
1	 (a) because
1	-fisca-year period following
1	agriculture and cooperation
1	experts, on the
7	withdraw approval of
1	food that present
1	(a)(2)(a) for the
2	expiration date provided
1	advertising and the
1	described by paragraph
1	emergencies; and 
1	dialysis solutions; (xvi)
1	(
 
 811.
1	partner agreements beginning
1	section 201(b). 
1	practitioner involved an
26	addition to any
1	patient. the subsequent
7	warehouse, or establishment
1	representatives of industries
1	vote.  (c)
1	required to place
1	waive the requirements
1	sector coordinating council,
1	specific vulnerable points,
1	care practitioners and
1	labeling appropriate for
5	addition to and
1	products for research,
1	(iv) 100 grams
1	mentoring activities by
1	exporting country, in
1	 (b) reliefthe
2	 (d) additional
1	use it only
1	shall not duplicate
4	shall be borne
1	successor committee) and
1	case of butter,
1	manufacturing) at the
1	data, and information
1	regulations).  (b)
2	sale within the
1	regulation, to an
1	enforced without further
1	1981 and the
1	respect to meat
1	promotion using the
1	of, any enterprise
1	subdivision may enforce
1	mentoring coalition under
1	prescription transfers any
1	activities to another
1	(2) changes not
2	application, no petition
1	additive, in or
1	(a) findingscongress makes
1	outside the customs
3	state, and the
2	categories to which
8	date of receipt
1	person in concert
1	may prescribe, to
1	withdrawn for any
1	website in accordance
1	13, as added
1	kind of food,
1	ch. 675, 742,
1	(1), either (i)
1	committee in the
1	indicated in an
1	seq.] and its
1	original notice under
1	based; and (ii)
1	photon positron emission
2	label required under
1	federal court challenges
1	product to zero,
1	(b) results in
1	persons involvement as
1	respect to patients
2	uses; (11) if
2	regarding its activities
1	premises; (2) in
1	consumption  (1)
1	controls; (c) the
1	diversion and other
1	chemical that the
5	settlement order or
1	(2) final regulationthe
1	specified under subparagraph
1	clinical trials, if
1	control any place,
1	summaries under subsection
1	
 112a. omitted

3	certainty that no
1	readily recovered from
1	(27) levomoramide. (28)
1	prior conviction, not
1	product involved) requiring
1	(i) within sixty
1	falls below, that
1	jurisdiction of district
3	proceedings initiated under
1	 (c) disclosure
1	request shall identify
1	thereof to be
4	section 355, 360(k),
1	months on july
1	order was issued.
5	order was issued,
2	fee under clause
1	grants for methamphetamin-related
1	42) shall be
1	carried out, and
1	year. (c) provision
1	illegal transaction 
1	(b) congress this
3	(or part thereof)
1	appropriate; and (c)
1	interest (a) definitionsfor
1	(hereafter in this
1	physician, dentist, veterinarian,
1	where, despite good
1	imports tobacco products
1	clause (a) and
1	october 1, 2008,
1	ch. 675, 505d,
1	(e) extensions for
1	(a) establishment 
2	probable benefit to
1	partly of insulin
1	consideration the need
1	proper installation, maintenance,
1	traffickers and required
1	standards not later
3	standard or standards
1	sel-incrimination. but no
1	conclusions. (v) the
1	notifies the regulated
1	review of biological
1	notice identifying the
1	sunscreen orders. 
9	trading partners that
1	means at least
2	used with respect
6	ingredient) that has
1	located within 2,500
1	(a) a tolerance
1	exclusionsthe term does
2	section 1182(a)(3)(b) of
3	$10,000,000 for all
2	proceedings; detainer authority
1	standards and consensus
1	completeness assessment, in
1	record, or make
3	ethics of the
1	foreign establishments 
8	publication in the
2	(ii) is a
1	active surveillance infrastructure
1	 (2) qualifying
3	(i) set forth
1	(i); and 
5	contracts entered into
2	contains more than
1	part.  (i)
1	(3) other persons,
2	bulk chemicals to
1	alter  (a)
1	products, human cell
2	chapter shall, at
4	evidence, shall be
4	affording opportunity for
6	100 percent of
1	official compendium. (d)
2	inspectors shall label,
1	recommend a classification
4	hermetically sealed containers
8	made in the
1	state or subdivision
1	periodic laboratory tests);
1	information act), or
2	agriculture and representatives
5	year 2018. 
1	intended purposes. the
3	every 3-day period
1	term pane-track supplement
1	disease.  (c)
1	paragraph (4), or
4	(c), shall be
1	(i) all notices
1	offender is brought
8	establishment there is
1	1971, or as
1	investigations, which may
1	holders submit to
1	(
 
 848.
1	costs and the
1	maintain an agreement
1	designate such device
1	attorneys fees. (5)
2	capacity to provide
1	financial assistance for
1	abuse issue within
1	year 2016, $12,300,000;
1	applicable; (ii) identifying
1	doses, or similar
1	drug, biologic, food,
4	authorized or required
1	material issue shall
2	control that do
1	parties, and, notwithstanding
1	successor regulations). if
6	imprisonment which may
1	identified and assessed
2	order if placed
1	vehicle.  (2)
2	canned food facilities
1	purposes certify to
1	separate information for
1	(d) penalty for
1	title (i) except
4	ensure the protection
1	federal standard. nothing
1	investigations.  (b)
1	congress, however, must,
12	article or animal
2	(i)in general.no action
6	investigational use by
1	chemical product, the
1	change, summarizes the
3	subsections (c) and
1	affairs (a) access
5	chapter or section
1	court, and may
1	number, if available;
1	certified. (may 23,
1	projects, including those
5	central nervous system
2	territory, under a
2	(bb) in the
1	states pharmacopeia, the
2	show an amount
1	(ii) 500 grams
2	writing and the
1	(a)(4)(a), or a
1	added ingredients, excepting
1	manner, and with
2	discontinued section of
3	process and the
1	united states, be
1	by, poultry products
1	law, all poultry,
1	chapter. (e) the
1	subsection may provide
1	notified in writing
1	drugs, shall include
1	event reports to
1	list of substitute
2	right to an
2	complete on the
1	act) such information
1	originally received by
1	sale held by
1	residues resulting from
1	order required by
1	judge to whom
1	experience datafor purposes
1	year) is equal
1	adulterates a drug
1	property at any
2	if, after issuance
1	released to the
1	may exclude a
1	extent practicable, segregate
1	(a) in generalevery
1	subparagraph or of
1	means of disposing
4	whether the establishment
1	department in connection
1	entity is eligible
1	transmittal to the
1	statement, and (2)
1	manufacturer by service
1	(b)[1]) subject to
1	substances, he shall
3	subsection (c)(1). 
2	subsequently conditionally approved
18	section for a
1	ch. 675, 904,
3	insofar as may
1	(b) communication facility
60	respect to which
5	compliance with regulations
2	required to provide
1	anaphylaxis may sel-administer
2	columbia, or that
1	(b) may result
19	products shall be
1	sources of illegal
1	section 356c(f) of
2	subsection (k) until
1	amounts appropriated to
1	local drug crisisthe
2	date such notice
2	action was dismissed
1	sponsor agrees, in
2	commissioners request to
1	(9) is impracticable
7	approving the application
1	(or collectively by
1	subsection (a), subparagraph
1	advertising. (e) evaluation
1	combat international crime.
1	consolidation shall not
1	352. misbranded drugs
1	(c)(1), (d), (e),
1	secretary, specifying the
1	decision on renewal
1	100 kilocalories. 
6	control, both of
1	furthers the distribution
6	later than 210
2	licensed health care
1	respect to costs
1	handling regulations; violations;
1	electronic products who
1	morphine, cocaine, and
1	(including the extent
3	(8) if any
1	458, 459, 460,
1	information means 
1	date. the administrator
1	including advers-event reports.
5	period under subsection
1	operate to suspend
1	persons validly registered
1	observations to the
2	used only for
1	statement not for
2	kit) if 
1	 (d) definitionsas
1	establish a qualified
1	following the transmission
2	shall obtain annually
2	study was conducted
2	provides transaction history,
1	reviews equal to
2	new dosing regimen,
2	sealed containers under
2	time a request
1	order prohibiting the
2	shall, in coordination
1	seller or an
1	 (2) extrapolation
1	access to databases
1	
 205. display
1	stay any reinstatement
1	27, 2007, by
1	(iv) due datethe
1	enforcement administration showing
1	distribution to retail
1	establishment registration $2,575
1	necessarily a conclusion
1	individuals who conduct
2	period for issuance
1	accordance with those
2	accomplish the intended
2	may establish) of
1	1395w104(b)(3)(c)(ii) of title
1	football, basketball, baseball,
1	notice to identify
1	comment rulemaking. 
1	inspections and reinspections
1	 (e) hearing
1	submits a premarket
1	security precautions respecting
1	opening each case,
1	producer, and if
1	pay paid or
1	debarred for multiple
1	drug would present
1	changes and each
1	si-tenths degrees of
1	may routinely contract
1	(b) due datethe
5	used in a
3	subparagraph (a). (c)
11	standards for the
5	secretary to determine,
1	addition to collection
3	year, the number
1	addressing the conditions
2	transportation, and that
5	regulation, or by
2	(3) not more
1	regulation published by
1	physically inspected or
1	15 g/gm of
1	impediments identified by
1	outbreak, or if
1	effect, except 
1	provides a photograph
3	process, pack, or
3	necessary to demonstrate
1	obtain tentative approval
3	submit a petition
3	responsible party shall
12	request for such
2	 (bb) the
1	accepting the submission
1	subsection specifying the
1	notice).  (iv)contents
3	examination prescribed or
1	30, 1998, and
1	label bears, to
1	canal zone. (h)
1	(aaa) a printed
1	possess, or distribute
1	application in drug
1	listed in schedules
2	 (4) serious
1	different agencies and
1	affect any obligation
1	indicating that a
1	chemical residue, such
1	suspension the attorney
6	recommendationsafter negotiations with
1	filing, except that
1	refusal upon the
1	minor species that
1	subject to further
2	request.  (c)
1	(i) submit a
1	pethidine. (15) pethidin-intermediat-a,
1	statements specified by
1	then, and in
1	30, 2010, notwithstanding
1	benefit of reductions
1	whether the secretarys
1	106, 107. omitted

1	drug, to another
1	(a) the specific
1	designated, the director
3	modify the requirements
2	state shall immediately
1	(2) its label
1	producer with an
1	submitted and for
2	acting on referrals
1	inspections to ascertain
2	excess of one
2	last 4 years.
1	(a) that created,
2	receptacle, wrapper, or
1	sections 101(a), 102,
1	provide technical assistance
1	testing programs) required
10	systems and processes
1	356c of this
1	(a) termthe term
2	persons may present
2	use referred to
1	organizations: _____________. i
1	him.  (b)
1	entities, including the
3	practitioner pursuant to
1	application, or (c)
1	section 342(a)(2)(d)[1] of
1	savings nothing in
2	offense involved, including
15	fee for a
2	fee revenue amount
2	(a) in generalwith
1	including regulations promulgated
1	modify the requirement,
1	effective health programs
1	order shall remain
1	application (including the
1	subsection, or to
1	manufacture, shipment, or
1	infant formula has
1	cause the device
1	appropriate. (iv) the
1	(b) trend analysis
1	situations except in
1	tentative determination published
1	convictions of the
2	subsection (f) for
24	apply with respect
1	may impose temperature
1	title between the
1	 (6) final
4	certification as provided
1	correction was undertaken
1	imprisoned or fined,
2	report, supplement, premarket
1	act. upon receipt
1	reporting for 25
1	currently sel-certified in
1	addressed in at
1	products sold, or
1	late payment if
1	analyzing data on
1	cheese act of
2	engaged in wholesale
1	282(j)(5)(b) of such
1	protocols to ensure
1	second conviction for
1	bring his plant
1	(2), by regulation
1	subparagraph (b)(ii) available
1	(2). (c) definitionsfor
3	improvements in the
1	1296), and acts
1	regulation, including monitoring
1	terrorism task forces
1	(d) adjustment to
1	substances for which
1	revise the requirements
1	evaluate transferred technology.
1	export under section
1	identity or composition;
1	subsequent purchaser 
1	constitutes an implant.
1	proposed labels, labeling,
1	plant nutrient, or
1	targeted, the following
6	(e) effect of
1	 (1) intends
2	section 601(w)(2) of
1	providing the secretary
5	accredited person shall
1	federal law (if
2	threat agents and
1	(2), how such
1	report (a) identification
1	available, for the
2	subsection as an
3	means the administrator
1	product no earlier
2	interpretations of a
5	request meets the
1	department, including enhanced
1	practitioner to comply
2	secretary in regulations
1	electronic submission the
2	fiscal year 2003,
3	respect to advertisements
1	person, which information
1	appropriate, shall provide
4	term is used
1	bruises, and other
3	(i) which was
3	862; 7 u.s.c.
1	brought in bad
1	fiscal year 2003;
1	licensed physician 
1	grown tobacco. 
1	hold, or import
1	et seq.) to
1	subsection (c) and,
1	strategy report, a
1	 (e) automated
4	petition is submitted.
1	per biosimilar biological
2	humans; (c) is
1	may include licenses,
10	45 days after
2	number of audits
2	formula is not
1	entertainment event determined
8	expenses in connection
1	rulemaking), and of
1	laboratory database at
1	product development; and
2	verified statement by
1	use container for
1	hearing, may modify
1	 (f) objections
6	exemption  (1)
3	raised in the
1	safely used. (2)
3	secretary has authorized
1	 (i) disposition
1	importer pursuant to
1	protect the rights
3	granted to the
1	dispense such narcotic
1	(b)), exceeds the
1	(b) small food
1	paragraph. (3) workload
8	penalty under this
1	(i) address receipt,
1	repeatedly demonstrated a
1	voting member who
1	substances; (2) the
12	rodenticide act [7
1	number of active
1	
 452. congressional
1	petitioner has established
1	knowledge and information
1	level requested; or
1	hig-risk foods, provided
1	 (p) forfeiture
1	(i) the testing,
1	(i) involves ephedrine,
2	recommendations the commissioner
1	activities to facilitate
3	reported to or
1	distribution by a
1	based. the advisory
1	information should be
1	consideration the standards
2	means an officer
1	technology to expanding
1	tolerated in or
1	use to evaluate
1	(6) patien-reported outcome
1	involving or related
2	subsection, the holder
1	(a). thereafter such
2	foodborne illness, and
1	(b)(1) or a
1	title 21 code
1	action on an
1	political subdivision applicable
1	3-day period preceding
1	affiliate) to all
1	pass a review
1	track research and
1	device. applicants submitting
1	section 342(a)(2)(c) of
4	secretary by the
1	telephone number at
2	drug, he has
1	(b) detection limit
1	request publicly available,
2	following conditions: 
1	personnel who regularly
2	sheep, swine, goat,
2	misbranded; (iii) resulting
1	property used, or
1	drug; and (3)
1	379j42. authority to
1	chain and notified
3	regulations, the common
1	title 22). 
1	person believes to
1	committees.  (3)
1	studies, that shall
1	inspection under regulations
3	suspends or revokes
16	title, the secretary
1	sections apply to
31	carry out this
5	refunds to qualify
1	1263; renumbered 18
1	attach to the
1	science, medicine, engineering,
8	brought in the
1	secretary (a) report
1	device, except where,
3	262(a)(3)].  (3)
1	(c)(4)(b), (d)(4)(b), and
1	congress on or
2	(iii) was a
1	center to regulate
1	provisions, by the
2	transaction  (a)
1	year. (b) coalition
1	design, device, or
1	national media campaign)
1	heroin addiction, substantially
2	form the primary
1	15; and 
1	consumption. (c) records
1	involved is 
1	respect to clinical
1	february 1, 1973)
1	markets affected by
1	labeled or marked
1	receiving notice of
2	(a) whether the
1	$10 million dollars
1	shall publish it
1	shows, by a
3	changes in ownership,
3	outside thereof, any
1	drugs, shall review
2	provides notification of
1	standards. (c) the
3	(2) and (3),
2	drug substances for
1	support of, the
1	 (2) standards
1	sem-critical devices, the
1	said establishment; and
1	address funding priorities
1	states, either personally
27	shall publish in
14	local educational agency
224	added 
 

2	labeling requirements, applicable
2	(2)(b) relates to
1	title 18 (including
9	additive which is
1	executed a written
1	subparagraph (a) (referred
1	(2) general powersthe
1	said article shall
1	verifying the correctness
1	appropriate for bottled
3	knowingly possess, without
1	identifier associated with
3	device under an
1	data sets in
3	facility (or the
2	data regarding the
1	(m) onchocerciasis. (n)
1	initiative; or (b)
4	reports shall be
1	afford a higher
2	violate any provision
1	397. contracts for
2	public disclosures of
1	health care intervention,
1	supplement  (a)
1	(e)(1)(b) and to
1	member. (3) the
1	21st century cures
1	fail to sel-certify
3	authority is exercised.
1	biomaterials supplier; (b)
4	made, formed, or
1	requires one or
1	(ii) upon an
3	will not occur
2	application containing a
2	finding as to
1	person to carry
3	order either deny
3	(13) the term
1	evaluation purposes or
2	committee on armed
1	consumption of an
1	import notification or
1	address the prevention
1	(d) an amino
1	
 387. definitionsin
1	issue to persons
1	different active ingredients
1	(b) an unapproved
1	(4) the sponsor
1	person who receives
1	methods, controls, and
1	(5) evaluation of
1	suffered by an
1	transferred to the
1	(ii) is exempt
2	animal food; (2)
1	recommendation. where appropriate,
1	assign start dates
2	logistics provider the
1	activation) of the
1	shall encourage such
1	type  fiscal
1	facts and order
7	use for which
1	misleading label if
1	reference or any
1	distributed, made on
1	safety informationthe term
2	applications, and supplements.
1	month of such
1	provide advice on
4	(16) of subsection
1	entity.  (c)
4	engaged in its
1	finding that registration
1	control program activities
1	file such request
1	history, or transaction
1	secretary at which
1	paraphernaliain determining whether
1	675, 900, as
1	reasonably likely for
3	generalif the secretary
1	formerly 746, as
1	achieved under the
1	described for the
1	equivalent to on-half
7	fees in accordance
1	(4) bufotenine. (5)
1	exclusively to physicians,
1	(a) the department
1	action to preserve
1	previously been refused
6	chapter.  (

4	association, or other
1	infringed. (4) 
2	inhabitant or wherever
1	restricted devices 
1	reasonable period which
1	agency contained in
1	reduce the level
2	guidance document available
1	future survey published
2	slaughtered and handled
1	tomography drugs shall
1	food slaughter any
1	administration a current
3	federal mark, stamp,
1	disclosure, as determined
1	activity, or the
1	h of part
1	limited confidentiality of
19	patent is invalid
1	private entities 
1	respect to whole
2	samoa, and any
1	title or from
1	input and evaluations
1	
 360e1. pediatric
2	approval is in
1	 (a) corporations,
1	authority of said
1	of, tobacco products
1	(b) coordinating and
1	suppliers would raise
3	incorporates or utilizes
1	commerce, during the
4	may administer oaths
2	withdraw the exemption
3	37 stat. 832;
1	conduct a national
1	variance the secretary,
1	reducing substance abuse.
5	manufacturer, importer, distributor,
17	portion of the
1	agent of each
2	condition, the period
1	seeking food and
1	subsection (b)(2)(c); (x)
2	persons who request
1	reducing substance abuse;
2	prior to manufacture
5	agency and the
8	per fiscal year
1	issue subpenas, administer
1	ascertaining whether such
1	narcotic drugs concluded
1	drug. any animal
1	order, or after
4	section involving 
1	applicant that submits,
1	indictment, or other
1	plan and a
1	schedule in accordance
1	section 545 of
1	labeling or containers;
1	title 42 has
1	10.35 of title
1	otherwise determined under
4	either in interstate
3	 (3) rule
1	identifier shall be
1	post the item
3	fee amounts under
1	3 distinct sponsors
1	(d) focus its
1	deemed unsafe under
1	secretary regarding activities
1	(b) have been
1	food advertising and
2	committee in acting
1	exempt the device,
1	grant application has
1	persons the attorney
4	delay is necessary
1	limits  (i)
2	practices, and processes
1	manufacturing processes and
2	methamphetamine, ecstasy, and
1	product manufacturer provides
1	known and serious
1	(5) paragraphs (1)
1	symbol required under
1	determines will provide
1	sources other than
5	hospitals or other
1	revision thereof, and
1	section 530c(a) of
1	otherwise, the term
2	hearing, in such
1	types of risk
1	2002 in excess
1	species may request
1	inspection observations and
1	manufacturers, packagers, or
1	8, 2008. (4)
1	means any list
1	both. (7) notwithstanding
1	reduction and demand
1	pending requests, including
3	classification and general
1	children of substance
1	market data; and
1	directly affected by
1	tobacco manufacturers based
1	local agency in
26	 (a) if
1	representatives of said
1	ethy--phenylpiperidin--carboxylate. (17) pethidin-intermediat-c,
1	requirement applicable under
1	integrity of athletic
1	unless the human
1	section 353(d)(3)(e) of
5	members of an
1	develop a screening
1	final regulations the
1	(3) certain devices
1	(iv) a timeline
3	(ii) of the
1	subparagraph (2). (2)
1	sell, assign, transfer,
2	shall be preserved
3	threat described in
2	obtain annually a
1	following, as applicable
1	regulatory authority of
1	followed under the
1	products of more
2	voucher after such
1	submit such article
7	federal rules of
1	without a valid
1	partnerthe term trading
1	provide for cooperative
3	prescribed by section
1	supply means a
2	registration in accordance
1	includes the district
1	notice and report
2	currency to dollars,
4	paragraph (3); and
1	shall include leaders
2	dispenser may enter
1	addiction; (v) marketing
1	costs means all
1	extend to recipes
1	-year and -year
1	2, as added
1	(b)(1), shall remove
1	period until the
1	importance of a
1	evidence if a
1	product expiration date.
2	interdiction activities, as
1	controls, performance standards,
1	standard described under
1	budget priorities. (iv)
1	regulatory review under
2	fill a prescription
1	(i) for prevention
1	product identifier associated
4	safety signals and
1	hyperlink is also
1	(2) if, before
1	states under article
1	physical inspection of
1	model standards described
1	develop robust and
1	inspection functions must
2	registration and in
1	drug violations by
2	360, or 360i
1	amphetamine or methamphetamine
1	mentioned, until the
1	contract or agreement
1	findings: (1) drug
2	regulations pursuant to
5	(b) on the
1	export the substance
1	project implemented by
1	shipping container of
1	schedules under this
1	including the incorporation
1	regulation revise the
1	transferee means a
1	otherwise introduce food
6	federal register; (c)
1	address in such
1	who, for reasons
1	shall issue only
2	made available by
1	activities (as defined
1	means; and (2)
6	following activities of
2	secretary shall place
1	accreditation or inspection
1	terminate, and the
2	associated with use
4	diversity of the
1	effectiveness, except as
1	characteristics in subparagraph
3	responsibly be concluded
1	(p) the distribution
1	political subdivision shall
1	accurate; (ii) internal
1	section. such penalties
1	675, 311, as
1	level, sufficient to
1	youth 12 to
1	esters and ethers,
1	agency.  (iii)
6	condemnation or seizure
1	enactment date be
2	assure safe usethe
1	title 15 to
1	may establish by
3	except with respect
1	105. repealed. 

1	make a motion
1	inclusion of biological
1	best practices; (5)
1	(i) within 18
1	congress further declares
3	income and net
2	education, labor and
1	current expert advice.
1	(1) the amount
1	within his territorial
1	transshipped if and
1	marijuana early in
5	developed and will
1	bring such product
1	including descriptions of
1	387e(e) of this
1	substantial evidence defined;
1	(c) all relevant
1	section 360(o)(1)(a) of
1	regulation been designated
1	issued only if
1	 (c) investigational
1	including standards relevant
2	clause (i) may
1	possession, or use
1	secretary or such
2	development protocol for
1	(including any lot
1	furnishing of training
1	demand for, illegal
21	information to the
1	substance in any
1	year, the product
2	subsection (d) applies,
1	community ant-drug coalition,
1	classification panels. 
1	inquiries; jurisdiction of
1	(c) prospectively planned
1	hazards, including through
3	terms small business
1	sample to a
2	particular active ingredient
1	(d) improve the
8	based upon a
3	approved june 25,
1	fifty points out
1	whoever violates this
3	ingredients, the common
1	section 353(e)(3) of
1	year 2013 (to
1	conferred on representatives
1	comparable to the
1	distributors, and dispensers,
1	revocation, reissuance, and
2	processed in an
1	used for registration
1	(3) one or
1	(6) local drug
1	title regarding the
1	 (1) ingredient
1	rely on the
1	may enforce any
1	law enforcementnotwithstanding any
1	(c)(2)(a)(i)) or any
1	construed as prohibiting
2	special scientific purposes
1	manufactured each calendar
1	research; (e) drug
1	enforcement of all
5	article subject to
1	(3) require that
1	1, 2017. (12)
1	study or studies.
1	submitting the premarket
1	ch. 675, 515c,
1	interim final rule;
1	person from seeking
1	alter, and use
1	deferral extension, and
1	another drug, to
1	notice to consumers
1	previous -year period.
1	modes of transportation,
1	previous -year period,
1	evasion of the
1	seve-year period beginning
1	review shall take
1	standar-setting entities, and
1	institute of food
2	community ant-drug coalitions
1	collected after fiscal
1	coalition the term
1	received and distributed
2	(1) abbreviated application
1	integrated into business
1	shall be concurred
1	likelihood that consuming
1	encouraging formal consultation
1	(b) shall apply
1	assist in agency
4	subsequent recipient of
1	congress which shall
4	technical assistance and
1	determine if it
1	publicity (a) reports
1	lawful export requirements,
1	identifying or combating
1	required to remove
1	wholesale distribution within
1	detailee shall retain
1	(3) rescission or
1	regulatory burden, and
1	periodic basis to
1	title 15, on
1	public. (f) strengthen
1	drug administration conducted
1	strength or (2)
1	(2) biennial reportson
1	expenses to the
1	cure a serious
1	similar chemistry that
1	(e) a description
1	2014;  (7)
1	387 et seq.],
1	(b)(1)(a)(i), priority shall
1	recognizing the new
1	finished form through
10	secretary determines appropriate.
10	secretary determines appropriate,
1	ii, which is
3	absence the officer
1	requirements. such requirements
1	-years prior to
1	otherwise, the personnel,
1	number of vacancies
1	depresses the market
29	controls used for,
1	(4) as determined
12	exemption under this
1	evaluations as may
1	remedy the violation
3	secretary determines appropriate;
4	harm caused by
1	articles are adulterated
1	prosecutions or any
1	specific scientific, medical,
2	barrier to innovation
2	may not provide
1	343(w), or 343(x)
1	review, subject to
1	record and jurisdiction
1	conflict with or
1	market for the
1	231 of title
1	pediatric patient groups),
1	 (4) tropical
2	scope of such
1	21, 1997) or
4	manufacturer of electronic
6	unless it is
1	sale and are
2	naming each: provided,
1	antibiotic drugs (a)
1	foreign commerce, (1)
6	350g of this
3	establishments within its
1	(b) custom devices
1	subsection (n) that
1	frequency, method, and
2	secretary as an
3	equal to 150
1	criminal, exclusion of
9	receive payment of
1	request. paragraphs (4)
2	conspicuous locations and
2	secretary shall increase
4	accelerated approval of
1	care providers, pharmacists,
3	application is approved
1	applicable performance appraisal
1	practices and publishes
1	quality of current
7	meat and poultry
3	section 825 of
1	repackager means a
1	among the agencies
1	exported or in
1	and, through other
1	country, and product.
1	gives an order
1	adjusted each fiscal
1	tobacco product characteristics
1	receives the report
1	completed not later
1	said act for
1	researchers, and drug
1	report any information
1	authorization under subsection
2	secretary shall set
1	 (c) evaluation
1	(c) exception nothing
1	days before marketing
2	drug, with respect
1	comment the secretary
1	protocol, and (ii)
1	fiscal year, based
1	court in such
1	2 or phase
1	claimed to have
1	unless such restaurant
1	products. such positions
1	title concerning any
1	provides links to
1	existing approved or
1	aggregate number of
1	became final) assessed
1	salts, derivatives, and
1	subsection relating to
1	submissions for fiscal
1	(ii) meets all
1	will be located
1	documentation the owner,
1	fund means the
3	amend or revoke
1	drug substance, drug
1	formula. such records
1	violating any of
1	menu in type
2	therapeutics from providing
1	clause (ii)(ii) publicly
2	(b) to inspect,
4	state agencies in
3	animal drug has
1	notices, bulletins, and
1	distributor means 
1	shall furnish samples
1	accreditation within 60
1	annual reports concerning
2	clinical evidence indicates
1	developing promising compounds;
1	points; and (c)
1	avoid conflict with
1	without direction from
1	regulated person. the
1	dispensed only by
2	section 375(b) of
1	civil action pursuant
2	effective. (iv) statutory
1	board to serve
1	applications reviewed under
1	manufacturers if a
1	use; (c) the
1	manufacturer shall advise
2	prevent such endangering
2	reasons, it may
1	channels by 
1	place an immediate
1	348. food additives
1	clauses (c) and
1	standard regarding the
1	hundred thousand, and
1	consultation on initial
6	amendment of a
1	applies, its advertising
1	later established under
1	paper, electronic data,
1	compliance with paragraph
3	year 2013 and
1	 (3) nonapplication
2	revoke any permit
1	section or otherwise
45	collected under this
2	tomography drugs 
1	subsection (g)(2), the
1	treasury, after consultation
2	greatest priority given
1	process, quality controls,
1	recruitment and retention
1	1997) or a
1	ordered and shall
1	capacity, function, or
1	assessed on all
1	agents, or a
1	materials accompanying the
1	investigation relate to
1	
 883. enforcement
2	 (c) exceptions
1	data carrier that
1	entertainment industry outreach,
1	(a) employed or
1	disease or conditions;
3	general the priority
54	(referred to in
1	$99,000,000 for fiscal
1	neither a drug
2	timing of reports
6	secretarys review of
1	regulations of attorney
1	compensation (a) in
3	will be found
2	(i) reviewed and
1	trafficking areasnot later
1	ingredient which was
6	provisions of said
1	appointment by the
1	processing, which is
2	whose blood or
1	particular tobacco product.
1	physiological, pathological, or
1	device. (7) the
1	repackager notified pursuant
2	that, if the
2	recordkeeping, reporting, and
1	(unless exempted by
1	office, as appropriate,
1	drug substances) if
1	disagree with request
1	number of containers;
1	report also shall
7	will result in
1	together are not
1	subchapter: (1) the
1	communities.  (3)
1	pesticide within the
1	(3) order restitution
1	directed.  (2)
1	modifications made during
1	5 [15 u.s.c.
2	states. (5) 
1	manage quantities of
6	paragraph; (b) publish
2	(2); and (b)
2	(c) consideration of
1	 (d) internal
1	spoken by a
1	whether permitting a
2	respecting the retention
1	called neonates, infants,
1	 (4) advertisingthe
1	demand for its
1	suspended or canceled
1	351(b), or 352(d)
2	government entity), or
2	appeals stating that
1	facility, once during
1	druggist or apothecary,
1	year 2012, or
3	drug, animal drug,
1	expiration date for
1	meeting under such
2	requests described in
2	device may require
1	order. (3) determination
1	515c, as added
1	business as carriers,
1	transferred). from and
1	appropriate standards and
1	drug, whether approved
1	25, as added
1	time thereafter, require
1	ch. 675, 913,
1	clinical setting; and
3	section 360b(b) of
1	affiliation) with such
1	37 stat. 250.)

1	business they may
1	authorities relating to
1	(i) none of
1	
 356d. coordination;
1	(3), because of
1	proceeding initiated under
1	agent at his
1	using any lane,
2	copy of which
1	changes on the
1	so, or transporting
1	development tool determined
1	drug risks. 
1	demonstration that a
2	person using or
2	stat. 1487.)
 

16	account of the
2	genetically engineered seafood
1	3 packages or
1	administration. (july 12,
2	falsely labeled or
1	classified information any
1	items unless such
1	falsely represents, or
1	territory any dairy
1	subparagraph (d) shall
1	audit report; and
1	product development, manufacturing,
1	notice under such
1	cheese not the
1	federa-state cooperation the
1	(d) definitionsfor purposes
1	amounts of compounded
1	substances may have
2	achieve a level
1	waiver and the
1	denominator class ii
1	oil, creosote, chloroform,
3	advice and recommendations
1	deny any application
5	requirements with respect
3	section and in
1	order to transport
1	benefit managers and
1	studies for an
4	announcing the amount
1	numerical identifier, of
1	(a) promulgation of
2	will be recovered
1	shortage or shortage,
1	interim list 
8	interdiction command and
7	scope of the
1	fda employees (a)
1	budget proposalfor each
1	application; and 
2	safe or effective
1	treatment of matchbooks
3	include a unique
1	(e), (i), (j),
1	least two or
2	formally affiliated with
1	 (h) representation
1	matching funds may
1	(iii) amount notwithstanding
1	applicable statutory deadlines.
2	mitigate a specific
1	describing the findings
1	rights and remedies
2	give testimony touching
3	drug shortage or
1	court shall continue
1	(4) accredited thir-party
3	operations conducted at
1	(c) assaulting, resisting,
1	establishment; functions; general
1	drug shortage of
1	compound regularly or
1	(iv). (iv) the
1	product code, labeler
1	listed chemicals by
1	30, 2016. (b)
1	term incubator reject
2	reduction act), with
1	funding under this
1	secretary describes shall
1	centers, the timely
1	assembled product for
2	public a list
2	six months of
2	application, the attorney
1	inspected by a
1	1331 or 1337
9	follows:  (i)
1	asking applicants for
1	programs for which
1	supplement is not
1	miscellaneous activities subject
4	manufacture or distribution
2	person named in
1	continuation of testing
1	smoke constituents, and
1	(5) foreign laboratories
1	professional labeling and
1	point of production
4	(ii) the applicant
2	appointment  (1)
1	otherwise be false
1	submits a substantially
1	ultimate user, lon-term
1	operating reserve, of
1	(d) designation 
1	study plans 
3	provisions of subparagraph
2	business phone number
1	biological product, a
1	(6) manufacturerthe term
1	1,4butanediol in order
2	scientific standards, and
1	physician, is guilty
6	reasonably cooperate in
2	judgment absent infringement
1	determined for purposes
3	revocation order becoming
1	manufacturers products. 
6	period ending on
1	steroids.  (1)
1	raised to attack
12	fiscal year 2014
1	elect, in lieu
1	direction and in
1	considerations, the considerations
1	date, have in
2	served the mandatory
4	general a person
1	request. (b) drug
1	species before they
1	hydroponically grown marijuana,
1	(a) product tracing
1	(1) may require
2	provisions of federal
1	convicted, after may
20	355(b) of this
1	required for acceptance
1	(1), and the
1	applications to state,
1	drug that incorporates
1	comparative national adverse
1	include software functions
1	
 
 129a
1	accelerate the development,
1	submissions. (i) any
1	steroid by the
1	(v). each signed
1	hospital repackaging of
1	improvement of foodborne
1	record makes the
1	 (c) failure
1	manufacturer, a manufacturer
1	per dosage unit.
1	supplement within 135
7	per dosage unit,
4	tolerance under this
1	drug is recognized
2	upon filing its
1	paragraph regarding the
1	certainty for the
1	animals, and which
1	fully respond to
1	remaining members of
1	accepted safety for
1	consequences, if any,
1	shall not render
1	675, 1010, formerly
1	things specified in
2	illegitimate product. 
1	including describing genotypic
1	(or combination thereof)
1	appropriations acts until
1	sunscreen order included
1	limitations upon entry
1	sizes and manner
1	paragraph or section
1	providers (a) requirementsno
1	procedure the provisions
1	criminal, initiated by
1	shall only request
1	resin. such term
2	agency conducting drug
2	numerical identifier, for
2	expended.  (d)
1	enter onto a
1	united states, violating
1	(iii) identify the
1	iv, to be
2	compliance with clause
2	coordinator shall 
2	product standard and
1	rehabilitation program, but
1	bear also a
1	disease product 
1	manufacturer is duly
1	isomers. (f) any
1	poultry which are
1	prevention programs include
94	section shall be
1	violations the secretary
1	filled or refilled
1	penalties (a) in
1	number; and (b)
1	product. (g) enhanced
1	recommendations about changes
1	occupies a position
1	title 18; (v)
1	representatives employment or
2	year 2019. if
1	$450,000,000. (d) for
23	order under paragraph
1	coalition that is
5	advisory review fees
3	identified under clause
2	(d), the term
2	drug not so
1	(2) application process
1	user receives actual
1	proceedings. (b) after
1	law, following the
1	corporation who violates
1	organizations to provide
1	administrative authorities relating
1	information publicly available
2	date of compliance
1	subsection and late
4	district court is
1	plainly stated on
1	inspections. for the
5	benefit over existing
1	744c, as added
1	recordkeeping requirements established
1	poultry, for commerce,
1	human generic activities
1	kitchen facility the
1	lands, or into
1	otherwise authorized, by
2	seeking permission to
1	propylene oxide when
1	forth under subsection
1	dependence products a
1	deferred. further, upon
2	costs for travel,
1	committee (hereafter in
1	advisory review fee)
2	performance standard shall
1	(a) imprisoned for
2	condition that may
2	established within the
3	dispositioned; (ii) disposition
1	professional qualifications of
1	advisory review fee.
1	associate the saleable
5	person required to
1	statutory deadlines. (b)
1	medical societies; (iii)
1	drug application. within
1	broken so that
6	(a) the committee
3	requests under section
3	carcasses, meat or
2	individual, and to
1	individuals to serve
1	(c) mult-drug resistant
1	trace the receipt
8	labeling or advertising
2	submit adverse event
1	 (1) detention
1	chapter or when
1	spent by the
3	(b)(2) for the
1	year the registrant
3	facility fee under
1	owner and consignee
1	section only because
1	administration a product
2	interest. registration under
1	(ii) such other
1	(c) disseminating information
1	(c) 280 grams
1	
 
 333a.
3	applicable law, be
3	section.  (6)
1	breakthrough therapy 
2	(ii) the extent
1	(i) identify each
1	2007, productssubparagraph (a)
1	clinical and regulatory
1	distributed any sample
4	bulk or weight,
1	outcomes, of the
2	 (c) adjustments
1	 (n) regulations
2	applicable law, by
1	581, as added
1	 (b) request
4	years or a
1	term additive means
1	upon such other
1	(a) testing, reporting,
1	appropriate, while still
1	(i) has bribed
1	shall thereafter register
1	(a) full waiverat
1	agenda for use
1	(6), extend the
21	results of the
2	public health. such
1	5.  (c)
1	involved. (ii) to
1	 (e) sunset
1	subparagraph, there is
1	making necessary improvements
1	employer, the federal
1	laboratory; and (c)
1	toxicology, pharmacology, addiction,
1	dietary supplements under
1	functions.  (g)[2]
1	implant, including a
3	portion thereof) that
1	user facility. (b)
1	title, a thir-party
1	filing fee 
1	secretary. (3) for
1	seeks approval for
1	determines that sufficient
1	2017 through 2021.
1	applicant.  nothing
1	exclusive distributor the
1	(ii) extrapolation between
1	temporary order adding
1	(c) (other than
1	state official may
1	establishing the foreign
1	section 379j(h) of
1	statement provides that
1	regulations) for drugs
1	sponsors of a
1	regulations).  (june
1	detailing emergency treatment
1	total quantity and
1	shall not collect
1	specifying the policies
1	(a), an order
1	 (1) establish,
1	(ii) requires a
1	disease or pest
1	(1) authority for
1	include wrapped meats
3	uses a deadly
1	require a medical
1	listed patent has
1	objectively measured and
1	formatting, or translation
1	drug and annually
1	interested person that
2	act of 2007.
1	respond adequately to
1	additives) for all
1	tropical diseases and
1	device granted review
1	operations. (
 

2	title, compliance with
1	chapter. (gg) the
1	terms narcotic drug,
1	9, 2012, including
1	construed to grant
4	reasons of the
1	penalties; boobytrap defined
1	states should be
1	interested person, showing
1	(b) revised guidance
1	user facility unless
1	level, such as
1	enforcement agency; (2)
1	teams established pursuant
4	filled as to
1	notice specifies the
3	person shall specify
1	labeling; (e) anticipated
1	1059; renumbered 1001,
1	short title this
1	includes black, white,
1	amendment of application
1	clause, antibacterial ingredient
1	human and veterinary
1	medical gas. (b)
2	systems  (1)
2	accidental or intentional;
1	act) shall not
1	pharmacies so registered
5	terms of an
1	input prior to
1	implementation of his
2	act, or the
1	occurring during a
1	 (a) identification
1	person enters the
1	paragraph (3), because
1	provide information under
2	convened under paragraph
2	maximum residue level
27	(1) shall be
1	offense be permanently
1	ch. 646, 32,
1	discretion, grant a
1	guidance document for
3	requesting, any registration
2	labeling, or other
1	york, new york,
1	prevent him from
1	(d) denial of
3	shall be conditioned
1	increase in opioi-related
2	burdening of commerce
1	(e) information to
1	number of participants
1	will mitigate the
1	tobacco leaf; (ii)
1	following verification: i
1	subsection (a), shall
1	minimum punishment under
2	title; or (5)
1	convictions occurring on
1	use unobligated carryover
1	exception from annual
3	regulations and guidance
3	disclosure of such
3	application withdrawn if
1	number; (ii) the
1	background checks and
1	that, applying the
2	prepare, sell, barter,
1	article, unless the
2	direct, after entry
1	(iii) except as
2	(ii) the actions
1	last testing and
1	engaging in an
1	public comment not
4	entered into with
2	section from participating
2	136 et seq.].
1	proceeding. (b) enhanced
2	system for adverse
1	congressthe location of
6	deface, or destroy
1	772, as added
1	section 824(a) of
2	federal register not
1	(iv) availability of
3	appropriately diversified professional
1	2 times the
2	 (b) penalties
2	(including necessary curricular
4	necessary studies are
1	importation, including as
1	issued without regard
1	following terms shall
1	retail prices of
2	pharmacies which maintain
1	statistical approach); (ii)
2	evaluation are conducted
1	application or extension
2	excellence, lack of
3	section 355(b)(2) of
1	unless the plan
1	containing best practice
1	travel expenses each
1	application. the annual
1	data in lieu
1	(a) narcotic drugs
1	practitioner and that
8	case may be.
1	chemical, the administrator
1	misbranded. (b) labeling
1	states), or import
2	system; (ii) take
1	5 years, the
1	(7) review of
1	food shipments 
1	immunity of federal,
1	alternative or accelerated
1	360e3. breakthrough devices
3	deemed the act,
2	arrears list, such
3	(b) in determining
3	 (b) activities
1	application; period for,
2	master file fee,
1	withdraws the certification
1	master file fee.
13	inspected under this
1	establishments. (3) the
1	subchapter. (9) all
1	(a)(i) may require
1	organizations which would
1	illegal transactions of
3	operates in any
1	adulteration eggs and
1	represents the county.
1	including methicilli-resistant staphylococcus
2	thir-party auditors to
1	 (3) duration
1	information procedures act)
1	program agency may
1	path initiative. (3)
1	features of the
5	listed drug, or
5	afford the applicant
1	funds are first
1	applicant and provide
1	5, this subsection
2	pay a user
2	party to submit
1	held or will
2	grants a full
1	disseminates or causes
1	governing emissions of
1	amounts to terminate
1	submission for changes
1	jurisdiction of federal
1	advisory review, and
3	differs from the
1	shall seek recommendations
1	depressant effect on
1	treatment in lieu
1	section includes 
1	drug substances) that
1	351(a) or 351(k)
1	proceedings in other
2	shall permit an
1	order, detailed findings
1	determining the sufficiency
3	marketed (other than
1	request a change
1	secretary; regarding cleaning,
1	notificationsexcept as provided
1	individual has experience
1	appoint a chief
1	reporting the regulations
2	regulations for submission
1	quota increases at
5	subtracted from the
2	food products. 
8	together with all
1	(11) supplement, not
1	court orders under
1	(q) petitions and
1	generic drug facilities).
1	facility. (3) the
2	known or anticipated
1	partnerships, with one
1	encourage the secretary
1	strategy. (xiv) a
1	2202 and 2224
2	et seq.) 
1	therapeutic ingredient becomes
1	(f) provide information
4	plan no. iv,
1	permit such export
1	(i) the integrity
1	(2) reports on
1	occurring in a
1	barrels packed with
1	title based on
1	grant provides assurances
2	absence of that
1	need for qualified
1	statutory authority as
1	percentages were calculated
18	determines that it
2	120 calendar days
1	title, is substantially
1	issued. this section
1	(vi) 400 grams
1	prescribe the rules
1	primary point or
1	removal or correction
1	(i) that there
1	methyprylon. (7) phencyclidine.
1	difficile.  (2)
1	shall not submit
1	 b6 (pyridoxine)
1	(
 
 1711.
1	hearing is sought
1	(a) a new
1	substantial participation from
1	et seq.); (f)
1	potential emergency (referred
1	provide modifications to,
1	ingredient information. 
1	purity of heroin,
1	generalin any civil
1	set after the
1	importations or periodic
1	shall be documented
1	meeting, regarding the
1	quota, has manufactured
2	fee in excess
1	private organizations for
1	may use such
2	shall allow any
1	activities, or (for
1	(g) for such
1	continuing criminal enterprise,
1	continuing criminal enterprise.
2	transaction to the
1	sponsors and applicants,
2	subsection, be considered
1	care or during
1	fees to qualify
1	country has occurred.
1	cooperative agreement between
1	public; and 
1	22, 2016 and
2	electronic products for
1	(f), the secretary,
1	subclause; or (bb)
1	director temporarily in
1	period under that
2	standard on the
1	conduct or manage
1	conduct private research
1	therein in original
1	standard for exemptions
1	(f) disclose to
2	subclause from such
1	one management, either
1	food category (as
2	designation under subsection
2	raw material used
2	jurisdiction of enforcement
1	research contracts under
1	bound; scope of
1	-methy--phenylpiperidin--carboxylic acid. (18)
1	person. if enactment
1	specifications or certifications
2	subsection (g)(1), that
1	community care facilities
1	related activities, the
1	limitation a direc-t-consumer
1	pharmacist or wholesaler.
2	person or to
1	cause such harm
1	products using any
1	finished drug products.
1	regarding the timeliness
1	(iv) identification of
1	enter such appropriate
1	otherwise misbranded and
1	supply to the
1	(b) referral to
1	held for sale,
1	searchable drug safety
1	administration of, or
1	sources. (3) the
1	(
 
 1046.
1	shall provide recommendations
1	product experience; (2)
2	bears any statement,
3	carriage, holding, or
1	respect to ephedrine
2	head of an
1	determination of priorities
1	logistics providers that
1	eligible for funds
1	l., whether growing
1	conduct such reviews
1	advance or otherwise
1	entry is written
16	disease or condition,
4	business in commerce
2	purposes of a
2	 (f) revocation
1	demand reduction; and
1	canned vegetable, consideration
1	drug, not later
1	drugs among youth
1	(d). (b) advisory
5	place at which
1	located upon the
2	drug shortages. 
1	unless the entity
10	costs related to
1	persons are subject
1	may access the
1	drug at a
1	patient need; and
1	secretary, any significant
5	registration of the
2	ensure that at
1	(ii) make such
3	ensure that an
3	provided in subsections
1	control.  (

1	clearance, such officer
1	testing, inspection, investigation,
1	(13) shall require
1	applied consistent with
1	position, or any
2	order within such
1	enforce safety standards.
1	single written requesta
1	discontinue the manufacture
12	date of submission
1	effect a license
1	foreign suppliers used
1	considerations in the
2	submission under subparagraph
1	pet food manufacturers,
2	task force shall
1	in, or providing
1	 (b) on-time
2	international union of
1	 (6) qualified
1	(ii) capture the
1	containing an evaluation
1	review and decisionmaking
1	letters issued under
1	denied admission if
1	concerning matters related
1	customers, if the
2	believes, or has
1	exercise discretion to
1	adoption of the
1	sentence, and notwithstanding
2	one active ingredient
1	(a) to furnish
1	mitigation strategy to
1	also revoke a
1	make rules and
2	product designated under
1	cotton root, cocculus
1	person, showing reasonable
2	secretary determines there
1	proposal or by
6	least once every
1	year, subject to
1	corporation of carcasses,
2	identified, the secretary
1	means the optical
1	restricted device a
1	(v) whether the
1	notification program of
1	care entity at
1	subsection (k) submitted
1	shall, if practicable,
2	sufficiently similar in
1	storage of raw
1	shall remove the
1	federal, state, local
1	means a controlled
1	complainant.  (c)
3	subclause shall be
2	(2) the holder
2	(4) exemption the
1	show  (i)
4	communities act of
1	including small business
1	675, 586a, as
2	notice.an applicant required
1	 all of
5	pandemic or epidemic
1	therapies, and genetic
1	imported food products
1	regarding review of
1	article within the
1	generic use; and
1	may submit additional
4	sentence of subsection
1	360i. records and
1	including as it
1	(i) may on
2	chapter; (e) is
1	dosing and administration
1	services, a report
1	additional remedies the
1	awarded under this
1	revision of any
2	licensed veterinarian, the
1	devices will lead
1	criminal liability solely
1	congressional findings the
1	agricultural commodities and
1	whether and under
5	requesting that the
1	standard.  (f)
1	carcasses of amenable
1	food is evaluated
1	
 
 379d2.
2	antifungal drugs; and
1	bring or possess
1	387h, 387i, or
1	national intelligence shall
1	distributions to a
1	device, dated july
1	 (iii) program
1	 (d) renewal
1	probation prohibited in
1	supplemental application. the
1	unless such report
4	shall update the
1	another company. (5)
1	estimated population in
1	manner, as determined
1	salted, stuffed, rendered,
1	stat. 250.)
 

1	establishment registration base
1	programs; and (ii)
1	 (a) fiscal
1	remove a hig-risk
1	studies to determine
1	methodologies determined appropriate
1	product for emergency
1	shall be privileged
1	privacy and security,
2	include a product
1	treatment through washing,
1	(4) annual fee
12	 (i) 
1	respect to milk
1	actions that are
1	may reasonably require,
2	(i) has failed
2	(3) prior conviction
18	section 360ccc of
1	supplement provides the
3	procedures and requirements
1	tobacco or menthol)
1	entity that the
1	receiving reimbursement or
2	(5) not more
1	correct these deficiencies,
1	study groups. 
21	owner or consignee
1	senate, in writing,
1	exchange  (a)
4	master file that
1	care professionals, representatives
1	sections 1918 and
6	agent or employee
1	subparagraph (a), whichever
2	pot, tin, canvas,
1	chemical, a tableting
2	ch. 74, 6,
3	quality, species verification,
1	shall receive no
1	(a)[1] not later
1	similar entity with
3	information before it,
1	unconstitutional, or the
2	unknown; and (iii)
1	subchapter; or (3)
1	chapter for a
1	(iii) directions for
1	office as he
1	reasonable attorneys fees.
1	(iii) the substance
5	year is the
1	(iii) is subject
2	(6) has entered
2	consignee, into a
1	subsection, accredit persons
1	part owner or
1	users; and (b)
1	subparagraph (b): 
1	drug order information
1	substances a federal
5	extension of any
1	approved application a
1	(c) the receipt
2	suppliers of the
10	persons in the
1	states if it
2	existing controls and
20	information required under
1	individuals who may
1	means the sale,
1	shall recommend that
2	examine data and
1	
 
 301.
1	component parts; (6)
1	sale, or transportation
1	activities within such
1	conditions or, in
1	medical device submissions
2	circuit or for
1	(c) hearing on
1	reserves needed to
1	subsection (c), in
1	specific intended use
2	delivers to the
1	sufficient basis exists
2	subject to local
1	system) which are
1	licensed pharmacist to
2	request, make the
1	(1) the preamble
1	intelligence center undertake
28	submit to congress
1	made exclusively from
2	products; and (3)
1	requires the development
1	title, unless (1)
1	exporting, may possess)
1	determine otherwise; 
1	(2) award a
1	
 854. investment
1	ends, the attorney
1	whether domestic or
3	fund  (1)
4	regulation, after notice
2	section) to eliminate
1	repeal or otherwise
1	 (2) inspections
2	retention of records
1	trials leading to
1	prescribing the procedure
1	writing. (d) data
1	composed of fifteen
1	foods imported or
1	(i) in a
3	drug control activities
1	(iii)amendment of certification.
4	tobacco product, the
1	property, if the
1	licensed product under
1	providers as wholesale
2	causing to be
1	determination to recognize
2	difference, as determined
1	marihuana laws 
1	demonstrating conformity of
1	detoxification treatment, be
1	federal government with
1	trade commission for
2	label and labeling
1	health, to enable
1	standards, premarket review,
1	part, including guidance
2	meanings given such
1	freezing. (june 25,
1	drugs when necessary
1	general determines, after
1	poultry products comply
7	secretary receives a
1	another designated gas
1	electron), and other
8	reasonable time as
1	make payments under
2	measures needed to
1	standar-setting entities; and
1	
 360b. new
1	387e. annual registration
1	deems necessary and
1	name. (c) if
4	guidance documents and
1	(b) an amended
4	informal hearing under
1	2015, and for
1	safety means factors
2	notice or a
1	control plan 
11	report  (1)
1	subsection (a). if
2	transactions; and (2)
1	993
 
 97
2	foreign facility that
1	per centum below
1	body to conduct
2	 (12) the
8	written consent of
4	penalty in an
1	exporter registered under
1	cut, harvest, carry
2	otherwise specified by
1	october 8, 2008.
1	resin extracted therefrom),
2	october 8, 2008,
1	fraud upon the
1	
 356c. discontinuance
1	applicable, to antimicrobial
1	equivalence between devices
1	criminal enforcement of
1	project or program
2	establish panels of
2	departments of health
1	disqualify a regular
2	applications. (d) fee
1	population; (e) that1
1	ch. 192, 35
2	direction to the
1	paragraph (6)(b), 1
1	organization means an
3	 (2) requirements
1	duly authorized officers
1	(b)(1), or (3)
1	accomplished  (1)
1	regulations, may provide
1	needs to be
2	shall publish any
1	(a) improving public
1	262]; or (c)
1	title 20), patient
4	pediatric patients in
1	pediatrics or may
1	postmarket surveillance, patient
1	harvesting of those
1	[21 u.s.c. 61
1	health professionals; and
3	matter to the
1	efficient response to
1	balanced consideration of
1	42. such certification
1	 (d) confectionery
1	 (2) on
1	product is of
1	food regulatory agencies
7	shall remain in
1	control means any
2	(1), if such
2	suspension if a
1	included in schedule
5	may authorize the
1	months. the secretary
1	product, by brand
1	them. (mar. 4,
1	representative responsible for
2	conformity with an
9	person making the
1	adoption of specific
1	least 300 times
1	vessels the requirements
2	require, except that
3	section 6101 of
1	 (3) person
1	(n)(1)(g) and is
1	time whenever such
3	practice of pharmacy
1	together with compensation
1	food product therefrom,
3	subparagraph (a)(i), the
5	iii to class
1	renewal of any
1	may occur by
1	administration as are
1	use and would
1	ingredient) a single
5	investigational submission for
1	clinical trial. with
1	standard in section
1	protection, on a
3	(i) death; (ii)
2	facilities of varying
5	within the previous
1	contractors performing activities
1	566, as added
1	foods. (2) standard
1	appear in magazines
4	records required under
1	met in that
1	(c), the operating
1	clinical trials used
4	shall be afforded
1	(d) clostridium difficile.
1	(i)(ii)  (i)
1	practices, taking into
1	device that affects
2	including any component,
1	center. agency communications
1	dusting powder, or
1	chloral hydrate. (4)
2	development program and
3	interpretive criteria included
1	alimentarius commission. if
1	secretary of not
1	purchase, manufacture, transfer,
1	
 394. scientific
1	2018.  (3)
1	product derived from
1	 (c) defenses
1	
 
 159.
10	6 months after
2	means (1) articles
1	undertake examinations, inspections,
1	(ii) provide recommendation
1	experience, including experience
1	clause (i) by
2	analogue of an
1	establishments; nonprofit food
1	ongoing and regular
3	approved risk evaluation
1	bodily harm, or
1	harmful. (mar. 4,
1	biological product, as
3	exercised in a
1	(b) manufacture or
1	section 331(a) or
2	$2,786,000 for fiscal
1	formerly 6th par.,
3	extent otherwise permitted
1	2003, for that
1	case shall such
2	subchapter:  (1)
2	section 331(a) of
1	advance in the
1	year. (c) fee
4	secretary. any such
1	(4) an applicant
1	certified mail to
1	enforcement any nondiscretionary
1	fairly and reasonably
1	(i) the prospective
1	impose additional restrictions
2	without a prescription
7	(e) the term
2	section 202 of
1	device improvement, and
1	
 360n1. priority
2	policy who shall
1	pharmacist; unauthorized use
1	(d) 100 grams
1	(1) remains incidental
1	state governmentsparticularly those
1	permit the applicant
1	consumption of tobacco;
2	date from the
1	seized and a
2	product radiation safety,
1	501 to 517.
1	novo judicial review
1	population and members
1	safety of its
2	guidance to the
1	feed is manufactured
3	states and for
4	section 360kk(h) of
1	secretary; and (d)
1	(
 
 176
2	passed in a
1	(1) oversee, coordinate,
4	logistics provider from
1	(a) a clinical
3	chemical that produces
27	order under subsection
1	needed for approval
1	located when receiving
1	parts of such
1	proposed advertisements and
1	health. (c) issuance
1	title), and a
1	marginalized populations, designated
1	receives a description
1	programs of a
2	terminate the debarment
1	petition for classification
2	issued under item
2	facts so require,
2	scientific information the
1	testing, reporting, or
1	critically evaluating tools,
3	contracts under such
36	established under section
1	(a) not fewer
6	use, by the
2	sentence with respect
3	secretary by order
1	available, its chemical
1	combination have previously
1	design effective enforcement
1	broader population. 
1	disclosure statement means
3	sentence shall be
2	(a)(1) shall be
1	device. (j) training
2	importer on the
1	claims arising under
1	dietary supplement will
1	notice to congress
1	partially filled, the
1	10, 2005, or
1	variance provides the
1	
 453. definitionsfor
1	 (c) secretarial
1	term state, local,
3	voucher means a
1	consult with such
1	committee.  (3)
1	exceed 18 months.
1	coalition shall demonstrate
2	reporting for its
1	(d) the actions
1	ensures the recovery
4	advisory committee 
1	resources are utilized
11	manufacturer or the
9	regenerative advanced therapy
17	attorney general determines
2	result in labeling
2	18.  (3)
2	may require on
1	manufacturer relating to
3	fail to use,
1	investigations, and inspections,
1	(d) with respect
1	products, and shall
1	composed of ex
2	 (c) report
1	1091(r)(1)[1] of title
1	 (e) small
2	marking or labeling;
1	711, as added
1	regulated person is
1	appeal or dispute
1	guidelines (including guidelines
1	consolidate the hearing
1	prescription drugs. (i)
1	food safety grounds
1	sells cigarettes or
1	quantity or amount.
10	shall make a
1	retained as a
1	disease product. (c)
1	1 [part], as
1	distributed if the
1	advertising described in
2	(a)(2), if the
1	file supplemental return
1	number and amount
2	verified statement, a
1	authenticated by the
4	period the court
5	states to the
1	herbs or herbal
1	$75,000. (h) fiscal
1	application is reasonably
2	exercise concurrent jurisdiction
1	shall be kept
1	distributor shall verify
1	drug master filein
1	countries to reduce
2	unmet medical need
1	devastation to the
1	(l) jurisdiction to
5	subsection with respect
1	health concern, (e)
3	dtc advertisements for
1	related activities shall
2	using the drug.
2	right for a
1	u.s.c. 387a1(a)]. 
1	republished on an
1	olympic committee and
1	chemical, or (2)
1	generalin carrying out
1	regulations (a) storage
1	pending, the responsible
1	1973; $100,000,000 for
1	(2) premarket application,
1	certified organic, not
1	description of progress
1	may be eligible
1	terms importer and
1	clear any application
1	(e) availability of
1	ingredients required by
1	(b) to immediately
1	possession, use, or
1	statement of reasons,
2	upon the payment
1	 (e) obligation
1	(n)(3), the application
1	extent practicable, render
1	packaged, or held
4	subsection (c)(3)(e) and
1	drug abuse education,
1	training programs under
2	devices pursuant to
3	(i) the results
2	manufacture, exportation, or
1	teaching and not
2	inspections of such
1	daytime when the
1	export the narcotic
1	manufacturer has made
1	veterinary diagnostics the
3	section and which
31	exempt from the
1	reaction with other
4	state programs and
1	(a) contractors the
1	unsafe color additivesa
1	notification of government
1	refusing to cooperate
1	paragraph (1)(a), including
1	(6)(b) was issued
1	pharmacy recognized by
1	effectiveness reasons; (x)
1	become so recognized,
1	abuse problems and
1	data, and at
6	paragraph (1) does
1	seq.] do not
1	first offense, and
1	of, any premarket
1	issue an interim
2	42.  (c)
1	cause an infant
1	14th day after
1	areas relevant to
1	united states, for
1	drug abuse education;
1	term direc-t-consumer television
1	section 360b(a)(5) of
1	crises (a) definitionsin
1	practice compliance at
1	membranes to the
1	aforesaid, shall be
1	technology means a
2	certain functions by
1	(a)(1)(c) of such
1	regulated person believes
1	1985, the secretary
1	entity funds the
1	section. such notice
1	nervous system, and
1	considerations  (1)
2	(h) limitations 
3	exceed 48 hours,
1	dosage and administration.
1	thereafter such reports
1	(c) inform the
3	subchapter.  (c)
1	(3) authorized generic
2	penalty has become
4	including whether such
1	practice by 
1	interim or revised
1	pr- and pos-natal
1	sensitive information any
1	sponsors developing combination
1	prevention.  (b)
1	remaining in effect
1	error.  (b)
1	regarding the reason
1	identified individual patient
1	report. (iii) actions
1	president to submit
1	(a) feedback from
1	destroyed under the
2	program are expended
1	information specified in
1	determined by considering
2	may as the
1	assessment of 
2	reduction, the deputy
5	inputprior to beginning
2	registrant, or his
4	commerce between any
1	planning to the
1	application is deemed
1	675, 749, formerly
1	device submitted under
1	establishments; rejection of
1	verify the term
1	predicate tobacco product,
6	person may submit
1	food may require
14	paragraph, the secretary
1	products from selling
1	350c. maintenance and
1	(ii) postapproval clinical
1	including public statements,
1	ch. 675, 577,
1	organization for which
1	1046; apr. 15,
1	services may destroy,
1	emergency authorized use
2	drugs with the
1	1989, the congress
2	field of electronic
2	subparagraph (a)(ii); and
1	comments by interested
1	prominent and conspicuous
1	directions and warnings
1	tribal agency, shall
2	subsection (i) shall
2	united states person
1	food product analyzed
1	product manufacturer the
3	agencies with responsibilities
1	filed.  (3)
1	provided such application
1	restrictionsthe director shall
1	 (i) labeling
1	guidance since 1997.
4	subparagraph (a)(ii), and
1	(i), so long
1	magistrate judge, may,
1	persons of a
1	i, 5, formerly
1	indicated should be
1	gamma butyrolactone (gbl)
1	program in the
1	subchapter, or upon
1	gas, alone or
1	eggs have at
1	local efforts 
23	prescribed by regulations
2	(1) shall contain
1	person, this paragraph
1	manufacturing practices, between
1	recall order. (3)
2	coordination of the
1	(a) sponsor of
1	paragraph is a
1	finding required under
9	upon application of
1	(iii) an exemption
1	property ordered forfeited.
1	compel their attendance,
2	purpose by the
1	utilization of employees;
2	excess amount shall
1	application or applicationsthe
2	measure the progress
1	account all fees
1	match advertising not
1	laboratory capacity to
1	device, they shall
1	revise the classification
1	prescribed by regulation,
1	division and to
1	interest in, or
1	cases; (d) augmenting
12	registered with the
1	upon its delivery
1	comprehend the information
1	production includes the
1	performed in official
1	 (c) condemnation;
1	controlled substances moneys
1	related to devices
1	publication of designation;
1	(ii) maintain the
1	establishment there are
2	brought. the document
1	device requiring further
1	drugs (a) necessity
1	different, information showing
1	involving listed chemicalsany
2	compounded in accordance
1	include the particulars
1	shall a person
1	motion seeking dismissal
1	part; (ii) recognizing
1	providing advisory comments
1	(d) any actions
5	gamma hydroxybutyric acid
1	ninety days, unless
5	(iii)  (i)
1	(ii) awards with
1	reports by attorney
1	successful and efficient
1	appropriate organizations, including
1	ch. 675, 806,
1	(iii)recipients of notice.an
1	approve an antibacterial
1	shall so advise
1	foreign government, if
1	obligated for payment
1	(i) a provider
1	require and shall
2	promulgate rules and
2	which, without authorization,
1	least $11,250,000 in
1	ch. 800, 1,
1	patient or an
1	knowledge, (iii) knew
10	information, transaction history,
7	shall order the
2	relief prescribed by
1	establishment. (c) the
1	include additional elements
1	states ability to
1	mutation is responsible
2	purposes of registration
2	containing such pesticide
2	available from other
1	works in collaboration
1	classification, and (iv)
1	enact, adopt, promulgate,
1	good importer practices,
1	law; or (b)
1	testing obtaining a
1	offense, or (ii)
1	interdiction coordinator concerning
1	suspend the authority
4	regulatory requirements that
5	responsibilities under the
2	makes recommendations with
1	collections notwithstanding any
1	professionals agree to
1	reinspection fees assessed
5	violation of such
1	(6) no preemption
2	title which is
1	industry and fda
1	methods to show
2	march 4, 1907,
2	make the written
1	prescription use, and
1	articles means carcasses,
2	event report submitted
1	(2) jointly by
2	working on behalf
1	medical, veterinary, food,
1	historical use, reports
1	known set of
1	international labeling symbols.
1	v unless the
1	development tools under
1	used in products
1	(iii) labeling submitted
1	(xi) establish specific
1	foreign material. (8)
1	civil action on
1	 (ii) not
2	term human drug
1	found with the
1	(4) if, in
1	vaccine shortage notification
1	petition or supplemental
2	cosmetic, and biotechnology
1	ch. 74, 3,
1	least 8 feet
1	product is modified
4	civil action or
5	records, or has
1	(ii) the center
1	fact on which
2	abuse may be
1	mistaken in taste
1	sanitary practices and
1	foreign country determines
1	sold to, or
1	manufactured without the
1	application which would
1	plants exporting eggs
1	sum equal to
1	(c) securing funding
1	maintenance, for not
3	title or for
1	acquired by him
1	requires standards respecting
1	1997).  (c)
1	person in response
1	measurement system; (3)
1	act. (june 25,
1	standards, or premarket
1	
 62. manufacture,
1	device marketed by
1	part thereof for
1	compounding before issuing
1	1503 to 1505.
5	title 5, the
1	appoint receivers, conservators,
1	subsection (g)(2)(c)(ii) or
1	condition involving a
1	nonprescription sunscreen, the
1	360j(l)(5)(b) of this
1	application therefor permits
1	implement a strategy
2	interstate commerce to
1	interactions with biological
1	managers of the
2	(c) notice to
8	harm to the
1	public display, except
1	transporting, or holding),
2	population for which
3	statement signed by
1	targeting inspection resources
2	application concerning the
1	justify the commencement
1	treatment) considers to
2	reimburse a state
1	include provision by
1	 (d) national
1	range of experts
1	auditor.  (2)
2	(a) classes of
1	eligible partnership definedin
1	level information) consistent
47	necessary for the
1	precautions, side effects,
1	610(b), and 623
1	chapter; (3) promote
1	reports referred to
1	year, the future
1	(a) lif-supporting; (b)
1	substances, through referrals
3	found (by methods
1	sets forth any
2	shortage of an
5	provided to a
1	(a) the adulteration
2	labeling to avoid
1	national uniform nutrition
1	initiative or by
1	new applicants or
3	going forward with
1	safety and efficacy.
1	foundation in the
4	analysis of data
1	product is a
1	products, shall be
6	cocaine, ecgonine, and
1	unless such standard
1	assessing pediatric safety
1	mitigation of forfeitures
1	exemptions that appear
1	intends to donate
8	state boards of
2	(ii), include such
1	practice or good
1	 (d) board
1	medical devices, many
1	data sources, as
1	packaging, isolation, and
1	program; (2) describes
1	facilitate judicial review,
1	agriculture may apply,
1	prohibit a manufacturer,
2	shall prescribe through
1	title; and (h)
1	implementing this division.
1	implementing this division,
1	stat. 1500.)
 

2	vitro diagnostic biologic
3	audit of an
1	42, except that
1	not, because of
1	(4) refund of
1	subsection (c)(1), the
1	product radiation safety.
1	alternative methodsthe secretary,
2	fact for effective
31	drug administration for
1	labeling. (b) 
1	promotional material prior
1	natural disasters or
1	additional meetings, which
2	administration take custody
1	seq.); (2) alter
1	committee under subparagraph
1	traditional approval of
2	device safety and
1	844(a) of this
1	(c) the adequacy
7	secretary under such
1	u.s.c. 619(5)], when
1	(relating to judicial
3	drug to any
1	holder to propose
1	shall be implemented
1	issues; (6) training
2	title despite the
1	public internet web
2	title and for
1	mitigation of forfeiture,
2	unwholesome, or otherwise
1	concepts to premarket
1	year refers to
1	(e) contemporary research
1	place for the
1	referral; considerations the
1	indications, and production
1	reserve fee assessment.
1	license a person
1	application exist or
1	cumulative effects on
1	publish, on the
1	section 387k(g)(2)(c)(ii) or
5	applications under section
4	paragraph (1), (2),
1	properly labeled; (b)
1	agency, use the
1	authority over tobacco
1	development program, including
1	protocol described under
1	(
 
 1541.
1	units in liquid
2	purchaser or user
2	recall of the
1	product. the office
2	commerce, or engage
2	panel shall be
3	methods of examination
1	periods:  (i)
1	harms the environment
6	fiscal year 
2	products thereof, shall
1	section 379g of
1	except paragraphs (a),
1	drug, a biological
1	amended or repealed,
1	facility shall 
1	strike, fire, or
1	biological products under
1	minimum specified in
2	local law. if
1	 (j) factors
2	term eligible establishment
1	state.  (b)
1	scope of paragraph
1	products and identify
1	year, which shall
2	request for purposes
6	section 802 of
3	(2) there is
2	federal trade commission,
1	federal trade commission.
1	cause, issue warrants
1	act,[1] the secretary
1	medical gas, alone
1	assist such agencies
1	compatible or do
1	unless before trial,
2	section 360 or
6	corporation engaged in
2	product, including the
1	amount, the appropriateness
1	acquired, or intended
1	5 shall apply
1	temporary shortages of
6	secretary when the
1	food, other than
1	reviewing court ex
1	designation shall terminate
1	(b) post the
1	device effectiveness or
1	(2) requirement to
1	another name if
1	(b) upon approval
1	subsection (f), including
1	includes any individual,
4	parts thereof of
1	iv, 404, as
2	establishment, notwithstanding the
1	issuance of 
1	currently informed pursuant
1	includes data that
1	introduction of devices
1	fine applies. 
1	regulation remove drugs
4	otherwise be authorized
1	penalty in addition
1	new devices 
3	use and cautionary
17	applications for generic
1	(i) is the
2	amount of revenue
1	animal feed, as
1	user fee for
1	(3) consultation the
2	products.  (

2	(except a new
1	(ii) 50 percent
1	product, if assigned.
1	persons.  (2)
1	plan on or
1	
 387h. notification
1	gas into interstate
1	light of such
2	comply with, and
1	(b) other listthe
7	studies and clinical
1	states exceeds the
1	(i) beginning 7
1	meet appropriate standards
3	subgroups, including subgroups
1	dioxide that meets
1	eating place or
1	food additive, the
1	agency center by
1	(1) articles used
2	system to link
15	offered for sale
1	basis of other
2	possible infringement of
1	fees. (4) offset
1	funding level; how
1	develop a comprehensive
1	solutions; (xvi) the
1	disseminating the report,
4	355(j)(5)(f) of this
1	provisions with respect
1	security (a) in
1	tobacco warehouse in
1	(ii) providing timely
1	analysis, (iv) the
1	control; and 
1	different from, federal
4	declaration pursuant to
1	science or in
1	seafood imports that
1	2016; and 
1	application may, by
3	official certificate provided
1	e (iu) 0.7
1	nanomaterials on biological
1	machines for amusement
1	maintain thereafter, on
1	may find necessary,
2	application, the thirt-month
1	affected under paragraph
2	forth the date
1	chapter, including standards
2	following findings and
1	process in issuing
1	 (a) slaughters
2	drug is dispensed
1	(a) 20 percent
25	report on the
2	refund, if any,
2	manufactures a drug
1	performance measurement systemnot
1	compilation under the
1	paragraph (3), shall
14	injury results from
1	product tampering; or
1	harm to physical
1	production, processing, or
3	(b) complete application
4	state official, in
2	 (d) for
1	effects, for purposes
2	chapter in response
1	animal illness; and
1	sample to execute
1	advice or recommendations
1	establishing effective controls
1	provides notice as
1	 fee type
1	processed, and at
1	 (d) penalties
1	clinical endpoints, consumer
1	13, or 19
2	subchapter; all dangerous,
3	administration of such
1	obtained from private
1	subsector to comply
1	product or device
1	standards of a
1	(b) offer for
32	published in the
1	received a certification,
1	uninterrupted supply of
1	clinical protocol) for
1	paid or payable
2	payable under subparagraph
1	food with results;
4	proposed regulation is
4	advance in appropriation
1	(d) development and
1	achieve the voting
1	$2,500,000 if the
1	equivalent of two
1	376. examination of
1	sale deposited in
1	request pertains to
1	administrative support services
2	remedy provided by
2	whose body, or
1	care such substances
2	balance in the
1	clinical trial 
1	5 units per
1	15 days before
1	definition of covered
1	emission of radiation
1	(2) information about
1	include an electronic
1	in, state or
1	individually accredited, is
2	secretary, in determining
1	process under the
1	(a) such device
1	program for monitoring
2	identified after the
8	initial or annual
3	scientific advisory panel
1	food, while there
1	 (3) tobacco
1	fact, the secretary
1	whether debarment periods
3	requirement that 
17	(i) or (ii)
1	(a) the purchase
2	may reinstate or
1	written agreement executed
1	vacancy for an
2	 (c) sales
1	(i) a controlled
16	(1) shall not
1	(21 u.s.c. 802(33),[1]
2	select the establishment
1	states) from penetration
1	determine whether denial,
1	section applies means
1	thereof.  (4)
1	involving methamphetamine or
1	added or applied
1	basis.  (2)
5	respect to drugs
2	reduction regarding premarket
1	829(e) of this
3	conduct the activities
1	processes; and (ii)
2	 (4) designation
2	condition which is
2	facilitate the efficient
2	party to identify,
1	occurrence of such
1	regulation or notification,
1	type for which
1	contamination of the
1	unit the appropriate
1	address, and contact
1	deferral, deferral extension,
1	person, shall order,
3	commodity and such
1	form and concentration
1	passed;  (d)
1	(f) limits 
2	detrimental effects in
2	program in any
1	trade commission (a)
3	210 calendar days
1	entered consents to
1	cooperation, coordination, and
1	year 2003, except
1	(b)(3)(a), the secretary
1	uses for, and
3	shall be independent
2	effect on such
2	notice.  an
2	review of tolerances
1	interagency collaborationin carrying
1	seq.] on april
1	chapter, and other
1	drug product; (d)
1	elected officialsif feasible,
1	exemptions, a statement
1	title; (b) full
1	final judicial affirmance
1	knowledge, shall be
1	assist federal, state,
1	permit on and
1	testing, and adjudication
1	study in laboratory
1	designed to treat
2	produced by such
1	[42 u.s.c. 263a],
1	trial information for
2	admission on any
9	opportunity to present
1	assist in the
1	pediatric populations, and
1	(2) name the
1	(1) unless an
1	(a)(6). (4) updates
1	paragraph if the
1	industry on 
2	local drug crises
1	secretaryin carrying out
4	(iii) such other
1	limit revocation or
5	gravity of the
1	providing for a
1	believes may indicate
2	secretary, pursuant to
1	drug administration imported
1	insufficient access to
2	offense against property
1	nondiscretionary duty imposed
1	authorized under such
1	moneys.  (

1	property declared forfeited
3	order, on the
1	states marshals service
2	thereof be subject
1	outsourcing facility. (iv)
1	2009. until such
1	requirement imposes a
1	record shall report
1	(7) the existence
2	determinations under paragraphs
1	tracing products through
1	national governing body
2	perform the functions
1	facility shall remit
1	security a notification
2	(i) the sale
1	 (f) office
1	refer such proposed
1	review of countermeasures
1	etc., meat of
2	manufacturer shall notify
1	manufacturer recalls; (v)
1	(iii) food from
1	360e. premarket approval
1	
 
 399e.
1	orders or injunctions,
1	submission of and
2	inspections of foreign
1	shall pay an
1	may warrant good
1	(b)(ii) shall be
1	 (3) schedule
1	dispensing the same;
1	competition). (vi)expiration of
1	(a) that assistance
1	assistance concerning preventive
1	
 695. payment
2	believe that they
1	2223 of this
2	subsection (n)(1)(g), the
1	medical use, or
1	holder a written
4	submission of any
1	complaint from which
1	page 13 of
1	merits of the
3	secretarys determination of
1	methods to obtain
1	smokeless tobacco. if
1	practice in this
1	program and performance
1	stating the condition
1	shall provide advice,
1	seller enters in
1	subparagraph (b) applies.
1	estrogen.  (5)
2	(h) preemption 
1	remove such medical
1	conditionally approved intended
1	paperwork reduction act
1	request submitted based
2	shall, 60 days
1	section. (c) if
1	1-day period, be
3	data supporting the
1	remove, break, injure,
2	incentive program, including
1	related to any
1	rare diseases, targeted
2	(6) knowingly represent
1	state.  (b)standards.
1	unless ordered by
1	years, retained on
3	organization that 
1	program to export
1	violations by the
1	develop and coordinate
2	determinations  (1)
1	(7) its psychic
7	petition submitted under
1	review, and at
1	device, (ii) set
2	declaration, or in
1	affiliates. in addition,
2	period  (i)
2	eggs for the
2	proceeding shall be
1	located, or by
1	approved, the secretary
1	 (b) factors
1	testimony of the
1	notice of application
1	refuses to give
1	judicial review only
1	title 42), the
1	notwithstanding such requirement
1	population. no fee
3	months after december
1	effective.  while
1	illness outbreak interviews.
3	costs of developing
2	restaurant if the
1	(a)(1) shall describe
2	accept or review
1	criminal fine imposed
3	give high priority
5	withdrawn before filing
2	federal register stating
1	establishment processing any
1	drug samples in
2	impracticable, or results
1	 (2) pharmacist
1	title. (3) abbreviated
1	(2) frameworknot later
1	final regulations issued
2	determination of a
1	title 31. (g)
1	(1) 3,-methylenedioxy amphetamine.
1	phenomorphan. (37) phenoperidine.
1	including renewal grants
1	application; and (f)
1	manufacture the biosimilar
1	change in meat
4	generalupon making a
1	(including any reduction
1	 (ii) limitationsfor
2	review and evaluate
1	provide a food
1	locations and manners,
1	technological characteristics and
4	court of a
9	business or its
1	title i, 17,
3	intended to treat,
1	(a) to clarify
1	basis a summary
1	first point of
1	may require, with
1	sense of congressit
1	subchapter with respect
1	average) for the
1	product being compared
1	order.  (c)
1	appropriate content requirements
1	receipt or transfer
1	control program shall
2	(i) the tobacco
1	distributors sufficient to
1	(a) regulations for
1	program agencies programs,
1	purpose and administration
2	chemical, knowing, intending,
1	health are at
1	human food, not
3	review the application
1	local levels to
1	drug applications; and
1	report acquisition and
1	state which shall
1	action. (g) suspension
2	use except under
1	international agreements and
1	use the procedures
3	time under such
1	 (c) labeling:
1	 (3) governing
1	drugs and biologics
2	best knowledge and
1	data may be
2	revenue amount of
1	mitigate the impact
1	section and govern
1	(e) classification changes
1	seized by hidt-funded
2	relieved of the
1	fact.  (b)
1	activities; (ii) requests
4	september 30, 2012,
3	food shall apply
1	product manufacturer and
1	title 31. all
1	facility.  (iii)
1	except such information
3	direct that all
1	proposal. the secretary
1	(1), as applicable.
1	summary shall include
1	(1) within thirty
2	appropriate to such
1	675, 916, as
1	receives such statement,
1	title, as described
1	inapplicability of paperwork
3	secretary may suspend
1	
 
 379j43.
1	(i) such fees
2	directions for use,
1	factors, good manufacturing
1	directions for use.
1	eligible product is
1	provide, in writing,
1	parts of laws
1	form shall be
1	secretary, information submitted
1	exposes consumers to
1	draft framework for
8	committees of congress
2	result in ingestion
1	(d) rulemaking procedures
1	objections and public
1	(2) required submission
1	application $248,000 
1	drug addiction and
1	2, 65 stat.
1	evaluate and respond
1	issued and the
1	356c. discontinuance or
1	sponsor referencing information
1	combination on target
15	prior conviction, impose
1	pathogen  (1)
2	danger to health
1	requirements; applicability; preemption
10	fiscal year may
1	treatment planning, overdose
1	process of synthesis
1	bulk manufacturer of
1	 (a) design
2	revoked, or suspended.
1	register and available
1	process drugs, or
1	certified under subclause
59	conditions of use
1	notification described in
2	paragraph (2) as
1	 (f) authorization
1	2014; (b) $6,944,000
1	regulation require each
3	(b) an order
1	meat products outside
1	termination the secretary
1	ownership interest in
1	paragraph (4). (june
2	determines appropriate. (d)
2	liability similar to
1	title or fas-track
1	register and may
8	conducted under such
8	data management systems
2	expertise in such
1	public health. for
1	
 360a2. susceptibility
3	describing an investigation
2	(ii) subject to
1	ii, or two
1	manufacturing and quality
1	preceding sentence, such
1	devices, for which
1	saleable returnsnotwithstanding subparagraph
1	enforcement administration certificate
1	360mm. imports (a)
1	42.  (5)
1	(public law 103417);
1	product characteristics of
1	practice, so long
1	residue meeting the
1	plan and the
1	opportunity for submission
1	customs laws relating
1	(g) clarification this
1	formerly 21st, 22nd
1	23, 1985, any
2	clinical trials of
1	(1) it conforms
1	committee meeting may
1	products, or otherwise
1	(a)(1)(f)(i).  (b)
2	practitioner, without regard
1	feed directive applicable
1	353(e)(3) of this
1	(i) responding to
1	shall be labeled
3	device referred to
1	and/or video machines.
1	constitutes a serious
1	effectiveness, or substantial
1	(i)  (aa)
1	further, by regulation,
1	dependence upon heroin
8	insanitary conditions whereby
1	means the point
17	less than 30
1	1035. sanitary operating
3	designation under this
6	federal register. 
1	stat. 817.)
 

1	distributor by name,
1	(2) inspection report
1	contain meat or
1	criteria for public
10	384b of this
1	residue level has
1	food means 
1	distributed such drug
1	affairs shall each
2	proceedings to deny,
1	1982. of the
1	reduction by 
1	practicable, infer the
1	sentence shall remain
1	agreements, contracts, and
1	syrup, (4) any
1	made. no drug
2	facility.  (b)
1	pending or instituted
1	animals, (2) chewing
1	amended and extended
2	pharmacy or pharmacies
2	section.  (ii)
1	protocol containing best
2	judicial review any
1	13th par., 34
5	united states a
1	next following. 
3	thereby appeals to
1	case that such
2	chapter 57 of
1	variety, normal shape,
1	policies that may
1	b1 (thiamine) (g)
1	necessary expertise can
1	term operating reserve
1	entered are correct.
8	application or submission
48	energy and commerce
1	trade bureau of
1	access. (ii) the
2	storage, handling, and
1	regulations requiring, when
1	labeling, and for
1	1103.)
 
 148.
1	paragraph on a
3	360j(l) of this
2	paragraph (5). (4)
3	46 and the
1	otherwise is or
1	least 3 packages
5	chapter. the secretary
2	within 5 miles
1	businesses; and (c)
6	shall be applicable
1	abuse and alcoholism
1	(b)(iii) unless 
1	systems, and the
2	pesticide chemicals; and
1	foreign grown tobacco,
1	(c) general services
1	subsection shall continue
1	
 
 321.
1	advisory committee nominations;
2	shall visit selected
2	inspection of facilities
1	person who relied
1	unless, when required
1	times. (3) except
2	food, food ingredients,
1	team by senior
1	foreign grown tobacco;
2	(b) at a
1	warrant control or
1	paragraph to carry
1	apply to manufacturers
2	supplied by other
1	medical purpose based
1	event report, a
1	level requirements shall
1	supplementary thereto. (r)
1	infrastructure among the
7	subparagraph (a). the
1	chemical was, with
1	period of less
1	coalition for purposes
1	office  (1)
1	standard or standards,
1	reference to this
1	general discussion regarding
1	field investigation that
1	information or factors
5	conferences or meetings
4	drug are produced
2	body structure, or
1	(ii) may request
1	substances the attorney
1	
 360eee4. uniform
1	granted to him
1	prescribed from time
1	(8) savings nothing
1	coalition information 
1	675, 505a, as
1	made available from
1	analogous product prepared
4	suspect product for
1	designed to compare
1	dietary supplement. in
1	manner that clearly
1	reinstatement of such
1	conservators, appraisers, accountants,
1	container includes any
31	active pharmaceutical ingredient
1	drug product upon
1	review under chapter
2	section 360b(b)(2) of
2	of, contact information
3	single official name
1	wholesale distribution means
1	adverse event regarding
2	official plants (a)
1	paragraph, be sentenced
1	(b) notwithstanding subparagraph
1	relevant information, to
2	application and the
3	may, for purposes
2	contained or was
1	applicant under the
1	optional ingredients which
1	animal feed within
3	authorized by subparagraph
1	applicability this subsection
1	prescribe the records
1	chemical, including full
1	chapter (a) 
2	health. (d) if
1	small businessa facility
1	inspection fees 
2	petitioner of any
2	unless that civil
1	target material, electronic
1	ingredient to establish
1	additional information in
1	(i).  (b)class
1	(5) conduct programs
1	62. manufacture, shipment,
1	eligible entities; application
2	including based on
1	document issued under
1	forth the nature
1	official, except to
1	office of a
3	health and safety;
1	exists under the
2	panel and committee
1	restitution as provided
1	drug marketed in
1	initially introduce or
1	fund demonstration programs
1	individual establishments to
1	5.  (d)
1	agency response 
4	made by an
5	health and safety,
10	give the applicant
1	permitted by law,
1	seq.].  (j)
1	emergency dispensingthe requirements
2	entitled to one
1	
 
 115
1	
 
 114
1	property appropriate to
1	drug. such analysis
1	upon submission by
1	(d) the statement
1	facility, as determined
1	etc., where drug
1	(18) nicocodeine. (19)
1	grants, in accordance
1	675, 503b, as
1	standards; and 
1	(5) all books,
100	consultation with the
1	consult the internal
1	whoever, while manufacturing
1	title 18, entering
3	illness surveillance systems
1	drug (unless exempted
1	opiate, and any
1	months. except as
1	device conform to
1	repackager. if a
2	drugs or biological
1	form and, as
1	offense prohibited by
1	subsection (b)(2)(a)(i); and
1	1531(c) of this
1	white, large meat
1	shall issue, upon
1	human services an
4	case of such
3	drug products at
1	emergency use, if
1	sent to the
3	regulations for the
1	health administration can
1	compliant with, the
1	subject to 1
1	supply reduction; and
1	30, 2010, for
1	processed means slaughtered,
2	clinical significance of
1	term knowingly or
1	facility shall verify
1	account.  (c)
7	 (c) notice
1	(d)(2)(a)(i) and may,
1	(and any release
2	information) shall be
1	labeling and review
4	dru-free communities act
1	factorsin establishing, modifying,
1	merger or acquisition
1	chapter, or as
2	demonstrated a pattern
1	specific efficacy of
1	effectiveness.  (e)
2	 (a) redactions
1	partial fills of
1	deposited into the
1	pharmacy or a
1	effectiveness. regulations prescribed
1	media or otherwise,
1	retained in conformity
1	2007, the value
1	(d) administrative inspection
2	title xiii, 1313,
1	one clinical investigation
1	to, the applicant,
1	product no longer
1	managing pr-submission interactions
62	subject to a
1	term final product
1	eliminate burdens on
1	federal establishment. (8)
2	30, 1906, as
2	notice that the
1	develop and make
1	animals or to
1	terms, the benefits
1	designated book, paper,
1	thereunder.  (e)
1	 (b)class ii,
1	stat. 885; 1940
1	ma-made structure in
2	following the 1-month
2	limit the inspection
1	defendant, or on
1	completed not less
1	administration) levels of
1	within the persons
2	(b)(1) or section
1	give prompt notice
1	enterprise includes any
1	notices  (1)
1	shall interpret such
2	device.  (h)
1	records for at
1	contractors with the
2	 (i) reviewed
1	262]. (c) timelines
1	secretary determines under
1	available, including through
1	date. the period
2	drug use among
4	extent practicable given
2	coalitions that are
1	drug substances, as
1	 (i) comprehensive,
2	paragraph (1), for
1	article is fraudulent,
1	person who sells
1	populations, in coordination
1	determined, pursuant to
1	(3) identifies any
1	minimum, identify 
1	strategy, and the
2	measurable objectives and
4	title 7 shall
1	administration do not
1	state, pursuant to
1	sharpened stakes, and
1	illness and serious
1	 (2) reportable
2	individuals under the
1	publicly available, and
1	product will enter
1	matters related to
2	reuse payments), provided
1	problem in the
1	(ii) identify, record,
1	(ii) the debarment
1	summarize, and evaluate
1	administration of all
1	maintained under the
2	effect before november
1	proposed rulemaking. (f)
1	(i) and shall
1	potential for miscommunication
2	investigation from continuing
1	index. such no-federal
4	delivery, distribution, or
1	notwithstanding any penalty
1	(b) two of
3	 (2) each
1	public sale after
1	subsection (a), without
1	plan that documents
1	effective, and (ii)
2	retailer may distribute
1	solely, or in
1	(c) annual review
1	advertisement disseminated in
1	providers of health
1	subsection (b)(1), establish
1	506d, as added
1	innovative and flexible
1	data used to
7	preceding fiscal year
1	(d) partnerships with
1	prosecution, or for
1	(iii) 50 percent
1	de minimis nature
1	provide for separately
1	(c) an annual
1	subchapter or to
1	(a) a certification
1	assist importers in
2	animal food manufacturer
1	regulated seller who
2	years and fined
1	prospective purchaser must
1	keeping every manufacturer
1	memorandum; and (iii)
1	shall consult before
1	concentrate, metabolite, constituent,
1	transcription of a
10	use with other
1	42; (e) enabling
1	(ii) modify elements
1	poultry products required
6	section in a
1	animals to prevent
1	tribal affairs means
2	delivered into interstate
4	(b) action by
1	products, of such
1	employees, and committees,
29	issued under paragraph
1	submit to a
1	compliance, as applicable;
1	united states ability
1	time of its
1	public health exception
2	additional elements described
1	(iii) proceedings of
1	1; or (ii)
1	meat spots, a
6	u.s.c. 262(a)] for
1	30, 1998: 
1	(3) contents of
1	drug, which has
2	border protection, shall
1	food products, as
1	one another; and
1	control policy, which
1	organizations, including physician,
1	373, 374(a), 379aa,
1	required under paragraphs
1	written material presented
1	device involved are
1	products); (c) 26
2	use of environmentall-approved
6	relevant in any
1	(13) package the
6	october 1 and
2	upon the secretary
1	sentence a compilation
3	report described in
1	licensed physician distributes
1	export permit, notification,
1	served with meals
25	4, 2011, the
1	determination, including published
1	states, that evades
8	regulatory management plan
1	sustain the order
1	protect information provided
2	offense, the commission
1	u.s.c. 262]. (2)
1	suggestions proposed for
9	follows:  (a)
6	pesticide chemical, food
1	regulated person; and
1	registration to prescribe
2	use the marking,
5	hearing, to be
1	transfers of funds
1	states; (2) increasing
2	person shall maintain
2	issue an administrative
2	report voluntarily submitted
1	(d) reports to
1	is, if an
1	psychotropic substances, it
1	contact information and
1	persons debarred under
1	approval of covered
3	outweigh the known
1	cumulative effect of
1	appropriated $15,000,000 for
1	notifications, for such
1	proceeding pending or
2	notify the responsible
1	section, relevant to
1	chemicals; and (5)
4	shall, prior to
1	 (i) patient
2	regarding drug trafficking
1	compliance at the
1	vary from that
1	inspections the secretary
1	carrier under this
1	 (1) expedite
1	reinspections an outsourcing
1	proposes to dispense,
1	administrator may, when
1	drugs and variant
2	submit the adverse
1	analysis similar to
1	greater.  (3)
1	chapter. (k) the
1	timetable required under
1	section 1531(d) of
1	respect to newl-identified
6	indirectly  (a)
2	consistent with subsection
1	rulewhenever the secretary
1	year. such notifications
1	symptoms, overall mental
1	eligibility in the
1	appoint subcommittees and
2	illness outbreak and
2	title, the period
1	reasons other than
1	(
 
 889.
1	secretary makes revisions
1	(c) conduct of
1	production, preparation, propagation,
2	use to be
1	animal feeds, based
1	shall they apply
1	establishments designated representative
1	care entity and
1	developing and critically
1	illicit trade or
2	register as an
1	case of helium,
1	897.3 and insert
1	including a drug
1	achieve the objectives
1	written policies to
1	burdensome requirements 
1	drugs as to
1	(f) eliminating backlogs
1	may require. a
1	violating the requirements
3	names of optional
1	(5) at the
1	finding before the
1	unnecessary electronic product
1	meet the stated
2	designation if the
1	waived by the
1	existing electronic communications
1	demand for particular
1	require any entity
1	locally usually have
1	manufacturers of prescription
1	(i) in order
1	
 2107. sense
1	pediatric product under
4	inspection resources. 
1	suspension or withholding
1	(3) contentthe regulations
4	agent of a
1	distribution within a
11	drug application submitted
1	pay biosimilar development
1	registrant to (1)
9	article or poultry
1	(a) adulterationan infant
2	years thereafter. 
1	shortages.  (c)
5	section 958 of
1	protection of classified
1	(3) multiple recalls
1	i-person medical evaluation)
1	shipper, and consignee
1	(iii) the increased
1	identifies the particular
1	ingredient. (b) containerthe
1	
 
 603.
1	application, or data
2	statistically sampled and
1	fact in connection
1	duly authorized officer
1	including any impact
2	significant barrier to
1	risk populations such
1	register (a) except
1	subsequent calendar year
2	relevant or material
1	mitigate such serious
1	publicly available under
1	seq.); (b) a
2	(i) have been
1	heat or other
1	submitted, such different
2	paid the same
1	commissioner shall 
2	 (1) assistance
1	(2) according to
1	applicable to menthol
1	subsection (b), be
1	abbreviated applications. (iii)
1	products under such
1	prior written approval
2	(a), a determination
1	device the term
1	denial may file
19	release of at
1	secretarys approval an
1	butane. (13) moramid-intermediate,
1	margarine is oleomargarine
2	interruption of the
5	administration in the
1	states representative responsible
1	organization established by
71	deemed to be
1	term finished dosage
4	thereto or mixed
2	28 to enforce
2	believe the active
8	2016, the secretary
1	organizations.  (g)
1	dietary ingredient notification
3	benefits of using
4	box, bottle, or
2	secretary; and 
1	subsection (e)(2)(b)(ii), as
1	ii device because
1	holder involved validates
1	(ii) conditionsa drug
2	activity by committee
1	(i) satisfy any
5	within the same
1	drug as they
4	notice of a
1	efforts taken pursuant
1	defense available to
1	monograph exists, or
1	 is to
1	determinations of substantial
1	convincing evidence 
4	secretary to disclose
1	specifying the limited
3	contains substantial evidence
2	rule of law
1	regarding the process
1	facilities.  (ii)
1	tobacco product who
1	employee, whether at
1	caused by either
3	supplement and conducted
1	related to public
1	unduly interfere with
11	 (1) not
1	available only for
1	supplier; or (iii)
1	(c) nonreceival for
1	ordinary meaning, such
2	products; and (b)
1	fee and the
2	reviewing division determines
1	drugs are being
1	any, of other
1	administration (1) the
1	application.  (j)
2	subchapter ii, any
1	bulk vehicle), render
2	seafood, juice, and
1	applications and supplements,
1	label in bold
1	paragraph (5)(a), a
1	(b)(8).  (4)
1	farms; restaurants; other
3	court of competent
1	clause (iv). 
3	consent of such
1	advance the mission
3	section 351, 352,
1	(b) known food
1	renders it adulterated
1	states; (3) conduct
2	applicable, may or
1	eggs, with or
1	(g) no limitation
1	determinations; data submission;
1	section; (3) contract
3	real or personal
1	exist only if
1	scientific information on
1	animal imported into
1	first being considered
1	review, as described
1	patient or a
3	pediatric disease priority
1	subsection during the
6	failure to adduce
1	meets the secretarys
16	approval under section
1	regions who are
1	notification the sponsor
1	39, such moneys
1	detect trends in
1	threat to national
1	impose restrictions on
2	may be entered
1	(b) will not
1	master files). (b)
1	science relating to
1	 (c) one
3	association, as well
1	operation of programs
2	appropriate, advice on
1	physiological dependence liability.
1	appropriate registration, or
2	consult with individuals
1	poppy straw means
1	governing colored oleomargarine
1	subsection (n)(1)(g) or
2	(1) shall become
1	effect; or (2)
2	accompanying such denial)
1	(i) the quantities
1	egg product under
1	delay if the
1	form, including, for
2	report the susceptibility
1	states pharmacopoeia unless
2	may be permitted
1	application, within 30
4	limit on a
1	use in their
1	seq.). (n) labeling
1	vessel carrying meat
1	drug for which,
1	(aa) necessary for
4	dietary supplement that
1	intentionally provide or
1	secretary may, if
1	preventive controls adopted
1	hospitalization or prolongation
1	
 678. no-federal
7	secretary may, in
1	(3) thir-party auditor
1	applications and supplements:
1	suspending applicability of
1	efficacy supplement, means
4	funds available to
1	combination products 
1	that, on or
1	patients treated with
1	potential drug safety
1	(cc) initial and
1	package. (d)review. 
3	drug listed under
1	(i) the inclusion
1	(j). (3) the
1	collected through september
1	substances notwithstanding any
1	(aa) presents an
1	meat science, or
1	application, (5) knowingly
1	(c) the inherent
1	(2)(a)(vii)(iv), the federal
1	whoever willfully violates
1	assessing the sufficiency
1	(ii) adequate pediatric
3	portion thereof moves
1	regulating traffic therein,
1	thereunder).  (june
3	risk, the secretary
1	require by regulations
1	appearance.  (3)
1	(a) revise the
79	pesticide chemical residue
1	(3) maximum number
1	guidance.  (2)
1	(including a chemically
2	subject to suspension
1	(1) reportnot later
1	701, 52 stat.
1	government organizations related
2	particular expert or
1	promulgation  (1)
1	title, in which
1	importer or manufacturer
1	agriculture, shall establish
2	objective. in furtherance
3	central intelligence agency
1	human services; (ii)
10	behalf of the
1	reports for nonprescription
1	unless extended as
1	developed plans to
1	license, order, rule,
1	states, a controlled
1	undertaking to the
1	making the determinations
1	hearing. in addition
1	dispenser of a
1	drugs) under this
1	ingredients identified, or
1	registered manufacturer for
3	prior to august
1	2011, food testing
2	estimates, and statistics
1	use the criminal
1	u.s.c. 262(a)]; (c)
3	national security act
1	secretary shall distribute,
1	(f).  (d)
1	within such fora,
1	ownership not later
2	products developed by
1	involved (including when
1	instructions for the
1	effective, he shall,
1	of, the international
1	jurisdictions, as contemplated
1	inspection methods and
1	location. (b) regulations
1	producers of tobacco
1	duly authorized official
1	 (2) inapplicability
2	that, on average,
1	country and shall
2	subparagraph if the
1	act, if the
1	(
 
 825.
1	becomes effective, except
1	products; and (ii)
1	decision on such
1	promptly to a
2	activities will be
1	(a) notification; exemption
1	labeling of another
1	exemptsubsection (a) shall
1	form or size;
1	medical product, shall
2	subsection and shall
2	shall proceed expeditiously
1	variety of lifesaving
5	performance standard under
1	revocation of certification
1	forfeiture in accordance
1	periodic testing or
1	health as a
6	fiscal year involved.
1	(a) certification of
1	conditions, including information
8	admission that the
1	(3) the approval
5	marking or labeling
1	
 387d. submission
3	hours after receiving
2	(a) it conforms
1	program evaluation, funding
1	(1)(b), and there
1	provide for procedures
1	supplemented to add
1	fiscal year involved:
1	alter the standard
3	subsection is necessary
1	registrant, and (3)
1	athlete competes (36
1	1263; renumbered 17
1	action in any
1	review; other matters
1	interdict illicit drugs
2	service the applicant
1	(2) waivers 
1	including, where necessary,
1	explanations for any
1	standard or remedy
1	enforcement intelligence and
1	performing functions subject
1	division; (ii) the
1	subdivision requirement under
6	2201 of title
1	principles and characteristics
1	1, such adjustment
1	(3) return of
2	district under this
2	stimulant substances, have
1	safe manufacturing, processing,
5	fees under subparagraph
1	law, the director
1	property through the
1	seq.); (e) the
11	twice that authorized
1	public input by
1	property forfeited, the
1	master files. (f)
1	government submitted after
1	such[1] subsection by
1	federal determination applicable
1	order to an
1	(c) secretarys determination
5	liable as a
3	finding under paragraph
1	gain admission to
1	expired.  (2)
2	harmful to health
1	(j)]; or (ii)
8	agriculture and the
2	device. upon a
2	interests in property
1	study shall include,
6	additional data or
1	formula) is adulterated
1	patient regarding the
1	drug sponsor or
1	(f) limitations 
1	deems appropriate. 
1	records each person
1	label upon, nor
3	(b)(1) or (c)(3)
1	contain substances that
2	information identifying the
25	authorized by section
1	dangers of illegal
3	(2) priority review
1	administration official responsible
4	201 et seq.],
1	regulations may further
1	drug amendments of
1	facility for dispensing
1	senate, and shall
1	thereof which enter
1	(i) phenylpropanolamine, its
1	animal drugs, with
1	atmospheric administration may
1	evaluate any appropriate
1	drugs occurs only
1	violations, of section
6	leaves and extracts
1	preclude the secretary
2	801 et seq.];
1	public information to
2	sponsor does not
1	equipment of any
2	punishment by reason
2	molar dose of
1	diseases; (6) the
1	 (i) released
1	counterfeit product, each
1	
 348. food
1	note); and (3)
11	sale or transportation,
1	(f) records 
2	title (including a
1	states any narcotic
1	section 346a regulations
1	1179. national drug
3	customs and border
1	(i) postapproval studies
2	complete, the secretary
2	(b) within 30
1	product manufacturer relating
17	provide a period
1	title when targeting
1	(a)(4)(a), and other
1	disease or similar
1	modernization act; and
2	made the election
1	(7) the number,
2	administration or by
2	application that 
1	verification activities under
35	applicable to the
1	strategy and make
1	675, 506f, as
2	alternatives to the
2	whether an action
1	(c). such process
1	quality systems standards
1	area, or utilized
1	(c) fishing vessels
1	take final agency
1	address to which
1	(b) minor violations;
3	section 802(41) of
1	(1) facilitate the
1	directed to consumers
1	obtain such certification
3	part, or accessory
1	poultry of their
1	subchapter. (6) all
1	title was disseminated
1	meeting such united
2	national security activities
1	pharmacy services. 
1	273, 6, 37
1	 (1) 15
1	(2) advisory committee
1	(including the tobacco,
2	reasons as the
1	used on the
1	order authorized by
1	time the presence
1	eve-numbered year, a
1	involved; and (4)
1	party; (b) the
1	establish a draft
1	whereof the subpenaed
1	(ii) that may
2	operations, and records
2	right of action
1	reinspection means, with
2	capture through bar
1	amended by section
1	drug action. 
1	(d) the sponsor
1	accreditation, poses a
2	applies, subject to
1	testing to improve
1	advertisement that refers
1	lower than the
1	whether the evidence
1	marijuana, are significantly
1	(3) contract with
1	necessary, shall so
1	(a) action plan
1	use and availability,
1	use or uses,
1	apply such additional
1	serve a copy
1	determines bears such
1	reported or until
1	guidance as part
2	due not later
1	schools, academic medical
1	(i) all property
1	staff, as appropriate,
1	presented pursuant to
1	ingredients, a determination
2	deem the drug
2	opportunity to nominate
1	sponsor or holder.
1	used for its
1	includes generic new
1	atomic energy commission,
5	advisory committee, the
1	(ii) mechanisms for
1	determination. (b) a
1	bringing any civil
1	producers and processors,
1	(14) pethidine. (15)
1	less than $20,000,000,
1	incurred by them
2	expenses (including per
1	7801 of title
1	businessa facility is
12	effect under section
1	marketed under the
1	advantage, or to
5	credible evidence or
1	agricultural commodity (including
1	(3) require that,
1	providers no state
1	complainant makes a
2	written agreement with
1	(2) procedures notwithstanding
2	process described in
1	may include studying
1	advancing efforts to
1	5, on the
3	52 stat. 1046;
1	(h) the provision
2	federal register designating
2	secretary) shall perform
1	(ii) develop additional
1	ch. 675, 569,
2	recommendations if the
1	(l) 3,-methylenedioxypheny--propanone. (m)
1	manufacturer of implant
6	clause (i) of
1	cessation if such
1	reflecting, or scattering
1	animal drug approved
1	containing such data,
21	clause (i) or
2	reasonable grounds therefor,
1	professional and civic
1	reasonable grounds therefor.
2	administrator shall review
1	international drug control
1	(d), the -
2	upon which i
1	infringed. (cc) the
1	work required to
1	beginning one year
5	estimated to be
1	section affects the
1	specified, and in
1	subsequent studies. 
3	possession, or within
1	jurisdiction may require
7	establishment shall be
1	subpenas, and summonses
1	(1)(f), the secretary
1	monographs of the
2	priority voucher under
1	operating reserves, annual
1	following fiscal year.
1	jurisdiction to regulate
2	approved protocol, under
1	explain the determination
1	documentation submitted under
1	food, and (b)
8	procedures for the
2	one suitable antidote,
1	379j51(4) of this
1	permanently stationed in
1	review of prescriptio-drug
1	references to secretary
4	changes made as
1	except that for
1	(b) relating to
1	(8) to encourage
1	present information demonstrating
3	animal drug. 
1	subsection (k) and
1	objection may include
1	appear to his
1	paper format, limit
1	risk. (6) tolerance
1	 (ii) list
1	certain sales subparagraph
1	revocation of approval
1	substantial harm with
3	risk of a
3	fiscal years. the
1	constituent the term
2	 (b) report
1	date (whether weekly
1	direct responsibility for
1	complied with, the
2	may invoke the
1	secretary associated with
1	manufacturers product to
1	time, the locations
2	section or by
1	facility includes any
1	safety; and may
1	equine, that is
2	(b) shall require
2	rigor and effectiveness
5	(1), the secretary,
1	printed document that
1	34 stat. 1265;
1	including procedures, processes,
4	intelligence, the director
2	form, by the
1	(1) critical control
11	included in a
1	dismiss without prejudice
1	title withdrawing approval
1	maintain electronically and
1	midway islands, kingman
1	(a) submission 
1	 (9) licensedthe
1	one year shall
4	that, if an
1	written request and
1	3, 1954, ch.
1	faith effort to
1	condition and in
4	equilibrium of water
2	previously been reviewed
2	oversee the training
1	methods. (3) if
1	future, and (ii)
1	prohibits disclosure to
1	compounding. (3) the
1	generic drug submissions,
1	generic drug submissions.
2	may refer to
1	contracts, management of
4	period within which
9	cosmetic act (21
2	full and complete
2	pending completion of
2	effect a notice
1	body or an
1	additional notice requirements
1	best strategy for
1	times to be
1	returnsnotwithstanding subparagraph (a)(i),
1	ethical or feasible,
3	annual fee for
4	federal benefits for
5	include a process
2	scientific, trade, and
1	requirements, including under
1	item, is a
1	are, as of
2	public comment and
3	case it is
1	(5) collection of
1	360fff2. eligibility determinations;
1	inflicts increasing pain
3	restrictions  (1)
2	articles, whenever the
1	corrections, parole, or
1	compoundingthe drug 
1	material (except for
1	fees from a
5	year preceding the
1	emergency condition, limited
2	records a wholesale
2	inspections shall be
1	year 2016 exceeds
4	(b), or (d)
1	section. under the
1	notification.  (3)
1	response. any challenge
1	v of section
1	office shall 
1	assistant attorney general
1	materials, or equipment
3	qualified in the
3	exception the secretary
1	(b) verification of
1	 (s) savings
1	classes established by
1	decisions and policies
2	stating that a
1	subpart 8 of
1	ensure the consistency
1	practicable study objectives
1	administration to produce
1	requirements and review
1	identifying information about,
3	labeling means all
1	furethidine. (25) hydroxypethidine.
7	public to provide
1	condition if 
1	[21 u.s.c. 853].
1	enter amenable species
3	blood or a
1	hopper truck, rail
1	columbia, any territory
3	notice of termination
1	possible; or (b)
1	directors the deputy
1	revised in response
1	annual reports 
1	(a)(3)(f) shall be
1	employs fewer than
56	shall be sentenced
3	defect; or 
1	 (2) investigate,
5	investigations (other than
1	identical in strength,
2	device, a detailed
1	export under this
1	result in misbranding
10	intelligence of the
1	unless the coalition
1	(mar. 2, 1944,
1	submission shall be
2	one species, or
1	meet the accreditation
1	requirement to exports
1	purposes of judicial
1	labeling and administrative
1	requeststhe director shall
2	state. (2) no
1	30 or less
1	675, 744k, as
1	specific initiatives relating
1	execute the duties
1	track product. a
1	seal.  (

1	objective of significantly
1	licensed distributor or
4	engaged; and while
1	state and any
3	annual reportnot later
1	needed. the secretary
3	advisory committee any
230	new animal drug
2	drug administration (exclusive
1	advisory committee and
1	within its authority
1	alcoholism as well
1	special labeling requirements
3	foreign facilities registered
1	food of concern
1	within six months
1	beyond the jurisdiction
2	serving economically disadvantaged
2	logistics provider, having
1	1974, respectively)) on
1	fees and expenses
1	substances which the
1	outsourcing facility. (3)
1	salts of barbituric
1	provide the permanent
2	packaging act of
20	performance of the
3	used.  (b)
1	with, (1) such
1	requirementsa request for
89	described in section
1	subsection (a): 
1	preventing the manufacture,
1	substances it dispenses,
1	(c). (l) harmonization
1	another country occur
1	shortage.  (h)
1	activities verification activities
1	specific diseases or
1	require measurement and
1	colored glass, roughened
1	order. the appropriate
1	consider hazards that
7	accounting for resources
1	fees all fees
1	(2)(b)(ii) only by
3	collection of the
1	(4) serve as
2	refund a fee
1	rating period, or
1	certificates, permits, credentials,
1	properties, and of
1	courts and the
1	significant advantages over
1	(d) such tobacco
1	(1), to stimulate
1	employment of chinese
2	amount that was
2	offense is committed
1	tracking of individuals
1	societies about any
4	right, title, and
3	labeling or proposed
1	factors may relate
5	violation shall be
1	(2) that on
1	left an establishment
1	matters arising therein,
1	reconstituting, or otherwise
4	title to the
1	petition for de
1	warrant), shall have
1	 (i) because
1	conformance with such
1	(
 
 467c.
7	increase in the
4	debarment of an
1	twenty days unless
1	secretary upon completion
1	clinical medicine and
1	research community. 
2	dose of such
2	currency of such
1	(2) nonprescription drugthe
1	public notifications under
1	chemical by the
1	shipment of meat
1	operations at such
1	serve for the
1	direction of, the
1	tobacco products; (3)
1	made any changes
2	forces of the
1	affairs who is
1	effective, except that
2	review, except that
1	sanitary and other
2	including its territories
1	register each declaration,
1	fiscal year 2017)
1	years of all
2	act and the
13	fiscal year 2017,
1	was, with respect
7	manufacturer of a
1	organizations that threatens
2	(4) or (5),
1	proceeding, his attorney
1	(b) size the
2	lead to limited
2	chapter unless they
1	activities threaten the
1	untrue and the
4	following an informal
1	secretary made a
1	shall enter findings
1	consider such factors
5	general finds that
1	detention greater than
1	good guidance practices
2	specified conditions, to
3	waiver of application
2	reagents, and techniques
2	requirements.  (2)
4	title 5, for
1	exemptions for certain
1	
 1536. communit-based
1	(a) by distributing
1	section any food
1	october 1, 2017,
4	october 1, 2017.
1	records that the
1	attorney general through
3	states from the
3	substances which are
2	ground or floor
3	supply chain, as
1	paragraph may be
1	(b) of nonprofit
1	manufacture or labels
1	(vi) rol-you-own tobacco.
3	unless, within thirty
4	required and permitted
1	experience in dispensing,
1	additionally, the office
1	 (1) evaluating
1	whichever best serves
1	(a) to control
2	result in adulteration
1	facility is removed
1	disparities issued by
2	determine the most
2	attorney generals determination.
1	smoke, smokefree, smok-free,
1	identity promulgated in
1	subparagraph (4), deems
1	reduction activities; (b)
1	use. (f) an
2	article into the
1	secretary if an
1	person may otherwise
1	(a) impleading of
2	federal control of
2	party receives a
2	inspections that meet
1	committee includes the
4	state and other
1	prohibit a facility
1	(4) in any
1	applicant believes to
1	subsection (b)(1)(b) for
2	laboratories accredited by
1	acts on behalf
1	subsection, assign a
1	methods which would
1	capture transaction information
1	use (including the
2	sources of supply
1	combat the production,
1	 (i) demonstrates
1	debarred is able
1	treatment described in
2	exempt from inspection
1	term material threat
1	required by law,
3	product, a dispenser
8	held under insanitary
1	et seq.] referred
1	investigation that is
1	dependence.  (2)
1	factors  (1)
1	ways in which
1	entitled guidance for
1	notified firm distributes
2	user or research
1	implementation of qualifications
1	takes place in
1	submission of progress
1	requirements would have
1	report confirmed losses
1	drug involved. (b)
1	issue contaminan-specific and
1	may be obligated
2	product before the
2	various types of
1	regarding early agreement
1	title shall, subject
1	 (a) requests
1	2012, references a
1	person shall apply
30	secretary may require
1	resale shall treat
1	star-up period may
29	title for a
1	purposes and conditions
1	provide increased federal
1	$10,000,000 for fiscal
2	criminal procedure. 
1	requesting agency and
1	(b) $6,944,000 for
1	using the adverse
1	clinical holds under
3	evaluation under this
1	appropriations, and the
1	age, or relating
1	children, and adolescents.
1	related matters assigned
10	attorney general and
1	commerce (1) in
1	drug application pursuant
1	auditor present; and
1	assessment; (iii) the
1	guidance to such
1	division; (vi) the
1	entry for each
4	program.  (d)
1	licensed pharmacy for
1	targets and goals;
1	made before sentence
1	animal models of
1	distributor provide to
1	relative potential for
2	product (including in
1	review, and regulation
2	information.  (d)
1	(1). (q) petitions
1	fiscal year refers
1	progra-sponsored programs held
1	consumption, be treated,
2	registration of business,
1	(c) a shortage
1	efforts in support
1	(d) articles intended
1	preserved for a
1	limitations to studying
4	department of justice.
1	informal conference, that
1	residues, (b) the
1	1320a7(a) of title
1	eating places no
1	term resubmission means
2	quantities of narcotic
1	system for food
1	department of justice;
1	distributed a list
4	subsection (a), including
1	submissionsas part of
3	well as injury
2	(i) the inactive
3	every 5 years,
1	identifier of a
1	shall contain an
1	recommendations on an
1	council. (
 

1	methadone. (12) methadon-intermediate,
1	device, such as
5	(1), (2), and
4	validating any applicable
1	exposure. (3) detection
1	employees and contractors
3	award a priority
1	administered enterally under
2	reports of which
1	facility, the secretary
1	drug be subject
1	physician; (2) is
1	drug. (2) public
1	including, where relevant
1	2012, in a
2	types of imports,
1	387e of this
4	(3) authorized trading
1	reviewed, all information
1	prevent unauthorized reproduction
1	advertising in carrying
1	
 387f1. enforcement
1	353(b)]. such prescriptions
1	food allergy, and
1	expansion and modernization
3	means any device
1	committee per meeting.
4	notice or findings
1	pharmacys telephone number
1	pathogens; or (2)
2	intention of the
2	interest regarding an
2	section 321(n), 341,
2	approved, the labeling
1	review and analysis
1	matchbooks shall not
1	(h), and (2)
1	may include documentation
1	agent; (ii) in
1	made, into the
1	(c) under any
2	issuing a new
1	inspection warrant shall
1	(ii) as required
1	treasury as a
2	eligible countermeasures that
1	conveyance, or contents
1	(3) provide that
4	function or permanent
2	review at a
1	satisfy postapproval study
1	make inspection of
1	timely advice to,
2	food product under
1	office shall, not
2	nonprescription drugs intended
1	387e(d), or 387e(h)
1	(a) the appropriations
2	met by each
1	demonstrated capability to
1	rent and the
2	dedicated to drug
2	manufacturer or distributor.
1	applied at the
1	drug adequate to
1	ingredients shall not
1	intentional; (b) an
2	2008 and each
1	classified information or
1	plan, or a
1	reaccreditation of persons
1	(d) to a
1	circuit in such
1	residue monitoring program,
1	otherwise modified. such
1	(f) injunctions 
1	(1) because of
1	applies may not
1	data summary. 
1	collecting, reporting, and
1	device applications (as
1	product exports that
7	fiscal year by
2	address, telephone number,
3	commerce, to effectively
1	350d, 355, or
1	 (2) contributions
1	247d7e(e)(1) of title
4	flavoring, artificial coloring,
2	shall vest in
1	harvest.  (u)
3	manufacture, packing, and
1	only, a color
1	laws, except that
1	oil, or cake,
1	prescription drug the
1	suspend the listing
1	(1), the total
10	drug administration a
1	development protocol has
1	 (1) slaughter
1	 (a) on-third
1	excess proceeds if
1	scope of authorizationan
3	applicant submitting the
1	shall complete review
1	individual, or any
4	notice announcing the
1	(a) data management
1	(2) objectives of
1	certification to accompany
1	structure constructed, designated,
1	tobacco warehouse includes
1	shall indicate whether
1	commerce. incidents of
2	information, including the
21	within thirty days
1	identified under subclause
1	drug. (b) a
34	expiration of such
1	trial design, epidemiology,
1	seller meeting the
1	clinical trial, an
1	egg products. (x)
1	means the plant
1	title 7,2 by
1	endpoints, including biomarkers,
1	facility:  (1)
1	reporting programs and
1	specified date after
3	liability of any
1	secretary that there
1	schedule not later
1	may be unsafe
2	slaughter by the
1	effectiveness, and (ii)
1	importer or agent
1	attorney general, bears
1	high psychological dependence.
1	ingredient, the interpretive
1	programs comparable to
1	title.  second.
1	define their respective
1	special controls described
1	issues a proposed
1	821.)
 
 205.
1	authority provided under
3	publish the list
2	supply of food.
2	will enforce state
3	fails to continue
1	device with which
1	refuses to comply
1	title) with an
2	intended conditions of
2	products for the
1	revocation under this
7	agency action subject
4	pharmacist or licensed
1	electronic list of
1	may specify the
1	conduct of research
2	lien against such
1	secretary will address
1	(17) myrophine. (18)
1	grounds that the
3	diagnosis, cure, mitigation,
1	adverse determination by
1	methods and tools
1	checks in a
1	guidance; other provisions
1	publication of recommendations,
4	(b) such person
1	make relevant information
7	criteria specified in
1	softgel, gelcap, or
1	secretary; (d) is
1	remove the property
1	investigational requirement, which
3	united states relating
1	produced in that
1	determination. if the
1	submit a timetable
2	jurisdiction with the
1	intent whatsoever, shall
1	product; (b) a
8	issue a regulation
1	subsection or other
1	section to make
1	iii.  (a)
1	administration, the director
8	judicial review. 
1	384 of this
1	(1) alphaprodine. (2)
2	regulatory requirements which
1	data sources including
1	paragraph (7)(c) with
1	same; (f) information
3	labeling, and advertising
1	drug); (ii) 
1	mentoring coalition shall
1	action for violation
1	preliminary testing. for
1	agents; (2) agents
1	section would result
1	including rights, privileges,
1	drequired to be
1	either in law
2	alleged violation and
1	(b) exploring means
2	20 of this
5	 fiscal year
1	commission established under
1	substance. and before
1	2009, shall, with
1	repealed.  (b)
1	changesfor purposes of
1	product for such
1	(c) offenses involving
1	(1) for 120
1	ensure coordination with
1	sale under another
6	suspect product or
1	office personnel demonstrate
1	adulterated food if
1	issue a small
1	solely or predominantly
1	diminish the rights,
2	projects in coordination
1	adult tobacco users,
1	organizations, pharmaceutical and
1	placement agencies; (ii)
1	academy of physician
1	columbia. (i) the
9	start of each
1	pharmacologically related color
1	shall improve coordination
1	use.  (g)
1	local capacities, and
2	responsible person regarding
1	order to accelerate
1	plasma protein and
1	modify the order
2	shall notify, in
2	secretary provides a
1	abuse. (6) what,
1	drug law enforcement,
1	model number, (iii)
1	statement in paper
1	recommendation on how
1	may be refused
1	daysthe secretary shall
1	drug distributed by
2	will notify the
1	services shall, in
6	 (b) in
2	ingredients in final
1	 (a) radio
2	secure, interoperable electronic
2	sponsors of the
1	death of that
4	section 802(6) of
1	summary and judicial
2	practitioner is not
1	year thereafter, there
1	carcasses contained in
1	determination, the eggs
1	creative services to
1	(b) whenever the
1	approval, and to
1	may, notwithstanding title
1	quality.  (c)
1	submission of, any
1	laboratories that have
2	appropriated for salaries
1	appropriate registration to
1	issue a press
1	objections and, if
1	testing and sanctions
1	meet to be
4	notice of intent
1	container or other
1	traffickers, their organizations,
2	 (ii) additional
1	contract to which
1	(b) exemption 
1	case of medical
1	 (d) agency
2	enforce such order.
10	product to the
1	outbreaks. (b) final
1	
 3432. dietary
1	care services, for
1	(i) has conducted
1	cleared conditions of
5	products regulated by
1	information on persons
1	attorney general. (c)
2	may examine data
1	terms qualification and
7	30 days for
1	found or transacts
1	immediately upon notice
1	limitation the annual
1	title 22. 
1	classification under clause
1	product promotion using
1	formation, or any
1	distribution system) which
1	person (including manufacturers,
1	postmarket safety performance
1	take the form
1	 (a) ensuring
1	addresses such drug.
3	manufacturer or wholesale
1	exemption or approval
1	field investigation. a
1	
 379dd2. activities
1	provider from the
1	product thereof, that
1	graduated sanctions program
1	destroy harmful viable
1	senior than such
9	register an applicant
1	drug applications (a)
1	of, such testing
1	acid)  
1	(i) adverse event
2	tribal affairs, including
1	importers make disclosures
1	evaluate on a
1	stat. 1054.)
 

1	condition. (2) the
1	deficiencies, unless the
1	(38) piritramide. (39)
1	person designated under
3	shall be presented
1	sections.  (ii)
1	exemption will otherwise
1	(b) proposed findings
1	federal inspection of
1	cros-contact of a
1	take to correct
1	terms investigational drug,
1	quotas shall be
1	amounts owed an
1	information disclosure requirements
1	purpose, and that
1	determining compliance with
1	health; or (4)
3	punishable under section
2	provided in an
1	years, the applicable
2	may be suspended
1	(c) shall, if
2	least one use
1	timelines for internal
1	
 113. repealed.
1	prescription. (2) dextromethorphan
1	least 100,000,000 patients
4	shall be awarded
2	drug applications (as
1	subsection (b)(1)(a) and
1	become a final
1	required  (a)
6	drug.  (b)
1	records a shipper,
1	served is displayed
1	chapter would significantly
6	years after fiscal
1	discovers that an
1	control at all
1	facility is operative.
1	change is warranted
1	opium convention of
1	rule; date of
1	tobacco product introduced
1	effective.  (iii)
2	whenever the manufacturer
1	athletic activities recognized
2	concerning any matter
1	penalty, and any
1	agreement with another
1	(ii) the maintenance
1	storage immediately after
2	class of the
1	(b) if he
3	data to the
2	(i) in response
1	renewal grants subject
2	ingredient therein to
1	(a) the identification
1	de novo. (k)
1	following suspension of
1	 (a) -year
2	customer during a
1	narcotics trafficking, are
1	gamma butyrolactone. (y)
1	reliable information. 
1	
 676. violations
1	claimant shall be
1	aware of 
1	upon said manufacturer
2	200,000 persons in
2	states as a
1	seeking such a
1	fluids or internal
1	belief that an
1	sections or subsections
1	varieties of such
2	region of origin
1	extent practicable shall
5	title (as in
2	partial waiver, or
1	phenazocine. (19) piminodine.
1	formula, an infant
1	1161 to 1165.
1	term adequate expertise
3	section 360e(c)(4) of
1	providers or individuals
1	(a) produced in
2	undertake specific tasks
1	need for data
1	specific listed chemical
1	public dissemination and,
1	(a) annual registrationupon
1	reg. 4145341787 (august
2	safety  (1)
1	(o) prompt approval
1	specifying whether and
1	experience in its
1	(a) requirements regarding
1	permitted in connection
1	shall be 3
1	term drug control
1	submitting any report
1	enable the public
1	operations provided for
1	charge, are thereafter
1	extract product; (iii)
2	smoke may present
1	(2) within one
4	 (i) approval
1	includes the combining,
1	records inspection (a)
1	subsection (a)(4)(a)(i) (relating
1	june 26, 1934,
1	determination in accordance
1	named -(-methy--pyrrolidinyl) pyridine
1	actual transaction in
2	be, of the
1	399a. office of
2	disseminated or caused
1	to, controlled substances
1	additive would promote
1	may be feasible
1	report, shall be
1	appropriate agencies may
1	june 30, 2016,
1	subsection (f)) into
4	administrator shall, not
1	eligible countermeasure and
1	regarding a reportable
1	benefits under this
3	(i) the person
1	(ii) a serious
1	disapproving an application
2	courts independent review
1	issuance on consumer
1	subsection agrees to
1	applicant shall document
1	shall state, prominently
3	amounts as are
3	amendment or repeal
1	public about the
1	submitted, by the
1	reviewed under paragraph
14	request for designation
2	date of that
2	packaged for the
1	certification. such notice
1	secretary grants, in
3	consumption of the
1	registrants to submit
1	promote the safety
3	tobacco products on
2	information which contains
1	-mail address. (2)
1	(iii) invite interested
1	360ll(f) of this
2	reviewed by a
1	120 days, the
1	(b) determine whether
1	accreditation system 
3	(4) a drug
1	safety protocols (such
1	cholera, each bottle
1	section only under
1	subsection (a)(2). 
1	et seq.] as
2	preceding introduction of
2	part 208 of
1	drug products or
2	appropriate public health
1	(i) in subparagraphs
1	(5) exemptions the
1	1012, formerly 1011,
2	due diligence; (b)
1	upon request, provide
3	allow the secretary
1	securities, or other
1	374a. inspections relating
1	injury. (2) not
5	drug administration, minutes
1	public comment. if
1	section preempts or
1	services, to any
1	protocol in conducting
9	forth in detail
1	in[3] voluntary qualified
1	product exemption for
1	conduct a retrospective
3	control strategy. 
1	security, develop and
2	(2) guidance contentsin
1	secretary to grant
1	(d) carbon dioxide
1	stat. 1261; renumbered
1	submitted, submitting to
1	farm marketing 
5	finance of the
1	alien, an entity
1	patient or returns)
1	detained article an
1	claimant is unlikely
1	title or exempted
1	food safety criteria
1	request for export
1	warning.  (mar.
1	change in classification,
1	foreign countries. 
1	section 4202 of
2	appropriate, such as
2	30, 1906, ch.
9	mode of action
1	(j) piperidine and
1	characteristics, as applicable;
1	described are prepared;
1	additive, including all
1	strategy; (18) shall
1	warrant shall state
1	additional approval of
1	subjects of final
1	(a) shall thereafter
1	 (7) thir-party
4	drug establishments and
2	considers to demonstrate
1	$1,000,000 for each
1	product covered under
1	killing of an
2	(a)(1), based on
2	 (5) review
1	educational programs, and
7	written notice of
1	section 841(b)(1)(b) of
1	prior such violations,
1	monitoring program to
1	them. (k) the
1	property for the
1	1.5d  
1	serious illness and
1	use by children,
2	 (b) requires,
1	opiat-dependent patients. any
1	longer met; or
1	shall consider which
2	signed and contains
1	waiver is necessary
1	minimum, the name
1	30, 1973, $5,000,000
1	summary as part
2	642 of this
1	established as a
1	thir-party auditors. (b)
2	union and the
1	introduction a designated
1	legislative body solely
1	18; and (2)
1	1403. pesticide analytical
1	differentiate between food
1	partial waiveron the
2	secretary shall enforce
1	take all measures
1	identified patient. such
1	board aircraftit shall
2	posting of communication
2	provide for not
1	regulatory audits. 
1	forth for returns
3	compliance with section
1	adjusted, as the
1	size; trade names,
1	subsection (a)(1)(c); and
1	approval (a) general
1	unless such professional
1	submission for such
3	(2) through (4)
1	(4) permanence of
2	given the circumstances
2	certification to assist
2	eligible establishment means
1	drug distribution problems.
1	(vi) the number
1	will be presented
1	receipts, and records
2	relied on by
1	order on such
1	safeguards against discrimination,
1	chapter is declared
1	9[1] of the
1	activities of international
2	costs thereof, and
1	required to eliminate
4	deems necessary; (ii)
4	(i) necessary studies
1	raw materials, yield
1	(4) standards for
1	postapproval requirements, for
2	1, 1902, ch.
1	partnerships with state
1	crustacean shellfish (e.g.,
2	agencies may designate
1	$25,000 if the
4	shown to conform
2	control of health
1	estimates meet diagnostic
1	commercially marketed and
1	(a), including 
1	(4) any substance
1	262]; (b) 
2	number of abbreviated
1	product constituents, ingredients,
1	714c) for the
5	terms in section
1	tobacco products. (2)
1	ensure that regulatory
3	established under such
1	directly to consumers,
1	853. criminal forfeitures
1	societies in the
1	original foreign supplier,
2	seq.], approval of
1	manufacturer reports to
6	small business means
3	copy all such
1	jurisdiction, a reprogramming
1	(3) if a
1	court enters a
1	secretary at a
1	article; or (5)
1	1605 or 1606
1	imports; denial of
2	year.  (iii)
4	governed by section
1	survivors by virtue
1	requirements, as the
1	defect is not
1	senate, or at
1	
 
 360a.
7	standard under section
2	legal entity organized
1	information, has experience
1	substance abusers and
1	regulations), is required;
1	title, or unless
1	(iii) shall inform
1	distributions of such
1	case which resulted
1	submit with the
1	 (c) domestic
1	paragraph (2). a
1	secretary for accreditation
1	sunscreen orderwith respect
1	periodic evaluation 
2	shall (unless such
2	title compliance with
1	august 18, 1968.
1	higher above the
1	uses, including labeled
1	drug and abbreviated
1	chapter, may, at
1	coordinating such reviews,
1	investigations to meet
1	threatening situation involving
1	(b) is based
1	importation, or distribution;
1	(a)(3) for a
1	memorandum shall contain
3	prohibit the secretary
1	reveal (other than
1	measure. (3) for
1	if, under applicable
1	drug abuse not
1	imported products regulated
1	state law (or
1	valid prescription or
1	therefor because of
1	colors ground in
1	compliance budget or
1	territory and any
2	facility in which
1	market (for example
1	relating to wholesale
1	capsule, solution, or
1	 (6) grant
1	describe the device,
1	inedible means eggs
3	 (i) immediately
28	human services shall
2	august 18, 1968,
2	advisory committee process
1	secretary may inspect
1	(a) improve foodborne
1	tremendous pressures with
2	1, 52 stat.
1	(1), except that
1	maintain sanitary conditions
1	complies with subsection
4	exempt from such
1	organization in breach
1	present less of
1	(4) remote sales
1	rely on inspections
1	assistant administrator of
1	detailing publicly the
1	leaf; (ii) is
1	processors of poultry
1	increasing the amount
1	marketed in that
1	issue means a
1	develop a standardized
1	title except sections
1	including a data
8	provisions of paragraph
2	article, until such
5	condition under section
1	5, the decision
1	wholesale distribution. 
1	applies and publish
2	secretary as the
2	affording an opportunity
1	facilitate the establishment
1	seize or place
1	facility and/or gymnasium
1	recalled human and
1	store shall furnish
2	shall adopt final
1	attorney or agent;
1	(or c-chairpersons) of
1	2002; and (b)
1	mineral (or combination
7	person who owns
1	carriers engaged in
1	proper and efficient
13	introduction or delivery
1	(iv) -(-naphthylmethylene)indene by
1	cannabimimetic agents, or
1	court finds, based
2	appears on a
1	subsection, that 
1	(1) performance report
1	following any period
1	(a) shall meet
2	program.  (2)
1	infant formula test
1	less. the decision
1	parents. (k) other
1	thereof; (b) on
33	officers or employees
1	enhance food safety
1	within such area
1	manufacturer), unless the
1	569b, as added
1	passed under the
1	[15 u.s.c. 45(b)]
1	condensing plants in
2	public health within
1	18. (b)definition. 
1	item is displayed
1	already in effect.
1	proposes, in writing,
2	2013, a wholesale
1	affect  (i)
1	notification; timetables; periodic
5	product.  (c)
1	defendant or any
1	meaning objects used
1	rule shall be
1	tobacco product, not
1	(5) identifies the
1	sentence prohibits submissions
2	 (i) publish
1	record of 
2	hearing, finds that
2	submit comments on
2	revocation of order
1	manufacturing industry. scientific,
2	respect to persons
1	1947.  (e)
2	occurring from abuse
1	humans, the administrator
1	 (g) publication
1	(1) is described
1	without appropriate justification
1	effect.  (5)
1	(bb)first applicant. 
4	applications pending on
1	grounds for such
1	sufficient audits, conducted
1	market within one
1	include farms; restaurants;
1	determination or approval
7	advisory committee act
2	placard, or documents
1	u.s.c. 262(i)). (c)
9	persons engaged in
10	licensure, or clearance
1	means the intended
1	(b) the disposal
1	 (1) metal,
1	processed by him
1	pediatric information in
1	residues regardless of
1	board an aircraft
1	1, 1973) he
1	term significant foreign
1	pediatric information is
1	requirements for being
1	olympic committee are
1	extent. (ii) -(-naphthoyl)indole
2	program agency to
1	issue a certification
1	terminate any institute
1	(bb) at least
1	certification by an
1	guidance) of any
1	clearly suggesting to
1	personal consumption. common
1	 (4) revisions
1	year 2012, $477,000,000.
6	 (a) which
1	grade a pasteurized
4	prescription drug under
1	(a) a practitioner
1	review the entire
2	person) shall submit
1	cause or exacerbate
1	(c) recall authority
1	nov. 2, 1951,
4	lo-acid foods packaged
1	shall head the
2	specific objectives of
1	need for controlling
1	closing statement at
1	contact substance, notify
1	physical, mental, or
1	3, 1996; and
1	stat. 991; apr.
1	transmit in writing
1	funds a local
1	may include, as
2	(i) a summary
1	generalupon application of
1	individual; or (d)
1	judicial or other
1	phenylpropanolamine or any
6	if, directly or
1	planning since july
1	(ii) presents a
1	applies under subsection
1	additional or revised
1	capacity as a
1	received, within the
1	ensure timely review
1	prior transaction going
1	communities.  (b)
1	chapter, or (2)
3	manufacturing, distributing, or
2	 (c) regulations
1	pharmacist, licensed pharmacy,
1	allergy, and any
2	communities throughout the
1	that, not later
1	(1) require dealers
1	accessing health care
1	production and interdiction
1	underweight, overweight, or
1	audit; and (ii)
1	article or made
1	products are condemned
1	use of products
1	authorityif  (a)
2	reactions to drugs
3	secretary within 30
1	separate account which
3	account the nature,
1	description that uses
1	action upon such
2	paragraph (2)(a)(iv) shall
1	including any citation
1	cooperative association, a
1	oral hearing; and
1	675, 422, as
2	product review activities
2	shall ensure 
1	
 106, 107.
1	device not included
1	administer oaths or
3	containing the information
1	report any change
1	upon which good
1	pertaining to online
1	country. (g) notification
1	participants representative of
1	account any investigational
2	 (i) records
1	may, as appropriate
1	foreign country with
1	reinstate the applications
1	positrons and is
2	code portions of
1	court with a
1	make disclosures relating
1	security countermeasures for
1	investigational use or
1	state for regulation;
1	additive). (4) the
1	final rule shall
1	also the making
1	chapter; (5) which
1	commercial use; (b)
3	 (a) one;
12	investigational use of
1	iv; controlled substances
1	specific order. 
2	purposes of coloring
1	may include monitoring
1	(i) contains or
2	purchaser of the
4	fees under paragraphs
1	services may award
1	petition procedure 
3	assessments described in
1	901. severability if
2	issued a letter
3	denies that the
1	chicks (at or
1	oversight of least
1	(d) the availability
1	shall by notice,
1	criminal offense or
1	states pharmacopeia or
1	modified, meets the
1	recognized in whole,
3	process under subsection
1	include all requests
1	standards shall include
3	(a). if the
1	recommended in the
2	scheduling decision or
1	subsection (j)(5)(d)(i)(iv) and
1	multiple recalls or
1	shall be deducted
1	pilot projects that
1	 (aa)in general.
1	applies); and (ii)
1	subparagraph. (e) the
1	compensatory damages to
1	immediate container of
1	store or pharmacy
1	 (1) agree
1	request upon the
1	amphetamine or methamphetamine,
1	modify the applicable
2	(b) authorized personfor
1	order was based,
3	subsection (c) 
1	(c) supplying a
1	recordkeeping the secretary,
1	solely to incorporate
2	use of each
1	pesticidal purpose in
1	(4) substantial evidence
3	if, at the
1	tested or in
2	individual into whose
1	voluntary health associations,
1	condition or similar
1	(b) recordkeeping pursuant
1	necessary to defray
2	drug product application,
2	voting stock or
1	labeling (a) except
1	time period required
3	355(k)(5) of this
1	section 350a, 350c,
1	nominated, and willing
1	shall reconsider the
1	awards  (i)
2	form as read-t-eat
1	terminate such denial
1	adequately support and
1	offenses  (1)
1	guidelines will be
1	
 2203. food
1	codes on the
2	information), transaction history,
1	congress the strategy.
1	review flexibility under
1	twent-one years or
1	security; (c) the
1	
 15. repealed.
1	classification of devices,
2	study reports; and
1	secretary to institute
1	representative and the
4	least one generic
1	expire during the
1	(b) an adverse
2	application contain information
1	feesin establishing the
1	dispense at the
17	shall, with respect
2	following persons shall
1	amendatory of, supplemental
1	 (b) post
1	determines necessary: 
1	communication the secretary
1	additional penalties in
1	use may upon
1	ingredients are included;
1	required:  (a)
1	paragraph (1), or,
1	1996, shall be
1	protocol; (ii) the
1	commodities produced, personnel,
1	effective in diagnosing,
1	amend part 352
1	successor regulations) for
2	women, and the
4	27, 2007, or
1	public the report
1	alternatives to conviction
1	product as soon
1	ingredients are included,
1	drug administration. (m)
1	(c) each report
3	subparagraphs (b) through
1	streamlining, where appropriate,
4	2017, and for
4	value of such
1	(e) notification with
1	use) of a
1	nontopical antibacterial ingredients
1	675, 505d, as
1	subsection is achieving
1	iii. (b) the
1	meeting request or
1	correct any deficiencies
4	submitted for approval
3	path publi-private partnership
1	respecting the product
1	(3) and subsection
2	applicable when such
1	356d. coordination; task
1	(i) such submission
1	provide for more
2	deny clearance to
1	order containing a
1	veterinarian, scientific investigator,
1	law enforcement, treatment,
1	electronic products manufactured
1	programs; and recommendations
1	drugs. (3) elements
2	solely because it
1	meeting or teleconference,
1	schedule for the
1	device may, by
1	discretion to permit
1	cancer, including a
2	access to or
2	title; or (8)
1	342(a)(2)(c)(ii) of this
1	requirements. (2) priorities
1	handling instructions; (viii)
1	exemption, the investigational
1	review the decision
3	3-day period (or
1	payment when due
1	marketing of devices
1	effect of such
1	recent prospective transferee
11	may be prescribed
2	used.  (3)
1	protections set forth
2	38 stat. 818.)

7	lack of a
1	whether to approve
1	title by manufacturing
1	discretion in subparagraph
1	grams of dihydrocodeine
1	through, as appropriate
1	307, 63 stat.
1	term modified risk
5	(i) there is
4	authorized by regulations
2	court (after giving
1	rate of 
6	leaves, except coca
1	facilities and reporting
1	fee by the
1	(f)(2), (n)(3), or
1	understanding.  (b)
2	iv, or vthe
1	neither the exclusion
1	antifungal drug that
1	of, and trends
1	storing a controlled
3	amendments act of
1	paragraph (b) hereof
1	products, in each
1	scientific procedures (or,
1	additive, an article
1	shall sell, transport,
1	display such summary
1	recipient of, the
1	(c) review by
1	shall prescribe which,
5	(3) periodic consultation
1	scientifically necessary, of
1	september 1, 1989.
1	general makes a
3	witnesses who are
1	shall conduct training
1	(b) disseminating information
1	u.s.c. 355) of
1	appropriate, the extent
2	master file is
1	experts the secretary
1	review of, complaints
10	importer or exporter
1	request; (b) the
1	263a] notwithstanding any
1	(2) at the
2	products; (ii) the
4	841(b)(1)(a) of this
1	detailing the progress
8	withdrawing approval of
3	subsections (b), (c),
1	(d) false statements
1	children any tolerance
1	(i);  (2)
1	advanced therapies industry
1	total amount proposed
2	shall agree in
19	department of agriculture
1	law, the requirements
1	(4) a permit
1	(c) pizzas containing
4	drug is to
5	regulations as the
1	administrator shall, to
3	(i) a pesticide
1	lacks sufficient information
1	campaign (referred to
1	manufacturing process to
1	categories:  (i)
1	consumers might not
1	numbers of annual
1	records, and reports
1	dates that are
3	preventive controls to
2	file fee, the
3	may be collected
1	finality of judgment
1	state, is authorized
1	3, corresponds with
1	studies, evidence and
3	within its jurisdiction
1	manner. (ii)qualification.the secretary
1	number is to
1	partnership, trust, association,
1	notwithstanding the requirements
1	upon any lands,
2	burden (as defined
1	product is the
1	smuggling methamphetamine or
2	retailer through the
1	requirement for basic
1	states agent or
1	subsections (b)(2)(a)(iii) or
1	entrythe secretary, in
1	felony by the
1	claims that any
2	patent was issued
2	procedures to withdraw
1	(ii) certify in
2	(1) that are
1	(g) annual reportthe
1	furnish manufacturers of
1	clearly identifying an
2	conditions respecting the
2	subpena. witnesses summoned
1	property forfeited to
1	performance standards, postmarket
1	title, or section
1	(4) disposition the
1	submit such information
2	patent certainty. 
1	(c) a final
1	 (l) new
3	investigational device for
1	subsection (c). (

1	level information, transaction
1	nature and sources
1	investigations. any such
1	(3) do, with
1	preceding sentence a
1	product into interstate
3	annual basis to
1	food processing sector
1	fiscal year, abbreviated
1	including a recommendation
1	675, 744j, as
1	impact of those
1	tools the secretary
1	domestic supplies of
1	appropriate state laboratories,
1	(h) if such
1	shipped stating that
3	act which results
1	contamination of agriculture
1	drug labeling the
1	made, to implement
2	assets of an
2	construction except as
1	(
 
 2241.
1	secretary issues final
2	appoint to the
9	intended to reduce
2	indictment which alleges
2	distributes a listed
1	procedures to dispose
4	levels of the
3	grants  (1)
1	(ii) the following
1	term of life
1	illegal drug traffic
3	number of inspectors
2	administrators, organizers, or
1	psychiatry, and other
1	factorthe small business
1	outside of it;
1	area countries, including
1	
 
 136.
1	purchased outside the
25	may not exceed
2	review thereof, unless
1	data for which
1	establishment or operation
1	year because paragraph
1	tests were conducted);
1	fill the resulting
1	involving a biological,
2	developed under this
1	chapter as if
1	outside any premises
1	substance) or any
1	management plans. 
1	section. (b) for
1	concern to the
1	application.  subject
1	caps) at retail
1	product by its
1	report disclaimers with
1	 (i) procedures
1	thir-party accreditation or
1	importation regulated and
2	wholesale distributor with
2	(2) authority to
1	form, that is
1	secretary add the
1	including assistance with
1	findings or preliminary
1	methylphenidate.  (b)
1	1992, of a
1	controlled substances on
1	sentence shall (a)
2	order) to the
1	chapter. (b) this
1	sales subparagraph (a)
1	stay of an
1	guidance on replication
1	carbon monoxide, use
1	(18) the term
1	(2) initial grants
1	1 year. (3)
27	controlled substances or
2	imported when the
1	representative of not
1	import, and (b)
1	contain such descriptive
1	1920 of title
1	funds for this
1	plan under subsection
2	sanctions imposed under
1	determination.  the
1	31, 1971. 
1	pediatric study under
1	(a) members who
2	continue to do
2	pay  (i)
1	facility. (b) amount
1	labeled for pediatric
1	 (a) rulemaking
1	 (f) dietary
1	generalfor the purpose
1	owns, resides, or
1	(3)(a), the provision
1	title, or, in
1	(b), the board
1	general, it shall
2	recommendation, make a
1	application) or a
1	coordinate activities under
1	year 2013, for
4	extensions, and waivers
1	loss or damage
1	 (ii) disagree
1	available. (i) the
1	millions of citizens
1	section 31301 of
1	2007, publish a
1	situations, as described
1	characteristics of any
1	required studies has
1	acquiring or obtaining
1	emergency use involved.
1	state substance abuse
3	device that has
1	audit; and (iv)
1	forfeitures, shall apply
6	infringement of the
1	(ii) prohibit accessing,
8	official inspection legend
1	may inform national,
1	(c)(1)(b); and (2)
1	
 2205. food
3	activities necessary to
2	imprint, or device,
2	2000, and not
1	progress toward reducing
1	suspended. (2) an
2	supplement to any
1	market unless such
1	protection to safeguard
1	nin-month period, the
1	section 360ll(a) of
1	annual report (a)
1	importer program in
4	data deemed appropriate
1	authority to 
1	estimate by a
2	provided is the
1	provision, but which
1	federal benefits. 
1	(ii) under the
1	customer. for purposes
11	use in a
1	aiding, retarding, or
2	section are no
1	providers about how
1	shall not mean
1	approving such application
2	country engaged in
1	whether a drug
5	place of manufacture
1	additive or an
2	track and make
9	section 142 of
1	assessment means 
1	ingredients are listed
2	conspired to commit,
1	infant formula means
1	establish tolerances for
4	section 356 of
1	bureau of the
3	reduction, and the
1	section prohibits the
1	laws. (
 

1	manufacturer, or exporter
2	(1) establish a
1	2015, a wholesale
2	40 years and
1	(
 
 1033.
1	center. (p) authorization
1	agriculture coordinating councils
1	term official standards
1	person that plays
10	senate a report
2	exposure to a
1	egg whose shell
1	device. (june 25,
2	u.s.c. 3001 et
16	ensure that such
2	significant contribution. (b)
1	restaurants, hotels, and
1	compounds of and
1	range of public
1	paragraph (2),[2] as
1	approved with elements
1	secretary a request
1	(2) on request
2	support its claim
1	(f) training law
1	year 1999, the
10	determination that the
2	shall terminate such
1	services, including appropriate
1	general of any
1	49 stat. 871;
36	bearing or containing
1	practice regulations promulgated
2	exercise the authority
1	appropriated, to remain
1	general within a
1	natural conditions, the
1	registrant to maintain
2	application contains substantial
1	complies with this
1	subparagraph. (ii) more
1	independent establishment in
8	identification of the
2	shall establish panels
1	campaign, the director
2	identity, quality, purity,
1	(a), paragraphs (1)
2	no-racemic drug described
1	application; (iii) information
1	specification of valid
1	documents pertaining to
3	including requirements for
1	hydroxybutyric acid for
1	preserve the confidentiality
1	risk products enable
2	clause (b), the
1	barbituric acid. (2)
2	prescribe: (1) the
1	approved racemic drug,
2	drug sponsor means
1	(c) restrictions notwithstanding
1	sentence requires more
1	also shall take
1	(i) requirement to
2	use if the
1	559, 3, 68
1	457. labeling and
2	shall perform, as
1	solely by selective
2	control program means
1	(directly or as
1	subsequent to any
4	food may have
1	modified in order
1	registration has not
1	incorporation of more
1	title, and includes
1	shall designate 1
2	(including the amendments
1	inspections at device
1	 (e) te-year
1	product is labeled
1	  phosphorus
1	shortage, as determined
1	distributor with a
1	food; regulations any
1	effectuated through a
1	certifications are sel-certifications
1	eggs, eggs showing
1	tobacco growers, tobacco
1	approved application and
3	must be in
10	fees authorized by
2	 (2) action
4	investigation that the
7	1254 of title
1	account (among other
1	authority, a requirement
1	create an agency
1	made, except that
1	residue of an
1	sheep carcasses, parts
1	subclause (iii), and
1	withdrawn after a
1	term fair packaging
1	loss of or
1	 (2) four
1	licensed veterinarian, shall
2	supplemental application is
6	shall designate a
2	assessed (plus interest
1	fully remedy the
1	(iv) the inspection
1	liable in such
1	conformity with exemption
1	affirm or withdraw
1	2 years, a
3	reasonable steps to
2	limitation the amount
6	(ii) the date
1	equal to five
1	violation. (3) any
1	supplemental application if
4	(ii) the data
1	unreasonable risk was
1	considered a reprocessed
1	 (8) investigational
1	contract manufacturers, academic
1	cosmetics which are
1	brand of a
1	obtain such consent
13	paid by the
1	years, shall be
6	treatment or detoxification
2	used by that
1	u.s.c. 101 et
2	regulate official plants
1	however, any state
1	fields of science
1	caring for such
1	implement any aspect
1	title. (r) the
1	racemic drug approved
1	violation occurred, or
1	regulation include an
1	eligible coalition awarded
1	hearing to adjudicate
1	good cause under
1	inspectors to a
1	site or phone
1	orders issued following
1	proposed standard on
2	(a)(5)).  (3)
1	pharmacy benefit managers
1	review, if requested
3	possession with intent
1	auditor may not
1	invalidating the notice
1	ingredient for a
1	persons name and
1	property for forfeiture,
1	investigation of food
1	discovery prior to
6	congress with respect
1	commission. the commission
1	subset of user
1	u.s.c. 262(a)] may
1	seized, if any.
4	drug application means
1	paragraph, a drug
1	shall be modified
1	20 days prescribed
1	history the term
1	supplement containing the
1	sell, furnish, or
2	verify a record,
1	drug.  (june
1	rate of increase
1	control programs in
1	seeks approval under
2	blank in accordance
1	submitter, unless the
3	consultation nothing in
1	subchapter the person
1	available.  (2)
1	meeting such goals.
1	property for forfeiture.
2	assurances that such
1	stating his purpose
1	privileges, interests, claims,
1	court may find
1	subsection. (c) time
1	18 (relating to
4	expedited development and
1	prohibit  (a)
1	exemptions granted by
1	process of continuous
1	whether a food
1	(b) adequate information
1	remove any substance
2	(i) appropriate conditions
3	award grants to
2	made in such
1	personnel; privacy protections
1	acceptable by the
1	repealed. nov. 2,
1	either electronic or
1	(b) a drug,
1	commercial loss or
1	(a)authorized fees of
1	new drug applications.
1	contracts.  (

1	facility will not
1	abuse is a
3	shall award a
1	decision is not
1	(a) process for
3	secretary shall vacate
1	including data from
3	may extend the
1	claimant in an
22	holder of an
1	imposition of sanctions
1	funds, be made
1	alert about potential
1	(d).  (3)
2	grounds unless the
2	coordinator shall visit
1	whether alone or
2	paragraph (2)(a)(vii)(iv) and
1	investigational requirement shall
2	general.  (f)
1	registered, except with
3	review and action
3	deadly or dangerous
1	permit the submission
2	later than 150
9	controlled substance and
1	state from the
2	individual basis) of
1	fresh milk from
1	records for the
1	(b); and (b)
2	drug is in
4	(d) reauthorization 
1	use is, or
1	ship as aforesaid
1	imports foods, the
2	title).  (d)
2	(a) as part
1	prior conviction or
1	inspection report in
18	costs of the
2	standard under subsection
1	unit, the dosage
1	make information collected
1	harmful, and the
1	except that, of
1	availability, which assessment
2	personnel means inspection
1	due each fiscal
1	days have passed
1	focused national media
1	public, industry, and
1	compel testimony or
1	individual to be
1	enforcement provisions (a)
1	laboratory means a
1	barriers at federal,
5	periodic reports to
1	 (3) schoolthe
1	 (1) methods,
1	training, drug treatment,
1	semiannual basis, submit
1	considered convicted of
1	practices that are
1	section to investigational
1	387j. application for
1	investigations or prosecutions
1	necessary additional review
13	animal drug and
1	including at critical
1	tobacco products; (6)
1	(
 
 1706.
1	(f) that the
31	united states shall
1	experience of the
1	regular place of
1	ii the attorney
1	users occurs for
1	collected in previous
2	alter the primary
1	may propose electronic
1	finalized to implement
7	person accredited under
2	failure to establish
1	tobacco  (1)
1	subsection (a)(2). (e)
1	importers, packers, distributors,
1	control program designed
1	describe in detail
1	children from aggregate
19	approved under this
1	upon to approve
2	product on such
1	motion, (2) at
1	(6) dimethyltryptamine. (7)
1	board, rough, or
1	level of marijuana
1	questions to a
1	24, 1919, ch.
1	product and to
1	(i) shall review
1	duplicate thereof on
1	food safety requirements.
1	section 829(e) of
23	described in the
1	considering the reports,
1	subchapter if (1)
1	response, the person
1	 (b) misbranding
1	presence, or (b)
2	otherwise would be
1	force resources are
1	regulatory action in
1	enactment date in
1	ch. 675, 402,
1	stat. 1235; renumbered
9	shall, upon request
1	submit a detailed,
1	to, among other
1	(10) youth the
1	1930[3] (19 u.s.c.
1	needs.  (2)
3	drug contained in
1	initial meeting 
1	(ii).  (e)
1	chemical and material
1	(including, if applicable,
1	 (a) inflation
1	number of doses
1	leaker means an
1	section 360c(g) of
1	(ii) a locality;
1	countries which are
1	(2) bases for
1	detained. any person
18	united states government
1	unavoidability of the
1	1 and fewer
1	appropriate. (c) definitions
6	section  (i)
1	(2) any recommendations
1	 (1) undertake
1	unless an order
1	[21 u.s.c. 355a],
1	law. (c) scope
2	importers  (1)
1	approval.a device which
1	establish collaborations with
1	said person is
1	trac-an-trace or authentication
1	localities, among the
1	biotechnology industries. 
1	articles may be
1	annual recertification by
1	notice of that
3	1984, and if
1	party the right
4	sale as the
1	subsection (a)(1)(c) by
1	negative impact on
11	formerly act july
1	milk, when used
2	controls would provide
1	current food and
2	2013 may be
1	community. (
 

11	import or export
1	patient named in
1	applicable, the responsible
2	 (b) enforcement
1	period. (31) the
1	amount. (4) the
1	secretary, a tolerance
1	objections is taken
1	ch. 675, 537,
1	(2) drug abuse
1	inspection services in
1	 (h) civil
1	package containing such
1	secretary responded to
1	annual chartering and
1	control or eradication
1	classification.  (c)
1	(ii) crediting of
1	knowing or with
1	secretary demonstrating that
1	manufacturer may continue
3	approved abbreviated applications.
1	subparagraph (a)) that
2	armed forces of
2	title; (3) training
3	assistance and training
1	final decision from
1	consent from the
1	(d) develop a
1	controlled substance if
1	(2) and identified
2	832833) (commonly known
1	(a) is composed
1	times the committee
1	524, as added
1	shortage of raw
1	outsourcing facility for
1	clause (i). (vi)
1	writing regarding any
1	person solely within
1	judge and establishing
1	shortage  (1)
1	officialsif feasible, in
1	laws; planning, technical
1	process, as the
12	limitation to such
1	investigational purposes and
2	informal hearing, shall
1	statement. (2) the
14	maintenance, and repair
1	name upon a
4	(2) the provisions
1	laboratory services throughout
5	social security act
7	may petition the
1	differ substantially from
1	person charged and
1	supplying of the
4	renewal grant to
1	substance abuse has
1	(j) training and
2	potential for waste,
1	availability of law
1	recruit meeting participants
1	court, upon the
5	of, such records
8	determined under paragraph
1	residues, data on
1	pharmacist, or licensed
1	title, or prohibited
1	shall deliver the
1	various ports of
2	basis that such
1	
 22. barrels
1	manufacturers current rate
1	(i) any generic
1	petition that the
2	determining whether such
2	prescription drugs, nonprescription
3	exhausted, (c) if
1	appropriate panel or
1	(a)(4) is paid
1	determines that adequate
2	information when presenting
3	nitrogen atom of
1	tobacco product which,
1	(c) other circumstances
1	title, and (c)
1	trials, trial enrollment,
3	drug to which
1	regulations prohibiting or
1	person is licensed
1	drugs. (30) the
2	commissioner shall, not
1	assistance), or establish
3	therefrom; or if
3	recognized in the
1	request (with or
1	subsection (a) from
1	occupying a position
1	5 years, of
1	emergency situations except
6	within one hundred
1	(2) executive order
1	area or enclosure
1	respecting a debarment
1	describing in detail
2	5 years, or
1	goalimprove agriculture and
2	(b) only labeling
1	safety commitments to
1	title. (b) petition
1	title; (e) on
2	clinical investigation of
1	importer is required
1	director may provide
1	judicial review, except
1	surveys of illicit
1	federal laws and
1	safrole. (r) piperonal.
1	subject at the
2	(a) and (b).
1	product, consistent with
3	drugs that is
8	distributors of record
1	meetings. (5) panel
1	subparagraph for all
1	intention of controlling
1	status of, and
1	quality, or reasonable
1	27, 2007, agrees
1	patient for any
1	board for such
1	include the right
1	authorizations of appropriations
1	facility. (iv) the
2	device from a
1	providers, and shall
1	contain an assurance
1	present the observations
2	constitute a violation
2	compliance of the
1	makes such determination.
3	date the order
4	safe, the secretary
1	facility because such
1	field trips, befor-
1	initiative  (1)
1	675, 406, 52
1	regulatory agencies with
1	pose no additional
1	chemicals.  (3)
1	maintain their stability,
1	(a) assign a
1	supply of, and
1	(i) subsection (c)
1	defendant was the
1	established distribution, procurement,
1	change in accordance
2	drugs, nonprescription drugs
1	response network laboratories,
1	general principles that
1	controls for appointments
1	labeling of which
5	clinical trials and
5	product under one
1	informal hearing and
1	give each small
1	term subsidiary means
1	property right shall
1	tag permanently affixed
1	manufacturer, of each
1	necessary of eggs
1	cream, or both,
1	drug that, by
1	regulation establishing or
1	30 years, fined
2	person, and shall
1	(1) generic drug
1	imposed, be imprisoned
1	analysis.  (vi)
1	title; (2) for
1	device is required
1	chapter to meet
1	therapies manufacturers and
1	tobacco dependence products
1	priorities, and objectives
1	(a) and carries
2	reporting requirement 
1	party to any
1	675, 516, as
1	title), and industry,
1	demonstrates that all
2	list such devices
1	 (15) shall
1	advertisement review feesbeginning
2	uniformity among the
1	consumption for medical,
2	principle or principles
1	equal to 1.6
1	clause (i) that
1	countermeasures referred to
1	title, the performance
1	zoonotic diseases; (4)
1	additional articles that
1	(
 
 856.
1	revoke a variance
1	effects; and (ix)
1	675, 503a, as
2	(as defined under
1	(1) against 
1	delay in approval
3	 (i) during
1	report regarding when
1	contents of noticeat
1	(e) review any
1	tool qualified under
2	contract, or cooperative
1	undergone training provided
1	(c) state meat
1	nothing in subparagraph
1	conditionsany extension of
2	administration responsible for
1	standards development organization.
2	agent of any
1	official compendium (and
1	find necessary, together
1	
 2104. state
45	protection of the
2	limitation  (a)
1	drugs; and (v)
1	substance, increase the
1	standards development organization;
1	states) with respect
2	necessary to promptly
1	secretarys findings with
1	(ii) transfer after
1	 (b) jurisdictionthere
1	manufacturer, and in
1	countermeasure applications and
3	sponsor fee published
1	(e), the attorney
1	authorized and encouraged
1	deducted from the
1	collected in each
2	illness outbreak that
1	general amounts made
3	additive) which may,
1	compensation the members
1	agreed upon between
1	limitation a tobacco
1	(b) emergency situationsin
24	term in section
2	adequate state program
1	combination contains more
1	considered for priority
6	subsection (d) of
1	abstinence in chronic
1	limit  (i)
1	revising any guidance
4	exercise of due
2	prescribe the procedures
1	list i chemicalsthe
4	(1) or (2),
1	
 
 360ddd2.
1	court would have
1	$45,600,000,000 to $64,000,000,000;
2	552(a)(4)(a) of title
1	finished medical devices
1	authorization. a new
1	disproportionate use of
1	age, except upon
1	amount of certain
1	standards consistent with
1	(1) the progress
2	(6) the remedies
1	6(b) of the
1	entity never assumes
1	witnesses; evidence; production
1	inspect such facility
1	listing the signs
1	foundations, and other
1	22).  (d)
6	capacity of the
1	involving dispensing of
1	petition; and (c)
1	effective approval until
7	device user facility
6	unreasonable risk to
2	devices under the
9	accepted by the
1	mean expanding the
1	(except when used
1	745, formerly 741,
1	application is substantial,
1	denied accreditation, were
1	submitting the report.
1	granted in paragraph
1	secretary. to be
1	electronic product for
2	section 360j(m) of
1	year (or, with
1	corporation; (2) solely
1	application. (ii) not
2	violation that is
1	of, or for
3	conformity with, a
1	current production of
1	shall (with respect
1	distributor or any
1	november 3, 1966
1	 (e) compliance
1	cause or unless
15	information submitted in
1	(2) limitation except
2	federal government or
1	egg means the
1	examine whether incentives
1	influenced the safety
1	compiler of official
1	improve the administration
2	device be classified
1	(1) and (4)
2	experts employed by
1	public interest. a
1	enterprise which is
1	simulations (a) devices
1	chemical, shall obtain
1	379j61. definitionsin this
2	facilities that are
1	trafficking areas with
1	samples of seized
1	clearance shall be
2	830(b)(3) of this
1	equivalent.  (3)
3	purpose of avoiding
1	publicly available; and
1	review; or (2)
1	identification of scientific
1	amend the final
1	resulting from this
1	pharmacy offers to
8	activities necessary for
1	enforcement strategies and
1	360j(m), or 360bbb3
1	(c) memorandum of
1	assure the establishment
1	farms, including the
1	disease, and their
2	(a), any person
1	system or its
3	proposed drug control
1	second country under
1	provided the distributor
1	person with an
6	states or the
1	dates by which
1	event of intentional
3	dietary exposure to
1	regulation promulgated pursuant
1	provisions to part
1	confidential information maintained
1	5, 37 stat.
2	(i) such sponsor
1	parts thereof solely
2	information, that such
1	adulteration (a) determinations
1	used for bottled
1	
 335. hearing
1	termination of debarments.
1	country or the
1	(5) the establishment
1	december 31, the
2	human services, may
1	(6) direct or
3	product application; and
1	(i) an order
1	means the strategy
1	(2) the known
1	national uniformity for
1	amenable species were
1	(a) notwithstanding paragraph
1	rule on a
2	(ii) based on
1	otherwise applicable under
3	shall make public
1	properly labeled on
1	upon publication unless
1	(3) contact information
1	2012, as adjusted
1	compliance or enforcement
1	(relating to viruses,
2	responsible for postapproval
1	predictability, the development,
2	subsection (a)(2)(a) for
2	reserves, the adjustment
1	states, so long
1	director believes such
1	device with a
1	product, (b) production,
1	holder provides the
1	violations under applicable
23	tobacco product standard
2	register not later
8	hearing before the
5	denying approval specified
1	commerce consistent with
5	meeting the requirements
1	persons so notified.
1	secretary to support
2	persons ability to
2	institute of medicine,
1	evidence concerning 
4	portal established under
1	concerning the killing
1	application has the
5	nonnarcotic ingredients in
1	authorities or laws.
1	retailer means any
6	person in charge
6	advisory committee to
1	process for a
2	advertisements and other
1	final rule 
4	(ii) or (iii)
1	retailer to maintain
1	campaign, except advertisements
8	prepared, propagated, compounded,
1	condition means (1)
1	(1) or (2).
1	 (a) prioritize
1	provision of a
3	petition praying that
1	species; and (b)
1	standard review 
1	proof that a
1	penalty for subsequent
1	list filed by
1	exceed the percentage
1	agency (such as
2	chain against counterfeit,
1	substance classified in
1	absence of prior
2	selected from the
1	tracking or tracing
1	used in fiscal
1	container.  (e)
1	milk being offered
1	commerce.  (

3	appoint as members
3	constitutes an admission
1	(g) of section
1	use and may
1	demonstration programs funded
2	addict and submits
1	manufacture, pr-production design
1	rape or sexual
1	seeks an i-person
1	compensation of advisory
1	users is reasonably
1	device.  (d)
1	(ii) mineral, or
1	deem necessary for
1	(e), the administrator
1	abuse, use among
5	accredited person, and
1	issuing the draft
1	review fee. (e)
1	large meat spots,
3	program.  (c)
1	tobacco leaf who
2	grown tobacco; and
1	subjects, that the
3	amendments of 2012
1	order to become
1	congressional committeesthe congressional
1	(o) consumer right
1	term accredited thir-party
1	along with any
1	 (3) temporary
1	following penalties: (1)
1	(3) prescription drugthe
1	(b) validation data,
1	general) or regulated
1	(34) or (35)
1	distributors of the
1	oral order promptly
3	secretary shall consider,
1	(iii) rapidly removing,
1	emergency pursuant to
2	(c) the name
1	agent; or (2)
1	treaties relating to
1	faith for the
1	which, effective upon
1	resubmissions may be
1	making widely available,
1	involved is adulterated
1	(i) includes full
1	(b) recordkeeping requirements;
1	shor-term goals. 
1	appointed to staggered
1	conduct additional investigations
1	representative shall recommend
1	invalid, the validity
1	youth workers, and
4	applicable requirement under
1	term premarket notification
1	unless the data
1	shall include employees
1	(d) projections of
3	public disclosure of
1	limitation each animal
1	2010, this chapter
4	general regulation, or
1	 (h) public
1	2017. (g) effect
1	203, as added
1	establishments any officer
5	advocacy groups to
1	acts of manufacture
1	testing resources for
2	shall not operate
1	termination of a
1	register announcing such
1	employment. (3) an
4	determined under the
3	antibacterial ingredient or
1	form or size
1	1.227 of chapter[3]
1	qualified and distinguished
1	qualified entity. the
1	(i) each state
1	duplicative testing of
1	over, the continuing
1	use in connection
1	(iii) involving senior
1	validation data. (june
1	prescription; and (d)
1	antimicrobial drugs, where
2	pending request. 
1	transaction statements required
2	device, a proposed
1	1997), none of
10	year and the
1	360bbb6. risk communication
3	definitionsin this section
1	data) for approving
1	using expedited procedures
1	prescription in accordance
2	exemptions for pesticide
1	grants or contracts.
6	drug to be
2	prescriptions of practitioners
1	coordinated and cos-effective
6	advance in a
1	(e);  (2)
1	third party confidentially
1	secretary shall select
1	sooner.  (4)
1	(3) effective period
1	district courts and
1	license virus, serum,
1	(d) the introduction
2	display (in a
1	use in animals
1	restaurant which uses
2	committees and organizations
1	requirement; training of
1	documents in accordance
1	product has left
2	colorings may, when
1	experience, or are
2	purchase, sell, or
1	systems specified under
3	institution of proceedings
1	(ii) published by
1	309..  (d)
1	law restricts this
1	across, where appropriate,
3	recipient and an
1	(a) $693,099,000; (b)
1	slaughtering or packing
1	publish such on-page
1	immune from civil
1	renderer, or engages
1	substances at wholesale
2	subsection (b)(3) is
2	shall such adjustment
1	procedures which he
3	drug product in
1	
 204. issuance
1	banning all cigarettes,
2	subparagraph has expired;
1	penalty if such
1	reinspection of an
1	subchapter to the
1	audits to establish
1	product syringes) shall
2	subsection (b)(3) if
1	surveillance, patient registries,
8	drug product is
1	subchapter. the fees
1	investigators for clinical
1	entities to develop
1	mentors for persons
10	355(j)(5)(a) of this
2	are, in accordance
1	support the growth
3	records, reports, or
1	reasons underlying such
3	authority provided by
1	indicates otherwise, the
1	disclosed, except that
1	offense as provided
1	state cooperation in
2	(including information from
2	nonprofit institutions. 
1	use were not
2	accepted or refused
1	deliberately adulterated, the
1	term nonprescription drug
2	training programs on
1	use that are
1	event surveillance using
1	agency.  (8)
1	harmfulness, if the
8	written or oral
2	list under section
5	every person in
1	(including paper and
1	(iv) to identify
5	upon the effective
1	evidence.  (4)
1	$249,000,000 shall be
1	vitamins and minerals
1	title to any
1	adopt appropriate changes
1	consignee seeking to
1	secretarys initiative the
1	soliciting 2 nominees
3	(a), based on
1	title; (c) feedback
1	renewal process for
2	marketing submitted under
3	(iii) developing and
1	(b) be accompanied
1	participate in partnership
2	may be granted
1	approved, it shall
1	available for federal,
1	made personally upon
1	agents to help
1	dissemination shall, except
1	recalled pet foods,
5	chapter. (
 

1	falls below $9,000,000,
3	prescribe the terms
1	lease, profit from,
2	exceeding the applicable
2	written response provided
1	owing to such
1	prohibition of subchapter
3	title) and by
2	manufacture, or utilization
1	administrator, within a
1	(mg) 80.0 
1	5 to proposed
1	risk, and signal
1	information alleging such
1	affect interstate or
1	verification or in
1	take final action
1	subsection (o)(3). (d)
2	include provisions for
1	schedule iv. (b)
1	981(b) of title
1	penalty in the
2	quantity of (i)
2	proceeding other than
1	(e) regulations and
1	certifying board recognized
1	united states was
10	department of agriculture,
1	department of agriculture.
1	(b) contain such
1	department of agriculture)
1	case of nonconsumer
1	identical to a
1	applicable pilot projects
1	classified under such
1	title 15, except
1	among youth are
1	practices to be
1	recommendation which he
2	1 year. 
1	
 347a. congressional
2	department of agriculture;
2	display, at the
2	title, a request
3	response on all
1	states as required
2	inspect eggs or
1	enforcement intelligence information
1	companies to reimburse
3	shall ensure the
1	information which will
1	update referred to
1	rapid detection, and
2	prescription drug at
1	 section 262(a)
1	shall place a
1	use as paints,
1	methods by the
1	experts for purposes
1	protect information described
1	show cause shall
1	testing, inspections and
1	technologies, and devices;
1	additional exemptions from
1	outside entities to
1	mixture intended to
2	paragraphs (1)(a) and
1	beginning 48 months
1	implementing preventive controls,
1	both. (b) if
1	 (8) unexpected
1	together are sufficient
1	(b) comply with
1	diverted for possible
1	committee (a) establishment
3	public notice of
2	petition within 180
1	(3).  (iii)
1	
 861. employment
2	drug use (including
1	located, to the
1	program demonstrates that
1	title i, 19,
4	product standard is
1	(8) encourage the
3	period or other
1	(4) application of
2	product standard in
2	unless the panel
1	officials (a) trainingthe
3	reserve fee shall
1	foreign facility registered
1	1701 of this
1	animal accompanying him,
1	identify individuals. all
1	control over international
4	device or any
7	shall be final,
1	discussion and regulatory
3	food, if any
1	address the emerging
1	registration  (a)
1	coordinating committee on
1	decision, including a
1	formulas shall be
2	review and revocation
4	requirement under subsection
2	use of all
4	illegitimate product of
2	submission of views,
3	reports, and provide
1	intervention  (a)
1	board, acting through
1	information, may be
1	evidence under 
1	inspectors, after said
1	continue to exist,
1	v. reilly (533
6	recall or for
1	wholesale distribution shall
1	parts have generally
1	(ii) patients who
3	exceed twenty days,
1	(f) a written
1	items; u.s. city
1	appropriate prominence on
2	final judgment, as
1	 (4) publication
1	1973) he has
1	activities the secretary
1	360bbb4a. priority review
1	teens who have
4	expiration of two
1	(5) vessel for
1	application notice and
1	retailer who distributes
2	intentionally tortious conduct
1	person to 
2	section 607 of
1	producers for delivery
2	requirement under paragraph
1	manufacturing supplements submitted
1	becoming effective pursuant
1	(ii) a brand
1	chapter:  (i)
1	drug, elect to
1	studies should be
1	tracking pediatric studies
4	shall include as
1	information. any regulation
1	(2) as soon
4	held. the article
1	law. (d) statutory
1	percentages of children
1	establishment, or (iii)
1	amount specified, and
1	5; (5) accept
1	determine, and the
1	subsection shall exempt
1	drugs. (2) for
2	act giving rise
6	shall include an
1	committee) or other
1	goals of ensuring
13	secretary, acting through
1	report has not
1	(ii) had actual
1	misleading promotional materials
1	substance, (2) contrary
1	reduction of a
1	information. if no
1	use other emergency
2	registration of foreign
4	manufacturer or packer
1	regulated components (such
2	 (b) payment
2	identificationthe secretary shall
1	effect regulations pursuant
1	section 823(a) of
1	commingled with other
1	both. (2) the
13	9, 2012, the
1	obtained an experimental
2	will not interfere
1	(i) approving another
1	device)  (a)
1	characterize and report
1	countermeasures, the secretary
1	compared with marketed
2	establishment, and a
2	may, when authorized
2	approval supplement for
1	countries shall specify
1	offenses and punishment
1	$2,000,000 for a
4	animals, which are
3	administrator  (i)
1	employing all powers
1	duration, an order
2	person under section
2	labeler code and
1	treatment, be considered
1	section 170.3 of
2	food as a
1	drug advertising; and
1	notification submission, a
3	geographic location or
1	 (k) sunsetthe
1	new drugs because
1	submission to reference
2	estimated total cost
1	determinative of control
1	(e) hearing after
1	advisory committees at
1	restaurants; other retail
1	auditor to the
1	882. injunctions (a)
1	obtained any sample
2	concurrent jurisdiction over
1	instituted before january
1	panel (a) establishment
1	substantially equivalent. 
2	importers of such
1	term active pharmaceutical
1	section 4706 of
1	(b) matters to
1	(a) any responsible
1	501, 52 stat.
1	transaction, the wholesale
2	november 21, 1997).
1	amount agreed upon
1	2003, the secretary
1	use review flexibility
1	 (1) hazards
1	drug, subject to
1	iodine (g) 5.0
1	applicationsthe following persons
3	every 5 years
5	chemical may be
1	implement subsection (a)
2	shall require such
1	general shall administer
1	notice, and (ii)
2	comment period on
1	warranted.  (c)
1	establish shor-range and
1	require bioequivalency data
2	followed by the
1	senate  (1)
3	comment period of
1	modified risk and
2	submission of patent
7	constitute final agency
1	2, 37 stat.
1	approved shall be
1	order included by
3	registrant to distribute
4	certification is invalid
2	psychological dependence relative
1	unless the court
1	dispensers; (ii) the
1	 (iii) annual
1	conduct or engage
1	compounded and copies
3	scientific review groups
1	schedule notice) that
1	government internet web
2	classroom situations, seminars
2	(h) of this
1	demonstrable difficulties described
1	consultant for, the
1	later than ninety
1	employed intermittently. 
1	transferees, and such
1	
 351. adulterated
1	-[-(ethylthio-2,-dimethoxyphenyl]ethanamine (2ct2). (25)
1	final, or commits
3	(as described in
2	program under the
1	concerning preventive strategies.
1	(ii) whether a
2	law.  (f)
1	security and governmental
1	recall authority (a)
1	arise in a
1	containers of fresh
1	(4) recommending methods
2	food additive involved,
1	(i) prepare an
1	services. (e) extensions
1	reaccredited.  (3)
8	section 830 of
1	title or requirement
1	expertise in a
1	grants. each application
1	order, with the
3	section 360m of
1	(1) develop a
1	drug treatment program
2	reasonably supports the
1	(1) technical achievability
1	countermeasures, as applicable
1	fluid carrier and
1	involved upon the
1	certificate no clearance
1	 (a)authorized fees
1	(6), section 351(a)(3),
1	also, to the
1	decomposed substance. 
3	term drug has
1	(b), and shall
1	registrant conducts business,
2	registration should not
1	request transmitted under
1	networks of communication,
1	upon commerce, of
1	modify agency guidance
1	accordance with current
1	(d) reimportation 
1	material extent and
2	(g), and (h)
1	seq.), the secretary
1	within each high
1	office to ensure
1	services. (june 25,
1	(4) national interdiction
1	387t of this
1	infant formula. 
1	ch. 675, 586g,
1	(h).  (k)
2	eligible for extension
1	(e) declaratory and
2	purpose of ascertaining
1	legible form on
1	organization or individual
1	 (3) disclosure
1	pertinent information concerning
1	rehabilitation research and
1	original application. 
1	taking of depositions
1	entity demonstrates to
26	resources allocated for
1	action:  (a)
1	drug establishment for
1	specific business systems
1	scale and duration
1	demonstrations required under
1	annual public report,
1	causing chemicals than
1	shall select the
3	fee has not
3	bearing any counterfeit,
1	sample requested, the
1	consider international efforts,
1	(b). (2) frameworknot
1	initial schedules of
1	expertise in womens
1	section for judicial
1	number, type, and
1	review conclusions. (v)
2	paso intelligence center
1	commingling of food.
1	manufacture or production
1	predicate device contains
1	authority in connection
1	format in which
1	committees each panel
1	(a). (3) volum-based
1	order, from a
8	refund 75 percent
1	institution, to the
1	lower economic productivity.
4	products and other
1	(d) information technology
1	center; or (iii)
2	manufacture, that is
1	 (a) animal
1	1702(a) of this
2	strength differ from
1	application under clause
1	term inspection means
1	taken in support
1	history of anaphylaxis;
1	food of communicable
3	state to transmit
2	political subdivision may
1	(b) the regulations
2	identify a level
8	(d) if the
1	egg means an
1	ability to safeguard
12	secretary, permit such
1	compounding, packaging, or
2	convene and consult
177	health and human
1	campaign; (6) specific
1	manufacturer, except as
1	stakeholders, including 
1	recall an article
2	disclosed by such
1	section 356c of
1	groups a study
2	applications filed in
1	review; (c) is
9	shall, in consultation
1	stakeholder. nothing in
1	 (1) notify
1	foreign person has
1	article. (t) the
1	regulations.  (4)
1	event the limitation
2	subsection (c), such
1	 (8) program
1	trade. in establishing
1	election referred to
1	fees to recover
1	ii device so
1	certification under subsection
3	witnesses, receive evidence,
1	(5) which prescribe
1	monitoring); (dd) individualized
2	clause (i) for
1	action enter into
1	qualify for export
1	decedent that is
1	products and otherwise
1	 (5) exemptions
1	formatted in a
1	bear directly thereon
1	42, and other
12	wholesome and not
1	officethere is established
2	paragraphs (a) and
1	(mg) 7.0d 
1	activities subject to
1	permitted by regulations
1	documentation to be
1	including fingerprinting strategies,
1	exchange of scientific
2	management advisory committee
1	analyses described in
1	used to identify
1	degrades or harms
1	administrator for authorization
1	commonly accepted scientific
1	 (c) charges
1	chapter applies to
1	allows no greater
1	units, or where
1	distribute, methamphetamine on
1	dietary supplement is
1	secretary shall prescribe)
3	opposes, impedes, intimidates,
2	secretary shall prescribe,
2	secretary shall prescribe.
1	advertisements so identified,
1	patients, if such
1	emergency medical care.
1	involvement of, two
4	program agency that
1	percent of fruits,
1	existing agency authorities
1	case shall provide
1	(e) uniform product
4	(a)(ii); or (ii)
7	agent of the
1	medications, specifically opioids
10	days after december
1	subchapter may, without
2	real property, including
1	requirements for licensure
3	control program agencies;
3	ethers, whenever the
1	represent the policy
1	order and provide
1	commercial importers 
1	administration, the materials
1	additional data gathering
1	committeethe secretary may
1	subsection (b)(1); (vii)
1	first appropriated for
2	standard together with
8	manufacturer or secretary
1	exceeds three hundred
2	documents that set
1	employee reasonably believes
1	concluded except that
1	quotas to the
1	(1)(a)(i), the term
1	(c) authority and
1	unless alternate sources
1	substantial experience and
1	government may request
1	 (g) report
1	inapplicability of sections
1	plants  (1)
1	drug sponsor the
1	applications whose effective
1	(5) proposed sunscreen
1	necessary to assess
10	absorption of the
3	recipient of, such
1	administration. (
 

1	object, except that
1	credentialing bodies and
1	obligation contrary to
1	applicable industry standards
1	fee described in
5	violates a requirement
2	(1) each regulated
1	method not in
1	individual has complied
5	implant that failed
2	transportation, sale, receipt,
2	development of regulations
1	organizations, and womens
1	title or sections
20	drug enforcement administration
3	responsible for implementing
1	challenges associated with,
1	directly relate to
1	certain petitions 
5	investigation, the administrator
1	business tobacco manufacturers
1	collaboration among all
1	(2)(a) shall not
1	childs physician or
3	abbreviated application. 
2	vendor. (c) such
1	amenable species that
5	salting, packing, rendering,
2	paragraph is impracticable,
1	changes as it
1	pending premarket applications,
2	approve or conditionally
1	1487.)
 
 64.
3	18.  (

1	shall, except to
1	facilitate reviews of
1	including clinical data
1	state to which
1	product radiation means
2	amenable species or
1	subsection (c), to
2	report for criminal
2	refused admission. if
1	biological products shall
1	(2) benefi-risk consideration
2	processed food because
1	dispenser. (8) the
1	 (e) diagnosis,
1	adverse events submitted
1	may by order,
1	clearly and conspicuously
1	(e) a process,
1	additional -year terms.
1	(iupac). (2) 
2	review time for
1	qualified experts as
1	proffer was made
1	subsection (k) should
1	year.  (

1	declared forfeited and
3	(4) for the
2	changesthe secretary, in
1	supplement.  the
1	processing (as defined
1	subsection  (i)
1	of, in furtherance
1	convention of the
1	judgment, the biomaterials
1	 (2) n-cost
1	number. except as
1	within which such
1	report if so
1	administrative services, funds,
1	(g) if an
1	revoke an authorization
1	without the registration
1	(4) basis for
1	(b) activitiesin conducting
1	green, carbolic acid,
1	calendar year; (2)
1	used in packaging
1	chemical residue than
1	wherever handled on
1	introduced for any
12	chemical residue that
1	prohibition on the
1	complied with requirements
1	package.  (d)
1	(20) the term
18	serious or lif-threatening
4	(b).  (4)
1	subparagraph (a), render
1	human food; inspection;
2	material fact. in
1	required to furnish
1	(
 
 830.
1	article. (n) if
5	pending drug product
2	(a) is grase
3	(a) provide for
23	360b of this
3	timelines in calendar
1	current pattern of
1	level of such
2	public health advisory
1	title inconsistent with
1	steps taken under
1	(b)(1).  (2)
1	(2) water pipes;
1	section is required
1	drug paraphernalia; or
1	narcotic drug alone:
1	action. (ii) a
1	health for which
3	product identifier to
1	recovered shall be
1	listed chemical (other
1	petition, and shall
2	make and maintain
3	agreement under subsection
1	drinking water standards;
1	further, that such
1	identifies the best
1	submit recommendations with
1	submission, review, clearance,
1	continual device improvement,
1	science of novel
1	retirement, welfare, social
3	requires the exercise
2	(a) the impact
1	taking steps to
1	reasonable manner, as
1	(a) who, upon
1	disposing of electronic
1	fulfill a specific
1	carries out an
1	1036. pasteurization and
1	ability of donors
1	matter. (d) any
1	
 692. inspection
1	pathogens, and shall
1	order notwithstanding this
5	shall not constitute
2	information by the
2	device and that
2	(i) to assess
2	may permit the
1	conspicuously marked or
1	availability or use
3	agency account be
2	expedite the review
1	(ii) provide an
1	savin; croton oil,
1	dispute resolutions; (ii)
1	secretary. (iv) any
1	collected from the
3	(7) of subsection
2	country involved is
1	paragraph (1), entities
1	truth or falsity
1	clause (iii)(i) or
22	shall be determined
2	food for pesticide
2	determination may be
1	identity prescribed by
1	secretary; and (iv)
1	otherwise indicates, means
2	controlled substance 
10	registered under this
1	statement if an
1	quotas the attorney
1	reason; (d) the
2	criteria for waivers
1	factor be negative.
1	infant formula) for
1	incorporation of the
1	study and report
3	 (3) other
1	additional selection. clauses
1	information so made
1	(1). thereafter, the
1	paragraph (2)(c), information
1	incorporated any comments
1	notice of regulation
1	administration.  (f)
1	(c) an itemization
1	(vi) requests funding
1	component of an
1	38 stat. 817.)

1	petition includes representative
1	deadline for compliance
2	places of business;
1	disposed of until
1	372 and 374
1	cocaine, hashish, hashish
2	postmarketing study of
1	take effect 12
1	 (b) designation
1	(1). a list
1	taken to implement
2	 (1) technical
2	compel the attendance
1	office for resolution,
7	change that occurred
1	shall address communication
6	certification has been
1	drug is listed
13	class iii device
1	harm with respect
1	sentence upon him
1	standards activities pertaining
1	(b) be scienc-based;
1	coalition that expressly
1	acceptance and review
2	food manufacturer means
1	(iii) in section
1	diploma. (mar. 3,
3	value for such
1	means the chemical
4	secretary shall update
3	construction  (1)
1	states under this
2	primary purpose of
1	director may solicit
2	both; except that
3	apples is two
1	distributes drugs into
1	entities in a
2	general by any
1	authorized to cause
1	eggs. (4) the
2	provisions requiring that
1	therapeutics. in considering
2	identical with, a
3	due.  (j)
1	testing of all
2	shall permit such
1	trade under a
5	require that a
1	application, as calculated
1	program areas such
1	(2) designations 
1	funds used under
1	2014, $1,736,000 for
6	criteria established by
1	cosmetics (a) unsafe
1	interests of such
1	quantifiable goals for
1	intended, he may
1	commissioner may accept
4	standard shall set
2	ii or for
8	year after fiscal
2	order to repatriate
1	(a)(1)(c), that person
1	imports a substance
1	event of their
1	(a)(2)(a). (7) the
2	substances may be
3	membership of the
1	dispensers, including related
1	(v) antibiotic drugs
1	unless the sponsor
1	informantsthe secretary may
3	technical and scientific
1	effects; (xi) information
1	costs to be
1	term eligible coalition
1	distribute, human growth
1	sum of $3,000,000
1	spoons with level
1	(b) no penalty
1	offense under the
1	neutralizing costs the
2	reinstate such approval,
1	thereof) to such
1	appropriate, the rationale
1	certain egg products,
1	cream and the
1	adulterated (a) if
1	(a) efficiently update
1	representative copy of
5	administration for meeting
1	programs have proven
1	strategies related to
1	sector to promote
1	drug refers to
2	pay a fee
1	assistance, follo-up effectiveness
1	obtain specialized training
1	petition; and (ii)
1	tomography drugs or
2	5 kilograms or
1	review, such as
1	homepage a statement
4	may be only
2	(c) safety factors
1	(c) lysergic acid
1	21 - food
1	(n) of such
1	substance, (c) safety
1	showing the recommended
1	title, either in
1	agreement on a
1	federal drug treatment
2	intermittently in the
1	4, formerly 2nd
1	ordinarily contained in
3	owned or possessed
1	patient risk to
1	anticipated and actual
3	biological product (including
1	safety and other
1	section 1361 of
1	new dietary ingredients
1	
 321b. package
1	printed upon them
1	limitations that the
20	regulation under section
1	paragraph, and is
1	entity, to a
1	(a) symbol it
8	otherwise subject to
1	determination. (h) dissemination
2	judgment can make
1	number of and
1	copies the inspectors
1	exportation, manufacturing, distribution,
1	requires the licensure
1	standards, for medical
1	appraisers, accountants, or
1	disseminated.  (june
1	processing, packing, and
4	sale of tobacco
1	(i) for guidance
1	organizations that represent
1	(which may vary
2	subpenaed person to
1	review, unless the
2	fact; or (f)
5	flavorings, and colorings
1	section only has
1	letters under section
3	important source of
1	459. compliance by
1	appointment there shall
1	reporting deadline, whichever
1	nalorphine. (d) unless
1	information disclosed to
1	review.  (g)
1	possess any eggs
1	subparagraph (a), unless
2	aggregate of the
1	clause (ii), no
1	reinstatement in, and
1	following federal benefits:
1	cover additional foods.
1	annual meetings) and
1	sale under subparagraph
3	nonprofit affiliate of
1	asset control (in
1	commitments; and (c)
6	360d or 360e
2	periods described in
1	government authorized by
3	small businesses such
3	grant the request
2	certification made under
4	may relate to
1	(b) record keeping
1	may require by
1	(4) for any
1	materials regulated under
1	individual for dependence
1	dispense the drug
1	(b) reasonable cause
1	show what percentage
1	
 
 350l.
1	may, by specific
3	rulemaking under paragraph
1	interfere with ethical
2	expedited review and
1	approved; and (iii)
1	2017 not more
1	include provisions 
1	misbranded and capable
1	states attorneya united
1	new and rapid
4	committee regarding whether
3	secure tracing of
2	year 2010 and
1	within 150 daysthe
1	appropriate, shall issue
1	ch. 675, 506b,
3	taken, and he
1	notification of findings
1	period. (f) internal
1	product changes ownership
2	upon the initiative
1	public warehouseman, or
2	upon entry into
5	associated with a
3	application submitted for
1	regarding nanomaterials included
1	food including the
2	establishment is an
1	(ii)(i), but the
1	product; (ii) address
1	center shall, in
1	order.  (6)
1	combination products; and
1	(8) betameprodine. (9)
6	viruses, serums, toxins,
1	state, except as
1	institutes within the
1	officers to the
1	detailed criteria for
1	personnel to administer
2	longer make the
2	safety, and welfare
2	local agencies responsible
1	requirement (a) testing,
1	recognized standard organization.[1]
1	section. the foundation
1	world evidence 
1	warrant good title
1	safety programs is
1	except when such
1	development of new,
2	major manufacturing change,
1	accredited person who
2	generalthe secretary, on
2	(2) protection of
6	shall not extend
3	subsection (g). 
1	amendments to rule
1	radar imaging; (b)
1	accepting and reviewing
1	any, under which
2	kinds of cases;
1	(8) unless, in
1	fraudulent identification where
1	exportations or periodic
1	encourage the conduct
1	insurance under the
8	3583 of title
1	entry; annual report
1	substantial evidence obtained
1	results, and other
1	shall be exchanged
1	may submit concerning
1	action to require
4	f.r. 2421,54 stat.
1	pharmacy that compounds
6	following information: 
1	state license described
1	subparagraph (b) result
1	shall improve the
1	379j12(a) of this
1	food safety standards
1	 (ii) treatment
2	secretary denies the
1	protection of consumers
1	subbrand. effective beginning
1	drug rehabilitation program
1	(iii) any person
4	sale is made
1	subsection (j). any
1	subparagraph (a)(iii)(x), if
1	returned at the
1	exemption takes effect
1	contain evidence) which
6	provided in the
1	substantive review under
1	final rule without
2	may be offered
1	databases with drug
1	claimant seasonably made
4	determination, in consultation
2	sold or disposed
1	undertaken, of reports,
2	would, but for
1	accelerated inspection system,
3	ruleexcept as provided
2	include, but are
1	results of regularly
1	subsection (a) result
1	statement that clinical
1	iii, 531, formerly
1	privilege with respect
1	second country have
1	include any requirement
2	health care professionals,
1	crops, including coca,
1	health care professionals.
15	meets the definition
1	protocol does not
1	resolutions; (ii) identifying
1	playground means any
2	producers and processors
1	ingredient with another
1	applicable authorities of
1	675, 807, as
2	state (including the
1	substances, by whatever
2	public swimming pool,
1	assigned.  (b)
1	2015, the following
1	subsection (f)(1) require
4	health care professionals;
1	(12) attempts to
1	based. (2) bases
1	produced opening for
1	initiatives, in consultation
1	suggests use of
1	shall submit, as
2	experience associated with
2	twice the gross
1	justifying such return
1	(36 u.s.c. 22501(b)(1)).[1]
2	changed to reflect
4	labeling change requested
1	act in furtherance
2	active ingredient, new
1	substances. (4) compliance
1	$4,000,000 if the
1	month in which
1	drug, from a
1	(7) qualification the
1	  zinc
1	1037(c) of this
1	federal law as
1	permits for importation
1	 (1) reports
4	established in such
5	fiscal year are
1	 (g) return
1	implant who is
2	clearance of countermeasures,
1	general to track
5	transportation of food
8	appropriations there is
1	upon application be
3	programs administered by
1	drug. (5) 
2	accredit or deny
2	submits to congress
1	activities. (c) fees
1	government from testing
1	petition in a
1	report, the secretary
3	whose active ingredients,
3	assessed for the
1	further, upon conviction,
3	shall display the
1	calculating the number
1	general shall review
1	(b)(2) upon the
1	(b) may, in
1	purity; (d) upon
1	change or modification,
5	administration modernization act
1	change or modification.
1	distributed in the
1	2 years. in
1	antibiotic resistance, including
1	exemption is otherwise
1	declared not completed
1	 (c) authority
2	plans available to
2	effective regulation of
1	 (i) encouraging
1	contribute to an
1	condition prescribed under
1	(a) authorization for
1	condemnation proceedings under
2	penalty which may
1	implement this subsection.
1	species, or the
1	general marketing in
1	cream or for
1	(b) imported, exported,
2	may amend such
1	consider which records
2	necessary or desirable
1	536, formerly act
1	medical evaluations which
1	representative described in
3	safety factors which
1	letter could reasonably
1	consumer may be
3	found that all
1	violation and the
1	physician, manufacturer, or
1	regarding genetically engineered
1	thir-party auditor no
1	furnishes in advance
6	second business entity
4	food industry, and
1	execution of satisfactory
2	purchasing, or trading
1	ineligibility referred to
2	applicable state boards
1	refusal or withdrawal
1	(b) topics for
1	foods (a) determination
1	(g) norpseudoephedrine, its
10	responding to a
1	plan. (f) current
1	(a) contrary, in
1	type that has
1	preparations and sales
1	regarding the procedures
1	available the policy
1	(c). an exemption
18	necessary to provide
1	boards of pharmacyin
1	(18) dimethylthiambutene. (19)
1	appropriate coordinate with
1	(d). (viii) the
4	drug is bioequivalent
1	act at such
1	adulterated.  (c)
1	firm means any
1	compound or dispense
1	methamphetamine seized and
1	least burdensome concepts
1	describing genotypic and
3	has, with respect
1	showing of undue
1	audits that, during
4	remit, with or
1	shall either (a)
1	wholesale distributor includes
1	purposes not specified
1	delivery was made
1	manufacturing changes) that
1	participants, retain any
9	shall continue to
1	(1)(a). a small
2	egg products are
1	review of names
1	often as necessary
1	often than quarterly,
1	judicial review all
1	audits conducted is
1	markers, the use
1	special rule the
1	use within the
2	exclusion of imports,
1	existing practices or
2	regulation, a state
2	secretary, including 
2	selling any poultry
1	territories, or possessions);
3	biological products and
1	european union or
1	regarding their experiences
1	dispenser by means
1	time a claimant
1	disposal plans; (v)
1	extract, or combination
2	court as a
1	written and filled
1	means the convention
1	importer practices, taking
1	eggs, and the
2	applicable standards for
1	505e of such
1	actions. the secretary
1	efficient process for
1	(1)(b); and (b)
1	 (1) which,
1	format as may
4	(d) health care
1	policy regarding oleomargarine
1	(ii) subsequent years
2	inspection personnel of
1	(a) any drug
1	application provides a
1	upon an application
1	(2) increased efficiency
1	administrative inspections authorized
4	regulation or guidance
2	materials related to
1	may issue interim
1	designates as owned,
1	2011, $450,000,000. (d)
15	public or private
2	include a request
1	title); or (xviii)
1	opportunity to review
2	extrapolated to another
1	(d) consultation in
1	inspection of permi-holding
1	filed a petition,
1	(b) repealed. 

3	 (b) petition
1	ii. it shall
1	subchapter, and to
1	(m) prior notice
1	compilation, publication, and
1	(34) phenadoxone. (35)
2	secretary, the petitioner
4	shall take effect,
13	animal feed bearing
3	specific mixes or
1	subpena issued under
1	applicants experience in
2	(including travel, per
1	needs at the
2	u.s.c. 262]; or
1	review by publication
1	poison, the name
2	subsection.  (4)
17	listed drug referred
1	authenticate the prescription
9	conclusion of the
3	regulation is based.
1	instrument providing that
1	tangible and intangible
1	was, prior to
9	shall register an
3	greater quantity of
2	reference in other
1	staff and resources
1	en-o-phase 2 meeting
1	secretary issues the
1	produce component parts
1	(4) nothing in
1	require approval or
4	detailed description of
2	section and accounting
3	states government. 
1	period.  (n)
1	action to assess
1	(4) repealed. 

1	paragraph (3) will
1	said virus, serum,
1	term product identifier
1	products will not
1	interstate commerce an
1	appropriate activities of
1	success of those
2	appropriate, not later
1	ongoing clinical investigations
1	1193. transferred
 

1	laws for eggs
1	(1) establishment fee
1	handle in connection
1	order determines that
2	practicable, minimize the
1	states government internet
1	dispensed only upon
1	submission of facility
3	labeling changes) and
1	event of removal
1	substance or labeling
2	de novo classification
1	engaged in activities
1	1605(c)(3)(b)(ii) of this
9	establishment of the
2	alleging harm caused
2	controls over the
1	1033. definitionsfor purposes
1	(v) carry out
5	(ii) not later
1	supplement, within 30
11	execution of a
2	presiding officers report
1	days  (i)
1	business, and may
2	valid prescription means
1	inventory position, the
1	(2), any of
1	necessary, a manufacturer
1	(a)(1) is, with
1	379. confidential information
2	territory, to use
1	united states dealing
1	possible in good
2	date, a manufacturer
1	products as requested
1	illegal channels; and
3	iii unless the
2	one in which
1	laboratories, and to
1	director.  (3)
1	relevant and appropriate,
2	constituted entity permitted
4	products the secretary
1	morphine methylbromide. (15)
1	states; (4) the
1	(2) between points
1	registration fee under
1	ketamine; (iii) flunitrazepam;
1	avoid imminent hazards
1	safe usethe secretary,
1	qualification plan, the
1	quarter involved. 
3	may direct and
1	subsection (a). for
2	construction the submission
1	rule shall take
1	product label with
1	officials; (5) responds
1	inspection, and that
1	emergency or foodborne
1	applicable under subparagraph
1	consider, at a
1	(2) exceptions 
1	financial resources of
1	labeling could confer
3	hundred and twent-day
14	secretary shall specify
3	appropriations for fiscal
1	fruits or vegetables,
1	ch. 675, 503b,
1	ris-based evidence, that
1	u.s.c. 262(a)]. (b)
1	irreparable injury, harm,
1	effect, and has
1	prescription was compounded
2	freezing, storing, or
1	summary and citation
1	including a staff
1	programs.  (

1	notice, issues a
1	nonrenewal.if a contract
1	combination product, consult
1	effect of evading
2	transaction statement of
1	(a) information provided
1	title, such person
1	shall not, because
1	pediatric population (including
6	understanding, or cooperative
2	processes needed to
1	service to conduct
2	permit, notification, or
2	determines by order
3	 (i) upon
1	services who exercise
6	terms as to
3	bears such information
52	amount of the
1	approved. (4) the
1	registration described under
1	papers or other
1	perform its other
1	drug production and
3	investigation is intended
1	(1) before december
2	produces the residue
1	exempt requirementsupon application
1	published.  (june
1	aircraft owned by
1	(i) to increase
1	flavor of the
1	evidence) which the
1	
 
 1401.
1	foreign country, of
1	strike subpart clabels
1	contractor shall not
1	products, requirements applicable
2	informs the applicant
1	term meat item
2	national organic program
1	arrangements for examining
2	evidence indicates that
1	modifications a description
2	welfare of an
4	devices for which
3	shall, where appropriate,
2	order of debarment.
2	state has failed
1	administrator shall suspend
1	drug samples. 
4	 (1) subject
1	reckless disregard of
1	information from disclosure.
1	 (i)effectiveness of
1	robust and mult-faceted
2	effect on august
1	purposes.  (june
7	basis of which
1	1903(g)(1) of this
1	critical issues and
1	identify a person
1	effective approval because
2	removal of exemption
2	(i) who meets
1	corporation, shall introduce
1	transmission of proposed
1	holding such animal
2	occurred after its
1	acid (g) 300.0
1	(am2201); (xii) -(-fluoropentyl--(-iodobenzoyl)indole
1	instituted shall, on
1	level in subparagraph
1	humans; (iii) the
1	following terms: could
1	(c) are adequate
2	(b) whenever a
1	supplement within 15
1	affording a source
1	product).  (3)
2	shall, in revisions
1	productan authorization under
1	convicted before may
1	food involved is
1	(2) the applicant
2	motion for impleader
1	population; (ii) available
1	shall document agreement
1	application. the sponsor
1	containing silicone gel,
1	passed. (mar. 4,
1	canned, salted, rendered,
1	establishment is one
2	reporting requirements under
4	final year adjustment
43	employee of the
1	 (iii) congressional
2	attempt to resolve
3	labeling and reasonably
1	grant a coalition
1	title 28. process
1	somatrem, somatropin, or
1	use a grant
1	product, from a
1	testing positive for
1	funding under the
4	subsection (d); or
4	bond conditioned that
1	implement preventive controls
1	accreditation, were denied;
2	labeled as required
5	brief statement of
1	designed and have
1	standards, requirements, or
1	certification within the
1	electronic product involved,
1	1997, but not
1	(2)(c);  (d)
1	nicotine dependence; and
1	fillsa prescription for
1	chemicals; and (b)
1	paragraph, a person
1	organization providing services
1	basis of credible
3	inspection the secretary
1	certain monitoring; or
5	drug or the
1	action if an
1	comment not later
3	access for patients
1	accomplish lon-term quantifiable
1	agency center or
1	techniques as are
2	formal enforcement action
1	(3) no official
3	 (2) transferability
1	detail shall be
1	placed beyond the
1	oil and intended
1	leaves) in schedule
1	descriptions: black rots,
1	data determined by
1	batch, (ii) regularly
4	enabling the secretary
1	year  (1)
1	names of manufacturers
2	person whose description
2	designed or manufactured
3	emergency conditions exist
1	recent 1-month period
2	concurrent jurisdiction with
1	rate, for abbreviated
6	drug in animal
1	present, or in
1	public stakeholders may
1	product is likely
1	26 percent shall
1	vehicle, for purposes
1	includes an indication
1	chapter prohibits or
10	recipient of the
1	shall review regulatory
2	contracts under paragraphs
2	 (3) review
1	section 346 regulations
3	federal law for
1	ind a clinical
1	(i) $652,709,000 plus
1	occurrences since the
2	no-federal funds and
1	administration, university consortia,
1	rare disease to
1	federal register proposing
1	classification information means
4	title 5 governing
1	proposed set of
1	(i) the research,
1	whole, or in
1	meetings the members
1	1970, and shall
1	(1) the provisions
1	custom slaughtering for
2	information respecting a
2	136 et seq.],
1	which, as to
1	rare disease product
1	prior conviction which
2	felony, involving fraud,
1	registrant if the
1	(b) twent-four percent
3	proportion or historically
1	systems in the
1	programs the administrator
1	(2) amendment of
1	package for approval.
1	year 2003, means
1	entry of sale;
6	upon the written
1	indexed under this
2	(ii) was a
1	safety report disclaimers
1	proposed regulation, provide
3	countermeasure has the
2	include a person
3	person continues to
1	(3)(a).  (b)
1	27, 2013; or
1	diagnostics the secretary
1	whether such a
2	identification number of
1	event in which
1	drug, a component
2	promptness in conducting
2	manufacturing change, the
1	seq.] (37 stat.
1	(c). (2) product
1	conclude that adult
1	occurring in the
1	include the centers
1	licensure of any
1	administration under paragraph
2	forms they submitted
2	lon-term treatment program
1	(b)(2)(b). if such
1	health or as
1	packaging inserts; (ii)
3	submission of this
1	issued only after
1	(c) inaction of
1	entry is made.
1	petition addressing issues
1	 (i) rule
1	enforce the drug
1	administration who review
1	from, any application,
1	administration under which
18	22, 2009, the
1	permits the importation
1	register (61 fed.
5	devices or types
1	container or wrapper.
1	container or wrapper,
2	states not licensed
2	353a of this
1	(iv) ensures the
2	committees consulted with
1	receipt, security, storage,
1	adulterated need not
2	pay fees a
1	occurs in the
1	filing decision of
1	quotas for each
1	representatives of law
5	(ii) the first
2	fact specifically finds
1	demonstrating safety and
1	(g) 100 kilograms
4	whether to accept
1	list of final
2	pediatric formulations not
1	involving the development
1	establish good manufacturing
1	data, such margin
1	may be related
1	(a).  (j)
1	choline (mg) 7.0d
1	health of such
1	subsection (m)(4) of
2	requests received under
1	second fiscal years
3	(b) of such
2	secretary. such request
1	canada, such permit
1	adjustment act (7
2	specific initiatives that
1	foodborne illness attributed
1	timing for review
1	publicly available information
1	environmental policy act
1	(b). if such
1	2007; (11) $109,000,000
1	internet information location
1	product and relevant
1	following export transactions,
3	products shall not
10	marketing of a
1	type of data
1	 (2) timing;
1	approved covered application.
1	(b) contentseach report
2	successful program evaluation
1	findings required under
1	biological product against
1	potential, compared to
1	justified by compelling
1	committees or otherwise
2	sentence.  (c)
1	grant recipient means
1	drug the drug
1	substances, or list
2	shows that the
1	actually collected for
1	(a)(vii). the certification
5	applicable to any
1	quarter to be
1	engaged in extracurricular
11	solely for the
2	may be effective
1	undertake enhanced and
16	inconsistent with the
1	pediatric formulation described
1	index entry; (d)
1	(b)(2) and the
1	facilitate an effort
1	chapter solely because
1	good faith effort
2	funds are used
1	states are so
1	accredited persons pursuant
1	qualified laboratories that
1	designation of drug
1	(1) grant petitions
1	products; (d) measures
1	agent. such regulations
6	forged, or improperly
1	indirectly from the
1	access provided under
1	enhance foodborne illness
1	requesting a review
1	products including any
1	responsibility or the
1	list its ingredients
1	dropouts, and lower
1	(b) the participation
1	standard so that
3	action levels, or
1	including a draft
1	form) that 
1	 (3) any
6	means  (1)
1	administrator may use
1	general the total
1	determination, the carcasses,
1	2014 to reflect
1	september 30, 2002,
6	extent a greater
1	items; or (2)
1	subparagraph (b)(iii); and
5	unless exempt under
2	standard; (e) such
1	orders, including regulations
3	consider, among other
1	law regarding whether
1	away for free
1	advantages over existing
1	wrote the prescription;
1	significant improvements over
3	inspectors from any
4	submitted under clause
4	upon a fair
4	matter referred to
1	basis for findingfor
1	compensation for the
1	u.s.c. 2603]; (iii)
1	research methods for
1	states agent of
3	subsection (a)(2)(a), a
1	application datefacilities shall
3	section not later
1	advisory council. 
1	states. (b) a
1	(f) progress and
6	application, premarket report,
2	general that the
1	telemedicine for purposes
1	food is produced
1	homeland security not
1	subsection, that (1)
2	controlled substance based
1	require inclusion in
1	perform ris-based foreign
1	president as the
1	 (1) reportnot
1	351(k) of the
1	
 694. authorization
1	subsection is advancing
1	
 379. confidential
1	several states; (3)
1	release of the
1	complies with storage
1	u.s.c. 262(a)] upon
1	federal drug reduction
1	2015. (d) $129,339,949
1	demonstrates, by clear
1	rights under this
2	standards respecting the
1	raw cream seven
1	plus web sites,
1	verification of product
4	costs fell below
1	warehouseman, or employee
1	research with, controlled
6	poultry products are
1	drugs for coverage
1	review and shall
1	
 
 399h.
1	(iv), beginning not
2	reference in such
1	finality and conclusiveness
1	(6) the application
1	devices; initial and
4	drinking water act
1	shipment in or
1	seeking to export
2	dealing in the
1	marketed, in 1
1	direction from such
1	(aa), shall submit
1	summary judgment subject
1	recommendations for process
2	payment by the
1	events or transactions
1	inspection to a
1	456. operation of
2	exemption shall not
1	 (c) special
1	material for use
2	90 days before
1	may decide which
1	states resident who
15	number of the
2	protocol has not
4	year until the
6	ports of entry
1	section 360, 360c,
1	food for consumption
1	labeling if applicable,
1	present or reside
1	u.s.c. 9831 et
1	(aa) in an
1	(at the option
1	including antimicrobials to
1	maintains a certification
1	request studies in
1	generalthe regulations promulgated
1	safety, the administrator
1	(iii)private sector resources.
1	conditions, as described
2	means unless the
1	food produced and
1	efficient and effective
1	clarifying information, and
20	compound, mixture, or
1	standard and demonstrate
1	secretary has, with
1	deemed necessary to
1	decision to destroy
1	(ii) an information
1	information for patients
3	containing such ingredient
1	calendar month beginning
4	issues an order
2	(ii) technical and
1	medical purpose. 
4	total cost of
1	reviewed only as
1	plan may support
1	laboratory preparedness; and
1	anhydrous ammonia across
1	(in this subparagraph
1	lists the names
1	upon such submissions
2	december 13, 2016),
1	facility:  (a)
1	
 
 360ccc2.
1	time of notification
1	supervisory concurrence. the
1	waived the requirements
1	from, a study
1	individual upon application
1	infeasible, the product
3	repackager, to the
4	subsection (j) shall
1	(3) upon request
1	approving such petition
1	action; but such
1	subsection (j)) that
3	sanction authorized by
1	term institution of
1	facility at one
1	lon-term manner, with
1	providing the applicable
1	bioequivalence if the
1	secretary if a
1	devices reclassified in
2	committee shall, within
1	cause therefor. the
2	drugs and in
1	title 25. 
9	may, in the
1	product certification every
1	refund all amounts
1	agencies to promote
1	public.  (g)
1	associations and scientific
1	subsection prohibits an
1	applicant amends or
1	15 or the
1	public interest. (ii)
1	provision, of the
1	(2) customs territory
1	extent practicable the
1	paragraph1 (1) shall
1	time such repackager
1	exemptions; variances 
1	bringing of the
1	products produced in
1	119, 70 stat.
1	shall give prompt
1	authorized the introduction
4	property that is
1	every 14 days
1	1505. repealed. 

1	1706. high intensity
1	responsible person or,
1	container standards (a)
1	1997. (june 25,
1	state.  (8)
1	information concerning initiatives,
1	(3) the reason
1	paragraph; and (j)
1	hydroxypethidine. (26) ketobemidone.
1	informal hearing. 
6	date in such
3	thereof, or any
1	device if, upon
2	extent practicable, shall
1	products. such regulations
2	single report. 
1	safety of raw
32	approved application under
1	immediate proximity to
2	believe the product
1	operations have corrected
1	machine, contrivance, implant,
2	documents, and other
2	manufactures, processes, transports,
2	authorization by the
1	attorney for the
1	almonds, colchicum, cotton
4	increase the number
2	trade commission act
5	proposed conditions of
1	construction the requirements
1	advertisements shall be
1	form, delivery system,
1	manufacturing other material,
1	jurisdiction in any
3	single proceeding. 
1	ingredient of another
1	standards. (m) documentation
1	may revise the
1	 (b) results
1	obtain such training
1	consisting of an
1	importer (as defined
2	monitoring the future
2	entered into or
1	version of the
1	early head start
6	342(a) of this
1	animal feeds under
4	conforms to such
2	resources under section
15	conviction, impose a
1	relevant exposure from,
1	manufactures, possesses with
2	directors within the
2	year, an applicant
1	applicant is a
1	thereafter,,[1] the director
1	accept and use
1	administrative remedies 
1	proposed tolerance or
5	may be issued
1	notice or his
3	sentence  (1)
1	
 191 to
1	transaction dates if
1	treated under this
1	subsection (a) occurs
9	derived from the
1	subsection (h); and
1	animal; or (b)
1	ful-time employees) with
1	waived by any
2	may not directly
1	(4) final year
11	required by such
1	commission does make
1	epinephrine to a
1	cause death or
19	adverse event reports
3	making a decision
10	review user fee
1	food product means
1	5. the commencement
2	(ii) has refused
1	section was in
1	associated clinical trials
1	brings or possesses
3	accurate record of
3	implement the requirements
5	shall be retained
1	repackaging, transport, labeling,
1	(b).  (3)
1	list and description
2	 (i) address
1	public, of which
1	entitled deciding when
1	additive, or a
6	united states. (5)
1	chairman thereof. the
1	certify, or audit
1	(d) key barriers
1	current rate of
2	application the term
5	section 379v of
1	opportunity for hearings,
1	focus of an
1	substance or presents
1	necessary for its
2	requirement are sufficient
1	1046; sept. 3,
1	fine. (june 25,
1	agency has received
1	develop a means
6	secretary determines, after
1	changes in manufacturing
1	conference. no later
1	practices for ensuring
1	2013, 2014, and
1	evidence standard under
2	appropriate person (including
2	sites of the
3	(1) in generalbeginning
1	terms. a conditional
6	business of buying
1	anaphylaxis of a
1	(b) revocation of
1	(c) the egg
1	petition to an
4	department or agency.
7	department or agency,
2	products of any
2	point of origin
1	351(a) or subsection
1	initial notification, the
1	(1) to enter,
1	lessor of real
1	chain and provide
1	days, unless a
1	substance;  (ii)
2	abbreviated application which
1	products shall register
2	 (1) emergency
1	except by a
51	high intensity drug
1	assigned, during the
1	food establishments; (3)
3	least 2 years
1	witness in any
1	countermeasure applicationthe term
1	assist state, tribal,
3	(1), the administrator
1	(10) sulfonmethane. 
1	isomers or salts
1	(g)). (ii) with
1	(ii) transaction history
1	residue. in establishing
2	additional information requested
1	seller, or to
6	secretary; and (b)
1	sprinkled, or sprayed
1	otherwise endeavor or
2	may accept returned
1	conviction of, such
1	possession of representatives
2	requirement, or decision
1	deny the application
1	805, as added
1	developing a countermeasure
2	pleadings and affidavits,
1	activity as required
1	tenants and sharecroppers.
1	resources are available,
1	sentence shall demonstrate
1	information obtained or
1	triangular in shape.
1	no-alcohol food, provided
1	makes the distributions
1	appointed to positions
1	countermeasures, through workshops
1	2016; (d) $7,936,000
1	 (e) conditions
1	director;  (b)
1	(1)(b). (b) in
1	imposed therein. (c)
1	recognizing one or
4	bears, in such
2	states; and the
7	sample of the
3	amount shall double
1	hold, administer, invest,
1	information act [5
1	571, as added
1	extent practicable, obtain
1	identifying the existence
1	tracing system to
1	performance accountabilitythe director
1	appropriate, revising such
1	made in meeting
3	action to protect
1	condition defined 
1	information act) shall
1	information, including lot
1	including requests for
1	(a) a vitamin;
2	establishments are operating
2	sponsor submits a
1	testimony on the
1	peer reviewed medical
1	title and from
1	deadline for the
1	may not obtain
1	studies the committee
1	paragraph (6)) that
2	organizations and individuals
1	section, the income
1	designate an appointed
15	(1) of this
1	(ii) the likelihood
1	corporation with respect
1	container requirements (a)
1	manufacturer to cease
3	subparagraph (b) to
5	verification of, such
1	person charged. (d)
1	among youth on
1	(2) the owner,
1	performance measurement system;
1	1701(1)[1] of this
1	support clearance or
1	location of any
4	may make recommendations
1	title i, 2,
2	(1); (3) the
1	(b) to define,
1	2014, and 2015,
3	shall with respect
1	reasonable manner, upon
1	suspension exist. (4)
1	claimant, seasonably made,
1	anticipated requirements for
5	necessary to address
1	subsections (a)(3)(d) and
1	(3) provides accessible,
1	use of preventive
4	(b), and (d)
2	holiday pay paid
2	body for a
1	30, 2002, the
1	(4) sell, transport,
1	procedures for such
1	illness surveillance data
1	term of not
2	establishments registered pursuant
3	may prosecute any
1	occurs.  (b)
1	disseminate to physicians,
1	(c) major manufacturing
2	evade or defeat
1	records. (3) 
1	campaign for a
1	device establishments required
1	(4) final dosage
1	full hearing, if
1	warning that the
3	practices that the
1	administration guidance entitled
1	commission, members of
1	policy and deputy
1	substances, and every
1	person shall assess
4	 (2) consultation
1	manufacturers, importers, packers,
1	information regarding pharmaceuticals
1	private sector veterinary
2	state coordinators designated
1	article. (8) 
1	means a unit
1	references, by a
1	675, 532, formerly
6	subsection.  (b)
1	inform the process
1	(c) the measurements
1	investigations and promptly
1	care entity, to
1	human use would
3	commerce within the
9	distribute a controlled
1	foundations, researchers, and
1	term includes 
3	payment  (a)
1	filled, the attorney
1	drugsthe term process
1	(iv) provide support
1	(iii) request the
2	states citizens living
2	person, the attorney
1	section exceeds the
1	thereof or under
3	showing by the
1	product, consult with
1	518d of title
1	traffic in the
1	arrangement with the
1	(e), or (ii)
1	year 2000; (4)
1	establish alternative, scientifically
1	8, 38 stat.
1	agency that disseminates
1	 (g) regulation
1	fees) to any
1	 (j) exemptions
2	section that may
1	continuing need for
1	congressional committees means
1	product), the agency
1	title revoking an
3	condition of the
1	design, age groups,
1	(2) alter the
1	seeking designation under
1	controls are adequate
1	$500,000 for all
1	human body for
1	powers to the
1	subsection (a) solely
2	of, or as
1	sunsetthe following requirements
1	made publicly available,
1	(b) partnerships for
13	agreed upon by
1	effect an exemption
2	patent is valid
2	changes and unless
1	powers, duties, and
1	manufacture, and evaluation
1	construction, and operation
1	760, as added
2	submit an abbreviated
1	field office of
1	request justifying such
1	access to, to
1	assistance (including necessary
1	review each drug
2	advisory committees consulted
1	lawful if the
1	effectiveness issues for
1	corrections, probation, or
1	management and budget)
2	use of electronic
1	additional standards respecting
1	consumption of food
1	property was acquired
1	monetary penalties in
4	determines are appropriate
1	packaged liners) of
2	ensure that a
2	section, including any
1	(d) penalties 
5	cost of such
1	opportunities to improve
1	five years. (3)
4	uniform system for
1	plan unless the
7	revenue amount determined
1	appropriate means necessary
1	 (a) retain
1	provide (1) for
1	drug substances (as
1	establish such policies
1	complied with regarding
1	subsectors, including both
1	although the congress
1	833.)
 
 157.
1	distribution of ephedrine,
1	security, as appropriate.
1	shall accept voluntary
1	drugs; or (2)
1	may be commercially
1	(3) the manufacturer
3	shall, as soon
3	required, unless exempt
1	form is issued
1	limitations, as to
1	information), such report
1	human milk or
1	trade, offer to
1	agricultural commodities based
17	 (i) such
1	testing; (f) specimens
1	prescribe restrictions on
1	title 18. (5)
5	person if the
1	 (a) conducting
1	responsible for delivering
1	offense or a
1	categorization under the
5	patent has been
1	disclosure is otherwise
1	(c) program framework
1	sources of drug
3	 the determination
1	262], and subject
2	(3) of section
1	will be updated
1	greater than twenty
1	animal will not
3	including any drug
1	warehouseman refuses to
1	duplication of existing
1	appropriate for use
1	parole until the
2	rather than seven
1	periods of exclusivity
2	skimmed milk, whether
2	free of, a
1	(d)(1)(b) or (d)(2).
1	tobacco products, except
7	made publicly available
7	relating to such
1	demand reductionthe term
6	drug product for
1	case of r-exportation
1	based shall be
4	secretary for such
1	standards in establishing
2	2017, and $3,175,000
1	program means 
2	(1) which is
2	misbranded and the
1	food has received
1	articles.  (c)
1	explain or depict
1	submission of supplemental
2	offering illegally to
4	lack of adequate
1	title,[1] consist of
7	affected by the
1	consider  (i)
3	necessary to implement
3	(6) in the
2	clinical trials with
1	treating such diseases
1	local authorities engaged
1	person doing the
2	provided by an
4	imports or exports
1	claimant, was required
1	authorized in an
1	shall by regulations
1	markets of foreign
1	(2) submissions pending
4	assessed a fee
1	prohibited; preparation to
1	facility from seeing
1	treatments that eliminate
17	cause to believe
1	substance, pursuant to
1	adulterated. (c) in
1	requesting any person
1	paragraph (3)(c), the
1	use of vehicles;
1	paragraph (4), manufacturers,
1	impose on a
1	completion should not
2	(5), and (6)
1	devices manufactured or
1	use of vehicles,
2	identified by paragraph
1	convicted (under federal
1	hearing, be based
1	enforcing the requirements
1	clause (iii)(i); or
1	processing and manufacturing
2	packed, or distributed
2	submitted or which
3	foods that are
1	statement published in
1	response to 1
1	healthy poultry raised
1	services shall establish
7	drug application under
1	section amending or
1	address complaints that
1	(3) does 
1	products, except as
1	nonconforming plants the
3	met by such
1	petitioner rather than
1	process or treatment;
1	export to ensure
1	technologiesthe standards developed
1	(n). (3) any
1	(m). (2) an
5	360eee(16)(a) of this
1	may hereafter be
1	terrorism; (d) take
2	new tools, standards,
1	includes any recommendations
2	(b) consult with
1	concerning the investigation.
1	360a, as added
1	promptly to complaints
1	applications, including the
1	recall; (2) use
1	drug use; (ii)
1	therapeutics), biopharmacology, statistics,
1	675, 423, as
1	members.  (iii)
1	comment beginning on
6	party controls, or
1	(b) actions related
20	interstate or foreign
1	quarterly fee beginning
2	chapter. in carrying
1	board; and (ii)
1	distribution, receipt, holding,
1	(f), populated with
1	part 897 of
1	ch. 675, 1011,
1	poultry (1) in
1	performance standards or
1	develop plans for
2	decides to disapprove
2	regulations pertaining to
1	food derived from
1	tobacco product, evaluated
1	(e) cholera. (f)
1	materials require redaction
6	information before him,
3	exemption of the
1	aggregate quantity of
1	
 
 360a2.
1	maintenance of establishments
1	fee when that
1	nonparties. (e) dismissal
1	uses a poison,
1	exports of certain
1	medical centers, and
1	human services. if
1	devices (other than
1	interests of physicians
2	section for an
1	development tools (a)
2	section 342(f) of
1	material means a
4	subject to priority
1	blood or tissue,
1	foods and a
1	poisonous deleterious foods,
1	ris-based information and
1	device, and either
1	share as determined
4	maximum number of
4	shall have no
4	disease; and (b)
1	 (b) strategic
2	necessary to prevent,
2	recommendation respecting such
1	reason for deferral;
1	paragraph. (c) advisory
1	every inventory or
1	secretary for reports
1	processed food, a
1	local regulation (a)
1	attorney general files
1	procedures adopted by
1	responsible for contaminated
1	determination was made,
2	(a) or paragraph
2	drug sample to
1	upon whom a
5	 (2) prior
3	major portion thereof
1	physicians office. the
2	9, 2012, a
3	assessed only one
1	pending requests. 
1	license contains any
1	means a compilation
1	fees.  (june
1	business records of
1	agencies; (b) consult
1	part, or examination
1	ultimate sale to
2	(7 u.s.c. 1421
1	program strategy shall
1	response letters which
1	sections shall at
1	contribution no-federal funds
1	(i) or, if
1	proposals and give
1	articles shall, upon
1	per package, and
10	action may be
2	commission may be
1	imports of narcotic
1	necessary packing and
1	(ii) notify the
10	annually thereafter, the
1	may incorporate any
1	may be 
1	committees, and to
1	request. (c) any
3	inspection program of
1	shall be disposed
1	conveyance or relating
1	residues, (b) identify
1	committee on ways
1	(a) until notified
1	basis, in the
1	small business 
1	advertisement with the
1	federal government during
1	
 
 94
6	tolerance is in
1	trade commission, when
1	(a) basis for
1	increasing or decreasing
1	conduct of litigation
1	human use in
1	(d) the role
1	slaughtering and handling
1	recordin this section,
1	itemthe term poultry
1	research) to the
1	human use if
2	repealing, or superseding
1	reconsider the previous
1	entity independently of
2	new drugs 
1	iii of part
1	(b) food transportation
1	taken by a
1	including surrogate endpoints
1	promptly facilitate gathering
1	modifications to such
1	maintained, and for
1	budget an impact
1	on-year period described
1	published after june
1	secretary through june
1	diem instead of
8	institution of a
1	ch. 675, 563,
1	 (b) exemptionupon
1	indicate whether the
9	received within the
6	subparagraph (a) is
1	dealing and licensed
2	support the actions
1	(b) certain programs
2	appropriate conditions designed
1	(c) electronic format
1	resources directed towards
1	immediate precursor in
3	conditions exist necessitating
1	ensure  (a)
5	subparagraph (a) if
1	food imports into
1	bureau with a
1	monitor clinical trials
1	obtained a controlled
1	review of medical
2	device, or (b)
1	term manufacture means
2	grase for use
1	determines that product
1	exclusively for purposes
3	records documenting the
1	development, accelerate innovation,
1	producers do not
5	approve or deny
1	treasury department in
1	food sampling and
1	subsections (c)(3), (d),
1	chapter is pending
3	drugs, including 
1	may, after the
1	fungus; (ii) may
1	
 151. preparation
1	section to have
1	(7) in accordance
1	notwithstanding section 2680(k)
1	within such country;
2	traveltime; and while
1	952, 953, and
5	shall be considered:
2	(i) as of
1	level, are feasible,
1	change in production
1	importer means, with
2	conferred by section
1	applicants whose prescription
4	secretar-general of the
1	corned, packed, cured,
1	persons who distributed
1	repealed. (feb. 15,
1	period, be considered
1	generalthe regulations under
1	clinical trial have
2	without obtaining from
1	laws to inspect
1	updated guidance under
1	575, as added
1	estimated completion dates
3	 (c) publication
1	886. payments and
3	notify the applicant
1	2015, any person
1	term safe as
1	industry, agricultural producers,
1	conditions as are
1	forward such determination
1	carcasses, parts, or
1	director shall cause
1	revoke the grant
4	section 352(f) of
8	establish a program
1	written request made
1	whether existing legal
1	regulation, determines is
1	food, a copy
1	spice, including strawberry,
1	said secretaries, permit
1	export, and (d)
5	means a facility
1	(e) diagnosis, prevention,
1	respect to pet
1	general any state
6	drug which is
2	federal register for
1	party determines that
1	commission may secure
1	fashion; and (e)
1	accommodate the unique
3	regard to section
1	may contain, an
1	salts, yellow phosphorus,
1	enforcement strategies which
1	paid under subparagraphs
1	overseeing the timeliness
1	(3) articles used
1	determining the quantity,
1	general designates, pursuant
1	relevant enforcement action
1	tins, pots, canvas,
1	terminated under paragraph
1	states a prescription
1	settled the informal
10	product directly from
1	transaction means the
1	drug, provided such
2	packaging, and shipping
1	(b)(1) shall provide
1	transportation safety offenses
1	350j(c) of this
2	engage in wholesale
1	rehabilitate victims of
2	(1).  (

1	intramural research can
2	united states shall,
1	subsection (d); (3)
1	information, a fee
2	training and inspection
1	shall be considered,
2	(b)(3) to submit
1	teaching or chemical
2	ii  (a)
1	24, as added
1	specific methodology be
1	(including special labeling
1	singl-use device, means
1	application of annual
1	manufacturing process. 
1	(1) antibiotic drugs
5	business entities. 
1	tobacco; and (2)
1	grant recipients; (2)
1	relates to product
5	interest of the
1	sworn to before
1	shall undertake enhanced
1	(2ce). (21) -(2,-dimethox--methylphenyl)ethanamine
1	of, a significant
1	regulations for imports
1	subclause (i); or
1	recommending any modifications
1	law administered by
2	duties prescribed by
1	departure from such
1	committee act. (9)
1	application fees, supplemental
1	associated with carrying
1	pediatric subpopulations; and
5	copying or verification
1	deadline to create
1	funds for methamphetamine
2	tracing at the
1	licensed physician or
1	organization or from
7	illegitimate product, a
1	1191 to 1193.
4	person, if any,
2	chemical with intent
1	advertising. for purposes
1	peer review process
1	paper in section
1	include, but not
2	less than 50
1	adoption of measures
1	eligible coalitions demonstrate
1	drug expected to
2	effectiveness claim; or
4	use and disposition
1	prosecutions of offenses
4	costs paid from
1	inspect and ensure
1	(f) technology transfer
1	pay a subsequent
1	take effect only
5	involved is a
1	subsection by any
1	recalls or regarding
1	body in good
2	fiscal year preceding
1	sea food on
4	may, by petition
2	use, and is
3	secretary showing that
2	change, the holder
1	fiscal year 2000;
2	(b) after the
7	received or otherwise
1	use, the manufacturer
1	title and which
1	foundation and its
25	shall take into
13	drug administration salaries
1	(i) application refused
3	department of the
1	antifungal drug shall
1	order. in actions
1	except in emergency
2	provisions of such
1	may be symptomatically
1	issued a declaration
2	development fee as
1	(a) an infant
1	time taken to
1	following the last
1	development and dissemination
2	used in compounding
1	jurisdiction proceedings for
1	delivery thereof for
1	(2) required informationthe
2	materials and equipment),
67	secretary of the
2	higher than he
1	consumers, if, in
1	confirm the identity
1	including a person
1	analogous product shall
1	(2) shall apply
1	applicable state, federal,
2	coordination and cooperation
1	(1) or set
1	 (2) determination
1	(1).  (j)
1	placement on schedules;
1	shall apply for
13	1, 1944, ch.
1	treat that stage
1	 (i) withdrawing
1	secretary shall reconsider
1	development in accordance
1	encourage the creation
4	352(o) of this
1	treasury may invoke
1	section 524(c) of
4	shall thereafter be
1	advertising. notwithstanding the
1	year 2009 for
1	seal any controlled
2	(ii) if such
1	ingredient) of a
1	section 1802(18) of
1	(2) the notification
3	subchapter. (feb. 15,
1	obtain federal cooperation
2	importing, such articles,
1	use restrictions for
1	application the assessments
1	(3)(b). not later
1	contain not more
3	applicant the opportunity
1	drug involved caused
1	reductionthe term demand
1	reasonable manner, and
1	cooperation (a) in
1	uses within such
1	fiscal year, notwithstanding
1	performance standards established
1	(1) if during
1	830. regulation of
1	fund the inspections
3	racemic drug has
1	
 114 to
2	review. (g) meetings
1	accept a declaration
1	
 356f. hospital
1	assistance act[1] [25
1	targeted drug to
1	person. (ii) if
3	be, pertaining to
2	product sold, the
2	products at the
1	petitioner has a
1	period involved. 
2	section 1532(a) of
2	section to the
4	binding on the
4	small packages shall
1	effect.  (9)
2	general shall limit
3	hearing and final
1	paragraph (8)); (b)
1	oxygen that meets
1	entity and which
1	technologies, which may
1	made if 
1	experience data and
1	packaging, in order
2	2016, $2,976,000 for
1	published from time
1	prohibits lawful disclosure
3	person who forcibly
2	biological product a
1	hazardous to health;
7	identical to the
1	determination has established
2	nonfood products that
1	grown; or (ii)
1	warning letters, and
2	exportation of controlled
1	605. examination of
1	(b) alternative methodsthe
1	1, 2003, an
1	term authorized distributors
1	order to achieve
1	conducting vulnerability assessments
1	uncondensed gothic letters
1	be.  (4)
1	safety capacity of
2	enacted providing for
7	surveillance and studies
1	accessory is intended
1	sunscreen order of
2	burdensome to a
1	section 384(e) of
1	foodborne contaminants. 
1	immediately submit a
5	entity if, directly
3	persons specified in
1	reclassified in the
1	use, been exempted
1	reviewable. (june 25,
1	sunscreen order or
1	quarterly to include
1	identify methods and
2	commercial distribution which
1	secret information subject
1	(a); (iv) in
1	limitationsthis section shall
3	et seq.], as
5	quality, or purity
2	drug administration may
1	notifying the public
1	support and encourage
1	financial capacity with
1	illness outbreak. (c)
1	(2) limitationthe secretary
1	proposed active ingredients,
2	subparagraph (5), reasonable
1	use; (4) the
2	affiliates, or that
1	otherwise applicable statute
1	upon application for
1	modification of any
2	determine the effectiveness
1	within the system
1	may supervise the
1	shall, in any
1	morphine or preparation
3	communication and coordination
3	business or to
1	(c) an adverse
1	delivery. the term
1	device, that the
1	register (or, with
1	thefts or significant
2	330.14(g) of title
6	applications.  (2)
1	desire of such
5	portions of carcasses,
2	(ii) a class
1	cautionary statement and
1	drug products pursuant
64	engaged in the
1	title,,1 the responsible
1	information also appears
1	sentence on such
1	commissioner. (2) a
1	distributors:  (i)
1	(7) community ant-drug
1	review in any
1	often as needed,
3	(j)(5)(f), subject to
1	(2) has made
5	postapproval studies and
1	title. the owner
1	for, the same
3	taken under any
1	hig-risk foods and
1	list i chemical;
1	list i chemical:
1	conditions shall make
1	finally, unused advisory
1	twent-four percent shall
5	list i chemical,
1	drugs or containers
1	list i chemical)
1	chapter, which are
5	public meeting to
1	means the nonprescription
2	construction, components, ingredients,
1	investigations  (1)
2	state will activate
1	safety information if
1	class ii to
1	increase and spread
1	cause shown, keep
1	whose effective dates
2	drugs and animal
2	requirements of subclauses
1	subsection (a)(3) on
1	title; (3) for
2	(i) immediately notify
1	labeled and packaged.
1	convention and that
2	government as the
5	storage, cartage, and
1	public availabilitynot later
1	actions alleging inadequate
1	yellow over red,
1	(j) and the
1	(pyridoxine) (g) 35.0
1	(f) critical informationexcept
3	clauses (ii) and
1	subsection in class
5	treaties, conventions, or
1	associationsany person other
1	arrives at the
1	intent of congress.
1	impact on each
1	surveillance for preventing
1	 (i) capture
1	319f2(c)(2)(a)(ii) of the
2	exceed $15,000 for
1	(2) model accreditation
1	8, code of
9	deemed necessary by
1	subsection (a)(3) of
1	
 154. regulations
1	need the term
2	distribution in violation
2	use recommended or
1	limitations shall toll
1	communities and undermines
1	section their recommendations
3	workload adjustment for
1	communication strategies between
1	safety and integrity
1	factory or establishment,
5	fee is due.
1	effect, the person
1	section for media
1	may be achieved
1	filing the request
3	factors to be
3	imported pursuant to
1	strategy and policies
1	interstate and controlled
7	equipment, and other
1	term abbreviated drug
1	subsection notwithstanding a
1	class of products
1	salt, optical isomer,
1	development, or the
1	[part], as added
1	environmental, prevention, social
1	11 of title
1	models that could
1	failure to the
2	employee, upon presentation
1	initiative, establish a
1	bioavailability studies) 
1	secretary, including technical
2	audit under this
7	witnesses and the
1	target state and
1	partners of the
2	secretary disclosures of
1	repackager shall identify
1	party has systems
24	 (a) 
1	armed forces, under
1	 (e) distributors
2	275 miles from
2	distribution of eggs
3	commission under section
1	including reasonably appropriate
1	provided the results
1	in, or exercising
1	storage are not
4	387g, 387h, 387i,
5	period; and (ii)
1	state authority; (4)
1	recallthe secretary shall,
3	waiver or refund
1	waivers from the
2	agencies and state,
1	assessed shall be
1	
 196. repealed.
1	determined after such
2	shall enforce this
8	label or labeling
1	contains any material
1	analysis samples where
1	marketing such new
1	meeting. (b) annual
3	basis of an
2	prosecuted by an
2	section is no
2	within one thousand
2	provided under section
1	$11,250,000 in advisory
2	drug could be
1	substance, and each
1	
 
 617.
1	thereto) that 
1	(b) which occurred
1	(b) reduction in
1	shall give interested
2	program includes performance
1	(15) quarantine the
1	(2) sell, transport,
1	producer.  (b)
1	reduced cost, for
1	209. poisons; book
1	devices contained in
1	$299,000,000, as adjusted
1	enhance the scientific
12	may have been
1	treatment shall obtain
1	subsection pursuant to
1	apply;  (c)
2	information respecting all
1	additional nominees if
2	secretary, as the
1	consumers as a
1	subchapter v shall
1	nicotine means the
1	partial waivers granted;
1	(b) final guidance
1	judicial review in
1	establishments of that
1	penalty is calculated
1	species, or their
1	adequately shown through
1	inclosed in cans,
2	section 5(b) of
1	including the grade
1	chapter because of
2	seller, as provided
1	new safety informationthe
1	title, monitor the
2	inspection, sanitary, quality,
1	data every manufacturer
1	pathogens and other
1	societies; (ii) medical
1	shall establish, by
1	new products; (c)
1	claiming an interest
1	benefits which are
1	shall remain liable
1	acts of agents
4	applicant has no
1	dispenser received from
1	355(j)(5)(f)(ii) of this
3	dispense, or possess
1	(i) a list
1	general may enter
1	slaughter.  (c)
2	may be extended
1	45(a) of title
2	allocate resources to
1	 (f) limitation
1	14 days before
2	stat. 632.)
 

1	analysis.  (3)
1	relabeling, or testing.
1	disposal will permit
1	 (f) availability
2	program agency for
1	trials. minutes of
7	section.  (e)
1	(3), nothing in
1	carbon monoxide that
1	dismiss a complaint
4	punch, die, plate,
1	term pediatric subpopulation
1	retain the rights,
1	defined as a
1	(b), and the
3	fees.  (c)
2	food, in the
13	date of enactment
1	section) and did
7	eighteen years of
1	forms subject to
4	formal changes in
1	period, the sponsor
1	drug, because of
3	subparagraph does not
1	and, upon so
3	imposed on such
1	effective period notwithstanding
1	applicable to infant
1	applications; and (2)
1	informing the review
4	address of each
1	effort resulting in
1	make payment when
2	standard and, insofar
3	paragraph (1). such
1	programs of eradication
1	secretary regarding such
1	united states constitution.
1	undergone further processing
1	panels shall submit
1	subsection (k), upon
4	treasury pursuant to
1	judicial proceeding, any
2	conviction which served
6	present a risk
1	(1)(a)(i).  (r)
1	interstate incidents of
1	noncompliance with such
1	title; (f) did
1	(1) any carcass,
1	agencies with experience
2	residue is present
1	27, 2013, including
1	attended by the
1	applicable period, a
2	effect, but no
3	product which has
1	processed for credit
3	product only if
1	(b) prescription by
1	(a) in generalsubject
1	proceeding in court
1	certification  (i)
1	recipients; and (c)
1	title iv, 410,
1	(iv) is made
2	veterinaria-clien-patient relationship, as
1	hire, promote, compensate,
1	owner, lessee, agent,
6	assistant secretary for
1	supply.  (iv)
1	will be permitted.
1	authorization in any
1	psychotropic substances, which
1	use:  (i)
4	commence a civil
1	panels of petitions
1	individuals.  (3)
1	(2) petition contents
1	(i) established by
1	verification, residue, and
1	ingredients subject to
1	constituting the initial
2	methods for determining
1	secretary) may not
1	carrier does not
2	period of 45
5	use of fees
1	program to improve
1	cretinol equivalents. 
1	relationship of likely
1	107. omitted
 

1	drugs.  (9)
1	regulatory agencies of
1	(a) reviewing the
1	results and records
1	excluded (or directed
1	device applications subject
1	providing inspection services
1	analysis, documenting hazards,
2	title 5. such
1	action under other
1	commerce. however, notwithstanding
1	
 463. rules
1	ch. 155, 8,
1	general fees appropriated
1	initial approvalif the
1	dru-related offense not
1	171 to 174.
1	views shall be
1	 magnesium (mg)
5	term serious adverse
1	months with respect
1	market; (d) may
1	supervisors, receives training
3	paragraph (1)(a), the
1	826(h) of this
1	comes in direct
1	disease product. (iii)
3	documented by local
3	basis pursuant to
2	secretary shall evaluate
3	secretary of veterans
1	practice, or except
1	(4) private sector
1	making a material
1	judgment as set
2	package.  (f)
1	effective any final
1	(d) foreign facilities
1	colleges (a) penalty
1	chapter that any
1	of, any other
1	promulgate proposed regulations
3	test marketing) in
3	plans, assessments, deferrals,
2	court or grand
3	place such applications
1	growers.  (b)
1	(2) provide assistance
2	stating the reasons
1	(a), shall ensure,
1	(11) clonitazene. (12)
1	90 days. if
1	required under subsection[1]
1	account which shall
1	distributes a device
1	classes of nanomaterials
1	implant; or 
1	(e) fees the
1	chairman, and any
1	maintenance agreement a
6	approved in another
1	submit a plan
1	designation of united
1	provided under an
1	violations resulting in
1	required to terminate
2	inapplicability of certain
1	president determines that
2	products have been
1	(iii) the nurse
1	performance goals and
1	prescribe the scope
1	conditional dose; (d)
1	licensinga drug or
1	cleansing, beautifying, promoting
1	forfeited, and to
4	minimum, includes the
1	permits to which
6	secretary may approve
2	 (2) limitationthe
1	regulated transaction with
1	country does not
1	distribution of electronic
3	entities which are
1	regulation of drug
1	conformity is not
1	(c) administrative recordfor
5	delivery of such
1	clinical protocol). if
1	business shall submit
1	drug substance to
1	first production of
1	rulemaking under section
1	removed for dispensing
1	application is filed,
3	application is filed.
1	pays an initial
4	adjustment factor. 
2	include sufficient information
6	title.  (i)
1	documents to carry
1	important to the
1	years falls below
2	type of valid
1	require the following:
1	use, other elements
4	(a) it is
1	extortion, falsification or
1	free to exude
1	title shall govern
4	may be paid
1	thereby to procure
1	(including a device
1	small businesses; (b)
1	federal regulations) that
1	size of such
1	(b)(1); (h) a
1	subsection (a) may,
1	350e(c)(1)(e) of this
2	expertise available to
1	ch. 675, 714,
1	heightened risk of
1	355(c) and (d)
1	facilitate continual device
1	communication information provided
1	recruitment or placement
3	date certified under
1	5332 of title
1	data, personnel data,
1	use for animals
1	testing services the
2	(including small business
1	subchapter; except that
2	health care providers.
2	days after march
4	health care providers,
1	authority would reduce
1	reviewing applications under
16	fees collected under
13	secretary  (i)
13	secretary.  (c)
1	emergency situations. 
1	(b) benzyl cyanide.
1	request, (ii) the
1	therapies through regulatory
1	(iii) as a
2	(ii) on the
1	321(m) of this
3	 (c) a
2	discontinuance or interruption
1	disclosure for other
1	notification requirements under
1	models for pediatric
3	18 or $1,000,000
1	section shall, after
1	subsection (f)(6)(f) distribute,
1	laboratories and laboratories
1	actual compliance with
1	disputes concerning fees
1	months. any content
1	paragraph (2) upon
1	(including financial records)
1	(a) otherwise applicable
3	 (2) implementation
2	262(a)] for the
1	agencies, schools, early
1	section, or both.
1	class ii if
1	exclusivity period. (iv)failure
1	identification, by the
1	lot level data.
1	food is at
2	given by the
2	class ii in
1	
 379d3a. hiring
1	proceeding, or has
1	district wherein any
1	device, including a
2	tests by all
2	domestic animals, and
3	employees, including employees
1	(2) applicable period
1	section 387q(a) of
1	notify the manufacturer
1	 (1) protects
1	filed or which
1	disclose relating to
1	diversions, (d) programs
5	limitation on the
1	experts (including both
1	paragraph (1)) that
1	iv, unless the
1	device provides information
1	submit copies of
1	parts, or products
5	cease to be
2	(adjusted for changes
2	psychiatry, the american
1	conspicuously bears the
1	conduct, coordinate, and
1	sunscreens marketed in
23	products scientific advisory
1	frequently the subject
1	(5) conflicts of
1	rights, safety, or
2	electronic product as
2	subsection (f) to
1	court with regard
1	may include charging
1	november 1. 
2	serious risk related
1	institutional review committees
1	plant, any other
1	 (iv) no
1	application. (ii) if
2	using the drug
1	(d) ergonovine and
1	person shall forfeit,
2	section 552(a)(4)(a) of
1	specific countries and
3	buy or sell,
1	customers or importers;
1	 (5) fund
1	transportation, the secretary
1	receives shall be
8	 (c) no
1	treatment of opioi-dependent
1	certification of policy
2	include the lot
1	quarter; and[4] 
1	updated notice for
1	convicted of engaging
2	secretary may return
1	agreement.  (2)
2	article that are
19	sell, purchase, or
2	group purchasing organization
1	may be withdrawn
5	opportunity to cease
1	medical expertise, and
1	relapse prevention; and
1	back expansion (a)
1	notification requirement under
1	v of part
2	guidelines for the
1	practicable, so as
1	institutional review committee,
1	(6) lists the
1	463. rules and
1	involved is to
3	means review and
1	panel to assess
1	chapter: (1) entity
2	body or any
1	application. (5) 
1	subchapter iii to
1	concerning the variability
1	within a distance
2	advertisements prior to
2	subparagraph for a
2	(c); or (ii)
3	request if the
1	sector and 1
1	exclusivity  (1)
1	previously approved in
1	(1); and (10)
1	improving foodborne illness
5	(b) review of
9	product which is
1	cost or at
1	thereto. (j) the
1	 (ii) agreements
1	initiated, if the
2	opportunity for such
1	produce drugs in
1	diagnosis of disease
1	significant question has
1	1952, ch. 477,
2	clinical trials in
1	registration renewal for
1	seal of controlled
1	constitute advisory opinions
1	per meeting. 
1	name of that
1	primarily to natural
1	imported drug, provide
2	delegation the authority
1	site of transporting
1	immediate trading partner
1	modify a tolerance
1	8 hours of
1	relief as provided
1	shall be waived.
1	regulations (including such
1	adequate for review,
1	demonstrating that individuals
1	shortage, the qualified
2	regulations when such
1	inventory reports shall
1	seal; (8) to
1	states and foreign
1	disclosure to the
3	anabolic steroid or
1	responsibility for food
1	studies in adults,
2	assisting in the
1	receives the recommendation
2	(i) appropriate credentials,
1	used to make
1	shall be separate
1	(b) any modification
1	(b)(1) because the
2	refers to a
25	year shall be
1	meaning of subparagraphs
1	party to 
4	(c), the secretary
1	possible, give interested
1	states dollars, for
1	united nations in
1	drug; and (v)
3	human food, but
5	chapter may not
5	liable to be
3	food because it
1	strength which is
1	amendment) greater than
1	products; or (b)
3	authorization is issued,
2	particular class of
4	fiscal report beginning
14	controlled substances act
7	request made under
1	(c)(1)(c).  (b)
2	effective for one
1	expired.  (ii)forfeiture.
7	secretary to the
2	 (b) such
1	extension is pending.
1	 (c) descriptive
1	importer, or (ii)
1	data; (b) sales
2	type of food
1	information among national
2	drug and that
1	penalty may be
6	aggregate exposure to
3	drug, as used
1	products, and other
1	will prevail on
17	mules, or other
10	shall be effective
1	(i) or for
2	enforceable contract. any
1	may approve the
1	fewer than 24
2	title; (d) if
1	secretary of device
1	availability of certification
1	device recall audit
1	shall promulgate to
1	 (b) grants
1	term egg means
1	charitable contributions notwithstanding
1	products agreed to
1	small businesses to
1	 (1) declarationscongress
1	misbranded food if
1	(c) employing children
1	employers any person
1	 (ii) nonsaleable
1	year such that
1	affiliate, an animal
2	distributors of controlled
1	(2) establish shor-range
1	hand, except that
1	justice and protects
4	1532 of this
1	report. (2) 
1	disclosed pursuant to
1	burden illicit drug
1	improvements and initiate
1	(3); and (i)
4	schedule iii, such
1	-year periods. (3)
1	supply reductionthe deputy
2	notice and in
1	smoke, no smoke,
1	services for advertising
1	(b) requests for
1	authority would unduly
1	registration or form
1	holder provides written
1	good cause therefore.
2	outbreaks during the
1	 (2) examplesexamples
1	communit-wide prevention strategies
1	treatment, when such
1	substance (in any
1	term egg product
1	relevant databases within
1	qualifying it for
1	term device does
2	timely written application
2	labeling and promotion
2	comments on dtc
1	policy required for
1	concerning the inspection
1	implementing this division
1	may be. (ii)
1	(a)(6) through regulations.
1	publish the results
1	398. notices to
1	compensation  (a)
2	product, a sufficient
1	manufacture animal feed
3	general shall submit
1	reviewing the guidance
1	chapter 98 of
1	(2) ensuring safety
1	change to number
1	fishing vessels the
1	secretary for dietary
1	subject to three
1	act, uses a
1	department of education,
1	submitted to it
1	 (a) more
1	semiannual basis during
1	development. (7) 
1	devices or cosmetics,
1	amend section 331(j)
4	produced or distributed
1	(j)(5)(f)(ii) of section
2	regulations under part
2	subsection as a
1	subparagraph (a). fees
1	(b) the development
1	modifies under subparagraph
5	clinical investigations (other
1	neither adulterated nor
9	means any person
1	matter included in
1	issue the order.
2	food, cosmetic, and
6	section or under
1	review and duplication
1	(c) detect trends
2	stamp, tag, label,
1	(ii) such fees
1	article is ordered
1	activities could be
2	reports.  (2)
1	states shall also
1	exist necessitating the
1	word poison, the
1	grants any petition
1	statementsthe interpretive criteria
2	testing by the
3	assure the safety
1	(b) promptly notify
1	brand name, or
1	813. treatment of
1	(d) consistent with
1	required. registration applications
1	(a)(iii) for a
1	rendered other than
2	establishments, the unique
1	coloring matter, and
1	supply are rapidly
2	(f) assessment of
1	 (iii) perform
1	committee; or (ii)
1	relevant international organization
1	generals determination. the
1	(ii) such condition.
1	central nervous system;
2	proceeding of the
1	day and was
1	provided, that carcasses,
2	(the opportunity to
1	process for timely
1	reference. (e) fee
1	secretary determines exceptions,
4	unless the use
1	central nervous system.
1	
 872a. publi-private
2	central nervous system,
1	conditional approval for
1	accounting (including information
1	members.  (b)
1	education, or treatment.
1	person who uses,
1	conference is requested
1	(a) law determinative
1	staggered basis, as
1	appropriate, that the
1	unsatisfactory to the
14	assessed under subsection
1	material from tobacco
1	ch. 675, 517a,
4	alter the authority
1	requestor may be
1	federal animal quarantine
2	connection with rulemaking
1	implementing general policies
3	may reasonably require.
1	identifying any drug
58	subsection shall be
2	environmentall-approved herbicides to
1	drug applicationsthe following
2	 (i) registration
1	 (2) consent
1	purpose or (3)
1	eligible partnership means
4	may be held
1	medical gases (a)
1	personal assistance), or
2	secretary may (for
1	measure relating to
3	inflation adjustment factor
1	animal inspection and
1	occurrence of identified
1	regulations, authorize the
1	located in noncontiguous
1	evaluate implementation of
4	product application and
2	department of defense,
1	$20,000,000 for fiscal
2	1, 32 stat.
1	warning statement concerning
1	person regarding proposed
1	
 360m. accredited
1	provide the appropriate
1	studies (including neonates,
2	otherwise adulterated or
1	1391 of title
1	establish a task
1	reduce harm and
2	including small businesses;
1	(e) such device
1	 (c) objectives
1	analogous compounds with
1	(xiii);  (xiii)
2	item shipped in
2	information:  (a)
2	timely and efficient
1	psychiatry or addiction
3	unless extraordinary circumstances
1	(ii) providing that
1	marked inspected and
2	(2) may be
1	regulation from such
1	animal drug and,
2	detailed from federal
1	facilities in a
1	 (2) transportation
1	cause a serious
1	withdraws the application
1	government during the
1	exception no fee
1	patient quality of
1	-penty--(-methy--naphthoyl)indole (jwh122); (x)
1	relating to investigational
1	approving the extended
1	2011.  (4)
1	1, 1970; and
3	posted on the
2	consumers (and major
2	establishments in conformance
1	inspectors when necessary
1	enhancing and expanding
1	targeted by the
1	entities. a written
1	administrator shall, upon
1	title 5and which
1	official in the
1	partyin any civil
1	considers that waiver
1	(l), and the
1	availability of funds
1	entity, fined not
2	chemical on that
2	development, evaluation, and
1	 (i) importation
1	efficacy standard for
3	order published in
1	requested and present
1	treatment. (2) duties
1	states the secretary
1	administration and food
1	programs in existence
3	food and the
1	sentences of subsection
4	hearing by written
2	law prohibiting the
1	thereof, any nonnarcotic
1	engaging in research
1	pesticide monitoring and
3	drug product fee
1	(8) whether the
1	individual in charge
1	statement, invoice, or
1	$30,000,000 for the
1	eligibility determination on
1	 (c) pizzas
1	52 stat. 1059,
1	base; (iv) 100
1	opportunity to submit,
2	product application was
1	paragraph (1) against
2	new device and
1	devices (a) new
1	treatment of one
1	percentages described in
1	adulterated articles; good
1	effect upon interstate
1	section 5304 of
1	formula. (b) the
1	violates sections 552
5	52 stat. 1059;
1	necessary, cause to
13	health and safety.
1	attorney general, before
2	acting through one
1	stat. 511; amended
2	assurance that such
1	expertise, to review
1	(i) is exempted
1	unfinished drugs, listed
1	device effectiveness. the
2	will be monitored;
1	inspection services; hearing;
1	section 661(b) of
1	(4)(a), as a
1	energy and commerce,
1	relating to eggs,
3	eligible entity certified
2	states, including its
2	association, or partnership,
1	compensated at not
1	secretary not inconsistent
2	acquisition by a
1	symptoms of a
1	enable the manufacturer
2	prior to public
1	provide for oversight
1	criminal enterprise definedfor
2	available drug product.
2	law  (a)
2	elects to use
1	u.s.c. 45(b)] respecting
1	universities, colleges, other
1	
 360ddd. definitionsin
5	new infant formula
1	product, the secretary,
1	payable to a
1	approved; and (iv)
1	require shippers, carriers
1	(2) the severity
1	304, 402, 403,
1	role of the
11	class i or
1	penalties. (
 

1	both, with or
1	foreign government, agency
1	transacts business or
3	provided, that upon
1	area; and (2)
1	performed by such
1	animal drugs; or
1	shall be ground
1	order. the advisory
1	nothing in such
1	cosmetic, or the
1	substance to underage
1	confectionery is intended
1	stakeholders consistent with
1	586e, as added
3	paragraph (1) unless
2	chapter. a regulation
1	authority to impose
3	exempt from specific
1	360b(c)(2) of this
1	need to control
1	symptomatically and pathophysiologically
2	if, before the
1	early interactions to
1	review submission to
1	 (c) receipt
2	place stated in
1	territory, when the
2	(4) a report
1	opium convention signed
2	device establishment, the
17	respect to each
1	addictio-sustaining liability. (b)
1	clearly indicates otherwise,
1	effectively disposing of
1	services; (b) the
4	carryover balances for
1	petition, that a
1	harmful, any party
1	considered inspections under
1	medical data in
3	produced and handled
1	otherwise) notifying a
1	section 355(c) and
1	term sanitary protection
1	scientists; appropriations the
1	evaluation, or use
3	1996, the administrator
1	(b) very small
1	prescription medications, specifically
1	entities and may
1	nolo contendere by
1	
 360ddd1. regulation
2	permit an authorized
2	may be counted
1	capacity of a
1	receiving such approval,
1	(vii) 100 kilograms
1	331(i)(2) of this
1	conduct an annual
2	safety for use
1	exception any time
1	determination to leave
1	circumstantial evidence of
1	requirements.each contract with
1	 (m) color
1	adolescent brain development
1	written order or
10	court costs and
1	organizations. of such
1	
 355f. extension
1	standards and administer
1	establishment of officethere
4	12, eff. june
1	petition. except as
1	convictions for a
1	data the food
1	holder to comply
1	notify such persons
1	information.  this
1	expenses for 
1	 (a) investigations
2	tobacco products by
3	effectiveness of drugs
2	assembled, or imported
1	149. definitionswhen used
1	c-licensed partner, a
1	principles that the
1	combination with respect
1	inspection of meat
1	(if applicable) under
1	(a) shall identify
1	easily used in
1	person from using
1	 (iv) relief
1	years to ensure
1	sel-certify as required
1	funding from funds
1	ii and class
1	tolerance found by
1	supply reporting programs
1	timely, informed consideration
1	petition. the court
1	(4), (5), and
1	formulas necessary and
1	complete, including being
1	report requirements of
1	reimbursement is a
4	nutrition act of
2	will be significantly
1	act took place.
1	may not support
2	human services, determines
1	engaged in flagrant
1	(d) that the
1	may be entitled
1	document to aid
1	days, to have
1	patient a clinical
4	(a) general rule
2	federal agency (including
4	misleading form or
1	 (b) chairperson
1	act that require
1	delivery of food,
1	time when a
2	guidance from the
1	african trypanosomiasis. (j)
1	discontinuance. the secretary
3	sectors within the
1	ingredient becomes available
2	served in meals
1	media campaign will
1	handling requirements found
12	including the standardized
6	action of the
1	preparation by him
1	hazard or reduce
1	application and prior
1	contracts under subparagraph
2	exposed to a
1	statement except with
1	(2) product the
1	smoke of each
1	regarding such article,
1	administrator under subparagraph
1	least 95 percent
2	j of part
1	petition for designation
1	support and take
3	case of property
1	initial reportthe secretary,
1	document that establishes
1	human use contained
1	pediatric formulation, may
1	42, including with
1	 (2) timely
1	condition, prohibition, or
1	(e) the distribution
1	renders the registration
1	review the contract
1	(b) second offenders
1	 (3) except
4	secretary in response
1	drug application, (b)
1	possessed in violation
3	on-half years to
1	qualify such thir-party
1	medicine therapy includes
1	display for 14
1	(c) secretary of
1	government authorized to
3	262(a)] for which
1	acknowledgment from the
4	 (ii) making
1	risk assessment methodologies
1	general, the associate
1	authorize any nonnarcotic
1	labeling exemption for
1	drug. (vi) the
2	form (which measures
1	sponsor fees, animal
2	current level due
1	transaction in listed
1	paid. if the
1	application). the secretary
8	contractors of the
1	determination of status
1	list, required to
2	shall allocate resources
1	considered as communication
1	quantities of methamphetamine
1	purposes, approved march
3	cause to believe,
1	days, unless extended
7	acts, or otherwise
1	shall receive the
1	concerning nonprescription sunscreen
2	(b) definitionsfor purposes
1	animal drug, (ii)
1	traffic therein, and
1	comprehensive communit-wide prevention
1	will implement and
5	united states any
1	subsection (a)(1)(b) of
1	controlled under this
1	compendium. (b) nitrogen
45	united states and
1	held under refrigeration
3	identifier of each
1	dru-related activities. (

10	violates subsection (a)
1	corporation owing permanent
1	(a). the tobacco
1	bears such responsibility.
1	3,-methylenedioxypheny--propanone. (m) methylamine.
1	patient registries, or
1	agency centers and
2	prevention, the food
3	methods and approaches
1	chapter shall have
1	filed by united
1	(3) the court
1	possess.  (d)
1	term different technological
2	available, information regarding
1	website. such policies
1	death from the
2	(f) protected informationa
1	(2) submission of
1	ch. 675, 745a,
1	(3) flexibility for
2	held such food
3	section 343 of
2	animal drug at
15	drug intended for
1	drug administration exercised
1	commerce, pursuant to
1	limitation on number
1	section 381(b) of
2	requiring the device
1	reduction strategy upon
1	section 1005 of
1	licensing of inventions
1	drugs, the practitioner
1	containing a color
3	agriculture to provide
1	used such advertising
2	section 393(g) of
1	 (1) places
1	anticipated dietary exposure.
1	accepted scientific principles
1	substances and charges
1	requirement that a
1	application is subject
1	consideration of whether
3	revenue amount under
1	reckless disregard at
1	(iv) listing any
5	previous fiscal year.
2	section within 30
2	previous fiscal year,
2	signals and trends.
5	subpoenas requiring the
2	eight years, respectively;
2	information is received
1	exempt formula, be
3	identifier.  (ii)
12	previous fiscal year;
1	dried, or desiccated,
2	included in such
1	cancellation of a
1	unless such requirements
1	(b) action brought
1	expungement proceduresthe attorney
3	food subject to
1	conduct not fewer
1	products; (4) the
1	take such action;
1	including the development
4	marketed in accordance
1	report for prosecution,
1	laboratory supply means
2	information, report the
1	issue an alert
2	anticipated dietary exposures
1	(15) diethylthiambutene. (16)
2	completed with reasonable
3	amended to include
2	products of poultry
1	order, obtain review
2	title, or licensed
1	complete application that
1	(b) issues of
3	(v) carrying out
1	topic for one
7	amount of any
1	(b) the compliance
1	demonstrated expertise and
2	 (f) removal
1	additives which, with
1	states. (3) 
1	applicant withdraws the
1	ch. 675, 411,
1	commence an action
1	secretary or officers
1	with, the secretary
1	illegal gratuities, fraud,
1	provider under section
1	3.6 grams, without
3	engaged.  (k)
1	8811, 881a. transferred

1	held under conditions
6	take such actions
1	exemption, the administrator
1	previous fiscal years
1	health. (6) 
1	attribution of a
2	intentionally to possess
1	order a recall
1	service of orderan
2	use of amounts
1	substantial improvement over
2	food being adulterated
2	tribal government entity),
2	assure that adequate
1	drug administration stating
1	controls are necessary
3	applicant or recipient,
4	biological products 
1	data; (ii) prescribing
1	6-day period described
1	notwithstanding such definitions
1	prohibits or otherwise
1	least one institute
2	circumstance described in
1	injury results. (4)
1	reporting registrations and
1	nursing home, or
1	1056. separability if
2	(g), (h), and
1	title; (b) an
1	permit for a
1	part 803 in
1	device so listed
5	drug control policy,
1	applicants agreement to
2	69 stat. 685.)

5	(i) for the
1	use for cosmetics,
2	use, in carrying
1	section 352(r) of
1	practice is consistent
2	methods reasonably applicable
1	individual identified patient,
1	operate in any
3	adversely affected thereby
2	properly receive such
1	[21 u.s.c. 141
1	(2), if the
38	health consequences or
2	written notification of
1	cause inspection to
14	acquisition, maintenance, and
1	etc., arriving in
1	include transaction dates
1	purposes. the substance
8	prepared, packed, or
1	(d) operating reserves
4	may satisfy the
1	to, sliding boards,
1	effects on children
1	(b) vacancyany vacancy
4	secretary provides notice
2	case may be
1	(a) before the
1	individual) or an
2	secretary shall, except
1	producers, and nongovernmental
1	life imprisonment without
1	(28) the term
4	manufacturing practice requirements
1	transporting, shipping, or
1	drug beginning on
1	coalition as a
1	establishing requirements under
1	another subpopulation. (c)
1	appears that such
1	inspection, building, construction
1	slaughtered separately and
2	accredit persons for
1	importer, unless the
1	seafood examinations and
1	paragraph (1) except
1	 (d) program
3	acting in concert
1	grams. (3) not
2	address, and the
1	(a) the quantitative
1	title. (iii) the
1	procurement. (b) informationthe
1	levels, and regulations
6	year involved. 
1	(c)(1)(a)(i) for an
2	drug being misbranded
5	construed as requiring
1	operation of its
1	sources or methods.
2	policy related to
4	regulation, standard, or
1	building enforcement actions
1	(a) immediately cease
2	biomaterials suppliers (a)
1	1980, at least
1	according to fiscal
1	products; (2) improve
3	mark, or certificate,
1	columbia of dairy
1	expenditures of fees
3	pursuant to article
1	administrator relies on
1	identify strategies for
1	mitigate such risk,
1	schedule with a
5	applicant under federal
1	specific roles and
1	(a) protects an
1	of, two or
1	chemicals (including any
1	notice relating to
2	commissioned by the
1	including through expansion
1	201 of this
1	property, and such
2	approval of other
1	including by sharing
19	fungicide, and rodenticide
1	material the center
1	general has granted
1	(i).  (iii)
2	(ii)no independent cause
1	maintain records that
1	person occupies a
1	subpena issued to
1	sector; and (4)
13	title and the
1	shall consider a
1	designated under regulations
1	outcome assessment means
1	intelligence sources or
1	studies that the
1	assistance, guidance, and
1	small fruit and
1	 (b) limited
1	activities by such
2	receiving an order
1	(vi) information submitted
1	practices under paragraph
1	reasons including a
1	violate the provisions
1	issue of substance
2	sentence; probation; parole
1	subsequent country to
2	(3) not later
1	difficulty accessing health
1	(under standards established
2	rendered, boned, cut
1	feed directive requirement
1	(b) operates external
1	study (as such
4	kinds of business
3	safety and has
1	adopts changes to
1	shipment;  (ii)
1	outbreak response, inspection,
1	misbranded; or (c)
1	may assess bioavailability
1	operations and establishments
2	persons of the
1	state employees. 
2	animal drug from
1	(iii) correct errors
1	(6) an eligible
1	current or any
1	promptly issue a
1	(a) processing and
2	located in such
1	tobacco product exemption
1	administration, dosing schedule,
1	public posting of
1	(b) is a
2	determination under subsection
1	health or that
1	provide a substantive
2	(1) annual fee
1	import alerts; (v)
1	(a) upon completion
7	[7 u.s.c. 136
3	potential safety problems,
1	recuse himself or
1	use, when the
1	subparagraph (b) only
1	(24) furethidine. (25)
1	(b), the following
1	(2), to generate
1	funds to investigate
1	quality factors, good
1	available for consumption
2	requirement or other
1	wholesale distributor 
1	intends to manufacture
1	(a) to achieve
2	kitchen facility shall
1	shall have 
1	(
 
 849.
1	plant, fiber produced
1	containing three or
1	licensed entities in
4	u.s.c. 5301 et
3	processes, packs, or
1	subparagraph (a) unless,
2	study plan. 
1	institutions; (iii) recruitment
2	(7) are met
2	contemplated proceeding. nothing
1	normal life functions;
1	situations.  (b)
1	fiscal year 2006;
2	finds is not
1	change of a
2	secretary deems appropriate,
2	wholesome condition. 
4	punished as provided
1	506a, as added
1	(16) the term
1	shall consider among
1	282(j) of title
1	agreement. the rights
1	food by a
1	standards may include
1	health programs of
1	(2) food which
3	tools to assess
2	design, manufacture, promotion,
1	regulations. (h) limited
1	approved application, for
1	storage of packaged
1	standard by interested
1	agency to enter
1	assessing the number
1	may restrain or
2	 (b) detection
1	reasonably represents actual
1	(iii) validating any
1	upon implementation and
2	title; (6) the
1	criminal investigation in
1	eligible countermeasures for
1	chemicals usable to
1	within the administration;
1	require each individual
2	domestic animals, is
24	days before the
1	generallyfor the purposes
1	device because of
1	processor, and if
3	(3) contrary to
2	program; and the
2	commerce, for use
2	drug and shall
2	deciding a motion
1	year 1999, whichever
2	secretary and shall
1	forfeited and to
2	failed to do
3	infringement is commenced
1	chapter, and with
1	person file on
1	(a) are met
3	certified under section
1	year, as identified
3	promptly revoke the
2	title does not
3	subsection (c); and
1	public participation and
1	referral to tobacco
1	v.  (l)
1	approval filed under
1	reimbursement (user fee)
1	shall be reallocated
1	ounce or the
2	governing body or
1	41) to enter
1	also be provided
1	subject to, but
14	353(b)(1) of this
1	year. the establishment
2	affirmatively establishes, at
1	data and operational
1	offense have been
2	labeling to show
2	advertising that does
1	 (3) publication
1	assessing and evaluating
2	assure that any
26	subsection (b) of
1	verification which summarizes
1	applicable, that such
1	external experts are
1	trafficking threats and
2	food will cause
1	within its provisions,
1	considered an establishment
1	president a report
1	reporting, and disclosure
1	 (7) qualification
1	 (i) contaminated
2	effectiveness data are
10	required pursuant to
1	years. nothing in
1	subsection concerning first
2	regulation; (ii) provide
1	multiple sources, including
2	results, shall be
1	food harvested. 
1	(d) mixture with
1	(3) the narcotic
1	official duties of
1	right to judicial
1	agencies or private
1	(i) provide a
1	assessing and collecting
1	may be otherwise
1	materials, design, specification,
1	portion of poultry;
15	filed under paragraph
1	clinical trial information
1	drug use, and
1	resolved, recommendations for
7	drug with respect
2	petition, the petitioner
1	[7 u.s.c. 6501
1	long recognized the
6	adjustments provided under
1	exported, manufactured, possessed,
3	affiliate shall pay
1	clearance are informed
1	single report for
2	1 year of
1	duplicative notification. 
1	food for importation
1	reinspections; and (ii)
1	general for fiscal
1	applicant submits to
1	interested entities and
3	drug, or a
1	authorization was obtained.
2	1 year or
3	standard in effect
1	containing such new
2	relisted. after such
1	evidence to establish
1	point based on
1	 (3) consultation
1	animals, or the
3	by, and containing
1	fund under section
1	relevant national strategies.
2	transcript of any
2	similar to or
1	advertising and activities
1	data; and (f)
1	submits such additional
1	immediate exportation, if
1	substances sold over
2	report information required
1	18. (f) monitoringto
6	drug sponsor fee
1	aid trading partners
2	 (2) biennial
1	(5) authority for
2	containing a certification
1	surface. with respect
1	activity. (5) the
1	(b)(2)(b), subsection (b)(3)(b),
1	plan; vacating of
1	upon the conviction
2	devices.  (e)
2	unintentionally introduced, or
1	treatment for opiate
3	inspection service files
1	canada as may
2	office (referred to
1	(a) unless, after
6	stating that the
1	4 years from
1	bond if it
1	deems appropriate, the
1	control notice described
1	unless the rare
3	human services the
1	revoke a performance
2	directly to qualified
2	examinations or inspections
1	practice. (ii) any
1	 (f) renewal
2	regulation of any
1	coordination with all
1	notice is in
1	regulate products that
2	person within 1
1	device first begins
1	january 1, 1953,
1	significant, provides confidence
1	may deny the
1	activity.  (4)
2	607 of this
1	july 28, 1953,
1	required level for
28	safe and effective
1	360aaa to 360aaa6.
1	providing laboratory seizure
1	recall plan. (f)
1	(1) inspection procedures
1	licensed or authorized,
2	manufacturing practice or
1	pr-production design validation
1	means any concealed
2	term processing means
1	effective immediately unless
3	drugs, as safe
1	section will continue
1	criteria to reaccredit
2	sell, transport, or
2	reasonable medical judgment,
2	on-half of the
1	
 
 395.
1	voucher if transferred.
1	containing gamma hydroxybutyric
1	387l. judicial review
13	shall make the
1	tobacco products. the
1	inspection is provided
1	records pursuant to
1	procedure.  (3)
1	receive medical advice.
4	person  (1)
1	prescriptions (a) schedule
2	residue are the
1	quotas for controlled
1	(3) no state
1	offering of the
1	(d) report and
1	component part 
3	(1) safety and
1	authorityfor the purpose
1	proposed for such
1	case of 100
1	distributes drug samples
1	files no response
1	distributors under subsection
1	directions for such
1	commerce; standard grades
1	physical safety of
1	(2);[2]  (d)
1	transfers or payments
1	inspection upon this
4	intentionally introduced, including
1	gases has not
1	substance or controlled
1	(1) regarded by
1	point of manufacturing
1	subparagraph (a)(iii) to
2	pharmacists, and other
1	proceeds the person
1	regulations complies with
1	diseases and antibiotic
1	human use containing
1	drug shortages on
1	(g); or (d)
1	ecstasy, and precursor
1	package if that
1	regulatory flexibility and
4	well as statistical
1	personnel, services, and
2	deception or an
1	marihuana cigarette, that
1	ch. 307, 63
1	poisons; book entry
1	processing means manufacturing
2	drug manufactured in
1	other, at which
1	information or analysis
1	approved after 1981
1	pursuant to action
6	(a) the date
2	testing, and investigations.
1	initial meeting, the
3	considered an element
1	evidentiary hearing if
1	(ii) disagree with
1	occurs, the amount
3	account differences among
6	duration of the
2	(f) on the
1	need for additional
1	(6) continue to
1	states or prior
3	fiscal year; (b)
1	response to preventing
2	certification and for
1	drug) is decreed,
1	abuse prevention the
1	expert review is
1	shall accompany the
1	exceptionthe annual biosimilar
1	device manufacturers, health
1	title, by order
1	(1) any substance
1	iv substances except
2	section 3502(2) of
1	secretary reviews the
2	manufactures or distributes
1	14a. transferred
 

1	5301 et seq.];
1	fee is assessed
1	developing guidance documents,
1	reinspection fee for
1	devices and who
1	among children, africa-americans,
1	apply. each reference
2	pendency of proceedings
4	section 661 of
1	accept funding for
1	general notwithstanding sections
3	may be amended
1	tobacco product exports
2	clause (i), for
1	(c) duties of
1	(f)(2), the generic
1	(a) investigations for
1	first generic drug
2	states before october
7	drug, no active
1	$85,000,000 (subject to
1	title (referred to
1	provide, maintain, and
1	testing of food
1	assessments and the
1	applicable conditions identified
1	year increased by
1	consumers and vendors
1	kind of animal
1	regulation, in accordance
1	similar artifice, or
1	established offices, the
23	requirements set forth
1	education regarding requirements
2	otherwise deemed adulterated
1	(a)(i), a device
1	finished drug product,
2	sixt-day period beginning
1	bioequivalence studies, or
1	(
 
 23.
1	subsequent repackager, wholesale
1	manufacturers and wholesalers
1	methylsulfonate. (16) morphin--oxide.
1	845b. transferred
 

1	may commence review
1	order. the panel
1	peer norms against
1	3 years, shall
1	disease outbreaks; (b)
2	intended to maintain
1	epinephrine when the
1	pay of such
7	affirming or setting
1	violation of paragraph[2]
1	processing by him
1	(a); (b) for
3	unlawful to export
1	paragraph (9), and,
4	approve the drug
1	opioi-related deaths, as
1	extent practicable, identify
1	acts constituting a
6	shall terminate the
3	dispense narcotic drugs
1	(1) three times
1	granting a motion
1	(a) motion to
1	notifying state boards
1	(1), he shall
2	authority granted under
1	chillums; (12) bongs;
1	title, or (ii)
1	ground application of
1	consumers, designate the
1	extramural grants the
1	except as expressly
1	(a)(1), and (3)
1	conducted, such research
1	thereof; or (6)
1	first determine whether
1	device identified under
1	subsection, evidence and
1	standards as described
2	viru-serum toxin act)
2	determinations; and (iv)
1	chemical analysis, a
2	paragraph are as
1	(a) is required
1	substances by ultimate
2	ingredient  (i)
10	section 355a of
1	treasury under this
1	(t)  (1)
1	direct or indirect;
1	use a standard
1	contribution or indemnification,
1	 (1) $250,000,
1	(b). (3) 
2	280 grams or
1	u.s.c. 247d5]. such
1	preventive controls needed
1	assessment under such
1	countermeasures (a) in
2	grounds; immediate suspension
3	section may transfer
4	including the rationale
2	web site established
2	concerning drugs or
1	reasons.  (7)
3	application, including the
1	year, no device
1	(f) notice and
1	substance in section
1	prior to grant
1	including plasma products
1	(1) commerce between
1	thirty days. regulations
1	
 353c. prereview
5	chapter, except as
1	leaking; or overheated,
1	article held pursuant
1	authorized pursuant to
1	imports has increased
2	consolidated budget proposal
1	state law, or
1	100 grams. (2)
35	coordination with the
1	approved under biosimilar
1	predicate device after
1	country or r-exportation
10	authorized to remain
1	18. (e) if
1	(d)(3), in addition
1	pro rata fees
1	title, or there
1	utilization of timely
1	include preclinical studies.
1	listing or use
1	manufacturers liability for
1	proposed standard regarding
1	 (23) trading
1	recklessly tolerated by
1	administration, demonstrate that
1	designated as high
1	prompt and secure
17	manufacture of the
2	(2) paragraph (1)
1	component parts of
1	model development activities;
1	(a) violations; liability
2	course of its
1	office shall help
1	use, including specific
1	135 days after
1	387i, or 387t
1	holds, packages, exports,
2	2013 not later
1	disapproving, or withdrawing
1	2014 falls below
2	agrees to submit
1	citizens living abroad,
1	managerial agent acting
1	citizens living abroad.
2	subparagraph or subparagraph
3	illegal drugs, including
1	different manufacturers; (viii)
1	(37) phenoperidine. (38)
2	condition and the
1	emergency response to
1	whether in vitro
1	outsourcing facility may
22	sheep, swine, goats,
1	cooperation by each
1	certification or assurance.
1	educational agencies with
3	(i) each owner
1	2008 and 2009,
1	made public, 
1	products in emergencies.
1	enterprise; (7) the
1	distribution, and importation,
1	produce such food;
1	802(39)(a) of this
1	notice and application
2	funding for the
1	number (to be
1	provide recommendations on
8	less than 20
3	secrets and confidential
1	substances. (3) the
1	transaction.  (17)
1	current trends against
1	within any other
1	substance is anticipated
1	section applies, the
1	time of sale
1	submissions, and where
1	action or letter
1	business systems to
5	may authorize any
1	pounds.  (b)
1	paragraph. a determination
1	(a) in generaloutsourcing
1	period have expired.
1	patent application. the
1	i.  (a)
1	efforts by the
1	prompt transmittal to
1	subchapter, as amended
29	used for, the
1	illicit activity to
1	 (1) opium
1	including data related
2	population may produce
1	chemicals on raw
1	database and post
1	of, such violation;
1	timely renewal request;
1	regarding theft and
3	trials and labeling
3	reports of such
1	(xv) -penty--(-chlorophenylacetyl)indole (jwh203).
1	facilitate the manufacture
2	human food. 
1	letter; or (iii)
1	may also terminate
1	fraudulently obtained, and
1	subparagraph, the transaction
1	(2)(a)(vii) or in
1	repatriate any property
3	lack of alternative
1	participate; (ii) a
1	concerning refused articles
1	period.  (b)
1	interstate commerce; and
1	(d) determination by
1	direct reports to
1	
 
 360oo.
1	(vi) a practical
1	samples and any
1	criteria shall 
1	18 months beginning
1	title, including planning
1	drug application, (4)
1	distribution. (4) the
1	title, the -year
2	title, applicable to
1	concerning the sponsors
1	additive that has
1	agency; (c) in
1	 (f) prominence
1	214[1] of the
1	section, or if
2	certifications for all
4	method for detecting
5	committee on the
3	nonofficial or official
1	materials for patients
4	supplement, a fee
14	shall be given
4	(including increases in
1	aside. in such
2	means the rate
8	drug  (i)
1	device submission, that
2	controls would emit)
1	support the requirements
2	designation  (a)
1	basisthe determinations under
1	(bb) at the
1	qualification for the
1	bulk drug, and
2	provided, that they
16	necessary to assure
4	operating reserves of
1	(7) penalties for
3	products other than
1	proposed protocol to
1	 (d) notifying
1	consider, but is
2	sufficiently complete, the
1	supporting narrative descriptions
1	well as representatives
1	testing and control
1	systems developed under
2	secretary may cooperate
1	ports of entrythe
1	employed shall not
1	review submission. 
3	findings required by
1	subsection (b)(2) will
1	(ii) in evaluating
1	physician, as defined
1	supplier moves for
1	1, 1997. (e)
3	(5) to the
1	domestic emergency, or
41	request of the
1	document, published in
1	inspectors for whose
1	provides  (i)
2	subparagraph (a) beginning
2	food under conditions
1	(2) the suspension
1	regarding a requirement
1	
 1548. termination
1	treat, modify, reverse,
1	drug above the
1	label statements as
2	received through the
1	egg food industry,
1	section, $195,000,000 for
16	reasonably likely to
1	scientific advisory committeethe
1	(5) to refuse
1	activity after one
5	and, in the
1	may be made,
1	(1) an infant
1	grounds; person deemed
2	require a recall.
1	iii device or
1	26, 2014. (june
1	flexibility for each
20	assure that the
1	impose conditions that
1	fiscal year by,
1	 (a) of
4	section 4 of
1	subchapter the slaughter
1	other; and (ii)
1	funds authorized to
1	medical services is
2	violates section 331(t)
2	good manufacturing practices,
1	good manufacturing practices.
5	supplies; and (d)
1	reasonably require. (ix)
1	packaged egg products
1	ambulatory surgical facility,
3	paragraph (1)(b) shall
1	variety of tobacco
1	usethe elements to
4	good manufacturing practices;
1	subitem (aa), a
1	agency concerning the
2	general shall notify
3	made available pursuant
1	includes, at a
1	(rr)  (1)
2	official seal of
3	views of the
1	sponsor.  (h)
4	person at least
1	insert for such
3	stat. 833.)
 

2	upon entry of
1	designation a sponsor
2	isomer means any
1	act (36 u.s.c.
2	audit of each
2	upon presenting appropriate
1	entitiesfor purposes of
2	service to inspect
1	support policy formulation
1	saccharin. (z) the
3	pay fees 
1	routinely and systematically
1	date.  (h)
1	upon data and
3	manufacture controlled substances
10	schedule iii or
2	type included on
1	retention of qualified
1	(i) a significant
1	amendment or interpretation
15	secretary shall prepare
13	issued in accordance
1	expenses  (1)
1	(c) 26 percent
1	(b) suspension of
1	question of the
2	resulted in such
1	(d), such person
1	pesticide monitoring program,
3	least eighteen years
1	(b) and identifying
1	renumbered 5 and
1	inspectors employed by
2	5 and section
1	(c) development of
2	(c) fee collection
1	traceability of articles
2	business at which,
1	 (4) maintain
1	sunscreen that are
1	5 of whom
1	concerning storage and
1	federal acts or
1	(1)(a)(i).  (c)
1	and, to mitigate
2	service upon a
1	(1) its labeling
5	(b).  (b)
1	original priority new
1	effective legislation to
1	tobacco leaf other
1	pasteurization of meat
1	qualifying other practitioner,
1	informs the manufacturer
1	additive or any
1	convention.  (c)
1	reasonably believes such
1	(d) prohibited personsthe
1	scientific understanding, including,
1	educational agency will
1	officials and other
1	direct final rulemaking,
1	waivers or reductions
1	hig-risk foods. the
1	subject only to
1	required for emergency
1	post the communication
1	thir-party auditors. 
1	trade secret. (

1	small packages or
1	proposal; (ii) providing
1	animal drug applicationsthe
2	antibiotic drug that
1	(b) method the
1	following opium derivatives,
1	intentionally subject to
1	independent establishment, or
1	fund under subsection
9	subchapter i of
15	risk to the
2	law, regulation, order,
1	partnership, or (c)
1	(a) is unacceptable,
1	tolerance or if
1	fee claimed to
1	specific evaluation of
1	tobacco users occurs
1	methods, including surrogate
1	prescription drug received
1	consideration the public
2	calculation determined using
1	marketed for food
1	applicable conditions of
6	paragraph (1), or
1	provide direct written
1	filing, etc.; lists
2	team of staff,
1	file; and (ii)
2	drug involved, on
1	establish clarity and
1	states if the
1	(a) storage and
1	contact with such
1	allowed access to
1	tribe. nothing in
1	facts. clerical mistakes
1	drug involved, or
1	appropriate, dosage and
1	submission and filing
2	clearance or approval
1	hyperlink or other
1	title, constitute a
2	(b) as of
2	evidence and information
1	(b) provide that
1	(4) objected to,
1	applicant, meet with
1	(b) each regulated
5	dcmdvawv; not seasonally
2	 (a) require
1	(a) parental obligation
1	assure that informed
1	name, other marking
1	storage, handling and
1	diversion of such
1	document  (a)
1	concerning the handling
1	(b)(2)(a)(iv) and for
2	unless it meets
2	holding of the
2	appropriations acts, subject
1	within 2 years
1	 (d) except
1	section; (b) describing
1	(1) technical assistance
1	corporation, shall be
3	special rule for
4	used in or
1	(b) consider international
1	committees  (1)
3	formulations for each
1	 (d) definitionsfor
1	clinical investigation data
17	drug applications and
1	determination, the attorney
1	(5) list the
1	(1). subsection (b)
6	outsourcing facility that
3	secretary may extend
3	required information that
1	marketed the product
1	waivers for product
1	biomaterials supplier; (ii)
1	year 1998; (2)
1	drug application a
1	show kinds of
2	interest.  (2)
1	(1) currently marketed
5	measurement of the
2	regulations as are
1	regulations, such term
1	receiving written notice
1	2011, enter into
1	 (e) publication
2	stay of a
1	person shall pay
1	order require, as
1	submit revised labeling
3	evidence to be
1	subsection (b)) or
1	generalthe ex officio
1	diagnosis by mail,
1	(i), and not
1	modular applications if
1	bodies  (a)
1	good cause or
1	resolution at the
1	health risks involving
1	salaries congress has
1	tobacco smoke. nothing
2	establishing fee revenues
1	grant to more
1	(a) origin labeling
1	referral, or within
2	(including smoke constituents),
1	 (h) for
1	ingredient under its
1	hear and decide
1	biological for which
1	provisions determined by
1	paragraph against investigative
1	secretary considers the
2	due datethe annual
1	actionsthe owner, operator,
2	establishments that employ
3	(i), (ii), and
1	regarding any policy
2	(d) designation process
1	revised official names
1	supplement contains only
1	agencies for national
1	stockpiling, licensure, approval,
1	source leukocytes or
1	applying specific goals
1	objections have been
7	index for all
2	product produced, assembled,
4	application if he
1	consult before prescribing
1	i, 21, formerly
1	listed chemicals or
1	(v) in the
1	forfeit the 18-day
1	person knowledgeable about
1	stat. 1486.)
 

3	affected food is
1	whenever it appears
1	administration, including 
1	title, where the
1	(b), the director
1	(1) special rules
1	search warrant relating
4	(a) and the
1	adul-only facility shall
1	coming into direct
1	forwarded to congress.
1	purposes; (2) compliance
1	product a manufacturer
2	device which information
1	therapies; (b) identify
1	subparagraph (c), any
1	person who seeks
1	one avoirdupois ounce,
2	secretary was less
1	1005, formerly 905,
5	public health, including
2	render such drug
1	shall include, at
1	evidence which is
1	activities. (c) reimbursement
2	submission of report
1	record containing information
1	(2) knowledge definedfor
1	recommend that the
1	management participation in
1	(
 
 1710.
2	substance from one
1	apply to cigarette
1	court shall rule
1	360ccc, 360ccc1, 360ccc2,
1	translating basic research
4	drugs, and the
1	control act [21
1	facilitate the disposition
1	case for trialin
1	internet access service
1	modified registration under
1	(b) invite interested
1	upon the attorney
1	secretary respecting approval
2	paragraph.  (4)
1	goals nothing in
1	specified in subclause
7	formed in or
1	auditors under this
1	(1) the preventive
2	executive director of
1	methods, results, and
1	(e), the responsible
1	practitioner under subparagraph
1	measures to assure
4	(b), or a
1	inserted into a
2	otherwise handled by
1	promulgated; (ii) before
1	(iii) projected completion
2	(iii) contain such
1	exist or which
1	eggs are accompanied
4	product will be
1	paragraph (4)(b) shall
1	current assessment of
1	transfers direct possession
1	administration has credible
5	adjusted for inflation
4	provided an offer
1	distributor licenses notwithstanding
1	programsthe provisions of
1	sliding boards, swingsets,
1	requested, (iii) the
6	action in the
1	involved if the
1	systems are established
1	establish multiple or
2	827 of this
1	secretary (for such
1	means the transfer
1	chief scientist, who
1	health. (f) farms
2	sold by the
1	notice to any
1	among domestic law
2	(iii) any substance
2	deception or risk
1	lack of evidence
2	 (a) evaluate
2	paid for by
1	appropriate notice is
1	$14,800,000. (
 

1	criminal histories; (5)
1	director may require.
1	libel, and the
1	thereunder, or in
1	studies are required
1	(9) fees the
1	charge a receipt
1	
 
 362.
1	1701(10) of this
1	675, 744g, as
1	administered, or their
1	(1), which the
2	9 months prior
1	issuance and service
1	designated as, habit
1	qualified to conduct
1	administration or scienc-based
2	withdrawal and temporary
2	devices, solely for
4	section may include
1	(c) the acceptance
1	(i) such statement
1	met in such
1	industry of information
1	ii device under
1	exporting country in
1	submitted without regard
1	full term applicable
1	nonfinancial assistance to
1	development fee shall
1	purpose of foundation
1	2022, approved under
1	person listing the
1	effect as to
1	consumer protection, on
1	said subchapter i,
1	heating of tobacco,
1	office, including 
1	shape, practically free
1	disease products 
1	paralympic sports organization
1	appointed members described
1	chemical with which
1	standards, including requirements
1	physician who made
1	monitors consistency between
1	pedigree systems or
1	license which shall
4	considered an unapproved
1	punishable (1) by
2	may apply for
2	seven years; and
1	may indirectly reveal
8	manner as he
1	germination. (17) the
1	permit the article
1	conspicuously displayed thereon:
1	smokeless tobacco under
1	information in federal
1	collect fees from
1	scientific uses for,
1	intended uses under
1	360e, as added
21	imported or offered
8	to, or at
1	plant disease outbreaks;
1	jointly and severally
1	basis; or (iii)
1	met shall, in
2	demonstrated clear detrimental
2	secretary applies this
2	(iii) the director
1	clearly links that
2	(iv) the secretary
1	transfer.  (3)
1	members the board,
1	cultural activities. (3)
4	675, 1002(a), formerly
1	tribal organizations with
1	whichever is greater.
1	(1) hazards identified
2	minor species outweigh
1	oleomargarine, butterine, imitation,
1	database of authorized
1	foreseeable expenses actually
1	
 
 360bbb8b.
1	section to minimize
1	ii after such
1	prevention, education, or
1	
 360bbb4. countermeasure
1	term accreditation body
2	(i) effect nothing
1	60 days. 
1	department of defense
1	obtain such other
1	section 354(a)(3)(a) of
1	 (3) denial
1	prescription shall be
2	identity of such
1	(1) following the
1	sale thereof; the
1	range of criminal
6	enforcement of the
1	taking such actions
5	preliminary injunction prohibiting
1	purity at the
2	detriment of consumers
1	chemical residue or
3	secretary to enter
2	(m)(2) or (m)(3)
1	framework of the
1	manufacturers; (g) the
1	denying the request
5	secretarys own initiative
1	access to aggregated,
1	believe, that the
1	
 18. suspension
2	chemical product and
1	responds to foo-related
1	seizures (as reported
1	general schedule for
2	(d) shall apply
1	shall, where appropriate
1	food and raw
1	packaged carcasses (if
1	establishment, in accordance
1	amount so appropriated
1	determines, after the
1	complied with. such
1	training programs relating
2	time for such
1	testing device described
1	hospitals; (3) work
2	including production costs
1	licenses described under
1	persist in the
1	section 360e(g) of
1	1333] and section
1	views, and arguments
1	(x) for periodic
1	record in the
2	low potential for
1	effective 120 days
1	(b) assessment in
1	area or expand
4	2002, the secretary
1	medical devices, sales
1	 in the
1	from, the requirements
2	vacancy in such
1	required studies and
1	products and copies
1	corporation adversely affected
1	shall, for such
1	(q), in issuing
2	person is able
1	assistance that was
2	aggregate of individual
1	(a) inventoryexcept as
1	likelihood of an
1	respecting the advertising
1	scientific evidence is
1	office as may
2	drug control performance
1	categories listed in
1	(e) refrigeration and
1	(4) no operator
1	meeting, the advisory
1	review to provide
3	271(e)(4)(a) of title
1	(gg) diversion control;
1	audits on behalf
1	term prior approval
2	one schedule to
1	[15 u.s.c. 45]
1	currently informed as
1	drug (or conversion
1	appropriate), the secretary
1	among federal agencies,
5	shall refer the
1	(xiii) such additional
4	dose of the
1	(5) study 
1	(1) or (3).
1	controlled substances combined.
1	requirement authorized by
1	repackager responds to
1	appropriate, approve or
1	residue that 
1	different type than,
1	(ii) biennial surveys
3	marketing) in the
1	exported; (iii) importation
2	 (c) limited
1	cosmetic is collected
1	(1) until a
1	residues (a) requirement
1	animals treated with
3	entitled, approved june
1	described in subparagraphs[5]
1	area.  (

5	(d) of such
1	drug defined in
1	administration, for scientists,
1	adulterated poultry products
1	product bears a
1	(iii) the distribution
1	corporate seal, which
1	title ii, 205,
2	definitionsfor the purposes
1	unit, with an
1	(g). (i)review of
1	drugs the importation
1	complementary therapies, and
1	pregnant individual in
1	official compendium published
1	alerts the united
1	causing the evasion
1	(d) neonatology expertise
1	 (i) involves
7	title; or (2)
1	operations in the
1	services may by
11	title; and (b)
2	(a) because the
1	instructions  (1)
1	(iv) the same
1	[15 u.s.c. 45,
1	documentation upon request,
1	replacement, or refund
1	proposed amendment. 
6	provide the secretary
1	possessed commonly flow
1	(4) the raw
1	upon the recommendation
1	(3) a qualified
1	labeling submitted by
1	base; (iv) 10
1	review;  (b)
1	nicotine content, flavoring
1	(1) the state
1	injunctions (a) jurisdiction
1	shall display on
1	(g), and any
1	device which the
1	relating to meat
1	filing determinationnot later
1	(3). (f) rule
2	security, a report
2	shipment, documentation demonstrating
1	safety activities). (14)
1	space to ensure
1	including the personnel
1	drug, is based
1	(1) amountthe administrator
4	following conditions are
1	certain facilities unless
1	establish good importer
1	requirements regarding review
1	coalition grants 
2	process pursuant to
3	signed by, and
1	title, on promotion
1	imposition of random
1	contractual right of
1	may request review
12	consumer price index
1	(2) includes an
1	secretary, for review,
1	i, or an
1	apply to food
3	section 355(k)(5) of
1	(5) submits to
1	notice providing the
1	national intelligence or
1	fiscal year 2018
2	section 360eee(16)(b) of
3	fiscal year 2016
5	fiscal year 2017
6	prior to submission
9	fiscal year 2015
2	fiscal year 2012
19	fiscal year 2013
3	fiscal year 2010
1	paid. (4) collection
1	timinga notice required
1	permitting such tobacco
1	commerce for intellectual
1	managed health care
2	class iii shall
1	(2) a manufacturer,
1	formulations or manufacturing
1	sellers an explanation
2	subsection whenever the
5	(3) for purposes
1	vacancies of the
1	section, other than
2	request for data
1	prescription is written.
4	(6) or (7)
1	subjected to additional
1	elsewhere in this
3	 (e) the
1	(c), any information
2	species for which
1	reevaluation has occurred
1	reviewing official has
1	proceeding.  (iii)
3	(c)(3)(e)(ii) and (j)(5)(f)(ii)
1	notification if, after
1	lead to new
1	(1) such electronic
2	system.  (f)
1	(b) reductions in
2	chemical has been
1	(ii) any new
2	amount established by
15	history, and transaction
5	higher than the
1	(i), or (b)
3	agency that is
1	labeling of conditions
2	361 of the
1	procedures notwithstanding any
1	suspension, threats, harassment,
5	notice, published in
1	enforcement administration abroad.
1	(c) recommendations for
1	establishment to comply
1	(1), as appropriate,
1	information designated by
1	
 872. education
1	(a) necessity or
1	food or class
1	product specialization in
1	claim, subject to
1	per unit, the
1	regulatory assessment, including
2	receive, review, and
1	attorney general increase
2	study published by
1	drug be limited
2	grant amounts 
3	copy of its
2	 (e) registration
1	commission to enforce
1	agreement, but all
3	(1) if an
5	conducted under paragraph
1	practitioner, on the
2	(g) effect of
2	statement, a copy
1	determine what constitutes
5	benefits of the
1	(ii) document that
1	register that sets
1	advisory commission, compensation
2	infringement.  (ii)
5	drug shortage list
1	manufacturing industry. members
1	zinc (mg) 0.5
1	appropriate actions as
1	354, 355(i) or
1	(2) public notice
2	number of studies
22	take into account
1	(3) the unmet
1	alter or limit
1	manner.  (3)
2	whenever in the
2	standard and after
6	additional number of
1	enforcement activities; (c)
1	$100,000,000 for fiscal
1	(d), if the
1	fewer than three
1	reimbursement is required
3	treatment and prevention
1	fewer than 2
4	fewer than 3
1	fewer than 4
1	fewer than 5
1	cause made by
1	margarine unless 
2	margin of safety
1	certain drug applications;
1	drug abuse constitutes
25	notice of proposed
1	secretary) to the
1	188n. repealed. 

1	chapter. (b) applicability
1	product innovation, enabling
1	entity of which
1	thereof.  (b)
2	25 employees (including
1	entering into commerce
1	informed consent from
1	services into any
1	(including any action
1	(b) publication with
1	prior to regulations
1	(v) and clauses
2	also cause to
1	387a1. final rule
1	appropriate tests or
1	oil, pcp, methamphetamine,
1	sentencing a defendant
1	jurisdiction; (ii) a
1	following each agreement,
1	hearing) if 
1	2014. (c) $125,767,107
1	capacity prevents the
1	et seq.); (c)
6	currently accepted medical
1	200 milligrams of
1	stream of commerce.
1	chapter and by
2	(f) revocation of
1	serve colored oleomargarine
1	services shall annually
6	potential for abuse.
1	age group; or
1	administrator shall determine,
1	 (k) subchapter
1	applicant submitted the
6	secretary shall terminate
1	susceptibility, including categorization
1	(2) conduct a
1	program, that includes
1	make such inspections
1	time used by
1	ii substances 
1	applications. (iii) 50
1	are, subject to
1	capabilities at the
1	developing the product
1	investigation as a
1	dispenser of such
2	device of the
2	 subclause (i)
1	lozenges, containing any
1	handler (including a
1	agricultural commodities, not
1	drug and has
1	title 18; (2)
1	provided, the term
26	november 27, 2013,
2	transports, distributes, receives,
2	may, by order
2	report on workforce
2	pharmacology reviews of
3	advisory comments on
1	(2) the delivery
1	original manufacturer of
1	treatment.  (ix)
1	via telemedicine in
1	termination by the
1	general, determines are
1	state, that is
2	improperly labeled or
1	list to the
2	controls authorized by
1	sanctioning for testing
1	order to revoke
1	award for prior
3	offer or receive
1	patients and those
1	expose patients to
2	animals.  (4)
2	ten years. 
1	secretary are held
1	delays in or
1	secretary by regulations
3	services shall cause
2	manufacturer shall be
1	prescribe procedures and
1	675, 523, as
4	(6) of subsection
1	
 
 360h1.
2	will comply with
2	scale production facility
1	controlled substances distributed
2	combination product; and
1	(ii) cannot be
2	drug. if the
1	may be. subsection
1	observed early in
3	1, 2000, and
1	partnership programs for
1	upon the number
1	paragraph (1) include
2	subparagraph (b) is
4	necessary to develop
3	days, pending action
2	withdrawing, or suspending
1	whether the agreement,
1	whether to approve,
1	direct, and substantial
1	additional study based
1	united states marshals
45	issue an order
1	human food, offered
3	compliancethe secretary shall
1	species to this
1	numeral identifier not
1	tested using such
1	threats and design
1	 (4) new
1	(b). this information
1	facility has been
1	feed directive or
1	refers in its
1	forces within each
1	of, as applicable,
1	otherwise. (d) on
2	application and has
1	transaction history required
1	guidancenot less than
1	any, to provide
1	(b) designation of
2	whether to continue
1	section,[1] any person
1	administrator; (2) may
1	reimbursement of star-up
1	observers to meetings
1	terminates the exemption
1	 (a) authority
1	exceed 8 individual
2	shall approve a
1	provide medical evaluations
1	qualified researcher; (3)
1	reporting deadline has
2	egg products under
2	container, wrapper, or
1	agriculture and multiple
1	produce such effect;
1	smokeless tobacco means
1	
 
 360bb.
2	multiple doses and
1	evaluation of drug
1	(b) performance targets
2	program and conducting
1	on, introduced into,
1	pesticide chemicals producing
1	requirement may not
1	provision of chapter
1	medical product development
1	(c) time for
1	(ii) the petition
2	files, papers, processes,
1	(f) traceback and
1	notice of refusal
1	(independent of consulting
4	rule published under
1	(c), or revoke
1	(c) exceptionsthe following
2	activities; and (c)
1	section, a proceeding
2	criteria are available
2	(without a waiver),
1	secretary but not
7	term secretary means
1	
 1706. high
2	(1) timing of
5	food into the
1	lieu of susceptibility
1	provides anything of
3	(on a sample
1	account the gravity
1	transactions in food.
1	(d) $7,936,000 for
1	regulatory requirements 
2	reporting of tobacco
1	paragraph occurs within
1	rule and allows
3	effect for grade
1	considered as new
3	(within 60 days
1	health by ensuring
1	drugs or, at
1	conditions; or (5)
10	person who engages
1	chapter on indian
1	title 18. (d)
1	behavior, and health
1	production, transportation, or
2	reprocessed as intended
3	drug products are
1	order. (3) inclusion
1	 (2) labelingnotwithstanding
1	effect is not
1	subparagraph (c) to
1	interests of tenants
1	hours, for the
1	
 360k. state
1	 (d) recovery
1	(ii) will, if
3	product unless the
1	advisory to the
1	in, demand reduction
1	proportion by commodity
1	shall prohibit a
2	agent means an
1	year 1999; (3)
1	takes into consideration
1	thereafter, make a
2	person who stands
1	reported $30,000,000 or
1	campaign has contributed
1	include types of
1	litigation; (9) unless
1	sample, in violation
1	coordination and implementation
1	enforcement agencies on
1	program regarding such
1	licenses  (1)
1	agency centers within
1	article regulated under
1	assessments of health
1	tobacco users; (iii)
2	manner prescribed by
2	appointments to each
1	2000; (4) $40,000,000
4	inspection pursuant to
1	expected or actual
1	grocery store sold
1	subsection (d)(1) be
2	sunscreen order means
1	export certification within
1	vendor of articles
1	ship a suspect
1	certain unapproved products
1	out, to the
1	herb or herbal
2	testing conducted in
1	shall sell, or
1	state shall have
1	unlawful  (1)
13	administration for the
3	(a) one; (b)
1	formulation, the applicant
2	title, a conditionall-approved
1	(c) that offer
1	(
 
 847.
1	consistently grant waivers
2	1938, it was
1	intended for internal
1	(ii) shall indicate
3	stated in the
1	360b(c)(3), 360b(d)(1), 360b(e),
1	(b) would provide
2	including with regard
1	foods, the inspection
1	ch. 74, 12,
2	made in connection
1	directed to a
3	attempts or conspires
1	package level requirements
3	voucher was awarded
1	making under this
2	(c) of the
1	restaurants; access to
1	believes such article
1	standardization of data
4	(2), (3), (4),
1	validate effective technologies
3	center charged with
2	approved application filed
2	title pursuant to
1	reports under paragraph
1	electronic searches of
1	(iv) an applicant
1	4, 2011. (6)
1	food (a) processing
1	reaction; and (vii)
1	pediatric assessment granted
1	safety (a) in
1	(iii), a device
1	written determination, the
2	shall establish or
1	programs and capacity;
1	shall, unless he
1	ultimate disposition, and
1	report under such
1	(2) public input
2	use, or market,
1	permit the inspection
2	priorities for the
1	concerning an application
1	perception of harm
4	notification has been
1	tests that are
1	561a, as added
1	on, or after
12	(a), (b), and
1	enter into partnership
1	subsection (b)(2), that
1	registered facility. 
1	purposes of implementing
1	use and validation
2	use as another
10	emission tomography drug
1	attributed to such
1	commodity, having been
1	may specify, as
18	state, and local
5	administrator may award
12	beginning with fiscal
1	(c) inspection and
1	submitting separate applications
1	(d), the administrator
1	 (a) pose
1	though suppliers of
1	 (e) nominations
1	implement subsections (b)(1)(a)(i)(iii),
1	(ii) cigars, including
1	grant the authorization
1	establishments and animal
1	adulterated if 
1	new panel member
1	deny the petition,
1	recipient or other
1	cap on administrative
1	review, and technical
1	columbia, and remaining
2	developed pursuant to
1	(b) responsible parties.
1	(
 
 886a.
2	chain security act;
1	investigations of a
1	7 u.s.c. 19011906).
2	will assist in
9	authority nothing in
3	means a drug,
1	term includes a
1	897.16 to read
5	coca leaves, except
1	acquired the controlled
3	statement in any
1	additive in all
1	675, 561, as
1	year 2001; (5)
1	device are sufficiently
1	relied upon a
1	modifications: deciding when
1	national environmental policy
1	processes that a
8	conformity with the
1	6th par., 34
17	drug and the
5	disposition of any
1	grants, devises, or
1	data, personnel data
1	notice, (b) the
1	format to a
1	experience data includes
2	using, or marketing,
1	formulas are in
1	organizations specified in
1	provider means an
1	request; and (ii)
3	agency to implement
1	(except the elements
1	person may distribute
1	5 times more
1	cosmetic other than
5	paragraph (1), unless
1	food defense capabilities,
1	local data. 
1	summarizing the incorporation
1	(ii) file such
1	215. consul defined
1	real property, buildings,
1	 (a) directorthe
1	order to inform
1	 (1) highes-risk
1	reducing domestic and
1	metabolite or other
2	shall be under
1	coordination of staff
1	unique identifier related
1	public statements, throughout
1	(a)(2)(a) may be
1	patent. any action
1	(2) to very
1	involved. (b) the
1	eggs after the
1	services in support
1	agreement; (b) coordination
1	order the manufacturer,
1	produced, and the
2	30 month period
1	list a drug
1	feeds under this
1	research; import tolerances
1	person in violation
1	however, that a
1	domestic commerce of,
1	impede, or affect
1	ensure timely, informed
1	proposed labeling; and
1	drug but does
1	subsection (b)(2) that
1	may be distributed,
1	(i) register with
4	350d(b) of this
1	basis to, significant
1	species, inspection of
1	methamphetamine, the attorney
1	replacement imposed by
1	(a) its advertising
1	secretarys decision to
6	may have become
1	percentage of imported
1	importance of drugs
1	annually post on
2	affecting the public
2	intended for such
1	maintenance of duplicate
1	 (1) amendment
1	tobacco products label,
1	substances tested under
1	human body a
1	675, 419, as
1	use of interpretive
1	extent required in
2	new drug can
1	application which was
1	isomer, or salt
2	proceedings to be
1	prescription is issued.
1	publication of summary
1	27, 2013: 
1	notwithstanding subsection (c),
1	343(j), 344(a), 346,
1	charging cos-based fees
1	statement of all
1	paragraph (1)(a), (b),
1	(i) any activity
1	regulatory science research
1	national disposal rate
1	analyses, about a
2	undertaking supplied by
1	paragraph; (g) information
1	secretary shall allow
1	facts relating to
2	chapter against such
2	reflecting the decision;
1	corporations engaged therein
2	term patent means
1	342(a)(2)(d)[1] of this
1	term market clearance
1	least two recognized
1	(a) compounds the
1	355c(f) of this
2	information respecting safety
2	(g) review and
14	sponsor of an
4	patent expires (including
1	warehouse  (a)
1	1976; and $160,000,000
1	recipient to ensure
1	regularly participate in
1	expansion of food
1	(c) executed licenses,
3	(a) in generalin
1	time to apply
1	proposal for applicable
1	market, or transportation
1	reasonable potential for
3	seq.] and the
1	(4) waivers 
1	level greater than
1	modified in vitro,
1	conduct a technology
1	misbranded; (4) sell,
1	(4) duration of
1	516, as added
4	congress not later
1	means eggs of
1	provider provides services
1	seq.], conditional approval
1	consultation regarding genetically
1	review process by
1	secretary from definition
1	scientific requirement essential
1	 (e) modifications
1	individual, and (c)
1	advantage or reveal
1	(1) the following
3	security, foreign policy,
1	fees and accounting
3	biological product intended
1	providing administrative services,
1	theretofore been designated
1	use, consumption, sale,
2	containing such articles,
1	professional medical societies,
1	require a thir-party
1	immediately after prompt
1	standards and uniform
2	products in interstate
1	perform, administer, or
1	impedes r-exportation of
1	general a designated
1	federal agencies in
1	drugs (a) lawful
2	making a finding
1	pharmacy license or
7	(a) in generalbeginning
2	is, or purports
1	states thereunder may
1	upon request. (d)
1	2012.  (b)
1	existing federal programs
1	(23) -(-iod-2,-dimethoxyphenyl)ethanamine (2ci).
1	advances; reimbursement; installments
1	resided on the
6	activities under subsection
1	accessed by the
2	consider, with respect
8	may be allowed
1	conditionssubsection (b) shall
1	toolsubject to paragraph
1	slaughtering activities no
9	submitted in accordance
1	(3) at any
1	advertisements, the activities
2	contaminant in bottled
2	may be) in
1	persons, requiring training
1	(1)(a) of an
1	including the health
1	appropriate directions and
2	otherwise distributed or
1	(2) who is
1	(b) acknowledge differences
2	on-half years, fift-four
1	two recognized and
1	budget authority for
2	vacate the order
1	settings that dispense
1	(2) to help
1	sanctions program for
1	(1)(b) has been
2	required by sections
1	offense under subsection
1	information as required
1	settled such proceeding,
4	ingredient under similar
4	necessary to determine
1	regulations prescribe the
1	if, pursuant to
1	(2) administrative support
3	secretary becomes aware
1	use, in production,
1	defense in any
1	importation, or distribution
4	505 of the
1	health measure whenever
1	(1) ensure the
1	standards and identify
1	samples should be
1	quantity, or grade
3	may refund the
1	scientific, ris-based evidence,
1	attempts to use,
1	secretary whether the
1	framework established under
2	plea of guilty
1	diseases, targeted therapies,
1	clinical use of
1	including product codes,
1	entry made during
1	near the register;
1	(a) conductthe secretary
2	reversed, the secretary
1	safety; (ii) identifies
2	2009 (excluding the
1	 (e) exception
1	articles are offered
1	term nonprofit organization
1	refusal after hearingif
2	used as a
1	entity transferring ownership
2	used to demonstrate
1	fails to conform
1	establishment be operated
1	will be transferring
12	eligible entity to
2	class of device
5	potential for a
1	board shall designate
1	subsection (n)(3), information
1	recipients, other than
1	 (1) qualifying
1	states engaged in
10	active ingredients, route
3	contains one or
1	without interruption. (b)
4	commercial information and
2	-fisca-year period, the
1	(e)(1)(c), or any
1	buyers during such
1	(11) methadone. (12)
1	trade secrets, for
1	standard. any denial
1	which, in combination,
1	higher education and
1	practices and methods
1	agriculture (including with
1	159. enforcement; penalties
1	(1) made a
2	paragraph (1)(b) of
2	imitated; (4) if
1	months. (3) the
1	expertise in compounding,
1	basis that labeling
1	(d) include information
1	benefit, public housing,
2	(but not against
2	workload adjustmentfor fiscal
1	(b) $112,580,497 for
1	decomposed substance. (c)
1	practicable, license, distribute,
1	chemicals, products, materials,
2	subsection to the
1	consult with experts
1	condition on how
1	conditions of exemption
1	product, unless it
1	receive, hold, or
2	title; (c) if
2	controlled premises and
1	use in maintenance
4	disclosures of the
1	involved:  (a)
1	device tested under
1	 (1) conduct
1	title; (c) in
1	analogue of ghb,
2	 (a) prior
1	title; (c) is
1	facilitate the coordination
1	samples which identifies
1	 (a) sunscreen
2	thereof, to copy
1	involving an extraordinary
1	serve as its
1	classification or reclassification
1	
 1541. establishment
1	to, advertising and
3	immediate previous source
1	study plan, agreed
1	provisions, amendments, and
1	secretary designates under
3	act in a
2	(1), unless using
1	different tobacco product
8	use and abuse
1	exportation of such
1	applicant, (b) the
1	(4) before taking
1	request, at any
1	fee) by the
1	enforcement strategies on
2	diverted, subpotent, substandard,
1	shall conduct, at
1	labeled; (b) human
1	(3) limitation the
1	forth any revision
1	religious dietary laws,
1	considered.  (c)
1	order no. 12978
1	(e) repealed. 

1	combination of an
3	probation shall not
1	1984, whichever is
1	attorney on the
1	unless such increases
2	clause (ii), include
1	epidemic products, the
1	referenced the approved
1	act, provides a
1	disposition of property
1	states has the
1	responses to requests
1	
 
 387f1.
1	award paid for
1	(v). (cc) signing
1	approval order. (8)
1	state law) of
1	(a) be maintained
4	paragraph (1)(b) or
1	uses the internet
1	alcohol other than
1	plan, he shall
2	and, as applicable,
1	establishments for preparation
1	(3) action by
1	judicial proceeding for
1	grants by attorney
1	administrator.  (3)
1	corporations shall keep
1	books and other
1	enrolled in a
2	identification of facilities
1	(a) supporting or
1	establishments; samples from
1	section 360nn(f) of
1	(b). (e) effect
1	new molecular entity.
1	certificate for the
1	conclusion of a
1	collecting and analyzing
1	subsections (d)(4) and
1	steroids will assist
3	subparagraph (a), including
1	draft guidance for
1	satisfied based on
20	review of human
1	human services concurs
1	shall solicit contract
1	treasury may require
1	
 8811, 881a.
1	 (4) late
1	means an amount
1	regarding changes in
1	change in ownership
1	gift fund 
2	application by the
3	(c) applicability of
1	(c) the ability
1	detection technologies by
2	product standard; or
1	 (g) limitation
2	reason of a
4	preponderance of the
2	promptly publish in
1	enactment date. after
1	isomers. schedule iii
1	history supplied shall
1	federal health and
1	liquefied, nonliquefied, or
1	section 355(j)(5)(b)(iv) of
1	advisory assistance; (2)
2	also be deemed
1	fees for inspection
1	
 360bbb1. dispute
1	technical expertise needed
41	fees under subsection
2	subsection (b). (ii)
20	processes and procedures
1	agency are authorized
2	manner determined by
1	(2) process prior
1	reprinted in its
1	 (e) definitions
1	ensure the establishment
1	development of analysis
1	articles, prior to
1	statistical analysis, and
10	circumstances of the
2	use in nonprescription
3	360cc(a) of this
1	projects, with a
2	device, the device
1	hig-risk foods for
1	following statement, unless
1	2015; (c) $7,429,000
1	(or drugs). (2)
1	trade in violation
1	product is offered
1	concerning observed no-compliance
1	administration the director,
2	identified or intended
1	surveillance for any
2	protective order been
1	underage personany person
1	group; and (bb)
2	ch. 74, 1,
1	venue is proper
3	requirement that relates
1	review is proposed
5	suitable written notice
1	entity to evaluate
1	information about consumption
1	educate students as
1	safety and wholesomeness
9	subsequent fiscal year
1	judicially noticed; (2)
1	veterinary surgery in
1	content of such
1	name, contact information,
1	goats, excepting products
1	services receives shall
1	article included within
2	device. such a
2	certification as described
1	transportation, placement into
1	pertinent to any
1	reinspection means 
1	poultry, or any
25	fiscal year under
1	(c) unless 
1	general shall report
2	product radiation, or
1	health, (ii) there
4	products on the
1	piminodine. (20) racemethorphan.
1	interested professional, labor,
1	agents; or (ii)
1	(a), the remaining
1	prohibit the sale
1	finds that, if
2	partnership the name
1	 (f) fee
3	available to such
1	gas submitted in
1	(2) whoever commits
1	facility to comply
1	drug shortages; (5)
1	plan bringing the
1	section, shall refund
1	(b) any proposed
1	provides for such
1	practice as described
7	7 of title
1	(c) possession, manufacture,
1	board.  (2)
1	27, 2007), the
1	appropriate schedule, if
1	marketed subsequent to
1	application references a
11	fiscal year after
1	$500,000, or both,
1	related therapy, on
1	product application by
1	general except where
6	 (a) with
1	promptness; exclusions 
1	regulations concerning the
1	360e(d)(1)(a) of this
1	applicable period 
1	studies the secretary
1	 (k) food
1	accreditation, within 60
1	maximize, promote, and
1	communication information to
1	employees, except that
1	 (c) enterprise
28	subject of an
3	(a).  (5)
1	destruction. (2) the
3	 (1) development
1	(b)(2)(c); (x) such
1	reporting be conducted
1	butter and for
1	acceptance of a
4	foreign or domestic
1	coordination; task force
1	recommendations under subsection
4	wholesale and retail
1	useit is not
2	conferred by the
1	documents, or regulations
3	required in this
1	promulgate a standard
1	law and which
1	foundation shall have
1	(under federal or
1	residue; (b) establishing,
1	nonprescription active ingredients,
1	add to such
1	suppliers; or (b)
1	taken, if they
1	individual facility. 
1	may be marketed
1	partner means 
1	center.  (9)
3	(e) in the
1	 (2) procedurein
1	potency may relate
1	 (a) delivering,
1	title, or subchapter
1	securely sealed it
8	new animal drugs,
2	set aside his
5	new animal drugs.
1	report, where the
1	trial by order
2	accreditation, the secretary
1	manufacturer or importer.
1	explanatory or supporting
1	12 of title
1	(3) studies and
1	treat a unique
1	revising the list
1	new animal drugs;
1	commission and the
1	subsequent recipients of
1	(iii) application withdrawn
4	thereof, the secretary
1	 (b) custom
1	(5) a representative
1	public health. (b)
1	minimum sentence required
2	corps loan repayment
2	request a person
1	term smoke constituent
1	singl-use device does
1	security not later
1	quantity or quantities
2	purpose within the
1	comment.  (4)
1	earlier, petition the
4	authorized trading partners.
1	cleared, or licensed
1	(a) methods to
1	(as medically appropriate)
18	 (3) the
1	service; acceptance of
1	administration fees notwithstanding
1	(b) fee amountssubject
1	renumbered 10 and
1	device, an annual
1	receive an initial
1	applications withdrawn before
1	investigational device may
1	different investigation may
2	gas (as defined
1	basis to conclude
1	investigations; oaths; subpenas;
1	literature; (e) data
1	date. (ii) in
1	18th par., 34
1	date such new
1	 (g) expedited
1	fed to animals
2	extent feasible, possess
1	purpose of delivery,
1	distributor, or a
1	
 3561. accelerated
1	 (a) take
1	2012, from the
1	acts and the
1	by, or transferable
1	include packaging. (6)
1	underage tobacco use,
1	available analytical methodology.
1	ch. 675, 736b,
23	issuance of the
1	brand means a
1	neuroscientific advances; (b)
1	needs that are
1	potential sources of
1	approaches to expedite
2	health service act,
1	authorization by chief
1	drug and as
1	 (e) requirementsthe
1	human disease or
3	security, may determine
1	packaging, logo, registered
1	publishes the notice
1	auditor.  (7)
2	reclassification from class
1	entities. such a
1	states the secretarys
3	appropriate conditions on
1	facility has registered
1	foodborne illness, the
2	dependence or psychological
1	(
 
 379d.
4	among experts qualified
1	analogues a controlled
2	kinds of animals
1	et seq.). (june
4	otherwise investigating to
1	professional acting at
8	study of the
1	deception, or subterfuge;
13	described in clauses
2	radiation disclosure statement
2	ensure adequate training
1	inspection of certain
1	product manufacturers 
1	implant.  (9)
3	commodity shall not
2	including the substantial
1	filing.  (ii)
1	restrictions described in
1	section 360e(d)(1) of
1	raw milk if
1	apparent reduction in
1	facility managers or
2	one year. the
4	 (a) develop
1	tissue products, and
1	applicants last known
1	title i, 12,
2	(including neonates, as
1	underlying causes of
1	may convene a
3	control fee account
4	plan (including a
1	readily available, such
10	products of the
1	management plan process
1	
 24. omitted

1	menthol) or an
1	administration personnel with
1	official plant means
1	terminate such extension
1	regarding a use
1	nonradioactive reagent, reagent
1	terminated at any
1	actions the director
1	requirements to certain
1	ingredient when used
1	technical data at
1	without trial if
1	(f) dissolvable tobacco
2	educational agency has
1	law. (3) nothing
1	application is required,
1	statement submitted to
1	title, submit requests
1	data is not
1	united states during
1	hearing within 10
1	country, and product
1	(13) ice pipes
4	person unless the
1	deliver the information
2	professional degree, and
2	granted, the reasons
1	imported food from
1	dietary supplement, is
1	state agencies, courts,
3	residue depletion studies,
6	conform to such
1	upon the container.
1	addiction medicine or
1	regulation prescribe good
5	(b) application was
1	available. (h) the
2	maximizing the availability
1	means the commissioner
2	requested is not
4	food, if the
1	(2) expressing concerns
1	warnings or instructions;
2	establishment in response
1	abuse prevention regarding
1	nominee provided under
10	agreed initial pediatric
1	(i) a supplement
2	information or comments
1	investigations of an
1	(a) a pesticide
1	executive department, agency,
14	secretary shall grant
1	states have complied
1	relating to satisfactory
8	(3) authorization of
1	 (1) findingsthe
1	community boards; and
4	(a); (c) provide
1	i, general controls.
2	records of egg
1	engages in those
1	residue protects consumers
2	drugs the secretary
1	transferable for value
1	complete such plan;
2	need for an
23	subsections (a) and
1	recordkeeping requirements described
1	recall, each incident
1	if, on the
1	applicable guidance under
1	financial records) relating
1	draft proposal for
1	associate the product
1	(iii)subsequent applicant.if all
1	seeks a meeting
1	(3) has classified
2	regulations before november
2	early payments in
5	(all items; united
11	federal register and
1	unless such word,
3	alter the standards
1	subsequent offenses any
1	due to matters
1	upon conviction thereof
2	federal register any
2	enforcement administration in
2	identify potential immediate
1	provide such assistance,
1	undertaken by national
3	judicial review under
1	termthe term of
3	application or protocol
1	statementthe transaction statement
1	 (a) supplying
1	information regarding grants
1	made. as soon
1	awards of up
1	measure, or research
1	best practice guidelines
2	(i) publishing a
1	product application. such
1	state.  (e)
2	needed in each
6	shall provide an
2	grams or less
1	multiple or concurrent
1	subpart 2[1] are
2	years, by such
2	records described in
1	officers, employees, agents,
1	(1) one or
1	effectiveness checks, and
2	sentence. upon approval
1	eligible entities certified
1	(iii) any combination
1	imprisonment, such fines
1	shall not cause
1	(h) that is
1	management that addresses
1	less than twice
1	fees. the costs
1	filing, the secretary
4	order act upon
2	45 stat. 993

2	exceed $500,000 for
1	year according to
1	filing.  (f)
2	rate.  (ii)
1	agreement executed under
1	 (b) receives
1	(2) inflation adjustments
3	inspection by the
1	(a) foundation the
1	reprocessed device. (xii)
1	communication facility shall
1	(b) placement on
1	secretary has taken
2	exposures and all
1	smoke constituents, by
28	iii, iv, or
1	abbreviated application has
1	pharmacy is registered
1	administer oaths, examine
1	include a commitment
1	bottled water. (3)
1	dismissal of certain
1	quantities for research
2	drug included in
1	means that a
2	chemicals to be
1	representative employed in
1	best serves the
8	agreement between the
1	raw material or
2	institute a civil
1	possess a security
3	sponsor has failed
1	proceeding  (a)
1	interdiction committee 
2	subject document is
2	record shall maintain
2	300.0  
3	assure that it
1	stating the grounds
1	suggested by statement,
1	proposed regulated transaction
1	communications, food and
1	sellers any establishment
1	(a) or (c);
1	agency and federal
2	goats, or equines
1	food meets applicable
2	1, 38 stat.
1	labeling changes. 
1	 (d) no-prescription
1	manufacturer shall affix
1	schedule iv (

1	shall not delegate
1	labeling, registration, good
10	master file fee
1	assessments; (b) consider
1	shall reevaluate only
1	inspectionthe results of
8	initial biosimilar biological
1	shall, if recommending
2	held pursuant to
1	traveltime) during which
1	pattern of diversion
1	no-federal sources to
1	programs primarily intended
1	support to those
1	determination is a
2	institute of medicine
1	(1)). the secretary
1	results do not
1	(
 
 882.
1	tank a physical
1	prevention programs in
1	products are worthless,
1	year, and unobligated
1	conditions; direct reports
1	program that requires
1	secretary upon oral
1	health. (4) a
1	active ingredients, the
1	required to mark
1	youth could be
1	conduct which may
1	knowingly importing a
1	(g) collection of
1	newl-approved drugs,[2] safety
1	42. (e) monitoring
1	request, or if
1	2012, the amount
1	25. oleomargarine, butterine,
2	information:  (1)
1	4.5.  fat:
2	address, and license
1	request, or in
1	thereof (including dosage
1	sharing of food
1	regulations fixing and
1	office, either directly
1	term importer means,
1	 (1) department
1	guidance to implement
1	identify unmet needs
1	year 2002, to
1	age of twent-one
1	existing programs have
1	drug administration, upon
1	(9) administrative funds
2	will document the
1	file that has
1	necessary to produce
1	(5) does not
1	(g) grocery store
1	convention, for review
3	360bbb3(a)(2)(a) of this
1	fee the initial
1	title iii, 533,
1	made or derived
1	thereof.  (3)
1	permit the investigational
1	subsection (c), including
1	shall pay application
1	sel-administer medication. (c)
4	transported in commerce
7	resides or has
1	schools served by
8	unfit for human
2	severity of foodborne
1	license, distribute, and
2	countermeasure under review
2	hire a consultant
1	interest.  (b)
1	and, except as
1	designate any specified
1	 (ii) part
1	(3) community the
4	results of each
1	methamphetamine, lsd, and
1	secretary that is
1	(i) in generalnotwithstanding
1	administrative entities within
1	inspection service approved
17	active ingredient (including
1	section 848 of
1	respect to, and
2	misbranded, or expired
2	institutional review committee
1	controlled substances notwithstanding
4	suspect product, or
1	substantial treatment effects
4	(k) the term
1	site or organization.
2	another hospital within
1	type of change
1	drug products) or
1	(ll)  (1)
2	authorized to perform
1	(iv) for manufacturers
1	person to place
1	size  (i)
1	pay, awards, bonuses,
2	entitled to the
1	apply to eggs
1	variance to other
1	classification panel (except
1	tobacco product. in
2	wholesale distributor, having
1	(which shall conform
1	consumption before such
2	accrued interest on
1	tobacco product. if
1	countries to discuss
5	national academy of
2	surveillance, outbreak response,
2	product distributed or
1	requirement after approval
1	shall make relevant
3	prior approval of
1	(6)(a) revoking such
4	establish a tolerance
1	proceeded against shall
1	response and containment.
1	conferences, and other
2	assign the practitioner
1	originates from an
1	  60.0.
1	least one voting
1	customarily given away
1	department; (b) ensure
2	views orally or
3	administration of state
2	section 802(25)[1] of
1	product application. (ii)
1	information, or criteria,
1	100 days after
1	 (a) protects
3	among infants and
1	(3) evaluationthe secretary,
1	administration, or (b)
1	subbrand. the secretary
1	withdrawing the approval
1	inert ingredients of
4	general a state
1	section, a sponsor
4	device in the
1	license, or clear
1	leaves in addition
1	interested third parties,
7	shall approve or
4	secretary shall either
3	function of a
2	information identified by
1	order, grant the
1	section 331(b), (c)
1	final results of
1	subsections (b)(3) and
4	determination of whether
1	steps, if any,
1	whether such tobacco
1	product, not consumed
1	status under section
1	(i) youth. (ii)
1	shall (a) be
1	prescribe. no crude
1	thereof, duly commissioned
17	veterinary feed directive
3	patent and trademark
1	licensed by each
1	[7 u.s.c. 136w(d)]
1	vivo bioequivalence studies,
1	ethical or practicable,
1	outbreak response, and
1	final order 
1	commingling of food
2	provided under such
1	(j) report preceding
1	iii, 533, formerly
1	guilty or nolo
1	nanotechnology; (c) encryption
1	financial data; (b)
3	communication with the
2	manufacturer; and (bb)
1	implementing regulations or
3	studies (other than
1	appropriate. (3) the
1	(including an application
1	manufacturer (as defined
1	final decision regarding
1	food; (2) reasonably
2	(3) the amount
1	provides or coordinates
1	(a); and (iv)
1	general ordering such
1	priorities  (1)
1	means any united
4	extent as such
1	deviates from an
1	(x) date of
2	condemnation (a) proceedings
1	manner, and in
1	
 
 3433.
1	regarded as exempt
1	assigning a cros-disciplinary
1	person; and (d)
1	execute it. the
1	apply except to
2	355(j)(7) of this
1	reduced fee amounts
1	(e) an agreement
1	effectiveness. (b) for
1	convention, transferring a
1	took effect. (8)
1	(e) prohibit a
1	served  (1)
1	false labeling of
1	 (f) evaluation
2	persons who in
1	person includes individual,
1	secretary finds (and
1	priorities which, in
1	(1) that every
1	including all directions,
1	practices (cgmps) under
1	safety the term
1	larges-selling tobacco products
1	conduct a clinical
1	failed to fully
1	 (e) biosimilar
1	secretary shall complete
1	done within such
1	investigator, pharmacy, hospital,
1	receive or otherwise
1	management of a
1	medical schools, academic
2	-year period thereafter.
1	month beginning after
1	slaughtering or processing
1	order, any hearing
8	reports by the
1	u.s.c. 262(h)]. (ii)
1	national counterdrug research
1	activities in any
1	bears the symbol
1	intended for that
2	inspections conducted under
1	assistance. section 14
3	programs within the
1	ignorance or reckless
1	343(q)(5)(h)(ix) of this
1	business of a
1	(d) no person
1	secretary determines applicable)
1	every manufacturer registered
1	contains a controlled
22	summary of the
1	equitable allocation of
1	misleading. (f) rule
1	gaps in its
1	 (1) notificationif
1	reduction in overall
1	finished dosage that
2	listed in paragraph
3	amounts appropriated for
2	application for purposes
1	it; (2) the
1	individual  (a)
1	product effective october
1	changes in meat
1	isolated, or otherwise
2	proceedings of advisory
1	special damages sustained
1	risk of death
1	written inspection observations
2	section 1604(b) of
1	area.  (b)
1	section, direct and
2	additive in the
2	articles regulated under
1	shipment data, pricing
1	(h). (q) reusable
1	security and confidential
1	(3)(c)  (i)
2	serious disease or
1	product usually known
2	 (b) compliance
1	person for information
1	term bioavailability means
1	individual under this
1	(i) each biosimilar
6	congressional committees specified
1	existing processes, by
2	extend the deadline
1	grants to institutions
1	june of 2005;
1	
 360rr. federa-state
1	(6) false statements
1	certificationsnotwithstanding section 107(a)(2)
1	sept. 3, 1954,
1	(1) application the
1	unmet medical needs.
1	conduct a vulnerability
1	declining to recognize
1	application is referred
2	columbia by any
1	(1)(b) and section
1	variance process under
3	provided under sections
1	(i) 4 shall
1	measures, or describes
1	ways for the
5	shall commence not
1	knows  (1)
1	usual place of
1	(c) the date
1	of, and compliance
2	(a) the increased
1	(c) the data
1	shall publicly post
1	section 331(ll), 344,
5	grants a request
1	stat. 769
 

2	drug will notify
2	members of advisory
1	necessary to perform
1	refund is equitable
1	making a counterfeit
1	title iii, 531,
1	omission, or failure,
1	abuse reduction organizations.
2	product by an
5	public interest will
2	diagnosis, prevention, or
1	produces, or which
2	require the execution
1	auditor  (a)
1	conviction record under
1	formerly 3rd par.,
1	device. (b) for
3	issued under authority
1	value to any
2	forth in subparagraph
3	802(39)(a)(iv) of this
1	minimum, includes initiatives
1	active participation of,
1	promulgate regulations within
2	shall require reporting
1	register, any type
1	label to be
1	 (i) violates
4	conduct described in
1	expenses to be
1	data and informationthe
1	(3) deferral 
4	(d) a description
3	consumer organizations, and
2	purpose of evading
2	variance shall prescribe
2	effectiveness by an
2	private right of
1	(ii) for each
1	(a) describes 
3	device in lieu
1	 (g) delivery
1	panel known as
5	traffickers and their
1	required to successfully
1	illicit drug profits
1	action is brought,
1	ii device for
1	machin-readable methods. (b)
1	proceeding is so
2	board under subparagraph
1	section, or (iii)
2	achieve the following
2	change the classification
3	subparagraph (b), no
1	priority review, including
1	(b) foodborne illness
3	time fixed therefor
3	released for public
2	 (i) submit
1	application, means such
1	secretary identifying bulk
1	terms serious illness
1	(a) prohibition against
1	make such device
1	profit from, or
2	humans or other
1	treatment facility. 
1	(excluding expenses) specified
2	prior fiscal year),
1	enforcement agencies and
1	(ii) special rule
1	dietary risk, consider
1	information where the
1	appraise conduct or
1	tolerance, a pesticide
1	manufacturer expects to
1	methods, tests, or
1	date, quantity, chemical,
1	product (including limitation
2	exception for activities
1	growing or not;
1	 (iii) appropriate
1	effect.  (c)
1	title. paragraph (3)
1	paragraph. (3) approval
1	(2) clarify procedures
1	laws or parts
1	et seq.] nonfat
1	relating to device
1	dismissed biomaterials supplier
1	countries in the
39	notwithstanding any other
1	animal model does
1	(a); (c) in
1	(1) contact information
4	irreversible morbidity or
1	319e of the
1	formerly 20th par.,
1	602. congressional statement
5	secretary did not
1	final guidance to
1	(b) that includes,
4	enter into any
1	warnings nothing in
1	(a), that the
1	enforcement and investigation
2	distributor, which is
3	(c) is withdrawn
2	3, 1996, and
1	oversee and coordinate
1	may be reviewed
1	possess skill in
2	 (d) other
2	(b) notice to
2	unsafe under such
1	farm and rural
1	devices are made
1	chapter, have been
1	(4) study and
1	paperwork reductionthe secretary
1	investigation, if the
1	outweighs the hardship
3	size and prominence,
1	country official, manufacturer,
1	controlled substances 
1	seeking to submit,
1	shall be notified
2	records, facilities, and
1	fee) for the
8	family smoking prevention
1	specific technologies for
1	active and inert
1	determines appropriate. (c)
1	responsibilities, including any
1	donated at no
1	manufacture move in
2	organizations, disease research
1	pay a civil
1	provisions becoming effective
1	(8) apply to
1	registration of food
1	terminated. the period
1	application. the supplemental
1	assumptions, methods, results,
1	(other than devices
2	research by the
1	(c) permanent ineligibility
1	supply chain, which
1	sale, or trade
3	federal government, or
2	describing the use
1	initiatives described under
1	(i) a document;
1	primary jurisdiction in
3	health care delivery
3	may modify the
1	sponsor; (ii) resulting
1	civil action, the
1	illness outbreaks attributed
2	application that provides
1	submission and review
1	(a) biological, chemical,
1	written advertisement that
1	registration an outsourcing
1	health emergency pursuant
1	number of full
1	matters under the
1	coordinating council and
1	may exceed 80
1	section 321(k) of
1	slaughter of cattle,
1	operate an eligible
3	shall be tested
1	section 156 of
1	(a) in any
1	subsection apply. in
1	heads of executive
1	section 1701 of
1	title). (f) if
1	reasonable time for
2	related to an
1	cleared and may
1	activities involving supply
1	(c) action if
1	iii, an application
2	jury of the
2	immediately removed from
1	description of methods
1	buildings, all of
1	able to link
1	believes that he
1	specifying, as appropriate,
1	(a)(2)(b), the term
2	registrant an order
1	title 5, this
1	guidance in a
1	studies. the sponsor
1	penalty (plus interest
1	aerial and ground
1	initiative, or clearly
1	condition. (d) rule
2	pediatric populations, as
1	president; and (c)
1	applies.  (ii)
2	investigate the cause
1	same. (mar. 3,
9	301 et seq.],
1	wholesomeness in accordance
1	provide for research
3	term official certificate
1	welfare, for the
1	partnership definedin this
1	substance which, or
1	fraudulent representations so
1	secretary determines aids
1	testing of other
1	regular importer, if
1	carcasses, etc., meat
1	inspection service and
1	global response to
6	written requests for
1	representatives, and various
1	government concerned for
1	referral. within sixty
1	monitoring as a
1	privilege. each such
1	title) and recommendations
2	event reports. (ii)
1	for, assessing, decontaminating,
1	iii device because
1	finds and declares
2	thereof, of any
1	courts, and law
1	nanomaterials that might
3	(ii) information to
2	(b) this chapter,
4	qualifying federal determination
1	claims against, and
1	officer in charge
1	fifty pounds. 
1	chemical therein and
2	food covered by
2	subclause (but not
1	review of internal
1	facilitate the secretarys
1	(4)[1] a summary
1	timely development and
1	short period of
1	shall be scheduled
1	(
 
 2011.
2	withdrawn before first
1	subject to authorization
1	whole.  (d)
1	investigation, arrest, prosecution,
1	alteration, removal, or
1	number of members
1	(b) controlled substance
2	drug submission submitted
1	
 1050. jurisdiction
1	penalty whoever violates
11	number of applications
1	title; (4) the
16	360fff1 of this
1	administrator for the
1	branch, food and
1	report, the product
8	federal register notice
1	agency (referred to
1	date that would
1	event of default,
1	countermeasure for which
1	agreement, paragraph (1)
1	control the risks
1	coordinate with federal,
1	maintains, in accordance
1	explanatory matter as
1	meetings to enhance
1	civil action for
1	determinations. such office
1	statement directly to
1	licensure of pharmacies
1	possess) such substances
4	limit on the
2	(21 u.s.c. 1521
1	functions as the
1	article to him;
2	 (1) definitionin
1	substances to manufacturers,
1	require a reanalysis
3	property of a
1	describing criteria, processes,
2	clause (i); and
1	including studies and
1	
 360bbb7. notification
1	persons cannot be
10	substance is not
2	partner and, in
1	accused, by a
1	repackage, process, or
2	disclosed in records,
2	provider that meets
1	operating the various
1	shipment as aforesaid
1	ii which, in
1	substance the sale
1	(a) creative services
1	prosecution or adjudication
1	likely overall impact
1	(i) such producers
1	regulation require, for
1	categorization of laboratory
2	condemned may not
1	distribution of list
1	means the subjecting
3	providing opportunity for
1	timing not later
1	requirements of drug
2	specific purposes of
1	(a).  (

2	similar to morphine
1	sectionsafety rest area
1	title. (2) any
24	general of the
1	person provides information
1	demonstrated to the
2	subject to seizure
1	statement: this drug
1	describe such product
2	(d)(3) is made
1	submitted; (9) issue
1	initiated under subsections
1	reprocessed singl-use device.
1	effectively advance the
2	time of suspension
1	management plan within
1	manufactured from other
2	prior to initial
1	report from an
1	may exercise jurisdiction.
1	memorandum. (3) in
3	excepting products which
1	reprocessed singl-use device:
1	contentfor the purpose
1	form, as a
3	secretary deems appropriate
1	eligible for 
1	1 to 5.
1	tribal food laboratories,
1	linkages with other
3	use with respect
2	reports a state
1	modifications to section
1	files an application
2	labeled effectiveness; (ii)
2	 (a) have
1	required products for
1	(8)); (b) the
1	559, 2, 68
1	color additive, in
1	commodity has been
1	field and laboratory
6	appropriation acts for
1	 (ii) average
1	public health interest
1	shell egg packers
1	nonclinical data demonstrate
1	research for which
1	days in the
10	upon submission of
2	description of fees
1	produce safety (a)
1	drug and, to
2	standards, practices, and
1	faxed, or electronic
1	ii, or ephedrine,
1	advice on the
29	accordance with subsection
1	devices, under such
1	means information derived
3	reprocessed singl-use devices
1	 (e) deputy
1	evidence on any
1	believes is relevant
1	veterinary medicine and
1	so; or (ii)
3	related to drug
1	transferred; (d) funds
1	(b) exclusion from
6	assure the availability
1	fails to verify
1	provide by regulation
1	general determines to
1	title) applicable to
1	appropriate; (iii) to
1	approval under that
1	additional controls are
1	fills of schedule
1	gross annual revenues
2	(b) the establishment
1	title. where such
1	adulterated. the court
1	(e) repackager requirements
1	requests fulfilled during
1	defendant is located
1	subparagraph applies shall
2	studies will be
1	previous ten years,
1	corporations excepted; insecticides
1	sel-generated paper, electronic
1	(b) gao reportnot
5	regulations to implement
1	numerical identifier applied
1	treatment of upper
3	days of receipt
1	subsection (j). (4)
1	31, 1976, declared
1	dependence, or health
1	request within 30
1	 (iv) a
1	title in any
8	identity of the
1	secretary through regulations,
1	prescribe by regulation)
1	use of recognized
1	chapter) may refuse
2	considerations in determining
3	thereof subject to
1	federal effectiveness in
1	 (2) remaining
1	local agencies under
1	exemption fails to
1	
 1032. congressional
1	specifies  (a)
1	subsection as drug
8	first 5 fiscal
1	675, 802, as
2	submitted a certification
1	application. (8) the
1	safety of a
2	upon his own
2	determines that inadequate
2	additive will not
1	exported. (mar. 4,
2	program residue monitoring
1	
 350l1. annual
1	transaction informationthe term
3	defendant has its
1	product, and maintain
1	drugs (including drug
1	effective for use;
1	year, budget recommendations,
1	360b, 360ccc] or
2	investigational device exemption,
1	both)  (a)
2	drug code, and
12	application approved under
1	representatives. (d) one
1	verification requirements under
2	subclause (i)(cc), the
1	(c) process in
1	513, as added
1	representative.  (c)
10	both. if any
1	successor regulation)), unless
1	admitting to listing
2	deemed under section
2	notification with respect
2	action to obtain
1	shall determine, after
2	year regarding the
1	infections, teenage pregnancy,
1	
 850. information
2	purposes of determinations
1	ch. 675, 582,
1	food primarily as
1	analysis and critical
3	earlier of 
1	certain petitions the
1	nonclinical, clinical, or
2	national drug abuse
1	(i)(3), and (p)
1	(a) there shall
1	drugs; (c) activities
1	available clear written
2	supply reduction missions
1	share information regarding
1	stakeholders and maintain
4	certifies and the
1	including regulations that
2	identify and implement
3	subsection (e) of
1	(b) the initial
1	shall receive submissions
1	thereafter, there is
1	produced, personnel, research,
11	information submitted under
2	basis thereafter. 
1	applications (a) pending
1	(2) facility the
1	comprehensive resources of
1	 (1) consider
3	information deemed necessary
1	ch. 675, 709,
1	(ii) finds that
2	42 for a
1	5. if during
2	waiver is granted,
1	ensure public safety.
1	clear identification as
3	entity that is
1	public safety. (k)
1	(b)(2). (3) limitationan
1	5. (4) prohibition
2	 (d) limitation
1	domestic hig-risk facilitiesthe
1	(a), as applicable,
1	indian health service.
2	federal register and,
1	article maintained by
4	 (a) after
1	recall.  (2)
2	pesticide program residue
1	(ix), and (x)
2	device will have
1	exception notwithstanding paragraph
3	buy, sell, or
1	(ii) annual quantifiable
1	may bring an
1	use, and 
1	(e) registration period
1	involving combination animal
7	hazard to the
2	notice; and (iii)
1	subsection (d) have
2	malfunctioned, caused or
1	notice that a
1	established by federal
1	used under the
1	imprisonment for a
2	28. (2) if
4	abbreviated drug applications
1	statement regarding the
1	may require recordkeeping,
1	cocaine, and derivative
1	classify any natural
1	tropical disease means
1	675, 743, as
1	security  (1)
1	business, and process
3	carrying out any
1	report all manufacturing
1	agreement shall remain
1	product shall apply
1	food safety authorities
1	bulk vehicle the
1	grant described in
2	957 of this
1	wholesale distributor in
1	prioritize and provide
1	wholesale distributor if
1	summary review; (ii)
1	financing for terrorist
1	changes needed to
1	secretary to increase
2	title, knowingly or
1	otherwise distributed to
1	(13) courts that
2	establishment that employs
1	financial and performance
1	hazard exists; and
1	title with a
1	refrigeration is required.
1	title. (c) subparagraph
2	become effective not
1	facilitating the distribution
2	drug and device
1	response, inspection, and
1	 (i) exportation
1	prosecutions of such
2	establishments every person
1	review and revision
1	private nonprofit entities
2	registrant that has
1	preventing or controlling
1	retailer of such
1	chapter; (2) informal
1	government and bring
8	reasonable times to
1	disclosure or the
1	state laboratories to
1	index prompt notice
1	ingredients that is
1	(c) communit-based organizations;
1	(1) metal, wooden,
1	(ii)component of another
1	use of humane
1	(2);  (8)
5	supplemental application for
2	administrator shall by
1	misleading labeling. 
1	products to meet
1	professional practice that
1	available for examination
1	based on competent
1	extent practicable, include
1	access records of
2	drugs throughout the
2	acting under the
1	propylene oxide, and
1	information concerning observed
1	published, and publicly
2	dispenser is a
4	use by experts
3	licensed to prescribe
1	application, product, and
1	emergency departments in
2	furtherance of this
2	direct, fac-t-face exchange
1	subpopulation has the
1	chapter 2 of
1	reclassification is not
2	agreement, authorize the
1	agreement under subparagraph
1	made within 30
1	conditionsnotwithstanding the requirements
1	relevant laboratory networks
2	examination of carcasses
1	judgment pursuant to
1	ch. 675, 1,
1	investigation for the
1	known severity, including
1	shortages described in
1	entity at such
1	without added ingredients,
4	derived from a
2	different than, those
1	benefit  (a)
2	misleading labeling in
1	contracts are made
1	coerce abstinence in
2	refused admission on
1	make grants under
2	performance measures for
1	thereafter authorized (1)
5	vehicle or rail
2	general the director,
2	postapproval safety with
1	listed drug, such
1	(c) work with
1	information shall also
1	entities) no-federal funds
1	vacancies  (a)
1	(h) relation to
1	agriculture may transport
1	one credible person
2	debarment.  (ii)
1	personal consumption, or
1	(3) any requirement
1	isomer of the
1	97 to 97d.
1	(b) to class
1	direct accreditation if,
1	making determinations on
1	public health. (3)
1	i) in his
1	 (3) request
1	measurement) that is
1	paragraph (1). thereafter,
9	absence of such
1	714 et seq.),
1	determinations. in making
1	controlsthe owner, operator,
1	limited population pathway
1	injure, or deface
1	(a) determine, in
1	mentioned shall not
1	form means 
2	program agency in
1	(b) the adulteration
2	used by a
1	shell membranes intact
1	determination by secretarynot
1	although such protections
1	information. (b) factors
1	states provided such
1	adolescent educational achievement
1	404 of this
1	participates in the
1	(a) in distributing
8	experience in the
1	requests; (4) the
1	manufacturers, distributors, pharmacies,
1	respect to general
1	 (l) jurisdiction
1	(a) may convene
1	made of such
1	designation; publication in
1	whether the conditions
1	secretary as harmful
8	criteria set forth
2	dispensing the label
1	contributions, during the
1	applicable to carriers
1	residue monitoring 2003;
3	allocated for human
1	exempt any or
1	 (b) limit
5	seeking approval under
1	(a)(i) continue to
2	whose description or
1	application. (ii) for
1	2013, be submitted
1	human beings; (c)
1	authorities of the
1	plant of origin
1	335. hearing before
1	(i) authorized trading
1	response regarding the
1	sodium (mg) 20.0
1	order outweighs the
1	notification of federal
2	devices, which may
1	mileage of witnesses
1	paragraph, the person
5	animals, the secretary
1	dispenser to another
1	contents of order;
1	(relating to publication
1	facility has manufactured,
1	list of pathogens
1	1008, formerly 908,
10	distribution, or dispensing
1	article and was
1	field. (ii) the
1	faces tremendous pressures
1	displays of tobacco
2	investigational device will
1	preproduction design validation
1	require the provision
1	section. (d) the
1	include information describing
1	secretary has identified
1	percent of fish
1	mechanisms of section
1	order. (3) except
14	tobacco product or
1	conditions of such
4	panel or panels
1	(4) personnel matters
1	united states: refused
1	(5) provide support
1	finding of substantial
1	(with respect to
1	neonatology.  (

1	pay the user
5	hallucinogenic effect on
2	general, after consultation
1	limitation.  (4)
1	substance; and (3)
1	tobacco product on
1	article ii, section
1	plan at the
2	purpose of protecting
2	method of its
1	401, 52 stat.
1	obtain signed agreements
1	title) and the
2	regulations, orders, instructions,
1	pharmacy of a
2	court is appealed,
1	submission contains information
4	shall be by
1	findingscongress finds that
1	(11) an assessment
1	interested entities; (16)
5	ensure the safety
1	research; (4) develop
1	transferred shall notify
1	collude with others
1	retailer or wholesaler.
1	evidence (obtained prior
1	avoiding unnecessary duplication,
1	introduced; and 
1	(b) enhanced penalties.
1	means a physician
1	receive such evidence
1	surveillance has sufficient
1	leaving the registration
1	conforming to the
1	directors or by
1	(b) detection goalimprove
2	safety and applied
1	 (j) service
1	introduce evidence. except
1	otherwise supplied at
1	(k) research and
1	products as provided
1	records of any
1	procedure. (2) 
1	(g), as may
1	comments on a
3	television advertisement under
1	year 2008 fee
1	effect. if a
1	testimony, and receive
3	manufacture, processing, and,
3	(2) as used
2	determine the time,
8	regulation or order,
1	include in each
2	paragraphs (1)(b) and
2	institutions, and restaurants,
1	treatment of tropical
2	clause (i) does
6	country described in
4	human food, or
1	ensure that athletes
2	testimony touching the
7	pending or approved
1	section 956(a) of
1	shall jointly develop
1	difference in strength,
3	use in pediatric
1	section 413 of
1	committee of any
1	believes, or the
1	phenolic ring by
1	paragraph (1)(a) applies,
1	investigation, or concerns
1	upon payment by
1	dosage form shall
1	shall not delay
1	shall docket the
1	suspension, including specific
1	substantially equivalent, the
1	qualified indication. 
2	pertaining to such
2	federal regulations before
10	finding that the
1	criteriaa coalition meets
1	network that (1)
1	foreign country; and
1	deficiency. (ii) for
1	morphin--oxide. (17) myrophine.
2	entity that meets
1	upon request. (2)
1	bezitramide. (4) dihydrocodeine.
1	$1,000,000 or less
1	1923 [21 u.s.c.
2	shall, at all
1	forfeitureany person convicted
1	strategies, policies, and
1	may distribute such
2	section 334(a)(2) of
1	seeks approval, licensure,
1	combination thereof, but
2	applicable to maple
1	providing financial or
1	committee appointed pursuant
1	public information, news
2	rule, regulation, or
1	part thereof, is
1	grant amountthe amount
1	(9) take such
1	industry regarding the
16	(other than a
1	(a) new drugs
1	387g, 387k, or
2	regulations) shall be
1	import alert that
1	general services shall
2	make required reports
1	(or controlled substances)
1	natural  (i)
1	seq.] for distribution
1	tribal agencies (such
1	treatment facility where
1	approved march 3,
1	title and making
1	of.  (3)
1	commingling, processing, transporting,
1	part or raw
1	package or other
1	 (a) establishmenta
2	online pharmacy that
1	smoke constituents as
5	substance.  (b)
2	eligible establishmentthe term
2	recipient fails to
1	declare the protocol
1	whoever engages in
1	project to other
2	control of any
1	process, to support,
1	shall include 1
2	chemical shall be
1	42, for such
1	hidta are providing
1	(2) omitted (

1	exemption, be considered
2	request is eligible
1	respect to reprocessed
4	action letters which
1	without being registered,
1	reasonably necessary to
1	assigned to inspect
1	(b) and any
1	certain provisions notwithstanding
1	false transaction information;
1	pethidin-intermediat-c, -methy--phenylpiperidin--carboxylic acid.
1	endpoint means a
1	site. (v) the
1	quarterly basis, to
2	safe production and
1	building construction standards,
1	 (2) biomedical
1	attorney generalwith respect
2	type of facility
1	system to an
1	secretary may choose
1	path publi-private partnership,
3	analysis and ris-based
1	tribe has the
1	conducting exercises of
1	without notice or
2	personally identifiable information
1	30 days, commenced
1	effective technologies for
4	applies, the secretary
2	section 1050 of
1	birth weight, or
1	(2), as so
1	products, poultry, and
1	chemical and pesticide
5	eff. apr. 11,
1	showing blood rings,
1	353 of this
2	health information when
1	(j)(5)(f) of section
1	subchapter; or (ii)
1	inspections by such
3	burdensome means of
2	advance notice of
1	criteria established for
1	information demonstrating the
1	quality controls of
2	united states; (b)
1	interested law enforcement
1	path publi-private partnerships
1	article be labeled
1	agent acting on
3	centum or more
1	identification as such
1	mission of the
1	(i) the original
1	conditions that achieve
1	balancing in a
1	(including with respect
1	following factors with
6	manufacture of such
1	effectiveness and a
1	regarding oleomargarine sales
2	unduly burdensome to
2	offered by laws,
1	three or more
1	facilities covered by
1	 (f) verificationthe
2	appropriate labeling changes,
1	engaged in corrections,
11	(as such term
7	contributed to a
1	copy records, reports,
1	(1) in support
1	control of pseudorabies
6	drug are inadequate
5	shall be deposited
2	handling required to
1	size of business
1	enhancing law enforcement
1	forfeited personal property
1	determines that all
1	regulatory, and administrative
5	act of 1970
1	amount of educational
1	(6) the commission
1	(e) withdrawal and
1	monitor drugs pursuant
1	u.s.c. 2021], and
1	licensed veterinarian, and
1	qualified testing expenses,
1	350a, 350c, 355,
3	 (b) submission
1	expenses, incurred in
2	equines, capable of
1	patients, physicians, pharmacists,
1	assess and evaluate
2	not, under the
1	(iii) an in
1	council for drug
1	(b) mult-drug resistant
1	(a) processing operations
1	reported, notice of
1	faith as such
1	consumers, restaurants, hotels,
1	governments;  (iv)
2	proposed, or final
1	restricted; (b) nothing
2	secretary, or any
2	provide a report
3	investigation or hearing
5	active postmarket risk
1	loss means an
1	voting stock, or
1	funds expended by
1	extracted from any
4	will  (a)
5	falls below such
11	generalexcept as provided
1	importers that volunteer
2	registrant for commercial
1	(6) serve as
1	reactions; or (ii)
1	gross receipts during
1	harmful or potentially
2	period; and (cc)
6	drug that 
1	alternate sources of
1	submission of certifications
9	laws relating to
7	demonstrates that the
1	legislative, or other
2	run and operated
2	expert witness fees)
1	practicable, shall be
1	expert witness fees,
1	petition or a
1	on-page summary on
4	june 30, 1940,
5	negotiation meetings 
1	ensure, to the
5	article, or from
1	unprotected; (2) would
1	biomedical research to
1	risk; (iii) identifies
3	manufacturing establishments, institutions,
1	paragraph (d) of
1	certification includes a
1	facilities associated with
2	mandatory minimum sentencing
3	labeling, distribution, holding,
1	investigations (a) authority
1	unnecessary imposition of
1	antifungal resistance. 
1	applicable, the guidelines
1	regulated transaction, the
1	communities. the mentoring
1	(1)(d) the application
1	medical devices; 
1	62 stat. 198;
3	use and conditions
1	affidavits of the
1	retention of records.
1	(1) information, document,
1	redaction by the
1	corporation. (b) the
1	grant eligibilityto be
5	 (1) has
2	(3) a new
2	title for pediatric
1	hospitals that are
120	defined in section
3	et seq.], the
1	submits a notification
1	harmful viable micr-organisms
2	secretary shall meet
2	subsection (l)(3), or
1	replication otherwise complies
1	include a proposed
20	violation of subsection
2	expressly provided in
1	johnston atoll, the
1	law on the
1	criteria may only
6	subparagraph (a) by
9	1903 of this
1	determines, after preliminary
34	shall ensure that
1	(a)(1) (other than
3	protocol for the
2	quantitative formulation of
1	360c, and 360e
1	subparagraph (a) be
1	section; (14) who
2	device will remain
2	analysis and mechanical
2	title are applicable.
1	evaluation or medical
1	women and health
2	drug sample, the
1	practitioners a practitioner
1	matter issued or
1	budget year scheduled
1	program, including demand
2	eligible establishment; and
2	liability under federal
1	secretary shall issue,
1	agencies, to enhance
1	subsection (i) which
1	may be necessary,
1	presence or, in
1	period. for the
2	 (b) data
1	 (aa) federal
1	foundation; (vi) specify
1	tobacco product through
1	transport vehicle) to
2	secretary; and (iii)
1	ginseng.  (2)
1	states, from any
2	designate an additional
1	(ii) application withdrawn
1	confirmed adulteration of
5	to, or different
1	notice; updated notice
1	request, and make
1	filtration, packaging, logo,
1	issues; and (20)
1	involved has appeared
16	final agency action
1	exemption meets the
1	importation is being
1	notification to homeland
2	products for purposes
1	(2) export from
1	 (b) extension
1	international drug abuse
1	designate for the
1	interagency agreements or
1	(which person is
2	class i shall
1	(c)(3) respecting a
1	title 26 to
1	course or via
1	(ii) complies with
1	science profession, appointed
1	building; (2) task
1	holds an application
1	recall shall be
1	actions referred to
12	[42 u.s.c. 262(a)]
1	may approve antibacterial
1	traveling on official
2	title the secretary
2	review (a) in
2	regarding a transferee
1	determination, set forth
2	grant made under
1	(h) interventions for
1	inspectors shall mark,
1	antidote, and the
1	time for modification
2	fulfillment of the
3	information, published or
1	recover a civil
1	guard licensed by
3	person by the
5	subsection (a) during
1	submitted, or after
1	(e)(1)(a), (e)(1)(b), (f)(2),
1	standards means the
2	part, to a
1	regulation. (4) availability
1	20 years in
1	controlled substances contribute
1	letter of intent
2	device because insufficient
1	drugthe terms investigational
6	360fff(7) of this
1	approval. any order
1	$10,000,000 or less.
1	(2cn). (28) -(2,-dimethox--(n-propylphenyl)ethanamine
1	regulation exempt test
1	attractiveness, or altering
1	partner, employee, or
1	protection achieved under
2	(relating to prescription
1	review and final
1	21; july 22,
1	component parts is
1	(2) contentsuch regulations
1	shall not disapprove
1	request. (d) drug
2	constitute an admission
2	labeling and that
1	review the plan
1	identity it has
1	establish a safe
1	193. repealed. 

2	subsection (j) to
1	 (5) list
1	to, unnecessary electronic
1	use, distribution, dispensing,
1	secretary, after making
1	(a) reports the
1	recordkeeping by retailers
1	disclosure of proprietary
1	area.  (3)
1	individual in order
2	respecting the active
1	duplicates information which
1	group of patients.
1	subsection (b) if,
2	package includes any
1	(b), submit the
1	potential pilot opportunities
2	practices implemented to
1	governments subject to
1	promotes the public
1	form of nicotine
1	(d) success in
1	products, materials, or
1	relating to illicit
1	marijuana,[1] cocaine, hashish,
1	agriculture a technical
6	publish such recommendations
1	ability to pay.
7	1, 2015, the
1	applicable federal law;
1	term youth shall
1	letter. such response
3	information and the
1	aggregation, statistical analysis,
1	1, 2013 shall
1	ii in accordance
1	(3) in situations
2	parenteral drug product
1	penalty and who
1	 (a) post
1	secretary of labor
1	tribe to enact,
1	 (a) qualified
1	(2) applies to
4	made effective as
2	13, 2016. 
1	prepare any such
1	6.  (e)
25	together with the
1	(2) electronic databasenot
1	(6) may, from
5	human services for
2	used to fund
4	nonnarcotic controlled substances
1	112. repealed. 

1	ch. 675, 506g,
1	extent applications (a)
1	extracted therefrom), fiber,
1	regulationsthe secretary shall
1	tomography compounding standards
3	reports. (ii) developing
3	[42 u.s.c. 262];
1	following the meeting
1	includes initiatives that
1	identified.  (c)
1	judge allows additional
3	subsection (h) of
1	(i) the administrator
1	1996).  (june
24	authorized in accordance
4	appropriations act is
1	general, upon the
1	immediately furnish the
1	study would help
1	vancomyci-resistant staphylococcus aureus,
10	effect it purports
1	report a holder
1	evidence, as the
1	(2) a person
1	secretary copies of
1	implant is placed,
1	(2) collection of
2	(ii) the conditions
1	authorization; (2) the
1	subsection (i) to
1	(2) contrary to
1	provides an estimate
1	(b) a farm
1	containing an ingredient
1	ensuring safety and
4	conducting a review
1	resources among federal
9	37 of title
4	conducted during the
1	employees of any
2	section 355(o)(3) of
1	served at any
1	disease, in such
1	 (j) effective
1	clandestine laboratory database
1	traditionally intended for
2	results of which
1	identifying inspection shall
1	plans and programs
1	obtained under this
1	program to verify
1	separation of funds
9	labeling for such
5	secretary may authorize
1	exemption, may request
1	june 30, 1906
1	processing any egg
2	personnel unless the
1	cream where such
30	secretary shall promulgate
2	practitioners who dispense
1	food.  (

1	providing reasonable notice
1	imposing sentence on
1	new and improved
2	requirements under such
1	(3) administrative procedures
1	(a) in generalbefore
1	prescribe.  (2)
2	full information as
1	drugs, to treat
1	manage or control
2	(and major identifiable
1	subsection, if such
1	means the codex
1	subpart b of
1	supplants the authority
1	transgenic animal does
1	state agency; subordinate
1	court  (i)
3	include the following
1	(a):  (i)
1	
 
 387f.
3	filed application or
1	effective. nothing in
7	year after december
1	person has previously
1	pane-track supplement and
4	procedures for review
1	refund of application
4	cleared product if
1	(iv) or (v)
1	enhanced by this
1	information relied on
3	years to have
1	(j)  (i)
1	used  (a)
1	services. (b) establishment
1	device establishment at
1	representatives, the authorizing
1	matchbooks of conventional
1	identifying the notifier
4	agreement described in
1	accredited person may
5	small business adjustment
1	contract, memorandum of
1	1543(a)(2) of this
1	term qualified pandemic
3	mark or simulation,
2	excluding any amount
1	coalition and the
7	nature of the
2	 (2) requirementsto
2	homepage of its
1	carcasses all poultry
1	commission shall have
2	marked, labeled, and
1	ch. 675, 506,
1	(ii) medical societies;
3	regarding the parameters
1	conduct examinations, testing,
1	states shall register
3	purchase and use;
1	sanctions or penalties,
3	modified or revoked
1	(b) civil penalties
1	shortage.  (c)
1	area, provided that
1	drug administration electronic
1	(d) as a
3	purchase and use.
1	june 29, 1938,
2	offense except as
1	audits of food
1	title that may
1	paragraph (1) ceases
1	marketed in combination
1	(c) nonprescription status
1	describe such effect
2	captured through electronic
2	specific patient need
1	list is terminated
1	adjustment  (a)
1	(vii) the number
2	found. (2) if
1	manufactured, introduced into
1	annex. (4) the
8	articles subject to
1	i, class ii,
3	[7 u.s.c. 2011
1	(4) meat itemthe
7	identifier, including the
1	civil penalty after
2	records a manufacturer
1	means any poultry
6	secretary determines such
1	difficulties for compoundingthe
1	food ingredient, and
1	state that requires
2	duration the authority
1	delivery or other
1	liable for costs
1	alcoholic beverages, as
1	(ii) in examining
1	expert review and
1	recipient has been
3	acting pursuant to
1	may not withdraw
3	substances. (
 

1	united states owning
2	time of registration.
2	issue a warrant
1	time of registration,
1	drug consumer protection
2	may receive and
1	product if directed
1	i, 24, as
1	regarding womens participation
1	rail vehicle, receivers,
1	individual patient and
1	
 959. possession,
1	food, with the
1	(3) award compensation
1	requirements, including 
12	means a person
1	adulteration. (c) drug
1	permanent screens, hashish
1	products, or to
1	(d)(1)(c)(i), and (e)(4)(e).
1	oral suspensions or
1	articles, and any
2	agreements with the
1	terminate expanded access
1	section for receiving
4	product in violation
1	(ff) in, or
2	fiscal year 2010;
5	public meeting at
2	shall identify and
1	directions, recommendations, and
5	1953 reorg. plan
2	comments and information
1	(c) the fees
1	otherwise be collected
1	appointment the secretary
2	interpretive criteria 
1	state court, regardless
3	drug will not
1	made from the
2	fiscal year 2010,
1	full implementation of
3	number of qualified
1	staff the administrator
1	shall identify any
1	may limit revocation
1	postal service, the
1	paragraph pursuant to
1	abbreviated application fees
1	removal of any
2	designated medical gas.
1	research by academic
1	designated medical gas,
1	entities.  (i)in
1	laboratory testing capacity
2	specifies the number
1	offense after a
2	may be fined
1	clinical trials; and
6	date specified in
1	distribution security at
1	(or other such
2	unit of the
2	designated medical gas;
1	help support the
1	base period consisting
1	transfusion; (vii) the
1	extent and for
1	(c) this section
1	exported by such
1	used electronic products,
2	reduce the burden
1	assistance. (
 

1	(c) the standards
2	 (a) within
1	(b) criminal penalties
1	shall establish, not
1	(including any increased
1	data, views, and
1	sentence, the commitment
1	title, misbranded under
1	of, or had
1	delivery or proffer
2	conditions, including sanitary
1	drugs for human
1	percentage of applications
1	making the change
2	includes an assessment
1	administration and any
1	facilities or other
1	existence and scope
1	144. unlawful receiving
1	containment. (b) accelerate
1	carries out activities
1	able to fulfill
1	drug industry on
1	fraud, or be
1	food, a food
1	enforcement activities. if
1	fulfill such requirements,
2	otherwise manufactured or
1	fat content is
1	i, an administrative
6	committee on agriculture,
1	requirementsthe regulations promulgated
1	 (a) before
1	solely as a
1	make recommendations about
1	2013.  (b)
1	encapsulating machines, the
1	owns the abbreviated
1	shall knowingly pack
1	timetable for research
2	support or implement
1	chapter, or in
1	global clinical trials
2	may commence a
1	coordinated and joint
15	prescribed pursuant to
1	introduction constitutes an
1	(ii) to furnish
1	rehabilitation of alcohol
1	additional 18-day period
1	patient based on
1	targets to accomplish
1	(f)(1)(c) or (g)(2)(c),
2	condition, outweigh the
1	(ii) to remain
1	collected for analysis
1	necessary because the
3	services or the
1	(1) upon application
1	administrator proposing the
1	columbia from any
1	experts on rare
1	notice and designations
1	 (h) offenses
4	elects to accept
1	(iii) any sentence
1	provided if the
2	evaluation of advertising
1	regard to subsections
1	inhaled during surgery;
1	iii, 532, formerly
1	reduction.  (5)
1	waiver if the
1	
 360g1. agency
1	produced or handled
3	may transfer (including
2	secretary; (b) as
1	pharmacy. (c) an
1	receive or accept
1	scientific gaps that
2	qualification process under
1	(ii)(i) are data
1	application resulted in
7	fiscal year is
2	secretary determines causes
2	training in administrative
1	institute) for a
1	(l) construction this
1	advertising is misleading
2	(a) apply to
1	toward meeting approval
2	substance abuse activities
2	civilly or criminally
2	additional amounts of
1	feedback on the
1	authority the detainer
31	fiscal year in
1	likely to occur;
1	u.s.c. 2281 et
1	additive deemed necessary
1	(
 
 469.
1	including claims data,
2	requirements in effective
3	prescribing, amending, or
1	drug on such
2	title 44 (commonly
1	testing protocols as
1	application. (10) 
1	(1) are made
8	whether the drug
4	secretary under any
4	damage to a
1	submitted is appropriate
2	prescribe through rules
1	public process the
1	comments, data, and
1	action to enforce
1	storage facility loan
1	later than 330
1	(g)(2)(a)(ii), such index
1	hectares of marijuana,
1	animal drugs, as
3	prohibited by state
1	certifications and guarantees
1	identify, clarify, and
1	disseminate information and
4	shipments  (1)
3	imprinted upon, a
3	subject to 
1	equivalence and request
6	section 194 of
1	application is considered
1	intermediary, or other
1	initial determination was
8	days after july
1	instructions, or directions,
1	disposable wet wipes,
2	certifications under this
2	beginning 7 years
1	methods for classifying
1	related seller meeting
3	species are slaughtered
2	(relating to the
1	chapter to secure
1	subsequent proceeding whether
5	554 of title
2	access to their
2	971 of this
1	2017, the fees
1	individual providing such
1	safeguards as prescribed
1	subchapter requiring inspection
1	record. the filing
6	section 247d6b of
1	final under this
2	section 361 of
1	(ii) any clinical
1	in, revocation of
2	punishable under this
1	675, 711, formerly
1	period. (ii) distributions
1	ionizing or no-ionizing
5	shall be filled
1	locally collected data,
6	deviation from such
1	rule making under
1	penalties prescribed by
1	subsection (i), or
1	requirements to permit
1	sentence may be
1	appropriate communications to
2	waiveron the initiative
1	(mg) 4.0d 
1	delivery is about
1	
 679c. expansion
1	national drug use
1	states by any
2	involving a heightened
1	title 15. (june
1	physically inspect or
1	count per cubic
1	may approve a
1	(e) suspension if
1	federal regulations, except
2	safety report received
1	(6) methyprylon. (7)
1	part and shall,
1	(2) coordinate the
1	consumers. (mar. 4,
1	health waiver the
1	controls, as described
1	organic farms and
1	applicant of effective
1	commission shall promptly
1	trend analysis the
1	handler with a
4	interpretive criteria to
1	403(a)(10), 66 stat.
1	packages from which
3	approval shall mean
1	available:  (aa)
1	food for commerce
2	determination or certification,
1	act, suspends the
1	director, on a
2	control of imports
1	draft or revised
1	product, it may
1	recorded and the
1	federal, state and
1	pet food supply
1	denied, or limited
1	offense which is
1	index contents; publication
1	1996, exempt any
1	similar establishment, in
1	certification under[1] 381(q)[2]
1	directly purchased the
1	expensive to obtain,
1	 (9) as
1	made.  (iii)
1	customers upon purchase
3	commodity credit corporation
1	export, any drug
1	entered under this
4	sale or transportation
1	single sales package
1	decree that enters
2	paid for that
1	listed drug) by
1	(ii) shall, if
6	data, views, or
1	mean a determination
1	product meets all
1	innocent persons; and
1	paragraph (1)(d), for
2	receive a priority
1	including a separate
2	committee with the
1	(b) vacancies any
1	 (b) drugs
1	(d) coordination the
1	(c). (2) drug
1	 (g) certain
1	b of chapter
1	establishment for such
1	hearing.  (

1	require the person
1	section are used
1	specifications, hereafter in
2	secretary, and to
1	currently lawful partial
1	evaluationthe secretary, in
2	secretary conducts a
2	(a) poisonous, insanitary,
1	risk identification is
1	patient, or receipt
1	program, in consultation
3	secretary, with respect
1	promote honesty and
1	authorization issued pursuant
1	subsection) by the
1	professional practice where
1	background, character, and
1	person a registration
1	executive order shall
1	salts of antimony,
1	issuance of authorizationthe
1	occur within a
1	schoolthe term school
1	qualification an exemption
1	unsafe under this
1	established, under the
1	used by tobacco
1	office within the
1	requirement to prepare
2	professional practice of
1	performed to establish
3	use authorized under
1	reimbursable basis, the
1	limited population, taking
8	supplemental abbreviated applications,
1	conduct testing in
2	significant adverse device
1	applicable list 
1	361(e) of this
10	 (b) exception
2	(b), the attorney
1	(c) enforcement in
2	warrant under this
1	title, the distributor
1	(i) establishes and
1	means (a) the
1	(6) what, if
3	columbia, the commonwealth
1	complainant, shall assess
1	activities (including by
1	fee that may
1	timelines, and identification
3	distributed, or dispensed
1	required by part
1	cause the bureau
1	identified shall be
3	 (1) there
1	(2) within 15
2	apr. 15, 1954,
1	diverse product expertise
1	186, 187. transferred

1	requirements respecting devices
1	written plan and
3	given that term
2	local levels, including
2	disapprove the application.
1	maintains, in conformity
31	provided by the
1	(5) for having
1	 (h) effective
1	chemical or chemicals,
1	initial report for
2	fees pursuant to
1	regulation activities. (c)
1	title:  (a)in
2	secretary, the petitioner,
1	inspection and such
2	eliminate the potential
1	import supply chain
1	placing the person
1	cultivated and destroyed
1	continue funding for
2	321(s) of this
1	
 1036. pasteurization
1	chemical residues, including
2	shall specify a
1	content of drug
1	(25) the term
1	european union, if
1	
 693. inspection
1	nations are refusing
15	obligation of fees
1	ch. 229, 62
1	drug trafficking areasnot
3	determines is intended
1	giving a false
1	inspections and enforce
21	date of approval
2	1011, as added
1	product, device, or
1	infrastructure in place
1	10.45(d) of title
9	granted under section
1	prior to destruction,
1	use.  (b)
1	report summarizing the
1	interdiction activities of
1	chapter. (g) clarification
2	unless naturally inedible
1	controlled substances nor
2	reactivation fee for
1	almonds, pennyroyal, tansy,
1	drug product identified
1	pharmacy.  (d)
1	submitted.  (3)
1	medicinal qualities other
1	created under the
1	system (a) in
3	dosage form of
1	675, 731, formerly
1	identified individual patients.
1	heightened risk to
1	physical locations, then
1	devices shall 
1	brings a civil
3	full fee under
1	responsible personthe term
1	(1) any food,
1	murder; protection of
1	effect on foods
1	351, 360, 360d,
1	water regulation. (b)
1	public in a
1	support and commitment
2	protocol submitted under
1	labeling found therein,
1	communities in formulating
15	end of each
1	upon application and
1	application means a
1	
 350a. infant
1	exception under paragraph
1	tribal governmental agencies
1	condition, where such
1	drug; (ii) providing
1	schedule he deems
1	terms of controls,
1	issued in the
1	information, that a
1	rendered adulterated. 
1	(a). (2) an
1	standards; and (c)
2	eggs under the
1	install, and maintain
2	controls to provide
1	reports through the
1	diagnose; and (ii)
1	result in irreparable
2	broker means any
1	awards to fund
1	individuals knowledge means
1	
 1035. sanitary
1	(1)(b) than the
1	chapter, the requirements
1	1946, and the
8	circumstances in which
1	additional provisions regarding
1	documented calculation the
1	tobacco warehouse 
1	less than $500,000
1	necessary, in accordance
1	conduct  (i)
1	preclinical studies, or
1	thereafter renewable by
1	offense, (c) the
1	submitted by that
1	means of a
1	lon-term plans and
1	seized would, in
1	generala farm that
1	disruption in domestic
1	(5) eligible coalition
1	accredited person for
1	regulation issued in
1	made, the secretary,
4	setting aside of
2	dealing by a
1	adult consumer containing
1	subsection (d), during
1	may apply sanctions
1	family[1] smoking prevention
1	interstate source or
3	guests and employees,
1	limited as above
1	guests and employees.
1	article being adulterated
2	allowable previousl-paid carry
1	agency means any
1	 (1) audit
1	clause for each
1	propagating, compounding, or
3	guests and employees;
1	 (a) completes
1	strategy submitted under
1	transaction constituting the
1	additional staff resources
3	thereof) that the
2	average cost of
1	355(j)(5)(b)(ii) of this
1	subsection is governed
1	nonetheless believes that
1	trials which, in
2	recall and at
4	september 1, 2003,
1	concerning indian tribes
1	met.  (e)
1	makes a report
1	finality of judgments
1	exist and the
1	(4)[2] congressional notice
3	group is so
1	subsection (a)(3)(c), the
2	implementation of subsection
2	prescribed under paragraph
6	360i of this
1	(1), entities that
1	issues, consumer organizations,
1	alleging a violation
3	order or prescription
1	paragraph respecting a
1	 (i) nonsaleable
1	
 2105. enhanced
1	recipients of the
1	availability of any
3	destroyed, court costs
1	added substance to
1	change under paragraph
1	(ii) the counterdrug
1	(2) assessments 
1	refused to participate
1	basis of scientific
1	semiannual reports to
2	inspectors appointed by
4	section 353(c)(1) of
3	conferred by other
1	136a(c)(2)(b)] or section
1	 (21) suspect
1	153. inspection of
6	(d) of subsection
1	section 350c(d) of
1	(1) was submitted,
1	develop a detailed
2	46, 48, 49
1	allowable safe tolerance
1	 (a) advertising
1	duty of each
1	subsection (g), and
1	tobacc-related disease to
1	provider shall be
1	device, the agency
1	dovers powder, when
1	(1) as provided
1	shall post such
1	(a) timely and
1	262]; or (b)
12	application is filed
1	strategy; (5) shall
1	dispute resolution within
1	enclosed area for
2	quantity identified in
9	(iv) of paragraph
1	requirementsbeginning on november
1	evidence and documentation
4	secretary shall only
1	 unless such
1	injury or death;
1	vasopressor; or (vii)
2	lack of bias
1	regulation issued before
1	condition.  (i)
1	diseases. (may 29,
1	administration. (d) termination
1	drug or importations
1	service status or
1	together with existing
1	man or animal.
3	manufacturer or a
5	parole during the
1	integration of international,
1	drug samples, or
1	360fff2(b) and 360fff3(b)
1	 (ii) extrapolation
1	applicable, or in
1	criminal case, including
1	supports the national
1	13, 2013, the
2	means an individual
3	shall establish, before
1	[21 u.s.c. 360ccc1],
2	appropriate consideration of
2	applications and supplements);
1	abuse and other
2	1524(a) of this
1	secretary is providing
1	make any fraudulent
1	retail, predominantly to
1	may not import
1	language and units
1	item should be
1	prescribing regulations under
1	drug that seeks
1	effect of qualification
1	given and due
1	secretary, to demonstrate
1	identified hazard or
1	outlines and makes
1	i, 13, as
1	opium poppy, after
1	supplement must be
3	(c) submission of
2	measures may include
1	i-process controls including,
2	stamp, or tag
1	standards and the
1	concerns the transportation
1	mail order reporting)
1	registration to engage
1	 (d) procedure
1	(c)(3) was not
1	importer has not
1	tank truck, hopper
4	poultry that died
1	websites of the
1	activities exclusively related
1	punishments or penalties.
1	cos-effective meat inspection
1	agents, employees, and
1	petitioners claim, and
1	applicable to restricted
1	defined in such
1	animal drug contains
2	issued before the
1	registration for violations
1	 (e) menthol
3	efforts by state
1	distribution, of any
3	(c) that the
1	inference as necessary.
4	results in deception
1	transparent decisionmaking; (ii)
1	overall drug traffic
1	report to include
1	ingredient defined for
1	license be canceled;
2	capacity of state
1	written request, shall
2	examination and evaluation
1	blocked as of
2	required by clauses
1	reviewed after receipt
1	section 123.3(k) of
1	27, 2007, that
1	safety problem; and
3	federal register criteria
1	preparing and making
1	account the laboratory
1	recognized religious dietary
1	(v)agreement with another
1	(i) changes in
1	(c) an outsourcing
1	exchange, and all
1	 (b) awarding
1	national narcotics leadership
1	determine shall be
3	taken as a
6	upon the later
2	appears in a
1	twent-one days, of
3	grounds for revocation
1	(b)(iii) should be
1	(3) ingredients (other
1	warrant shall issue
1	potential if, at
1	chemical, and radiological
1	shor-, mediu-, and
1	(2) the net
1	independent ant-doping organization
1	recor-keeping and reporting
1	shall set an
1	becomes available to
1	(e) publish a
2	labeling requirement of
4	state the reason
1	license for such
1	appropriate, update pursuant
2	retained for at
1	phrase factors as
1	amounts amounts reimbursed
1	applicant in the
1	education, training, and
1	soon as possible
7	make recommendations to
1	engaged in research.
1	unstable or cannot
1	identifying the number
1	paragraph (2)(b) is
1	hiring bonuses, if
1	seq.); (d) a
1	modified by adding
1	area, conditional upon
1	filing. not later
1	tribal organizations to
1	experience, tests, or
1	devices is marketed,
52	substance in schedule
1	request shall contain
1	suspension and reinstatement
1	incidental to the
2	applicable final sunscreen
1	(1) specify how
1	administrator may facilitate
1	(c); and (2)
1	ordinance to ensure
5	therewith so as
1	appropriate measures necessary
1	receives a period
4	used in section
1	136w(d)] or the
2	rulemaking under any
1	group shall provide
2	reasonable belief that
1	(b) is (i)
3	trade secrets. 
1	hazards, including hazards
1	administrative order changing
2	drug is intentional,
1	production, transportation, and
3	determination. the secretary
1	(10) betaprodine. (11)
1	within a general
1	(b) withdrawal of
1	recalls the secretary
1	food testing, including
1	determination to limit
1	riskthe term signal
1	year, a summary
2	paragraph; and (b)
1	within such 30-day
2	representation by a
1	3,-methylenedioxy amphetamine. (2)
3	safe.  (ii)
1	i, 8, formerly
1	approval and for
1	corporation, or officers,
1	sunscreens; and (b)
1	thereof for export
1	databasenot later than
1	(d), the administrator,
1	animal industry to
6	apply to operations
1	shipment offered for
3	reduction under this
1	identity the definitions
1	device. (ii) a
2	required information; regulations
1	century cures act
1	reports.  (9)
1	distributing drugs in
2	dosage form, and
3	establishment  (1)
1	(b)(2).  (4)
4	said inspectors shall
1	programs outside such
1	emergency communication or
1	of, the owner
1	critical devices, the
3	control procedures prescribed
1	nominees if any
2	including such recommendations
1	(p) risk evaluation
1	modification of false
1	trade mark than
1	good standing; or
1	employed or retained
1	paragraph, the period
1	
 1044. exemption
1	allocations under subsections
3	information to patients
1	u.s.c. 2012), when
1	sale; (5) whether
1	900, as added
2	marketed as a
1	surgery. when a
1	trachoma. (d) buruli
1	carcasses, of poultry.
1	drug by hospitals
1	investigational submissions. (e)
1	performance, include 
1	(a), the manufacturer
1	thir-party auditor becomes
1	of, or is
16	convention on psychotropic
1	1052. state or
1	contents such regulation
1	360f, 360i, or
1	360j, or 360k
1	ethics, science, or
1	(a) may obtain
1	prosecution, courts, corrections,
1	availability to owner
1	video arcade facility
1	(i) is or
1	356c(c) of this
7	decides that such
1	of, or in
1	identify and inform
2	data required by
1	original device. (p)
1	monitoring program in
4	notice under subsection
1	advice, information, and
2	(b) notification of
1	penalty may on
1	temperature requirements pertaining
1	(2) a subsequent
1	approved the product;
1	average total time
1	upon commission of
1	article, or is
1	rodenticide act. (m)
1	distributor shall make
1	warehouse, consulting laboratory,
2	approves a drug
1	application under different
1	(b), no component
7	title, or a
1	final decision by
1	provider located in
1	recruit and retain
1	persons liable; scope
1	fingerprinting of facility
4	claims a method
1	ultimate consumer unless
1	states. (4) the
2	(b) the submission
1	used by man
1	themes into the
6	civil penalty in
2	shorter period for
1	register following publication
1	additives, including smoke
1	improve food safety
1	title. (2) 
2	timelinesthe timelines in
1	institute, such institute
8	limit the authority
1	(7) congressional review
1	occurred in a
1	prescribe such drug,
3	knowing, or having
7	208 of title
1	regarding the use
2	apply, he shall
12	behalf of such
1	secretary only data
1	office. the secretary
1	
 347. intrastate
3	health emergency declaration
18	general subject to
1	therapeutic category identified
1	strength, etc., where
1	permits its standards
1	paraphernalia involved in
1	indian country has
1	hard copy; (c)
1	period as determined
1	enforce an agreement
1	award costs of
1	shall give each
1	thereof; (d) the
1	(3) with the
3	21 months after
1	 (5) effect
1	apply sanctions authorized
4	name and business
2	within the national
1	(k) that are
1	subparagraph (a) information
1	facility; and 
1	accredited persons (a)
1	period july 1,
1	(1) adverse eventthe
1	gao reportnot later
5	 (b) application
1	person who requests
2	injury or illness
1	use in ingesting,
1	
 
 360l.
1	made unless immediate
1	 (c) duties
1	animal.  (b)
1	(b)(i).  (c)
1	(a)(ii)(iv) is untrue
1	products thereof, be
2	will be safe:
1	regulation shall take
1	commercial distribution, and
5	derived from such
1	353c2 of this
1	(a) to appropriate
1	personal use by
1	will be safe.
1	appropriate (and in
2	will be safe,
1	 (b)database.not later
1	timely postmarket data
2	prescribe such drugs
1	health authority understands
1	systems.  (b)
5	result in fee
5	packing, rendering, or
1	(ii) the record,
1	section 360eee(9)(a) of
1	exposure and toxicity
2	administration costs for
1	achieves the level
2	inspection regulations, the
1	sample. (f) drug
1	regulations), for facilities
1	termination.  (2)
1	registration or vacate
1	section 960(b) of
1	means domestic activities
1	supervision the director
1	amount determined necessary
2	effectiveness are not
1	days before making
1	dtc advertisements regarding
3	provide the transaction
1	secretary. (ii) a
1	(i) limitation on
2	academy of addiction
1	united states, managing
1	(18) -methylmethcathinone (mephedrone).
1	(including tests on
1	store notification 
1	(except the resin
1	susceptibility of bacteria
4	health.  (2)
1	
 360fff5. sunscreen
5	listed in schedule
1	trial standards with
1	except that deletion
1	chemical; waiver 
1	$1,250,000, to the
3	(relating to postapproval
1	saccharin, sodium saccharin,
2	premarket report, a
1	local agencies; (4)
1	labeling thereof; (d)
4	notify the governor
1	(a) an unapproved
1	grant the secretary
1	acid or any
2	information.  (3)
1	breakthrough technologies. 
1	use the information,
1	performance standard to
1	trained personnel. 
1	report, notification, declaration,
2	(ii) a new
1	chapter, the poultry
1	title or deemed
1	trials, or the
1	term repackager means
3	subsequent to the
4	subsection, or if
8	result of such
1	illness and its
3	term priority review,
1	343(a), or 348
1	part thereof; or
6	form of the
2	prescribe) for the
1	person who applies
4	decreased by the
1	 (ii) report
1	administration and shall
1	administration to human
2	(5), reasonable variations
7	(b) the committee
1	new information, can
2	delivery, report to
1	title is applicable,
1	examinations, inspections, and
4	establishment fee under
2	 (c) content
1	governmental officials concerning
1	officers of the
1	slaughtering, processing, or
1	plan to coordinate
2	less.  (b)
1	drug administration used
1	use of resources
2	analytical testing methodology
1	operations and management
1	standard set forth
1	permanently implantable, is
1	 (3) research
1	(d) other remedies
3	unless the party
9	secretary may provide
1	pathophysiologically related to
1	period. (b) additional
1	infected or contaminated
2	cos-effectiveness, and scientific
1	food registry available
3	affected thereby appeals
1	attempted to import
1	(4) secretary the
1	secretary will consistently
1	ch. 675, 505b,
1	order shall become
1	assigned to such
1	reimbursement of the
1	extent necessary, coordinate
1	cigarettethe term cigarette
2	detoxification treatment, the
1	clearly identified ballot
1	(1)(c). (3) withdrawal;
2	reporting requirements for
1	standard is intended
1	(1), the dollar
1	concerned with the
1	including traveltime, at
2	contracts, memoranda of
1	submission of health
1	may directly or
1	physically incompatible or
1	representation that such
1	13, 1992, of
1	condition, within the
1	formula)  
1	costs in an
1	use no fee
1	shall, if warranted,
1	13, 1992, or
1	period and considerations
9	meaning of this
1	druggists, hospitals, and
1	support the development
1	data, in compliance
1	via an electronic
1	regarding drug shortages.
1	intermittently. (6) the
1	reducing violent crime
2	(ii) if no
1	classification information. 
1	improve the control
1	growth of dru-resistant
1	prescription drug), with
1	sale, movement, and
1	uses of legally
1	describe each observation.
2	local partnerships to
1	subcommittees and convene
1	additional studies that
1	of, such representative
1	reasonable standard of
1	paragraph (2), whoever
1	order published by
2	center, public swimming
9	13, 2016, the
1	approaches to assessing
1	1 in the
6	implementation of such
2	organizations who in
1	places an implant
1	(i), of such
2	registration of certain
2	state law for
1	review. for the
1	title. (iv) 
1	(b) as applied
1	675, 535, formerly
1	jurisdiction, shall be
1	control programs or
1	reason of section
2	offense relating to
3	director the term
2	distributed commercially. 
1	law, move to
1	made for referral
1	mist; or (iii)
1	that[1] relies on
1	(
 
 460.
1	may periodically request
3	interferes with any
1	person requires the
2	substance, which is
1	contract awarded by
1	(m), are exempt
1	circumstances and conditions,
1	color additive as
1	use funds for
11	industry, the secretary
1	requiring inspection upon
1	exist, at a
28	(4)  (a)
3	issue guidance for
1	available, and (b)
2	court may issue
4	days after august
3	considered as a
4	food contact substance,
1	property in any
1	event or transaction,
1	following rules shall
2	identifies a product
1	materials, design, energy
1	research centers, professional
1	effectiveness information, including
1	engage external stakeholders
1	validation data for
1	york) and issues
1	(i) closely related
1	chemicals by this
1	substances laws or
2	contact with whose
1	preceding -month period.
1	protection agency for
13	product means a
1	stat. 420.)
 

1	pharmacy, hospital pharmacy,
1	federal criminal investigation
1	incubation or the
1	term unapproved use
1	effectiveness and will
1	basic information, certified
11	user fee amendments
1	extent appropriate, solicit,
1	designated food; (k)
1	(k) records and
1	safety. to the
2	year of a
1	expenses) specified in
1	review, under the
1	feasible, it is
1	 legally marketed
1	title) intended to
2	agree to make
1	cream imported into
1	original or renewed
1	(5), an advisory
1	handle or store
2	extent practicable, minimize
1	chemical pursuant to
1	making any finding
1	relationship means a
1	(a)(ii). (3) public
1	(g), including the
1	likely to refuse
1	iii device may
1	adulterated products; destruction
1	agencies, (b) consult
1	(2) may make
1	economy and the
9	reference or use
2	case of imported
1	$60, as determined
1	issued with respect
1	(c)(2) and shall,
1	174. repealed. 

1	market in developed
1	 (2) investigation
1	387o. regulation requirement
1	phenylpropanolamine as incidentally
1	limit, or otherwise
1	ipecac and opium,
1	imminent hazards to
1	information in determining
3	failure to provide
1	employees may serve
1	changes and designate
1	 (2) bulk
1	regulation, provide a
1	shall recommend a
1	66 percent of
1	be, under subsection
2	effect, and such
3	formulary monograph, if
2	shall expire not
2	secretary approving a
2	act is enacted.
1	precluding action by
1	context most appropriate
1	seller, or biomaterials
1	(2) or (5)
1	biomaterials supplier (a)
2	implicit representation that
1	cause the internet
1	shade containing more
1	concerning a violation
1	owner that all
1	practitioner will provide
4	later than 270
1	(except with respect
1	outsourcing facility means
1	inspection warrants shall
1	petitions for remission
3	year, and (ii)
1	additives, to induce
1	reports and notificationsexcept
1	(c) to respond
1	unsafe with respect
1	diseased poultry is
1	means a measurement
1	(1) pharmacies which
3	three times any
1	lawfully used or
1	relates to devices.
1	pose a public
1	
 
 372a.
1	(a) premises, facilities,
2	tax return, the
1	provide on the
2	entrees only to
1	licensing process for
1	title continues to
6	controls against diversion
1	case of removal
1	2206. alcoho-related facilities
3	achieve the goals
1	states inspectors or
1	executive director, may
2	application (as defined
1	within the discretion
1	regarding such certifications
1	drug, and informs
1	35, or (iii)
1	collaborative, cros-disciplinary review;
1	act entitled an
12	subparagraphs (a) and
1	programs and other
1	populations if such
1	health outcomes, of
1	notification (other than
1	importation by individuals
1	recipients of grants,
1	(a). in prescribing
1	current drug trafficking
1	ensured that the
1	countermeasure may initiate
1	presentation provided by
1	trainees of the
1	methamphetamine, shall 
1	sites, in addition
1	public; and (c)
1	(b) modulates the
1	implementation plan the
2	term record means
4	placed into effect
4	use by such
1	year, respectively, to
1	expenses for transportation
1	(f)(6)(h) distribute such
1	culpability, and history
1	require  (1)
1	(including estimated collections
1	equivalent level that
2	records which fully
1	sales restrictions; bond;
1	protect the consumer
1	(5) termination of
1	use.  (4)
2	application, shall pay
1	(1) as the
1	343(f), 343(g), 343(h),
1	disapproval and a
1	assessment is safe
2	shall establish advisory
1	accelerated approval for
1	television advertisement. (11)
1	 (1) proposed
1	significant subpopulation group;
1	renewed by such
7	course of professional
2	quality, purity, or
3	recall order under
1	drug are specially
1	adverse event trends,
1	(b) notification to
1	must determine that
3	food defense strategy
4	biological product applications.
1	channels, including electronic
1	term gross annual
1	combination product, a
1	adverse event trends;
2	general, as are
1	water of ammonia
1	conditions with respect
1	therapy.)  (2)
1	subsection (a)(2)(a) has
2	states pharmacopoeia, official
2	may not carry
4	days of such
1	without paying duties
1	places, or causes
1	
 379s. preemption
1	secretary shall measure
1	wholesale, shall be
10	secretary, after consultation
1	
 460. miscellaneous
3	substituted, wholly or
6	records, reports, and
1	known or potential
2	treat such product
1	insert, if the
2	matter published in
1	analyze such data
1	refuse access, at
7	product to be
1	studies. (iv) the
1	changes requested by
2	necessary for purposes
1	recordkeeping relating to
1	387q. tobacco products
1	(i) unduly burdensome
1	(ii) the commissioner
2	number of responsible
1	 (b) very
1	(2) action taken
2	resubmitted or filed
1	appropriate qualifications prescribed
1	judicial proceeding arising
12	secretary shall approve
1	$1,000. for purposes
3	apply to articles
1	expense of such
1	person the accredited
1	supplement to make
2	interest of public
1	target food inspection
1	thereafter amended, under
1	absence of those
1	patients report by
1	economic information relates
2	drug study submissions,
6	secretary shall accept
1	manufacturer and shall,
1	safety and efficacy,
1	punishment which may
2	seeking a grant
2	entity shall use
1	section 679a of
1	processor or packer
2	(h), including any
2	sale, receipt, possession,
1	treasury and shall
1	(1); and (7)
4	drug fees (a)
1	complexity, usefulness, multiplicity,
1	motion or other
1	(ii) a separate
1	(a) a term
1	$5,000,000 for the
1	days; or (ii)
1	medical research companies,
3	charges for storage,
1	(b) procedurethe secretary
1	determines appropriate, that
1	injury that the
1	supplant current ant-drug
1	consignee, such owner
2	strategy, including any
3	processed or packed,
1	(c) the notice
5	content the minutes
1	clause (i), and
1	congress intends that,
1	title revoking the
1	practitioner, whether such
1	toxin act). 
3	way derogate from
1	shall fairly evaluate
8	made pursuant to
1	exemption, as the
1	may not refuse
1	section 897.34(c). (d)
1	certification would assist
1	establishment. (b) the
1	farm, as appropriate,
1	960a. foreign terrorist
6	contains a certification
1	states in finished
1	export if 
1	(1) the special
2	products for rare
2	taken with respect
2	convention will interfere
1	represent an improvement
1	publi-private partnerships and
2	(4), the secretary
1	content and format
1	parole, or treatment
4	analysis critical control
2	gene, with the
1	feed, as used
1	(7) that the
2	equivalence under paragraph
2	stage of a
1	percentage of combination
1	(h) registration by
1	complete previous distribution
1	1013, formerly 1012,
1	u.s.c. 56(b)] it
1	substance to be
1	motion or at
1	impose sanctions upon
1	iv, 407, as
1	chapter that relates
1	(d) not later
1	(e) restricted devices
1	dietary ingredient, or
1	schedule i(c), the
1	sparsely populated and
1	319 of the
1	(1) exemption from
1	unapproved usewith respect
1	scope of judicial
4	provided that the
1	seq.] may be
1	dialogue and build
1	cosmetics, be deemed
1	solely to establishing
4	unfair competition, exemptions
1	 (ii) adequate
13	required by regulations
2	(3) or (4)
1	authority may conduct
1	(k) the alteration,
5	 (i) each
1	ch. 675, 761,
1	secretary; or (iii)
1	order of consolidation
1	affected antibacterial or
1	enforcement officer (whether
1	tobacco product recall
2	brings a patent
1	shall have had
1	first publishes the
1	necessary, guidance that
1	consumer groups; (b)
1	offering for import
1	media campaign, or
1	devices and may
1	manner established by
1	title, and may
2	ant-doping organization for
1	disclose, to an
1	track products; and
1	year multiplied by
1	child is engaged
8	exceed the daily
1	378. advertising of
2	conferences, workshops, or
1	section 356c(g)(1) of
3	term administrator means
1	
 
 371.
1	(4); and (b)
1	meetings in the
1	(1)(a), including the
1	opiat-dependent patients. 
3	representative sampling of
1	superior to any
1	describes how the
1	lists of approved
1	used in infant
1	among youth; (6)
1	(vi) ensure that
2	protection equivalent to
1	30, 1906 (thirt-fourth
1	regulations of sanitation
1	separate registrations for
1	manufacturing of drugs,
2	regulation (a) prohibition
3	authority for condemnation
1	enforcement or drug
3	applicant has failed
1	discourage persons from
1	investigators of the
1	generaldata and information
2	applicant, or serve
1	(i) coordination of
1	significant presence in
1	$12,900,000; (5) for
6	per ful-time equivalent
1	transportation practices if
1	annual report regarding
2	section 343(i)(2) of
2	(f) exception for
1	(i) the risks
1	priority pursuant to
1	title 28 shall
3	later, the secretary
1	access protocols submitted
3	slaughter by any
1	(1) whenever either
1	services at such
1	delivery device, or
1	addressed, consistent with
1	hospital, ambulatory surgical
1	(d) treatment in
1	guidance that accurately
2	(2) no egg
1	effect unless modified
1	dispensed; or (b)
2	secretary using the
1	paragraph (2) unless
1	establish research laboratories,
1	proposal to issue
1	service.  (h)
1	interest a member
4	times as the
3	evidence contained in
1	tobacco smoke; (iii)
2	guidance shall 
1	applicable; or 
6	records or to
1	education (as defined
1	operative. such owner,
1	paragraph (2) available
1	possession current approved
1	enforcement agency efforts
1	extending beyond december
1	enrollment for which
2	business as a
1	found that there
1	floor (which area
1	moisture. the fat
2	shall appoint an
1	seizure, maintenance of
1	recall has performed
5	reviewed by the
1	without permit on
1	thereafter.  (g)
1	675, 505f, as
1	(2) a common
9	proposed rulemaking that
1	participation in national
1	authority for distributionin
1	(d) factors for
1	made, the administrator
1	detect microquantities of
2	101(4) of the
2	income tax return,
1	violates subsection (a),
3	list is not
2	collection of finished
1	reversed, and (ii)
2	(i) or (k)
4	(b) rule of
1	shipped in violation
3	distributor of a
1	gift, devise, or
1	event such recalled
1	subchapter unless they
1	criminal offense described
1	initial list, or
3	28. upon the
1	entity would meet
1	implement a structured
1	valid for a
6	adjustment is necessary,
2	reflect the public
1	uniform proportionate basis,
1	facility, and during
8	360eee1 of this
2	disposition may be
1	(b)(1)(c) is revoked
1	products (a) extension
12	effectiveness of such
1	provisions shall also
1	athletic, civic, or
3	following the subsequent
4	central intelligence, the
1	set forth conditions
9	determining that a
1	(b) slaughters or
1	raw materialthe term
1	year, and 
1	services, that proceedings
1	(a) bearing on
1	time had any
2	burdensome appropriate means
1	14. any board
1	article, or has
1	subpopulation group; (iii)
1	experts on the
5	controlled substance; and
1	(1)(b)(i), unless the
1	false, fictitious, or
2	dispenser that is
1	drug administration inspections
1	list of establishments
1	business or employment,
1	(a) or any
32	case of any
1	email address. (3)
3	facility identifier of
1	administration, who may
1	shall conduct surveys
1	determination regarding the
4	receives or otherwise
1	applications that met
1	recover the full
1	life and fined
2	interpretive criteria and
1	substantial evidence when
3	shall appoint as
1	factors:  (i)
1	provider  (1)
1	privileged or confidential.
1	(2), and shall
1	(3) on which
1	infancy, allergic hypersensitivity
1	submit such request
1	(b) notification upon
1	type and severity
1	exposure for any
1	false statement, and
1	(a) to include
1	exported drug or
1	advertising (a) types
1	safety, except that
6	(b) the average
1	compliance data for
2	applicant, revoke a
2	advertising, the secretary
1	(i), except that
1	import adulterated food
1	971(c)(2) of this
1	procedures that the
1	2009, the commissioner
1	item of the
1	standards (a) requirements
2	respondent at his
1	simplicity.  (c)
1	satisfactory inspections, and
2	whenever property is
1	diverted; or (b)
1	(i), for each
2	agreed upon goals
1	v of this
1	states; and (e)
2	subparagraph (b). the
1	tobacco co. v.
2	adequate directions for
2	information for consumers
1	percent less than
1	entities certified by
1	director considers appropriate.
2	otherwise changing the
1	large quantity of
1	admission the secretary
1	consisting of amounts
2	otherwise not in
4	 (b) persons
15	agriculture and food
1	position or practice,
2	competence and capacity
1	service would be
1	health information related
5	director for state,
1	advisory assistance, technical
1	 (2) general
6	accordance with clause
1	testing methodology or
1	(3) panel members
3	immediately thereafter, the
5	publish the comments
5	(b) for such
1	manner of distribution
1	(i) estimates of
1	human health of
2	date under the
1	disclosure about a
2	federal employees employed
1	subsection (b)(4)(a). all
1	drug abuse; and
3	referral to the
1	intelligence information); (3)
1	sufficient number of
1	nonprescription drug to
1	registrant receives the
1	require.  (d)
1	written response; hearing
1	device, indicated should
3	show the safety
1	strategy goal and
1	regulatory status of
2	class ii and
1	particular; or (e)
1	secretary; (iv) promptly
20	shall establish a
3	chapter or under
1	entity.  (e)
22	following:  (i)
1	sale, or storage
1	generalsections 351(a)(2)(b), 352(f)(1),
1	(h) product certification
1	involved (especially in
1	commercial distribution; (d)
1	201 et seq.).
3	pediatric formulation cannot
2	supplier and the
1	section 331(q) of
1	(d), as applicable.
1	removed to the
1	review and develop
1	user fees. the
4	substantially affect such
1	gross worldwide revenue
1	studies relating to
4	fails to bear
1	system through which
1	issued under clause
1	since the agreement
1	activities for a
1	change has the
1	modify, or revoke
1	expertise on, the
1	 (1) those
1	to, administer, or
1	regarding an obligation
1	methamphetamine or its
1	telephone number, professional
1	strategy. (xii) a
1	parents. (iii) businesses.
1	regarding the improvement
8	manufacture, preparation, compounding,
1	warehousemans business. (4)
1	beyond the minimum
1	achievement of each
1	on, product sampling,
1	including the international
3	qualified employee of
1	350k of this
1	special populations, in
1	assessment.  (f)
1	shall establish 1
1	improve interagency coordination;
2	title, the director
1	(vi) available information
1	assess a known
1	manufactured in an
1	556, or 557
1	equipment; and (e)
1	natural flavor, herb,
1	imported drugs are
1	establish such requirement
1	omitted (
 

2	withdrawn and all
1	marketing of rare
1	groups of countermeasures,
1	substance and potential
1	placing the product
1	detail the reasons
1	proceeding.  (g)
3	patent will expire,
2	including recommendations on
1	appropriate; or 
1	2, 1956, ch.
1	conditions:  (i)
1	support thereof. it
3	applicant prompt notice
1	drug omits a
1	computer system design
1	360eee2. national standards
1	 (b) timing
1	transaction; (h) the
1	extension; and (c)
1	making such evaluation
11	filing of such
2	fee in such
1	
 1101. congressional
1	timing the secretary
1	following fees: 
1	shall be covered
1	155, 1, 44
1	824(a) of this
1	 (2) continued
1	registrant, or (b)
1	 (1) compensation
1	subpena; proof of
1	emissions of electronic
2	licensed to administer
2	identified in an
2	per violation. for
2	(1), unless the
1	suspend approval of
2	rates of abuse
1	379c. transferred
 

3	standard for the
3	serving at the
1	is, in accordance
1	application) for a
1	implementing strategies developed
1	quota shall be
1	emphasis on prevention
1	clinician or any
1	identify, through publication
1	fees to designated
3	june 30, 1906,
2	appeal has elapsed
1	paragraphs of this
5	order is issued
2	pizzas are to
1	supplies and records
3	funds for any
3	include provisions to
2	responsibly to purchase
1	18) any activity
1	report is not
1	purchase price including
1	policythe deputy director
1	determining for a
1	regarding the recall,
3	paragraph shall apply
1	providers, and with
1	publishes in the
1	expertise when practicable
2	375(b) of this
2	will not use
1	(3) limitation 
6	section 553 of
1	210. pharmacist; unauthorized
1	recommendation the tobacco
2	course of action
1	(iii) is plainly
2	preservatives shall not
21	shall be exempt
1	devices authorized or
1	suspension order under
1	devices is for
1	production exception notwithstanding
1	regulations) that may
5	needs of the
1	maintains, places, or
1	sustained if based
1	board membership includes
46	statement of the
1	(
 
 1703.
1	person.  (6)
1	to, inter alia,
1	scientific evidence shows
2	2017. if the
1	25 calendar days
1	(b) the assessment
1	chemical residues 
5	drug abuse and
2	facility that manufactured,
1	steroid; and (b)
2	(1) for fiscal
1	acinetobacter, klebsiella, pseudomonas,
1	states in any
1	26 (and exempt
1	cigars shall be
1	agriculture shall jointly
1	effective, such additional
1	(2) no registration
1	(ii)(i), in accordance
4	notify immediate trading
1	(1)(c)(i) shall expire
1	2012, and every
1	concerning the combination
1	 (2) listing
1	involved) requiring that
2	submitted, nothing in
3	assistance to the
1	(1) would result
2	required in the
1	title. (ii) the
1	unless the regulations
1	lists under subparagraphs
2	food no person
1	(c) protracted loss
1	 (2) procedures
1	confidential information from
1	(i) except with
2	demonstrating the safety
3	with, or at
1	consultation initiated under
2	used, transported, or
1	may be conditioned
1	pharmacy licensing fees
2	may affect the
1	shall so notify
1	379dd. establishment and
1	thirtieth calendar month
2	pediatric study was
1	order reviewed; (ii)
4	purpose of making
2	provide the responsible
1	application. (ii) documents
1	(b) real world
2	 (b) conditions
1	full and actual
1	3 years, except
1	therapeutic, pharmacologic, or
1	authorization for medical
1	withdraw approval for
1	effect an authorization
2	drug do not
1	(b) the exceptions
4	additives for use
1	(e) a loan
1	(4) if any
1	paragraph (2), if
1	(
 
 1056.
1	shall cause an
1	without obtaining the
1	section 457(d) or
1	pharmacist. the act
1	labeling when used
1	general shall approve
1	22, 1934, ch.
1	product not manufactured
1	receiving recommendations from
1	claimant, issued a
3	agency or instrumentality
1	part, an initial
1	means a form
1	(2). a device
1	706, formerly 702a,
1	eligible for accelerated
27	regulations promulgated by
2	7, 1953, ch.
1	packaging that 
1	food safety program
1	vessels, etc., arriving
1	deny the request.
2	work to that
2	(d) labeling requirement
5	et seq.), or
1	outbreaks and facilitate
2	ante mortem and
1	identify and validate
1	first applicant has
1	(1), which are
1	57b] with respect
2	designate a member
1	testing and treatment
3	actions as are
1	analyses are qualified
1	(b) coordination and
2	1, 1992, had
3	medical, scientific, research,
2	termination of debarment
1	importation of dead,
1	ch. 675, 407,
1	adopt other administrative
2	blood or blood
1	2017, the base
1	population, taking into
1	ch. 675, 532,
8	manner consistent with
1	required by treaty
1	determination definedfor purposes
2	schedule of the
1	entered the pharmaceutical
1	commerce as may
3	chapter or of
7	immediately notify the
2	smokeless tobacco 
1	proposed regulation. (c)
1	interested person, if
1	cream is used
1	shortages regarding whether
2	account or as
1	approved drug treatment
1	360e(f), 360j(g), 360j(m),
1	states, and such
1	including pilot projects
1	uniformity of standards
1	distribution system. 
1	(ii) the opportunity
1	responsible party; (b)
1	considered in determination
1	sections the act,
1	(2) establish procedures
1	connected with refusal
1	trade secret, confidential
1	activities are coordinated
2	bioavailability and bioequivalence
1	(b) rule for
4	review.  (2)
1	(1), (4), and
1	complete response letter;
1	file shall be
11	2013, the secretary
2	use and feeding
2	agencies in helping
1	0.7 iu/gm linoleic
1	thereafter, on the
5	accompanied by the
1	600 foreign facilities.
2	reportable food. 
2	requirements otherwise applicable
1	transportation of any
3	adjusted under paragraph
1	
 2223. enhancing
1	renumbered 7 and
1	diagnosis, or prevention
2	sufficient time to
1	committee within the
2	article to which
1	development of written
1	title 5with regard
3	major identifiable subgroups
2	monitoring and enforcement
1	receive no additional
2	tobacco product with
1	 (nn) the
3	applications for such
1	implantable, is life
2	promptly reduced to
1	products. the secretary
1	drug to design
1	title i, 101,
1	issued.  (k)
1	administered to the
1	2003. authorization of
2	includes an individual,
1	control, and shall
3	creation of a
1	complete response letters
2	detailing why a
1	disease and the
1	possess a valid
1	(c). (3) 
1	substance for such
1	secretary withdraws under
1	pediatric use when
3	 (c) action
3	(or in the
1	v shall, unless
1	terrorism and prevention
1	initiating pivotal animal
1	equivalence  (1)
1	(b)(1); (2) periodically,
1	cigarettes.  (16)
1	(4), select an
1	compliance budget), and
1	detained, or from
4	effect of section
1	sustained as a
1	nine months after
1	drug applications in
1	conditions under this
1	10 days, on
1	 (2) medication
1	law, for a
1	available, 6 years
1	data to support
1	united states attorneys;
2	timely and coordinated
1	preventive controls. (d)
1	substance to reduce
1	953. exportation of
1	restricted to sale,
1	facility, (b) an
1	any, would be
1	services are effective
1	list representing the
1	person considers to
1	patients, sponsors, and
1	u.s.c. 262(a)) with
1	(a) obligate such
2	section, unless (1)
1	compendium, and its
1	(iii) the plan
2	changes beginning on
2	general may, during
1	facility to change
2	derivative, mixture, or
1	organic, not include
1	(c) any rescissions
1	women, in order
1	maintained by such
1	petition be denied
1	treatment of anaphylaxis;
1	applicable, is specified
1	behalf) a complaint
1	disease product has
13	2009, the secretary
1	time the budget
1	thereof. (mar. 4,
1	possession in any
1	section 830(b)(3)(b) of
1	 (iii) violation
4	secretary to identify
1	controlled substance. in
1	priority ranking of
1	reviews, and overseeing
1	agency, subject to
3	formulation and implementation
1	ris-benefit assessment framework
1	compliance[1] with these
1	person affirmatively establishes,
1	evaluation of performance
1	rare diseases; (2)
4	counterdrug technology assessment
2	ensure that selected
22	addition to the
1	containing the lists
1	animals in any
1	3 years. any
1	achievability the secretary
1	(iv) issuance of
5	meetings  (a)
1	(e) testingthe regulations
1	(b) include validated
1	encourage the exchange
1	practical, analytical method
1	facilities, and ports
3	secretary has a
1	ingredients, additives, and
1	sound and wholesome,
1	performance targetsthe developmental
1	(b). (b) penalties
1	371(e), (f), and
1	
 826a. attorney
3	withheld pending hearing
1	warning letter that
1	based.  (f)
1	new tobacco additive
1	registrant) shall submit
1	rely on evidence
4	subsection (e) shall
2	purpose.  (d)
1	methods of slaughter;
1	licensed physician, on
28	used in the
5	tax return for
1	advisory committee (other
1	device, within the
1	thereunder; (b) the
9	otherwise obtained by
1	(b) prioritize and
1	(b) the sponsor
2	section 384e of
1	new drug and
2	certification, in english,
1	tobacco regulation activities),
2	resulting from marijuana
12	expenses with such
1	intended use authorized
2	within its jurisdiction,
1	period provided in
2	publish and make
1	(b) chairperson the
1	registration, good manufacturing
1	destroy, without the
1	humans.  (22)
1	cigarthe term little
3	sold contrary to
2	used responsibly to
1	subparagraph (a) between
1	use, that laboratory
23	6 years after
1	unused fees and
1	elevated risk of
4	27, 2013, upon
1	supplier a biomaterials
4	state departments of
1	(2) anileridine. (3)
3	review of 
1	section 398 of
2	dihydrocodeine per 100
1	produced from poultry
4	consent decree signed
1	adulterated, or unfit
1	drug. (i) the
1	rates, the commissioner
2	number for such
1	675, 511, as
1	(c) new producersevery
1	medicine nothing in
2	(k); and (b)
1	review fee paid
1	suspend immediately upon
1	petitioner or applicant
1	aureus, vancomyci-resistant staphylococcus
1	contracting the director
1	antimicrobial drug labeling
2	examination to any
1	programs.  (ii)
1	one institute under
2	united states, shall
1	entered, as provided
7	upon request by
2	title unless (a)
1	free with the
1	punishment; duty to
3	strategy programs and
4	physician or dentist
2	conducted and published
7	secretary or a
1	infant formulas necessary
1	hearing; (9) if
4	(4), a summary
1	process solely in
4	notify the sponsor
1	basis, a complete
1	rule prior to
2	selected establishment under
5	(5) transmittal of
1	report to file
1	colors not required
1	establishment identified in
2	product is compounded
1	notificationthe notification (other
1	revoke any tolerance
1	formulas made after
1	replication of multiple
1	criteria upon which
1	range of threatened
1	refused or is
1	756, 2, 48
1	treatment with other
22	abbreviated application for
1	
 
 360fff7.
1	274a.2(b)(1)(v)(a) and 274a.2(b)(1)(v)(b)
1	(b) the convention
1	adduce additional evidence
1	drug safety questions,
1	for; appointment; duties;
8	article pursuant to
1	(1) manufacture, preparation,
2	subsection, including a
1	products of equines
1	cocaine, heroin, marijuana,
1	handled so as
1	data on material
1	828. order forms
1	treating such disease
1	infant formula and
3	filed in the
1	help ensure the
1	apply sanctions 
1	evaluation. a state
1	travel members of
1	processed, sold, transported,
3	thir-party auditors and
1	(b) applicability this
1	333 of this
3	drug, or the
1	formerly 357, as
1	forms pursuant to
1	cigarette tobacco the
1	records at the
1	reinspections that the
1	devices attached to
1	cases in the
1	states holds a
1	15, 2007; and
1	lines; and (iii)
4	provide reasonable assurances
1	360h, or 360i
1	rules under paragraph
1	deferred for the
1	equines, and the
1	specific facility at
1	(a) inspection procedures
1	dru-related services provided;
5	proposed rulemaking under
2	directed by the
1	effort to coordinate
1	substances (a) in
1	health professionals under
1	maintenance any record
4	secretary, the court
1	360h of this
1	safe nonnutritive substance
1	state fees. 
1	purposes, and no
2	determined with respect
2	penalty against any
2	grants an exemption
1	(d) 10 grams
1	title. the exception
8	5 fiscal years
1	allows a qualified
1	information disclosed on
1	services have been
1	shall as appropriate
1	scientific societies to
1	cosmetic, medical device,
1	part; (9) take
1	basis under extraordinary
1	product must not
2	article thereafter imported
1	-year period, or
1	generalsubject to subsection
2	agriculture pursuant to
1	substance whoever, while
1	1976, through september
1	regulation in such
1	management and sharing
1	general a registration
1	trials and analysis
2	equipment, or services.
1	substantial financial support
2	agent; and 
1	publicationthe secretary shall
1	product distinguished by
1	level that was
1	require changes except
2	food or drink
1	scientific, educational, or
1	maintenance and access
1	signature. (bb) signing
1	master filean applicant
1	withdrawing the order
3	federal government to
3	condition to the
1	issued from any
2	imported articles which
1	trading partners may
1	 (1) rare
2	(b) the nature
1	per 100 grams,
1	(3) regulations under
4	appropriations for salaries
3	serious risk means
3	secretary upon any
1	additional information is
1	cell therapy, therapeutic
2	market exclusivity for
2	operating in a
1	consultation to reviewing
1	safe); and (b)
4	subject to subsections
2	advances in the
1	warning. (june 25,
6	sentenced to life
1	enter findings of
1	types of documents
1	impose a n-tobacc-sale
1	review for, devices,
1	
 346. tolerances
1	including the database
2	handler shall possess
1	evaluation of postmarket
2	communications to the
1	(2).  (j)
1	(1)(a) may petition
1	established an ongoing
1	subject to fee[1]
1	labeling thereof, or
1	morphin-like drugs. (30)
2	fees fees authorized
4	shall be filed
1	subdivision may establish
1	community initiatives for
8	drug is issued
1	recommendations of relevant
2	direct possession of
1	(1) in minority
1	(e) feedback from
1	(ii) public availabilitynot
1	post mortem inspection
1	  100.0.
1	stat. 1044; june
2	november 21, 1997
1	ch. 675, 743,
1	states, or attempts
4	drug which contains
1	(3) the defendant
1	place in accordance
1	fund created by
1	premises means 
5	slaughtered poultry, or
1	results of inspections
1	clause (ii), unless
1	device users) who
3	report  (a)
1	submission of each
1	1976, is classified
1	attendance, take evidence,
1	adulterated. (4) health
5	(iv) any other
1	(ii) clauses (ii),
1	clea-up, clearance, and
2	obtained pursuant to
1	precedence restriction; project
1	available detailed summaries
2	drugs by chronic
1	availability of illegal
1	issues identified in
1	(i) whether the
1	section 352(b)(1) of
1	(c) shall immediately
2	consumer interests and
1	labeling and with
1	terms shall have
1	review workload. with
1	343(i)(1), or 343(k)
1	determines otherwise. (d)
1	(1) additional determinations
1	said consul that
1	(7) ensure that
1	(a) manufacturers of
1	section shall immediately
4	control act [15
2	panel, the secretary
2	 (f) labeling
1	shall, upon entry
1	chemical if such
1	party (as defined
1	storage, or receipt
5	sole discretion to
1	petition with a
1	predicate device. (iii)
2	(p) of such
8	confidential access shall
1	strategy the term
1	use of clinical
1	screening chemicals for
1	record as a
1	may be redeemed,
1	(a) persons accredited
1	 (2) vacating
5	use  (a)
1	(i) when dispensed
1	subsection (a)(4)(c), the
1	 (4) implementation
1	local drug laws
1	sold or transferred
1	advertisement of a
1	 (6) annual
1	industries.  (iii)
2	states, shall be
1	title and issued
1	specific to one
1	chapter;[1]  (2)
1	effective and meet
4	states shall not
3	shall by order,
1	require a pediatric
1	title) shall, except
1	(e) no person
4	decree signed and
2	registration.  (3)
1	orderif, in response
1	(b) jointly by
2	regulation waive the
1	applies to functions
2	color additive for
1	state unless each
1	vacate an order
2	controlled or removed
3	351(f)(1)(b) of this
3	food allergy management
1	section shall cease
1	abuse, and the
5	pediatric advisory committee,
1	either in person
2	pediatric advisory committee.
1	use or consumption
2	negotiating purchases or
2	informal petitions or
1	transferring repackaged drugs
1	drinking water or
1	16 of title
1	start dates and
1	$252,960  $258,019
1	articles, or means
1	seq.). (s) the
1	capacity of such
1	control policy under
1	equivalent to its
1	product radiation or
1	patients.  (iii)
1	regulations; (6) if
3	pay an assessment
3	26, 2002, the
5	list of each
1	conspicuously thereon, printed
1	reasonably have been
1	submits a valid
1	delayed. (c) annual
1	unless the eligible
1	539, formerly act
6	business entity; or
1	affected agency centers,
2	approvalfor purposes of
1	qualifications prescribed by
1	treatments for rare
1	section shall begin
1	processors transitioning into
1	local law. 
1	label disclosure 
6	exemptions as to
1	incompetent.  (d)
1	(after due notice
5	accredited under this
1	inspectors that were
2	provide an adequate
1	information and technology.
2	shall prescribe and
1	(iv) 1 shall
1	(5) the individual
1	cessation approved under
1	written unique identifier
2	(b) annual biosimilar
1	interest  (a)
1	consignee thereof; and
1	proclamation, suspend the
1	practice; (c) persons
1	exemptions provided for
1	certification only an
1	uniformity of tolerances
1	person in records
1	imported from canadain
1	including elderly populations,
2	make the determination
1	standardsnot later than
1	proceeding may be
1	outsourcing facility, and
1	points); and (2)
1	(a) documentation of
1	(3) considerationsin determining
7	additional period as
1	42, been approved
1	agriculture. (3) the
15	1915, ch. 74,
1	additional grants 
1	(ii) at one
1	disability, veterans benefit,
3	upon the exercise
1	353(g)(5)(c) of this
1	medical evaluation via
2	reception, holding, or
1	1 year, for
1	attempting to do
1	allocation, until september
1	misdemeanor, and shall,
3	within the pharmaceutical
1	settings. the secretary
1	subsection. the recommendations
1	tolerated by the
1	product tracing at
1	includes on the
1	secretary waives the
1	flunitrazepam or a
1	product tracing as
11	patent that is
1	numbers, with the
1	secretary before june
1	application to make
1	of-labeled indications, studied
1	inadequate for the
1	provides for an
9	unpaid fees in
12	department of homeland
1	provide notice of
1	
 457. labeling
1	available) of the
2	dietary exposures and
1	ii controlled substances
6	considered:  (1)
3	business and very
1	deliver such notice
1	sponsorship and participation.
1	shall dismiss the
1	section. for each
1	(d) initial meeting
2	transportation, or receipt
1	gas; (b) the
1	unapproved product authorized
1	use prescribed pursuant
1	drug administration, except
1	chemicals); and (ii)
1	policy or sets
1	species were sound
2	respect to clause
1	health care settings
3	carrying out its
3	regulation by the
1	employee of an
1	(h)competitive procedures. 
1	mark. (o) the
1	situation described in
1	ability (a) utilize
1	phrases to describe
1	may not list
1	(2) provide a
21	serious adverse event
3	n-tobacc-sale order may
1	(b) could not
5	secretary, and the
1	advertisement), each person
1	drug by any
2	packer all adverse
1	dispenser; except that
1	
 1705. development,
2	judicial review thereof,
1	criteria used in
3	(b) to submit
1	(c) success in
3	penalties) of sections
10	will have the
1	means chapter 2
1	determined necessary each
1	incidentally and necessarily
1	shall specify by
1	1602. definitions as
1	methamphetamine or scheduled
2	individuals, if such
1	effect. if the
1	reporting or inspection
1	panels from appearing
1	disclosure. responsibility for
2	manner, to have
1	device. a class
1	command operations or
1	administration, the department
1	regulation establishing, modifying,
1	will be substantially
1	petitions for the
2	investigate and prosecute
1	administration may make
1	beneficial to the
1	paragraph (1)(c) by
12	sections of this
2	place subject to
1	ingestion of a
2	rate in accordance
1	fields of clinical
16	head of the
1	general shall prescribe.
1	methodologies; and (c)
3	complaint filed under
3	united states, except
1	activities, the director,
8	finds  (i)
1	seq.], a product
2	247d7e of title
2	pending application for
1	term clinical outcome
1	provide or may
1	animals, or any
10	subject to fees
1	accept voluntary submissions
1	additive satisfies the
1	containing a minimum
1	countries to ensure
11	(a) the drug
1	prevent an attorney
1	products and tobacco
2	model standards, the
2	number of illicit
4	held at such
1	changes in threats,
1	review required 
1	(2) to establish
1	review by such
1	plan for such
1	condition and preliminary
1	time period specified
1	health, the administrator
2	information concerning any
1	reason of subparagraph
1	control strategy 
1	-year period shall
1	title. (d) denial
1	parties.  (b)
1	title, is confidential
1	implementation systemthe elements
2	drinking water unless
3	slaughter or in
1	disease product no
1	assessment and planning
1	published at section
1	nearest regional or
1	secure means of
2	hazardous electronic product
1	(2) procedurein promulgating
1	initial grants in
1	state, or a
2	withdrawn during the
1	lists of the
2	inspection, reinspection and
1	may demonstrate substantial
1	notwithstanding section 903
3	allegedly caused harm
2	fails to bear,
1	legislative or regulatory
1	retail grocers for
1	subsection (c)(4). such
2	1111 and 1114
2	offense involved and
1	security act; (b)
1	food containing a
1	serious risk, and
1	-year projection for
1	australia, canada, israel,
8	manufacturing, processing, packing,
1	voluntary action indicated.
2	42), a security
1	requirements are fully
1	constituents as applicable,
1	knownot later than
2	revenue service. if
1	programs, including economic
2	supplements, or submissions
1	manufacturer, and need
1	studies. (c) for
1	ingredients; and (10)
2	slaughtered and the
2	list, it shall
1	benefits referred to
3	subsection (b)(1)(a)(ii), the
7	order requiring the
2	united states, any
1	further, that custom
1	issues presented by
4	regulations shall not
1	mean illness or
1	may include providing
1	humans solely for
1	person holding the
1	services shall jointly
1	food is transported.
1	containing vegetable or
1	(c)(3)(a). the notification
14	united states, and
1	period that prior
1	pending application submitted
1	ingredients, additives, constituents,
1	report on inspections
1	intelligence sharing in
1	receiptstransfers shall be
1	specify which person
1	substances) if any
1	program; (4) oversee
2	studies of a
1	inspection, building construction
1	commerce any gift,
1	illicit trafficking and
1	(2), and (b)
1	educational agency; (ii)
1	accreditation system under
1	manufacturer; and (ii)
28	case of an
5	otherwise in compliance
1	website or at
1	financial certification or
1	whether revision of
1	foreign seller specifying
1	reserve fee) for
1	 (iii) definition
1	slaughter at such
3	manner; or if
1	various content, complexity,
1	compare the deterrent
1	outbound distribution of
1	review of report;
2	document, for each
2	conformance with any
1	institution that furnished
1	period previously established
2	facility is required
5	removed to a
1	movement, and disposition
2	application. if the
1	penalties:  (a)
1	(b). (ii)withdrawal of
1	give the person
1	study shall include
2	research on the
1	acting as the
2	registrant filing a
1	manufacturer or controlled
1	(3) reasonably believes
1	commercial aircraft, commercial
1	implant as a
1	class with fewer
1	petition is filed,
1	transferred
 
 197,
1	activities describedthe activities
1	furnish, pursuant to
1	importations by a
1	veterinary surgery. when
1	become final at
4	subsection (b) by
1	full costs associated
4	next fiscal year.
1	parent or guardian
4	next fiscal year,
2	date of publication
23	generalthe secretary shall
1	intervene as a
1	subsection (b) be
2	comment from interested
3	states patent and
3	period for review
1	furnish such form
1	concerning the proposed
1	(i) a product
1	energy; annual index)
1	full pedigree, or
1	number, and expiration
1	level data. the
1	professional  (a)
1	avoiding or resolving
1	3, 37 stat.
1	electronic searches, for
1	(iii) issue an
1	practitioners engaging in
1	including experience with
3	including the use
1	purchased for use
1	examining addiction and
3	drug administration, a
2	(iv) any substance
1	secretary); and (b)
1	human services regarding
1	patients, such as
1	diagnostic criteria for
1	authorizing committees for
1	determination; appeal if
2	notification is provided
1	another, or deleting
2	format and content
1	food products. this
1	
 
 379h1.
1	public. except as
3	audits conducted by
3	export the controlled
1	federal benefits to
2	(a) a determination
1	approval after any
1	issue such other
1	 (b) vacancies
1	preemption for labeling
1	understanding of safe
1	related categorizations of
1	critical controls for
2	analysis and not
1	except that with
1	 (5) date
1	amount in controversy,
1	businesses. (iv) the
2	section only if
1	meanings stated below:
1	(i) the importation
1	surveys to document
1	unit of a
1	granted. based on
1	evaluation of program
5	27, 2013 (except
1	section, so that
1	prescription drugs, other
1	shall require tobacco
1	manufacturers holding registrations
1	returned thereto; conditions
1	7, 44 stat.
1	team of experts
4	clinical investigations which
11	public and private
1	party to cease
1	drugs, or to
1	consideration, consistent with
2	law.  (c)
1	drug shortages are
1	remaining therein for
2	requiring inspection under
1	regularly come into
1	sentence.  (5)
1	poisons, or for
2	participated in the
3	constitute an amendment
1	262(a)] may be
1	(1) develop national
1	funding for a
1	chief scientist (a)
1	notice of default
1	possible time. (iii)
1	assurance that a
2	food safety standards.
2	 (g) grocery
1	procedures for approval
1	consult with dispensers
2	supervision of authorized
1	 $3,200 
1	assist in defraying
4	impose recordkeeping and
20	one of the
1	quantities before the
1	 (f) suspension
1	contract analytical testing
1	and, if not
1	require a farm
1	majority of the
1	$1,000, to be
1	lobelia, nux vomica,
1	based the order
5	drug, which includes
1	1103; 
 

1	certain abbreviated applications
1	(19) piminodine. (20)
1	patented inventions of
1	combined into a
1	states with residues
1	grants a coalition
2	engaged, in any
1	parents, and children.
1	amendments of 1962,
1	data for establishing
1	prohibited by this
2	part 113 of
1	(including inhalants and
2	received) are referred
1	approved uses. 
1	physician, if the
1	indexing based on
1	registered pesticide that
9	states, and the
1	drug is owned
1	respectively.  (

1	therein any nonnutritive
1	support services; (ff)
2	action.  subclause
1	committees advisory to
1	meeting; (ii) limit
2	death; (ii) a
1	act), or any
1	affiliate thereof or
1	include validated biomarkers,
2	holder referred to
1	centers).  (g)
1	property from federal,
14	consent of the
1	synthesized or made)
2	dollars, the exchange
2	 (3) designation
1	recommendation, and, if
1	product review program
1	affiliation (including a
1	(c) identify the
1	common carrier whose
20	pursuant to such
1	2009, shall be
1	products be delivered
1	article originates; the
1	4 years. (v)
1	facility during the
1	 (c) investigations
1	drug control strategies
1	 (2) customs
3	effect for the
1	holiday, or day
4	et seq.), the
1	relevant factors, (a)
1	 (b) revised
1	relating to rulemaking
1	used for slaughtering
2	submitted for payment
1	need; and (iii)
2	may issue subpoenas
1	 (ii) definitionsfor
2	occurred, the secretary
1	assist individuals described
1	entity shall be
1	material determined appropriate
1	devices, which inspections
2	exempted from such
1	dietary supplements; and
1	secretary placing the
5	resources available to
1	(f)(1).  (iv)
2	term shipping container
1	increasing the possibility
1	(n) ethylamine. (o)
1	(2) track and,
1	state requirement that
1	label (as defined
1	 (ii) consult
1	boobytrap on federal
1	committee input, as
1	evaluated in a
2	transaction, provides transaction
1	function of such
1	review a report
1	similar illness resulting
1	administrator appointed by
2	shall be supported
1	(a) trainingthe secretary
4	drug (such as
1	licenseexcept as provided
1	(a), the comptroller
8	applies with respect
1	directly conducting ris-based
2	may authorize a
2	(ii) information concerning
1	papaver somniferum l.,
1	year such sums
2	inspection requirements at
2	measurement instruments and
1	substance, either directly
1	premarket approval to
3	application and supplement
2	applicable state or
1	submissionfor purposes of
3	services of the
1	cause the tobacco
1	pilot projects. 
1	(b) refusal of
4	(j) of section
4	added thereto or
1	identifying such drug
3	application or license
1	felony conviction which
5	commerce in the
1	2021, a qualifying
1	ingredients and such
1	(c), the workload
1	360i, or 360j
3	transporting, in commerce,
1	appropriate animal models
1	added to such
1	cognizable under the
1	379, 379e, 387d,
2	substances (a) establishment
1	related activities of
1	development; (b) provides
1	distributor to facilitate
1	drug safety data
1	clause (i). (vii)
1	title, except a
1	store drug samples
1	resources, (c) leasing,
2	exempt under section
1	(i) failure to
1	caution: federal law
1	(d) cocaine, its
6	maximum punishment authorized
1	file fee when
1	notification program in
1	injury; and (2)
1	section 262; (d)
1	tests and investigations;
3	section (including any
1	355f. extension of
1	343. misbranded fooda
1	(ii) appoint the
1	establishment or modification
1	event determined by
3	u.s.c. 151 et
1	title 5. proceedings
1	medical products. (2)
1	additional information. (p)
1	(5) timelinesthe timelines
1	product that does
1	active ingredient with
1	secretary but in
2	coordinators designated under
1	 (b) not
1	(e), or (f),
1	period as agreed
4	cancer in man
1	pose a significant
1	control and measurement
2	drug or substance,
1	administration. (b) recommendations
1	ensure that scientific
1	discrete -year periods
1	least 25,000,000 patients
1	developing drugs for
2	(i) the medical
1	product stage means
1	section 355(j)(7)(a) of
1	color thereto; except
8	 (a) one
2	(42 u.s.c. 201
1	manufactured by, or
1	pediatric assessment conducted
1	applicant with 1
2	section 350l(a) of
3	person submitted the
1	outbreak of human
1	establish conditions on
1	inspect or sample
1	listing of its
1	reasons that no
1	(i) which drug
1	bases of other
2	warrant. if the
1	similar genetically targeted
2	inspection panel (a)
2	law, for purposes
3	needed to carry
1	(e) a drug
1	agencies, and changes
1	united states. (mar.
1	prohibited by law
5	without substantial further
1	facilitate access to
1	advance of revising
1	(i) is within
1	section, an applicant
1	codex level, the
1	accepted and verified
2	contents, i received
1	violation of, this
1	(3) the general
1	false information or
1	authorities, and direction
1	(a) voluntary procedures
1	conditions for obtaining
1	abuse rehabilitation; (f)
1	iii, establish a
1	results for the
2	including all anticipated
1	1979, there is
1	(f) veterinary prescription
1	 (2) criteriaa
2	subparagraph (9) is
1	year 2018. (h)
4	stat. 1059; renumbered
1	teleconference, 30 days
1	false swearing, or
1	customer, such importer
2	certificationthe secretary shall
1	transport, or in
1	connection with 2
2	order means an
1	physically compatible. (5)
1	establish a performance
1	203 of the
2	unless, in addition
1	(2) may withdraw
3	(i) the device
1	public health regarding
1	(d) additional establishments
1	(e) devices not
1	appropriate persons a
1	positions on classification
3	animal drug will
1	travel expenses while
1	(a) the notice
1	copies of the
1	 (d) treatment
1	1487.)
 
 63.
6	regulatory management plans
1	borrowing by the
1	court of record,
1	food; and (d)
1	effectiveness of that
1	supplant funds received
1	foundation any recipient
1	submit by a
1	deadline for a
1	(h) inspections 
1	(b) may, by
1	resulting rulemaking; (4)
1	scientists; and (c)
2	blocking of assets
1	phone number); and
1	title, except subsections
1	motion, other than
1	nuclide generator, accelerator,
2	aided or abetted,
1	objectives, including objectives
1	rol-you-own tobacco the
4	information and data
3	(6) any person
4	countermeasure (as defined
1	be) from selling
1	egg handlers; inspection
1	one year period.
1	posed by dietary
1	team that is
1	certification for all
1	timely manner; and
1	office means the
1	activities by a
1	603, 604, 605,
1	audit of such
2	application (excluding an
2	pregnant women, or
1	
 
 678.
1	response may include
1	lieu thereof; waiver
1	(d).  (ii)
1	regulatory management plan.
1	actions, and 
3	regular and established
1	levels, or regulations.
1	purchaser in the
1	satisfaction; and (ii)
1	reasonable costs of
1	renewable by the
1	may, under the
1	include each authorized
2	misbranding if the
1	conditions as described
1	sterilization of the
1	specialty; (ii) 1
2	packing thereof in
1	clinical data to
1	infant formula. (b)
2	whole taking into
5	within 1 year
1	becoming final. 
1	animal inspection the
1	(5) monitors consistency
1	food sold during
2	(c) pediatric formulation
9	territory, or political
1	performance of an
1	(iii) approval of
2	6 years in
1	specific fruits and
1	planthe content of
3	means as the
1	 (3) abbreviated
1	states, for lawful
1	suspension the importation
1	true statement of
1	no-federal jurisdiction the
1	activity; (iv) the
1	limits the secretarys
2	fail or to
2	isomers; such person
1	recipient, or anyone
1	tracing and other
1	safety data from
2	 (b) relation
1	use to determine
2	distribution of narcotic
1	obtain the consent
1	(1) first compliance
1	secretary to implement
1	development, manufacturing, and
1	form all carcasses,
1	tobacco product). 
1	food; (c) providing
2	amends section 1905
1	new drug shall
1	establishing  (i)
2	2011) beginning on
1	class ii device,
1	(a) complete review
3	year 2018, the
2	understanding under subparagraph
5	employee or agent
1	entry program administered
2	pharmaceutical manufacturer or
1	(i) provide that
1	approval of medical
1	(2) the controlled
1	finds upon a
1	pharmaceutical preparation upon
2	pursuant to diagnosis
1	recent quantity or
1	(b) which may
1	revocation of recognition
1	homoeopathic drug, in
2	four years from
1	chapter, including any
1	conditions for entry
1	secretary designate such
1	drug administration point
1	infringement action brought
1	publish the strategic
1	conditionally approved until
1	parties unless the
1	sales transaction is
2	pay fees an
1	related activities, including
4	request submitted by
1	order. such an
1	grown, and the
1	person forfeit to
1	place at the
3	dietary properties as
1	section nothing in
1	use and caution
3	2017, fees under
4	secretary by a
14	fee required by
1	device if he
1	chapter are hereby
1	expired; (2) a
3	recommendations to him
1	subsection on the
1	master file number;
1	(3) research the
1	persons as may
2	radiation, or (b)
1	hundred thousand; (5)
1	fees, any late
2	lawful veterinary feed
1	quarantine suspect product;
1	(including a factory,
2	provide a simple
1	food; inspection; denaturing
5	ninetieth day after
2	authority granted to
2	offices within the
2	thereunder applicable to
1	general (a) authorizationthe
2	assessed among the
1	(ii) biological products
1	submitting a notification
1	(a) is 
1	dosage forms known
1	additivesa color additive
9	refused for filing
1	399c. improving the
1	involved or the
1	marketed drug not
4	individuals and organizations
2	obtaining from any
1	reducing abuse of
1	include such regulation.
1	title, or (7)
1	product is necessary
1	(including drug trade
4	formula shall be
1	panel members may
1	
 860. distribution
2	program to obtain
1	period in which,
1	dietary supplement labeling
1	coordinate counterdrug technology
3	generalupon determining, in
1	shall be inserted
1	health protection. 
1	ai-driven pipes; (11)
1	together with charges
2	(ii) a listed
1	(b) during the
1	sponsor seeks approval
4	sufficient flexibility to
1	prevents persons outside
28	proposed sunscreen order
1	title, of the
1	(a)(1), the period
3	(d) rule of
1	general. (b) the
1	social services, and
1	proposed standards 
1	label fails to
1	act subject to
1	land; and (2)
1	application if all
1	practitioner may, in
1	iii (a) unless
1	persons, to submit
2	reason to know
1	applicants forfeit the
1	necessary activities regarding
1	establishments which can
4	intent of such
1	military intelligence program,
1	cas-b-case basis, delay
1	recovery of the
7	tobacco product manufacturers
1	product. in submitting
1	complainant the secretary
1	necessary to investigate
1	shall consider whether
1	consultation with consulting
1	condition which the
1	subparagraph (d), if
3	 (1) priority
1	following individuals or
1	government information, suggestions,
1	proposed standard, including
1	cell and tissue
1	control policy gift
1	appropriate) deemed under
3	27, 1958 (72
1	determinations  (a)
1	willingness of potential
2	hearing  (1)
1	reports of analyses
2	3717 of title
2	tobacco product manufacturer,
1	
 467c. federal
1	shipment, if more
1	ii, which are
1	person to bring
1	process for any
2	services for purposes
2	conviction thereof, shall
1	seeds, of the
1	chemicals; and (iii)
1	(c) 28 grams
1	waived, importers of
3	shall in no
1	compliance of a
1	institutes the secretary
1	 (a) three
2	convenience kit does
4	applicant referred to
1	(1) and publish
2	4, 2011, to
3	internet site of
1	
 466. imports
1	scientific justification specific
2	report on drug
4	supporting justification that
1	whether an item
1	eligible entity if
1	refusing administration of
3	registration and control
1	without restricting the
2	applicable to antimicrobial
1	13, 1992), a
4	manufacture, process, pack,
1	documents relevant to
1	eligible entity is
1	communication; and (3)
1	device, but excluding
1	marketed under paragraph
1	counterdrug and homeland
1	
 
 350i.
1	drug, if 
2	agricultural commodities for
1	used such a
2	shall obtain from
1	application. within 60
13	(a) the number
2	documents delivered contemporaneously
1	1921 (7 u.s.c.
1	occurring after september
1	items;  (3)
6	grant a waiver
5	types of feesbeginning
3	general respecting such
1	drug submission to
1	introducing such new
3	products under the
2	subsection, a statement
1	feasible, the secretary
1	specify the amount
3	drug at least
6	ordered forfeited under
1	cleared device before
1	18, relating to
1	assessment and monitoring
1	capabilities with respect
2	exposure to, such
3	standard under this
1	machine shall keep
1	laboratories; (b) establish
1	transaction; (i) the
3	container shall, if
1	379h(a)(2) of this
1	(d) the united
1	deleterious foods, drugs,
2	cosmeticsa cosmetic shall
1	reflect adjustments in
1	subparagraph (a), an
1	inapplicability of misbranding
1	imports, including based
1	official plants; authority
1	paid in one
1	device involved. such
1	type;  (b)
1	(i) humanitarian device
1	mortality, intermediate clinical
1	suppliers, (iii) the
1	concern to womens
1	availability the annual
2	(iii) publish the
1	final rulemaking, and
1	 (a) 33
2	kit does not
1	animal trials a
1	including interagency agreements
2	challenge to a
1	comments on other
1	might not otherwise
3	record of each
1	retail unless such
1	likely to pose
1	(vii) specify a
1	(1) petition in
1	92. transferred
 

1	immediate precursor is
1	related guidance documents
1	require a risk
1	held for emergency
1	(a) that was
1	website.  (b)
1	facilitate, when scientifically
1	years on the
1	validity of such
4	secretary is authorized,
1	withdrawn and no
2	methods under subparagraph
2	pediatric therapeutics shall
53	opportunity for an
1	cost effective, and
1	order.  (3)
1	device shall bear
1	services of experts
1	responsibilities  (a)
1	changes to be
1	101 et seq.)
2	fees are assessed
1	proposed; (viii) if
1	(b) regular customers
1	domestic facility, the
1	(a) law enforcement
1	substances compared to
1	subchapter.  (e)
1	successor has been
1	pharmacy with a
1	constitute multiple facilities,
1	prior to each
2	action of such
2	describes the coordination
4	importing, any dead,
1	transaction solely because
2	declaration under this
3	compound a drug
1	 (i) timelines
1	state court in
1	year and has
1	created and maintained
1	(1) milk, egg,
1	additives. (2) any
1	paragraph (1)(c)(i) shall
1	guidance, the general
1	 (a) methods
1	manufacturer had, or
1	pending generic drug
1	identifying symbol it
1	modified within the
1	form, or condition
1	interstate commerce, (b)
1	among state and
1	database; (f) allowing
1	annually. (qq) the
1	clauses for that
9	relied upon by
1	(i) notification the
1	supervisor, manager, and
1	amounts for each
6	bioequivalent to the
1	address such specific
2	headquartered. the certification
1	publish such compilation
1	(b) compensation 
1	authoritythis section shall
1	 (a) patient
1	indian tribes; and
1	partial waiverat the
1	applicable. (b) review
3	subsection or the
1	means a factor
1	predominantly by departments
1	analyses, current good
2	commission, or otherwise
2	devicesa drug or
1	(c) crop insurance
1	guidance, to avoid
7	refund of any
1	public health. any
1	(4) to a
1	system of controls
1	organizations funds appropriated
2	claimant prevail. 
1	containing no more
2	inspection authority of
1	provider has not
1	fact, the power
1	respecting all devices
1	(a) through (f),
1	influence an assessment
1	transactions in food;
8	keep records of
1	220501(b)(2)).  (3)
1	purchaser enters the
2	poultry or parts
1	(b) in accordance
1	meanings given those
1	limited to, specifications,
1	available, multiplied by
1	development protocol with
1	(b) shall, during
3	additional recordkeeping requirements
1	commission as follows:
1	
 902. savings
1	least sixty days
6	may make a
2	summary of labeling
1	variety of countries;
1	agency shall make
1	primary system. 
3	owners and operators
2	general or dissolved
1	section 360c(a)(1)(a) of
1	low to moderate
2	drug due to
1	meetings related to
1	quitting behavior and
1	237. repealed. july
3	import the controlled
1	use. the regulations
1	educational agency under
1	27-calenda-day period, as
1	ch. 675, 571,
2	adult medicinal dose
1	use in communities
1	enactment date. the
1	shall reimburse each
1	contain information related
1	performance appraisal system
2	dosage form marketed
2	(b), except that
2	person serving the
1	petition. any such
1	(5) trade secrets
1	cooperative agreements, grants,
1	research to withhold
1	section 387e(i)(1) of
5	states the reasons
1	annual estimates of
1	demonstrated by binding
1	facilitating the development
1	supplies.  (b)
1	(n) schistosomiasis. (o)
1	preparation, which contains
1	(c) within 30
1	affect its powers,
2	render the product
1	208
 
 98.
1	 (3) restrictions
1	program budget proposalfor
4	decree of condemnation
11	labeling of a
1	him; or (2)
1	enabling patients, providers,
1	term department means
1	controls. (d) whether
1	components (such as
1	device. such term
4	calendar year; and
1	 (i) nutrient
1	government may withhold
1	(a). (i) registration
1	act described in
1	term cigarette 
1	director or administrator
1	(including reasons established
1	disease product that
1	sponsor the opportunity
2	shall consider, in
1	(i) whenever the
1	academic research centers,
1	product to 1
1	period for any
2	(a) definitions 
1	marijuana facilitates trade
1	services donated at
1	may establish appropriate
1	events regarding drugs
1	made promptly available
1	permit into the
1	consumer.  (2)
1	section 102(33) of
1	believing that each
2	involved and provide
3	(other than bioequivalence
1	tobacco product. such
2	written commitment to
1	(ii) documentation, as
1	section. with respect
1	ingredient submitted under
2	exceptionthe secretary may
2	testing, and demonstrations
1	unit dose packets
2	suspension occurred after
1	healthy diet, including
1	(c) a sudden
1	assessment of such
2	entry or inspection
1	goals.  (2)
1	requirements for premarket
2	used to produce
1	respect to data
1	(2) personnel of
1	preceding calendar years.
1	produce a report
1	(e) periodic reaccreditation
1	standards in carrying
2	extend the temporary
1	sector and on
1	compound, combination, or
1	coalitions are collaborating
1	salts. (3) any
1	holding, or importing
1	placed upon controlled
1	unsafe solely because
2	products produced and
1	change, in processing
1	parent have the
2	use will be
37	subject to this
9	oleomargarine or margarine
1	inventory increases, including
1	place and in
2	petitioners determination that
1	agencies needed to
1	(b) the collection
1	(a) a security
1	moderate or low
1	direct that they
1	funds needed to
1	term bulk vehicle
1	355) of such
1	(2) qualifying pathogens
1	strength and dosage
1	international trade; (ii)
1	meeting (as such
2	prescribing, with respect
1	authority (a) individual
1	section 387o of
1	container in accordance
1	tobacco products, their
4	control budget request
1	intervention, or to
1	designed.  (2)
3	approval to engage
1	device, and (2)
1	filed has been
1	enhanced communication and
1	ingredient with respect
1	(a) banning all
1	42, including claims
1	detailing how the
1	drugs by developing
1	including whether any
1	no-interchangeable biosimilar biological
1	determines by such
1	health information in
1	 (a) demonstrates
1	defective or unsafe
1	mean an abbreviated
2	dispensing its label
1	year. (g) crediting
1	form as may
1	appropriated such other
1	993
 
 25.
1	caused such food
1	property which cannot
1	additional period is
1	foreign person means
1	writing the consent
2	additional requirements relating
1	wit: the compounds
2	requiring the subpenaed
1	postal service. 
1	consumed by smoking,
1	
 335b. civil
1	disseminate the advertisement
1	2.0.  protein
5	agency shall submit
1	thc in the
1	ch. 155, 3,
1	(i) selling an
8	transaction information and
2	(e) shall be
1	title using the
1	(6) additional mechanisms
1	624. storage and
11	present its views
1	adulterated as described
3	territorial, or tribal
5	 (i) except
1	prior to use
1	 (10) indian
1	calendar days, with
1	883. enforcement proceedings
2	average, employs more
1	determined for each
1	chloral betaine. (3)
2	reasonably require. 
1	(i) be ineligible
1	percent of funds
2	publish any such
1	egg products as
3	upon presentation of
2	section 342(a)(1) of
32	controlled substances in
1	
 
 204.
2	official plant. 
1	shall, upon approval
2	certain establishments 
1	grade which are
1	powersin carrying out
1	prevent and treat
1	information from pediatric
1	
 1711. authorization
1	(2) to strengthen
1	(c), to discuss
1	title; or to
1	withhold the names
1	pantothenic acid (g)
1	(a) a certification,
3	facilities  (a)
1	awarding grants in
1	tested for vitamin
1	chapter to protect
1	repleviable, but shall
1	reports, and documents
5	risk tobacco product
1	interdiction committee described
1	(b) and (c))
1	determines such institute
1	submit more than
1	incremental change to
2	period, the secretary
1	42. (e) the
1	defense plans; and
1	 (6) to
1	additional evidence if
1	preventive controls under
1	prior conviction. 
1	conduct the examinations
2	deposited in the
1	resubmission means a
1	(b) matchbooks for
1	products; venue if
4	additional evidence is
1	(9) reporting and
2	serve it. service
1	risk of and
1	developed for premarket
4	banned device under
1	property, or leas-purchase
1	675, 706, formerly
2	if, as a
1	pertaining to pediatric
2	facility to be
1	ch. 675, 738,
1	isomer. (15) the
1	(b) individual saleable
1	affecting the provisions
1	dietary supplement shall
1	demonstrates that such
1	list, the person
1	distribution if the
1	limited annual monetary
1	paragraph (6). (5)
1	(2) longer surveillance
11	exposure to the
1	illness outbreaks. (b)
1	device recall system
1	providing the transaction
1	(d) registration of
1	sixth sentence of
1	human services determines
1	title. in addition,
2	determines appropriate, with
1	purpose of research,
1	corporation may request
1	inspection and regulation
1	successfully complete an
2	supply chain that
1	device recommended to
1	quantities of each
1	nonnutritive object if,
1	determine the period
2	use as are
2	classes of devices
1	poultry, and poultry
1	extent found necessary
1	(b) shall so
1	exceeds 150 by
2	useful for any
1	questions for drugs
1	become effective only
1	cleared under such
1	section; (c) to
1	 (i) whole
1	compliance by all
1	information from congress
1	title, no state
1	hearings, and administrative
1	denial with the
1	qualified to provide
3	burden of going
1	(12) bongs; (13)
3	violation involves intent
1	respond aggressively to
1	responsible for compliance
2	request for approval
2	age to assist
1	grant funding under
1	laboratory networks (a)
1	(g) the purchase
1	criteria website, in
1	program for, and
4	may be so
1	8.0  
1	disease than 1
1	providing the person
2	submit a corrective
1	person dies while
1	clause (v). any
1	state cause of
1	writing whether the
2	criteria website under
1	risk; and (bb)
1	expertise to study
2	contentseach application submitted
1	development organization, the
1	childhood education programs.
1	upon him as
1	childhood education programs,
1	(c) reactivation fee
1	subparagraph (a) made
1	regulation)), unless 
1	consul to investigate
2	clause (2)(a) of
2	cartage, or labor
1	childhood education programs;
1	writing request a
1	hotels, and boarding
10	name and place
1	criminal forfeitures section
4	chapter and regulations
2	risk related to
1	clinical data from
3	federal register each
1	determination. (2) the
1	food of 
1	evidence relevant to
1	(14) morphine methylbromide.
2	extension under this
1	using the same.
2	 (ii)filing of
1	sale in, state
13	determined to be
1	(c) civil action
1	developed in such
2	specified in subparagraphs
1	electronic formats) and
1	application; or 
1	submit an article
1	public identification of
1	process, to state,
1	foreign countries from
1	additional determinations 
1	 (2) means
1	withhold, or to
2	conform to or
1	states as plaintiff;
1	section. (b) sponsor
1	health condition without
1	responsibilities under section
1	(1)(a) and which
2	dispose of controlled
1	cardiology, toxicology, pharmacology,
1	designated under subparagraph
1	360bbb8a. optimizing global
1	365 days after
1	(b) fiscal year
1	applicable;  (3)
3	may take effect
1	title.  (j)
1	1958, through either
2	listing and certification
1	following persons are
3	title, and it
1	taken any action
4	states. (5) the
1	title, and is
1	subclause (i), (ii),
1	feasible, cost effective,
2	devices for the
1	pending time and
1	section 1958(b)(1) of
1	breakthrough technologies; (b)
1	requirements and conditionsany
1	party. (2) the
1	title, and if
6	meaning of paragraphs
1	new concepts or
1	section shall extend
1	person in such
6	title, and in
1	isomers. (2) phenmetrazine
1	assertion, either in
1	 (i) -(-hydroxycyclohexyl)phenol
1	made. (3) the
1	part of state
1	significance that are
4	foreign relations, armed
1	subcommittee[2] regarding whether
1	personal costs, of
11	general may by
1	disruption  (a)
1	scientific and other
1	general the foundation
2	stat. 1040) [21
1	proposals under subsection
3	designation the sponsor
1	fee as specified
3	extent of any
1	term thir-party auditor
1	species for an
1	fiscal year. (g)
1	homeland security are
1	prevention (to the
1	defendant owning such
1	52 stat. 1048.)

4	excluding costs paid
1	united states, allowing
1	provide periodic bonus
1	concentrations on chronic
1	number of importers
2	active medicinal ingredients
1	determine the total
1	(5) serious risk
1	chemical residue specified
1	drugs, the elements
1	feasible, the disclosure
1	demonstrated ability to
3	manufacturer shall, not
1	complies with clause
1	will review that
1	(1)(a) and (2)(a)(i)
1	utilize good handling
3	class iii devices
1	types of ionizing
1	meets appropriate content
1	foreig-chain distributor), request
4	business adjustment factor
1	animal drug, there
1	hard core or
1	whenever, in the
1	publicly identified as
1	date, and, in
1	article is refused
1	(ii) an animal
2	drug abuse. to
1	means of security
2	fee or a
2	appropriate, require the
1	commercially distributed devices.
1	exemptions listed in
1	retail pharmacy; (4)
1	enhancing tracking and
1	one such proceeding
3	person of such
4	 (2) a
1	citizens and organizations
1	onsite pharmacy; (6)
1	encouraging parents and
2	surveillance using the
1	actions the sponsor
1	program (as identified
1	2013; or (ii)
1	agricultural practices and
1	strategy, to the
1	deem a notification
1	(b) reportingbeginning 1
1	numerical designation. if
1	 section 552(a)(3)
1	(c) an accurate
1	advertising the process
1	review such article
1	 (iv) premarket
1	final guidance the
1	(
 
 881.
2	investigation. the attendance
1	recommendations therein, regarding
1	(a) coverageno person
3	class iii device;
1	premises at which
1	general powersthe secretary,
3	of, and not
1	medical gas bears
2	will enable the
4	class iii device,
1	amount of assistance
2	class iii device.
1	funds estimated to
1	security; and (iii)
1	888. repealed. 

1	3915, 10a, as
1	petitioner may testify
1	clinical consequences of
1	applicable prescribed time
1	samples.  (5)
1	844. penalties for
1	shall regularly participate
1	(ii) treatment of
3	means the director
1	permi-holding establishments any
1	united states will
1	response to reaccreditation
1	degradation.  (4)
1	capsules, which have
1	(iv) an initial
1	probable risk of
1	provision (including penalties)
1	nonnarcotic active medicinal
4	strongly suggesting that
1	particular device type,
1	opium and opiates,
2	drug establishment means
1	received tentative approval),
1	reform, the committee
1	renewed conditional approval
7	scientific equipment, and
4	may be approved
1	similar notice sets
4	review thereof in
1	 (a) draft
1	law, including section
1	
 358. authority
2	whichever is earlier.
1	effectiveness data respecting
1	take affirmative action
1	offense after two
4	animal drug submission
1	final regulations including
1	registrants registered principal
1	secure the return
1	preapproval trials; rare,
1	(ii) maintaining adequate
1	paragraph (1)(a)(ii), (2)(a)(iii),
1	pose a significantly
1	(c) response by
1	sponsor may submit
1	(1) educational and
1	directing the responsible
1	listing; or (d)
1	manufacturer; (iii) take
2	5 of section
3	may run into
1	(a) fostering participation
1	(b) a meeting
1	3, 2003. such
1	which, as of
1	part 25 of
1	periodic bonus payments
3	title 15(except paragraphs
2	division directors within
2	importer receives or
1	informal hearing, withdraw
1	use; (ii) illicit
2	diagnose, or treat
1	year are sufficient
1	defendant, the court
1	center to the
1	american nurses credentialing
1	advers-event reporting (a)
1	existing medical products;
1	retai-type establishments; operations
1	making of research
1	adjustment factor be
1	(ii) there are
1	portal, from 
1	(b) and that
1	2009, the label,
1	appropriate. (b) susceptibility
1	upon appeal from
1	auditors  (a)
1	 (c) inspection
1	focus postapproval studies
1	complete address (street
1	records showing the
1	secretary, including effectiveness
1	temporarily unavailable to
1	requirements of one
4	administrator may establish
3	special projects designed
1	article was imported,
1	operating characteristics and
1	sulfonethylmethane. (10) sulfonmethane.
1	epidemic product; (2)
1	fda pending a
1	panel.  (c)
1	title i, 5,
5	manufacturer or importer,
1	quality thereof does
1	graphic that includes,
2	surveillance of a
1	registrant  (1)
1	composition may be
1	passed; supervision by
1	demonstrable support from
1	evaluation.  (2)
3	registration is consistent
5	subpart as expressed
1	tolerance in the
1	advertisement into the
1	(j) exemptions for
3	review within thirty
1	suspending such order.
3	approved as a
5	provided by law.
2	clauses, the approval
1	order; or (b)
1	controls, and maintain
4	example, the number
1	identificationeach person that
1	drug sample means
1	documents and regulationsbased
1	based; and (2)
1	matter within the
1	general nanomaterials interactions
1	major sources of
2	(in addition to
1	societies; (iii) academic
1	 (5)3 restrictions
1	(a) may license
1	practicable after july
3	ingredient and if
5	attorney general, shall
1	review of state
1	 (o) registration
1	fund shall be
1	ch. 578, 1,
1	health benefits and
1	duties and such
1	coordination of federal,
1	secretarys request shall
1	regulation have previously
1	state, federal, or
1	transaction, including the
2	seized and condemned
2	requirement. such a
1	(2) in excess
1	sheepmeat food products.
1	consistency between the
1	renewal during the
1	subsection (b)(1), is
1	reached through a
1	entertainment group; or
1	feesfees amounts established
1	(including manufacturers, importers,
1	drug product does
1	contributions notwithstanding any
9	subsections (b) and
1	
 
 399c.
1	75 days before
1	device applications 
1	(d) for purposes
1	establishing partnerships, consortia,
1	
 
 360bbb8a.
9	result in the
2	animal experimentation data.
1	submit a surety
1	parties made pursuant
1	congressional review provisions
1	(4) develop a
1	379d3a. hiring authority
1	meeting under paragraph
1	court shall allow
1	ordinary individual being
1	rules and regulations.
1	846. attempt and
1	five or more
1	august 22, 1996.
1	authority the apples
2	august 22, 1996,
1	employed intermittently. (4)
1	purchase, trade, delivery,
2	procedures, the secretary
1	c-chairpersons from among
3	contribute to a
2	penalty under subparagraph
1	facility involved to
1	discouraging the trafficking
8	prepare, propagate, compound,
1	2014, such application
2	application; approval of
1	(f) verificationthe owner,
1	requesting updates to
1	domestic facilities identified
1	(6) counterfeit tobacco
1	evidence demonstrates that
1	dietary use if
1	specifically exempted or
1	paragraph alters the
1	(1) each recipient
1	classification (if any)
1	(6) under the
1	purchasers name, address,
7	repair of fixtures,
2	obtained an order
1	products, with particular
1	 (g) presidential
1	ii, and prior
2	commission shall receive
1	possession on board
1	(2) use existing
4	iii of chapter
1	conditional approval should
1	i, 22, formerly
1	product, drug substance,
1	training, and reporting
1	conform to any
1	include pharmacokinetic studies)
2	commodity means any
1	process issued pursuant
3	established place of
1	262(a)(3) of title
1	1923, ch. 268,
1	extent practicable, not
1	(h), and every
1	individual grant recipient
1	concerning such violation;
1	regulation activities) for
39	protect the public
1	available new information
2	person of the
1	may require prior
1	(c) exceptionthe secretary
2	prior investigations of
1	(e)(1)(a)(ii); (ii) transaction
4	(d) monitoring of
13	safe for use
1	trialin the case
1	(9). the amount
2	illness outbreaks and
1	use during the
10	year.  (2)
1	informed personsin carrying
1	manufacturer. any manufacturer
1	secretary for nonprescription
1	(iii) suspension of
1	feedback regarding such
3	health; (7) if
1	title. such a
1	9-, 21-, or
3	and, if available,
1	efforts to enhance
8	national interdiction command
1	registries, claims, and
1	order or prescription.
1	offense. (4) 
3	establishments, institutions, and
1	use and criminal
2	(f) no action
3	binding commitment to
6	corrected within a
2	seq.].  (2)
1	judiciary, and the
1	switch to the
1	inspection of individual
1	affecting the responsibility
1	1999 for carrying
1	shall collaborate and
1	responsible person fails
2	drug, medicine, or
1	distributors, except that
1	advertising. (2) the
1	(3) posting of
1	services coordinating committee
7	shall perform the
1	income, in acquisition
1	plants authorized or
1	residue. such a
1	package; and (iv)
5	(c).  (b)
1	safety, or human
2	submitted but was
1	tobacco product involved;
4	pesticide chemical and
7	(b) is not
1	issue to a
6	classified under section
1	effects of tobacco
1	statement identifies the
1	research proposals from
1	 (d) timing
1	authority may accept
1	agency, upon the
2	electronic data capture
2	handling procedures, the
1	crops the secretary
1	assessed. in an
1	available and appropriate;
1	order imposing the
1	assessment; (ii) publish
1	subchapter.  (iv)
1	-year performance measures
1	special circumstance (including
2	pediatric patients, the
1	effective. (vi) a
5	seven and on-half
1	required assessment described
4	secretary, at the
1	practices that specify
1	reduce such hazard
1	subchapter. in prescribing
1	persons exemptsubsection (a)
1	within a safe
12	distributor, or dispenser
1	preceding -year periods.
1	interstate commerceeach person
2	optical isomer of
7	secretary shall identify
1	appropriate means, the
1	test costs, and
1	transferred
 
 379d5.
1	regulation to which
1	recommendations relating to
3	fee determined under
2	scientific, technical, regulatory,
1	(3) ris-based schedule
1	decide any issue
11	paid under subparagraph
1	indexed and all
1	advisory committee; report
2	public web site
2	compensation for an
1	accelerate innovation, and
1	
 865. smuggling
1	food sector of
15	exemption for a
1	
 
 153.
1	party shall amend
5	effective date described
1	
 
 379f.
1	physicians prescriptions under
1	provided in accordance
1	qualifying physician means
1	(i) in generalsubject
1	changed device. 
1	organizations, and the
1	requirements of each
1	approval and which
1	(d) activities to
1	respectively, of section
2	term essentially a
1	upon the lawful
2	controlled substances pursuant
1	threat justifying emergency
3	prevent adulteration of
2	secretary is directed
1	panel; (b) include
1	board may continue
1	racial minorities. such
1	psychotropic substances that
1	provide for expanded
1	sale, or purchase
1	fully corrected the
1	food, except where
1	(d) facsimile labeling;
1	voting member of
1	me. i further
1	facilities:  (a)
10	 (1) an
1	(3) amounts in
2	drug, or (e)
1	food and prevent
2	recipient of assistance
1	directly linked in
1	respecting a civil
1	animal surveillance program,
1	determine the fees
5	(i) except as
1	order shall continue
1	establishing such a
1	additional preventive controls
1	comment in accordance
3	 (1) at
1	section, except the
4	 (1) as
1	clause (ii) at
1	contributions the office
2	federal register, that
1	iii devices reclassified
1	1948, ch. 423,
1	cases where the
2	authorized person means
1	reportingthe secretary of
1	policy, shall coordinate
1	(or successor regulations)
3	facility located in
6	federal bureau of
1	detected using the
1	convictions of one
1	otherwise. the administrator
1	form; and (d)
2	determined not to
1	order for a
1	review the adequacy
2	comment, finding that
1	general an accreditation
5	18-day exclusivity period
1	requirements, as determined
2	manufacturing use only,
1	entered into by
1	30, 1974; $160,000,000
1	title of pharmacist,
1	item by a
1	antimicrobials to treat
3	report is submitted
1	care costs, hiv
1	publish, and update
1	term sterile drug
1	lif-sustaining, and intended
5	act upon such
1	utility of specific
1	training, or for
1	purchaser. (iii) the
1	report available to
1	substitution of another
1	risks involving the
1	fee and prior
1	august 1, 1986),
6	$5,000,000 if the
2	(3) any order
1	unavailable on such
1	operations as infertile
1	(2) voluntary service;
1	process actions under
2	agent authorized by
1	history.  (28)
1	made therefor, unless
3	information pursuant to
1	fed. reg. 4145341787
1	shall identify, clarify,
2	 (1) carry
1	prima facie showing
1	either in the
1	(2) no later
1	prohibit states from
1	(c) administration not
1	device, or other
1	360ee. grants and
1	unintentionally introduced; and
1	year. (2) limit
2	condemnation may be
1	5(b) of the
2	penalty imposed for
1	et seq.). (n)
1	pursuant to other
1	conduct a detailed
1	379j1. reauthorization; reporting
1	special clinical needs
1	demotion, discharge, suspension,
1	minorities, native americans
1	use without a
1	fined any amount
1	sponsors seeking designation
1	form that has
3	director shall establish
1	(m)(1) to manufacture
2	poultry products other
1	date to comply
3	database shall not
1	changes required by
1	date when facts
1	safety, that remain
1	(b) the names
1	negotiation or otherwise)
1	secretary less than
3	inquiry necessary to
1	data.  (7)
1	demand increase for
2	submissions. (f) development
1	problem, which, at
1	information detailing the
1	(ii) a device,
2	request.  (2)
1	step, or procedure
1	drug. (iii) to
1	procedures  (a)
2	timeliness of the
3	civil penalty imposed
1	subparagraph (b); and
1	manage the risk
1	times display on
3	august 27, 1958
1	offset ordinary and
1	applicant or requester
1	application at issue
1	(2), nothing in
1	379g(8) of this
1	permanent resident alien,
2	shall not select
1	matters considered in
1	rehabilitation program after
2	agencies to accomplish
2	pediatric therapeutics all
1	failure shall not
1	review divisions for
1	center in a
1	sought with respect
2	 (b) applicable
1	(xi) an assessment
1	equivalent products manufactured,
1	practitioners, or health
1	order conditionally approving
1	(iii), the transaction
1	subsection. (2) submissions
1	(1) the removal
1	production.  (d)
1	classification panel with
1	(b), and (i)
1	considered in violation
1	reinstated. (4) 
1	paragraph (2)(a)(vii)(iv), the
1	device and 1
2	unsafe in pediatric
2	appoint advisory committees
1	distribution.  (c)
1	upon notice any
2	designed to be
2	damage to an
1	(1). (b) 
2	balances for such
1	importation of tissue
1	design, composition, heating
1	prior fiscal years
1	information under any
1	350a, 350c, 350f(j),
1	exemption notwithstanding paragraph
1	activities in them
1	general, a regulated
3	effective for use
1	office under this
7	final regulation not
1	iii is required,
1	(a), that could
1	ch. 675, 403b,
1	funds.  (f)
1	establish production quotas
1	regulation prescribing conditions
1	subsection (f) and
1	assessments shall be
1	audits required by
1	subsection (a), during
1	including regulations prescribing
2	drug, as defined
1	individual patients. 
4	prior fiscal year.
1	investigations which must
1	agency; (d) provide
1	(bb) the wholesale
1	dispenser  (i)
2	submissions.  (10)
1	360eee(22) of this
1	transfer, distribute, import,
1	met 1 of
1	designated for that
1	essential, in the
1	prior fiscal year;
7	device and a
1	468. cost of
1	entry and destruction
2	also listed in
1	appropriate, enter into
1	source, including a
1	request for reprogramming
3	subsection.  (e)
1	provide the school
1	section, involving the
1	29, 1970, the
4	date by which
2	device, or to
1	estrogen, or such
1	related foodborne illness
1	include regular and
1	experience  (1)
1	300g1), the secretary
1	312.47 of title
1	public by 
1	chapter no box,
1	 (i) failure
4	state, local, territorial,
1	shall consider, with
1	proposed funding level;
1	potential benefit of
1	use in lung
1	allegations contained in
2	dismiss in accordance
1	child for the
1	therapy or respiratory
1	-ethy--piperidyl benzilate. (14)
1	complete the determinations
1	requirement under federal
1	known food safety
1	
 467f. federal
2	appropriate relief, including
1	testifies with the
2	application that receives
2	time limits prescribed
1	applies to all
1	ordered forfeited upon
2	listed drug for
2	health reasons based
1	nonprescription drugs, that
1	money penalties, including
1	records and audit
3	education program personnel
2	received a tentative
21	labeling of the
2	 (f) assessment
1	(4) notice respecting
1	outreach, media projects
1	whether such standards
1	pharmacy as it
1	together to purchase
1	status, and privileges
3	drug monograph system
1	paragraph.  (g)
2	(2) audit conducted
1	considered by him
2	truck stop or
2	order assessing a
1	(i) a state;
3	create a significant
1	rendered on and
1	(c) custody of
3	therefor; or if
1	taken under a
2	mandatory recall or
1	opinion of such
8	paragraph (3) for
1	relevant information, as
2	15, 1954, ch.
1	demand for, commonly
1	lists of candidates
1	marketing  (i)
1	disclosure to any
1	20 or more
1	world evidence; and
1	salts, or any
1	independent experts acceptable
1	device; and 
2	articles other than
2	 (4) report
1	seq.]. (b) examples
1	retail such a
1	identify other matters
1	agreed upon under
1	agency; (4) serve
1	(d) $129,339,949 for
2	 (1) purpose
2	enforce the requirements
1	505(c), 512, or
1	(1), a united
1	penalties: (1) except
1	state petition to
3	bovine blood product
1	proposed change and
1	(a) delivering, distributing,
1	diethylamide. (10) marihuana.
4	subsection (c). (b)
1	involved (independent of
1	coordination of relevant
1	allows a period
1	violated. the holder
1	credible information (as
1	thereof and are
1	person elects to
1	(11) phenobarbital. schedule
1	exception, or exemption
21	effectiveness of a
1	benefitfor the purposes
4	isomers; or (iv)
3	applicability  (1)
1	public safety, only
1	tribal drug enforcement
1	person. the written
1	dispense, conduct research
2	susceptibility information in
1	area are sharing
3	states government or
1	(e) an environmental
1	convention, of the
1	586a, as added
1	foundation a report
1	pediatric therapeutics within
2	drug; (ii) the
1	harbor pests, or
2	fiscal year (referred
2	conditions for destruction
1	processing operations and
3	deployment of narcotics
1	program; and (2)
1	request the state
6	united states olympic
1	requirement for approval
1	(lsd); (f) 400
1	list publicly available.
3	devices (a) general
1	program a state
3	standards under this
2	method is not
1	certain therapeutic categories
1	committee clerical and
2	upon application therefor,
1	appropriate, may request
1	administrator, at the
1	new zealand, switzerland,
4	may be disclosed
1	requests submitted under
1	poultry products inspected
1	disease or another
1	 (2) issues
1	secretary to allocate
1	appropriate. (d) use
1	drug control the
1	(3); or (ii)
1	consumers completion of
3	secretary and to
1	representatives. (
 

1	drug applications the
1	determining priorities for
2	clear detrimental effects
1	108; july 2,
1	 (viii) if
5	access to, or
1	 (e) immediate
1	importer shall perform
1	grant petitions for
1	1(100), 45 stat.
1	scienc-based; (c) not
1	denial described in
1	adulterated, misbranded, and
1	application is denied
1	(adjusted each year
1	persons accredited to
1	additive, file with
1	product).  (b)
1	modification of existing
1	granted under paragraph
2	article was inspected
1	actual drug shortages,
1	sharing of surveillance
1	title. while such
1	includes information related
12	class of tobacco
1	drug administration (hereinafter
1	advertisingthe secretary may
2	involves information classified
1	following findings: 
1	deny an eligibility
1	illegal drug cultivation
7	authority to assess
1	requested concerning an
2	considered for purposes
1	recall regulations and
1	words that would
1	remedy the patterns
2	trials (if any)
1	(4)(b); (ii) for
1	interest at the
1	authorization if such
1	authority under the
1	hearings instituted before
2	action shall be
1	360(k) report is
1	section. (b) 
1	plan to monitor
1	vessel for the
1	failure to comply.
1	government agencies. (xiii)
1	1 calendar day
1	action.  (j)
7	finished dosage form
3	whether the request
1	propose the issuance
7	second or subsequent
1	driven clinical trial
1	warning surveillance systems
1	nature, extent, and
1	receives training regarding
1	provide a framework
1	repackager shall, not
2	(1) administrator the
3	inspection, to any
8	approved after september
1	condition, and it
1	average, as determined
1	(a) is made
2	cause of action.
1	new drug applicationsexcept
4	projects under paragraph
5	4, 2011, and
2	regulation would be
1	offering the article
1	voucher awarded under
1	beyond those authorized
1	(1) and of
1	 (iii) exceptionthe
1	request information from
1	control over the
3	using improved analytical
1	application fee and
2	meat for export
1	radiological health regarding
1	specific disclosures 
1	restrictions herein imposed.
1	products in that
3	user fee shall
1	amendment to an
1	food prior to
1	restrictions adopted pursuant
2	guests and employees:
1	(a) the meat
1	reasonable promptness furnish
1	information clearinghouse to
2	 (1) who
1	
 353. exemptions
1	exhaustion of administrative
1	particular uses of
1	secretary may, notwithstanding
1	issues, pediatric ethics,
1	emit) such radiation;
1	induce another person
2	alignment of the
2	directly linked to
9	consists in whole
2	support the approval
1	remedy such defect
1	procedure on such
1	(5) no private
1	constituted committees and
1	(e) that1 does
1	technology.  (c)
5	device, or any
1	exporters if he
2	effects of such
1	drug submission of
1	application is in
2	device and of
1	(n) referral if
1	information demonstrating conformity
1	
 
 350g.
1	country in connection
1	proportion to confer
1	associated with pet
1	(a), and is
2	(2) any request
2	accredited to conduct
1	premarket approval.a device
2	issue involved. (e)
2	appropriate federal and
1	(i)in general.not later
1	applicable; enforcement 
2	based his order,
1	(i) issue or
1	years unless the
2	drug product if
1	completeness, coding, cleansing,
6	26, 2014, the
1	estimates of drug
2	(b) availability of
1	drug abuse. (6)
1	persons shall, for
1	data collection not
2	(a), and in
1	notice or update
1	source of funding.
1	reduce the likelihood
1	public hearing is
3	and/or cream is
1	laws and proceedings
1	chemical residue meeting
1	reports of audits
1	(6) qualified adul-only
1	1111 and 1112
1	requests. (d) a
1	matter that involves
1	protocol and all
1	immediately furnishing such
1	medical specialties or
2	activities as may
1	substance; (2) manage
1	tableting machines, all
1	patients.  (5)
1	revised, or eliminated.
1	360i, or 374
1	use, availability, and
1	application to contain
1	regulation. (c) notwithstanding
1	supplemental applications, or
2	applicant, or manufacturer
1	workload adjustments for
1	already operational as
1	holds the index
1	principal within the
3	distributor with respect
1	analytical procedures (including
1	discontinuance or interruption;
1	congressional committees, and
2	respect to articles
2	dollars, and the
1	 if a
1	
 611. devices,
1	personal consumption. (c)
1	privacy protections 
2	subjects involved; or
1	design, energy source,
2	appointment and compensation
2	(i) declaratory judgment
1	(1), (2), (5),
1	level, or other
1	1994 and does
1	(f) the development
1	subsection (l)(5). 
2	means inspection personnel
1	unnecessary duplication of
1	including the dispensing
1	aircraft to another
1	will occur in
5	failed to comply
1	systems, to facilitate
1	error, the requirements
1	appropriate.  (mar.
1	subject all employees,
1	manufacturers of devices,
1	enacted.  (ii)
2	-mail address for
1	bodies and auditors.
1	
 154a. special
1	customer or to
1	confidential information; (b)
1	clinical benefit; or
2	either the director
1	either separately or
1	means the 18-day
9	partners that the
1	persons initially appointed
1	(alone or through
2	used on a
1	supporting coordinated law
1	subparagraph (b); 
1	3-day period notifies
1	drug, the committee
1	(a), or the
1	 (b) activitiesin
3	(2), (3), and
1	agents thereof) that
1	chapter, or a
1	secretary may, without
1	procedure for updating
1	secretary prescribed under
2	criteria for priority
4	conditional approval shall
1	name, as defined
1	residue and other
1	statutes administered by
1	labeling would not
1	area; and (d)
1	reportson a biennial
1	sections 353(e), 360eee2,
1	establishments separate from
1	drugs. (i) other
1	regional drug trafficking
1	safety programs, especially
1	state prekindergarten program
1	upon these significant
2	administrator to examine
1	laboratory; (2) if
1	determine and set
1	petition, and provide
1	regulation was promulgated
1	even if the
1	transferred
 
 379r.
4	recognized, among experts
1	substances scheduled under
1	cosmetic condemned under
1	may require, pursuant
1	drug shall, upon
1	device 30 days
1	new drug until
1	sel-incrimination, to testify
2	section 101(4) of
1	otherwise identified, as
2	thereof, shall submit
1	person. subsection (b)
1	may include verification
1	food safety capacity
4	alteration of the
1	(g), or the
1	claimant has moved
1	make it a
1	wel-controlled investigations, specified
1	media campaign (a)
1	motion by a
2	operated in accordance
1	mea-inspection law may
2	procedures in the
1	reevaluated not less
1	review the statement
1	(2) the penalties
3	 (1) limitation
3	amenable species are
1	retrospective review and
5	applicant shall be
1	medicine and the
1	conducting the study
1	o-site technical assistance
1	incurred in developing
2	regulation relating to
2	manufacturer, or a
1	physical sign, or
13	tobacco product to
29	required by section
1	device submits to
1	incident to his
12	resources of the
1	group; or (b)
2	seller has submitted
1	designates a drug
4	appointed under section
1	(or any person
1	section. for such
1	secretary shall gather
2	database.  (e)
3	(by methods of
6	united states trade
1	animal drug; 
2	subsection (h). 
1	determined by a
1	credentials, certification by
1	determination of amount
1	furnish raw materials
12	(a) does not
2	secretary, in light
1	2012, at least
1	rare pediatric diseases
1	tolerances for eligible
1	known to such
1	submitted in support
1	(ii) a notice
1	otherwise recognizes the
2	imposed under section
1	give a claimant
1	notification, or recordkeeping
6	postmarket surveillance and
2	source, or other
2	regulation.  (g)
2	shall be dispensed
1	prescription order. (b)
1	regulations)) with respect
1	water which is
1	(iii) the value
1	 (4) content
1	(c)(1) and the
1	lif-threatening food allergies.
1	business to employ
2	data are necessary
3	product, a wholesale
1	(1) beginning 270
7	pursuant to subsections
9	otherwise identified as
1	security countermeasures; and
1	volume of a
5	(b) and (c),
1	section 356(g) of
1	drug, the -year
1	additive previously listed
4	product for a
1	delivery system; and
1	electronic logbook includes,
2	upon being resubmitted
4	nominees from the
1	article specified in
1	(2) if necessary,
2	registrant of the
1	distribute, sell, finance,
2	packing eggs for
1	secretarys judgment can
1	(2) impediments identified
1	states from an
1	serves the interest
1	herein for assuring
1	welfare recipients who
1	women and minorities
1	title who intentionally
1	subparagraph shall include
1	drug, chemical, poison,
2	paragraph (1)(e) refusing
3	secretary may, on
1	seq.] in response
1	drug administration guidance
1	rule on the
1	(k) bar on
4	 (2) effect
3	petition was submitted
1	supplements to biosimilar
1	(c) advisory committeethe
1	within such greater
1	prevented from entering
1	states and localities
1	person has acquired
1	export regulations; and
5	(b) is approved
1	drug so as
9	revoking a tolerance
1	them, (2) intended
1	delivery of, the
2	auditor means a
1	facility at which
1	 (6) limitation
3	1.8 grams of
1	health. such regulation
2	offenses involving 5
1	practitioner to begin
1	(3) the performance
1	information in, or
1	employees.  (

1	issue another license
1	foundation activities could
2	primary message intended
1	forfeitures under this
2	package that is
1	via at least
1	package that it
3	action under the
1	tobacco product consistent
1	stat. 1103; 

1	trading a drug
1	preventive control programs
1	industry as described
2	misbranded (a) false
4	federal regulations (as
1	isomers. (e) ecgonine,
1	wired cigarette papers;
2	264(c) of the
1	(8) carburetor pipes;
1	may conduct activities
1	facilities and progress
1	 in this
1	application is complete.
1	licensed to practice
1	violation of, as
1	(or an officer
1	section 355(j)(5)(b)(iv)(ii)(cc) of
1	notwithstanding a final
1	paragraph (1) made
1	identity under section
1	paragraph. (iii) such
3	(3) rule of
1	territory shall have
1	ch. 675, 513,
1	(c). (2) a
2	percent of food
1	corporate name, and
10	employee designated by
1	title i, 22,
2	request written recommendations
1	remove drugs subject
2	district courts, the
2	date a labeling
1	imports from each
1	persons and groups
3	refer the matter
2	september 30, 2013,
1	conference, the secretary
1	written request. 
1	foods, that is
1	united states department
1	paragraph.  (35)
1	fifteen miles of
1	(a). except as
1	sector contributions to
1	administration and is
8	necessary materials and
1	investigation in connection
1	1, 1990, and
3	denial, revocation, or
1	(a) the violation
1	upon a review
1	violates section 954
2	information after the
2	shall provide information
1	(2) the adverse
38	shall be in
2	less than 25
1	qualified (under standards
1	
 1103. repealed.
3	conditions relating to
1	proceeded against while
1	subsection.  (12)
1	lists of drugs,
1	age verification; and
2	355(c)(3)(e) of this
1	repackager shall verify
6	(5) the secretary
5	product development program
2	(1)(a), the secretary
1	term eligible countermeasure
3	standards of accreditation,
1	registration number, (b)
1	drug) if the
1	written clearance, or
2	quantities of product
1	cattle, horses, swine,
1	(a). (iii) not
2	result of investigations
1	modulates the function
1	(e) staff 
2	whether produced directly
1	control policy has
1	1543(a)(1) of this
1	letters in red
2	received, records, reports,
1	1891, as amended,
1	first biosimilar biological
1	(3) encouraging parents
1	information. (5) 
1	report for fiscal
1	goals using the
1	design modification creates
1	elderly. (13) effective
1	control, or mitigate
2	 (i) priority
1	(i) consider 
1	necessarily caused in
2	eliminate the risk
1	deemed, alone or
1	encourage such development
3	unduly burdensome on
2	centers and the
3	poultry products and
3	except under the
1	enumerated in paragraph
1	office shall, in
1	(a) an action
1	irritation on certain
1	united states. (f)
1	enforcement activities that
2	columbia, except that
1	illicit dru-related crime
2	finding imminent hazard
4	deemed available for
2	exercised with respect
1	whose behalf an
1	(b). (b) exemptions
8	request from the
5	unsafe for purposes
2	(c) invite appropriate
1	(a) manufactures, fabricates,
1	grant by letter
1	ris-based approach and
1	drug submission or
1	involves  (a)
2	information and coordinate
1	center or alternative
2	economic area. 
1	prior to may
5	sell at retail
2	official names by
1	register any waiver
1	requirements; (d) summarize
1	records, or to
5	reason of bearing
1	drug submission on
2	quantity of drug
1	compliance with each
1	subsection (d)(7)(a). (11)
1	program amounts for
3	information has not
1	perform testing as
1	classes that are
1	term milk, when
1	permitted, by the
1	dispensing of any
1	package insert for
1	user fees associated
1	(b)(i) shall include
1	individuals to eliminate
7	food and agriculture
1	representatives, in writing,
1	substance under section
1	submission without the
1	(iii) cleared product
1	2014; and (b)
1	(c) assessing the
1	members to execute
2	notifies the secretary
1	unauthorized reproduction of
2	accordance with rules
1	traffic. (7) the
1	provide final guidance
7	additive, color additive,
1	data); and (cc)
1	(b) the receipt
2	contain detailed information
1	determines that these
2	owner or consignee;
1	2013, a repackager
1	distribution that such
1	product prepared, sold,
2	perishable controlled substances
2	authorization under section
1	panel shall, subject
1	sanctions authorized under
1	(d) copies to
1	distributed to the
1	section 1541 of
1	distributors. such database
1	humans or of
1	(i) manufacturing, processing,
2	(j)(2)(a)(vii)(iii) of section
1	act for inspection
1	children to take
1	planned law enforcement
1	licensed individual under
1	ii to class
1	(2) in section
2	things therein (including
1	expiration of certificate
1	may be treated
1	many controlled substances
1	cosmetic to which
1	eliminate the need
6	secretary shall, after
2	limited to, knowingly
1	accelerated approval and
2	course of an
1	cost matches of
2	negotiated enforcement resolutions
2	(2) list of
1	measures available or
1	360(k), 360c(f)(2), and
1	(g) regulation of
1	(vi) -[-(-morpholinyl)ethyl--(-naphthoyl)indole (jwh200);
1	drug include 1
1	i-kind emergency disaster
1	subsection (n)(1)(g). the
1	rights or obligations
1	product (including a
1	rebuttable presumptionthere is
1	emergency situations 
1	title, or facility
1	expertise to provide
